PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sato, T; Mushiake, S; Kato, Y; Sato, K; Sato, M; Takeda, N; Ozono, K; Miki, K; Kubo, Y; Tsuji, A; Harada, R; Harada, A				Sato, Takashi; Mushiake, Sotaro; Kato, Yukio; Sato, Ken; Sato, Miyuki; Takeda, Naoki; Ozono, Keiichi; Miki, Kazunori; Kubo, Yoshiyuki; Tsuji, Akira; Harada, Reiko; Harada, Akihiro			The Rab8 GTPase regulates apical protein localization in intestinal cells	NATURE			English	Article							CONGENITAL MICROVILLOUS ATROPHY; BETA-LACTAM ANTIBIOTICS; EPITHELIAL-CELLS; MEMBRANE; MICE; ABSORPTION; MECHANISMS; TRANSPORT; POLARITY; NEURONS	A number of proteins are known to be involved in apical/basolateral transport of proteins in polarized epithelial cells(1-7). The small GTP-binding protein Rab(8) was thought to regulate basolateral transport in polarized kidney epithelial cells through the AP1B-complex-mediated pathway(8,9). However, the role of Rab8 (Rab8A) in cell polarity in vivo remains unknown. Here we show that Rab8 is responsible for the localization of apical proteins in intestinal epithelial cells. We found that apical peptidases and transporters localized to lysosomes in the small intestine of Rab8-deficient mice. Their mislocalization and degradation in lysosomes led to a marked reduction in the absorption rate of nutrients in the small intestine, and ultimately to death. Ultrastructurally, a shortening of apical microvilli, an increased number of enlarged lysosomes, and microvillus inclusions in the enterocytes were also observed. One microvillus inclusion disease patient who shows an identical phenotype to Rab8-deficient mice expresses a reduced amount of RAB8 (RAB8A; NM_005370). Our results demonstrate that Rab8 is necessary for the proper localization of apical proteins and the absorption and digestion of various nutrients in the small intestine.	Osaka Univ, Grad Sch Med, Dept Pediat, Suita, Osaka 5650871, Japan; Kanazawa Univ, Div Pharmaceut Sci, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; Kumamoto Univ, Div Transgen Technol, CARD, IRDA, Kumamoto 8600811, Japan; Itami Municipal Hosp, Dept Pediat, Itami, Hyogo 6648540, Japan	Osaka University; Kanazawa University; Kumamoto University	Harada, A (corresponding author), Gunma Univ, Lab Mol Traff, Dept Mol & Cellular Biol, Inst Mol & Cellular Regulat, Gunma 3718512, Japan.	aharada@showa.gunma-u.ac.jp	KATO, Yukio/D-8396-2015; Kubo, Yoshiyuki/Q-6069-2019; Sato, Miyuki/S-5112-2018	Sato, Miyuki/0000-0002-1944-4918; Kubo, Yoshiyuki/0000-0002-7905-5666				Ang AL, 2003, J CELL BIOL, V163, P339, DOI 10.1083/jcb.200307046; DAVIDSON GP, 1978, GASTROENTEROLOGY, V75, P783; Harada A, 2002, J CELL BIOL, V158, P541, DOI 10.1083/jcb.200110134; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; HARADA A, 1990, CELL STRUCT FUNCT, V15, P329, DOI 10.1247/csf.15.329; HOMAREDA H, 1993, FEBS LETT, V327, P99, DOI 10.1016/0014-5793(93)81048-5; HUBER LA, 1993, J CELL BIOL, V123, P35, DOI 10.1083/jcb.123.1.35; Ishida Y, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.24.e35; Kagitani K, 1998, J BONE MINER RES, V13, P1946, DOI 10.1359/jbmr.1998.13.12.1946; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; LOUVARD D, 1992, ANNU REV CELL BIOL, V8, P157, DOI 10.1146/annurev.cellbio.8.1.157; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; MATTER K, 1994, CURR OPIN CELL BIOL, V6, P545, DOI 10.1016/0955-0674(94)90075-2; Nakamura N, 2001, J BIOCHEM-TOKYO, V130, P765, DOI 10.1093/oxfordjournals.jbchem.a003047; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; PHILLIPS AD, 1985, ARCH DIS CHILD, V60, P135, DOI 10.1136/adc.60.2.135; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rodriguez-Boulan E, 2004, CURR OPIN CELL BIOL, V16, P436, DOI 10.1016/j.ceb.2004.06.013; Sabatini DD, 2005, ANNU REV CELL DEV BI, V21, P1, DOI 10.1146/annurev.cellbio.21.020904.151711; Saito H, 1995, J PHARMACOL EXP THER, V275, P1631; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Sasaki T, 2002, TRANSPLANTATION, V73, P560, DOI 10.1097/00007890-200202270-00013; Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261; Schuck S, 2004, J CELL SCI, V117, P5955, DOI 10.1242/jcs.01596; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Tamai I, 1997, J PHARM PHARMACOL, V49, P796, DOI 10.1111/j.2042-7158.1997.tb06115.x; UMESAKI Y, 1982, J BIOCHEM-TOKYO, V92, P373, DOI 10.1093/oxfordjournals.jbchem.a133943; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	28	239	245	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2007	448	7151					366	369		10.1038/nature05929	http://dx.doi.org/10.1038/nature05929			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17597763				2022-12-01	WOS:000248118300061
J	Lyerly, AD; Faden, RR				Lyerly, Anne Drapkin; Faden, Ruth R.			Embryonic stem cells - Willingness to donate frozen embryos for stem cell research	SCIENCE			English	Editorial Material							COUPLES DECISIONS; ATTITUDES		Duke Univ, Med Ctr, Durham, NC 27710 USA; Johns Hopkins Berman Inst Bioeth, Baltimore, MD 21205 USA	Duke University; Johns Hopkins University	Lyerly, AD (corresponding author), Duke Univ, Med Ctr, Durham, NC 27710 USA.	lyerl003@mc.duke.edu		Lyerly, Anne/0000-0003-2211-6920	NHLBI NIH HHS [K01 HL79517-01] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BRIDGES A, 2007, WASHINGTON POST 0319; Burton PJ, 2004, MED J AUSTRALIA, V180, P559, DOI 10.5694/j.1326-5377.2004.tb06091.x; Choudhary M, 2004, HUM REPROD, V19, P2091, DOI 10.1093/humrep/deh401; de Lacey S, 2005, HUM REPROD, V20, P1661, DOI 10.1093/humrep/deh831; Hammarberg K, 2006, FERTIL STERIL, V86, P86, DOI 10.1016/j.fertnstert.2005.11.071; Hoffman DI, 2003, FERTIL STERIL, V79, P1063, DOI 10.1016/S0015-0282(03)00172-9; HUDSON K, 2005, VALUES CONFLICT PUBL; LARUELLE C, 1995, FERTIL STERIL, V63, P1047, DOI 10.1016/S0015-0282(16)57546-3; Lyerly AD, 2006, FERTIL STERIL, V85, P1623, DOI 10.1016/j.fertnstert.2005.11.056; McMahon CA, 2003, HUM REPROD, V18, P871, DOI 10.1093/humrep/deg167; Van Voorhis BJ, 1999, FERTIL STERIL, V71, P604, DOI 10.1016/S0015-0282(98)00545-7; 2006, PRESIDENT DISCUSSES	12	39	39	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2007	317	5834					46	47		10.1126/science.1145067	http://dx.doi.org/10.1126/science.1145067			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186KD	17588897				2022-12-01	WOS:000247776700030
J	Carlton, JG; Martin-Serrano, J				Carlton, Jez G.; Martin-Serrano, Juan			Parallels between cytokinesis and retroviral budding: A role for the ESCRT machinery	SCIENCE			English	Article							PROTEIN; TSG101; MIDBODY; REVEALS; NETWORK; MECHANISMS; ABSCISSION; COMPLEXES; DOMAINS; CEP55	During cytokinesis, as dividing animal cells pull apart into two daughter cells, the final stage, termed abscission, requires breakage of the midbody, a thin membranous stalk connecting the daughter cells. This membrane fission event topologically resembles the budding of viruses, such as HIV-1, from infected cells. We found that two proteins involved in HIV-1 budding-tumor susceptibility gene 101 (Tsg101), a subunit of the endosomal sorting complex required for transport I (ESCRT-I), and Alix, an ESCRT-associated protein-were recruited to the midbody during cytokinesis by interaction with centrosome protein 55 (Cep55), a centrosome and midbody protein essential for abscission. Tsg101, Alix, and possibly other components of ESCRT-I were required for the completion of cytokinesis. Thus, HIV-1 budding and cytokinesis use a similar subset of cellular components to carry out topologically similar membrane fission events.	Kings Coll London, Sch Med, Dept Infect Dis, London, England	University of London; King's College London	Martin-Serrano, J (corresponding author), Kings Coll London, Sch Med, Dept Infect Dis, London, England.	juan.martin_serrano@kcl.ac.uk	Carlton, Jeremy/X-2918-2019; Carlton, Jeremy/C-7702-2014	Carlton, Jeremy/0000-0002-7255-1894; Martin-Serrano, Juan/0000-0002-8183-3914	MRC [G0400207] Funding Source: UKRI; Medical Research Council [G0400207] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Albertson R, 2005, TRENDS CELL BIOL, V15, P92, DOI 10.1016/j.tcb.2004.12.008; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Jantsch-Plunger V, 1999, CURR BIOL, V9, P738, DOI 10.1016/S0960-9822(99)80333-9; Krempler A, 2002, J BIOL CHEM, V277, P43216, DOI 10.1074/jbc.M207662200; Low SH, 2003, DEV CELL, V4, P753, DOI 10.1016/S1534-5807(03)00122-9; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Martin-Serrano J, 2003, J VIROL, V77, P4794, DOI 10.1128/JVI.77.8.4794-4804.2003; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Pornillos O, 2002, EMBO J, V21, P2397, DOI 10.1093/emboj/21.10.2397; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruland J, 2001, P NATL ACAD SCI USA, V98, P1859, DOI 10.1073/pnas.98.4.1859; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Spitzer C, 2006, DEVELOPMENT, V133, P4679, DOI 10.1242/dev.02654; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Welsch S, 2006, TRAFFIC, V7, P1551, DOI 10.1111/j.1600-0854.2006.00489.x; Xie WQ, 1998, P NATL ACAD SCI USA, V95, P1595, DOI 10.1073/pnas.95.4.1595; Zhao WM, 2006, MOL BIOL CELL, V17, P3881, DOI 10.1091/mbc.E06-01-0015	26	533	543	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2007	316	5833					1908	1912		10.1126/science.1143422	http://dx.doi.org/10.1126/science.1143422			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183WI	17556548	Green Submitted			2022-12-01	WOS:000247602700043
J	Linding, R; Jensen, LJ; Ostheimer, GJ; van Vugt, MATM; Jorgensen, C; Miron, IM; Diella, F; Colwill, K; Taylor, L; Elder, K; Metalnikov, P; Nguyen, V; Pasculescu, A; Jin, J; Park, JG; Samson, LD; Woodgett, JR; Russell, RB; Bork, P; Yaffe, MB; Pawson, T				Linding, Rune; Jensen, Lars Juhl; Ostheimer, Gerard J.; van Vugt, Marcel A. T. M.; Jorgensen, Claus; MIron, Ioana M.; Diella, Francesca; Colwill, Karen; Taylor, Lorne; Elder, Kelly; Metalnikov, Pavel; Nguyen, Vivian; Pasculescu, Adrian; Jin, Jing; Park, Jin Gyoon; Samson, Leona D.; Woodgett, James R.; Russell, Robert B.; Bork, Peer; Yaffe, Michael B.; Pawson, Tony			Systematic discovery of in vivo phosphorylation networks	CELL			English	Article							DNA-DAMAGE RESPONSE; SPECTROMETRY-BASED PROTEOMICS; MASS-SPECTROMETRY; PROTEIN-PHOSPHORYLATION; EUKARYOTIC PROTEINS; SIGNALING NETWORKS; KINASE; 53BP1; ATM; ACTIVATION	Protein kinases control cellular decision processes by phosphorylating specific substrates. Thousands of in vivo phosphorylation sites have been identified, mostly by proteome-wide mapping. However, systematically matching these sites to specific kinases is presently infeasible, due to limited specificity of consensus motifs, and the influence of contextual factors, such as protein scaffolds, localization, and expression, on cellular substrate specificity. We have developed an approach ( NetworKIN) that augments motif-based predictions with the network context of kinases and phosphoproteins. The latter provides 60%-80% of the computational capability to assign in vivo substrate specificity. NetworKIN pinpoints kinases responsible for specific phosphorylations and yields a 2.5-fold improvement in the accuracy with which phosphorylation networks can be constructed. Applying this approach to DNA damage signaling, we show that 53BP1 and Rad50 are phosphorylated by CDK1 and ATM, respectively. We describe a scalable strategy to evaluate predictions, which suggests that BCLAF1 is a GSK-3 substrate.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; MIT, Ctr Canc Res, Cambridge, MA 02139 USA; European Mol Biol Lab, Heidelberg, Germany; MIT, Ctr Environm Hlth Sci, Cambridge, MA 02139 USA; Erasmus Univ, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands; Max Delbruck Ctr Mol Med, Berlin, Germany	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Massachusetts Institute of Technology (MIT); European Molecular Biology Laboratory (EMBL); Massachusetts Institute of Technology (MIT); Erasmus University Rotterdam; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Linding, R (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	linding@mshri.on.ca; bork@embl.de; myaffe@mit.edu; pawson@mshri.on.ca	Russell, Rob/AAH-9145-2019; Woodgett, Jim/F-1087-2010; Pawson, Tony J/E-4578-2013; Jensen, Lars Juhl/C-6492-2008; Colwill, Karen/K-5101-2012; Bork, Peer/F-1813-2013; Russell, Robert/GWU-6389-2022	Russell, Rob/0000-0002-1905-4717; Woodgett, Jim/0000-0003-3731-5797; Jensen, Lars Juhl/0000-0001-7885-715X; Colwill, Karen/0000-0002-8979-1659; Bork, Peer/0000-0002-2627-833X; Russell, Robert/0000-0002-7213-1398; Jorgensen, Claus/0000-0002-7841-943X; Linding, Rune/0000-0003-0420-4839; Metalnikov, Pavel/0000-0003-3261-4421	Canadian Institutes of Health Research [12043] Funding Source: Medline; NCI NIH HHS [U54-CA112967-03, U54 CA112967, U54 CA112967-03] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U54CA112967] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Aloy P, 2002, TRENDS BIOCHEM SCI, V27, P633, DOI 10.1016/S0968-0004(02)02204-1; Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Bullock AN, 2005, J BIOL CHEM, V280, P41675, DOI 10.1074/jbc.M510711200; Chen PL, 2005, MOL CELL BIOL, V25, P3535, DOI 10.1128/MCB.25.9.3535-3542.2005; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Foster LJ, 2006, CELL, V125, P187, DOI 10.1016/j.cell.2006.03.022; Hjerrild M, 2004, J PROTEOME RES, V3, P426, DOI 10.1021/pr0341033; HOUTHAEVE T, 1995, FEBS LETT, V376, P91, DOI 10.1016/0014-5793(95)01242-7; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Kamer I, 2005, CELL, V122, P593, DOI 10.1016/j.cell.2005.06.014; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kasof GM, 1999, MOL CELL BIOL, V19, P4390; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mizukami Y, 1997, J BIOL CHEM, V272, P16657, DOI 10.1074/jbc.272.26.16657; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Rashi-Elkeles S, 2006, ONCOGENE, V25, P1584, DOI 10.1038/sj.onc.1209189; Remenyi A, 2005, MOL CELL, V20, P951, DOI 10.1016/j.molcel.2005.10.030; Saric J, 2006, BIOINFORMATICS, V22, P645, DOI 10.1093/bioinformatics/bti597; Schmezle K, 2006, CURR OPIN BIOTECH, V17, P406, DOI 10.1016/j.copbio.2006.06.004; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Takemoto A, 2004, J BIOL CHEM, V279, P4551, DOI 10.1074/jbc.M310925200; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Wang Y, 2000, GENE DEV, V14, P927; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Whitmarsh AJ, 2001, GENE DEV, V15, P2421, DOI 10.1101/gad.922801; Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Zinkel SS, 2005, CELL, V122, P579, DOI 10.1016/j.cell.2005.06.022	46	579	601	0	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 29	2007	129	7					1415	1426		10.1016/j.cell.2007.05.052	http://dx.doi.org/10.1016/j.cell.2007.05.052			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	188HQ	17570479	Bronze, Green Accepted			2022-12-01	WOS:000247911400025
J	Perrin, JM; Bloom, SR; Gortmaker, SL				Perrin, James M.; Bloom, Sheila R.; Gortmaker, Steven L.			The increase of childhood chronic conditions in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							YOUNG ADULTHOOD; CHILDREN; OBESITY; PREVALENCE; OVERWEIGHT; ASTHMA; ADOLESCENTS; DISABILITY; DISORDERS; TRENDS		MassGen Hosp Children, Ctr Child & Adolescent Hlth Policy, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Perrin, JM (corresponding author), MassGen Hosp Children, Ctr Child & Adolescent Hlth Policy, 50 Staniford St,Suite 901, Boston, MA 02114 USA.	jperrin@partners.org		Perrin, James/0000-0002-1810-3708	PHS HHS [U 53 MC 04473, U48/CCU115807] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		American Psychiatric Association, 1968, DIAGN STAT MAN MENT; [Anonymous], 2006, ADV DATA; Biederman J, 2005, LANCET, V366, P237, DOI 10.1016/S0140-6736(05)66915-2; Christakis DA, 2004, PEDIATRICS, V113, P708, DOI 10.1542/peds.113.4.708; Costello EJ, 2006, J CHILD PSYCHOL PSYC, V47, P1263, DOI 10.1111/j.1469-7610.2006.01682.x; Dietz WH, 2001, ANNU REV PUBL HEALTH, V22, P337, DOI 10.1146/annurev.publhealth.22.1.337; Fischer M, 2002, J ABNORM CHILD PSYCH, V30, P463, DOI 10.1023/A:1019864813776; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; Gold DR, 2005, ANNU REV PUBL HEALTH, V26, P89, DOI 10.1146/annurev.publhealth.26.021304.144528; GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406; GORTMAKER SL, 1984, PEDIATR CLIN N AM, V31, P3; GREEN M, 1999, DIAGNOSIS ATTENTION, V3; Koplan J.P., 2005, PREVENTING CHILDHOOD; *NAT COMM CHILDH D, 1995, SUPPL SEC INC CHILDR; National Center for Health Statistics, 2006, HLTH US CHARTB TREND; NEWACHECK PW, 1984, AM J PUBLIC HEALTH, V74, P232, DOI 10.2105/AJPH.74.3.232; Newacheck PW, 2000, ARCH PEDIAT ADOL MED, V154, P287, DOI 10.1001/archpedi.154.3.287; Newacheck PW, 1998, PEDIATRICS, V102, P117, DOI 10.1542/peds.102.1.117; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; *SOC SEC ADM, 2005, CHILDR REC SSI; US Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; von Kries R, 2002, AM J EPIDEMIOL, V156, P954, DOI 10.1093/aje/kwf128; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; WHO, INT CLASS FUNCT DIS	25	336	344	1	21	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2007	297	24					2755	2759		10.1001/jama.297.24.2755	http://dx.doi.org/10.1001/jama.297.24.2755			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	182UE	17595277				2022-12-01	WOS:000247528700026
J	Mann, DL				Mann, Douglas L.			MicroRNAs and the failing heart	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FAILURE		Baylor Coll Med, Winters Ctr Heart Failure Res, Houston, TX 77030 USA; St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX USA	Baylor College of Medicine; Saint Lukes Episcopal Hospital; Texas Heart Institute	Mann, DL (corresponding author), Baylor Coll Med, Winters Ctr Heart Failure Res, Houston, TX 77030 USA.		Mann, Douglas Lowell/AAQ-3524-2021	Mann, Douglas/0000-0002-2516-0145				JACKSON RJ, 2007, SCI STKE, V367, pRE1, DOI DOI 10.1126/STKE.3672007RE1; Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546; MANN DL, 2005, CIRCULATION, V112, pE75; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103	5	42	46	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 21	2007	356	25					2644	2645		10.1056/NEJMcibr072068	http://dx.doi.org/10.1056/NEJMcibr072068			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180GN	17582077				2022-12-01	WOS:000247351200014
J	North, TE; Goessling, W; Walkley, CR; Lengerke, C; Kopani, KR; Lord, AM; Weber, GJ; Bowman, TV; Jang, IH; Grosser, T; FitzGerald, GA; Daley, GQ; Orkin, SH; Zon, LI				North, Trista E.; Goessling, Wolfram; Walkley, Carl R.; Lengerke, Claudia; Kopani, Kamden R.; Lord, Allegra M.; Weber, Gerhard J.; Bowman, Teresa V.; Jang, Il-Ho; Grosser, Tilo; FitzGerald, Garret A.; Daley, George Q.; Orkin, Stuart H.; Zon, Leonard I.			Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis	NATURE			English	Article							ZEBRAFISH; EXPRESSION; MICE; CYCLOOXYGENASE-2; TRANSPLANTATION; EMBRYO; BLOOD; STAT5; RUNX1	Haematopoietic stem cell (HSC) homeostasis is tightly controlled by growth factors, signalling molecules and transcription factors. Definitive HSCs derived during embryogenesis in the aorta gonad - mesonephros region subsequently colonize fetal and adult haematopoietic organs(1,2). To identify new modulators of HSC formation and homeostasis, a panel of biologically active compounds was screened for effects on stem cell induction in the zebrafish aorta - gonad - mesonephros region. Here, we show that chemicals that enhance prostaglandin ( PG) E2 synthesis increased HSC numbers, and those that block prostaglandin synthesis decreased stem cell numbers. The cyclooxygenases responsible for PGE2 synthesis were required for HSC formation. A stable derivative of PGE2 improved kidney marrow recovery following irradiation injury in the adult zebrafish. In murine embryonic stem cell differentiation assays, PGE2 caused amplification of multipotent progenitors. Furthermore, ex vivo exposure to stabilized PGE2 enhanced spleen colony forming units at day 12 post transplant and increased the frequency of long-term repopulating HSCs present in murine bone marrow after limiting dilution competitive transplantation. The conserved role for PGE2 in the regulation of vertebrate HSC homeostasis indicates that modulation of the prostaglandin pathway may facilitate expansion of HSC number for therapeutic purposes.	Harvard Univ, Sch Med, Childrens Hosp, Div Hematol Oncol,Harvard Stem Cell Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Stem Cell Program, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; University of Pennsylvania; Pennsylvania Medicine	Zon, LI (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Div Hematol Oncol,Harvard Stem Cell Inst, Boston, MA 02115 USA.	zon@enders.tch.harvard.edu	Walkley, Carl/AAO-6021-2020; FitzGerald, Garret A/A-4222-2010; Grosser, Tilo/A-1057-2007; North, Trista/ABG-4789-2020; Lengerke, Claudia/AAV-8745-2021	Walkley, Carl/0000-0002-4784-9031; Grosser, Tilo/0000-0001-8569-8396; North, Trista/0000-0003-1249-563X; Lengerke, Claudia/0000-0001-5442-2805; Jang, Il Ho/0000-0002-0820-3035; Goessling, Wolfram/0000-0001-9972-1569	NHLBI NIH HHS [R01 HL048801, R01 HL048801-16] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048801] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; Boer AK, 2002, BLOOD, V100, P467, DOI 10.1182/blood.V100.2.467; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; CAYEUX SJ, 1993, BONE MARROW TRANSPL, V12, P603; Cha YI, 2006, GENE DEV, V20, P77, DOI 10.1101/gad.1374506; Cha YI, 2005, DEV BIOL, V282, P274, DOI 10.1016/j.ydbio.2005.03.014; Dzierzak E, 2005, CURR OPIN HEMATOL, V12, P197, DOI 10.1097/01.moh.0000160736.44726.0e; FEHER I, 1974, NATURE, V247, P550, DOI 10.1038/247550a0; Galloway JL, 2003, CURR TOP DEV BIOL, V53, P139, DOI 10.1016/S0070-2153(03)53004-6; Grosser T, 2002, P NATL ACAD SCI USA, V99, P8418, DOI 10.1073/pnas.112217799; HERTELENDY F, 1973, PROSTAG OTH LIPID M, V3, P223, DOI 10.1016/0090-6980(73)90090-7; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kalev-Zylinska ML, 2002, DEVELOPMENT, V129, P2015; Kyba M, 2003, P NATL ACAD SCI USA, V100, P11904, DOI 10.1073/pnas.1734140100; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; Langenbach R, 1999, BIOCHEM PHARMACOL, V58, P1237, DOI 10.1016/S0006-2952(99)00158-6; Lorenz M, 1999, EXP HEMATOL, V27, P1494, DOI 10.1016/S0301-472X(99)00087-9; Mukouyama YS, 1999, CURR BIOL, V9, P833, DOI 10.1016/S0960-9822(99)80368-6; Nakano T, 1996, SCIENCE, V272, P722, DOI 10.1126/science.272.5262.722; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Pini B, 2005, ARTERIOSCL THROM VAS, V25, P315, DOI 10.1161/01.ATV.0000152355.97808.10; Rocca B, 2002, P NATL ACAD SCI USA, V99, P7634, DOI 10.1073/pnas.112202999; Talosi G, 2004, J PERINAT MED, V32, P368, DOI 10.1515/JPM.2004.069; THANOPOULOS BD, 1987, EUR J PEDIATR, V146, P279, DOI 10.1007/BF00716473; Traver D, 2004, BLOOD, V104, P1298, DOI 10.1182/blood-2004-01-0100; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; Weber GJ, 2005, BLOOD, V106, P521, DOI 10.1182/blood-2004-11-4541; Zhang CC, 2004, BLOOD, V103, P2513, DOI 10.1182/blood-2003-08-2955; Zhu H, 2005, DEV BIOL, V281, P256, DOI 10.1016/j.ydbio.2005.01.034	30	846	912	3	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2007	447	7147					1007	U7		10.1038/nature05883	http://dx.doi.org/10.1038/nature05883			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180NU	17581586	Green Accepted			2022-12-01	WOS:000247373100048
J	Yool, A; Martin, AP; Fernandez, C; Clark, DR				Yool, Andrew; Martin, Adrian P.; Fernandez, Camila; Clark, Darren R.			The significance of nitrification for oceanic new production	NATURE			English	Article							MARINE NITRIFYING BACTERIA; ORGANIC NITROGEN; NITRATE; NITRITE; RATES; PHOTOINHIBITION; AMMONIUM; PACIFIC; CARBON; CYCLE	The flux of organic material sinking to depth is a major control on the inventory of carbon in the ocean(1). To first order, the oceanic system is at equilibrium such that what goes down must come up(2). Because the export flux is difficult to measure directly, it is routinely estimated indirectly by quantifying the amount of phytoplankton growth, or primary production, fuelled by the upward flux of nitrate(3). To do so it is necessary to take into account other sources of biologically available nitrogen. However, the generation of nitrate by nitrification in surface waters has only recently received attention. Here we perform the first synthesis of open-ocean measurements of the specific rate of surface nitrification(4-12) and use these to configure a global biogeochemical model(13,14) to quantify the global role of nitrification. We show that for much of the world ocean a substantial fraction of the nitrate taken up is generated through recent nitrification near the surface. At the global scale, nitrification accounts for about half of the nitrate consumed by growing phytoplankton. A consequence is that many previous attempts to quantify marine carbon export, particularly those based on inappropriate use of the f-ratio ( a measure of the efficiency of the 'biological pump'), are significant overestimates.	Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; Ctr Oceanol Marseille, Lab Oceanog & Biogeochim, F-13288 Marseille, France; Univ Concepcion, Dept Oceanog, Lab Proc Oceanog & Clima, Concepcion, Chile; Univ Concepcion, Ctr Invest Oceanog Pacifico Sur Oriental, Concepcion, Chile; Plymouth Marine Lab, Plymouth PL1 3DH, Devon, England	NERC National Oceanography Centre; Universidad de Concepcion; Universidad de Concepcion; Plymouth Marine Laboratory	Yool, A (corresponding author), Natl Oceanog Ctr, European Way, Southampton SO14 3ZH, Hants, England.	axy@noc.soton.ac.uk	Yool, Andrew/B-4799-2012; Fernandez, Camila/F-6938-2010	Yool, Andrew/0000-0002-9879-2776; /0000-0002-8492-5881	NERC [soc010008, pml010002, pml010001] Funding Source: UKRI; Natural Environment Research Council [soc010008, NER/O/S/2001/00680, NE/C00387X/1, pml010002, pml010001] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Allen AE, 2002, J MARINE SYST, V38, P93, DOI 10.1016/S0924-7963(02)00171-9; Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; Bianchi M, 1997, DEEP-SEA RES PT II, V44, P1017, DOI 10.1016/S0967-0645(96)00109-9; Clark DR, 2007, MAR CHEM, V103, P84, DOI 10.1016/j.marchem.2006.06.005; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Diaz F, 2000, MAR ECOL PROG SER, V197, P51, DOI 10.3354/meps197051; Dore JE, 1996, LIMNOL OCEANOGR, V41, P1619, DOI 10.4319/lo.1996.41.8.1619; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; EPPLEY RW, 1979, NATURE, V282, P677, DOI 10.1038/282677a0; Fernandez C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002616; FERNANDEZ C, 2003, THESIS U MEDITERRANE; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Guerrero MA, 1996, MAR ECOL PROG SER, V141, P183, DOI 10.3354/meps141183; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; Lipschultz F, 2001, DEEP-SEA RES PT II, V48, P1897, DOI 10.1016/S0967-0645(00)00168-5; Marsh R, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022281; Martin AP, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002608; MIYAZAKI T, 1975, MAR SCI COMMUN, V1, P381; OLSON RJ, 1981, J MAR RES, V39, P203; OLSON RJ, 1981, J MAR RES, V39, P227; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Oschlies A, 2001, GEOPHYS RES LETT, V28, P1751, DOI 10.1029/2000GL012328; Raimbault P, 1999, J GEOPHYS RES-OCEANS, V104, P3341, DOI 10.1029/1998JC900004; Raven JA, 1999, PLANT CELL ENVIRON, V22, P741, DOI 10.1046/j.1365-3040.1999.00419.x; SLAWYK G, 1995, MAR ECOL PROG SER, V124, P289, DOI 10.3354/meps124289; Sutka RL, 2004, GEOCHIM COSMOCHIM AC, V68, P517, DOI 10.1016/S0016-7037(03)00483-6; Takahashi T, 2002, DEEP-SEA RES PT II, V49, P1601, DOI 10.1016/S0967-0645(02)00003-6; WARD BB, 1989, LIMNOL OCEANOGR, V34, P493, DOI 10.4319/lo.1989.34.3.0493; Ward BB, 2005, MAR ECOL PROG SER, V292, P97, DOI 10.3354/meps292097; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103	30	293	301	3	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2007	447	7147					999	1002		10.1038/nature05885	http://dx.doi.org/10.1038/nature05885			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180NU	17581584				2022-12-01	WOS:000247373100046
J	Kruhlak, M; Crouch, EE; Orlov, M; Montano, C; Gorski, SA; Nussenzweig, A; Misteli, T; Phair, RD; Casellas, R				Kruhlak, Michael; Crouch, Elizabeth E.; Orlov, Marika; Montano, Carolina; Gorski, Stanislaw A.; Nussenzweig, Andre; Misteli, Tom; Phair, Robert D.; Casellas, Rafael			The ATM repair pathway inhibits RNA polymerase I transcription in response to chromosome breaks	NATURE			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE; CELLS; PHOSPHORYLATION; COMPONENTS; NUCLEOLUS; STRESS; GENOME; KINASE; VIVO	DNA lesions interfere with DNA and RNA polymerase activity. Cyclobutane pyrimidine dimers and photoproducts generated by ultraviolet irradiation cause stalling of RNA polymerase II, activation of transcription-coupled repair enzymes, and inhibition of RNA synthesis(1,2). During the S phase of the cell cycle, collision of replication forks with damaged DNA blocks ongoing DNA replication while also triggering a biochemical signal that suppresses the firing of distant origins of replication(3,4). Whether the transcription machinery is affected by the presence of DNA double-strand breaks remains a long-standing question. Here we monitor RNA polymerase I ( Pol I) activity in mouse cells exposed to genotoxic stress and show that induction of DNA breaks leads to a transient repression in Pol I transcription. Surprisingly, we find Pol I inhibition is not itself the direct result of DNA damage but is mediated by ATM kinase activity and the repair factor proteins NBS1 ( also known as NLRP2) and MDC1. Using live-cell imaging, laser micro-irradiation, and photobleaching technology we demonstrate that DNA lesions interfere with Pol I initiation complex assembly and lead to a premature displacement of elongating holoenzymes from ribosomal DNA. Our data reveal a novel ATM/NBS1/MDC1-dependent pathway that shuts down ribosomal gene transcription in response to chromosome breaks.	NIAMS, NIH, Bethesda, MD 20892 USA; NCI, NIH, Bethesda, MD 20892 USA; Integrat Bioinformat, Los Altos, CA 94024 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Casellas, R (corresponding author), NIAMS, NIH, Bethesda, MD 20892 USA.	casellar@mail.nih.gov		Gorski, Stan/0000-0003-0539-3395; Crouch, Elizabeth/0000-0002-4110-9892; Montano, Carolina/0000-0002-2772-2025; Orlov, Marika/0000-0003-1961-0813	NATIONAL CANCER INSTITUTE [ZIABC010309, ZIABC010283, Z01BC010283, Z01BC010309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041149, Z01AR041149] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Chen DY, 2001, J CELL BIOL, V153, P169, DOI 10.1083/jcb.153.1.169; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Dundr M, 2002, SCIENCE, V298, P1623, DOI 10.1126/science.1076164; Hanawalt PC, 2002, ONCOGENE, V21, P8949, DOI 10.1038/sj.onc.1206096; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kleiman FE, 2005, GENE DEV, V19, P1227, DOI 10.1101/gad.1309505; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Mari PO, 2006, P NATL ACAD SCI USA, V103, P18597, DOI 10.1073/pnas.0609061103; Mayer C, 2005, CELL CYCLE, V4, P1036, DOI 10.4161/cc.4.8.1925; Mayer C, 2005, GENE DEV, V19, P933, DOI 10.1101/gad.333205; MAYNE LV, 1982, CANCER RES, V42, P1473; Michaelidis TM, 2002, BIOL CHEM, V383, P1683, DOI 10.1515/BC.2002.189; Mone MJ, 2001, EMBO REP, V2, P1013, DOI 10.1093/embo-reports/kve224; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Olson Mark O J, 2004, Sci STKE, V2004, ppe10; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Seither P, 1997, MOL GEN GENET, V255, P180, DOI 10.1007/s004380050487; Shav-Tal Y, 2005, MOL BIOL CELL, V16, P2395, DOI 10.1091/mbc.E04-11-0992; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stefanovsky V, 2006, MOL CELL, V21, P629, DOI 10.1016/j.molcel.2006.01.023	22	214	219	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2007	447	7145					730	U16		10.1038/nature05842	http://dx.doi.org/10.1038/nature05842			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554310				2022-12-01	WOS:000247030700047
J	Haag, AL				Haag, Amanda Leigh			Algae bloom again	NATURE			English	News Item																			0	73	86	3	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2007	447	7144					520	521		10.1038/447520a	http://dx.doi.org/10.1038/447520a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17538590				2022-12-01	WOS:000246842000013
J	Buhler, M; Haas, W; Gygi, SP; Moazed, D				Buehler, Marc; Haas, Wilhelm; Gygi, Steven P.; Moazed, Danesh			RNAi-dependent and -independent RNA turnover mechanisms contribute to heterochromatic gene silencing	CELL			English	Article							FISSION YEAST; EPIGENETIC CONTROL; LYSINE-9 METHYLATION; POLY(A) POLYMERASE; QUALITY-CONTROL; MESSENGER-RNAS; COMPLEX; INTERFERENCE; PROTEIN; RITS	In fission yeast, the RNAi pathway is required for heterochromatin-dependent silencing of transgene insertions at centromeric repeats and acts together with other pathways to silence transgenes at the silent mating-type locus. Here, we show that transgene transcripts at centromeric repeats are processed into siRNAs and are therefore direct targets of RNAL Furthermore, we show that Cid14, a member of the Trf4/5 family of poly(A) polymerases, has poly(A) polymerase activity that is required for heterochromatic gene silencing. Surprisingly, while siRNA levels in cid14 Delta cells are dramatically reduced, the structural integrity of heterochromatin appears to be preserved. Cid14 resides in a complex similar to the TRAMP complex found in budding yeast, which is part of a nuclear surveillance mechanism that degrades aberrant transcripts. Our findings indicate that polyadenylation by a TRAMP-like complex contributes to robust silencing of heterochromatic genes in fission yeast via the recruitment of the exosome and/or the RNAi machinery.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Moazed, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	danesh@hms.harvard.edu	Buehler, Marc/S-5866-2019; Bühler, Marc/B-1134-2010	Buehler, Marc/0000-0001-6661-9795; Bühler, Marc/0000-0001-6661-9795				Alen C, 2002, MOL CELL, V10, P1441, DOI 10.1016/S1097-2765(02)00778-5; ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bjerling P, 2002, MOL CELL BIOL, V22, P2170, DOI 10.1128/MCB.22.7.2170-2181.2002; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Buker SM, 2007, NAT STRUCT MOL BIOL, V14, P200, DOI 10.1038/nsmb1211; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Chen CCG, 2005, CURR BIOL, V15, P378, DOI 10.1016/j.cub.2005.01.009; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; Hutvagner G, 2005, FEBS LETT, V579, P5850, DOI 10.1016/j.febslet.2005.08.071; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Iida T, 2006, CURR BIOL, V16, P1459, DOI 10.1016/j.cub.2006.05.061; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Mitchell P, 2000, NAT STRUCT BIOL, V7, P843, DOI 10.1038/82817; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; Partridge JF, 2000, GENE DEV, V14, P783; Read RL, 2002, P NATL ACAD SCI USA, V99, P12079, DOI 10.1073/pnas.192467799; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; THON G, 1992, GENETICS, V131, P287; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Win TZ, 2006, MOL CELL BIOL, V26, P1710, DOI 10.1128/MCB.26.5.1710-1721.2006; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030	49	190	197	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2007	129	4					707	721		10.1016/j.cell.2007.03.038	http://dx.doi.org/10.1016/j.cell.2007.03.038			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512405	Bronze			2022-12-01	WOS:000246788300016
J	Brandt, A; Gooday, AJ; Brandao, SN; Brix, S; Brokeland, W; Cedhagen, T; Choudhury, M; Cornelius, N; Danis, B; De Mesel, I; Diaz, RJ; Gillan, DC; Ebbe, B; Howe, JA; Janussen, D; Kaiser, S; Linse, K; Malyutina, M; Pawlowski, J; Raupach, M; Vanreusel, A				Brandt, Angelika; Gooday, Andrew J.; Brandao, Simone N.; Brix, Saskia; Broekeland, Wiebke; Cedhagen, Tomas; Choudhury, Madhumita; Cornelius, Nils; Danis, Bruno; De Mesel, Ilse; Diaz, Robert J.; Gillan, David C.; Ebbe, Brigitte; Howe, John A.; Janussen, Dorte; Kaiser, Stefanie; Linse, Katrin; Malyutina, Marina; Pawlowski, Jan; Raupach, Michael; Vanreusel, Ann			First insights into the biodiversity and biogeography of the Southern Ocean deep sea	NATURE			English	Article							SPECIES-DIVERSITY; BENTHIC DIVERSITY; WEDDELL SEA; ECOLOGY; ORIGIN; SCALE; FORAMINIFERA; ANTARCTICA; PERACARIDA; CRUSTACEA	Shallow marine benthic communities around Antarctica show high levels of endemism, gigantism, slow growth, longevity and late maturity, as well as adaptive radiations that have generated considerable biodiversity in some taxa(1). The deeper parts of the Southern Ocean exhibit some unique environmental features, including a very deep continental shelf(2) and a weakly stratified water column, and are the source for much of the deep water in the world ocean. These features suggest that deep-sea faunas around the Antarctic may be related both to adjacent shelf communities and to those in other oceans. Unlike shallow-water Antarctic benthic communities, however, little is known about life in this vast deep-sea region(2,3). Here, we report new data from recent sampling expeditions in the deep Weddell Sea and adjacent areas ( 748 - 6,348 m water depth) that reveal high levels of new biodiversity; for example, 674 isopods species, of which 585 were new to science. Bathymetric and biogeographic trends varied between taxa. In groups such as the isopods and polychaetes, slope assemblages included species that have invaded from the shelf. In other taxa, the shelf and slope assemblages were more distinct. Abyssal faunas tended to have stronger links to other oceans, particularly the Atlantic, but mainly in taxa with good dispersal capabilities, such as the Foraminifera. The isopods, ostracods and nematodes, which are poor dispersers, include many species currently known only from the Southern Ocean. Our findings challenge suggestions that deep-sea diversity is depressed in the Southern Ocean and provide a basis for exploring the evolutionary significance of the varied biogeographic patterns observed in this remote environment.	Zool Museum Hamburg, D-20146 Hamburg, Germany; Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; Univ Aarhus, Dept Marine Ecol, DK-8200 Aarhus, Denmark; Inst Royal Sci Nat Belgique, B-1000 Brussels, Belgium; Univ Ghent, Dept Biol, Marine Biol Sect, B-9000 Ghent, Belgium; Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA; Univ Libre Bruxelles, Marine Biol Lab, B-1050 Brussels, Belgium; Forschungsmuseum Konig, Forschungsinst Senckenberg, DZMB CeDAMar, D-53113 Bonn, Germany; Scottish Assoc Marine Sci, Dunstaffnage Marine Lab, Oban PA37 1QA, Argyll, Scotland; Forschungs & Nat Museum Senckenberg, D-60325 Frankfurt, Germany; British Antarctic Survey, NERC, Cambridge CB3 0ET, England; FEB RAS, Inst Marine Biol, Vladivostok 690041, Russia; Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva 4, Switzerland; Ruhr Univ Bochum, D-44780 Bochum, Germany	University of Hamburg; NERC National Oceanography Centre; Aarhus University; Ghent University; William & Mary; Virginia Institute of Marine Science; Universite Libre de Bruxelles; Senckenberg Gesellschaft fur Naturforschung (SGN); UHI Millennium Institute; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Russian Academy of Sciences; National Scientific Center of Marine Biology, Far East Branch of the Russian Academy of Sciences; University of Geneva; Ruhr University Bochum	Brandt, A (corresponding author), Zool Museum Hamburg, Martin Luther King Pl 3, D-20146 Hamburg, Germany.	abrandt@zoologie.uni-hamburg.de	Raupach, Michael J./AAF-7566-2020; Gooday, Andrew/ABB-4267-2020; Gooday, Andrew/AAH-8991-2021; Raupach, Michael/G-7072-2012; Cedhagen, Tomas/J-6426-2013; Brandt, Angelika/C-1630-2018; Danis, Bruno/AAS-8444-2021; Brandao, Simone/C-9416-2013; Malyutina, Marina/A-6839-2014	Raupach, Michael J./0000-0001-8299-6697; Gooday, Andrew/0000-0002-5661-7371; Cedhagen, Tomas/0000-0003-4550-8177; Danis, Bruno/0000-0002-9037-7623; Brandao, Simone/0000-0002-3487-6129; Linse, Katrin/0000-0003-3477-3047; Malyutina, Marina/0000-0003-2161-3917; Kaiser, Stefanie/0000-0003-2026-4663	Natural Environment Research Council [soc010009, bas010015] Funding Source: researchfish; NERC [soc010009, bas010015] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Alve E, 2003, LIMNOL OCEANOGR, V48, P2163, DOI 10.4319/lo.2003.48.6.2163; Brandt A, 2007, PHILOS T R SOC B, V362, P39, DOI 10.1098/rstb.2006.1952; Brandt A., 1991, Berichte zur Polarforschung, V98, P1; Brandt A, 1999, SCI MAR, V63, P261, DOI 10.3989/scimar.1999.63s1261; BREY T, 1994, NATURE, V368, P297, DOI 10.1038/368297a0; Brey T, 1996, ANTARCT SCI, V8, P3, DOI 10.1017/S0954102096000028; Clarke A, 2003, ECOSY WORLD, V28, P239; Clarke A, 2003, OCEANOGR MAR BIOL, V41, P47; Cornelius N, 2004, DEEP-SEA RES PT II, V51, P1571, DOI 10.1016/j.dsr2.2004.06.024; De Mesel I, 2006, POLAR BIOL, V29, P860, DOI 10.1007/s00300-006-0124-7; Gage JD, 2004, DEEP-SEA RES PT II, V51, P1689, DOI 10.1016/j.dsr2.2004.07.013; Hessler R., 1983, EVOLUTION TIME SPACE, P227; HESSLER RR, 1975, MAR BIOL, V32, P155, DOI 10.1007/BF00388508; Hilbig B, 2006, B MAR SCI, V78, P243; KUSSAKIN OG, 1973, MAR BIOL, V23, P19, DOI 10.1007/BF00394108; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Murray JW, 2004, MAR MICROPALEONTOL, V53, P67, DOI 10.1016/j.marmicro.2004.04.001; PAWLOWSKI J, UNPUB DEEP SEA RES, V2; PAWLOWSKI J, UNPUB MOL ECOL; POORE GCB, 1993, NATURE, V361, P597, DOI 10.1038/361597a0; Raupach MJ, 2004, DEEP-SEA RES PT II, V51, P1787, DOI 10.1016/j.dsr2.2004.06.035; RAUPACH MJ, UNPUB DEEP SEA RES, V2; Rex MA, 2005, ECOLOGY, V86, P2288, DOI 10.1890/04-1056; REX MA, 1993, NATURE, V365, P636, DOI 10.1038/365636a0; SANDERS HL, 1969, SCIENCE, V163, P1419, DOI 10.1126/science.163.3874.1419; Snelgrove PVR, 2002, OCEANOGR MAR BIOL, V40, P311; Tyler PA, 2000, MAR ECOL PROG SER, V192, P173, DOI 10.3354/meps192173; Vinogradova NG, 1997, ADV MAR BIOL, V32, P325	29	359	375	8	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2007	447	7142					307	311		10.1038/nature05827	http://dx.doi.org/10.1038/nature05827			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17507981				2022-12-01	WOS:000246520300043
J	Butler, MA; Sawyer, SA; Losos, JB				Butler, Marguerite A.; Sawyer, Stanley A.; Losos, Jonathan B.			Sexual dimorphism and adaptive radiation in Anolis lizards	NATURE			English	Article							ECOLOGICAL CAUSES; HABITAT USE; SIZE; EVOLUTION; DIVERSIFICATION; FEATURES	Sexual dimorphism is widespread and substantial throughout the animal world(1,2). It is surprising, then, that such a pervasive source of biological diversity has not been integrated into studies of adaptive radiation, despite extensive and growing attention to both phenomena(1,3-7). Rather, most studies of adaptive radiation either group individuals without regard to sex or focus solely on one sex. Here we show that sexual differences contribute substantially to the ecomorphological diversity produced by the adaptive radiations of West Indian Anolis lizards: within anole species, males and females occupy mostly non-overlapping parts of morphological space; the overall extent of sexual variation is large relative to interspecific variation; and the degree of variation depends on ecological type. Thus, when sexual dimorphism in ecologically relevant traits is substantial, ignoring its contribution may significantly underestimate the adaptive component of evolutionary radiation. Conversely, if sexual dimorphism and interspecific divergence are alternative means of ecological diversification, then the degree of sexual dimorphism may be negatively related to the extent of adaptive radiation.	Univ Hawaii Manoa, Dept Zool, Honolulu, HI 96822 USA; Washington Univ, Dept Biol, St Louis, MO 63130 USA; Washington Univ, Dept Math, St Louis, MO 63130 USA	University of Hawaii System; University of Hawaii Manoa; Washington University (WUSTL); Washington University (WUSTL)	Butler, MA (corresponding author), Univ Hawaii Manoa, Dept Zool, 2538 McCarthy Mall, Honolulu, HI 96822 USA.	mbutler@hawaii.edu	Butler, Marguerite/B-6700-2011	Butler, Marguerite/0000-0002-2039-5965				Andersson Malte, 1994; Bolnick DI, 2003, EVOLUTION, V57, P2433, DOI 10.1554/02-595; Butler MA, 2000, EVOLUTION, V54, P259, DOI 10.1111/j.0014-3820.2000.tb00026.x; Butler MA, 2002, ECOL MONOGR, V72, P541, DOI 10.1890/0012-9615(2002)072[0541:MSDSSA]2.0.CO;2; DAYAN T, 1994, ECOLOGY, V75, P1063, DOI 10.2307/1939430; Delph LF, 2005, AM NAT, V166, pS1, DOI 10.1086/462434; DUONG TK, 2005, KERNAL SMOOTHING VER; Fukami T, 2007, NATURE, V446, P436, DOI 10.1038/nature05629; Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875; HEDRICK AV, 1989, TRENDS ECOL EVOL, V4, P136, DOI 10.1016/0169-5347(89)90212-7; Hendry AP, 2006, J EVOLUTION BIOL, V19, P741, DOI 10.1111/j.1420-9101.2005.01061.x; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Langerhans RB, 2004, AM NAT, V164, P335, DOI 10.1086/422857; LOSOS JB, 1990, ECOL MONOGR, V60, P369, DOI 10.2307/1943062; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; LOSOS JB, 1993, OECOLOGIA, V95, P525, DOI 10.1007/BF00317437; Losos JB, 2004, ADAPTIVE SPECIATION, P335; Olejnik S, 2000, CONTEMP EDUC PSYCHOL, V25, P241, DOI 10.1006/ceps.2000.1040; Ricklefs RE, 2004, NATURE, V430, P338, DOI 10.1038/nature02700; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schoener T.W., 1977, P35; SCHOENER TW, 1967, SCIENCE, V155, P474, DOI 10.1126/science.155.3761.474; SCHOENER TW, 1969, SYST ZOOL, V18, P386, DOI 10.2307/2412183; Selander R.K., 1972, SEXUAL SELECTION DES, P180, DOI DOI 10.4324/9781315129266-8; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; SLATKIN M, 1984, EVOLUTION, V38, P622, DOI 10.1111/j.1558-5646.1984.tb00327.x; Stamps JA., 1983, LIZARD ECOLOGY STUDI, P169, DOI 10.4159/harvard.9780674183384.c11; Temeles EJ, 2000, SCIENCE, V289, P441, DOI 10.1126/science.289.5478.441; Waxman D, 2005, J EVOLUTION BIOL, V18, P1139, DOI 10.1111/j.1420-9101.2005.00948.x; Williams E.E., 1983, LIZARD ECOLOGY STUDI, P326, DOI DOI 10.4159/HARVARD.9780674183384.C18	30	162	174	0	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2007	447	7141					202	205		10.1038/nature05774	http://dx.doi.org/10.1038/nature05774			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17495925				2022-12-01	WOS:000246338700042
J	Thai, TH; Calado, DP; Casola, S; Ansel, KM; Xiao, CC; Xue, YZ; Murphy, A; Frendewey, D; Valenzuela, D; Kutok, JL; Schmidt-Supprian, M; Rajewsky, N; Yancopoulos, G; Rao, A; Rajewsky, K				Thai, To-Ha; Calado, Dinis Pedro; Casola, Stefano; Ansel, K. Mark; Xiao, Changchun; Xue, Yingzi; Murphy, Andrew; Frendewey, David; Valenzuela, David; Kutok, Jeffery L.; Schmidt-Supprian, Marc; Rajewsky, Nikolaus; Yancopoulos, George; Rao, Anjana; Rajewsky, Klaus			Regulation of the germinal center response by microRNA-155	SCIENCE			English	Article							VIRUS-INDUCED LYMPHOMAS; B-CELL PROLIFERATION; HIGH EXPRESSION; NONCODING RNA; GENE; MICE; LYMPHOTOXIN; RECEPTOR; ENCODES; BETA	MicroRNAs are small RNA species involved in biological control at multiple levels. Using genetic deletion and transgenic approaches, we show that the evolutionarily conserved microRNA-155 (miR-155) has an important role in the mammalian immune system, specifically in regulating T helper cell differentiation and the germinal center reaction to produce an optimal T cell-dependent antibody response. miR-155 exerts this control, at least in part, by regulating cytokine production. These results also suggest that individual microRNAs can exert critical control over mammalian differentiation processes in vivo.	Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; IFOM FIRC Inst Mol Oncol, I-20139 Milan, Italy; Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; IFOM - FIRC Institute of Molecular Oncology; Regeneron; Harvard University; Brigham & Women's Hospital; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Rajewsky, K (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA.	rajewsky@cbr.med.harvard.edu	Schmidt-Supprian, Marc/F-5893-2011; Casola, Stefano/O-3922-2014; Calado, Dinis/U-8379-2019; Casola, Stefano/AAN-8319-2021	Schmidt-Supprian, Marc/0000-0002-8543-6166; Calado, Dinis/0000-0001-8239-7184; Casola, Stefano/0000-0001-5580-0986; Murphy, Andrew/0000-0003-4152-4081; Frendewey, David/0000-0003-2305-3490; Rajewsky, Nikolaus/0000-0002-4785-4332; Rajewsky, Klaus/0000-0002-6633-6370	NIAID NIH HHS [AI064345] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064345] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; CLURMAN BE, 1989, MOL CELL BIOL, V9, P2657, DOI 10.1128/MCB.9.6.2657; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Endres R, 1999, J EXP MED, V189, P159, DOI 10.1084/jem.189.1.159; Esposito G, 2000, P NATL ACAD SCI USA, V97, P1166, DOI 10.1073/pnas.97.3.1166; Fu YX, 1997, J EXP MED, V185, P2111, DOI 10.1084/jem.185.12.2111; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Roers A, 2004, J EXP MED, V200, P1289, DOI 10.1084/jem.20041789; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tam W, 2002, J VIROL, V76, P4275, DOI 10.1128/JVI.76.9.4275-4286.2002; Tam W, 2001, GENE, V274, P157, DOI 10.1016/S0378-1119(01)00612-6; Tam W, 1997, MOL CELL BIOL, V17, P1490, DOI 10.1128/MCB.17.3.1490; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; van den Berg A, 2003, GENE CHROMOSOME CANC, V37, P20, DOI 10.1002/gcc.10186; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Wang Y, 2001, J IMMUNOL, V166, P330, DOI 10.4049/jimmunol.166.1.330	24	1169	1278	0	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2007	316	5824					604	608		10.1126/science.1141229	http://dx.doi.org/10.1126/science.1141229			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463289				2022-12-01	WOS:000245983100047
J	Cui, HC; Levesque, MP; Vernoux, T; Jung, JW; Paquette, AJ; Gallagher, KL; Wang, JY; Blilou, I; Scheres, B; Benfey, PN				Cui, Hongchang; Levesque, Mitchell P.; Vernoux, Teva; Jung, Jee W.; Paquette, Alice J.; Gallagher, Kimberly L.; Wang, Jean Y.; Blilou, Ikram; Scheres, Ben; Benfey, Philip N.			An evolutionarily conserved mechanism delimiting SHR movement defines a single layer of endodermis in plants	SCIENCE			English	Article							ASYMMETRIC CELL-DIVISION; ARABIDOPSIS ROOT; SCARECROW GENE; INTERCELLULAR MOVEMENT; RADIAL ORGANIZATION; EXPRESSION; TRAFFICKING; PROTEIN; NETWORKS; MERISTEM	Intercellular protein movement plays a critical role in animal and plant development. SHORTROOT (SHR) is a moving transcription factor essential for endodermis specification in the Arabidopsis root. Unlike diffusible animal morphogens, which form a gradient across multiple cell layers, SHR movement is limited to essentially one cell layer. However, the molecular mechanism is unknown. We show that SCARECROW (SCR) blocks SHR movement by sequestering it into the nucleus through protein-protein interaction and a safeguard mechanism that relies on a SHR/SCR-dependent positive feedback loop for SCR transcription. Our studies with SHR and SCR homologs from rice suggest that this mechanism is evolutionarily conserved, providing a plausible explanation why nearly all plants have a single layer of endodermis.	Duke Univ, Dept Biol, Durham, NC 27708 USA; Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; Univ Utrecht, Dept Mol Genet, NL-3584 CH Utrecht, Netherlands	Duke University; Duke University; Utrecht University	Benfey, PN (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	philip.benfey@duke.edu	Cui, Hongchang/ABD-3278-2021; Vernoux, Teva/J-1695-2019	Cui, Hongchang/0000-0002-9870-748X; Vernoux, Teva/0000-0002-8257-4088; Blilou, Ikram/0000-0001-8003-3782; Scheres, Ben/0000-0001-5400-9578	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043778] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM043778] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; Benfey PN, 2001, PLANT PHYSIOL, V125, P109, DOI 10.1104/pp.125.1.109; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; DOLAN L, 1993, DEVELOPMENT, V119, P71; Gallagher KL, 2005, GENE DEV, V19, P189, DOI 10.1101/gad.1271005; Gallagher KL, 2004, CURR BIOL, V14, P1847, DOI 10.1016/j.cub.2004.09.081; Heidstra R, 2004, GENE DEV, V18, P1964, DOI 10.1101/gad.305504; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Kamiya N, 2003, PLANT J, V36, P45, DOI 10.1046/j.1365-313X.2003.01856.x; Kim JY, 2002, P NATL ACAD SCI USA, V99, P4103, DOI 10.1073/pnas.052484099; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kurata T, 2005, DEVELOPMENT, V132, P5387, DOI 10.1242/dev.02139; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Lee JY, 2003, SCIENCE, V299, P392, DOI 10.1126/science.1077813; Levesque MP, 2006, PLOS BIOL, V4, P739, DOI 10.1371/journal.pbio.0040143; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Lim J, 2000, PLANT CELL, V12, P1307, DOI 10.1105/tpc.12.8.1307; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Sassa N, 2001, PLANT CELL PHYSIOL, V42, P385, DOI 10.1093/pcp/pce048; SCHERES B, 1995, DEVELOPMENT, V121, P53; Sena G, 2004, DEVELOPMENT, V131, P2817, DOI 10.1242/dev.01144; Wang YC, 2005, NATURE, V434, P229, DOI 10.1038/nature03318; Weinl C, 2005, PLANT CELL, V17, P1704, DOI 10.1105/tpc.104.030486; Wu XL, 2003, DEVELOPMENT, V130, P3735, DOI 10.1242/dev.00577	27	394	441	2	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2007	316	5823					421	425		10.1126/science.1139531	http://dx.doi.org/10.1126/science.1139531			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446396				2022-12-01	WOS:000245813400049
J	Osborne, AR; Rapoport, TA				Osborne, Andrew R.; Rapoport, Tom A.			Protein translocation is mediated by oligomers of the SecY complex with one SecY copy forming the channel	CELL			English	Article							ESCHERICHIA-COLI; ENDOPLASMIC-RETICULUM; CONDUCTING CHANNEL; ATPASE SECA; CRYSTAL-STRUCTURE; DISULFIDE BRIDGE; MEMBRANE-PROTEIN; CROSS-LINKING; ER MEMBRANE; BINDING	Many proteins are translocated across the bacterial plasma membrane by the interplay of the cytoplasmic ATPase SecA with a protein-conducting channel, formed from the evolutionarily conserved heterotrimeric SecY complex. Here, we have used purified E. coli components to address the mechanism of translocation. Disulfide bridge crosslinking demonstrates that SecA transfers both the signal sequence and the mature region of a secreted substrate into a single SecY molecule. However, protein translocation involves oligomers of the SecY complex, because a SecY molecule defective in translocation can be rescued by linking it covalently with a wild-type SecY copy. SecA interacts through one of its domains with a nontranslocating SecY copy and moves the polypeptide chain through a neighboring SecY copy. Oligomeric channels with only one active pore likely mediate protein translocation in all organisms.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	tom_raoport@hms.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052586] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM052586] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; Dapic V, 2000, J BIOL CHEM, V275, P25000, DOI 10.1074/jbc.M001100200; Duong F, 2003, EMBO J, V22, P4375, DOI 10.1093/emboj/cdg418; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Eichler J, 2004, TRENDS BIOCHEM SCI, V29, P221, DOI 10.1016/j.tibs.2004.03.001; Gumbart J, 2006, BIOPHYS J, V90, P2356, DOI 10.1529/biophysj.105.075291; Hamman BD, 1997, CELL, V89, P535, DOI 10.1016/S0092-8674(00)80235-4; Ismail N, 2006, J CELL SCI, V119, P2826, DOI 10.1242/jcs.03018; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; Kowarik M, 2002, MOL CELL, V10, P769, DOI 10.1016/S1097-2765(02)00685-8; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Mitra K, 2006, NAT STRUCT MOL BIOL, V13, P957, DOI 10.1038/nsmb1166; Mori H, 2003, J BIOL CHEM, V278, P14257, DOI 10.1074/jbc.M300230200; Mori H, 2001, P NATL ACAD SCI USA, V98, P5128, DOI 10.1073/pnas.081617398; Mori H, 2006, P NATL ACAD SCI USA, V103, P16159, DOI 10.1073/pnas.0606390103; Or E, 2005, J BIOL CHEM, V280, P9097, DOI 10.1074/jbc.M413947200; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Osborne AR, 2004, P NATL ACAD SCI USA, V101, P10937, DOI 10.1073/pnas.0401742101; Plath K, 2004, MOL BIOL CELL, V15, P1, DOI 10.1091/mbc.E03-06-0390; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Sadlish H, 2005, NAT STRUCT MOL BIOL, V12, P870, DOI 10.1038/nsmb994; Schaletzky J, 2006, MOL BIOL CELL, V17, P3860, DOI 10.1091/mbc.e06-05-0439; Scheuring J, 2005, J MOL BIOL, V354, P258, DOI 10.1016/j.jmb.2005.09.058; Sharma V, 2003, P NATL ACAD SCI USA, V100, P2243, DOI 10.1073/pnas.0538077100; Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804; TANI K, 1990, J BIOL CHEM, V265, P17341; Thanassi DG, 2005, MOL MEMBR BIOL, V22, P63, DOI 10.1080/09687860500063290; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vassylyev DG, 2006, J MOL BIOL, V364, P248, DOI 10.1016/j.jmb.2006.09.061; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023	32	120	125	2	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 6	2007	129	1					97	110		10.1016/j.cell.2007.02.036	http://dx.doi.org/10.1016/j.cell.2007.02.036			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418789	Bronze			2022-12-01	WOS:000245661100014
J	Kumar, P; Wu, HQ; McBride, JL; Jung, KE; Kim, MH; Davidson, BL; Lee, SK; Shankar, P; Manjunath, N				Kumar, Priti; Wu, Haoquan; McBride, Jodi L.; Jung, Kyeong-Eun; Kim, Moon Hee; Davidson, Beverly L.; Lee, Sang Kyung; Shankar, Premlata; Manjunath, N.			Transvascular delivery of small interfering RNA to the central nervous system	NATURE			English	Article							CELL-PENETRATING PEPTIDES; INHIBITS TUMOR-GROWTH; IN-VIVO DELIVERY; INTRACELLULAR DELIVERY; MODIFIED SIRNAS; GENE-THERAPY; BRAIN; VIRUS; RECEPTORS; TRANSPORTERS	A major impediment in the treatment of neurological diseases is the presence of the blood - brain barrier, which precludes the entry of therapeutic molecules from blood to brain. Here we show that a short peptide derived from rabies virus glycoprotein (RVG) enables the transvascular delivery of small interfering RNA ( siRNA) to the brain. This 29-amino-acid peptide specifically binds to the acetylcholine receptor expressed by neuronal cells. To enable siRNA binding, a chimaeric peptide was synthesized by adding nonamer arginine residues at the carboxy terminus of RVG. This RVG-9R peptide was able to bind and transduce siRNA to neuronal cells in vitro, resulting in efficient gene silencing. After intravenous injection into mice, RVG-9R delivered siRNA to the neuronal cells, resulting in specific gene silencing within the brain. Furthermore, intravenous treatment with RVG-9R-bound antiviral siRNA afforded robust protection against fatal viral encephalitis in mice. Repeated administration of RVG-9R-bound siRNA did not induce inflammatory cytokines or anti-peptide antibodies. Thus, RVG-9R provides a safe and noninvasive approach for the delivery of siRNA and potentially other therapeutic molecules across the blood - brain barrier.	Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Univ Iowa, Dept Internal Med, Roy J & Lucille J Carver Coll Med, Iowa City, IA 52242 USA; Samchully Pharm Co Ltd, Res Ctr, Seoul 135735, South Korea; Hanyang Univ, Dept Bioengn, Seoul 133791, South Korea; Hanyang Univ, Hanyang Fus Mat Program, Seoul 133791, South Korea	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; University of Iowa; Hanyang University; Hanyang University	Manjunath, N (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA.	shankar@cbrinstitute.org; swamy@cbrinstitute.org	Kumar, Priti/C-5699-2009; McBride, Jodi/C-4494-2016	McBride, Jodi/0000-0002-4816-7569; Wu, Haoquan/0000-0001-9386-3187; Davidson, Beverly/0000-0002-3715-6290				Akaneya Y, 2005, J NEUROPHYSIOL, V93, P594, DOI 10.1152/jn.00161.2004; Chen TJ, 2005, CHINESE J PHYSIOL, V48, P129; de Boer AG, 2007, ANNU REV PHARMACOL, V47, P323, DOI 10.1146/annurev.pharmtox.47.120505.105237; Deshayes S, 2005, CELL MOL LIFE SCI, V62, P1839, DOI 10.1007/s00018-005-5109-0; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Dietz GPH, 2005, BRAIN RES BULL, V68, P103, DOI 10.1016/j.brainresbull.2005.08.015; Dorn G, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh044; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; Gupta B, 2005, ADV DRUG DELIVER REV, V57, P637, DOI 10.1016/j.addr.2004.10.007; Henriques ST, 2006, BIOCHEM J, V399, P1, DOI 10.1042/BJ20061100; Hino T, 2006, BIOCHEM BIOPH RES CO, V340, P263, DOI 10.1016/j.bbrc.2005.11.173; Hoyer D, 2006, J RECEPT SIG TRANSD, V26, P527, DOI 10.1080/10799890600929663; Hu-Lieskovan S, 2005, CANCER RES, V65, P8984, DOI 10.1158/0008-5472.CAN-05-0565; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Juliano RL, 2005, CURR OPIN MOL THER, V7, P132; Kim WL, 2006, MOL THER, V14, P343, DOI 10.1016/j.ymthe.2006.03.022; Kumar P, 2006, PLOS MED, V3, P505, DOI 10.1371/journal.pmed.0030096; Lafon M, 2005, J NEUROVIROL, V11, P82, DOI 10.1080/13550280590900427; Lentz T L, 1990, J Mol Recognit, V3, P82, DOI 10.1002/jmr.300030205; LENTZ TL, 1982, SCIENCE, V215, P182, DOI 10.1126/science.7053569; Leonard S, 2001, Nicotine Tob Res, V3, P203; Mazarakis ND, 2001, HUM MOL GENET, V10, P2109, DOI 10.1093/hmg/10.19.2109; Melikov K, 2005, CELL MOL LIFE SCI, V62, P2739, DOI 10.1007/s00018-005-5293-y; Miller G, 2002, SCIENCE, V297, P1116, DOI 10.1126/science.297.5584.1116; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; Neyts J, 1999, Verh K Acad Geneeskd Belg, V61, P661; Noble CO, 2004, EXPERT OPIN THER TAR, V8, P335, DOI 10.1517/14728222.8.4.335; NOTTER MFD, 1985, J CELL PHYSIOL, V125, P476, DOI 10.1002/jcp.1041250317; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Schlachetzki F, 2004, NEUROLOGY, V62, P1275, DOI 10.1212/01.WNL.0000120551.38463.D9; Schutz B, 2005, J NEUROSCI, V25, P7805, DOI 10.1523/JNEUROSCI.2038-05.2005; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Zhang Y, 2004, CLIN CANCER RES, V10, P3667, DOI 10.1158/1078-0432.CCR-03-0740; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	36	926	1060	16	256	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2007	448	7149					39	43		10.1038/nature05901	http://dx.doi.org/10.1038/nature05901			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185OS	17572664				2022-12-01	WOS:000247720900032
J	Zuo, T; Wang, LZ; Morrison, C; Chang, X; Zhang, HM; Li, WQ; Liu, Y; Wang, Y; Liu, XL; Chan, MWY; Liu, JQ; Love, R; Liu, CG; Godfrey, V; Shen, RL; Huang, THM; Yang, TY; Park, BK; Wang, CY; Zheng, P; Liu, Y				Zuo, Tao; Wang, Lizhong; Morrison, Carl; Chang, Xing; Zhang, Huiming; Li, Weiquan; Liu, Yan; Wang, Yin; Liu, Xingluo; Chan, Michael W. Y.; Liu, Jin-Qing; Love, Richard; Liu, Chang-gong; Godfrey, Virginia; Shen, Rulong; Huang, Tim H. -M.; Yang, Tianyu; Park, Bae Keun; Wang, Cun-Yu; Zheng, Pan; Liu, Yang			FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene	CELL			English	Article							IN-SITU HYBRIDIZATION; SCURFY SF MOUSE; LYMPHORETICULAR DISEASE; OVARIAN-CANCER; NEU ONCOGENE; T-CELLS; PROTEIN; AMPLIFICATION; CHROMOSOME; IMMUNOHISTOCHEMISTRY	The X-linked Foxp3 is a member of the forkhead/winged helix transcription factor family. Germline mutations cause lethal autoimmune diseases in males. Serendipitously, we observed that female mice heterozygous for the "scurfin'' mutation of the Foxp3 gene (Foxp3(sf/+)) developed cancer at a high rate. The majority of the cancers were mammary carcinomas in which the wild-type Foxp3 allele was inactivated and HER-2/ErbB2 was overexpressed. Foxp3 bound and repressed the HER-2/ErbB2 promoter. Deletion, functionally significant somatic mutations, and downregulation of the FOXP3 gene were commonly found in human breast cancer samples and correlated significantly with HER-2/ErbB2 overexpression, regardless of the status of HER-2 amplification. Our data demonstrate that FOXP3 is an X-linked breast cancer suppressor gene and an important regulator of the HER-2/ErbB2 oncogene.	Univ Michigan, Ctr Comprehens Canc, Dept Surg, Sect Gen Surg,Div Immunotherapy, Ann Arbor, MI 48109 USA; Univ Michigan, Program Mol Mech Dis, Ann Arbor, MI 48109 USA; Ohio State Univ, Med Ctr, Dept Virol Immunol & Med Genet, Program Mol Cellular & Dev Biol, Columbus, OH 43210 USA; Ohio State Univ, Med Ctr, Dept Pathol, Columbus, OH 43210 USA; Ohio State Univ, Med Ctr, Dept Internal Med, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; Univ N Carolina, Dept Pathol, Chapel Hill, NC 27599 USA; Univ Michigan, Dept Biol & Mat Sci, Lab Mol Signaling & Apoptosis, Sch Dent, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan	Zheng, P (corresponding author), Univ Michigan, Ctr Comprehens Canc, Dept Surg, Sect Gen Surg,Div Immunotherapy, Ann Arbor, MI 48109 USA.	panz@umich.edu; yangl@umich.edu	Chan, Michael/F-9615-2018; Zheng, Pan/E-8691-2011; Wang, Lizhong/J-4268-2019; Li, Weiquan/B-4897-2011; Shen, Rulong/E-4079-2011	Chan, Michael/0000-0003-1431-322X; Zheng, Pan/0000-0003-2598-3544; Wang, Lizhong/0000-0003-1980-4730; Chang, Xing/0000-0002-5072-9225; Liu, Yang/0000-0002-9442-700X; Chan, Michael/0000-0003-0314-2437	NCI NIH HHS [R01 CA058033, R01 CA112001-02, R01 CA112001, R01 CA058033-15] Funding Source: Medline; NIAID NIH HHS [R01 AI051342, R01 AI064350, R01 AI051342-05, R01 AI064350-01A2] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA112001, R01CA058033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051342, R01AI064350] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bofin AM, 2004, AM J CLIN PATHOL, V122, P110, DOI 10.1309/8A2DJFT07NE6EWHE; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chang X, 2005, J EXP MED, V202, P1141, DOI 10.1084/jem.20050157; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; DEPALAZZO IG, 1993, INT J BIOL MARKER, V8, P233; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; GODFREY VL, 1994, AM J PATHOL, V145, P281; GODFREY VL, 1991, P NATL ACAD SCI USA, V88, P5528, DOI 10.1073/pnas.88.13.5528; Im Hogune, 2004, Methods Mol Biol, V284, P129; Jimenez RE, 2000, MODERN PATHOL, V13, P37, DOI 10.1038/modpathol.3880007; KALLIONIEMI OP, 1992, P NATL ACAD SCI USA, V89, P5321, DOI 10.1073/pnas.89.12.5321; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kristiansen M, 2005, J MED GENET, V42, P877, DOI 10.1136/jmg.2005.032433; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Piao Z, 2002, GENE CHROMOSOME CANC, V33, P262, DOI 10.1002/gcc.10024; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Roncuzzi L, 2002, CANCER GENET CYTOGEN, V135, P173, DOI 10.1016/S0165-4608(01)00652-5; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spatz A, 2004, NAT REV CANCER, V4, P617, DOI 10.1038/nrc1413; Todorovic-Rakovic N, 2005, PATHOL INT, V55, P318, DOI 10.1111/j.1440-1827.2005.01831.x; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wooster R, 2003, NEW ENGL J MED, V348, P2339, DOI 10.1056/NEJMra012284; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Xing XM, 2000, NAT MED, V6, P189, DOI 10.1038/72294; Yaziji H, 2004, JAMA-J AM MED ASSOC, V291, P1972, DOI 10.1001/jama.291.16.1972; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	35	311	335	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 29	2007	129	7					1275	1286		10.1016/j.cell.2007.04.034	http://dx.doi.org/10.1016/j.cell.2007.04.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	188HQ	17570480	Green Accepted, Green Submitted, Bronze			2022-12-01	WOS:000247911400014
J	Persson, L; Amundsen, PA; De Roos, AM; Klemetsen, A; Knudsen, R; Primicerio, R				Persson, Lennart; Amundsen, Per-Arne; De Roos, Andre M.; Klemetsen, Anders; Knudsen, Rune; Primicerio, Raul			Culling prey promotes predator recovery - Alternative states in a whole-lake experiment	SCIENCE			English	Article							LIFE-HISTORY TRAITS; TROUT SALMO-TRUTTA; SALVELINUS-ALPINUS; ARCTIC CHARR; BROWN TROUT; STABLE EQUILIBRIA; FOOD-WEB; SIZE; POPULATIONS; GROWTH	Many top-predator fish stocks in both freshwater and marine systems have collapsed as a result of overharvesting. Consequently, some of these communities have shifted into seemingly irreversible new states. We showed, for predators feeding on prey that exhibit food-dependent growth, that culling of fish prey may promote predator recovery. We removed old stunted individuals of a prey-fish species in a large, low-productive lake, which caused an increase in the availability of small-sized prey and allowed the predator to recover. The shift in community state has been sustained for more than 15 years after the cull ended and represents an experimental demonstration of an alternative stable state in a large-scale field system. Because most animals exhibit food-dependent growth, shifts into alternative stable states resulting from overcompensating prey growth may be common in nature and may require counterintuitive management strategies.	Umea Univ, Dept Ecol & Environm Sci, S-90187 Umea, Sweden; Univ Tromso, Norwegian Coll Fishery Sci, Dept Aquat Biosci, N-9037 Tromso, Norway; Univ Amsterdam, Inst Biodivers & Ecosyst, NL-1090 GB Amsterdam, Netherlands	Umea University; UiT The Arctic University of Tromso; University of Amsterdam	Persson, L (corresponding author), Umea Univ, Dept Ecol & Environm Sci, S-90187 Umea, Sweden.	lennart.persson@emg.umu.se	De Roos, Andre M./A-1590-2008; Persson, Lennart/B-2885-2012	De Roos, Andre M./0000-0002-6944-2048; Amundsen, Per-Arne/0000-0002-2203-8216				Amundsen PA, 2007, J ANIM ECOL, V76, P149, DOI 10.1111/j.1365-2656.2006.01179.x; Chase JM, 1999, AM NAT, V154, P559, DOI 10.1086/303260; Chase JM, 2003, ECOL LETT, V6, P733, DOI 10.1046/j.1461-0248.2003.00482.x; CONNELL JH, 1983, AM NAT, V121, P789, DOI 10.1086/284105; De Roos AM, 2002, P NATL ACAD SCI USA, V99, P12907, DOI 10.1073/pnas.192174199; De Roos AM, 2003, ECOL LETT, V6, P473, DOI 10.1046/j.1461-0248.2003.00458.x; Duplisea DE, 2005, ICES J MAR SCI, V62, P412, DOI 10.1016/j.icesjms.2004.11.005; Edison TW, 2006, N AM J FISH MANAGE, V26, P800, DOI 10.1577/M04-020.1; Hutchings JA, 2005, CAN J FISH AQUAT SCI, V62, P824, DOI 10.1139/F05-081; Hutchings JA, 2000, NATURE, V406, P882, DOI 10.1038/35022565; Hyvarinen P, 2006, J FISH BIOL, V68, P87, DOI 10.1111/j.0022-1112.2006.00879.x; Jansen PA, 2002, CAN J FISH AQUAT SCI, V59, P6, DOI 10.1139/F01-184; Jansen PA, 2002, ENVIRON BIOL FISH, V64, P313, DOI 10.1023/A:1016009625754; JOHNSON L, 2002, IMPERFECT SYMMETRY T; Klemetsen A, 2002, ENVIRON BIOL FISH, V64, P39, DOI 10.1023/A:1016062421601; LABEELUND JH, 1992, J FISH BIOL, V41, P91, DOI 10.1111/j.1095-8649.1992.tb03172.x; Mora C, 2006, SCIENCE, V314, P758; PAINE RT, 1985, AM NAT, V125, P679, DOI 10.1086/284371; Persson L, 1996, ECOLOGY, V77, P900, DOI 10.2307/2265510; Post JR, 2002, FISHERIES, V27, P6, DOI 10.1577/1548-8446(2002)027&lt;0006:CRF&gt;2.0.CO;2; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schmitz OJ, 2004, ECOL LETT, V7, P403, DOI 10.1111/j.1461-0248.2004.00592.x; Schroder A, 2005, OIKOS, V110, P3, DOI 10.1111/j.0030-1299.2005.13962.x; SEBENS KP, 1987, ANNU REV ECOL SYST, V18, P371, DOI 10.1146/annurev.ecolsys.18.1.371; TONN WM, 1992, ECOLOGY, V73, P951, DOI 10.2307/1940171; van Kooten T, 2005, J THEOR BIOL, V237, P67, DOI 10.1016/j.jtbi.2005.03.032; Walters C, 2001, CAN J FISH AQUAT SCI, V58, P39, DOI 10.1139/cjfas-58-1-39; Werner E.E., 1988, P60	28	145	150	2	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2007	316	5832					1743	1746		10.1126/science.1141412	http://dx.doi.org/10.1126/science.1141412			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180XE	17588929				2022-12-01	WOS:000247400500046
J	Kyle, RA; Remstein, ED; Therneau, TM; Dispenzieri, A; Kurtin, PJ; Hodnefield, JM; Larson, DR; Plevak, MF; Jelinek, DF; Fonseca, R; Melton, LJI; Rajkumar, SV				Kyle, Robert A.; Remstein, Ellen D.; Therneau, Terry M.; Dispenzieri, Angela; Kurtin, Paul J.; Hodnefield, Janice M.; Larson, Dirk R.; Plevak, Matthew F.; Jelinek, Diane F.; Fonseca, Rafael; Melton, Lee Joseph, III; Rajkumar, S. Vincent			Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MONOCLONAL GAMMOPATHY; NATURAL-HISTORY	Background: Smoldering (asymptomatic) multiple myeloma is an asymptomatic plasma-cell proliferative disorder associated with a high risk of progression to symptomatic multiple myeloma or amyloidosis. Prognostic factors for the progression and outcome of this disease are unclear. Methods: We searched a computerized database and reviewed the medical records of all patients at Mayo Clinic who fulfilled the criteria of the International Myeloma Working Group for the diagnosis of smoldering multiple myeloma between 1970 and 1995. Bone marrow aspirate and biopsy specimens were studied, and patients were followed throughout the course of disease. Results: During the 26-year period, 276 patients fulfilled the criteria for smoldering multiple myeloma. During 2131 cumulative person-years of follow-up, symptomatic multiple myeloma or amyloidosis developed in 163 persons (59%). The overall risk of progression was 10% per year for the first 5 years, approximately 3% per year for the next 5 years, and 1% per year for the last 10 years; the cumulative probability of progression was 73% at 15 years. At diagnosis, significant risk factors for progression included the serum level and type of monoclonal protein, the presence of urinary light chain, the extent and pattern of bone marrow involvement, and the reduction in uninvolved immunoglobulins. The proportion of plasma cells in the bone marrow and the serum monoclonal protein level were combined to create a risk-stratification model with three distinct prognostic groups. Conclusions: The risk of progression from smoldering multiple myeloma to symptomatic disease is related to the proportion of bone marrow plasma cells and the serum monoclonal protein level at diagnosis.	Mayo Clin, Div Hematol, Rochester, MN 55905 USA; Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; Mayo Clin, Div Biostat, Rochester, MN USA; Mayo Clin, Dept Immunol, Rochester, MN USA; Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Kyle, RA (corresponding author), Mayo Clin, Div Hematol, 200 1st St SW, Rochester, MN 55905 USA.	kyle.robert@mayo.edu	McPhail, Ellen D. Remstein/AAF-3474-2020; Rajkumar, S. Vincent/AAV-1834-2021	McPhail, Ellen D. Remstein/0000-0001-6918-3376; Rajkumar, S. Vincent/0000-0002-5862-1833; Fonseca, Rafael/0000-0002-5938-3769; Dispenzieri, Angela/0000-0001-8780-9512	NATIONAL CANCER INSTITUTE [P01CA062242, R01CA107476] Funding Source: NIH RePORTER; NCI NIH HHS [CA62242, CA107476] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALEXANIAN R, 1988, ARCH INTERN MED, V148, P1963, DOI 10.1001/archinte.148.9.1963; BERRY G, 1983, BIOMETRICS, V39, P173, DOI 10.2307/2530817; Cesana C, 2002, J CLIN ONCOL, V20, P1625, DOI 10.1200/JCO.20.6.1625; COX DR, 1972, J R STAT SOC B, V34, P187; DIMOPOULOS MA, 1993, AM J MED, V94, P57, DOI 10.1016/0002-9343(93)90120-E; FACON T, 1995, AM J HEMATOL, V48, P71, DOI 10.1002/ajh.2830480201; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Kyle RA, 2003, MAYO CLIN PROC, V78, P21, DOI 10.4065/78.1.21; Kyle RA, 2002, NEW ENGL J MED, V346, P564, DOI 10.1056/NEJMoa01133202; KYLE RA, 1992, BLOOD, V79, P1817; KYLE RA, 1980, NEW ENGL J MED, V302, P1347, DOI 10.1056/NEJM198006123022405; Kyle RA, 2002, MANUAL CLIN LAB IMMU, P71; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; Rajkumar SV, 2003, LEUKEMIA, V17, P775, DOI 10.1038/sj.leu.2402866; Rajkumar SV, 2001, LEUKEMIA, V15, P1274, DOI 10.1038/sj.leu.2402183; Rosinol L, 2003, BRIT J HAEMATOL, V123, P631, DOI 10.1046/j.1365-2141.2003.04654.x; *SEER PROGR, 2005, SEER STAT DAT INC SE; SUKPANICHNANT S, 1994, HUM PATHOL, V25, P308, DOI 10.1016/0046-8177(94)90204-6; Weber DM, 1997, BRIT J HAEMATOL, V97, P810, DOI 10.1046/j.1365-2141.1997.1122939.x; WEBER DM, 2003, HEMATOL J, V4, pS31	23	544	569	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 21	2007	356	25					2582	2590		10.1056/NEJMoa070389	http://dx.doi.org/10.1056/NEJMoa070389			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180GN	17582068				2022-12-01	WOS:000247351200005
J	Alsos, IG; Eidesen, PB; Ehrich, D; Skrede, I; Westergaard, K; Jacobsen, GH; Landvik, JY; Taberlet, P; Brochmann, C				Alsos, Inger Greve; Eidesen, Pernille Bronken; Ehrich, Dorothee; Skrede, Inger; Westergaard, Kristine; Jacobsen, Gro Hilde; Landvik, Jon Y.; Taberlet, Pierre; Brochmann, Christian			Frequent long-distance plant colonization in the changing Arctic	SCIENCE			English	Article							ENVIRONMENTAL-CHANGE; CLIMATE-CHANGE; DISPERSAL; SVALBARD; DISTRIBUTIONS; MECHANISMS; MIGRATION; EUROPE; AREA	The ability of species to track their ecological niche after climate change is a major source of uncertainty in predicting their future distribution. By analyzing DNA fingerprinting ( amplified fragment-length polymorphism) of nine plant species, we show that long-distance colonization of a remote arctic archipelago, Svalbard, has occurred repeatedly and from several source regions. Propagules are likely carried by wind and drifting sea ice. The genetic effect of restricted colonization was strongly correlated with the temperature requirements of the species, indicating that establishment limits distribution more than dispersal. Thus, it may be appropriate to assume unlimited dispersal when predicting long-term range shifts in the Arctic.	Univ Oslo, Museum Nat Hist, Natl Ctr Biosystemat, NO-0318 Oslo, Norway; Univ Tromso, Tromso Univ Museum, NO-9037 Tromso, Norway; Norwegian Univ Life Sci, NO-1432 As, Norway; Univ Grenoble 1, CNRS, UMR 5553, Lab Ecol Alpine, F-38041 Grenoble 09, France	University of Oslo; UiT The Arctic University of Tromso; Norwegian University of Life Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie	Alsos, IG (corresponding author), Univ Ctr Svalbard, POB 156, NO-9171 Svalbard, Norway.	ingera@unis.no	Westergaard, Kristine/M-7084-2018; Alsos, Inger G/A-9507-2016; Alsos, Inger Greve/O-8154-2019; Ehrich, Dorothee/F-6492-2015; Taberlet, Pierre/D-1178-2010; Brochmann, Christian/A-4105-2009; Westergaard, Kristine Bakke/GYJ-6582-2022	Westergaard, Kristine/0000-0003-4609-8704; Alsos, Inger G/0000-0002-8610-1085; Alsos, Inger Greve/0000-0002-8610-1085; Ehrich, Dorothee/0000-0002-3028-9488; Taberlet, Pierre/0000-0002-3554-5954; Skrede, Inger/0000-0002-1113-7403				Abbott RJ, 2000, SCIENCE, V289, P1343, DOI 10.1126/science.289.5483.1343; ACIA, 2006, ARCT CLIM IMP ASS SC; BIRKS HH, 1994, J QUATERNARY SCI, V9, P133, DOI 10.1002/jqs.3390090207; Brochmann C, 2003, TAXON, V52, P417, DOI 10.2307/3647444; Cain ML, 2000, AM J BOT, V87, P1217, DOI 10.2307/2656714; Callaghan TV, 2004, AMBIO, V33, P404, DOI 10.1639/0044-7447(2004)033[0404:BDAAOA]2.0.CO;2; Cooper EJ, 2004, J VEG SCI, V15, P115, DOI 10.1111/j.1654-1103.2004.tb02244.x; Elven R, 2005, CHECKLIST PANARCTIC; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Higgins SI, 2003, ECOLOGY, V84, P1945, DOI 10.1890/01-0616; Hulten E., 1986, ATLAS N EUROPEAN VAS; Karlsen SR, 2003, J BIOGEOGR, V30, P1469, DOI 10.1046/j.1365-2699.2003.00942.x; Landvik JY, 1998, QUATERNARY SCI REV, V17, P43, DOI 10.1016/S0277-3791(97)00066-8; Landvik JY, 2003, GEOLOGY, V31, P905, DOI 10.1130/G19703.1; Moore KA, 2006, ECOL LETT, V9, P797, DOI 10.1111/j.1461-0248.2006.00923.x; Nathan R, 2002, NATURE, V418, P409, DOI 10.1038/nature00844; Nathan R, 2003, OIKOS, V103, P261, DOI 10.1034/j.1600-0706.2003.12146.x; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Neilson RP, 2005, BIOSCIENCE, V55, P749, DOI 10.1641/0006-3568(2005)055[0749:FRTGPM]2.0.CO;2; Ronning O.I., 1963, N ATLANTIC BIOTA THE, P99; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102	23	265	286	2	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1606	1609		10.1126/science.1139178	http://dx.doi.org/10.1126/science.1139178			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569861				2022-12-01	WOS:000247239900038
J	Cushing, MC; Anseth, KS				Cushing, Melinda C.; Anseth, Kristi S.			Hydrogel cell cultures	SCIENCE			English	Editorial Material							PROTEIN; GROWTH		Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA; Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Cushing, MC (corresponding author), Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.	kristi.anseth@colorado.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016523] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL089260-01A1, R01 HL089260] Funding Source: Medline; NIDCR NIH HHS [R01 DE016523-04, R01 DE016523] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Dodla MC, 2006, J BIOMED MATER RES A, V78A, P213, DOI 10.1002/jbm.a.30747; Ehrick JD, 2005, NAT MATER, V4, P298, DOI 10.1038/nmat1352; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Hu CJ, 2006, MOL CELL BIOL, V26, P3514, DOI 10.1128/MCB.26.9.3514-3526.2006; Klein Y, 2007, SCIENCE, V315, P1116, DOI 10.1126/science.1135994; Liu H, 2005, TISSUE ENG, V11, P319, DOI 10.1089/ten.2005.11.319; Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092; Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818; Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007; Malkoch M, 2006, CHEM COMMUN, P2774, DOI 10.1039/b603438a; Murakami Y, 2005, BIOMACROMOLECULES, V6, P2927, DOI 10.1021/bm0504330; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Salinas CN, 2007, TISSUE ENG, V13, P1025, DOI 10.1089/ten.2006.0126; Shen W, 2006, NAT MATER, V5, P153, DOI 10.1038/nmat1573; Tsang VL, 2007, FASEB J, V21, P790, DOI 10.1096/fj.06-7117com	15	402	413	16	255	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1133	1134		10.1126/science.1140171	http://dx.doi.org/10.1126/science.1140171			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	171GQ	17525324				2022-12-01	WOS:000246724300025
J	Gatfield, D; Schibler, U				Gatfield, David; Schibler, Ueli			Proteasomes keep the circadian clock ticking	SCIENCE			English	Editorial Material							CLONING; LIMB; GENE		Univ Geneva, Dept Biol Mol, CH-1211 Geneva, Switzerland; Univ Geneva, NCCR Frontiers Genet, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Gatfield, D (corresponding author), Univ Geneva, Dept Biol Mol, CH-1211 Geneva, Switzerland.	david.gatfield@molbio.unige.ch; ueli.schibler@molbio.unige.ch	Gatfield, David/C-2354-2011	Gatfield, David/0000-0001-5114-2824				Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Gachon F, 2004, CHROMOSOMA, V113, P103, DOI 10.1007/s00412-004-0296-2; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; SIEPKA SM, 2007, CELL            0425	10	30	32	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2007	316	5828					1135	1136		10.1126/science.1144165	http://dx.doi.org/10.1126/science.1144165			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	171GQ	17495136				2022-12-01	WOS:000246724300026
J	Chan, AT; Ogino, S; Fuchs, CS				Chan, Andrew T.; Ogino, Shuji; Fuchs, Charles S.			Aspirin and the risk of colorectal cancer in relation to the expression of COX-2	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CYCLOOXYGENASE-2 GENE-EXPRESSION; FOOD FREQUENCY QUESTIONNAIRE; MALE HEALTH-PROFESSIONALS; CORONARY-HEART-DISEASE; RANDOMIZED-TRIAL; ADENOMA RECURRENCE; COMPETING RISKS; UP-REGULATION; PREVENTION	Background: Regular use of aspirin reduces the risk of a colorectal neoplasm, but the mechanism by which aspirin affects carcinogenesis in the colon is not well understood. Methods: We estimated cyclooxygenase-2 (COX-2) expression by immunohistochemical assay of sections from paraffin-embedded colorectal-cancer specimens from two large cohorts of participants who provided data on aspirin use from a questionnaire every 2 years. We applied Cox regression to a competing-risks analysis to compare the effects of aspirin use on the relative risk of colorectal cancer in relation to the expression of COX-2 in the tumor. Results: During 2,446,431 person-years of follow-up of 82,911 women and 47,363 men, we found 636 incident colorectal cancers that were accessible for determination of COX-2 expression. Of the tumors, 423 (67%) had moderate or strong COX-2 expression. The effect of aspirin use differed significantly in relation to COX-2 expression (P for heterogeneity=0.02). Regular aspirin use conferred a significant reduction in the risk of colorectal cancers that overexpressed COX-2 (multivariate relative risk, 0.64; 95% confidence interval [CI], 0.52 to 0.78), whereas regular aspirin use had no influence on tumors with weak or absent expression of COX-2 (multivariate relative risk, 0.96; 95% CI, 0.73 to 1.26). The age-standardized incidence rate for cancers that overexpressed COX-2 was 37 per 100,000 person-years among regular aspirin users, as compared with 56 per 100,000 person-years among those who did not use aspirin regularly; in contrast, the rate for cancers with weak or absent COX-2 expression was 27 per 100,000 person-years among regular aspirin users, as compared with 28 per 100,000 person-years among nonregular aspirin users. Conclusions: Regular use of aspirin appears to reduce the risk of colorectal cancers that overexpress COX-2 but not the risk of colorectal cancers with weak or absent expression of COX-2.	Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Chan, AT (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, 55 Fruit St,GRJ 728A, Boston, MA 02114 USA.	achan@partners.org	Chan, Andy/D-3361-2013; Chan, Andrew T/P-8293-2014	Chan, Andrew T/0000-0001-7284-6767; Ogino, Shuji/0000-0002-3909-2323	NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NCI NIH HHS [CA87969, CA55075, CA10741] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Baron JA, 2006, GASTROENTEROLOGY, V131, P1674, DOI 10.1053/j.gastro.2006.08.079; Benamouzig R, 2003, GASTROENTEROLOGY, V125, P328, DOI 10.1016/S0016-5085(03)00887-4; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Brown JR, 2005, J CLIN ONCOL, V23, P2840, DOI 10.1200/JCO.2005.09.051; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chan AT, 2004, ANN INTERN MED, V140, P157, DOI 10.7326/0003-4819-140-3-200402030-00006; Chan AT, 2005, JAMA-J AM MED ASSOC, V294, P914, DOI 10.1001/jama.294.8.914; Chan AT, 2003, CANCER CAUSE CONTROL, V14, P413, DOI 10.1023/A:1024986220526; Chan TA, 1998, P NATL ACAD SCI USA, V95, P681, DOI 10.1073/pnas.95.2.681; Chulada PC, 2000, CANCER RES, V60, P4705; Cianchi F, 2001, GASTROENTEROLOGY, V121, P1339, DOI 10.1053/gast.2001.29691; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; Glynn RJ, 2005, AM J EPIDEMIOL, V162, P975, DOI 10.1093/aje/kwi309; Haile Robert W, 2005, Clin Colorectal Cancer, V4, P390, DOI 10.3816/CCC.2005.n.011; Hanif R, 1996, BIOCHEM PHARMACOL, V52, P237, DOI 10.1016/0006-2952(96)00181-5; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Huls G, 2003, LANCET, V362, P230, DOI 10.1016/S0140-6736(03)13915-3; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Martinez ME, 2003, P NATL ACAD SCI USA, V100, P7859, DOI 10.1073/pnas.1332465100; Masunaga R, 2000, CLIN CANCER RES, V6, P4064; Ogino S, 2006, MODERN PATHOL, V19, P59, DOI 10.1038/modpathol.3800482; Ogino S, 2006, NEOPLASIA, V8, P458, DOI 10.1593/neo.06247; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Sandler RS, 2003, NEW ENGL J MED, V348, P1939; Schwenger P, 1997, P NATL ACAD SCI USA, V94, P2869, DOI 10.1073/pnas.94.7.2869; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Shureiqi I, 2000, CANCER RES, V60, P6846; Soumaoro LT, 2004, CLIN CANCER RES, V10, P8465, DOI 10.1158/1078-0432.CCR-04-0653; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Zhang H, 2002, AM J GASTROENTEROL, V97, P1037; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	42	588	614	1	78	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2007	356	21					2131	2142		10.1056/NEJMoa067208	http://dx.doi.org/10.1056/NEJMoa067208			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170ON	17522398	Bronze			2022-12-01	WOS:000246673100003
J	Barnes, AP; Lilley, BN; Pan, YA; Plummer, LJ; Powell, AW; Raines, AN; Sanes, JR; Polleux, F				Barnes, Anthony P.; Lilley, Brendan N.; Pan, Y. Albert; Plummer, Lisa J.; Powell, Ashton W.; Raines, Alexander N.; Sanes, Joshua R.; Polleux, Franck			LKB1 and SAD kinases define a pathway required for the polarization of cortical neurons	CELL			English	Article							SERINE/THREONINE PROTEIN-KINASE; DOUBLECORTIN-LIKE-KINASE; NEURITE OUTGROWTH; TUMOR-SUPPRESSOR; MICROTUBULE AFFINITY; HIPPOCAMPAL-NEURONS; MIGRATORY BEHAVIOR; CEREBRAL-CORTEX; AXON FORMATION; POLARITY	The polarization of axon and dendrites underlies the ability of neurons to integrate and transmit information in the brain. We show here that the serine/threonine kinase LKB1, previously implicated in the establishment of epithelial polarity and control of cell growth, is required for axon specification during neuronal polarization in the mammalian cerebral cortex. LKB1 polarizing activity requires its association with the pseudokinase Strado alpha and phosphorylation by kinases such as PKA and p90RSK, which transduce neurite outgrowth-promoting cues. Once activated, LKB1 phosphorylates and thereby activates SAD-A and SAD-B kinases, which are also required for neuronal polarization in the cerebral cortex. SAD kinases, in turn, phosphorylate effectors such as microtubule-associated proteins that implement polarization. Thus, we provide evidence in vivo and in vitro for a multikinase pathway that links extracellular signals to the intracellular machinery required for axon specification.	Univ N Carolina, Ctr Neurosci, Dept Pharmacol, Chapel Hill, NC 27599 USA; Univ N Carolina, Neurodev Disorders Res Ctr, Chapel Hill, NC 27599 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard University	Polleux, F (corresponding author), Univ N Carolina, Ctr Neurosci, Dept Pharmacol, Chapel Hill, NC 27599 USA.	polleux@med.unc.edu	Polleux, Franck/H-9948-2014	Barnes, Anthony/0000-0002-4598-9591; Polleux, Franck/0000-0003-4313-0481	NINDS NIH HHS [P30 NS45892-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Arimura N, 2005, NEURON, V48, P881, DOI 10.1016/j.neuron.2005.11.007; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Bareyre FM, 2005, NAT MED, V11, P1355, DOI 10.1038/nm1331; Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Biernat J, 2002, MOL BIOL CELL, V13, P4013, DOI 10.1091/mbc.02-03-0046; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; Chang SL, 2000, J NEUROSCI METH, V97, P1, DOI 10.1016/S0165-0270(99)00190-9; Chen YM, 2006, P NATL ACAD SCI USA, V103, P8534, DOI 10.1073/pnas.0509955103; Collins SP, 2000, BIOCHEM J, V345, P673, DOI 10.1042/0264-6021:3450673; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Ebneth A, 1999, CELL MOTIL CYTOSKEL, V44, P209, DOI 10.1002/(SICI)1097-0169(199911)44:3<209::AID-CM6>3.0.CO;2-4; Gorski JA, 2002, J NEUROSCI, V22, P6309; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hatanaka Y, 2004, J COMP NEUROL, V479, P1, DOI 10.1002/cne.20256; Hatanaka Y, 2002, J COMP NEUROL, V454, P1, DOI 10.1002/cne.10421; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hung W, 2007, DEVELOPMENT, V134, P237, DOI 10.1242/dev.02725; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Inoue E, 2006, NEURON, V50, P261, DOI 10.1016/j.neuron.2006.03.018; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Jishage K, 2002, P NATL ACAD SCI USA, V99, P8903, DOI 10.1073/pnas.122254599; Kao HT, 2002, NAT NEUROSCI, V5, P431, DOI 10.1038/nn840; Kawano H, 1999, J COMP NEUROL, V408, P147, DOI 10.1002/(SICI)1096-9861(19990531)408:2<147::AID-CNE1>3.0.CO;2-L; Kempf M, 1996, J NEUROSCI, V16, P5583; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Martone ME, 2003, NEUROINFORMATICS, V1, P379, DOI 10.1385/NI:1:4:379; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Miyoshi H, 2002, CANCER RES, V62, P2261; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Polleux F, 1997, J COMP NEUROL, V385, P95; Polleux F, 1998, SCIENCE, V282, P1904, DOI 10.1126/science.282.5395.1904; POLLEUX F, 2002, SCI STKE, V136, pPL9; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Su JY, 1996, J BIOL CHEM, V271, P14430, DOI 10.1074/jbc.271.24.14430; Watts JL, 2000, DEVELOPMENT, V127, P1467; Wiggin GR, 2005, DEV CELL, V8, P803, DOI 10.1016/j.devcel.2005.05.007; Wong EV, 1996, J BIOL CHEM, V271, P18217, DOI 10.1074/jbc.271.30.18217; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074; Yoshimura T, 2006, BIOCHEM BIOPH RES CO, V340, P62, DOI 10.1016/j.bbrc.2005.11.147; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Yu WQ, 2000, J NEUROSCI, V20, P5782, DOI 10.1523/JNEUROSCI.20-15-05782.2000	68	310	322	0	33	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 4	2007	129	3					549	563		10.1016/j.cell.2007.03.025	http://dx.doi.org/10.1016/j.cell.2007.03.025			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482548	Green Submitted, Bronze			2022-12-01	WOS:000246373600021
J	Kostelansky, MS; Schluter, C; Tam, YYC; Lee, S; Ghirlando, R; Beach, B; Conibear, E; Hurley, JH				Kostelansky, Michael S.; Schluter, Cayetana; Tam, Yuen Yi C.; Lee, Sangho; Ghirlando, Rodolfo; Beach, Bridgette; Conibear, Elizabeth; Hurley, James H.			Molecular architecture and functional model of the complete yeast ESCRT-I heterotetramer	CELL			English	Article							SORTING COMPLEX; UBIQUITIN RECOGNITION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; TRANSPORT; PROTEINS; TSG101; DOMAIN; COMPONENT; PATHWAY	The endosomal sorting complex required for transport-1 (ESCRT-1) complex, which is conserved from yeast to humans, directs the lysosomal degradation of ubiquitinated transmembrane proteins and the budding of the HIV virus. Yeast ESCRT-1 contains four subunits, Vps23, Vps28, Vps37, and Mvb12. The crystal structure of the heterotetrameric ESCRT-1 complex reveals a highly asymmetric complex of 1:1:1:1 subunit stoichiometry. The core complex is nearly 18 nm long and consists of a headpiece attached to a 13 nm stalk. The stalk is important for cargo sorting by ESCRT-1 and is proposed to serve as a spacer regulating the correct disposition of cargo and other ESCRT components. Hydrodynamic constraints and crystallographic structures were used to generate a model of intact ESCRT-1 in solution. The results show how ESCRT-1 uses a combination of a rigid stalk and flexible tethers to interact with lipids, cargo, and other ESCRT complexes over a span of similar to 25 nm.	NIDDKD, Mol Biol Lab, NIH, US Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Univ British Columbia, Ctr Mol Med & Therapeut, Child & Family Res Inst, Dept Med Genet, Vancouver, BC V5Z 4H4, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Child & Family Research Institute; University of British Columbia	Hurley, JH (corresponding author), NIDDKD, Mol Biol Lab, NIH, US Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	hurley@helix.nih.gov	Conibear, Elizabeth/G-5297-2010; Ghirlando, Rodolfo/A-8880-2009; Lee, Sangho/P-4204-2018	Lee, Sangho/0000-0003-3886-4579; Conibear, Elizabeth/0000-0001-5129-0499	Intramural NIH HHS [Z01 DK036118-14] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036118, Z01DK033007, Z01DK036123] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; Bilodeau PS, 2003, J CELL BIOL, V163, P237, DOI 10.1083/jcb.200305007; Bonangelino CJ, 2002, MOL BIOL CELL, V13, P2486, DOI 10.1091/mbc.02-01-0005; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Chu T, 2006, J CELL BIOL, V175, P815, DOI 10.1083/jcb.200608053; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Conibear E, 2002, METHOD ENZYMOL, V351, P408; Conibear E, 2002, MOL CELL, V10, P215, DOI 10.1016/S1097-2765(02)00601-9; Curtiss M, 2007, MOL BIOL CELL, V18, P636, DOI 10.1091/mbc.E06-07-0588; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Eastman SW, 2005, J BIOL CHEM, V280, P628, DOI 10.1074/jbc.M410384200; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gill DJ, 2007, EMBO J, V26, P600, DOI 10.1038/sj.emboj.7601501; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hierro A, 2004, NATURE, V431, P221, DOI 10.1038/nature02914; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kim JW, 2005, DEV CELL, V8, P937, DOI 10.1016/j.devcel.2005.04.001; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Kostelansky MS, 2006, CELL, V125, P113, DOI 10.1016/j.cell.2006.01.049; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lee S, 2006, NAT STRUCT MOL BIOL, V13, P264, DOI 10.1038/nsmb1064; Martin-Serrano J, 2003, J VIROL, V77, P4794, DOI 10.1128/JVI.77.8.4794-4804.2003; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Nickerson Daniel P, 2006, J Cell Biol, V175, P715, DOI 10.1083/jcb.200606113; Oestreich AJ, 2007, MOL BIOL CELL, V18, P646, DOI 10.1091/mbc.E06-07-0601; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pineda-Molina E, 2006, TRAFFIC, V7, P1007, DOI 10.1111/j.1600-0854.2006.00440.x; Pornillos O, 2002, NAT STRUCT BIOL, V9, P812, DOI 10.1038/nsb856; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Slagsvold T, 2005, J BIOL CHEM, V280, P19600, DOI 10.1074/jbc.M501510200; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Sundquist WI, 2004, MOL CELL, V13, P783, DOI 10.1016/S1097-2765(04)00129-7; Teo H, 2004, J BIOL CHEM, V279, P28689, DOI 10.1074/jbc.M400023200; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Teo HL, 2006, CELL, V125, P99, DOI 10.1016/j.cell.2006.01.047	43	117	126	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					485	498		10.1016/j.cell.2007.03.016	http://dx.doi.org/10.1016/j.cell.2007.03.016			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17442384	Green Accepted, Bronze			2022-12-01	WOS:000246373600016
J	Peter, ME; Budd, RC; Desbarats, J; Hedrick, SM; Hueber, AO; Newell, MK; Owen, LB; Tschopp, J; Wajant, H; Wallach, D; Wiltrout, RH; Zornig, M; Lynch, DH				Peter, Marcus E.; Budd, Ralph C.; Desbarats, Julie; Hedrick, Stephen M.; Hueber, Anne-Odile; Newell, M. Karen; Owen, Laurie B.; Tschopp, Juerg; Wajant, Harald; Wallach, David; Wiltrout, Robert H.; Zornig, Martin; Lynch, David H.			The CD95 receptor: Apoptosis revisited	CELL			English	Article							HEMATOPOIETIC PROGENITOR CELLS; FAS LIGAND; DEATH; ACTIVATION; PROLIFERATION; CASPASE-8; SIGNALS; INJURY; LEADS; FADD	CD95 is the quintessential death receptor and, when it is bound by ligand, cells undergo apoptosis. Recent evidence suggests, however, that CD95 mediates not only apoptosis but also diverse nonapoptotic functions depending on the tissue and the conditions.	Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; Univ Vermont, Coll Med, Dept Med, Burlington, VT 05405 USA; McGill Univ, Dept Physiol, Montreal, PQ, Canada; Univ Calif San Diego, La Jolla, CA 92093 USA; CNRS, UMR 6543, Inst Signaling Dev Biol & Canc Res, F-06189 Nice, France; Univ Colorado, Inst Bioenerget, Colorado Springs, CO 80907 USA; Univ Calif Riverside, Riverside, CA 92521 USA; Northwestern Univ, Feinberg Sch Med, Div Rheumatol, Chicago, IL 60611 USA; Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; Univ Wurzburg, Dept Mol Internal Med, Med Clin & Polyclin 2, D-97070 Wurzburg, Germany; Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; NCI, Ctr Canc Res, Expt Immunol Lab, Ft Detrick, MD 21702 USA; Bainbridge Biopharma Consulting, Bainbridge Is, WA 98110 USA	University of Chicago; University of Vermont; McGill University; University of California System; University of California San Diego; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; University of Colorado System; University of Colorado at Colorado Springs; University of California System; University of California Riverside; Northwestern University; Feinberg School of Medicine; University of Lausanne; University of Wurzburg; Weizmann Institute of Science; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Peter, ME (corresponding author), Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA.	mpeter@uchicago.edu	Wajant, Harald/A-3020-2017; Hedrick, Stephen M/E-9171-2010; Anne-Odile, Hueber/P-9860-2019; Anne-Odile, Hueber/G-4352-2013	Wajant, Harald/0000-0002-2005-3949; Anne-Odile, Hueber/0000-0003-3816-2446; Anne-Odile, Hueber/0000-0003-3816-2446; Peter, Marcus Ernst/0000-0003-3216-036X; Desbarats, Julie/0000-0002-2495-7152; Pope, Richard M./0000-0003-2416-8660; Hedrick, Stephen/0000-0002-6345-8751	NATIONAL CANCER INSTITUTE [ZIABC009262, ZIABC009322, Z01BC009322, Z01BC009262] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALDERSON MR, 1993, J EXP MED, V178, P2231, DOI 10.1084/jem.178.6.2231; Algeciras-Schimnich A, 2003, P NATL ACAD SCI USA, V100, P11445, DOI 10.1073/pnas.2034995100; Apostolou I, 2003, J EXP MED, V198, P1103, DOI 10.1084/jem.20030698; Badorff C, 2002, J CLIN INVEST, V109, P373, DOI 10.1172/JCI13779; Barnhart BC, 2004, EMBO J, V23, P3175, DOI 10.1038/sj.emboj.7600325; Ben Moshe T, 2007, HEPATOLOGY, V45, P1014, DOI 10.1002/hep.21495; Bidere N, 2006, ANNU REV IMMUNOL, V24, P321, DOI 10.1146/annurev.immunol.24.021605.090513; Chakrabandhu K, 2007, EMBO J, V26, P209, DOI 10.1038/sj.emboj.7601456; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Desbarats J, 2000, NAT MED, V6, P920, DOI 10.1038/78688; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Devadas S, 2006, IMMUNITY, V25, P237, DOI 10.1016/j.immuni.2006.06.011; Diehl AM, 2000, IMMUNOL REV, V174, P160, DOI 10.1034/j.1600-0528.2002.017411.x; Green DR, 2001, NAT REV MOL CELL BIO, V2, P917, DOI 10.1038/35103104; Hao ZY, 2004, J EXP MED, V199, P1355, DOI 10.1084/jem.20032196; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Josefsen D, 1999, EXP HEMATOL, V27, P1451, DOI 10.1016/S0301-472X(99)00073-9; Lee JK, 2003, APOPTOSIS, V8, P151, DOI 10.1023/A:1022918625509; Lee KH, 2006, EMBO J, V25, P1009, DOI 10.1038/sj.emboj.7601016; Ma YY, 2004, NAT IMMUNOL, V5, P380, DOI 10.1038/ni1054; Matsumoto N, 2007, FEBS J, V274, P2376, DOI 10.1111/j.1742-4658.2007.05772.x; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Mitsiades CS, 2006, CLIN CANCER RES, V12, P3705, DOI 10.1158/1078-0432.CCR-05-2493; Muschen M, 2000, J MOL MED-JMM, V78, P312, DOI 10.1007/s001090000112; Park SM, 2005, CURR OPIN CELL BIOL, V17, P610, DOI 10.1016/j.ceb.2005.09.010; Pellegrini M, 2005, BLOOD, V106, P1581, DOI 10.1182/blood-2005-01-0284; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Schuchmann M, 2005, WORLD J GASTROENTERO, V11, P7248, DOI 10.3748/wjg.v11.i46.7248; Sun MY, 2006, J IMMUNOL, V177, P1481, DOI 10.4049/jimmunol.177.3.1481; Tamm C, 2004, EUR J NEUROSCI, V19, P2613, DOI 10.1111/j.0953-816X.2004.03391.x; Zuliani C, 2006, CELL DEATH DIFFER, V13, P31, DOI 10.1038/sj.cdd.4401720	31	315	325	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 4	2007	129	3					447	450		10.1016/j.cell.2007.04.031	http://dx.doi.org/10.1016/j.cell.2007.04.031			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482535	Bronze			2022-12-01	WOS:000246373600007
J	Han, JH; Kushner, SA; Yiu, AP; Cole, CJ; Matynia, A; Brown, RA; Neve, RL; Guzowski, JF; Silva, AJ; Josselyn, SA				Han, Jin-Hee; Kushner, Steven A.; Yiu, Adelaide P.; Cole, Christy J.; Matynia, Anna; Brown, Robert A.; Neve, Rachael L.; Guzowski, John F.; Silva, Alcino J.; Josselyn, Sheena A.			Neuronal competition and selection during memory formation	SCIENCE			English	Article							ELEMENT-BINDING PROTEIN; LONG-TERM-MEMORY; FEAR MEMORIES; IN-VIVO; AMYGDALA; CREB; EXPRESSION; OVEREXPRESSION; PLASTICITY; ACTIVATOR	Competition between neurons is necessary for refining neural circuits during development and may be important for selecting the neurons that participate in encoding memories in the adult brain. To examine neuronal competition during memory formation, we conducted experiments with mice in which we manipulated the function of CREB ( adenosine 3',5'-monophosphate response element-binding protein) in subsets of neurons. Changes in CREB function influenced the probability that individual lateral amygdala neurons were recruited into a fear memory trace. Our results suggest a competitive model underlying memory formation, in which eligible neurons are selected to participate in a memory trace as a function of their relative CREB activity at the time of learning.	Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; Columbia Univ, Dept Psychiat, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; Harvard Univ, Sch Med, Dept Psychiat, Mol Neurogenet Lab, Belmont, MA 02478 USA; Univ Calif Irvine, Sch Biol Sci, Irvine, CA 92697 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Columbia University; New York State Psychiatry Institute; Harvard University; University of California System; University of California Irvine	Josselyn, SA (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	sheena.josselyn@sickkids.ca	Silva, Alcino/ABD-7684-2021; Han, Jin-Hee/C-2069-2011	Silva, Alcino/0000-0002-1587-4558; Han, Jin-Hee/0000-0002-2139-5596; Kushner, Steven/0000-0002-9777-3338; Silva, Alcino/0000-0001-5525-0494	NIA NIH HHS [AG13622] Funding Source: Medline; NICHD NIH HHS [P01HD33098] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD033098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013622, U01AG013622, R37AG013622] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Barco A, 2005, NEURON, V48, P123, DOI 10.1016/j.neuron.2005.09.005; Barrientos RM, 2002, BEHAV BRAIN RES, V134, P299, DOI 10.1016/S0166-4328(02)00045-1; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Dong Y, 2006, NAT NEUROSCI, V9, P475, DOI 10.1038/nn1661; Du KY, 2000, MOL CELL BIOL, V20, P4320, DOI 10.1128/MCB.20.12.4320-4327.2000; Fanselow MS, 2003, ANN NY ACAD SCI, V985, P125; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Jasnow AM, 2005, BEHAV NEUROSCI, V119, P1125, DOI 10.1037/0735-7044.119.4.1125; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Marie H, 2005, NEURON, V45, P741, DOI 10.1016/j.neuron.2005.01.039; Mower AF, 2002, J NEUROSCI, V22, P2237, DOI 10.1523/JNEUROSCI.22-06-02237.2002; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Pham TA, 2001, NEURON, V31, P409, DOI 10.1016/S0896-6273(01)00381-6; Pham TA, 1999, NEURON, V22, P63, DOI 10.1016/S0896-6273(00)80679-0; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; WAITEREIT R, 2001, J NEUROSCI, V21, P5484; Wallace TL, 2004, BIOL PSYCHIAT, V56, P151, DOI 10.1016/j.biopsych.2004.04.010; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5	27	422	444	4	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2007	316	5823					457	460		10.1126/science.1139438	http://dx.doi.org/10.1126/science.1139438			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446403				2022-12-01	WOS:000245813400059
J	Fox, MA; Sanes, JR; Borza, DB; Eswarakumar, VP; Fassler, R; Hudson, BG; John, SWM; Ninomiya, Y; Pedchenko, V; Pfaff, SL; Rheault, MN; Sado, Y; Segal, Y; Werle, MJ; Umemori, H				Fox, Michael A.; Sanes, Joshua R.; Borza, Dorin-Bogdan; Eswarakumar, Veraragavan P.; Faessler, Reinhard; Hudson, Billy G.; John, Simon W. M.; Ninomiya, Yoshifumi; Pedchenko, Vadim; Pfaff, Samuel L.; Rheault, Michelle N.; Sado, Yoshikazu; Segal, Yoav; Werle, Michael J.; Umemori, Hisashi			Distinct target-derived signals organize formation, maturation, and maintenance of motor nerve terminals	CELL			English	Article							FIBROBLAST-GROWTH-FACTOR; NEUROMUSCULAR-JUNCTION; BASEMENT-MEMBRANE; IV COLLAGEN; ALPORT-SYNDROME; NEUROTRANSMITTER RELEASE; NONCOLLAGENOUS DOMAINS; CALCIUM-CHANNEL; XVIII COLLAGEN; MUTANT MICE	Target-derived factors organize synaptogenesis by promoting differentiation of nerve terminals at synaptic sites. Several candidate organizing molecules have been identified based on their bioactivities in vitro, but little is known about their roles in vivo. Here, we show that three sets of organizers act sequentially to pattern motor nerve terminals: FGFs, beta 2 laminins, and collagen alpha(IV) chains. FGFs of the 7/10/22 subfamily and broadly distributed collagen IV chains (alpha 1/2) promote clustering of synaptic vesicles as nerve terminals form. beta 2 laminins concentrated at synaptic sites are dispensable for embryonic development of nerve terminals but are required for their postnatal maturation. Synapse-specific collagen IV chains (alpha 3-6) accumulate only after synapses are mature and are required for synaptic maintenance. Thus, multiple target-derived signals permit discrete control of the formation, maturation, and maintenance of presynaptic specializations.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Vanderbilt Univ, Med Ctr, Ctr Matrix Biol, Nashville, TN 37232 USA; Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; Howard Hughes Med Inst, Bar Harbor, ME 04609 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Okayama Univ, Dept Mol Biol & Biochem, Okayama 700, Japan; Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; Univ Minnesota, Dept Med, Div Renal, Minneapolis, MN 55455 USA; Shigei Med Res Inst, Div Immunol, Okayama 7010202, Japan; Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA; Univ Michigan, Sch Med, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	Harvard University; Yale University; Vanderbilt University; Max Planck Society; Howard Hughes Medical Institute; Jackson Laboratory; Okayama University; Salk Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Kansas; University of Kansas Medical Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sanes, JR (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	sanesj@mcb.harvard.edu	Pedchenko, Vadim/A-6873-2009; Borza, Dorin-Bogdan/AAF-2156-2020	Borza, Dorin-Bogdan/0000-0003-4568-279X; Fox, Michael/0000-0002-1649-7782; Eswarakumar, V.P./0000-0001-7941-8714; Umemori, Hisashi/0000-0001-7198-2062; Eswarakumar, Jacob/0000-0003-0784-0507; Rheault, Michelle N./0000-0003-2494-3970; Hudson, Billy/0000-0002-5420-4100				Ackley BD, 2001, J CELL BIOL, V152, P1219, DOI 10.1083/jcb.152.6.1219; Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Borza DB, 2001, J BIOL CHEM, V276, P28532, DOI 10.1074/jbc.M103690200; Boutaud A, 2000, J BIOL CHEM, V275, P30716, DOI 10.1074/jbc.M004569200; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Cosgrove D, 1996, GENE DEV, V10, P2981, DOI 10.1101/gad.10.23.2981; Craig AM, 2006, TRENDS NEUROSCI, V29, P8, DOI 10.1016/j.tins.2005.11.002; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Eswarakumar VP, 2002, DEVELOPMENT, V129, P3783; Feng GP, 2000, NEURON, V25, P295, DOI 10.1016/S0896-6273(00)80895-8; Fox MA, 2006, J NEUROCHEM, V97, P1215, DOI 10.1111/j.1471-4159.2006.03834.x; Goritz C, 2005, MOL CELL NEUROSCI, V29, P190, DOI 10.1016/j.mcn.2005.02.006; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Gould DB, 2006, NEW ENGL J MED, V354, P1489, DOI 10.1056/NEJMoa053727; HENDERSON CE, 1996, NERVE CELL CULTURE P, P69; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; HUNTER DD, 1989, NATURE, V338, P229, DOI 10.1038/338229a0; Knight D, 2003, J PHYSIOL-LONDON, V546, P789, DOI 10.1113/jphysiol.2002.030924; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Kummer TT, 2004, J CELL BIOL, V164, P1077, DOI 10.1083/jcb.200401115; Lee SK, 2004, DEVELOPMENT, V131, P3295, DOI 10.1242/dev.01179; LEIN PJ, 1991, J CELL BIOL, V113, P417, DOI 10.1083/jcb.113.2.417; LUPA MT, 1990, DEV BIOL, V142, P31, DOI 10.1016/0012-1606(90)90148-C; Miner JH, 2006, DEVELOPMENT, V133, P967, DOI 10.1242/dev.02270; MINER JH, 1994, J CELL BIOL, V127, P879, DOI 10.1083/jcb.127.3.879; Miner JH, 1996, J CELL BIOL, V135, P1403, DOI 10.1083/jcb.135.5.1403; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; NINOMIYA Y, 1995, J CELL BIOL, V130, P1219, DOI 10.1083/jcb.130.5.1219; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; OOHASHI T, 1995, J BIOL CHEM, V270, P26863, DOI 10.1074/jbc.270.45.26863; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Ortega N, 2002, J CELL SCI, V115, P4201, DOI 10.1242/jcs.00106; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; Petitclerc E, 2000, J BIOL CHEM, V275, P8051, DOI 10.1074/jbc.275.11.8051; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Pun S, 2002, NEURON, V34, P357, DOI 10.1016/S0896-6273(02)00670-0; Rheault MN, 2004, J AM SOC NEPHROL, V15, P1466, DOI 10.1097/01.ASN.0000130562.90255.8F; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schneider VA, 2006, NEURON, V50, P683, DOI 10.1016/j.neuron.2006.04.024; Smirnov SP, 2005, J BIOL CHEM, V280, P41449, DOI 10.1074/jbc.M508939200; Son YJ, 1999, EUR J NEUROSCI, V11, P3457, DOI 10.1046/j.1460-9568.1999.00766.x; Sons MS, 2006, NEUROSCIENCE, V138, P433, DOI 10.1016/j.neuroscience.2005.11.040; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sunderland WJ, 2000, J NEUROSCI, V20, P1009, DOI 10.1523/JNEUROSCI.20-03-01009.2000; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Urbano FJ, 2002, MOL MEMBR BIOL, V19, P293, DOI 10.1080/0968768021000035087; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370	56	187	198	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					179	193		10.1016/j.cell.2007.02.035	http://dx.doi.org/10.1016/j.cell.2007.02.035			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418794	Bronze			2022-12-01	WOS:000245661100020
J	Geenen, MM; Cardous-Ubbink, MC; Kremer, LCM; van den Bos, C; van der Pal, HJH; Heinen, RC; Jaspers, MWM; Koning, CCE; Oldenburger, F; Langeveld, NE; Hart, AAM; Bakker, PJM; Caron, HN; van Leeuwen, FE				Geenen, Maud M.; Cardous-Ubbink, Mathilde C.; Kremer, Leontien C. M.; van den Bos, Cor; van der Pal, Helena J. H.; Heinen, Richard C.; Jaspers, Monique W. M.; Koning, Caro C. E.; Oldenburger, Foppe; Langeveld, Nelia E.; Hart, Augustinus A. M.; Bakker, Piet J. M.; Caron, Huib N.; van Leeuwen, Flora E.			Medical assessment of adverse health outcomes in long-term survivors of childhood cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; 2ND MALIGNANT NEOPLASMS; FOLLOW-UP; 5-YEAR SURVIVORS; ADULT SURVIVORS; ADOLESCENT CANCER; HODGKINS-DISEASE; HEART-FAILURE; CLINICAL CARE; BRAIN-TUMORS	Context Improved survival of children with cancer has been accompanied by multiple treatment-related complications. However, most studies in survivors of childhood cancer focused on only 1 late effect. Objective To assess the total burden of adverse health outcomes ( clinical or subclinical disorders ["adverse events"]) following childhood cancer in a large cohort of childhood cancer survivors with long-term and complete medical follow-up. Design, Setting, and Population Retrospective cohort study of 1362 five-year survivors of childhood cancer treated in a single institution in the Netherlands between 1966 and 1996. All survivors were invited to a late-effects clinic for medical assessment of adverse events. Adverse events occurring before January 2004 were graded for severity in a standardized manner. Main Outcome Measures Treatment-specific prevalence of adverse events ( according to severity) at end of follow-up and relative risk of high or severe burden of disease ( >= 2 severe or >= 1 life-threatening or disabling adverse events) associated with various treatments. Results Medical follow-up was complete for 94.3% of survivors ( median follow-up, 17.0 years). The median attained age at end of follow-up was 24.4 years. Almost 75% of survivors had 1 or more adverse events, and 24.6% had 5 or more adverse events. Furthermore, 40% of survivors had at least 1 severe or life-threatening or disabling adverse event. A high or severe burden of adverse events was observed in 55% of survivors who received radiotherapy only and 15% of survivors treated with chemotherapy only, compared with 25% of survivors who had surgery only ( adjusted relative risks, 2.18 [95% confidence interval, 1.62 - 2.95] and 0.65 [ 95% confidence interval, 0.46 - 0.90], respectively). A high or severe burden of adverse events was most often observed in survivors of bone tumors (64%) and least often in survivors of leukemia or Wilms tumor (12% each). Conclusions In young adulthood, a substantial proportion of childhood cancer survivors already has a high or severe burden of disease, particularly after radiotherapy. This underscores the need for lifelong risk-stratified medical surveillance of childhood cancer survivors.	Emma Childrens Hosp, Acad Med Ctr, Late Effects Study Grp, NL-1100 DD Amsterdam, Netherlands; Emma Childrens Hosp, Acad Med Ctr, Outpatient Clin, Poliklin Late Effecten Kindertumoren, NL-1100 DD Amsterdam, Netherlands; Emma Childrens Hosp, Acad Med Ctr, Dept Pediat Oncol, NL-1100 DD Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Med Oncol, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Med Informat, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Radiotherapy, NL-1105 AZ Amsterdam, Netherlands; Netherlands Canc Inst, Dept Radiotherapy, Amsterdam, Netherlands; Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Cancer Institute; Netherlands Cancer Institute	Caron, HN (corresponding author), Emma Childrens Hosp, Acad Med Ctr, Late Effects Study Grp, POB 22660, NL-1100 DD Amsterdam, Netherlands.	h.n.caron@amc.uva.nl	koning, caro/A-5339-2008	Kremer, Leontien/0000-0001-7422-3248				Adams MJ, 2004, J CLIN ONCOL, V22, P3139, DOI 10.1200/JCO.2004.09.109; Bhatia S, 2003, J CLIN ONCOL, V21, P4386, DOI 10.1200/JCO.2003.11.059; Bhatia S, 2006, PEDIATR BLOOD CANCER, V46, P143, DOI 10.1002/pbc.20613; Bhatia S, 2005, CANCER J, V11, P340, DOI 10.1097/00130404-200507000-00010; Cardous-Ubbink MC, 2004, PEDIATR BLOOD CANCER, V42, P563, DOI 10.1002/pbc.20028; Curry HL, 2006, EUR J CANCER, V42, P501, DOI 10.1016/j.ejca.2005.11.003; DONALDSON SS, 1993, INT J RADIAT ONCOL, V26, P739, DOI 10.1016/0360-3016(93)90487-G; Gleeson HK, 2004, ENDOCR-RELAT CANCER, V11, P589, DOI 10.1677/erc.1.00779; Green DM, 2001, J CLIN ONCOL, V19, P1926, DOI 10.1200/JCO.2001.19.7.1926; Gurney JG, 2003, CANCER-AM CANCER SOC, V97, P663, DOI 10.1002/cncr.11095; Hawkins MM, 2006, PEDIATR BLOOD CANCER, V46, P174, DOI 10.1002/pbc.20609; Hewitt M, 2003, CHILDHOOD CANC SURVI; Hudson MM, 2003, JAMA-J AM MED ASSOC, V290, P1583, DOI 10.1001/jama.290.12.1583; Jenkinson HC, 2004, BRIT J CANCER, V91, P1905, DOI 10.1038/sj.bjc.6602226; JOFFE MM, 1995, STAT MED, V14, P2131, DOI 10.1002/sim.4780141907; Kenney LB, 2004, ANN INTERN MED, V141, P590, DOI 10.7326/0003-4819-141-8-200410190-00006; Kremer LCM, 2001, J CLIN ONCOL, V19, P191, DOI 10.1200/JCO.2001.19.1.191; Landier W, 2004, J CLIN ONCOL, V22, P4979, DOI 10.1200/JCO.2004.11.032; Langer T, 2002, MED PEDIATR ONCOL, V38, P320, DOI 10.1002/mpo.10055; LIPSHULTZ SE, 1991, NEW ENGL J MED, V324, P808, DOI 10.1056/NEJM199103213241205; Mackie E, 2000, LANCET, V355, P1310, DOI 10.1016/S0140-6736(00)02112-7; Marks LB, 2003, SEMIN RADIAT ONCOL, V13, P333, DOI 10.1016/S1053-4296(03)00034-1; Mertens AC, 2001, J CLIN ONCOL, V19, P3163, DOI 10.1200/JCO.2001.19.13.3163; Mulhern RK, 2005, J CLIN ONCOL, V23, P5511, DOI 10.1200/JCO.2005.00.703; Mulhern RK, 2004, LANCET ONCOL, V5, P399, DOI 10.1016/S1470-2045(04)01507-4; Neglia JP, 2006, J NATL CANCER I, V98, P1528, DOI 10.1093/jnci/djj411; Neglia JP, 2001, J NATL CANCER I, V93, P618, DOI 10.1093/jnci/93.8.618; Nicholson H S, 1993, Cancer Treat Res, V62, P45; Oeffinger KC, 2004, CA-CANCER J CLIN, V54, P208, DOI 10.3322/canjclin.54.4.208; Oeffinger KC, 2000, CANCER-AM CANCER SOC, V88, P1687, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1687::AID-CNCR24>3.0.CO;2-M; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Simbre Valeriano C, 2005, Paediatr Drugs, V7, P187, DOI 10.2165/00148581-200507030-00005; Skinner R, 1996, LANCET, V348, P578, DOI 10.1016/S0140-6736(96)03480-0; Skinner R, 2006, LANCET ONCOL, V7, P489, DOI 10.1016/S1470-2045(06)70724-0; SKLAR CA, 1995, INT J RADIAT ONCOL, V31, P1113, DOI 10.1016/0360-3016(94)00427-M; Sklar CA, 1999, ACTA PAEDIATR, V88, P1, DOI 10.1111/j.1651-2227.1999.tb14395.x; Speechley KN, 2006, J CLIN ONCOL, V24, P2536, DOI 10.1200/JCO.2005.03.9628; Stevens MCG, 1998, EUR J CANCER, V34, P694, DOI 10.1016/S0959-8049(98)00012-4; van Santen HM, 2005, EUR J CANCER, V41, P1767, DOI 10.1016/j.ejca.2005.02.036; Wallace WHB., 2004, LATE EFFECTS CHILDHO, P49; Zebrack BJ, 2004, J CLIN ONCOL, V22, P999, DOI 10.1200/JCO.2004.06.148	41	577	582	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2007	297	24					2705	2715		10.1001/jama.297.24.2705	http://dx.doi.org/10.1001/jama.297.24.2705			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182UE	17595271	Bronze			2022-12-01	WOS:000247528700020
J	Lee, JH; Koh, H; Kim, M; Kim, Y; Lee, SY; Karess, RE; Lee, SH; Shong, M; Kim, JM; Kim, J; Chung, JK				Lee, Jun Hee; Koh, Hyongjong; Kim, Myungjin; Kim, Yongsung; Lee, Soo Young; Karess, Roger E.; Lee, Sang-Hee; Shong, Minho; Kim, Jin-Man; Kim, Jaeseob; Chung, Jongkyeong			Energy-dependent regulation of cell structure by AMP-activated protein kinase	NATURE			English	Article							MYOSIN-II; NONMUSCLE MYOSIN; LIGHT-CHAIN; CYTOKINESIS; MUTANTS; ROLES; DISC	AMP-activated protein kinase ( AMPK, also known as SNF1A) has been primarily studied as a metabolic regulator that is activated in response to energy deprivation(1). Although there is relatively ample information on the biochemical characteristics of AMPK, not enough data exist on the in vivo function of the kinase. Here, using the Drosophila model system, we generated the first animal model with no AMPK activity and discovered physiological functions of the kinase. Surprisingly, AMPK-null mutants were lethal with severe abnormalities in cell polarity and mitosis, similar to those of lkb1-null mutants. Constitutive activation of AMPK restored many of the phenotypes of lkb1-null mutants, suggesting that AMPK mediates the polarity- and mitosis-controlling functions of the LKB1 serine/threonine kinase. Interestingly, the regulatory site of non-muscle myosin regulatory light chain (MRLC; also known as MLC2)(2,3) was directly phosphorylated by AMPK. Moreover, the phosphomimetic mutant of MRLC3 rescued the AMPK-null defects in cell polarity and mitosis, suggesting MRLC is a critical downstream target of AMPK. Furthermore, the activation of AMPK by energy deprivation was sufficient to cause dramatic changes in cell shape, inducing complete polarization and brush border formation in the human LS174T cell line, through the phosphorylation of MRLC. Taken together, our results demonstrate that AMPK has highly conserved roles across metazoan species not only in the control of metabolism, but also in the regulation of cellular structures.	Korea Adv Inst Sci & Technol, Natl Creat Res Initiat Ctr Cell Growth Regulat, Taejon 305701, South Korea; Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France; Korea Basic Sci Inst, Div Electron Microscop Res, Taejon 305333, South Korea; Chungnam Natl Univ, Sch Med, Dept Pathol, Taejon 301721, South Korea; Chungnam Natl Univ, Sch Med, Dept Internal Med, Taejon 301721, South Korea; GenExel, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Korea Basic Science Institute (KBSI); Chungnam National University; Chungnam National University	Chung, JK (corresponding author), Korea Adv Inst Sci & Technol, Natl Creat Res Initiat Ctr Cell Growth Regulat, 373-1 Kusong Dong, Taejon 305701, South Korea.	jchung@kaist.ac.kr	/H-7803-2012; Koh, Hyoungjong/C-1615-2012	Lee, Jun Hee/0000-0002-2200-6011; shong, minho/0000-0002-0247-7115; KIM, JIN MAN/0000-0003-0905-9730; Lee, Soo Young/0000-0003-1524-836X; Karess, Roger/0000-0002-7299-0600; Koh, Hyongjong/0000-0003-2594-4799				Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Edwards KA, 1996, DEVELOPMENT, V122, P1499; HAY BA, 1994, DEVELOPMENT, V120, P2121; Ivanov AI, 2005, MOL BIOL CELL, V16, P2636, DOI 10.1091/mbc.E05-01-0043; Jordan P, 1997, J CELL BIOL, V139, P1805, DOI 10.1083/jcb.139.7.1805; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; KARESS RE, 1991, CELL, V65, P1177, DOI 10.1016/0092-8674(91)90013-O; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Lee A, 2004, MOL BIOL CELL, V15, P3285, DOI 10.1091/mbc.E04-01-0057; Lee JH, 2006, CELL DEATH DIFFER, V13, P1110, DOI 10.1038/sj.cdd.4401790; Lee JH, 2003, FEBS LETT, V550, P5, DOI 10.1016/S0014-5793(03)00771-3; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; MARTELLONE AM, 1984, PERSPECT AM HIST, V1, P379; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Michell BJ, 1996, J BIOL CHEM, V271, P28445, DOI 10.1074/jbc.271.45.28445; MONFAR M, 1995, MOL CELL BIOL, V15, P326, DOI 10.1128/MCB.15.1.326; Pan DA, 2002, BIOCHEM J, V367, P179, DOI 10.1042/BJ20020703; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Sakurada K, 1998, AM J PHYSIOL-CELL PH, V274, pC1563, DOI 10.1152/ajpcell.1998.274.6.C1563	21	333	343	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2007	447	7147					1017	U9		10.1038/nature05828	http://dx.doi.org/10.1038/nature05828			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180NU	17486097				2022-12-01	WOS:000247373100050
J	Luo, J; Ye, W; Zendehdel, K; Adami, J; Adami, HO; Boffetta, P; Nyren, O				Luo, Juhua; Ye, Weimin; Zendehdel, Kazem; Adami, Johanna; Adami, Hans-Olov; Boffetta, Paolo; Nyren, Olaf			Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study	LANCET			English	Article							SMOKELESS TOBACCO USE; SQUAMOUS-CELL CARCINOMA; N-NITROSAMINES; ALCOHOL-CONSUMPTION; NORTHERN SWEDEN; UNITED-STATES; SMOKING; CARCINOGENICITY; MORTALITY; ETIOLOGY	Background Although classified as carcinogenic, snuff is used increasingly in several populations. Scandinavian moist snuff (snus) has been proposed as a less harmful alternative to smoking, but precise data on the independent associations of snus use with site-specific cancers are sparse. We aimed to assess the risks for cancer of the oral cavity, lung, and pancreas. Methods Detailed information about tobacco smoking and snus use was obtained from 279 897 male Swedish construction workers in 1978-92. Complete follow-up until end of 2004 was accomplished through links with population and health registers. To distinguish possible effects of snus from those of smoking, we focused on 125 576 workers who were reported to be never-smokers at entry. Adjusted relative risks were derived from Cox proportional hazards regression models. Findings 60 cases of oral, 154 of lung, and 83 of pancreatic cancer were recorded in never-smokers. Snus use was independently associated with increased risk of pancreatic cancer (relative risk for ever-users of snus 2.0; 95% Ci 1.2-3.3, compared with never-users of any tobacco), but was unrelated to incidence of oral (0.8, 95% CI 0.4-1.7) and lung cancer (0.8, 0.5-1.3). Interpretation Use of Swedish snus should be added to the list of tentative risk factors for pancreatic cancer. We were unable to confirm any excess of oral or lung cancer in snus users.	Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Med, Clin Epidemiol Unit, SE-17177 Stockholm, Sweden; Univ Tehran, Canc Inst Res Ctr, Tehran, Iran; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Int Agcy Res Canc, F-69372 Lyon, France	Karolinska Institutet; Karolinska Institutet; University of Tehran; Harvard University; Harvard T.H. Chan School of Public Health; World Health Organization; International Agency for Research on Cancer (IARC)	Nyren, O (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Box 281, SE-17177 Stockholm, Sweden.	olof.nyren@ki.se	Boffetta, Paolo/AAI-7767-2021; Ye, Weimin/A-5939-2008; Adami, Johanna/AAA-3312-2021	Boffetta, Paolo/0000-0002-3811-2791; luo, juhua/0000-0002-8901-4462; Zendehdel, Kazem/0000-0002-0269-4945				Accortt NA, 2005, CANCER CAUSE CONTROL, V16, P1107, DOI 10.1007/s10552-005-0247-0; Alguacil J, 2004, CANCER EPIDEM BIOMAR, V13, P55, DOI 10.1158/1055-9965.EPI-03-0033; [Anonymous], 1985, IARC Monogr Eval Carcinog Risk Chem Hum, V37, P1; BJELKE E, 1982, P 13 INT C CANC SEAT, P207; Boffetta P, 2006, INT J CANCER, V118, P1586, DOI 10.1002/ijc.21319; Boffetta P, 2005, INT J CANCER, V114, P992, DOI 10.1002/ijc.20811; Cogliano V, 2004, LANCET ONCOL, V5, P708, DOI 10.1016/S1470-2045(04)01633-X; EKBOM A, 2002, TXB CANC EPIDEMIOLOG, P233; Ekstrom AM, 1999, JNCI-J NATL CANCER I, V91, P786, DOI 10.1093/jnci/91.9.786; FARROW DC, 1990, INT J CANCER, V45, P816, DOI 10.1002/ijc.2910450504; Furberg H, 2006, ADDICTION, V101, P1509, DOI 10.1111/j.1360-0443.2006.01550.x; Gapstur SM, 2000, JAMA-J AM MED ASSOC, V283, P2552, DOI 10.1001/jama.283.19.2552; Gilljam H, 2003, ADDICTION, V98, P1183, DOI 10.1046/j.1360-0443.2003.00379.x; Gupta PC, 2003, RESPIROLOGY, V8, P419, DOI 10.1046/j.1440-1843.2003.00507.x; Hecht SS, 1999, MUTAT RES-FUND MOL M, V424, P127, DOI 10.1016/S0027-5107(99)00014-7; Hecht SS, 1998, CHEM RES TOXICOL, V11, P559, DOI 10.1021/tx980005y; Henley SJ, 2005, CANCER CAUSE CONTROL, V16, P347, DOI 10.1007/s10552-004-5519-6; Hoffmann D, 1997, Adv Dent Res, V11, P322; HOFFMANN D, 1995, J NATL CANCER I, V87, P1862, DOI 10.1093/jnci/87.24.1862; Lewin F, 1998, CANCER-AM CANCER SOC, V82, P1367, DOI 10.1002/(SICI)1097-0142(19980401)82:7&lt;1367::AID-CNCR21&gt;3.0.CO;2-3; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; MATTSSON B, 1984, ACTA RADIOL ONCOL, V23, P305, DOI 10.3109/02841868409136026; Muscat JE, 1997, CANCER EPIDEM BIOMAR, V6, P15; Nyren O, 1996, JNCI-J NATL CANCER I, V88, P1302, DOI 10.1093/jnci/88.18.1302; Persson PG, 2000, J INTERN MED, V248, P103, DOI 10.1046/j.1365-2796.2000.00708.x; Prokopczyk B, 2002, CHEM RES TOXICOL, V15, P677, DOI 10.1021/tx0101088; PROKOPCZYK B, 1991, CANCER LETT, V60, P153, DOI 10.1016/0304-3835(91)90222-4; RAMSTROM L, 1997, REDUCTION SMOKING SM; RIVENSON A, 1988, CANCER RES, V48, P6912; Rodu B, 2005, TOB CONTROL, V14, P405, DOI 10.1136/tc.2005.011429; Rodu B, 2004, CRIT REV ORAL BIOL M, V15, P252, DOI 10.1177/154411130401500502; Rodu B, 2002, J INTERN MED, V252, P398, DOI 10.1046/j.1365-2796.2002.01057.x; Rosenquist K, 2005, ACTA OTO-LARYNGOL, V125, P991, DOI 10.1080/00016480510043440; Schildt EB, 1998, INT J CANCER, V77, P341, DOI 10.1002/(SICI)1097-0215(19980729)77:3<341::AID-IJC6>3.0.CO;2-O; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Schuller HM, 2002, NAT REV CANCER, V2, P455, DOI 10.1038/nrc824; Stegmayr B, 2005, SCAND J PUBLIC HEALT, V33, P321, DOI 10.1080/14034940510032301; WILLIAMS RR, 1977, JNCI-J NATL CANCER I, V58, P525, DOI 10.1093/jnci/58.3.525; Zheng W, 1993, CANCER CAUSE CONTROL, V4, P477	39	163	167	0	24	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 16	2007	369	9578					2015	2020		10.1016/S0140-6736(07)60678-3	http://dx.doi.org/10.1016/S0140-6736(07)60678-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180HT	17498797	Green Submitted			2022-12-01	WOS:000247354400025
J	Lundqvist, T; Fisher, SL; Kern, G; Folmer, RHA; Xue, YF; Newton, DT; Keating, TA; Alm, RA; de Jonge, BLM				Lundqvist, Tomas; Fisher, Stewart L.; Kern, Gunther; Folmer, Rutger H. A.; Xue, Yafeng; Newton, D. Trevor; Keating, Thomas A.; Alm, Richard A.; de Jonge, Boudewijn L. M.			Exploitation of structural and regulatory diversity in glutamate racemases	NATURE			English	Article							AMINO-ACID TRANSAMINASE; ESCHERICHIA-COLI; ALLOSTERIC SITE; L-ALANINE; INHIBITION; MECHANISM; IDENTIFICATION; PHOSPHATASE; MUTAGENESIS; DISCOVERY	Glutamate racemase is an enzyme essential to the bacterial cell wall biosynthesis pathway, and has therefore been considered as a target for antibacterial drug discovery. We characterized the glutamate racemases of several pathogenic bacteria using structural and biochemical approaches. Here we describe three distinct mechanisms of regulation for the family of glutamate racemases: allosteric activation by metabolic precursors, kinetic regulation through substrate inhibition, and D-glutamate recycling using a D-amino acid transaminase. In a search for selective inhibitors, we identified a series of uncompetitive inhibitors specifically targeting Helicobacter pylori glutamate racemase that bind to a cryptic allosteric site, and used these inhibitors to probe the mechanistic and dynamic features of the enzyme. These structural, kinetic and mutational studies provide insight into the physiological regulation of these essential enzymes and provide a basis for designing narrow-spectrum antimicrobial agents.	AstraZeneca R&D Boston, Infect Discovery, Waltham, MA 02451 USA; AstraZeneca R&D, AstraZeneca Global Struct Chem, SE-43188 Molndal, Sweden	AstraZeneca; AstraZeneca	Fisher, SL (corresponding author), AstraZeneca R&D Boston, Infect Discovery, Waltham, MA 02451 USA.	stewart.fisher@astrazeneca.com	DeJonge, Boudewijn/AAR-6717-2020	Xue, Yafeng/0000-0002-7526-8672				ANDERSON M, 2005, Patent No. 20050037478; ASHIUCHI M, 1993, BIOSCI BIOTECH BIOCH, V57, P1978, DOI 10.1271/bbb.57.1978; de Dios A, 2002, J MED CHEM, V45, P4559, DOI 10.1021/jm020901d; DOUBLET P, 1994, BIOCHEMISTRY-US, V33, P5285, DOI 10.1021/bi00183a035; Doublet P, 1996, MICROB DRUG RESIST, V2, P43, DOI 10.1089/mdr.1996.2.43; FISHER LM, 1986, BIOCHEMISTRY-US, V25, P2529, DOI 10.1021/bi00357a037; Fotheringham IG, 1998, J BACTERIOL, V180, P4319, DOI 10.1128/JB.180.16.4319-4323.1998; GHOSH NK, 1966, J BIOL CHEM, V241, P2516; Glavas S, 1997, BIOORG MED CHEM LETT, V7, P2265, DOI 10.1016/S0960-894X(97)00413-7; Glavas S, 2001, BIOCHEMISTRY-US, V40, P6199, DOI 10.1021/bi002703z; Hardy JA, 2004, CURR OPIN STRUC BIOL, V14, P706, DOI 10.1016/j.sbi.2004.10.009; Hardy JA, 2004, P NATL ACAD SCI USA, V101, P12461, DOI 10.1073/pnas.0404781101; HO HT, 1995, BIOCHEMISTRY-US, V34, P2464, DOI 10.1021/bi00008a009; Hwang KY, 1999, NAT STRUCT BIOL, V6, P422; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; MENGINLECREULX D, 1982, J BACTERIOL, V151, P1109, DOI 10.1128/JB.151.3.1109-1117.1982; Newsholme P, 2003, CELL BIOCHEM FUNCT, V21, P1, DOI 10.1002/cbf.1003; Oikonomakos NG, 2000, STRUCTURE, V8, P575, DOI 10.1016/S0969-2126(00)00144-1; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; PUCCI MJ, 1995, J BACTERIOL, V177, P336, DOI 10.1128/jb.177.2.336-342.1995; Ruzheinikov SN, 2005, STRUCTURE, V13, P1707, DOI 10.1016/j.str.2005.07.024; Seidler J, 2003, J MED CHEM, V46, P4477, DOI 10.1021/jm030191r; Song JH, 2005, MOL CELLS, V19, P365; TANNER ME, 1994, TETRAHEDRON LETT, V35, P4073, DOI 10.1016/S0040-4039(00)73115-7; van Heijenoort J, 2001, NAT PROD REP, V18, P503, DOI 10.1039/a804532a; WANG L, 2005, Patent No. 20050026189A1; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803	27	108	136	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2007	447	7146					817	822		10.1038/nature05689	http://dx.doi.org/10.1038/nature05689			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17568739				2022-12-01	WOS:000247207500035
J	Menand, B; Yi, KK; Jouannic, S; Hoffmann, L; Ryan, E; Linstead, P; Schaefer, DG; Dolan, L				Menand, Benoit; Yi, Keke; Jouannic, Stefan; Hoffmann, Laurent; Ryan, Eoin; Linstead, Paul; Schaefer, Didier G.; Dolan, Liam			An ancient mechanism controls the development of cells with a rooting function in land plants	SCIENCE			English	Article							MOSS PHYSCOMITRELLA-PATENS; ARABIDOPSIS-THALIANA; ORIGIN; GROWTH; FAMILY; AUXIN; HAIRS; GENE	Root hairs and rhizoids are cells with rooting functions in land plants. We describe two basic helix-loop-helix transcription factors that control root hair development in the sporophyte ( 2n) of the angiosperm Arabidopsis thaliana and rhizoid development in the gametophytes ( n) of the bryophyte Physcomitrella patens. The phylogeny of land plants supports the hypothesis that early land plants were bryophyte-like and possessed a dominant gametophyte and later the sporophyte rose to dominance. If this hypothesis is correct, our data suggest that the increase in morphological complexity of the sporophyte body in the Paleozoic resulted at least in part from the recruitment of regulatory genes from gametophyte to sporophyte.	John Innes Ctr, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Hangzhou 310058, Peoples R China; Univ Lausanne, Dept Biol Mol Vegetale, CH-1015 Lausanne, Switzerland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Zhejiang University; University of Lausanne	Dolan, L (corresponding author), John Innes Ctr, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England.	liam.dolan@bbsrc.ac.uk	Yi, Keke/N-8482-2019; Yi, Keke/P-3964-2017	Yi, Keke/0000-0002-3916-477X; Yi, Keke/0000-0002-3916-477X; Menand, Benoit/0000-0001-9713-5275; Dolan, Liam/0000-0003-1206-7096	Natural Environment Research Council [NE/C510732/1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BBS/E/J/0000A218] Funding Source: Medline	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bailey PC, 2003, PLANT CELL, V15, P2497, DOI 10.1105/tpc.151140; Berner R. A., 2001, PLANTS INVADE LAND E, P173; Blackwell WH, 2003, BOT REV, V69, P125, DOI 10.1663/0006-8101(2003)069[0125:TTOOOT]2.0.CO;2; Carol RJ, 2002, PHILOS T ROY SOC B, V357, P815, DOI 10.1098/rstb.2002.1092; DUCKETT JG, 1998, BRYOLOGY 21 CENTURY, P223; EDWARDS D, 1995, NATURE, V374, P635, DOI 10.1038/374635a0; Gahoonia TS, 1997, PLANT SOIL, V191, P181, DOI 10.1023/A:1004270201418; Graham LE, 2000, P NATL ACAD SCI USA, V97, P4535, DOI 10.1073/pnas.97.9.4535; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Kenrick P., 2004, FOSSIL PLANTS; Kerp H, 2004, T ROY SOC EDIN-EARTH, V94, P411, DOI 10.1017/S026359330000078X; Kerp H., 2001, PLANTS INVADE LAND E, P52, DOI 10.7312/gens11160-005; Liljegren SJ, 2004, CELL, V116, P843, DOI 10.1016/S0092-8674(04)00217-X; MASUCCI JD, 1994, PLANT PHYSIOL, V106, P1335, DOI 10.1104/pp.106.4.1335; Menand B, 2007, J EXP BOT, V58, P1843, DOI 10.1093/jxb/erm047; Sakakibara K, 2003, DEVELOPMENT, V130, P4835, DOI 10.1242/dev.00644; Schiefelbein J, 2003, CURR OPIN PLANT BIOL, V6, P74, DOI 10.1016/S136952660200002X; Tanahashi T, 2005, DEVELOPMENT, V132, P1727, DOI 10.1242/dev.01709; Thelander M, 2005, J EXP BOT, V56, P653, DOI 10.1093/jxb/eri040; Wellman CH, 2003, NATURE, V425, P282, DOI 10.1038/nature01884	21	283	296	9	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2007	316	5830					1477	1480		10.1126/science.1142618	http://dx.doi.org/10.1126/science.1142618			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556585	Green Submitted			2022-12-01	WOS:000247066400043
J	Sims, TN; Soos, TJ; Xenias, HS; Dubin-Thaler, B; Hofman, JM; Waite, JC; Cameron, TO; Thomas, VK; Varma, R; Wiggins, CH; Sheetz, MP; Littman, DR; Dustin, ML				Sims, Tasha N.; Soos, Timothy J.; Xenias, Harry S.; Dubin-Thaler, Benjamin; Hofman, Jake M.; Waite, Janelle C.; Cameron, Thomas O.; Thomas, V. Kaye; Varma, Rajat; Wiggins, Chris H.; Sheetz, Michael P.; Littman, Dan R.; Dustin, Michael L.			Opposing effects of PKC theta and WASp on symmetry breaking and relocation of the immunological synapse	CELL			English	Article							T-CELL-ACTIVATION; ALDRICH-SYNDROME PROTEIN; KINASE-C-THETA; IN-VIVO; DENDRITIC CELL; IMMUNE SYNAPSE; CUTTING EDGE; ACTIN; LYMPHOCYTES; POLARIZATION	The immunological synapse (IS) is a junction between the T cell and antigen-presenting cell and is composed of supramolecular activation clusters (SMACs). No studies have been published on naive T cell IS dynamics. Here, we find that IS formation during antigen recognition comprises cycles of stable IS formation and autonomous naive T cell migration. The migration phase is driven by PKC theta, which is localized to the F-actin-dependent peripheral (p)SMAC. PKC theta(-/-) T cells formed hyperstable, IS in vitro and in vivo and, like WT cells, displayed fast oscillations in the distal SMAC, but they showed reduced slow oscillations in pSMAC integrity. IS reformation is driven by the Wiscoft Aldrich Syndrome protein (WASp). WASp(-/-) T cells displayed normal IS formation but were unable to reform IS after migration unless PKC theta was inhibited. Thus, opposing effects of PKC theta and WASp control IS stability through pSMAC symmetry breaking and reformation.	NYU, Sch Med, Mol Pathogenesis Program, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Columbia Univ, Dept Phys, New York, NY 10027 USA; Columbia Univ, Dept Appl Phys & Appl Math, New York, NY 10027 USA	New York University; Howard Hughes Medical Institute; New York University; Columbia University; Columbia University; Columbia University	Dustin, ML (corresponding author), NYU, Sch Med, Mol Pathogenesis Program, Skirball Inst Biomol Med, New York, NY 10016 USA.	dustin@saturn.med.nyu.edu	Varma, Rajat/I-1209-2012; Dustin, Michael/AAM-4611-2020	Varma, Rajat/0000-0001-5131-0402; Dustin, Michael/0000-0003-4983-6389				Al-Alwan MM, 2001, J IMMUNOL, V166, P1452, DOI 10.4049/jimmunol.166.3.1452; Badour K, 2003, IMMUNITY, V18, P141, DOI 10.1016/S1074-7613(02)00516-2; Berg-Brown NN, 2004, J EXP MED, V199, P743, DOI 10.1084/jem.20031022; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Calle Y, 2004, BLOOD, V103, P3552, DOI 10.1182/blood-2003-04-1259; Cannon JL, 2004, J IMMUNOL, V173, P1658, DOI 10.4049/jimmunol.173.3.1658; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Cywin CL, 2007, BIOORG MED CHEM LETT, V17, P225, DOI 10.1016/j.bmcl.2006.09.056; Depoil D, 2005, IMMUNITY, V22, P185, DOI 10.1016/j.immuni.2004.12.010; Dobereiner HG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.038102; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; Freiberg BA, 2002, NAT IMMUNOL, V3, P911, DOI 10.1038/ni836; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Gomez TS, 2006, IMMUNITY, V24, P741, DOI 10.1016/j.immuni.2006.03.022; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; KRAAL G, 1986, J EXP MED, V163, P981, DOI 10.1084/jem.163.4.981; Krzewski K, 2006, J CELL BIOL, V173, P121, DOI 10.1083/jcb.200509076; Kucik DF, 1996, J CLIN INVEST, V97, P2139, DOI 10.1172/JCI118651; Lin CH, 1996, NEURON, V16, P769, DOI 10.1016/S0896-6273(00)80097-5; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Marsland BJ, 2004, J EXP MED, V200, P181, DOI 10.1084/jem.20032229; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Salek-Ardakani S, 2004, J IMMUNOL, V173, P6440, DOI 10.4049/jimmunol.173.10.6440; Sanchez-Lockhart M, 2004, J IMMUNOL, V173, P7120, DOI 10.4049/jimmunol.173.12.7120; Sasahara Y, 2002, MOL CELL, V10, P1269, DOI 10.1016/S1097-2765(02)00728-1; Sevilla N, 2003, CURR TOP MICROBIOL, V276, P125; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Smith A, 2005, J CELL BIOL, V170, P141, DOI 10.1083/jcb.200412032; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Somersalo K, 2004, J CLIN INVEST, V113, P49, DOI 10.1172/JCI200419337; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Thome M, 2003, DEV CELL, V4, P3, DOI 10.1016/S1534-5807(02)00407-0; Trifari S, 2006, J IMMUNOL, V177, P7451, DOI 10.4049/jimmunol.177.10.7451; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Verkhovsky AB, 1999, CURR BIOL, V9, P11, DOI 10.1016/S0960-9822(99)80042-6; Villalba M, 2002, J CELL BIOL, V157, P253, DOI 10.1083/jcb.200201097; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Zell T, 2001, P NATL ACAD SCI USA, V98, P10805, DOI 10.1073/pnas.191567898	52	274	275	1	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2007	129	4					773	785		10.1016/j.cell.2007.03.037	http://dx.doi.org/10.1016/j.cell.2007.03.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512410	Bronze			2022-12-01	WOS:000246788300021
J	Grundy, SM				Grundy, Scott M.			Should women be offered cholesterol lowering drugs to prevent cardiovascular disease?	BRITISH MEDICAL JOURNAL			English	Article									Univ Texas, SW Med Ctr Dallas, Ctr Human Nutr, Dept Clin Nutr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr Dallas, Ctr Human Nutr, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Grundy, SM (corresponding author), Univ Texas, SW Med Ctr Dallas, Ctr Human Nutr, Dept Clin Nutr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	scott.grundy@utsouthwestern.edu							0	18	18	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 12	2007	334	7601					982	983		10.1136/bmj.39202.399942.AD	http://dx.doi.org/10.1136/bmj.39202.399942.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170AI	17494017	Green Published			2022-12-01	WOS:000246632800027
J	Pessiglione, M; Schmidt, L; Draganski, B; Kalisch, R; Lau, H; Dolan, RJ; Frith, CD				Pessiglione, Mathias; Schmidt, Liane; Draganski, Bogdan; Kalisch, Raffael; Lau, Hakwan; Dolan, Ray J.; Frith, Chris D.			How the brain translates money into force: A neuroimaging study of subliminal motivation	SCIENCE			English	Article							BASAL GANGLIA; ORBITOFRONTAL CORTEX; REWARD; HUMANS; CIRCUITS; AMYGDALA; REPRESENTATION; STRIATUM; PARALLEL; BEHAVIOR	Unconscious motivation in humans is often inferred but rarely demonstrated empirically. We imaged motivational processes, implemented in a paradigm that varied the amount and reportability of monetary rewards for which subjects exerted physical effort. We show that, even when subjects cannot report how much money is at stake, they nevertheless deploy more force for higher amounts. Such a motivational effect is underpinned by engagement of a specific basal forebrain region. Our findings thus reveal this region as a key node in brain circuitry that enables expected rewards to energize behavior, without the need for the subjects' awareness.	UCL, Wellcome Trust, Ctr Neuroimaging, Inst Neurol, London WC1N 3BG, England; Univ Paris 06, INSERM, Unite 610,Grp Pitie Salpetriere, Ctr Neuroimagerie & Rech, F-75013 Paris, France	University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Pessiglione, M (corresponding author), UCL, Wellcome Trust, Ctr Neuroimaging, Inst Neurol, 12 Queen Sq, London WC1N 3BG, England.	pessigli@ccr.jussieu.fr	Kalisch, Raffael/A-9863-2018; Frith, Chris D/A-2171-2009; Pessiglione, Mathias/E-2141-2017; Kalisch, Raffael/H-6624-2016; Draganski, Bogdan/C-3096-2016	Frith, Chris D/0000-0002-8665-0690; Pessiglione, Mathias/0000-0002-6992-3677; Draganski, Bogdan/0000-0002-5159-5919; Dolan, Ray/0000-0001-9356-761X; Schmidt, Liane/0000-0002-4159-9705	Wellcome Trust [078865] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Berridge KC, 2004, PHYSIOL BEHAV, V81, P179, DOI 10.1016/j.physbeh.2004.02.004; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Critchley HD, 2002, NEUROSCIENTIST, V8, P132, DOI 10.1177/107385840200800209; Dai TH, 2001, EXP BRAIN RES, V140, P290, DOI 10.1007/s002210100815; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; DETIMERS C, 1995, J NEUROPHYSIOL, V74, P802; Elliott R, 2003, J NEUROSCI, V23, P303; Etkin A, 2004, NEURON, V44, P1043, DOI 10.1016/j.neuron.2004.12.006; Friedman DP, 2002, J COMP NEUROL, V450, P345, DOI 10.1002/cne.10336; Gaillard R, 2006, NEURON, V50, P191, DOI 10.1016/j.neuron.2006.03.031; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Heimer L, 2006, NEUROSCI BIOBEHAV R, V30, P126, DOI 10.1016/j.neubiorev.2005.06.006; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Lehericy S, 2004, ANN NEUROL, V55, P522, DOI 10.1002/ana.20030; Lehericy S, 2006, CEREB CORTEX, V16, P149, DOI 10.1093/cercor/bhi089; MCALONAN GM, 1993, NEUROSCIENCE, V52, P605, DOI 10.1016/0306-4522(93)90410-H; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; PANAGIS G, 1995, BEHAV BRAIN RES, V68, P165, DOI 10.1016/0166-4328(94)00169-G; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Tindell AJ, 2004, J NEUROSCI, V24, P1058, DOI 10.1523/JNEUROSCI.1437-03.2004; Vaillancourt DE, 2004, NEUROIMAGE, V23, P175, DOI 10.1016/j.neuroimage.2004.04.040; Yelnik J, 2007, NEUROIMAGE, V34, P618, DOI 10.1016/j.neuroimage.2006.09.026	30	417	428	2	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2007	316	5826					904	906		10.1126/science.1140459	http://dx.doi.org/10.1126/science.1140459			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166HM	17431137	Green Accepted, Green Published			2022-12-01	WOS:000246369800042
J	Ren, M; Yoshimura, Y; Takada, N; Horibe, S; Komatsu, Y				Ren, Ming; Yoshimura, Yumiko; Takada, Naoki; Horibe, Shoko; Komatsu, Yukio			Specialized inhibitory synaptic actions between nearby neocortical pyramidal neurons	SCIENCE			English	Article							PRESYNAPTIC IONOTROPIC RECEPTORS; VESICULAR GLUTAMATE TRANSPORTERS; KAINATE RECEPTORS; HIPPOCAMPAL INTERNEURONS; TRANSMITTER RELEASE; CEREBRAL-CORTEX; RAT NEOCORTEX; AMPA RECEPTOR; GABA RELEASE; DESENSITIZATION	We found that, in the mouse visual cortex, action potentials generated in a single layer-2/3 pyramidal ( excitatory) neuron can reliably evoke large, constant-latency inhibitory postsynaptic currents in other nearby pyramidal cells. This effect is mediated by axo-axonic ionotropic glutamate receptor-mediated excitation of the nerve terminals of inhibitory interneurons, which connect to the target pyramidal cells. Therefore, individual cortical excitatory neurons can generate inhibition independently from the somatic firing of inhibitory interneurons.	Nagoya Univ, Environm Med Res Inst, Dept Neurosci, Nagoya, Aichi 4648601, Japan	Nagoya University	Komatsu, Y (corresponding author), Nagoya Univ, Environm Med Res Inst, Dept Neurosci, Nagoya, Aichi 4648601, Japan.	komatsu@riem.nagoya-u.ac.jp		Yoshimura, Yumiko/0000-0002-7526-4153				Ali AB, 2001, J NEUROSCI, V21, P2992, DOI 10.1523/JNEUROSCI.21-09-02992.2001; Alonso-Nanclares L, 2004, NEUROSCIENCE, V123, P547, DOI 10.1016/j.neuroscience.2003.09.033; Braga MFM, 2003, J NEUROSCI, V23, P442, DOI 10.1523/JNEUROSCI.23-02-00442.2003; Buhl EH, 1997, J PHYSIOL-LONDON, V500, P689, DOI 10.1113/jphysiol.1997.sp022053; Bureau I, 1999, J NEUROSCI, V19, P653; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; Cossart R, 2001, NEURON, V29, P497, DOI 10.1016/S0896-6273(01)00221-5; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DECAMILLI P, 2000, SYNAPSES, pCH2; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Engelman HS, 2004, NAT REV NEUROSCI, V5, P135, DOI 10.1038/nrn1297; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fujiyama F, 2001, J COMP NEUROL, V435, P379, DOI 10.1002/cne.1037; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Jiang L, 2001, NEURON, V30, P503, DOI 10.1016/S0896-6273(01)00298-7; Kawaguchi Y, 2002, J NEUROCYTOL, V31, P277, DOI 10.1023/A:1024126110356; Kerchner GA, 2001, NEURON, V32, P477, DOI 10.1016/S0896-6273(01)00479-2; Li P, 1999, NATURE, V397, P161, DOI 10.1038/16469; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; Min MY, 1999, P NATL ACAD SCI USA, V96, P9932, DOI 10.1073/pnas.96.17.9932; More JCA, 2003, BRIT J PHARMACOL, V138, P1093, DOI 10.1038/sj.bjp.0705148; Mulle C, 2000, NEURON, V28, P475, DOI 10.1016/S0896-6273(00)00126-4; Pelletier JC, 1996, J MED CHEM, V39, P343, DOI 10.1021/jm950740w; Rodriguez-Moreno A, 2000, P NATL ACAD SCI USA, V97, P1293, DOI 10.1073/pnas.97.3.1293; Rozov A, 2001, J NEUROSCI, V21, P8062, DOI 10.1523/JNEUROSCI.21-20-08062.2001; Satake S, 2000, NAT NEUROSCI, V3, P551, DOI 10.1038/75718; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; Wilding TJ, 1997, J NEUROSCI, V17, P2713; Zilberter Y, 2000, J PHYSIOL-LONDON, V528, P489, DOI 10.1111/j.1469-7793.2000.00489.x	30	60	62	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2007	316	5825					758	761		10.1126/science.1135468	http://dx.doi.org/10.1126/science.1135468			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17478724				2022-12-01	WOS:000246181400050
J	Peng, CH; Ouyang, H; Gao, Q; Jiang, Y; Zhang, F; Li, J; Yu, Q				Peng, Changhui; Ouyang, Hua; Gao, Qiong; Jiang, Yuan; Zhang, Feng; Li, Jun; Yu, Qiang			Environment - Building a "green" railway in China	SCIENCE			English	Editorial Material									Univ Quebec, Inst Environm Sci, Dept Biol Sci, Montreal, PQ H3C 3P8, Canada; Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing 100101, Peoples R China; Beijing Normal Univ, Coll Resources Sci & Technol, Beijing 100875, Peoples R China	University of Quebec; University of Quebec Montreal; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Beijing Normal University	Peng, CH (corresponding author), Univ Quebec, Inst Environm Sci, Dept Biol Sci, Montreal, PQ H3C 3P8, Canada.	peng.changhui@uqam.ca	Yu, Qiang/D-3702-2009; Peng, Changhui/G-8248-2012	Yu, Qiang/0000-0001-6950-1821; 				LI WH, 1998, ECOSYSTEM QINGHAI XI, P1; Liu J.Y., 2005, INTEGRATED ECOSYSTEM; Liu JG, 2005, NATURE, V435, P1179, DOI 10.1038/4351179a; National Research Council, 2003, TECHN DEV ARM UNM GR, P1; *QINGH TIB RAILW, ENV PROT; Wu ZY, 2006, SCIENCE, V312, P1475, DOI 10.1126/science.1120682; XI GJ, 2001, ECOLOGICAL ENV W CHI; ZHANG ZY, 2002, EXPLOITATION USAGE W; 2006, CHINA THROUGH LENS; PROTECTION ENDANGERE; RESTORING GRASSLAND; 2002, PEOPLES DAILY   1105	12	38	44	6	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2007	316	5824					546	547		10.1126/science.1134134	http://dx.doi.org/10.1126/science.1134134			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	160ZC	17463272				2022-12-01	WOS:000245983100026
J	Katona, G; Carpentier, P; Niviere, V; Amara, P; Adam, V; Ohana, J; Tsanov, N; Bourgeois, D				Katona, Gergely; Carpentier, Philippe; Niviere, Vincent; Amara, Patricia; Adam, Virgile; Ohana, Jereny; Tsanov, Nikolay; Bourgeois, Dominique			Raman-assisted crystallography reveals end-on peroxide intermediates in a nonheme iron enzyme	SCIENCE			English	Article							SUPEROXIDE REDUCTASE; ACTIVE-SITE; DESULFOARCULUS-BAARSII; ELECTRONIC-STRUCTURES; PYROCOCCUS-FURIOSUS; CATALYTIC PATHWAY; MECHANISM; DIOXYGEN; BINDING; IDENTIFICATION	Iron-peroxide intermediates are central in the reaction cycle of many iron-containing biomolecules. We trapped iron(III)-(hydro) peroxo species in crystals of superoxide reductase (SOR), a nonheme mononuclear iron enzyme that scavenges superoxide radicals. X-ray diffraction data at 1.95 angstrom resolution and Raman spectra recorded in crystallo revealed iron-(hydro) peroxo intermediates with the ( hydro) peroxo group bound end-on. The dynamic SOR active site promotes the formation of transient hydrogen bond networks, which presumably assist the cleavage of the iron- oxygen bond in order to release the reaction product, hydrogen peroxide.	Univ Grenoble 1, CNRS, CEA, Inst Biol Struct Jean Pierre Ebel, F-38027 Grenoble, France; Univ Grenoble 1, CNRS, CEA,Lab Chim & Biol Met, Inst Rech Technol & Sci Vivant, F-38054 Grenoble 9, France; European Synchrotron Radiat Facil, F-38043 Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); European Synchrotron Radiation Facility (ESRF)	Bourgeois, D (corresponding author), Univ Grenoble 1, CNRS, CEA, Inst Biol Struct Jean Pierre Ebel, 41 Rue Jules Horowitz, F-38027 Grenoble, France.	dominique.bourgeois@ibs.fr	Carpentier, Philippe/AAF-5995-2019; , Bourgeois/AAI-2337-2020; Adam, Virgile/B-9359-2009; Katona, Gergely/B-3491-2008	Adam, Virgile/0000-0003-2209-7846; Katona, Gergely/0000-0002-2031-8716; Niviere, Vincent/0000-0002-5132-457X; Amara, Patricia/0000-0001-9634-7305; Ohana, Jeremy/0000-0002-2772-7483				Adam V, 2004, STRUCTURE, V12, P1729, DOI 10.1016/j.str.2004.07.013; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; Bourgeois D, 2005, CURR OPIN STRUC BIOL, V15, P538, DOI 10.1016/j.sbi.2005.08.002; Brines LM, 2007, EUR J INORG CHEM, P29, DOI 10.1002/ejic.200600461; Brunold TC, 1999, J AM CHEM SOC, V121, P8277, DOI 10.1021/ja990334s; Bukowski MR, 2005, ANGEW CHEM INT EDIT, V44, P584, DOI 10.1002/anie.200461527; Carey PR, 2004, BIOCHEMISTRY-US, V43, P8885, DOI 10.1021/bi049138a; Clay MD, 2006, BIOCHEMISTRY-US, V45, P427, DOI 10.1021/bi052034v; Clay MD, 2002, J AM CHEM SOC, V124, P788, DOI 10.1021/ja016889g; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Emerson JP, 2002, BIOCHEMISTRY-US, V41, P4348, DOI 10.1021/bi0119159; Girerd JJ, 2000, STRUCT BOND, V97, P145; Jenney FE, 1999, SCIENCE, V286, P306, DOI 10.1126/science.286.5438.306; Karlsson A, 2003, SCIENCE, V299, P1039, DOI 10.1126/science.1078020; Kuhnel K, 2007, P NATL ACAD SCI USA, V104, P99, DOI 10.1073/pnas.0606285103; Loew GH, 2000, CHEM REV, V100, P407, DOI 10.1021/cr980389x; Lombard M, 2000, J BIOL CHEM, V275, P27021; Mathe C, 2006, BIOPHYS CHEM, V119, P38, DOI 10.1016/j.bpc.2005.06.013; Mathe C, 2005, J AM CHEM SOC, V127, P16436, DOI 10.1021/ja053808y; Mathe C, 2002, J AM CHEM SOC, V124, P4966, DOI 10.1021/ja025707v; Niviere V, 2004, BIOCHEMISTRY-US, V43, P808, DOI 10.1021/bi035698i; Rodrigues JV, 2006, BIOCHEMISTRY-US, V45, P9266, DOI 10.1021/bi052489k; Roelfes G, 2003, INORG CHEM, V42, P2639, DOI 10.1021/ic034065p; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Tobi D, 2005, P NATL ACAD SCI USA, V102, P18908, DOI 10.1073/pnas.0507603102; Yeh AP, 2000, BIOCHEMISTRY-US, V39, P2499, DOI 10.1021/bi992428k	27	125	127	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					449	453		10.1126/science.1138885	http://dx.doi.org/10.1126/science.1138885			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446401	Green Submitted, Green Accepted			2022-12-01	WOS:000245813400057
J	van der Wel, N; Hava, D; Houben, D; Fluitsma, D; van Zon, M; Pierson, J; Brenner, M; Peters, PJ				van der Wel, Nicole; Hava, David; Houben, Diane; Fluitsma, Donna; van Zon, Maaike; Pierson, Jason; Brenner, Michael; Peters, Peter J.			M-tuberculosis and M-leprae translocate from the phagolysosome to the cytosol in myeloid cells	CELL			English	Article							CROSS-PRESENTATION; CALMETTE-GUERIN; BOVIS BCG; ALVEOLAR MACROPHAGES; PHAGOSOMAL MEMBRANES; DENDRITIC CELLS; II MOLECULES; HOST-CELLS; INFECTION; VIRULENCE	M. tuberculosis and M. leprae are considered to be prototypical intracellular pathogens that have evolved strategies to enable growth in the intracellular phagosomes. In contrast, we show that lysosomes rapidly fuse with the virulent M. tuberculosis- and M. leprae-containing phagosomes of human monocyte-derived dendritic cells and macrophages. After 2 days, M. tuberculosis progressively translocates from phagolysosomes into the cytosol in nonapoptotic cells. Cytosolic entry is also observed for M. leprae but not for vaccine strains such as M. bovis BCG or in heat-killed mycobacteria and is dependent upon secretion of the mycobacterial gene products CFP-10 and ESAT-6. The cytosolic bacterial localization and replication are pathogenic features of virulent mycobacteria, causing significant cell death within a week. This may also reveal a mechanism for MHC-based antigen presentation that is lacking in current vaccine strains.	Netherlands Canc Inst, Antoni Van Leeuwenhoek Hosp, NL-1066 CX Amsterdam, Netherlands; Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA; VU Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; VU Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands	Netherlands Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Peters, PJ (corresponding author), Netherlands Canc Inst, Antoni Van Leeuwenhoek Hosp, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	p.peters@nki.nl	Van Der Wel, Nicole/AAE-7569-2020	van der Wel, Nicole/0000-0001-6392-3417				Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; Adams LB, 2002, J INFECT DIS, V185, pS1, DOI 10.1086/338002; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Derrick SC, 2007, CELL MICROBIOL, V9, P1547, DOI 10.1111/j.1462-5822.2007.00892.x; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Gao LY, 2006, INFECT IMMUN, V74, P1757, DOI 10.1128/IAI.74.3.1757-1767.2006; Glomski IJ, 2002, J CELL BIOL, V156, P1029, DOI 10.1083/jcb.200201081; Gordon SV, 1999, MOL MICROBIOL, V32, P643, DOI 10.1046/j.1365-2958.1999.01383.x; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Kang PB, 2005, J EXP MED, V202, P987, DOI 10.1084/jem.20051239; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lazarevic V, 2005, J IMMUNOL, V175, P1107, DOI 10.4049/jimmunol.175.2.1107; LEAKE ES, 1984, INFECT IMMUN, V45, P443, DOI 10.1128/IAI.45.2.443-446.1984; Lee J, 2006, J IMMUNOL, V176, P4267, DOI 10.4049/jimmunol.176.7.4267; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; Majlessi L, 2005, J IMMUNOL, V174, P3570, DOI 10.4049/jimmunol.174.6.3570; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; MCDONOUGH KA, 1993, INFECT IMMUN, V61, P2763, DOI 10.1128/IAI.61.7.2763-2773.1993; Mostowy S, 2002, J INFECT DIS, V186, P74, DOI 10.1086/341068; MYRVIK QN, 1984, AM REV RESPIR DIS, V129, P322; Orme I, 2004, CURR OPIN MICROBIOL, V7, P58, DOI 10.1016/j.mib.2003.11.002; Peters P. J., 2006, CURRENT PROTOCOLS CE; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; Philipp WJ, 1996, MICROBIOL-UK, V142, P3135, DOI 10.1099/13500872-142-11-3135; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Placido R, 1997, J PATHOL, V181, P31, DOI 10.1002/(SICI)1096-9896(199701)181:1<31::AID-PATH722>3.0.CO;2-G; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; Riendeau CJ, 2003, INFECT IMMUN, V71, P254, DOI 10.1128/IAI.71.1.254-259.2003; Russell DG, 2002, J CELL BIOL, V158, P421, DOI 10.1083/jcb.200205034; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Schuerch DW, 2005, P NATL ACAD SCI USA, V102, P12537, DOI 10.1073/pnas.0500558102; Stamm LM, 2005, P NATL ACAD SCI USA, V102, P14837, DOI 10.1073/pnas.0504663102; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Stevens JM, 2006, NAT REV MICROBIOL, V4, P91, DOI 10.1038/nrmicro1320; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; van der Wel NN, 2005, CURR OPIN MICROBIOL, V8, P323, DOI 10.1016/j.mib.2005.04.014; van der Wel NN, 2003, MOL BIOL CELL, V14, P3378, DOI 10.1091/mbc.E02-11-0744; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015	53	684	694	0	34	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 29	2007	129	7					1287	1298		10.1016/j.cell.2007.05.059	http://dx.doi.org/10.1016/j.cell.2007.05.059			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	188HQ	17604718	Bronze			2022-12-01	WOS:000247911400015
J	Okie, S				Okie, Susan			An elusive balance - Residents' work hours and the continuity of care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ADVERSE EVENTS											Barger LK, 2006, PLOS MED, V3, P2440, DOI 10.1371/journal.pmed.0030487; Petersen L A, 1998, Jt Comm J Qual Improv, V24, P77; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008; Vidyarthi AR, 2006, J HOSP MED, V1, P257, DOI 10.1002/jhm.103	4	67	68	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 28	2007	356	26					2665	2667		10.1056/NEJMp078085	http://dx.doi.org/10.1056/NEJMp078085			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	183HS	17596598				2022-12-01	WOS:000247564500001
J	Ohto, U; Fukase, K; Miyake, K; Satow, Y				Ohto, Umeharu; Fukase, Koichi; Miyake, Kensuke; Satow, Yoshinori			Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa	SCIENCE			English	Article							LIPOPOLYSACCHARIDE; TLR4; RECOGNITION; IMMUNITY; BINDING	Endotoxic lipopolysaccharide (LPS) with potent immunostimulatory activity is recognized by the receptor complex of MD-2 and Toll-like receptor 4. Crystal structures of human MD-2 and its complex with the antiendotoxic tetra-acylated lipid A core of LPS have been determined at 2.0 and 2.2 angstrom resolutions, respectively. MD-2 shows a deep hydrophobic cavity sandwiched by two beta sheets, in which four acyl chains of the ligand are fully confined. The phosphorylated glucosamine moieties are located at the entrance to the cavity. These structures suggest that MD-2 plays a principal role in endotoxin recognition and provide a basis for antiseptic drug development.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Osaka Univ, Grad Sch Sci, Dept Chem, Osaka 5600043, Japan; Univ Tokyo, Inst Med Sci, Div Infect Genet, Minato Ku, Tokyo 1088639, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Osaka University; University of Tokyo; Japan Science & Technology Agency (JST)	Satow, Y (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	satowy@mol.f.u-tokyo.ac.jp						Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Alexander C, 2002, TRENDS GLYCOSCI GLYC, V14, P69, DOI 10.4052/tigg.14.69; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Gangloff M, 2004, TRENDS BIOCHEM SCI, V29, P294, DOI 10.1016/j.tibs.2004.04.008; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; Inohara N, 2002, TRENDS BIOCHEM SCI, V27, P219, DOI 10.1016/S0968-0004(02)02084-4; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Kusumoto S, 2003, J ENDOTOXIN RES, V9, P361, DOI 10.1179/096805103225002737; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Mancek M, 2002, BIOCHEM BIOPH RES CO, V292, P880, DOI 10.1006/bbrc.2002.6748; Means TK, 2000, CYTOKINE GROWTH F R, V11, P219, DOI 10.1016/S1359-6101(00)00006-X; Miyake K, 2004, SEMIN IMMUNOL, V16, P11, DOI 10.1016/j.smim.2003.10.007; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Mullen GED, 2003, P NATL ACAD SCI USA, V100, P3919, DOI 10.1073/pnas.0630495100; Muroi M, 2006, J BIOL CHEM, V281, P5484, DOI 10.1074/jbc.M509193200; Muroi M, 2002, INFECT IMMUN, V70, P3546, DOI 10.1128/IAI.70.7.3546-3550.2002; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Poltorak A, 2000, P NATL ACAD SCI USA, V97, P2163, DOI 10.1073/pnas.040565397; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Re F, 2003, J IMMUNOL, V171, P5272, DOI 10.4049/jimmunol.171.10.5272; Viriyakosol S, 2001, J BIOL CHEM, V276, P38044; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200; Visintin A, 2006, IMMUNOBIOLOGY, V211, P437, DOI 10.1016/j.imbio.2006.05.010; WILSON IA, 1994, CURR OPIN STRUC BIOL, V4, P857, DOI 10.1016/0959-440X(94)90267-4; Wright CS, 2004, J MOL BIOL, V342, P585, DOI 10.1016/j.jmb.2004.07.063	29	370	379	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1632	1634		10.1126/science.1139111	http://dx.doi.org/10.1126/science.1139111			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569869				2022-12-01	WOS:000247239900046
J	Tang, X; Orlicky, S; Lin, Z; Willems, A; Neculai, D; Ceccarelli, D; Mercurio, F; Shilton, BH; Sicheri, F; Tyers, M				Tang, Xiaojing; Orlicky, Stephen; Lin, Zhenyuan; Willems, Andrew; Neculai, Dante; Ceccarelli, Derek; Mercurio, Frank; Shilton, Brian H.; Sicheri, Frank; Tyers, Mike			Suprafacial orientation of the SCFCdc4 dimer accommodates multiple geometries for substrate ubiquitination	CELL			English	Article							F-BOX PROTEINS; ANGLE SCATTERING DATA; CYCLIN-E; LIGASE COMPLEX; MULTISITE PHOSPHORYLATION; DEPENDENT UBIQUITINATION; STRUCTURAL-ANALYSIS; SCF; DEGRADATION; PROTEOLYSIS	SCF ubiquitin ligases recruit substrates for degradation via F box protein adaptor subunits. WD40 repeat F box proteins, such as Cdc4 and beta-TrCP, contain a conserved dimerization motif called the D domain. Here, we report that the D domain protomers of yeast Cdc4 and human beta-TrCP form a superhelical homotypic dimer. Disruption of the D domain compromises the activity of yeast SCFCdc4 toward the CDK inhibitor Sicl and other substrates. SCFCdc4 dimerization has little effect on the affinity for Sicl but markedly stimulates ubiquitin conjugation. A model of the dimeric holo-SCFCdc4 complex based on small-angle X-ray scatter measurements reveals a suprafacial configuration, in which substrate-binding sites and E2 catalytic sites lie in the same plane with a separation of 64 angstrom within and 102 angstrom between each SCIF monomer. This spatial variability may accommodate diverse acceptor lysine geometries in both substrates and the elongating ubiquitin chain and thereby increase catalytic efficiency.	Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; Cellgene Corp, Summit, NJ 07901 USA; Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Western University (University of Western Ontario); University of Toronto	Tyers, M (corresponding author), Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada.	sicheri@mshri.on.ca; tyers@mshri.on.ca	Sicheri, Frank/F-8856-2013; Neculai, Dante/A-9923-2011; Shilton, Brian H/A-6667-2011; Neculai, Dante/M-2884-2013; Tyers, Michael/ABE-3194-2021	Neculai, Dante/0000-0001-8887-9168; Orlicky, Stephen/0000-0002-8172-2042; Ceccarelli, Derek/0000-0002-2674-9234	NCRR NIH HHS [RR-08630] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; Aviv T, 2003, NAT STRUCT BIOL, V10, P614, DOI 10.1038/nsb956; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Chung J, 2006, ONCOGENE, V25, P3079, DOI 10.1038/sj.onc.1209328; Dixon C, 2003, EUKARYOT CELL, V2, P123, DOI 10.1128/EC.2.1.123-133.2003; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Flick K, 2004, NAT CELL BIOL, V6, P634, DOI 10.1038/ncb1143; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jia JH, 2005, DEV CELL, V9, P819, DOI 10.1016/j.devcel.2005.10.006; Klein P, 2003, CURR BIOL, V13, P1669, DOI 10.1016/j.cub.2003.09.027; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kominami K, 1998, GENES CELLS, V3, P721, DOI 10.1046/j.1365-2443.1998.00225.x; Kostic M, 2006, J MOL BIOL, V363, P433, DOI 10.1016/j.jmb.2006.08.027; MCTIGUE MA, 1995, J MOL BIOL, V246, P21, DOI 10.1006/jmbi.1994.0061; Moberg KH, 2004, CURR BIOL, V14, P965, DOI 10.1016/j.cub.2004.04.040; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Passmore LA, 2005, MOL CELL, V20, P855, DOI 10.1016/j.molcel.2005.11.003; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Petroski MD, 2006, MOL CELL, V24, P523, DOI 10.1016/j.molcel.2006.10.010; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Petroski MD, 2003, MOL CELL, V11, P1435, DOI 10.1016/S1097-2765(03)00221-1; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Spruck CH, 2002, CANCER RES, V62, P4535; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Suzuki H, 2000, J BIOL CHEM, V275, P2877, DOI 10.1074/jbc.275.4.2877; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tang XJ, 2005, METHOD ENZYMOL, V399, P433, DOI 10.1016/S0076-6879(05)99030-7; Vander Kooi CW, 2006, BIOCHEMISTRY-US, V45, P121, DOI 10.1021/bi051787e; Varelas X, 2003, MOL CELL BIOL, V23, P5388, DOI 10.1128/MCB.23.15.5388-5400.2003; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Welcker M, 2003, MOL CELL, V12, P381, DOI 10.1016/S1097-2765(03)00287-9; Welcker M, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-7; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wolf DA, 1999, CURR BIOL, V9, P373, DOI 10.1016/S0960-9822(99)80165-1; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	50	160	166	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2007	129	6					1165	1176		10.1016/j.cell.2007.04.042	http://dx.doi.org/10.1016/j.cell.2007.04.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574027	Bronze			2022-12-01	WOS:000247390400019
J	Rossi, DJ; Bryder, D; Seita, J; Nussenzweig, A; Hoeijmakers, J; Weissman, IL				Rossi, Derrick J.; Bryder, David; Seita, Jun; Nussenzweig, Andre; Hoeijmakers, Jan; Weissman, Irving L.			Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age	NATURE			English	Article							LIFE-SPAN; SERIAL TRANSPLANTATION; SELF-RENEWAL; MOUSE MODEL; MICE; TELOMERASE; CANCER; TRANSCRIPTION; DEFECTS; STRESS	A diminished capacity to maintain tissue homeostasis is a central physiological characteristic of ageing. As stem cells regulate tissue homeostasis, depletion of stem cell reserves and/or diminished stem cell function have been postulated to contribute to ageing(1). It has further been suggested that accumulated DNA damage could be a principal mechanism underlying age-dependent stem cell decline(2). We have tested these hypotheses by examining haematopoietic stem cell reserves and function with age in mice deficient in several genomic maintenance pathways including nucleotide excision repair(3,4), telomere maintenance(5,6) and non-homologous end-joining(7,8). Here we show that although deficiencies in these pathways did not deplete stem cell reserves with age, stem cell functional capacity was severely affected under conditions of stress, leading to loss of reconstitution and proliferative potential, diminished self-renewal, increased apoptosis and, ultimately, functional exhaustion. Moreover, we provide evidence that endogenous DNA damage accumulates with age in wild-type stem cells. These data are consistent with DNA damage accrual being a physiological mechanism of stem cell ageing that may contribute to the diminished capacity of aged tissues to return to homeostasis after exposure to acute stress or injury.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; NCI, Lab Receptor Biol, NIH, Bethesda, MD 20892 USA; Erasmus MC, MGC CBG Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands	Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Erasmus University Rotterdam; Erasmus MC	Rossi, DJ (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	drossi@stanford.edu	Hoeijmakers, Jan/AAX-6972-2021; Seita, Jun/AAM-1478-2020; Bryder, David/Q-6292-2019	Seita, Jun/0000-0002-3008-3615; Bryder, David/0000-0002-8761-4237	NATIONAL CANCER INSTITUTE [ZIABC010283, Z01BC010283] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Allsopp RC, 2001, J EXP MED, V193, P917, DOI 10.1084/jem.193.8.917; Bender CF, 2002, GENE DEV, V16, P2237, DOI 10.1101/gad.1007902; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; de Boer J, 1998, MOL CELL, V1, P981, DOI 10.1016/S1097-2765(00)80098-2; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Hathcock KS, 2002, P NATL ACAD SCI USA, V99, P3591, DOI 10.1073/pnas.012549799; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Ishikawa K, 2006, DNA CELL BIOL, V25, P406, DOI 10.1089/dna.2006.25.406; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Kim M, 2003, ANN NY ACAD SCI, V996, P195, DOI 10.1111/j.1749-6632.2003.tb03247.x; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Morales M, 2005, GENE DEV, V19, P3043, DOI 10.1101/gad.1373705; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Navarro S, 2006, MOL THER, V14, P525, DOI 10.1016/j.ymthe.2006.05.018; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Nussenzweig A, 1997, P NATL ACAD SCI USA, V94, P13588, DOI 10.1073/pnas.94.25.13588; Park Y, 2005, ANNU REV MED, V56, P495, DOI 10.1146/annurev.med.56.082103.104546; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Prasher JM, 2005, EMBO J, V24, P861, DOI 10.1038/sj.emboj.7600542; Reese JS, 2003, BLOOD, V102, P1626, DOI 10.1182/blood-2002-10-3035; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Samper E, 2002, BLOOD, V99, P2767, DOI 10.1182/blood.V99.8.2767; Schlessinger D, 2001, MECH AGEING DEV, V122, P1537, DOI 10.1016/S0047-6374(01)00299-8; Seita J, 2007, P NATL ACAD SCI USA, V104, P2349, DOI 10.1073/pnas.0606238104; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236	35	814	845	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2007	447	7145					725	U15		10.1038/nature05862	http://dx.doi.org/10.1038/nature05862			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554309				2022-12-01	WOS:000247030700046
J	Gill, SS; Bronskill, SE; Normand, SLT; Anderson, GM; Sykora, K; Lam, K; Bell, CM; Lee, PE; Fischer, HD; Herrmann, N; Gurwitz, JH; Rochon, PA				Gill, Sudeep S.; Bronskill, Susan E.; Normand, Sharon-Lise T.; Anderson, Geoffrey M.; Sykora, Kathy; Lam, Kelvin; Bell, Chaim M.; Lee, Philip E.; Fischer, Hadas D.; Herrmann, Nathan; Gurwitz, Jerry H.; Rochon, Paula A.			Antipsychotic drug use and mortality in older adults with dementia	ANNALS OF INTERNAL MEDICINE			English	Article							SUDDEN CARDIAC DEATH; RANDOMIZED CONTROLLED-TRIAL; PROPENSITY SCORE MODELS; QUALITY-OF-LIFE; NURSING-HOMES; ATYPICAL ANTIPSYCHOTICS; PSYCHOLOGICAL SYMPTOMS; ELDERLY-PATIENTS; NEUROPSYCHIATRIC SYMPTOMS; VENOUS THROMBOEMBOLISM	Background: Antipsychotic drugs are widely used to manage behavioral and psychological symptoms in dementia despite concerns about their safety. Objective: To examine the association between treatment with antipsychotics (both conventional and atypical) and all-cause mortality. Design: Population -based, retrospective cohort study. Setting: Ontario, Canada. Patients: Older adults with dementia who were followed between 1 April 1997 and 31 March 2003. Measurements: The risk for death was determined at 30, 60, 120, and 180 days after the initial dispensing of antipsychotic medication. Two pairwise comparisons were made: atypical versus no antipsychotic use and conventional versus atypical antipsychotic use. Groups were stratified by place of residence (community or long-term care). Propensity score matching was used to adjust for differences in baseline health status. Results: A total of 27 259 matched pairs were identified. New use of atypical antipsychotics was associated with a statistically significant increase in the risk for death at 30 days compared with nonuse in both the community-dwelling cohort (adjusted hazard ratio, 1.31 [95% CI, 1.02 to 1.70]; absolute risk difference, 0.2 percentage point) and the long-term care cohort (adjusted hazard ratio, 1.55 [CI, 1.15 to 2.07]; absolute risk difference, 1.2 percentage points). Excess risk seemed to persist to 180 days, but unequal rates of censoring over time may have affected these results. Relative to atypical antipsychotic use, conventional antipsychotic use was associated with a higher risk for death at all time points. Sensitivity analysis revealed that unmeasured confounders that in- crease the risk for death could diminish or eliminate the observed associations. Limitations: Information on causes of death was not available. Many patents did not continue their initial treatments after 1 month of therapy. Unmeasured confounders could affect associations. Conclusions: Atypical antipsychotic use is associated with an increased risk for death compared with nonuse among older adults with dementia. The risk for death may be greater with conventional antipsychotics than with atypical antipsychotics.	Queens Univ, Kingston, ON K7L 2V7, Canada; Univ Toronto, Toronto, ON M4X 1K9, Canada; Inst Clin Evaluat Sci, Toronto, ON M4X 1K9, Canada; Harvard Univ, Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; Univ Massachusetts, Sch Med, Meyers Primary Care Inst, Fallon Clin Fdn, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Meyers Primary Care Inst, Fallon Community Hlth Plan, Worcester, MA 01605 USA	Queens University - Canada; University of Toronto; University of Toronto; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of British Columbia; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Gill, SS (corresponding author), St Marys Lake Hosp, 340 Union St, Kingston, ON K7L 5A2, Canada.		Bell, Chaim/C-4611-2015; Rochon, Paula A/J-2918-2016	Bell, Chaim/0000-0002-3778-9469; Rochon, Paula A/0000-0002-5973-4151; Normand, Sharon-Lise/0000-0001-7027-4769				Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Ballard C, 2005, INT PSYCHOGERIATR, V17, P4, DOI 10.1017/S1041610205221026; Ballard CG, 2004, J CLIN PSYCHIAT, V65, P23; Barnett MJ, 2006, J CLIN PSYCHOPHARM, V26, P182, DOI 10.1097/01.jcp.0000203598.43314.34; Belle SH, 2006, ANN INTERN MED, V145, P727, DOI 10.7326/0003-4819-145-10-200611210-00005; Berzlanovich AM, 1999, AM J MED, V107, P351, DOI 10.1016/S0002-9343(99)00242-9; Bronskill SE, 2004, J AM GERIATR SOC, V52, P749, DOI 10.1111/j.1532-5415.2004.52212.x; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Callahan CM, 2006, JAMA-J AM MED ASSOC, V295, P2148, DOI 10.1001/jama.295.18.2148; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Covinsky KE, 2006, ANN INTERN MED, V145, P780, DOI 10.7326/0003-4819-145-10-200611210-00011; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DAGOSTINO RB, 2004, TUTORIALS BIOSTSATIS, V1; Fahey T, 2003, BRIT MED J, V326, P580, DOI 10.1136/bmj.326.7389.580; Fossey J, 2006, BMJ-BRIT MED J, V332, P756, DOI 10.1136/bmj.38782.575868.7C; Gill SS, 2005, BMJ-BRIT MED J, V330, P445, DOI 10.1136/bmj.38330.470486.8F; Gill SS, 2006, JAMA-J AM MED ASSOC, V295, P495, DOI 10.1001/jama.295.5.495-b; Gurwitz JH, 2005, AM J MED, V118, P251, DOI 10.1016/j.amjmed.2004.09.018; Hennessy S, 2004, BRIT J CLIN PHARMACO, V58, P81, DOI 10.1111/j.1365-2125.2004.02098.x; Hennessy S, 2002, BRIT MED J, V325, P1070, DOI 10.1136/bmj.325.7372.1070; *HLTH CAN, 2005, 200563 HLTH CAN; Joukamaa M, 2006, BRIT J PSYCHIAT, V188, P122, DOI 10.1192/bjp.188.2.122; Keene J, 2001, INT J GERIATR PSYCH, V16, P969, DOI 10.1002/gps.474; Kern LM, 2005, ANN INTERN MED, V142, P173, DOI 10.7326/0003-4819-142-3-200502010-00007; Kryzhanovskaya LA, 2006, J CLIN PSYCHIAT, V67, P933, DOI 10.4088/JCP.v67n0610; Lanctot KL, 1998, J CLIN PSYCHIAT, V59, P550, DOI 10.4088/JCP.v59n1010; Lee PE, 2004, BMJ-BRIT MED J, V329, P75, DOI 10.1136/bmj.38125.465579.55; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Liperoti R, 2003, J CLIN PSYCHIAT, V64, P1106, DOI 10.4088/JCP.v64n0918; Liperoti R, 2005, J CLIN PSYCHIAT, V66, P1090, DOI 10.4088/JCP.v66n0901; Liperoti R, 2005, ARCH INTERN MED, V165, P2677, DOI 10.1001/archinte.165.22.2677; Liperoti R, 2005, ARCH INTERN MED, V165, P696, DOI 10.1001/archinte.165.6.696; Livingston G, 2007, J NEUROL NEUROSUR PS, V78, P25, DOI 10.1136/jnnp.2006.094342; Livingston G, 2005, AM J PSYCHIAT, V162, P1996, DOI 10.1176/appi.ajp.162.11.1996; McKeith I, 2005, LANCET NEUROL, V4, P735, DOI 10.1016/S1474-4422(05)70219-2; Meador KG, 1997, J AM GERIATR SOC, V45, P207, DOI 10.1111/j.1532-5415.1997.tb04509.x; Nasrallah HA, 2004, AM J GERIAT PSYCHIAT, V12, P437, DOI 10.1176/appi.ajgp.12.4.437; Normand SLT, 2005, BMJ-BRIT MED J, V330, P1021, DOI 10.1136/bmj.330.7498.1021; Rabins PV, 2005, JAMA-J AM MED ASSOC, V294, P1963, DOI 10.1001/jama.294.15.1963; Rapoport M, 2005, INT J GERIATR PSYCH, V20, P749, DOI 10.1002/gps.1358; RAY WA, 1993, ARCH INTERN MED, V153, P713, DOI 10.1001/archinte.153.6.713; Ray WA, 2005, NEW ENGL J MED, V353, P2319, DOI 10.1056/NEJMp058267; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Ray WA, 2002, BRIT J PSYCHIAT, V180, P483, DOI 10.1192/bjp.180.6.483; Ray WA, 2001, ARCH GEN PSYCHIAT, V58, P1161, DOI 10.1001/archpsyc.58.12.1161; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Ruschena D, 2003, BRIT J PSYCHIAT, V183, P446, DOI 10.1192/bjp.183.5.446; Scarmeas N, 2005, ARCH NEUROL-CHICAGO, V62, P1601, DOI 10.1001/archneur.62.10.1601; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Schneider LS, 2006, NEW ENGL J MED, V355, P1525, DOI 10.1056/NEJMoa061240; SCHNEIDER LS, 1990, J AM GERIATR SOC, V38, P553, DOI 10.1111/j.1532-5415.1990.tb02407.x; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; Shah A, 2005, INT PSYCHOGERIATR, V17, P12, DOI 10.1017/S1041610205231022; Sink KM, 2005, JAMA-J AM MED ASSOC, V293, P596, DOI 10.1001/jama.293.5.596; Straus SMJM, 2004, ARCH INTERN MED, V164, P1293, DOI 10.1001/archinte.164.12.1293; Straus SMJM, 2005, EUR HEART J, V26, P2007, DOI 10.1093/eurheartj/ehi312; Suh GH, 2005, INT PSYCHOGERIATR, V17, P429, DOI 10.1017/S1041610205002243; THAPA PB, 1994, J AM GERIATR SOC, V42, P280, DOI 10.1111/j.1532-5415.1994.tb01752.x; Tiihonen J, 2006, BRIT MED J, V333, P224, DOI 10.1136/bmj.38881.382755.2F; TRIFIRO G, 2006, PHARMACOEPIDEMIOL DR; Tschanz JT, 2004, NEUROLOGY, V62, P1156, DOI 10.1212/01.WNL.0000118210.12660.C2; *US FDA, T0513 US FDA; van Reekum R, 2002, INT PSYCHOGERIATR, V14, P197, DOI 10.1017/S1041610202008396; Vickrey BG, 2006, ANN INTERN MED, V145, P713, DOI 10.7326/0003-4819-145-10-200611210-00004; Wang PS, 2005, NEW ENGL J MED, V353, P2335, DOI 10.1056/NEJMoa052827; Warner J, 2004, LANCET, V363, P674, DOI 10.1016/S0140-6736(04)15664-X; Zornberg GL, 2000, LANCET, V356, P1219, DOI 10.1016/S0140-6736(00)02784-7	67	409	416	0	52	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2007	146	11					775	786		10.7326/0003-4819-146-11-200706050-00006	http://dx.doi.org/10.7326/0003-4819-146-11-200706050-00006			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175HR	17548409	Green Published			2022-12-01	WOS:000247005200003
J	Bishop, NA; Guarente, L				Bishop, Nicholas A.; Guarente, Leonard			Two neurons mediate diet-restriction-induced longevity in C-elegans	NATURE			English	Article							LIFE-SPAN; CAENORHABDITIS-ELEGANS; CHEMOSENSORY NEURONS; CALORIC RESTRICTION; LARVAL DEVELOPMENT; OXIDATIVE STRESS; METABOLIC-RATE; GENETICS; INTERFERENCE; SPECIFY	Dietary restriction extends lifespan and retards age-related disease in many species and profoundly alters endocrine function in mammals. However, no causal role of any hormonal signal in diet-restricted longevity has been demonstrated. Here we show that increased longevity of diet-restricted Caenorhabditis elegans requires the transcription factor gene skn-1 acting in the ASIs, a pair of neurons in the head. Dietary restriction activates skn-1 in these two neurons, which signals peripheral tissues to increase metabolic activity. These findings demonstrate that increased lifespan in a diet-restricted metazoan depends on cell non-autonomous signalling from central neuronal cells to non-neuronal body tissues, and suggest that the ASI neurons mediate diet-restriction-induced longevity by an endocrine mechanism.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Guarente, L (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@mit.edu						Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646; BOWERMAN B, 1992, CELL, V68, P1061, DOI 10.1016/0092-8674(92)90078-Q; Braeckman BP, 2002, AGING CELL, V1, P82, DOI 10.1046/j.1474-9728.2002.00021.x; BRENNER S, 1974, GENETICS, V77, P71; de Cabo R, 2003, EXP GERONTOL, V38, P631, DOI 10.1016/S0531-5565(03)00055-X; Dowell P, 2005, ANNU REV BIOCHEM, V74, P515, DOI 10.1146/annurev.biochem.73.011303.074027; Golden TR, 2002, AGING CELL, V1, P117, DOI 10.1046/j.1474-9728.2002.00015.x; Houthoofd K, 2003, EXP GERONTOL, V38, P947, DOI 10.1016/S0531-5565(03)00161-X; Houthoofd K, 2002, EXP GERONTOL, V37, P1359, DOI 10.1016/S0531-5565(02)00172-9; Houthoofd K, 2002, EXP GERONTOL, V37, P1371, DOI 10.1016/S0531-5565(02)00173-0; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Jin Y., 1999, C ELEGANS PRACTICAL, P69; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kim K, 2005, DEV BIOL, V286, P136, DOI 10.1016/j.ydbio.2005.07.024; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lawless, 2011, STAT MODELS METHODS; Li C, 2005, PARASITOLOGY, V131, pS109, DOI 10.1017/S0031182005009376; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; McKay RM, 2003, DEV CELL, V4, P131, DOI 10.1016/S1534-5807(02)00411-2; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mobbs CV, 2001, J GERONTOL A-BIOL, V56, P34, DOI 10.1093/gerona/56.suppl_1.34; Peckol EL, 1999, DEVELOPMENT, V126, P1891; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Walker G, 2005, MECH AGEING DEV, V126, P929, DOI 10.1016/j.mad.2005.03.014; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	37	481	505	1	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2007	447	7144					545	+		10.1038/nature05904	http://dx.doi.org/10.1038/nature05904			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17538612				2022-12-01	WOS:000246842000038
J	Elf, J; Li, GW; Xie, XS				Elf, Johan; Li, Gene-Wei; Xie, X. Sunney			Probing transcription factor dynamics at the single-molecule level in a living cell	SCIENCE			English	Article							COLI-LAC REPRESSOR; DIFFUSION-DRIVEN MECHANISMS; ESCHERICHIA-COLI; PROTEIN TRANSLOCATION; NUCLEIC-ACIDS; OPERATOR INTERACTION; GENE-EXPRESSION; DNA; BINDING; TIME	Transcription factors regulate gene expression through their binding to DNA. In a living Escherichia coli cell, we directly observed specific binding of a lac repressor, labeled with a fluorescent protein, to a chromosomal lac operator. Using single-molecule detection techniques, we measured the kinetics of binding and dissociation of the repressor in response to metabolic signals. Furthermore, we characterized the nonspecific binding to DNA, one-dimensional (1D) diffusion along DNA segments, and 3D translocation among segments through cytoplasm at the single-molecule level. In searching for the operator, a lac repressor spends similar to 90% of time nonspecifically bound to and diffusing along DNA with a residence time of < 5 milliseconds. The methods and findings can be generalized to other nucleic acid binding proteins.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Harvard University	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu	Li, Gene-Wei/E-7657-2010	elf, johan/0000-0001-5522-1810; Li, Gene-Wei/0000-0001-7036-8511	NIH HHS [DP1 OD000277, DP1 OD000277-02] Funding Source: Medline; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000277] Funding Source: NIH RePORTER	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bates D, 2005, CELL, V121, P899, DOI 10.1016/j.cell.2005.04.013; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; BERG OG, 1976, BIOPHYS CHEM, V4, P367, DOI 10.1016/0301-4622(76)80017-8; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; DUNAWAY M, 1980, J BIOL CHEM, V255, P115; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; FIECK A, 1992, NUCLEIC ACIDS RES, V20, P1785, DOI 10.1093/nar/20.7.1785; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Golding I, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.098102; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; KAOHUANG Y, 1977, P NATL ACAD SCI USA, V74, P4228, DOI 10.1073/pnas.74.10.4228; Kepes A, 1969, Prog Biophys Mol Biol, V19, P199, DOI 10.1016/0079-6107(69)90006-6; Le TT, 2005, P NATL ACAD SCI USA, V102, P9160, DOI 10.1073/pnas.0503311102; Lewis M, 2005, CR BIOL, V328, P521, DOI 10.1016/j.crvi.2005.04.004; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Mller-Hill B., 1996, LAC OPERON; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; OEHLER S, 1994, EMBO J, V13, P3348, DOI 10.1002/j.1460-2075.1994.tb06637.x; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; WANG AC, 1977, NUCLEIC ACIDS RES, V4, P1579, DOI 10.1093/nar/4.5.1579; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6961, DOI 10.1021/bi00527a030; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6948, DOI 10.1021/bi00527a029; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	29	776	789	3	184	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2007	316	5828					1191	1194		10.1126/science.1141967	http://dx.doi.org/10.1126/science.1141967			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525339	Green Accepted			2022-12-01	WOS:000246724300043
J	Zoltowski, BD; Schwerdtfeger, C; Widom, J; Loros, JJ; Bilwes, AM; Dunlap, JC; Crane, BR				Zoltowski, Brian D.; Schwerdtfeger, Carsten; Widom, Joanne; Loros, Jennifer J.; Bilwes, Alexandrine M.; Dunlap, Jay C.; Crane, Brian R.			Conformational switching in the fungal light sensor vivid	SCIENCE			English	Article							PHOTOACTIVE YELLOW PROTEIN; PLANT PHOTORECEPTOR DOMAIN; STRUCTURAL-CHANGES; PHOT-LOV1 DOMAIN; WHITE COLLAR-1; LOV2 DOMAIN; BLUE; RECEPTOR; BINDING; SIGNAL	The Neurospora crassa photoreceptor Vivid tunes blue-light responses and modulates gating of the circadian clock. Crystal structures of dark-state and light-state Vivid reveal a light, oxygen, or voltage Per-Arnt-Sim domain with an unusual N-terminal cap region and a loop insertion that accommodates the flavin cofactor. Photoinduced formation of a cystein-flavin adduct drives flavin protonation to induce an N-terminal conformational change. A cysteine-to-serine substitution remote from the flavin adenine dinucleotide binding site decouples conformational switching from the flavin photocycle and prevents Vivid from sending signals in Neurospora. Key elements of this activation mechanism are conserved by other photosensors such as White Collar-1, ZEITLUPE, ENVOY, and flavin-binding, kelch repeat, F-BOX 1 ( FKF1).	Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; Dartmouth Med Sch, Dept Genet, Hanover, NH 03755 USA; Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Cornell University; Dartmouth College; Dartmouth College	Crane, BR (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	bc69@cornell.edu	Dunlap, Jay/L-6232-2013; Loros, Jennifer/B-6293-2014	Dunlap, Jay/0000-0003-1577-0457; Bilwes Crane, Alexandrine/0000-0001-9922-0692	NIGMS NIH HHS [F31 GM079879, R37GM34985, R01 GM034985, P01 GM068087, R37 GM034985, GM079879-01, R01 GM034985-24] Funding Source: Medline; NIMH NIH HHS [R01 MH044651, MH44651] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034985, F31GM079879, R37GM034985, P01GM068087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH044651] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ballario P, 1997, TRENDS MICROBIOL, V5, P458, DOI 10.1016/S0966-842X(97)01144-X; Bernard C, 2005, STRUCTURE, V13, P953, DOI 10.1016/j.str.2005.04.017; Brudler R, 2006, J MOL BIOL, V363, P148, DOI 10.1016/j.jmb.2006.07.078; Cheng P, 2003, P NATL ACAD SCI USA, V100, P5938, DOI 10.1073/pnas.1031791100; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l; Crosson S, 2002, PLANT CELL, V14, P1067, DOI 10.1105/tpc.010475; Elvin M, 2005, GENE DEV, V19, P2593, DOI 10.1101/gad.349305; Fedorov R, 2003, BIOPHYS J, V84, P2474, DOI 10.1016/S0006-3495(03)75052-8; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Harper SM, 2004, BIOCHEMISTRY-US, V43, P16184, DOI 10.1021/bi048092i; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Jung A, 2005, P NATL ACAD SCI USA, V102, P12350, DOI 10.1073/pnas.0500722102; Kottke T, 2003, BIOPHYS J, V84, P1192, DOI 10.1016/S0006-3495(03)74933-9; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Loros JJ, 2001, ANNU REV PHYSIOL, V63, P757, DOI 10.1146/annurev.physiol.63.1.757; Losi A, 2005, PHOTOCHEM PHOTOBIOL, V81, P1145, DOI 10.1562/2005-05-25-RA-541; Losi A, 2004, BIOPHYS J, V86, P1051, DOI 10.1016/S0006-3495(04)74180-6; Losi A, 2003, PHOTOCH PHOTOBIO SCI, V2, P759, DOI 10.1039/b301782f; Nozaki D, 2004, BIOCHEMISTRY-US, V43, P8373, DOI 10.1021/bi0494727; Pellequer JL, 1998, P NATL ACAD SCI USA, V95, P5884, DOI 10.1073/pnas.95.11.5884; Rubinstenn G, 1998, NAT STRUCT BIOL, V5, P568, DOI 10.1038/823; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Schwerdtfeger C, 2003, EMBO J, V22, P4846, DOI 10.1093/emboj/cdg451; Shrode LB, 2001, FUNGAL GENET BIOL, V32, P169, DOI 10.1006/fgbi.2001.1264; Swartz TE, 2002, BIOCHEMISTRY-US, V41, P7183, DOI 10.1021/bi025861u; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Yildiz O, 2005, MOL CELL, V17, P69, DOI 10.1016/j.molcel.2004.11.022; Yoshida Y, 2004, J BIOL CHEM, V279, P6986, DOI 10.1074/jbc.M310060200	31	285	296	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					1054	1057		10.1126/science.1137128	http://dx.doi.org/10.1126/science.1137128			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17510367	Green Accepted			2022-12-01	WOS:000246554000054
J	Bandfield, JL				Bandfield, Joshua L.			High-resolution subsurface water-ice distributions on Mars	NATURE			English	Article							MARTIAN GROUND-ICE; NEAR-SURFACE; STABILITY; BEHAVIOR	Theoretical models indicate that water ice is stable in the shallow subsurface ( depths of < 1 - 2 m) of Mars at high latitudes(1-7). These models have been mainly supported by the observed presence of large concentrations of hydrogen detected by the Gamma Ray Spectrometer suite of instruments on the Mars Odyssey spacecraft(8-10). The models and measurements are consistent with a water-ice table that steadily increases in depth with decreasing latitude. More detailed modelling has predicted that the depth at which water ice is stable can be highly variable, owing to local surface heterogeneities such as rocks and slopes, and the thermal inertia of the ground cover(11-13). Measurements have, however, been limited to the footprint ( several hundred kilometres) of the Gamma Ray Spectrometer suite, preventing the observations from documenting more detailed water-ice distributions. Here I show that by observing the seasonal temperature response of the martian surface with the Thermal Emission Imaging System on the Mars Odyssey spacecraft(14), it is possible to observe such heterogeneities at subkilometre scale. These observations show significant regional and local water-ice depth variability, and, in some cases, support distributions in the subsurface predicted by atmospheric exchange and vapour diffusion models. The presence of water ice where it follows the depth of stability under current climatic conditions implies an active martian water cycle that responds to orbit-driven climate cycles(15-17). Several regions also have apparent deviations from the theoretical stability level, indicating that additional factors influence the ice-table depth. The high-resolution measurements show that the depth to the water-ice table is highly variable within the potential Phoenix spacecraft landing ellipses, and is likely to be variable at scales that may be sampled by the spacecraft.	Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Bandfield, JL (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA.	joshband@asu.edu		Bandfield, Joshua/0000-0003-3571-3716				Aharonson O, 2006, J GEOPHYS RES-PLANET, V111, DOI [10.1029/2005JE002636, 10.1029/2005JE002636.]; Armstrong JC, 2005, ICARUS, V174, P360, DOI 10.1016/j.icarus.2004.10.032; ARVIDSON RE, 2006, LUNAR PLANET SCI C, V37; Bandfield JL, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002289; BETTS BH, 1995, J GEOPHYS RES-PLANET, V100, P5285, DOI 10.1029/95JE00226; Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; Christensen PR, 2004, SPACE SCI REV, V110, P85, DOI 10.1023/B:SPAC.0000021008.16305.94; EDWARDS CS, 2005, EOS, V158; FANALE FP, 1986, ICARUS, V67, P1, DOI 10.1016/0019-1035(86)90170-3; Feldman WC, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002160; HABERLE RM, 1990, J GEOPHYS RES-SOLID, V95, P1423, DOI 10.1029/JB095iB02p01423; Head JW, 2003, NATURE, V426, P797, DOI 10.1038/nature02114; Jakosky BM, 1997, ICARUS, V130, P87, DOI 10.1006/icar.1997.5799; Jakosky BM, 2005, ICARUS, V175, P58, DOI 10.1016/j.icarus.2004.11.014; JAKOSKY BM, 1995, J GEOPHYS RES-PLANET, V100, P1579, DOI 10.1029/94JE02801; Kieffer H. H., 1977, Journal of Geophysical Research, V82, P4249, DOI 10.1029/JS082i028p04249; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; Mellon MT, 2004, ICARUS, V169, P324, DOI 10.1016/j.icarus.2003.10.022; Mellon MT, 2000, ICARUS, V148, P437, DOI 10.1006/icar.2000.6503; Mitrofanov IG, 2004, SOLAR SYST RES+, V38, P253, DOI 10.1023/B:SOLS.0000037461.70809.45; PAIGE DA, 1992, NATURE, V356, P43, DOI 10.1038/356043a0; PAIGE DA, 1994, J GEOPHYS RES-PLANET, V99, P25959, DOI 10.1029/93JE03428; Schorghofer N, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002350; Sizemore HG, 2006, ICARUS, V185, P358, DOI 10.1016/j.icarus.2006.07.018; Smith MD, 2004, ICARUS, V167, P148, DOI 10.1016/j.icarus.2003.09.010; Titus TN, 2003, SCIENCE, V299, P1048, DOI 10.1126/science.1080497; TITUS TN, 2006, LUNAR PLANET SCI C, V37; ZENT AP, 1986, ICARUS, V67, P19, DOI 10.1016/0019-1035(86)90171-5	29	78	79	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2007	447	7140					64	U1		10.1038/nature05781	http://dx.doi.org/10.1038/nature05781			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17476262				2022-12-01	WOS:000246149300043
J	Guan, CB; Xu, HT; Jin, M; Yuan, XB; Poo, MM				Guan, Chen-bing; Xu, Hua-tai; Jin, Ming; Yuan, Xiao-bing; Poo, Mu-ming			Long-range Ca2+ signaling from growth cone to soma mediates reversal of neuronal migration induced by Slit-2	CELL			English	Article							RHO-FAMILY GTPASES; LEECH RETZIUS NEURONS; NERVE GROWTH; AXON GUIDANCE; ENDOPLASMIC-RETICULUM; DIRECTIONAL GUIDANCE; REGULATED FORMATION; TARGET CONTACT; IN-VIVO; CALCIUM	Neuronal migration and growth-cone extension are both guided by extracellular factors in the developing brain, but whether these two forms of guidance are mechanistically linked is unclear. Application of a Slit-2 gradient in front of the leading process of cultured cerebellar granule cells led to the collapse of the growth cone and the reversal of neuronal migration, an event preceded by a propagating Ca2+ wave from the growth cone to the soma. The Ca2+ wave was required for the Slit-2 effect and was sufficient by itself to induce the reversal of migration. The Slit-2-induced reversal of migration required active RhoA, which was accumulated at the front of the migrating neuron, and this polarized RhoA distribution was reversed during the migration reversal induced by either the Slit-2 gradient or the Ca (2+) wave. Thus, longrange Ca (2+) signaling coordinates the Slit-2induced changes in motility at two distant parts of migrating neurons by regulating RhoA distribution.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Neurobiol, Shanghai 200031, Peoples R China; Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China; Univ Calif Berkeley, Helen Willis Inst Neurosci, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of California System; University of California Berkeley	Poo, MM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China.	yuanxb@ion.ac.cn; mpoo@berkeley.edu		Yuan, Xiaobing/0000-0002-1632-8460	NINDS NIH HHS [NS22764] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022764] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; BRUNDAGE RA, 1991, SCIENCE, V254, P703, DOI 10.1126/science.1948048; Causeret F, 2004, DEVELOPMENT, V131, P2841, DOI 10.1242/dev.01162; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Davenport RW, 1999, NAT NEUROSCI, V2, P254, DOI 10.1038/6360; DeBiasio RL, 1996, MOL BIOL CELL, V7, P1259, DOI 10.1091/mbc.7.8.1259; Du JL, 2004, NATURE, V429, P878, DOI 10.1038/nature02618; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; GILKEY JC, 1978, J CELL BIOL, V76, P448, DOI 10.1083/jcb.76.2.448; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; HEATH JP, 1983, NATURE, V302, P532, DOI 10.1038/302532a0; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; HIRD SN, 1993, J CELL BIOL, V121, P1343, DOI 10.1083/jcb.121.6.1343; Hivert B, 2002, MOL CELL NEUROSCI, V21, P534, DOI 10.1006/mcne.2002.1193; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; JELLIES J, 1987, J NEUROSCI, V7, P2618; Jin M, 2005, J NEUROSCI, V25, P2338, DOI 10.1523/JNEUROSCI.4889-04.2005; Johnson LA, 2000, J NEUROBIOL, V43, P365, DOI 10.1002/1097-4695(20000615)43:4<365::AID-NEU5>3.3.CO;2-7; KATER SB, 1991, J NEUROSCI, V11, P891; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; Komuro H, 2001, J NEUROSCI, V21, P527, DOI 10.1523/JNEUROSCI.21-02-00527.2001; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; LOER CM, 1987, J NEUROSCI, V7, P2630; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Marillat V, 2002, J COMP NEUROL, V442, P130, DOI 10.1002/cne.10068; Meinhardt H, 1999, J CELL SCI, V112, P2867; MEISSNER G, 1986, J BIOL CHEM, V261, P6300; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Sutko JL, 1997, PHARMACOL REV, V49, P53; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Verkhratsky A, 2002, CELL CALCIUM, V32, P393, DOI 10.1016/S0143416002001896; Ward ME, 2005, MOL CELL NEUROSCI, V30, P378, DOI 10.1016/j.mcn.2005.08.002; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; Xu HT, 2004, P NATL ACAD SCI USA, V101, P4296, DOI 10.1073/pnas.0303893101; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yacubova E, 2002, NATURE, V415, P77, DOI 10.1038/415077a; Yee KT, 1999, NEURON, V24, P607, DOI 10.1016/S0896-6273(00)81116-2; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895; ZHENG JQ, 1994, J CELL BIOL, V127, P1693, DOI 10.1083/jcb.127.6.1693	61	112	121	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2007	129	2					385	395		10.1016/j.cell.2007.01.051	http://dx.doi.org/10.1016/j.cell.2007.01.051			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448996	Bronze			2022-12-01	WOS:000246474600024
J	Perrier, E				Perrier, Emilie			A patient's journey - Intensive care	BMJ-BRITISH MEDICAL JOURNAL			English	Article												azanome@hotmail.com							0	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2007	334	7597					796	797		10.1136/bmj.39157.723090.BE	http://dx.doi.org/10.1136/bmj.39157.723090.BE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161SX	17431267	Green Published, Bronze			2022-12-01	WOS:000246037300032
J	Gibbs, RA; Rogers, J; Katze, MG; Bumgarner, R; Weinstock, GM; Mardis, ER; Remington, KA; Strausberg, RL; Venter, JC; Wilson, RK; Batzer, MA; Bustamante, CD; Eichler, EE; Hahn, MW; Hardison, RC; Makova, KD; Miller, W; Milosavljevic, A; Palermo, RE; Siepel, A; Sikela, JM; Attaway, T; Bell, S; Bernard, KE; Buhay, CJ; Chandrabose, MN; Dao, M; Davis, C; Delehaunty, KD; Ding, Y; Dinh, HH; Dugan-Rocha, S; Fulton, LA; Gabisi, RA; Garner, TT; Godfrey, J; Hawes, AC; Hernandez, J; Hines, S; Holder, M; Hume, J; Jhangiani, SN; Joshi, V; Khan, ZM; Kirkness, EF; Cree, A; Fowler, RG; Lee, S; Lewis, LR; Li, ZW; Liu, YS; Moore, SM; Muzny, D; Nazareth, LV; Ngo, DN; Okwuonu, GO; Pai, G; Parker, D; Paul, HA; Pfannkoch, C; Pohl, CS; Rogers, YH; Ruiz, SJ; Sabo, A; Santibanez, J; Schneider, BW; Smith, SM; Sodergren, E; Svatek, AF; Utterback, TR; Vattathil, S; Warren, W; White, CS; Chinwalla, AT; Feng, Y; Halpern, AL; Hillier, LW; Huang, XQ; Minx, P; Nelson, JO; Pepin, KH; Qin, X; Sutton, GG; Venter, E; Walenz, BP; Wallis, JW; Worley, KC; Yang, SP; Jones, SM; Marra, MA; Rocchi, M; Schein, JE; Baertsch, R; Clarke, L; Csuros, M; Glasscock, J; Harris, RA; Haviak, P; Jackson, AR; Jiang, HY; Liu, Y; Messina, DN; Shen, YF; Song, HXZ; Wylie, T; Zhang, L; Birney, E; Han, K; Konkel, MK; Lee, JN; Smit, AFA; Ullmer, B; Wang, H; Xing, J; Burhans, R; Cheng, Z; Karro, JE; Ma, J; Raney, B; She, XW; Cox, MJ; Demuth, JP; Dumas, LJ; Han, SG; Hopkins, J; Karimpour-Fard, A; Kim, YH; Pollack, JR; Vinar, T; Addo-Quaye, C; Degenhardt, J; Denby, A; Hubisz, MJ; Indap, A; Kosiol, C; Lahn, BT; Lawson, HA; Marklein, A; Nielsen, R; Vallender, EJ; Clark, AG; Ferguson, B; Hernandez, RD; Hirani, K; Kehrer-Sawatzki, H; Kolb, J; Patil, S; Pu, LL; Ren, Y; Smith, DG; Wheeler, DA; Schenck, I; Ball, EV; Chen, R; Cooper, DN; Giardine, B; Hsu, F; Kent, WJ; Lesk, A; Nelson, DL; O'Brien, WE; Prufer, K; Stenson, PD; Wallace, JC; Ke, H; Liu, XM; Wang, P; Xiang, AP; Yang, F; Barber, GP; Haussler, D; Karolchik, D; Kern, AD; Kuhn, RM; Smith, KE; Zwieg, AS				Gibbs, Richard A.; Rogers, Jeffrey; Katze, Michael G.; Bumgarner, Roger; Weinstock, George M.; Mardis, Elaine R.; Remington, Karin A.; Strausberg, Robert L.; Venter, J. Craig; Wilson, Richard K.; Batzer, Mark A.; Bustamante, Carlos D.; Eichler, Evan E.; Hahn, Matthew W.; Hardison, Ross C.; Makova, Kateryna D.; Miller, Webb; Milosavljevic, Aleksandar; Palermo, Robert E.; Siepel, Adam; Sikela, James M.; Attaway, Tony; Bell, Stephanie; Bernard, Kelly E.; Buhay, Christian J.; Chandrabose, Mimi N.; Dao, Marvin; Davis, Clay; Delehaunty, Kimberly D.; Ding, Yan; Dinh, Huyen H.; Dugan-Rocha, Shannon; Fulton, Lucinda A.; Gabisi, Ramatu Ayiesha; Garner, Toni T.; Godfrey, Jennifer; Hawes, Alicia C.; Hernandez, Judith; Hines, Sandra; Holder, Michael; Hume, Jennifer; Jhangiani, Shalini N.; Joshi, Vandita; Khan, Ziad Mohid; Kirkness, Ewen F.; Cree, Andrew; Fowler, R. Gerald; Lee, Sandra; Lewis, Lora R.; Li, Zhangwan; Liu, Yih-shin; Moore, Stephanie M.; Muzny, Donna; Nazareth, Lynne V.; Ngo, Dinh Ngoc; Okwuonu, Geoffrey O.; Pai, Grace; Parker, David; Paul, Heidie A.; Pfannkoch, Cynthia; Pohl, Craig S.; Rogers, Yu-Hui; Ruiz, San Juana; Sabo, Aniko; Santibanez, Jireh; Schneider, Brian W.; Smith, Scott M.; Sodergren, Erica; Svatek, Amanda F.; Utterback, Teresa R.; Vattathil, Selina; Warren, Wesley; White, Courtney Sherell; Chinwalla, Asif T.; Feng, Yucheng; Halpern, Aaron L.; Hillier, LaDeana W.; Huang, Xiaoqiu; Minx, Pat; Nelson, Joanne O.; Pepin, Kymberlie H.; Qin, Xiang; Sutton, Granger G.; Venter, Eli; Walenz, Brian P.; Wallis, John W.; Worley, Kim C.; Yang, Shiaw-Pyng; Jones, Steven M.; Marra, Marco A.; Rocchi, Mariano; Schein, Jacqueline E.; Baertsch, Robert; Clarke, Laura; Csuros, Miklos; Glasscock, Jarret; Harris, R. Alan; Haviak, Paul; Jackson, Andrew R.; Jiang, Huaiyang; Liu, Yue; Messina, David N.; Shen, Yufeng; Song, Henry Xing-Zhi; Wylie, Todd; Zhang, Lan; Birney, Ewan; Han, Kyudong; Konkel, Miriam K.; Lee, Jungnam; Smit, Arlan F. A.; Ullmer, Brygg; Wang, Hui; Xing, Jinchuan; Burhans, Richard; Cheng, Ze; Karro, John E.; Ma, Jian; Raney, Brian; She, Xinwei; Cox, Michael J.; Demuth, Jeffrey P.; Dumas, Laura J.; Han, Sang-Gook; Hopkins, Janet; Karimpour-Fard, Anis; Kim, Young H.; Pollack, Jonathan R.; Vinar, Tomas; Addo-Quaye, Charles; Degenhardt, Jeremiah; Denby, Alexandra; Hubisz, Melissa J.; Indap, Amit; Kosiol, Carolin; Lahn, Bruce T.; Lawson, Heather A.; Marklein, Alison; Nielsen, Rasmus; Vallender, Eric J.; Clark, Andrew G.; Ferguson, Betsy; Hernandez, Ryan D.; Hirani, Kashif; Kehrer-Sawatzki, Hildegard; Kolb, Jessica; Patil, Shobha; Pu, Ling-Ling; Ren, Yanru; Smith, David Glenn; Wheeler, David A.; Schenck, Ian; Ball, Edward V.; Chen, Rui; Cooper, David N.; Giardine, Belinda; Hsu, Fan; Kent, W. James; Lesk, Arthur; Nelson, David L.; O'Brien, William E.; Prufer, Kay; Stenson, Peter D.; Wallace, James C.; Ke, Hui; Liu, Xiao-Ming; Wang, Peng; Xiang, Andy Peng; Yang, Fan; Barber, Galt P.; Haussler, David; Karolchik, Donna; Kern, Andy D.; Kuhn, Robert M.; Smith, Kayla E.; Zwieg, Ann S.		Rhesus Macaque Genome Sequencing Consortium	Evolutionary and biomedical insights from the rhesus macaque genome	SCIENCE			English	Article							PRIMATE SEGMENTAL DUPLICATIONS; SUBSTITUTION; SEQUENCE; DATABASE; MODELS; SITES; MOUSE; DNA; INFORMATION; DIVERGENCE	The rhesus macaque ( Macaca mulatta) is an abundant primate species that diverged from the ancestors of Homo sapiens about 25 million years ago. Because they are genetically and physiologically similar to humans, rhesus monkeys are the most widely used nonhuman primate in basic and applied biomedical research. We determined the genome sequence of an Indian-origin Macaca mulatta female and compared the data with chimpanzees and humans to reveal the structure of ancestral primate genomes and to identify evidence for positive selection and lineage-specific expansions and contractions of gene families. A comparison of sequences from individual animals was used to investigate their underlying genetic diversity. The complete description of the macaque genome blueprint enhances the utility of this animal model for biomedical research and improves our understanding of the basic biology of the species.	Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78227 USA; Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; Washington Univ, Genome Sequencing Ctr, St Louis, MO 63108 USA; J Craig Veriter Inst, Rockville, MD 20850 USA; Louisiana State Univ, Ctr Biomodular Multiscale Syst, Dept Biol Sci, Biol Computat & Visualizat Ctr, Baton Rouge, LA 70803 USA; Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Indiana Univ, Sch Informat, Bloomington, IN 47405 USA; Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; Univ Colorado, Dept Pharmacol, Human Med Genet Program, Denver, CO USA; Univ Colorado, Dept Pharmacol, Program Neurosci, Denver, CO USA; Ctr Hlth Sci, Aurora, CO 80045 USA; Iowa State Univ, Dept Comp Sci, Ames, IA 50011 USA; British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; Univ Bari, Dept Genet & Microbiol, Bari, Italy; Univ Calif Santa Cruz, Genome Sci Ctr, Santa Cruz, CA 95060 USA; Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; Univ Montreal, Dept Informat & Rech Operat, Montreal, PQ H3C 3J7, Canada; Inst Syst Biol, Seattle, WA 98103 USA; Louisiana State Univ, Dept Comp Sci, Ctr Computat & Technol, Baton Rouge, LA 70803 USA; Univ Utah, Eccles Inst Human Genet, Salt Lake City, UT 84112 USA; Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; Univ Colorado, Dept Prevent Med & Biometr, Denver, CO 80202 USA; Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Copenhagen, Inst Biol, DK-1017 Copenhagen, Denmark; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; Oregon Reg Primate Res Ctr, Genet Res & Informat Program, Beaverton, OR 97006 USA; Univ Ulm, Inst Human Genet, D-89081 Ulm, Germany; Cardiff Univ, Inst Med Genet, Cardiff CF14 4XN, Wales; Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; Sun Yat Sen Univ, Ctr Stem Cell Biol & Tissue Engn, Guangzhou 510080, Peoples R China; S China Primate Res & Dev Ctr, Guangzhou 510080, Peoples R China; Howard Hughes Med Inst, Santa Cruz, CA 95060 USA	Baylor College of Medicine; Baylor College of Medicine; Texas Biomedical Research Institute; University of Washington; University of Washington Seattle; Washington University (WUSTL); Louisiana State University System; Louisiana State University; Cornell University; University of Washington; University of Washington Seattle; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Denver; Iowa State University; British Columbia Cancer Agency; Universita degli Studi di Bari Aldo Moro; University of California System; University of California Santa Cruz; Wellcome Trust Sanger Institute; Universite de Montreal; Institute for Systems Biology (ISB); Louisiana State University System; Louisiana State University; Utah System of Higher Education; University of Utah; University of California System; University of California Santa Cruz; University of Colorado System; University of Colorado Denver; Stanford University; University of Chicago; University of Copenhagen; Cornell University; Oregon Health & Science University; Oregon National Primate Research Center; Ulm University; Cardiff University; Max Planck Society; Sun Yat Sen University; Howard Hughes Medical Institute	Gibbs, RA (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.	agibbs@bcm.edu	Raney, Brian/ABE-6267-2020; Nielsen, Rasmus/D-4405-2009; Cooper, David N/H-4384-2011; Han, Kyudong/AAF-1788-2019; Vinar, Tomas/I-3695-2014; Xing, Jinchuan/A-2489-2012; Bumgarner, Roger E/K-3531-2015; Weinstock, George M/C-6314-2013; Addo-Quaye, Charles/J-3694-2016; Bumgarner, Roger/AAA-6846-2020; Harris, R. Alan/AAI-2784-2020; Hardison, Ross C/G-1142-2010; Wilson, Richard K./AAF-4139-2019; Mardis, Elaine/W-2202-2019; Jones, Steven J/C-3621-2009; Marra, Marco A/B-5987-2008; Messina, Dave/B-2405-2009; Vallender, Eric/A-2450-2008; Wheeler, David A/M-9740-2018; Schein, Jacquie E/G-3674-2015; Ma, Jian/A-9838-2008	Nielsen, Rasmus/0000-0003-0513-6591; Cooper, David N/0000-0002-8943-8484; Han, Kyudong/0000-0001-6791-2408; Vinar, Tomas/0000-0003-3898-3447; Bumgarner, Roger E/0000-0002-8168-6985; Weinstock, George M/0000-0002-2997-4592; Addo-Quaye, Charles/0000-0003-0598-5980; Harris, R. Alan/0000-0002-7333-4752; Hardison, Ross C/0000-0003-4084-7516; Wilson, Richard K./0000-0002-1992-1358; Jones, Steven J/0000-0003-3394-2208; Marra, Marco A/0000-0001-7146-7175; Vallender, Eric/0000-0003-3506-0540; Wheeler, David A/0000-0002-9056-6299; Ma, Jian/0000-0002-4202-5834; Messina, David/0000-0002-2287-2761; Worley, Kim/0000-0002-0282-1000; Clarke, Laura/0000-0002-5989-6898; Indap, Amit/0000-0002-3322-4735; Lawson, Heather/0000-0002-3550-5485; Chinwalla, Asif/0000-0001-7831-3996; Siepel, Adam/0000-0002-3557-7219; Lesk, Arthur/0000-0002-2596-0601; Hubisz, Melissa/0000-0002-9561-6830; Clark, Andrew/0000-0001-7159-8511; Hahn, Matthew/0000-0002-5731-8808; Birney, Ewan/0000-0001-8314-8497; Rocchi, Mariano/0000-0002-9451-5616	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003068, R01HG002939, U54HG003079] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashurst JL, 2005, NUCLEIC ACIDS RES, V33, pD459, DOI 10.1093/nar/gki135; Baas T, 2006, J VIROL, V80, P10813, DOI 10.1128/JVI.00851-06; Bailey JA, 2003, COLD SPRING HARB SYM, V68, P115, DOI 10.1101/sqb.2003.68.115; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Barton NH, 2006, CURR BIOL, V16, pR647, DOI 10.1016/j.cub.2006.07.032; Bartosch-Harlid A, 2003, EVOLUTION, V57, P2398, DOI 10.1554/03-036; Betancourt AJ, 2004, GENETICS, V168, P2261, DOI 10.1534/genetics.104.030999; Birtle Zoe, 2005, BMC Genomics, V6, P120, DOI 10.1186/1471-2164-6-120; Blanchette M, 2004, GENOME RES, V14, P2412, DOI 10.1101/gr.2800104; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Chismar JD, 2002, BIOTECHNIQUES, V33, P516, DOI 10.2144/02333st01_11836a; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Daza-Vamenta R, 2004, GENOME RES, V14, P1501, DOI 10.1101/gr.2134504; DUTRILLAUX B, 1979, HUM GENET, V48, P251, DOI 10.1007/BF00272830; Fortna A, 2004, PLOS BIOL, V2, P937, DOI 10.1371/journal.pbio.0020207; Gao LZ, 2003, TRENDS GENET, V19, P678, DOI 10.1016/j.tig.2003.10.002; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Goetting-Minesky MP, 2006, J MOL EVOL, V63, P537, DOI 10.1007/s00239-005-0308-8; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Graur D., 2000, FUNDAMENTALS MOL EVO; Groves CP., 2001, PRIMATE TAXONOMY; Hahn MW, 2005, GENOME RES, V15, P1153, DOI 10.1101/gr.3567505; Han K, 2007, SCIENCE, V316, P238, DOI 10.1126/science.1139462; Harris RA, 2007, SCIENCE, V316, P235, DOI 10.1126/science.1139477; Hernandez RD, 2007, SCIENCE, V316, P240, DOI 10.1126/science.1140462; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; *I MED GEN CARD, 2006, HUM GEN MUT DAT; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kalafus KJ, 2004, GENOME RES, V14, P672, DOI 10.1101/gr.1963804; Kehrer-Sawatzki H, 2007, HUM GENET, V120, P759, DOI 10.1007/s00439-006-0270-6; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lynch M, 2001, GENETICS, V159, P1789; Lynch Michael, 2003, Journal of Structural and Functional Genomics, V3, P35, DOI 10.1023/A:1022696612931; Ma J, 2006, GENOME RES, V16, P1557, DOI 10.1101/gr.5383506; Makova KD, 2004, GENOME RES, V14, P567, DOI 10.1101/gr.1971104; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Milosavljevic A, 2005, GENOME RES, V15, P292, DOI 10.1101/gr.3162505; Murphy WJ, 2005, GENOMICS, V86, P383, DOI 10.1016/j.ygeno.2005.05.013; NEEL JV, 1962, AM J HUM GENET, V14, P353; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nielsen R, 1998, GENETICS, V148, P929; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rogers J, 2006, GENOMICS, V87, P30, DOI 10.1016/j.ygeno.2005.10.004; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; She XW, 2006, GENOME RES, V16, P576, DOI 10.1101/gr.4949406; Spindel ER, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-160; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Taylor F, 2006, MOL BIOL EVOL, V23, P565, DOI 10.1093/molbev/msj060; Umeda S, 2005, INVEST OPHTH VIS SCI, V46, P683, DOI 10.1167/iovs.04-1031; van Baren MJ, 2006, GENOME RES, V16, P678, DOI 10.1101/gr.4766206; Ventura M, 2007, SCIENCE, V316, P243, DOI 10.1126/science.1140615; Wallace JC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-28; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WIENBERG J, 1992, CHROMOSOMA, V101, P265, DOI 10.1007/BF00346004; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861; Zahn LM, 2007, SCIENCE, V316, P215, DOI 10.1126/science.316.5822.215	71	984	1043	6	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					222	234		10.1126/science.1139247	http://dx.doi.org/10.1126/science.1139247			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431167	Green Submitted			2022-12-01	WOS:000245654500037
J	Hadler, NM; Tait, RC; Chibnall, JT				Hadler, Nortin M.; Tait, Raymond C.; Chibnall, John T.			Back pain in the Workplace	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK-FACTORS; PSYCHOSOCIAL FACTORS; SICKNESS ABSENCE; FOLLOW-UP; WORKERS; PREDICTORS; DISORDERS; DURATION; INJURIES; SURGERY		Univ N Carolina, Sch Med, Dept Med, Div Rheumatol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Microbiol, Chapel Hill, NC 27599 USA; St Louis Univ, Sch Med, Dept Psychiat, St Louis, MO USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Saint Louis University	Hadler, NM (corresponding author), Univ N Carolina, Sch Med, Dept Med, Div Rheumatol, 3300 Thurston Bldg CB 7280, Chapel Hill, NC 27599 USA.	nmh@med.unc.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS013087] Funding Source: NIH RePORTER; AHRQ HHS [R01-HS-013087-01] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Battie MC, 2004, SPINE, V29, P2679, DOI 10.1097/01.brs.0000146457.83240.eb; Blum F., 2006, WORKERS COMPENSATION, V6, P3; Carragee E, 2006, SPINE, V31, P2942, DOI 10.1097/01.brs.0000248429.10963.13; Cassidy JD, 2005, SPINE, V30, P2817, DOI 10.1097/01.brs.0000190448.69091.53; Chibnall JT, 2006, SPINE, V31, P1272, DOI 10.1097/01.brs.0000217584.79528.9b; HADLER NM, 1978, ANN INTERN MED, V89, P992; HADLER NM, 1986, NEW ENGL J MED, V315, P1090, DOI 10.1056/NEJM198610233151711; Hadler NM, 1997, NEW ENGL J MED, V337, P341, DOI 10.1056/NEJM199707313370511; Hadler NM, 2003, JAMA-J AM MED ASSOC, V289, P2863, DOI 10.1001/jama.289.21.2863; Hadler NM., 2005, OCCUPATIONAL MUSCULO; Harkness EF, 2003, RHEUMATOLOGY, V42, P959, DOI 10.1093/rheumatology/keg265; Harris I, 2005, JAMA-J AM MED ASSOC, V293, P1644, DOI 10.1001/jama.293.13.1644; Hashemi L, 1998, J OCCUP ENVIRON MED, V40, P1110; Head J, 2006, J EPIDEMIOL COMMUN H, V60, P55, DOI 10.1136/jech.2005.038752; Hoogendoorn WE, 2000, SPINE, V25, P2114, DOI 10.1097/00007632-200008150-00017; Kaila-Kangas L, 2004, SPINE, V29, P1823, DOI 10.1097/01.BRS.0000134572.46151.0A; Linton SJ, 2000, SPINE, V25, P1148, DOI 10.1097/00007632-200005010-00017; Lotters F, 2006, OCCUP ENVIRON MED, V63, P794, DOI 10.1136/oem.2005.020420; Mixter WJ, 1935, NEW ENGL J MED, V213, P385, DOI 10.1056/NEJM193508292130901; Nielsen ML, 2006, J OCCUP ENVIRON MED, V48, P591, DOI 10.1097/01.jom.0000201567.70084.3a; Pengel LHM, 2003, BMJ-BRIT MED J, V327, P323, DOI 10.1136/bmj.327.7410.323; Tait RC, 2006, J PAIN, V7, P951, DOI 10.1016/j.jpain.2006.05.007; Tait RC, 2004, PAIN, V112, P389, DOI 10.1016/j.pain.2004.09.027; Volinn E, 2005, SPINE, V30, P697, DOI 10.1097/01.brs.0000155404.32725.f8; Waddell G, 2002, BACK PAIN INCAPACITY	25	22	23	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2007	297	14					1594	1596		10.1001/jama.297.14.1594	http://dx.doi.org/10.1001/jama.297.14.1594			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155PG	17426279				2022-12-01	WOS:000245589800028
J	Affara, NI; Coussens, LM				Affara, Nesrine I.; Coussens, Lisa M.			IKK alpha at the crossroads of inflammation and metastasis	CELL			English	Editorial Material							CANCER DEVELOPMENT; MASPIN; BONE	The development of solid tumors is regulated by dynamic interactions between evolving neoplastic cells and their microenvironment. Luo et al. (2007) recently demonstrated that tumor-infiltrating immune cells expressing RANKL induce activation and nuclear localization of IKK alpha in prostatic epithelial tumor cells. This leads to repression of maspin, a critical suppressor of metastasis, and thus commits malignant prostatic epithelial cells to a metastatic fate.	Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Coussens, LM (corresponding author), Univ Calif San Francisco, Dept Pathol, 2340 Sutter St, San Francisco, CA 94143 USA.	coussens@cc.ucsf.edu	Coussens, Lisa/ABH-9834-2020					Clezardin P, 2005, CANCER RES, V65, P4971, DOI 10.1158/0008-5472.CAN-05-0264; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; LUO JL, 2007, NATURE; Sato N, 2004, ONCOGENE, V23, P1531, DOI 10.1038/sj.onc.1207269; Sheng SJ, 2004, FRONT BIOSCI-LANDMRK, V9, P2733, DOI 10.2741/1432; Zhang J, 2001, J CLIN INVEST, V107, P1235, DOI 10.1172/JCI11685	8	38	43	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					25	26		10.1016/j.cell.2007.03.029	http://dx.doi.org/10.1016/j.cell.2007.03.029			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418780	Bronze			2022-12-01	WOS:000245661100005
J	Ng, SS; Kavanagh, KL; McDonough, MA; Butler, D; Pilka, ES; Lienard, BMR; Bray, JE; Savitsky, P; Gileadi, O; von Delft, F; Rose, NR; Offer, J; Scheinost, JC; Borowski, T; Sundstrom, M; Schofield, CJ; Oppermann, U				Ng, Stanley S.; Kavanagh, Kathryn L.; McDonough, Michael A.; Butler, Danica; Pilka, Ewa S.; Lienard, Benoit M. R.; Bray, James E.; Savitsky, Pavel; Gileadi, Opher; von Delft, Frank; Rose, Nathan R.; Offer, John; Scheinost, Johanna C.; Borowski, Tomasz; Sundstrom, Michael; Schofield, Christopher J.; Oppermann, Udo			Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificity	NATURE			English	Article							DOMAIN-CONTAINING PROTEINS; KETOGLUTARATE DIOXYGENASE; LYSINE METHYLATION; FAMILY; TRANSCRIPTION; INTERMEDIATE	Post-translational histone modification has a fundamental role in chromatin biology and is proposed to constitute a 'histone code' in epigenetic regulation(1,2). Differential methylation of histone H3 and H4 lysyl residues regulates processes including heterochromatin formation, X-chromosome inactivation, genome imprinting, DNA repair and transcriptional regulation(3). The discovery of lysyl demethylases using flavin (amine oxidases)(4) or Fe( II) and 2-oxoglutarate as cofactors (2OG oxygenases)(5-7) has changed the view of methylation as a stable epigenetic marker. However, little is known about how the demethylases are selective for particular lysyl-containing sequences in specific methylation states, a key to understanding their functions. Here we reveal how human JMJD2A ( jumonji domain containing 2A), which is selective towards tri- and dimethylated histone H3 lysyl residues 9 and 36 (H3K9me3/me2 and H3K36me3/me2), discriminates between methylation states and achieves sequence selectivity for H3K9. We report structures of JMJD2A - Ni( II) - Zn( II) inhibitor complexes bound to tri-, di- and monomethyl forms of H3K9 and the trimethyl form of H3K36. The structures reveal a lysyl-binding pocket in which substrates are bound in distinct bent conformations involving the Zn-binding site. We propose a mechanism for achieving methylation state selectivity involving the orientation of the substrate methyl groups towards a ferryl intermediate. The results suggest distinct recognition mechanisms in different demethylase subfamilies and provide a starting point to develop chemical tools for drug discovery and to study and dissect the complexity of reversible histone methylation and its role in chromatin biology.	Univ Oxford, Struct Genom Consortium, Botnar Res Ctr, Oxford OX3 7LD, England; Univ Oxford, Dept Chem, Oxford OX1 3TA, England; Univ Oxford, Oxford Ctr Integrated Syst Biol, Oxford OX1 3TA, England; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; PAS Univ, Inst Catalysis & Surface Chem, PL-830239 Krakow, Poland	University of Oxford; University of Oxford; University of Oxford; University of Oxford; Polish Academy of Sciences; Jerzy Haber Institute of Catalysis & Surface Chemistry	Schofield, CJ (corresponding author), Univ Oxford, Struct Genom Consortium, Botnar Res Ctr, Oxford OX3 7LD, England.	christopher.schofield@chemistry.oxford.ac.uk	Gileadi, Opher/F-1105-2013; Borowski, Tomasz/E-8569-2016; Rose, Nathan R/A-9270-2013; McDonough, Michael/N-8913-2019; McDonough, Michael A/G-2744-2013	Gileadi, Opher/0000-0001-6886-898X; Borowski, Tomasz/0000-0002-3450-3576; Rose, Nathan R/0000-0002-1871-1156; McDonough, Michael/0000-0003-4664-6942; McDonough, Michael A/0000-0003-4664-6942; von Delft, Frank/0000-0003-0378-0017; offer, john/0000-0002-2471-1216; Schofield, Christopher/0000-0002-0290-6565; Savitsky, Pavel/0000-0001-8584-7750; BRAY, JAMES/0000-0003-3554-4254	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Flashman E, 2007, NAT CHEM BIOL, V3, P86, DOI 10.1038/nchembio0207-86; Grzyska PK, 2005, BIOCHEMISTRY-US, V44, P3845, DOI 10.1021/bi048746n; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Liang G, 2007, NAT STRUCT MOL BIOL, V14, P243, DOI 10.1038/nsmb1204; Lo WS, 2001, SCIENCE, V293, P1142, DOI 10.1126/science.1062322; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	17	255	260	2	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2007	448	7149					87	91		10.1038/nature05971	http://dx.doi.org/10.1038/nature05971			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185OS	17589501				2022-12-01	WOS:000247720900043
J	Takashima, Y; Era, T; Nakao, K; Kondo, S; Kasuga, M; Smith, AG; Nishikawa, SI				Takashima, Yasuhiro; Era, Takumi; Nakao, Kazuki; Kondo, Saki; Kasuga, Masato; Smith, Austin G.; Nishikawa, Shin-Ichi			Neuroepithelial cells supply an initial transient wave of MSC differentiation	CELL			English	Article							MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; NEURAL CREST; BONE-MARROW; MOUSE; EXPRESSION; ORIGIN; GROWTH; MESODERM; LINEAGE	Mesenchymal stem cells (MSCs) are defined as cells that undergo sustained in vitro growth and are able to give rise to multiple mesenchymal lineages. Although MSCs are already used in regenerative medicine little is known about their in vivo behavior and developmental derivation. Here, we show that the earliest wave of MSC in the embryonic trunk is generated from Sox1(+) neuroepithelium but not from mesoderm. Using lineage marking by direct gfp knock- in and Cre-recombinase mediated lineage tracing, we provide evidence that Sox1(+) neuroepithelium gives rise to MSCs in part through a neural crest intermediate stage. This pathway can be distinguished from the pathway through which Sox1(+) cells give rise to oligodendrocytes by expression of PDGFR beta and A2B5. MSC recruitment from this pathway, however, is transient and is replaced by MSCs from unknown sources. We conclude that MSC can be defined as a definite in vivo entity recruited from multiple developmental origins.	Riken Ctr Dev Biol, Lab Stem Cell Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; Riken Ctr Dev Biol, Lab Anim Resources & Genet Engn, Chuo Ku, Kobe, Hyogo 6500047, Japan; Kobe Univ, Grad Sch Med, Div Diabet & Digest & Kidney Dis, Dept Clin Mol Med,Chuo Ku, Kobe, Hyogo 6500017, Japan; Univ Tokyo, Inst Med Sci, Mol Genet Lab, Tokyo 1088639, Japan; Univ Cambridge, Inst Stem Cell Biol, Cambridge CB2 1QT, England	RIKEN; RIKEN; Kobe University; University of Tokyo; University of Cambridge	Era, T (corresponding author), Riken Ctr Dev Biol, Lab Stem Cell Biol, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	tera@cdb.riken.jp		zhong wei, he gui/0000-0002-3066-3564; Takashima, Yasuhiro/0000-0003-0126-7260; Smith, Austin/0000-0002-3029-4682	Medical Research Council [G0800784, G9806702] Funding Source: Medline; MRC [G9806702] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Bailey P, 2001, CURR OPIN CELL BIOL, V13, P679, DOI 10.1016/S0955-0674(00)00271-4; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Dani C, 1997, J CELL SCI, V110, P1279; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; Dennis JE, 2002, STEM CELLS, V20, P205, DOI 10.1634/stemcells.20-3-205; Dezawa M, 2001, EUR J NEUROSCI, V14, P1771, DOI 10.1046/j.0953-816x.2001.01814.x; DROZDOFF V, 1991, J BIOL CHEM, V266, P17165; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; GRONTHOS S, 1994, BLOOD, V84, P4164, DOI 10.1182/blood.V84.12.4164.bloodjournal84124164; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Javazon EH, 2004, EXP HEMATOL, V32, P414, DOI 10.1016/j.exphem.2004.02.004; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429; Kawaguchi J, 2005, BONE, V36, P758, DOI 10.1016/j.bone.2004.07.019; KILBY NJ, 1993, TRENDS GENET, V9, P413, DOI 10.1016/0168-9525(93)90104-P; Kondo S, 2006, MICROBIOL IMMUNOL, V50, P831, DOI 10.1111/j.1348-0421.2006.tb03850.x; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; LaBonne C, 1999, ANNU REV CELL DEV BI, V15, P81, DOI 10.1146/annurev.cellbio.15.1.81; Le Douarin NM, 2004, DEVELOPMENT, V131, P4637, DOI 10.1242/dev.01350; Li M, 2002, Methods Mol Biol, V185, P205; Matsuoka T, 2005, NATURE, V436, P347, DOI 10.1038/nature03837; McCormick MB, 1996, MOL CELL BIOL, V16, P5792; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Ogawa M, 2006, BLOOD, V108, P2893, DOI 10.1182/blood-2006-04-016600; PARR BA, 1993, DEVELOPMENT, V119, P247; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Pietri T, 2003, DEV BIOL, V259, P176, DOI 10.1016/S0012-1606(03)00175-1; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Sakurai H, 2006, STEM CELLS, V24, P575, DOI 10.1634/stemcells.2005-0256; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stolt CC, 2006, DEV CELL, V11, P697, DOI 10.1016/j.devcel.2006.08.011; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Takakura N, 1997, J HISTOCHEM CYTOCHEM, V45, P883, DOI 10.1177/002215549704500613; Weston JA, 2004, DEV DYNAM, V229, P118, DOI 10.1002/dvdy.10478; Wilson YM, 2004, DEVELOPMENT, V131, P6153, DOI 10.1242/dev.01533; Wobus A M, 2002, Methods Mol Biol, V185, P127; Yamauchi Y, 1999, DEV BIOL, V212, P191, DOI 10.1006/dbio.1999.9323; ZON LI, 1995, BLOOD, V86, P2876	45	387	409	3	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2007	129	7					1377	1388		10.1016/j.cell.2007.04.028	http://dx.doi.org/10.1016/j.cell.2007.04.028			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	188HQ	17604725	Bronze			2022-12-01	WOS:000247911400022
J	Rock, FL; Mao, WM; Yaremchuk, A; Tukalo, M; Crepin, T; Zhou, HC; Zhang, YK; Hernandez, V; Akama, T; Baker, SJ; Plattner, JJ; Shapiro, L; Martinis, SA; Benkovic, SJ; Cusack, S; Alley, MRK				Rock, Fernando L.; Mao, Weimin; Yaremchuk, Anya; Tukalo, Mikhail; Crepin, Thibaut; Zhou, Huchen; Zhang, Yong-Kang; Hernandez, Vincent; Akama, Tsutomu; Baker, Stephen J.; Plattner, Jacob J.; Shapiro, Lucy; Martinis, Susan A.; Benkovic, Stephen J.; Cusack, Stephen; Alley, M. R. K.			An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing site	SCIENCE			English	Article							CRYSTAL-STRUCTURE	Aminoacyl-transfer RNA (tRNA) synthetases, which catalyze the attachment of the correct amino acid to its corresponding tRNA during translation of the genetic code, are proven antimicrobial drug targets. We show that the broad-spectrum antifungal 5-fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole (AN2690), in development for the treatment of onychomycosis, inhibits yeast cytoplasmic leucyl-tRNA synthetase by formation of a stable tRNA(Leu)-AN2690 adduct in the editing site of the enzyme. Adduct formation is mediated through the boron atom of AN2690 and the 2'- and 3'-oxygen atoms of tRNA's 3'-terminal adenosine. The trapping of enzyme-bound tRNALeu in the editing site prevents catalytic turnover, thus inhibiting synthesis of leucyl-tRNA(Leu) and consequentially blocking protein synthesis. This result establishes the editing site as a bona fide target for aminoacyl-tRNA synthetase inhibitors.	Anacor Pharmaceut Inc, Palo Alto, CA 94303 USA; European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France; Ukrainian Acad Sci, Inst Mol Biol & Genet, UA-252627 Kiev, Ukraine; Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200240, Peoples R China; Stanford Univ, Sch Med, Dept Dev Biol, Beckman Ctr, Stanford, CA 94305 USA; Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; Penn State Univ, Dept Chem, University Pk, PA 16802 USA	European Molecular Biology Laboratory (EMBL); National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; Shanghai Jiao Tong University; Stanford University; University of Illinois System; University of Illinois Urbana-Champaign; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Alley, MRK (corresponding author), Anacor Pharmaceut Inc, 1060 E Meadow Circle, Palo Alto, CA 94303 USA.	dalley@anacor.com		CREPIN, Thibaut/0000-0003-2663-1794; Tukalo, Michael/0000-0002-0982-2372; Martinis, Susan/0000-0001-5730-8346; Cusack, Stephen/0000-0002-9324-0796	NIDCR NIH HHS [R01 DE16835] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016835] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Baker SJ, 2006, J MED CHEM, V49, P4447, DOI 10.1021/jm0603724; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; Fukunaga R, 2005, J MOL BIOL, V346, P57, DOI 10.1016/j.jmb.2004.11.060; Hendrickson T.L., 2003, TRANSLATION MECH, P34; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; MCCUTCHAN TF, 1975, NUCLEIC ACIDS RES, V2, P853, DOI 10.1093/nar/2.6.853; SCHIMMEL P, 1995, TRENDS BIOCHEM SCI, V20, P1, DOI 10.1016/S0968-0004(00)88937-9; Zhai YX, 2005, BIOCHEMISTRY-US, V44, P15437, DOI 10.1021/bi0514461	9	460	517	3	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2007	316	5832					1759	1761		10.1126/science.1142189	http://dx.doi.org/10.1126/science.1142189			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180XE	17588934				2022-12-01	WOS:000247400500051
J	Whittall, JB; Hodges, SA				Whittall, Justen B.; Hodges, Scott A.			Pollinator shifts drive increasingly long nectar spurs in columbine flowers	NATURE			English	Article							ANCESTRAL CHARACTER STATES; EVOLUTION; RATES	Directional evolutionary trends have long garnered interest because they suggest that evolution can be predictable. However, the identification of the trends themselves and the underlying processes that may produce them have often been controversial(1). In 1862, in explaining the exceptionally long nectar spur of Angraecum sesquipedale, Darwin proposed that a coevolutionary 'race' had driven the directional increase in length of a plant's spur and its pollinator's tongue(2). Thus he predicted the existence of an exceptionally long-tongued moth. Though the discovery of Xanthopan morgani ssp. praedicta in 1903 with a tongue length of 22 cm validated Darwin's prediction(3), his 'race' model for the evolution of long-spurred flowers remains contentious(4). Spurs may also evolve to exceptional lengths by way of pollinator shifts as plants adapt to a series of unrelated pollinators, each with a greater tongue length(5). Here, using a species-level phylogeny of the columbine genus, Aquilegia, we show a significant evolutionary trend for increasing spur length during directional shifts to pollinators with longer tongues. In addition, we find evidence for 'punctuated' change in spur length during speciation events(6), suggesting that Aquilegia nectar spurs rapidly evolve to fit adaptive peaks predefined by pollinator morphology. These findings show that evolution may proceed in predictable pathways without reversals and that change may be concentrated during speciation.	Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Whittall, JB (corresponding author), Univ Calif Davis, Sect Evolut & Ecol, 1 Shields Ave, Davis, CA 95616 USA.	jbwhittall@ucdavis.edu; hodges@lifesci.ucsb.edu		Hodges, Scott/0000-0002-0401-6072				Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Darwin C., 1862, VARIOUS CONTRIVANCES; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fulton M, 1999, P ROY SOC B-BIOL SCI, V266, P2247, DOI 10.1098/rspb.1999.0915; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Gould SJ, 1997, NATURE, V385, P199, DOI 10.1038/385199a0; GRANT V, 1992, P NATL ACAD SCI USA, V89, P9400, DOI 10.1073/pnas.89.20.9400; GRANT V, 1949, EVOLUTION, V3, P82, DOI 10.2307/2405454; GRANT VERNE, 1952, ALISO, V2, P341; HODGES SA, 1994, P NATL ACAD SCI USA, V91, P5129, DOI 10.1073/pnas.91.11.5129; HODGES SA, 1995, AM J BOT, V82, P197, DOI 10.2307/2445527; Hodges SA, 1995, P ROY SOC B-BIOL SCI, V262, P343, DOI 10.1098/rspb.1995.0215; Hodges SA, 2004, NEW PHYTOL, V161, P113, DOI 10.1046/j.1469-8137.2003.00950.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hundsdoerfer AK, 2005, MOL PHYLOGENET EVOL, V35, P442, DOI 10.1016/j.ympev.2005.02.004; Johnson SD, 1997, EVOLUTION, V51, P45, DOI [10.1111/j.1558-5646.1997.tb02387.x, 10.2307/2410959]; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; Lee Chunghau, 2006, Evolutionary Bioinformatics Online, V2, P193; Maddison W. P., 2004, MESQUITE MODULAR SYS; Maddison WP., 2005, PDAP PACKAGE MESQUIT; Millard E., 1997, GENDER EDUC, V9, P31, DOI DOI 10.1080/09540259721439; Nilsson LA, 1998, TRENDS ECOL EVOL, V13, P259, DOI 10.1016/S0169-5347(98)01359-7; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; ROTHENBORG HW, 1972, CRYOBIOLOGY, V9, P1, DOI 10.1016/0011-2240(72)90002-8; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WALLACE AR, 1867, Q J SCI S, V140, P471; Wasserthal LT, 1997, BOT ACTA, V110, P343, DOI 10.1111/j.1438-8677.1997.tb00650.x	29	463	483	24	595	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 7	2007	447	7145					706	U12		10.1038/nature05857	http://dx.doi.org/10.1038/nature05857			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554306				2022-12-01	WOS:000247030700042
J	Kawai, T; Akira, S				Kawai, Taro; Akira, Shizuo			SnapShot: Pattern-recognition receptors	CELL			English	Editorial Material									Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 565, Japan	Osaka University	Kawai, T (corresponding author), Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 565, Japan.			Kawai, Taro/0000-0001-7510-4662					0	25	28	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2007	129	5					1024	U20	1024.e1	10.1016/j.cell.2007.05.017	http://dx.doi.org/10.1016/j.cell.2007.05.017			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540179	Bronze			2022-12-01	WOS:000247084600020
J	Mathy, N; Benard, L; Pellegrini, O; Daou, R; Wen, TY; Condon, C				Mathy, Nathalie; Benard, Lionel; Pellegrini, Olivier; Daou, Roula; Wen, Tingyi; Condon, Ciaran			5 '-to-3 ' exoribonuclease activity in Bacteria: Role of RNase J1 in rRNA maturation and 5 ' stability of mRNA	CELL			English	Article							BACILLUS-SUBTILIS; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; PHYLOGENETIC DISTRIBUTION; DEGRADATION; PROTEIN; STABILITY; PURIFICATION; RIBONUCLEASE; TRANSLATION	Although the primary mechanism of eukaryotic messenger RNA decay is exoribonucleolytic degradation in the 5'-to-3' orientation, it has been widely accepted that Bacteria can only degrade RNAs with the opposite polarity, i.e. 3' to 5'. Here we show that maturation of the 5' side of Bacillus subtilis 16S ribosomal RNA occurs via a 5'-to-3'exonucleolytic pathway, catalyzed by the widely distributed essential ribonuclease RNase J1. The presence of a 5'-to-3'exoribonuclease activity in B. subtilis suggested an explanation for the phenomenon whereby mRNAs in this organism are stabilized for great distances downstream of "roadblocks" such as stalled ribosomes or stable secondary structures, whereas upstream sequences are never detected. We show that a 30S ribosomal subunit bound to a Shine Dalgarno-like element (Stab-SID) in the cryIIIA mRNA blocks exonucleolytic progression of RNase J1, accounting for the stabilizing effect of this element in vivo.	Univ Paris 07, CNRS UPR 9073, Inst Biol Phys CHim, F-75005 Paris, France	UDICE-French Research Universities; Universite Paris Cite	Condon, C (corresponding author), Univ Paris 07, CNRS UPR 9073, Inst Biol Phys CHim, 13 Rue Pierre & Marie Curie, F-75005 Paris, France.	condon@ibpc.fr	Wen, Tingyi/M-6095-2014; BENARD, LIONEL/E-4057-2019; Condon, Ciaran/F-6798-2011	Wen, Tingyi/0000-0003-2583-7088; BENARD, LIONEL/0000-0003-1745-1361; Condon, Ciaran/0000-0002-2199-9621				Agaisse H, 1996, MOL MICROBIOL, V20, P633, DOI 10.1046/j.1365-2958.1996.5401046.x; AGAISSE H, 1994, MOL MICROBIOL, V13, P97, DOI 10.1111/j.1365-2958.1994.tb00405.x; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Bechhofer D., 1993, CONTROL MESSENGER RN, P31; BECHHOFER DH, 1987, P NATL ACAD SCI USA, V84, P498, DOI 10.1073/pnas.84.2.498; Belasco J, 1993, CONTROL MESSENGER RN, P3; Britton RA, 2007, MOL MICROBIOL, V63, P127, DOI 10.1111/j.1365-2958.2006.05499.x; Callebaut I, 2002, NUCLEIC ACIDS RES, V30, P3592, DOI 10.1093/nar/gkf470; Carpousis AJ, 2002, BIOCHEM SOC T, V30, P150, DOI 10.1042/bst0300150; CARPOUSIS AJ, 1994, CELL, V76, P889, DOI 10.1016/0092-8674(94)90363-8; Cheng ZF, 2002, J BIOL CHEM, V277, P21624, DOI 10.1074/jbc.M202942200; Condon C, 2003, MICROBIOL MOL BIOL R, V67, P157, DOI 10.1128/MMBR.67.2.157-174.2003; Condon C, 2002, NUCLEIC ACIDS RES, V30, P5339, DOI 10.1093/nar/gkf691; Deana A, 2005, GENE DEV, V19, P2526, DOI 10.1101/gad.1348805; Deutscher MP, 2006, NUCLEIC ACIDS RES, V34, P659, DOI 10.1093/nar/gkj472; Dominski Z, 2005, CELL, V123, P37, DOI 10.1016/j.cell.2005.08.002; Dreyfus M., 2002, TRANSLATIONAL MECH; Even S, 2005, NUCLEIC ACIDS RES, V33, P2141, DOI 10.1093/nar/gki505; Ghosh S, 1999, P NATL ACAD SCI USA, V96, P4372, DOI 10.1073/pnas.96.8.4372; Glatz E, 1996, MOL MICROBIOL, V19, P319, DOI 10.1046/j.1365-2958.1996.376903.x; Hambraeus G, 2002, MICROBIOL-SGM, V148, P1795, DOI 10.1099/00221287-148-6-1795; HUANG J, 1988, NUCLEIC ACIDS RES, V16, P9737, DOI 10.1093/nar/16.20.9737; JOHNSON AW, 1991, J BIOL CHEM, V266, P14046; Joyce SA, 1998, J MOL BIOL, V282, P241, DOI 10.1006/jmbi.1998.2027; Khemici V, 2004, MOL MICROBIOL, V51, P777, DOI 10.1046/j.1365-2958.2003.03862.x; Lee A, 2005, MOL CELL, V19, P39, DOI 10.1016/j.molcel.2005.05.021; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lorentzen E, 2005, NAT STRUCT MOL BIOL, V12, P575, DOI 10.1038/nsmb952; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; QUSSENKO IA, 2002, J BACTERIOL, V184, P6250; SHIVAKUMAR AG, 1980, P NATL ACAD SCI-BIOL, V77, P3903, DOI 10.1073/pnas.77.7.3903; STEVENS A, 1980, J BIOL CHEM, V255, P3080; STEVENS A, 1995, J BIOL CHEM, V270, P16063, DOI 10.1074/jbc.270.27.16063; Stevens A, 2001, METHOD ENZYMOL, V342, P251, DOI 10.1016/S0076-6879(01)42549-3; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	38	259	266	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2007	129	4					681	692		10.1016/j.cell.2007.02.051	http://dx.doi.org/10.1016/j.cell.2007.02.051			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512403	Bronze			2022-12-01	WOS:000246788300014
J	McGillicuddy, DJ; Anderson, LA; Bates, NR; Bibby, T; Buesseler, KO; Carlson, CA; Davis, CS; Ewart, C; Falkowski, PG; Goldthwait, SA; Hansell, DA; Jenkins, WJ; Johnson, R; Kosnyrev, VK; Ledwell, JR; Li, QP; Siegel, DA; Steinberg, DK				McGillicuddy, Dennis J., Jr.; Anderson, Laurence A.; Bates, Nicholas R.; Bibby, Thomas; Buesseler, Ken O.; Carlson, Craig A.; Davis, Cabell S.; Ewart, Courtney; Falkowski, Paul G.; Goldthwait, Sarah A.; Hansell, Dennis A.; Jenkins, William J.; Johnson, Rodney; Kosnyrev, Valery K.; Ledwell, James R.; Li, Qian P.; Siegel, David A.; Steinberg, Deborah K.			Eddy/wind interactions stimulate extraordinary mid-ocean plankton blooms	SCIENCE			English	Article							ATLANTIC TIME-SERIES; NORTH PACIFIC-OCEAN; MESOSCALE EDDY; SARGASSO SEA; PRIMARY PRODUCTIVITY; NITROGEN-FIXATION; BERMUDA; BIOGEOCHEMISTRY; PHYTOPLANKTON; IMPACT	Episodic eddy-driven upwelling may supply a significant fraction of the nutrients required to sustain primary productivity of the subtropical ocean. New observations in the northwest Atlantic reveal that, although plankton blooms occur in both cyclones and mode-water eddies, the biological responses differ. Mode-water eddies can generate extraordinary diatom biomass and primary production at depth, relative to the time series near Bermuda. These blooms are sustained by eddy/wind interactions, which amplify the eddy-induced upwelling. In contrast, eddy/wind interactions dampen eddy-induced upwelling in cyclones. Carbon export inferred from oxygen anomalies in eddy cores is one to three times as much as annual new production for the region.	Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; Bermuda Inst Ocean Sci, Ferry Reach GEO1, Bermuda; Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; Univ Southampton, Natl Oceanog Ctr, Sch Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England; Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA; Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA; Humboldt State Univ, Arcata, CA 95521 USA; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA	Woods Hole Oceanographic Institution; Bermuda Institute of Ocean Sciences; Rutgers State University New Brunswick; NERC National Oceanography Centre; University of Southampton; University of California System; University of California Santa Barbara; William & Mary; Virginia Institute of Marine Science; California State University System; California State Polytechnic University, Humboldt; University of Miami	McGillicuddy, DJ (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	dmcgillicuddy@whoi.edu	Siegel, David A/C-5587-2008; Li, Qian P/P-7335-2018; Bibby, Thomas/C-9159-2014; Hansell, Dennis A./AAC-1271-2019	Li, Qian P/0000-0002-9846-3243; Hansell, Dennis A./0000-0001-9275-3445; Bibby, Thomas/0000-0003-1743-473X; McGillicuddy, Dennis/0000-0002-1437-2425				Allen JT, 2005, NATURE, V437, P728, DOI 10.1038/nature03948; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; CARBILLIDO BM, 2006, LIMNOL OCEANOGR, V51, P2675; Dadou I, 1996, J MAR RES, V54, P311, DOI 10.1357/0022240963213411; Davis CS, 2005, LIMNOL OCEANOGR-METH, V3, P59, DOI 10.4319/lom.2005.3.59; DEWAR WK, 1987, J PHYS OCEANOGR, V17, P1653, DOI 10.1175/1520-0485(1987)017<1653:SEOTWO>2.0.CO;2; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; Emerson S, 2001, GLOBAL BIOGEOCHEM CY, V15, P535, DOI 10.1029/2000GB001320; FALKOWSKI PG, 1991, NATURE, V352, P55, DOI 10.1038/352055a0; FRANKS PJS, 1986, J GEOPHYS RES-OCEANS, V91, P7603, DOI 10.1029/JC091iC06p07603; Goldman JC, 2003, LIMNOL OCEANOGR, V48, P1176, DOI 10.4319/lo.2003.48.3.1176; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; HOOD RR, 2004, J GEOPHYS RES, V109; JENKINS WJ, 1985, J MAR RES, V43, P465, DOI 10.1357/002224085788438702; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Karl DM, 2003, NATURE, V426, P32, DOI 10.1038/426032a; Leben R.R., 2002, MAR GEOD, V25, P3, DOI [10.1080/014904102753516697, DOI 10.1080/014904102753516697]; LETELIER RM, 1993, LIMNOL OCEANOGR, V38, P1420, DOI 10.4319/lo.1993.38.7.1420; Levitus S., 1982, 13 NOAA; Levy M, 2001, J MAR RES, V59, P535, DOI 10.1357/002224001762842181; LEWIS MR, 1986, SCIENCE, V234, P870, DOI 10.1126/science.234.4778.870; Mahadevan A, 2000, J GEOPHYS RES-OCEANS, V105, P1209, DOI 10.1029/1999JC900216; Martin AP, 2001, DEEP-SEA RES PT II, V48, P757, DOI 10.1016/S0967-0645(00)00096-5; McGillicuddy DJ, 1998, NATURE, V394, P263, DOI 10.1038/28367; McGillicuddy DJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001987; McNeil JD, 1999, J GEOPHYS RES-OCEANS, V104, P15537, DOI 10.1029/1999JC900137; MICHAELS AF, 1994, DEEP-SEA RES PT I, V41, P1013, DOI 10.1016/0967-0637(94)90016-7; Oschlies A, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001830; Palter JB, 2005, NATURE, V437, P687, DOI 10.1038/nature03969; PLATT T, 1985, NATURE, V318, P55, DOI 10.1038/318055a0; SHULENBERGER E, 1981, DEEP-SEA RES, V28, P901, DOI 10.1016/0198-0149(81)90009-1; Siegel DA, 2001, DEEP-SEA RES PT II, V48, P1865, DOI 10.1016/S0967-0645(00)00167-3; Spall SA, 2000, DEEP-SEA RES PT I, V47, P1261, DOI 10.1016/S0967-0637(99)00081-3; Steinberg DK, 2001, DEEP-SEA RES PT II, V48, P1405, DOI 10.1016/S0967-0645(00)00148-X; STRASS VH, 1992, DEEP-SEA RES, V39, P75, DOI 10.1016/0198-0149(92)90021-K; Sweeney EN, 2003, DEEP-SEA RES PT II, V50, P3017, DOI 10.1016/j.dsr2.2003.07.008; WILLIAMS RG, 2003, OCEAN BIOGEOCHEMISTR, V19; WOODS JD, 1988, THEORY BIOL PHYS INT, P1; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759	39	596	609	10	242	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2007	316	5827					1021	1026		10.1126/science.1136256	http://dx.doi.org/10.1126/science.1136256			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17510363				2022-12-01	WOS:000246554000045
J	Richards, T				Richards, Tessa			A better way to die - Why dying and death need to be "rehabilitated" back to a more central position in society	BRITISH MEDICAL JOURNAL			English	Editorial Material												trichards@bmj.com							0	4	4	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 21	2007	334	7598					830	830		10.1136/bmj.39188.592940.59	http://dx.doi.org/10.1136/bmj.39188.592940.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	162MD	17446614	Green Published			2022-12-01	WOS:000246090800030
J	Bowman, JL; Floyd, SK; Sakakibara, K				Bowman, John L.; Floyd, Sandra K.; Sakakibara, Keiko			Green genes - Comparative genomics of the green branch of life	CELL			English	Article							LAND PLANTS; EVOLUTION; ARABIDOPSIS; EUKARYOTES; ORIGINS	As more plant genome sequences become available, researchers are increasingly using comparative genomics to address some of the major questions in plant biology. Such questions include the evolution of photosynthesis and multicellularity, the developmental genetic changes responsible for alterations in body plan, and the origin of important plant innovations such as roots, leaves, and vascular tissue.	Monash Univ, Sch Biol Sci, Melbourne, Vic 3800, Australia	Monash University	Bowman, JL (corresponding author), Monash Univ, Sch Biol Sci, Clayton Campus, Melbourne, Vic 3800, Australia.	john.bowman@sci.monash.edu.au	Sakakibara, Keiko/Q-5748-2018	Sakakibara, Keiko/0000-0003-4420-9351; Bowman, John/0000-0001-7347-3691				Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Floyd SK, 2007, INT J PLANT SCI, V168, P1, DOI 10.1086/509079; Floyd SK, 2006, CURR BIOL, V16, P1911, DOI 10.1016/j.cub.2006.07.067; Friedman WE, 2004, AM J BOT, V91, P1726, DOI 10.3732/ajb.91.10.1726; Grossman AR, 2007, CURR OPIN PLANT BIOL, V10, P190, DOI 10.1016/j.pbi.2007.01.012; Harrison CJ, 2005, NATURE, V434, P509, DOI 10.1038/nature03410; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Nishiyama T, 2003, P NATL ACAD SCI USA, V100, P8007, DOI 10.1073/pnas.0932694100; Ohno S., 1970, EVOLUTION GENE DUPLI, DOI [DOI 10.1007/978-3-642-86659-3, 10.1007/978-3-642-86659-3_11]; Ruiz-Trillo I, 2007, TRENDS GENET, V23, P113, DOI 10.1016/j.tig.2007.01.005; Turmel M, 2003, PLANT CELL, V15, P1888, DOI 10.1105/tpc.013169; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691	18	155	158	2	48	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 20	2007	129	2					229	234		10.1016/j.cell.2007.04.004	http://dx.doi.org/10.1016/j.cell.2007.04.004			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448980	Bronze			2022-12-01	WOS:000246474600006
J	Lohman, DJ; Bickford, D; Sodhi, NS				Lohman, David J.; Bickford, David; Sodhi, Navjot S.			The burning issue	SCIENCE			English	Editorial Material							FOREST; SMOKE		Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	National University of Singapore	Lohman, DJ (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.	lohman@nus.edu.sg; dbsns@nus.edu.sg	Bickford, David P/A-5306-2011	Bickford, David P/0000-0003-1478-3387; Lohman, David/0000-0002-0689-2906				Barber C, 2000, TRIAL FIRE FOREST FI; Byron N, 2004, AGR ECOSYST ENVIRON, V104, P57, DOI 10.1016/j.agee.2004.01.006; FAO, 2007, FIR MAN GLOB ASS 200; Glover D., 1999, INDONESIAS FIRES HAZ; Jayachandran S, 2005, 95 BREAD; Kinnaird MF, 1998, CONSERV BIOL, V12, P954, DOI 10.1046/j.1523-1739.1998.012005954.x; Marten G. G., 1986, TRADITIONAL AGR SE A; Nichol J, 1998, ATMOS ENVIRON, V32, P3917; Nichol J, 1997, ATMOS ENVIRON, V31, P1209, DOI 10.1016/S1352-2310(96)00260-9; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; Sastry N, 2002, DEMOGRAPHY, V39, P1, DOI 10.1353/dem.2002.0009; Tomich TP, 2004, AGR ECOSYST ENVIRON, V104, P229, DOI 10.1016/j.agee.2004.01.017; 2007, STRAITS TIMES   0106, P24	13	54	54	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					376	376		10.1126/science.1140278	http://dx.doi.org/10.1126/science.1140278			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446376				2022-12-01	WOS:000245813400026
J	Lomakin, IB; Xiong, Y; Steitz, TA				Lomakin, Ivan B.; Xiong, Yong; Steitz, Thomas A.			The crystal structure of yeast fatty acid synthase, a cellular machine with eight active sites working together	CELL			English	Article							CARRIER PROTEIN TRANSACYLASE; SACCHAROMYCES-CEREVISIAE; SUBSTRATE-BINDING; SYNTHETASE; MALONYL; SUBUNIT; BIOSYNTHESIS; REDUCTASE; ENZYME; COMPLEMENTATION	In yeast, the whole metabolic pathway for making 16- and 18-carbon fatty acids is carried out by fatty acid synthase, a 2.6 megadalton molecular-weight macromolecular assembly containing six copies of all eight catalytic centers. We have determined its crystal structure, which illuminates how this enzyme is initially activated and then carries out multiple steps of synthesis in each of six sterically isolated reaction chambers. Six of the catalytic sites are in the wall of the assembly facing an acyl carrier protein (ACP) bound to the ketoacyl synthase domain. Two-dimensional diffusion of substrates to the catalytic sites may be achieved by the electrostatically negative ACP swinging to each of the six electrostatically positive catalytic sites. The phosphopantetheinyl transferase domain lies outside the shell of the assembly, inaccessible to ACP that lies inside, suggesting that the attachment of the pantetheine arm to ACP must occur before complete assembly of the complex.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Xiong, Y (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	yong.xiong@yale.edu; eatherton@csb.yale.edu	Steitz, Thomas A./C-6559-2009	Lomakin, Ivan/0000-0001-6528-5068	NIGMS NIH HHS [GM22778] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHIRALA SS, 1987, J BIOL CHEM, V262, P4231; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; DIETLEIN G, 1975, EUR J BIOCHEM, V58, P177, DOI 10.1111/j.1432-1033.1975.tb02362.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGESER H, 1979, EUR J BIOCHEM, V101, P413, DOI 10.1111/j.1432-1033.1979.tb19734.x; Fichtlscherer F, 2000, EUR J BIOCHEM, V267, P2666, DOI 10.1046/j.1432-1327.2000.01282.x; Fisher M, 2000, STRUCTURE, V8, P339, DOI 10.1016/S0969-2126(00)00115-5; FOX JL, 1980, EUR J BIOCHEM, V109, P417, DOI 10.1111/j.1432-1033.1980.tb04810.x; Ha JY, 2006, J BIOL CHEM, V281, P18660, DOI 10.1074/jbc.M601658200; Heath RJ, 2000, NATURE, V406, P145, DOI 10.1038/35018162; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Jenni S, 2006, SCIENCE, V311, P1263, DOI 10.1126/science.1123251; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keatinge-Clay AT, 2003, STRUCTURE, V11, P147, DOI 10.1016/S0969-2126(03)00004-2; Kolodziej SJ, 1996, J BIOL CHEM, V271, P28422, DOI 10.1074/jbc.271.45.28422; Koski MK, 2004, J BIOL CHEM, V279, P24666, DOI 10.1074/jbc.M400293200; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; LAMBALOT RH, 1995, J BIOL CHEM, V270, P24658, DOI 10.1074/jbc.270.42.24658; LAMBALOT RH, 1996, CHEM BIOL, V3, P9223; Leesong M, 1996, STRUCTURE, V4, P253, DOI 10.1016/S0969-2126(96)00030-5; Lupu R, 2006, ENDOCRINOLOGY, V147, P4056, DOI 10.1210/en.2006-0486; LYNEN F, 1980, EUR J BIOCHEM, V112, P431; LYNEN F, 1967, BIOCHEM J, V102, P381, DOI 10.1042/bj1020381; LYNEN F, 1969, METHOD ENZYMOL, V14, P17; Marrakchi H, 2003, BIOCHEM J, V370, P1055, DOI 10.1042/BJ20021699; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MOHAMED AH, 1988, J BIOL CHEM, V263, P12315; Oefner C, 2006, ACTA CRYSTALLOGR D, V62, P613, DOI 10.1107/S0907444906009474; Olsen JG, 1999, FEBS LETT, V460, P46, DOI 10.1016/S0014-5793(99)01303-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; Rangan VS, 1997, J BIOL CHEM, V272, P11975, DOI 10.1074/jbc.272.18.11975; Reuter K, 1999, EMBO J, V18, P6823, DOI 10.1093/emboj/18.23.6823; Ronnett GV, 2005, PHYSIOL BEHAV, V85, P25, DOI 10.1016/j.physbeh.2005.04.014; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; Saitoh S, 1996, J CELL BIOL, V134, P949, DOI 10.1083/jcb.134.4.949; SCHRECKENBACH T, 1977, EUR J BIOCHEM, V80, P13, DOI 10.1111/j.1432-1033.1977.tb11850.x; SCHUSTER H, 1995, EUR J BIOCHEM, V228, P417; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; SERRE L, 1995, J BIOL CHEM, V270, P12961, DOI 10.1074/jbc.270.22.12961; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; Torkko JM, 2003, J BIOL CHEM, V278, P41213, DOI 10.1074/jbc.M307664200; WERKMEISTER K, 1981, EUR J BIOCHEM, V116, P303, DOI 10.1111/j.1432-1033.1981.tb05334.x; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; WIELAND F, 1978, P NATL ACAD SCI USA, V75, P5792, DOI 10.1073/pnas.75.12.5792; WIELAND F, 1979, EUR J BIOCHEM, V94, P189, DOI 10.1111/j.1432-1033.1979.tb12885.x; Zhang YM, 2003, J LIPID RES, V44, P1, DOI 10.1194/jlr.R200016-JLR200; Zhang YM, 2006, J BIOL CHEM, V281, P17541, DOI 10.1074/jbc.R600004200	49	169	179	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2007	129	2					319	332		10.1016/j.cell.2007.03.013	http://dx.doi.org/10.1016/j.cell.2007.03.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448991	Bronze			2022-12-01	WOS:000246474600019
J	Gudbjartsson, DF; Arnar, DO; Helgadottir, A; Gretarsdottir, S; Holm, H; Sigurdsson, A; Jonasdottir, A; Baker, A; Thorleifsson, G; Kristjansson, K; Palsson, A; Blondal, T; Sulem, P; Backman, VM; Hardarson, GA; Palsdottir, E; Helgason, A; Sigurjonsdottir, R; Sverrisson, JT; Kostulas, K; Ng, MCY; Baum, L; So, WY; Wong, KS; Chan, JCN; Furie, KL; Greenberg, SM; Sale, M; Kelly, P; MacRae, CA; Smith, EE; Rosand, J; Hillert, J; Ma, RCW; Ellinor, PT; Thorgeirsson, G; Gulcher, JR; Kong, A; Thorsteinsdottir, U; Stefansson, K				Gudbjartsson, Daniel F.; Arnar, David O.; Helgadottir, Anna; Gretarsdottir, Solveig; Holm, Hilma; Sigurdsson, Asgeir; Jonasdottir, Adalbjorg; Baker, Adam; Thorleifsson, Gudmar; Kristjansson, Kristleifur; Palsson, Arnar; Blondal, Thorarinn; Sulem, Patrick; Backman, Valgerdur M.; Hardarson, Gudmundur A.; Palsdottir, Ebba; Helgason, Agnar; Sigurjonsdottir, Runa; Sverrisson, Jon T.; Kostulas, Konstantinos; Ng, Maggie C. Y.; Baum, Larry; So, Wing Yee; Wong, Ka Sing; Chan, Juliana C. N.; Furie, Karen L.; Greenberg, Steven M.; Sale, Michelle; Kelly, Peter; MacRae, Calum A.; Smith, Eric E.; Rosand, Jonathan; Hillert, Jan; Ma, Ronald C. W.; Ellinor, Patrick T.; Thorgeirsson, Gudmundur; Gulcher, Jeffrey R.; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari			Variants conferring risk of atrial fibrillation on chromosome 4q25	NATURE			English	Article							OF-FUNCTION MUTATION; FAMILIAL AGGREGATION; ISCHEMIC-STROKE; GENE; PREVALENCE; KCNQ1	Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in humans and is characterized by chaotic electrical activity of the atria(1). It affects one in ten individuals over the age of 80 years, causes significant morbidity and is an independent predictor of mortality(2). Recent studies have provided evidence of a genetic contribution to AF(3-5). Mutations in potassium-channel genes have been associated with familial AF(6-10) but account for only a small fraction of all cases of AF(11,12). We have performed a genome-wide association scan, followed by replication studies in three populations of European descent and a Chinese population from Hong Kong and find a strong association between two sequence variants on chromosome 4q25 and AF. Here we show that about 35% of individuals of European descent have at least one of the variants and that the risk of AF increases by 1.72 and 1.39 per copy. The association with the stronger variant is replicated in the Chinese population, where it is carried by 75% of individuals and the risk of AF is increased by 1.42 per copy. A stronger association was observed in individuals with typical atrial flutter. Both variants are adjacent to PITX2, which is known to have a critical function in left-right asymmetry of the heart(13-15).	deCODE Genet, IS-101 Reykjavik, Iceland; Landspitali Univ, Div Cardiol, Dept Med, IS-101 Reykjavik, Iceland; Akureyri Reg Hosp, Dept Med, IS-600 Akureyri, Iceland; Karolinska Univ Hosp, Dept Neurol, S-14186 Huddinge, Sweden; Chinese Univ Hong Kong, Dept Med & Therapeut, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Karolinska Institutet; Karolinska University Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Gudbjartsson, DF (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	daniel.gudbjartsson@decode.is; kstefans@decode.is	Demchuk, Andrew M/E-1103-2012; Wong, Ka Sing Lawrence/N-3434-2015; Baum, Lawrence/B-1005-2013; Helgason, Agnar/K-1522-2015; Ma, Ronald/C-2788-2009; Chan, Juliana/B-7918-2016; Palsson, Arnar/M-2742-2015; Smith, Eric E/C-5443-2012; Stefansson, Kari/AAE-7187-2019	Demchuk, Andrew M/0000-0002-4930-7789; Wong, Ka Sing Lawrence/0000-0002-2031-9866; Baum, Lawrence/0000-0002-5345-9355; Ma, Ronald/0000-0002-1227-803X; Chan, Juliana/0000-0003-1325-1194; Palsson, Arnar/0000-0002-6525-8112; Smith, Eric E/0000-0003-3956-1668; Gudbjartsson, Daniel/0000-0002-5222-9857; Ellinor, Patrick/0000-0002-2067-0533; Helgason, Agnar/0000-0002-8545-3767; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Kong, Augustine/0000-0001-8193-5438	NHLBI NIH HHS [R01 HL075431] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075431] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Arnar DO, 2006, EUR HEART J, V27, P708, DOI 10.1093/eurheartj/ehi727; Baum L, 2004, CLIN CHEM LAB MED, V42, P1370, DOI 10.1515/CCLM.2004.256; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; Ellinor PT, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-70; Ellinor PT, 2005, HUM GENET, V118, P179, DOI 10.1007/s00439-005-0034-8; Ellinor PT, 2004, HEART, V90, P1487, DOI 10.1136/hrt.2003.027227; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Faucourt M, 2001, DEV BIOL, V229, P287, DOI 10.1006/dbio.2000.9950; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P2851, DOI 10.1001/jama.291.23.2851; Frank B, 2003, TAPPI J, V2, P13; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Hong K, 2005, J CARDIOVASC ELECTR, V16, P394, DOI 10.1046/j.1540-8167.2005.40621.x; MANTEL N, 1959, J NATL CANCER I, V22, P719; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Mommersteeg MTM, 2007, CIRC RES, V100, P354, DOI 10.1161/01.RES.0000258019.74591.b3; Olson TM, 2006, HUM MOL GENET, V15, P2185, DOI 10.1093/hmg/ddl143; Waldo AL, 2005, PROG CARDIOVASC DIS, V48, P41, DOI 10.1016/j.pcad.2005.06.015; Xia M, 2005, BIOCHEM BIOPH RES CO, V332, P1012, DOI 10.1016/j.bbrc.2005.05.054; Yang RG, 2005, J COMPUT THEOR NANOS, V2, P75; Yang X, 2007, DIABETES CARE, V30, P65, DOI 10.2337/dc06-1273; Zini S, 1996, P NATL ACAD SCI USA, V93, P11968, DOI 10.1073/pnas.93.21.11968	24	658	684	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2007	448	7151					353	357		10.1038/nature06007	http://dx.doi.org/10.1038/nature06007			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17603472				2022-12-01	WOS:000248118300058
J	Puthalakath, H; O'Reilly, LA; Gunn, P; Lee, L; Kelly, PN; Huntington, ND; Hughes, PD; Michalak, EM; McKimm-Breschkin, J; Motoyama, N; Gotoh, T; Akira, S; Bouillet, P; Strasser, A				Puthalakath, Hamsa; O'Reilly, Lorraine A.; Gunn, Priscilla; Lee, Lily; Kelly, Priscilla N.; Huntington, Nicholas D.; Hughes, Peter D.; Michalak, Ewa M.; McKimm-Breschkin, Jennifer; Motoyama, Noburo; Gotoh, Tomomi; Akira, Shizuo; Bouillet, Philippe; Strasser, Andreas			ER stress triggers apoptosis by activating BH3-only protein Bim	CELL			English	Article							ENDOPLASMIC-RETICULUM STRESS; FAMILY-MEMBER BIM; CELLS; PUMA; EXPRESSION; INHIBITOR; RESPONSES	Endoplasmic reticulum ( ER) stress caused by misfolded proteins or cytotoxic drugs can kill cells and although activation of this pathway has been implicated in the etiology of certain degenerative disorders its mechanism remains unresolved. Bim, a proapoptotic BH3-onlymember of the Bcl-2 family is required for initiation of apoptosis induced by cytokine deprivation or certain stress stimuli. Its proapoptotic activity can be regulated by several transcriptional or posttranslational mechanisms, such as ERK-mediated phosphorylation, promoting its ubiquitination and proteasomal degradation. We found that Bim is essential for ER stress-induced apoptosis in a diverse range of cell types both in culture and within the whole animal. ER stress activates Bim through two novel pathways, involving protein phosphatase 2A-mediated dephosphorylation, which prevents its ubiquitination and proteasomal degradation and CHOP-C/EBP alpha-mediated direct transcriptional induction. These results define the molecular mechanisms of ER stress-induced apoptosis and identify targets for therapeutic intervention in ER stress-related diseases.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; CSIRO, Div Mol & Hlth Technol, Melbourne, Vic, Australia; Natl Ctr Geriatr & Gerontol, Natl Inst Longev Sci, Dept Geriatr Med, Aichi, Japan; Kumamoto Univ, Dept Mol Genet, Kumamoto 8608556, Japan; Osaka Univ, Dept Host Def, Suita, Osaka 5650871, Japan; Univ Melbourne, Dept Biochem, Bio21, Parkville, Vic 3052, Australia; Inst Pasteur, Dept Immunol, Cytokine & Lymphoid Dev Unit, F-75724 Paris, France	Walter & Eliza Hall Institute; University of Melbourne; Commonwealth Scientific & Industrial Research Organisation (CSIRO); National Center for Geriatrics & Gerontology; Kumamoto University; Osaka University; University of Melbourne; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Strasser, A (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	strasser@wehi.edu.au	McKimm-Breschkin, Jennifer L/D-1880-2013; Strasser, Andreas/C-7581-2013; Bouillet, Philippe/E-1241-2013; Puthalakath, Hamsa/B-8541-2011; Lee, Lily/GWZ-7968-2022; Huntington, NICHOLAS/AAV-4704-2020; Akira, Shizuo/C-3134-2009	Strasser, Andreas/0000-0002-5020-4891; Bouillet, Philippe/0000-0002-9012-6058; Huntington, NICHOLAS/0000-0002-5267-7211; McKimm-Breschkin, Jennifer/0000-0002-2345-6786; Michalak, Ewa/0000-0002-5772-2122	NATIONAL CANCER INSTITUTE [R01CA080188, R01CA043540] Funding Source: NIH RePORTER; NCI NIH HHS [CA 43540, CA 80188] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Becker EBE, 2006, NEURON, V49, P655, DOI 10.1016/j.neuron.2006.01.034; Bouillet P, 2005, CELL DEATH DIFFER, V12, P831, DOI 10.1038/sj.cdd.4401603; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2001, MAMM GENOME, V12, P163, DOI 10.1007/s003350010242; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Enders A, 2003, J EXP MED, V198, P1119, DOI 10.1084/jem.20030411; ETLINGER JD, 1977, P NATL ACAD SCI USA, V74, P54, DOI 10.1073/pnas.74.1.54; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kong M, 2004, SCIENCE, V306, P695, DOI 10.1126/science.1100537; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Okada T, 2003, J BIOL CHEM, V278, P31024, DOI 10.1074/jbc.M300923200; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Reimertz C, 2003, J CELL BIOL, V162, P587, DOI 10.1083/jcb.200305149; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Rutishauser J, 2002, SWISS MED WKLY, V132, P211; Saleh M, 2006, NATURE, V440, P1064, DOI 10.1038/nature04656; SCHNEIDER C, 1982, J BIOL CHEM, V257, P766; Tsutsumi S, 2004, CELL DEATH DIFFER, V11, P1009, DOI 10.1038/sj.cdd.4401436; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108	35	1058	1096	0	91	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2007	129	7					1337	1349		10.1016/j.cell.2007.04.027	http://dx.doi.org/10.1016/j.cell.2007.04.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	188HQ	17604722	Bronze			2022-12-01	WOS:000247911400019
J	Jin, JP; Li, X; Gygi, SP; Harper, JW				Jin, Jianping; Li, Xue; Gygi, Steven P.; Harper, J. Wade			Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging	NATURE			English	Article							CYCLE MUTANT TS85; AFFINITY PURIFICATION; PROTEIN-ACTIVATION; DEGRADATION; CONJUGATION; COMPLEX; TRANSCRIPTOMES; RECRUITMENT; RESOLUTION; MECHANISM	Modification of proteins with ubiquitin or ubiquitin-like proteins (UBLs) by means of an E1-E2-E3 cascade controls many signalling networks(1-3). Ubiquitin conjugation involves adenylation and thioesterification of the carboxy-terminal carboxylate of ubiquitin by the E1-activating enzyme Ube1 (Uba1 in yeast), followed by ubiquitin transfer to an E2-conjugating enzyme through a trans-thiolation reaction(4-7). Charged E2s function with E3s to ubiquitinate substrates(1). It is currently thought that Ube1/Uba1 is the sole E1 for charging of E2s with ubiquitin in animals and fungi(1,8). Here we identify a divergent E1 in vertebrates and sea urchin, Uba6, which specifically activates ubiquitin but not other UBLs in vitro and in vivo. Human Uba6 and Ube1 have distinct preferences for E2 charging in vitro, and their specificity depends in part on their C-terminal ubiquitin-fold domains, which recruit E2s. In tissue culture cells, Uba6 is required for charging a previously uncharacterized Uba6-specific E2 (Use1), whereas Ube1 is required for charging the cell-cycle E2s Cdc34A and Cdc34B. Our data reveal unexpected complexity in the pathways that control the conjugation of ubiquitin, in which dual E1s orchestrate the charging of distinct cohorts of E2s.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Harper, JW (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu	Jin, Jianping/K-5002-2018	Jin, Jianping/0000-0003-4175-9104; Harper, Jeffrey/0000-0002-6944-7236	NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG011085] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Booth JW, 2002, EMBO J, V21, P251, DOI 10.1093/emboj/21.3.251; Chen XY, 2004, MOL CELL, V16, P839, DOI 10.1016/j.molcel.2004.11.011; CIECHANOVER A, 1984, CELL, V37, P57, DOI 10.1016/0092-8674(84)90300-3; CIECHANOVER A, 1982, J BIOL CHEM, V257, P2537; Duda DM, 2005, J MOL BIOL, V349, P774, DOI 10.1016/j.jmb.2005.04.011; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; FINLEY D, 1984, CELL, V37, P43, DOI 10.1016/0092-8674(84)90299-X; GU X, IN PRESS MOL BIOL RE; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1988, J BIOL CHEM, V263, P13258; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Huang DT, 2004, ONCOGENE, V23, P1958, DOI 10.1038/sj.onc.1207393; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Lehmann C, 2006, BIOCHEMISTRY-US, V45, P11, DOI 10.1021/bi051502y; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; MCGRATH JP, 1991, EMBO J, V10, P227, DOI 10.1002/j.1460-2075.1991.tb07940.x; Odorisio T, 1996, DEV BIOL, V180, P336, DOI 10.1006/dbio.1996.0305; PICKART CM, 1985, J BIOL CHEM, V260, P1573; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Shringarpure R, 2003, J BIOL CHEM, V278, P311, DOI 10.1074/jbc.M206279200; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456	30	254	268	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2007	447	7148					1135	U17		10.1038/nature05902	http://dx.doi.org/10.1038/nature05902			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183HT	17597759				2022-12-01	WOS:000247564600042
J	Wicks, E				Wicks, Emma			A patient's journey - Cystic fibrosis	BRITISH MEDICAL JOURNAL			English	Editorial Material									Cyst Fibrosis Trust, Bromley BR1 1B, Kent, England		Wicks, E (corresponding author), Cyst Fibrosis Trust, Bromley BR1 1B, Kent, England.	ewicks@cftrust.org.uk							0	3	3	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 16	2007	334	7606					1270	1271		10.1136/bmj.39188.741944.47	http://dx.doi.org/10.1136/bmj.39188.741944.47			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183AM	17569935	Bronze, Green Published			2022-12-01	WOS:000247545100040
J	Boehm, JS; Zhao, JJ; Yao, J; Kim, SY; Firestein, R; Dunn, IF; Sjostrom, SK; Garraway, LA; Weremowicz, S; Richardson, AL; Greulich, H; Stewart, CJ; Mulvey, LA; Shen, RR; Ambrogio, L; Hirozane-Kishikawa, T; Hill, DE; Vidal, M; Meyerson, M; Grenier, JK; Hinkle, G; Root, DE; Roberts, TM; Lander, ES; Polyak, K; Hahn, WC				Boehm, Jesse S.; Zhao, Jean J.; Yao, Jun; Kim, So Young; Firestein, Ron; Dunn, Ian F.; Sjostrom, Sarah K.; Garraway, Levi A.; Weremowicz, Stanislawa; Richardson, Andrea L.; Greulich, Heidi; Stewart, Carly J.; Mulvey, Laura A.; Shen, Rhine R.; Ambrogio, Lauren; Hirozane-Kishikawa, Tomoko; Hill, David E.; Vidal, Marc; Meyerson, Matthew; Grenier, Jennifer K.; Hinkle, Greg; Root, David E.; Roberts, Thomas M.; Lander, Eric S.; Polyak, Kornelia; Hahn, William C.			Integrative genomic approaches identify IKBKE as a breast cancer oncogene	CELL			English	Article							NF-KAPPA-B; IKK-EPSILON; INDUCED SENESCENCE; GENETIC SCREEN; LUNG-CANCER; RNAI SCREEN; KINASE; MUTATIONS; CELLS; PHOSPHORYLATION	The karyotypic chaos exhibited by human epithelial cancers complicates efforts to identify mutations critical for malignant transformation. Here we integrate complementary genomic approaches to identify human oncogenes. We show that activation of the ERK and phosphatidylinositol 3-kinase (PI3K) signaling pathways cooperate to transform human cells. Using a library of activated kinases, we identify several kinases that replace PI3K signaling and render cells tumorigenic. Whole genome structural analyses reveal that one of these kinases, IKBKE (IKK epsilon), is amplified and overexpressed in breast cancer cell lines and patient-derived tumors. Suppression of IKK epsilon expression in breast cancer cell lines that harbor IKBKE amplifications induces cell death. IKK epsilon activates the nuclear factor-kappaB (NF-kappa B) pathway in both cell lines and breast cancers. These observations suggest a mechanism for NF-kappa B activation in breast cancer, implicate the NF-kappa B pathway as a downstream mediator of PI3K, and provide a framework for integrated genomic approaches in oncogene discovery.	Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; MIT, Broad Inst, Cambridge, MA 02142 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Hahn, WC (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	jean_zhao@dfci.harvard.edu; william_hahn@dfci.harvard.edu	Hill, David E/B-6617-2011; Meyerson, Matthew L/E-7123-2012	Boehm, Jesse/0000-0002-6795-6336	NCI NIH HHS [P50 CA089393-080014, CA89021, P50 CA089393, CA30002, R01 CA094074-01A1, CA015607, R01 CA094074-05, P50 CA089393-070014, R01 CA094074-04, K01 CA94223, P50 CA089393-060014, R01 CA094074-03, P50 CA112962, R01 CA094074, R01 CA094074-02] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA089021, P50CA089393, R01CA030002, K01CA094223, R37CA030002, R01CA094074] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adli M, 2006, J BIOL CHEM, V281, P26976, DOI 10.1074/jbc.M603133200; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; BARTKOVA J, 1994, INT J CANCER, V57, P353, DOI 10.1002/ijc.2910570311; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Boehm JS, 2005, MOL CELL BIOL, V25, P6464, DOI 10.1128/MCB.25.15.6464-6474.2005; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; BRUNET A, 1994, ONCOGENE, V9, P3379; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dupuy AJ, 2006, HUM MOL GENET, V15, pR75, DOI 10.1093/hmg/ddl061; Eddy SF, 2005, CANCER RES, V65, P11375, DOI 10.1158/0008-5472.CAN-05-1602; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Harris J, 2006, J IMMUNOL, V177, P2527, DOI 10.4049/jimmunol.177.4.2527; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Kuranaga E, 2006, CELL, V126, P583, DOI 10.1016/j.cell.2006.05.048; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Morrison C, 2005, J CLIN ONCOL, V23, P9369, DOI 10.1200/JCO.2005.03.7127; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Oshima K, 2006, CURR BIOL, V16, P1531, DOI 10.1016/j.cub.2006.06.032; Ozes ON, 1999, NATURE, V401, P82; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Peeper DS, 2002, NAT CELL BIOL, V4, P148, DOI 10.1038/ncb742; Peters RT, 2000, MOL CELL, V5, P513, DOI 10.1016/S1097-2765(00)80445-1; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Rennstam K, 2003, CANCER RES, V63, P8861; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shapiro RS, 2006, DEVELOPMENT, V133, P1467, DOI 10.1242/dev.02318; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; STANTON VP, 1989, MOL CELL BIOL, V9, P639, DOI 10.1128/MCB.9.2.639; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Yao J, 2006, CANCER RES, V66, P4065, DOI 10.1158/0008-5472.CAN-05-4083; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhao JJ, 2004, TRENDS MOL MED, V10, P344, DOI 10.1016/j.molmed.2004.05.005; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	55	470	506	2	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2007	129	6					1065	1079		10.1016/j.cell.2007.03.052	http://dx.doi.org/10.1016/j.cell.2007.03.052			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574021	Bronze			2022-12-01	WOS:000247390400012
J	Harbaugh, WT; Mayr, U; Burghart, DR				Harbaugh, William T.; Mayr, Ulrich; Burghart, Daniel R.			Neural responses to taxation and voluntary giving reveal motives for charitable donations	SCIENCE			English	Article							PUBLIC-GOODS; WARM-GLOW; REWARD; ALTRUISM; PREFERENCES; PUNISHMENT; STRIATUM; BRAIN	Civil societies function because people pay taxes and make charitable contributions to provide public goods. One possible motive for charitable contributions, called "pure altruism," is satisfied by increases in the public good no matter the source or intent. Another possible motive, " warm glow," is only fulfilled by an individual's own voluntary donations. Consistent with pure altruism, we find that even mandatory, tax-like transfers to a charity elicit neural activity in areas linked to reward processing. Moreover, neural responses to the charity's financial gains predict voluntary giving. However, consistent with warm glow, neural activity further increases when people make transfers voluntarily. Both pure altruism and warm-glow motives appear to determine the hedonic consequences of financial transfers to the public good.	Univ Oregon, Dept Econ, Eugene, OR 97403 USA; Natl Bur Econ Res, Cambridge, MA 02138 USA; Univ Oregon, Dept Psychol, Eugene, OR 97403 USA	University of Oregon; National Bureau of Economic Research; University of Oregon	Harbaugh, WT (corresponding author), Univ Oregon, Dept Econ, Eugene, OR 97403 USA.	harbaugh@uoregon.edu; mayr@uoregon.edu	Harbaugh, William/A-8743-2008	Harbaugh, William/0000-0002-4127-3983	NIA NIH HHS [R01 AG1929601A1] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG019296] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Andreoni J, 2002, ECONOMETRICA, V70, P737, DOI 10.1111/1468-0262.00302; ANDREONI J, 1990, ECON J, V100, P464, DOI 10.2307/2234133; BERGSTROM T, 1986, J PUBLIC ECON, V29, P25, DOI 10.1016/0047-2727(86)90024-1; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Diamond P, 2006, J PUBLIC ECON, V90, P897, DOI 10.1016/j.jpubeco.2005.06.001; Eckel CC, 2003, J PUBLIC ECON, V87, P681, DOI 10.1016/S0047-2727(01)00094-9; Elliott R, 2004, NEUROIMAGE, V21, P984, DOI 10.1016/j.neuroimage.2003.10.010; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Harbaugh WT, 1998, J PUBLIC ECON, V67, P269, DOI 10.1016/S0047-2727(97)00062-5; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; Kolm S. -C., 1969, PUBLIC EC, P145, DOI DOI 10.1007/978-1-349-15294-0_7; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Palfrey TR, 1997, AM ECON REV, V87, P829; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Singer T, 2004, NEURON, V41, P653, DOI 10.1016/S0896-6273(04)00014-5; Tankersley D, 2007, NAT NEUROSCI, V10, P150, DOI 10.1038/nn1833; Tricomi EM, 2004, NEURON, V41, P281, DOI 10.1016/S0896-6273(03)00848-1; Zink CF, 2004, NEURON, V42, P509, DOI 10.1016/S0896-6273(04)00183-7	27	566	581	19	181	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1622	1625		10.1126/science.1140738	http://dx.doi.org/10.1126/science.1140738			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	178SH	17569866				2022-12-01	WOS:000247239900043
J	Kiriakidou, M; Tan, GS; Lamprinaki, S; De Planell-Saguer, M; Nelson, PT; Mourelatos, Z				Kiriakidou, Marianthi; Tan, Grace S.; Lamprinaki, Styliani; De Planell-Saguer, Mariangels; Nelson, Peter T.; Mourelatos, Zissimos			An mRNA m(7)G cap binding-like motif within human Ago2 represses translation	CELL			English	Article							HUMAN-CELLS; CRYSTAL-STRUCTURE; PROTEIN-SYNTHESIS; ANIMAL MICRORNAS; ARGONAUTE FAMILY; SLICER ACTIVITY; IN-VIVO; RECOGNITION; INITIATION; COMPLEX	microRNAs (miRNAs) bind to Argonaute (Ago) proteins and inhibit translation or promote degradation of mRNA targets. Human let-7 miRNA inhibits translation initiation of mRNA targets in an m(7)G cap-dependent manner and also appears to block protein production, but the molecular mechanism(s) involved is unknown and the role of Ago proteins in translational regulation remains elusive. Here we identify a motif (MC) within the Mid domain of Ago proteins, which bears significant similarity to the m(7)G cap-binding domain of elF4E, an essential translation initiation factor. We identify conserved aromatic residues within the MC motif of human Ago2 that are required for binding to the m(7)G cap and for translational repression but do not affect the assembly of Ago2 with miRNA or its catalytic activity. We propose that Ago2 represses the initiation of mRNA translation by binding to the m(7)G cap of mRNA targets, thus likely precluding the recruitment of elF4E.	Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pathol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Kiriakidou, M (corresponding author), Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA.	kiriakim@uphs.upenn.edu; mourelaz@uphs.upenn.edu		Mourelatos, Zissimos/0000-0002-9852-1845	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD026979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI063030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS050110] Funding Source: NIH RePORTER; NIAID NIH HHS [K08-AI63030] Funding Source: Medline; NICHD NIH HHS [PA30-HD026979] Funding Source: Medline; NIGMS NIH HHS [GM0720777] Funding Source: Medline; NINDS NIH HHS [NS053839, K08-NS050110] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMANN M, 1988, J BIOL CHEM, V263, P17229; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bonnet E, 2006, NEW PHYTOL, V171, P451, DOI 10.1111/j.1469-8137.2006.01806.x; Calero G, 2002, NAT STRUCT BIOL, V9, P912, DOI 10.1038/nsb874; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; De Gregorio E, 1999, EMBO J, V18, P4865, DOI 10.1093/emboj/18.17.4865; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hodel AE, 1997, NAT STRUCT BIOL, V4, P350, DOI 10.1038/nsb0597-350; Hu GH, 1999, P NATL ACAD SCI USA, V96, P7149, DOI 10.1073/pnas.96.13.7149; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Kataoka Y, 2001, GENES CELLS, V6, P313, DOI 10.1046/j.1365-2443.2001.00427.x; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Kim VN, 2006, GENE DEV, V20, P1993, DOI 10.1101/gad.1456106; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kiriakidou M, 2005, METH MOL B, V309, P295; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Legault P, 1998, CELL, V93, P289, DOI 10.1016/S0092-8674(00)81579-2; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Merrick WC, 2004, GENE, V332, P1, DOI 10.1016/j.gene.2004.02.051; Meyer WJ, 2006, PLOS GENET, V2, P1224, DOI 10.1371/journal.pgen.0020134; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Mourelatos Z, 2001, EMBO J, V20, P5443, DOI 10.1093/emboj/20.19.5443; Murchison EP, 2004, CURR OPIN CELL BIOL, V16, P223, DOI 10.1016/j.ceb.2004.04.003; Nelson PT, 2004, RNA, V10, P387, DOI 10.1261/rna.5181104; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Rom E, 1998, J BIOL CHEM, V273, P13104, DOI 10.1074/jbc.273.21.13104; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011	74	304	337	0	25	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2007	129	6					1141	1151		10.1016/j.cell.2007.05.016	http://dx.doi.org/10.1016/j.cell.2007.05.016			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17524464	Bronze			2022-12-01	WOS:000247390400017
J	LaDeau, SL; Kilpatrick, AM; Marra, PP				LaDeau, Shannon L.; Kilpatrick, A. Marm; Marra, Peter P.			West Nile virus emergence and large-scale declines of North American bird populations	NATURE			English	Article							INFECTIOUS-DISEASE; BIODIVERSITY; TRANSMISSION; WILDLIFE; ECOLOGY	Emerging infectious diseases present a formidable challenge to the conservation of native species in the twenty-first century(1). Diseases caused by introduced pathogens have had large impacts on species abundances(2), including the American chestnut(3), Hawaiian bird species(4) and many amphibians(5). Changes in host population sizes can lead to marked shifts in community composition and ecosystem functioning(3,4,6). However, identifying the impacts of an introduced disease and distinguishing it from other forces that influence population dynamics ( for example, climate(7)) is challenging and requires abundance data that extend before and after the introduction(2,5). Here we use 26 yr of Breeding Bird Survey ( BBS)(8) data to determine the impact of West Nile virus ( WNV) on 20 potential avian hosts across North America. We demonstrate significant changes in population trajectories for seven species from four families that concur with a priori predictions and the spatio-temporal intensity of pathogen transmission. The American crow population declined by up to 45% since WNV arrival, and only two of the seven species with documented impact recovered to pre-WNV levels by 2005. Our findings demonstrate the potential impacts of an invasive species on a diverse faunal assemblage across broad geographical scales, and underscore the complexity of subsequent community response.	Smithsonian Migratory Bird Ctr, Washington, DC 20008 USA; Consortium Conservat Med, New York, NY 10001 USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	LaDeau, SL (corresponding author), Smithsonian Migratory Bird Ctr, Natl Zool Pk, Washington, DC 20008 USA.	ladeaus@si.edu		LaDeau, Shannon/0000-0003-4825-5435; Marra, Peter/0000-0002-0508-7577				ACEVEDO W, 2006, RATES TRENDS CAUSES; Atkinson CT, 2001, CONDOR, V103, P209, DOI 10.1650/0010-5422(2001)103[0209:PSRADO]2.0.CO;2; Bonter D.N., 2003, AM BIRDS, V57, P22; Caffrey C, 2005, CONDOR, V107, P128, DOI 10.1650/7646; CAFFREY C, 2003, AM BIRDS, V57, P14; *CDCP, 2006, W NIL VIR STAT SURV; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Clark JS, 2003, ECOLOGY, V84, P1370, DOI 10.1890/0012-9658(2003)084[1370:UAVIDA]2.0.CO;2; Daszak P, 2005, ECOLOGY, V86, P3232, DOI 10.1890/05-0598; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; GELFAND AE, 2006, MARKOV CHAIN MONTE C, P145; Hochachka W. M, 2004, ECOHEALTH, V1, P60; Hochachka WM, 2000, P NATL ACAD SCI USA, V97, P5303, DOI 10.1073/pnas.080551197; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Link WA, 2002, ECOLOGY, V83, P2832, DOI 10.2307/3072019; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Marra PP, 2004, BIOSCIENCE, V54, P393, DOI 10.1641/0006-3568(2004)054[0393:WNVAW]2.0.CO;2; MARZLUFF JM, 2001, AVIAN CONSERATION EC; Molaei G, 2006, EMERG INFECT DIS, V12, P468, DOI 10.3201/eid1203.051004; Naugle DE, 2004, ECOL LETT, V7, P704, DOI 10.1111/j.1461-0248.2004.00631.x; Paillet FL, 2002, J BIOGEOGR, V29, P1517, DOI 10.1046/j.1365-2699.2002.00767.x; Reisen WK, 2006, J MED ENTOMOL, V43, P356, DOI 10.1603/0022-2585(2006)043[0356:ROCIEO]2.0.CO;2; Sauer J. R., 2005, N AM BREEDING BIRD S; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Spielman A., 2001, MOSQUITO NATURAL HIS; Turell MJ, 2002, CURR TOP MICROBIOL, V267, P241; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550	30	340	364	2	191	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2007	447	7145					710	U13		10.1038/nature05829	http://dx.doi.org/10.1038/nature05829			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17507930				2022-12-01	WOS:000247030700043
J	Murray, F				Murray, Fiona			The stem-cell market - Patents and the pursuit of scientific progress	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									MIT, Alfred P Sloan Sch Management, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Murray, F (corresponding author), MIT, Alfred P Sloan Sch Management, Cambridge, MA 02139 USA.							DASGUPTA P, 1994, RES POLICY, V23, P487; Thomson JA, 1998, SCIENCE, V282, P1827; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145	3	19	20	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2007	356	23					2341	2343		10.1056/NEJMp068256	http://dx.doi.org/10.1056/NEJMp068256			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	175QY	17554114				2022-12-01	WOS:000247029300001
J	Glickman, SW; Ou, FS; DeLong, ER; Roe, MT; Lytle, BL; Mulgund, J; Rumsfeld, JS; Gibler, WB; Ohman, EM; Schulman, KA; Peterson, ED				Glickman, Seth W.; Ou, Fang-Shu; DeLong, Elizabeth R.; Roe, Matthew T.; Lytle, Barbara L.; Mulgund, Jyotsna; Rumsfeld, John S.; Gibler, W. Brian; Ohman, E. Magnus; Schulman, Kevin A.; Peterson, Eric D.			Pay for performance, quality of care, and outcomes in acute myocardial infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE CORONARY SYNDROMES; HEALTH-CARE; FINANCIAL INCENTIVES; IMPORTANT DIFFERENCE; FOR-PERFORMANCE; UNSTABLE ANGINA; IMPROVEMENT; MANAGEMENT; ASSOCIATION; STRATEGIES	of Context Pay for performance has been promoted as a tool for improving quality of care. In 2003, the Centers for Medicare & Medicaid Services ( CMS) launched the largest pay-for-performance pilot project to date in the United States, including indicators for acute myocardial infarction. Objective To determine if pay for performance was associated with either improved processes of care and outcomes or unintended consequences for acute myocardial infarction at hospitals participating in the CMS pilot project. Design, Setting, and Participants An observational, patient-level analysis of 105 383 patients with acute non-ST-segment elevation myocardial infarction enrolled in the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association ( ACC/AHA) Guidelines ( CRUSADE) national quality-improvement initiative. Patients were treated between July 1, 2003, and June 30, 2006, at 54 hospitals in the CMS program and 446 control hospitals. Main Outcome Measures The differences in the use of ACC/AHA class I guideline recommended therapies and in-hospital mortality between pay for performance and control hospitals. Results Among treatments subject to financial incentives, there was a slightly higher rate of improvement for 2 of 6 targeted therapies at pay-for-performance vs control hospitals ( odds ratio [ OR] comparing adherence scores from 2003 through 2006 at half-year intervals for aspirin at discharge, 1.31; 95% confidence interval [ CI], 1.181.46 vs OR, 1.17; 95% CI, 1.12-1.21; P=. 04) and for smoking cessation counseling ( OR, 1.50; 95% CI, 1.29-1.73 vs OR, 1.28; 95% CI, 1.22-1.35; P=. 05). There was no significant difference in a composite measure of the 6 CMS rewarded therapies between the 2 hospital groups ( change in odds per half-year period of receiving CMS therapies: OR, 1.23; 95% CI, 1.15-1.30 vs OR, 1.17; 95% CI, 1.14-1.20; P=. 16). For composite measures of acute myocardial infarction treatments not subject to incentives, rates of improvement were not significantly different ( OR, 1.09; 95% CI, 1.051.14 vs OR, 1.08; 95% CI, 1.06- 1.09; P=. 49). Overall, there was no evidence that improvements in in-hospital mortality were incrementally greater at pay-for-performance sites ( change in odds of in-hospital death per half-year period, 0.91; 95% CI, 0.84-0.99 vs 0.97; 95% CI, 0.94-0.99; P=. 21). Conclusions Among hospitals participating in a voluntary quality-improvement initiative, the pay-for-performance program was not associated with a significant incremental improvement in quality of care or outcomes for acute myocardial infarction. Conversely, we did not find evidence that pay for performance had an adverse association with improvement in processes of care that were not subject to financial incentives. Additional studies of pay for performance are needed to determine its optimal role in quality-improvement initiatives.	Duke Clin Res Inst, Outcomes Res & Assessment Grp, Durham, NC 27715 USA; Duke Clin Res Inst, Ctr Clin & Genet Econ, Durham, NC 27715 USA; Duke Univ, Med Ctr, Dept Surg, Div Emergency Med, Durham, NC USA; Duke Univ, Med Ctr, Hlth Sector Management Program, Fuqua Sch Business, Durham, NC USA; Denver VA Med Ctr, Cardiol Sect, Denver, CO USA; Univ Cincinnati, Coll Med, Dept Emergency Med, Cincinnati, OH USA	Duke University; Duke University; Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University System of Ohio; University of Cincinnati	Peterson, ED (corresponding author), Duke Clin Res Inst, Outcomes Res & Assessment Grp, POB 17969, Durham, NC 27715 USA.	peter016@mc.duke.edu	Peterson, Eric David/ABF-5033-2021; Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285	NATIONAL INSTITUTE ON AGING [R01AG025312] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG025312 01A1] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Barrett B, 2005, MED DECIS MAKING, V25, P250, DOI 10.1177/0272989X05276863; Berwick DM, 2003, HEALTH AFFAIR, V22, P8, DOI 10.1377/hlthaff.22.6.8; Bhatt DL, 2004, JAMA-J AM MED ASSOC, V292, P2096, DOI 10.1001/jama.292.17.2096; Birkmeyer NJO, 2006, NEW ENGL J MED, V354, P864, DOI 10.1056/NEJMsb053364; Boersma E, 2000, CIRCULATION, V101, P2557, DOI 10.1161/01.CIR.101.22.2557; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; Braunwald E, 2000, J AM COLL CARDIOL, V36, P970, DOI 10.1016/S0735-1097(00)00889-5; Chassin MR, 1998, JAMA-J AM MED ASSOC, V280, P1000, DOI 10.1001/jama.280.11.1000; *CMS QHID, IMPR CONT YEAR 2; Coeytaux RR, 2006, J CLIN EPIDEMIOL, V59, P374, DOI 10.1016/j.jclinepi.2005.05.010; Conrad DA, 2004, MED CARE RES REV, V61, p37S, DOI 10.1177/1077558704266770; *CTR MED MED SERV, HOSP QUAL IN WEB PAG; Darr Kurt, 2003, Hosp Top, V81, P30; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Grumbach K, 1998, NEW ENGL J MED, V339, P1516, DOI 10.1056/NEJM199811193392106; Hoekstra JW, 2002, ACAD EMERG MED, V9, P1146, DOI 10.1111/j.1553-2712.2002.tb01569.x; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; KOHN A, 1993, HARVARD BUS REV, V71, P54; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Marshall M, 2003, QUAL SAF HEALTH CARE, V12, P397, DOI 10.1136/qhc.12.6.397; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; Peterson ED, 2006, JAMA-J AM MED ASSOC, V295, P1912, DOI 10.1001/jama.295.16.1912; Porter ME., 2006, CREATING VALUE BASED; *PREM INC CMS, PREM HOSP QUAL INC D; Robinson JC, 2001, MILBANK Q, V79, P149, DOI 10.1111/1468-0009.00202; Roe MT, 2003, AM HEART J, V146, P605, DOI 10.1016/S0002-8703(03)00388-0; Rosenthal MB, 2006, MED CARE RES REV, V63, P135, DOI 10.1177/1077558705285291; Rosenthal MB, 2004, HEALTH AFFAIR, V23, P127, DOI 10.1377/hlthaff.23.2.127; Rowe JW, 2006, ANN INTERN MED, V145, P695, DOI 10.7326/0003-4819-145-9-200611070-00013; Staman Karen L, 2003, Crit Pathw Cardiol, V2, P34, DOI 10.1097/01.HPC.0000053684.59325.88	30	222	223	0	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2007	297	21					2373	2380		10.1001/jama.297.21.2373	http://dx.doi.org/10.1001/jama.297.21.2373			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	175IL	17551130	Bronze			2022-12-01	WOS:000247007200019
J	Reeves, MB; Davies, AA; McSharry, BP; Wilkinson, GW; Sinclair, JH				Reeves, Matthew B.; Davies, Andrew A.; McSharry, Brian P.; Wilkinson, Gavin W.; Sinclair, John H.			Complex I binding by a virally encoded RNA regulates mitochondria-induced cell death	SCIENCE			English	Article							HUMAN CYTOMEGALOVIRUS; LOCALIZED INHIBITOR; GENE-EXPRESSION; APOPTOSIS; GRIM-19; PROTEIN; ACTIVATION; INFECTION; REVEALS; PRODUCT	Human cytomegalovirus infection perturbs multiple cellular processes that could promote the release of proapoptotic stimuli. Consequently, it encodes mechanisms to prevent cell death during infection. Using rotenone, a potent inhibitor of the mitochondrial enzyme complex I (reduced nicotinamide adenine dinucleotide-ubiquinone oxido-reductase), we found that human cytomegalovirus infection protected cells from rotenone-induced apoptosis, a protection mediated by a 2.7-kilobase virally encoded RNA (beta 2.7). During infection, beta 2.7 RNA interacted with complex I and prevented the relocalization of the essential subunit genes associated with retinoid/interferon-induced mortality-19, in response to apoptotic stimuli. This interaction, which is important for stabilizing the mitochondrial membrane potential, resulted in continued adenosine triphosphate production, which is critical for the successful completion of the virus' life cycle. Complex I targeting by a viral RNA represents a refined strategy to modulate the metabolic viability of the infected host cell.	Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; Univ Wales Coll Cardiff, Coll Med, Sect Infect & Immun, Cardiff CF14 4XX, S Glam, Wales	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cardiff University	Sinclair, JH (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Hills Rd, Cambridge CB2 2QQ, England.	js@mole.bio.cam.ac.uk	Wilkinson, Gavin WG/J-6388-2015; McSharry, Brian/AAE-3351-2019	Wilkinson, Gavin WG/0000-0002-5623-0126; McSharry, Brian/0000-0003-0473-2789; Reeves, Matthew/0000-0002-4909-1076	Medical Research Council [G0700142, G9202171] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0700142, G9202171] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Angell JE, 2000, J BIOL CHEM, V275, P33416, DOI 10.1074/jbc.M003929200; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Chernyak BV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P240, DOI 10.1007/s10541-005-0106-3; Crowe WE, 2004, AM J PHYSIOL-CELL PH, V287, pC1023, DOI 10.1152/ajpcell.00511.2003; Eckert A, 2003, BIOCHEM PHARMACOL, V66, P1627, DOI 10.1016/S0006-2952(03)00534-3; Fish KN, 1998, J VIROL, V72, P5661, DOI 10.1128/JVI.72.7.5661-5668.1998; Gawn JM, 2002, J VIROL, V76, P4441, DOI 10.1128/JVI.76.9.4441-4455.2002; Goldmacher VS, 1999, P NATL ACAD SCI USA, V96, P12536, DOI 10.1073/pnas.96.22.12536; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; GREENAWAY PJ, 1987, VIRUS RES, V7, P17, DOI 10.1016/0168-1702(87)90055-4; Hertel L, 2004, J VIROL, V78, P11988, DOI 10.1128/JVI.78.21.11988-12011.2004; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; Ladha JS, 2005, CELL DEATH DIFFER, V12, P1417, DOI 10.1038/sj.cdd.4401668; Li J, 2005, J NEUROCHEM, V92, P462, DOI 10.1111/j.1471-4159.2004.02872.x; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Lufei CC, 2003, EMBO J, V22, P1325, DOI 10.1093/emboj/cdg135; McCormick AL, 2003, J VIROL, V77, P631, DOI 10.1128/JVI.77.1.631-641.2003; McSharry BP, 2003, J GEN VIROL, V84, P2511, DOI 10.1099/vir.0.19298-0; Murata T, 2000, J GEN VIROL, V81, P401, DOI 10.1099/0022-1317-81-2-401; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Reboredo M, 2004, J GEN VIROL, V85, P3555, DOI 10.1099/vir.0.80379-0; Simon DK, 1999, ANNU REV MED, V50, P111; Singer T P, 1979, Methods Enzymol, V55, P454; Sissons JGP, 2002, J INFECTION, V44, P73, DOI 10.1053/jinf.2001.0948; Skaletskaya A, 2001, P NATL ACAD SCI USA, V98, P7829, DOI 10.1073/pnas.141108798; Spector DH, 1996, INTERVIROLOGY, V39, P361, DOI 10.1159/000150507; Terhune S, 2007, J VIROL, V81, P3109, DOI 10.1128/JVI.02124-06	27	194	210	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2007	316	5829					1345	1348		10.1126/science.1142984	http://dx.doi.org/10.1126/science.1142984			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17540903				2022-12-01	WOS:000246885600052
J	Cheah, MT; Wachter, A; Sudarsan, N; Breaker, RR				Cheah, Ming T.; Wachter, Andreas; Sudarsan, Narasimhan; Breaker, Ronald R.			Control of alternative RNA splicing and gene expression by eukaryotic riboswitches	NATURE			English	Article							MESSENGER-RNA; NEUROSPORA-CRASSA; ASPERGILLUS-NIDULANS; YEAST THI4P; THIAMINE; BINDING; TRANSCRIPTION; FREQUENCY; PROMOTER; CYPBP37	Bacteria make extensive use of riboswitches(1,2) to sense metabolites and control gene expression, and typically do so by modulating premature transcription termination or translation initiation. The most widespread riboswitch class known in bacteria responds to the coenzyme thiamine pyrophosphate (TPP)(3,4), which is a derivative of vitamin B-1. Representatives of this class have also been identified(5,6) in fungi and plants, where they are predicted(5,7) to control messenger RNA splicing or processing. We examined three TPP riboswitches in the filamentous fungus Neurospora crassa, and found that one activates and two repress gene expression by controlling mRNA splicing. A detailed mechanism involving riboswitch-mediated base-pairing changes and alternative splicing control was elucidated for precursor NMT1 mRNAs, which code for a protein involved in TPP metabolism. These results demonstrate that eukaryotic cells employ metabolite-binding RNAs to regulate RNA splicing events that are important for the control of key biochemical processes.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Breaker, RR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	ronald.breaker@yale.edu	Breaker, Ronald/E-9679-2010; Wachter, Andreas/P-9038-2014	Wachter, Andreas/0000-0002-3132-5161; Breaker, Ronald/0000-0002-2165-536X				Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Borsuk P, 2007, BIOL CHEM, V388, P135, DOI 10.1515/BC.2007.015; Buratti E, 2004, MOL CELL BIOL, V24, P10505, DOI 10.1128/MCB.24.24.10505-10514.2004; Colot HV, 2005, MOL BIOL CELL, V16, P5563, DOI 10.1091/mbc.E05-08-0756; Davis RH, 2000, NEUROSPORA CONTRIBUT; EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079; EDDY SR, INFERNAL VERSION 0 5; Edwards TE, 2006, STRUCTURE, V14, P1459, DOI 10.1016/j.str.2006.07.008; Faou P, 2004, J MOL BIOL, V344, P1147, DOI 10.1016/j.jmb.2004.09.097; Faou P, 2003, J MOL BIOL, V333, P831, DOI 10.1016/j.jmb.2003.09.003; Froehlich AC, 2003, P NATL ACAD SCI USA, V100, P5914, DOI 10.1073/pnas.1030057100; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Kim DS, 2005, RNA, V11, P1667, DOI 10.1261/rna.2162205; Kubodera T, 2003, FEBS LETT, V555, P516, DOI 10.1016/S0014-5793(03)01335-8; LOROS JJ, 1991, MOL CELL BIOL, V11, P558, DOI 10.1128/MCB.11.1.558; Mandal M, 2004, NAT REV MOL CELL BIO, V5, P451, DOI 10.1038/nrm1403; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; McColl D, 2003, CURR GENET, V44, P216, DOI 10.1007/s00294-003-0441-0; MEHRA A, 2002, SOC RES BIOL RHYTHMS, V27; Mironov AS, 2002, CELL, V111, P747, DOI 10.1016/S0092-8674(02)01134-0; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; ORBACH MJ, 1986, MOL CELL BIOL, V6, P2452, DOI 10.1128/MCB.6.7.2452; Romfo CM, 2000, MOL CELL BIOL, V20, P7955, DOI 10.1128/MCB.20.21.7955-7970.2000; Seetharaman S, 2001, NAT BIOTECHNOL, V19, P336, DOI 10.1038/86723; Serganov A, 2006, NATURE, V441, P1167, DOI 10.1038/nature04740; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Sudarsan N, 2003, RNA, V9, P644, DOI 10.1261/rna.5090103; Thore S, 2006, SCIENCE, V312, P1208, DOI 10.1126/science.1128451; Vann DC, 1995, FUNGAL GENET NEWSL A, V42, P53; Vilela C, 2003, MOL MICROBIOL, V49, P859, DOI 10.1046/j.1365-2958.2003.03622.x; WELZ R, 2007, RNA             0216, DOI DOI 10.1261/RNA.407707; WESTERGAARD M, 1947, AM J BOT, V34, P573, DOI 10.2307/2437339; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; [No title captured]	36	297	324	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2007	447	7143					497	U7		10.1038/nature05769	http://dx.doi.org/10.1038/nature05769			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17468745				2022-12-01	WOS:000246693100052
J	Feachem, RGA; Sabot, OJ				Feachem, Richard G. A.; Sabot, Oliver J.			Global malaria control in the 21st century - A historic but fleeting opportunity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Clinton Fdn, HIV AIDS Initiat, New York, NY 10024 USA; Univ Calif San Francisco, Global Fund Fight AIDS TB & Malaria, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Global Hlth, San Francisco, CA 94143 USA; Univ Calif Berkeley, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Sabot, OJ (corresponding author), Clinton Fdn, HIV AIDS Initiat, 65 W 86th St, New York, NY 10024 USA.	osabot@clintonfoundation.org						Alilio MS, 2004, AM J TROP MED HYG, V71, P205, DOI 10.4269/ajtmh.2004.71.205; Alilio MS, 2004, AM J TROP MED HYG, V71, P268, DOI 10.4269/ajtmh.2004.71.268; Ashley EA, 2005, CURR OPIN INFECT DIS, V18, P531, DOI 10.1097/01.qco.0000186848.46417.6c; BATE R, 2006, STILL TAXED DEATH AN; Booman Marlize, 2003, Malar J, V2, P13, DOI 10.1186/1475-2875-2-13; *CDCP, 2005, MMWR-MORBID MORTAL W, V55, P913; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P994; CHIKANDI S, 2005, 4 YEARS ABUJA MORE A; *GLOB FUND FIGHT A, 2006, FUND GLOB FIGHT HIV; Global strategic plan: roll back malaria 2005-2015, 2005, GLOB STRAT PLAN ROLL; Lengeler C., 2004, COCHRANE DB SYST REV, V2; Levine Ruth, 2004, MILLIONS SAVED PROVE; Lomborg B., 2004, GLOBAL CRISES GLOBAL; Low-Beer D., 2007, PARTNERS IMPACT RESU; Marsh VM, 2004, TROP MED INT HEALTH, V9, P451, DOI 10.1111/j.1365-3156.2004.01223.x; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; Trape JF, 2001, AM J TROP MED HYG, V64, P12, DOI 10.4269/ajtmh.2001.64.12; WHO UNICEF, 2005, WORLD MALARIA REPORT; Zambia Ministry of Health, 2006, ZAMB NAT MAL IND SUR; 2003, LANCET INFECT DIS, V3, P317; [No title captured]	21	17	17	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2007	297	20					2281	2284		10.1001/jama.297.20.2281	http://dx.doi.org/10.1001/jama.297.20.2281			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170JM	17519417				2022-12-01	WOS:000246659700028
J	Engelman, JA; Zejnullahu, K; Mitsudomi, T; Song, YC; Hyland, C; Park, JO; Lindeman, N; Gale, CM; Zhao, XJ; Christensen, J; Kosaka, T; Holmes, AJ; Rogers, AM; Cappuzzo, F; Mok, T; Lee, C; Johnson, BE; Cantley, LC; Janne, PA				Engelman, Jeffrey A.; Zejnullahu, Kreshnik; Mitsudomi, Tetsuya; Song, Youngchul; Hyland, Courtney; Park, Joon Oh; Lindeman, Neal; Gale, Christopher-Michael; Zhao, Xiaojun; Christensen, James; Kosaka, Takayuki; Holmes, Alison J.; Rogers, Andrew M.; Cappuzzo, Federico; Mok, Tony; Lee, Charles; Johnson, Bruce E.; Cantley, Lewis C.; Janne, Pasi A.			MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling	SCIENCE			English	Article							GROWTH-FACTOR-RECEPTOR; GASTROINTESTINAL STROMAL TUMORS; TYROSINE KINASE; ACQUIRED-RESISTANCE; IMATINIB MESYLATE; INHIBITOR; MUTATIONS; THERAPY; GENE; ADENOCARCINOMA	The epidermal growth factor receptor (EGFR) kinase inhibitors gefitinib and erlotinib are effective treatments for lung cancers with EGFR activating mutations, but these tumors invariably develop drug resistance. Here, we describe a gefitinib-sensitive lung cancer cell line that developed resistance to gefitinib as a result of focal amplification of the MET proto-oncogene. inhibition of MET signaling in these cells restored their sensitivity to gefitinib. MET amplification was detected in 4 of 18 (22%) lung cancer specimens that had developed resistance to gefitinib or erlotinib. We find that amplification of MET causes gefitinib resistance by driving ERBB3 (HER3)-dependent activation of PI3K, a pathway thought to be specific to EGFR/ERBB family receptors. Thus, we propose that MET amplification may promote drug resistance in other ERBB-driven cancers as well.	Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Dept Signal Transduct, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Aichi Canc Ctr Hosp, Dept Thorac Surg, Nagoya, Aichi 4648681, Japan; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Pfizer Global Res & Dev, Dept Res Pharmacol, San Diego, CA 92121 USA; Ist Clin Humanitas, Dept Hematol Oncol, I-20089 Rozzano, Italy; Chinese Univ Hong Kong, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Aichi Cancer Center; Harvard University; Brigham & Women's Hospital; Pfizer; IRCCS Humanitas Research Hospital; Chinese University of Hong Kong	Janne, PA (corresponding author), Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA.	pjanne@partners.org	Cantley, Lewis C/D-1800-2014; Cappuzzo, federico/R-2827-2016; Mok, Tony Shu Kam/B-2310-2019	Cantley, Lewis C/0000-0002-1298-7653; Cappuzzo, federico/0000-0002-6295-6767; Mok, Tony Shu Kam/0000-0002-8251-0551; Mitsudomi, Tetsuya/0000-0001-9860-8505	NCI NIH HHS [K08CA120060-01, P20CA90578-02, P01 CA089021, R01CA114465-01, 1K12CA87723-01, R01-CA111560] Funding Source: Medline; NIGMS NIH HHS [GM41890, R01 GM041890] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K12CA087723, R01CA111560, P20CA090578, K08CA120060, R01CA114465, P01CA089021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041890, R37GM041890] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Christensen JG, 2003, CANCER RES, V63, P7345; Debiec-Rychter M, 2005, GASTROENTEROLOGY, V128, P270, DOI 10.1053/j.gastro.2004.11.020; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Heinrich MC, 2006, J CLIN ONCOL, V24, P4764, DOI 10.1200/JCO.2006.06.2265; Hochhaus A, 2002, LEUKEMIA, V16, P2190, DOI 10.1038/sj.leu.2402741; Inoue A, 2006, J CLIN ONCOL, V24, P3340, DOI 10.1200/JCO.2005.05.4692; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Kosaka T, 2006, CLIN CANCER RES, V12, P5764, DOI 10.1158/1078-0432.CCR-06-0714; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Miller CT, 2006, ONCOGENE, V25, P409, DOI 10.1038/sj.onc.1209057; Mukohara T, 2005, CLIN CANCER RES, V11, P8122, DOI 10.1158/1078-0432.CCR-05-1191; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Shibata T, 2005, CLIN CANCER RES, V11, P6177, DOI 10.1158/1078-0432.CCR-05-0293; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; Yakes FM, 2002, CANCER RES, V62, P4132	22	3598	3824	7	392	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					1039	1043		10.1126/science.1141478	http://dx.doi.org/10.1126/science.1141478			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17463250				2022-12-01	WOS:000246554000050
J	Li, B; Gogol, M; Carey, M; Lee, D; Seidel, C; Workman, JL				Li, Bing; Gogol, Madelaine; Carey, Mike; Lee, Daeyoup; Seidel, Chris; Workman, Jerry L.			Combined action of PHD and chromo domains directs the Rpd3S HDAC to transcribed chromatin	SCIENCE			English	Article							METHYLATION; DEACETYLATION; ELONGATION	Nucleosomes must be deacetylated behind elongating RNA polymerase II to prevent cryptic initiation of transcription within the coding region. RNA polymerase II signals for deacetylation through the methylation of histone H3 lysine 36 ( H3K36), which provides the recruitment signal for the Rpd3S histone deacetylase complex ( HDAC). The recognition of methyl H3K36 by Rpd3S requires the chromodomain of its Eaf3 subunit. Paradoxically, Eaf3 is also a subunit of the NuA4 acetyltransferase complex, yet NuA4 does not recognize methyl H3K36 nucleosomes. In Saccharomyces cerevisiae, we found that methyl H3K36 nucleosome recognition by Rpd3S also requires the plant homeobox domain ( PHD) of its Rco1 subunit. Thus, the coupled chromo and PHD domains of Rpd3S specify recognition of the methyl H3K36 mark, demonstrating the first combinatorial domain requirement within a protein complex to read a specific histone code.	Univ Calif Los Angeles, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90095 USA; Stowers Inst Med Res, Kansas City, MO 64110 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Stowers Institute for Medical Research	Workman, JL (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	jlw@stowers-institute.org	Lee, Daeyoup/C-1653-2011	Lee, Daeyoup/0000-0003-2006-1823; Gogol, Madelaine/0000-0002-8738-0995; Carey, Michael/0000-0003-3899-6280				Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Zhang Y, 2006, NAT STRUCT MOL BIOL, V13, P572, DOI 10.1038/nsmb0706-572	10	241	245	2	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					1050	1054		10.1126/science.1139004	http://dx.doi.org/10.1126/science.1139004			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17510366				2022-12-01	WOS:000246554000053
J	Hedenstrom, A; Johansson, LC; Wolf, M; von Busse, R; Winter, Y; Spedding, GR				Hedenstrom, A.; Johansson, L. C.; Wolf, M.; von Busse, R.; Winter, Y.; Spedding, G. R.			Bat flight generates complex aerodynamic tracks	SCIENCE			English	Article							WIND-TUNNEL; PLECOTUS-AURITUS; FLAPPING FLIGHT; SLOW FLIGHT; WAKE; KINEMATICS; SPEEDS; UPSTROKE; NUMBERS	The flapping flight of animals generates an aerodynamic footprint as a time-varying vortex wake in which the rate of momentum change represents the aerodynamic force. We showed that the wakes of a small bat species differ from those of birds in some important respects. In our bats, each wing generated its own vortex loop. Also, at moderate and high flight speeds, the circulation on the outer ( hand) wing and the arm wing differed in sign during the upstroke, resulting in negative lift on the hand wing and positive lift on the arm wing. Our interpretations of the unsteady aerodynamic performance and function of membranous-winged, flapping flight should change modeling strategies for the study of equivalent natural and engineered flying devices.	Univ Munich, Dept Biol, D-80539 Munich, Germany; Lund Univ, Dept Theoret Ecol, SE-22362 Lund, Sweden; Max Planck Inst Ornithol, Seewiesen, Germany; Univ So Calif, Dept Aerosp & Mech Engn, Los Angeles, CA 90089 USA	University of Munich; Lund University; Max Planck Society; University of Southern California	Hedenstrom, A (corresponding author), Univ Munich, Dept Biol, D-80539 Munich, Germany.	anders.hedenstrom@teorekol.lu.se	Johansson, Christoffer/B-2189-2013; Spedding, Geoffrey R/A-1860-2010; Hedenström, Anders/F-5377-2010; Wolf, Marta/B-4599-2013	Johansson, Christoffer/0000-0002-1851-3635; Spedding, Geoffrey R/0000-0003-3033-7897; Hedenström, Anders/0000-0002-1757-0945; Winter, York/0000-0002-7828-1872				ALDRIDGE HDJN, 1986, J EXP BIOL, V126, P479; ALDRIDGE HDJN, 1987, J EXP BIOL, V130, P275; Hedenstrom A, 2006, J R SOC INTERFACE, V3, P263, DOI 10.1098/rsif.2005.0091; KOKSHAYSKY NV, 1979, NATURE, V279, P146, DOI 10.1038/279146a0; Laitone EV, 1997, EXP FLUIDS, V23, P405, DOI 10.1007/s003480050128; Lian YS, 2005, J AIRCRAFT, V42, P865, DOI 10.2514/1.5909; Norberg UML, 2006, J EXP BIOL, V209, P3887, DOI 10.1242/jeb.02446; NORBERG UM, 1976, J EXP BIOL, V65, P459; NORBERG UM, 1976, J EXP BIOL, V65, P179; PRANDTL L, 1957, FUNDAMENTALS HYDRO A; PRANDTL L, 1957, APPL HYDR AEROMECHAN; RAYNER JMV, 1986, NATURE, V321, P162, DOI 10.1038/321162a0; ROSEN M, J R SOC INTERFACE; SPEDDING GR, 1987, J EXP BIOL, V127, P59; SPEDDING GR, 1984, J EXP BIOL, V111, P81; SPEDDING GR, 1986, J EXP BIOL, V125, P287; Spedding GR, 2003, J EXP BIOL, V206, P2313, DOI 10.1242/jeb.00423; Swartz SM, 1996, J ZOOL, V239, P357, DOI 10.1111/j.1469-7998.1996.tb05455.x; SWARTZ SM, 2006, FUNCTIONAL EVOLUTION, P110; Taylor GK, 2003, NATURE, V425, P707, DOI 10.1038/nature02000; von Helversen O., 1986, BAT FLIGHT, P107; Warrick DR, 2005, NATURE, V435, P1094, DOI 10.1038/nature03647; Winter Y, 1999, J EXP BIOL, V202, P1917	23	157	167	2	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2007	316	5826					894	897		10.1126/science.1142281	http://dx.doi.org/10.1126/science.1142281			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17495171				2022-12-01	WOS:000246369800039
J	Stracker, TH; Morales, M; Couto, SS; Hussein, H; Petrini, JHJ				Stracker, Travis H.; Morales, Monica; Couto, Suzana S.; Hussein, Hussein; Petrini, John H. J.			The carboxy terminus of NBS1 is required for induction of apoptosis by the MRE11 complex	NATURE			English	Article							NIJMEGEN BREAKAGE SYNDROME; DNA-DAMAGE RESPONSE; ATAXIA-TELANGIECTASIA; CELLULAR-RESPONSE; ATM ACTIVATION; CHECKPOINT; MICE; PROTEIN; RECRUITMENT; METABOLISM	The MRE11 complex (MRE11, RAD50 and NBS1) and the ataxia-telangiectasia mutated (ATM) kinase function in the same DNA damage response pathway to effect cell cycle checkpoint activation and apoptosis(1-3). The functional interaction between the MRE11 complex and ATM has been proposed to require a conserved C-terminal domain of NBS1 for recruitment of ATM to sites of DNA damage(4,5). Human Nijmegen breakage syndrome (NBS) cells and those derived from multiple mouse models of NBS express a hypomorphic NBS1 allele that exhibits impaired ATM activity despite having an intact C-terminal domain(3,6-11). This indicates that the NBS1 C terminus is not sufficient for ATM function. We derived Nbs1(Delta C/Delta C) mice in which the C-terminal ATM interaction domain is deleted. Nbs1(Delta C/Delta C) cells exhibit intra-S-phase checkpoint defects, but are otherwise indistinguishable from wild-type cells with respect to other checkpoint functions, ionizing radiation sensitivity and chromosome stability. However, multiple tissues of Nbs1(Delta C/Delta C) mice showed a severe apoptotic defect, comparable to that of ATM- or CHK2-deficient animals. Analysis of p53 transcriptional targets and ATM substrates showed that, in contrast to the phenotype of Chk2(-/-) mice, NBS1(Delta C) does not impair the induction of proapoptotic genes. Instead, the defects observed in Nbs1(Delta C/Delta C) result from impaired phosphorylation of ATM targets including SMC1 and the proapoptotic factor, BID.	Sloan Kettering Inst, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Weill Cornell Grad Sch Med Sci, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Weill Cornell Medical College Qatar	Petrini, JHJ (corresponding author), Sloan Kettering Inst, New York, NY 10021 USA.	petrinij@mskcc.org	Stracker, Travis H/I-2815-2015; Morales-Ballús, Mònica/AAE-3086-2021	Stracker, Travis H/0000-0002-8650-2081; Morales-Ballús, Mònica/0000-0002-9478-6280; Petrini, John/0000-0001-5102-5679	NCI NIH HHS [R13 CA162528] Funding Source: Medline; NIGMS NIH HHS [R01 GM059413, R01 GM056888, R01 GM056888-08, R01 GM059413-08, R01 GM056888-09] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059413, R01GM056888] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bender CF, 2002, GENE DEV, V16, P2237, DOI 10.1101/gad.1007902; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Kamer I, 2005, CELL, V122, P593, DOI 10.1016/j.cell.2005.06.014; Kang J, 2005, MOL CELL BIOL, V25, P661, DOI 10.1128/MCB.25.2.661-670.2005; Kang J, 2002, EMBO J, V21, P1447, DOI 10.1093/emboj/21.6.1447; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; Maser RS, 2001, NAT GENET, V27, P417, DOI 10.1038/86920; Morales M, 2005, GENE DEV, V19, P3043, DOI 10.1101/gad.1373705; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; Takai H, 2002, EMBO J, V21, P5195, DOI 10.1093/emboj/cdf506; Theunissen JWF, 2006, METHOD ENZYMOL, V409, P251, DOI 10.1016/S0076-6879(05)09015-4; Theunissen JWF, 2003, MOL CELL, V12, P1511, DOI 10.1016/S1097-2765(03)00455-6; Williams BR, 2002, CURR BIOL, V12, P648, DOI 10.1016/S0960-9822(02)00763-7; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; XU Y, 1996, GENE DEV, V10, P24111; Yamazaki V, 1998, CANCER RES, V58, P2316; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005; Zinkel SS, 2005, CELL, V122, P579, DOI 10.1016/j.cell.2005.06.022	29	96	102	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2007	447	7141					218	U7		10.1038/nature05740	http://dx.doi.org/10.1038/nature05740			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17429352	Green Accepted			2022-12-01	WOS:000246338700046
J	Senoo, M; Pinto, F; Crum, CP; McKeon, F				Senoo, Makoto; Pinto, Filipa; Crum, Christopher P.; McKeon, Frank			p63 is essential for the proliferative potential of stem cells in stratified epithelia	CELL			English	Article						u	THYMIC EPITHELIUM; HAIR-FOLLICLES; POLYCOMB-GROUP; SELF-RENEWAL; P53 HOMOLOG; BMI-1; DIFFERENTIATION; EXPRESSION; KERATINOCYTES; PROGENITOR	The distinguishing feature of adult stem cells is their extraordinary capacity to divide prior to the onset of senescence. While stratified epithelia such as skin, prostate, and breast are highly regenerative and account disproportionately for human cancers, genes essential for the proliferative capacity of their stem cells remain unknown. Here we analyze p63, a gene whose deletion in mice results in the catastrophic loss of all stratified epithelia. We demonstrate that p63 is strongly expressed in epithelial cells with high clonogenic and proliferative capacity and that stem cells lacking p63 undergo a premature proliferative rundown. Additionally, we show that p63 is dispensable for both the commitment and differentiation of these stem cells during tissue morphogenesis. Together, these data identify p63 as a key, lineage-specific determinant of the proliferative capacity in stem cells of stratified epithelia.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	McKeon, F (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	fmckeon@hms.harvard.edu		Senoo, Makoto/0000-0002-0155-0683				ADKINS B, 1988, IMMUNOGENETICS, V27, P180, DOI 10.1007/BF00346584; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; BARRANDON Y, 1985, P NATL ACAD SCI USA, V82, P5390, DOI 10.1073/pnas.82.16.5390; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; Blackburn CC, 2004, NAT REV IMMUNOL, V4, P278, DOI 10.1038/nri1331; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Chilosi M, 2003, VIRCHOWS ARCH, V443, P175, DOI 10.1007/s00428-003-0857-4; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; De Luca M, 2006, REGEN MED, V1, P45, DOI 10.2217/17460751.1.1.45; Di Como CJ, 2002, CLIN CANCER RES, V8, P494; Gill J, 2003, IMMUNOL REV, V195, P28, DOI 10.1034/j.1600-065X.2003.00077.x; Gordon J, 2004, NAT IMMUNOL, V5, P546, DOI 10.1038/ni1064; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Klug DB, 2002, J IMMUNOL, V169, P2842, DOI 10.4049/jimmunol.169.6.2842; Kolly C, 2005, J INVEST DERMATOL, V124, P1014, DOI 10.1111/j.0022-202X.2005.23655.x; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Langbein L, 2003, EUR J CELL BIOL, V82, P385, DOI 10.1078/0171-9335-00330; Lavker RM, 2003, J INVEST DERM SYMP P, V8, P28, DOI 10.1046/j.1523-1747.2003.12169.x; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; McKeon F, 2004, GENE DEV, V18, P465, DOI 10.1101/gad.1190504; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; Nylander K, 2002, J PATHOL, V198, P417, DOI 10.1002/path.1231; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ropke Carsten, 2002, Methods Mol Biol, V188, P27; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Schumacher A, 1997, TRENDS GENET, V13, P167, DOI 10.1016/S0168-9525(97)01133-5; Senoo M, 2004, CANCER CELL, V6, P85, DOI 10.1016/j.ccr.2004.06.005; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; van Ewijk W, 2000, DEVELOPMENT, V127, P1583; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Watt FM, 2001, CURR OPIN GENET DEV, V11, P410, DOI 10.1016/S0959-437X(00)00211-2; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018	50	660	678	0	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 4	2007	129	3					523	536		10.1016/j.cell.2007.02.045	http://dx.doi.org/10.1016/j.cell.2007.02.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482546	Bronze			2022-12-01	WOS:000246373600019
J	van der Steeg, WA; Boekholdt, SM; Stein, EA; El-Harchaoui, K; Stroes, ESG; Sandhu, MS; Wareham, NJ; Jukema, JW; Luben, R; Zwinderman, AH; Kastelein, JJP; Khaw, KT				van der Steeg, Wim A.; Boekholdt, S. Matthijs; Stein, Evan A.; El-Harchaoui, Karim; Stroes, Erik S. G.; Sandhu, Manjinder S.; Wareham, Nicholas J.; Jukema, J. Wouter; Luben, Robert; Zwinderman, Aeilko H.; Kastelein, John J. P.; Khaw, Kay-Tee			Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: A case--control analysis in EPIC-Norfolk	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-ARTERY-DISEASE; CHEMISTRY STANDARDIZATION PROJECT; LOW-DENSITY-LIPOPROTEIN; ISCHEMIC-HEART-DISEASE; APPARENTLY HEALTHY-MEN; C-REACTIVE PROTEIN; MYOCARDIAL-INFARCTION; INTERNATIONAL-FEDERATION; HDL CHOLESTEROL; POPULATION	Background: An elevated apolipoprotein B-apolipoprotein A-I (apo B-apo A-I) ratio is a risk factor for future coronary artery disease (CAD). It is not known whether this ratio is better than traditional lipid values for risk assessment and prediction and whether it adds predictive value to the Framingham risk score. Objective: To evaluate whether the ape B-apo A-I ratio is associated with future CAD events independent of traditional lipid measurements and the Framingham risk score and to evaluate the ability of this ratio to predict occurrence of future CAD. Design: Prospective, nested case-control study. Setting: Norfolk, United Kingdom. Participants: Apparently healthy men and women (45 to 79 years of age) in the European Prospective Investigation into Cancer and Nutrition-Norfolk. Cases (n = 869) were persons who developed fatal or nonfatal CAD. Controls (n = 1511) were persons without CAD who were matched for age, sex, and enrollment period. Measurements: Total cholesterol, high-density lipoprotein (HDL) cholesterol, triglyceride, apolipoprotein, and C-reactive protein levels were measured directly. Low-density lipoprotein (LDL) cholesterol values were calculated by using the Friedewald formula. Results: The apo B-apo A-I ratio was associated with future CAD events, independent of traditional lipid values (adjusted odds ratio, 1.85 [95% Cl, 1.15 to 2.98]), including the total cholesterol-HDL cholesterol ratio, and independent of the Framingham risk score (adjusted odds ratio, 1.77 [Cl, 1.31 to 2.39]). However, it did no better than lipid values at discriminating between CAD cases and controls (area under the receiver-operating characteristic curve, 0.670 for total cholesterol-HDL cholesterol ratio vs. 0.673 for ape B-apo A-I ratio [P = 0.38]) and added little to the predictive value of the Framingham risk score (area under the receiver-operating characteristic curve, 0.594 for Framingham risk score alone vs. 0.613 for Framingham risk score plus ape 6-apo A-I ratio [P < 0.001]), In addition, it incorrectly classified 41.1% of cases and 50.4% of controls. Limitations: No participant was taking lipid-lowering medication, and diabetes was uncommon. Conclusions: The apo B-apo A-I ratio is independently associated with, but adds little to, existing measures for CAD risk assessment and discrimination in the general population. Other characteristics of the test, such as the ability to perform it on nonfasting samples, may still make it useful in some settings.	Acad Med Ctr, Dept Vasc Med, NL-1100 DD Amsterdam, Netherlands; Leiden Univ, Med Ctr, Leiden, Netherlands; Metab & Atherosclerosis Res Ctr, Cincinnati, OH USA; MRC, Epidemiol Unit, Cambridge, England; Inst Publ Hlth, Cambridge, England	University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Cambridge	Kastelein, JJP (corresponding author), Acad Med Ctr, Dept Vasc Med, Room F4-159-2,POB 22660, NL-1100 DD Amsterdam, Netherlands.	j.j.kastelein@amc.uva.nl	Luben, Robert N/H-5519-2015; Jukema, J. Wouter/ABD-6503-2021; Khaw, Kay-Tee/AAZ-3209-2021; Boekholdt, Matthijs S.M./G-7562-2014; Kastelein, John/AAF-7950-2020	Luben, Robert N/0000-0002-5088-6343; Jukema, J. Wouter/0000-0002-3246-8359; Boekholdt, Matthijs/0000-0002-0861-0765	Medical Research Council [MC_U106179471, G0401527] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALBERS JJ, 1992, CLIN CHEM, V38, P658; *ATH RISK COMM STU, 2001, CIRCULATION, V104, P1108; Barter PJ, 2006, J INTERN MED, V259, P247, DOI 10.1111/j.1365-2796.2006.01616.x; Boekholdt MS, 2004, AM J MED, V117, P390, DOI 10.1016/j.amjmed.2004.04.010; Boekholdt SM, 2004, CIRCULATION, V110, P1418, DOI 10.1161/01.CIR.0000141730.65972.95; Boekholdt SM, 2004, ARTERIOSCL THROM VAS, V24, P1503, DOI 10.1161/01.ATV.0000134294.54422.2e; Breslow NE., 1980, IARC SCI PUBLICATION, V32; Bruins P, 1997, CIRCULATION, V96, P3542; Castelli W P, 1992, Ann Epidemiol, V2, P23, DOI 10.1016/1047-2797(92)90033-M; Corsetti JP, 2004, ATHEROSCLEROSIS, V177, P367, DOI 10.1016/j.atherosclerosis.2004.07.019; CREMER P, 1994, EUR J CLIN INVEST, V24, P444, DOI 10.1111/j.1365-2362.1994.tb02373.x; Day N, 1999, BRIT J CANCER, V80, P95; Efron B., 1993, INTRO BOOSTRAP; FIELDING CJ, 1972, BIOCHIM BIOPHYS ACTA, V270, P513, DOI 10.1016/0005-2760(72)90116-6; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gotto AM, 2000, CIRCULATION, V101, P477, DOI 10.1161/01.CIR.101.5.477; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; HONG MK, 1991, AM J CARDIOL, V68, P1646, DOI 10.1016/0002-9149(91)90323-D; Jiang R, 2004, DIABETES CARE, V27, P1991, DOI 10.2337/diacare.27.8.1991; Lamarche B, 1997, CIRCULATION, V95, P69, DOI 10.1161/01.CIR.95.1.69; Law MR, 2002, BMJ-BRIT MED J, V324, P1570, DOI 10.1136/bmj.324.7353.1570; Lee JY, 2005, CURR OPIN LIPIDOL, V16, P19, DOI 10.1097/00041433-200502000-00005; Luc G, 2002, ARTERIOSCL THROM VAS, V22, P1155, DOI 10.1161/01.ATV.0000022850.59845.E0; MARCOVINA SM, 1993, CLIN CHEM, V39, P773; MARCOVINA SM, 1994, CLIN CHEM, V40, P586; MOISE A, 1985, COMPUT BIOMED RES, V18, P125, DOI 10.1016/0010-4809(85)90039-4; Navab M, 2000, J LIPID RES, V41, P1495; Njolstad I, 1996, CIRCULATION, V93, P450; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Pepe MS, 2004, STAT EVALUATION MED; Prescott E, 1998, BMJ-BRIT MED J, V316, P1043; Rutter MK, 2004, CIRCULATION, V110, P380, DOI 10.1161/01.CIR.0000136581.59584.0E; SALONEN JT, 1985, AM J CARDIOL, V56, P226, DOI 10.1016/0002-9149(85)90839-2; SIGURDSSON G, 1992, AM J CARDIOL, V69, P1251, DOI 10.1016/0002-9149(92)91215-P; St-Pierre AC, 2001, CIRCULATION, V104, P2295, DOI 10.1161/hc4401.098490; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P373, DOI 10.1056/NEJM199108083250601; Sweetnam PM, 2000, EUR J CLIN INVEST, V30, P947, DOI 10.1046/j.1365-2362.2000.00725.x; van Lennep JER, 2000, ARTERIOSCL THROM VAS, V20, P2408, DOI 10.1161/01.ATV.20.11.2408; Wagner AM, 1999, DIABETES CARE, V22, P812, DOI 10.2337/diacare.22.5.812; WALD NJ, 1994, LANCET, V343, P75, DOI 10.1016/S0140-6736(94)90814-1; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; Walldius G, 2004, J INTERN MED, V255, P188, DOI 10.1046/j.1365-2796.2003.01276.x; Wallis EJ, 2000, BMJ-BRIT MED J, V320, P671, DOI 10.1136/bmj.320.7236.671; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	45	121	124	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2007	146	9					640	648		10.7326/0003-4819-146-9-200705010-00007	http://dx.doi.org/10.7326/0003-4819-146-9-200705010-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	162EV	17470832				2022-12-01	WOS:000246070500003
J	Blain, S; Queguiner, B; Armand, L; Belviso, S; Bombled, B; Bopp, L; Bowie, A; Brunet, C; Brussaard, C; Carlotti, F; Christaki, U; Corbiere, A; Durand, I; Ebersbach, F; Fuda, JL; Garcia, N; Gerringa, L; Griffiths, B; Guigue, C; Guillerm, C; Jacquet, S; Jeandel, C; Laan, P; Lefevre, D; Lo Monaco, C; Malits, A; Mosseri, J; Obernosterer, I; Park, YH; Picheral, M; Pondaven, P; Remenyi, T; Sandroni, V; Sarthou, G; Savoye, N; Scouarnec, L; Souhaut, M; Thuiller, D; Timmermans, K; Trull, T; Uitz, J; van Beek, P; Veldhuis, M; Vincent, D; Viollier, E; Vong, L; Wagener, T				Blain, Stephane; Queguiner, Bernard; Armand, Leanne; Belviso, Sauveur; Bombled, Bruno; Bopp, Laurent; Bowie, Andrew; Brunet, Christian; Brussaard, Corina; Carlotti, Francois; Christaki, Urania; Corbiere, Antoine; Durand, Isabelle; Ebersbach, Frederike; Fuda, Jean-Luc; Garcia, Nicole; Gerringa, Loes; Griffiths, Brian; Guigue, Catherine; Guillerm, Christophe; Jacquet, Stephanie; Jeandel, Catherine; Laan, Patrick; Lefevre, Dominique; Lo Monaco, Claire; Malits, Andrea; Mosseri, Julie; Obernosterer, Ingrid; Park, Young-Hyang; Picheral, Marc; Pondaven, Philippe; Remenyi, Thomas; Sandroni, Valerie; Sarthou, Geraldine; Savoye, Nicolas; Scouarnec, Lionel; Souhaut, Marc; Thuiller, Doris; Timmermans, Klaas; Trull, Thomas; Uitz, Julia; van Beek, Pieter; Veldhuis, Marcel; Vincent, Dorothee; Viollier, Eric; Vong, Lilita; Wagener, Thibaut			Effect of natural iron fertilization on carbon sequestration in the Southern Ocean	NATURE			English	Article							ATMOSPHERIC CO2; SEA; CLIMATE; ATLANTIC; EXCHANGE; SEAWATER; SAMPLES; WATERS; BLOOM; RATES	The availability of iron limits primary productivity and the associated uptake of carbon over large areas of the ocean. Iron thus plays an important role in the carbon cycle, and changes in its supply to the surface ocean may have had a significant effect on atmospheric carbon dioxide concentrations over glacial - interglacial cycles(1-5). To date, the role of iron in carbon cycling has largely been assessed using short-term iron-addition experiments(6,7). It is difficult, however, to reliably assess the magnitude of carbon export to the ocean interior using such methods, and the short observational periods preclude extrapolation of the results to longer timescales(8). Here we report observations of a phytoplankton bloom induced by natural iron fertilization - an approach that offers the opportunity to overcome some of the limitations of short-term experiments. We found that a large phytoplankton bloom over the Kerguelen plateau in the Southern Ocean was sustained by the supply of iron and major nutrients to surface waters from iron-rich deep water below. The efficiency of fertilization, defined as the ratio of the carbon export to the amount of iron supplied, was at least ten times higher than previous estimates from short-term blooms induced by iron-addition experiments(7). This result sheds new light on the effect of long-term fertilization by iron and macronutrients on carbon sequestration, suggesting that changes in iron supply from below - as invoked in some palaeoclimatic(9,10) and future climate change scenarios(11) - may have a more significant effect on atmospheric carbon dioxide concentrations than previously thought.	Univ Aix Marseille 2, Ctr Oceanol Marseille, Lab Oceanog & Biogeochim, F-13288 Marseille 09, France; CEN Saclay, IPSL, Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France; Antarct Climate & Ecosyst CRC, Hobart, Tas 7001, Australia; Univ Tasmania, Sch Chem, ACROSS, Hobart, Tas 7001, Australia; Univ Paris 06, CNRS, UMR 7159, LOCEAN IPSL, F-75252 Paris 5, France; Royal Netherlands Inst Sea Res, NL-1790 AB Den Burg, Texel, Netherlands; Univ Littoral Cote dOpale, FRE ELICO, MREN, F-62930 Wimereux, France; Museum Natl Hist Nat, USM402 LOCEAN, Dept Milieux & Peuplements Marins, F-75231 Paris 05, France; Fac Sci Luminy, Ctr Oceanol Marseille, F-13288 Marseille 09, France; CSIRO, Div Marine & Atmospher Res, Hobart, Tas 7001, Australia; CNRS, UMR 617, LMGEM, F-13288 Marseille 09, France; Technopole Brest Iroise, DT INSU CNRS, F-29280 Plouzane, France; Free Univ Brussels, Dept Analyt & Environm Chem, B-1050 Brussels, Belgium; Observ Midi Pyrenees, LEGOS, CNRS CNES IRD UPS, F-31400 Toulouse, France; Lab Oceanog Villefranche, F-06238 Villefranche Sur Mer, France; Univ Paris 06, CNRS, UMR7621, F-66650 Banyuls sur Mer, France; Technopole Brest Iroise, UMR 6539 LEMAR IUEM, F-29280 Plouzane, France; Univ Arcachon, Observ Aquitain Sci, UMR CNRS 5805 EPOC, Stn Marine Arcachon, F-33120 Arcachon, France; Univ Paris 07, UMP IPGP 7154, Lab Geochim Eaux, F-75251 Paris 05, France	UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); University of Tasmania; University of Tasmania; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Universite du Littoral-Cote-d'Opale; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Aix-Marseille Universite; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Laboratoire d'Etudes en Geophysique et oceanographie spatiales; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Blain, S (corresponding author), Univ Aix Marseille 2, Ctr Oceanol Marseille, Lab Oceanog & Biogeochim, Campus Luminy,Case 901, F-13288 Marseille 09, France.	stephane.blain@univmed.fr	bopp, laurent/ABF-5302-2020; Malits, Andrea/U-6869-2018; jacquet, stéphanie/K-8678-2016; Obernosterer, Ingrid/A-5434-2011; blain, stéphane/F-6917-2010; UITZ, Julia/Q-7487-2018; Trull, Tom W/B-7028-2014; Lefevre, Dominique/AAN-8201-2021; Jeandel, Catherine/P-3789-2014; Lo Monaco, Claire/E-1696-2012; Bowie, Andrew/C-8677-2013; Vincent, Dorothee/I-8109-2013; Quéguiner, Bernard/B-4060-2008; Armand, Leanne/C-9004-2009	bopp, laurent/0000-0003-4732-4953; Obernosterer, Ingrid/0000-0002-2530-8111; blain, stéphane/0000-0002-5234-2446; UITZ, Julia/0000-0001-5461-0216; Lefevre, Dominique/0000-0003-1694-3807; Jeandel, Catherine/0000-0002-4915-4719; Bowie, Andrew/0000-0002-5144-7799; Quéguiner, Bernard/0000-0001-5020-8297; Armand, Leanne/0000-0003-3995-308X; Christaki, Urania/0000-0002-2061-5278; wagener, thibaut/0000-0002-3968-0678; Lo Monaco, Claire/0000-0002-5653-5018; timmermans, klaas/0000-0002-3214-4354; Sarthou, Geraldine/0000-0001-6560-6669; VINCENT, Dorothee/0000-0003-0931-3014; Viollier, Eric/0000-0002-8863-4563; Remenyi, Tomas/0000-0002-4145-9323; Pondaven, Philippe/0000-0002-3427-7767				Blain S, 2001, DEEP-SEA RES PT I, V48, P163, DOI 10.1016/S0967-0637(00)00047-9; BOPP L, 2003, PALEOCEANOGRAPHY, V18; Bowie AR, 2001, DEEP-SEA RES PT II, V48, P2703, DOI 10.1016/S0967-0645(01)00015-7; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; Boyd PW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014210; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; BOYD PW, 2005, GLOB BIOCH CYCLES, V19; BRZEZINSKY MA, 2002, GEOPHYS RES LETT, V29; Buesseler KO, 2003, SCIENCE, V300, P67, DOI 10.1126/science.1082959; Buesseler KO, 2004, SCIENCE, V304, P414, DOI 10.1126/science.1086895; Chisholm SW, 2001, SCIENCE, V294, P309, DOI 10.1126/science.1065349; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; Croot PL, 2000, ELECTROANAL, V12, P565, DOI 10.1002/(SICI)1521-4109(200005)12:8<565::AID-ELAN565>3.0.CO;2-L; Cullen JT, 1999, MAR CHEM, V67, P233, DOI 10.1016/S0304-4203(99)00060-2; DEBAAR HJW, 2005, J GEOPHYS RES, V110; DILLON TM, 1982, J GEOPHYS RES-OCEANS, V87, P9601, DOI 10.1029/JC087iC12p09601; FERNANDEZ C, 2005, J GEOPHYS RES, V110; Gervais F, 2002, LIMNOL OCEANOGR, V47, P1324, DOI 10.4319/lo.2002.47.5.1324; GNANADESIKAN A, 2003, GLOB BIOCH CYCLES, V17; Hartman O., 1942, Bulletin of the Bingham Oceanographic Collection, V8, P1; JABAUD A, 2004, GLOB BIOCH CYCLES, V18; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; JOHNSON KS, 2006, EOS T AGU S, V87; Latimer JC, 2001, PALEOCEANOGRAPHY, V16, P627, DOI 10.1029/2000PA000586; LAW C, 2003, J GEOPHYS RES, V108; Marinov I, 2006, NATURE, V441, P964, DOI 10.1038/nature04883; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Measures CI, 2001, DEEP-SEA RES PT II, V48, P3913, DOI 10.1016/S0967-0645(01)00074-1; Nightingale PD, 2000, GLOBAL BIOGEOCHEM CY, V14, P373, DOI 10.1029/1999GB900091; OSBORN TR, 1980, J PHYS OCEANOGR, V10, P83, DOI 10.1175/1520-0485(1980)010<0083:EOTLRO>2.0.CO;2; Pike SM, 2005, J RADIOANAL NUCL CH, V263, P355, DOI 10.1007/s10967-005-0062-9; Ridgwell AJ, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000729; Robinson C, 1999, DEEP-SEA RES PT II, V46, P745, DOI 10.1016/S0967-0645(98)00126-X; Sarmiento JL, 1998, NATURE, V393, P245, DOI 10.1038/30455; Sarthou G, 2003, DEEP-SEA RES PT I, V50, P1339, DOI 10.1016/S0967-0637(03)00126-2; Savoye N, 2006, MAR CHEM, V100, P234, DOI 10.1016/j.marchem.2005.10.014; SIGMAN DM, 2000, SCIENCE, V407, P859; SULLIVAN CW, 1993, SCIENCE, V262, P1832, DOI 10.1126/science.262.5141.1832; Timmermans KR, 2001, LIMNOL OCEANOGR, V46, P260, DOI 10.4319/lo.2001.46.2.0260; TYRELL T, 2005, J GEOPHYS RES, V110; van der Loeff MMR, 2002, DEEP-SEA RES PT II, V49, P3849; Wanninkhof R, 1999, GEOPHYS RES LETT, V26, P1889, DOI 10.1029/1999GL900363; Watson AJ, 2000, NATURE, V407, P730, DOI 10.1038/35037561; WEDEPOHL KH, 1995, GEOCHIM COSMOCHIM AC, V59, P1217, DOI 10.1016/0016-7037(95)00038-2	44	559	565	4	404	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2007	446	7139					1070	U1		10.1038/nature05700	http://dx.doi.org/10.1038/nature05700			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17460670				2022-12-01	WOS:000245950400047
J	Odegaard, JI; Ricardo-Gonzalez, RR; Goforth, MH; Morel, CR; Subramanian, V; Mukundan, L; Eagle, AR; Vats, D; Brombacher, F; Ferrante, AW; Chawla, A				Odegaard, Justin I.; Ricardo-Gonzalez, Roberto R.; Goforth, Matthew H.; Morel, Christine R.; Subramanian, Vidya; Mukundan, Lata; Eagle, Alex Red; Vats, Divya; Brombacher, Frank; Ferrante, Anthony W.; Chawla, Ajay			Macrophage-specific PPAR gamma controls alternative activation and improves insulin resistance	NATURE			English	Article							ADIPOSE-TISSUE; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE-METABOLISM; OBESITY; INFLAMMATION; EXPRESSION; ADIPOCYTES; MONOCYTE; MICE	Obesity and insulin resistance, the cardinal features of metabolic syndrome, are closely associated with a state of low-grade inflammation(1,2). In adipose tissue chronic overnutrition leads to macrophage infiltration, resulting in local inflammation that potentiates insulin resistance(3,4). For instance, transgenic expression of Mcp1 (also known as chemokine ligand 2, Ccl2) in adipose tissue increases macrophage infiltration, inflammation and insulin resistance(5,6). Conversely, disruption of Mcp1 or its receptor Ccr2 impairs migration of macrophages into adipose tissue, thereby lowering adipose tissue inflammation and improving insulin sensitivity(5,7). These findings together suggest a correlation between macrophage content in adipose tissue and insulin resistance. However, resident macrophages in tissues display tremendous heterogeneity in their activities and functions, primarily reflecting their local metabolic and immune microenvironment(8). While Mcp1 directs recruitment of pro-inflammatory classically activated macrophages to sites of tissue damage(5,8), resident macrophages, such as those present in the adipose tissue of lean mice, display the alternatively activated phenotype(9). Despite their higher capacity to repair tissue(10), the precise role of alternatively activated macrophages in obesity-induced insulin resistance remains unknown. Using mice with macrophage-specific deletion of the peroxisome proliferator activated receptor-gamma (PPAR gamma), we showhere that PPAR gamma is required for maturation of alternatively activated macrophages. Disruption of PPAR gamma in myeloid cells impairs alternative macrophage activation, and predisposes these animals to development of diet-induced obesity, insulin resistance, and glucose intolerance. Furthermore, gene expression profiling revealed that downregulation of oxidative phosphorylation gene expression in skeletal muscle and liver leads to decreased insulin sensitivity in these tissues. Together, our findings suggest that resident alternatively activated macrophages have a beneficial role in regulating nutrient homeostasis and suggest that macrophage polarization towards the alternative state might be a useful strategy for treating type 2 diabetes.	Stanford Univ, Dept Med, Sch Med, Div Endocrinol Metab & Gerontol, Stanford, CA 94305 USA; Stanford Univ, Grad Program Immunol, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; Univ Cape Town, Observ, Fac Hlth Sci, Inst Infect Dis & Mol Med,Div Immunol, ZA-7925 Cape Town, South Africa; Columbia Univ Coll Phys & Surg, Dept Med, Naomi Berrie Diabet Ctr, New York, NY 10032 USA	Stanford University; Stanford University; Stanford University; University of Cape Town; Columbia University	Chawla, A (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Endocrinol Metab & Gerontol, Stanford, CA 94305 USA.	achawla@stanford.edu	Ferrante, Anthony/AAC-7763-2019	Ferrante, Anthony/0000-0001-9272-2593; Ricardo-Gonzalez, Roberto/0000-0002-6135-4035	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI066402, T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076760, R01DK066525, K08DK062386] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL076746-03, R01 HL076746-04, R01 HL076746, R01 HL076746-02, R01 HL076746-01, R01 HL076746-05] Funding Source: Medline; NIAID NIH HHS [AI07290, T32 AI007290, F31 AI066402] Funding Source: Medline; NIDDK NIH HHS [K08 DK062386-06, R01 DK066525, K08 DK062386-05, R01 DK076760, K08 DK062386, R01 DK066525-05] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; Alexander J, 1999, J CELL SCI, V112, P2993; Civitarese AE, 2006, CELL METAB, V4, P75, DOI 10.1016/j.cmet.2006.05.002; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Holscher C, 2006, J IMMUNOL, V176, P1115, DOI 10.4049/jimmunol.176.2.1115; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2007, AM J PHYSIOL-ENDOC M, V292, pE166, DOI 10.1152/ajpendo.00284.2006; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rutschman R, 2001, J IMMUNOL, V166, P2173, DOI 10.4049/jimmunol.166.4.2173; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Vianna CR, 2006, CELL METAB, V4, P453, DOI 10.1016/j.cmet.2006.11.003; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	30	1514	1597	4	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2007	447	7148					1116	U12		10.1038/nature05894	http://dx.doi.org/10.1038/nature05894			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183HT	17515919	Green Accepted			2022-12-01	WOS:000247564600038
J	Longmore, GD				Longmore, Gregory D.			Do cancer cells express functional erythropoietin receptors?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Washington Univ, St Louis, MO 63130 USA	Washington University (WUSTL)	Longmore, GD (corresponding author), Washington Univ, St Louis, MO 63130 USA.								0	22	22	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2007	356	24					2447	2447		10.1056/NEJMp078112	http://dx.doi.org/10.1056/NEJMp078112			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	178DR	17568024				2022-12-01	WOS:000247201900002
J	Laporte, NT; Stabach, JA; Grosch, R; Lin, TS; Goetz, SJ				Laporte, Nadine T.; Stabach, Jared A.; Grosch, Robert; Lin, Tiffany S.; Goetz, Scott J.			Expansion of industrial logging in Central Africa	SCIENCE			English	Article							FOREST STRUCTURE; CONSERVATION		Woods Hole Res Ctr, Falmouth, MA 02540 USA	Woods Hole Research Center	Laporte, NT (corresponding author), Woods Hole Res Ctr, Falmouth, MA 02540 USA.	nlaporte@whrc.org	Stabach, Jared/AEX-9187-2022; Goetz, Scott J/A-3393-2015	Stabach, Jared/0000-0002-7896-1237; Goetz, Scott J/0000-0002-6326-4308				BUYS P, 2006, 4097 WPS WORLD BANK; Hall JS, 2003, FOREST ECOL MANAG, V183, P249, DOI 10.1016/S0378-1127(03)00107-5; Malcolm JR, 2000, CONSERV BIOL, V14, P1623, DOI [10.1046/j.1523-1739.2000.99070.x, 10.1111/j.1523-1739.2000.99070.x]; Robinson JG, 1999, SCIENCE, V284, P595, DOI 10.1126/science.284.5414.595; WHITE LIT, 1994, J TROP ECOL, V10, P309	5	223	228	1	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2007	316	5830					1451	1451		10.1126/science.1141057	http://dx.doi.org/10.1126/science.1141057			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556578				2022-12-01	WOS:000247066400034
J	Rivalan, P; Delmas, V; Angulo, E; Bull, LS; Hall, RJ; Courchamp, F; Rosser, AM; Leader-Williams, N				Rivalan, Philippe; Delmas, Virginie; Angulo, Elena; Bull, Leigh S.; Hall, Richard J.; Courchamp, Franck; Rosser, Alison M.; Leader-Williams, Nigel			Can bans stimulate wildlife trade?	NATURE			English	Editorial Material									Univ Paris 11, CNRS, UMR 8079, Lab Ecol Systemat & Evolut, F-91405 Orsay, France; Univ Kent, Durrell Inst Conservat & Ecol, Canterbury CT2 7NR, Kent, England	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; University of Kent	Rivalan, P (corresponding author), Univ Paris 11, CNRS, UMR 8079, Lab Ecol Systemat & Evolut, F-91405 Orsay, France.		Hall, Richard John/A-3931-2013; Courchamp, Franck/ABE-7204-2020; Angulo, Elena/A-8107-2013	Hall, Richard John/0000-0002-6102-4183; Courchamp, Franck/0000-0001-7605-4548; Angulo, Elena/0000-0001-5545-4032				Baillie J. E. M., 2004, 2004 IUCN RED LIST T; CITES, 2018, CITES AC30 DOC 15 AN; *FAO, 2001, FAO FOR RES ASS; *FAO FISH DEP, 2004, STAT WORLDS FISH AQ; Food and Agriculture Organization (FAO), 2007, 833 FAO; Hutton JM, 2003, ORYX, V37, P215, DOI 10.1017/S0030605303000395; *IUCN, 2000, TRAD MEAS MULT ENV A; Nowell K, 1996, WILD CATS STATUS SUR; Oldfield S., 1998, WORLD LIST THREATENE; PERALA J, 2003, 2006 IUCN RED LIST T; VANRIJSOORT J, 2000, NONTIMBER FOREST PRO	11	104	105	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2007	447	7144					529	530		10.1038/447529a	http://dx.doi.org/10.1038/447529a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	172YZ	17538599	Green Submitted			2022-12-01	WOS:000246842000023
J	Liu, C; Li, SM; Liu, TH; Borjigin, J; Lin, JD				Liu, Chang; Li, Siming; Liu, Tiecheng; Borjigin, Jimo; Lin, Jiandie D.			Transcriptional coactivator PGC-1a integrates the mammalian clock and energy metabolism	NATURE			English	Article							CONTROLLING MITOCHONDRIAL BIOGENESIS; CIRCADIAN GENE-EXPRESSION; OSCILLATORS; PGC-1-ALPHA; HOMEOSTASIS; COMPONENT; LIVER	The mammalian clock regulates major aspects of energy metabolism, including glucose and lipid homeostasis and mitochondrial oxidative metabolism(1,2). The biochemical basis for coordinated control of the circadian clock and diverse metabolic pathways is not well understood. Here we show that PGC-1 alpha (Ppargc1a), a transcriptional coactivator that regulates energy metabolism(3-9), is rhythmically expressed in the liver and skeletal muscle of mice. PGC-1 alpha stimulates the expression of clock genes, notably Bmal1 (Arntl) and Rev-erba (Nr1d1), through coactivation of the ROR family of orphan nuclear receptors. Mice lacking PGC-1 alpha show abnormal diurnal rhythms of activity, body temperature and metabolic rate. The disruption of physiological rhythms in these animals is correlated with aberrant expression of clock genes and those involved in energy metabolism. Analyses of PGC-1 alpha-deficient fibroblasts and mice with liver-specific knockdown of PGC-1 alpha indicate that it is required for cell-autonomous clock function. We have thus identified PGC-1 alpha as a key component of the circadian oscillator that integrates the mammalian clock and energy metabolism.	Univ Michigan, Med Ctr, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Med Ctr, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Med Ctr, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lin, JD (corresponding author), Univ Michigan, Med Ctr, Inst Life Sci, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	jdlin@umich.edu	Borjigin, Jimo/GXA-3484-2022					Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Lau P, 2004, J BIOL CHEM, V279, P36828, DOI 10.1074/jbc.M404927200; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schibler U, 2005, CURR OPIN CELL BIOL, V17, P223, DOI 10.1016/j.ceb.2005.01.007; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	30	470	494	3	57	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 24	2007	447	7143					477	U4		10.1038/nature05767	http://dx.doi.org/10.1038/nature05767			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17476214	Green Published			2022-12-01	WOS:000246693100048
J	Dodd, IB; Micheelsen, MA; Sneppen, K; Thon, G				Dodd, Ian B.; Micheelsen, Mille A.; Sneppen, Kim; Thon, Genevive			Theoretical analysis of epigenetic cell memory by nucleosome modification	CELL			English	Article							YEAST SCHIZOSACCHAROMYCES-POMBE; FISSION YEAST; METHYLATION PATTERNS; HISTONE DEACETYLASE; IN-VIVO; HETEROCHROMATIN FORMATION; DROSOPHILA SU(VAR)3-9; CHROMODOMAIN PROTEIN; POSITIVE-FEEDBACK; RNA INTERFERENCE	Chromosomal regions can adopt stable and heritable alternative states resulting in bistable gene expression without changes to the DNA sequence. Such epigenetic control is often associated with alternative covalent modifications of histones. The stability and heritability of the states are thought to involve positive feedback where modified nucleosomes recruit enzymes that similarly modify nearby nucleosomes. We developed a simplified stochastic model for dynamic nucleosome modification based on the silent mating-type region of the yeast Schizosaccharomyces pombe. We show that the mechanism can give strong bistability that is resistant both to high noise due to random gain or loss of nucleosome modifications and to random partitioning upon DNA replication. However, robust bistability required: (1) cooperativity, the activity of more than one modified nucleosome, in the modification reactions and (2) that nucleosomes occasionally stimulate modification beyond their neighbor nucleosomes, arguing against a simple continuous spreading of nucleosome modification.	Niels Bohr Inst, Ctr Models Life, DK-2100 Copenhagen O, Denmark; Univ Adelaide, Dept Mol & Biomed Sci Biochem, Adelaide, SA 5005, Australia; Univ Copenhagen, Bioctr, Dept Mol Biol, DK-2200 Copenhagen N, Denmark	University of Copenhagen; Niels Bohr Institute; University of Adelaide; University of Copenhagen	Sneppen, K (corresponding author), Niels Bohr Inst, Ctr Models Life, Blegdamsvej 17, DK-2100 Copenhagen O, Denmark.	sneppen@nbi.dk	; Thon, Genevieve/L-9497-2014	Sneppen, Kim/0000-0001-9820-3567; Thon, Genevieve/0000-0001-8550-5945; Dodd, Ian/0000-0003-2969-6841				Annunziato AT, 2005, J BIOL CHEM, V280, P12065, DOI 10.1074/jbc.R400039200; Arney KL, 2001, INT J DEV BIOL, V45, P533; Ayoub N, 2000, GENETICS, V156, P983; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BELL LR, 1991, CELL, V65, P229, DOI 10.1016/0092-8674(91)90157-T; Bi X, 2004, MOL CELL BIOL, V24, P2118, DOI 10.1128/MCB.24.5.2118-2131.2004; Bjerling P, 2002, MOL CELL BIOL, V22, P2170, DOI 10.1128/MCB.22.7.2170-2181.2002; Chen ZX, 2005, BIOCHEM CELL BIOL, V83, P438, DOI 10.1139/O05-138; Cowieson NP, 2000, CURR BIOL, V10, P517, DOI 10.1016/S0960-9822(00)00467-X; Eskeland R, 2004, BIOCHEMISTRY-US, V43, P3740, DOI 10.1021/bi035964s; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Grewal SIS, 1998, GENETICS, V150, P563; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Horn PJ, 2005, GENE DEV, V19, P1705, DOI 10.1101/gad.1328005; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Kim HS, 2004, J BIOL CHEM, V279, P42850, DOI 10.1074/jbc.M407259200; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kubicek S, 2004, CELL, V119, P903, DOI 10.1016/j.cell.2004.12.006; LEWIS J, 1977, J THEOR BIOL, V65, P579, DOI 10.1016/0022-5193(77)90216-8; Martienssen RA, 2005, TRENDS GENET, V21, P450, DOI 10.1016/j.tig.2005.06.005; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Oppenheim AB, 2005, ANNU REV GENET, V39, P409, DOI 10.1146/annurev.genet.39.073003.113656; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Petrie VJ, 2005, MOL CELL BIOL, V25, P2331, DOI 10.1128/MCB.25.6.2331-2346.2005; PFEIFER GP, 1990, P NATL ACAD SCI USA, V87, P8252, DOI 10.1073/pnas.87.21.8252; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Polo SE, 2006, CELL, V127, P481, DOI 10.1016/j.cell.2006.08.049; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; Ringrose L, 1999, EMBO J, V18, P6630, DOI 10.1093/emboj/18.23.6630; Rippe K, 2001, TRENDS BIOCHEM SCI, V26, P733, DOI 10.1016/S0968-0004(01)01978-8; Rusche LN, 2001, GENE DEV, V15, P955; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Thomas R, 2001, CHAOS, V11, P170, DOI 10.1063/1.1350439; Thon G, 1999, GENETICS, V151, P945; Thon G, 2005, GENETICS, V171, P1583, DOI 10.1534/genetics.105.048298; Thon G, 1997, GENETICS, V145, P685; Thon G, 2002, GENETICS, V161, P611; Turner BM, 1998, CELL MOL LIFE SCI, V54, P21, DOI 10.1007/s000180050122; Vilar JMG, 2003, J CELL BIOL, V161, P471, DOI 10.1083/jcb.200301125; Wiren M, 2005, EMBO J, V24, P2906, DOI 10.1038/sj.emboj.7600758; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yamada T, 2005, MOL CELL, V20, P173, DOI 10.1016/j.molcel.2005.10.002; ZIMM BH, 1959, P NATL ACAD SCI USA, V45, P1601, DOI 10.1073/pnas.45.11.1601	55	302	305	0	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2007	129	4					813	822		10.1016/j.cell.2007.02.053	http://dx.doi.org/10.1016/j.cell.2007.02.053			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512413	Bronze			2022-12-01	WOS:000246788300024
J	Nowack, MK; Shirzadi, R; Dissmeyer, N; Dolf, A; Endl, E; Grini, PE; Schnittger, A				Nowack, Moritz K.; Shirzadi, Reza; Dissmeyer, Nico; Dolf, Andreas; Endl, Elmar; Grini, Paul E.; Schnittger, Arp			Bypassing genomic imprinting allows seed development	NATURE			English	Article							POLYCOMB GROUP-COMPLEXES; ENDOSPERM DEVELOPMENT; ARABIDOPSIS-THALIANA; GROUP GENE; MEDEA; FERTILIZATION; EXPRESSION; PLANTS; EMBRYOGENESIS; MAIZE	In developing progeny of mammals the two parental genomes are differentially expressed according to imprinting marks, and embryos with only a uniparental genetic contribution die(1-3). Gene expression that is dependent on the parent of origin has also been observed in the offspring of flowering plants, and mutations in the imprinting machinery lead to embryonic lethality, primarily affecting the development of the endosperm - a structure in the seed that nourishes the embryo, analogous to the function of the mammalian placenta(4). Here we have generated Arabidopsis thaliana seeds in which the endosperm is of uniparental, that is, maternal, origin. We demonstrate that imprinting in developing seeds can be bypassed and viable albeit smaller seedlings can develop from seeds lacking a paternal contribution to the endosperm. Bypassing is only possible if the mother is mutant for any of the FIS-class genes, which encode Polycomb group chromatin-modifying factors. Thus, these data provide functional evidence that the action of the FIS complex balances the contribution of the paternal genome. As flowering plants have evolved a special reproduction system with a parallel fusion of two female with two male gametes, our findings support the hypothesis that only with the evolution of double fertilization did the action of the FIS genes become a requirement for seed development. Furthermore, our data argue for a gametophytic origin of endosperm in flowering plants, thereby supporting a hypothesis raised in 1900 by Eduard Strasburger.	Univ Cologne, Dept Bot 3, Max Delbruck Lab, Max Planck Inst Plant Breeding Res,Univ Grp, D-50829 Cologne, Germany; Univ Oslo, Dept Mol Biosci, N-0316 Oslo, Norway; Inst Mol Med & Expt Immunol, D-53105 Bonn, Germany	Max Planck Society; University of Cologne; University of Oslo; University of Bonn	Schnittger, A (corresponding author), Univ Cologne, Dept Bot 3, Max Delbruck Lab, Max Planck Inst Plant Breeding Res,Univ Grp, Carl von Linne Weg 10, D-50829 Cologne, Germany.	schnitt@mpiz-koeln.mpg.de	Grini, Paul/N-5948-2019; Grini, Paul/H-9471-2016; Schnittger, Arp/AAO-6920-2020; dissmeyer, nico/A-4738-2015; Schnittger, Arp/F-8989-2010	Grini, Paul/0000-0003-3898-6277; Grini, Paul/0000-0003-3898-6277; Schnittger, Arp/0000-0001-7067-0091; dissmeyer, nico/0000-0002-4156-3761; Schnittger, Arp/0000-0001-7067-0091; Nowack, Moritz/0000-0001-8918-7577				Autran D, 2005, CURR OPIN PLANT BIOL, V8, P19, DOI 10.1016/j.pbi.2004.11.011; Baroux U, 2006, GENE DEV, V20, P1081, DOI 10.1101/gad.378106; BARTON SC, 1984, NATURE, V311, P374, DOI 10.1038/311374a0; Berger F, 2004, SCIENCE, V303, P483, DOI 10.1126/science.1094375; Chaudhury AM, 1997, P NATL ACAD SCI USA, V94, P4223, DOI 10.1073/pnas.94.8.4223; FAURE JE, 1993, PLANT CELL, V5, P747, DOI 10.1105/tpc.5.7.747; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gehring M, 2004, PLANT CELL, V16, pS203, DOI 10.1105/tpc.017988; Grini PE, 2002, GENETICS, V162, P1911; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; Guitton AE, 2005, INT J DEV BIOL, V49, P707, DOI 10.1387/ijdb.051990ag; HAIG D, 1991, PHILOS T ROY SOC B, V333, P1, DOI 10.1098/rstb.1991.0057; HAIG D, 1989, AM NAT, V134, P147, DOI 10.1086/284971; Ingouff M, 2005, PLANT J, V42, P663, DOI 10.1111/j.1365-313X.2005.02404.x; Jullien PE, 2006, CURR BIOL, V16, P486, DOI 10.1016/j.cub.2006.01.020; Kiyosue T, 1999, P NATL ACAD SCI USA, V96, P4186, DOI 10.1073/pnas.96.7.4186; Kohler C, 2005, NAT GENET, V37, P28, DOI 10.1038/ng1495; Kohler C, 2005, PROG MOLEC, V38, P237; Kohler C, 2003, GENE DEV, V17, P1540, DOI 10.1101/gad.257403; LIN BY, 1982, GENETICS, V100, P475; LIN BY, 1984, GENETICS, V107, P103; Lukowitz W, 1996, CELL, V84, P61, DOI 10.1016/S0092-8674(00)80993-9; MAHESHWARI P, 1967, BIOL REV, V42, P88, DOI 10.1111/j.1469-185X.1967.tb01341.x; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Nowack MK, 2006, NAT GENET, V38, P63, DOI 10.1038/ng1694; Ohad N, 1996, P NATL ACAD SCI USA, V93, P5319, DOI 10.1073/pnas.93.11.5319; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sargant E, 1900, ANN BOT-LONDON, V14, P689, DOI 10.1093/oxfordjournals.aob.a088799; Scott RJ, 2006, CYTOGENET GENOME RES, V113, P53, DOI 10.1159/000090815; Scott RJ, 1998, DEVELOPMENT, V125, P3329; Sessions A, 1999, PLANT J, V20, P259, DOI 10.1046/j.1365-313x.1999.00594.x; STRASBURGER E, 1900, BOT Z, V58, P294; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Wersto RP, 2001, CYTOMETRY, V46, P296, DOI 10.1002/cyto.1171	34	83	86	4	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2007	447	7142					312	U3		10.1038/nature05770	http://dx.doi.org/10.1038/nature05770			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17468744	Green Published			2022-12-01	WOS:000246520300044
J	Widboom, PF; Fielding, EN; Liu, Y; Bruner, SD				Widboom, Paul F.; Fielding, Elisha N.; Liu, Ye; Bruner, Steven D.			Structural basis for cofactor-independent dioxygenation in vancomycin biosynthesis	NATURE			English	Article							CRYSTAL-STRUCTURE; ACTIVE-SITE; MECHANISM; CATALYSIS; SUPERFAMILY; REQUIREMENT; POLYKETIDE; ACTIVATION; HYDRATASE; OXIDATION	Enzyme-catalysed oxidations are some of the most common transformations in primary and secondary metabolism. The vancomycin biosynthetic enzyme DpgC belongs to a small class of oxygenation enzymes that are not dependent on an accessory cofactor or metal ion(1). The detailed mechanism of cofactor-independent oxygenases has not been established. Here we report the first structure of an enzyme of this oxygenase class in complex with a bound substrate mimic. The use of a designed, synthetic substrate analogue allows unique insights into the chemistry of oxygen activation. The structure confirms the absence of cofactors, and electron density consistent with molecular oxygen is present adjacent to the site of oxidation on the substrate. Molecular oxygen is bound in a small hydrophobic pocket and the substrate provides the reducing power to activate oxygen for downstream chemical steps. Our results resolve the unique and complex chemistry of DpgC, a key enzyme in the biosynthetic pathway of an important class of antibiotics(2). Furthermore, mechanistic parallels exist between DpgC and cofactor-dependent flavoenzymes(3), providing information regarding the general mechanism of enzymatic oxygen activation.	Boston Coll, Merkert Chem Ctr, Dept Chem, Chestnut Hill, MA 02467 USA	Boston College	Bruner, SD (corresponding author), Boston Coll, Merkert Chem Ctr, Dept Chem, Chestnut Hill, MA 02467 USA.	bruner@bc.edu						ADAM W, 1977, J AM CHEM SOC, V99, P5768, DOI 10.1021/ja00459a038; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agnihotri G, 2003, BIOORGAN MED CHEM, V11, P9, DOI 10.1016/S0968-0896(02)00333-4; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beaman TW, 2002, PROTEIN SCI, V11, P974, DOI 10.1110/ps.4310102; Beinker P, 2006, J MOL BIOL, V359, P728, DOI 10.1016/j.jmb.2006.03.060; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; Chen HW, 2001, P NATL ACAD SCI USA, V98, P14901, DOI 10.1073/pnas.221582098; Colloch N, 1997, NAT STRUCT BIOL, V4, P947, DOI 10.1038/nsb1197-947; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswaramoorthy S, 2006, P NATL ACAD SCI USA, V103, P9832, DOI 10.1073/pnas.0602398103; Fetzner S, 2002, APPL MICROBIOL BIOT, V60, P243, DOI 10.1007/s00253-002-1123-4; Frerichs-Deeken U, 2004, BIOCHEMISTRY-US, V43, P14485, DOI 10.1021/bi048735u; Holden HM, 2001, ACCOUNTS CHEM RES, V34, P145, DOI 10.1021/ar000053l; Hubbard BK, 2003, ANGEW CHEM INT EDIT, V42, P730, DOI 10.1002/anie.200390202; Karlsson A, 2003, SCIENCE, V299, P1039, DOI 10.1126/science.1078020; KOO JY, 1978, P NATL ACAD SCI USA, V75, P30, DOI 10.1073/pnas.75.1.30; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pootoolal J, 2002, P NATL ACAD SCI USA, V99, P8962, DOI 10.1073/pnas.102285099; Roth JP, 2003, P NATL ACAD SCI USA, V100, P62, DOI 10.1073/pnas.252644599; Sciara G, 2003, EMBO J, V22, P205, DOI 10.1093/emboj/cdg031; Silverman R.B., 2002, ORGANIC CHEM ENZYME, V2nd; Tseng CC, 2004, CHEM BIOL, V11, P1195, DOI 10.1016/j.chembiol.2004.06.012; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Wentworth P, 2001, SCIENCE, V293, P1806, DOI 10.1126/science.1062722; Xiang H, 1999, BIOCHEMISTRY-US, V38, P7638, DOI 10.1021/bi9901432	29	64	66	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2007	447	7142					342	345		10.1038/nature05702	http://dx.doi.org/10.1038/nature05702			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17507985				2022-12-01	WOS:000246520300051
J	Mok, KH; Kuhn, LT; Goez, M; Day, IJ; Lin, JC; Andersen, NH; Hore, PJ				Mok, K. Hun; Kuhn, Lars T.; Goez, Martin; Day, Iain J.; Lin, Jasper C.; Andersen, Niels H.; Hore, P. J.			A pre-existing hydrophobic collapse in the unfolded state of an ultrafast folding protein	NATURE			English	Article							TRP-CAGE; PHOTO-CIDNP; RESIDUAL STRUCTURE; DENATURED STATE; NMR; INTERMEDIATE; SIMULATIONS; MINIPROTEIN; RESOLUTION; BEHAVIOR	Insights into the conformational passage of a polypeptide chain across its free energy landscape have come from the judicious combination of experimental studies and computer simulations(1,2). Even though some unfolded and partially folded proteins are now known to possess biological function(3) or to be involved in aggregation phenomena associated with disease states(1,4), experimentally derived atomic-level information on these structures remains sparse as a result of conformational heterogeneity and dynamics. Here we present a technique that can provide such information. Using a 'Trp-cage' miniprotein known as TC5b ( ref. 5), we report photochemically induced dynamic nuclear polarization NMR6 pulse-labelling experiments that involve rapid in situ protein refolding(7,8). These experiments allow dipolar cross-relaxation with hyperpolarized aromatic side chain nuclei in the unfolded state to be identified and quantified in the resulting folded-state spectrum. We find that there is residual structure due to hydrophobic collapse in the unfolded state of this small protein, with strong inter-residue contacts between side chains that are relatively distant from one another in the native state. Prior structuring, even with the formation of non-native rather than native contacts, may be a feature associated with fast folding events in proteins.	Univ Oxford, Phys & Theoret Chem Lab, Dept Chem, Oxford OX1 3QZ, England; Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland; Univ Halle Wittenberg, Fachbereich Chem, D-06120 Halle, Germany; Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA	University of Oxford; Trinity College Dublin; Martin Luther University Halle Wittenberg; University of Massachusetts System; University of Massachusetts Worcester; University of Washington; University of Washington Seattle	Mok, KH (corresponding author), Univ Oxford, Phys & Theoret Chem Lab, Dept Chem, S Parks Rd, Oxford OX1 3QZ, England.	mok1@tcd.ie; peter.hore@chem.ox.ac.uk	Kuhn, Lars Thorsten/J-5451-2015; Hore, Peter/R-1923-2017; Mok, K. Hun/C-2607-2009	Kuhn, Lars Thorsten/0000-0002-3701-580X; Hore, Peter/0000-0002-8863-570X; Mok, K Hun/0000-0003-3663-2002; Day, Iain/0000-0002-2311-6837	NIGMS NIH HHS [R01 GM059658] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059658] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmed Z, 2005, J AM CHEM SOC, V127, P10943, DOI 10.1021/ja050664e; Balbach J, 1997, P NATL ACAD SCI USA, V94, P7182, DOI 10.1073/pnas.94.14.7182; Bunagan MR, 2006, J PHYS CHEM B, V110, P3759, DOI 10.1021/jp055288z; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chowdhury S, 2003, J MOL BIOL, V327, P711, DOI 10.1016/S0022-2836(03)00177-3; Crowhurst KA, 2003, BIOCHEMISTRY-US, V42, P8687, DOI 10.1021/bi034601p; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fersht AR, 2002, CELL, V108, P573, DOI 10.1016/S0092-8674(02)00620-7; HORE PJ, 1982, J MAGN RESON, V49, P122, DOI 10.1016/0022-2364(82)90302-X; KAPTEIN R, 1982, BIOL MAGN RESON, V4, P145; Khan F, 2006, J AM CHEM SOC, V128, P10729, DOI 10.1021/ja060618u; Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680; Kohn JE, 2004, P NATL ACAD SCI USA, V101, P12491, DOI 10.1073/pnas.0403643101; Lyon CE, 1999, J AM CHEM SOC, V121, P6505, DOI 10.1021/ja9907663; Mok KH, 2005, P NATL ACAD SCI USA, V102, P8899, DOI 10.1073/pnas.0500661102; Mok KH, 2004, METHODS, V34, P75, DOI 10.1016/j.ymeth.2004.03.006; Mok KH, 2003, J AM CHEM SOC, V125, P12484, DOI 10.1021/ja036357v; Neidigh JW, 2002, NAT STRUCT BIOL, V9, P425, DOI 10.1038/nsb798; Neuweiler H, 2005, P NATL ACAD SCI USA, V102, P16650, DOI 10.1073/pnas.0507351102; Pitera JW, 2003, P NATL ACAD SCI USA, V100, P7587, DOI 10.1073/pnas.1330954100; Qiu LL, 2002, J AM CHEM SOC, V124, P12952, DOI 10.1021/ja0279141; Religa TL, 2005, NATURE, V437, P1053, DOI 10.1038/nature04054; Sanchez IE, 2003, J MOL BIOL, V327, P867, DOI 10.1016/S0022-2836(03)00171-2; SHORT PF, 1989, J HEALTH ECON, V8, P293, DOI 10.1016/0167-6296(89)90023-4; Simmerling C, 2002, J AM CHEM SOC, V124, P11258, DOI 10.1021/ja0273851; Snow CD, 2002, J AM CHEM SOC, V124, P14548, DOI 10.1021/ja028604l; Yi Q, 2000, J MOL BIOL, V299, P1341, DOI 10.1006/jmbi.2000.3816; Zhou RH, 2003, P NATL ACAD SCI USA, V100, P13280, DOI 10.1073/pnas.2233312100	30	136	139	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2007	447	7140					106	109		10.1038/nature05728	http://dx.doi.org/10.1038/nature05728			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17429353	Green Accepted			2022-12-01	WOS:000246149300053
J	Burgdorf, S; Kautz, A; Bohnert, V; Knolle, PA; Kurts, C				Burgdorf, Sven; Kautz, Andreas; Boehnert, Volker; Knolle, Percy A.; Kurts, Christian			Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation	SCIENCE			English	Article							DENDRITIC CELLS; CROSS-PRESENTATION; IN-VIVO; MANNOSE RECEPTOR; CROSSPRESENTATION; COMPARTMENT; ENDOCYTOSIS; MEMORY; ER	The mechanisms that allow antigen-presenting cells (APCs) to selectively present extracellular antigen to CD8(+) effector T cells (cross-presentation) or to CD4(+) T helper cells are not fully resolved. We demonstrated that APCs use distinct endocytosis mechanisms to simultaneously introduce soluble antigen into separate intracellular compartments, which were dedicated to presentation to CD8(+) or CD4(+) T cells. Specifically, the mannose receptor supplied an early endosomal compartment distinct from lysosomes, which was committed to cross-presentation. These findings imply that antigen does not require intracellular diversion to access the cross-presentation pathway, because it can enter the pathway already during endocytosis.	Univ Bonn, Inst Mol Med & Expt Immunol, D-5300 Bonn, Germany	University of Bonn	Burgdorf, S (corresponding author), Univ Bonn, Inst Mol Med & Expt Immunol, D-5300 Bonn, Germany.	sven.burgdorf@ukb.uni-bonn.de; ckurts@web.de	Eckhardt, Erik/G-1567-2010	Knolle, Percy A./0000-0003-2983-0414; Bohnert, Volker/0000-0002-3205-827X				Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Bennett SRM, 1997, J EXP MED, V186, P65, DOI 10.1084/jem.186.1.65; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Burgdorf S, 2006, J IMMUNOL, V176, P6770, DOI 10.4049/jimmunol.176.11.6770; Castellino F, 2000, J EXP MED, V191, P1957, DOI 10.1084/jem.191.11.1957; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Groothuis TAM, 2005, J EXP MED, V202, P1313, DOI 10.1084/jem.20051379; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Norbury CC, 2004, SCIENCE, V304, P1318, DOI 10.1126/science.1096378; Palecanda Aiyappa, 2001, Current Molecular Medicine (Hilversum), V1, P589, DOI 10.2174/1566524013363384; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Pozzi LAM, 2005, J IMMUNOL, V175, P2071, DOI 10.4049/jimmunol.175.4.2071; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; SOUSA CRE, 1995, J EXP MED, V182, P841, DOI 10.1084/jem.182.3.841; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Yewdell JW, 2005, ANNU REV IMMUNOL, V23, P651, DOI 10.1146/annurev.immunol.23.021704.115702; Zinkernagel RM, 2002, EUR J IMMUNOL, V32, P2385, DOI 10.1002/1521-4141(200209)32:9<2385::AID-IMMU2385>3.0.CO;2-V	32	469	484	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2007	316	5824					612	616		10.1126/science.1137971	http://dx.doi.org/10.1126/science.1137971			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463291				2022-12-01	WOS:000245983100049
J	Lindsey, JB; Hillis, LD				Lindsey, Jason B.; Hillis, L. David			Clinical update: atrial septal defect in adults	LANCET			English	Article							SURGICAL-TREATMENT; FOLLOW-UP; TRANSCATHETER CLOSURE; DEVICE; EXPERIENCE; OCCLUDER; COMPLICATIONS; CHILDREN; TRIAL		Univ Texas, SW Med Ctr, Div Cardiol, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Hillis, LD (corresponding author), Univ Texas, SW Med Ctr, Div Cardiol, Dept Internal Med, Dallas, TX 75390 USA.	dhilli@parknet.pmh.org						Amin Z, 2004, CATHETER CARDIO INTE, V63, P496, DOI 10.1002/ccd.20211; Attie F, 2001, J AM COLL CARDIOL, V38, P2035, DOI 10.1016/S0735-1097(01)01635-7; Butera G, 2006, AM HEART J, V151, P228, DOI 10.1016/j.ahj.2005.02.051; Carminati M, 2000, CARDIOL YOUNG, V10, P519; Divekar A, 2005, J AM COLL CARDIOL, V45, P1213, DOI 10.1016/j.jacc.2004.12.072; Du ZD, 2002, J AM COLL CARDIOL, V39, P1836, DOI 10.1016/S0735-1097(02)01862-4; Fischer G, 2003, HEART, V89, P199, DOI 10.1136/heart.89.2.199; Giamberti A, 2006, ANN THORAC SURG, V82, P1327, DOI 10.1016/j.athoracsur.2006.05.010; Hausdorf G, 1996, HEART, V75, P83, DOI 10.1136/hrt.75.1.83; HORVATH KA, 1992, J AM COLL CARDIOL, V20, P1156, DOI 10.1016/0735-1097(92)90372-T; KONSTANTINIDES S, 1995, NEW ENGL J MED, V333, P469, DOI 10.1056/NEJM199508243330801; Masura J, 2005, J AM COLL CARDIOL, V45, P505, DOI 10.1016/j.jacc.2004.10.066; Mills NL, 2003, AM J CARDIOL, V92, P353, DOI 10.1016/S0002-9149(03)00647-7; MURPHY JG, 1990, NEW ENGL J MED, V323, P1645, DOI 10.1056/NEJM199012133232401; Podnar T, 2001, CATHETER CARDIO INTE, V53, P386, DOI 10.1002/ccd.1187; SHAH D, 1994, BRIT HEART J, V71, P224; Sharafuddin MJA, 1997, CIRCULATION, V95, P2162, DOI 10.1161/01.CIR.95.8.2162; SUTTON MGS, 1981, CIRCULATION, V64, P402, DOI 10.1161/01.CIR.64.2.402; Thanopoulos BD, 1998, J AM COLL CARDIOL, V31, P1110, DOI 10.1016/S0735-1097(98)00039-4; Theodoro DA, 1998, ANN THORAC SURG, V65, P149, DOI 10.1016/S0003-4975(97)01193-4	20	46	49	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2007	369	9569					1244	1246		10.1016/S0140-6736(07)60576-5	http://dx.doi.org/10.1016/S0140-6736(07)60576-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164YA	17434386				2022-12-01	WOS:000246269700010
J	Han, K; Konkel, MK; Xing, J; Wang, H; Lee, J; Meyer, TJ; Huang, CT; Sandifer, E; Hebert, K; Barnes, EW; Hubley, R; Miller, W; Smit, AFA; Ullmer, B; Batzer, MA				Han, Kyudong; Konkel, Miriam K.; Xing, Jinchuan; Wang, Hui; Lee, Jungnam; Meyer, Thomas J.; Huang, Charles T.; Sandifer, Erin; Hebert, Kristi; Barnes, Erin W.; Hubley, Robert; Miller, Webb; Smit, Arian F. A.; Ullmer, Brygg; Batzer, Mark A.			Mobile DNA in old world monkeys: A glimpse through the rhesus macaque genome	SCIENCE			English	Article							LYON REPEAT HYPOTHESIS; INTERSPERSED REPEATS; LINE-1 ELEMENTS; ALU ELEMENTS; RETROTRANSPOSITION; EVOLUTION; PRIMATES; INACTIVATION; DIVERSITY; LINEAGES	The completion of the draft sequence of the rhesus macaque genome allowed us to study the genomic composition and evolution of transposable elements in this representative of the Old World monkey lineage, a group of diverse primates closely related to humans. The L1 family of long interspersed elements appears to have evolved as a single lineage, and Alu elements have evolved into four currently active lineages. We also found evidence of elevated horizontal transmissions of retroviruses and the absence of DNA transposon activity in the Old World monkey lineage. In addition, similar to 100 precursors of composite SVA ( short interspersed element, variable number of tandem repeat, and Alu) elements were identified, with the majority being shared by the common ancestor of humans and rhesus macaques. Mobile elements compose roughly 50% of primate genomes, and our findings illustrate their diversity and strong influence on genome evolution between closely related species.	Louisiana State Univ, Dept Biol Sci, Biol Computat & Visualizat Ctr, Ctr Biomodular Multiscale Syst, Baton Rouge, LA 70803 USA; Inst Syst Biol, Seattle, WA 98103 USA; Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; Louisiana State Univ, Dept Comp Sci, Ctr Computat Technol, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Institute for Systems Biology (ISB); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Louisiana State University System; Louisiana State University	Batzer, MA (corresponding author), Louisiana State Univ, Dept Biol Sci, Biol Computat & Visualizat Ctr, Ctr Biomodular Multiscale Syst, Baton Rouge, LA 70803 USA.	mbatzer@lsu.edu	Han, Kyudong/AAF-1788-2019; Xing, Jinchuan/A-2489-2012	Han, Kyudong/0000-0001-6791-2408; Barnes, Erin W./0000-0002-9930-7664	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Benit L, 2003, VIROLOGY, V312, P159, DOI 10.1016/S0042-6822(03)00163-6; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Callinan P, 2006, GENOME DYN, V1, P104, DOI 10.1159/000092503; Carlsson HE, 2004, AM J PRIMATOL, V63, P225, DOI 10.1002/ajp.20054; Chen JM, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/56182; Cordaux R, 2004, TRENDS GENET, V20, P464, DOI 10.1016/j.tig.2004.07.012; Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013; Deininger PL, 2002, GENOME RES, V12, P1455, DOI 10.1101/gr.282402; Furano AV, 2004, TRENDS GENET, V20, P9, DOI 10.1016/j.tig.2003.11.006; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Han KD, 2005, NUCLEIC ACIDS RES, V33, P4040, DOI 10.1093/nar/gki718; Hansen RS, 2003, HUM MOL GENET, V12, P2559, DOI 10.1093/hmg/ddg268; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lev-Maor G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r29; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Mills RE, 2006, AM J HUM GENET, V78, P671, DOI 10.1086/501028; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Ray DA, 2006, SYSTEMATIC BIOL, V55, P928, DOI 10.1080/10635150600865419; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; Shedlock AM, 2004, TRENDS ECOL EVOL, V19, P545, DOI 10.1016/j.tree.2004.08.002; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; Wang H, 2005, J MOL BIOL, V354, P994, DOI 10.1016/j.jmb.2005.09.085; Xing J, 2006, P NATL ACAD SCI USA, V103, P17608, DOI 10.1073/pnas.0603224103	27	78	81	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					238	240		10.1126/science.1139462	http://dx.doi.org/10.1126/science.1139462			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431169	Green Submitted			2022-12-01	WOS:000245654500039
J	Anderson, KB; Chunsuttiwat, S; Nisalak, A; Mammen, MP; Libraty, DH; Rothman, AL; Green, S; Vaughn, DW; Ennis, FA; Endy, TP				Anderson, Katie B.; Chunsuttiwat, Supamit; Nisalak, Ananda; Mammen, Mammen P.; Libraty, Daniel H.; Rothman, Alan L.; Green, Sharone; Vaughn, David W.; Ennis, Francis A.; Endy, Timothy P.			Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study	LANCET			English	Article							FEVER/DENGUE HEMORRHAGIC-FEVER; ADJUSTED LIFE YEARS; ECONOMIC-IMPACT; KAMPHAENG PHET; HEALTH PROBLEM; EMERGENCE; AMERICA	Background Dengue viruses are a major cause of morbidity and mortality in tropical and subtropical areas. Our aim was to assess prospectively the burden of dengue-related illness in children in Thailand. Methods We did a prospective study in a cohort of children at primary school in northern Thailand from 1998 to 2002. We assessed the burden of dengue illness as disability-adjusted life years (DALYs) and patient costs per illness. Findings Dengue accounted for 328 (11%) of the 3056 febrile cases identified in 2114 children during the study period. The mean burden of dengue was 465.3 (SD 358.0; range 76.5-954.0) DALYs per million population per year accounting for about 15% of DALYs lost to all febrile illnesses (3213.1 [SD 2624.2] DALYs per million per year). Non-hospitalised patients with dengue illnesses represented a substantial proportion of the overall burden of disease, with 44-73% of the total DALYs lost to dengue each year due to such illness. The infecting dengue serotype was an important determinant of DALYs lost: DEN4 was responsible for 1% of total DALYs lost, DEN1 for 9%, DEN2 for 30%, and DEN3 for 29%. Interpretation Use of prospective data to estimate the burden of disease shows that most DALYs lost to dengue illness were the result of non-hospitalised illnesses of long duration. Thus, inclusion of non-hospitalised cases is critical to accurately assess the total burden of dengue illness.	Walter Reed Army Inst Res, Div Communicable Dis & Immunol, Silver Spring, MD USA; Minist Publ Hlth, Nonthaburi, Thailand; Armed Forces Res Inst Med Sci, Dept Virol, Bangkok 10400, Thailand; Univ Massachusetts, Sch Med, Ctr Infect Dis & Vaccine Res, Worcester, MA USA; Mil Infect Dis Res Program, Ft Detrick, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Ministry of Public Health - Thailand; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); University of Massachusetts System; University of Massachusetts Worcester	Endy, TP (corresponding author), SUNY, Upstate Med Univ, Dept Med, Div Infect Dis, Syracuse, NY 13210 USA.	endyt@upstate.edu			NIAID NIH HHS [P01 AI034533, AI34533] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI034533] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Almond Jeffrey, 2002, Vaccine, V20, P3043, DOI 10.1016/S0264-410X(02)00246-3; Clark DV, 2005, AM J TROP MED HYG, V72, P786, DOI 10.4269/ajtmh.2005.72.786; DeRoeck D, 2003, VACCINE, V22, P121, DOI 10.1016/S0264-410X(03)00533-4; Dietz V, 1996, P R Health Sci J, V15, P201; Endy TP, 2002, AM J EPIDEMIOL, V156, P52, DOI 10.1093/aje/kwf006; Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005; Gubler D. J., 1998, Annals Academy of Medicine Singapore, V27, P227; Gubler DJ, 1999, ADV VIRUS RES, V53, P35, DOI 10.1016/S0065-3527(08)60342-5; GUBLER DJ, 1993, INFECT AGENT DIS, V2, P383; GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guzmán María G., 2002, Rev Panam Salud Publica, V11, P223, DOI 10.1590/S1020-49892002000400003; Halstead Scott B., 1997, P23; Meltzer MI, 1998, AM J TROP MED HYG, V59, P265, DOI 10.4269/ajtmh.1998.59.265; Murray C. J. L., 1996, GLOBAL HLTH STAT COM; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Murray CJL., 1996, GLOBAL BURDEN DIS CO; *NAT STAT OFF THAI, 2003, HOUS SOC SURV 2003; Nimmannitya Suchitra, 1997, P133; Okanurak K, 1997, Southeast Asian J Trop Med Public Health, V28, P711; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Shepard DS, 2004, VACCINE, V22, P1275, DOI 10.1016/j.vaccine.2003.09.019; World Bank, 1993, WORLD DEV REP INV HL; World Health Organization, 2004, WORLD HLTH REP 2003; [No title captured]	25	137	140	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR-MAY	2007	369	9571					1452	1459		10.1016/S0140-6736(07)60671-0	http://dx.doi.org/10.1016/S0140-6736(07)60671-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161LW	17467515				2022-12-01	WOS:000246017700031
J	Webb, DJ; Walker, A				Webb, David J.; Walker, Andrew			Value-based pricing of drugs in the UK	LANCET			English	Editorial Material									Queens Med Res Inst, Clin Pharmacol Unit, Edinburgh EH16 4TJ, Midlothian, Scotland; Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland	University of Edinburgh; University of Glasgow	Webb, DJ (corresponding author), Queens Med Res Inst, Clin Pharmacol Unit, Edinburgh EH16 4TJ, Midlothian, Scotland.	d.j.webb@ed.ac.uk						*ASS BRIT PHARM IN, 2007, OFT STUD UK MED PRIC; Cooksey Sir David, 2006, REV UK HLTH RES FUND; UK Department of Health, PHARM PRIC REG SCHEM; UK Office of Fair Trading, 2007, PHARM PRIC REG SCHEM	4	17	17	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2007	369	9571					1415	1416		10.1016/S0140-6736(07)60648-5	http://dx.doi.org/10.1016/S0140-6736(07)60648-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161LW	17467498				2022-12-01	WOS:000246017700010
J	Chow, CY; Zhang, YL; Dowling, JJ; Jin, N; Adamska, M; Shiga, K; Szigeti, K; Shy, ME; Li, J; Zhang, XB; Lupski, JR; Weisman, LS; Meisler, MH				Chow, Clement Y.; Zhang, Yanling; Dowling, James J.; Jin, Natsuko; Adamska, Maja; Shiga, Kensuke; Szigeti, Kinga; Shy, Michael E.; Li, Jun; Zhang, Xuebao; Lupski, James R.; Weisman, Lois S.; Meisler, Miriam H.			Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J	NATURE			English	Article							CHARCOT-MARIE-TOOTH; PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE; MYOTUBULARIN FAMILY; MEMBRANE DYNAMICS; SODIUM-CHANNEL; PHOSPHATASE; DISEASE; NEUROPATHY; PROTEIN; GENE	Membrane-bound phosphoinositides are signalling molecules that have a key role in vesicle trafficking in eukaryotic cells(1). Proteins that bind specific phosphoinositides mediate interactions between membrane-bounded compartments whose identity is partially encoded by cytoplasmic phospholipid tags. Little is known about the localization and regulation of mammalian phosphatidylinositol-3,5-bisphosphate ( PtdIns( 3,5)P-2), a phospholipid present in small quantities that regulates membrane trafficking in the endosome - lysosome axis in yeast(2). Here we describe a multi-organ disorder with neuronal degeneration in the central nervous system, peripheral neuronopathy and diluted pigmentation in the 'pale tremor' mouse. Positional cloning identified insertion of ETn2 beta ( early transposon 2 beta)(3) into intron 18 of Fig4 (A530089I17Rik), the homologue of a yeast SAC ( suppressor of actin) domain PtdIns(3,5) P-2 5-phosphatase located in the vacuolar membrane. The abnormal concentration of PtdIns( 3,5) P2 in cultured fibroblasts from pale tremor mice demonstrates the conserved biochemical function of mammalian Fig4. The cytoplasm of fibroblasts from pale tremor mice is filled with large vacuoles that are immunoreactive for LAMP-2 (lysosomal-associated membrane protein 2), consistent with dysfunction of the late endosome - lysosome axis. Neonatal neurodegeneration in sensory and autonomic ganglia is followed by loss of neurons from layers four and five of the cortex, deep cerebellar nuclei and other localized brain regions. The sciatic nerve exhibits reduced numbers of large-diameter myelinated axons, slowed nerve conduction velocity and reduced amplitude of compound muscle action potentials. We identified pathogenic mutations of human FIG4 (KIAA0274) on chromosome 6q21 in four unrelated patients with hereditary motor and sensory neuropathy. This novel form of autosomal recessive Charcot - Marie - Tooth disorder is designated CMT4J.	Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Cellular & Dev Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA; Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; John D Dingle VA Med Ctr, Detroit, MI 48201 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Wayne State University	Meisler, MH (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.	meislerm@umich.edu	Adamska, Maja/M-4128-2014; Zhang, Yanling/E-8932-2013; Adamska, Maja/L-3306-2015	Zhang, Yanling/0000-0002-1483-9021; Shy, Michael/0000-0001-8460-6971; Adamska, Maja/0000-0002-4223-8450	NIGMS NIH HHS [T32 GM007544, R01 GM024872-30, R01 GM024872] Funding Source: Medline; NINDS NIH HHS [R01 NS064015] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007544, R01GM024872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064015] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adamska M, 2005, DEV DYNAM, V233, P368, DOI 10.1002/dvdy.20437; Begley MJ, 2006, P NATL ACAD SCI USA, V103, P927, DOI 10.1073/pnas.0510006103; Bolino A, 2004, J CELL BIOL, V167, P711, DOI 10.1083/jcb.200407010; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Bonneick S, 2005, HUM MOL GENET, V14, P3685, DOI 10.1093/hmg/ddi400; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Duex JE, 2006, EUKARYOT CELL, V5, P723, DOI 10.1128/EC.5.4.723-731.2006; Duex JE, 2006, J CELL BIOL, V172, P693, DOI 10.1083/jcb.200512105; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Gary JD, 2002, MOL BIOL CELL, V13, P1238, DOI 10.1091/mbc.01-10-0498; Hughes WE, 2000, BIOCHEM J, V350, P337, DOI 10.1042/0264-6021:3500337; Kohrman DC, 1996, J BIOL CHEM, V271, P17576, DOI 10.1074/jbc.271.29.17576; Li J, 2006, J COMP NEUROL, V498, P252, DOI 10.1002/cne.21051; Maksakova IA, 2006, PLOS GENET, V2, P1, DOI 10.1371/journal.pgen.0020002; Marks MS, 2001, NAT REV MOL CELL BIO, V2, P738, DOI 10.1038/35096009; Michell RH, 2006, TRENDS BIOCHEM SCI, V31, P52, DOI 10.1016/j.tibs.2005.11.013; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Rainier S, 2006, ARCH NEUROL-CHICAGO, V63, P445, DOI 10.1001/archneur.63.3.445; Rudge SA, 2004, MOL BIOL CELL, V15, P24, DOI 10.1091/mbc.E03-05-0297; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Schmitt-John T, 2005, NAT GENET, V37, P1213, DOI 10.1038/ng1661; Schroder JM, 2006, NEUROMOL MED, V8, P23, DOI 10.1385/NMM:8:1-2:23; Senderek J, 2003, HUM MOL GENET, V12, P349, DOI 10.1093/hmg/ddg030; STENDEL C, IN PRESS AM J HUM GE; Szigeti K, 2006, GENET MED, V8, P86, DOI 10.1097/01.gim.0000200160.29385.73; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	28	354	370	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2007	448	7149					68	72		10.1038/nature05876	http://dx.doi.org/10.1038/nature05876			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185OS	17572665	Green Published, Green Accepted			2022-12-01	WOS:000247720900039
J	Sandrelli, F; Tauber, E; Pegoraro, M; Mazzotta, G; Cisotto, P; Landskron, J; Stanewsky, R; Piccin, A; Rosato, E; Zordan, M; Costa, R; Kyriacou, CP				Sandrelli, Federica; Tauber, Eran; Pegoraro, Mirko; Mazzotta, Gabriella; Cisotto, Paola; Landskron, Johannes; Stanewsky, Ralf; Piccin, Alberto; Rosato, Ezio; Zordan, Mauro; Costa, Rodolfo; Kyriacou, Charalambos P.			A molecular basis for natural selection at the timeless locus in Drosophila melanogaster	SCIENCE			English	Article							CIRCADIAN CLOCK; LATITUDINAL CLINES; CRYPTOCHROME; PHOTORECEPTOR; ENTRAINMENT; PACEMAKER; PROTEIN	Diapause is a protective response to unfavorable environments that results in a suspension of insect development and is most often associated with the onset of winter. The ls-tim mutation in the Drosophila melanogaster clock gene timeless has spread in Europe over the past 10,000 years, possibly because it enhances diapause. We show that the mutant allele attenuates the photosensitivity of the circadian clock and causes decreased dimerization of the mutant TIMELESS protein isoform to CRYPTOCHROME, the circadian photoreceptor. This interaction results in a more stable TIMELESS product. These findings reveal a molecular link between diapause and circadian photoreception.	Univ Padua, Dept Biol, I-35131 Padua, Italy; Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Univ Regensburg, Lehrstuhl Entwicklungsbiol, Inst Zool, D-93040 Regensburg, Germany; Univ London Queen Mary Coll, Sch Biol & Chem Sci, London E1 4NS, England	University of Padua; University of Leicester; University of Regensburg; University of London; Queen Mary University London	Costa, R (corresponding author), Univ Padua, Dept Biol, I-35131 Padua, Italy.	rodolfo.costa@unipd.it	Tauber, Eran/F-9826-2011; Tauber, Eran/AAA-1562-2022; Stanewsky, Ralf/ABB-9193-2021	Tauber, Eran/0000-0003-4018-6535; Tauber, Eran/0000-0003-4018-6535; Pegoraro, Mirko/0000-0001-9381-5249; Stanewsky, Ralf/0000-0001-8238-6864; Rosato, Ezio/0000-0001-7297-4697; MAZZOTTA, GABRIELLA MARGHERITA/0000-0001-5461-6837; SANDRELLI, FEDERICA/0000-0002-5631-7467	NERC [NE/D012058/1] Funding Source: UKRI; Natural Environment Research Council [NE/D012058/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Ashmore LJ, 2003, J BIOL RHYTHM, V18, P206, DOI [10.1177/0748730403018003003, 10.1177/0748730403253385]; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Dissel S, 2004, NAT NEUROSCI, V7, P834, DOI 10.1038/nn1285; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Lin FJ, 2001, MOL CELL BIOL, V21, P7287, DOI 10.1128/MCB.21.21.7287-7294.2001; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Peschel N, 2006, P NATL ACAD SCI USA, V103, P17313, DOI 10.1073/pnas.0606675103; PITTENDRIGH CS, 1989, J BIOL RHYTHM, V4, P217; PITTENDRIGH CS, 1991, J BIOL RHYTHM, V6, P299, DOI 10.1177/074873049100600402; Rosato E, 1997, NUCLEIC ACIDS RES, V25, P455, DOI 10.1093/nar/25.3.455; Rosato E, 2001, CURR BIOL, V11, P909, DOI 10.1016/S0960-9822(01)00259-7; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Tauber E, 2007, SCIENCE, V316, P1895, DOI 10.1126/science.1138412; Young MW, 1996, COLD SPRING HARB SYM, V61, P279; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0	18	129	130	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2007	316	5833					1898	1900		10.1126/science.1138426	http://dx.doi.org/10.1126/science.1138426			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183WI	17600216				2022-12-01	WOS:000247602700040
J	Molnar, A; Schwach, F; Studholme, DJ; Thuenemann, EC; Baulcombe, DC				Molnar, Attila; Schwach, Frank; Studholme, David J.; Thuenemann, Eva C.; Baulcombe, David C.			miRNAs control gene expression in the single-cell alga Chlamydomonas reinhardtii	NATURE			English	Article							TRANS-ACTING SIRNAS; SMALL RNAS; MICRORNAS; METHYLATION; SEQUENCES; CLONING	MicroRNAs (miRNAs) in eukaryotes guide post-transcriptional regulation by means of targeted RNA degradation and translational arrest(1). They are released by a Dicer nuclease as a 21-24-nucleotide RNA duplex from a precursor in which an imperfectly matched inverted repeat forms a partly double-stranded region. One of the two strands is then recruited by an Argonaute nuclease that is the effector protein of the silencing mechanism. Short interfering RNAs (siRNAs), which are similar to miRNAs, are also produced by Dicer but the precursors are perfectly double-stranded RNA. These siRNAs guide post-transcriptional regulation, as with miRNAs, and epigenetic genome modification. Diverse eukaryotes including fungi, plants, protozoans and metazoans produce siRNAs(2-5) but, until now, miRNAs have not been described in unicellular organisms and it has been suggested that they evolved together with multicellularity in separate plant and animal lineages(6). Here we show that the unicellular alga Chlamydomonas reinhardtii contains miRNAs, putative evolutionary precursors of miRNAs and species of siRNAs resembling those in higher plants. The common features of miRNAs and siRNAs in an alga and in higher plants indicate that complex RNA-silencing systems evolved before multicellularity and were a feature of primitive eukaryotic cells.	John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; Univ E Anglia, Sch Comp Sci, Norwich NR4 7TJ, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia	Baulcombe, DC (corresponding author), John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England.	david.baulcombe@tsl.ac.uk	Molnar, Attila/F-5833-2011; Studholme, David/H-6790-2019	Molnar, Attila/0000-0002-1044-6327; Studholme, David/0000-0002-3010-6637; Schwach, Frank/0000-0001-5495-7535; Baulcombe, David/0000-0003-0780-6878				Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Arazi T, 2005, PLANT J, V43, P837, DOI 10.1111/j.1365-313X.2005.02499.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; CHAPPELL L, 2005, CURRENT PROTOCOLS MI; Djikeng A, 2001, RNA, V7, P1522; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Han J, 2001, DRUG DELIV, V8, P125; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; WEGENER D, 1989, PLANT PHYSIOL, V90, P512, DOI 10.1104/pp.90.2.512; Yang ZY, 2006, NUCLEIC ACIDS RES, V34, P667, DOI 10.1093/nar/gkj474; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130	30	361	433	0	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2007	447	7148					1126	U15		10.1038/nature05903	http://dx.doi.org/10.1038/nature05903			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183HT	17538623				2022-12-01	WOS:000247564600040
J	Griffiths, C; Foster, G; Ramsay, J; Eldridge, S; Taylor, S				Griffiths, Chris; Foster, Gill; Ramsay, Jean; Eldridge, Sandra; Taylor, Stephanie			How effective are expert patient (lay led) education programmes for chronic disease?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SELF-MANAGEMENT PROGRAM; ARTHRITIS; CARE; REHABILITATION; INTERVENTIONS		Barts & London Queen Marys Sch Med & Dent, Hlth Sci Ctr, London E1 2A5, England	University of London; Queen Mary University London	Griffiths, C (corresponding author), Barts & London Queen Marys Sch Med & Dent, Hlth Sci Ctr, London E1 2A5, England.	c.j.griffiths@qmul.ac.uk	TAYLOR, STEPHANIE/GYV-4768-2022	Taylor, Stephanie/0000-0001-7454-6354	Medical Research Council [G0400503B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Barlow JH, 2000, HEALTH EDUC RES, V15, P665, DOI 10.1093/her/15.6.665; Bethell HJN, 2007, J PUBLIC HEALTH, V29, P57, DOI 10.1093/pubmed/fdl091; *BRIT THOR SOC, 2003, PULM REH SURV; BURY M, 2005, RAPID REV CURRENT ST; Buszewicz M, 2006, BMJ-BRIT MED J, V333, P879, DOI 10.1136/bmj.38965.375718.80; Coulter A, 1999, BRIT MED J, V319, P719, DOI 10.1136/bmj.319.7212.719; *DEP HLTH, 1999, CMND4386; Donaldson L, 2003, BRIT MED J, V326, P1279, DOI 10.1136/bmj.326.7402.1279; Griffiths C, 2005, BRIT J GEN PRACT, V55, P831; GRIFFITHS C, 2005, COCHRANE DB SYST REV; Haas M, 2005, J MANIP PHYSIOL THER, V28, P228, DOI 10.1016/j.jmpt.2005.03.010; Ismail K, 2004, LANCET, V363, P1589, DOI 10.1016/S0140-6736(04)16202-8; Jolliffe JA, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800, DOI 10.1093/eurheartj/ehm316, DOI 10.1002/14651858.CD001800]; Kennedy A, 2007, J EPIDEMIOL COMMUN H, V61, P254, DOI 10.1136/jech.2006.053538; Lacasse Y, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003793.pub2; LEWIN B, 1992, LANCET, V339, P1036, DOI 10.1016/0140-6736(92)90547-G; Lewin SA, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003267; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Lorig KR, 2003, NURS RES, V52, P361, DOI 10.1097/00006199-200311000-00003; LORIG KR, 1993, ARTHRITIS RHEUM, V36, P439, DOI 10.1002/art.1780360403; *NAT HLTH SERV, 2007, EXP PAT PROGR; Newman S, 2004, LANCET, V364, P1523, DOI 10.1016/S0140-6736(04)17277-2; *SECR STAT HLTH, 2001, EXP PAT NEW APPR CHR; Walters JAE, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001288.pub3; Wanless, 2002, SECURING OUR FUTURE; *WHO, 2007, CHRON DIS HLTH PROM	27	123	124	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2007	334	7606					1254	1256		10.1136/bmj.39227.698785.47	http://dx.doi.org/10.1136/bmj.39227.698785.47			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	183AM	17569933	Green Published			2022-12-01	WOS:000247545100032
J	Krimsky, S; Simoncelli, T				Krimsky, Sheldon; Simoncelli, Tania			Testing pesticides in humans - Of mice and men divided by ten	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Columbia Univ, Ctr Hist & Eth Publ Hlth, Dept Sociomed Sci, Mailman Sch Publ Hlth, New York, NY 10032 USA; Amer Civil Liberties Union, Tech Liberty Program, New York, NY USA	Columbia University	Krimsky, S (corresponding author), Columbia Univ, Ctr Hist & Eth Publ Hlth, Dept Sociomed Sci, Mailman Sch Publ Hlth, 722 W 168th St, New York, NY 10032 USA.	sheldon.krimsky@tufts.edu	Krimsky, Sheldon/F-3147-2010					CAIN WS, 2005, HUMAN SENSORY IRRITA; Committee on International Human Rights of the Association of the Bar of the City of New York and The Center for Human Rights and Global Justice New York University School of Law, 2004, INT HUM DOS STUD EPA, P4; Gostin LO, 2007, JAMA-J AM MED ASSOC, V297, P737, DOI 10.1001/jama.297.7.737; Lockwood AH, 2004, AM J PUBLIC HEALTH, V94, P1908, DOI 10.2105/AJPH.94.11.1908; NEEDLEMAN H, 2000, COMMENTS USE DATA TE, pC1; Needleman HL, 2005, ENVIRON HEALTH PERSP, V113, pA804, DOI 10.1289/ehp.113-a804; Oleskey C, 2004, ENVIRON HEALTH PERSP, V112, P914, DOI 10.1289/ehp.6522; Resnik David B, 2007, Account Res, V14, P35, DOI 10.1080/08989620601122842; Resnik DB, 2007, AM J PUBLIC HEALTH, V97, P414, DOI 10.2105/AJPH.2005.081729; World Medical Association, DECL HELS ETH PRINC; 2006, FED REG, V71, P6137	11	5	5	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2007	297	21					2405	2407		10.1001/jama.297.21.2405	http://dx.doi.org/10.1001/jama.297.21.2405			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	175IL	17551133				2022-12-01	WOS:000247007200022
J	Gupta, S; Ramjaun, AR; Haiko, P; Wang, YH; Warne, PH; Nicke, B; Nye, E; Stamp, G; Alitalo, K; Downward, J				Gupta, Surbhi; Ramjaun, Antoine R.; Haiko, Paula; Wang, Yihua; Warne, Patricia H.; Nicke, Barbara; Nye, Emma; Stamp, Gordon; Alitalo, Kari; Downward, Julian			Binding of Ras to phosphoinositide 3-kinase p110 alpha is required for Ras-driven tumorigenesis in mice	CELL			English	Article							PROTEIN-KINASE B; GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; VEGF RECEPTOR-3; ACTIVATION; TRANSFORMATION; CANCER; INHIBITION; DROSOPHILA; DEFICIENT	Ras proteins signal through direct interaction with a number of effector enzymes, including type I phosphoinositide (PI) 3-kinases. Although the ability of Ras to control PI 3-kinase has been well established in manipulated cell culture models, evidence for a role of the interaction of endogenous Ras with PI 3-kinase in normal and malignant cell growth in vivo has been lacking. Here we generate mice with mutations in the Pi3kca gene encoding the catalytic p110 alpha isoform that block its interaction with Ras. Cells from these mice show proliferative defects and selective disruption of signaling from growth factors to PI 3-kinase. The mice display defective development of the lymphatic vasculature, resulting in perinatal appearance of chylous ascites. Most importantly, they are highly resistant to endogenous Ras oncogene-induced tumorigenesis. The interaction of Ras with p110 alpha is thus required in vivo for certain normal growth factor signaling and for Ras-driven tumor formation.	Canc Res UK, London Res Inst, Signal Transduct Lab, London WC2A 3PX, England; Canc Res UK, London Res Inst, Expt Pathol Lab, London WC2A 3PX, England; Univ Helsinki, Biomedicum Helsinki, FIN-00014 Helsinki, Finland	Cancer Research UK; Cancer Research UK; University of Helsinki	Downward, J (corresponding author), Canc Res UK, London Res Inst, Signal Transduct Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	downward@cancer.org.uk	Alitalo, Kari K/J-5013-2014; Downward, Julian/A-3251-2012	Alitalo, Kari K/0000-0002-7331-0902; Wang, Yihua/0000-0001-5561-0648; Downward, Julian/0000-0002-2331-4729				Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Dajee M, 2002, ONCOGENE, V21, P1527, DOI 10.1038/sj.onc.1205287; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Fruman DA, 2000, NAT GENET, V26, P379, DOI 10.1038/81715; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Gonzalez-Garcia A, 2005, CANCER CELL, V7, P219, DOI 10.1016/j.ccr.2005.01.029; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Joukov V, 1996, EMBO J, V15, P1751; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; KAZLAUSKAS A, 1989, CELL, V58, P1121, DOI 10.1016/0092-8674(89)90510-2; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Makinen T, 2001, NAT MED, V7, P199, DOI 10.1038/84651; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Mattoon DR, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-24; Nakahara R, 2001, THORAX, V56, P302, DOI 10.1136/thorax.56.4.302; Ong SH, 2001, P NATL ACAD SCI USA, V98, P6074, DOI 10.1073/pnas.111114298; Orme MH, 2006, NAT CELL BIOL, V8, P1298, DOI 10.1038/ncb1493; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; PRESS OW, 1982, ANN INTERN MED, V96, P358, DOI 10.7326/0003-4819-96-3-358; Prober DA, 2002, GENE DEV, V16, P2286, DOI 10.1101/gad.991102; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Repasky GA, 2004, TRENDS CELL BIOL, V14, P639, DOI 10.1016/j.tcb.2004.09.014; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; Saharinen P, 2004, TRENDS IMMUNOL, V25, P387, DOI 10.1016/j.it.2004.05.003; Schulze A, 2001, GENE DEV, V15, P981, DOI 10.1101/gad.191101; SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550; Suire S, 2002, CURR BIOL, V12, P1068, DOI 10.1016/S0960-9822(02)00933-8; Suire S, 2006, NAT CELL BIOL, V8, P1303, DOI 10.1038/ncb1494; van Weering DHJ, 1998, MOL CELL BIOL, V18, P1802, DOI 10.1128/MCB.18.4.1802; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Weir B, 2004, CANCER CELL, V6, P433, DOI 10.1016/j.ccr.2004.11.004; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; WHITMAN M, 1985, NATURE, V315, P239, DOI 10.1038/315239a0; Zhao JJ, 2006, P NATL ACAD SCI USA, V103, P16296, DOI 10.1073/pnas.0607899103	43	430	441	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2007	129	5					957	968		10.1016/j.cell.2007.03.051	http://dx.doi.org/10.1016/j.cell.2007.03.051			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540175	Bronze			2022-12-01	WOS:000247084600015
J	Beral, V; Bull, D; Green, J; Reeves, G				Beral, Valerie; Bull, Diana; Green, Jane; Reeves, Gillian		Million Women Study Collaborators	Ovarian cancer and hormone replacement therapy in the Million Women Study	LANCET			English	Article							NONCONTRACEPTIVE ESTROGEN USE; RISK; HEALTH	Background Ovarian cancer is the fourth most common cancer in women in the UK, with about 6700 developing the malignancy and 4600 dying from it every year. However, there is limited information about the risk of ovarian cancer associated with the use of hormone replacement therapy (HRT). Methods 948 576 postmenopausal women from the UK Million Women Study who did not have previous cancer or bilateral oophorectomy were followed-up for an average of 5.3 years for incident ovarian cancer and 6.9 years for death. Information on HRT use was obtained at recruitment and updated where possible. Relative risks for ovarian cancer were calculated, stratified by age and hysterectomy status, and adjusted by area of residence, socioeconomic group, time since menopause, parity; body-mass index, alcohol consumption, and use of oral contraceptives. Findings When they last reported HRT use, 287143 women (30%) were current users and 186 751 (20%) were past users. During follow-up, 2273 incident ovarian cancers and 15 91 deaths from the malignancy were recorded. Current users were significantly more likely to develop and die from ovarian cancer than never users (relative risk 1.20 [95% Cl 1.09-1.32; p=0.0002] for incident disease and 1.23 [1.09-1.38; p=0.0006] for death). For current users of HRT incidence of ovarian cancer increased with increasing duration of use, but did not differ significantly by type of preparation used, its constituents, or mode of administration. Risks associated with HRT varied significantly according to tumour histology (p < 0.0001), and in women with epithelial tumours the relative risk for current versus never use of HRT was greater for serous than for mucinous, endometroid, or clear cell tumours (1.53 [1.31-1.79], 0.72 [0.52-1.00], 1.05 [0.77-1.43], or 0.77 [0.48-1.23], respectively). Past users of HRT were not at an increased risk of ovarian cancer (0.98 [0.88-1.11] and 0.97 [0.84-1.11], respectively, for incident and fatal disease). Over 5 years, the standardised. incidence rates for ovarian cancer in current and never users of HRT were 2.6 (2.4-2.9) and 2.2 (2.1-2.3) per 1000, respectively-ie, one extra ovarian cancer in roughly 2500 users; death rates were 1.6 (1.4-1.8) and 1.3 (1.2-1.4) per 1000, respectively-ie, one extra ovarian cancer death in roughly 3300 users. Interpretation Women who use HRT are at an increased risk of both incident and fatal ovarian cancer. Since 1991, use of HRT has resulted in some 1300 additional ovarian cancers and 1000 additional deaths from the malignancy in the UK.	Mill Women Study Coordinating Ctr, Canc Res UK Epidemiol Unit, Oxford OX3 7LF, England	Cancer Research UK; University of Oxford	Beral, V (corresponding author), Mill Women Study Coordinating Ctr, Canc Res UK Epidemiol Unit, Richard Doll Bldg,Roosevelt Dr, Oxford OX3 7LF, England.	pa.valerie.beral@ceu.ox.ac.uk			MRC [G0700474] Funding Source: UKRI; Medical Research Council [G0700474] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anderson GL, 2003, JAMA-J AM MED ASSOC, V290, P1739, DOI 10.1001/jama.290.13.1739; Bakken L, 2004, INT J CANCER, V112, P130, DOI 10.1002/ijc.20389; Banks E, 2001, J Epidemiol Biostat, V6, P357; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Beral V, 2005, LANCET, V365, P1543, DOI 10.1016/S0140-6736(05)66455-0; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Beral V, 1999, J Epidemiol Biostat, V4, P191; BOSETTI C, 2001, JAMA-J AM MED ASSOC, V285, P308; Folsom AR, 2004, EPIDEMIOLOGY, V15, P100, DOI 10.1097/01.ede.0000091606.31903.8e; Glud E, 2004, ARCH INTERN MED, V164, P2253, DOI 10.1001/archinte.164.20.2253; HARTGE P, 1988, AM J EPIDEMIOL, V127, P990, DOI 10.1093/oxfordjournals.aje.a114902; Hempling RE, 1997, OBSTET GYNECOL, V89, P1012, DOI 10.1016/S0029-7844(97)00118-X; *IARC, 1999, IARC MON EV CARC RIS, V72; KAUFMAN DW, 1989, AM J EPIDEMIOL, V130, P1142, DOI 10.1093/oxfordjournals.aje.a115441; Lacey JV, 2006, JNCI-J NATL CANCER I, V98, P1397, DOI 10.1093/jnci/djj375; Lacey JV, 2002, JAMA-J AM MED ASSOC, V288, P334, DOI 10.1001/jama.288.3.334; LAVECCHIA C, 1982, J NATL CANCER I, V69, P1207; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Pike MC, 2004, FERTIL STERIL, V82, P186, DOI 10.1016/j.fertnstert.2004.03.013; Purdie DM, 1999, BRIT J CANCER, V81, P559, DOI 10.1038/sj.bjc.6690731; Reeves GK, 2006, LANCET ONCOL, V7, P910, DOI 10.1016/S1470-2045(06)70911-1; Riman T, 2002, JNCI-J NATL CANCER I, V94, P497, DOI 10.1093/jnci/94.7.497; Risch HA, 1996, GYNECOL ONCOL, V63, P254, DOI 10.1006/gyno.1996.0315; Risch HA, 1996, AM J EPIDEMIOL, V144, P363, DOI 10.1093/oxfordjournals.aje.a008937; Rodriguez C, 2001, JAMA-J AM MED ASSOC, V285, P1460, DOI 10.1001/jama.285.11.1460; The Million Women Study Collaborative Group, 1999, BREAST CANCER RES, V1, P73, DOI DOI 10.1186/BCR16; WEISS NS, 1982, J NATL CANCER I, V68, P95; World Health Organization, 1994, INT CLASS DIS	28	298	314	1	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 20	2007	369	9574					1703	1710		10.1016/S0140-6736(07)60534-0	http://dx.doi.org/10.1016/S0140-6736(07)60534-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	169ZT	17512855				2022-12-01	WOS:000246631300026
J	Cibelli, J				Cibelli, Jose			A decade of cloning mystique	SCIENCE			English	Editorial Material							NUCLEAR TRANSFER; MOUSE EMBRYOS; CELLS; CULTURE; MICE		Program Cell Therapy & Regenerat Med, Andalucia, Spain		Cibelli, J (corresponding author), Michigan State Univ, Dept Anim Sci & Physiol, Cellular Reprogramming Lab, E Lansing, MI 48824 USA.	cibelli@msu.edu		Cibelli, Jose/0000-0002-2176-3854				Arnold DR, 2006, REPRODUCTION, V132, P279, DOI 10.1530/rep.1.01217; Chung YG, 2002, BIOL REPROD, V66, P1178, DOI 10.1095/biolreprod66.4.1178; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Jaenisch R, 2001, SCIENCE, V291, P2552, DOI 10.1126/science.1060463; Kubota C, 2000, P NATL ACAD SCI USA, V97, P990, DOI 10.1073/pnas.97.3.990; Lanza RP, 2000, SCIENCE, V288, P665, DOI 10.1126/science.288.5466.665; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; MA B, 2005, NAT REV GENET, V6, P611; Mann MRW, 2003, BIOL REPROD, V69, P902, DOI 10.1095/biolreprod.103.017293; Shiels PG, 1999, NATURE, V399, P316, DOI 10.1038/20580; Wakayama T, 2000, NATURE, V407, P318, DOI 10.1038/35030301; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0	13	26	28	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					990	992		10.1126/science.1143512	http://dx.doi.org/10.1126/science.1143512			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17510352				2022-12-01	WOS:000246554000033
J	Halfar, J; Fujita, RM				Halfar, Jochen; Fujita, Rodney M.			Danger of deep-sea mining	SCIENCE			English	Editorial Material									Univ Toronto, Dept Chem & Phys Sci, Mississauga, ON L5L 1C6, Canada; Environm Def, Oakland, CA 94618 USA	University of Toronto; University Toronto Mississauga	Halfar, J (corresponding author), Univ Toronto, Dept Chem & Phys Sci, Mississauga, ON L5L 1C6, Canada.	jochen.halfar@utoronto.ca; rfujita@environmentaldefense.org	Halfar, Jochen/C-7317-2014					CLIFFORD D, 2005, MINING MAGAZINE  SEP, P58; Glasby GP, 2000, SCIENCE, V289, P551, DOI 10.1126/science.289.5479.551; GLOWKA L, 2001, MANAGING RISKS BIODI, P195; Halfar J, 2002, MAR POLICY, V26, P103, DOI 10.1016/S0308-597X(01)00041-0; Hannington M. D., 2004, GLOBAL DATABASE SEAF; HEILMAN K, 2006, NAUTILUS ONE STEP CL; Mero JL, 1965, MINERAL RESOURCES SE, P103, DOI [10.1016/S0422-9894(08)70765-7, DOI 10.1016/S0422-9894(08)70765-7]; Rona PA, 2003, SCIENCE, V299, P673, DOI 10.1126/science.1080679; SCHNEIDER J, 1998, N JB GEOL PALAEONT A, V208, P397; THIEL H, 1995, ISOPE OC MIN S P TSU, P39; Van Dover CL, 2001, SCIENCE, V294, P818, DOI 10.1126/science.1064574; Wolfrum R., 1990, P INT S KIEL I INT L	12	71	71	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2007	316	5827					987	987		10.1126/science.1138289	http://dx.doi.org/10.1126/science.1138289			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	168WF	17510349				2022-12-01	WOS:000246554000030
J	Tamaki, S; Matsuo, S; Wong, HL; Yokoi, S; Shimamoto, K				Tamaki, Shojiro; Matsuo, Shoichi; Wong, Hann Ling; Yokoi, Shuji; Shimamoto, Ko			Hd3a protein is a mobile flowering signal in rice	SCIENCE			English	Article							PHOTOPERIODIC CONTROL; INTEGRATOR FT; SHOOT APEX; ARABIDOPSIS; PHLOEM; ACTIVATION; ORTHOLOG; CONSTANS; TISSUES; GROWTH	Florigen, the mobile signal that moves from an induced leaf to the shoot apex and causes flowering, has eluded identification since it was first proposed 70 years ago. Understanding the nature of the mobile flowering signal would provide a key insight into the molecular mechanism floral induction. Recent studies suggest that the Arabidopsis FLOWERING LOCUS T ( FT) gene is a candidate for encoding florigen. We show that the protein encoded by Hd3a, a rice ortholog of moves from the leaf to the shoot apical meristem and induces flowering in rice. These results suggest that the Hd3a protein may be the rice florigen.	Nara Inst Sci & Technol, Plant Mol Genet Lab, Ikoma 6300101, Japan	Nara Institute of Science & Technology	Yokoi, S (corresponding author), Nara Inst Sci & Technol, Plant Mol Genet Lab, 8916-5 Takayama, Ikoma 6300101, Japan.	simamoto@bs.naist.jp	Yokoi, Shuji/B-4102-2012; Yokoi, Shuji/L-3988-2019; Wong, Hann Ling/S-8148-2017; Ding, Cheng-Qiang/B-6287-2011	Yokoi, Shuji/0000-0001-9358-1876; Wong, Hann Ling/0000-0001-8903-1812; 				Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Arimura S, 2004, P NATL ACAD SCI USA, V101, P7805, DOI 10.1073/pnas.0401077101; Asano T, 2002, PLANT CELL PHYSIOL, V43, P668, DOI 10.1093/pcp/pcf083; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Bohlenius H, 2007, SCIENCE, V316, P367; Chailakhyan MK., 1936, C R ACAD SCI URSS, V13, P79; Corbesier L, 2005, PLANT CELL ENVIRON, V28, P54, DOI 10.1111/j.1365-3040.2005.01283.x; Giavalisco P, 2006, PROTEOMICS, V6, P896, DOI 10.1002/pmic.200500155; Guivarch A, 1996, TRANSGENIC RES, V5, P3, DOI 10.1007/BF01979917; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Imaizumi T, 2006, TRENDS PLANT SCI, V11, P550, DOI 10.1016/j.tplants.2006.09.004; Ishikawa R, 2005, PLANT CELL, V17, P3326, DOI 10.1105/tpc.105.037028; Izawa T, 2002, GENE DEV, V16, P2006, DOI 10.1101/gad.999202; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Lang A., 1965, ENCYCL PLANT PHYSIOL, VVolume XV/1, P1380; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Muszynski MG, 2006, PLANT PHYSIOL, V142, P1523, DOI 10.1104/pp.106.088815; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; Teper-Bamnolker P, 2005, PLANT CELL, V17, P2661, DOI 10.1105/tpc.105.035766; Thomas B., 1996, PHOTOPERIODISM PLANT; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; ZEEVAART JAD, 1976, ANNU REV PLANT PHYS, V27, P321, DOI 10.1146/annurev.pp.27.060176.001541; Zeevaart JAD, 2006, PLANT CELL, V18, P1783, DOI 10.1105/tpc.106.043513	28	822	921	14	205	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					1033	1036		10.1126/science.1141753	http://dx.doi.org/10.1126/science.1141753			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17446351				2022-12-01	WOS:000246554000048
J	Sato, M; Toda, T				Sato, Masamitsu; Toda, Takashi			Alp7/TACC is a crucial target in Ran-GTPase-dependent spindle formation in fission yeast	NATURE			English	Article							XENOPUS EGG EXTRACTS; SCHIZOSACCHAROMYCES-POMBE; IMPORTIN-BETA; CELL-DIVISION; MICROTUBULES; PROTEIN; KINETOCHORE; CHECKPOINT; ALPHA; CYCLE	Microtubules are essential intracellular structures involved in several cellular phenomena, including polarity establishment and chromosome segregation(1). Because the nuclear envelope persists during mitosis ( closed mitosis) in fission yeast ( Schizosaccharomyces pombe), cytoplasmic microtubules must be reorganized into the spindle in the compartmentalized nucleus on mitotic entry(2). An ideal mechanism might be to take advantage of an evolutionarily conserved microtubule formation system that uses the Ran-GTPase nuclear transport machinery(3-5), but no targets of Ran for spindle formation have been identified in yeast. Here we show that a microtubule-associated protein, Alp7, which forms a complex with Alp14, is a target of Ran in yeast for spindle formation. The Ran-deficient pim1 mutant (pim1-F201S) failed to show mitosis-specific nuclear accumulation of Alp7. Moreover, this mutant exhibited compromised spindle formation and early mitotic delay. Importantly, these defects were suppressed by Alp7 that was artificially targeted to the nucleus by a Ran-independent and importin-alpha-mediated system. Thus, Ran targets Alp7 - Alp14 to achieve nuclear spindle formation, and might differentiate its targets depending on whether the organism undergoes closed or open mitosis.	Canc Res UK, London Res Inst, Lincolns Inn Fields Labs, Lab Cell Regulat, London WC2A 3PX, England	Cancer Research UK	Sato, M (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan.	masasato@biochem.s.u-tokyo.ac.jp; Takashi.Toda@cancer.org.uk						Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Brittle AL, 2005, CURR BIOL, V15, pR880, DOI 10.1016/j.cub.2005.10.022; Carazo-Salas RE, 2003, CURR BIOL, V13, P1728, DOI 10.1016/j.cub.2003.09.006; Caudron M, 2005, SCIENCE, V309, P1373, DOI 10.1126/science.1115964; Fleig U, 2000, J CELL BIOL, V151, P1101, DOI 10.1083/jcb.151.5.1101; Garcia MA, 2001, EMBO J, V20, P3389, DOI 10.1093/emboj/20.13.3389; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; HAGAN IM, 1988, J CELL SCI, V89, P343; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hetzer M, 2002, NAT CELL BIOL, V4, pE177, DOI 10.1038/ncb0702-e177; Hirose E, 2006, GENES CELLS, V11, P29, DOI 10.1111/j.1365-2443.2005.00919.x; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; MATSUMOTO T, 1991, CELL, V66, P347, DOI 10.1016/0092-8674(91)90624-8; Miyamoto Y, 2002, EMBO J, V21, P5833, DOI 10.1093/emboj/cdf569; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Nakaseko Y, 2001, CURR BIOL, V11, P537, DOI 10.1016/S0960-9822(01)00155-5; Oliferenko S, 2002, NAT CELL BIOL, V4, P816, DOI 10.1038/ncb861; Salus SS, 2002, MOL CELL BIOL, V22, P8491, DOI 10.1128/MCB.22.24.8491-8505.2002; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Sato M, 2004, MOL BIOL CELL, V15, P1609, DOI 10.1091/mbc.e03-11-0837; Sato M, 2003, NAT CELL BIOL, V5, P764, DOI 10.1038/ncb0903-764; SAZER S, 1994, EMBO J, V13, P606, DOI 10.1002/j.1460-2075.1994.tb06298.x; Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070; Umeda M, 2005, GENETICS, V171, P7, DOI 10.1534/genetics.105.042598; Usui T, 2003, EMBO J, V22, P4779, DOI 10.1093/emboj/cdg459; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Yamashita A, 2005, MOL BIOL CELL, V16, P1378, DOI 10.1091/mbc.e04-10-0859; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013; Zheng YX, 2004, ANNU REV CELL DEV BI, V20, P867, DOI 10.1146/annurev.cellbio.20.012103.094648	33	57	58	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2007	447	7142					334	U9		10.1038/nature05773	http://dx.doi.org/10.1038/nature05773			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17476213				2022-12-01	WOS:000246520300049
J	Liu, J; Fan, DM				Liu, Jie; Fan, Daiming			Hepatitis B in China	LANCET			English	Editorial Material									Fourth Mil Med Univ, Xijing Hosp, Inst Digest Dis, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University	Liu, J (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Inst Digest Dis, Xian 710032, Shaanxi, Peoples R China.	jieliu@fmmu.edu.cn						Cui FQ, 2006, CHIN J VACCINES IMMU, V12, P206; Janssen HLA, 2005, LANCET, V365, P123, DOI 10.1016/S0140-6736(05)17701-0; Jia Ji-dong, 2004, Zhonghua Gan Zang Bing Za Zhi, V12, P698; Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2; Liang Xiao-feng, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P655; Lok AS, 2005, NEW ENGL J MED, V352, P2743, DOI 10.1056/NEJMe058119; Si CW, 2006, CLIN MED J, V4, P1; Sung JJY, 2005, GASTROENTEROLOGY, V128, P1890, DOI 10.1053/j.gastro.2005.03.009; Wang X.J., 2004, DIS SURVEILLANCE, V19, P290; Zhuang H, 2005, CHIN J INFECT DIS S, V23, P2; 刘耕陶, 2002, [中华医学杂志, National Medical Journal of China], V82, P74	11	198	215	1	31	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 12	2007	369	9573					1582	1583		10.1016/S0140-6736(07)60723-5	http://dx.doi.org/10.1016/S0140-6736(07)60723-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	167YO	17499584				2022-12-01	WOS:000246488800007
J	Gill, B; Okie, S				Gill, Bates; Okie, Susan			China and HIV - A window of opportunity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Ctr Strateg & Int Studies, Washington, DC 20006 USA	Centre for Strategic & International Studies	Gill, B (corresponding author), Ctr Strateg & Int Studies, Washington, DC 20006 USA.			Gill, Bates/0000-0002-9425-5623				*WHO PEOPL REP CHI, 2006, 2005 UPD HIV AIDS EP; 2006, GENEVA GLOBAL FUND F; 2005, CHINA DAILY BEI 1028; 2005, CHINA DAILY BEI 1228; 2006, CHINA DAILY BEI 0405	5	49	49	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2007	356	18					1801	1805		10.1056/NEJMp078010	http://dx.doi.org/10.1056/NEJMp078010			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	163CL	17476005				2022-12-01	WOS:000246136200001
J	Berner, RA; VandenBrooks, JM; Ward, PD				Berner, Robert A.; VandenBrooks, John M.; Ward, Peter D.			Evolution - Oxygen and evolution	SCIENCE			English	Editorial Material							ATMOSPHERIC OXYGEN; RESPONSES; HYPEROXIA; INSECTS; HYPOXIA; OCEAN; RISE		Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; Univ Washington, Dept Biol, Seattle, WA 98195 USA	Yale University; Arizona State University; Arizona State University-Tempe; University of Washington; University of Washington Seattle	Berner, RA (corresponding author), Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA.	robert.berner@yale.edu						Berner R., 2004, PHANEROZOIC CARBON C; Berner RA, 2005, GEOCHIM COSMOCHIM AC, V69, P3211, DOI 10.1016/j.gca.2005.03.021; Berner RA, 2003, ANNU REV EARTH PL SC, V31, P105, DOI 10.1146/annurev.earth.31.100901.141329; Berner RA, 2006, GEOCHIM COSMOCHIM AC, V70, P5653, DOI 10.1016/j.gca.2005.11.032; Canfield DE, 2007, SCIENCE, V315, P92, DOI 10.1126/science.1135013; Dabrowski K, 2004, AQUACULTURE, V233, P383, DOI 10.1016/j.aquaculture.2003.09.047; Dudley R, 1998, J EXP BIOL, V201, P1043; Falkowski PG, 2005, SCIENCE, V309, P2202, DOI 10.1126/science.1116047; FARZIN M, 2007, ANN M SOC INT COMP B; Frazier MR, 2001, PHYSIOL BIOCHEM ZOOL, V74, P641, DOI 10.1086/322172; GRAHAM JB, 1995, NATURE, V375, P117, DOI 10.1038/375117a0; Harrison J, 2006, RESP PHYSIOL NEUROBI, V154, P4, DOI 10.1016/j.resp.2006.02.008; Henry JR, 2004, J EXP BIOL, V207, P3559, DOI 10.1242/jeb.01189; Jammes Y, 1975, Poumon Coeur, V31, P165; KAISER A, 2006, COMP PHYS M INT DIV; Kump LR, 2005, GEOLOGY, V33, P397, DOI 10.1130/G21295.1; MCALESTER A L, 1970, Journal of Paleontology, V44, P405; O'Connor PM, 2005, NATURE, V436, P253, DOI 10.1038/nature03716; Scott AC, 2006, P NATL ACAD SCI USA, V103, P10861, DOI 10.1073/pnas.0604090103; VANDENBROOKS JM, 2007, THESIS YALE U; WARD PD, 2006, OUT THIN AIR; Ward P, 2006, P NATL ACAD SCI USA, V103, P16818, DOI 10.1073/pnas.0607824103; Warkentin KM, 2002, PHYSIOL BIOCHEM ZOOL, V75, P155, DOI 10.1086/339214	23	236	256	7	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2007	316	5824					557	558		10.1126/science.1140273	http://dx.doi.org/10.1126/science.1140273			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463279				2022-12-01	WOS:000245983100033
J	Lu, BX; Su, YH; Das, S; Liu, J; Xia, JS; Ren, DJ				Lu, Boxun; Su, Yanhua; Das, Sudipto; Liu, Jin; Xia, Jingsheng; Ren, Dejian			The neuronal channel NALCN contributes resting sodium permeability and is required for normal respiratory rhythm	CELL			English	Article							VOLTAGE-GATED SODIUM; ION SELECTIVITY; PERMEATION; CURRENTS; DETERMINANTS; MECHANISMS	Sodium plays a key role in determining the basal excitability of the nervous systems through the resting '' leak '' Na+ permeabilities, but the molecular identities of the TTX- and Cs+-resistant Na+ leak conductance are totally unknown. Here we show that this conductance is formed by the protein NALCN, a substantially uncharacterized member of the sodium/calcium channel family. Unlike any of the other 20 family members, NALCN forms a voltage-independent, nonselective cation channel. NALCN mutant mice have a severely disrupted respiratory rhythm and die within 24 hours of birth. Brain stem-spinal cord recordings. reveal reduced neuronal firing. The TTX- and Cs+-resistant background Na+ leak current is absent in the mutant hippocampal neurons. The resting membrane potentials of the mutant neurons are relatively insensitive to changes in extracellular Na+ concentration. Thus, NALCN, a nonselective cation channel, forms the background Na+ leak conductance and controls neuronal excitability.	Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Ren, DJ (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	dren@sas.upenn.edu	Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051				Atherton JF, 2005, J NEUROSCI, V25, P8272, DOI 10.1523/JNEUROSCI.1475-05.2005; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Crill WE, 1996, ANNU REV PHYSIOL, V58, P349, DOI 10.1146/annurev.ph.58.030196.002025; DiPasquale E, 1996, DEV BRAIN RES, V91, P121, DOI 10.1016/0165-3806(95)00170-0; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Eggermann E, 2003, J NEUROSCI, V23, P1557; Feldman JL, 2003, ANNU REV NEUROSCI, V26, P239, DOI 10.1146/annurev.neuro.26.041002.131103; Franks CJ, 2002, J NEUROPHYSIOL, V87, P954, DOI 10.1152/jn.00233.2001; Goldin AL, 2002, J EXP BIOL, V205, P575; Goldstein SAN, 2005, PHARMACOL REV, V57, P527, DOI 10.1124/pr.57.4.12; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Hille B., 2001, ION CHANNELS EXCITAB, V3; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; HOM R, 2002, J GEN PHYSIOL, V120, P449; Jackson AC, 2004, J NEUROSCI, V24, P7985, DOI 10.1523/JNEUROSCI.2146-04.2004; JONES SW, 1989, NEURON, V3, P153, DOI 10.1016/0896-6273(89)90028-7; KIM MS, 1993, FEBS LETT, V318, P145, DOI 10.1016/0014-5793(93)80009-J; KRISHNAN KS, 1990, P NATL ACAD SCI USA, V87, P8632, DOI 10.1073/pnas.87.21.8632; Lear BC, 2005, NEURON, V48, P965, DOI 10.1016/j.neuron.2005.10.030; Lee JH, 1999, FEBS LETT, V445, P231, DOI 10.1016/S0014-5793(99)00082-4; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Mir B, 1997, GENETICS, V147, P701; Nash HA, 2002, CURR BIOL, V12, P2152, DOI 10.1016/S0960-9822(02)01358-1; Nicholls J.G., 2001, NEURON BRAIN; NILIUS B, 2005, SCI STKE; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Pena F, 2004, J NEUROSCI, V24, P7549, DOI 10.1523/JNEUROSCI.1871-04.2004; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Raman IM, 2000, J NEUROSCI, V20, P9004; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Sather WA, 2003, ANNU REV PHYSIOL, V65, P133, DOI 10.1146/annurev.physiol.65.092101.142345; SIMASKO SM, 1994, AM J PHYSIOL, V266, pC709, DOI 10.1152/ajpcell.1994.266.3.C709; Strohl KP, 2003, RESP PHYSIOL NEUROBI, V135, P179, DOI 10.1016/S1569-9048(03)00036-3; TANG SQ, 1993, J BIOL CHEM, V268, P13026; van Swinderen B, 2006, J NEUROBIOL, V66, P1195, DOI 10.1002/neu.20300; Viemari JC, 2003, EUR J NEUROSCI, V17, P1233, DOI 10.1046/j.1460-9568.2003.02561.x; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; YANG XC, 1989, SCIENCE, V243, P1068, DOI 10.1126/science.2466333; YU FH, 2004, SCI STKE 2004	44	221	227	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2007	129	2					371	383		10.1016/j.cell.2007.02.041	http://dx.doi.org/10.1016/j.cell.2007.02.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448995	Bronze			2022-12-01	WOS:000246474600023
J	Shuchman, M				Shuchman, Miriam			Approving the vagus-nerve stimulator for depression	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Andress G, 2001, BRIT MED J, V322, P419, DOI 10.1136/bmj.322.7283.419; Rush AJ, 2005, BIOL PSYCHIAT, V58, P347, DOI 10.1016/j.biopsych.2005.05.025; US Senate Committee on Finance, 2006, REV FDAS APPR PROC V	3	34	34	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 19	2007	356	16					1604	1607		10.1056/NEJMp078035	http://dx.doi.org/10.1056/NEJMp078035			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158AB	17442903				2022-12-01	WOS:000245762000002
J	Costa-Mattioli, M; Gobert, D; Stern, E; Gamache, K; Colina, R; Cuello, C; Sossin, W; Kaufman, R; Pelletier, J; Rosenblum, K; Krnjevic, K; Lacaille, JC; Nader, K; Sonenberg, N				Costa-Mattioli, Mauro; Gobert, Delphine; Stern, Elad; Gamache, Karine; Colina, Rodney; Cuello, Claudio; Sossin, Wayne; Kaufman, Randal; Pelletier, Jerrf; Rosenblum, Kobi; Krnjevic, Kresimir; Lacaille, Jean-Claude; Nader, Karim; Sonenberg, Nahum			eIF2 alpha phosphorylation bidirectionally regulates the switch from short- to long-term synaptic plasticity and memory	CELL			English	Article							MESSENGER-RNA TRANSLATION; PROTEIN-SYNTHESIS; POTENTIATION; MECHANISMS; RECONSOLIDATION; CONSOLIDATION; REINITIATION; NEUROSCIENCE; ENHANCEMENT; INHIBITION	The late phase of long-term potentiation (LTP) and memory (LTM) requires new gene expression, but the molecular mechanisms that underlie these processes are not fully understood. Phosphorylation of eIF2 alpha inhibits general translation but selectively stimulates translation of ATF4, a repressor of CREB-mediated late-LTP (L-LTP) and LTM. We used a pharmacogenetic bidirectional approach to examine the role of eIF2 alpha phosphorylation in synaptic plasticity and behavioral learning. We show that in eIF2 alpha(+/S51A) mice, in which eIF2 alpha phosphorylation is reduced, the threshold for eliciting L-LTP in hippocampal slices is lowered, and memory is enhanced. In contrast, only early-LTP is evoked by repeated tetanic stimulation and LTM is impaired, when eIF2 alpha phosphorylation is increased by injecting into the hippocampus a small molecule, Sal003, which prevents the dephosphorylation of eIF2 alpha. These findings highlight the importance of a single phosphorylation site in eIF2 alpha as a key regulator of L-LTP and LTM formation.	McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Psychol, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Pharmacol, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Neurol, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Neurosurg, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada; Univ Haifa, Ctr Brain & Behav, IL-30905 Haifa, Israel; Univ Michigan, Howard Hughes Med Inst, Dept Biol Chem, Ann Arbor, MI 48109 USA	McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; Universite de Montreal; University of Haifa; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Costa-Mattioli, M (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada.	mauro.costa-mattioli@mail.mcgill.ca; nahum.sonenberg@mcgill.ca		Colina, Rodney/0000-0003-3731-5383	Canadian Institutes of Health Research [15121] Funding Source: Medline; NCI NIH HHS [R01 CA154916] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA154916] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chen A, 2003, NEURON, V39, P655, DOI 10.1016/S0896-6273(03)00501-4; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; COTE SL, 1993, IMMUNOHISTOCHEMISTRY, V2; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Masuoka HC, 2002, BLOOD, V99, P736, DOI 10.1182/blood.V99.3.736; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; Pavlov IP, 1927, CONDITIONED REFLEXES; Pittenger C, 2003, PHILOS T ROY SOC B, V358, P757, DOI 10.1098/rstb.2002.1247; Robert F, 2006, MOL BIOL CELL, V17, P4632, DOI 10.1091/mbc.E06-06-0478; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Schafe GE, 1999, LEARN MEMORY, V6, P97; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; SHEFFIELD FD, 1950, J COMP PHYSIOL PSYCH, V43, P471, DOI 10.1037/h0061365; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Small SA, 2000, NEURON, V28, P653, DOI 10.1016/S0896-6273(00)00144-6; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Takei N, 2001, J BIOL CHEM, V276, P42818, DOI 10.1074/jbc.M103237200; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang HB, 2004, NAT NEUROSCI, V7, P635, DOI 10.1038/nn1248	41	347	366	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 6	2007	129	1					195	206		10.1016/j.cell.2007.01.050	http://dx.doi.org/10.1016/j.cell.2007.01.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418795	Green Accepted, Bronze, Green Submitted			2022-12-01	WOS:000245661100021
J	Gregg, EW; Gu, Q; Cheng, YJ; Narayan, V; Cowie, CC				Gregg, Edward W.; Gu, Qiuping; Cheng, Yiling J.; Narayan, Venkat; Cowie, Catherine C.			Mortality trends in men and women with diabetes, 1971 to 2000	ANNALS OF INTERNAL MEDICINE			English	Article							HEART-DISEASE MORTALITY; UNITED-STATES; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; NATIONAL-HEALTH; SEX-DIFFERENCES; SECULAR TRENDS; ADULTS; POPULATION; PREVALENCE	Background: Whether mortality rates among diabetic adults or excess mortality associated with diabetes in the United States has declined in recent decades is not known. Objective: To examine whether all-cause and cardiovascular disease mortality rates have declined among the U.S. population with and without self-reported diabetes. Design: Comparison of 3 consecutive, nationally representative cohorts. Setting: Population-based health surveys (National Health and Nutrition Examination Surveys I, II, and III) with mortality follow-up assessment. Patients: Survey participants age 35 to 74 years with and without diabetes. Measurements: Diabetes was determined by self-report for each survey (1971-1975, 1976-1980, and 1988-1994), and mortality rates were determined through 1986, 1992, and 2000 for the 3 surveys, respectively. Results: Among diabetic men, the all-cause mortality rate decreased by 18.2 annual deaths per 1000 persons (from 42.6 to 24.4 annual deaths per 1000 persons; P = 0.03) between 1971 to 1986 and 1988 to 2000, accompanying decreases in the nondiabetic population. Trends for cardiovascular disease mortality paralleled those of all-cause mortality, with 26.4 annual deaths per 1000 persons in 1971 to 1986 and 12.8 annual deaths per 1000 persons in 1988 to 2000 (P = 0.06). Among women with diabetes, however, neither all-cause nor cardiovascular disease mortality declined between 1971 to 1986 and 1988 to 2000, and the all-cause mortality rate difference between diabetic and nondiabetic women more than doubled (from a difference of 8.3 to 18.2 annual deaths per 1000 persons). The difference in all-cause mortality rates by sex among people with diabetes in 1971 to 1986 were essentially eliminated in 1988 to 2000. Limitations: Diabetes was assessed by self-report, and statistical power to examine the factors explaining mortality trends was limited. Conclusions: Progress in reducing mortality rates among persons with diabetes has been limited to men. Diabetes continues to greatly increase the risk for death, particularly among women.	Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA; NIDDKD, NIH, Bethesda, MD 20892 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Gregg, EW (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, K 10,4770 Buford Highway NE, Atlanta, GA 30341 USA.		Cheng, Yiling J/A-6547-2009	Cheng, Yiling J/0000-0002-5053-0814; Gregg, Edward/0000-0003-2381-6822				ABBOTT RD, 1988, JAMA-J AM MED ASSOC, V260, P3456, DOI 10.1001/jama.260.23.3456; BARRETTCONNOR E, 1983, AM J EPIDEMIOL, V118, P489, DOI 10.1093/oxfordjournals.aje.a113654; Briefel RR, 2004, ANNU REV NUTR, V24, P401, DOI 10.1146/annurev.nutr.23.011702.073349; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P80; Chandra NC, 1998, ARCH INTERN MED, V158, P981, DOI 10.1001/archinte.158.9.981; Cohen B B, 1987, Vital Health Stat 1, P1; Cooper R, 2000, CIRCULATION, V102, P3137; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Ergin A, 2004, AM J MED, V117, P219, DOI 10.1016/j.amjmed.2004.03.017; Ernst ND, 1997, AM J CLIN NUTR, V66, P965; Flaherty JD, 2005, JAMA-J AM MED ASSOC, V293, P1501, DOI 10.1001/jama.293.12.1501; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; FORTHOFER RN, 1983, AM J EPIDEMIOL, V117, P507, DOI 10.1093/oxfordjournals.aje.a113568; Fox CS, 2004, JAMA-J AM MED ASSOC, V292, P2495, DOI 10.1001/jama.292.20.2495; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Geiss Linda, 2005, Diabetes Technol Ther, V7, P198, DOI 10.1089/dia.2005.7.198; Goldberg RB, 1998, CIRCULATION, V98, P2513, DOI 10.1161/01.CIR.98.23.2513; Gregg EW, 2004, DIABETES CARE, V27, P2806, DOI 10.2337/diacare.27.12.2806; Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291; Gustafsson I, 2004, J AM COLL CARDIOL, V43, P771, DOI 10.1016/j.jacc.2003.11.024; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Hoehner CM, 2006, J DIABETES COMPLICAT, V20, P8, DOI 10.1016/j.jdiacomp.2005.06.003; Imperatore G, 2004, AM J EPIDEMIOL, V160, P531, DOI 10.1093/aje/kwh232; Kanaya AM, 2002, ARCH INTERN MED, V162, P1737, DOI 10.1001/archinte.162.15.1737; Koopman RJ, 2005, ANN FAM MED, V3, P60, DOI 10.1370/afm.214; KORN EL, 1999, ANAL HLTH SURVEYS, P279; LABBATE A, 2005, PHARM REP, V57; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Loria C M, 1999, Vital Health Stat 1, P1; McDowell A, 1981, Vital Health Stat 1, P1; MOHADJER L, 1996, NATL HLTH NUTR EXAMI; Narayan KMV, 2000, DIABETES RES CLIN PR, V50, pS77; Natarajan S, 2005, ARCH INTERN MED, V165, P430, DOI 10.1001/archinte.165.4.430; National Center for Health Statistics, 1996, AN REP GUID 3 NAT HL; Nichol KL, 1998, ARCH INTERN MED, V158, P1769, DOI 10.1001/archinte.158.16.1769; Pambianco G, 2006, DIABETES, V55, P1463, DOI 10.2337/db05-1423; Pavkov ME, 2004, DIABETES CARE, V27, P1132, DOI 10.2337/diacare.27.5.1132; Persell SD, 2004, ARCH INTERN MED, V164, P2492, DOI 10.1001/archinte.164.22.2492; Plan and operation of the Third National Health and Nutrition Examination Survey, 1994, VITAL HLTH STAT, P1; Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; Saydah SH, 2004, ANN EPIDEMIOL, V14, P507, DOI 10.1016/j.annepidem.2003.09.016; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; STEINGART RM, 1991, NEW ENGL J MED, V325, P226, DOI 10.1056/NEJM199107253250402; Stettler C, 2006, AM HEART J, V152, P27, DOI 10.1016/j.ahj.2005.09.015; Thomas RJ, 2003, ARCH INTERN MED, V163, P445, DOI 10.1001/archinte.163.4.445; Tierney EF, 2004, DIABETES CARE, V27, P2723, DOI 10.2337/diacare.27.11.2723	48	338	342	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 7	2007	147	3					149	155		10.7326/0003-4819-147-3-200708070-00167	http://dx.doi.org/10.7326/0003-4819-147-3-200708070-00167			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	196AV	17576993				2022-12-01	WOS:000248454700001
J	Lartigue, C; Glass, JI; Alperovich, N; Pieper, R; Parmar, PP; Hutchison, CA; Smith, HO; Venter, JC				Lartigue, Carole; Glass, John I.; Alperovich, Nina; Pieper, Rembert; Parmar, Prashanth P.; Hutchison, Clyde A., III; Smith, Hamilton O.; Venter, J. Craig			Genome transplantation in bacteria: Changing one species to another	SCIENCE			English	Article							MYCOPLASMA-CAPRICOLUM; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; COMPETENT CELLS; DNA; TRANSFORMATION; PLASMIDS; CLONING	As a step toward propagation of synthetic genomes, we completely replaced the genome of a bacterial cell with one from another species by transplanting a whole genome as naked DNA. Intact genomic DNA from Mycoplasma mycoides large colony (LC), virtually free of protein, was transplanted into Mycoplasma capricolum cells by polyethylene glycol-mediated transformation. Cells selected for tetracycline resistance, carried by the M. mycoides LC chromosome, contain the complete donor genome and are free of detectable recipient genomic sequences. These cells that result from genome transplantation are phenotypically identical to the M. mycoides LC donor strain as judged by several criteria.	J Craig Venter Inst, Rockville, MD 20850 USA	J. Craig Venter Institute	Glass, JI (corresponding author), J Craig Venter Inst, Rockville, MD 20850 USA.	jglass@jcvi.org	Lartigue, Carole/GQP-4896-2022; lartigue, carole/I-1576-2013; Glass, John/A-6572-2015	Lartigue, Carole/0000-0001-5550-7579; Glass, John/0000-0002-3784-5301				Akamatsu T, 2001, BIOSCI BIOTECH BIOCH, V65, P823, DOI 10.1271/bbb.65.823; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; BEVERLEY SM, 1988, NUCLEIC ACIDS RES, V16, P925, DOI 10.1093/nar/16.3.925; BRIGGS R, 1952, P NATL ACAD SCI USA, V38, P455, DOI 10.1073/pnas.38.5.455; Cho MK, 1999, SCIENCE, V286, P2087, DOI 10.1126/science.286.5447.2087; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; Garfinkel M. S., SYNTHETIC GENOMICS O; Gatlin CL, 2006, PROTEOMICS, V6, P1530, DOI 10.1002/pmic.200500253; *GENBANK, NC007633 GENBANK; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Gurdon JB, 2003, P NATL ACAD SCI USA, V100, P8048, DOI 10.1073/pnas.1337135100; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Holt RA, 2007, BIOESSAYS, V29, P580, DOI 10.1002/bies.20585; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Itaya M, 2005, P NATL ACAD SCI USA, V102, P15971, DOI 10.1073/pnas.0503868102; Lartigue C, 2003, NUCLEIC ACIDS RES, V31, P6610, DOI 10.1093/nar/gkg848; Saito Y, 2006, J BIOSCI BIOENG, V101, P334, DOI 10.1263/jbb.101.334; Seto S, 1999, J BACTERIOL, V181, P6073, DOI 10.1128/JB.181.19.6073-6080.1999; Seto S, 1998, J BACTERIOL, V180, P256, DOI 10.1128/JB.180.2.256-264.1998; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; TARSHIS M, 1993, BIOPHYS J, V64, P709, DOI 10.1016/S0006-3495(93)81430-9; Teachman AM, 2002, J BACTERIOL, V184, P947, DOI 10.1128/jb.184.4.947-951.2002; TULLY JG, 1979, J INFECT DIS, V139, P478, DOI 10.1093/infdis/139.4.478; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0	24	265	310	3	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2007	317	5838					632	638		10.1126/science.1144622	http://dx.doi.org/10.1126/science.1144622			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	196PL	17600181	Green Published			2022-12-01	WOS:000248494400037
J	Ousman, SS; Tomooka, BH; van Noort, JM; Wawrousek, EF; O'Connor, KC; Hafler, DA; Sobel, RA; Robinson, WH; Steinman, L				Ousman, Shalina S.; Tomooka, Beren H.; van Noort, Johannes M.; Wawrousek, Eric F.; O'Connor, Kevin C.; Hafler, David A.; Sobel, Raymond A.; Robinson, William H.; Steinman, Lawrence			Protective and therapeutic role for alpha B-crystallin in autoimmune demyelination	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; LENS EPITHELIAL-CELLS; NF-KAPPA-B; MULTIPLE-SCLEROSIS; CANDIDATE AUTOANTIGEN; A-CRYSTALLIN; APOPTOSIS; EXPRESSION; DISEASE; ENCEPHALOMYELITIS	alpha B-crystallin (CRYAB) is the most abundant gene transcript present in early active multiple sclerosis lesions, whereas such transcripts are absent in normal brain tissue(1). This crystallin has anti-apoptotic(2-7) and neuroprotective(8) functions. CRYAB is the major target of CD4(+) T-cell immunity to the myelin sheath from multiple sclerosis brain(9,10). The pathophysiological implications of this immune response were investigated here. We demonstrate that CRYAB is a potent negative regulator acting as a brake on several inflammatory pathways in both the immune system and central nervous system (CNS). Cryab(-/-) mice showed worse experimental autoimmune encephalomyelitis (EAE) at the acute and progressive phases, with higher Th1 and Th17 cytokine secretion from T cells and macrophages, and more intense CNS inflammation, compared with their wild-type counterparts. Furthermore, Cryab(-/-) astrocytes showed more cleaved caspase-3 and more TUNEL staining, indicating an anti-apoptotic function of Cryab. Antibody to CRYAB was detected in cerebrospinal fluid from multiple sclerosis patients and in sera from mice with EAE. Administration of recombinant CRYAB ameliorated EAE. Thus, the immune response against a negative regulator of inflammation, CRYAB, in multiple sclerosis, would exacerbate inflammation and demyelination. This can be countered by giving CRYAB itself for therapy of ongoing disease.	Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Div Rheumatol & Immunol, Sch Med, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Lab Serv, Palo Alto, CA 94304 USA; Vet Affairs Palo Alto Hlth Care Syst, GRECC, Palo Alto, CA 94304 USA; TNO Qual Life, Dept Biosci, NL-2301 CE Leiden, Netherlands; NEI, NIH, Bethesda, MD 20892 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Netherlands Organization Applied Science Research; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Harvard University; Brigham & Women's Hospital; Harvard Medical School	Steinman, L (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA.	steinman@stanford.edu	Wawrousek, Eric/A-4547-2008	Steinman, Lawrence/0000-0002-2437-2250; Sobel, Raymond/0000-0002-0477-9002; Robinson, William/0000-0003-4385-704X; van Noort, Johannes/0000-0002-9060-5921	Multiple Sclerosis Society [835] Funding Source: Medline; NATIONAL EYE INSTITUTE [Z01EY000286, ZIAEY000286] Funding Source: NIH RePORTER	Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Andley UP, 2000, J BIOL CHEM, V275, P36823, DOI 10.1074/jbc.M004233200; AOYAMA A, 1993, MOL CELL BIOL, V13, P1824, DOI 10.1128/MCB.13.3.1824; Bajramovic JJ, 2000, J IMMUNOL, V164, P4359, DOI 10.4049/jimmunol.164.8.4359; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Cobb BA, 2000, J BIOL CHEM, V275, P6664, DOI 10.1074/jbc.275.9.6664; DASGUPTA S, 1992, EXP EYE RES, V54, P461, DOI 10.1016/0014-4835(92)90058-Z; Doerwald L, 2004, J MOL EVOL, V59, P674, DOI 10.1007/s00239-004-2659-y; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ellmerich S, 2004, EUR J IMMUNOL, V34, P1839, DOI 10.1002/eji.200324044; Finley EL, 1998, PROTEIN SCI, V7, P2391, DOI 10.1002/pro.5560071116; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; Kamradt MC, 2002, J BIOL CHEM, V277, P38731, DOI 10.1074/jbc.M201770200; Korlimbinis A, 2006, BIOCHEMISTRY-US, V45, P1852, DOI 10.1021/bi051737+; Li DWC, 2001, EXP CELL RES, V266, P279, DOI 10.1006/excr.2001.5223; Liu JP, 2004, EXP EYE RES, V79, P393, DOI 10.1016/j.exer.2004.06.015; Mao YW, 2001, J BIOL CHEM, V276, P43435, DOI 10.1074/jbc.M102195200; Masilamoni JG, 2006, BBA-MOL BASIS DIS, V1762, P284, DOI 10.1016/j.bbadis.2005.11.007; Matsuoka Y, 2003, J NEUROSCI, V23, P29; Mehlen P, 1996, EMBO J, V15, P2695, DOI 10.1002/j.1460-2075.1996.tb00630.x; Morrison LE, 2003, CIRC RES, V92, P203, DOI 10.1161/01.RES.0000052989.83995.A5; Robinson WH, 2003, NAT BIOTECHNOL, V21, P1033, DOI 10.1038/nbt859; Suzuki A, 1998, J CELL BIOL, V140, P1113, DOI 10.1083/jcb.140.5.1113; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Loo G, 2006, NAT IMMUNOL, V7, P954, DOI 10.1038/ni1372; van Noort JM, 2006, MULT SCLER J, V12, P287, DOI 10.1191/135248506ms1271oa; VANNOORT JM, 1995, NATURE, V375, P798, DOI 10.1038/375798a0; Webster KA, 2003, CIRC RES, V92, P130, DOI 10.1161/01.RES.0000056967.51841.21; Youssef S, 2006, NAT IMMUNOL, V7, P901, DOI 10.1038/ni0906-901	30	397	411	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2007	448	7152					474	U7		10.1038/nature05935	http://dx.doi.org/10.1038/nature05935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17568699				2022-12-01	WOS:000248302700047
J	Nozue, K; Covington, MF; Duek, PD; Lorrain, S; Fankhauser, C; Harmer, SL; Maloof, JN				Nozue, Kazunari; Covington, Michael F.; Duek, Paula D.; Lorrain, Severine; Fankhauser, Christian; Harmer, Stacey L.; Maloof, Julin N.			Rhythmic growth explained by coincidence between internal and external cues	NATURE			English	Article							DISRUPTS CIRCADIAN-RHYTHMS; LIGHT-SIGNAL-TRANSDUCTION; STEM ELONGATION; TRANSCRIPTION FACTORS; FLOWERING TIME; TOMATO PLANTS; ARABIDOPSIS; DEGRADATION; EXPRESSION; PHOSPHORYLATION	Most organisms use circadian oscillators to coordinate physiological and developmental processes such as growth with predictable daily environmental changes like sunrise and sunset. The importance of such coordination is highlighted by studies showing that circadian dysfunction causes reduced fitness in bacteria(1) and plants(2), as well as sleep and psychological disorders in humans(3). Plant cell growth requires energy and water-factors that oscillate owing to diurnal environmental changes. Indeed, two important factors controlling stem growth are the internal circadian oscillator(4-6) and external light levels(7). However, most circadian studies have been performed in constant conditions, precluding mechanistic study of interactions between the clock and diurnal variation in the environment. Studies of stem elongation in diurnal conditions have revealed complex growth patterns, but no mechanism has been described(8-10). Here we show that the growth phase of Arabidopsis seedlings in diurnal light conditions is shifted 8-12 h relative to plants in continuous light, and we describe a mechanism underlying this environmental response. We find that the clock regulates transcript levels of two basic helix-loop-helix genes, phytochrome-interacting factor 4 (PIF4) and PIF5, whereas light regulates their protein abundance. These genes function as positive growth regulators; the coincidence of high transcript levels (by the clock) and protein accumulation (in the dark) allows them to promote plant growth at the end of the night. Thus, these two genes integrate clock and light signalling, and their coordinated regulation explains the observed diurnal growth rhythms. This interaction may serve as a paradigm for understanding how endogenous and environmental signals cooperate to control other processes.	Univ Calif Davis, Plant Biol Sect, Coll Biol Sci, Davis, CA 95616 USA; Univ Lausanne, Ctr Integrative Genom, CH-1015 Lausanne, Switzerland	University of California System; University of California Davis; University of Lausanne	Maloof, JN (corresponding author), Univ Calif Davis, Plant Biol Sect, Coll Biol Sci, 1 Shields Ave, Davis, CA 95616 USA.	jnmaloof@ucdavis.edu	Fankhauser, Christian/C-4291-2018; Fankhauser, Christian/ABE-8757-2021; Covington, Michael/G-9208-2014; Duek, Paula/AAV-2308-2020	Fankhauser, Christian/0000-0003-4719-5901; Fankhauser, Christian/0000-0003-4719-5901; Covington, Michael/0000-0002-0555-6409; Maloof, Julin/0000-0002-9623-2599; Duek Roggli, Paula/0000-0002-0819-0473; Harmer, Stacey/0000-0001-6813-6682	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069418] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM069418] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Al-Sady B, 2006, MOL CELL, V23, P439, DOI 10.1016/j.molcel.2006.06.011; B?nning E., 1936, BER DEUT BOT GES, V54, P590, DOI DOI 10.1038/424033A; BERTRAM L, 1994, SCI HORTIC-AMSTERDAM, V58, P139, DOI 10.1016/0304-4238(94)90134-1; Bertram L, 1997, PHOTOCHEM PHOTOBIOL, V66, P396, DOI 10.1111/j.1751-1097.1997.tb03164.x; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Covington MF, 2001, PLANT CELL, V13, P1305, DOI 10.1105/tpc.13.6.1305; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dowson-Day MJ, 1999, PLANT J, V17, P63, DOI 10.1046/j.1365-313X.1999.00353.x; Doyle MR, 2002, NATURE, V419, P74, DOI 10.1038/nature00954; Duek PD, 2005, TRENDS PLANT SCI, V10, P51, DOI 10.1016/j.tplants.2004.12.005; Duek PD, 2004, CURR BIOL, V14, P2296, DOI 10.1016/j.cub.2004.12.026; DUNLAP JC, 2005, CHRONOBIOLOGY; Fujimori T, 2004, PLANT CELL PHYSIOL, V45, P1078, DOI 10.1093/pcp/pch124; Gardner MJ, 2006, BIOCHEM J, V397, P15, DOI 10.1042/BJ20060484; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; HSIAO TC, 1973, ANNU REV PLANT PHYS, V24, P519, DOI 10.1146/annurev.pp.24.060173.002511; Huq E, 2002, EMBO J, V21, P2441, DOI 10.1093/emboj/21.10.2441; IBRAHIM C A, 1981, Plant Physiology (Rockville), V67, P113; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Khanna R, 2004, PLANT CELL, V16, P3033, DOI 10.1105/tpc.104.025643; Kohchi T, 2001, PLANT CELL, V13, P425, DOI 10.1105/tpc.13.2.425; LECHARNY A, 1984, PHYSIOL PLANTARUM, V60, P437, DOI 10.1111/j.1399-3054.1984.tb06089.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McWatters HG, 2000, NATURE, V408, P716, DOI 10.1038/35047079; Mockler TC, 2004, P NATL ACAD SCI USA, V101, P12759, DOI 10.1073/pnas.0404552101; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Park E, 2004, PLANT CELL PHYSIOL, V45, P968, DOI 10.1093/pcp/pch125; R Development Core Team, 2005, R LANG ENV STAT COMP; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Shen H, 2005, PLANT J, V44, P1023, DOI 10.1111/j.1365-313X.2005.02606.x; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Thain SC, 2004, PLANT PHYSIOL, V136, P3751, DOI 10.1104/pp.104.042523; Tsuda M, 2000, J EXP BOT, V51, P823, DOI 10.1093/jexbot/51.345.823; TUTTY JR, 1994, J AM SOC HORTIC SCI, V119, P138, DOI 10.21273/JASHS.119.2.138; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Woelfle MA, 2004, CURR BIOL, V14, P1481, DOI 10.1016/j.cub.2004.08.023; Yamashino T, 2003, PLANT CELL PHYSIOL, V44, P619, DOI 10.1093/pcp/pcg078	41	496	518	0	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2007	448	7151					358	U11		10.1038/nature05946	http://dx.doi.org/10.1038/nature05946			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17589502				2022-12-01	WOS:000248118300059
J	Koster, DA; Palle, K; Bot, ESM; Bjornsti, MA; Dekker, NH				Koster, Daniel A.; Palle, Komaraiah; Bot, Elisa S. M.; Bjornsti, Mary-Ann; Dekker, Nynke H.			Antitumour drugs impede DNA uncoiling by topoisomerase I	NATURE			English	Article							CELL-DEATH; CAMPTOTHECIN; MECHANISM; RELAXATION; INHIBITORS; YEAST; REPLICATION; MUTATIONS; COMPLEXES; TOXICITY	Increasing the ability of chemotherapeutic drugs to kill cancer cells is often hampered by a limited understanding of their mechanism of action. Camptothecins, such as topotecan, induce cell death by poisoning DNA topoisomerase I, an enzyme capable of removing DNA supercoils(1-4). Topotecan is thought to stabilize a covalent topoisomerase-DNA complex(5-7), rendering it an obstacle to DNA replication forks(2,3,8,9). Here we use single-molecule nanomanipulation to monitor the dynamics of human topoisomerase I in the presence of topotecan. This allowed us to detect the binding and unbinding of an individual topotecan molecule in real time and to quantify the drug-induced trapping of topoisomerase on DNA. Unexpectedly, our findings also show that topotecan significantly hinders topoisomerase-mediated DNA uncoiling, with a more pronounced effect on the removal of positive (overwound) versus negative supercoils. In vivo experiments in the budding yeast verified the resulting prediction that positive supercoils would accumulate during transcription and replication as a consequence of camptothecin poisoning of topoisomerase I. Positive supercoils, however, were not induced by drug treatment of cells expressing a catalytically active, camptothecin-resistant topoisomerase I mutant. This combination of single-molecule and in vivo data suggests a cytotoxic mechanism for camptothecins, in which the accumulation of positive supercoils ahead of the replication machinery induces potentially lethal DNA lesions.	Delft Univ Technol, Fac Sci Appl, Kavli Inst Nanosci, NL-2628 CJ Delft, Netherlands; St Jude Childrens Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA	Delft University of Technology; St Jude Children's Research Hospital	Dekker, NH (corresponding author), Delft Univ Technol, Fac Sci Appl, Kavli Inst Nanosci, Lorentzweg 1, NL-2628 CJ Delft, Netherlands.	n.h.dekker@tudelft.nl		Dekker, Nynke/0000-0003-4029-0973				Bjornsti MA, 2002, CANCER CELL, V2, P267, DOI 10.1016/S1535-6108(02)00160-5; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; CHAMPOUX JJ, 1989, J BIOL CHEM, V264, P1010; Chrencik JE, 2004, J MOL BIOL, V339, P773, DOI 10.1016/j.jmb.2004.03.007; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; GIAEVER GN, 1988, CELL, V55, P849, DOI 10.1016/0092-8674(88)90140-7; GOTO T, 1984, CELL, V36, P1073, DOI 10.1016/0092-8674(84)90057-6; Hann C, 1998, J BIOL CHEM, V273, P8425, DOI 10.1074/jbc.273.14.8425; HOLM C, 1989, CANCER RES, V49, P6365; HSIANG YH, 1989, CANCER RES, V49, P5077; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Koster DA, 2005, NATURE, V434, P671, DOI 10.1038/nature03395; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Megonigal MD, 1997, J BIOL CHEM, V272, P12801, DOI 10.1074/jbc.272.19.12801; Minsky Bruce D, 2004, Oncology (Williston Park), V18, P49; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; PORTER SE, 1989, NUCLEIC ACIDS RES, V17, P8521, DOI 10.1093/nar/17.21.8521; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Rodriguez-Galindo C, 2000, MED PEDIATR ONCOL, V35, P385, DOI 10.1002/1096-911X(20001001)35:4<385::AID-MPO1>3.0.CO;2-E; SEKIGUCHI J, 1994, J BIOL CHEM, V269, P31731; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Stewart DJ, 2004, ONCOLOGIST, V9, P33, DOI 10.1634/theoncologist.9-90006-33; Stewart L, 1999, J BIOL CHEM, V274, P32950, DOI 10.1074/jbc.274.46.32950; Stivers JT, 1997, BIOCHEMISTRY-US, V36, P5212, DOI 10.1021/bi962880t; Strick T, 2000, PROG BIOPHYS MOL BIO, V74, P115, DOI 10.1016/S0079-6107(00)00018-3; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Woo MH, 2003, P NATL ACAD SCI USA, V100, P13767, DOI 10.1073/pnas.2235886100; Woo MH, 2002, J BIOL CHEM, V277, P3813, DOI 10.1074/jbc.M110484200	30	224	228	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2007	448	7150					213	217		10.1038/nature05938	http://dx.doi.org/10.1038/nature05938			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188QN	17589503				2022-12-01	WOS:000247934500047
J	Foster, SL; Hargreaves, DC; Medzhitov, R				Foster, Simmie L.; Hargreaves, Diana C.; Medzhitov, Ruslan			Gene-specific control of inflammation by TLR-induced chromatin modifications	NATURE			English	Article							KAPPA-B; MACROPHAGE ACTIVATION; MOLECULAR-MECHANISMS; MURINE MACROPHAGES; BACTERIAL PYROGENS; MESSENGER-RNA; TNF-ALPHA; IN-VITRO; RECEPTOR; LIPOPOLYSACCHARIDE	Toll-like receptors (TLRs) induce a multi-component inflammatory response that must be tightly regulated to avoid tissue damage. Most known regulatory mechanisms target TLR signalling pathways and thus broadly inhibit multiple aspects of the inflammatory response. Given the functional diversity of TLR-induced genes, we proposed that additional, gene-specific regulatory mechanisms exist to allow individual aspects of the TLR-induced response to be differentially regulated. Using an in vitro system of lipopolysaccharide tolerance in murine macrophages, we show that TLR-induced genes fall into two categories on the basis of their functions and regulatory requirements. We demonstrate that representatives from the two classes acquire distinct patterns of TLR-induced chromatin modifications. These gene-specific chromatin modifications are associated with transient silencing of one class of genes, which includes pro-inflammatory mediators, and priming of the second class, which includes antimicrobial effectors. These findings illustrate an adaptive response in macrophages and reveal component-specific regulation of inflammation.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06405 USA; Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06405 USA	Howard Hughes Medical Institute; Yale University; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06405 USA.	ruslan.medzhitov@yale.edu						BEESON PB, 1947, J EXP MED, V86, P29, DOI 10.1084/jem.86.1.29; BEESON PB, 1947, J EXP MED, V86, P39, DOI 10.1084/jem.86.1.39; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Chi T, 2004, NAT REV IMMUNOL, V4, P965, DOI 10.1038/nri1501; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Flohe S, 1999, CYTOKINE, V11, P796, DOI 10.1006/cyto.1998.0490; Fujihara M, 2000, J LEUKOCYTE BIOL, V68, P267; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; HENRICSON BE, 1993, INFECT IMMUN, V61, P2325, DOI 10.1128/IAI.61.6.2325-2333.1993; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kaufmann A, 2000, EUR J IMMUNOL, V30, P1562, DOI 10.1002/1521-4141(200006)30:6<1562::AID-IMMU1562>3.0.CO;2-Q; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Learn CA, 2000, J BIOL CHEM, V275, P12185, DOI 10.1074/jbc.275.16.12185; Leoni F, 2005, MOL MED, V11, P1, DOI 10.2119/2006-00005.Dinarello; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; Medvedev AE, 2002, J IMMUNOL, V169, P5209, DOI 10.4049/jimmunol.169.9.5209; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Nieuwdorp M, 2005, CURR OPIN PHARMACOL, V5, P155, DOI 10.1016/j.coph.2004.10.003; Nusinzon I, 2005, J INTERF CYTOK RES, V25, P745, DOI 10.1089/jir.2005.25.745; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Shnyra A, 1998, J IMMUNOL, V160, P3729; Smale ST, 2003, NAT IMMUNOL, V4, P607, DOI 10.1038/ni0703-607; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; West MA, 2002, CRIT CARE MED, V30, pS64, DOI 10.1097/00003246-200201001-00009	37	871	911	6	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2007	447	7147					972	U4		10.1038/nature05836	http://dx.doi.org/10.1038/nature05836			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180NU	17538624				2022-12-01	WOS:000247373100040
J	Furuhashi, M; Tuncman, G; Gorgun, CZ; Makowski, L; Atsumi, G; Vaillancourt, E; Kono, K; Babaev, VR; Fazio, S; Linton, MF; Sulsky, R; Robl, JA; Parker, RA; Hotamisligil, GS				Furuhashi, Masato; Tuncman, Guerol; Goerguen, Cem Z.; Makowski, Liza; Atsumi, Genichi; Vaillancourt, Eric; Kono, Keita; Babaev, Vladimir R.; Fazio, Sergio; Linton, MacRae F.; Sulsky, Richard; Robl, Jeffrey A.; Parker, Rex A.; Hotamisligil, Goekhan S.			Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2	NATURE			English	Article							HUMAN THP-1 MACROPHAGES; FOAM CELL-FORMATION; INSULIN-RESISTANCE; METABOLIC-RESPONSES; MURINE MACROPHAGES; DEFICIENT MICE; EXPRESSION; OBESITY; GENE; ACTIVATION	Adipocyte fatty-acid-binding protein, aP2 (FABP4) is expressed in adipocytes and macrophages, and integrates inflammatory and metabolic responses. Studies in aP2-deficient mice have shown that this lipid chaperone has a significant role in several aspects of metabolic syndrome, including type 2 diabetes and atherosclerosis. Here we demonstrate that an orally active small-molecule inhibitor of aP2 is an effective therapeutic agent against severe atherosclerosis and type 2 diabetes in mouse models. In macrophage and adipocyte cell lines with or without aP2, we also show the target specificity of this chemical intervention and its mechanisms of action on metabolic and inflammatory pathways. Our findings demonstrate that targeting aP2 with small-molecule inhibitors is possible and can lead to a new class of powerful therapeutic agents to prevent and treat metabolic diseases such as type 2 diabetes and atherosclerosis.	Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USA	Harvard University; Harvard T.H. Chan School of Public Health; Vanderbilt University; Bristol-Myers Squibb	Hotamisligil, GS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	ghotamis@hsph.harvard.edu	Furuhashi, Masato/AAT-5518-2021; Eckhardt, Erik/G-1567-2010	Furuhashi, Masato/0000-0002-0145-3541; Makowski, Liza/0000-0002-5337-8037; Vaillancourt, Eric/0000-0002-1810-126X	NHLBI NIH HHS [F32 HL075970] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL075970] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Babaev VR, 2000, J BIOL CHEM, V275, P26293, DOI 10.1074/jbc.M002423200; BLASI E, 1985, NATURE, V318, P667, DOI 10.1038/318667a0; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boord JB, 2002, ARTERIOSCL THROM VAS, V22, P1686, DOI 10.1161/01.ATV.0000033090.81345.E6; Cao H, 2006, DIABETES, V55, P1915, DOI 10.2337/db05-1496; DISTEL RJ, 1992, J BIOL CHEM, V267, P5937; Fisher RM, 2001, DIABETOLOGIA, V44, P1268, DOI 10.1007/s001250100643; Fu YC, 2002, ATHEROSCLEROSIS, V165, P259, DOI 10.1016/S0021-9150(02)00305-2; Fu YC, 2000, J LIPID RES, V41, P2017; Hertzel AV, 2000, TRENDS ENDOCRIN MET, V11, P175; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; HUNT CR, 1986, P NATL ACAD SCI USA, V83, P3786, DOI 10.1073/pnas.83.11.3786; Kazemi MR, 2005, ARTERIOSCL THROM VAS, V25, P1220, DOI 10.1161/01.ATV.0000159163.52632.1b; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; Llaverias G, 2004, BIOCHEM BIOPH RES CO, V318, P265, DOI 10.1016/j.bbrc.2004.04.021; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Makowski L, 2005, J BIOL CHEM, V280, P12888, DOI 10.1074/jbc.M413788200; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; MELKI SA, 1993, J LIPID RES, V34, P1527; Pelton PD, 1999, BIOCHEM BIOPH RES CO, V261, P456, DOI 10.1006/bbrc.1999.1071; Scheja L, 1999, DIABETES, V48, P1987, DOI 10.2337/diabetes.48.10.1987; Sethi JK, 2000, FEBS LETT, V469, P77, DOI 10.1016/S0014-5793(00)01250-3; SULSKY R, IN PRESS BIOORG MED; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P6970, DOI 10.1073/pnas.0602178103; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388	28	528	570	2	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2007	447	7147					959	U2		10.1038/nature05844	http://dx.doi.org/10.1038/nature05844			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180NU	17554340	Green Accepted			2022-12-01	WOS:000247373100038
J	Birney, E; Stamatoyannopoulos, JA; Dutta, A; Guigo, R; Gingeras, TR; Margulies, EH; Weng, ZP; Snyder, M; Dermitzakis, ET; Stamatoyannopoulos, JA; Thurman, RE; Kuehn, MS; Taylor, CM; Neph, S; Koch, CM; Asthana, S; Malhotra, A; Adzhubei, I; Greenbaum, JA; Andrews, RM; Flicek, P; Boyle, PJ; Cao, H; Carter, NP; Clelland, GK; Davis, S; Day, N; Dhami, P; Dillon, SC; Dorschner, MO; Fiegler, H; Giresi, PG; Goldy, J; Hawrylycz, M; Haydock, A; Humbert, R; James, KD; Johnson, BE; Johnson, EM; Frum, TT; Rosenzweig, ER; Karnani, N; Lee, K; Lefebvre, GC; Navas, PA; Neri, F; Parker, SCJ; Sabo, PJ; Sandstrom, R; Shafer, A; Vetrie, D; Weaver, M; Wilcox, S; Yu, M; Collins, FS; Dekker, J; Lieb, JD; Tullius, TD; Crawford, GE; Sunyaev, S; Noble, WS; Dunham, I; Dutta, A; Guigo, R; Denoeud, F; Reymond, A; Kapranov, P; Rozowsky, J; Zheng, DY; Castelo, R; Frankish, A; Harrow, J; Ghosh, S; Sandelin, A; Hofacker, IL; Baertsch, R; Keefe, D; Flicek, P; Dike, S; Cheng, J; Hirsch, HA; Sekinger, EA; Lagarde, J; Abril, JF; Shahab, A; Flamm, C; Fried, C; Hackermuller, J; Hertel, J; Lindemeyer, M; Missal, K; Tanzer, A; Washietl, S; Korbel, J; Emanuelsson, O; Pedersen, JS; Holroyd, N; Taylor, R; Swarbreck, D; Matthews, N; Dickson, MC; Thomas, DJ; Weirauch, MT; Gilbert, J; Drenkow, J; Bell, I; Zhao, X; Srinivasan, KG; Sung, WK; Ooi, HS; Chiu, KP; Foissac, S; Alioto, T; Brent, M; Pachter, L; Tress, ML; Valencia, A; Choo, SW; Choo, CY; Ucla, C; Manzano, C; Wyss, C; Cheung, E; Clark, TG; Brown, JB; Ganesh, M; Patel, S; Tammana, H; Chrast, J; Henrichsen, CN; Kai, C; Kawai, J; Nagalakshmi, U; Wu, JQ; Lian, Z; Lian, J; Newburger, P; Zhang, XQ; Bickel, P; Mattick, JS; Carninci, P; Hayashizaki, Y; Weissman, S; Dermitzakis, ET; Margulies, EH; Hubbard, T; Myers, RM; Rogers, J; Stadler, PF; Lowe, TM; Wei, CL; Ruan, YJ; Snyder, M; Birney, E; Struhl, K; Gerstein, M; Antonarakis, SE; Gingeras, TR; Brown, JB; Flicek, P; Fu, YT; Keefe, D; Birney, E; Denoeud, F; Gerstein, M; Green, ED; Kapranov, P; Karaoz, U; Myers, RM; Noble, WS; Reymond, A; Rozowsky, J; Struhl, K; Siepel, A; Stamatoyannopoulos, JA; Taylor, CM; Taylor, J; Thurman, RE; Tullius, TD; Washietl, S; Zheng, DY; Liefer, LA; Wetterstrand, KA; Good, PJ; Feingold, EA; Guyer, MS; Collins, FS; Margulies, EH; Cooper, GM; Asimenos, G; Thomas, DJ; Dewey, CN; Siepel, A; Birney, E; Keefe, D; Hou, MM; Taylor, J; Nikolaev, S; Montoya-Burgos, JI; Loytynoja, A; Whelan, S; Pardi, F; Massingham, T; Brown, JB; Huang, HY; Zhang, NR; Bickel, P; Holmes, I; Mullikin, JC; Ureta-Vidal, A; Paten, B; Seringhaus, M; Church, D; Rosenbloom, K; Kent, WJ; Stone, EA; Gerstein, M; Antonarakis, SE; Batzoglou, S; Goldman, N; Hardison, RC; Haussler, D; Miller, W; Pachter, L; Green, ED; Sidow, A; Weng, ZP; Trinklein, ND; Fu, YT; Zhang, ZDD; Karaoz, U; Barrera, L; Stuart, R; Zheng, DY; Ghosh, S; Flicek, P; King, DC; Taylor, J; Ameur, A; Enroth, S; Bieda, MC; Koch, CM; Hirsch, HA; Wei, CL; Cheng, J; Kim, J; Bhinge, AA; Giresi, PG; Jiang, N; Liu, J; Yao, F; Sung, WK; Chiu, KP; Vega, VB; Lee, CWH; Ng, P; Shahab, A; Sekinger, EA; Yang, A; Moqtaderi, Z; Zhu, Z; Xu, XQ; Squazzo, S; Oberley, MJ; Inman, D; Singer, MA; Richmond, TA; Munn, KJ; Rada-Iglesias, A; Wallerman, O; Komorowski, J; Clelland, GK; Wilcox, S; Dillon, SC; Andrews, RM; Fowler, JC; Couttet, P; James, KD; Lefebvre, GC; Bruce, AW; Dovey, OM; Ellis, PD; Dhami, P; Langford, CF; Carter, NP; Vetrie, D; Kapranov, P; Nix, DA; Bell, I; Patel, S; Rozowsky, J; Euskirchen, G; Hartman, S; Lian, J; Wu, JQ; Urban, AE; Kraus, P; Van Calcar, S; Heintzman, N; Kim, TH; Wang, K; Qu, CX; Hon, G; Luna, R; Glass, CK; Rosenfeld, MG; Aldred, SF; Cooper, SJ; Halees, A; Lin, JM; Shulha, HP; Zhang, XL; Xu, MS; Haidar, JNS; Yu, Y; Birney, E; Weissman, S; Ruan, YJ; Lieb, JD; Iyer, VR; Green, RD; Gingeras, TR; Wadelius, C; Dunham, I; Struhl, K; Hardison, RC; Gerstein, M; Farnham, PJ; Myers, RM; Ren, B; Snyder, M; Thomas, DJ; Rosenbloom, K; Harte, RA; Hinrichs, AS; Trumbower, H; Clawson, H; Hillman-Jackson, J; Zweig, AS; Smith, K; Thakkapallayil, A; Barber, G; Kuhn, RM; Karolchik, D; Haussler, D; Kent, WJ; Dermitzakis, ET; Armengol, L; Bird, CP; Clark, TG; Cooper, GM; de Bakker, PIW; Kern, AD; Lopez-Bigas, N; Martin, JD; Stranger, BE; Thomas, DJ; Woodroffe, A; Batzoglou, S; Davydov, E; Dimas, A; Eyras, E; Hallgrimsdottir, IB; Hardison, RC; Huppert, J; Sidow, A; Taylor, J; Trumbower, H; Zody, MC; Guigo, R; Mullikin, JC; Abecasis, GR; Estivill, X; Birney, E; Bouffard, GG; Guan, XB; Hansen, NF; Idol, JR; Maduro, VVB; Maskeri, B; McDowell, JC; Park, M; Thomas, PJ; Young, AC; Blakesley, RW; Muzny, DM; Sodergren, E; Wheeler, DA; Worley, KC; Jiang, HY; Weinstock, GM; Gibbs, RA; Graves, T; Fulton, R; Mardis, ER; Wilson, RK; Clamp, M; Cuff, J; Gnerre, S; Jaffe, DB; Chang, JL; Lindblad-Toh, K; Lander, ES; Koriabine, M; Nefedov, M; Osoegawa, K; Yoshinaga, Y; Zhu, BL; de Jong, PJ				Birney, Ewan; Stamatoyannopoulos, John A.; Dutta, Anindya; Guigo, Roderic; Gingeras, Thomas R.; Margulies, Elliott H.; Weng, Zhiping; Snyder, Michael; Dermitzakis, Emmanouil T.; Stamatoyannopoulos, John A.; Thurman, Robert E.; Kuehn, Michael S.; Taylor, Christopher M.; Neph, Shane; Koch, Christoph M.; Asthana, Saurabh; Malhotra, Ankit; Adzhubei, Ivan; Greenbaum, Jason A.; Andrews, Robert M.; Flicek, Paul; Boyle, Patrick J.; Cao, Hua; Carter, Nigel P.; Clelland, Gayle K.; Davis, Sean; Day, Nathan; Dhami, Pawandeep; Dillon, Shane C.; Dorschner, Michael O.; Fiegler, Heike; Giresi, Paul G.; Goldy, Jeff; Hawrylycz, Michael; Haydock, Andrew; Humbert, Richard; James, Keith D.; Johnson, Brett E.; Johnson, Ericka M.; Frum, Tristan T.; Rosenzweig, Elizabeth R.; Karnani, Neerja; Lee, Kirsten; Lefebvre, Gregory C.; Navas, Patrick A.; Neri, Fidencio; Parker, Stephen C. J.; Sabo, Peter J.; Sandstrom, Richard; Shafer, Anthony; Vetrie, David; Weaver, Molly; Wilcox, Sarah; Yu, Man; Collins, Francis S.; Dekker, Job; Lieb, Jason D.; Tullius, Thomas D.; Crawford, Gregory E.; Sunyaev, Shamil; Noble, William S.; Dunham, Ian; Dutta, Anindya; Guigo, Roderic; Denoeud, France; Reymond, Alexandre; Kapranov, Philipp; Rozowsky, Joel; Zheng, Deyou; Castelo, Robert; Frankish, Adam; Harrow, Jennifer; Ghosh, Srinka; Sandelin, Albin; Hofacker, Ivo L.; Baertsch, Robert; Keefe, Damian; Flicek, Paul; Dike, Sujit; Cheng, Jill; Hirsch, Heather A.; Sekinger, Edward A.; Lagarde, Julien; Abril, Josep F.; Shahab, Atif; Flamm, Christoph; Fried, Claudia; Hackermueller, Joerg; Hertel, Jana; Lindemeyer, Manja; Missal, Kristin; Tanzer, Andrea; Washietl, Stefan; Korbel, Jan; Emanuelsson, Olof; Pedersen, Jakob S.; Holroyd, Nancy; Taylor, Ruth; Swarbreck, David; Matthews, Nicholas; Dickson, Mark C.; Thomas, Daryl J.; Weirauch, Matthew T.; Gilbert, James; Drenkow, Jorg; Bell, Ian; Zhao, XiaoDong; Srinivasan, K. G.; Sung, Wing-Kin; Ooi, Hong Sain; Chiu, Kuo Ping; Foissac, Sylvain; Alioto, Tyler; Brent, Michael; Pachter, Lior; Tress, Michael L.; Valencia, Alfonso; Choo, Siew Woh; Choo, Chiou Yu; Ucla, Catherine; Manzano, Caroline; Wyss, Carine; Cheung, Evelyn; Clark, Taane G.; Brown, James B.; Ganesh, Madhavan; Patel, Sandeep; Tammana, Hari; Chrast, Jacqueline; Henrichsen, Charlotte N.; Kai, Chikatoshi; Kawai, Jun; Nagalakshmi, Ugrappa; Wu, Jiaqian; Lian, Zheng; Lian, Jin; Newburger, Peter; Zhang, Xueqing; Bickel, Peter; Mattick, John S.; Carninci, Piero; Hayashizaki, Yoshihide; Weissman, Sherman; Dermitzakis, Emmanouil T.; Margulies, Elliott H.; Hubbard, Tim; Myers, Richard M.; Rogers, Jane; Stadler, Peter F.; Lowe, Todd M.; Wei, Chia-Lin; Ruan, Yijun; Snyder, Michael; Birney, Ewan; Struhl, Kevin; Gerstein, Mark; Antonarakis, Stylianos E.; Gingeras, Thomas R.; Brown, James B.; Flicek, Paul; Fu, Yutao; Keefe, Damian; Birney, Ewan; Denoeud, France; Gerstein, Mark; Green, Eric D.; Kapranov, Philipp; Karaoez, Ulas; Myers, Richard M.; Noble, William S.; Reymond, Alexandre; Rozowsky, Joel; Struhl, Kevin; Siepel, Adam; Stamatoyannopoulos, John A.; Taylor, Christopher M.; Taylor, James; Thurman, Robert E.; Tullius, Thomas D.; Washietl, Stefan; Zheng, Deyou; Liefer, Laura A.; Wetterstrand, Kris A.; Good, Peter J.; Feingold, Elise A.; Guyer, Mark S.; Collins, Francis S.; Margulies, Elliott H.; Cooper, Gregory M.; Asimenos, George; Thomas, Daryl J.; Dewey, Colin N.; Siepel, Adam; Birney, Ewan; Keefe, Damian; Hou, Minmei; Taylor, James; Nikolaev, Sergey; Montoya-Burgos, Juan I.; Loeytynoja, Ari; Whelan, Simon; Pardi, Fabio; Massingham, Tim; Brown, James B.; Huang, Haiyan; Zhang, Nancy R.; Bickel, Peter; Holmes, Ian; Mullikin, James C.; Ureta-Vidal, Abel; Paten, Benedict; Seringhaus, Michael; Church, Deanna; Rosenbloom, Kate; Kent, W. James; Stone, Eric A.; Gerstein, Mark; Antonarakis, Stylianos E.; Batzoglou, Serafim; Goldman, Nick; Hardison, Ross C.; Haussler, David; Miller, Webb; Pachter, Lior; Green, Eric D.; Sidow, Arend; Weng, Zhiping; Trinklein, Nathan D.; Fu, Yutao; Zhang, Zhengdong D.; Karaoez, Ulas; Barrera, Leah; Stuart, Rhona; Zheng, Deyou; Ghosh, Srinka; Flicek, Paul; King, David C.; Taylor, James; Ameur, Adam; Enroth, Stefan; Bieda, Mark C.; Koch, Christoph M.; Hirsch, Heather A.; Wei, Chia-Lin; Cheng, Jill; Kim, Jonghwan; Bhinge, Akshay A.; Giresi, Paul G.; Jiang, Nan; Liu, Jun; Yao, Fei; Sung, Wing-Kin; Chiu, Kuo Ping; Vega, Vinsensius B.; Lee, Charlie W. H.; Ng, Patrick; Shahab, Atif; Sekinger, Edward A.; Yang, Annie; Moqtaderi, Zarmik; Zhu, Zhou; Xu, Xiaoqin; Squazzo, Sharon; Oberley, Matthew J.; Inman, David; Singer, Michael A.; Richmond, Todd A.; Munn, Kyle J.; Rada-Iglesias, Alvaro; Wallerman, Ola; Komorowski, Jan; Clelland, Gayle K.; Wilcox, Sarah; Dillon, Shane C.; Andrews, Robert M.; Fowler, Joanna C.; Couttet, Phillippe; James, Keith D.; Lefebvre, Gregory C.; Bruce, Alexander W.; Dovey, Oliver M.; Ellis, Peter D.; Dhami, Pawandeep; Langford, Cordelia F.; Carter, Nigel P.; Vetrie, David; Kapranov, Philipp; Nix, David A.; Bell, Ian; Patel, Sandeep; Rozowsky, Joel; Euskirchen, Ghia; Hartman, Stephen; Lian, Jin; Wu, Jiaqian; Urban, Alexander E.; Kraus, Peter; Van Calcar, Sara; Heintzman, Nate; Kim, Tae Hoon; Wang, Kun; Qu, Chunxu; Hon, Gary; Luna, Rosa; Glass, Christopher K.; Rosenfeld, M. Geoff; Force Aldred, Shelley; Cooper, Sara J.; Halees, Anason; Lin, Jane M.; Shulha, Hennady P.; Zhang, Xiaoling; Xu, Mousheng; Haidar, Jaafar N. S.; Yu, Yong; Birney, Ewan; Weissman, Sherman; Ruan, Yijun; Lieb, Jason D.; Iyer, Vishwanath R.; Green, Roland D.; Gingeras, Thomas R.; Wadelius, Claes; Dunham, Ian; Struhl, Kevin; Hardison, Ross C.; Gerstein, Mark; Farnham, Peggy J.; Myers, Richard M.; Ren, Bing; Snyder, Michael; Thomas, Daryl J.; Rosenbloom, Kate; Harte, Rachel A.; Hinrichs, Angie S.; Trumbower, Heather; Clawson, Hiram; Hillman-Jackson, Jennifer; Zweig, Ann S.; Smith, Kayla; Thakkapallayil, Archana; Barber, Galt; Kuhn, Robert M.; Karolchik, Donna; Haussler, David; Kent, W. James; Dermitzakis, Emmanouil T.; Armengol, Lluis; Bird, Christine P.; Clark, Taane G.; Cooper, Gregory M.; de Bakker, Paul I. W.; Kern, Andrew D.; Lopez-Bigas, Nuria; Martin, Joel D.; Stranger, Barbara E.; Thomas, Daryl J.; Woodroffe, Abigail; Batzoglou, Serafim; Davydov, Eugene; Dimas, Antigone; Eyras, Eduardo; Hallgrimsdottir, Ingileif B.; Hardison, Ross C.; Huppert, Julian; Sidow, Arend; Taylor, James; Trumbower, Heather; Zody, Michael C.; Guigo, Roderic; Mullikin, James C.; Abecasis, Goncalo R.; Estivill, Xavier; Birney, Ewan; Bouffard, Gerard G.; Guan, Xiaobin; Hansen, Nancy F.; Idol, Jacquelyn R.; Maduro, Valerie V. B.; Maskeri, Baishali; McDowell, Jennifer C.; Park, Morgan; Thomas, Pamela J.; Young, Alice C.; Blakesley, Robert W.; Muzny, Donna M.; Sodergren, Erica; Wheeler, David A.; Worley, Kim C.; Jiang, Huaiyang; Weinstock, George M.; Gibbs, Richard A.; Graves, Tina; Fulton, Robert; Mardis, Elaine R.; Wilson, Richard K.; Clamp, Michele; Cuff, James; Gnerre, Sante; Jaffe, David B.; Chang, Jean L.; Lindblad-Toh, Kerstin; Lander, Eric S.; Koriabine, Maxim; Nefedov, Mikhail; Osoegawa, Kazutoyo; Yoshinaga, Yuko; Zhu, Baoli; de Jong, Pieter J.		ENCODE Project Consortium	Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project	NATURE			English	Review							FACTOR-BINDING-SITES; POLYCOMB TARGET GENES; SEQUENCE TAG ANALYSIS; HIGH-RESOLUTION; ANTISENSE TRANSCRIPTION; REGULATORY ELEMENTS; ADENINE TRACT; C-MYC; DNA; REPLICATION	We report the generation and analysis of functional data from multiple, diverse experiments performed on a targeted 1% of the human genomeas part of the pilot phase of the ENCODE Project. These data have been further integrated and augmented by a number of evolutionary and computational analyses. Together, our results advance the collective knowledge about human genome function in several major areas. First, our studies provide convincing evidence that the genome is pervasively transcribed, such that the majority of its bases can be found in primary transcripts, including non-protein-coding transcripts, and those that extensively overlap one another. Second, systematic examination of transcriptional regulation has yielded new understanding about transcription start sites, including their relationship to specific regulatory sequences and features of chromatin accessibility and histone modification. Third, a more sophisticated view of chromatin structure has emerged, including its inter-relationship with DNA replication and transcriptional regulation. Finally, integration of these new sources of information, in particular with respect to mammalian evolution based on inter-and intra-species sequence comparisons, has yielded new mechanistic and evolutionary insights concerning the functional landscape of the human genome. Together, these studies are defining a path for pursuit of a more comprehensive characterization of human genome function.	EMBL European Bioinformat Inst, Cambridge CB10 1SD, England; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; Univ Pompeu Fabra, Inst Municipal Invest Med, Res Grp Biomed Informat, Barcelona 08003, Spain; Univ Pompeu Fabra, Ctr Genom Regulat, Genom Bioinformat Program, Barcelona 08003, Spain; Affymetrix Inc, Santa Clara, CA 95051 USA; NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; Boston Univ, Bioinformat Program, Boston, MA 02215 USA; Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Washington, Div Med Genet, Seattle, WA 98195 USA; Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Boston Univ, Dept Chem, Boston, MA 02215 USA; Boston Univ, Program Bioinformat, Boston, MA 02215 USA; NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; Allen Inst Brain Sci, Seattle, WA 98103 USA; Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; Duke Univ, Dept Pediat, Durham, NC 27708 USA; Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; Univ Geneva, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; RIKEN, Yokohama Inst, RIKEN Genom Sci Ctr, Genome Explorat Res Grp,Tsurumi Ku, Kanagawa 2300045, Japan; Univ Vienna, Inst Theoret Chem, A-1090 Vienna, Austria; Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Univ Barcelona, Fac Biol, Dept Genet, Barcelona 08028, Catalonia, Spain; Bioinformat Inst, Singapore 138671, Singapore; Univ Leipzig, Interdisciplinary Ctr Bioinformat, D-04107 Leipzig, Germany; Univ Leipzig, Dept Comp Sci, Bioinformat Grp, D-04107 Leipzig, Germany; Fraunhofer Inst Zelltherapie & Immunol, D-04103 Leipzig, Germany; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Genome Inst Singapore, Singapore 138672, Singapore; Washington Univ, Lab Computat Genom, St Louis, MO 63130 USA; Univ Calif Berkeley, Dept Math & Comp Sci, Berkeley, CA 94720 USA; Spanish Natl Canc Res Ctr, CNIO, E-28029 Madrid, Spain; Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; Univ Calif Berkeley, Dept Appl Sci & Technol, Berkeley, CA 94720 USA; RIKEN, Wako Inst, Discovery & Res Inst, Genome Sci Lab, Wako, Saitama 3510198, Japan; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01605 USA; Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; Santa Fe Inst, Santa Fe, NM 87501 USA; Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; NHGRI, NIH Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA; Penn State Univ, Dept Comp Sci & Engn, University Pk, PA 16802 USA; Penn State Univ, Ctr Comparat Genom & Bioinformat, Huck Inst Life Sci, University Pk, PA 16802 USA; NHGRI, Div Extramural Res, NIH, Bethesda, MD 20892 USA; NHGRI, Off Director, NIH, Bethesda, MD 20892 USA; Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53706 USA; Univ Geneva, Fac Sci, Dept Zool & Anim Biol, CH-1205 Geneva, Switzerland; Stanford Univ, Dept Stat, Stanford, CA 94305 USA; Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; Penn State Univ, HUck Inst Life Sci, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, HUman Genome Sequencing Ctr, Houston, TX 77030 USA; Washington Univ, Genom Sequencing Ctr, St Louis, MO 63108 USA; Harvard Univ, Broad Inst, Cambridge, MA 02141 USA; MIT, Cambridge, MA 02141 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Childrens Hosp, Oakland Res Inst, BACPAC Resources, Oakland, CA 94609 USA; Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Uppsala Univ, Linnaeus Ctr Bioinformat, SE-75124 Uppsala, Sweden; Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA; NimbleGen Syst Inc, Madison, WI 53711 USA; Univ Wisconsin, Sch Med, Madison, WI 53706 USA; Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, SE-75185 Uppsala, Sweden; Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; Ctr Genom Regulat, Genes & Dis Program, Barcelona 08003, Spain; MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Cambridge, MA 02142 USA; Ctr Stat Genet, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Oxford, Dept Stat, Oxford OX1 3TG, England	European Molecular Biology Laboratory (EMBL); University of Washington; University of Washington Seattle; University of Virginia; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Affymetrix; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Boston University; Boston University; Yale University; Yale University; Wellcome Trust Sanger Institute; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston University; Boston University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Allen Institute for Brain Science; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Duke University; Duke University; University of Lausanne; University of Geneva; RIKEN; University of Vienna; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Harvard University; Harvard Medical School; University of Barcelona; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Leipzig University; Leipzig University; Fraunhofer Gesellschaft; Stanford University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Washington University (WUSTL); University of California System; University of California Berkeley; Centro Nacional de Investigaciones Oncologicas (CNIO); Imperial College London; University of California System; University of California Berkeley; RIKEN; Yale University; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California Berkeley; University of Queensland; The Santa Fe Institute; Yale University; Yale University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Stanford University; University of Wisconsin System; University of Wisconsin Madison; University of Geneva; Stanford University; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Stanford University; Baylor College of Medicine; Baylor College of Medicine; Washington University (WUSTL); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; Ludwig Institute for Cancer Research; Uppsala University; University of California System; University of California Davis; University of California System; University of California Davis; University of Texas System; University of Texas Austin; Roche Holding; Roche NimbleGen; University of Wisconsin System; University of Wisconsin Madison; Uppsala University; University of California System; University of California San Diego; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; University of Oxford	Birney, E (corresponding author), EMBL European Bioinformat Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England.	birney@ebi.ac.uk; jstam@u.washington.edu; ad8q@virginia.edu; rguigo@imim.es; Tom_Gingeras@affymetrix.com; elliott@nhgri.nih.gov; zhiping@bu.edu; michael.snyder@yale.edu; md4@sanger.ac.uk	Gasull, Martina/J-4076-2019; Brown, James/H-2971-2015; Choo, Siew Woh/E-3406-2010; Califano, Andrea/F-7239-2012; Parker, Stephen/ABF-1063-2021; Hinrichs, Angie S./H-9159-2019; Dermitzakis, Emmanouil/B-7687-2013; Bruce, Alexander W/H-4235-2014; Lagarde, Julien/AAI-1686-2020; Ameur, Adam/E-6207-2011; Pedersen, Jakob/G-3382-2012; Kim, Jonghwan/AAR-2815-2021; Antonarakis, Stylianos E/N-8866-2014; Alioto, Tyler/K-7267-2015; Guigo, Roderic/D-1303-2010; Hofacker, Ivo L/A-2378-2013; Karaoz, Ulas/J-7093-2014; Ferrando, Josep F Abril/B-3877-2014; Taylor, James/F-1026-2011; Mardis, Elaine/W-2202-2019; Glass, Christopher/AAI-3933-2021; Pedersen, Jakob/C-4985-2009; Eyras, Eduardo/A-1560-2010; Oberley, Matthew/L-4326-2019; Chiu, Kuo-Ping/AAG-8855-2020; Malhotra, Ankit/I-3752-2012; Dillon, Shane/A-2280-2011; Carninci, Piero/K-1568-2014; Mattick, John S/I-7789-2012; Wilson, Richard K./AAF-4139-2019; Zhang, Xiaoling/A-7132-2013; Lowe, Todd Michael/ABJ-5261-2022; Enroth, Stefan/C-7396-2009; Hardison, Ross C/G-1142-2010; Weinstock, George M/C-6314-2013; Korbel, Jan O/G-6470-2012; Peng, Bo/A-6920-2009; Brent, Michael/AAK-3702-2020; Kawai, Jun/A-6451-2016; Mattick, John/ABH-6130-2020; Huppert, Julian/C-6664-2008; Tanzer, Andrea/L-3147-2015; Alioto, Tyler/AAF-6342-2020; Karnani, Neerja/G-2539-2012; Hor, Charlotte/H-5908-2015; Valencia, Alfonso/I-3127-2015; Hubbard, Tim J.P./AAT-4571-2020; Hackermüller, Jörg/F-2494-2016; Hubbard, Tim J/C-2567-2008; Malhotra, Ankit/J-8130-2019; Stone, Eric/Q-7840-2016; Dutta, Anindya/P-3203-2016; Whelan, Simon/A-6638-2011; Tullius, Thomas D./A-9685-2008; Komorowski, Jan/M-2667-2013; Komorowski, Jan/AAP-1685-2020; Stadler, Peter F. F/L-7857-2015; Couttet, Philippe/AAH-5489-2019; Castelo, Robert/A-4679-2010; Cooper, Gregory/D-6914-2011; de Bakker, Paul IW/B-8730-2009; Sandelin, Albin/G-2881-2011; Clawson, Hiram/ABE-6101-2020; Lopez-Bigas, Nuria/F-6193-2011; Estivill, Xavier/E-2957-2012; Tanzer, Andrea/AAY-5431-2021; Hor, Charlotte/AAB-4850-2020; Eyras, Eduardo/ABG-7144-2020; Oberley, Matthew/I-8107-2019; Nikolaev, Sergey/F-3148-2012; Abecasis, Goncalo R/B-7840-2010; Clark, Taane G./AAM-2570-2020; Schor, Jana/F-8503-2017; Eduardo, Eyras/L-1053-2014; Estivill, Xavier/A-3125-2013; Wheeler, David A/M-9740-2018; Frankish, Adam/G-6545-2011; Davis, Sean/AAD-1801-2021; Weirauch, Matthew/M-5459-2019; Taylor, Christopher M./AAF-5480-2020; Komorowski, Jan/A-9175-2010	Hinrichs, Angie S./0000-0002-1697-1130; Bruce, Alexander W/0000-0003-4297-4412; Lagarde, Julien/0000-0002-0290-7445; Ameur, Adam/0000-0001-6085-6749; Pedersen, Jakob/0000-0002-7236-4001; Antonarakis, Stylianos E/0000-0001-8907-5823; Alioto, Tyler/0000-0002-2960-5420; Guigo, Roderic/0000-0002-5738-4477; Hofacker, Ivo L/0000-0001-7132-0800; Karaoz, Ulas/0000-0002-8238-6757; Ferrando, Josep F Abril/0000-0001-7793-589X; Taylor, James/0000-0001-5079-840X; Glass, Christopher/0000-0003-4344-3592; Chiu, Kuo-Ping/0000-0001-9144-0674; Carninci, Piero/0000-0001-7202-7243; Mattick, John S/0000-0002-7680-7527; Wilson, Richard K./0000-0002-1992-1358; Enroth, Stefan/0000-0002-5056-9137; Hardison, Ross C/0000-0003-4084-7516; Weinstock, George M/0000-0002-2997-4592; Korbel, Jan O/0000-0002-2798-3794; Peng, Bo/0000-0001-8225-2284; Brent, Michael/0000-0002-8689-0299; Mattick, John/0000-0002-7680-7527; Huppert, Julian/0000-0001-5207-4886; Tanzer, Andrea/0000-0003-2873-4236; Alioto, Tyler/0000-0002-2960-5420; Hor, Charlotte/0000-0002-5361-2372; Valencia, Alfonso/0000-0002-8937-6789; Hubbard, Tim J.P./0000-0002-1767-9318; Hackermüller, Jörg/0000-0003-4920-7072; Hubbard, Tim J/0000-0002-1767-9318; Malhotra, Ankit/0000-0002-1905-0732; Tullius, Thomas D./0000-0003-4425-796X; Komorowski, Jan/0000-0002-0766-8789; Komorowski, Jan/0000-0002-0766-8789; Stadler, Peter F. F/0000-0002-5016-5191; Castelo, Robert/0000-0003-2229-4508; Cooper, Gregory/0000-0001-5509-9923; de Bakker, Paul IW/0000-0001-7735-7858; Sandelin, Albin/0000-0002-7109-7378; Lopez-Bigas, Nuria/0000-0003-4925-8988; Tanzer, Andrea/0000-0003-2873-4236; Hor, Charlotte/0000-0002-5361-2372; Eyras, Eduardo/0000-0003-0793-6218; Oberley, Matthew/0000-0001-6419-2513; Clark, Taane G./0000-0001-8985-9265; Schor, Jana/0000-0003-1200-6234; Eduardo, Eyras/0000-0003-0793-6218; Estivill, Xavier/0000-0002-0723-2256; Wheeler, David A/0000-0002-9056-6299; Davis, Sean/0000-0002-8991-6458; Taylor, Christopher M./0000-0002-7983-5275; Cooper, Sara/0000-0002-9627-0309; Stuart, Rhona/0000-0001-5916-9693; Cuff, James/0000-0003-0570-4106; Montoya-Burgos, Juan I./0000-0001-9080-9820; Reymond, Alexandre/0000-0003-1030-8327; Karnani, Neerja/0000-0002-5301-409X; Dunham, Ian/0000-0003-2525-5598; Rada-Iglesias, Alvaro/0000-0001-7137-1341; Reiche, Kristin/0000-0002-4452-4872; Flamm, Christoph/0000-0001-5500-2415; Fosker, Christine/0000-0002-3799-9474; Lefebvre, Greg/0000-0001-7519-2316; Siepel, Adam/0000-0002-3557-7219; Marz, Manja/0000-0003-4783-8823; Adzhubey, Ivan/0000-0002-1483-9259; King, David/0000-0003-1601-1612; Vetrie, David/0000-0003-2075-4662; Farnham, Peggy/0000-0003-4469-7914; Stranger, Barbara/0000-0001-9021-7331; Sung, Wing-Kin/0000-0001-7806-7086; Flicek, Paul/0000-0002-3897-7955; Gingeras, Thomas/0000-0001-9106-3573; Worley, Kim/0000-0002-0282-1000; Kandhadayar, Gopalan Srinivasan/0000-0003-4387-8502; Stone, Eric/0000-0002-2725-4209; Wallerman, Ola/0000-0003-1037-7904; /0000-0001-9150-3954; Foissac, Sylvain/0000-0002-2631-5356; Holmes, Ian/0000-0001-7639-5369; Snyder, Michael/0000-0003-0784-7987; Harrow, Jennifer/0000-0003-0338-3070; Bhinge, Akshay/0000-0003-2939-099X; Frankish, Adam/0000-0002-4333-628X; Soriaga, Leah/0000-0001-5852-741X; Clawson, Hiram/0000-0002-0480-0545; Rozowsky, Joel/0000-0002-3565-0762; Newburger, Peter/0000-0002-8615-673X; Kapranov, Philipp/0000-0003-2647-4856; Halees, Anason/0000-0001-5880-7067; Abecasis, Goncalo/0000-0003-1509-1825; Goldman, Nick/0000-0001-8486-2211; Loytynoja, Ari/0000-0001-5389-6611; Dutta, Anindya/0000-0002-4319-0073; Pachter, Lior/0000-0002-9164-6231; Zheng, Deyou/0000-0003-4354-5337; Lieb, Jason/0000-0001-7601-8061; Swarbreck, David/0000-0002-5453-1013; Denoeud, France/0000-0001-8819-7634; Koch, Christof/0000-0001-6482-8067; FRUM, Tristan/0000-0003-3452-8762; Hallgrimsdottir, Ingileif/0000-0002-4710-0047; Birney, Ewan/0000-0001-8314-8497; Tress, Michael/0000-0001-9046-6370; Kim, Tae Hoon/0000-0003-3950-7557; Sandstrom, Richard/0000-0002-3356-1547; Kim, Jonghwan/0000-0002-9919-9843	NCI NIH HHS [F32 CA108313] Funding Source: Medline; NHGRI NIH HHS [U01 HG003156, U54 HG003079, K22 HG003169-01A1, R01 HG003541-03, R01 HG003110-03, U01 HG003161-03, U01 HG003150-03, U01 HG003162, K22 HG003169, R01 HG002238, R01 HG003532-01, U01 HG003147-02, R01 HG003129-03, P41 HG002371-03S1, R01 HG003521, U01 HG003161, U01 HG003147, U01 HG003156-03, R01 HG003110, U54 HG003079-01, U01 HG003162-03, U01 HG002523-01, U01 HG003151, R01 HG003532, U01 HG003157, R01 HG002238-15, U54 HG003273, U54 HG003067, U54 HG003273-01, U54 HG003067-01, U01 HG002523, U01 HG003157-03, P41 HG002371, R01 HG003143, R01 HG003521-01, R01 HG003143-04, R01 HG003541, U01 HG003151-03, U01 HG003168-02, U01 HG003150] Funding Source: Medline; Wellcome Trust [062023, 077198] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA108313] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003110, U01HG003168, U54HG003273, U01HG003147, U01HG003156, Z01HG000196, U01HG003150, U01HG003157, R01HG003532, R01HG003143, U54HG003067, R01HG003541, Z01HG200341, R01HG003129, R01HG002238, U54HG003079, K22HG003169, R01HG003521, P41HG002371, U01HG003151, U01HG003162, U01HG003161, U01HG002523, Z01HG200330, Z01HG000060] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [Z01LM000160] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; ASTHANA S, UNPUB PLOS COMP BIOL; Azuara V, 2003, NAT CELL BIOL, V5, P668, DOI 10.1038/ncb1006; Bajic VB, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s3; Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Bhinge AA, 2007, GENOME RES, V17, P910, DOI 10.1101/gr.5574907; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Blakesley RW, 2004, GENOME RES, V14, P2235, DOI 10.1101/gr.2648404; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bray N, 2004, GENOME RES, V14, P693, DOI 10.1101/gr.1960404; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; BURKHOFF AM, 1988, NATURE, V331, P455, DOI 10.1038/331455a0; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; CLARK TG, 2007, UNPUB GENOME BIOL; Cohen SM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-301; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cooper GM, 2004, GENOME RES, V14, P539, DOI 10.1101/gr.2034704; Cooper GM, 2003, GENOME RES, V13, P813, DOI 10.1101/gr.1064503; Cooper SJ, 2006, GENOME RES, V16, P1, DOI 10.1101/gr.4222606; Crawford GE, 2006, NAT METHODS, V3, P503, DOI 10.1038/NMETH888; de Laat W, 2003, CHROMOSOME RES, V11, P447, DOI 10.1023/A:1024922626726; Delaval K, 2006, BIOESSAYS, V28, P453, DOI 10.1002/bies.20407; Denoeud F, 2007, GENOME RES, V17, P746, DOI 10.1101/gr.5660607; Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Dillon N, 2006, CHROMOSOME RES, V14, P117, DOI 10.1007/s10577-006-1027-8; Dorschner M, 2004, NAT METHODS, V1, P219, DOI 10.1038/NMETH721; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Eddy SR, 2005, PLOS BIOL, V3, P95, DOI 10.1371/journal.pbio.0030010; Emanuelsson O, 2007, GENOME RES, V17, P886, DOI 10.1101/gr.5014606; Euskirchen GM, 2007, GENOME RES, V17, P898, DOI 10.1101/gr.5583007; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Gartler SM, 1999, HUM MOL GENET, V8, P1085, DOI 10.1093/hmg/8.6.1085; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gilbert DM, 2002, CURR OPIN CELL BIOL, V14, P377, DOI 10.1016/S0955-0674(02)00326-5; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Greenbaum JA, 2007, GENOME RES, V17, P940, DOI 10.1101/gr.5602807; GUIGO R, 2006, GENOME BIOL S1, V7, P1; Halees AS, 2004, NUCLEIC ACIDS RES, V32, pW191, DOI 10.1093/nar/gkh433; Harrison PM, 2005, NUCLEIC ACIDS RES, V33, P2374, DOI 10.1093/nar/gki531; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; HATTON KS, 1988, MOL CELL BIOL, V8, P2149, DOI 10.1128/MCB.8.5.2149; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hogan GJ, 2006, PLOS GENET, V2, P1433, DOI 10.1371/journal.pgen.0020158; Horak CE, 2002, P NATL ACAD SCI USA, V99, P2924, DOI 10.1073/pnas.052706999; HUDSON RR, 1987, GENETICS, V116, P153; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jeon Y, 2005, P NATL ACAD SCI USA, V102, P6419, DOI 10.1073/pnas.0405088102; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Karnani N, 2007, GENOME RES, V17, P865, DOI 10.1101/gr.5427007; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kim JW, 2005, NAT METHODS, V2, P47, DOI 10.1038/NMETH726; Kim TH, 2005, GENOME RES, V15, P830, DOI 10.1101/gr.3430605; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Ludwig MZ, 2005, PLOS BIOL, V3, P588, DOI 10.1371/journal.pbio.0030093; LUDWIG MZ, 1995, MOL BIOL EVOL, V12, P1002; MacAlpine DM, 2004, GENE DEV, V18, P3094, DOI 10.1101/gad.1246404; Margulies EH, 2005, P NATL ACAD SCI USA, V102, P4795, DOI 10.1073/pnas.0409882102; Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; McAuliffe JD, 2005, P NATL ACAD SCI USA, V102, P7900, DOI 10.1073/pnas.0502790102; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mighell AJ, 2000, FEBS LETT, V468, P109, DOI 10.1016/S0014-5793(00)01199-6; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Parra G, 2006, GENOME RES, V16, P37, DOI 10.1101/gr.4145906; PRICE MA, 1993, BIOCHEMISTRY-US, V32, P127, DOI 10.1021/bi00052a018; Rada-Iglesias A, 2005, HUM MOL GENET, V14, P3435, DOI 10.1093/hmg/ddi378; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rozowsky JS, 2007, GENOME RES, V17, P732, DOI 10.1101/gr.5696007; Runte M, 2001, HUM MOL GENET, V10, P2687, DOI 10.1093/hmg/10.23.2687; RUPPERT S, 1993, NATURE, V362, P175, DOI 10.1038/362175a0; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Schubeler D, 2002, NAT GENET, V32, P438, DOI 10.1038/ng1005; Schwaiger M, 2006, CURR OPIN GENET DEV, V16, P177, DOI 10.1016/j.gde.2006.02.007; Seidl CIM, 2006, EMBO J, V25, P3565, DOI 10.1038/sj.emboj.7601245; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Stone EA, 2005, ANNU REV GENOM HUM G, V6, P143, DOI 10.1146/annurev.genom.6.080604.162146; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Thomas JW, 2002, GENOME RES, V12, P1277, DOI 10.1101/gr.283202; Thurman RE, 2007, GENOME RES, V17, P917, DOI 10.1101/gr.6081407; Tress ML, 2007, P NATL ACAD SCI USA, V104, P5495, DOI 10.1073/pnas.0700800104; Trinklein ND, 2007, GENOME RES, V17, P720, DOI 10.1101/gr.5716607; Trinklein ND, 2003, GENOME RES, V13, P308, DOI 10.1101/gr.794803; Turner BM, 2005, NAT STRUCT MOL BIOL, V12, P110, DOI 10.1038/nsmb0205-110; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Washietl S, 2007, GENOME RES, V17, P852, DOI 10.1101/gr.5650707; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; White EJ, 2004, P NATL ACAD SCI USA, V101, P17771, DOI 10.1073/pnas.0408170101; Willingham AT, 2006, CELL, V125, P1215, DOI 10.1016/j.cell.2006.06.009; Woodfine K, 2004, HUM MOL GENET, V13, P191, DOI 10.1093/hmg/ddh016; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zhang ZDD, 2007, GENOME RES, V17, P787, DOI 10.1101/gr.5573107; Zheng DY, 2007, GENOME RES, V17, P839, DOI 10.1101/gr.5586307; Zheng D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s13; Zheng DY, 2005, J MOL BIOL, V349, P27, DOI 10.1016/j.jmb.2005.02.072; [No title captured]	128	3794	3979	8	520	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2007	447	7146					799	816		10.1038/nature05874	http://dx.doi.org/10.1038/nature05874			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17571346	Bronze, Green Submitted, Green Published, Green Accepted			2022-12-01	WOS:000247207500034
J	Wohrl, S; Geusau, A				Woehrl, Stefan; Geusau, Alexandra			Clinical update: syphilis in adults	LANCET			English	Article							NEUROSYPHILIS; EPIDEMIC; HIV; TESTS		Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, A-1090 Vienna, Austria	Medical University of Vienna	Wohrl, S (corresponding author), Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, A-1090 Vienna, Austria.	stefan.woehrl@meduniwien.ac.at	Wöhrl, Stefan/B-6954-2013; Geusau, Alexandra/AAL-5272-2020	Wöhrl, Stefan/0000-0002-6324-0007; Geusau, Alexandra/0000-0003-0347-065X				Antal GM, 2002, MICROBES INFECT, V4, P83, DOI 10.1016/S1286-4579(01)01513-1; Augenbraun MH, 2002, CLIN INFECT DIS, V35, pS187, DOI 10.1086/342106; Aynalem G, 2006, SEX TRANSM INFECT, V82, P439, DOI 10.1136/sti.2006.020412; *BRIT ASS SEX HLTH, 2006, BASHH CLIN EFF GUID; Centers for Disease Control and Prevention, 2006, MMWR Recomm Rep, V55, P1; Chen ZQ, 2007, LANCET, V369, P132, DOI 10.1016/S0140-6736(07)60074-9; Flood JM, 1998, J INFECT DIS, V177, P931, DOI 10.1086/515245; Geusau A, 2005, INT J STD AIDS, V16, P722, DOI 10.1258/095646205774763207; Goh BT, 2001, INT J STD AIDS, V12, P14, DOI 10.1258/0956462011924065; JOHNS DR, 1987, NEW ENGL J MED, V316, P1569, DOI 10.1056/NEJM198706183162503; LARSEN SA, 1995, CLIN MICROBIOL REV, V8, P1; Lukehart SA, 2004, NEW ENGL J MED, V351, P154, DOI 10.1056/NEJMoa040216; Marcus U, 2005, SEX TRANSM INFECT, V81, P456, DOI 10.1136/sti.2005.014555; Marra CM, 2004, J INFECT DIS, V189, P369, DOI 10.1086/381227; Nicoll A, 2002, BMJ-BRIT MED J, V324, P1324, DOI 10.1136/bmj.324.7349.1324; Reynolds SJ, 2006, SEX TRANSM INFECT, V82, P121, DOI 10.1136/sti.2005.015040; Romano A, 2004, ANN INTERN MED, V141, P16, DOI 10.7326/0003-4819-141-1-200407060-00010; Simms I, 2005, SEX TRANSM DIS, V32, P220, DOI 10.1097/01.olq.0000149848.03733.c1; Wohrl S, 2006, ACTA DERM-VENEREOL, V86, P335, DOI 10.2340/00015555-0092	19	20	23	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 9	2007	369	9577					1912	1914		10.1016/S0140-6736(07)60895-2	http://dx.doi.org/10.1016/S0140-6736(07)60895-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	177IQ	17560432				2022-12-01	WOS:000247147200009
J	Kapranov, P; Cheng, J; Dike, S; Nix, DA; Duttagupta, R; Willingham, AT; Stadler, PF; Hertel, J; Hackermuller, J; Hofacker, IL; Bell, I; Cheung, E; Drenkow, J; Dumais, E; Patel, S; Helt, G; Ganesh, M; Ghosh, S; Piccolboni, A; Sementchenko, V; Tammana, H; Gingeras, TR				Kapranov, Philipp; Cheng, Jill; Dike, Sujit; Nix, David A.; Duttagupta, Radharani; Willingham, Aarron T.; Stadler, Peter F.; Hertel, Jana; Hackermueller, Joerg; Hofacker, Ivo L.; Bell, Ian; Cheung, Evelyn; Drenkow, Jorg; Dumais, Erica; Patel, Sandeep; Helt, Gregg; Ganesh, Madhavan; Ghosh, Srinka; Piccolboni, Antonio; Sementchenko, Victor; Tammana, Hari; Gingeras, Thomas R.			RNA maps reveal new RNA classes and a possible function for pervasive transcription	SCIENCE			English	Article							GENE; EVOLUTION	Significant fractions of eukaryotic genomes give rise to RNA, much of which is unannotated and has reduced protein-coding potential. The genomic origins and the associations of human nuclear and cytosolic polyadenylated RNAs longer than 200 nucleotides ( nt) and whole-cell RNAs less than 200 nt were investigated in this genome-wide study. Subcellular addresses for nucleotides present in detected RNAs were assigned, and their potential processing into short RNAs was investigated. Taken together, these observations suggest a novel role for some unannotated RNAs as primary transcripts for the production of short RNAs. Three potentially functional classes of RNAs have been identified, two of which are syntenically conserved and correlate with the expression state of protein-coding genes. These data support a highly interleaved organization of the human transcriptome.	Affymetrix Inc, Affymetrix Lab, Santa Clara, CA 95051 USA; Univ Leipzig, Dept Comp Sci, D-7010 Leipzig, Germany; Univ Vienna, Inst Theoret Chem, A-1010 Vienna, Austria; Fraunhofer Inst Cell Therapy & Immunol, Leipzig, Germany	Affymetrix; Leipzig University; University of Vienna; Fraunhofer Gesellschaft	Gingeras, TR (corresponding author), Affymetrix Inc, Affymetrix Lab, 3420 Cent Expressway, Santa Clara, CA 95051 USA.	tom_gingeras@affymetrix.com	Stadler, Peter F. F/L-7857-2015; Schor, Jana/F-8503-2017; Hackermüller, Jörg/F-2494-2016; Hofacker, Ivo L/A-2378-2013	Stadler, Peter F. F/0000-0002-5016-5191; Schor, Jana/0000-0003-1200-6234; Hackermüller, Jörg/0000-0003-4920-7072; Hofacker, Ivo L/0000-0001-7132-0800; Kapranov, Philipp/0000-0003-2647-4856; Gingeras, Thomas/0000-0001-9106-3573	NCI NIH HHS [N01-CO-12400] Funding Source: Medline; NHGRI NIH HHS [U01HG003147] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG003147] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; MATTICK JS, 1994, CURR OPIN GENET DEV, V4, P823, DOI 10.1016/0959-437X(94)90066-3; Ohler U, 2004, RNA, V10, P1309, DOI 10.1261/rna.5206304; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Willingham AT, 2006, CELL, V125, P1215, DOI 10.1016/j.cell.2006.06.009	11	1818	1971	5	179	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2007	316	5830					1484	1488		10.1126/science.1138341	http://dx.doi.org/10.1126/science.1138341			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17510325				2022-12-01	WOS:000247066400045
J	Lee, H; Cheng, YC; Fleming, GR				Lee, Hohjai; Cheng, Yuan-Chung; Fleming, Graham R.			Coherence dynamics in photosynthesis: Protein protection of excitonic coherence	SCIENCE			English	Article							ENERGY-TRANSFER DYNAMICS; RHODOBACTER-SPHAEROIDES; REACTION CENTERS; PHOTON-ECHO; ELECTRON-DONOR; SPECTROSCOPY	The role of quantum coherence in promoting the efficiency of the initial stages of photosynthesis is an open and intriguing question. We performed a two-color photon echo experiment on a bacterial reaction center that enabled direct visualization of the coherence dynamics in the reaction center. The data revealed long-lasting coherence between two electronic states that are formed by mixing of the bacteriopheophytin and accessory bacteriochlorophyll excited states. This coherence can only be explained by strong correlation between the protein-induced fluctuations in the transition energy of neighboring chromophores. Our results suggest that correlated protein environments preserve electronic coherence in photosynthetic complexes and allow the excitation to move coherently in space, enabling highly efficient energy harvesting and trapping in photosynthesis.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Univ Calif Berkeley, QB3 Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Fleming, GR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	GRFleming@lbl.gov	Cheng, Yuan-Chung/A-6566-2008	Cheng, Yuan-Chung/0000-0003-0125-4267				Agarwal R, 2002, J CHEM PHYS, V116, P6243, DOI 10.1063/1.1459414; [Anonymous], 2002, PHOTOSYNTHETICA; Arnett DC, 1999, J PHYS CHEM B, V103, P2014, DOI 10.1021/jp984464j; BREE PD, 1979, J CHEM PHYS, V70, P790, DOI 10.1063/1.437512; Brixner T, 2004, J CHEM PHYS, V121, P4221, DOI 10.1063/1.1776112; Engel GS, 2007, NATURE, V446, P782, DOI 10.1038/nature05678; ERMLER U, 1994, STRUCTURE, V2, P925, DOI 10.1016/S0969-2126(94)00094-8; Groot ML, 1998, J PHYS CHEM B, V102, P5923, DOI 10.1021/jp9808680; Jackson JA, 1997, J PHYS CHEM B, V101, P5747, DOI 10.1021/jp970380j; Jang SJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.218301; JEAN JM, 1995, J CHEM PHYS, V103, P2092, DOI 10.1063/1.469684; Jordanides XJ, 2004, J PHYS CHEM B, V108, P1753, DOI 10.1021/jp036516x; Kuhn O, 2002, CHEM PHYS, V275, P15, DOI 10.1016/S0301-0104(01)00526-2; Meier T, 1997, J CHEM PHYS, V107, P8759, DOI 10.1063/1.475169; Novoderezhkin V, 2003, J PHYS CHEM B, V107, P11534, DOI 10.1021/jp035432l; OHTSUKI Y, 1989, J CHEM PHYS, V91, P3903, DOI 10.1063/1.456822; Parkinson DY, 2007, J PHYS CHEM B, V111, P7449, DOI 10.1021/jp070029q; PISILAKOV AV, 2006, J CHEM PHYS, V124; Renger T, 2001, PHYS REP, V343, P138, DOI 10.1016/S0370-1573(00)00078-8; Rickard MA, 2006, J PHYS CHEM A, V110, P11384, DOI 10.1021/jp063917e; Rubtsov IV, 2003, P NATL ACAD SCI USA, V100, P5601, DOI 10.1073/pnas.0931292100; Souaille M, 1997, J AM CHEM SOC, V119, P3948, DOI 10.1021/ja943841c; Stanley RJ, 1996, J PHYS CHEM-US, V100, P12052, DOI 10.1021/jp9614916; TREUTLEIN H, 1992, P NATL ACAD SCI USA, V89, P75, DOI 10.1073/pnas.89.1.75; van Grondelle R, 2006, PHYS CHEM CHEM PHYS, V8, P793, DOI 10.1039/b514032c; Vos MH, 1997, J PHYS CHEM B, V101, P9820, DOI 10.1021/jp971486h; WRAIGHT CA, 1974, BIOCHIM BIOPHYS ACTA, V333, P246, DOI 10.1016/0005-2728(74)90009-7; WYNNE K, 1993, CHEM PHYS, V171, P179, DOI 10.1016/0301-0104(93)85142-U	28	860	869	8	229	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2007	316	5830					1462	1465		10.1126/science.1142188	http://dx.doi.org/10.1126/science.1142188			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556580	Green Submitted			2022-12-01	WOS:000247066400038
J	Kasahara, M; Naruse, K; Sasaki, S; Nakatani, Y; Qu, W; Ahsan, B; Yamada, T; Nagayasu, Y; Doi, K; Kasai, Y; Jindo, T; Kobayashi, D; Shimada, A; Toyoda, A; Kuroki, Y; Fujiyama, A; Sasaki, T; Shimizu, A; Asakawa, S; Shimizu, N; Hashimoto, SI; Yang, J; Lee, Y; Matsushima, K; Sugano, S; Sakaizumi, M; Narita, T; Ohishi, K; Haga, S; Ohta, F; Nomoto, H; Nogata, K; Morishita, T; Endo, T; Shin-I, T; Takeda, H; Morishita, S; Kohara, Y				Kasahara, Masahiro; Naruse, Kiyoshi; Sasaki, Shin; Nakatani, Yoichiro; Qu, Wei; Ahsan, Budrul; Yamada, Tomoyuki; Nagayasu, Yukinobu; Doi, Koichiro; Kasai, Yasuhiro; Jindo, Tomoko; Kobayashi, Daisuke; Shimada, Atsuko; Toyoda, Atsushi; Kuroki, Yoko; Fujiyama, Asao; Sasaki, Takashi; Shimizu, Atsushi; Asakawa, Shuichi; Shimizu, Nobuyoshi; Hashimoto, Shin-ichi; Yang, Jun; Lee, Yongjun; Matsushima, Kouji; Sugano, Sumio; Sakaizumi, Mitsuru; Narita, Takanori; Ohishi, Kazuko; Haga, Shinobu; Ohta, Fumiko; Nomoto, Hisayo; Nogata, Keiko; Morishita, Tomomi; Endo, Tomoko; Shin-, Tadasu, I; Takeda, Hiroyuki; Morishita, Shinichi; Kohara, Yuji			The medaka draft genome and insights into vertebrate genome evolution	NATURE			English	Article							MITOCHONDRIAL-DNA SEQUENCES; RAY-FINNED FISHES; GENE MAP; DUPLICATION; CHROMOSOMES; PERSPECTIVE; PHYLOGENY; ZEBRAFISH; LATIPES; DMY	Teleosts comprise more than half of all vertebrate species and have adapted to a variety of marine and freshwater habitats(1). Their genome evolution and diversification are important subjects for the understanding of vertebrate evolution. Although draft genome sequences of two pufferfishes have been published(2,3), analysis of more fish genomes is desirable. Here we report a high-quality draft genome sequence of a small egg-laying freshwater teleost, medaka ( Oryzias latipes). Medaka is native to East Asia and an excellent model system for a wide range of biology, including ecotoxicology, carcinogenesis, sex determination(4-6) and developmental genetics(7). In the assembled medaka genome ( 700 megabases), which is less than half of the zebrafish genome, we predicted 20,141 genes, including 2,900 new genes, using 5'-end serial analysis of gene expression tag information. We found single nucleotide polymorphisms ( SNPs) at an average rate of 3.42% between the two inbred strains derived from two regional populations; this is the highest SNP rate seen in any vertebrate species. Analyses based on the dense SNP information show a strict genetic separation of 4 million years ( Myr) between the two populations, and suggest that differential selective pressures acted on specific gene categories. Four-way comparisons with the human, pufferfish ( Tetraodon), zebrafish and medaka genomes revealed that eight major interchromosomal rearrangements took place in a remarkably short period of similar to 50 Myr after the whole-genome duplication event in the teleost ancestor and afterwards, intriguingly, the medaka genome preserved its ancestral karyotype for more than 300 Myr.	Univ Tokyo, Dept Computat Biol, Grad Sch Frontier Sci, Kashiwa, Chiba 2770882, Japan; Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Tokyo 1130033, Japan; RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan; Natl Inst Informat, Tokyo 1018430, Japan; Keio Univ, Sch Med, Dept Mol Biol, Tokyo 1608582, Japan; Univ Tokyo, Dept Mol Prevent Med, Sch Med, Tokyo 1130033, Japan; Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Tokyo 1088639, Japan; Niigata Univ, Dept Environm Sci, Fac Sci, Niigata 9502181, Japan; Natl Inst Genet, Ctr Genet Resource Informat, Mishima, Shizuoka 4118540, Japan	University of Tokyo; University of Tokyo; RIKEN; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; Keio University; University of Tokyo; University of Tokyo; Niigata University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Kohara, Y (corresponding author), Univ Tokyo, Dept Computat Biol, Grad Sch Frontier Sci, Kashiwa, Chiba 2770882, Japan.	htakeda@biol.s.u-tokyo.ac.jp; ykohara@lab.nig.ac.jp	Narita, Takanori/F-1092-2011; TAKEDA, HIROYUKI/G-4950-2014; Sasaki, Takashi/AAD-1461-2019	Narita, Takanori/0000-0003-0295-5014; Kobayashi, Daisuke/0000-0001-9755-6168; Morishita, Shinichi/0000-0002-6201-8885; Sasaki, Takashi/0000-0002-6275-046X; Kasahara, Masahiro/0000-0001-8430-1414; Naruse, Kiyoshi/0000-0001-9185-3495; Nakatani, Yoichiro/0000-0001-7604-0242				Aida T, 1921, GENETICS, V6, P554; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; Crow KD, 2006, MOL BIOL EVOL, V23, P121, DOI 10.1093/molbev/msj020; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P629, DOI 10.1016/j.mod.2004.05.010; Hashimoto S, 2004, NAT BIOTECHNOL, V22, P1146, DOI 10.1038/nbt998; Hedges SB, 2002, SCIENCE, V297, P1283; Hyodo-Taguchi Y, 1996, FISH BIOL J MEDAKA, V8, P11; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kondo M, 2001, GENET RES, V78, P23, DOI 10.1017/S0016672301005109; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Miya M, 2003, MOL PHYLOGENET EVOL, V26, P121, DOI 10.1016/S1055-7903(02)00332-9; Naruse K, 2004, MECH DEVELOP, V121, P619, DOI 10.1016/j.mod.2004.04.014; Naruse K, 2004, GENOME RES, V14, P820, DOI 10.1101/gr.2004004; Nelson J.S., 2016, FISHES WORLD, DOI 10.1002/9781119174844; Ohno S., 1970, EVOLUTION GENE DUPLI, DOI [DOI 10.1007/978-3-642-86659-3, 10.1007/978-3-642-86659-3_11]; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Takehana Y, 2005, MOL PHYLOGENET EVOL, V36, P417, DOI 10.1016/j.ympev.2005.01.016; Takehana Y, 2003, ZOOL SCI, V20, P1279, DOI 10.2108/zsj.20.1279; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; YAMAMOTO TO, 1953, J EXP ZOOL, V123, P571, DOI 10.1002/jez.1401230309; Yamanoue Y, 2006, GENES GENET SYST, V81, P29, DOI 10.1266/ggs.81.29; Zhang JZ, 2004, GENETICS, V166, P1887, DOI 10.1534/genetics.166.4.1887	30	797	839	6	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2007	447	7145					714	719		10.1038/nature05846	http://dx.doi.org/10.1038/nature05846			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554307	hybrid			2022-12-01	WOS:000247030700044
J	Parmentier, E; Colleye, O; Fine, ML; Frederich, B; Vandewalle, P; Herrel, A				Parmentier, Eric; Colleye, Orphal; Fine, Michael L.; Frederich, Bruno; Vandewalle, Pierre; Herrel, Anthony			Sound production in the clownfish Amphiprion clarkii	SCIENCE			English	Article									Univ Liege, Inst Chim, Lab Morphol Fonct & Evolut, B-4000 Liege, Belgium; Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA; Univ Antwerp, Dept Biol, Lab Funct Morphol, B-2610 Antwerp, Belgium	University of Liege; Virginia Commonwealth University; University of Antwerp	Parmentier, E (corresponding author), Univ Liege, Inst Chim, Lab Morphol Fonct & Evolut, Batiment B6, B-4000 Liege, Belgium.	E.Parmentier@ulg.ac.be	Herrel, Anthony/C-3712-2013; Parmentier, Eric/P-9733-2018; Fine, Michael/I-2656-2019	Herrel, Anthony/0000-0003-0991-4434; Fine, Michael/0000-0001-9665-1462; Frederich, Bruno/0000-0003-3438-0243; Parmentier, Eric/0000-0002-0391-7530				Ladich Friedrich, 2006, P3; Mann DA, 1997, J ACOUST SOC AM, V101, P3783, DOI 10.1121/1.418425; Osse J.W.M., 1969, NETH J ZOOL, V19, P290; Parmentier E, 2005, P ROY SOC B-BIOL SCI, V272, P1697, DOI 10.1098/rspb.2005.3146; STIASSNY M L J, 1987, Bulletin of the Museum of Comparative Zoology, V151, P269; Tavolga W.N., 1971, FISH PHYSIOL BIOCHEM, V5, P135; Van Wassenbergh S, 2005, J EXP BIOL, V208, P4627, DOI 10.1242/jeb.01919; VERWEY J., 1930, TREUBIA, V12, P305	8	45	45	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2007	316	5827					1006	1006		10.1126/science.1139753	http://dx.doi.org/10.1126/science.1139753			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17510359	Green Submitted			2022-12-01	WOS:000246554000040
J	Kraft, M; Israel, E; O'Connor, GT				Kraft, Monica; Israel, Elliot; O'Connor, George T.			Treatment of mild persistent asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ORAL MONTELUKAST; CORTICOSTEROIDS; BECLOMETHASONE; SALMETEROL		Duke Med Ctr, Div Pulm, Durham, NC 27710 USA; Brigham & Womens Hosp, Div Pulm & Crit Care, Boston, MA 02115 USA; Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA	Duke University; Harvard University; Brigham & Women's Hospital; Boston University	Kraft, M (corresponding author), Duke Med Ctr, Div Pulm, Durham, NC 27710 USA.			O'Connor, George/0000-0002-6476-3926				Boulet LP, 2004, CURR OPIN PULM MED, V10, P15, DOI 10.1097/00063198-200401000-00004; Boushey HA, 2005, NEW ENGL J MED, V352, P1519, DOI 10.1056/NEJMoa042552; Breekvedt-Postma NS, 2004, RESP MED, V98, P752, DOI 10.1016/j.rmed.2004.01.014; Busse WW, 2002, J ALLERGY CLIN IMMUN, V110, P703, DOI 10.1067/mai.2002.129368; CHROININ MN, 2005, COCHRANE DB SYST REV, V4; Edelman JM, 2000, ANN INTERN MED, V132, P97, DOI 10.7326/0003-4819-132-2-200001180-00002; Ernst P, 2006, ANN INTERN MED, V145, P692, DOI 10.7326/0003-4819-145-9-200611070-00012; Israel E, 2001, NEW ENGL J MED, V345, P941, DOI 10.1056/NEJMoa002304; Malmstrom K, 1999, ANN INTERN MED, V130, P487, DOI 10.7326/0003-4819-130-6-199903160-00005; National Asthma Education and Prevention Program, 2002, NAT HEART LUNG BLOOD, V02-5075; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Papi A, 2007, NEW ENGL J MED, V356, P2040, DOI 10.1056/NEJMoa063861; Peters SP, 2007, NEW ENGL J MED, V356, P2027; Tattersfield Anne E, 2004, Proc Am Thorac Soc, V1, P171, DOI 10.1513/pats.200402-016MS; Zeiger RS, 2005, AM J MED, V118, P649, DOI 10.1016/j.amjmed.2005.03.003	15	8	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2007	356	20					2096	2100						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	167ZD	17507711				2022-12-01	WOS:000246490500014
J	McMichael, AJ; Bambrick, HJ				McMichael, Anthony J.; Bambrick, Hilary J.			Greenhouse-gas costs of clinical trials	LANCET			English	Editorial Material									Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia	Australian National University	McMichael, AJ (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia.	tony.mcmichael@anu.edu.au		Bambrick, Hilary/0000-0001-5361-950X				Burnett J, 2007, BMJ-BRIT MED J, V334, P671; McMichael AJ, 2006, EUR J PUBLIC HEALTH, V16, P579, DOI 10.1093/eurpub/ckl102; Stern N., 2007, EC CLIMATE CHANGE, DOI 10.1017/CBO9780511817434	3	6	6	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 12	2007	369	9573					1584	1585		10.1016/S0140-6736(07)60725-9	http://dx.doi.org/10.1016/S0140-6736(07)60725-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167YO	17499586				2022-12-01	WOS:000246488800009
J	Maeda, T; Merghoub, T; Hobbs, RM; Dong, L; Maeda, M; Zakrzewski, J; van den Brink, MRM; Zelent, A; Shigematsu, H; Akashi, K; Teruya-Feldstein, J; Cattoretti, G; Pandolfi, PP				Maeda, Takahiro; Merghoub, Taha; Hobbs, Robin M.; Dong, Lin; Maeda, Manami; Zakrzewski, Johannes; van den Brink, Marcel R. M.; Zelent, Arthur; Shigematsu, Hirokazu; Akashi, Koichi; Teruya-Feldstein, Julie; Cattoretti, Giorgio; Pandolfi, Pier Paolo			Regulation of B versus T lymphoid lineage fate decision by the proto-oncogene LRF	SCIENCE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; ZINC-FINGER PROTEIN; MOUSE BONE-MARROW; DIFFERENTIATION; NOTCH1; MICE; MAINTENANCE; PROGENITORS; APOPTOSIS	Hematopoietic stem cells in the bone marrow give rise to lymphoid progenitors, which subsequently differentiate into B and T lymphocytes. Here we show that the proto-oncogene LRF plays an essential role in the B versus T lymphoid cell-fate decision. We demonstrate that LRF is key for instructing early lymphoid progenitors in mice to develop into B lineage cells by repressing T cell-instructive signals produced by the cell-fate signal protein, Notch. We propose a new model for lymphoid lineage commitment, in which LRF acts as a master regulator of the cell's determination of B versus T lineage.	Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; Inst Canc Res, Leukemia Res Fund Ctr, Inst Canc Res, Chester Beatty Labs, London SW3 6JB, England; Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Columbia Univ, Inst Canc Genet, New York, NY 10032 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Harvard University; Dana-Farber Cancer Institute; Columbia University	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	p-pandolfi@ski.mskcc.org	Cattoretti, Giorgio/H-2340-2011; Maeda, Takahiro/AAC-4563-2019; Zelent, Arthur/B-3532-2009; Hobbs, Robin/I-2577-2014	Maeda, Takahiro/0000-0003-4530-6460; Zelent, Arthur/0000-0002-7968-9888; Hobbs, Robin/0000-0002-3853-2614; Cattoretti, Giorgio/0000-0003-3799-3221	NCI NIH HHS [R01 CA102142-06A1, R01 CA102142, CA-102142] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA102142] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; Davies JM, 1999, ONCOGENE, V18, P365, DOI 10.1038/sj.onc.1202332; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Harman BC, 2003, SEMIN IMMUNOL, V15, P91, DOI 10.1016/S1044-5323(03)00005-8; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Kikuchi K, 2005, J EXP MED, V201, P1197, DOI 10.1084/jem.20050158; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kukita A, 1999, BLOOD, V94, P1987, DOI 10.1182/blood.V94.6.1987.418k26_1987_1997; Lewis HD, 2007, CHEM BIOL, V14, P209, DOI 10.1016/j.chembiol.2006.12.010; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Medina KL, 2005, CURR OPIN HEMATOL, V12, P203, DOI 10.1097/01.moh.0000160735.67596.a0; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; Pessler F, 1997, MOL CELL BIOL, V17, P3786, DOI 10.1128/MCB.17.7.3786; Piazza F, 2004, MOL CELL BIOL, V24, P10456, DOI 10.1128/MCB.24.23.10456-10469.2004; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Sitnicka E, 2002, IMMUNITY, V17, P463, DOI 10.1016/S1074-7613(02)00419-3; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Vieira Paulo, 2004, Methods Mol Biol, V271, P67; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Zweidler-McKay PA, 2005, BLOOD, V106, P3898, DOI 10.1182/blood-2005-01-0355	27	170	176	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2007	316	5826					860	866		10.1126/science.1140881	http://dx.doi.org/10.1126/science.1140881			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17495164	Green Accepted			2022-12-01	WOS:000246369800030
J	van der Heide, A; Onwuteaka-Philipsen, BD; Rurup, ML; Buiting, HM; van Delden, JJM; Hanssen-de Wolf, JE; Janssen, AGJM; Pasman, HRW; Rietjens, JAC; Prins, CJM; Deerenberg, IM; Gevers, JKM; van der Maas, PJ; van der Wal, G				van der Heide, Agnes; Onwuteaka-Philipsen, Bregje D.; Rurup, Mette L.; Buiting, Hilde M.; van Delden, Johannes J. M.; Hanssen-de Wolf, Johanna E.; Janssen, Anke G. J. M.; Pasman, H. Roeline W.; Rietjens, Judith A. C.; Prins, Cornelis J. M.; Deerenberg, Ingeborg M.; Gevers, Joseph K. M.; van der Maas, Paul J.; van der Wal, Gerrit			End-of-life practices in the Netherlands under The Euthanasia Act	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TERMINAL SEDATION; DECISION-MAKING; DEATH; EXPERIENCES; BELGIUM; OPIOIDS; CARE	BACKGROUND: In 2002, an act regulating the ending of life by a physician at the request of a patient with unbearable suffering came into effect in the Netherlands. In 2005, we performed a follow-up study of euthanasia, physician-assisted suicide, and other end-of-life practices. METHODS: We mailed questionnaires to physicians attending 6860 deaths that were identified from death certificates. The response rate was 77.8%. RESULTS: In 2005, of all deaths in the Netherlands, 1.7% were the result of euthanasia and 0.1% were the result of physician-assisted suicide. These percentages were significantly lower than those in 2001, when 2.6% of all deaths resulted from euthanasia and 0.2% from assisted suicide. Of all deaths, 0.4% were the result of the ending of life without an explicit request by the patient. Continuous deep sedation was used in conjunction with possible hastening of death in 7.1% of all deaths in 2005, significantly increased from 5.6% in 2001. In 73.9% of all cases of euthanasia or assisted suicide in 2005, life was ended with the use of neuromuscular relaxants or barbiturates; opioids were used in 16.2% of cases. In 2005, 80.2% of all cases of euthanasia or assisted suicide were reported. Physicians were most likely to report their end-of-life practices if they considered them to be an act of euthanasia or assisted suicide, which was rarely true when opioids were used. CONCLUSIONS: The Dutch Euthanasia Act was followed by a modest decrease in the rates of euthanasia and physician-assisted suicide. The decrease may have resulted from the increased application of other end-of-life care interventions, such as palliative sedation.	Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; Univ Med Ctr, Utrecht, Netherlands; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; Stat Netherlands, Voorburg, Netherlands	Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	van der Heide, A (corresponding author), Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	a.vanderheide@erasmusmc.nl						[Anonymous], 1993, HIST PUBLIC HLTH; Bercovitch M, 2004, CANCER-AM CANCER SOC, V101, P1473, DOI 10.1002/cncr.20485; Blank RH, 2005, END OF LIFE DECISION; Deliens L, 2003, LANCET, V362, P1239, DOI 10.1016/S0140-6736(03)14520-5; Deliens L, 2000, LANCET, V356, P1806, DOI 10.1016/S0140-6736(00)03233-5; den Hartogh G, 2003, MED CONTACT, V58, P1063; Drazen JM, 2003, NEW ENGL J MED, V349, P1109, DOI 10.1056/NEJMp038146; FOLEYY K, 2002, CASE ASSISTED SUICID; Ganzini L, 2000, NEW ENGL J MED, V342, P1538; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; Ganzini L, 2002, NEW ENGL J MED, V347, P582, DOI 10.1056/NEJMsa020562; Morita T, 2001, J PAIN SYMPTOM MANAG, V21, P282, DOI 10.1016/S0885-3924(01)00258-5; Murray SA, 2005, BRIT MED J, V330, P611, DOI 10.1136/bmj.330.7492.611; Onwuteaka-Philipsen BD, 2005, BMJ-BRIT MED J, V331, P1065; Onwuteaka-Philipsen BD, 2003, LANCET, V362, P395, DOI 10.1016/S0140-6736(03)14029-9; Quill T.E., 2004, PHYS ASSISTED DYING; Quill TE, 2004, NEW ENGL J MED, V350, P2029, DOI 10.1056/NEJMp038216; Rietjens JAC, 2006, ARCH INTERN MED, V166, P749, DOI 10.1001/archinte.166.7.749; Rietjens JAC, 2004, ANN INTERN MED, V141, P178, DOI 10.7326/0003-4819-141-3-200408030-00006; Rurup M L, 2006, Ned Tijdschr Geneeskd, V150, P618; *STAT COMM EUTH, 1985, REP EUTH; Sykes N, 2003, LANCET ONCOL, V4, P312, DOI 10.1016/S1470-2045(03)01079-9; Thorns A, 2000, LANCET, V356, P398, DOI 10.1016/S0140-6736(00)02534-4; Tolle SW, 2004, J CLIN ETHIC, V15, P111; van der Heide A, 2003, LANCET, V362, P345, DOI 10.1016/S0140-6736(03)14019-6; van der Maas PJ, 1991, LANCET, V338, P669, DOI 10.1016/0140-6736(91)91241-L; van der Maas PJ, 1996, NEW ENGL J MED, V335, P1699, DOI 10.1056/NEJM199611283352227; vanderWal G, 1996, NEW ENGL J MED, V335, P1706	28	274	280	0	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2007	356	19					1957	1965		10.1056/NEJMsa071143	http://dx.doi.org/10.1056/NEJMsa071143			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165KX	17494928				2022-12-01	WOS:000246305500007
J	Amunts, A; Drory, O; Nelson, N				Amunts, Alexey; Drory, Omri; Nelson, Nathan			The structure of a plant photosystem I supercomplex at 3.4 angstrom resolution	NATURE			English	Article							LIGHT-HARVESTING-COMPLEX; STATE TRANSITIONS; ARABIDOPSIS-THALIANA; TRANSFER DYNAMICS; ELECTRON-TRANSFER; CRYSTAL-STRUCTURE; 14 KDA; PSI-G; SUBUNIT; EVOLUTION	All higher organisms on Earth receive energy directly or indirectly from oxygenic photosynthesis performed by plants, green algae and cyanobacteria. Photosystem I ( PSI) is a supercomplex of a reaction centre and light-harvesting complexes. It generates the most negative redox potential in nature, and thus largely determines the global amount of enthalpy in living systems. We report the structure of plant PSI at 3.4 angstrom resolution, revealing 17 protein subunits. PsaN was identified in the luminal side of the supercomplex, and most of the amino acids in the reaction centre were traced. The crystal structure of PSI provides a picture at near atomic detail of 11 out of 12 protein subunits of the reaction centre. At this level, 168 chlorophylls ( 65 assigned with orientations for Q(x) and Q(y) transition dipole moments), 2 phylloquinones, 3 Fe4S4 clusters and 5 carotenoids are described. This structural information extends the understanding of the most efficient nano-photochemical machine in nature.	Tel Aviv Univ, Dept Biochem, George S Wise Fac Life Sci, Daniella Rich Inst Struct Biol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Nelson, N (corresponding author), Tel Aviv Univ, Dept Biochem, George S Wise Fac Life Sci, Daniella Rich Inst Struct Biol, IL-69978 Tel Aviv, Israel.	nelson@post.tau.ac.il	Amunts, A./AAZ-2279-2020	Amunts, A./0000-0002-5302-1740; Nelson, Nathan/0000-0003-3588-7265				Allen JF, 2003, TRENDS PLANT SCI, V8, P15, DOI 10.1016/S1360-1385(02)00006-7; Amunts A, 2005, PHOTOCH PHOTOBIO SCI, V4, P1011, DOI 10.1039/b506132f; Anderson J M, 1995, Photosynth Res, V46, P129, DOI 10.1007/BF00020423; Bailey S, 2001, PLANTA, V213, P794, DOI 10.1007/s004250100556; Barber J, 2004, PHOTOSYNTH RES, V80, P137, DOI 10.1023/B:PRES.0000030662.04618.27; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; Ben-Shem A, 2004, PHOTOSYNTH RES, V81, P239, DOI 10.1023/B:PRES.0000036881.23512.42; Ben-Shem A, 2003, ACTA CRYSTALLOGR D, V59, P1824, DOI 10.1107/S0907444903016056; Ben-Shem A, 2004, FEBS LETT, V564, P274, DOI 10.1016/S0014-5793(04)00360-6; Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; Consoli E, 2005, EMBO REP, V6, P782, DOI 10.1038/sj.embor.7400464; Dashdorj N, 2005, BIOPHYS J, V88, P1238, DOI 10.1529/biophysj.104.050963; Durnford DG, 1999, J MOL EVOL, V48, P59, DOI 10.1007/PL00006445; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Ganeteg U, 2001, PLANT PHYSIOL, V127, P150, DOI 10.1104/pp.127.1.150; Haldrup A, 2001, TRENDS PLANT SCI, V6, P301, DOI 10.1016/S1360-1385(01)01953-7; Haldrup A, 1999, PLANT J, V17, P689, DOI 10.1046/j.1365-313X.1999.00419.x; HE WZ, 1992, FEBS LETT, V308, P298, DOI 10.1016/0014-5793(92)81297-Y; Ihalainen JA, 2002, BIOPHYS J, V83, P2190, DOI 10.1016/S0006-3495(02)73979-9; IKEUCHI M, 1991, FEBS LETT, V280, P332, DOI 10.1016/0014-5793(91)80324-V; Jansson S, 1996, PLANT PHYSIOL, V112, P409, DOI 10.1104/pp.112.1.409; Jensen PE, 2004, J BIOL CHEM, V279, P24212, DOI 10.1074/jbc.M403147200; Joliot P, 1999, BIOCHEMISTRY-US, V38, P11130, DOI 10.1021/bi990857c; Jolley C, 2005, J BIOL CHEM, V280, P33627, DOI 10.1074/jbc.M500937200; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kargul J, 2005, FEBS J, V272, P4797, DOI 10.1111/j.1742-4658.2005.04894.x; Khrouchtchova A, 2005, FEBS LETT, V579, P4808, DOI 10.1016/j.febslet.2005.07.061; KNOETZEL J, 1993, PLANT MOL BIOL, V22, P337, DOI 10.1007/BF00014940; Kouril R, 2005, BIOCHEMISTRY-US, V44, P10935, DOI 10.1021/bi051097a; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; KYLE DJ, 1983, ARCH BIOCHEM BIOPHYS, V222, P527, DOI 10.1016/0003-9861(83)90551-9; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Lucinski R, 2006, FEBS LETT, V580, P6485, DOI 10.1016/j.febslet.2006.10.063; Lunde C, 2000, NATURE, V408, P613, DOI 10.1038/35046121; Morosinotto T, 2005, J BIOL CHEM, V280, P31050, DOI 10.1074/jbc.M502935200; Morosinotto T, 2002, J BIOL CHEM, V277, P36253, DOI 10.1074/jbc.M205062200; Mozzo M, 2006, BBA-BIOENERGETICS, V1757, P1607, DOI 10.1016/j.bbabio.2006.06.018; Nelson N, 2005, BIOESSAYS, V27, P914, DOI 10.1002/bies.20278; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Scheller HV, 2001, BBA-BIOENERGETICS, V1507, P41, DOI 10.1016/S0005-2728(01)00196-7; Schmid VHR, 2002, BIOCHEMISTRY-US, V41, P9126, DOI 10.1021/bi016042x; Sener MK, 2005, BIOPHYS J, V89, P1630, DOI 10.1529/biophysj.105.066464; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; Takahashi H, 2006, P NATL ACAD SCI USA, V103, P477, DOI 10.1073/pnas.0509952103; TRISSL HW, 1993, TRENDS BIOCHEM SCI, V18, P415, DOI 10.1016/0968-0004(93)90136-B; Zygadlo A, 2006, J BIOL CHEM, V281, P10548, DOI 10.1074/jbc.M512687200	49	368	387	6	143	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 3	2007	447	7140					58	63		10.1038/nature05687	http://dx.doi.org/10.1038/nature05687			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17476261	Green Accepted			2022-12-01	WOS:000246149300042
J	Blackman, T				Blackman, Tim			Statins, saving lives, and shibbloleths	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Durham, Durham DH1 3HP, England	Durham University	Blackman, T (corresponding author), Univ Durham, Durham DH1 3HP, England.	tim.blackman@dur.ac.uk							0	8	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 28	2007	334	7599					902	902		10.1136/bmj.39163.563519.55	http://dx.doi.org/10.1136/bmj.39163.563519.55			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164FB	17463464	Green Published			2022-12-01	WOS:000246217800034
J	Anand, S; Barnighausen, T				Anand, Sudhir; Baernighausen, Till			Health workers and vaccination coverage in developing countries: an econometric analysis	LANCET			English	Article							IMMUNIZATION COVERAGE; HUMAN-RESOURCES; MEASLES; DETERMINANTS; ERADICATION; CHILDREN; BANGLADESH; EDUCATION; POLIO; AREA	Background Vaccine-preventable diseases cause more than 1 million deaths among children in developing countries every year. Although health workers are needed to do vaccinations, the role of human resources for health as a determinant of vaccination coverage at the population level has not been investigated. our aim was to test whether health worker density was positively associated with childhood vaccination coverage in developing countries. Methods We did cross-country multiple regression analyses with coverage of three vaccinations-measles-containing vaccine (MCV); diphtheria, tetanus, and pertussis (DTP3); and poliomyelitis (polio3)-as dependent variables. Aggregate health worker density was an independent variable in one set of regressions; doctor and nurse densities were used separately in another set. We controlled for national income per person, female adult literacy, and land area. Findings Health worker density was significantly associated with coverage of all three vaccinations (MCV p=0.0024; DTP3 p=0.0004; polio3 p=0.0008). However, when the effects of doctors and nurses were assessed separately, we found that nurse density was significantly associated with coverage of all three vaccinations (MCV p=0.0097; DTP3 p=0.0083; polio3 p=0.0089), but doctor density was not (MCV p=0.7953; DTP3 p=0.7971; polio3 p=0.7885). Female adult literacy was positively associated, and land area negatively associated, with vaccination coverage. National income per person had no effect on coverage. Interpretation A higher density of health workers (nurses) increases the availability of vaccination services over time and space, making it more likely that children will be vaccinated. After controlling for other determinants, the level of income does not contribute to improved immunisation coverage. Health workers can be a major constraining factor on vaccination coverage in developing countries.	Univ Oxford St Catherines Coll, Dept Econ, Oxford OX1 3UJ, England; Harvard Univ, Cambridge, MA 02138 USA; Univ KwaZulu Natal, Africa Ctr hlth & Populat Studies, Mtubatuba, South Africa; Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, Boston, MA 02115 USA	University of Oxford; Harvard University; University of Kwazulu Natal; Harvard University; Harvard T.H. Chan School of Public Health	Anand, S (corresponding author), Univ Oxford St Catherines Coll, Dept Econ, Oxford OX1 3UJ, England.	sudhir.anand@economics.ox.ac.uk	Bärnighausen, Till/Y-2388-2019					Abuwa P N, 1997, West Afr J Med, V16, P174; Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; Aylward RB, 2005, B WORLD HEALTH ORGAN, V83, P268; BERRY DJ, 1991, S AFR MED J, V79, P433; BOERMA JT, 1994, QUALITY DATA CHILD I; Brown J., 2002, WP0253 MEASURE U N C; BRUGHA R, 1995, HEALTH POLICY PLANN, V10, P312, DOI 10.1093/heapol/10.3.312; Chowdhury AMR, 2003, J HEALTH POPUL NUTR, V21, P193; COETZEE N, 1990, S AFR MED J, V78, P733; CUTTS FT, 1991, INT J EPIDEMIOL, V20, P1099, DOI 10.1093/ije/20.4.1099; CUTTS FT, 1989, INT J EPIDEMIOL, V18, P427, DOI 10.1093/ije/18.2.427; Dayan GH, 2004, VACCINE, V22, P475, DOI 10.1016/j.vaccine.2003.07.007; de Quadros CA, 2002, MED MICROBIOL IMMUN, V191, P75, DOI 10.1007/s00430-002-0120-7; DEFO BK, 1994, SOC BIOL, V41, P181; DIALLO K, 2004, METHODOLOGICAL NOTE; Dubois CA, 2006, HEALTH ECON POLICY L, V1, P59, DOI 10.1017/S1744133105001027; Ekwueme DU, 2000, ARCH PEDIAT ADOL MED, V154, P797, DOI 10.1001/archpedi.154.8.797; ENGLAND S, 2001, CHM WORKING PAPER SE; Gauri V, 2002, WORLD DEV, V30, P2109, DOI 10.1016/S0305-750X(02)00151-1; *GAVI, 2003, 11 GAVI BOARD M HUM; *GAVI, 2005, ANN DEATHS 2002 VACC; *GAVI, 2005, GAVI OBJ; *GAVI, 2005, KEY EUR NAT JOIN UK; Gilling C M, 1989, Nurse Educ Today, V9, P82, DOI 10.1016/0260-6917(89)90058-0; HADI AS, 1994, J ROY STAT SOC B MET, V56, P393; JLI (Joint Learning Initiative), 2004, HUM RES HLTH OV CRIS; Kamau N, 2001, East Afr Med J, V78, P590; Khaleghian P, 2004, SOC SCI MED, V59, P163, DOI 10.1016/j.socscimed.2003.10.013; Langsten R, 1998, SOC SCI MED, V46, P1205, DOI 10.1016/S0277-9536(97)10049-1; Luman ET, 2003, PEDIATRICS, V111, P1215; *MACR INT, 2007, DEM HLTH SURV STATC; Murray CJL, 2003, LANCET, V362, P1022, DOI 10.1016/S0140-6736(03)14411-X; Nokes DJ, 1997, TRENDS MICROBIOL, V5, P14, DOI 10.1016/S0966-842X(97)81769-6; Nolte A, 1995, Curationis, V18, P49; NUTTER DO, 1983, J MED EDUC, V58, P555; OBERMEYER CM, 1993, J BIOSOC SCI, V25, P371, DOI 10.1017/S0021932000020708; PILLAI VK, 1992, J BIOSOC SCI, V24, P201, DOI 10.1017/S0021932000019738; REES H, 1991, S AFR MED J, V80, P378; Rolls C, 1996, Aust Coll Midwives Inc J, V9, P18, DOI 10.1016/S1031-170X(96)80007-9; Steele F, 1996, J ROY STAT SOC A STA, V159, P289, DOI 10.2307/2983175; STREATFIELD K, 1990, DEMOGRAPHY, V27, P447, DOI 10.2307/2061378; Stronegger WJ, 1998, ZBL HYG UMWELTMED, V201, P437; (The) World Bank, 2006, WORLD DEV IND; Ughade S N, 2000, J Indian Med Assoc, V98, P4; *UNDP, 1993, HUM DEV REP 1993 200; United Nations Development Programme (UNDP), 2007, MILL DEV GOALS TRACK; Uzicanin A, 2004, VACCINE, V22, P3419, DOI 10.1016/j.vaccine.2004.02.042; *WHO, 2002, COR INF DEV IMM POL; *WHO, 2005, GLOB POL IN 2004 ANN; *WHO, IMM PRACT PRACT RES; *WHO, 2004, WHO EST HLTH PERS PH; *WHO, 2005, EC IMM GUI LIT OTH R; *WHO, 2005, IMM COV; *WHO, 2004, EST ANN DEATHS DIS A; World Health Organization, 2006, WORK HLTH WORLD HLTH; World Health Organization, 2005, GLOB ATL HLTH WORKF GLOB ATL HLTH WORKF; Zeleke SA, 2000, LANCET, V356, pS21, DOI 10.1016/S0140-6736(00)92007-5	57	163	165	2	20	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 14	2007	369	9569					1277	1285		10.1016/S0140-6736(07)60599-6	http://dx.doi.org/10.1016/S0140-6736(07)60599-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	164YA	17434403				2022-12-01	WOS:000246269700030
J	Mikkelsen, TS; Ku, MC; Jaffe, DB; Issac, B; Lieberman, E; Giannoukos, G; Alvarez, P; Brockman, W; Kim, TK; Koche, RP; Lee, W; Mendenhall, E; O'Donovan, A; Presser, A; Russ, C; Xie, XH; Meissner, A; Wernig, M; Jaenisch, R; Nusbaum, C; Lander, ES; Bernstein, BE				Mikkelsen, Tarjei S.; Ku, Manching; Jaffe, David B.; Issac, Biju; Lieberman, Erez; Giannoukos, Georgia; Alvarez, Pablo; Brockman, William; Kim, Tae-Kyung; Koche, Richard P.; Lee, William; Mendenhall, Eric; O'Donovan, Aisling; Presser, Aviva; Russ, Carsten; Xie, Xiaohui; Meissner, Alexander; Wernig, Marius; Jaenisch, Rudolf; Nusbaum, Chad; Lander, Eric S.; Bernstein, Bradley E.			Genome-wide maps of chromatin state in pluripotent and lineage-committed cells	NATURE			English	Article							EMBRYONIC STEM-CELLS; HISTONE LYSINE METHYLATION; DEVELOPMENTAL REGULATORS; DNA METHYLATION; GENE-EXPRESSION; NONCODING RNAS; MOUSE; POLYCOMB; TRANSCRIPTION; DIFFERENTIATION	We report the application of single-molecule-based sequencing technology for high-throughput profiling of histone modifications in mammalian cells. By obtaining over four billion bases of sequence from chromatin immunoprecipitated DNA, we generated genome-wide chromatin-state maps of mouse embryonic stem cells, neural progenitor cells and embryonic fibroblasts. We find that lysine 4 and lysine 27 trimethylation effectively discriminates genes that are expressed, poised for expression, or stably repressed, and therefore reflect cell state and lineage potential. Lysine 36 trimethylation marks primary coding and non-coding transcripts, facilitating gene annotation. Trimethylation of lysine 9 and lysine 20 is detected at satellite, telomeric and active long-terminal repeats, and can spread into proximal unique sequences. Lysine 4 and lysine 9 trimethylation marks imprinting control regions. Finally, we show that chromatin state can be read in an allele-specific manner by using single nucleotide polymorphisms. This study provides a framework for the application of comprehensive chromatin profiling towards characterization of diverse mammalian cell populations.	Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; MIT, Div Hlth Sci & Technol, Cambridge, MA 02142 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Neurol, Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Lander, ES (corresponding author), Harvard Univ, Broad Inst, Cambridge, MA 02142 USA.	lander@broad.mit.edu; bbernstein@partners.org	Aiden, Erez Lieberman/A-2908-2010; Kim, Tae-Kyung/AAX-4230-2020; Mikkelsen, Tarjei S/A-1306-2007	Kim, Tae-Kyung/0000-0001-5161-9864; Mikkelsen, Tarjei S/0000-0002-8133-3135; Xie, Xiaohui/0000-0002-5479-6345; Issac, Biju/0000-0002-7311-678X; Koche, Richard/0000-0002-6820-5083; Mendenhall, Eric/0000-0002-7395-6295	NATIONAL CANCER INSTITUTE [T32CA009216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078986] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA009216] Funding Source: Medline; NIGMS NIH HHS [R01 GM078986, R01 GM078986-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexander DL, 1998, J CELL SCI, V111, P3311; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Baust C, 2003, J VIROL, V77, P11448, DOI 10.1128/JVI.77.21.11448-11458.2003; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Buck MJ, 2004, GENOMICS, V83, P349, DOI 10.1016/j.ygeno.2003.11.004; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cho DH, 2005, MOL CELL, V20, P483, DOI 10.1016/j.molcel.2005.09.002; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Delaval K, 2007, EMBO J, V26, P720, DOI 10.1038/sj.emboj.7601513; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Feng YQ, 2005, MOL CELL BIOL, V25, P3864, DOI 10.1128/MCB.25.10.3864-3874.2005; Garreta E, 2006, TISSUE ENG, V12, P2215, DOI 10.1089/ten.2006.12.2215; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Kim A, 2007, MOL CELL BIOL, V27, P1271, DOI 10.1128/MCB.01684-06; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lengner CJ, 2004, J CELL PHYSIOL, V200, P327, DOI 10.1002/jcp.20118; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Mockler TC, 2005, GENOMICS, V85, P1, DOI 10.1016/j.ygeno.2004.10.005; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Svoboda P, 2004, DEV BIOL, V269, P276, DOI 10.1016/j.ydbio.2004.01.028; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083; Wang XZ, 2002, GENE DEV, V16, P1890, DOI 10.1101/gad.1004802; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016	48	3054	3186	3	315	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2007	448	7153					553	U2		10.1038/nature06008	http://dx.doi.org/10.1038/nature06008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	195XV	17603471	Green Accepted			2022-12-01	WOS:000248446700035
J	Dominguez-Sola, D; Ying, CY; Grandori, C; Ruggiero, L; Chen, B; Li, MY; Galloway, DA; Gu, W; Gautier, J; Dalla-Favera, R				Dominguez-Sola, David; Ying, Carol Y.; Grandori, Carla; Ruggiero, Luca; Chen, Brenden; Li, Muyang; Galloway, Denise A.; Gu, Wei; Gautier, Jean; Dalla-Favera, Riccardo			Non-transcriptional control of DNA replication by c-Myc	NATURE			English	Article							LEUKEMIA-CELL-LINE; NEGATIVE AUTOREGULATION; GENOMIC INSTABILITY; BURKITT-LYMPHOMA; DAMAGE RESPONSE; ONC GENE; TUMORIGENESIS; PROTEIN; ACTIVATION; CHECKPOINT	The c-Myc proto-oncogene encodes a transcription factor that is essential for cell growth and proliferation and is broadly implicated in tumorigenesis. However, the biological functions required by c-Myc to induce oncogenesis remain elusive. Here we show that c-Myc has a direct role in the control of DNA replication. c-Myc interacts with the pre-replicative complex and localizes to early sites of DNA synthesis. Depletion of c-Myc from mammalian ( human and mouse) cells as well as from Xenopus cell-free extracts, which are devoid of RNA transcription, demonstrates a non-transcriptional role for c-Myc in the initiation of DNA replication. Overexpression of c-Myc causes increased replication origin activity with subsequent DNA damage and checkpoint activation. These findings identify a critical function of c-Myc in DNA replication and suggest a novel mechanism for its normal and oncogenic functions.	Columbia Univ, Med Ctr, Inst Canc Genet, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ, Med Ctr, Herbert Irving Ctr Comprehens Canc, New York, NY 10032 USA; Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA	Columbia University; Columbia University; Fred Hutchinson Cancer Center	Gautier, J (corresponding author), Columbia Univ, Med Ctr, Inst Canc Genet, Dept Genet & Dev, New York, NY 10032 USA.	jg130@columbia.edu; rd10@columbia.edu	Gautier, jean/A-2774-2008	Dominguez-Sola, David/0000-0001-9569-8402				Abdurashidova G, 2000, SCIENCE, V287, P2023, DOI 10.1126/science.287.5460.2023; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Cobb JA, 2005, GENE DEV, V19, P3055, DOI 10.1101/gad.361805; COLLINS S, 1982, NATURE, V298, P679, DOI 10.1038/298679a0; Costanzo V, 2001, MOL CELL, V8, P137, DOI 10.1016/S1097-2765(01)00294-5; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; DALLAFAVERA R, 1982, NATURE, V299, P61; DELLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P6497, DOI 10.1073/pnas.79.21.6497; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Facchini LM, 1997, MOL CELL BIOL, V17, P100, DOI 10.1128/MCB.17.1.100; Felsher DW, 2000, P NATL ACAD SCI USA, V97, P10544, DOI 10.1073/pnas.190327097; Felsher DW, 1999, P NATL ACAD SCI USA, V96, P3940, DOI 10.1073/pnas.96.7.3940; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gilbert DM, 2004, NAT REV MOL CELL BIO, V5, P848, DOI 10.1038/nrm1495; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grandori C, 2003, GENE DEV, V17, P1569, DOI 10.1101/gad.1100303; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; GRIGNANI F, 1990, EMBO J, V9, P3913, DOI 10.1002/j.1460-2075.1990.tb07612.x; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; IGUCHIARIGA SMM, 1987, EMBO J, V6, P2365, DOI 10.1002/j.1460-2075.1987.tb02513.x; Jackson JR, 2000, CANCER RES, V60, P566; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Koch HB, 2007, CELL CYCLE, V6, P205, DOI 10.4161/cc.6.2.3742; Kovalchuk AL, 2000, J EXP MED, V192, P1183, DOI 10.1084/jem.192.8.1183; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Mai Sabine, 2003, Journal of Environmental Pathology Toxicology and Oncology, V22, P179; McCormack SJ, 1998, ONCOGENE, V16, P2755, DOI 10.1038/sj.onc.1201804; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Michael WM, 2000, SCIENCE, V289, P2133, DOI 10.1126/science.289.5487.2133; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Norio P, 2006, EMBO REP, V7, P779, DOI 10.1038/sj.embor.7400766; Obaya AJ, 1999, ONCOGENE, V18, P2934, DOI 10.1038/sj.onc.1202749; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Prathapam T, 2006, P NATL ACAD SCI USA, V103, P2695, DOI 10.1073/pnas.0511186103; RAO PN, 1970, NATURE, V225, P159, DOI 10.1038/225159a0; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; SMYTHE C, 1991, METHOD CELL BIOL, V35, P449; Tao L, 2000, J CELL BIOCHEM, V78, P442, DOI 10.1002/1097-4644(20000901)78:3<442::AID-JCB9>3.0.CO;2-1; VENNSTROM B, 1982, J VIROL, V42, P773, DOI 10.1128/JVI.42.3.773-779.1982; Wade M, 2006, CURR TOP MICROBIOL, V302, P169; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wang X, 2004, MOL CELL BIOL, V24, P6891, DOI 10.1128/MCB.24.16.6891-6899.2004; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108; Zhang JJ, 1998, EMBO J, V17, P6963, DOI 10.1093/emboj/17.23.6963	51	489	503	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2007	448	7152					445	U3		10.1038/nature05953	http://dx.doi.org/10.1038/nature05953			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17597761				2022-12-01	WOS:000248302700041
J	Brons, IGM; Smithers, LE; Trotter, MWB; Rugg-Gunn, P; Sun, BW; Lopes, SMCD; Howlett, SK; Clarkson, A; Ahrlund-Richter, L; Pedersen, RA; Vallier, L				Brons, I. Gabrielle M.; Smithers, Lucy E.; Trotter, Matthew W. B.; Rugg-Gunn, Peter; Sun, Bowen; de Sousa Lopes, Susana M. Chuva; Howlett, Sarah K.; Clarkson, Amanda; Ahrlund-Richter, Lars; Pedersen, Roger A.; Vallier, Ludovic			Derivation of pluripotent epiblast stem cells from mammalian embryos	NATURE			English	Article							PRIMORDIAL GERM-CELLS; MOUSE EMBRYO; ES CELLS; DIFFERENTIATION; CULTURE; LINE; GASTRULATION; BLASTOCYSTS; EXPRESSION	Although the first mouse embryonic stem (ES) cell lines were derived 25 years ago(1,2) using feeder-layer-based blastocyst cultures, subsequent efforts to extend the approach to other mammals, including both laboratory and domestic species, have been relatively unsuccessful. The most notable exceptions were the derivation of non-human primate ES cell lines(3) followed shortly thereafter by their derivation of human ES cells(4). Despite the apparent common origin and the similar pluripotency of mouse and human embryonic stem cells, recent studies have revealed that they use different signalling pathways to maintain their pluripotent status. Mouse ES cells depend on leukaemia inhibitory factor and bone morphogenetic protein, whereas their human counterparts rely on activin (INHBA)/nodal (NODAL) and fibroblast growth factor (FGF). Here we show that pluripotent stem cells can be derived from the late epiblast layer of post-implantation mouse and rat embryos using chemically defined, activin-containing culture medium that is sufficient for long-term maintenance of human embryonic stem cells. Our results demonstrate that activin/Nodal signalling has an evolutionarily conserved role in the derivation and the maintenance of pluripotency in these novel stem cells. Epiblast stem cells provide a valuable experimental system for determining whether distinctions between mouse and human embryonic stem cells reflect species differences or diverse temporal origins.	Univ Cambridge, Addenbrookes Hosp, Dept Surg, Cambridge CB2 0XY, England; Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 0XY, England; UCL, Wolfson Inst Biomed Res, CR UK Viral Oncol Grp, London WC1E 6BT, England; Univ Cambridge, Wellcome Trust Canc Res UK, Gurdon Inst Canc & Dev Biol, Cambridge CB2 1QR, England; Univ Cambridge, Dept Physiol, Cambridge CB2 1QR, England; Univ Cambridge, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Cambridge CB2 0XY, England; Univ Cambridge, Hosp NHS Fdn Trust, Dept Med Genet, Cambridge CB2 2FF, England; Karolinska Inst, Karolinska Univ Hosp, Clin Res Ctr, Dept Lab Med, S-14157 Stockholm, Sweden	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; University College London; Cancer Research UK; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; Karolinska Institutet; Karolinska University Hospital	Vallier, L (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Surg, Cambridge CB2 0XY, England.	lv225@cam.ac.uk	vallier, ludovic/C-6368-2011; Ahrlund-Richter, Lars/C-6226-2012	Vallier, Ludovic/0000-0002-3848-2602; Trotter, Matthew/0000-0003-3702-915X; Rugg-Gunn, Peter/0000-0002-9601-5949	Medical Research Council [G0300723, G0600275] Funding Source: Medline; Wellcome Trust Funding Source: Medline; Medical Research Council [G0300723B] Funding Source: researchfish; MRC [G0300723, G0600275] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brook FA, 2003, DIABETES, V52, P205, DOI 10.2337/diabetes.52.1.205; Camus A, 2006, DEV BIOL, V295, P743, DOI 10.1016/j.ydbio.2006.03.047; CONLON FL, 1994, DEVELOPMENT, V120, P1919; DEFELICI M, 1982, EXP CELL RES, V142, P476, DOI 10.1016/0014-4827(82)90393-7; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Gu ZY, 1999, DEVELOPMENT, V126, P2551; James D, 2006, DEV BIOL, V295, P90, DOI 10.1016/j.ydbio.2006.03.026; JOHANSSON MW, 1995, TECHNIQUES FISH IMMU, V4, P141; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Mesnard D, 2006, DEVELOPMENT, V133, P2497, DOI 10.1242/dev.02413; Nichols J, 2001, DEVELOPMENT, V128, P2333; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Pelton TA, 2002, J CELL SCI, V115, P329; Rathjen J, 1999, J CELL SCI, V112, P601; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; Song JW, 1999, DEV BIOL, V213, P157, DOI 10.1006/dbio.1999.9370; Sun BW, 2006, HUM MOL GENET, V15, P65, DOI 10.1093/hmg/ddi427; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761	26	1424	1494	3	157	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2007	448	7150					191	U7		10.1038/nature05950	http://dx.doi.org/10.1038/nature05950			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188QN	17597762				2022-12-01	WOS:000247934500042
J	Fath, S; Mancias, JD; Bi, XP; Goldberg, J				Fath, Stephan; Mancias, Joseph D.; Bi, Xiping; Goldberg, Jonathan			Structure and organization of coat proteins in the COPII cage	CELL			English	Article							MEMBRANE DEFORMATION; VESICLE FORMATION; CLATHRIN COAT; HYDROLYSIS; TRANSPORT; SOFTWARE; BINDING	COPII-coated vesicles export newly synthesized proteins from the endoplasmic reticulum. The COPII coat consists of the Sec23/24-Sar1 complex that selects cargo and the Sec13/31 assembly unit that can polymerize into an octahedral cage and deform the membrane into a bud. Crystallographic analysis of the assembly unit reveals a 28 nm long rod comprising a central alpha-solenoid dimer capped by two beta-propeller domains at each end. We construct a molecular model of the COPII cage by fitting Sec13/31 crystal structures into a recently determined electron microscopy density map. The vertex geometry involves four copies of the Sec31 beta-propeller that converge through their axial ends; there is no interdigitation of assembly units of the kind seen in clathrin cages. We also propose that the assembly unit has a central hinge-an arrangement of interlocked alpha-solenoids-about which it can bend to adapt to cages of variable curvature.	Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Goldberg, J (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, 1275 York Ave, New York, NY 10021 USA.	jonathan@ximpact4.ski.mskcc.org						Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Antonny B, 2006, CURR OPIN CELL BIOL, V18, P386, DOI 10.1016/j.ceb.2006.06.003; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; BRAELL WA, 1984, J CELL BIOL, V99, P734, DOI 10.1083/jcb.99.2.734; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheng YF, 2007, J MOL BIOL, V365, P892, DOI 10.1016/j.jmb.2006.10.036; CROWTHER RA, 1976, J MOL BIOL, V103, P785, DOI 10.1016/0022-2836(76)90209-6; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Dokudovskaya S, 2006, STRUCTURE, V14, P653, DOI 10.1016/j.str.2006.02.006; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Fotin A, 2004, NATURE, V432, P649, DOI 10.1038/nature03078; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Fromme JC, 2005, CURR OPIN CELL BIOL, V17, P345, DOI 10.1016/j.ceb.2005.06.004; HEUSER J, 1980, J CELL BIOL, V84, P560, DOI 10.1083/jcb.84.3.560; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kajava AV, 2002, J BIOL CHEM, V277, P49791, DOI 10.1074/jbc.M204982200; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P941, DOI 10.1107/S0907444999001031; Lederkremer GZ, 2001, P NATL ACAD SCI USA, V98, P10704, DOI 10.1073/pnas.191359398; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Matsuoka K, 2001, P NATL ACAD SCI USA, V98, P13705, DOI 10.1073/pnas.241522198; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearse BMF, 2000, CURR OPIN STRUC BIOL, V10, P220, DOI 10.1016/S0959-440X(00)00071-3; Shaywitz DA, 1997, J BIOL CHEM, V272, P25413, DOI 10.1074/jbc.272.41.25413; Shugrue CA, 1999, J CELL SCI, V112, P4547; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; ter Haar E, 1998, CELL, V95, P563, DOI 10.1016/S0092-8674(00)81623-2; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Ybe JA, 1999, NATURE, V399, P371, DOI 10.1038/20708	39	210	218	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2007	129	7					1325	1336		10.1016/j.cell.2007.05.036	http://dx.doi.org/10.1016/j.cell.2007.05.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	188HQ	17604721	Bronze			2022-12-01	WOS:000247911400018
J	Rinn, JL; Kertesz, M; Wang, JK; Squazzo, SL; Xu, X; Brugmann, SA; Goodnough, LH; Helms, JA; Farnham, PJ; Segal, E; Chang, HY				Rinn, John L.; Kertesz, Michael; Wang, Jordon K.; Squazzo, Sharon L.; Xu, Xiao; Brugmann, Samantha A.; Goodnough, L. Henry; Helms, Jill A.; Farnham, Peggy J.; Segal, Eran; Chang, Howard Y.			Functional demarcation of active and silent chromatin domains in human HOX loci by Noncoding RNAs	CELL			English	Article							DEVELOPMENTAL REGULATORS; RESPONSE ELEMENTS; GENE-EXPRESSION; HISTONE H3; CELL FATE; POLYCOMB; TRANSCRIPTION; GENOME; ROLES; EVOLUTION	Noncoding RNAs (ncRNA) participate in epigenetic regulation but are poorly understood. Here we characterize the transcriptional landscape of the four human HOX loci at five base pair resolution in 11 anatomic sites and identify 231 HOX ncRNAs that extend known transcribed regions by more than 30 kilobases. HOX ncRNAs are spatially expressed along developmental axes and possess unique sequence motifs, and their expression demarcates broad chromosomal domains of differential histone methylation and RNA polymerase accessibility. We identified a 2.2 kilobase ncRNA residing in the HOXC locus, termed HOTAIR, which represses transcription in trans across 40 kilobases of the HOXD locus. HOTAIR interacts with Polycomb Repressive Complex 2 (PRC2) and is required for PRC2 occupancy and histone H3 lysine-27 trimethylation of HOXD locus. Thus, transcription of ncRNA may demarcate chromosomal domains of gene silencing at a distance; these results have broad implications for gene regulation in development and disease states.	Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; Univ Calif Davis, Dept Pharmacol, Genome Ctr, Livermore, CA 95616 USA	Weizmann Institute of Science; Stanford University; Stanford University; University of California System; University of California Davis	Segal, E (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	eran.segal@weizmann.ac.il; howchang@stanford.edu	Segal, Eran/AAF-4855-2019	Helms, Jill/0000-0002-0463-396X; Farnham, Peggy/0000-0003-4469-7914; Segal, Eran/0000-0002-6859-1164; Wang, Jordon/0000-0003-1108-2534; Rinn, John/0000-0002-7231-7539	NATIONAL CANCER INSTITUTE [R01CA119176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR050007] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA119176-02, R01 CA119176] Funding Source: Medline; NIAMS NIH HHS [K08 AR050007-03, K08 AR050007] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Albrecht U, 1997, MOL CELLULAR METHODS, P23; Bae E, 2002, P NATL ACAD SCI USA, V99, P16847, DOI 10.1073/pnas.222671299; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; CARROLL SB, 1995, NATURE, V376, P479, DOI 10.1038/376479a0; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chuong CM, 2003, J INVEST DERMATOL, V120, P9, DOI 10.1046/j.1523-1747.2003.00002.x; Denisenko O, 1998, MOL CELL BIOL, V18, P5634, DOI 10.1128/MCB.18.10.5634; Drewell RA, 2002, P NATL ACAD SCI USA, V99, P16853, DOI 10.1073/pnas.222671199; GOZANI O, 1994, EMBO J, V13, P3356, DOI 10.1002/j.1460-2075.1994.tb06638.x; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kmita M, 2000, NAT GENET, V26, P451, DOI 10.1038/82593; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lemons D, 2006, SCIENCE, V313, P1918, DOI 10.1126/science.1132040; Nelson CE, 1996, DEVELOPMENT, V122, P1449; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Rinn JL, 2004, DEV CELL, V6, P791, DOI 10.1016/j.devcel.2004.05.005; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Sanchez-Elsner T, 2006, SCIENCE, V311, P1118, DOI 10.1126/science.1117705; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Segal E, 2003, BIOINFORMATICS, V19, pi273, DOI 10.1093/bioinformatics/btg1038; Sessa L, 2007, RNA, V13, P223, DOI 10.1261/rna.266707; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Suemori H, 2000, DEV BIOL, V220, P333, DOI 10.1006/dbio.2000.9651; Sun Yinyan, 2005, RNA Biol, V2, P8, DOI 10.4161/rna.2.1.1465; Zakany J, 1997, P NATL ACAD SCI USA, V94, P13695, DOI 10.1073/pnas.94.25.13695; Zhang H, 2004, MOL CELL, V14, P841, DOI 10.1016/j.molcel.2004.06.001	45	3215	3456	15	324	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2007	129	7					1311	1323		10.1016/j.cell.2007.05.022	http://dx.doi.org/10.1016/j.cell.2007.05.022			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	188HQ	17604720	Green Accepted, Bronze			2022-12-01	WOS:000247911400017
J	Kaiser, SM; Malik, HS; Emerman, M				Kaiser, Shari M.; Malik, Harmit S.; Emerman, Michael			Restriction of an extinct retrovirus by the human TRIM5 alpha antiviral protein	SCIENCE			English	Article							OLD-WORLD; PRIMATE TRIM5-ALPHA; ADAPTIVE EVOLUTION; HIV-1 INFECTION; DOMAIN; SELECTION; VARIANTS; VIRUSES; CAPSIDS	Primate genomes contain a large number of endogenous retroviruses and encode evolutionarily dynamic proteins that provide intrinsic immunity to retroviral infections. We report here the resurrection of the core protein of a 4-million-year-old endogenous virus from the chimpanzee genome and show that the human variant of the intrinsic immune protein TRIM5 alpha can actively prevent infection by this virus. However, we suggest that selective changes that have occurred in the human lineage during the acquisition of resistance to this virus, and perhaps similar viruses, may have left our species more susceptible to infection by human immunodeficiency virus type 1 (HIV-1).	Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Emerman, M (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA.	memerman@fhcrc.org	Malik, Harmit S/I-5591-2019; Malik, Harmit S/E-8519-2012; Liu, FL/D-1795-2009	Malik, Harmit S/0000-0001-6005-0016; 				Dewannieux M, 2006, GENOME RES, V16, P1548, DOI 10.1101/gr.5565706; Hatziioannou T, 2004, P NATL ACAD SCI USA, V101, P10774, DOI 10.1073/pnas.0402361101; Javanbakht H, 2006, VIROLOGY, V354, P15, DOI 10.1016/j.virol.2006.06.031; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Lee SK, 2005, J VIROL, V79, P4159, DOI 10.1128/JVI.79.7.4159-4169.2005; Lee YN, 2007, PLOS PATHOG, V3, P119, DOI 10.1371/journal.ppat.0030010; Li Y, 2006, J VIROL, V80, P6738, DOI 10.1128/JVI.00270-06; Liu HF, 2005, GENE, V362, P109, DOI 10.1016/j.gene.2005.06.045; Mische CC, 2005, J VIROL, V79, P14446, DOI 10.1128/JVI.79.22.14446-14450.2005; Newman RM, 2006, P NATL ACAD SCI USA, V103, P19134, DOI 10.1073/pnas.0605838103; Perron MJ, 2004, P NATL ACAD SCI USA, V101, P11827, DOI 10.1073/pnas.0403364101; Sawyer SL, 2006, CURR BIOL, V16, P95, DOI 10.1016/j.cub.2005.11.045; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2005, J VIROL, V79, P3139, DOI 10.1128/JVI.79.5.3139-3145.2005; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Van Heuverswyn F, 2006, NATURE, V444, P164, DOI 10.1038/444164a; Wu XL, 2006, P NATL ACAD SCI USA, V103, P7465, DOI 10.1073/pnas.0510483103; Yap MW, 2005, CURR BIOL, V15, P73, DOI 10.1016/j.cub.2004.12.042; Yohn CT, 2005, PLOS BIOL, V3, P577, DOI 10.1371/journal.pbio.0030110	22	106	107	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2007	316	5832					1756	1758		10.1126/science.1140579	http://dx.doi.org/10.1126/science.1140579			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180XE	17588933				2022-12-01	WOS:000247400500050
J	Li, XH; Monks, B; Ge, QY; Birnbaum, MJ				Li, Xinghai; Monks, Bobby; Ge, Qingyuan; Birnbaum, Morris J.			Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1 alpha transcription coactivator	NATURE			English	Article							FATTY LIVER-DISEASE; PROTEIN-KINASE-B; CARDIOVASCULAR-DISEASE; RECEPTOR-ALPHA; INSULIN; GLUCONEOGENESIS; ACTIVATION; GLUCOSE; PGC-1; EXPRESSION	Type 2 diabetes mellitus, a disease with significant effects on the health and economy of Western societies, involves disturbances in both lipid and carbohydrate metabolism(1-3). In the insulin-resistant or diabetic state, the liver is unresponsive to the actions of insulin with regard to the suppression of glucose output but continues to produce large amounts of lipid, the latter mimicking the fed, insulin-replete condition(4,5). The disordered distribution of lipids contributes to the cardiovascular disease that is the greatest cause of mortality of type 2 diabetes mellitus(6,7). Yet the precise signal transduction pathways by which insulin regulates hepatic lipid synthesis and degradation remain largely unknown. Here we describe a mechanism by which insulin, through the intermediary protein kinase Akt2/protein kinase B (PKB)-beta, elicits the phosphorylation and inhibition of the transcriptional coactivator peroxisome proliferator-activated receptor-coactivator 1 alpha (PGC-1 alpha), a global regulator of hepatic metabolism during fasting. Phosphorylation prevents the recruitment of PGC-1 alpha to the cognate promoters, impairing its ability to promote gluconeogenesis and fatty acid oxidation. These results define a mechanism by which insulin controls lipid catabolism in the liver and suggest a novel site for therapy in type 2 diabetes mellitus.	Univ Penn, Sch Med, Inst Diabet Obes & Metab, Cox Inst, Philadelphia, PA 19104 USA; Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Cell Signaling Technol Inc, Danvers, MA 01923 USA	University of Pennsylvania; Howard Hughes Medical Institute	Birnbaum, MJ (corresponding author), Univ Penn, Sch Med, Inst Diabet Obes & Metab, Cox Inst, Philadelphia, PA 19104 USA.	birnbaum@mail.med.upenn.edu		Birnbaum, Morris/0000-0001-9972-8680				Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Bouche C, 2004, ENDOCR REV, V25, P807, DOI 10.1210/er.2003-0026; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Diraison F, 2003, DIABETES METAB, V29, P478, DOI 10.1016/S1262-3636(07)70061-7; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI [10.1172/JCI23621, 10.1172/JCI200523621]; Eckel RH, 2006, CIRCULATION, V113, P2943, DOI 10.1161/CIRCULATIONAHA.106.176583; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Kanaya E, 2004, BIOCHEM J, V382, P913, DOI 10.1042/BJ20040432; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Li XH, 2001, EMBO J, V20, P4122, DOI 10.1093/emboj/20.15.4122; Liao JF, 1998, J BIOL CHEM, V273, P27320, DOI 10.1074/jbc.273.42.27320; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI12876; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Ono H, 2003, DIABETES, V52, P2905, DOI 10.2337/diabetes.52.12.2905; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Schilling MM, 2006, NATURE, V443, pE10, DOI 10.1038/nature05288; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Ueki K, 1998, J BIOL CHEM, V273, P5315, DOI 10.1074/jbc.273.9.5315; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Wolfrum C, 2003, P NATL ACAD SCI USA, V100, P11624, DOI 10.1073/pnas.1931483100; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	29	356	367	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2007	447	7147					1012	U8		10.1038/nature05861	http://dx.doi.org/10.1038/nature05861			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180NU	17554339				2022-12-01	WOS:000247373100049
J	Lachmann, HJ; Goodman, HJB; Gilbertson, JA; Gallimore, JR; Sabin, CA; Gillmore, JD; Hawkins, PN				Lachmann, Helen J.; Goodman, Hugh J. B.; Gilbertson, Janet A.; Gallimore, J. Ruth; Sabin, Caroline A.; Gillmore, Julian D.; Hawkins, Philip N.			Natural history and outcome in systemic AA amyloidosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SECONDARY AMYLOIDOSIS; SERUM; AL; PROTEIN; SCINTIGRAPHY; REGRESSION; BINDING; DISEASE	BACKGROUND: Deposition of amyloid fibrils derived from circulating acute-phase reactant serum amyloid A protein (SAA) causes systemic AA amyloidosis, a serious complication of many chronic inflammatory disorders. Little is known about the natural history of AA amyloidosis or its response to treatment. METHODS: We evaluated clinical features, organ function, and survival among 374 patients with AA amyloidosis who were followed for a median of 86 months. The SAA concentration was measured serially, and the amyloid burden was estimated with the use of whole-body serum amyloid P component scintigraphy. Therapy for inflammatory diseases was administered to suppress the production of SAA. RESULTS: Median survival after diagnosis was 133 months; renal dysfunction was the predominant disease manifestation. Mortality, amyloid burden, and renal prognosis all significantly correlated with the SAA concentration during follow-up. The risk of death was 17.7 times as high among patients with SAA concentrations in the highest eighth, or octile, (greater/equal 155 mg per liter) as among those with concentrations in the lowest octile (< 4 mg per liter); and the risk of death was four times as high in the next-to-lowest octile (4 to 9 mg per liter). The median SAA concentration during follow-up was 6 mg per liter in patients in whom renal function improved and 28 mg per liter in those in whom it deteriorated (P < 0.001). Amyloid deposits regressed in 60% of patients who had a median SAA concentration of less than 10 mg per liter, and survival among these patients was superior to survival among those in whom amyloid deposits did not regress (P=0.04). CONCLUSIONS: The effects of renal dysfunction dominate the course of AA amyloidosis, which is associated with a relatively favorable outcome in patients with SAA concentrations that remain in the low-normal range (< 4 mg per liter).	UCL Royal Free & Univ Coll Med Sch, Natl Amyloidosis Ctr, London, England; UCL Royal Free & Univ Coll Med Sch, Ctr Amyloidosis & Acute Phase Prot, Dept Med, London, England; UCL Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London, England	University of London; University College London; UCL Medical School; University of London; University College London; UCL Medical School; University of London; University College London; UCL Medical School	Lachmann, HJ (corresponding author), UCL Royal Free & Univ Coll Med Sch, Natl Amyloidosis Ctr, London, England.		Hawkins, Philip N/C-5573-2008; Sabin, Caroline/C-2464-2008	Sabin, Caroline/0000-0001-5173-2760; Lachmann, Helen/0000-0001-8378-2498	MRC [G7900510] Funding Source: UKRI; Medical Research Council [G7900510] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Gertz MA, 2005, AM J HEMATOL, V79, P319, DOI 10.1002/ajh.20381; Gillmore JD, 2001, LANCET, V358, P24, DOI 10.1016/S0140-6736(00)05252-1; HAMER JPM, 1992, EUR HEART J, V13, P623, DOI 10.1093/oxfordjournals.eurheartj.a060225; HAWKINS PN, 1993, Q J MED, V86, P365; HAWKINS PN, 1990, NEW ENGL J MED, V323, P508, DOI 10.1056/NEJM199008233230803; Hawkins PN, 2003, NEW ENGL J MED, V348, P2583, DOI 10.1056/NEJM200306193482523; HAZENBERG BPC, 1991, AMYLOID AND AMYLOIDOSIS 1990, P809; KISILEVSKY R, 1995, AMYLOID, V2, P128, DOI 10.3109/13506129509031899; Lachmann HJ, 2002, NEW ENGL J MED, V346, P1786, DOI 10.1056/NEJMoa013354; Laiho K, 1999, CLIN RHEUMATOL, V18, P122, DOI 10.1007/s100670050068; Ledue TB, 1998, ANN CLIN BIOCHEM, V35, P745, DOI 10.1177/000456329803500607; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; PARMELEE DC, 1982, BIOCHEMISTRY-US, V21, P3298, DOI 10.1021/bi00257a008; Pepys MB, 2006, ANNU REV MED, V57, P223, DOI 10.1146/annurev.med.57.121304.131243; Poole S, 1998, J IMMUNOL METHODS, V214, P1, DOI 10.1016/S0022-1759(98)00057-X; PUCHTLER H, 1962, J HISTOCHEM CYTOCHEM, V10, P355, DOI 10.1177/10.3.355; Rajkumar, 2006, MAYO CLIN PROC, V81, P1509; Rajkumar SV, 2006, MAYO CLIN PROC, V81, P693, DOI 10.4065/81.5.693; Rydh A, 1998, EUR J NUCL MED, V25, P709; Schnitzer T J, 1977, Arthritis Rheum, V20, P245; Shimojima Y, 2006, AMYLOID, V13, P184, DOI 10.1080/13506120600876930; Singh G, 2007, J RHEUMATOL, V34, P371; TANAKA K, 1995, INTERNAL MED, V34, P122, DOI 10.2169/internalmedicine.34.122; Urieli-Shoval S, 2000, CURR OPIN HEMATOL, V7, P64, DOI 10.1097/00062752-200001000-00012; WERDELIN O, 1966, ACTA PATHOL MIC SC, V68, P1	26	583	629	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2007	356	23					2361	2371		10.1056/NEJMoa070265	http://dx.doi.org/10.1056/NEJMoa070265			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QY	17554117	Green Published			2022-12-01	WOS:000247029300005
J	Millard, SS; Flanagan, JJ; Pappu, KS; Wu, W; Zipursky, SL				Millard, S. Sean; Flanagan, John J.; Pappu, Kartik S.; Wu, Wei; Zipursky, S. Lawrence			Dscam2 mediates axonal tiling in the Drosophila visual system	NATURE			English	Article							REPRESSIBLE CELL MARKER; SENSORY NEURONS; MOLECULAR DIVERSITY; MOSAIC ANALYSIS; NERVOUS-SYSTEM; MORPHOGENESIS; SPECIFICITY; EXPRESSION	Sensory processing centres in both the vertebrate and the invertebrate brain are often organized into reiterated columns, thus facilitating an internal topographic representation of the external world. Cells within each column are arranged in a stereotyped fashion and form precise patterns of synaptic connections within discrete layers. These connections are largely confined to a single column, thereby preserving the spatial information from the periphery. Other neurons integrate this information by connecting to multiple columns. Restricting axons to columns is conceptually similar to tiling. Axons and dendrites of neighbouring neurons of the same class use tiling to form complete, yet non-overlapping, receptive fields(1-3). It is thought that, at the molecular level, cell-surface proteins mediate tiling through contact-dependent repulsive interactions(1,2,4,5), but proteins serving this function have not yet been identified. Here we show that the immunoglobulin superfamily member Dscam2 restricts the connections formed by L1 lamina neurons to columns in the Drosophila visual system. Our data support a model in which Dscam2 homophilic interactions mediate repulsion between neurites of L1 cells in neighbouring columns. We propose that Dscam2 is a tiling receptor for L1 neurons.	Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zipursky, SL (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90095 USA.	lzipursky@mednet.ucla.edu	Millard, Sean/A-8522-2013	Zipursky, Stephen/0000-0001-5630-7181; Millard, Sean/0000-0001-8573-4625	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Barlow GM, 2002, BIOCHEM BIOPH RES CO, V299, P1, DOI 10.1016/S0006-291X(02)02548-2; BLACKSHAW SE, 1982, J PHYSIOL-LONDON, V326, P261, DOI 10.1113/jphysiol.1982.sp014190; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; Clandinin TR, 2002, NEURON, V35, P827, DOI 10.1016/S0896-6273(02)00876-0; Fusaoka E, 2006, GENES CELLS, V11, P541, DOI 10.1111/j.1365-2443.2006.00962.x; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Graveley BR, 2004, RNA, V10, P1499, DOI 10.1261/rna.7105504; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; KRAMER AP, 1985, J NEUROSCI, V5, P768; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Meinertzhagen I.A., 1993, DEV DROSOPHILA MELAN; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Pappu KS, 2005, DEVELOPMENT, V132, P2895, DOI 10.1242/dev.01869; Sagasti A, 2005, CURR BIOL, V15, P804, DOI 10.1016/j.cub.2005.03.048; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zipursky SL, 2006, TRENDS BIOCHEM SCI, V31, P581, DOI 10.1016/j.tibs.2006.08.003	30	107	107	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2007	447	7145					720	U14		10.1038/nature05855	http://dx.doi.org/10.1038/nature05855			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554308	Green Accepted			2022-12-01	WOS:000247030700045
J	Tessier, PM; Lindquist, S				Tessier, Peter M.; Lindquist, Susan			Prion recognition elements govern nucleation, strain specificity and species barriers	NATURE			English	Article							GENETIC-VARIATION; PROTEIN; TRANSMISSION; SCRAPIE; SUP35; MICE; REPLICATION; PROPAGATION; PRINCIPLES; MECHANISM	Prions are proteins that can switch to self-perpetuating, infectious conformations. The abilities of prions to replicate, form structurally distinct strains, and establish and overcome transmission barriers between species are poorly understood. We exploit surface-bound peptides to overcome complexities of investigating such problems in solution. For the yeast prion Sup35, we find that the switch to the prion state is controlled with exquisite specificity by small elements of primary sequence. Strikingly, these same sequence elements govern the formation of distinct self-perpetuating conformations ( prion strains) and determine species-specific seeding activities. A Sup35 chimaera that traverses the transmission barrier between two yeast species possesses the critical sequence elements from both. Using this chimaera, we show that the influence of environment and mutations on the formation of species-specific strains is driven by selective recognition of either sequence element. Thus, critical aspects of prion conversion are enciphered by subtle differences between small, highly specific recognition elements.	Whitehead Inst Biomed Res, Howard Hughes Med Inst, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, Howard Hughes Med Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu	Tessier, Peter/GPP-3396-2022; Tessier, Peter/I-5730-2013	Tessier, Peter/0000-0002-3220-007X	NIGMS NIH HHS [R01 GM025874, R37 GM025874-27, R37 GM025874] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025874, R37GM025874] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRUCE M, 1994, PHILOS T R SOC B, V343, P405, DOI 10.1098/rstb.1994.0036; BRUCE ME, 1991, J GEN VIROL, V72, P595, DOI 10.1099/0022-1317-72-3-595; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Chien P, 2003, NATURE, V424, P948, DOI 10.1038/nature01894; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; COLLINGE J, 1995, NATURE, V378, P779, DOI 10.1038/378779a0; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 1996, GENETICS, V144, P1375; Eaglestone SS, 1999, EMBO J, V18, P1974, DOI 10.1093/emboj/18.7.1974; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; King CY, 2001, J MOL BIOL, V307, P1247, DOI 10.1006/jmbi.2001.4542; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Kushnirov VV, 2000, EMBO J, V19, P324, DOI 10.1093/emboj/19.3.324; Mukhopadhyay S, 2007, P NATL ACAD SCI USA, V104, P2649, DOI 10.1073/pnas.0611503104; Nakayashiki T, 2001, MOL CELL, V7, P1121, DOI 10.1016/S1097-2765(01)00259-3; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Resende C, 2002, MICROBIOL-SGM, V148, P1049, DOI 10.1099/00221287-148-4-1049; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shewmaker F, 2006, P NATL ACAD SCI USA, V103, P19754, DOI 10.1073/pnas.0609638103; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Supattapone S, 1999, CELL, V96, P869, DOI 10.1016/S0092-8674(00)80596-6; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Tuite MF, 2003, NAT REV MOL CELL BIO, V4, P878, DOI 10.1038/nrm1247; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 1996, CURR TOP MICROBIOL, V207, P147; Zhao ZG, 1999, BIOCONJUGATE CHEM, V10, P424, DOI 10.1021/bc980120k	51	118	120	0	17	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 31	2007	447	7144					556	+		10.1038/nature05848	http://dx.doi.org/10.1038/nature05848			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17495929	Green Accepted			2022-12-01	WOS:000246842000040
J	Stuart, DR; Fagnou, K				Stuart, David R.; Fagnou, Keith			The catalytic cross-coupling of unactivated arenes	SCIENCE			English	Article							ARYL BOND FORMATION; DIRECT ARYLATION; DERIVATIVES; BENZENE; INDOLES	The industrially important coupling of aromatic compounds has generally required differential prefunctionalization of the arene coupling partners with a halide and an electropositive group. Here we report that palladium, in conjunction with a copper oxidant, can catalyze the cross-coupling of N-acetylindoles and benzenes in high yield and high regioselectivity across a range of indoles without recourse to activating groups. These reactions are completely selective for arene cross-coupling, with no products arising from indole or benzene homo-coupling detected by spectroscopic analysis. This efficient reactivity should be useful in the design of other oxidative arene cross-couplings as well.	Univ Ottawa, Dept Chem, Ctr Catalysis Res & Innovat, Ottawa, ON K1N 6N5, Canada	University of Ottawa	Fagnou, K (corresponding author), Univ Ottawa, Dept Chem, Ctr Catalysis Res & Innovat, 10 Marie Curie, Ottawa, ON K1N 6N5, Canada.	keith.fagnou@uottawa.ca						Alberico D, 2007, CHEM REV, V107, P174, DOI 10.1021/cr0509760; Diederich F., 1998, METAL CATALYZED CROS; Ding KL, 1997, CHEM COMMUN, P693, DOI 10.1039/a608256d; Ferreira EM, 2003, J AM CHEM SOC, V125, P9578, DOI 10.1021/ja035054y; Garcia-Cuadrado D, 2006, J AM CHEM SOC, V128, P1066, DOI 10.1021/ja056165v; Goossen LJ, 2006, SCIENCE, V313, P662, DOI 10.1126/science.1128684; Hassan J, 2002, CHEM REV, V102, P1359, DOI 10.1021/cr000664r; Hull KL, 2006, J AM CHEM SOC, V128, P14047, DOI 10.1021/ja065718e; Jia CG, 2000, J AM CHEM SOC, V122, P7252, DOI 10.1021/ja0005845; Lafrance M, 2006, J AM CHEM SOC, V128, P16496, DOI 10.1021/ja067144j; Lafrance M, 2006, J AM CHEM SOC, V128, P8754, DOI 10.1021/ja062509L; Lane BS, 2005, J AM CHEM SOC, V127, P8050, DOI 10.1021/ja043273t; Li RS, 2006, ORGANOMETALLICS, V25, P5973, DOI 10.1021/om060889d; Li XL, 2003, J ORG CHEM, V68, P5500, DOI 10.1021/jo0340206; Mukhopadhyay S, 2001, ADV SYNTH CATAL, V343, P455, DOI 10.1002/1615-4169(200107)343:5<455::AID-ADSC455>3.0.CO;2-O; Park CH, 2004, ORG LETT, V6, P1159, DOI 10.1021/ol049866q; SMRCINA M, 1992, J ORG CHEM, V57, P1917, DOI 10.1021/jo00032a055; Takahashi M, 2006, J AM CHEM SOC, V128, P10930, DOI 10.1021/ja060749v	18	898	900	7	256	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2007	316	5828					1172	1175		10.1126/science.1141956	http://dx.doi.org/10.1126/science.1141956			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	171GQ	17525334				2022-12-01	WOS:000246724300037
J	Mitchell, B; Jacobs, R; Li, J; Chien, S; Kintner, C				Mitchell, Brian; Jacobs, Richard; Li, Julie; Chien, Shu; Kintner, Chris			A positive feedback mechanism governs the polarity and motion of motile cilia	NATURE			English	Article							MALE-INFERTILITY; MICE DEFICIENT; FLOW; DIAGNOSIS	Ciliated epithelia produce fluid flow in many organ systems, ranging from the respiratory tract where it clears mucus(1) to the ventricles of the brain where it transports cerebrospinal fluid(2). Human diseases that disable ciliary flow, such as primary ciliary dyskinesia, can compromise organ function or the ability to resist pathogens, resulting in recurring respiratory infections, otitis, hydrocephaly and infertility(3). To create a ciliary flow, the cilia within each cell need to be polarized coordinately along the planar axis of the epithelium, but how polarity is established in any ciliated epithelia is not known. Here we analyse the developmental mechanisms that polarize cilia, using the ciliated cells in the developing Xenopus larval skin as a model system(4). We show that cilia acquire polarity through a sequence of events, beginning with a polar bias set by tissue patterning, followed by a refinement phase. Our results indicate that during refinement, fluid flow is both necessary and sufficient in determining cilia polarity. These findings reveal a novel mechanism in which tissue patterning coupled with fluid flow act in a positive feedback loop to direct the planar polarity of cilia.	Salk Inst Biol Studies, San Diego, CA 92186 USA; Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; Univ Calif San Diego, Whitehead Inst Biomed Engn, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of California System; University of California San Diego	Kintner, C (corresponding author), Salk Inst Biol Studies, San Diego, CA 92186 USA.	kintner@salk.edu		Mitchell, Brian/0000-0001-6281-1536				Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; ASSHETON R, 1896, Q J MICROSC SCI, V38, P465; Bush A, 1998, EUR RESPIR J, V12, P982, DOI 10.1183/09031936.98.12040982; CHIEN S, 1975, RED BLOOD CELL, P1031; Davidson LA, 2002, DEV BIOL, V242, P109, DOI 10.1006/dbio.2002.0537; FRANGOS JA, 1985, SCIENCE, V227, P1477, DOI 10.1126/science.3883488; FRISCH D, 1968, ANAT REC, V162, P221, DOI 10.1002/ar.1091620209; Hsu PP, 2001, BIOCHEM BIOPH RES CO, V285, P751, DOI 10.1006/bbrc.2001.5221; KONIG G, 1993, DEV BIOL, V160, P355, DOI 10.1006/dbio.1993.1312; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nieuwkoop P.D., 1994, NORMAL TABLES XENOPU; Roomans GM, 2006, UPSALA J MED SCI, V111, P155, DOI 10.3109/2000-1967-010; Sapiro R, 2002, MOL CELL BIOL, V22, P6298, DOI 10.1128/MCB.22.17.6298-6305.2002; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Sive HL, 1998, EARLY DEV XENOPUS LA; Tanaka H, 2004, MOL CELL BIOL, V24, P7958, DOI 10.1128/MCB.24.18.7958-7964.2004; Tung Ti-Chow, 1940, ARCH BIOL, V51, P203; Twitty VC, 1928, J EXP ZOOL, V50, P319, DOI 10.1002/jez.1400500302; Witzgall R, 2005, CURR MOL MED, V5, P455, DOI 10.2174/1566524054553496; Woerdeman MW, 1925, ROUX ARCH DEV BIOL, V106, P41; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301	21	200	202	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2007	447	7140					97	U8		10.1038/nature05771	http://dx.doi.org/10.1038/nature05771			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17450123				2022-12-01	WOS:000246149300051
J	Marco, E; Wedlich-Soldner, R; Li, R; Altschuler, SJ; Wu, LF				Marco, Eugenio; Wedlich-Soldner, Roland; Li, Rong; Altschuler, Steven J.; Wu, Lani F.			Endocytosis optimizes the dynamic localization of membrane proteins that regulate cortical polarity	CELL			English	Article							BUDDING YEAST; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; CELL POLARITY; MYOSIN; GROWTH; CDC42P; POLARIZATION; DIFFUSION; TRANSPORT	Diverse cell types require the ability to maintain dynamically polarized membrane-protein distributions through balancing transport and diffusion. However, design principles underlying dynamically maintained cortical polarity are not well understood. Here we constructed a mathematical model for characterizing the morphology of dynamically polarized protein distributions. We developed analytical approaches for measuring all model parameters from single-cell experiments. We applied our methods to a well-characterized system for studying polarized membrane proteins: budding yeast cells expressing activated Cdc42. We found that a balance of diffusion, directed transport, and endocytosis was sufficient for accurately describing polarization morphologies. Surprisingly, the model predicts that polarized regions are defined with a precision that is nearly optimal for measured endocytosis rates and that polarity can be dynamically stabilized through positive feedback with directed transport. Our approach provides a step toward understanding how biological systems shape spatially precise, unambiguous cortical polarity domains using dynamic processes.Diverse cell types require the ability to maintain dynamically polarized membrane-protein distributions through balancing transport and diffusion. However, design principles underlying dynamically maintained cortical polarity are not well understood. Here we constructed a mathematical model for characterizing the morphology of dynamically polarized protein distributions. We developed analytical approaches for measuring all model parameters from single-cell experiments. We applied our methods to a well-characterized system for studying polarized membrane proteins: budding yeast cells expressing activated Cdc42. We found that a balance of diffusion, directed transport, and endocytosis was sufficient for accurately describing polarization morphologies. Surprisingly, the model predicts that polarized regions are defined with a precision that is nearly optimal for measured endocytosis rates and that polarity can be dynamically stabilized through positive feedback with directed transport. Our approach provides a step toward understanding how biological systems shape spatially precise, unambiguous cortical polarity domains using dynamic processes.Diverse cell types require the ability to maintain dynamically polarized membrane-protein distributions through balancing transport and diffusion. However, design principles underlying dynamically maintained cortical polarity are not well understood. Here we constructed a mathematical model for characterizing the morphology of dynamically polarized protein distributions. We developed analytical approaches for measuring all model parameters from single-cell experiments. We applied our methods to a well-characterized system for studying polarized membrane proteins: budding yeast cells expressing activated Cdc42. We found that a balance of diffusion, directed transport, and endocytosis was sufficient for accurately describing polarization morphologies. Surprisingly, the model predicts that polarized regions are defined with a precision that is nearly optimal for measured endocytosis rates and that polarity can be dynamically stabilized through positive feedback with directed transport. Our approach provides a step toward understanding how biological systems shape spatially precise, unambiguous cortical polarity domains using dynamic processes. Diverse cell types require the ability to maintain dynamically polarized membrane-protein distributions through balancing tranport and diffusion. However, design principles underlying dynamically maintained cortical polarity are not well understood. Here we constructed a mathematical model for characterizing the morphology of dynamically polarized protein distributions. We developed analytical approaches for measuring all model parameters from single-cell experiments. We applied our methods to a well-characterized system for studying polarized membrane proteins: budding yeast cells expressing activated Cdc42. We found that a balance of diffusion, directed transport, and endocytosis was sufficient for accurately describing polarization morphologies. Surprisingly, the model predicts that polarized regions are defined with a precision that is nearly optimal for measured endocytosis rates and that polarity can be dynamically stabilized through positive feedback with directed transport. Our approach provides a step toward understanding how biological systems shape spatially precise, unambiguous cortical polarity domains using dynamic processes.	Univ Texas, SW Med Ctr, Dept Pharmacol, Div Syst Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Green Ctr, Div Syst Biol, Dallas, TX 75390 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Max Planck Inst Biochem, D-82152 Martinsried, Germany; Stowers Inst Med Res, Kansas City, MO 64112 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Max Planck Society; Stowers Institute for Medical Research	Altschuler, SJ (corresponding author), Univ Texas, SW Med Ctr, Dept Pharmacol, Div Syst Biol, Dallas, TX 75390 USA.	steven.altschuler@utsouthwestern.edu; lani.wu@utsouthwestern.edu	Marco, Eugenio/F-4583-2011	Marco, Eugenio/0000-0002-3675-263X	NIGMS NIH HHS [R01 GM071794, R01 GM071794-03] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071794] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Affolter M, 2005, DEV CELL, V9, P19, DOI 10.1016/j.devcel.2005.06.003; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Berg, 2018, RANDOM WALKS BIOL; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; BRETSCHER MS, 1983, EMBO J, V2, P599, DOI 10.1002/j.1460-2075.1983.tb01469.x; Cheeks RJ, 2004, CURR BIOL, V14, P851, DOI 10.1016/j.cub.2004.05.022; Chen KC, 2000, MOL BIOL CELL, V11, P369, DOI 10.1091/mbc.11.1.369; Delley PA, 1999, J CELL BIOL, V147, P163, DOI 10.1083/jcb.147.1.163; Desrivieres S, 1998, J BIOL CHEM, V273, P15787, DOI 10.1074/jbc.273.25.15787; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; GOVINDAN B, 1995, J CELL BIOL, V128, P1055, DOI 10.1083/jcb.128.6.1055; GREENBERG ML, 1993, J MEMBRANE BIOL, V131, P115, DOI 10.1007/BF02791320; Huckaba TM, 2004, J CELL BIOL, V167, P519, DOI 10.1083/jcb.200404173; Irazoqui JE, 2005, MOL BIOL CELL, V16, P1296, DOI 10.1091/mbc.E04-05-0430; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; JOHNSTON GC, 1991, J CELL BIOL, V113, P539, DOI 10.1083/jcb.113.3.539; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; KARPOVA TS, 1995, J CELL BIOL, V131, P1483, DOI 10.1083/jcb.131.6.1483; Karpova TS, 1998, J CELL BIOL, V142, P1501, DOI 10.1083/jcb.142.6.1501; Knoblich JA, 1997, P NATL ACAD SCI USA, V94, P13005, DOI 10.1073/pnas.94.24.13005; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; LILLIE SH, 1994, J CELL BIOL, V125, P825, DOI 10.1083/jcb.125.4.825; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Martin SG, 2006, CURR BIOL, V16, P1161, DOI 10.1016/j.cub.2006.04.040; Mayer B, 2005, CURR BIOL, V15, P1847, DOI 10.1016/j.cub.2005.08.067; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Newpher TM, 2005, DEV CELL, V9, P87, DOI 10.1016/j.devcel.2005.04.014; Ozbudak EM, 2005, DEV CELL, V9, P565, DOI 10.1016/j.devcel.2005.08.014; Petritsch C, 2003, DEV CELL, V4, P273, DOI 10.1016/S1534-5807(03)00020-0; Pruyne D, 2000, J CELL SCI, V113, P571; Pruyne D, 2004, MOL BIOL CELL, V15, P4971, DOI 10.1091/mbc.E04-04-0296; Pruyne DW, 1998, J CELL BIOL, V143, P1931, DOI 10.1083/jcb.143.7.1931; Pyenta PS, 2003, J PHYS CHEM A, V107, P8310, DOI 10.1021/jp030005t; Severson AF, 2003, J CELL BIOL, V161, P21, DOI 10.1083/jcb.200210171; Slaughter B, 2006, CURR OPIN CELL BIOL, V18, P47, DOI 10.1016/j.ceb.2005.11.003; Snaith HA, 2003, NATURE, V423, P647, DOI 10.1038/nature01672; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Toshima JY, 2006, P NATL ACAD SCI USA, V103, P5793, DOI 10.1073/pnas.0601042103; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Wedlich-Soldner R, 2004, J CELL BIOL, V166, P889, DOI 10.1083/jcb.200405061; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899; ZIMAN M, 1993, MOL BIOL CELL, V4, P1307, DOI 10.1091/mbc.4.12.1307	45	166	166	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2007	129	2					411	422		10.1016/j.cell.2007.02.043	http://dx.doi.org/10.1016/j.cell.2007.02.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448998	Green Accepted, Bronze			2022-12-01	WOS:000246474600026
J	Sevier, CS; Qu, HJ; Heldman, N; Gross, E; Fass, D; Kaiser, CA				Sevier, Carolyn S.; Qu, Hongjing; Heldman, Nimrod; Gross, Einav; Fass, Deborah; Kaiser, Chris A.			Modulation of cellular disulfide-bond formation and the ER redox environment by feedback-regulation of Ero1	CELL			English	Article							ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; PROTEIN; GLUTATHIONE; ISOMERASE; PATHWAY; OXIDASE; YEAST; PAIRS	Introduction of disulfide bonds into proteins entering the secretory pathway is catalyzed by Ero1p, which generates disulfide bonds de novo, and Pdi1p, which transfers disulfides to substrate proteins. A sufficiently oxidizing environment must be maintained in the endoplasmic reticulum (ER) to allow for disulfide formation, but a pool of reduced thiols is needed for isomerization of incorrectly paired disulfides. We have found that hyperoxidation of the ER is prevented by attenuation of Ero1p activity through noncatalytic cysteine pairs. Deregulated Ero1p mutants lacking certain cysteines show increased enzyme activity, a decreased lag phase in kinetic assays, and growth defects in vivo. We hypothesize that noncatalytic cysteine pairs in Ero1p sense the level of potential substrates in the ER and correspondingly modulate Ero1p activity as part of a homeostatic regulatory system governing the thiol-disulfide balance in the ER.	MIT, Dept Biol, Cambridge, MA 02139 USA; Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel	Massachusetts Institute of Technology (MIT); Weizmann Institute of Science	Kaiser, CA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ckaiser@mit.edu	Gross, Einav/AAS-7417-2021	Sevier, Carolyn/0000-0003-3245-6988	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046941] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM046941, GM46941] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bader MW, 2001, EMBO J, V20, P1555, DOI 10.1093/emboj/20.7.1555; Benham AM, 2000, EMBO J, V19, P4493, DOI 10.1093/emboj/19.17.4493; Bertoli G, 2004, J BIOL CHEM, V279, P30047, DOI 10.1074/jbc.M403192200; Chakravarthi S, 2006, EMBO REP, V7, P271, DOI 10.1038/sj.embor.7400645; Chakravarthi S, 2004, J BIOL CHEM, V279, P39872, DOI 10.1074/jbc.M406912200; Cuozzo JW, 1999, NAT CELL BIOL, V1, P130, DOI 10.1038/11047; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Frand AR, 2000, MOL BIOL CELL, V11, P2833, DOI 10.1091/mbc.11.9.2833; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Gross E, 2006, P NATL ACAD SCI USA, V103, P299, DOI 10.1073/pnas.0506448103; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; LUNDSTROM J, 1993, BIOCHEMISTRY-US, V32, P6649, DOI 10.1021/bi00077a018; Messens J, 2006, INT J BIOCHEM CELL B, V38, P1050, DOI 10.1016/j.biocel.2005.12.011; Molteni SN, 2004, J BIOL CHEM, V279, P32667, DOI 10.1074/jbc.M404992200; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Porat A, 2004, RES MICROBIOL, V155, P617, DOI 10.1016/j.resmic.2004.05.005; Rozhkova A, 2004, EMBO J, V23, P1709, DOI 10.1038/sj.emboj.7600178; Segatori L, 2006, J BIOL CHEM, V281, P4911, DOI 10.1074/jbc.M505453200; Sevier CS, 2006, MOL BIOL CELL, V17, P2256, DOI 10.1091/mbc.E05-05-0417; Sevier CS, 2001, NAT CELL BIOL, V3, P874, DOI 10.1038/ncb1001-874; STEPHEN DWS, 1995, MOL MICROBIOL, V16, P415, DOI 10.1111/j.1365-2958.1995.tb02407.x; Takemori Y, 2006, MOL GENET GENOMICS, V275, P89, DOI 10.1007/s00438-005-0065-9; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2	30	184	189	0	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 20	2007	129	2					333	344		10.1016/j.cell.2007.02.039	http://dx.doi.org/10.1016/j.cell.2007.02.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448992	Bronze			2022-12-01	WOS:000246474600020
J	Ross, DB				Ross, David B.			The FDA and the case of Ketek	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TELITHROMYCIN		George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA	George Washington University	Ross, DB (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA.							Clay KD, 2006, ANN INTERN MED, V144, P415, DOI 10.7326/0003-4819-144-6-200503210-00121; *FOOD DRUG ADM, 2004, NDA21144 FOOD DRUG A; Graham DJ, 2006, NEW ENGL J MED, V355, P2260, DOI 10.1056/NEJMc066372; GRASSLEY CE, 2006, COMMUNICATION   1213; Kaul S, 2006, ANN INTERN MED, V145, P62, DOI 10.7326/0003-4819-145-1-200607040-00011	5	91	94	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 19	2007	356	16					1601	1604		10.1056/NEJMp078032	http://dx.doi.org/10.1056/NEJMp078032			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158AB	17442902				2022-12-01	WOS:000245762000001
J	Zhang, K; Guo, JZ; Peng, YQ; Xi, W; Guo, AK				Zhang, Ke; Guo, JianZeng; Peng, Yueqing; Xi, Wang; Guo, Aike			Dopamine-mushroom body circuit regulates saliency-based decision-making in Drosophila	SCIENCE			English	Article							EXPRESSION; NEURONS; BEHAVIOR; MEMORY; BRAIN; MELANOGASTER; VALUATION; BODIES; SYSTEM; REWARD	Drosophila melanogaster can make appropriate choices among alternative flight options on the basis of the relative salience of competing visual cues. We show that this choice behavior consists of early and late phases; the former requires activation of the dopaminergic system and mushroom bodies, whereas the latter is independent of these activities. Immunohistological analysis showed that mushroom bodies are densely innervated by dopaminergic axons. Thus, the circuit from the dopamine system to mushroom bodies is crucial for choice behavior in Drosophila.	Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Neurobiol, Inst Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Guo, AK (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Neurobiol, Inst Neurosci, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	akguo@ion.ac.cn						Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Guo FZ, 2005, SCIENCE, V309, P307, DOI 10.1126/science.1111280; Han KA, 1996, NEURON, V16, P1127, DOI 10.1016/S0896-6273(00)80139-7; Heekeren HR, 2004, NATURE, V431, P859, DOI 10.1038/nature02966; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Kim YC, 2003, GENE EXPR PATTERNS, V3, P237, DOI 10.1016/S1567-133X(02)00098-4; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Salzman CD, 2005, CURR OPIN NEUROBIOL, V15, P721, DOI 10.1016/j.conb.2005.10.016; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Tang SM, 2001, SCIENCE, V294, P1543, DOI 10.1126/science.1058237; Unoki S, 2005, EUR J NEUROSCI, V22, P1409, DOI 10.1111/j.1460-9568.2005.04318.x; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wolf R, 1998, LEARN MEMORY, V5, P166; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	28	147	159	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2007	316	5833					1901	1904		10.1126/science.1137357	http://dx.doi.org/10.1126/science.1137357			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183WI	17600217				2022-12-01	WOS:000247602700041
J	Foerster, K; Coulson, T; Sheldon, BC; Pemberton, JM; Clutton-Brock, TH; Kruuk, LEB				Foerster, Katharina; Coulson, Tim; Sheldon, Ben C.; Pemberton, Josephine M.; Clutton-Brock, Tim H.; Kruuk, Loeske E. B.			Sexually antagonistic genetic variation for fitness in red deer	NATURE			English	Article							NATURAL-POPULATIONS; ONTOGENIC CONFLICT; MATE CHOICE; SELECTION; HERITABILITY; DIMORPHISM; PLEIOTROPY; EVOLUTION; SEXES; WILD	Evolutionary theory predicts the depletion of genetic variation in natural populations as a result of the effects of selection, but genetic variation is nevertheless abundant for many traits that are under directional or stabilizing selection(1). Evolutionary geneticists commonly try to explain this paradox with mechanisms that lead to a balance between mutation and selection(2). However, theoretical predictions of equilibrium genetic variance under mutation-selection balance are usually lower than the observed values, and the reason for this is unknown(3). The potential role of sexually antagonistic selection in maintaining genetic variation has received little attention in this debate, surprisingly given its potential ubiquity in dioecious organisms. At fitness-related loci, a given genotype may be selected in opposite directions in the two sexes. Such sexually antagonistic selection will reduce the otherwise-expected positive genetic correlation between male and female fitness(4). Both theory(5-7) and experimental data(8-12) suggest that males and females of the same species may have divergent genetic optima, but supporting data from wild populations are still scarce(13-15). Here we present evidence for sexually antagonistic fitness variation in a natural population, using data from a long-term study of red deer (Cervus elaphus). We show that male red deer with relatively high fitness fathered, on average, daughters with relatively low fitness. This was due to a negative genetic correlation between estimates of fitness in males and females. In particular, we show that selection favours males that carry low breeding values for female fitness. Our results demonstrate that sexually antagonistic selection can lead to a trade-off between the optimal genotypes for males and females; this mechanism will have profound effects on the operation of selection and the maintenance of genetic variation in natural populations.	Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; Univ London Imperial Coll Sci Technol & Med, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot SL5 7PY, Berks, England	University of Edinburgh; University of Cambridge; University of Oxford; Imperial College London; Imperial College London	Foerster, K (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland.	foerster@orn.mpg.de; loeske.kruuk@ed.ac.uk	Kruuk, Loeske E. B./J-3295-2012; Coulson, Tim/AAL-8148-2021; Pemberton, Josephine M/F-3100-2010; Foerster, Katharina/AAX-3894-2020; Kruuk, Loeske/AAB-8714-2019; Sheldon, Ben C/A-8056-2010	Kruuk, Loeske E. B./0000-0001-8588-1123; Coulson, Tim/0000-0001-9371-9003; Kruuk, Loeske/0000-0001-8588-1123; Sheldon, Ben C/0000-0002-5240-7828	Natural Environment Research Council [cpb010001, NE/B504314/1] Funding Source: researchfish; NERC [cpb010001] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; Calsbeek R, 2004, J EVOLUTION BIOL, V17, P464, DOI 10.1046/j.1420-9101.2003.00665.x; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P1671, DOI 10.1073/pnas.041378098; Clutton-Brock T.H., 1982, RED DEER BEHAV ECOLO; CLUTTONBROCK TH, 1983, J ANIM ECOL, V52, P367, DOI 10.2307/4560; Coulson T, 2006, P ROY SOC B-BIOL SCI, V273, P547, DOI 10.1098/rspb.2005.3357; Coulson T, 1997, ECOLOGY, V78, P852, DOI 10.1890/0012-9658(1997)078[0852:PSLDAC]2.0.CO;2; Fedorka KM, 2004, NATURE, V429, P65, DOI 10.1038/nature02492; FORSMAN A, 1995, J EVOLUTION BIOL, V8, P53, DOI 10.1046/j.1420-9101.1995.8010053.x; Gibson JR, 2002, P ROY SOC B-BIOL SCI, V269, P499, DOI 10.1098/rspb.2001.1863; GILMOUR AW, 2002, ASREML USER GUIDE 1; Hedrick PW, 1999, HEREDITY, V82, P126, DOI 10.1038/sj.hdy.6884400; HOULE D, 1992, GENETICS, V130, P195; Kokko H, 2001, ECOL LETT, V4, P322, DOI 10.1046/j.1461-0248.2001.00224.x; Kruuk LEB, 1999, P ROY SOC B-BIOL SCI, V266, P1655, DOI 10.1098/rspb.1999.0828; Kruuk LEB, 2002, EVOLUTION, V56, P1683, DOI 10.1111/j.0014-3820.2002.tb01480.x; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Kruuk LEB, 2000, P NATL ACAD SCI USA, V97, P698, DOI 10.1073/pnas.97.2.698; Lynch M., 1998, AM J HUM GENET; Marshall TC, 2002, P ROY SOC B-BIOL SCI, V269, P1533, DOI 10.1098/rspb.2002.2035; MEAGHER TR, 1992, EVOLUTION, V46, P445, DOI 10.1111/j.1558-5646.1992.tb02050.x; Merila J, 2001, GENETICA, V112, P199, DOI 10.1023/A:1013391806317; Metcalf CJE, 2007, TRENDS ECOL EVOL, V22, P205, DOI 10.1016/j.tree.2006.12.001; Pischedda A, 2006, PLOS BIOL, V4, P2099, DOI 10.1371/journal.pbio.0040356; Rice WR, 2000, P NATL ACAD SCI USA, V97, P12953, DOI 10.1073/pnas.97.24.12953; RICE WR, 1992, SCIENCE, V256, P1436, DOI 10.1126/science.1604317; RICE WR, 1984, EVOLUTION, V38, P735, DOI [10.1111/j.1558-5646.1984.tb00346.x, 10.2307/2408385]; Rice WR, 2001, J EVOLUTION BIOL, V14, P685, DOI 10.1046/j.1420-9101.2001.00319.x; Robinson MR, 2006, EVOLUTION, V60, P2168, DOI 10.1111/j.0014-3820.2006.tb01854.x; Sokal R., 2000, BIOMETRY, V3rd ed., P451; Turelli M, 2004, GENETICS, V166, P1053, DOI 10.1534/genetics.166.2.1053	31	279	282	0	169	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2007	447	7148					1107	U9		10.1038/nature05912	http://dx.doi.org/10.1038/nature05912			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183HT	17597758				2022-12-01	WOS:000247564600036
J	Wu, RC; Feng, Q; Lonard, DM; O'Malley, BW				Wu, Ray-Chang; Feng, Qin; Lonard, David M.; O'Malley, Bert W.			SRC-3 coactivator functional lifetime is regulated by a phospho-dependent ubiquitin time clock	CELL			English	Article							ESTROGEN-RECEPTOR; PROTEIN-DEGRADATION; STEROID-RECEPTOR; CYCLIN-E; KINASE; AIB1; PHOSPHORYLATION; LIGASE; CANCER; ACTIVATION	SRC-3/AlB1 is an important growth coactivator whose activity should be tightly regulated since excess activation results in oncogenesis. Herein, we provide evidence that coordinated phosphorylation-dependent ubiquitination regulates SRC-3 coactivator activation and transcriptional specificity. We discovered a critical "actron/degron" element in SRC-3 that is required for this phosphorylation-dependent ubiquitination event and identified GSK3 and SCIFFbw7 alpha as the respective responsible kinase and E3 ubiquitin ligase. Interestingly, despite that SCFFbw7 alpha enhances ubiquitination and promotes eventual transcription-coupled degradation of SRC-3 in a phosphorylation- and Fbw7 alpha dosage-dependent manner, our results also uncovered a nonproteolytic "activation" code for SRC-3 ubiquitination induced by Fbw7a. We propose that ubiquitination of SRC-3 is a phospho-mediated biphasic event and that a transition from multi-(mono)ubiquitination (SRC-3 activation) to long-chain polyubiquitination (SIRC-3 degradation) is processive during the transcriptional coactivation of select transcription factors and can serve as a "transcriptional time clock" to control both the activation and the functional lifetime of coactivators.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine	O'Malley, BW (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	berto@bcm.tmc.edu	Wu, Ray-chang/X-2018-2019					Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Cohen P, 1999, PHILOS T R SOC B, V354, P485, DOI 10.1098/rstb.1999.0399; de Mora JF, 2000, MOL CELL BIOL, V20, P5041, DOI 10.1128/MCB.20.14.5041-5047.2000; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; ELLEDGE SJ, 1998, BIOCHIM BIOPHYS ACTA, V1377, P61; Feng Q, 2006, MOL CELL BIOL, V26, P7846, DOI 10.1128/MCB.00568-06; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Kamura T, 2003, P NATL ACAD SCI USA, V100, P10231, DOI 10.1073/pnas.1831009100; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kuang SQ, 2004, CANCER RES, V64, P1875, DOI 10.1158/0008-5472.CAN-03-3745; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Lonard DM, 2004, MOL CELL BIOL, V24, P14, DOI 10.1128/MCB.24.1.14-24.2004; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Shao WL, 2004, P NATL ACAD SCI USA, V101, P11599, DOI 10.1073/pnas.0402997101; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Wu RC, 2002, MOL CELL BIOL, V22, P3549, DOI 10.1128/MCB.22.10.3549-3561.2002; Wu RC, 2004, MOL CELL, V15, P937, DOI 10.1016/j.molcel.2004.08.019; Yi P, 2005, MOL CELL BIOL, V25, P9687, DOI 10.1128/MCB.25.21.9687-9699.2005; Zheng FHF, 2005, MOL CELL BIOL, V25, P8273, DOI 10.1128/MCB.25.18.8273-8284.2005	31	183	188	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2007	129	6					1125	1140		10.1016/j.cell.2007.04.039	http://dx.doi.org/10.1016/j.cell.2007.04.039			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574025	Bronze			2022-12-01	WOS:000247390400016
J	Egli, D; Rosains, J; Birkhoff, G; Eggan, K				Egli, Dieter; Rosains, Jacqueline; Birkhoff, Garrett; Eggan, Kevin			Developmental reprogramming after chromosome transfer into mitotic mouse zygotes	NATURE			English	Article							EMBRYONIC STEM-CELLS; ADULT SOMATIC-CELLS; NUCLEAR TRANSFER; ENUCLEATED ZYGOTES; HUMAN OOCYTES; MICE; TRANSPLANTATION; CLONING; FETAL; DIFFERENTIATION	Until now, animal cloning and the production of embryonic stem cell lines by somatic cell nuclear transfer have relied on introducing nuclei into meiotic oocytes. In contrast, attempts at somatic cell nuclear transfer into fertilized interphase zygotes have failed. As a result, it has generally been assumed that unfertilized human oocytes will be required for the generation of tailored human embryonic stem cell lines from patients by somatic cell nuclear transfer. Here we report, however, that, unlike interphase zygotes, mouse zygotes temporarily arrested in mitosis can support somatic cell reprogramming, the production of embryonic stem cell lines and the full-term development of cloned animals. Thus, human zygotes and perhaps human embryonic blastomeres may be useful supplements to human oocytes for the creation of patient-derived human embryonic stem cells.	Harvard Univ, Stowers Med Inst, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; Harvard Univ, Stowers Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Stowers Institute for Medical Research; Harvard University; Stowers Institute for Medical Research	Eggan, K (corresponding author), Harvard Univ, Stowers Med Inst, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	eggan@mcb.harvard.edu	Eggan, Kevin/P-7119-2018					Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; BECK F, 1995, DEV DYNAM, V204, P219, DOI 10.1002/aja.1002040302; Behringer R., 2003, MANIPULATING MOUSE E; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; CHEONG HT, 1992, JPN J VET RES, V40, P149; CHEONG HT, 1993, THERIOGENOLOGY, V39, P451, DOI 10.1016/0093-691X(93)90388-L; Chesne P, 2002, NAT BIOTECHNOL, V20, P366, DOI 10.1038/nbt0402-366; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Damario MA, 1999, FERTIL STERIL, V72, P1049, DOI 10.1016/S0015-0282(99)00444-6; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Ehrhardt AG, 2005, J CELL PHYSIOL, V204, P808, DOI 10.1002/jcp.20335; Gao SR, 2002, BIOL REPROD, V67, P928, DOI 10.1095/biolreprod.102.004606; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Greda P, 2006, REPRODUCTION, V132, P741, DOI 10.1530/rep.1.01204; Hall VJ, 2007, HUM REPROD, V22, P52, DOI 10.1093/humrep/del345; HAMILTON BT, 1982, EUR J CELL BIOL, V28, P190; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; KOLA I, 1987, BIOL REPROD, V37, P395, DOI 10.1095/biolreprod37.2.395; MCGRATH J, 1983, SCIENCE, V220, P1300, DOI 10.1126/science.6857250; MCGRATH J, 1984, SCIENCE, V226, P1317, DOI 10.1126/science.6542249; Munne S, 1998, HUM REPROD UPDATE, V4, P842, DOI 10.1093/humupd/4.6.842; Nikolettos N, 2000, MOL CELL ENDOCRINOL, V169, P55, DOI 10.1016/S0303-7207(00)00352-X; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; NORSIGIAN J, 2005, BOSTON GLOBE    0225, pA13; Ono Y, 2001, BIOL REPROD, V64, P44, DOI 10.1095/biolreprod64.1.44; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; PRATHER RS, 1989, BIOL REPROD, V41, P414, DOI 10.1095/biolreprod41.3.414; ROBL JM, 1987, J ANIM SCI, V64, P642, DOI 10.2527/jas1987.642642x; Rudner AD, 1996, CURR OPIN CELL BIOL, V8, P773, DOI 10.1016/S0955-0674(96)80077-9; SATHANANTHAN AH, 1991, P NATL ACAD SCI USA, V88, P4806, DOI 10.1073/pnas.88.11.4806; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; Schurmann A, 2006, REPRODUCTION, V132, P839, DOI 10.1530/REP-06-0054; Steinbrook R, 2006, NEW ENGL J MED, V354, P324, DOI 10.1056/NEJMp058313; STICE SL, 1988, BIOL REPROD, V39, P657, DOI 10.1095/biolreprod39.3.657; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; VANDERVEN HH, 1985, ANN NY ACAD SCI, V442, P88; Wakayama S, 2004, J REPROD DEVELOP, V50, P627, DOI 10.1262/jrd.50.627; Wakayama S, 2007, CURR BIOL, V17, pR120, DOI 10.1016/j.cub.2006.12.020; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wakayama T, 2000, NAT GENET, V24, P108, DOI 10.1038/72749; Wakayama T, 1999, NAT GENET, V22, P127, DOI 10.1038/9632; WILLADSEN SM, 1986, NATURE, V320, P63, DOI 10.1038/320063a0; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wolf JP, 1997, FERTIL STERIL, V67, P1095, DOI 10.1016/S0015-0282(97)81445-8; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Zhou Q, 2003, SCIENCE, V302, P1179, DOI 10.1126/science.1088313; 2004, FERTIL STERIL, V81, P1207	53	213	235	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2007	447	7145					679	U8		10.1038/nature05879	http://dx.doi.org/10.1038/nature05879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554301				2022-12-01	WOS:000247030700036
J	Kaurah, P; MacMillan, A; Boyd, N; Senz, J; De Luca, A; Chun, N; Suriano, G; Zaor, S; Van Manen, L; Gilpin, C; Nikkel, S; Connolly-Wilson, M; Weissman, S; Rubinstein, WS; Sebold, C; Greenstein, R; Stroop, J; Yim, D; Panzini, B; McKinnon, W; Greenblatt, M; Wirtzfeld, D; Fontaine, D; Coit, D; Yoon, S; Chung, D; Lauwers, G; Pizzuti, A; Vaccaro, C; Redal, MA; Oliveira, C; Tischkowitz, M; Olschwang, S; Gallinger, S; Lynch, H; Green, J; Ford, J; Pharoah, P; Fernandez, B; Huntsman, D				Kaurah, Pardeep; MacMillan, Andree; Boyd, Niki; Senz, Janine; De Luca, Alessandro; Chun, Nicki; Suriano, Gianpaolo; Zaor, Sonya; Van Manen, Lori; Gilpin, Cathy; Nikkel, Sarah; Connolly-Wilson, Mary; Weissman, Scott; Rubinstein, Wendy S.; Sebold, Courtney; Greenstein, Robert; Stroop, Jennifer; Yim, Dwight; Panzini, Benoit; McKinnon, Wendy; Greenblatt, Marc; Wirtzfeld, Debrah; Fontaine, Daniel; Coit, Daniel; Yoon, Sam; Chung, Daniel; Lauwers, Gregory; Pizzuti, Antonio; Vaccaro, Carlos; Redal, Maria Ana; Oliveira, Carla; Tischkowitz, Marc; Olschwang, Sylviane; Gallinger, Steven; Lynch, Henry; Green, Jane; Ford, James; Pharoah, Paul; Fernandez, Bridget; Huntsman, David			Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							E-CADHERIN GENE; PROPHYLACTIC TOTAL GASTRECTOMY; GERMLINE MISSENSE MUTATIONS; BREAST-CANCER; COLORECTAL-CANCER; MESSENGER-RNA; CARCINOMA; PREDISPOSITION; NEWFOUNDLAND; MANAGEMENT	Context Hereditary diffuse gastric cancer is caused by germline mutations in the epithelial cadherin ( CDH1) gene and is characterized by an increased risk for diffuse gastric cancer and lobular breast cancer. Objective To determine whether recurring germline CDH1 mutations occurred due to independent mutational events or common ancestry. Design, Setting, and Patients Thirty-eight families diagnosed clinically with hereditary diffuse gastric cancer were accrued between November 2004 and January 2006 and were analyzed for CDH1 mutations as part of an ongoing study at the British Columbia Cancer Agency. Twenty-six families had at least 2 gastric cancer cases with 1 case of diffuse gastric cancer in a person younger than 50 years; 12 families had either a single case of diffuse gastric cancer diagnosed in a person younger than 35 years or multiple cases of diffuse gastric cancer diagnosed in persons older than 50 years. Main Outcome Measures Classification of family members as carriers or noncarriers of CDH1 mutations. Haplotype analysis to assess recurring mutations for common ancestry was performed on 7 families from this study and 7 previously reported families with the same mutations. Results Thirteen mutations ( 6 novel) were identified in 15 of the 38 families ( 40% detection rate). The 1137G > A splicing mutation and the 1901C > T ( A634V) missense/splicing mutation occurred on common haplotypes in 2 families but on different haplotypes in a third family. The 2195G > A ( R732Q) missense/splicing mutation occurred in 2 families on different haplotypes. The 2064-2065delTG mutation occurred on a common haplotype in 2 families. Two families from this study plus 2 additional families carrying the novel 2398delC mutation shared a common haplotype, suggesting a founder effect. All 4 families originate from the southeast coast of Newfoundland. Due to concentrations of lobular breast cancer cases, 2 branches of this family had been diagnosed as having hereditary breast cancer and were tested for BRCA mutations. Within these 4 families, the cumulative risk by age 75 years in mutation carriers for clinically detected gastric cancer was 40% ( 95% confidence interval [ CI], 12%91%) for males and 63% ( 95% CI, 19%-99%) for females and the risk for breast cancer in female mutation carriers was 52% ( 95% CI, 29%-94%). Conclusions Recurrent CDH1 mutations in families with hereditary diffuse gastric cancer are due to both independent mutational events and common ancestry. The presence of a founder mutation from Newfoundland is strongly supported.	British Columbia Canc Agcy, Hereditary Canc Program, Ctr Translat & Appl Genom, Vancouver, BC V5Z 4E6, Canada; Hlth Sci Ctr, Prov Med Genet Program, St John, NF, Canada; Stanford Univ, Sch Med, Canc Genet Program, Div Oncol, Stanford, CA 94305 USA; Univ Porto, Inst Mol Pathol & Immunol, Fac Med, P-4100 Oporto, Portugal; Sir Mortimer B Davis Jewish Hosp, Canc Prevent Ctr, Montreal, PQ H3T 1E2, Canada; Kingston Gen Hosp, Familial Oncol Program, Canc Ctr SE Ontario, Kingston, ON K7L 2V7, Canada; Childrens Hosp Eastern Ontario, Dept Genet, Ottawa, ON K1H 8L1, Canada; Evanston NW Healthcare, Ctr Med Genet, Evanston, IL USA; Wilford Hall USAF Med Ctr, Pediat Subspecialty Clin, San Antonio, TX 78236 USA; Univ Connecticut, Ctr Hlth, Hereditary Canc Program, Div Med Genet, Farmington, CT USA; Kaiser Permanente, Dept Pediat, Honolulu, HI USA; CHUM Hotel Dieu, Clin Canc Hereditaires, Montreal, PQ, Canada; CHUM Hop Notre Dame, Serv Gastroenterol, Montreal, PQ, Canada; Univ Vermont, Coll Med, Familial Canc Program, Burlington, VT USA; Mem Univ Newfoundland, Div Surg, St John, NF, Canada; Mem Univ Newfoundland, Div Clin Genet, St John, NF, Canada; Mem Univ Newfoundland, Dept Anat Pathol, St John, NF, Canada; Mem Univ Newfoundland, Discipline Genet, Fac Med, St John, NF, Canada; Mem Sloan Kettering Canc Ctr, Gastric & Mixed Tumor Serv, Dept Surg, New York, NY 10021 USA; Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; Massachusetts Gen Hosp, Gastroenterol Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; Massachusetts Gen Hosp, Gastrointestinal Pathol Serv, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; IRCCS, CCS Hosp, San Giovanni Rotondo, Italy; CSS Mendel Inst, Rome, Italy; Hosp Italiano Buenos Aires, Serv Gen Surg, Buenos Aires, DF, Argentina; Hosp Italiano Buenos Aires, Inst Ciencias Basicas & Med Expt, Buenos Aires, DF, Argentina; McGill Univ, Program Canc Genet, Montreal, PQ, Canada; McGill Univ, Dept Oncol, Montreal, PQ, Canada; McGill Univ, Dept Human Genet, Montreal, PQ, Canada; Inst J Paoli I Calmettes, INSERM, U599, F-13009 Marseille, France; Univ Toronto, Hepatobiliary & Pancreat Surg Grp, Div Gen Surg, Univ Hlth Network, Toronto, ON, Canada; Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Creighton Univ, Dept Prevent Med & Publ Hlth, Omaha, NE 68178 USA; Univ Cambridge, Dept Oncol, Cambridge, England	British Columbia Cancer Agency; Memorial University Newfoundland; University of Manitoba; Children's Hospital Research Institute of Manitoba; Stanford University; Universidade do Porto; McGill University; Cancer Care Ontario; Queens University - Canada; University of Ottawa; Children's Hospital of Eastern Ontario; NorthShore University Health System; United States Department of Defense; United States Air Force; University of Connecticut; Kaiser Permanente; Universite de Montreal; Universite de Montreal; University of Vermont; Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; Memorial Sloan Kettering Cancer Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Hospital Italiano de Buenos Aires; University of Buenos Aires; Hospital Italiano de Buenos Aires; University of Buenos Aires; McGill University; McGill University; McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Paoli-Calmette (IPC); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Creighton University; University of Cambridge	Huntsman, D (corresponding author), British Columbia Canc Agcy, Hereditary Canc Program, Ctr Translat & Appl Genom, 600 W 10th Ave, Vancouver, BC V5Z 4E6, Canada.	dhuntsma@bccancer.bc.ca	Tischkowitz, Marc/O-4452-2018; Olschwang, Sylviane/G-2716-2013; Pharoah, Paul/V-6658-2019; Huntsman, David/ABE-6082-2020; Gallinger, Steven/E-4575-2013; Oliveira, Carla/F-8188-2011; De Luca, Alessandro/B-2179-2017	Tischkowitz, Marc/0000-0002-7880-0628; Olschwang, Sylviane/0000-0001-7078-3029; Pharoah, Paul/0000-0001-8494-732X; Oliveira, Carla/0000-0001-8340-2264; Ford, James/0000-0002-2513-7025; PIZZUTI, Antonio/0000-0003-3245-1925; De Luca, Alessandro/0000-0002-4408-8062; Vaccaro, Carlos/0000-0002-1299-5864	NATIONAL CANCER INSTITUTE [U01CA086389] Funding Source: NIH RePORTER; NCI NIH HHS [5UO1 CA86389] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alberts SR, 2003, ANN ONCOL, V14, P31, DOI 10.1093/annonc/mdg726; Bacani JT, 2006, J MED GENET, V43, P867, DOI 10.1136/jmg.2006.043133; BEAR JC, 1988, AM J MED GENET, V29, P649, DOI 10.1002/ajmg.1320290324; BECKER KF, 1994, CANCER RES, V54, P3845; Berx G, 1996, ONCOGENE, V13, P1919; Blair V, 2006, CLIN GASTROENTEROL H, V4, P262, DOI 10.1016/j.cgh.2005.12.003; Brooks-Wilson AR, 2004, J MED GENET, V41, P508, DOI 10.1136/jmg.2004.018275; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Caldas C, 1999, J MED GENET, V36, P873; *CAN CANC SOC, 2006, CAN CANC STAT; Carneiro F, 2004, J PATHOL, V203, P681, DOI 10.1002/path.1564; Chun YS, 2001, CANCER, V92, P181, DOI 10.1002/1097-0142(20010701)92:1<181::AID-CNCR1307>3.0.CO;2-J; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Dussaulx-Garin L, 2001, EUR J GASTROEN HEPAT, V13, P711, DOI 10.1097/00042737-200106000-00016; FISHER B, 1989, NEW ENGL J MED, V320, P479, DOI 10.1056/NEJM198902233200802; Frebourg T, 2006, J MED GENET, V43, P138, DOI 10.1136/jmg.2005.031385; Gayther SA, 1998, CANCER RES, V58, P4086; GIARDIELLO FM, 1987, NEW ENGL J MED, V316, P1511, DOI 10.1056/NEJM198706113162404; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Henson DE, 2004, ARCH PATHOL LAB MED, V128, P765; Humar B, 2002, HUM MUTAT, V19, P518, DOI 10.1002/humu.10067; Huntsman DG, 2001, NEW ENGL J MED, V344, P1904, DOI 10.1056/NEJM200106213442504; Jonsson BA, 2002, INT J CANCER, V98, P838, DOI 10.1002/ijc.10258; Keller G, 1999, AM J PATHOL, V155, P337, DOI 10.1016/S0002-9440(10)65129-2; Keller G, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.015594; Kim HC, 2000, GUT, V47, P262, DOI 10.1136/gut.47.2.262; Kriege M, 2004, NEW ENGL J MED, V351, P427, DOI 10.1056/NEJMoa031759; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lewis FR, 2001, SURGERY, V130, P612, DOI 10.1067/msy.2001.117099; Lynch HT, 2005, J SURG ONCOL, V90, P114, DOI 10.1002/jso.20214; LYNCH HT, 1993, GASTROENTEROLOGY, V104, P1535, DOI 10.1016/0016-5085(93)90368-M; More H, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9473; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Norton JA, 2007, ANN SURG, V245, P873, DOI 10.1097/01.sla.0000254370.29893.e4; Oliveira C, 2006, INT J SURG PATHOL, V14, P21, DOI 10.1177/106689690601400105; Oliveira C, 2004, EUR J CANCER, V40, P1897, DOI 10.1016/j.ejca.2004.04.027; Oliveira C, 2003, EXPERT REV MOL DIAGN, V3, P201; Oliveira C, 2002, HUM MUTAT, V19, P510, DOI 10.1002/humu.10068; Oliveira Carla, 2004, Hered Cancer Clin Pract, V2, P51, DOI 10.1186/1897-4287-2-2-51; PFEIFFER CJ, 1977, DIGESTION, V16, P1, DOI 10.1159/000198048; PFEIFFER CJ, 1973, CAN MED ASSOC J, V108, P1374; Pharoah PDP, 2001, GASTROENTEROLOGY, V121, P1348, DOI 10.1053/gast.2001.29611; Richards FM, 1999, HUM MOL GENET, V8, P607, DOI 10.1093/hmg/8.4.607; Sarrio D, 2003, INT J CANCER, V106, P208, DOI 10.1002/ijc.11197; Shinmura K, 1999, CARCINOGENESIS, V20, P1127, DOI 10.1093/carcin/20.6.1127; Suriano G, 2003, HUM MOL GENET, V12, P3007, DOI 10.1093/hmg/ddg316; Suriano G, 2005, CLIN CANCER RES, V11, P5401, DOI 10.1158/1078-0432.CCR-05-0247; Suriano G, 2003, HUM MOL GENET, V12, P575, DOI 10.1093/hmg/ddg048; Suriano G, 2006, J MOL MED-JMM, V84, P1023, DOI 10.1007/s00109-006-0091-z; van Kouwen MCA, 2004, CLIN CANCER RES, V10, P6456, DOI 10.1158/1078-0432.CCR-04-0599; VARLEY JM, 1995, J MED GENET, V32, P942, DOI 10.1136/jmg.32.12.942; Vecsey-Semjen B, 2002, ONCOGENE, V21, P4646, DOI 10.1038/sj.onc.1205577; Wolmark N, 2001, ANN NY ACAD SCI, V949, P99	56	299	306	1	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2007	297	21					2360	2372		10.1001/jama.297.21.2360	http://dx.doi.org/10.1001/jama.297.21.2360			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175IL	17545690	Bronze			2022-12-01	WOS:000247007200018
J	Thorpe, SKS; Holder, RL; Crompton, RH				Thorpe, S. K. S.; Holder, R. L.; Crompton, R. H.			Origin of human bipedalism as an adaptation for locomotion on flexible branches	SCIENCE			English	Article							CHIMPANZEES; EVOLUTION; ECOLOGY; WALKING	Human bipedalism is commonly thought to have evolved from a quadrupedal terrestrial precursor, yet some recent paleontological evidence suggests that adaptations for bipedalism arose in an arboreal context. However, the adaptive benefit of arboreal bipedalism has been unknown. Here we show that it allows the most arboreal great ape, the orangutan, to access supports too flexible to be negotiated otherwise. Orangutans react to branch flexibility like humans running on springy tracks, by increasing knee and hip extension, whereas all other primates do the reverse. Human bipedalism is thus less an innovation than an exploitation of a locomotor behavior retained from the common great ape ancestor.	Univ Liverpool, Sch Biomed Sci, Liverpool L69 3GE, Merseyside, England; Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England	University of Liverpool; University of Birmingham; University of Birmingham	Crompton, RH (corresponding author), Univ Liverpool, Sch Biomed Sci, Sherrington Bldg,Ashton St, Liverpool L69 3GE, Merseyside, England.	rhcromp@liv.ac.uk						Alexander RM., 2003, PRINCIPLES ANIMAL LO; CARTMILL M, 1977, AM J PHYS ANTHROPOL, V47, P249, DOI 10.1002/ajpa.1330470206; Crompton RH, 2003, COUR FOR SEKENBG, V243, P135; FLEAGLE JG, 1981, S ZOOLOGICAL SOC LON, V48, P359; Gommery Dominique, 2002, Annales de Paleontologie, V88, P167, DOI 10.1016/S0753-3969(02)01044-3; Haile-Selassie Y, 2001, NATURE, V412, P178, DOI 10.1038/35084063; Hunt KD, 1996, PRIMATES, V37, P363, DOI 10.1007/BF02381373; HUNT KD, 1994, J HUM EVOL, V26, P183, DOI 10.1006/jhev.1994.1011; KINGDON J, 2003, LOWLY ORIGINS; KOVAROVIC K, IN PRESS J HUM EVOL, DOI DOI 10.1016/J.JHEVOI.2007.01.001; Larney E, 2004, AM J PHYS ANTHROPOL, V125, P42, DOI 10.1002/ajpa.10366; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Payne RC, 2006, J ANAT, V208, P709, DOI 10.1111/j.1469-7580.2006.00563.x; PICKFORD M, 2005, ANTHROPOLOGIE, V69, P191; Pickford Martin, 1999, P27; Pontzer H, 2004, J HUM EVOL, V46, P317, DOI 10.1016/j.jhevol.2003.12.006; Richmond BG, 2000, NATURE, V404, P382, DOI 10.1038/35006045; Senut B, 2006, DEV PRIMATOL-PROG PR, P199, DOI 10.1007/0-387-29798-7_15; Stern J., 1975, YEARB PHYS ANTHROPOL, V19, P59; Thorpe SKS, 2005, AM J PHYS ANTHROPOL, V127, P58, DOI 10.1002/ajpa.20151; Thorpe SKS, 1999, AM J PHYS ANTHROPOL, V110, P179, DOI 10.1002/(SICI)1096-8644(199910)110:2<179::AID-AJPA5>3.0.CO;2-Z; Thorpe SKS, 2006, AM J PHYS ANTHROPOL, V131, P384, DOI 10.1002/ajpa.20422; Ward C, 1999, EVOL ANTHROPOL, V7, P197, DOI 10.1002/(SICI)1520-6505(1999)7:6<197::AID-EVAN4>3.0.CO;2-T; Ward CV, 2002, YEARB PHYS ANTHROPOL, V45, P185, DOI 10.1002/ajpa.10185; Ward CV, 2007, HDB PALEOANTHROPOLOG, V2, P1011; White TD, 2006, NATURE, V440, P883, DOI 10.1038/nature04629; Wrangham RW, 1998, INT J PRIMATOL, V19, P949, DOI 10.1023/A:1020318102257; Young NM, 2004, J HUM EVOL, V46, P163, DOI 10.1016/j.jhevol.2003.11.002; Zollikofer CPE, 2005, NATURE, V434, P755, DOI 10.1038/nature03397	29	185	192	1	264	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2007	316	5829					1328	1331		10.1126/science.1140799	http://dx.doi.org/10.1126/science.1140799			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173PS	17540902				2022-12-01	WOS:000246885600048
J	Sobhian, B; Shao, GZ; Lilli, DR; Culhane, AC; Moreau, LA; Xia, B; Livingston, DM; Greenberg, RA				Sobhian, Bijan; Shao, Genze; Lilli, Dana R.; Culhane, Aedin C.; Moreau, Lisa A.; Xia, Bing; Livingston, David M.; Greenberg, Roger A.			RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites	SCIENCE			English	Article							HISTONE H2AX; GENOMIC INSTABILITY; PHOSPHORYLATION; PROTEIN; REPAIR; MDC1; K6	Mutations affecting the BRCT domains of the breast cancer-associated tumor suppressor BRCA1 disrupt the recruitment of this protein to DNA double-strand breaks (DSBs). The molecular structures at DSBs recognized by BRCA1 are presently unknown. We report the interaction of the BRCA1 BRCT domain with RAP80, a ubiquitin-binding protein. RAP80 targets a complex containing the BRCA1-BARD1 (BRCA1-associated ring domain protein 1) E3 ligase and the deubiquitinating enzyme (DUB) BRCC36 to MDC1-gamma H2AX- dependent lysine(6)- and lysine(63)-linked ubiquitin polymers at DSBs. These events are required for cell cycle checkpoint and repair responses to ionizing radiation, implicating ubiquitin chain recognition and turnover in the BRCA1-mediated repair of DSBs.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pathol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Livingston, DM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	david_livingston@dfci.harvard.edu; rogergr@mail.med.upenn.edu	Culhane, Aedin/AAG-8490-2019	Culhane, Aedin/0000-0002-1395-9734; Sobhian, Bijan/0000-0001-7255-6006	NATIONAL CANCER INSTITUTE [K08CA106597] Funding Source: NIH RePORTER; NCI NIH HHS [K08 CA106597, K08 CA106597-01A2] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ambroggio XI, 2004, PLOS BIOL, V2, P113, DOI 10.1371/journal.pbio.0020002; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Chen XW, 2006, CANCER RES, V66, P5039, DOI 10.1158/0008-5472.CAN-05-4194; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Wang YX, 2005, NAT GENET, V37, P750, DOI 10.1038/ng1587; Wu-Baer F, 2003, J BIOL CHEM, V278, P34743, DOI 10.1074/jbc.C300249200; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006	22	537	551	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1198	1202		10.1126/science.1139516	http://dx.doi.org/10.1126/science.1139516			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525341	Green Submitted, Green Accepted			2022-12-01	WOS:000246724300045
J	Corbesier, L; Vincent, C; Jang, SH; Fornara, F; Fan, QZ; Searle, I; Giakountis, A; Farrona, S; Gissot, L; Turnbull, C; Coupland, G				Corbesier, Laurent; Vincent, Coral; Jang, Seonghoe; Fornara, Fabio; Fan, Qingzhi; Searle, Iain; Giakountis, Antonis; Farrona, Sara; Gissot, Lionel; Turnbull, Colin; Coupland, George			FT protein movement contributes to long-distance signaling in floral induction of Arabidopsis	SCIENCE			English	Article							INTEGRATOR FT; CONSTANS; PHLOEM; TRAFFICKING; LEAVES; ACTIVATION; TISSUES; TOMATO; GENES; ROLES	In plants, seasonal changes in day length are perceived in leaves, which initiate long-distance signaling that induces flowering at the shoot apex. The identity of the long-distance signal has yet to be determined. In Arabidopsis, activation of FLOWERING LOCUS T ( FT) transcription in leaf vascular tissue ( phloem) induces flowering. We found that FT messenger RNA is required only transiently in the leaf. In addition, FT fusion proteins expressed specifically in phloem cells move to the apex and move long distances between grafted plants. Finally, we provide evidence that FT does not activate an intermediate messenger in leaves. We conclude that FT protein acts as a long- distance signal that induces Arabidopsis flowering.	Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; Univ London Imperial Coll Sci & Technol, Div Biol, Wye TN25 5AH, Kent, England	Max Planck Society; Imperial College London	Coupland, G (corresponding author), Max Planck Inst Plant Breeding Res, Carl von Linne Weg 0, D-50829 Cologne, Germany.	coupland@mpiz-koeln.mpg.de	Fornara, Fabio/AAL-3306-2020; Coupland, George/AAP-8609-2020; Fornara, Fabio/B-9978-2012; Turnbull, Colin/B-4742-2008; Searle, Iain/AAE-8869-2019; Searle, Iain/C-9300-2009	Fornara, Fabio/0000-0002-1050-0477; Coupland, George/0000-0001-6988-4172; Fornara, Fabio/0000-0002-1050-0477; Turnbull, Colin/0000-0001-6635-1418; Searle, Iain/0000-0003-4306-9756; Farrona, Sara/0000-0002-6855-2237; Giakountis, Antonis/0000-0001-8648-9908				Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Ayre BG, 2004, PLANT PHYSIOL, V135, P2271, DOI 10.1104/pp.104.040592; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Bohlenius H, 2007, SCIENCE, V316, P367; Gallagher KL, 2005, GENE DEV, V19, P189, DOI 10.1101/gad.1271005; Giavalisco P, 2006, PROTEOMICS, V6, P896, DOI 10.1002/pmic.200500155; Haritatos E, 2000, PLANT PHYSIOL, V123, P929, DOI 10.1104/pp.123.3.929; Haywood V, 2005, PLANT J, V42, P49, DOI 10.1111/j.1365-313X.2005.02351.x; Imaizumi T, 2003, NATURE, V426, P302, DOI 10.1038/nature02090; Imaizumi T, 2006, TRENDS PLANT SCI, V11, P550, DOI 10.1016/j.tplants.2006.09.004; Imlau A, 1999, PLANT CELL, V11, P309, DOI 10.1105/tpc.11.3.309; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kim M, 2001, SCIENCE, V293, P287, DOI 10.1126/science.1059805; KNOTT JAMES E., 1934, PROC AMER SOC HORT SCI, V31, P152; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Lang A., 1965, ENCYCL PLANT PHYSIOL, VVolume XV/1, P1380; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Lough TJ, 2006, ANNU REV PLANT BIOL, V57, P203, DOI 10.1146/annurev.arplant.56.032604.144145; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Searle I, 2004, EMBO J, V23, P1217, DOI 10.1038/sj.emboj.7600117; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Teper-Bamnolker P, 2005, PLANT CELL, V17, P2661, DOI 10.1105/tpc.105.035766; Turnbull C., 2004, FLOWERING NEWSLETTER, V37, P3; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; ZEEVAART J. A. D., 1958, MEDEDEL LANDBOUWHOGESCH WAGENINGEN, V58, P1; ZEEVAART JAD, 1976, ANNU REV PLANT PHYS, V27, P321, DOI 10.1146/annurev.pp.27.060176.001541	33	1440	1623	25	515	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2007	316	5827					1030	1033		10.1126/science.1141752	http://dx.doi.org/10.1126/science.1141752			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17446353	Green Published			2022-12-01	WOS:000246554000047
J	D'Souza, G; Kreimer, AR; Viscidi, R; Pawlita, M; Fakhry, C; Koch, WM; Westra, WH; Gillison, ML				D'Souza, Gypsyamber; Kreimer, Aimee R.; Viscidi, Raphael; Pawlita, Michael; Fakhry, Carole; Koch, Wayne M.; Westra, William H.; Gillison, Maura L.			Case-control study of human papillomavirus and oropharyngeal cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SQUAMOUS-CELL CARCINOMA; ORAL-CANCER; CERVICAL-CANCER; RISK; HEAD; NECK; INFECTION; HYGIENE; TYPE-16; ASSOCIATION	BACKGROUND: Substantial molecular evidence suggests a role for human papillomavirus (HPV) in the pathogenesis of oropharyngeal squamous-cell carcinoma, but epidemiologic data have been inconsistent. METHODS: We performed a hospital-based, case-control study of 100 patients with newly diagnosed oropharyngeal cancer and 200 control patients without cancer to evaluate associations between HPV infection and oropharyngeal cancer. Multivariate logistic-regression models were used for case-control comparisons. RESULTS: A high lifetime number of vaginal-sex partners (26 or more) was associated with oropharyngeal cancer (odds ratio, 3.1; 95% confidence interval [CI], 1.5 to 6.5), as was a high lifetime number of oral-sex partners (6 or more) (odds ratio, 3.4; 95% CI, 1.3 to 8.8). The degree of association increased with the number of vaginal-sex and oral-sex partners (P values for trend, 0.002 and 0.009, respectively). Oropharyngeal cancer was significantly associated with oral HPV type 16 (HPV-16) infection (odds ratio, 14.6; 95% CI, 6.3 to 36.6), oral infection with any of 37 types of HPV (odds ratio, 12.3; 95% CI, 5.4 to 26.4), and seropositivity for the HPV-16 L1 capsid protein (odds ratio, 32.2; 95% CI, 14.6 to 71.3). HPV-16 DNA was detected in 72% (95% CI, 62 to 81) of 100 paraffin-embedded tumor specimens, and 64% of patients with cancer were seropositive for the HPV-16 oncoprotein E6, E7, or both. HPV-16 L1 seropositivity was highly associated with oropharyngeal cancer among subjects with a history of heavy tobacco and alcohol use (odds ratio, 19.4; 95% CI, 3.3 to 113.9) and among those without such a history (odds ratio, 33.6; 95% CI, 13.3 to 84.8). The association was similarly increased among subjects with oral HPV-16 infection, regardless of their tobacco and alcohol use. By contrast, tobacco and alcohol use increased the association with oropharyngeal cancer primarily among subjects without exposure to HPV-16. CONCLUSIONS: Oral HPV infection is strongly associated with oropharyngeal cancer among subjects with or without the established risk factors of tobacco and alcohol use.	Johns Hopkins Univ, Div Viral Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; Johns Hopkins Univ Hosp, Dept Pediat, Baltimore, MD 21287 USA; Johns Hopkins Univ Hosp, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21287 USA; Johns Hopkins Univ Hosp, Dept Pathol, Baltimore, MD 21287 USA; NCI, Div Canc Prevent, Bethesda, MD 20892 USA; German Canc Res Ctr, Infect & Canc Control Program, D-6900 Heidelberg, Germany	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Helmholtz Association; German Cancer Research Center (DKFZ)	Gillison, ML (corresponding author), Johns Hopkins Univ, Div Viral Oncol, Sidney Kimmel Comprehens Canc Ctr, Canc Res Bldg 1,Rm 3M 54A,1650 Orleans St, Baltimore, MD 21231 USA.	gillima@jhmi.edu	Waterboer, Tim/G-1252-2010; Pawlita, Labor/C-9720-2011; Kreimer, Aimee ARK/H-1687-2015	Viscidi, Raphael/0000-0002-7906-8002; Pawlita, Michael/0000-0002-4720-8306	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI050056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016631] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI050056, T32AI50056] Funding Source: Medline; NIDCR NIH HHS [R01 DE016631, DE016631-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BENHAMOU S, 1986, INT J CANCER, V37, P825, DOI 10.1002/ijc.2910370605; Bosch F Xavier, 2003, J Natl Cancer Inst Monogr, P3; Brown LM, 2001, CANCER-AM CANCER SOC, V92, P2102, DOI 10.1002/1097-0142(20011015)92:8&lt;2102::AID-CNCR1551&gt;3.0.CO;2-9; BUNDGAARD T, 1995, CANCER CAUSE CONTROL, V6, P57, DOI 10.1007/BF00051681; D'Souza G, 2005, J CLIN MICROBIOL, V43, P5526, DOI 10.1128/JCM.43.11.5526-5535.2005; Dahlstrom KR, 2003, CLIN CANCER RES, V9, P2620; Dillner J, 1999, SEMIN CANCER BIOL, V9, P423, DOI 10.1006/scbi.1999.0146; FEARON ER, 1985, NATURE, V318, P377, DOI 10.1038/318377a0; Frisch M, 2000, CANCER CAUSE CONTROL, V11, P489, DOI 10.1023/A:1008918223334; Gillison Maura L, 2003, J Natl Cancer Inst Monogr, P57; Gillison ML, 2004, SEMIN ONCOL, V31, P744, DOI 10.1053/j.seminoncol.2004.09.011; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Gravitt PE, 2003, J VIROL METHODS, V112, P23, DOI 10.1016/S0166-0934(03)00186-1; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; Hansson BG, 2005, ACTA OTO-LARYNGOL, V125, P1337, DOI 10.1080/00016480510043945; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Hemminki K, 2001, EUR J CANCER PREV, V10, P83, DOI 10.1097/00008469-200102000-00010; Herrero R, 2003, JNCI-J NATL CANCER I, V95, P1772, DOI [10.1093/jnci/djg107, 10.1093/jnci/djg/107]; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Huang CC, 1998, MODERN PATHOL, V11, P971; Kreimer AR, 2006, INT J CANCER, V118, P2293, DOI 10.1002/ijc.21577; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; MADEN C, 1992, AM J EPIDEMIOL, V135, P1093, DOI 10.1093/oxfordjournals.aje.a116209; MAIER H, 1993, OTOLARYNG HEAD NECK, V108, P655, DOI 10.1177/019459989310800606; Moreno-Lopez LA, 2000, ORAL ONCOL, V36, P170, DOI 10.1016/S1368-8375(99)00084-6; Mork J, 2001, NEW ENGL J MED, V344, P1125, DOI 10.1056/NEJM200104123441503; Mosher William D, 2005, Adv Data, P1; Peyton CL, 2001, J INFECT DIS, V183, P1554, DOI 10.1086/320696; Rosenquist K, 2005, ACTA OTO-LARYNGOL, V125, P1327, DOI 10.1080/00016480510012273; Schwartz SM, 1998, JNCI-J NATL CANCER I, V90, P1626, DOI 10.1093/jnci/90.21.1626; Sehr P, 2001, J IMMUNOL METHODS, V253, P153, DOI 10.1016/S0022-1759(01)00376-3; Shiboski CH, 2005, CANCER-AM CANCER SOC, V103, P1843, DOI 10.1002/cncr.20998; Smith EM, 2004, JNCI-J NATL CANCER I, V96, P449, DOI 10.1093/jnci/djh074; Smith EM, 2004, INT J CANCER, V108, P766, DOI 10.1002/ijc.11633; Smith JS, 2004, INT J CANCER, V111, P431, DOI 10.1002/ijc.20257; Viscidi RP, 2003, J INFECT DIS, V187, P194, DOI 10.1086/346052; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Zelmanowicz ADM, 2005, INT J CANCER, V116, P599, DOI 10.1002/ijc.21048; ZHENG TZ, 1990, CANCER CAUSE CONTROL, V1, P235, DOI 10.1007/BF00117475	39	1838	1882	4	163	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2007	356	19					1944	1956		10.1056/NEJMoa065497	http://dx.doi.org/10.1056/NEJMoa065497			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165KX	17494927				2022-12-01	WOS:000246305500006
J	Matthews, BJ; Kim, ME; Flanagan, JJ; Hattori, D; Clemens, JC; Zipursky, SL; Grueber, WB				Matthews, Benjamin J.; Kim, Michelle E.; Flanagan, John J.; Hattori, Daisuke; Clemens, James C.; Zipursky, S. Lawrence; Grueber, Wesley B.			Dendrite self-avoidance is controlled by Dscam	CELL			English	Article							AXON GUIDANCE; DROSOPHILA DSCAM; SENSORY NEURONS; RECEPTOR; ORGANIZATION; DIVERSITY; REVEALS; GENE	Dendrites distinguish between sister branches and those of other cells. Self-recognition can often lead to repulsion, a process termed "self-avoidance." Here we demonstrate that dendrite self-avoidance in Drosophila da sensory neurons requires cell-recognition molecules encoded by the Dscam locus. By alternative splicing, Dscam encodes a vast number of cell-surface proteins of the immunoglobulin superfamily. We demonstrate that interactions between identical Dscam isoforms on the cell surface underlie self-recognition, while the cytoplasmic tail converts this recognition to dendrite repulsion. Sister dendrites expressing the same isoforms engage in homophilic repulsion. By contrast, Dscam diversity ensures that inappropriate repulsive interactions between dendrites sharing the same receptive field do not occur. The selectivity of Dscam-mediated cell interactions is likely to be widely important in the developing fly nervous system, where processes of cells must distinguish between self and nonself during the construction of neural circuits.	Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90095 USA; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Columbia University; Columbia University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Grueber, WB (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90095 USA.	wg2l35@columbia.edu		Zipursky, Stephen/0000-0001-5630-7181; Matthews, Benjamin/0000-0002-8697-699X; Grueber, Wesley/0000-0001-6751-256X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; NICHD NIH HHS [T32 HD007430] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AMTHOR FR, 1995, P NATL ACAD SCI USA, V92, P4002, DOI 10.1073/pnas.92.9.4002; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; BODMER R, 1987, ROUX ARCH DEV BIOL, V196, P69, DOI 10.1007/BF00402027; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; Crayton ME, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-16; Emoto K, 2004, CELL, V119, P245, DOI 10.1016/j.cell.2004.09.036; Fan XP, 2003, NEURON, V40, P113, DOI 10.1016/S0896-6273(03)00591-9; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Geng W, 2000, GENETICS, V156, P1817; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Grueber WB, 1999, J COMP NEUROL, V404, P127, DOI 10.1002/(SICI)1096-9861(19990201)404:1<127::AID-CNE10>3.0.CO;2-M; Grueber WB, 2007, DEVELOPMENT, V134, P55, DOI 10.1242/dev.02666; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; HITCHCOCK PF, 1989, DEVELOPMENT, V106, P589; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; KRAMER AP, 1985, J NEUROSCI, V5, P768; KRAMER AP, 1983, J NEUROSCI, V3, P2474; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Miller FD, 2003, CURR OPIN NEUROBIOL, V13, P391, DOI 10.1016/s0959-4388(03)00072-2; MONTAGUE PR, 1991, J NEUROSCI, V11, P1440; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; R_Development_Core_Team, 2006, R LANG ENV STAT COMP; Sagasti A, 2005, CURR BIOL, V15, P804, DOI 10.1016/j.cub.2005.03.048; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Sdrulla AD, 2006, CEREBELLUM, V5, P105, DOI 10.1080/14734220600620908; Sugimura K, 2003, J NEUROSCI, V23, P3752; Sweeney NT, 2002, DEV BIOL, V247, P76, DOI 10.1006/dbio.2002.0702; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Whitford KL, 2002, ANNU REV NEUROSCI, V25, P127, DOI 10.1146/annurev.neuro.25.112701.142932; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zipursky SL, 2006, TRENDS BIOCHEM SCI, V31, P581, DOI 10.1016/j.tibs.2006.08.003	40	255	258	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					593	604		10.1016/j.cell.2007.04.013	http://dx.doi.org/10.1016/j.cell.2007.04.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482551	Bronze			2022-12-01	WOS:000246373600024
J	Lake, JA				Lake, James A.			Disappearing act	NATURE			English	Editorial Material									Univ Calif Los Angeles, Dept MCD Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lake, JA (corresponding author), Univ Calif Los Angeles, Dept MCD Biol, 242 Boyer Hall, Los Angeles, CA 90095 USA.							Hey J., 2005, SYSTEMATICS ORIGIN S; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Martin W, 2004, NATURE, V431, P134, DOI 10.1038/431134a	3	9	9	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2007	446	7139					983	983		10.1038/446983a	http://dx.doi.org/10.1038/446983a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	160NU	17460647	Bronze			2022-12-01	WOS:000245950400023
J	Grassly, NC; Wenger, J; Durrani, S; Bahl, S; Deshpande, JM; Sutter, RW; Heymann, DL; Aylward, RB				Grassly, Nicholas C.; Wenger, Jay; Durrani, Sunita; Bahl, Sunil; Deshpande, Jagadish M.; Sutter, Roland W.; Heymann, David L.; Aylward, R. Bruce			Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study	LANCET			English	Article							SURVEILLANCE; SENSITIVITY; VIRUS; INDIA	Background A high-potency monovalent oral type 1 poliovirus vaccine (mOPV1) was developed in 2005 to tackle persistent poliovirus transmission in the last remaining infected countries. Our aim was to assess the efficacy of this vaccine in India. Methods We estimated the efficacy of mOPVl used in supplementary immunisation activities from 2076 matched case-control pairs of confirmed cases of poliomyelitis caused by type 1 wild poliovirus and cases of non-polio acute flaccid paralysis in India. The effect of the introduction of mOPVl on population immunity was calculated on the basis of estimates of vaccination coverage from data for non-polio acute flaccid paralysis. Findings In areas of persistent poliovirus transmission in Uttar Pradesh, the protective efficacy of mOPVl was estimated to be 30% (95% CI 19-41) per dose against type 1 paralytic disease, compared with 11% (7-14) for the trivalent oral vaccine. 76-82% of children aged 0-23 months were estimated to be protected by vaccination against type 1 poliovirus at the end of 2006, compared with 59% at the end of 2004, before the introduction of mOPV1. Interpretation Under conditions where the efficacy of live-attenuated oral poliovirus vaccines is compromised by a high prevalence of diarrhoea and other infections, a dose of high-potency mOPVl is almost three times more effective against type 1 poliomyelitis disease than is trivalent vaccine. Achieving high coverage with this new vaccine in areas of persistent poliovirus transmission should substantially improve the probability of rapidly eliminating transmission of the disease.	Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England; WHO, Natl Polio Surveillance Project, New Delhi, India; Enterovirus Res Ctr, Bombay, Maharashtra, India; WHO, Global Polio Eradicat Initiat, CH-1211 Geneva, Switzerland	Imperial College London; World Health Organization; Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV); ICMR - Enterovirus Research Centre; World Health Organization	Grassly, NC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Norfolk Pl, London W2 1PG, England.	n.grassly@imperial.ac.uk	Grassly, Nicholas C/C-6381-2008	Grassly, Nicholas C/0000-0001-6067-4507; Deshpande, Jagadish/0000-0001-5194-0375				[Anonymous], 2004, Wkly Epidemiol Rec, V79, P121; [Anonymous], 1995, J Infect Dis, V171, P1097; Aylward RB, 2006, RISK ANAL, V26, P1441, DOI 10.1111/j.1539-6924.2006.00840.x; Aylward RB, 2005, SCIENCE, V310, P625, DOI 10.1126/science.1115547; Banerjee K, 2000, B WORLD HEALTH ORGAN, V78, P321; Caceres VM, 2001, CLIN INFECT DIS, V33, P531, DOI 10.1086/321905; Clayton D., 1993, STAT MODELS EPIDEMIO; Gary HE, 1997, J INFECT DIS, V175, pS135, DOI 10.1093/infdis/175.Supplement_1.S135; GHENDON YZ, 1961, ACTA VIROL, V5, P265; Graf H, 2006, BIOLOGICALS, V34, P141, DOI 10.1016/j.biologicals.2006.03.011; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; HALSEY N, 1985, B WORLD HEALTH ORGAN, V63, P1151; HENRY JL, 1966, J HYG-CAMB, V64, P105, DOI 10.1017/S0022172400040389; Kohler KA, 2003, EPIDEMIOL INFECT, V131, P711, DOI 10.1017/S0950268803008562; Marx A, 2000, EPIDEMIOL REV, V22, P298, DOI 10.1093/oxfordjournals.epirev.a018041; ONORATO IM, 1991, J INFECT DIS, V163, P1, DOI 10.1093/infdis/163.1.1; PATRIARCA PA, 1991, REV INFECT DIS, V13, P926; Posey DL, 1997, J INFECT DIS, V175, pS258, DOI 10.1093/infdis/175.Supplement_1.S258; Sutter R. W., 2004, VACCINES, P651; *WHO, 2005, WKLY EPIDEMIOL REC, V80, P409; *WHO, 2004, WKLY EPIDEMIOL REC, V79, P401; *WHO, 2004, WKLY EPIDEMIOL REC, V79, P229; *WHO, 2004, WKLY EPIDEMIOL REC, V79, P316	23	105	116	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2007	369	9570					1356	1362		10.1016/S0140-6736(07)60531-5	http://dx.doi.org/10.1016/S0140-6736(07)60531-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	159HL	17448821				2022-12-01	WOS:000245856100028
J	Wang, CC; Lee, JC; Luo, SY; Kulkarni, SS; Huang, YW; Lee, CC; Chang, KL; Hung, SC				Wang, Cheng-Chung; Lee, Jinq-Chyi; Luo, Shun-Yuan; Kulkarni, Suvarn S.; Huang, Yu-Wen; Lee, Chia-Chen; Chang, Ken-Lien; Hung, Shang-Cheng			Regioselective one-pot protection of carbohydrates	NATURE			English	Article							SOLID-PHASE SYNTHESIS; OLIGOSACCHARIDE SYNTHESIS; O-GLYCOSYLATION; EFFICIENT; HEMAGGLUTININ; STRATEGY; ETHERS	Carbohydrates are involved in a wide range of biological processes(1-4). These structurally diverse compounds are more complex than other biological polymers, and are often present as heterogeneous mixtures in nature. The chemical synthesis of carbohydrates is one way to obtain pure oligosaccharides, but it is hampered by difficulties associated with the regioselective protection of polyhydroxyls and challenges related to the stereoselective assembly of glycosidic linkages(5-14). Here we describe a combinatorial, and highly-regioselective, method that can be used to protect individual hydroxy groups of a monosaccharide. This approach can be used to install an orthogonal protecting group pattern in a single reaction vessel (a 'one-pot' reaction), which removes the need to carry out the time-consuming isolation and purification of intermediates. Hundreds of building blocks have been efficiently prepared starting from D-glucose, and the iterative coupling of these building blocks enabled us to assemble beta-1,6-glucans and a library of oligosaccharides based on the influenza-virus binding trisaccharide.	Natl Tsing Hua Univ, Dept Chem, Hsinchu 300, Taiwan; Acad Sinica, Taiwan Int Grad Program, Chem Biol & Mol Biophys Program, Taipei 115, Taiwan; Acad Sinica, Inst Chem, Taipei 115, Taiwan; Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan	National Tsing Hua University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Hung, SC (corresponding author), Natl Tsing Hua Univ, Dept Chem, Hsinchu 300, Taiwan.	hung@mx.nthu.edu.tw	Wang, Cheng-Chung/D-8946-2015; Wang, Cheng-Chung/ABG-6014-2020; Lee, Jinq-Chyi/C-1373-2010	Wang, Cheng-Chung/0000-0002-2562-0658; 				Bertozzi CR, 2001, SCIENCE, V291, P2357, DOI 10.1126/science.1059820; DANISHEFSKY SJ, 1993, SCIENCE, V260, P1307, DOI 10.1126/science.8493573; De Meo C, 2005, TETRAHEDRON-ASYMMETR, V16, P303, DOI 10.1016/j.tetasy.2004.11.043; Demchenko AV, 2003, SYNLETT, P1225, DOI 10.1055/s-2003-40349; Douglas NL, 1998, J CHEM SOC PERK T 1, P51, DOI 10.1039/a705275h; Ernst B., 2000, CARBOHYDRATES CHEM B, V1-4; Flitsch SL, 2005, NATURE, V437, P201, DOI 10.1038/437201a; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; HATAKEYAMA S, 1994, TETRAHEDRON LETT, V35, P4367, DOI 10.1016/S0040-4039(00)73357-0; Huang XF, 2004, ANGEW CHEM INT EDIT, V43, P5221, DOI 10.1002/anie.200460176; Jobron L, 1999, J AM CHEM SOC, V121, P5835, DOI 10.1021/ja9836085; Kim JH, 2005, J AM CHEM SOC, V127, P12090, DOI 10.1021/ja052548h; Kocienski P. J, 2005, PROTECTING GROUPS; Lee JC, 2004, J AM CHEM SOC, V126, P476, DOI 10.1021/ja038244h; Parrish CR, 2005, ANNU REV MICROBIOL, V59, P553, DOI 10.1146/annurev.micro.59.030804.121059; Pellissier H, 2005, TETRAHEDRON, V61, P2947, DOI 10.1016/j.tet.2005.01.070; Plante OJ, 2000, J AM CHEM SOC, V122, P7148, DOI 10.1021/ja0008665; Plante OJ, 2001, SCIENCE, V291, P1523, DOI 10.1126/science.1057324; Schofield L, 2002, NATURE, V418, P785, DOI 10.1038/nature00937; Sears P, 2001, SCIENCE, V291, P2344, DOI 10.1126/science.1058899; Shie CR, 2005, ANGEW CHEM INT EDIT, V44, P1665, DOI 10.1002/anie.200462172; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; TSUNODA T, 1980, TETRAHEDRON LETT, V21, P1357, DOI 10.1016/S0040-4039(00)74575-8; Varki A., ESSENTIALS GLYCOBIOL, V2015, P77; Wang CC, 2002, ANGEW CHEM INT EDIT, V41, P2360, DOI 10.1002/1521-3773(20020703)41:13<2360::AID-ANIE2360>3.0.CO;2-R; Wright JA, 2001, TETRAHEDRON LETT, V42, P4033, DOI 10.1016/S0040-4039(01)00563-9; Wuts P. G. M., 2007, GREENS PROTECTIVE GR; YAMADA H, 1994, TETRAHEDRON LETT, V35, P3979, DOI 10.1016/S0040-4039(00)76718-9; Zhang ZY, 1999, J AM CHEM SOC, V121, P734, DOI 10.1021/ja982232s	29	299	300	0	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2007	446	7138					896	899		10.1038/nature05730	http://dx.doi.org/10.1038/nature05730			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	158IR	17443183				2022-12-01	WOS:000245785700038
J	Whitehurst, AW; Bodemann, BO; Cardenas, J; Ferguson, D; Girard, L; Peyton, M; Minna, JD; Michnoff, C; Hao, WH; Roth, MG; Xie, XJ; White, MA				Whitehurst, Angelique W.; Bodemann, Brian O.; Cardenas, Jessica; Ferguson, Deborah; Girard, Luc; Peyton, Michael; Minna, John D.; Michnoff, Carolyn; Hao, Weihua; Roth, Michael G.; Xie, Xian-Jin; White, Michael A.			Synthetic lethal screen identification of chemosensitizer loci in cancer cells	NATURE			English	Article							SALICYLIHALAMIDE-A; V-ATPASE; CHECKPOINT; DISCOVERY; COMPLEXES; MITOSIS; DRUGS	Abundant evidence suggests that a unifying principle governing the molecular pathology of cancer is the co-dependent aberrant regulation of core machinery driving proliferation and suppressing apoptosis(1). Anomalous proteins engaged in support of this tumorigenic regulatory environment most probably represent optimal intervention targets in a heterogeneous population of cancer cells. The advent of RNA-mediated interference (RNAi)-based functional genomics provides the opportunity to derive unbiased comprehensive collections of validated gene targets supporting critical biological systems outside the framework of preconceived notions of mechanistic relationships. We have combined a high-throughput cell-based one-well/one-gene screening platform with a genome-wide synthetic library of chemically synthesized small interfering RNAs for systematic interrogation of the molecular underpinnings of cancer cell chemoresponsiveness. NCI-H1155, a human non-small-cell lung cancer line, was employed in a paclitaxel-dependent synthetic lethal screen designed to identify gene targets that specifically reduce cell viability in the presence of otherwise sublethal concentrations of paclitaxel. Using a stringent objective statistical algorithm to reduce false discovery rates below 5%, we isolated a panel of 87 genes that represent major focal points of the autonomous response of cancer cells to the abrogation of microtubule dynamics. Here we show that several of these targets sensitize lung cancer cells to paclitaxel concentrations 1,000-fold lower than otherwise required for a significant response, and we identify mechanistic relationships between cancer-associated aberrant gene expression programmes and the basic cellular machinery required for robust mitotic progression.	Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Simmons Canc Ctr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Biostat & Clin Sci, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	White, MA (corresponding author), Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA.	michael.white@utsouthwestern.edu	Peyton, Michael/A-8728-2008	Roth, Michael/0000-0002-9056-332X	NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA070907] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benjamini Y, 1995, J R STAT SOC B, V57, P57, DOI DOI 10.2307/2346101; Boyd MR, 2001, J PHARMACOL EXP THER, V297, P114; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Davies KJA, 2005, HANDB ENVIRON CHEM, V2, P63, DOI 10.1007/b10146; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Jordan MA, 1999, METHOD CELL BIOL, V61, P267; Kawasaki-Nishi S, 2003, FEBS LETT, V545, P76, DOI 10.1016/S0014-5793(03)00396-X; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; Moritz M, 2001, CURR OPIN STRUC BIOL, V11, P174, DOI 10.1016/S0959-440X(00)00187-1; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Toschi L, 2005, Future Oncol, V1, P7, DOI 10.1517/14796694.1.1.7; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Wit E, 2003, BIOINFORMATICS, V19, P1055, DOI 10.1093/bioinformatics/btg003; Wu YS, 2002, J AM CHEM SOC, V124, P3245, DOI 10.1021/ja0177713; Xie XS, 2004, J BIOL CHEM, V279, P19755, DOI 10.1074/jbc.M313796200	21	385	408	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2007	446	7137					815	819		10.1038/nature05697	http://dx.doi.org/10.1038/nature05697			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17429401				2022-12-01	WOS:000245626800045
J	Kott, A				Kott, Andrea			Steven's violin	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2007	297	14					1529	1530		10.1001/jama.297.14.1529	http://dx.doi.org/10.1001/jama.297.14.1529			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155PG	17426262				2022-12-01	WOS:000245589800001
J	Colf, LA; Bankovich, AJ; Hanick, NA; Bowerman, NA; Jones, LL; Kranz, DM; Garcia, KC				Colf, Leremy A.; Bankovich, Alexander J.; Hanick, Nicole A.; Bowerman, Natalie A.; Jones, Lindsay L.; Kranz, David M.; Garcia, K. Christopher			How a single T cell receptor recognizes both self and foreign MHC	CELL			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; PEPTIDE-MHC; NEGATIVE SELECTION; DEGENERATE RECOGNITION; ANTIGEN RECOGNITION; HELICAL RESIDUES; STRUCTURAL BASIS; TCR BINDING; ALLOREACTIVITY; SPECIFICITY	alpha beta T cell receptors (TCRs) can crossreact with both self- and foreign- major histocompatibility complex (MHC) proteins in an enigmatic phenomenon termed alloreactivity. Here we present the 2.35 angstrom structure of the 2C TCR complexed with its foreign ligand H-2L(d)-QL9. Surprisingly, we find that this TCR utilizes a different strategy to engage the foreign pMHC in comparison to the manner in which it recognizes a self ligand H-2K(b)-dEV8. 2C engages both shared and polymorphic residues on L-d and K-b, as well as the unrelated QL9 and dEV8 peptide antigens, in unique pair-wise contacts, resulting in greater structural complementarity with the L-d-QL9 complex. In the structure of an engineered, high-affinity 2C TCR variant bound to H-2L(d)- QL9, the "wild-type" TCR-MHC binding orientation persists despite modified TCR-CDR3 alpha interactions with peptide. Thus, a single TCR recognizes two globally similar, but distinct ligands by divergent mechanisms, indicating that receptor-ligand crossreactivity can occur in the absence of molecular mimicry.	Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; University of Illinois System; University of Illinois Urbana-Champaign	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	kcgarcia@stanford.edu		Bankovich, Alexander/0000-0003-2368-4479; Jones, Lindsay/0000-0003-4360-6451	NIAID NIH HHS [AI 48540, T32 AI007290] Funding Source: Medline; NIGMS NIH HHS [GM55767] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290, R56AI048540, R01AI048540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055767] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anikeeva N, 2003, BIOCHEMISTRY-US, V42, P4709, DOI 10.1021/bi026864+; Archbold JK, 2006, J BIOL CHEM, V281, P34324, DOI 10.1074/jbc.M606755200; Balendiran GK, 1997, P NATL ACAD SCI USA, V94, P6880, DOI 10.1073/pnas.94.13.6880; BEVAN MJ, 1984, IMMUNOL TODAY, V5, P128, DOI 10.1016/0167-5699(84)90233-0; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Boulanger MJ, 2003, MOL CELL, V12, P577, DOI 10.1016/S1097-2765(03)00365-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buslepp J, 2003, IMMUNITY, V19, P595, DOI 10.1016/S1074-7613(03)00269-3; Chen JZ, 2003, MICROBES INFECT, V5, P233, DOI 10.1016/S1286-4579(03)00016-9; CONNOLLY JM, 1994, P NATL ACAD SCI USA, V91, P11482, DOI 10.1073/pnas.91.24.11482; Daniel C, 1998, IMMUNITY, V8, P543, DOI 10.1016/S1074-7613(00)80559-2; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Davis-Harrison RL, 2005, J MOL BIOL, V346, P533, DOI 10.1016/j.jmb.2004.11.063; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Ely LK, 2006, P NATL ACAD SCI USA, V103, P6641, DOI 10.1073/pnas.0600743103; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 2005, CELL, V122, P333, DOI 10.1016/j.cell.2005.07.015; Garcia KC, 1997, P NATL ACAD SCI USA, V94, P13838, DOI 10.1073/pnas.94.25.13838; Ge Q, 2006, P NATL ACAD SCI USA, V103, P1822, DOI 10.1073/pnas.0510561103; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Hansen T, 2000, IMMUNOL TODAY, V21, P83, DOI 10.1016/S0167-5699(98)01426-1; Holler PD, 2000, P NATL ACAD SCI USA, V97, P5387, DOI 10.1073/pnas.080078297; Holler PD, 2003, IMMUNITY, V18, P255, DOI 10.1016/S1074-7613(03)00019-0; Hornell TMC, 1999, J IMMUNOL, V163, P3217; Housset D, 2003, TRENDS IMMUNOL, V24, P429, DOI 10.1016/S1471-4906(03)00180-7; Huseby E, 2004, EUR J IMMUNOL, V34, P1243, DOI 10.1002/eji.200425000; Huseby ES, 2006, NAT IMMUNOL, V7, P1191, DOI 10.1038/ni1401; JERNE N K, 1971, European Journal of Immunology, V1, P1, DOI 10.1002/eji.1830010102; Jones LL, 2006, J BIOL CHEM, V281, P25734, DOI 10.1074/jbc.M604343200; Kieke MC, 1999, P NATL ACAD SCI USA, V96, P5651, DOI 10.1073/pnas.96.10.5651; KRANZ DM, 1984, P NATL ACAD SCI-BIOL, V81, P573, DOI 10.1073/pnas.81.2.573; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Lee PUY, 2000, J EXP MED, V191, P1355, DOI 10.1084/jem.191.8.1355; Luz JG, 2002, J EXP MED, V195, P1175, DOI 10.1084/jem.20011644; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; McFarland BJ, 2003, IMMUNITY, V19, P803, DOI 10.1016/S1074-7613(03)00320-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; RODEWALD HR, 1989, J IMMUNOL, V143, P4238; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Santori FR, 2002, IMMUNITY, V17, P131, DOI 10.1016/S1074-7613(02)00361-8; Schlueter CJ, 1996, J IMMUNOL, V157, P4478; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SHERMAN LA, 1993, ANNU REV IMMUNOL, V11, P385, DOI 10.1146/annurev.immunol.11.1.385; Shusta EV, 2000, NAT BIOTECHNOL, V18, P754, DOI 10.1038/77325; SKYULEV Y, 1994, P NATL ACAD SCI USA, V91, P11487; Speir JA, 1998, IMMUNITY, V8, P553, DOI 10.1016/S1074-7613(00)80560-9; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Tallquist MD, 1998, J IMMUNOL, V160, P802; TJOA BA, 1994, MOL IMMUNOL, V31, P705, DOI 10.1016/0161-5890(94)90144-9; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; UDAKA K, 1992, CELL, V69, P989, DOI 10.1016/0092-8674(92)90617-L; Udaka K, 1996, J IMMUNOL, V157, P670; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4	63	181	189	2	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					135	146		10.1016/j.cell.2007.01.048	http://dx.doi.org/10.1016/j.cell.2007.01.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418792	Bronze			2022-12-01	WOS:000245661100017
J	Houwing, S; Kamminga, LM; Berezikov, E; Cronembold, D; Girard, A; van den Elst, H; Filippov, DV; Blaser, H; Raz, E; Moens, CB; Plasterk, RHA; Hannon, GJ; Draper, BW; Ketting, RF				Houwing, Saskia; Kamminga, Leonie M.; Berezikov, Eugene; Cronembold, Daniela; Girard, Angelique; van den Elst, Hans; Filippov, Dmitri V.; Blaser, Heiko; Raz, Erez; Moens, Cecilia B.; Plasterk, Ronald H. A.; Hannon, Gregory J.; Draper, Bruce W.; Ketting, Rene F.			A role for Piwi and piRNAs in germ cell maintenance and transposon silencing in zebrafish	CELL			English	Article							SMALL RNAS; PROCESSING BODIES; DROSOPHILA; SIRNAS; MIGRATION; HOMOLOG; PATHWAY; PROTEIN; TESTES; VASA	Piwi proteins specify an animal-specific subclass of the Argonaute family that, in vertebrates, is specifically expressed in germ cells. We demonstrate that zebrafish Piwi (Ziwi) is expressed in both the male and the female gonad and is a component of a germline-specifying structure called nuage. Loss of Ziwi function results in a progressive loss of germ cells due to apoptosis during larval development. In animals that have reduced Ziwi function, germ cells are maintained but display abnormal levels of apoptosis in adults. In mammals, Piwi proteins associate with approximately 29-nucleotide-long, testis-specific RNA molecules called piRNAs. Here we show that zebrafish piRNAs are present in both ovary and testis. Many of these are derived from transposons, implicating a role for piRNAs in the silencing of repetitive elements in vertebrates. Furthermore, we show that piRNAs are Dicer independent and that their 3' end likely carries a 2'O-Methyl modification.	Netherlands Inst Dev Biol, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands; Univ Calif Davis, Davis, CA 95616 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Leiden Univ, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands; Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; Univ Munster, ZMBE, Inst Cell Biol, D-48149 Munster, Germany; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98019 USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); University of California System; University of California Davis; Cold Spring Harbor Laboratory; Leiden University; Leiden University - Excl LUMC; Max Planck Society; University of Munster; Fred Hutchinson Cancer Center	Ketting, RF (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	ketting@niob.knaw.nl	Hannon, Gregory/AAB-3568-2019; Kamminga, Leonie M/E-1771-2012; Filippov, Dmitri/J-7612-2017; Berezikov, Eugene/D-3363-2013; Kamminga, Leonie/O-5722-2019; Moens, Cecilia/AAN-1536-2020; Houwing, Saskia/E-4384-2011	Kamminga, Leonie M/0000-0002-0508-7796; Filippov, Dmitri/0000-0002-6978-7425; Berezikov, Eugene/0000-0002-1145-2884; Ketting, Rene/0000-0001-6161-5621; Moens, Cecilia/0000-0002-1099-0728; Draper, Bruce W/0000-0002-4397-7749				Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Birney E, 2006, NUCLEIC ACIDS RES, V34, pD556, DOI 10.1093/nar/gkj133; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Braat AK, 1999, DEV DYNAM, V216, P153, DOI 10.1002/(SICI)1097-0177(199910)216:2<153::AID-DVDY6>3.0.CO;2-1; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; CARMELL MA, 2007, IN PRESS DEV CELL; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Draper BW, 2004, METHOD CELL BIOL, V77, P91; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; GRUIDL ME, 1996, P NATL ACAD SCI USA, V93, P13937; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hashimoto Y, 2004, DEV BIOL, V268, P152, DOI 10.1016/j.ydbio.2003.12.013; Kennerdell JR, 2002, GENE DEV, V16, P1884, DOI 10.1101/gad.990802; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Krovel AV, 2002, MECH DEVELOP, V116, P141, DOI 10.1016/S0925-4773(02)00154-5; Kuramochi-Miyagawa S, 2001, MECH DEVELOP, V108, P121, DOI 10.1016/S0925-4773(01)00499-3; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lingel A, 2005, CURR OPIN STRUC BIOL, V15, P107, DOI 10.1016/j.sbi.2005.01.010; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Parker JS, 2006, TRENDS BIOCHEM SCI, V31, P622, DOI 10.1016/j.tibs.2006.09.010; Rongo C, 1997, COLD SPRING HARB SYM, V62, P1; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; SELMAN K, 1993, J MORPHOL, V218, P203, DOI 10.1002/jmor.1052180209; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Tan CH, 2002, MECH DEVELOP, V119, pS221, DOI 10.1016/S0925-4773(03)00120-5; URAMOCHIMIYAGAW.S, 2004, DEVELOPMENT, V131, P839; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Weidinger G, 2003, CURR BIOL, V13, P1429, DOI 10.1016/S0960-9822(03)00537-2; Westerfield M., 1993, ZEBRAFISH BOOK; Wienholds E, 2003, GENOME RES, V13, P2700, DOI 10.1101/gr.1725103; Yoon C, 1997, DEVELOPMENT, V124, P3157; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	53	766	819	4	87	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					69	82		10.1016/j.cell.2007.03.026	http://dx.doi.org/10.1016/j.cell.2007.03.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418787	Bronze, Green Submitted			2022-12-01	WOS:000245661100012
J	Maamar, H; Raj, A; Dubnau, D				Maamar, Hedia; Raj, Arjun; Dubnau, David			Noise in gene expression determines cell fate in Bacillus subtilis	SCIENCE			English	Article							COMPETENCE TRANSCRIPTION FACTOR; POSITIVE FEEDBACK; ESCHERICHIA-COLI; K-STATE; COMK; DIFFERENTIATION; STOCHASTICITY; PROTEIN; SWITCH; VISUALIZATION	Random cell-to-cell variations in gene expression within an isogenic population can lead to transitions between alternative states of gene expression. Little is known about how these variations ( noise) in natural systems affect such transitions. In Bacillus subtilis, noise in ComK, the protein that regulates competence for DNA uptake, is thought to cause cells to transition to the competent state in which genes encoding DNA uptake proteins are expressed. We demonstrate that noise in comK expression selects cells for competence and that experimental reduction of this noise decreases the number of competent cells. We also show that transitions are limited temporally by a reduction in comK transcription. These results illustrate how such stochastic transitions are regulated in a natural system and suggest that noise characteristics are subject to evolutionary forces.	Univ Med & Dent New Jersey, Publ Hlth Res Inst Ctr, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Dubnau, D (corresponding author), Univ Med & Dent New Jersey, Publ Hlth Res Inst Ctr, 225 Warren St, Newark, NJ 07103 USA.	dubnauda@umdnj.edu		Raj, Arjun/0000-0002-2915-6960	NIGMS NIH HHS [GM 070357, R01 GM070357, R01 GM057720, GM 57720] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070357, R01GM057720] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Albano M, 2005, J BACTERIOL, V187, P2010, DOI 10.1128/JB.187.6.2010-2019.2005; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; HAHN J, 1994, J BACTERIOL, V176, P5753, DOI 10.1128/JB.176.18.5753-5761.1994; Hamoen LW, 1998, GENE DEV, V12, P1539, DOI 10.1101/gad.12.10.1539; Hoa TT, 2002, MOL MICROBIOL, V43, P15, DOI 10.1046/j.1365-2958.2002.02727.x; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Leisner M, 2007, MOL MICROBIOL, V63, P1806, DOI 10.1111/j.1365-2958.2007.05628.x; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Prepiak P, 2007, MOL CELL, V26, P639, DOI 10.1016/j.molcel.2007.05.011; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rodriguez AJ, 2006, J CELL BIOL, V175, P67, DOI 10.1083/jcb.200512137; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Smits WK, 2005, MOL MICROBIOL, V56, P604, DOI 10.1111/j.1365-2958.2005.04488.x; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; VANSINDEREN D, 1994, J BACTERIOL, V176, P5762, DOI 10.1128/JB.176.18.5762-5770.1994; VANSINDEREN D, 1995, MOL MICROBIOL, V15, P455	30	480	535	3	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2007	317	5837					526	529		10.1126/science.1140818	http://dx.doi.org/10.1126/science.1140818			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17569828	Green Accepted			2022-12-01	WOS:000248339800049
J	Tesar, PJ; Chenoweth, JG; Brook, FA; Davies, TJ; Evans, EP; Mack, DL; Gardner, RL; McKay, RDG				Tesar, Paul J.; Chenoweth, Josh G.; Brook, Frances A.; Davies, Timothy J.; Evans, Edward P.; Mack, David L.; Gardner, Richard L.; McKay, Ronald D. G.			New cell lines from mouse epiblast share defining features with human embryonic stem cells	NATURE			English	Article							IN-VITRO; CLONAL ANALYSIS; SELF-RENEWAL; GERM-LINE; DIFFERENTIATION; PLURIPOTENCY; ORIGIN; GENOME; DERIVATION; NETWORK	The application of human embryonic stem (ES) cells in medicine and biology has an inherent reliance on understanding the starting cell population. Human ES cells differ from mouse ES cells and the specific embryonic origin of both cell types is unclear. Previous work suggested that mouse ES cells could only be obtained from the embryo before implantation in the uterus(1-5). Here we show that cell lines can be derived from the epiblast, a tissue of the post-implantation embryo that generates the embryo proper. These cells, which we refer to as EpiSCs (post-implantation epiblast-derived stem cells), express transcription factors known to regulate pluripotency, maintain their genomic integrity, and robustly differentiate into the major somatic cell types as well as primordial germ cells. The EpiSC lines are distinct from mouse ES cells in their epigenetic state and the signals controlling their differentiation. Furthermore, EpiSC and human ES cells share patterns of gene expression and signalling responses that normally function in the epiblast. These results show that epiblast cells can be maintained as stable cell lines and interrogated to understand how pluripotent cells generate distinct fates during early development.	NINDS, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; Univ Oxford, Dept Zool, Mammalian Dev Lab, Oxford OX1 3PS, England; NCI, Stem Cell Biol Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Oxford; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	McKay, RDG (corresponding author), NINDS, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	paultesar@ninds.nih.gov; mckayr@ninds.nih.gov	Mack, David/AAE-5437-2022; Tesar, Paul/GPK-5942-2022	Tesar, Paul/0000-0003-1532-3155	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002881, ZIANS002881] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission)		Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; BEDDINGTON RS, 1987, ISOLATION CULTURE MA; Behringer R., 2003, MANIPULATING MOUSE E; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; Cai JL, 2006, STEM CELLS, V24, P516, DOI 10.1634/stemcells.2005-0143; Camus A, 2006, DEV BIOL, V295, P743, DOI 10.1016/j.ydbio.2006.03.047; Chung Y, 2006, NATURE, V439, P216, DOI 10.1038/nature04277; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; DEOME KB, 1959, CANCER RES, V19, P515; Downs KM, 2006, METH MOLEC MED, V121, P241; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GARDNER RL, 1985, J EMBRYOL EXP MORPH, V88, P349; GARDNER RL, 1983, INT REV EXP PATHOL, V24, P63; Hayashi K, 2007, SCIENCE, V316, P394, DOI 10.1126/science.1137545; Hirst CE, 2006, DEV BIOL, V293, P90, DOI 10.1016/j.ydbio.2006.01.023; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Liu Y, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-20; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Pelton TA, 2002, J CELL SCI, V115, P329; Robertson E. J., 1987, TERATOCARCINOMAS EMB; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tesar PJ, 2005, P NATL ACAD SCI USA, V102, P8239, DOI 10.1073/pnas.0503231102; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yu RN, 1998, NAT GENET, V20, P353, DOI 10.1038/3822; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	38	1561	1647	1	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2007	448	7150					196	U10		10.1038/nature05972	http://dx.doi.org/10.1038/nature05972			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188QN	17597760				2022-12-01	WOS:000247934500043
J	Griffin, BM; Schott, J; Schink, B				Griffin, Benjamin M.; Schott, Joachim; Schink, Bernhard			Nitrite, an electron donor for anoxygenic photosynthesis	SCIENCE			English	Article									Univ Konstanz, Dept Biol, D-78457 Constance, Germany	University of Konstanz	Griffin, BM (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.	griff113@uiuc.edu						CUSANOVI.MA, 1968, BIOCHIM BIOPHYS ACTA, V153, P397, DOI 10.1016/0005-2728(68)90083-2; Imhoff J.F., 1995, ANOXYGENIC PHOTOSYNT, P1, DOI DOI 10.1007/0-306-47954-0_1; IMHOFF JF, 2006, PROKARYOTES, V6, P846; MEGONIGAL JP, 2004, BIOGEOCHEMISTRY, P317, DOI DOI 10.1016/B0-08-043751-6/08132-9; OLSON JM, 1970, SCIENCE, V168, P438, DOI 10.1126/science.168.3930.438	5	62	71	4	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2007	316	5833					1870	1870		10.1126/science.1139478	http://dx.doi.org/10.1126/science.1139478			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183WI	17600210	Green Submitted			2022-12-01	WOS:000247602700030
J	Maherali, H; Klironomos, JN				Maherali, Hafiz; Klironomos, John N.			Influence of Phylogeny on fungal community assembly and ecosystem functioning	SCIENCE			English	Article							PLANT-COMMUNITIES; CURRENT KNOWLEDGE; BIODIVERSITY; NICHE; EVOLUTION; ECOLOGY; PRODUCTIVITY; CONSERVATISM; CONVERGENCE	Ecology seeks to explain species coexistence and its functional consequences, but experimental tests of mechanisms that simultaneously account for both processes are difficult. We used an experimental mycorrhizal plant system to test whether functional similarity among closely related species (phylogenetic conservatism) can drive community assembly and ecosystem functioning. Communities were constructed with the same number of fungal species, but after 1 year of growth, realized species richness was highest where the starting species were more distantly related to each other. Communities with high realized species richness also stimulated plant productivity more than those with low realized species richness. Our findings suggest that phylogenetic trait conservatism can promote coexistence because of reduced competition between distinct evolutionary lineages and enhance ecosystem function because of functional complementarity among those same lineages.	Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Maherali, H (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	maherali@uoguelph.ca; jklirono@uoguelph.ca						Ackerly DD, 2006, ECOLOGY, V87, pS50, DOI 10.1890/0012-9658(2006)87[50:NEAART]2.0.CO;2; Ackerly DD, 2004, AM NAT, V163, P654, DOI 10.1086/383062; Anderson TM, 2004, AM NAT, V164, P709, DOI 10.1086/425372; Cavender-Bares J, 2004, AM NAT, V163, P823, DOI 10.1086/386375; Darwin C., 1859, ORIGIN SPECIES MEANS; ELTON C, 1946, J ANIM ECOL, V15, P54, DOI 10.2307/1625; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Hart MM, 2002, NEW PHYTOL, V153, P335, DOI 10.1046/j.0028-646X.2001.00312.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hubbell Stephen P., 2001, V32, pi; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Lekberg Y, 2007, J ECOL, V95, P95, DOI 10.1111/j.1365-2745.2006.01193.x; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Losos JB, 2003, NATURE, V424, P542, DOI 10.1038/nature01814; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; NEWSHAM KK, 1995, TRENDS ECOL EVOL, V10, P407, DOI 10.1016/S0169-5347(00)89157-0; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Pfisterer AB, 2004, BASIC APPL ECOL, V5, P5, DOI 10.1078/1439-1791-00215; Prinzing A, 2001, P ROY SOC B-BIOL SCI, V268, P2383, DOI 10.1098/rspb.2001.1801; Schmid B, 2002, MG POP BIOL, V33, P120; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Silvertown J, 2006, P ROY SOC B-BIOL SCI, V273, P39, DOI 10.1098/rspb.2005.3288; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Strauss SY, 2006, P NATL ACAD SCI USA, V103, P5841, DOI 10.1073/pnas.0508073103; Swenson NG, 2006, ECOLOGY, V87, P2418, DOI 10.1890/0012-9658(2006)87[2418:TPAPOS]2.0.CO;2; Tofts R, 2000, P ROY SOC B-BIOL SCI, V267, P363, DOI 10.1098/rspb.2000.1010; van der Heijden MGA, 2007, NEW PHYTOL, V174, P244, DOI 10.1111/j.1469-8137.2007.02041.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Wardle DA, 1999, OIKOS, V87, P403, DOI 10.2307/3546757; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; WEIHER E, 1995, OIKOS, V73, P323, DOI 10.2307/3545956; Weiher E., 1999, ECOLOGICAL ASSEMBLY; WINSTON MR, 1995, AM NAT, V145, P527, DOI 10.1086/285754; Zavaleta ES, 2004, SCIENCE, V306, P1175, DOI 10.1126/science.1102643	36	640	669	15	404	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2007	316	5832					1746	1748		10.1126/science.1143082	http://dx.doi.org/10.1126/science.1143082			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180XE	17588930				2022-12-01	WOS:000247400500047
J	Waterhouse, RM; Kriventseva, EV; Meister, S; Xi, ZY; Alvarez, KS; Bartholomay, LC; Barillas-Mury, C; Bian, GW; Blandin, S; Christensen, BM; Dong, YM; Jiang, HB; Kanost, MR; Koutsos, AC; Levashina, EA; Li, JY; Ligoxygakis, P; MacCallum, RM; Mayhew, GF; Mendes, A; Michel, K; Osta, MA; Paskewitz, S; Shin, SW; Vlachou, D; Wang, LH; Wei, WQ; Zheng, LB; Zou, Z; Severson, DW; Raikhel, AS; Kafatos, FC; Dimopoulos, G; Zdobnov, EM; Christophides, GK				Waterhouse, Robert M.; Kriventseva, Evgenia V.; Meister, Stephan; Xi, Zhiyong; Alvarez, Kanwal S.; Bartholomay, Lyric C.; Barillas-Mury, Carolina; Bian, Guowu; Blandin, Stephanie; Christensen, Bruce M.; Dong, Yuemei; Jiang, Haobo; Kanost, Michael R.; Koutsos, Anastasios C.; Levashina, Elena A.; Li, Jianyong; Ligoxygakis, Petros; MacCallum, Robert M.; Mayhew, George F.; Mendes, Antonio; Michel, Kristin; Osta, Mike A.; Paskewitz, Susan; Shin, Sang Woon; Vlachou, Dina; Wang, Lihui; Wei, Weiqi; Zheng, Liangbiao; Zou, Zhen; Severson, David W.; Raikhel, Alexander S.; Kafatos, Fotis C.; Dimopoulos, George; Zdobnov, Evgeny M.; Christophides, George K.			Evolutionary dynamics of immune-related genes and pathways in disease-vector mosquitoes	SCIENCE			English	Article							ANOPHELES-GAMBIAE; DROSOPHILA-MELANOGASTER; SERINE PROTEASES; ANTIVIRAL RESPONSE; SEPHADEX BEADS; AEDES-AEGYPTI; PLASMODIUM; MELANIZATION; PHAGOCYTOSIS; RECOGNITION	Mosquitoes are vectors of parasitic and viral diseases of immense importance for public health. The acquisition of the genome sequence of the yellow fever and Dengue vector, Aedes aegypti (Aa), has enabled a comparative phylogenomic analysis of the insect immune repertoire: in Aa, the malaria vector Anopheles gambiae (Ag), and the fruit fly Drosophila melanogaster (Dm). Analysis of immune signaling pathways and response modules reveals both conservative and rapidly evolving features associated with different functional gene categories and particular aspects of immune reactions. These dynamics reflect in part continuous readjustment between accommodation and rejection of pathogens and suggest how innate immunity may have evolved.	Univ Geneva, Sch Med, Dept Struct Biol & Bioinformat, CH-1211 Geneva, Switzerland; Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Cell & Mol Biol, London SW7 2AZ, England; Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA; Iowa State Univ, Dept Entomol, Ames, IA 50011 USA; NIAID, Lab Malaria & Vector Res, Twinbrook II Facil, NIH, Bethesda, MD 20892 USA; CNRS, Unite Propre Rech 9022, Avnir INSERM, Inst Mol & Cellulaire, Strasbourg, France; Univ Wisconsin, Dept Anim Hlth & Biomed Sci, Madison, WI 53706 USA; Oklahoma State Univ, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA; Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA; Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA; Yale Univ, Sch Med Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Fujian Ctr Prevent & Control Occupat Dis & Chem P, Fuzhou, Fujian, Peoples R China; Inst Plant Physiol & Ecol, Shanghai, Peoples R China; Univ Notre Dame, Ctr Global Hlth & Infect Dis, Dept Biol Sci, Notre Dame, IN 46556 USA; Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland	University of Geneva; Imperial College London; University of Geneva; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Riverside; University of California System; University of California Riverside; Iowa State University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Wisconsin System; University of Wisconsin Madison; Oklahoma State University System; Oklahoma State University - Stillwater; Kansas State University; Virginia Polytechnic Institute & State University; University of Oxford; University of Wisconsin System; University of Wisconsin Madison; Yale University; Chinese Academy of Sciences; University of Notre Dame; Swiss Institute of Bioinformatics	Kafatos, FC (corresponding author), Univ Geneva, Sch Med, Dept Struct Biol & Bioinformat, CH-1211 Geneva, Switzerland.	f.kafatos@imperial.ac.uk; zdobnov@medecine.unige.ch; g.christophides@imperial.ac.uk	Mayhew, George F/B-4042-2016; Waterhouse, Robert M/A-1858-2010; Zdobnov, Evgeny/AAB-2745-2022; Bian, Guowu/B-1572-2010; Meister, Stephan/M-6608-2014; Zdobnov, Evgeny M/K-1133-2012; zou, zhen/C-6134-2016; Blandin, Stephanie/I-2786-2016; Xi, Zhiyong/AAD-7936-2022; Alvarez, Kanwal/AAQ-6451-2020; Michel, Kristin/F-3400-2011; Blandin, Stephanie/ABH-2267-2021; Jiang, Haobo/A-6519-2008	Mayhew, George F/0000-0003-0609-6018; Waterhouse, Robert M/0000-0003-4199-9052; Zdobnov, Evgeny/0000-0002-5178-1498; Meister, Stephan/0000-0003-2436-7037; zou, zhen/0000-0003-3550-7656; Blandin, Stephanie/0000-0003-4566-1200; Xi, Zhiyong/0000-0001-7786-012X; Blandin, Stephanie/0000-0003-4566-1200; Shin, Sang Woon/0000-0001-9467-0803; Jiang, Haobo/0000-0003-1357-1315; Kanost, Michael/0000-0002-6827-0061; Christophides, George/0000-0002-3323-1687; MacCallum, Robert/0000-0001-5070-4493; Dimopoulos, George/0000-0001-6755-8111; Dong, Yuemei/0000-0002-7902-2899; Levashina, Elena/0000-0003-4605-906X; Vlachou, Dina/0000-0002-8305-3014; M. Mendes, Antonio/0000-0001-6562-5325	MRC [G0300170] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044220, R01AI059492, R01AI061576, R01AI037083, Z01AI000947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041247, R01GM041247, R01GM058634, R29GM041247] Funding Source: NIH RePORTER; Medical Research Council [G0300170] Funding Source: Medline; NIAID NIH HHS [1 R01 AI059492-01A1, 5 R01 AI61576-2, R01 AI037083, P01 AI044220-06A1] Funding Source: Medline; NIGMS NIH HHS [GM41247, R01 GM058634-09] Funding Source: Medline; Wellcome Trust [GR077229MA] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome Trust)		Bedoya RJU, 2005, INSECT MOL BIOL, V14, P89, DOI 10.1111/j.1365-2583.2004.00534.x; Bian G, 2005, P NATL ACAD SCI USA, V102, P13568, DOI 10.1073/pnas.0502815102; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Blandin S, 2004, MOL IMMUNOL, V40, P903, DOI 10.1016/j.molimm.2003.10.010; Christensen BM, 2005, TRENDS PARASITOL, V21, P192, DOI 10.1016/j.pt.2005.02.007; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Cohuet A, 2006, EMBO REP, V7, P1285, DOI 10.1038/sj.embor.7400831; DAFFRE S, 1994, MOL GEN GENET, V242, P152, DOI 10.1007/BF00391008; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Hillyer JF, 2003, J PARASITOL, V89, P62, DOI 10.1645/0022-3395(2003)089[0062:RPAMOB]2.0.CO;2; IMIER JL, 2004, J LEUKOCYTE BIOL, V75, P18; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; Kumar S, 2004, J BIOL CHEM, V279, P53475, DOI 10.1074/jbc.M409905200; Lazzaro BP, 2004, SCIENCE, V303, P1873, DOI 10.1126/science.1092447; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Li B, 2005, GENE, V360, P131, DOI 10.1016/j.gene.2005.07.001; Li JS, 2005, INSECT BIOCHEM MOLEC, V35, P1269, DOI 10.1016/j.ibmb.2005.07.001; Meister S, 2005, P NATL ACAD SCI USA, V102, P11420, DOI 10.1073/pnas.0504950102; Michel K, 2005, EMBO REP, V6, P891, DOI 10.1038/sj.embor.7400478; Michel K, 2006, P NATL ACAD SCI USA, V103, P16858, DOI 10.1073/pnas.0608033103; Moita LF, 2005, IMMUNITY, V23, P65, DOI 10.1016/j.immuni.2005.05.006; Muller HM, 1999, J BIOL CHEM, V274, P11727, DOI 10.1074/jbc.274.17.11727; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Ooi JY, 2002, EMBO REP, V3, P82, DOI 10.1093/embo-reports/kvf004; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Paskewitz SM, 2006, INSECT BIOCHEM MOLEC, V36, P701, DOI 10.1016/j.ibmb.2006.06.001; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Roxstrom-Lindquist K, 2004, EMBO REP, V5, P207, DOI 10.1038/sj.embor.7400073; Shin SW, 2006, J BIOL CHEM, V281, P39388, DOI 10.1074/jbc.M608912200; Shin SW, 2003, P NATL ACAD SCI USA, V100, P2616, DOI 10.1073/pnas.0537347100; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Volz J, 2005, J BIOL CHEM, V280, P40161, DOI 10.1074/jbc.M506191200; Volz J, 2006, CELL MICROBIOL, V8, P1392, DOI 10.1111/j.1462-5822.2006.00718.x; Wang LH, 2006, IMMUNOBIOLOGY, V211, P251, DOI 10.1016/j.imbio.2006.01.001; Wang LH, 2006, EMBO J, V25, P5005, DOI 10.1038/sj.emboj.7601363; Warr E, 2006, INSECT BIOCHEM MOLEC, V36, P769, DOI 10.1016/j.ibmb.2006.07.006; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102	42	468	488	3	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2007	316	5832					1738	1743		10.1126/science.1139862	http://dx.doi.org/10.1126/science.1139862			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180XE	17588928	Green Accepted, Green Submitted			2022-12-01	WOS:000247400500045
J	Osei-Atweneboano, MY; Eng, JKL; Boakye, DA; Gyapong, JO; Prichard, RK				Osei-Atweneboano, Mike Y.; Eng, Jeffrey K. L.; Boakye, Daniel A.; Gyapong, John O.; Prichard, Roger K.			Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study	LANCET			English	Article							MULTIPLE TREATMENTS; CONTROL-PROGRAM; P-GLYCOPROTEIN; WEST-AFRICA; SELECTION; CHEMOTHERAPY; VACCINE; FOCI	Background Ivermectin has been used for onchocerciasis control since 1987. Because of the long-term use of this drug and the development of resistance in other nematodes, we have assessed Onchocerca volvulus burdens, effectiveness of ivermectin as a microfilaricide, and its effect on adult female worm reproduction. Methods For the first phase of the study, 2501 individuals in Ghana, from 19 endemic communities who had received six to 18 annual rounds of ivermectin and one ivermectin naive community, were assessed for microfilarial loads 7 days before the 2004 yearly ivermectin treatment, by means of skin snips, and 30 days after treatment to assess the ivermectin microfilaricidal action. For the second phase, skin snips were taken from 342 individuals from ten communities, who were microfilaria positive at pretreatment assessment, on days 90 and 180 after treatment, to identify the effects of ivermectin on female worm fertility, assessed by microfilaria repopulation. Findings 487 (19%) of the 2501 participants were microfilaria positive. The microfilaria prevalence and community microfilarial load in treated communities ranged from 2.2% to 51.8%, and 0.06 microfilariae per snip to 2.85 microfilariae per snip, respectively. Despite treatment, the prevalence rate doubled between 2000 and 2005 in two communities. Microfilaria assessment 30 days after ivermectin treatment showed 100% clearance of microfilaria in more than 99% of people. At day 90 after treatment, four of ten communities had significant microfilaria repopulation, from 7.1% to 21.1% of pretreatment counts, rising to 53.9% by day 180. Interpretation Ivermectin remains a potent microfilaricide. However, our results suggest that resistant adult parasite populations, which are not responding as expected to ivermectin, are emerging. A high rate of repopulation of skin with microfilariae will allow parasite transmission, possibly with ivermectin-resistant 0 volvulus, which could eventually lead to recrudescence of the disease.	McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ H9X 3V9, Canada; Univ Ghana, Noguchi Mem Inst Med Res, Accra, Ghana; Ghana Hlth Serv, Hlth Res Unit, Accra, Ghana	McGill University; University of Ghana; Ghana Health Service	Prichard, RK (corresponding author), McGill Univ, Inst Parasitol, 21111 Lakeshore Rd, Ste Anne De Bellevue, PQ H9X 3V9, Canada.	roger.prichard@mcgill.ca		Gyapong, John/0000-0002-8415-1468				Ali MMM, 2002, ACTA TROP, V84, P49, DOI 10.1016/S0001-706X(02)00117-1; ALLEY ES, 1994, T ROY SOC TROP MED H, V88, P581, DOI 10.1016/0035-9203(94)90172-4; Ardelli BF, 2006, PARASITOLOGY, V132, P375, DOI 10.1017/S0031182005008991; Ardelli BF, 2006, MOL BIOCHEM PARASIT, V145, P94, DOI 10.1016/j.molbiopara.2005.09.011; Ardelli BF, 2005, MOL BIOCHEM PARASIT, V143, P58, DOI 10.1016/j.molbiopara.2005.05.006; Ardelli BF, 2004, ANN TROP MED PARASIT, V98, P371, DOI 10.1179/000349804225003415; AWADZI K, 1985, ANN TROP MED PARASIT, V79, P63, DOI 10.1080/00034983.1985.11811889; Awadzi K, 2004, ANN TROP MED PARASIT, V98, P231, DOI 10.1179/000349804225003253; Awadzi K, 2004, ANN TROP MED PARASIT, V98, P359, DOI 10.1179/000349804225003442; AWADZI K, 1995, TROP MED PARASITOL, V46, P131; AWADZI K, 1989, TROP MED PARASITOL, V40, P361; Basanez MG, 2006, PLOS MED, V3, P1454, DOI 10.1371/journal.pmed.0030371; BOATIN BA, 1998, ANN TROP MED PARASIT, V92, P46; Borsboom GJJM, 2003, FILARIA J, V2, P1; CHAVASSE DC, 1992, TROP MED PARASITOL, V43, P256; DUKE BOL, 1992, AM J TROP MED HYG, V46, P189, DOI 10.4269/ajtmh.1992.46.189; Eng JKL, 2006, MOL BIOCHEM PARASIT, V150, P229, DOI 10.1016/j.molbiopara.2006.08.007; Eng JKL, 2005, MOL BIOCHEM PARASIT, V142, P193, DOI 10.1016/j.molbiopara.2005.01.021; GREENE BM, 1985, NEW ENGL J MED, V313, P133, DOI 10.1056/NEJM198507183130301; Hoerauf A, 2001, LANCET, V357, P1415, DOI 10.1016/S0140-6736(00)04581-5; Lustigman S, 2002, TRENDS PARASITOL, V18, P135, DOI 10.1016/S1471-4922(01)02211-5; *MIN SAL PUBL, 2000, ORG DES CONTR PROC D, P1; Nutman TB, 2002, TRENDS PARASITOL, V18, P237, DOI 10.1016/S1471-4922(02)02310-3; PETER J, 2006, VACCINE, V24, P5787; PLAISIER AP, 1995, J INFECT DIS, V172, P204, DOI 10.1093/infdis/172.1.204; REMME J, 1986, B WORLD HEALTH ORGAN, V64, P667; REMME J, 1990, ACT LEIDENS, V59, P177; SCHULZ-KEY H, 1986, Parasitology Today, V2, P284, DOI 10.1016/0169-4758(86)90138-9; Whitworth JAG, 1996, TROP MED INT HEALTH, V1, P786; *WHO, 2001, OCP TDR M IMP IV ONC; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010; World Health Organization, 1995, WHO TECHN REP SER, V852	32	277	282	0	28	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 16	2007	369	9578					2021	2029		10.1016/S0140-6736(07)60942-8	http://dx.doi.org/10.1016/S0140-6736(07)60942-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180HT	17574093				2022-12-01	WOS:000247354400026
J	Hoskins, RA; Carlson, JW; Kennedy, C; Acevedo, D; Evans-Holm, M; Frise, E; Wan, KH; Park, S; Mendez-Lago, M; Rossi, F; Villasante, A; Dimitri, P; Karpen, GH; Celniker, SE				Hoskins, Roger A.; Carlson, Joseph W.; Kennedy, Cameron; Acevedo, David; Evans-Holm, Martha; Frise, Erwin; Wan, Kenneth H.; Park, Soo; Mendez-Lago, Maria; Rossi, Fabrizio; Villasante, Alfredo; Dimitri, Patrizio; Karpen, Gary H.; Celniker, Susan E.			Sequence finishing and mapping of Drosophila melanogaster heterochromatin	SCIENCE			English	Article							CENTRIC HETEROCHROMATIN; INSERTIONS; ELEMENTS	Genome sequences for most metazoans and plants are incomplete because of the presence of repeated DNA in the heterochromatin. The heterochromatic regions of Drosophila melanogaster contain 20 million bases (Mb) of sequence amenable to mapping, sequence assembly, and finishing. We describe the generation of 15 Mb of finished or improved heterochromatic sequence with the use of available clone resources and assembly methods. We also constructed a bacterial artificial chromosome-based physical map that spans 13 Mb of the pericentromeric heterochromatin and a cytogenetic map that positions 11 Mb in specific chromosomal locations. We have approached a complete assembly and mapping of the nonsatellite component of Drosophila heterochromatin. The strategy we describe is also applicable to generating substantially more information about heterochromatin in other species, including humans.	Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome & Computat Biol, Berkeley, CA 94720 USA; UAM, CSIC, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain; Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Sapienza University Rome; University of California System; University of California Berkeley	Celniker, SE (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome & Computat Biol, Berkeley, CA 94720 USA.	celniker@fruitfly.org			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000747, P50HG000750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066272] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG000747, R01 HG000747-16, P50-HG00750, R01 HG00747] Funding Source: Medline; NIGMS NIH HHS [R01 GM066272] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abad JP, 2004, MOL BIOL EVOL, V21, P1613, DOI 10.1093/molbev/msh174; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; CELNIKER SE, 2002, GENOME BIOL, V0003; CELNIKER SE, 2006, BDGP RELEASE 5 GENOM; Dernburg AF, 1996, CELL, V85, P745, DOI 10.1016/S0092-8674(00)81240-4; Eichler EE, 2004, NAT REV GENET, V5, P345, DOI 10.1038/nrg1322; GATTI M, 1994, METHOD CELL BIOL, V44, P371, DOI 10.1016/S0091-679X(08)60924-3; GATTI M, 1992, ANNU REV GENET, V26, P239, DOI 10.1146/annurev.ge.26.120192.001323; HOSKINS RA, 2002, GENOME BIOL, V0003; Hoskins RA, 2000, SCIENCE, V287, P2271, DOI 10.1126/science.287.5461.2271; JOHN B, 1988, EUKARYOTE GENOME DEV, P416; Karpen GH, 1996, SCIENCE, V273, P118, DOI 10.1126/science.273.5271.118; Konev AY, 2003, GENETICS, V165, P2039; LOHE AR, 1986, P NATL ACAD SCI USA, V83, P696, DOI 10.1073/pnas.83.3.696; Marra MA, 1997, GENOME RES, V7, P1072, DOI 10.1101/gr.7.11.1072; Stapleton M, 2002, GENOME RES, V12, P1294, DOI 10.1101/gr.269102; Talbert PB, 2006, NAT REV GENET, V7, P793, DOI 10.1038/nrg1920; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Wallrath L, 1998, CURR OPIN GENET DEV, V8, P147, DOI 10.1016/S0959-437X(98)80135-4; Yan CM, 2002, GENETICS, V161, P217	21	212	237	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1625	1628		10.1126/science.1139816	http://dx.doi.org/10.1126/science.1139816			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569867	Green Submitted, Green Accepted			2022-12-01	WOS:000247239900044
J	Womelsdorf, T; Schoffelen, JM; Oostenveld, R; Singer, W; Desimone, R; Engel, AK; Fries, P				Womelsdorf, Thilo; Schoffelen, Jan-Mathijs; Oostenveld, Robert; Singer, Wolf; Desimone, Robert; Engel, Andreas K.; Fries, Pascal			Modulation of neuronal interactions through neuronal synchronization	SCIENCE			English	Article							VISUAL-CORTEX; GAMMA-OSCILLATIONS; SYNAPTIC MODIFICATIONS; INTERNEURON NETWORKS; CORTICAL NEURON; BEHAVING RAT; COINCIDENCE; HIPPOCAMPUS; RESPONSES; MEMORY	Brain processing depends on the interactions between neuronal groups. Those interactions are governed by the pattern of anatomical connections and by yet unknown mechanisms that modulate the effective strength of a given connection. We found that the mutual influence among neuronal groups depends on the phase relation between rhythmic activities within the groups. Phase relations supporting interactions between the groups preceded those interactions by a few milliseconds, consistent with a mechanistic role. These effects were specific in time, frequency, and space, and we therefore propose that the pattern of synchronization flexibly determines the pattern of neuronal interactions.	Radboud Univ Nijmegen, FC Donders Ctr Cognit Neuroimaging, NL-6525 ED Nijmegen, Netherlands; Max Planck Inst Brain Res, Dept Neurophysiol, D-60528 Frankfurt, Germany; Univ Frankfurt, Frankfurt Inst Adv Studies, D-60438 Frankfurt, Germany; NIMH, Neuropsychol Lab, NIH, Bethesda, MD 20892 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, D-20246 Hamburg, Germany; Radboud Univ Nijmegen, Dept Biophys, NL-6525 EZ Nijmegen, Netherlands	Radboud University Nijmegen; Max Planck Society; Goethe University Frankfurt; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Massachusetts Institute of Technology (MIT); University of Hamburg; University Medical Center Hamburg-Eppendorf; Radboud University Nijmegen	Womelsdorf, T (corresponding author), Radboud Univ Nijmegen, FC Donders Ctr Cognit Neuroimaging, NL-6525 ED Nijmegen, Netherlands.	thilo.womelsdorf@tcdonders.ru.nl; jan.schoffelen@tcdonders.ru.nl	Oostenveld, Robert/D-3259-2009; Desimone, Robert/G-1121-2018; Fries, Pascal/E-3196-2010; Engel, Andreas K./AAH-6384-2019; Schoffelen, Jan-Mathijs/D-3716-2009; Singer, Wolf/D-6874-2012; Engel, Andreas K/C-7781-2012; Womelsdorf, Thilo/C-3096-2015	Oostenveld, Robert/0000-0002-1974-1293; Fries, Pascal/0000-0002-4270-1468; Engel, Andreas K./0000-0003-4899-8466; Schoffelen, Jan-Mathijs/0000-0003-0923-6610; Engel, Andreas K/0000-0003-4899-8466; Womelsdorf, Thilo/0000-0001-6921-4187	NATIONAL EYE INSTITUTE [R01EY017292] Funding Source: NIH RePORTER; NEI NIH HHS [R01EY017292] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BRAGIN A, 1995, J NEUROSCI, V15, P47; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; BUZSEKI G, 2006, RHYTHMS BRAIN; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P6048, DOI 10.1073/pnas.88.14.6048; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; Fries P, 2002, J NEUROSCI, V22, P3739; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Gross J, 2004, P NATL ACAD SCI USA, V101, P13050, DOI 10.1073/pnas.0404944101; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; KONIG P, 1995, NEURAL COMPUT, V7, P469, DOI 10.1162/neco.1995.7.3.469; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mishra J, 2006, NEURAL NETWORKS, V19, P1329, DOI 10.1016/j.neunet.2006.08.005; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Schoffelen JM, 2005, SCIENCE, V308, P111, DOI 10.1126/science.1107027; Tallon-Baudry C, 2004, CEREB CORTEX, V14, P713, DOI 10.1093/cercor/bhh031; Vida I, 2006, NEURON, V49, P107, DOI 10.1016/j.neuron.2005.11.036; Wespatat V, 2004, J NEUROSCI, V24, P9067, DOI 10.1523/JNEUROSCI.2221-04.2004; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258	28	896	911	0	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2007	316	5831					1609	1612		10.1126/science.1139597	http://dx.doi.org/10.1126/science.1139597			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569862	Green Published			2022-12-01	WOS:000247239900039
J	Magnani, F; Mencuccini, M; Borghetti, M; Berbigier, P; Berninger, F; Delzon, S; Grelle, A; Hari, P; Jarvis, PG; Kolari, P; Kowalski, AS; Lankreijer, H; Law, BE; Lindroth, A; Loustau, D; Manca, G; Moncrieff, JB; Rayment, M; Tedeschi, V; Valentini, R; Grace, J				Magnani, Federico; Mencuccini, Maurizio; Borghetti, Marco; Berbigier, Paul; Berninger, Frank; Delzon, Sylvain; Grelle, Achim; Hari, Pertti; Jarvis, Paul G.; Kolari, Pasi; Kowalski, Andrew S.; Lankreijer, Harry; Law, Beverly E.; Lindroth, Anders; Loustau, Denis; Manca, Giovanni; Moncrieff, John B.; Rayment, Mark; Tedeschi, Vanessa; Valentini, Riccardo; Grace, John			The human footprint in the carbon cycle of temperate and boreal forests	NATURE			English	Article							NITROGEN DEPOSITION; EUROPEAN FORESTS; PINE FORESTS; ECOSYSTEM; STORAGE; BALANCE; STAND; CHRONOSEQUENCE; SEQUESTRATION; RESPIRATION	Temperate and boreal forests in the Northern Hemisphere cover an area of about 2 x 10(7) square kilometres and act as a substantial carbon sink (0.6 - 0.7 petagrams of carbon per year)(1). Although forest expansion following agricultural abandonment is certainly responsible for an important fraction of this carbon sink activity, the additional effects on the carbon balance of established forests of increased atmospheric carbon dioxide, increasing temperatures, changes in management practices and nitrogen deposition are difficult to disentangle, despite an extensive network of measurement stations(2,3). The relevance of this measurement effort has also been questioned(4), because spot measurements fail to take into account the role of disturbances, either natural ( fire, pests, windstorms) or anthropogenic ( forest harvesting). Here we show that the temporal dynamics following stand-replacing disturbances do indeed account for a very large fraction of the overall variability in forest carbon sequestration. After the confounding effects of disturbance have been factored out, however, forest net carbon sequestration is found to be overwhelmingly driven by nitrogen deposition, largely the result of anthropogenic activities(5). The effect is always positive over the range of nitrogen deposition covered by currently available data sets, casting doubts on the risk of widespread ecosystem nitrogen saturation(6) under natural conditions. The results demonstrate that mankind is ultimately controlling the carbon balance of temperate and boreal forests, either directly ( through forest management) or indirectly ( through nitrogen deposition).	Univ Bologna, Dept Fruit Tree & Woody Plant Sci, I-40127 Bologna, Italy; Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JU, Midlothian, Scotland; Univ Basilicata, Dept Crop Syst Forestry & Environm Sci, I-85100 Potenza, Italy; INRA, UR1263 EPHYSE, F-33883 Villenave Dornon, France; Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada; Swedish Univ Agr Sci, Dept Ecol & Environm Res, SE-75007 Uppsala, Sweden; Univ Helsinki, Dept Forest Ecol, FIN-00014 Helsinki, Finland; Lund Univ, Dept Forest Geog & Ecosyst Anal, S-22362 Lund, Sweden; Oregon State Univ, Coll Forestry, Corvallis, OR 97331 USA; Univ Tuscia, Dept Forest Resources & Environm, I-01100 Viterbo, Italy	University of Bologna; University of Edinburgh; University of Basilicata; INRAE; University of Quebec; University of Quebec Montreal; Swedish University of Agricultural Sciences; University of Helsinki; Lund University; Oregon State University; Tuscia University	Magnani, F (corresponding author), Univ Bologna, Dept Fruit Tree & Woody Plant Sci, I-40127 Bologna, Italy.	federico.magnani@unibo.it	Grace, John/N-9280-2013; Kowalski, Andrew S./A-7515-2008; Mencuccini, Maurizio/B-9052-2011; Magnani, Federico/A-2448-2011; Sigurdsson, Bjarni D/E-4592-2012; Borghetti, Marco/C-4262-2012; Berninger, Frank/A-8891-2010; Law, Beverly/G-3882-2010; Lindroth, Anders/N-4697-2014; Rayment, Mark/L-9848-2016; Valentini, Riccardo/D-1226-2010; Delzon, Sylvain/R-9538-2018	Kowalski, Andrew S./0000-0001-9777-9708; Mencuccini, Maurizio/0000-0003-0840-1477; Magnani, Federico/0000-0003-4479-0916; Borghetti, Marco/0000-0003-3159-6655; Berninger, Frank/0000-0001-7718-1661; Law, Beverly/0000-0002-1605-1203; Lindroth, Anders/0000-0002-7669-784X; Valentini, Riccardo/0000-0002-6756-5634; Delzon, Sylvain/0000-0003-3442-1711; Kolari, Pasi/0000-0001-7271-633X; Loustau, Denis/0000-0003-3990-400X				Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; Andren O, 1997, ECOL APPL, V7, P1226, DOI 10.1890/1051-0761(1997)007[1226:ITICBM]2.0.CO;2; Bond-Lamberty B, 2004, GLOBAL CHANGE BIOL, V10, P473, DOI 10.1111/j.1529-8817.2003.0742.x; BOONE RD, 1988, ECOLOGY, V69, P714, DOI 10.2307/1941019; Davis MR, 2003, FOREST ECOL MANAG, V177, P313, DOI 10.1016/S0378-1127(02)00333-X; De Vries W, 2006, GLOBAL CHANGE BIOL, V12, P1151, DOI 10.1111/j.1365-2486.2006.01151.x; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.1890/1051-0761(2002)012[0891:FCSITN]2.0.CO;2; Harmon ME, 2004, ECOSYSTEMS, V7, P498, DOI 10.1007/s10021-004-0140-9; Hogberg P, 2006, GLOBAL CHANGE BIOL, V12, P489, DOI 10.1111/j.1365-2486.2006.01102.x; Holland EA, 2005, ECOL APPL, V15, P38, DOI 10.1890/03-5162; Howard EA, 2004, GLOBAL CHANGE BIOL, V10, P1267, DOI 10.1111/j.1529-8817.2003.00804.x; JOHNSON DW, 1992, J ENVIRON QUAL, V21, P1, DOI 10.2134/jeq1992.00472425002100010001x; Knohl A, 2003, AGR FOREST METEOROL, V118, P151, DOI 10.1016/S0168-1923(03)00115-1; Korner C, 2003, SCIENCE, V300, P1242, DOI 10.1126/science.1084460; Landsberg JJ, 1997, FOREST ECOL MANAG, V95, P209, DOI 10.1016/S0378-1127(97)00026-1; Law BE, 2003, GLOBAL CHANGE BIOL, V9, P510, DOI 10.1046/j.1365-2486.2003.00624.x; Law BE, 2002, AGR FOREST METEOROL, V113, P97, DOI 10.1016/S0168-1923(02)00104-1; Litvak M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000854; Magill AH, 2004, FOREST ECOL MANAG, V196, P7, DOI 10.1016/j.foreco.2004.03.033; Mund M., 2004, THESIS G AUGUST U GO; Nadelhoffer KJ, 1999, NATURE, V398, P145, DOI 10.1038/18205; PETERSON BJ, 1985, TELLUS B, V37, P117, DOI 10.1111/j.1600-0889.1985.tb00060.x; Pregitzer KS, 2004, GLOBAL CHANGE BIOL, V10, P2052, DOI 10.1111/j.1365-2486.2004.00866.x; Rothstein DE, 2004, CAN J FOREST RES, V34, P1908, DOI [10.1139/x04-063, 10.1139/X04-063]; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Thornton PE, 2002, AGR FOREST METEOROL, V113, P185, DOI 10.1016/S0168-1923(02)00108-9; Townsend AR, 1996, ECOL APPL, V6, P806, DOI 10.2307/2269486; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; Wirth C, 2002, TELLUS B, V54, P611, DOI 10.1034/j.1600-0889.2002.01343.x	30	736	801	15	596	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2007	447	7146					848	850		10.1038/nature05847	http://dx.doi.org/10.1038/nature05847			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17568744				2022-12-01	WOS:000247207500042
J	Steinbrook, R				Steinbrook, Robert			Erythropoietin, the FDA, and oncology	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						Berenson Alex, 2007, NY TIMES        0509, pA1; *FOOD DRUG ADM, 2007, FDA AL INF HEALTHC P; *ONC DRUG ADV COMM, 2007, CONT REASS RISKS ER; Steinbrook R, 2006, LANCET, V368, P2191, DOI 10.1016/S0140-6736(06)69707-9	4	47	50	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2007	356	24					2448	2451		10.1056/NEJMp078100	http://dx.doi.org/10.1056/NEJMp078100			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	178DR	17568025				2022-12-01	WOS:000247201900003
J	Wollert, T; Pasche, B; Rochon, M; Deppenmeier, S; van den Heuvel, J; Gruber, AD; Heinz, DW; Lengeling, A; Schubert, WD				Wollert, Thomas; Pasche, Bastian; Rochon, Maike; Deppenmeier, Stefanie; van den Heuvel, Joop; Gruber, Achim D.; Heinz, Dirk W.; Lengeling, Andreas; Schubert, Wolf-Dieter			Extending the host range of Listeria monocytogenes by rational protein design	CELL			English	Article							GUINEA-PIG; E-CADHERIN; INTERNALIN; RECEPTOR; INVASION; CELLS; ENTRY; SPECIFICITY; MODEL; PLACENTA	In causing disease, pathogens outmaneuver host defenses through a dedicated arsenal of virulence determinants that specifically bind or modify individual host molecules. This dedication limits the intruder to a defined range of hosts. Newly emerging diseases mostly involve existing pathogens whose arsenal has been altered to allow them to infect previously inaccessible hosts. We have emulated this chance occurrence by extending the host range accessible to the human pathogen Listeria monocytogenes by the intestinal route to include the mouse. Analyzing the recognition complex of the listerial invasion protein InIA and its human receptor E-cadherin, we postulated and verified amino acid substitutions in InIA to increase its affinity for E-cadherin. Two single substitutions increase binding affinity by four orders of magnitude and extend binding specificity to include formerly incompatible murine E-cadherin. By rationally adapting a single protein, we thus create a versatile murine model of human listeriosis.	Helmholtz Ctr Infect Res, Div Struct Biol, Mol Host Pathogen Interact, D-38124 Braunschweig, Germany; Helmholtz Ctr Infect Res, Dept Expt Mouse Genet, D-38124 Braunschweig, Germany; Helmholtz Ctr Infect Res, Div Struct Biol, D-38124 Braunschweig, Germany; Free Univ Berlin, Dept Vet Pathol, D-14163 Berlin, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Free University of Berlin	Lengeling, A (corresponding author), Helmholtz Ctr Infect Res, Div Struct Biol, Mol Host Pathogen Interact, Inhoffenstr 7, D-38124 Braunschweig, Germany.	wolf-dieter.schubert@helmholtz-hzi.de; andreas.lengeling@helmholtz-hzi.de	Gruber, Achim D./ABA-4514-2021; Schubert, Wolf-Dieter/A-5617-2009	Schubert, Wolf-Dieter/0000-0003-4998-519X; Wollert, Thomas/0000-0001-9732-4789				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bakardjiev AI, 2005, J INFECT DIS, V191, P1889, DOI 10.1086/430090; Bakardjiev AI, 2004, INFECT IMMUN, V72, P489, DOI 10.1128/IAI.72.1.489-497.2004; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; CHAKRABORTY T, 1992, J BACTERIOL, V174, P568, DOI 10.1128/jb.174.2.568-574.1992; CLARK MA, 2002, CELL BIOL, V118, P137; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Cossart P, 2003, TRENDS CELL BIOL, V13, P23, DOI 10.1016/S0962-8924(02)00006-5; D'Souza-Schorey C, 2005, TRENDS CELL BIOL, V15, P19, DOI 10.1016/j.tcb.2004.11.002; Dietrich G, 1998, NAT BIOTECHNOL, V16, P181, DOI 10.1038/nbt0298-181; Dramsi S, 1997, INFECT IMMUN, V65, P1615, DOI 10.1128/IAI.65.5.1615-1625.1997; Drevets DA, 1999, INFECT IMMUN, V67, P3512, DOI 10.1128/IAI.67.7.3512-3517.1999; ELSINGHORST EA, 1994, METHOD ENZYMOL, V236, P405; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GAILLARD JL, 1991, CELL, V65, P1127, DOI 10.1016/0092-8674(91)90009-N; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Guimaraes VD, 2005, MICROBES INFECT, V7, P836, DOI 10.1016/j.micinf.2005.02.012; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Heeney JL, 2006, SCIENCE, V313, P462, DOI 10.1126/science.1123016; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Khelef N, 2006, CELL MICROBIOL, V8, P457, DOI 10.1111/j.1462-5822.2005.00634.x; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Le Monnier A, 2006, INFECT IMMUN, V74, P663, DOI 10.1128/IAI.74.1.663-672.2006; Le Monnier A, 2007, INFECT IMMUN, V75, P950, DOI 10.1128/IAI.01570-06; Lecuit M, 2005, CLIN MICROBIOL INFEC, V11, P430, DOI 10.1111/j.1469-0691.2005.01146.x; Lecuit M, 2004, P NATL ACAD SCI USA, V101, P6152, DOI 10.1073/pnas.0401434101; Lecuit M, 2002, TRENDS MOL MED, V8, P537, DOI 10.1016/S1471-4914(02)02413-9; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; Lewis DB, 2006, ANNU REV MED, V57, P139, DOI 10.1146/annurev.med.57.121304.131333; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; LINGNAU A, 1995, INFECT IMMUN, V63, P3896, DOI 10.1128/IAI.63.10.3896-3903.1995; Marco AJ, 1997, MICROB PATHOGENESIS, V23, P255, DOI 10.1006/mpat.1997.0144; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; Pasche B, 2005, INFECT IMMUN, V73, P5952, DOI 10.1128/IAI.73.9.5952-5960.2005; Pentecost M, 2006, PLOS PATHOG, V2, P29, DOI 10.1371/journal.ppat.0020003; Sabet C, 2005, INFECT IMMUN, V73, P6912, DOI 10.1128/IAI.73.10.6912-6922.2005; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Sleator RD, 2006, CURR OPIN BIOTECH, V17, P211, DOI 10.1016/j.copbio.2006.01.006; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Weiss RA, 2003, CURR TOP MICROBIOL, V278, P47; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Yap GS, 2002, CELL MICROBIOL, V4, P627, DOI 10.1046/j.1462-5822.2002.00224.x	52	155	156	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2007	129	5					891	902		10.1016/j.cell.2007.03.049	http://dx.doi.org/10.1016/j.cell.2007.03.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540170	Bronze, Green Published			2022-12-01	WOS:000247084600010
J	Wolf, M; van Doorn, GS; Leimar, O; Weissing, FJ				Wolf, Max; van Doorn, G. Sander; Leimar, Olof; Weissing, Franz J.			Life-history trade-offs favour the evolution of animal personalities	NATURE			English	Article							INDIVIDUAL-DIFFERENCES; BEHAVIORAL-DIFFERENCES; AVIAN PERSONALITIES; HERITABILITY; CONSEQUENCES; STICKLEBACKS; POPULATIONS; BOLDNESS; SHYNESS	In recent years evidence has been accumulating that personalities are not only found in humans(1) but also in a wide range of other animal species(2-8). Individuals differ consistently in their behavioural tendencies and the behaviour in one context is correlated with the behaviour in multiple other contexts. From an adaptive perspective, the evolution of animal personalities is still a mystery, because a more flexible structure of behaviour should provide a selective advantage(9-11). Accordingly, many researchers view personalities as resulting from constraints imposed by the architecture of behaviour(7) (but see ref. 12). In contrast, we show here that animal personalities can be given an adaptive explanation. Our argument is based on the insight that the trade-off between current and future reproduction(13) often results in polymorphic populations(14) in which some individuals put more emphasis on future fitness returns than others. Life-history theory predicts that such differences in fitness expectations should result in systematic differences in risk-taking behaviour(15). Individuals with high future expectations (who have much to lose) should be more risk-averse than individuals with low expectations. This applies to all kinds of risky situations, so individuals should consistently differ in their behaviour. By means of an evolutionary model we demonstrate that this basic principle results in the evolution of animal personalities. It simultaneously explains the coexistence of behavioural types, the consistency of behaviour through time and the structure of behavioural correlations across contexts. Moreover, it explains the common finding that explorative behaviour and risk-related traits like boldness and aggressiveness are common characteristics of animal personalities(2-8).	Univ Groningen, Theoret Biol Grp, Ctr Ecol & Evolutionary Studies, NL-9751 NN Haren, Netherlands; Stockholm Univ, Dept Zool, SE-10691 Stockholm, Sweden	University of Groningen; Stockholm University	Weissing, FJ (corresponding author), Univ Groningen, Theoret Biol Grp, Ctr Ecol & Evolutionary Studies, NL-9751 NN Haren, Netherlands.	f.j.weissing@rug.nl	van Doorn, G. Sander/G-3247-2011; Wolf, Max/L-4903-2013; Leimar, Olof/L-3781-2014	van Doorn, G. Sander/0000-0002-4703-3788; Leimar, Olof/0000-0001-8621-6977; Wolf, Max/0000-0001-8878-0504; Weissing, Franz J./0000-0003-3281-663X				BAKKER TCM, 1986, BEHAVIOUR, V98, P1, DOI 10.1163/156853986X00937; Bell AM, 2005, J EVOLUTION BIOL, V18, P464, DOI 10.1111/j.1420-9101.2004.00817.x; Bell AM, 2004, ANIM BEHAV, V68, P1339, DOI 10.1016/j.anbehav.2004.05.007; BOISSY A, 1995, Q REV BIOL, V70, P165, DOI 10.1086/418981; CLARK CW, 1994, BEHAV ECOL, V5, P159, DOI 10.1093/beheco/5.2.159; Coleman K, 1998, ANIM BEHAV, V56, P927, DOI 10.1006/anbe.1998.0852; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; Dingemanse NJ, 2002, ANIM BEHAV, V64, P929, DOI 10.1006/anbe.2002.2006; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; Drent PJ, 2003, P ROY SOC B-BIOL SCI, V270, P45, DOI 10.1098/rspb.2002.2168; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P137, DOI 10.1016/j.neubiorev.2004.06.010; Hedrick AV, 2000, P ROY SOC B-BIOL SCI, V267, P671, DOI 10.1098/rspb.2000.1054; HUNTINGFORD FA, 1976, ANIM BEHAV, V24, P245, DOI 10.1016/S0003-3472(76)80034-6; John OP, 1999, HDB PERSONALITY THEO; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Maynard Smith J., 1982, pi; McNamara JM, 2004, NATURE, V428, P745, DOI 10.1038/nature02432; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Reale D, 2000, ANIM BEHAV, V60, P589, DOI 10.1006/anbe.2000.1530; Roff Derek, 2002, pi; Rueffler C, 2004, THEOR POPUL BIOL, V65, P165, DOI 10.1016/j.tpb.2003.10.001; Rueffler C, 2006, TRENDS ECOL EVOL, V21, P238, DOI 10.1016/j.tree.2006.03.003; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sinn DL, 2006, J EVOLUTION BIOL, V19, P1437, DOI 10.1111/j.1420-9101.2006.01136.x; Van Doorn GS, 2006, EVOLUTION, V60, P2226, DOI 10.1554/06-291.1; Wilson DS, 1998, PHILOS T R SOC B, V353, P199, DOI 10.1098/rstb.1998.0202; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1	30	906	923	13	649	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 31	2007	447	7144					581	584		10.1038/nature05835	http://dx.doi.org/10.1038/nature05835			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17538618				2022-12-01	WOS:000246842000046
J	Bird, A				Bird, Adrian			Perceptions of epigenetics	NATURE			English	Editorial Material							DNA METHYLATION	Geneticists study the gene; however, for epigeneticists, there is no obvious `epigene'. Nevertheless, during the past year, more than 2,500 articles, numerous scientific meetings and a new journal were devoted to the subject of epigenetics. It encompasses some of the most exciting contemporary biology and is portrayed by the popular press as a revolutionary new science - an antidote to the idea that we are hard-wired by our genes. So what is epigenetics?	Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Bird, A (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Kings Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.	apbird@staffmail.ed.ac.uk		Bird, Adrian/0000-0002-8600-0372	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Chong SY, 2004, CURR OPIN GENET DEV, V14, P692, DOI 10.1016/j.gde.2004.09.001; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Hong EJ, 2005, CURR OPIN NEUROBIOL, V15, P21, DOI 10.1016/j.conb.2005.01.002; JEGGO PA, 1986, MOL CELL BIOL, V6, P2944, DOI 10.1128/MCB.6.8.2944; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; Laird CD, 2004, P NATL ACAD SCI USA, V101, P204, DOI 10.1073/pnas.2536758100; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Russo VEA, 1996, EPIGENETIC MECH GENE; SILVA AJ, 1993, DEV BIOL, V156, P391, DOI 10.1006/dbio.1993.1086; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Waddington C.H., 1957, STRATEGY GENES; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wong AHC, 2005, HUM MOL GENET, V14, pR11, DOI 10.1093/hmg/ddi116	18	1809	1931	15	636	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2007	447	7143					396	398		10.1038/nature05913	http://dx.doi.org/10.1038/nature05913			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	170VA	17522671	Bronze			2022-12-01	WOS:000246693100033
J	Kovtun, IV; Liu, Y; Bjoras, M; Klungland, A; Wilson, SH; McMurray, CT				Kovtun, Irina V.; Liu, Yuan; Bjoras, Magnar; Klungland, Arne; Wilson, Samuel H.; McMurray, Cynthia T.			OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells	NATURE			English	Article							BASE-EXCISION-REPAIR; CAG/CTG TRIPLET REPEATS; HUNTINGTON-DISEASE; SUBSTRATE-SPECIFICITY; HUMAN DNA; INSTABILITY; MICE; MECHANISM; GLYCOSYLASE; TOXICITY	Although oxidative damage has long been associated with ageing and neurological disease, mechanistic connections of oxidation to these phenotypes have remained elusive. Here we show that the age-dependent somatic mutation associated with Huntington's disease occurs in the process of removing oxidized base lesions, and is remarkably dependent on a single base excision repair enzyme, 7,8-dihydro-8-oxoguanine-DNA glycosylase (OGG1). Both in vivo and in vitro results support a 'toxic oxidation' model in which OGG1 initiates an escalating oxidation - excision cycle that leads to progressive age-dependent expansion. Age-dependent CAG expansion provides a direct molecular link between oxidative damage and toxicity in post-mitotic neurons through a DNA damage response, and error-prone repair of single-strand breaks.	Mayo Clin & Mayo Fdn, Dept Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Program Neurosci, Rochester, MN 55905 USA; Univ Oslo, Ctr Mol Biol & Neurosci, Rikshosp Radiumhosp HF, N-0027 Oslo, Norway; Univ Oslo, Inst Med Microbiol, Rikshosp Radiumhosp HF, N-0027 Oslo, Norway; NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Oslo; University of Oslo; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	McMurray, CT (corresponding author), Mayo Clin & Mayo Fdn, Dept Pharmacol & Expt Therapeut, 200 1st St SW, Rochester, MN 55905 USA.	mcmurray.cynthia@mayo.edu	Wilson, Samuel H/E-6644-2019; Bjørås, Magnar/N-9286-2017; Kovtun, Irina/ABA-8484-2020; Klungland, Arne/X-1233-2019	Wilson, Samuel H/0000-0002-1702-5293; Klungland, Arne/0000-0001-7274-3661	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES050158, Z01ES050159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040738] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 ES050158-11] Funding Source: Medline; NIGMS NIH HHS [R01 GM066359-05A1, R01 GM066359] Funding Source: Medline; NINDS NIH HHS [R01 NS040738-05, R01 NS040738] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Bjelland S, 2003, MUTAT RES-FUND MOL M, V531, P37, DOI 10.1016/j.mrfmmm.2003.07.002; BOITEUX S, 1984, NUCLEIC ACIDS RES, V12, P5429, DOI 10.1093/nar/12.13.5429; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Chauhan C, 2002, J BIOMOL STRUCT DYN, V20, P253, DOI 10.1080/07391102.2002.10506841; Chong SS, 1997, HUM MOL GENET, V6, P301, DOI 10.1093/hmg/6.2.301; Cummings CJ, 2000, ANNU REV GENOM HUM G, V1, P281, DOI 10.1146/annurev.genom.1.1.281; Dizdaroglu M, 1999, BIOCHEMISTRY-US, V38, P243, DOI 10.1021/bi9819071; Dizdaroglu M, 2003, MUTAT RES-FUND MOL M, V531, P109, DOI 10.1016/j.mrfmmm.2003.07.003; Engelward BP, 1997, P NATL ACAD SCI USA, V94, P13087, DOI 10.1073/pnas.94.24.13087; Gacy AM, 1998, MOL CELL, V1, P583, DOI 10.1016/S1097-2765(00)80058-1; Goellner GM, 1997, AM J HUM GENET, V60, P879; Gomes-Pereira M, 2004, HUM MOL GENET, V13, P1815, DOI 10.1093/hmg/ddh186; Hartenstine MJ, 2000, J BIOL CHEM, V275, P18382, DOI 10.1074/jbc.275.24.18382; Hartenstine MJ, 2002, J BIOL CHEM, V277, P41379, DOI 10.1074/jbc.M207013200; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Kabbarah O, 2003, MOL CARCINOGEN, V38, P155, DOI 10.1002/mc.10157; Kennedy L, 2003, HUM MOL GENET, V12, P3359, DOI 10.1093/hmg/ddg352; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Kovtun IV, 2004, HUM MOL GENET, V13, P3057, DOI 10.1093/hmg/ddh325; Kovtun IV, 2001, BIOCHEM CELL BIOL, V79, P325, DOI 10.1139/bcb-79-3-325; Kovtun IV, 2001, NAT GENET, V27, P407, DOI 10.1038/86906; KOVTUN IV, 2006, GENETIC INSTABILITIE, P679; KREMER B, 1995, AM J HUM GENET, V57, P343; Lyons-Darden T, 1999, J BIOL CHEM, V274, P25975, DOI 10.1074/jbc.274.37.25975; Mangiarini L, 1997, NAT GENET, V15, P197, DOI 10.1038/ng0297-197; Manley K, 1999, NAT GENET, V23, P471, DOI 10.1038/70598; Marenstein DR, 2003, J BIOL CHEM, V278, P9005, DOI 10.1074/jbc.M212168200; O'Brien PJ, 2004, J BIOL CHEM, V279, P9750, DOI 10.1074/jbc.M312232200; Owen BAL, 2005, NAT STRUCT MOL BIOL, V12, P663, DOI 10.1038/nsmb965; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Petruska J, 1998, J BIOL CHEM, V273, P5204, DOI 10.1074/jbc.273.9.5204; Savouret C, 2003, EMBO J, V22, P2264, DOI 10.1093/emboj/cdg202; Sergent-Tanguy S, 2003, J NEUROSCI METH, V129, P73, DOI 10.1016/S0165-0270(03)00210-3; Seznec H, 2000, HUM MOL GENET, V9, P1185, DOI 10.1093/hmg/9.8.1185; Spiro C, 1999, MOL CELL, V4, P1079, DOI 10.1016/S1097-2765(00)80236-1; Stucki M, 1998, ONCOGENE, V17, P835, DOI 10.1038/sj.onc.1202001; Trushina E, 2003, P NATL ACAD SCI USA, V100, P12171, DOI 10.1073/pnas.2034961100; van den Broek WJAA, 2002, HUM MOL GENET, V11, P191, DOI 10.1093/hmg/11.2.191; vanderKemp PA, 1996, P NATL ACAD SCI USA, V93, P5197, DOI 10.1073/pnas.93.11.5197; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; Wilson SH, 1998, GENETIC INSTABILITIES AND HEREDITARY NEUROLOGICAL DISEASES, P693; Zharkov DO, 2000, J BIOL CHEM, V275, P28607, DOI 10.1074/jbc.M002441200	44	343	351	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2007	447	7143					447	U2		10.1038/nature05778	http://dx.doi.org/10.1038/nature05778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17450122	Green Accepted			2022-12-01	WOS:000246693100041
J	Visbeck, M				Visbeck, Martin			Oceanography - Power of pull	NATURE			English	Editorial Material									Univ Kiel, Leibniz Inst Marine Sci, D-24105 Kiel, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Kiel	Visbeck, M (corresponding author), Univ Kiel, Leibniz Inst Marine Sci, Dusternbrooker Weg 20, D-24105 Kiel, Germany.		Visbeck, Martin/G-2461-2011; zhu, xiaoting/E-9873-2011; Visbeck, Martin H/B-6541-2016	Visbeck, Martin/0000-0002-0844-834X; Visbeck, Martin H/0000-0002-0844-834X					0	22	23	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2007	447	7143					383	383		10.1038/447383a	http://dx.doi.org/10.1038/447383a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	170VA	17522660	Bronze			2022-12-01	WOS:000246693100023
J	Hanna, J; Meides, A; Zhang, DP; Finley, D				Hanna, John; Meides, Alice; Zhang, Dan Phoebe; Finley, Daniel			A ubiquitin stress response induces altered proteasome composition	CELL			English	Article							CARBOXY-TERMINAL HYDROLASE; SACCHAROMYCES-CEREVISIAE; DEUBIQUITINATING ENZYME; POLYUBIQUITIN GENE; FEEDBACK-CIRCUIT; HEAT-SHOCK; YEAST; DEGRADATION; TRANSCRIPTION; EXPRESSION	Ubiquitin-dependent protein degradation is essential for cells to survive many environmental stresses. Thus, it may be necessary to buffer ubiquitin and proteasome pools against fluctuation. Proteasome levels are tightly regulated, and proteasome deficiency stimulates a stress response. Here we report a novel pathway of cellular response to ubiquitin depletion. Unlike proteasome, stress, ubiquitin stress does not upregulate proteasome abundance. Instead, ubiquitin stress alters proteasome composition. The proteasome-associated deubiquitinating enzyme Ubp6, which spares ubiquitin from proteasomal degradation, is induced by ubiquitin deficiency. This enhances loading of proteasomes with Ubp6, thereby altering proteasome function. A catalytically inactive mutant of Ubp6 fails to recycle ubiquitin and also inhibits proteasome function directly, thus inducing both ubiquitin stress and proteasome stress. These results show that homeostatic control of the ubiquitin-proteasome pathway can be achieved through signal-dependent, subunit-specific regulation of the proteasome, and indicate a dual role of Ubp6 in regulating ubiquitin levels and proteasome function.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Finley, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	daniel_finley@hms.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065592] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM65592] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amerik AY, 1997, EMBO J, V16, P4826; ARNASON T, 1994, MOL CELL BIOL, V14, P7876, DOI 10.1128/MCB.14.12.7876; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; CHEN YP, 1995, BBA-MOL CELL RES, V1268, P59, DOI 10.1016/0167-4889(95)00044-S; Chernova TA, 2003, J BIOL CHEM, V278, P52102, DOI 10.1074/jbc.M310283200; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; HAAS AL, 1987, J BIOL CHEM, V262, P345; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; HIROI Y, 1992, FEBS LETT, V307, P156, DOI 10.1016/0014-5793(92)80757-8; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Ju DH, 2004, BIOCHEM BIOPH RES CO, V321, P51, DOI 10.1016/j.bbrc.2004.06.105; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; LENKINSKI RE, 1977, BIOCHIM BIOPHYS ACTA, V494, P126, DOI 10.1016/0005-2795(77)90140-4; London MK, 2004, FEBS LETT, V567, P259, DOI 10.1016/j.febslet.2004.04.078; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Mimnaugh EG, 1997, BIOCHEMISTRY-US, V36, P14418, DOI 10.1021/bi970998j; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; OZKAYNAK E, 1987, EMBO J, V6, P1429, DOI 10.1002/j.1460-2075.1987.tb02384.x; ROSE IA, 1987, P NATL ACAD SCI USA, V84, P1477, DOI 10.1073/pnas.84.6.1477; Ryu KY, 2006, ANAL BIOCHEM, V353, P153, DOI 10.1016/j.ab.2006.03.038; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Simon JR, 1999, MOL MICROBIOL, V31, P823, DOI 10.1046/j.1365-2958.1999.01220.x; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Watt R, 1997, MOL GEN GENET, V253, P439, DOI 10.1007/s004380050341; Wilson SM, 2002, NAT GENET, V32, P420, DOI 10.1038/ng1006; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298	30	153	154	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2007	129	4					747	759		10.1016/j.cell.2007.03.042	http://dx.doi.org/10.1016/j.cell.2007.03.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512408	Bronze			2022-12-01	WOS:000246788300019
J	Rodrigues-Martins, A; Riparbelli, M; Callaini, G; Glover, DM; Bettencourt-Dias, M				Rodrigues-Martins, A.; Riparbelli, M.; Callaini, G.; Glover, D. M.; Bettencourt-Dias, M.			Revisiting the role of the mother centriole in centriole biogenesis	SCIENCE			English	Article							C-ELEGANS; CENTROSOME DUPLICATION; MICROTUBULE ORGANIZATION; POLO KINASE; PROTEIN; SAS-4	Centrioles duplicate once in each cell division cycle through so-called templated or canonical duplication. SAK, also called PLK4 ( SAK/PLK4), a kinase implicated in tumor development, is an upstream regulator of canonical biogenesis necessary for centriole formation. We found that overexpression of SAK/PLK4 could induce amplification of centrioles in Drosophila embryos and their de novo formation in unfertilized eggs. Both processes required the activity of DSAS-6 and DSAS-4, two molecules required for canonical duplication. Thus, centriole biogenesis is a template-free self-assembly process triggered and regulated by molecules that ordinarily associate with the existing centriole. The mother centriole is not a bona fide template but a platform for a set of regulatory molecules that catalyzes and regulates daughter centriole assembly.	Univ Cambridge, Dept Genet, Canc Res UK, Cell Cycle Genet Res Grp, Cambridge CB2 3EH, England; Univ Siena, Dept Evolut Biol, I-53100 Siena, Italy; Gulbenkian Inst Sci, Cell Cycle Regulat Lab, P-2780156 Oeiras, Portugal	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Siena	Glover, DM (corresponding author), Univ Cambridge, Dept Genet, Canc Res UK, Cell Cycle Genet Res Grp, Downing St, Cambridge CB2 3EH, England.	dmg25@hermes.cam.ac.uk; mdias@igc.gulbenkian.pt	Callaini, Giuliano/T-6353-2018; Bettencourt-Dias, Monica/B-5176-2015	Callaini, Giuliano/0000-0003-2252-0309; Bettencourt-Dias, Monica/0000-0003-1987-5598; Glover, David/0000-0003-0956-0103				Bastiaens P, 2006, TRENDS CELL BIOL, V16, P125, DOI 10.1016/j.tcb.2006.01.005; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Belecz I, 2001, CURR BIOL, V11, P136, DOI 10.1016/S0960-9822(01)00025-2; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015; Delattre M, 2004, J CELL SCI, V117, P1619, DOI 10.1242/jcs.01128; Delattre M, 2006, CURR BIOL, V16, P1844, DOI 10.1016/j.cub.2006.07.059; FODE C, 1994, P NATL ACAD SCI USA, V91, P6388, DOI 10.1073/pnas.91.14.6388; Foe Victoria E., 1993, P149; FREEMAN M, 1987, GENE DEV, V1, P924, DOI 10.1101/gad.1.9.924; GAIL J, 2004, CENTROSOMES DEV DIS; Gonzalez C, 1998, J CELL SCI, V111, P2697; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Januschke J, 2006, DEVELOPMENT, V133, P129, DOI 10.1242/dev.02179; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; Ko MA, 2005, NAT GENET, V37, P883, DOI 10.1038/ng1605; KOCHANSKI RS, 1990, J CELL BIOL, V110, P1599, DOI 10.1083/jcb.110.5.1599; La Terra S, 2005, J CELL BIOL, V168, P713, DOI 10.1083/jcb.200411126; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Leidel S, 2003, DEV CELL, V4, P431, DOI 10.1016/S1534-5807(03)00062-5; MAHOWALD AP, 1970, J CELL BIOL, V45, P306, DOI 10.1083/jcb.45.2.306; Marshall WF, 2007, J CELL BIOCHEM, V100, P916, DOI 10.1002/jcb.21117; Marshall WF, 2001, CURR BIOL, V11, P308, DOI 10.1016/S0960-9822(01)00094-X; Martinez-Campos M, 2004, J CELL BIOL, V165, P673, DOI 10.1083/jcb.200402130; O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Perez-Mongiovi D, 2005, DEVELOPMENT, V132, P4509, DOI 10.1242/dev.02028; Riparbelli MG, 2003, DEV BIOL, V260, P298, DOI 10.1016/S0012-1606(03)00243-4; SHAMANSKI FL, 1991, CELL, V66, P1289, DOI 10.1016/0092-8674(91)90050-9; YAMAGUCHI M, 1991, J CELL SCI, V100, P729	31	190	193	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					1046	1050		10.1126/science.1142950	http://dx.doi.org/10.1126/science.1142950			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17463247	Green Submitted			2022-12-01	WOS:000246554000052
J	Aravin, AA; Sachidanandam, R; Girard, A; Fejes-Toth, K; Hannon, GJ				Aravin, Alexei A.; Sachidanandam, Ravi; Girard, Angelique; Fejes-Toth, Katalin; Hannon, Gregory J.			Developmentally regulated piRNA clusters implicate MILI in transposon control	SCIENCE			English	Article							SMALL RNAS; METHYLATION; MAINTENANCE; EXPRESSION; GENE	Nearly half of the mammalian genome is composed of repeated sequences. In Drosophila, Piwi proteins exert control over transposons. However, mammalian Piwi proteins, MIWI and MILI, partner with Piwi-interacting RNAs (piRNAs) that are depleted of repeat sequences, which raises questions about a role for mammalian Piwi's in transposon control. A search for murine small RNAs that might program Piwi proteins for transposon suppression revealed developmentally regulated piRNA loci, some of which resemble transposon master control loci of Drosophila. We also find evidence of an adaptive amplification loop in which MILI catalyzes the formation of piRNA 5' ends. Mili mutants derepress LINE-1 (L1) and intracisternal A particle and lose DNA methylation of L1 elements, demonstrating an evolutionarily conserved role for PIWI proteins in transposon suppression.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	Hannon, Gregory/AAB-3568-2019; sachidanandam, ravi/Q-6916-2019	sachidanandam, ravi/0000-0001-9844-4459				Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aufsatz W, 2002, P NATL ACAD SCI USA, V99, P16499, DOI 10.1073/pnas.162371499; Bestor TH, 2004, COLD SPRING HARB SYM, V69, P381, DOI 10.1101/sqb.2004.69.381; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; BRANCIFORTE D, 1994, MOL CELL BIOL, V14, P2584, DOI 10.1128/MCB.14.4.2584; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; BUCHETON A, 1995, TRENDS GENET, V11, P349, DOI 10.1016/S0168-9525(00)89105-2; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Gaudet F, 2004, MOL CELL BIOL, V24, P1640, DOI 10.1128/MCB.24.4.1640-1648.2004; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kuramochi-Miyagawa S, 2001, MECH DEVELOP, V108, P121, DOI 10.1016/S0925-4773(01)00499-3; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Liang GG, 2002, MOL CELL BIOL, V22, P480, DOI 10.1128/MCB.22.2.480-491.2002; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Mathieu O, 2004, J CELL SCI, V117, P4881, DOI 10.1242/jcs.01479; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	20	713	756	6	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2007	316	5825					744	747		10.1126/science.1142612	http://dx.doi.org/10.1126/science.1142612			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17446352				2022-12-01	WOS:000246181400046
J	Gupta, R; Hong, DL; Iborra, F; Sarno, S; Enver, T				Gupta, Rajeev; Hong, Dengli; Iborra, Francisco; Sarno, Samantha; Enver, Tariq			NOV (CCN3) functions as a regulator of human hematopoietic stem or progenitor cells	SCIENCE			English	Article							REPOPULATING CELLS; CORD BLOOD; SELF-RENEWAL; IN-VITRO; TRANSDUCTION; MICE; DIFFERENTIATION; EXPRESSION; EFFICIENCY; EXPANSION	Clinically successful hematopoietic cell transplantation is dependent on hematopoietic stem and progenitor cells. Here we identify the matricellular protein Nephroblastoma Overexpressed (Nov, CCN3) as being essential for their functional integrity. Nov expression is restricted to the primitive (CD34) compartments of umbilical vein cord blood, and its knockdown in these cells by lentivirus-mediated RNA interference abrogates their function in vitro and in vivo. Conversely, forced expression of Nov and addition of recombinant Nov protein both enhance primitive stem and/or progenitor activity. Taken together, our results identify Nov ( CCN3) as a regulator of human hematopoietic stem or progenitor cells.	Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Mol Haematol Unit, Headington OX3 9DS, England	University of Oxford	Enver, T (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Mol Haematol Unit, Headington OX3 9DS, England.	tenver@gwmail.jr2.ox.ac.uk	iborra, francisco j/K-9313-2015; Iborra, Francisco J/A-2943-2009	iborra, francisco j/0000-0002-0692-3696; Gupta, Rajeev/0000-0001-9573-0505	MRC [MC_U137973816, MC_U137961143, MC_U137973817] Funding Source: UKRI; Medical Research Council [MC_U137973817, MC_U137973816, MC_U137961143] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amsellem S, 2003, NAT MED, V9, P1423, DOI 10.1038/nm953; Attar EC, 2004, LEUKEMIA, V18, P1760, DOI 10.1038/sj.leu.2403515; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; Broxmeyer HE, 2005, CYTOTHERAPY, V7, P209, DOI 10.1080/14653240510027190; Bruno L, 2004, MOL CELL BIOL, V24, P741, DOI 10.1128/MCB.24.2.741-756.2004; Cho RH, 2000, EXP HEMATOL, V28, P1080, DOI 10.1016/S0301-472X(00)00507-5; DEHAAN G, COMMUNICATION; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Denning-Kendall PA, 2002, BRIT J HAEMATOL, V116, P218, DOI 10.1046/j.1365-2141.2002.03254.x; Dick JE, 2001, ANN NY ACAD SCI, V938, P184; Guenechea G, 2001, NAT IMMUNOL, V2, P75, DOI 10.1038/83199; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; JOLIOT V, 1992, MOL CELL BIOL, V12, P10, DOI 10.1128/MCB.12.1.10; Kustikova OS, 2003, BLOOD, V102, P3934, DOI 10.1182/blood-2003-05-1424; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; Lin CG, 2005, J BIOL CHEM, V280, P8229, DOI 10.1074/jbc.M404903200; Lin CG, 2003, J BIOL CHEM, V278, P24200, DOI 10.1074/jbc.M302028200; LU L, 1993, J EXP MED, V178, P2089, DOI 10.1084/jem.178.6.2089; Ohishi K, 2003, SEMIN CELL DEV BIOL, V14, P143, DOI 10.1016/S1084-9521(02)00183-0; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sakamoto K, 2002, J BIOL CHEM, V277, P29399, DOI 10.1074/jbc.M203727200; Sirven A, 2001, MOL THER, V3, P438, DOI 10.1006/mthe.2001.0282; Su BY, 2001, J CLIN PATHOL-MOL PA, V54, P184, DOI 10.1136/mp.54.3.184; Thibout H, 2003, J CLIN ENDOCR METAB, V88, P327, DOI 10.1210/jc.2002-020304; WARBURTON PE, 1991, GENOMICS, V11, P324, DOI 10.1016/0888-7543(91)90139-6; Zhang XB, 2006, PLOS MED, V3, P687, DOI 10.1371/journal.pmed.0030173	31	93	98	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2007	316	5824					590	593		10.1126/science.1136031	http://dx.doi.org/10.1126/science.1136031			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463287				2022-12-01	WOS:000245983100043
J	Rodriguez, A; Vigorito, E; Clare, S; Warren, MV; Couttet, P; Soond, DR; van Dongen, S; Grocock, RJ; Das, PP; Miska, EA; Vetrie, D; Okkenhaug, K; Enright, AJ; Dougan, G; Turner, M; Bradley, A				Rodriguez, Antony; Vigorito, Elena; Clare, Simon; Warren, Madhuri V.; Couttet, Philippe; Soond, Dalya R.; van Dongen, Stijn; Grocock, Russell J.; Das, Partha P.; Miska, Eric A.; Vetrie, David; Okkenhaug, Klaus; Enright, Anton J.; Dougan, Gordon; Turner, Martin; Bradley, Allan			Requirement of bic/microRNA-155 for normal immune function	SCIENCE			English	Article							GENOME-WIDE SEARCH; C-MAF; SUSCEPTIBILITY LOCI; GENE; MICRORNAS; IDENTIFICATION; CHROMOSOME-21; POPULATION; EXPRESSION; RESPONSES	MicroRNAs are a class of small RNAs that are increasingly being recognized as important regulators of gene expression. Although hundreds of microRNAs are present in the mammalian genome, genetic studies addressing their physiological roles are at an early stage. We have shown that mice deficient for bic/microRNA-155 are immunodeficient and display increased lung airway remodeling. We demonstrate a requirement of bic/microRNA-155 for the function of B and T lymphocytes and dendritic cells. Transcriptome analysis of bic/microRNA-155-deficient CD4(+) T cells identified a wide spectrum of microRNA-155-regulated genes, including cytokines, chemokines, and transcription factors. Our work suggests that bic/microRNA-155 plays a key role in the homeostasis and function of the immune system.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Babraham Inst, Lab Lymphocyte Signaling & Dev, Cambridge CB2 4AT, England; Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Cambridge CB2 2QQ, England; Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England; Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England	Wellcome Trust Sanger Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Cambridge	Turner, M (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	martin.turner@bbsrc.ac.uk; abradley@sanger.ac.uk	Okkenhaug, Klaus/D-5149-2012; Couttet, Philippe/AAH-5489-2019; Turner, Martin/N-9976-2014; Okkenhaug, Klaus/H-3154-2019; Enright, Anton/F-3094-2011	Okkenhaug, Klaus/0000-0002-9432-4051; Turner, Martin/0000-0002-3801-9896; Okkenhaug, Klaus/0000-0002-9432-4051; Enright, Anton/0000-0002-6090-3100; Bradley, Allan/0000-0002-2349-8839; Vetrie, David/0000-0003-2075-4662; Das, Partha Pratim/0000-0003-3544-2629; Miska, Eric/0000-0002-4450-576X	BBSRC [BBS/E/B/0000M206] Funding Source: UKRI; MRC [G117/424, G0601618] Funding Source: UKRI; Medical Research Council [G117/424] Funding Source: Medline; Wellcome Trust [077187] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blumenthal MN, 2006, J ALLERGY CLIN IMMUN, V117, P79, DOI 10.1016/j.jaci.2005.09.038; Bu LM, 2006, ALLERGY, V61, P617, DOI 10.1111/j.1398-9995.2006.01072.x; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Clare S, 2003, INFECT IMMUN, V71, P5881, DOI 10.1128/IAI.71.10.5881-5891.2003; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Engels BM, 2006, ONCOGENE, V25, P6163, DOI 10.1038/sj.onc.1209909; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Hwang ES, 2002, P NATL ACAD SCI USA, V99, P13026, DOI 10.1073/pnas.202474499; Jindal SK, 2005, CURR OPIN PULM MED, V11, P438, DOI 10.1097/01.mcp.0000170522.71497.61; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lai CK, 2006, SEMIN RESP CRIT CARE, V27, P613, DOI 10.1055/s-2006-957333; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Mastroeni P, 2001, VET J, V161, P132, DOI 10.1053/tvjl.2000.0502; MUIJO SA, 2005, J EXP MED, V202, P261; Ober C, 1998, HUM MOL GENET, V7, P1393, DOI 10.1093/hmg/7.9.1393; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tam W, 2001, GENE, V274, P157, DOI 10.1016/S0378-1119(01)00612-6; Tam W, 1997, MOL CELL BIOL, V17, P1490, DOI 10.1128/MCB.17.3.1490; van den Berg A, 2003, GENE CHROMOSOME CANC, V37, P20, DOI 10.1002/gcc.10186	27	1490	1654	2	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2007	316	5824					608	611		10.1126/science.1139253	http://dx.doi.org/10.1126/science.1139253			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463290	Green Accepted			2022-12-01	WOS:000245983100048
J	Wijeysundera, DN; Karkouti, K; Dupuis, JY; Rao, V; Chan, CT; Granton, JT; Beattie, WS				Wijeysundera, Duminda N.; Karkouti, Keyvan; Dupuis, Jean-Yves; Rao, Vivek; Chan, Christopher T.; Granton, John T.; Beattie, W. Scott			Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ESTIMATED CREATININE CLEARANCE; GLOMERULAR-FILTRATION-RATE; RISK INDEX; FAILURE; BYPASS; DYSFUNCTION; MORTALITY; ASSOCIATION; ADULT; OUTCOMES	Context A predictive index for renal replacement therapy (RRT; hemodialysis or continuous venovenous hemodiafiltration) after cardiac surgery may improve clinical decision making and research design. Objectives To develop a predictive index for RRT using preoperative information. Design, Setting, and Participants Retrospective cohort of 20 131 cardiac surgery patients at 2 hospitals in Ontario, Canada. The derivation cohort consisted of 10 751 patients at Toronto General Hospital (1999-2004). The validation cohorts consisted of 2566 patients at Toronto General Hospital (2004-2005) and 6814 patients at Ottawa Heart Institute (1999-2003). Main Outcome Measure Postoperative RRT. Results RRT rates in the derivation, Toronto validation, and Ottawa validation cohorts were 1.3%, 1.8%, and 2.2%, respectively. Multivariable predictors of RRT were preoperative estimated glomerular filtration rate, diabetes mellitus requiring medication, left ventricular ejection fraction, previous cardiac surgery, procedure, urgency of surgery, and preoperative intra-aortic balloon pump. The predictive index was scored from 0 to 8 points. An estimated glomerular filtration rate less than or equal to 30 mL/min was assigned 2 points; other components were assigned 1 point each: estimated glomerular filtration rate 31 to 60 mL/min, diabetes mellitus, ejection fraction less than or equal to 40%, previous cardiac surgery, procedure other than coronary artery bypass grafting, intra-aortic balloon pump, and nonelective case. Among the 53% of patients with low risk scores (<= 1), the risk of RRT was 0.4%; by comparison, this risk was 10% among the 6% of patients with high-risk scores (>= 4). The predictive index had areas under the receiver operating characteristic curve in the derivation, Toronto validation, and Ottawa validation cohorts of 0.81, 0.78, and 0.78, respectively. When these cohorts were stratified based on index scores, likelihood ratios for RRT were more concordant than observed RRT rates. Conclusions RRT after cardiac surgery is predicted by readily available preoperative information. A simple predictive index based on this information discriminated well between low- and high-risk patients in derivation and validation cohorts. The index had improved generalizability when used to predict likelihood ratios for RRT.	Toronto Gen Hosp, Dept Anesthesia, Toronto, ON M5G 2C4, Canada; Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; Univ Ottawa, Inst Heart, Dept Anesthesia, Ottawa, ON, Canada; Toronto Gen Hosp, Div Cardiac Surg, Toronto, ON M5G 2C4, Canada; Univ Hlth Network, Div Nephrol, Toronto, ON, Canada; Univ Hlth Network, Div Respirol & Crit Care Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Ottawa; University of Ottawa Heart Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Wijeysundera, DN (corresponding author), Toronto Gen Hosp, Dept Anesthesia, EN 3-450 200 Elizabeth St, Toronto, ON M5G 2C4, Canada.	duminda.wijeysundera@uhn.on.ca	Wijeysundera, Duminda/L-3350-2018; Beattie, William Scott/A-4352-2008	Wijeysundera, Duminda/0000-0002-5897-8605; Karkouti, Keyvan/0000-0001-8776-5660				Arozullah AM, 2001, ANN INTERN MED, V135, P847, DOI 10.7326/0003-4819-135-10-200111200-00005; Austin PC, 2020, STAT MED, V39, P103, DOI 10.1002/sim.8399; Burns KEA, 2005, JAMA-J AM MED ASSOC, V294, P342, DOI 10.1001/jama.294.3.342; Chertow GM, 1998, AM J MED, V104, P343, DOI 10.1016/S0002-9343(98)00058-8; Chertow GM, 1997, CIRCULATION, V95, P878; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; CONCATO J, 1993, ANN INTERN MED, V118, P201, DOI 10.7326/0003-4819-118-3-199302010-00009; Conlon PJ, 1999, NEPHROL DIAL TRANSPL, V14, P1158, DOI 10.1093/ndt/14.5.1158; Coresh J, 2002, J AM SOC NEPHROL, V13, P2811, DOI 10.1097/01.ASN.0000037420.89149.C9; David W, 2000, APPL LOGISTIC REGRES, P26, DOI 10.1002/0471722146; DeLong ER, 1997, STAT MED, V16, P2645, DOI 10.1002/(SICI)1097-0258(19971215)16:23<2645::AID-SIM696>3.0.CO;2-D; DETSKY AS, 1986, J GEN INTERN MED, V1, P211, DOI 10.1007/BF02596184; Dupuis JY, 2001, ANESTHESIOLOGY, V94, P194, DOI 10.1097/00000542-200102000-00006; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Ferguson TB, 2002, ANN THORAC SURG, V73, P480, DOI 10.1016/S0003-4975(01)03339-2; Fortescue EB, 2000, KIDNEY INT, V57, P2594, DOI 10.1046/j.1523-1755.2000.00119.x; GOLDMAN L, 1981, CIRCULATION, V64, P1227, DOI 10.1161/01.CIR.64.6.1227; GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601; HARRELL FE, DESIGN S FUNCTIONS B; Harrell Jr FE, 2001, REGRESSION MODELING, DOI DOI 10.1007/978-3-319-19425-7; Harrison DA, 2006, CRIT CARE MED, V34, P1378, DOI 10.1097/01.CCM.0000216702.94014.75; Hix JK, 2006, CRIT CARE MED, V34, P2979, DOI 10.1097/01.CCM.0000248905.67352.BA; Ivanov J, 1999, CIRCULATION, V99, P2098, DOI 10.1161/01.CIR.99.16.2098; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P389, DOI 10.1001/jama.271.5.389; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Karkouti K, 2005, J THORAC CARDIOV SUR, V129, P391, DOI 10.1016/j.jtcvs.2004.06.028; Landoni G, 2007, AM J KIDNEY DIS, V49, P56, DOI 10.1053/j.ajkd.2006.10.013; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mangano CM, 1998, ANN INTERN MED, V128, P194, DOI 10.7326/0003-4819-128-3-199802010-00005; Mathew JP, 2004, JAMA-J AM MED ASSOC, V291, P1720, DOI 10.1001/jama.291.14.1720; Mehta RH, 2006, CIRCULATION, V114, P2208, DOI 10.1161/CIRCULATIONAHA.106.635573; Moons KGM, 2002, J CLIN EPIDEMIOL, V55, P1054, DOI 10.1016/S0895-4356(02)00453-5; Noyez L, 2006, EUR J CARDIO-THORAC, V29, P461, DOI 10.1016/j.ejcts.2006.01.024; PIERPONT GL, 1985, J THORAC CARDIOV SUR, V89, P673; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Steyerberg EW, 2001, MED DECIS MAKING, V21, P45, DOI 10.1177/0272989X0102100106; Taher T, 2002, J GEN INTERN MED, V17, P933, DOI 10.1046/j.1525-1497.2002.11230.x; Thakar CV, 2005, J AM SOC NEPHROL, V16, P162, DOI 10.1681/ASN.2004040331; Thakar CV, 2003, AM J KIDNEY DIS, V41, P742, DOI 10.1016/S0272-6386(03)00021-0; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Wagener G, 2006, ANESTHESIOLOGY, V105, P485, DOI 10.1097/00000542-200609000-00011; Wang F, 2003, CHEST, V124, P1852, DOI 10.1378/chest.124.5.1852; Wijeysundera DN, 2006, ANESTHESIOLOGY, V104, P65, DOI 10.1097/00000542-200601000-00012; Yap CH, 2006, EUR J CARDIO-THORAC, V29, P441, DOI 10.1016/j.ejcts.2005.12.046	48	279	326	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2007	297	16					1801	1809		10.1001/jama.297.16.1801	http://dx.doi.org/10.1001/jama.297.16.1801			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	160DW	17456822	Bronze			2022-12-01	WOS:000245922100026
J	Galan-Caridad, JM; Harel, S; Arenzana, TL; Hou, ZE; Doetsch, FK; Mirny, LA; Reizis, B				Galan-Caridad, Jose M.; Harel, Sivan; Arenzana, Teresita L.; Hou, Z. Esther; Doetsch, Fiona K.; Mirny, Leonid A.; Reizis, Boris			Zfx controls the self-renewal of embryonic and hematopoietic stem cells	CELL			English	Article							GENE; MICE; BMI-1; NICHE; DIFFERENTIATION; PROLIFERATION; PLURIPOTENCY; MAINTENANCE; NETWORKS; BIOLOGY	Stem cells (SC) exhibit a unique capacity for self-renewal in an undifferentiated state. It is unclear whether the self-renewal of pluripotent embryonic SC (ESC) and of tissue-specific adult SC such as hernatopoietic SC (HSC) is controlled by common mechanisms. The deletion of transcription factor Zfx impaired the selfrenewal but not the differentiation capacity of murine ESC; conversely, Zfx overexpression facilitated ESC self-renewal by opposing differentiation. Furthermore, Zfx deletion abolished the maintenance of adult HSC but did not affect erythromyeloid progenitors or fetal HSC. Zfxdeficient ESC and HSC showed increased apoptosis and SC-specific upregulation of stressinducible genes. Zfx directly activated common target genes in ESC and HSC, as well as ESCspecific target genes including ESC selfrenewal regulators Tbx3 and Tcl1. These studies identify Zfx as a shared transcriptional regulator of ESC and HSC, suggesting a common genetic basis of self-renewal in embryonic and adult SC.	Columbia Univ, Med Ctr, Dept Microbiol, New York, NY 10032 USA; Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA; MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Columbia University; Columbia University; Harvard University; Massachusetts Institute of Technology (MIT)	Reizis, B (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol, New York, NY 10032 USA.	bvr2101@columbia.edu	Mirny, Leonid/ABE-8083-2020	Mirny, Leonid/0000-0002-0785-5410; Reizis, Boris/0000-0003-1140-7853	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084353] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072571, R21AI085439, F31AI066459, T32AI007525] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL084353, HL084353, R01 HL084353-01] Funding Source: Medline; NIAID NIH HHS [T32 AI007525, F31 AI066459-02, T32 AI007525-10, R01 AI072571, R21 AI085439, F31 AI066459, AI007525, AI066459] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; D'Amour KA, 2003, P NATL ACAD SCI USA, V100, P11866, DOI 10.1073/pnas.1834200100; Eckfeldt CE, 2005, NAT REV MOL CELL BIO, V6, P726, DOI 10.1038/nrm1713; Fortunel NO, 2003, SCIENCE, V302, P393; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lessard J, 1999, GENE DEV, V13, P2691, DOI 10.1101/gad.13.20.2691; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Luoh SW, 1997, DEVELOPMENT, V124, P2275; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Mikkers H, 2005, EMBO J, V24, P2715, DOI 10.1038/sj.emboj.7600749; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nichogiannopoulou A, 1999, J EXP MED, V190, P1201, DOI 10.1084/jem.190.9.1201; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Sakaguchi T, 2006, MOL CELL BIOL, V26, P6557, DOI 10.1128/MCB.00729-06; SCHNEIDERGADICKE A, 1989, NATURE, V342, P708, DOI 10.1038/342708a0; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	41	186	203	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2007	129	2					345	357		10.1016/j.cell.2007.03.014	http://dx.doi.org/10.1016/j.cell.2007.03.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448993	Green Accepted, Bronze			2022-12-01	WOS:000246474600021
J	Munch, J; Standker, L; Adermann, K; Schuz, A; Schindler, M; Chinnadurai, R; Pohlmann, S; Chaipan, C; Biet, T; Peters, T; Meyer, B; Wilhelm, D; Lu, H; Jing, WG; Jiang, SB; Forssmann, WG; Kirchhoff, F				Muench, Jan; Staendker, Ludger; Adermann, Knut; Schuz, Axel; Schindler, Michael; Chinnadurai, Raghavan; Poehlmann, Stefan; Chaipan, Chawaree; Biet, Thorsten; Peters, Thomas; Meyer, Bernd; Wilhelm, Dennis; Lu, Hong; Jing, Weiguo; Jiang, Shibo; Forssmann, Wolf-Georg; Kirchhoff, Frank			Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide	CELL			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ALPHA-1-ANTITRYPSIN DEFICIENCY; MONOCLONAL-ANTIBODY; RESISTANCE; INFECTION; REPLICATION; METALLOPROTEINASE; GLYCOPROTEIN-41; TRANSCRIPTION; MACROPHAGES	A variety of molecules in human blood have been implicated in the inhibition of HIV-1. However, it remained elusive which circulating natural compounds are most effective in controlling viral replication in vivo. To identify natural HIV-1 inhibitors we screened a comprehensive peptide library generated from human hemofiltrate. The most potent fraction contained a 20-residue peptide, designated VIRUS-INHIBITORY PEPTIDE (VIRIP), corresponding to the C-proximal region of alpha 1 -antitrypsin, the most abundant circulating serine protease inhibitor. We found that VIRIP inhibits a wide variety of HIV-1 strains including those resistant to current antiretroviral drugs. Further analysis demonstrated that VIRIP blocks HIV-1 entry by interacting with the gp41 fusion peptide and showed that a few amino acid changes increase its antiretroviral potency by two orders of magnitude. Thus, as a highly specific natural inhibitor of the HIV-1 gp41 fusion peptide, VIRIP may lead to the development of another class of antiretroviral drugs.	IPF PharmaCeut GmbH, D-30625 Hannover, Germany; Univ Ulm, Inst Virol, D-89081 Ulm, Germany; VIRO Pharmaceut GmbH & Co KG, D-30625 Hannover, Germany; Univ Erlangen Nurnberg, Inst Clin & Mol Virol, D-91054 Erlangen, Germany; Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr, D-91054 Erlangen, Germany; Med Univ Lubeck, Inst Chem, D-23538 Lubeck, Germany; Univ Hamburg, Fac Sci, D-20146 Hamburg, Germany; New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA; Hannover Med Sch, Ctr Pharmacol, D-30625 Hannover, Germany	Ulm University; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Lubeck; University of Hamburg; New York Blood Center; Hannover Medical School	Forssmann, WG (corresponding author), IPF PharmaCeut GmbH, D-30625 Hannover, Germany.	wgforssmann@ipf-pharmaceuticals.de; frank.kirchhoff@uniklinik-ulm.de	Jiang, Shibo/L-4500-2014; Kirchhoff, Frank/O-8367-2018; Pöhlmann, Stefan/H-2395-2011; Peters, Thomas/AAE-1509-2022; Abrams, William R/A-5782-2008; Schindler, Michael/C-1647-2015; Meyer, Bernd/A-8828-2008; Peters, Thomas/GQB-3622-2022	Jiang, Shibo/0000-0001-8283-7135; Kirchhoff, Frank/0000-0002-7052-2360; Pöhlmann, Stefan/0000-0001-6086-9136; Peters, Thomas/0000-0002-7570-8260; Schindler, Michael/0000-0001-8989-5813; Jan, Munch/0000-0001-7316-7141				ANDERSON ED, 1993, J BIOL CHEM, V268, P24887; Armand-Ugon M, 2003, ANTIVIR RES, V59, P137, DOI 10.1016/S0166-3542(03)00071-8; BRANTLY ML, 1988, AM REV RESPIR DIS, V138, P327, DOI 10.1164/ajrccm/138.2.327; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; DESROCHERS PE, 1988, J CLIN INVEST, V81, P1646, DOI 10.1172/JCI113500; Detheux M, 2000, J EXP MED, V192, P1501, DOI 10.1084/jem.192.10.1501; Eckstein DA, 2001, J EXP MED, V194, P1407, DOI 10.1084/jem.194.10.1407; Eron JJ, 2004, J INFECT DIS, V189, P1075, DOI 10.1086/381707; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Forssmann WG, 1992, PEPTIDE CHEM, P553; Gallo SA, 2006, J BIOL CHEM, V281, P18787, DOI 10.1074/jbc.M602422200; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Goetzl EJ, 1996, J IMMUNOL, V156, P1; Greenberg ML, 2004, J ANTIMICROB CHEMOTH, V54, P333, DOI 10.1093/jac/dkh330; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; Helmerhorst EJ, 1999, FEBS LETT, V449, P105, DOI 10.1016/S0014-5793(99)00411-1; Hiebenthal-Millow K, 2002, VIROLOGY, V292, P169, DOI 10.1006/viro.2001.1282; Jiang S, 1998, J VIROL, V72, P10213, DOI 10.1128/JVI.72.12.10213-10217.1998; JIANG S, 2000, P SOC PHOTO-OPT INS, V3926, P212, DOI DOI 10.1117/12.380514; Jiang SB, 1999, J VIROL METHODS, V80, P85, DOI 10.1016/S0166-0934(99)00041-5; Jiang SB, 2002, CURR PHARM DESIGN, V8, P563; Johnston JB, 2000, J VIROL, V74, P7211, DOI 10.1128/JVI.74.16.7211-7220.2000; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; KUSHNER I, 1988, METHOD ENZYMOL, V163, P373; Levy JA, 2003, TRENDS IMMUNOL, V24, P628, DOI 10.1016/j.it.2003.10.005; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Mark S, 1999, J CHROMATOGR A, V852, P197, DOI 10.1016/S0021-9673(99)00356-8; Miyazaki Y, 2002, AIDS RES HUM RETROV, V18, P469, DOI 10.1089/088922202753614236; MOBLEY PW, 1992, BIOCHIM BIOPHYS ACTA, V1139, P251, DOI 10.1016/0925-4439(92)90098-8; Mobley PW, 2001, AIDS RES HUM RETROV, V17, P311, DOI 10.1089/08892220150503681; Moore R A, 2000, BMC Fam Pract, V1, P1, DOI 10.1186/1471-2296-1-1; Munch J, 2002, ANTIMICROB AGENTS CH, V46, P982, DOI 10.1128/AAC.46.4.982-990.2002; Prechtel AT, 2005, J GEN VIROL, V86, P1645, DOI 10.1099/vir.0.80852-0; Ray N, 2006, CURR TOP MICROBIOL, V303, P97, DOI 10.1007/978-3-540-33397-5_5; Reimann KA, 1996, J VIROL, V70, P6922, DOI 10.1128/JVI.70.10.6922-6928.1996; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Schulz-Knappe P, 1996, Eur J Med Res, V1, P223; SchulzKnappe P, 1997, J CHROMATOGR A, V776, P125, DOI 10.1016/S0021-9673(97)00152-0; Shapiro L, 2001, FASEB J, V15, P115, DOI 10.1096/fj.00-0311com; Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853; Stoller JK, 2005, LANCET, V365, P2225, DOI 10.1016/S0140-6736(05)66781-5; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; WALKER CM, 1986, SCIENCE, V234, P1563, DOI 10.1126/science.2431484; Walter H, 2000, ANTIVIR THER, V5, P249	47	188	210	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2007	129	2					263	275		10.1016/j.cell.2007.02.042	http://dx.doi.org/10.1016/j.cell.2007.02.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448989	Bronze			2022-12-01	WOS:000246474600015
J	Hodge, JG; Gostin, LO; Vernick, JS				Hodge, James G., Jr.; Gostin, Lawrence O.; Vernick, Jon S.			The pandemic and all-hazards preparedness act - Improving public health emergency response	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PROFESSIONALS		Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Law & Publ Hlth, Baltimore, MD 21205 USA; Johns Hopkins Univ, Washington, DC USA; Johns Hopkins Univ, Baltimore, MD USA; Oneill Inst Natl & Global Hlth Law, Washington, DC USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University	Hodge, JG (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Law & Publ Hlth, 624 N Broadway,Hampton House Room 588, Baltimore, MD 21205 USA.	jhodge@jhsph.edu						Gostin LO, 2006, JAMA-J AM MED ASSOC, V295, P554, DOI 10.1001/jama.295.5.554; GOSTIN LO, IN PRESS PUBLIC HLTH; *HLTH RES SERV AG, 2006, EM SYST ADV REG VOL; Hodge JG, 2006, PUBLIC HEALTH REP, V121, P205, DOI 10.1177/003335490612100217; Hodge JG, 2005, BIOSECUR BIOTERROR, V3, P216, DOI 10.1089/bsp.2005.3.216; Hodge JG, 2004, J LAW MED ETHICS, V32, P670, DOI 10.1111/j.1748-720X.2004.tb01972.x; Institute of Medicine, 2002, FUT PUBL HLTH 21 CEN; THOMPSON AK, 2006, BMC MED ETHICS, V7, P1; *U NC SCH PUBL HLT, PUBL PRIV LEG PREP I; *US CDCP, BIOSENSE; US Department of Health and Human Services, HHS PAND INFL PLAN; *WHIT HOUS, 2006, FED RESP HURR KATR L, V58; *WHO DEP COMM DIS, 2005, WHO GLOB INFL PREP P; NATL RESPONSE PLAN	14	33	33	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2007	297	15					1708	1711		10.1001/jama.297.15.1708	http://dx.doi.org/10.1001/jama.297.15.1708			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	157UR	17440147				2022-12-01	WOS:000245747400024
J	Sims, EJ; Mugford, M; Clark, A; Aitken, D; McCormick, J; Mehta, G; Mehta, A				Sims, Erika J.; Mugford, Miranda; Clark, Allan; Aitken, David; McCormick, Jonathan; Mehta, Gita; Mehta, Anil		UK Cystic Fibrosis Database	Economic implications of newborn screening for cystic fibrosis: a cost of illness retrospective cohort study	LANCET			English	Article							CONTROLLED-TRIAL; DORNASE-ALPHA; LUNG-FUNCTION; DIAGNOSIS; BENEFITS; OUTCOMES	Background Newborn screening for cystic fibrosis might not be introduced if implementation and running costs are perceived as prohibitive. Compared with clinical diagnosis, newborn screening is associated with clinical benefit and reduced treatment needs. We estimate the potential savings in treatment costs attributable to newborn screening. Methods Using the UK Cystic Fibrosis Database, we used a prevalence strategy to undertake a cost of illness retrospective snapshot cohort study. We estimated yearly costs of long-term therapies and intravenous antibiotics for 184 patients who were diagnosed as a result of screening as newborn babies, and 950 patients who were clinically diagnosed aged 1-9 years in 2002. Costs of adding cystic fibrosis screening to an established newborn screening service in Scotland were adjusted to 2002 prices and applied to the UK as a whole. Costs were recalculated in US$. Findings Cost of therapy for patients diagnosed by newborn screening was significantly lower than equivalent therapies for clinically diagnosed patients: mean ($7228 vs $12008, 95% CI of difference -6736 to -2028, p < 0.0001) and median ($352 vs $2442, -1916 to -180, p < 0.0001). When we limited the clinically diagnosed group to only those diagnosable with a 31 cystic fibrosis transmembrane regulator mutation assay and assumed similar disease progression in the clinically diagnosed group as in the newborn screening group, we showed that mean ($3397 344) or median ($947 032) drug cost savings could have offset the estimated cost of adding cystic fibrosis to a UK national newborn screening service ($2 971551). Interpretation Including indirect costs savings, newborn screening for cystic fibrosis might have even greater financial benefits to society than our estimate shows. Clinical, social, and now economic evidence suggests that universal newborn screening programmes for cystic fibrosis should be adopted internationally.	Univ E Anglia, Hlth Econ Grp, Sch Med Hlth Policy & Practice, Sch Med, Norwich NR4 7TJ, Norfolk, England; Univ Dundee, UK Cyst Fibrosis Database, Div Maternal Child Hlth Sci, Ninewells Hosp, Dundee, Scotland; Univ Dundee, Sch Med, Dundee, Scotland; Univ E Anglia, Populat Hlth Grp, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; Univ E Anglia, Hlth Econ Grp, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; Inst Med Genet, Scottish Newborn Screening Lab, Glasgow, Lanark, Scotland; Royal Hosp Sick Children, Resp Unit, Yorkhill NHS Trust, Glasgow G3 8SJ, Lanark, Scotland	University of East Anglia; University of Dundee; University of Dundee; University of East Anglia; University of East Anglia; University of Glasgow; University of Glasgow	Sims, EJ (corresponding author), Univ E Anglia, Hlth Econ Grp, Sch Med Hlth Policy & Practice, Sch Med, Norwich NR4 7TJ, Norfolk, England.	e.sims@uea.ac.uk		Clark, Allan/0000-0003-2965-8941				[Anonymous], 1997, MMWR Recomm Rep, V46, P1; *BRIT MED ASS, 2002, BRIT NAT FORM; Farrell PM, 2003, AM J RESP CRIT CARE, V168, P1100, DOI 10.1164/rccm.200303-434OC; Farrell PM, 1997, NEW ENGL J MED, V337, P963, DOI 10.1056/NEJM199710023371403; Farrell PM, 2001, PEDIATRICS, V107, P1, DOI 10.1542/peds.107.1.1; FARRELL PM, 1997, PEDIATRICS, V100, P2; HALL P, 1991, BIOMETRICS, V47, P757, DOI 10.2307/2532163; Hamosh A, 1998, J PEDIATR-US, V132, P255, DOI 10.1016/S0022-3476(98)70441-X; Lee DS, 2003, J PEDIATR-US, V142, P617, DOI 10.1067/mpd.2003.209; LITTLEWOOD J, 2002, ANTIBIOTIC TREATMENT; Mastella G, 2001, PANCREATOLOGY, V1, P531, DOI 10.1159/000055856; McCabe ERB, 1999, ACTA PAEDIATR, V88, P58, DOI 10.1080/080352599750029402; McCormick J, 2002, EUR J HUM GENET, V10, P583, DOI 10.1038/sj.ejhg.5200850; McCormick Jonathan, 2005, J Cyst Fibros, V4, P53, DOI 10.1016/j.jcf.2004.11.003; Mehta A, 2001, LANCET, V358, P1546, DOI 10.1016/S0140-6736(01)06593-X; Mehta G, 2004, J ROY SOC MED, V97, P60; *NO IR STAT RES AG, 2002, 81 ANN NO IR STAT RE; *OFF NAT STAT, BIRTH STAT 2002; *ORG EC COOP DEV, PURCH POW PAR OECD C; *ORG EC COOP DEV, CONS PRIC IND IND HL; Paul K, 2004, AM J RESP CRIT CARE, V169, P719, DOI 10.1164/rccm.200307-959OC; POLLITT RJ, 1997, HEALTH TECHNOL ASSES, V1, pI202; Quan JM, 2001, J PEDIATR-US, V139, P813, DOI 10.1067/mpd.2001.118570; RANDALL J, SCOTLANDS POPULATION; Rosenberg MA, 2005, J PEDIATR-US, V147, pS101, DOI 10.1016/j.jpeds.2005.08.018; Simpson Neil, 2005, Cost Eff Resour Alloc, V3, P8, DOI 10.1186/1478-7547-3-8; Sims EJ, 2005, J PEDIATR-US, V147, pS42, DOI 10.1016/j.jpeds.2005.08.002; Sims EJ, 2005, J PEDIATR-US, V147, P306, DOI 10.1016/j.jpeds.2005.05.034; Sims EJ, 2005, DIABETES CARE, V28, P1581, DOI 10.2337/diacare.28.7.1581; Sims EJ, 2007, PEDIATRICS, V119, P19, DOI 10.1542/peds.2006-1498; Siret D, 2003, PEDIATR PULM, V35, P342, DOI 10.1002/ppul.10259; Smyth A, 2005, LANCET, V365, P573, DOI 10.1016/S0140-6736(05)17906-9; *UK NAT STAT, 2005, CONS PRIC IND IND 06; *US C OFF TECHN AS, 1992, CYST FIBR DNA TESTS; Waters DL, 1999, ARCH DIS CHILD-FETAL, V80, pF1, DOI 10.1136/fn.80.1.F1; Zielenski J, 2000, RESPIRATION, V67, P117, DOI 10.1159/000029497	36	70	71	1	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 7	2007	369	9568					1187	1195		10.1016/S0140-6736(07)60565-0	http://dx.doi.org/10.1016/S0140-6736(07)60565-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155RH	17416263				2022-12-01	WOS:000245595100030
J	Callen, E; Jankovic, M; Difilippantonio, S; Daniel, JA; Chen, HT; Celeste, A; Pellegrini, M; McBride, K; Wangsa, D; Bredemeyer, AL; Sleckman, BP; Ried, T; Nussenzweig, M; Nussenzweig, A				Callen, Elsa; Jankovic, Mila; Difilippantonio, Simone; Daniel, Jeremy A.; Chen, Hua-Tang; Celeste, Arkady; Pellegrini, Manuela; McBride, Kevin; Wangsa, Danny; Bredemeyer, Andrea L.; Sleckman, Barry P.; Ried, Thomas; Nussenzweig, Michel; Nussenzweig, Andre			ATM prevents the persistence and propagation of chromosome breaks in lymphocytes	CELL			English	Article							CLASS-SWITCH RECOMBINATION; DOUBLE-STRAND BREAKS; CYTIDINE DEAMINASE AID; B-CELL DEVELOPMENT; HEAVY-CHAIN LOCUS; GENOMIC INSTABILITY; V(D)J RECOMBINATION; DEFICIENT MICE; IONIZING-RADIATION; GENE AMPLIFICATION	DNA double- strand breaks ( DSBs) induce a signal transmitted by the ataxia- telangiectasia mutated ( ATM) kinase, which suppresses illegitimate joining of DSBs and activates cell- cycle checkpoints. Here we show that a significant fraction of mature ATM- deficient lymphocytes contain telomere- deleted ends produced by failed end joining during V( D) J recombination. These RAG- 1/ 2 endonuclease- dependent, terminally deleted chromosomes persist in peripheral lymphocytes for at least 2 weeks in vivo and are stable over several generations in vitro. Restoration of ATM kinase activity in mature lymphocytes that have transiently lostATM function leads to loss of cells with terminally deleted chromosomes. Thus, maintenance of genomic stability in lymphocytes requires faithful end joining as well a checkpoint that prevents the long- term persistence and transmission of DSBs. Silencing this checkpoint permits DNA ends produced by V( D) J recombination in a lymphoid precursor to serve as substrates for translocations with chromosomes subsequently damaged by other means in mature cells.	Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Howard Hughes Med Inst, New York, NY 10021 USA; NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; NCI, Sect Canc Genom, NIH, Genet Branch, Bethesda, MD 20892 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Rockefeller University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Washington University (WUSTL)	Nussenzweig, M (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA.	andre_nussenzweig@nih.gov; nussen@mail.rockefeller.edu	Nussenzweig, Michel/AAE-7292-2019; Daniel, Jeremy/S-4729-2016; Pellegrini, manuela/AAC-1423-2022; mcbride, kevin/E-8230-2011	Daniel, Jeremy/0000-0002-1981-5571; Bredemeyer, Andrea/0000-0003-2970-5998; pellegrini, manuela/0000-0001-6387-5187	NATIONAL CANCER INSTITUTE [Z01BC010283, ZIABC010283, Z01BC010837, ZICBC009255, Z01BC009255, ZIABC010837] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Arlt MF, 2006, DNA REPAIR, V5, P1126, DOI 10.1016/j.dnarep.2006.05.010; Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; Cuadrado M, 2006, J EXP MED, V203, P297, DOI 10.1084/jem.20051923; Difilippantonio MJ, 2002, J EXP MED, V196, P469, DOI 10.1084/jem.20020851; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Gladdy RA, 2003, CANCER CELL, V3, P37, DOI 10.1016/S1535-6108(02)00236-2; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; HUANG CY, 2007, J EXP MED, V334, P676; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kracker S, 2005, P NATL ACAD SCI USA, V102, P1584, DOI 10.1073/pnas.0409191102; Liyanage M, 2000, BLOOD, V96, P1940, DOI 10.1182/blood.V96.5.1940.h8001940_1940_1946; Lumsden JM, 2004, J EXP MED, V200, P1111, DOI 10.1084/jem.20041074; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Matei IR, 2007, BLOOD, V109, P1887, DOI 10.1182/blood-2006-05-020917; McBride KM, 2006, P NATL ACAD SCI USA, V103, P8798, DOI 10.1073/pnas.0603272103; Meffre E, 2000, NAT IMMUNOL, V1, P379, DOI 10.1038/80816; MIYAKE K, 1995, J IMMUNOL, V154, P3333; Mochan TA, 2004, DNA REPAIR, V3, P945, DOI 10.1016/j.dnarep.2004.03.017; Monroe RJ, 1999, IMMUNITY, V11, P201, DOI 10.1016/S1074-7613(00)80095-3; Morales JC, 2006, P NATL ACAD SCI USA, V103, P3310, DOI 10.1073/pnas.0511259103; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Myers JS, 2006, J BIOL CHEM, V281, P9346, DOI 10.1074/jbc.M513265200; Perkins EJ, 2002, GENE DEV, V16, P159, DOI 10.1101/gad.956902; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petiniot LK, 2002, MOL CELL BIOL, V22, P3174, DOI 10.1128/MCB.22.9.3174-3177.2002; Ramiro AR, 2006, CANCER RES, V66, P7837, DOI 10.1158/0008-5472.CAN-06-0863; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Reina-San-Martin B, 2005, P NATL ACAD SCI USA, V102, P1590, DOI 10.1073/pnas.0406289102; Reina-San-Martin B, 2004, J EXP MED, V200, P1103, DOI 10.1084/jem.20041162; Reina-San-Martin B, 2007, EUR J IMMUNOL, V37, P235, DOI 10.1002/eji.200636789; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rolink AG, 2000, J EXP MED, V191, P23, DOI 10.1084/jem.191.1.23; Rosenwald A, 2003, CANCER CELL, V3, P185, DOI 10.1016/S1535-6108(03)00028-X; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; SPRENT J, 1994, SCIENCE, V265, P1395, DOI 10.1126/science.8073282; Takao N, 1999, ONCOGENE, V18, P7002, DOI 10.1038/sj.onc.1203172; Vacchio MS, 2007, P NATL ACAD SCI USA, V104, P6323, DOI 10.1073/pnas.0611222104; Ward IM, 2005, MOL CELL BIOL, V25, P10079, DOI 10.1128/MCB.25.22.10079-10086.2005; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	52	151	153	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 13	2007	130	1					63	75		10.1016/j.cell.2007.06.016	http://dx.doi.org/10.1016/j.cell.2007.06.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WK	17599403	Bronze			2022-12-01	WOS:000248587000011
J	Teklehaimanot, A; Sachs, JD; Curtis, C				Teklehaimanot, Awash; Sachs, Jeffrey D.; Curtis, Chris			Malaria control needs mass distribution of insecticidal bednets	LANCET			English	Editorial Material							TREATED BEDNETS; CHILD-MORTALITY; NETS; TRANSMISSION; INFECTION; MORBIDITY; MOSQUITOS; COVERAGE; DISTRICT; IMPACT		Columbia Univ, Earth Inst, Ctr Global Hlth & Econ Dev, New York, NY 10025 USA; London Sch Hyg & Trop Med, London WC1, England	Columbia University; University of London; London School of Hygiene & Tropical Medicine	Teklehaimanot, A (corresponding author), Columbia Univ, Earth Inst, Ctr Global Hlth & Econ Dev, New York, NY 10025 USA.	at2076@columbia.edu						Binka FN, 1996, TROP MED INT HEALTH, V1, P147; Cham MK, 1997, HEALTH POLICY PLANN, V12, P240, DOI 10.1093/heapol/12.3.240; Curtis C, 2003, LANCET INFECT DIS, V3, P304, DOI 10.1016/S1473-3099(03)00612-1; Curtis CF, 1996, MED VET ENTOMOL, V10, P1, DOI 10.1111/j.1365-2915.1996.tb00075.x; Curtis CF, 1998, TROP MED INT HEALTH, V3, P619, DOI 10.1046/j.1365-3156.1998.00281.x; Grabowsky M, 2005, B WORLD HEALTH ORGAN, V83, P195; Guyatt HL, 2002, TROP MED INT HEALTH, V7, P846, DOI 10.1046/j.1365-3156.2002.00929.x; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Howard SC, 2000, T ROY SOC TROP MED H, V94, P357, DOI 10.1016/S0035-9203(00)90103-2; Le Menach A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-10; Lengeler C., 2004, COCHRANE DB SYST REV, V2; MAGESA SM, 1991, ACTA TROP, V49, P97, DOI 10.1016/0001-706X(91)90057-Q; Maxwell CA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-44; Maxwell CA, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-28; Sachs JD, 2005, NEW ENGL J MED, V352, P115, DOI 10.1056/NEJMp048319; Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13; Snow RW, 1999, HEALTH POLICY PLANN, V14, P18, DOI 10.1093/heapol/14.1.18; Soremekun S, 2004, TROP MED INT HEALTH, V9, P664, DOI 10.1111/j.1365-3156.2004.01250.x; TEKLEHAIMANOT A, IN PRESS AM J TROP M; WABWIREMANGEN F, 1989, AM J TROP MED HYG, V41, P504, DOI 10.4269/ajtmh.1989.41.504; Whitworth JAG, 2005, LANCET, V365, P196; *WORK GROUP MAL, 2005, COM GRIPS MAL NEW MI	23	86	88	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 30	2007	369	9580					2143	2146		10.1016/S0140-6736(07)60951-9	http://dx.doi.org/10.1016/S0140-6736(07)60951-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	184LX	17597200				2022-12-01	WOS:000247644200009
J	Davidson, EA; de Carvalho, CJR; Figueira, AM; Ishida, FY; Ometto, JPHB; Nardoto, GB; Saba, RT; Hayashi, SN; Leal, EC; Vieira, ICG; Martinelli, LA				Davidson, Eric A.; de Carvalho, Claudio J. Reis; Figueira, Adelaine Michela; Ishida, Francoise Yoko; Ometto, Jean Pierre H. B.; Nardoto, Gabriela B.; Saba, Renata Tuma; Hayashi, Sanae N.; Leal, Eliane C.; Vieira, Ima Celia G.; Martinelli, Luiz A.			Recuperation of nitrogen cycling in Amazonian forests following agricultural abandonment	NATURE			English	Article							LAND-USE CHANGE; EASTERN AMAZONIA; BRAZILIAN AMAZON; ISOTOPIC COMPOSITION; OXIDE EMISSIONS; GLOBAL PATTERNS; COSTA-RICA; SOIL; REGROWTH; ECOSYSTEMS	Phosphorus ( P) is generally considered the most common limiting nutrient for productivity of mature tropical lowland forests growing on highly weathered soils(1-5). It is often assumed that P limitation also applies to young tropical forests, but nitrogen (N) losses during land-use change may alter the stoichiometric balance of nutrient cycling processes. In the Amazon basin, about 16% of the original forest area has been cleared(6), and about 30 - 50% of cleared land is estimated now to be in some stage of secondary forest succession following agricultural abandonment(7). Here we use forest age chronosequences to demonstrate that young successional forests growing after agricultural abandonment on highly weathered lowland tropical soils exhibit conservative N-cycling properties much like those of N-limited forests on younger soils in temperate latitudes. As secondary succession progresses, N-cycling properties recover and the dominance of a conservative P cycle typical of mature lowland tropical forests re-emerges. These successional shifts in N: P cycling ratios with forest age provide a mechanistic explanation for initially lower and then gradually increasing soil emissions of the greenhouse gas nitrous oxide (N2O). The patterns of N and P cycling during secondary forest succession, demonstrated here over decadal timescales, are similar to N- and P-cycling patterns during primary succession as soils age over thousands and millions of years, thus revealing that N availability in terrestrial ecosystems is ephemeral and can be disrupted by either natural or anthropogenic disturbances at several timescales.	EMBRAPA Amazonia Oriental, BR-66095100 Belem, Para, Brazil; Woods Hole Res Ctr, Falmouth, MA 02540 USA; Univ Sao Paulo, CENA, BR-13416000 Piracicaba, SP, Brazil; Museu Paraensr Emilio Goeldi, Dept Bot, BR-66040179 Belem, Para, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Woods Hole Research Center; Universidade de Sao Paulo; Museu Paraense Emilio Goeldi	Davidson, EA (corresponding author), Woods Hole Res Ctr, 149 Woods Hole Rd, Falmouth, MA 02540 USA.	edavidson@whrc.org	Martinelli, Luiz Antonio/F-7870-2011; Nardoto, Gabriela Bielefeld/J-7459-2012; Davidson, Eric A/K-4984-2013; Vieira, Ima C.G./H-6897-2012; Ometto, Jean Pierre/B-3351-2013	Martinelli, Luiz Antonio/0000-0002-7103-7551; Nardoto, Gabriela Bielefeld/0000-0001-8062-7417; Davidson, Eric A/0000-0002-8525-8697; Vieira, Ima C.G./0000-0003-1233-318X; Ometto, Jean Pierre/0000-0002-4221-1039; E SILVA FIGUEIRA, ADELAINE MICHELA/0000-0002-3702-3180				Amundson R, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001903; [Anonymous], 2001, BIOGEOCHEMISTRY AMAZ; Davidson EA, 2000, BIOSCIENCE, V50, P667, DOI 10.1641/0006-3568(2000)050[0667:TACMOS]2.0.CO;2; Davidson EA, 2004, GEOPHYS MONOGR SER, V153, P147, DOI 10.1029/153GM12; Davidson EA, 2004, ECOL APPL, V14, pS150; Dias-Filho M.B., 2001, BIOGEOCHEM AMAZ BASI, P84; Erickson H, 2001, ECOSYSTEMS, V4, P67, DOI 10.1007/s100210000060; Gehring C, 2005, AGR ECOSYST ENVIRON, V111, P237, DOI 10.1016/j.agee.2005.06.009; Gehring C, 1999, BIOGEOCHEMISTRY, V45, P223, DOI 10.1023/A:1006138815453; Hedin LO, 2003, ECOLOGY, V84, P2231, DOI 10.1890/02-4066; Hirsch AI, 2004, GLOBAL CHANGE BIOL, V10, P908, DOI 10.1111/j.1529-8817.2003.00765.x; *INPE, 2004, MON AMB AM SAT; KAUFFMAN JB, 1995, OECOLOGIA, V104, P397, DOI 10.1007/BF00341336; KELLER M, 1994, GLOBAL BIOGEOCHEM CY, V8, P399, DOI 10.1029/94GB01660; KELLER M, 1993, NATURE, V365, P244, DOI 10.1038/365244a0; Markewitz D, 2004, ECOL APPL, V14, pS177; Martinelli LA, 1999, BIOGEOCHEMISTRY, V46, P45, DOI 10.1023/A:1006100128782; McGrath DA, 2001, ECOSYSTEMS, V4, P625, DOI 10.1007/s10021-001-0033-0; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; Melillo JM, 2001, J GEOPHYS RES-ATMOS, V106, P34179, DOI 10.1029/2000JD000036; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Verchot LV, 1999, GLOBAL BIOGEOCHEM CY, V13, P31, DOI 10.1029/1998GB900019; Vieira ICG, 2003, REMOTE SENS ENVIRON, V87, P470, DOI 10.1016/j.rse.2002.09.002; VIEIRA ICG, 1996, CIENCIA HOJE, V20, P38; VITOUSEK PM, 1982, ECOL MONOGR, V52, P155, DOI 10.2307/1942609; Vitousek PM, 2002, BIOGEOCHEMISTRY, V57, P1, DOI 10.1023/A:1015798428743; VITOUSEK PM, 1984, ECOLOGY, V65, P285, DOI 10.2307/1939481; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; Zarin DJ, 2005, FRONT ECOL ENVIRON, V3, P365, DOI 10.2307/3868585	29	318	339	11	239	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2007	447	7147					995	U6		10.1038/nature05900	http://dx.doi.org/10.1038/nature05900			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180NU	17581583				2022-12-01	WOS:000247373100045
J	Blow, N				Blow, Nathan			Antibodies: The generation game	NATURE			English	Editorial Material																			0	32	36	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2007	447	7145					741	+		10.1038/447741a	http://dx.doi.org/10.1038/447741a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554312	Bronze			2022-12-01	WOS:000247030700049
J	Colell, A; Ricci, JE; Tait, S; Milasta, S; Maurer, U; Bouchier-Hayes, L; Fitzgerald, P; Guio-Carrion, A; Waterhouse, NJ; Li, CW; Mari, B; Barbry, P; Newmeyer, DD; Beere, HM; Green, DR				Colell, Anna; Ricci, Jean-Ehrland; Tait, Stephen; Milasta, Sandra; Maurer, Ulrich; Bouchier-Hayes, Lisa; Fitzgerald, Patrick; Guio-Carrion, Ana; Waterhouse, Nigel J.; Li, Cindy Wei; Mari, Bernard; Barbry, Pascal; Newmeyer, Donald D.; Beere, Helen M.; Green, Douglas R.			GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation	CELL			English	Article							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE GENE; CELL-DEATH; MITOCHONDRIAL-FUNCTION; NUCLEAR TRANSLOCATION; SIGNALING PATHWAY; PROSTATE-CANCER; MEMBRANE-FUSION; OVARIAN-CANCER; BREAST-CANCER; ACTINOMYCIN-D	In cells undergoing apoptosis, mitochondrial outer-membrane permeabilization (MOMP) is followed by paspase activation promoted by released cytochrome c. Although caspases mediate the apoptotic phenotype, caspase inhibition is generally not sufficient for survival following MOMP; instead cells undergo a "caspase-independent cell death" (CICD). Thus, MOMP may represent a point of commitment to cell death. Here, we identify glyceraidehyde-3-phosphate dehydrogenase (GAPDH) as a critical regulator of CICD. GAPDH-expressing cells preserved their clonogenic potential following MOMP, provided that caspase activation was blocked. GAPDHmediated protection of cells from CICD involved an elevation in glycolysis and a nuclear function that correlated with and was replaced by an increase in Atg12 expression. Consistent with this, protection from CICD reflected an increase in and a dependence upon autophagy, associated with a transient decrease in mitochondrial mass. Therefore, GAPDH mediates an elevation in glycolysis and enhanced autophagy that cooperate to protect cells from CICD.	St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA; CSIC, IDIBAPS, Dept Cell Death & Proliferat, IIBB, Barcelona 08036, Spain; Univ Nice Sophia Antipolis, Inserm U526, Equipe Avenir, IFR 50,Fac Med, F-06107 Nice, France; Univ Freiburg, Inst Mol Med & Cell Res, Freiburg, Germany; La Jolla Inst Allergy & Immunol, Div Cellular Immunol, San Diego, CA 92121 USA; Univ Melbourne, Peter MacCallum Canc Ctr, Melbourne, Vic 8006, Australia; Univ Melbourne, Dept Pathol, Melbourne, Vic 8006, Australia; Univ Nice Sophia Antipolis, CNRS, Inst Pharmacol Mol & Cellulaire, UMR6097, F-06560 Valbonne, France	St Jude Children's Research Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Universite de Franche-Comte; University of Freiburg; La Jolla Institute for Immunology; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Green, DR (corresponding author), St Jude Childrens Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	douglas.green@stjude.org	Green, Douglas R/N-8083-2018; Bouchier-Hayes, Lisa/T-9491-2019; Colell, Anna/N-8710-2014; Mari, Bernard P/D-7445-2015; Mari, Bernard P/GVS-3100-2022; Mari, Bernard P/F-8960-2013; RICCI, Jean Ehrland/AAS-4379-2020; Mari, Bernard/Q-5832-2019; Ricci, Jean Ehrland/I-7117-2016; Waterhouse, Nigel/I-9813-2016; Barbry, Pascal/O-5021-2016	Green, Douglas R/0000-0002-7332-1417; Bouchier-Hayes, Lisa/0000-0003-3886-5977; Colell, Anna/0000-0001-5236-1834; Mari, Bernard P/0000-0002-0422-9182; Mari, Bernard P/0000-0002-0422-9182; Mari, Bernard P/0000-0002-0422-9182; RICCI, Jean Ehrland/0000-0003-1585-8117; Mari, Bernard/0000-0002-0422-9182; Ricci, Jean Ehrland/0000-0003-1585-8117; Barbry, Pascal/0000-0001-9632-6483; Tait, Stephen/0000-0001-7697-132X; Guio-Carrion, Ana/0000-0002-8963-4389	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040646] Funding Source: NIH RePORTER; NIAID NIH HHS [AI40646] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amarante-Mendes GP, 1998, CELL DEATH DIFFER, V5, P298, DOI 10.1038/sj.cdd.4400354; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brown VM, 2004, J BIOL CHEM, V279, P5984, DOI 10.1074/jbc.M307071200; Carujo S, 2006, ONCOGENE, V25, P4033, DOI 10.1038/sj.onc.1209433; Chesney J, 1999, P NATL ACAD SCI USA, V96, P3047, DOI 10.1073/pnas.96.6.3047; Chipuk JE, 2005, NAT REV MOL CELL BIO, V6, P268, DOI [10.1038/nrm1573, 10.1038/nrm2239]; Dastoor Z, 2001, J CELL SCI, V114, P1643; Deshmukh M, 2000, J CELL BIOL, V150, P131, DOI 10.1083/jcb.150.1.131; Devarajan E, 2002, ONCOGENE, V21, P8843, DOI 10.1038/sj.onc.1206044; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Ferraro E, 2003, J CELL MOL MED, V7, P21, DOI 10.1111/j.1582-4934.2003.tb00199.x; Ferreira CG, 2001, CLIN CANCER RES, V7, P2468; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Glaser PE, 2002, P NATL ACAD SCI USA, V99, P14104, DOI 10.1073/pnas.222542999; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016; Haraguchi M, 2000, J EXP MED, V191, P1709, DOI 10.1084/jem.191.10.1709; Hietanen S, 2000, P NATL ACAD SCI USA, V97, P8501, DOI 10.1073/pnas.97.15.8501; HUE L, 1987, BIOCHEM J, V245, P313, DOI 10.1042/bj2450313; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaneda M, 1997, J BIOCHEM-TOKYO, V122, P1233; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Krajewska M, 2003, CLIN CANCER RES, V9, P4914; Kundu M, 2005, CELL DEATH DIFFER, V12, P1484, DOI 10.1038/sj.cdd.4401780; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Liu JR, 2002, CANCER RES, V62, P924; Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013; Martinou I, 1999, J CELL BIOL, V144, P883, DOI 10.1083/jcb.144.5.883; Mazzola JL, 2003, BBA-GEN SUBJECTS, V1622, P50, DOI 10.1016/S0304-4165(03)00117-X; McCarthy NJ, 1997, J CELL BIOL, V136, P215, DOI 10.1083/jcb.136.1.215; MEYERSIEGLER K, 1991, P NATL ACAD SCI USA, V88, P8460, DOI 10.1073/pnas.88.19.8460; Mischo HE, 2005, J BIOL CHEM, V280, P9586, DOI 10.1074/jbc.M411444200; Nakagawa T, 2003, J BIOL CHEM, V278, P20395, DOI 10.1074/jbc.M210824200; Onishi M, 1996, EXP HEMATOL, V24, P324; Revillion F, 2000, EUR J CANCER, V36, P1038, DOI 10.1016/S0959-8049(00)00051-4; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089; Rondinelli RH, 1997, PROSTATE CANCER P D, V1, P66, DOI 10.1038/sj.pcan.4500208; Saunders PA, 1999, J NEUROCHEM, V72, P925, DOI 10.1046/j.1471-4159.1999.0720925.x; SAWICKI SG, 1972, J CELL BIOL, V55, P299, DOI 10.1083/jcb.55.2.299; SCHEK N, 1988, CANCER RES, V48, P6354; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Scott CL, 2004, J CELL BIOL, V164, P89, DOI 10.1083/jcb.200310041; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Sundararaj KP, 2004, J BIOL CHEM, V279, P6152, DOI 10.1074/jbc.M310549200; Tamm I, 2000, CLIN CANCER RES, V6, P1796; Teague TK, 1999, P NATL ACAD SCI USA, V96, P12691, DOI 10.1073/pnas.96.22.12691; TOKUNAGA K, 1987, CANCER RES, V47, P5616; Waterhouse NJ, 2001, J CELL BIOL, V153, P319, DOI 10.1083/jcb.153.2.319; Wolf BB, 2001, J BIOL CHEM, V276, P34244, DOI 10.1074/jbc.M011778200; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; Xue L, 2001, CURR BIOL, V11, P361, DOI 10.1016/S0960-9822(01)00100-2; Yang W, 2003, BRIT J PHARMACOL, V140, P402, DOI 10.1038/sj.bjp.0705450; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	61	401	421	0	43	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2007	129	5					983	997		10.1016/j.cell.2007.03.045	http://dx.doi.org/10.1016/j.cell.2007.03.045			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540177	Bronze			2022-12-01	WOS:000247084600017
J	Stewart, AJ; Schmidt, MW; van Westrenen, W; Liebske, C				Stewart, Andrew J.; Schmidt, Max W.; van Westrenen, Wim; Liebske, Christian			Mars: A new core-crystallization regime	SCIENCE			English	Article							THERMAL EVOLUTION; HIGH-PRESSURE; INNER-CORE; DYNAMO; INTERIOR; EQUATION; SULFUR; POINT; STATE; MODEL	The evolution of the martian core is widely assumed to mirror the characteristics observed for Earth's core. Data from experiments performed on iron-sulfur and iron-nickel-sulfur systems at pressures corresponding to the center of Mars indicate that its core is presently completely liquid and that it will not form an outwardly crystallizing iron-rich inner core, as does Earth. Instead, planetary cooling will lead to core crystallization following either a "snowing-core" model, whereby iron-rich solids nucleate in the outer portions of the core and sink toward the center, or a "sulfide inner-core" model, where an iron-sulfide phase crystallizes to form a solid inner core.	ETH, Inst Mineral & Petrol, CH-8092 Zurich, Switzerland; Vrije Univ Amsterdam, Fac Earth & Life Sci, NL-1081 HV Amsterdam, Netherlands	Swiss Federal Institutes of Technology Domain; ETH Zurich; Vrije Universiteit Amsterdam	Schmidt, MW (corresponding author), ETH, Inst Mineral & Petrol, CH-8092 Zurich, Switzerland.	max.schmidt@erdw.ethz.ch	van Westrenen, Wim/D-6495-2012; Schmidt, Max/A-1676-2008	van Westrenen, Wim/0000-0001-5828-8885; Schmidt, Max W./0000-0002-3870-5781				Acuna MH, 1999, SCIENCE, V284, P790, DOI 10.1126/science.284.5415.790; Balog PS, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001646; Bertka CM, 1997, J GEOPHYS RES-SOL EA, V102, P5251, DOI 10.1029/96JB03270; BESSON JM, 1990, J GEOPHYS RES-SOLID, V95, P21717, DOI 10.1029/JB095iB13p21717; BOEHLER R, 1993, NATURE, V363, P534, DOI 10.1038/363534a0; Connerney JEP, 1999, SCIENCE, V284, P794, DOI 10.1126/science.284.5415.794; Fei YW, 2005, SCIENCE, V308, P1120, DOI 10.1126/science.1110531; Fei YW, 2000, AM MINERAL, V85, P1830; Hauck SA, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001801; Hauck SA, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002557; Heimpel MH, 2005, EARTH PLANET SC LETT, V236, P542, DOI 10.1016/j.epsl.2005.04.032; Ito E, 1998, GEOPHYS RES LETT, V25, P821, DOI 10.1029/98GL00519; KAWAI N, 1970, REV SCI INSTRUM, V41, P1178, DOI 10.1063/1.1684753; Li J, 2001, EARTH PLANET SC LETT, V193, P509, DOI 10.1016/S0012-821X(01)00521-0; Lodders K, 1997, ICARUS, V126, P373, DOI 10.1006/icar.1996.5653; Nimmo F, 2000, J GEOPHYS RES-PLANET, V105, P11969, DOI 10.1029/1999JE001216; Sakuraba A, 1999, PHYS EARTH PLANET IN, V111, P105, DOI 10.1016/S0031-9201(98)00150-2; Sanloup C, 1999, PHYS EARTH PLANET IN, V112, P43, DOI 10.1016/S0031-9201(98)00175-7; Sanloup C, 2000, GEOPHYS RES LETT, V27, P811, DOI 10.1029/1999GL008431; Seagle CT, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004091; Sohl F, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002520; Solomon SC, 2005, SCIENCE, V307, P1214, DOI 10.1126/science.1101812; Stevenson DJ, 2001, NATURE, V412, P214, DOI 10.1038/35084155; Von Platen B., 1962, MODERN VERY HIGH PRE, P118; WALKER D, 1991, AM MINERAL, V76, P1092; WANKE H, 1988, PHILOS T R SOC A, V325, P545, DOI 10.1098/rsta.1988.0067; Williams JP, 2004, GEOLOGY, V32, P97, DOI 10.1130/G19975.1; Yoder CF, 2003, SCIENCE, V300, P299, DOI 10.1126/science.1079645	28	160	163	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2007	316	5829					1323	1325		10.1126/science.1140549	http://dx.doi.org/10.1126/science.1140549			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17540900				2022-12-01	WOS:000246885600046
J	Deindl, S; Kadlecek, TA; Brdicka, T; Cao, XX; Weiss, A; Kuriyan, J				Deindl, Sebastian; Kadlecek, Theresa A.; Brdicka, Tomas; Cao, Xiaoxian; Weiss, Arthur; Kuriyan, John			Structural basis for the inhibition of tyrosine kinase activity of ZAP-70	CELL			English	Article							CELL ANTIGEN RECEPTOR; SEVERE COMBINED IMMUNODEFICIENCY; GROWTH-FACTOR RECEPTOR; CRYSTAL-STRUCTURE; ZETA-CHAIN; T-CELLS; C-SRC; 3-DIMENSIONAL STRUCTURE; ADAPTER PROTEIN; INTERDOMAIN B	ZAP-70, a cytoplasmic tyrosine kinase required for T cell antigen receptor signaling, is controlled by a regulatory segment that includes a tandem SH2 unit responsible for binding to immunoreceptor tyrosine-based activation motifs (ITAMs). The crystal structure of autoinhibited ZAP-70 reveals that the inactive kinase domain adopts a conformation similar to that of cyclin-dependent kinases and Src kinases. The auto-inhibitory mechanism of ZAP-70 is, however, distinct and involves interactions between the regulatory segment and the hinge region of the kinase domain that reduce its flexibility. Two tyrosine residues in the SH2-kinase linker that activate ZAP-70 when phosphorylated are involved in aromatic-aromatic interactions that connect the linker to the kinase domain. These interactions are inconsistent with ITAM binding, suggesting that destabilization of this autoinhibited ZAP-70 conformation is the first step in kinase activation.	Univ Calif Berkeley, Dept Mol & Cell Biol, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Univ Calif San Francisco, Dept Med, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weiss, A (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Dept Chem, Berkeley, CA 94720 USA.	aweiss@medicine.ucsf.edu; kuriyan@berkeley.edu	Cao, Xiaoxian/C-9333-2019; Brdicka, Tomas/G-6205-2014	Cao, Xiaoxian/0000-0001-9097-6231; Brdicka, Tomas/0000-0002-1560-4398; Kadlecek, Theresa/0000-0002-1020-8169; Deindl, Sebastian/0000-0001-6807-8654				ARPAIA E, 1994, CELL, V76, P947, DOI 10.1016/0092-8674(94)90368-9; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Brdicka T, 2002, J EXP MED, V196, P1617, DOI 10.1084/jem.20021405; Brdicka T, 2005, MOL CELL BIOL, V25, P4924, DOI 10.1128/MCB.25.12.4924-4933.2005; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Di Bartolo V, 2002, EUR J IMMUNOL, V32, P568; Di Bartolo V, 1999, J BIOL CHEM, V274, P6285, DOI 10.1074/jbc.274.10.6285; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Folmer RHA, 2002, BIOCHEMISTRY-US, V41, P14176, DOI 10.1021/bi026465e; Goda S, 2004, J IMMUNOL, V172, P5379, DOI 10.4049/jimmunol.172.9.5379; Gong Q, 2001, J EXP MED, V194, P507, DOI 10.1084/jem.194.4.507; Grazioli L, 1998, J BIOL CHEM, V273, P8916, DOI 10.1074/jbc.273.15.8916; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; Horejsi V, 2004, NAT REV IMMUNOL, V4, P603, DOI 10.1038/nri1414; Jin L, 2004, J BIOL CHEM, V279, P42818, DOI 10.1074/jbc.M407096200; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; KURIYAN J, 1991, PROTEINS, V10, P340, DOI 10.1002/prot.340100407; LoGrasso PV, 1996, P NATL ACAD SCI USA, V93, P12165, DOI 10.1073/pnas.93.22.12165; MADRENAS J, 1995, SCIENCE, V267, P515, DOI 10.1126/science.7824949; Magnan A, 2001, J EXP MED, V194, P491, DOI 10.1084/jem.194.4.491; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; van Oers N S, 1995, Semin Immunol, V7, P227, DOI 10.1006/smim.1995.0027; VANOERS NSC, 1994, IMMUNITY, V1, P675, DOI 10.1016/1074-7613(94)90038-8; WANGE RL, 1995, J BIOL CHEM, V270, P18730, DOI 10.1074/jbc.270.32.18730; WATTS JD, 1994, J BIOL CHEM, V269, P29520; Williams BL, 1999, EMBO J, V18, P1832, DOI 10.1093/emboj/18.7.1832; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Wu JJ, 1997, APPL PHYS LETT, V70, P185, DOI 10.1063/1.118352; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4; Zeitlmann L, 1998, J BIOL CHEM, V273, P15445, DOI 10.1074/jbc.273.25.15445; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhao QH, 1999, MOL CELL BIOL, V19, P948	47	177	181	0	24	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2007	129	4					735	746		10.1016/j.cell.2007.03.039	http://dx.doi.org/10.1016/j.cell.2007.03.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512407	Bronze			2022-12-01	WOS:000246788300018
J	Caro, E; Castellano, MM; Gutierrez, C				Caro, Elena; Castellano, M. Mar; Gutierrez, Crisanto			A chromatin link that couples cell division to root epidermis patterning in Arabidopsis	NATURE			English	Article							E2F TRANSCRIPTION FACTOR; CYCLE; PROLIFERATION; REREPLICATION; ORGANIZATION; EXPRESSION; PROTEINS; PATHWAY; GEMININ; KINASE	Cell proliferation and cell fate decisions are strictly coupled processes during plant embryogenesis and organogenesis(1-5). In the Arabidopsis thaliana root epidermis, expression of the homeobox GLABRA2 (GL2) gene determines hair/non-hair cell fate(6,7). This requires signalling of positional information from the underlying cortical layer(8,9), complex transcriptional regulation(10,11) and a change in chromatin accessibility(12). However, the molecular connections among these factors and with cell division are not known. Here we have identified a GL2-expression modulator, GEM, as an interactor of CDT1, a DNA replication protein. GEM also interacts with TTG1 ( TRANSPARENT TESTA GLABRA1), a WD40-repeat protein involved in GL2-dependent cell fate decision, and modulates both cell division and GL2 expression. Here we show that GEM participates in the maintenance of the repressor histone H3K9 methylation status of root patterning genes, providing a link between cell division, fate and differentiation during Arabidopsis root development.	Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Gutierrez, C (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain.	cgutierrez@cbm.uam.es	Caro, Elena/D-2611-2014; Caro, Elena/A-8097-2011; Gutierrez, Crisanto/ABH-8782-2020; castellano, mar m/L-2063-2014; Caro, Elena/G-6352-2012	Caro, Elena/0000-0002-1034-1621; castellano, mar m/0000-0003-0339-4247; Gutierrez, Crisanto/0000-0001-8905-8222				Berger F, 1998, DEV BIOL, V194, P235, DOI 10.1006/dbio.1997.8813; Bernhardt C, 2005, DEVELOPMENT, V132, P291, DOI 10.1242/dev.01565; Blilou I, 2002, GENE DEV, V16, P2566, DOI 10.1101/gad.237302; Castellano MD, 2004, PLANT CELL, V16, P2380, DOI 10.1105/tpc.104.022400; Chevalier D, 2005, P NATL ACAD SCI USA, V102, P9074, DOI 10.1073/pnas.0503526102; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Costa S, 2006, NATURE, V439, P493, DOI 10.1038/nature04269; DePamphilis ML, 2006, CURR OPIN CELL BIOL, V18, P231, DOI 10.1016/j.ceb.2006.04.001; Desvoyes B, 2006, PLANT PHYSIOL, V140, P67, DOI 10.1104/pp.105.071027; Di Cristina M, 1996, PLANT J, V10, P393, DOI 10.1046/j.1365-313X.1996.10030393.x; DOLAN L, 1993, DEVELOPMENT, V119, P71; Egea-Cortines M, 1999, EMBO J, V18, P5370, DOI 10.1093/emboj/18.19.5370; Fischer A, 2006, J PLANT PHYSIOL, V163, P358, DOI 10.1016/j.jplph.2005.10.015; Fletcher JC, 2002, BIOESSAYS, V24, P27, DOI 10.1002/bies.10020; Fransz P, 2006, CHROMOSOME RES, V14, P71, DOI 10.1007/s10577-005-1022-5; Fuchs J, 2006, TRENDS PLANT SCI, V11, P199, DOI 10.1016/j.tplants.2006.02.008; Guimil S, 2006, TRENDS PLANT SCI, V11, P601, DOI 10.1016/j.tplants.2006.10.001; Gutierrez C, 2005, NAT CELL BIOL, V7, P535, DOI 10.1038/ncb0605-535; Jenik PD, 2005, PLANT CELL, V17, P3362, DOI 10.1105/tpc.105.036889; Kurata T, 2005, DEVELOPMENT, V132, P5387, DOI 10.1242/dev.02139; Kwak SH, 2005, SCIENCE, V307, P1111, DOI 10.1126/science.1105373; Larkin JC, 2003, ANNU REV PLANT BIOL, V54, P403, DOI 10.1146/annurev.arplant.54.031902.134823; Masucci JD, 1996, DEVELOPMENT, V122, P1253; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Menges M, 2005, PLANT J, V41, P546, DOI 10.1111/j.1365-313X.2004.02319.x; Menges M, 2002, PLANT J, V30, P203, DOI 10.1046/j.1365-313X.2002.01274.x; Ramirez-Parra E, 2004, PLANT CELL, V16, P2350, DOI 10.1105/tpc.104.023978; Ramirez-Parra E, 2000, FEBS LETT, V486, P73, DOI 10.1016/S0014-5793(00)02239-0; Ryu KH, 2005, DEVELOPMENT, V132, P4765, DOI 10.1242/dev.02055; Seo S, 2006, CELL CYCLE, V5, P374, DOI 10.4161/cc.5.4.2438; Serna L, 2004, PLANT CELL, V16, P2258, DOI 10.1105/tpc.104.160931; Wildwater M, 2005, CELL, V123, P1337, DOI 10.1016/j.cell.2005.09.042; Xu CR, 2005, P NATL ACAD SCI USA, V102, P14469, DOI 10.1073/pnas.0503143102; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004	34	105	117	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2007	447	7141					213	U6		10.1038/nature05763	http://dx.doi.org/10.1038/nature05763			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17450124				2022-12-01	WOS:000246338700045
J	Welch, EM; Barton, ER; Zhuo, J; Tomizawa, Y; Friesen, WJ; Trifillis, P; Paushkin, S; Patel, M; Trotta, CR; Hwang, SW; Wilde, RG; Karp, G; Takasugi, J; Chen, GM; Jones, S; Ren, H; Moon, YC; Corson, D; Turpoff, AA; Campbell, JA; Conn, MM; Khan, A; Almstead, NG; Hedrick, J; Mollin, A; Risher, N; Weetall, M; Yeh, S; Branstrom, AA; Colacino, JM; Babiak, J; Ju, WD; Hirawat, S; Northcutt, VJ; Miller, LL; Spatrick, P; He, F; Kawana, M; Feng, H; Jacobson, A; Peltz, SW; Sweeney, HL				Welch, Ellen M.; Barton, Elisabeth R.; Zhuo, Jin; Tomizawa, Yuki; Friesen, Westley J.; Trifillis, Panayiota; Paushkin, Sergey; Patel, Meenal; Trotta, Christopher R.; Hwang, Seongwoo; Wilde, Richard G.; Karp, Gary; Takasugi, James; Chen, Guangming; Jones, Stephen; Ren, Hongyu; Moon, Young-Choon; Corson, Donald; Turpoff, Anthony A.; Campbell, Jeffrey A.; Conn, M. Morgan; Khan, Atiyya; Almstead, Neil G.; Hedrick, Jean; Mollin, Anna; Risher, Nicole; Weetall, Marla; Yeh, Shirley; Branstrom, Arthur A.; Colacino, Joseph M.; Babiak, John; Ju, William D.; Hirawat, Samit; Northcutt, Valerie J.; Miller, Langdon L.; Spatrick, Phyllis; He, Feng; Kawana, Masataka; Feng, Huisheng; Jacobson, Allan; Peltz, Stuart W.; Sweeney, H. Lee			PTC124 targets genetic disorders caused by nonsense mutations	NATURE			English	Article							MESSENGER-RNA DECAY; CYSTIC-FIBROSIS; STOP MUTATIONS; TRANSLATION; TERMINATION; TRANSCRIPTS; SUPPRESSION; EFFICIENCY; PATHWAYS; PROTEINS	Nonsense mutations promote premature translational termination and cause anywhere from 5 - 70% of the individual cases of most inherited diseases(1). Studies on nonsense-mediated cystic fibrosis have indicated that boosting specific protein synthesis from < 1% to as little as 5% of normal levels may greatly reduce the severity or eliminate the principal manifestations of disease(2,3). To address the need for a drug capable of suppressing premature termination, we identified PTC124 - a new chemical entity that selectively induces ribosomal readthrough of premature but not normal termination codons. PTC124 activity, optimized using nonsense-containing reporters, promoted dystrophin production in primary muscle cells from humans and mdx mice expressing dystrophin nonsense alleles, and rescued striated muscle function in mdx mice within 2 - 8 weeks of drug exposure. PTC124 was well tolerated in animals at plasma exposures substantially in excess of those required for nonsense suppression. The selectivity of PTC124 for premature termination codons, its well characterized activity profile, oral bioavailability and pharmacological properties indicate that this drug may have broad clinical potential for the treatment of a large group of genetic disorders with limited or no therapeutic options.	PTC Therapeut, South Plainfield, NJ 07080 USA; Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA	University of Pennsylvania; University of Massachusetts System; University of Massachusetts Worcester	Peltz, SW (corresponding author), PTC Therapeut, 100 Corp Court, South Plainfield, NJ 07080 USA.	speltz@ptcbio.com	Sweeney, H Lee/F-1862-2010		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R42HD048137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM027757, R01GM027757] Funding Source: NIH RePORTER; NICHD NIH HHS [R42 HD048137] Funding Source: Medline; NIGMS NIH HHS [R37 GM027757, R01 GM027757] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942; Barton-Davis ER, 1999, J CLIN INVEST, V104, P375, DOI 10.1172/JCI7866; BONETTI B, 1995, J MOL BIOL, V251, P334, DOI 10.1006/jmbi.1995.0438; Clancy JP, 2001, AM J RESP CRIT CARE, V163, P1683, DOI 10.1164/ajrccm.163.7.2004001; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Grentzmann G, 1998, RNA, V4, P479; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; Hirawat S, 2007, J CLIN PHARMACOL, V47, P430, DOI 10.1177/0091270006297140; Howard MT, 2000, ANN NEUROL, V48, P164, DOI 10.1002/1531-8249(200008)48:2<164::AID-ANA5>3.0.CO;2-B; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Kerem E, 2004, CURR OPIN PULM MED, V10, P547, DOI 10.1097/01.mcp.0000141247.22078.46; Maderazo AB, 2000, MOL CELL BIOL, V20, P4591, DOI 10.1128/MCB.20.13.4591-4603.2000; Manuvakhova M, 2000, RNA, V6, P1044, DOI 10.1017/S1355838200000716; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; MCCAUGHAN KK, 1995, P NATL ACAD SCI USA, V92, P5431, DOI 10.1073/pnas.92.12.5431; Mendell JT, 2001, CELL, V107, P411, DOI 10.1016/S0092-8674(01)00583-9; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Neville C, 1997, METHOD CELL BIOL, V52, P85, DOI 10.1016/S0091-679X(08)60375-1; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Politano L, 2003, Acta Myol, V22, P15; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Ramalho AS, 2002, AM J RESP CELL MOL, V27, P619, DOI 10.1165/rcmb.2001-0004OC; Sambrook J., 1989, MOL CLONING LAB MANU, V3; Sweeney HL, 1997, METHOD CELL BIOL, V52, P275, DOI 10.1016/S0091-679X(08)60383-0; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; VANDERVELDEN A, 1995, VIROLOGY, V214, P82, DOI 10.1006/viro.1995.9952; Wagner KR, 2001, ANN NEUROL, V49, P706, DOI 10.1002/ana.1023.abs; Wang WR, 2001, EMBO J, V20, P880, DOI 10.1093/emboj/20.4.880; Welch EM, 2000, COLD SPRING HARBOR M, V39, P467; Weng YM, 1996, MOL CELL BIOL, V16, P5491, DOI 10.1128/mcb.16.10.5491; Weng YM, 1996, MOL CELL BIOL, V16, P5477; Wilschanski M, 2003, NEW ENGL J MED, V349, P1433, DOI 10.1056/NEJMoa022170	35	776	848	2	81	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 3	2007	447	7140					87	U6		10.1038/nature05756	http://dx.doi.org/10.1038/nature05756			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17450125				2022-12-01	WOS:000246149300049
J	Dean, R; Bonsall, MB; Pizzari, T				Dean, Rebecca; Bonsall, Michael B.; Pizzari, Tommaso			Aging and sexual conflict	SCIENCE			English	Editorial Material							YOUNG SPERM; AGE		Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England	University of Oxford	Dean, R (corresponding author), Univ Oxford, Dept Zool, Edward Grey Inst, S Parks Rd, Oxford OX1 3PS, England.	tommaso.pizzari@zoo.ox.ac.uk		Bonsall, Michael/0000-0003-0250-0423	Natural Environment Research Council [NE/C507196/1, NE/D003865/1, NE/D002788/1] Funding Source: researchfish; NERC [NE/D003865/1, NE/D002788/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Chow V, 2006, J REPROD MED, V51, P149; Jones TM, 2007, BEHAV ECOL, V18, P251, DOI 10.1093/beheco/arl077; Jones TM, 2004, P ROY SOC B-BIOL SCI, V271, P1311, DOI 10.1098/rspb.2004.2723; Lovlie H, 2005, CURR BIOL, V15, P1222, DOI 10.1016/j.cub.2005.05.060; Reinhardt K, 2005, AM NAT, V165, P718, DOI 10.1086/430010; Snook RR, 2004, NATURE, V428, P939, DOI 10.1038/nature02455; Wagner RH, 2004, P ROY SOC B-BIOL SCI, V271, pS134, DOI 10.1098/rsbl.2003.0142; White J, 2006, J ORNITHOL, V147, P88; Wyrobek AJ, 2006, P NATL ACAD SCI USA, V103, P9601, DOI 10.1073/pnas.0506468103	9	14	14	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					383	384		10.1126/science.1142201	http://dx.doi.org/10.1126/science.1142201			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	158RY	17446381				2022-12-01	WOS:000245813400032
J	Evans, JT; Smith, EG; Banerjee, A; Smith, RMM; Dale, J; Innes, JA; Hunt, D; Tweddell, A; Wood, A; Anderson, C; Hewinson, RG; Smith, NH; Hawkey, PM; Sonnenberg, P				Evans, Jason T.; Smith, E. Grace; Banerjee, Ashis; Smith, Robert M. M.; Dale, James; Innes, John A.; Hunt, David; Tweddell, Alan; Wood, Annette; Anderson, Charlotte; Hewinson, R. Glyn; Smith, Noel H.; Hawkey, Peter M.; Sonnenberg, Pam			Cluster of human tuberculosis caused by Mycobacterium bovis: evidence for person-to-person transmission in the UK	LANCET			English	Article							LENGTH-POLYMORPHISM ANALYSIS; VARIABLE NUMBERS; TANDEM REPEATS; INFECTION; PCR; DIFFERENTIATION; DISCRIMINATION; IDENTIFICATION; DIAGNOSIS; OUTBREAK	Background Despite a recent resurgence in the incidence of bovine tuberculosis in UK cattle herds, no associated rise in the number of cases in man has been noted. Disease due to human Mycobacterium bovis infection usually occurs in older patients, in whom drinking unpasteurised milk in the past is the probable source of infection. Person-to-person transmission is very rare. Methods After identification of two epidemiologically-linked cases of human M bovis infection through routine laboratory and surveillance activities, all patients identified with M bovis infection in the Midlands from 2001-05 (n=20) were assessed by DNA fingerprinting (MIRU-VNTR and spoligotyping), with additional interviews for patients with a clustered strain. Findings A cluster of six cases was identified. All clustered cases were young and UK-born; five patients had pulmonary disease, and one patient died due to M bovis meningitis, with four patients possessing factors predisposing to tuberculosis. All patients had common social links through visits to bars in two different areas. With the exception of the first case, there was an absence of zoonotic links or consumption of unpasteurised dairy products, suggesting that person-to-person transmission had occurred. Interpretation This report of several instances of M bovis transmission between people in a modem urban setting emphasises the need to maintain control measures for human and bovine tuberculosis. Transmission and subsequent disease was probably due to a combination of host and environmental factors. Prospective surveillance and DNA fingerprinting identified the cluster, enabling health protection teams to set up control measures and prevent further transmission.	Birmingham Heartlands Hosp, Hlth Protect Agcy, W Midlands Publ Hlth Lab, Reg Ctr Mycobacteriol, Birmingham B9 5SS, W Midlands, England; Natl Publ Hlth Serv Wales, Ctr Communicable Dis Surveillance, Zoonoses Surveillance Unit, Cardiff, Wales; Hlth Protect Agcy Ctr Infect, TB Sect, London, England; Vet Labs Agcy, TB Res Grp, Weybridge, Surrey, England; Heart England NHS Fdn Trust, Birmingham Chest Clin, Birmingham, W Midlands, England; Hlth Protect Agcy Reg Surveillance Unit W Midland, Birmingham, W Midlands, England; Univ Birmingham, Sch Med, Div Immun & Infect, Birmingham, W Midlands, England; UCL, Dept Primary Care & Populat Sci, London, England	Health Protection Agency; Heart of England NHS Foundation Trust; University of Birmingham; Health Protection Agency; Veterinary Laboratories Agency; Heart of England NHS Foundation Trust; University of Birmingham; University of London; University College London	Evans, JT (corresponding author), Birmingham Heartlands Hosp, Hlth Protect Agcy, W Midlands Publ Hlth Lab, Reg Ctr Mycobacteriol, Birmingham B9 5SS, W Midlands, England.	jason.evans@heartofengland.nhs.uk	Smith, Noel H/C-6708-2011; Hewinson, Glyn/F-7077-2010; Hewinson, Glyn/J-1902-2014; Hewinson, Glyn/AAA-2364-2019	Sonnenberg, Pam/0000-0002-1067-1583; Hewinson, Glyn/0000-0002-5517-4281				Allix C, 2006, J CLIN MICROBIOL, V44, P1951, DOI 10.1128/JCM.01775-05; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Cousins DV, 1998, INT J TUBERC LUNG D, V2, P471; Cowan LS, 2005, J CLIN MICROBIOL, V43, P688, DOI 10.1128/JCM.43.2.688-695.2005; DANKNER WM, 1993, MEDICINE, V72, P11, DOI 10.1097/00005792-199301000-00002; de la Rua-Domenech R, 2006, TUBERCULOSIS, V86, P77, DOI 10.1016/j.tube.2005.05.002; *DEEP HLTH, 2004, STOPP TUB ENGL ACT P; Delahay RJ, 2002, VET J, V164, P90, DOI 10.1053/tvjl.2001.0667; Drobniewski FA, 2003, LANCET INFECT DIS, V3, P141, DOI 10.1016/S1473-3099(03)00544-9; DUPON M, 1992, Q J MED, V85, P719; Evans JT, 2004, J CLIN MICROBIOL, V42, P4175, DOI 10.1128/JCM.42.9.4175-4180.2004; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Gardam MA, 2003, LANCET INFECT DIS, V3, P148, DOI 10.1016/S1473-3099(03)00545-0; GENEWEIN A, 1993, LANCET, V342, P841, DOI 10.1016/0140-6736(93)92698-S; Gibson AL, 2004, J CLIN MICROBIOL, V42, P431, DOI 10.1128/JCM.42.1.431-434.2004; GOYAL M, 1994, J CLIN MICROBIOL, V32, P3070, DOI 10.1128/JCM.32.12.3070-3071.1994; Grange JM, 2001, TUBERCULOSIS, V81, P71, DOI 10.1054/tube.2000.0263; Gutierrez MC, 1998, LANCET, V351, P758, DOI 10.1016/S0140-6736(05)78537-8; Hawkey PM, 2003, J CLIN MICROBIOL, V41, P3514, DOI 10.1128/JCM.41.8.3514-3520.2003; Hewinson RG, 2006, VET MICROBIOL, V112, P127, DOI 10.1016/j.vetmic.2005.11.050; Hilty M, 2005, VET MICROBIOL, V109, P217, DOI 10.1016/j.vetmic.2005.05.017; *HLTH PROT AG, TUB MYC BOV; Jalava K, 2007, EPIDEMIOL INFECT, V135, P40, DOI 10.1017/S0950268806006509; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; KLINE SE, 1995, NEW ENGL J MED, V333, P222, DOI 10.1056/NEJM199507273330404; LOBUE P, 2006, MYCOBACTERIUM BOVIS, P6; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; PablosMendez A, 1997, AM J PUBLIC HEALTH, V87, P574, DOI 10.2105/AJPH.87.4.574; Richter E, 2003, J CLIN MICROBIOL, V41, P2672, DOI 10.1128/JCM.41.6.2672-2675.2003; Rivero A, 2001, CLIN INFECT DIS, V32, P159, DOI 10.1086/317547; Roring S, 2002, J CLIN MICROBIOL, V40, P2126, DOI 10.1128/JCM.40.6.2126-2133.2002; Skuce RA, 2005, VET REC, V157, P501, DOI 10.1136/vr.157.17.501; Skuce RA, 2002, MICROBIOL-SGM, V148, P519, DOI 10.1099/00221287-148-2-519; Smith NH, 2006, J THEOR BIOL, V239, P220, DOI 10.1016/j.jtbi.2005.08.036; Smith NH, 2003, P NATL ACAD SCI USA, V100, P15271, DOI 10.1073/pnas.2036554100; Smith RMM, 2004, EMERG INFECT DIS, V10, P539, DOI 10.3201/eid1003.020819; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; [No title captured]	38	131	133	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2007	369	9569					1270	1276		10.1016/S0140-6736(07)60598-4	http://dx.doi.org/10.1016/S0140-6736(07)60598-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164YA	17434402				2022-12-01	WOS:000246269700029
J	Ziurys, LM; Milam, SN; Apponi, AJ; Woolf, NJ				Ziurys, L. M.; Milam, S. N.; Apponi, A. J.; Woolf, N. J.			Chemical complexity in the winds of the oxygen-rich supergiant star VY Canis Majoris	NATURE			English	Article							MASS-LOSS; BEARING MOLECULES; RED GIANTS; CIRCUMSTELLAR; ABUNDANCES; ENVELOPES; CHEMISTRY; EMISSION; HCN; CONVECTION	The interstellar medium is enriched primarily by matter ejected from old, evolved stars(1,2). The outflows from these stars create spherical envelopes, which foster gas-phase chemistry(3-5). The chemical complexity in circumstellar shells was originally thought to be dominated by the elemental carbon to oxygen ratio(6). Observations have suggested that envelopes with more carbon than oxygen have a significantly greater abundance of molecules than their oxygen-rich analogues(7). Here we report observations of molecules in the oxygen-rich shell of the red supergiant star VY Canis Majoris (VY CMa). A variety of unexpected chemical compounds have been identified, including NaCl, PN, HNC and HCO+. From the spectral line profiles, the molecules can be distinguished as arising from three distinct kinematic regions: a spherical outflow, a tightly collimated, blue-shifted expansion, and a directed, red-shifted flow. Certain species (SiO, PN and NaCl) exclusively trace the spherical flow, whereas HNC and sulphur-bearing molecules (amongst others) are selectively created in the two expansions, perhaps arising from shock waves. CO, HCN, CS and HCO+ exist in all three components. Despite the oxygen-rich environment, HCN seems to be as abundant as CO. These results suggest that oxygen-rich shells may be as chemically diverse as their carbon counterparts.	Univ Arizona, Astrobiol Inst, NASA, Tucson, AZ 85721 USA; Univ Arizona, Dept Chem, Tucson, AZ 85721 USA; Univ Arizona, Arizona Radio Observ, Tucson, AZ 85721 USA; Univ Arizona, Dept Astron, Steward Observ, Tucson, AZ 85721 USA	National Aeronautics & Space Administration (NASA); University of Arizona; University of Arizona; National Radio Astronomy Observatory (NRAO); University of Arizona; University of Arizona	Ziurys, LM (corresponding author), Univ Arizona, Astrobiol Inst, NASA, 1306 E Univ Blvd, Tucson, AZ 85721 USA.	lziurys@as.arizona.edu	Milam, Stefanie/D-1092-2012	Milam, Stefanie/0000-0001-7694-4129				ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; BOWERS PF, 1983, ASTROPHYS J, V274, P733, DOI 10.1086/161485; BUJARRABAL V, 1994, ASTRON ASTROPHYS, V285, P247; Cernicharo J, 2000, ASTRON ASTROPHYS SUP, V142, P181, DOI 10.1051/aas:2000147; Cherchneff I, 2006, ASTRON ASTROPHYS, V456, P1001, DOI 10.1051/0004-6361:20064827; Duari D, 1999, ASTRON ASTROPHYS, V341, pL47; Glassgold AE, 1996, ANNU REV ASTRON ASTR, V34, P241, DOI 10.1146/annurev.astro.34.1.241; Highberger JL, 2003, ASTROPHYS J, V593, P393, DOI 10.1086/376446; Humphreys RM, 2005, ASTRON J, V129, P492, DOI 10.1086/426565; IBEN I, 1983, ANNU REV ASTRON ASTR, V21, P271, DOI 10.1146/annurev.aa.21.090183.001415; Kemper F, 2003, ASTRON ASTROPHYS, V407, P609, DOI 10.1051/0004-6361:20030701; LAURIA EF, 2006, 553 ALMA; Lim J, 1998, NATURE, V392, P575, DOI 10.1038/33352; Marvel KB, 2005, ASTRON J, V130, P261, DOI 10.1086/430746; MCCABE EM, 1979, NATURE, V281, P263, DOI 10.1038/281263a0; Monnier JD, 2000, ASTROPHYS J, V543, P868, DOI 10.1086/317127; Muller S, 2007, ASTROPHYS J, V656, P1109, DOI 10.1086/510513; NEJAD LAM, 1988, MON NOT R ASTRON SOC, V230, P79, DOI 10.1093/mnras/230.1.79; NERCESSIAN E, 1989, ASTRON ASTROPHYS, V210, P225; Olofsson H, 1997, ASTROPHYS SPACE SCI, V251, P31, DOI 10.1023/A:1000747630702; SAHAI R, 1992, ASTROPHYS J, V394, P320, DOI 10.1086/171585; SCHILKE P, 1992, ASTRON ASTROPHYS, V256, P595; SCHWARZSCHILD M, 1975, ASTROPHYS J, V195, P137, DOI 10.1086/153313; Smith N, 2004, MON NOT R ASTRON SOC, V349, pL31, DOI 10.1111/j.1365-2966.2004.07718.x; Smith N, 2001, ASTRON J, V121, P1111, DOI 10.1086/318748; Szczerba R, 2007, BALT ASTRON, V16, P134; Wallerstein G, 2001, PUBL ASTRON SOC PAC, V113, P954, DOI 10.1086/322920; Willson LA, 2000, ANNU REV ASTRON ASTR, V38, P573, DOI 10.1146/annurev.astro.38.1.573; Ziurys LM, 2006, P NATL ACAD SCI USA, V103, P12274, DOI 10.1073/pnas.0602277103; Zubko V, 2004, ASTROPHYS J, V610, P427, DOI 10.1086/421700	30	102	103	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2007	447	7148					1094	1097		10.1038/nature05905	http://dx.doi.org/10.1038/nature05905			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183HT	17597755				2022-12-01	WOS:000247564600033
J	Robertson, CMT; Watt, MJ; Yasui, Y				Robertson, Charlene M. T.; Watt, Man-Joe; Yasui, Yutaka			Changes in the prevalence of cerebral palsy for children born very prematurely within a population-based program over 30 years	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BIRTH-WEIGHT INFANTS; GESTATIONAL-AGE; NEUROLOGIC DISABILITY; IMPROVED SURVIVAL; PRETERM INFANTS; TRENDS; GRAMS; MORTALITY; PROGNOSIS; PANORAMA	Context Although cerebral palsy (CP) among extremely premature infants has been reported as a major morbidity outcome, there are difficulties comparing published CP rates from many sites over various birth years. Objective To assess the changes in population-based, gestational age - specific prevalence rates of CP among extremely premature infants over 30 years. Design Prospective population-based longitudinal outcome study. Setting and Participants In Northern Alberta, 2318 infants 20 to 27 weeks' gestational age with birth weights of 500 to 1249 g were liveborn from 1974 through 2003. By 2 years of age, 1437 (62%) had died, 23 (1%) were lost to follow-up, and 858 (37%) had received multidisciplinary neurodevelopmental assessment. Main Outcome Measure Population-based prevalence rates of CP were determined. Logistic regression with linear spline was used to assess changes in CP prevalence over time. Results At age 2 years, 122 (14.2%) of 858 survivors had CP. This diagnosis was confirmed for each child by age 3 years or older. Among those whose gestational age was 20 to 25 weeks, population-based survival increased from 4% to 31% ( P <. 001), while CP prevalence per 1000 live births increased monotonically from 0 to 110 until the years 1992-1994 ( P <. 001) and decreased thereafter to 22 in the years 20012003 ( P <. 001). Among those whose gestational age was 26 to 27 weeks, population-based survival increased from 23% to between 75% and 80% ( P <. 001), while CP prevalence per 1000 live births increased monotonically from 15 to 155 until the years 1992-1994 ( P <. 001) and then decreased to 16 in the years 2001-2003 ( P <. 001). For all survivors born in the years 2001-2003, CP prevalence was 19 per 1000 live births. Conclusion Population-based CP prevalence rates for children whose gestational age was 20 to 27 weeks and whose birth weight ranged from 500 to 1249 g show steady reductions in the last decade with stable or reducing mortality, reversing trends prior to 1992-1994.	Glenrose Rehabil Hosp, Dept Pediat, Neonatal & Infant Follow Up Clin, Edmonton, AB T5G 0B7, Canada; Univ Alberta, Fac Med & Dent, Dept Pediat, Sect Neurosci, Edmonton, AB, Canada; Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; Glenrose Rehabil Hosp, Dept Rehabil Med, Edmonton, AB T5G 0B7, Canada	University of Alberta; University of Alberta	Robertson, CMT (corresponding author), Glenrose Rehabil Hosp, Dept Pediat, Neonatal & Infant Follow Up Clin, Edmonton, AB T5G 0B7, Canada.	charlene.robertson@capitalhealth.ca	Yasui, Yutaka/E-2564-2015	Yasui, Yutaka/0000-0002-7717-8638				ALBERMAN E, 1984, EPIDEMIOLOGY CEREBRA, P172; ALLEN AC, 1994, CAN MED ASSOC J, V151, P547; Ancel PY, 2006, PEDIATRICS, V117, P828, DOI 10.1542/peds.2005-0091; AZIZ K, 1995, PEDIATRICS, V95, P837; Bax M, 2005, DEV MED CHILD NEUROL, V47, P571, DOI 10.1017/S001216220500112X; BAX M C, 1964, Dev Med Child Neurol, V6, P295; Bax M, 2006, JAMA-J AM MED ASSOC, V296, P1602, DOI 10.1001/jama.296.13.1602; BHUSHAN V, 1993, PEDIATRICS, V91, P1094; Blackmon LR, 2002, PEDIATRICS, V109, P330; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; CASIRO O, 1995, J PEDIATR-US, V126, pS53, DOI 10.1016/S0022-3476(95)70008-0; Cooke RWI, 1999, ARCH DIS CHILD-FETAL, V80, pF115, DOI 10.1136/fn.80.2.F115; Dammann O, 2001, EARLY HUM DEV, V64, P79, DOI 10.1016/S0378-3782(01)00183-9; Doyle LW, 2001, PEDIATRICS, V108, P134, DOI 10.1542/peds.108.1.134; Emsley HCA, 1998, ARCH DIS CHILD-FETAL, V78, pF99, DOI 10.1136/fn.78.2.F99; Evans DJ, 2001, ARCH DIS CHILD-FETAL, V84, pF79, DOI 10.1136/fn.84.2.F79; *GOV SERV, ALB VIT STAT ANN REV; Grether JK, 2000, J PEDIATR-US, V136, P133, DOI 10.1016/S0022-3476(00)90071-4; Hagberg B, 2001, ACTA PAEDIATR, V90, P271, DOI 10.1080/080352501300067532; Harrell Jr FE, 2001, REGRESSION MODELING, P16; HENDSON L, 2005, 57 PED AC SOC ANN M; Himmelmann K, 2005, ACTA PAEDIATR, V94, P287, DOI 10.1111/j.1651-2227.2005.tb03071.x; Hintz SR, 2005, PEDIATRICS, V115, P1645, DOI 10.1542/peds.2004-2215; Jacobs SE, 2000, ACTA PAEDIATR, V89, P959; Lorenz JM, 2001, PEDIATRICS, V108, P1269, DOI 10.1542/peds.108.6.1269; Marlow N, 2004, ARCH DIS CHILD-FETAL, V89, pF224, DOI 10.1136/adc.2002.019752; Nelson KB, 2003, NEW ENGL J MED, V349, P1765, DOI 10.1056/NEJMsb035364; O'Shea TM, 1998, PEDIATRICS, V101, P642, DOI 10.1542/peds.101.4.642; PELIOWSKI A, 1998, PEDIATR RES, V43, P293; PHAROAH POD, 1990, ARCH DIS CHILD, V65, P602, DOI 10.1136/adc.65.6.602; PHAROAH POD, 1987, ARCH DIS CHILD, V62, P1035, DOI 10.1136/adc.62.10.1035; Pharoah POD, 1996, ARCH DIS CHILD-FETAL, V75, pF169, DOI 10.1136/fn.75.3.F169; Powell K, 2006, J MATERN-FETAL NEO M, V19, P43, DOI 10.1080/14767050500363519; R Development Core Team, 2005, LANG ENV STAT COMP; Robertson Charlene M T, 2002, J Obstet Gynaecol Can, V24, P138; ROBERTSON CMT, 1992, PEDIATRICS, V90, P750; Robertson CMT, 1998, CAN J NEUROL SCI, V25, P117, DOI 10.1017/S0317167100033710; Rosenbaum PL, 2002, JAMA-J AM MED ASSOC, V288, P1357, DOI 10.1001/jama.288.11.1357; ROSNER B, 2000, FUNDAMENTAL BIOSTATI, P296; Sauve RS, 1998, PEDIATRICS, V101, P438, DOI 10.1542/peds.101.3.438; SCHMIDT B, 2003, JAMA-J AM MED ASSOC, V289, P11142; STANLEY FJ, 1992, BRIT MED J, V304, P1658, DOI 10.1136/bmj.304.6843.1658; Surman G, 2003, DEV MED CHILD NEUROL, V45, P456, DOI 10.1017/S0012162203000859; Tommiska V, 2003, ARCH DIS CHILD-FETAL, V88, P29; Vincer MJ, 2006, PEDIATRICS, V118, pE1621, DOI 10.1542/peds.2006-1522; WATT JM, 1989, DEV MED CHILD NEUROL, V31, P766; Weber C, 2005, WIEN KLIN WOCHENSCHR, V117, P740, DOI 10.1007/s00508-005-0468-y; *WHO, 1997, INT CLASS DIS, P763; Wilson-Costello D, 2005, PEDIATRICS, V115, P997, DOI 10.1542/peds.2004-0221; Winter S, 2002, PEDIATRICS, V110, P1220, DOI 10.1542/peds.110.6.1220; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601	51	111	117	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2007	297	24					2733	2740		10.1001/jama.297.24.2733	http://dx.doi.org/10.1001/jama.297.24.2733			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182UE	17595274	Bronze			2022-12-01	WOS:000247528700023
J	Batt, CA				Batt, Carl A.			Materials science - Food pathogen detection	SCIENCE			English	Editorial Material							ESCHERICHIA-COLI O157-H7		Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA	Cornell University	Batt, CA (corresponding author), Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA.	cab10@cornell.edu						Cady NC, 2005, SENSOR ACTUAT B-CHEM, V107, P332, DOI 10.1016/j.snb.2004.10.022; Dierksen KP, 2004, J APPL TOXICOL, V24, P363, DOI 10.1002/jat.1030; FSIS-USDA, 1995, FED REGISTER, V60, P49553; Ilic B, 2001, J VAC SCI TECHNOL B, V19, P2825, DOI 10.1116/1.1421572; Ochoa ML, 2005, ANAL CHEM, V77, P5258, DOI 10.1021/ac0502596; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Ramos D, 2006, J APPL PHYS, V100, DOI 10.1063/1.2370507; Yu CX, 2006, ANAL CHEM, V78, P2500, DOI 10.1021/ac051828c	8	97	99	3	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1579	1580		10.1126/science.1140729	http://dx.doi.org/10.1126/science.1140729			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569853				2022-12-01	WOS:000247239900029
J	Kawaguchi, S; Ng, DTW				Kawaguchi, Shinichi; Ng, Davis T. W.			SnapShot: ER-associated protein degradation pathways	CELL			English	Editorial Material							ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; UBIQUITIN LIGASE		Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; Natl Univ Singapore, Dept Biol Sci, Singapore 117604, Singapore	National University of Singapore; National University of Singapore	Kawaguchi, S (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore.							Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Ismail N, 2006, CELL, V126, P237, DOI 10.1016/j.cell.2006.07.001; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Moremen KW, 2006, CURR OPIN STRUC BIOL, V16, P592, DOI 10.1016/j.sbi.2006.08.005; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	13	13	13	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2007	129	6					1230	+						2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574032	Bronze			2022-12-01	WOS:000247390400026
J	Lietha, D; Cai, XM; Ceccarelli, DFJ; Li, YQ; Schaller, MD; Eck, MJ				Lietha, Daniel; Cai, Xinming; Ceccarelli, Derek F. J.; Li, Yiqun; Schaller, Michael D.; Eck, Michael J.			Structural basis for the autoinhibition of focal adhesion kinase	CELL			English	Article							PROTEIN-TYROSINE KINASE; FERM DOMAIN; CRYSTAL-STRUCTURE; GROWTH-FACTOR; PHOSPHORYLATION; FAK; BINDING; ACTIVATION; MECHANISMS; COMPLEX	Appropriate tyrosine kinase signaling depends on coordinated sequential coupling of protein-protein interactions with catalytic activation. Focal adhesion kinase (FAK) integrates signals from integrin and growth factor receptors to regulate cellular responses including cell adhesion, migration, and survival. Here, we describe crystal structures representing both autoinhibited and active states of FAK The inactive structure reveals a mechanism of inhibition in which the N-terminal FERM domain directly binds the kinase domain, blocking access to the catalytic cleft and protecting the FAK activation loop from Src phosphorylation. Additionally, the FERM domain sequesters the Tyr397 autophosphorylation and Src recruitment site, which lies in the linker connecting the FERM and kinase domains. The active phosphorylated FAK kinase adopts a conformation that is immune to FERM inhibition. Our biochemical and structural analysis shows how the architecture of autoinhibited FAK orchestrates an activation sequence of FERM domain displacement, linker autophosphorylation, Src recruitment, and full catalytic activation.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Eck, MJ (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	eck@red.dfci.harvard.edu	Lietha, Daniel/AAD-1952-2022; Lietha, Daniel/L-8041-2014	Lietha, Daniel/0000-0002-6133-6486; Lietha, Daniel/0000-0002-6133-6486; Ceccarelli, Derek/0000-0002-2674-9234	NCI NIH HHS [CA080942, R01 CA080942, 5T32CA09361, T32 CA009361, R01 CA080942-07] Funding Source: Medline; NCRR NIH HHS [P41 RR001646-230082, P41 RR001646, P41 RR001646-220082] Funding Source: Medline; NHLBI NIH HHS [P01 HL048675, HL048675, P01 HL048675-135389, P01 HL045100, HL45100] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA080942, T32CA009361] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048675, P01HL045100] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arold ST, 2002, STRUCTURE, V10, P319, DOI 10.1016/S0969-2126(02)00717-7; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Boggon TJ, 2005, BLOOD, V106, P996, DOI 10.1182/blood-2005-02-0707; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Carter N, 2002, NAT CELL BIOL, V4, P565, DOI 10.1038/ncb823; Ceccarelli DFJ, 2006, J BIOL CHEM, V281, P252, DOI 10.1074/jbc.M509188200; Chen SY, 2006, MOL CELL BIOL, V26, P5155, DOI 10.1128/MCB.02186-05; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Cohen LA, 2005, CURR CANCER DRUG TAR, V5, P629, DOI 10.2174/156800905774932798; Cohen LA, 2005, J BIOL CHEM, V280, P8197, DOI 10.1074/jbc.M412021200; Cooper LA, 2003, MOL CELL BIOL, V23, P8030, DOI 10.1128/MCB.23.22.8030-8041.2003; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Dunty JM, 2004, MOL CELL BIOL, V24, P5353, DOI 10.1128/MCB.24.12.5353-5368.2004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; Harrison SC, 2003, CELL, V112, P737, DOI 10.1016/S0092-8674(03)00196-X; Hayashi I, 2002, NAT STRUCT BIOL, V9, P101, DOI 10.1038/nsb755; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Ilic D, 2003, CIRC RES, V92, P300, DOI 10.1161/01.RES.0000055016.36679.23; ILLC D, 1995, NATURE, V377, P539; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LaFevre-Bernt M, 1998, J BIOL CHEM, V273, P32129, DOI 10.1074/jbc.273.48.32129; Leu TH, 2002, ONCOGENE, V21, P6992, DOI 10.1038/sj.onc.1205904; Lyons PD, 2001, J BIOL CHEM, V276, P24422, DOI 10.1074/jbc.M011080200; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nikolopoulos SN, 2005, CELL CYCLE, V4, P429, DOI 10.4161/cc.4.3.1547; Nowakowski J, 2002, STRUCTURE, V10, P1659, DOI 10.1016/S0969-2126(02)00907-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P629, DOI 10.1128/MCB.9.2.629; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Schock F, 2002, ANNU REV CELL DEV BI, V18, P463, DOI 10.1146/annurev.cellbio.18.022602.131838; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tachibana K, 1997, J BIOL CHEM, V272, P29083, DOI 10.1074/jbc.272.46.29083; Thomas JW, 1999, J BIOL CHEM, V274, P36684, DOI 10.1074/jbc.274.51.36684; Toutant M, 2002, MOL CELL BIOL, V22, P7731, DOI 10.1128/MCB.22.22.7731-7743.2002; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Zhu XT, 1999, STRUCTURE, V7, P651, DOI 10.1016/S0969-2126(99)80086-0	57	316	328	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2007	129	6					1177	1187		10.1016/j.cell.2007.05.041	http://dx.doi.org/10.1016/j.cell.2007.05.041			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574028	Bronze, Green Accepted, Green Published			2022-12-01	WOS:000247390400020
J	Nachury, MV; Loktev, AV; Zhang, Q; Westlake, CJ; Peranen, J; Merdes, A; Slusarski, DC; Scheller, RH; Bazan, JF; Sheffield, VC; Jackson, PK				Nachury, Maxence V.; Loktev, Alexander V.; Zhang, Qihong; Westlake, Christopher J.; Peranen, Johan; Merdes, Andreas; Slusarski, Diane C.; Scheller, Richard H.; Bazan, J. Fernando; Sheffield, Val C.; Jackson, Peter K.			A core complex of BBS proteins cooperates with the GTPase Rab8 to promote ciliary membrane biogenesis	CELL			English	Article							BARDET-BIEDL-SYNDROME; DIGENIC RETINITIS-PIGMENTOSA; INTRAFLAGELLAR TRANSPORT; MOLECULAR CHARACTERIZATION; PLASMA-MEMBRANE; IFT PARTICLES; CELLS ANTENNA; FLAGELLAR; CILIUM; GENES	Primary cilium dysfunction underlies the pathogenesis of Bardet-Biedl syndrome (BBS), a genetic disorder whose symptoms include obesity, retinal degeneration, and nephropathy. However, despite the identification of 12 BBS genes, the molecular basis of BBS remains elusive. Here we identify a complex composed of seven highly conserved BBS proteins. This complex, the BBSome, localizes to nonmembranous centriolar satellites in the cytoplasm but also to the membrane of the cilium. Interestingly, the BBSome is required for ciliogenesis but is dispensable for centriolar satellite function. This ciliogenic function is mediated in part by the Rab8 GDP/GTP exchange factor, which localizes to the basal body and contacts the BBSome. Strikingly, Rab8(GTP) enters the primary cilium and promotes extension of the ciliary membrane. Conversely, preventing Rab8 GTP production blocks ciliation in cells and yields characteristic BBS phenotypes in zebrafish. Our data reveal that BBS may be caused by defects in vesicular transport to the cilium.	Genentech Inc, San Francisco, CA 94080 USA; Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; CNRS, Ctr Rech Pierre Fabre, Inst Sci & Technol Medicament Toulouse, F-31400 Toulouse, France; Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA	Roche Holding; Genentech; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Helsinki; Centre National de la Recherche Scientifique (CNRS); University of Iowa	Nachury, MV (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	nachury@gene.com	Bazan, J. Fernando/B-4562-2010; Nachury, Maxence/H-3695-2019; Westlake, Christopher/AAG-1150-2019; Nachury, Maxence/A-8759-2008	Nachury, Maxence/0000-0003-4918-1562; Westlake, Christopher/0000-0001-7476-2014; Nachury, Maxence/0000-0003-4918-1562; Sheffield, Val/0000-0002-6282-0835; Jackson, Peter/0000-0002-1742-2539; Slusarski, Diane/0000-0003-3793-8636	NEI NIH HHS [R01-EY-11298] Funding Source: Medline; NIGMS NIH HHS [R01-GM-54811] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054811] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ang AL, 2003, J CELL BIOL, V163, P339, DOI 10.1083/jcb.200307046; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Begley MJ, 2003, MOL CELL, V12, P1391, DOI 10.1016/S1097-2765(03)00486-6; Blacque OE, 2006, CELL MOL LIFE SCI, V63, P2145, DOI 10.1007/s00018-006-6180-x; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; CHEESEMAN IM, 2005, SCI STKE, pPI1, DOI DOI 10.1126/STKE.2662005PI1; Chiang AP, 2004, AM J HUM GENET, V75, P475, DOI 10.1086/423903; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; DOWLER S, 2002, SCI STKE, pPL6, DOI DOI 10.1126/STKE.2002.129.PL6; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Fan YL, 2004, NAT GENET, V36, P989, DOI 10.1038/ng1414; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Hames RS, 2005, MOL BIOL CELL, V16, P1711, DOI 10.1091/mbc.E04-08-0688; Hattula K, 2002, MOL BIOL CELL, V13, P3268, DOI 10.1091/mbc.E02-03-0143; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; HUBER LA, 1993, J CELL BIOL, V123, P35, DOI 10.1083/jcb.123.1.35; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Jekely G, 2006, BIOESSAYS, V28, P191, DOI 10.1002/bies.20369; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; Katsanis N, 2004, HUM MOL GENET, V13, pR65, DOI 10.1093/hmg/ddh092; Kim JC, 2005, J CELL SCI, V118, P1007, DOI 10.1242/jcs.01676; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Kubo A, 1999, J CELL BIOL, V147, P969, DOI 10.1083/jcb.147.5.969; Laurier V, 2006, EUR J HUM GENET, V14, P1195, DOI 10.1038/sj.ejhg.5201688; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Loewen CJR, 2001, J BIOL CHEM, V276, P22388, DOI 10.1074/jbc.M011710200; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; Marshall WF, 2006, CURR BIOL, V16, pR604, DOI 10.1016/j.cub.2006.07.012; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P1068, DOI 10.1093/nar/18.4.1068; Moritz OL, 2001, MOL BIOL CELL, V12, P2341, DOI 10.1091/mbc.12.8.2341; Nishimura DY, 2004, P NATL ACAD SCI USA, V101, P16588, DOI 10.1073/pnas.0405496101; OHLEMILLER KK, 1995, NEUROREPORT, V6, P845, DOI 10.1097/00001756-199504190-00005; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Peranen J, 1996, J CELL BIOL, V135, P153, DOI 10.1083/jcb.135.1.153; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Teo HL, 2006, CELL, V125, P99, DOI 10.1016/j.cell.2006.01.047; WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495; Wang CW, 2006, J CELL BIOL, V174, P973, DOI 10.1083/jcb.200605106; Yen HJ, 2006, HUM MOL GENET, V15, P667, DOI 10.1093/hmg/ddi468; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	50	964	993	2	66	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 15	2007	129	6					1201	1213		10.1016/j.cell.2007.03.053	http://dx.doi.org/10.1016/j.cell.2007.03.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574030	Bronze			2022-12-01	WOS:000247390400022
J	Coombes, R				Coombes, Rebecca			Cold turkey	BRITISH MEDICAL JOURNAL			English	Article												rcoombes@bmjgroup.com						Advisory Council on the Misuse of Drugs, 2005, METH REV; Fulde GWO, 2007, MED J AUSTRALIA, V186, P334, DOI 10.5694/j.1326-5377.2007.tb00931.x; GLOSSOP M, 2006, BRIT MED J, V333, P272; Gray SD, 2007, MED J AUSTRALIA, V186, P336, DOI 10.5694/j.1326-5377.2007.tb00932.x; *HAMPSH CONST, 2007, NAT PROBL PROF METH; *PROPR ASS GREAT B, 2007, INF US COUNT PSEUD L	6	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 9	2007	334	7605					1190	1192		10.1136/bmj.39223.422824.AD	http://dx.doi.org/10.1136/bmj.39223.422824.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179GF	17556470	Green Published			2022-12-01	WOS:000247277000028
J	McPherson, R; Pertsemlidis, A; Kavaslar, N; Stewart, AFR; Roberts, R; Cox, DR; Hinds, DA; Pennacchio, LA; Tybjaerg-Hansen, A; Folsom, AR; Boerwinkle, E; Hobbs, HH; Cohen, JC				McPherson, Ruth; Pertsemlidis, Alexander; Kavaslar, Nihan; Stewart, Alexandre F. R.; Roberts, Robert; Cox, David R.; Hinds, David A.; Pennacchio, Len A.; Tybjaerg-Hansen, Anne; Folsom, Aaron R.; Boerwinkle, Eric; Hobbs, Helen H.; Cohen, Jonathan C.			A common allele on chromosome 9 associated with coronary heart disease	SCIENCE			English	Article							GLOBAL MORTALITY; BURDEN	Coronary heart disease ( CHD) is a major cause of death in Western countries. We used genome-wide association scanning to identify a 58-kilobase interval on chromosome 9p21 that was consistently associated with CHD in six independent samples ( more than 23,000 participants) from four Caucasian populations. This interval, which is located near the CDKN2A and CDKN2B genes, contains no annotated genes and is not associated with established CHD risk factors such as plasma lipoproteins, hypertension, or diabetes. Homozygotes for the risk allele make up 20 to 25% of Caucasians and have a similar to 30 to 40% increased risk of CHD.	Univ Ottawa, Inst Heart, Div Cardiol, Ottawa, ON K1Y 4W7, Canada; Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; Perlegen Sci, Mountain View, CA 94043 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; Univ Copenhagen Hosp, Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA; Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Inst Mol Med, Houston, TX 77030 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Human Nutr, Dallas, TX 75390 USA	University of Ottawa; University of Ottawa Heart Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Rigshospitalet; University of Copenhagen; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Cohen, JC (corresponding author), Univ Ottawa, Inst Heart, Div Cardiol, Ottawa, ON K1Y 4W7, Canada.	rmcpherson@ottawaheart.ca; jonathan.cohen@utsouthwestern.edu	Wang, Weili/D-1546-2011; Stewart, Alexandre F.R./A-5677-2011; Pertsemlidis, Alexander/Q-7899-2017	Pertsemlidis, Alexander/0000-0003-1624-9372; Pennacchio, Len/0000-0002-8748-3732; Stewart, Alexandre/0000-0003-2673-9164; Hinds, David/0000-0002-4911-803X	NHLBI NIH HHS [HL-082896, R01 HL082896, HL-066681, R01 HL082896-02] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066681, R01HL082896] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; PASMANT E, 2007, CANCER RES, V67, P1; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Schnohr P, 2001, EUR HEART J SUPPL, V3, pH1; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	12	1363	1430	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2007	316	5830					1488	1491		10.1126/science.1142447	http://dx.doi.org/10.1126/science.1142447			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17478681	Green Submitted, Green Accepted			2022-12-01	WOS:000247066400046
J	Edgren, G; Hjalgrim, H; Reilly, M; Tran, TN; Rostgaard, K; Shanwell, A; Titlestad, K; Adami, J; Wikman, A; Jersild, C; Gridley, G; Wideroff, L; Nyren, O; Melbye, M				Edgren, Gustaf; Hjalgrim, Henrik; Reilly, Marie; Tran, Trung Nam; Rostgaard, Klaus; Shanwell, Agneta; Titlestad, Kjell; Adami, Johanna; Wikman, Agneta; Jersild, Casper; Gridley, Gloria; Wideroff, Louise; Nyren, Olof; Melbye, Mads			Risk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort study	LANCET			English	Article							NON-HODGKINS-LYMPHOMA; TRAUMA PATIENTS; OLDER WOMEN; RECIPIENTS; TRANSMISSION; MICROCHIMERISM; LEUKEMIA; HISTORY; MORBIDITY; REGISTRY	Background Although mechanisms for detection of short-term complications after blood transfusions are well developed, complications with delayed onset, notably transmission of chronic diseases such as cancer, have been difficult to assess. Our aim was to investigate the possible risk of cancer transmission from blood donors to recipients through blood transfusion. Methods We did a register-based retrospective cohort study of cancer incidence among patients who received blood from donors deemed to have a subclinical cancer at the time of donation. These precancerous donors were diagnosed with a cancer within 5 years of the donation. Data from all computerised blood bank registers in Sweden and Denmark gathered between 1968 and 2002 were merged into a common database. Demographic and medical data, including mortality and cancer incidence, were ascertained through linkages with nationwide, and essentially complete, population and health-care registers. The risk of cancer in exposed recipients relative to that in recipients who received blood from non-cancerous donors was estimated with multivariate Poisson regression, adjusting for potential confounding factors. Findings Of the 354094 transfusion recipients eligible for this analysis, 12012 (3%) were exposed to blood products from precancerous donors. There was no excess risk of cancer overall (adjusted relative risk 1.00, 95% CI 0.94-1.07) or in crude anatomical subsites among recipients of blood from precancerous donors compared with recipients of blood from non-cancerous donors. Interpretation Our data provide no evidence that blood transfusions from precancerous blood donors are associated with increased risk of cancer among recipients compared with transfusions from non-cancerous donors.	Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Clin Immunol & Transfus Med, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Med, Clin Epidemiol Unit, SE-17177 Stockholm, Sweden; Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; Odense Univ Hosp, Dept Clin Immunol, DK-5000 Odense, Denmark; Aarhus Univ Hosp, Dept Clin Immunol, DK-8000 Aarhus, Denmark; NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; NCI, Div Canc Control & Populat Sci, NIH, Bethesda, MD 20892 USA	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Statens Serum Institut; University of Southern Denmark; Odense University Hospital; Aarhus University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Nyren, O (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Box 281, SE-17177 Stockholm, Sweden.	olof.nyren@ki.se	Hjalgrim, Henrik/AAG-4973-2021; Adami, Johanna/AAA-3312-2021; Hernandez, Jessica/G-6527-2011; Edgren, Gustaf/F-4013-2014	Edgren, Gustaf/0000-0002-2198-4745; melbye, mads/0000-0001-8264-6785; Rostgaard, Klaus/0000-0001-6220-9414; Wikman, Agneta/0000-0002-8810-7974	NCI NIH HHS [N01-CP-21175] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adami J, 1997, ANN INTERN MED, V127, P365, DOI 10.7326/0003-4819-127-5-199709010-00004; Barozzi P, 2003, NAT MED, V9, P554, DOI 10.1038/nm862; Berg KD, 2001, NEW ENGL J MED, V345, P1458, DOI 10.1056/NEJMoa010041; BLOMBERG J, 1993, EUR J CANCER, V29A, P2101, DOI 10.1016/0959-8049(93)90042-E; Bodo I, 1999, NEW ENGL J MED, V341, P807, DOI 10.1056/NEJM199909093411105; Brandt L, 1996, BRIT J CANCER, V73, P1148, DOI 10.1038/bjc.1996.220; Buell Joseph F, 2004, Ann Transplant, V9, P53; Cerhan JR, 1997, J NATL CANCER I, V89, P314, DOI 10.1093/jnci/89.4.314; Cerhan JR, 2001, CANCER EPIDEM BIOMAR, V10, P361; CERHAN JR, 1993, ANN INTERN MED, V119, P8, DOI 10.7326/0003-4819-119-1-199307010-00002; Chow EJ, 2002, EPIDEMIOL REV, V24, P269, DOI 10.1093/epirev/mxf005; Chow EJ, 2002, AM J EPIDEMIOL, V155, P725, DOI 10.1093/aje/155.8.725; COMAN DR, 1951, CANCER RES, V11, P648; Edgren G, 2006, VOX SANG, V91, P316, DOI 10.1111/j.1423-0410.2006.00817.x; Ekstrom AM, 1999, JNCI-J NATL CANCER I, V91, P786, DOI 10.1093/jnci/91.9.786; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gartner HV, 1996, NEW ENGL J MED, V335, P1494, DOI 10.1056/NEJM199611143352004; GRAMEN K, 1928, ACTA CHIR SCAND, V64, P369; GREENWALD P, 1976, CANCER, V38, P324, DOI 10.1002/1097-0142(197607)38:1<324::AID-CNCR2820380147>3.0.CO;2-Q; GUGEL EA, 1986, NEW ENGL J MED, V315, P1487; Haque T, 1996, J GEN VIROL, V77, P1169, DOI 10.1099/0022-1317-77-6-1169; Hladik W, 2006, NEW ENGL J MED, V355, P1331, DOI 10.1056/NEJMoa055009; Kauffman HM, 2002, TRANSPLANTATION, V74, P358, DOI 10.1097/00007890-200208150-00011; Kleinman SH, 2000, BEST PRACT RES CL HA, V13, P631, DOI 10.1053/beha.2000.0104; LANMAN JT, 1950, BLOOD, V5, P1099, DOI 10.1182/blood.V5.12.1099.1099; Lee TH, 2005, TRANSFUSION, V45, P1280, DOI 10.1111/j.1537-2995.2005.00201.x; Lee TH, 1999, BLOOD, V93, P3127; Maguire-Boston EK, 1999, AM J EPIDEMIOL, V149, P1113; MEMON A, 1994, INT J CANCER, V58, P366, DOI 10.1002/ijc.2910580310; Racila E, 1998, P NATL ACAD SCI USA, V95, P4589, DOI 10.1073/pnas.95.8.4589; SCHIFFER CA, 1983, AM J HEMATOL, V15, P65, DOI 10.1002/ajh.2830150108; SOUTHAM C M, 1958, Bull N Y Acad Med, V34, P416; Storm HH, 1997, DAN MED BULL, V44, P535; THIERSCH JB, 1946, CANCER RES, V6, P695; THIERSCH JB, 1945, J LAB CLIN MED, V30, P866; Utter GH, 2004, J TRAUMA, V57, P702, DOI 10.1097/01.TA.0000140666.15972.37; Vamvakas EC, 2001, BLOOD, V97, P1180, DOI 10.1182/blood.V97.5.1180; WEISS L, 1992, CLIN EXP METASTAS, V10, P191, DOI 10.1007/BF00132751; Zhang YW, 2004, AM J EPIDEMIOL, V160, P325, DOI 10.1093/aje/kwh233	40	55	55	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 20	2007	369	9574					1724	1730		10.1016/S0140-6736(07)60779-X	http://dx.doi.org/10.1016/S0140-6736(07)60779-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	169ZT	17512857				2022-12-01	WOS:000246631300028
J	Schug, TT; Berry, DC; Shaw, NS; Travis, SN; Noy, N				Schug, Thaddeus T.; Berry, Daniel C.; Shaw, Natacha S.; Travis, Skylar N.; Noy, Noa			Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors	CELL			English	Article							BINDING PROTEIN-II; ACUTE-PROMYELOCYTIC-LEUKEMIA; TERATOCARCINOMA STEM-CELLS; BREAST-CANCER CELLS; MAMMARY-CARCINOMA; FATTY-ACIDS; SYMPATHETIC NEURONS; TARGET GENE; PPAR-BETA; E-FABP	Transcriptional activation of the nuclear receptor RAR by retinoic acid (RA) often leads to inhibition of cell growth. However, in some tissues, RA promotes cell survival and hyperplasia, activities that are unlikely to be mediated by RAR. Here, we show that, in addition to functioning through RAR, RA activates the "orphan" nuclear receptor PPAR beta/delta, which, in turn, induces the expression of prosurvival genes. Partitioning of RA between the two receptors is regulated by the intracellular lipid binding proteins CRABP-II and FABP5. These proteins specifically deliver RA from the cytosol to nuclear RAR and PPAR beta/delta, respectively, thereby selectively enhancing the transcriptional activity of their cognate receptors. Consequently, RA functions through RAR and is a proapoptotic agent in cells with high CRABP-II/FABP5 ratio, but it signals through PPAR beta/delta and promotes survival in cells that highly express FABP5. Opposing effects of RA on cell growth thus emanate from alternate activation of two different nuclear receptors.	Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA; Cornell Univ, Div Nutrit Sci, Ithaca, NY 14850 USA; Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University; Cornell University; Case Western Reserve University	Noy, N (corresponding author), Case Western Reserve Univ, Sch Med, 724 Biomed Res Bldg,10900 Euclid Ave, Cleveland, OH 44106 USA.	noa.noy@case.edu			NATIONAL CANCER INSTITUTE [R01CA068150, T32CA009682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060684, R01DK088969] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA009682, R01 CA068150-12, R01 CA068150, R01 CA68150, R01 CA068150-11, R01 CA068150-13, 5T32CA009682] Funding Source: Medline; NIDDK NIH HHS [R01 DK060684, R01 DK060684-05, R01 DK60684, R01 DK088969, R01 DK060684-06] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akagi K, 1997, NUCLEIC ACIDS RES, V25, P1766, DOI 10.1093/nar/25.9.1766; Allen GW, 2000, MOL BRAIN RES, V76, P315, DOI 10.1016/S0169-328X(00)00014-0; Altucci L, 2001, NAT MED, V7, P680, DOI 10.1038/89050; Brouard MC, 2002, MELANOMA RES, V12, P627, DOI 10.1097/00008390-200212000-00013; Bucco RA, 1997, BIOCHEMISTRY-US, V36, P4009, DOI 10.1021/bi962094o; Budhu AS, 2002, MOL CELL BIOL, V22, P2632, DOI 10.1128/MCB.22.8.2632-2641.2002; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chapellier B, 2002, EMBO J, V21, P3402, DOI 10.1093/emboj/cdf331; DeLeon M, 1996, J NEUROSCI RES, V44, P283; Di-Poi N, 2003, J STEROID BIOCHEM, V85, P257, DOI 10.1016/S0960-0760(03)00215-2; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Donato LJ, 2007, CANCER RES, V67, P609, DOI 10.1158/0008-5472.CAN-06-0989; Donato LJ, 2005, CANCER RES, V65, P8193, DOI 10.1158/0008-5472.CAN-05-1177; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; Guardavaccaro D, 2000, MOL CELL BIOL, V20, P1797, DOI 10.1128/MCB.20.5.1797-1815.2000; Gutierrez-Gonzalez LH, 2002, BIOCHEM J, V364, P725, DOI 10.1042/BJ20020039; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hanhoff T, 2002, MOL CELL BIOCHEM, V239, P45, DOI 10.1023/A:1020502624234; HENION PD, 1994, DEV BIOL, V161, P243, DOI 10.1006/dbio.1994.1024; Icre G, 2006, J INVEST DERM SYMP P, V11, P30, DOI 10.1038/sj.jidsymp.5650007; Jacobs S, 2006, P NATL ACAD SCI USA, V103, P3902, DOI 10.1073/pnas.0511294103; KANG SW, 1995, J INVEST DERMATOL, V105, P549, DOI 10.1111/1523-1747.ep12323445; Kawakubo H, 2004, ONCOGENE, V23, P8310, DOI 10.1038/sj.onc.1208008; Kawakubo H, 2006, CANCER RES, V66, P7075, DOI 10.1158/0008-5472.CAN-06-0379; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; Kitareewan S, 2002, P NATL ACAD SCI USA, V99, P3806, DOI 10.1073/pnas.052011299; KLEYWEGT GJ, 1994, STRUCTURE, V2, P1241, DOI 10.1016/S0969-2126(94)00125-1; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Laudet V., 2002, NUCL RECEPTOR FACTS; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; LIM RW, 1989, MOL CELL BIOL, V9, P1790, DOI 10.1128/MCB.9.4.1790; Liu Y, 2000, BRAIN RES, V852, P16, DOI 10.1016/S0006-8993(99)02158-7; Loudig O, 2000, MOL ENDOCRINOL, V14, P1483, DOI 10.1210/me.14.9.1483; Mangelsdorf David J., 1994, P319; Mangiarotti R, 1998, BRIT J CANCER, V77, P186, DOI 10.1038/bjc.1998.32; Manor D, 2003, CANCER RES, V63, P4426; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Norris AW, 2002, J LIPID RES, V43, P646; Park DJ, 1999, J CLIN INVEST, V103, P1399, DOI 10.1172/JCI2887; Plum LA, 2001, EXP BIOL MED, V226, P766, DOI 10.1177/153537020222600809; Rochette-Egly C, 2001, HISTOL HISTOPATHOL, V16, P909, DOI 10.14670/HH-16.909; RODRIGUEZTEBAR A, 1991, DEVELOPMENT, V112, P813; Schmuth M, 2004, J INVEST DERMATOL, V122, P971, DOI 10.1111/j.0022-202X.2004.22412.x; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; Soprano DR, 2004, ANNU REV NUTR, V24, P201, DOI 10.1146/annurev.nutr.24.012003.132407; STRICKLAND S, 1978, CELL, V15, P393, DOI 10.1016/0092-8674(78)90008-9; STRICKLAND S, 1980, CELL, V21, P347, DOI 10.1016/0092-8674(80)90471-7; Sussman F, 2005, J MED CHEM, V48, P6212, DOI 10.1021/jm050285w; Tan NS, 2004, EXPERT OPIN THER TAR, V8, P39, DOI 10.1517/eott.8.1.39.26404; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Tan NS, 2001, GENE DEV, V15, P3263, DOI 10.1101/gad.207501; Tari AM, 2002, ONCOGENE, V21, P5224, DOI 10.1038/sj.onc.1205660; Toma S, 1998, ANTICANCER RES, V18, P935; VEERKAMP JH, 1995, PROG LIPID RES, V34, P17, DOI 10.1016/0163-7827(94)00005-7; VERMA AK, 1982, CANCER RES, V42, P3519; White JA, 1996, J BIOL CHEM, V271, P29922, DOI 10.1074/jbc.271.47.29922; Widstrom RL, 2001, BIOCHEMISTRY-US, V40, P1070, DOI 10.1021/bi001602y; WOLBACH SB, 1978, NUTR REV, V36, P16; WUARIN L, 1990, INT J DEV NEUROSCI, V8, P317, DOI 10.1016/0736-5748(90)90038-4; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Zouboulis CC, 2001, SKIN PHARMACOL APPL, V14, P303, DOI 10.1159/000056361	63	497	521	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2007	129	4					723	733		10.1016/j.cell.2007.02.050	http://dx.doi.org/10.1016/j.cell.2007.02.050			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512406	Bronze, Green Accepted			2022-12-01	WOS:000246788300017
J	Tuffs, A				Tuffs, Annette			Medicine and the media - Thalidomide: the true story?	BRITISH MEDICAL JOURNAL			English	Editorial Material												ATuffs@web.de							0	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 5	2007	334	7600					933	933		10.1136/bmj.39199.637986.59	http://dx.doi.org/10.1136/bmj.39199.637986.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165YN	17478844	Green Published			2022-12-01	WOS:000246343800035
J	Roberson, ED; Scearce-Levie, K; Palop, JJ; Yan, FR; Cheng, IH; Wu, T; Gerstein, H; Yu, GQ; Mucke, L				Roberson, Erik D.; Scearce-Levie, Kimberly; Palop, Jorge J.; Yan, Fengrong; Cheng, Irene H.; Wu, Tiffany; Gerstein, Hilary; Yu, Gui-Qiu; Mucke, Lennart			Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model	SCIENCE			English	Article							TRANSGENIC MICE; PROTEIN; EXPRESSION; NEURODEGENERATION; SYNAPTOTOXICITY; PERSPECTIVE; INHIBITION; HYPOTHESIS; CLEARANCE; NEURONS	Many potential treatments for Alzheimer's disease target amyloid-beta peptides (A beta), which are widely presumed to cause the disease. The microtubule-associated protein tau is also involved in the disease, but it is unclear whether treatments aimed at tau could block A beta-induced cognitive impairments. Here, we found that reducing endogenous tau levels prevented behavioral deficits in transgenic mice expressing human amyloid precursor protein, without altering their high A beta levels. Tau reduction also protected both transgenic and nontransgenic mice against excitotoxicity. Thus, tau reduction can block A beta- and excitotoxin-induced neuronal dysfunction and may represent an effective strategy for treating Alzheimer's disease and related conditions.	Gladstone Inst Neurol Sci, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Roberson, ED (corresponding author), Gladstone Inst Neurol Sci, San Francisco, CA 94158 USA.	eroberson@gladstone.ucsf.edu; lmucke@gladstone.ucsf.edu	Palop, Jorge J./D-8128-2011; Palop, Jorge/AAH-9014-2020; Gerstein, Hertzel C/B-1235-2013; Roberson, Erik/A-5718-2009	Gerstein, Hertzel C/0000-0001-8072-2836; Roberson, Erik/0000-0002-1810-9763; Palop, Jorge/0000-0001-6086-1070; Wu, Tiffany/0000-0002-9273-0574	NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH070588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS054811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011385, R37AG011385, P01AG022074] Funding Source: NIH RePORTER; NCRR NIH HHS [RR18928-01] Funding Source: Medline; NIA NIH HHS [AG022074, AG011385] Funding Source: Medline; NIMH NIH HHS [MH070588] Funding Source: Medline; NINDS NIH HHS [K08 NS054811-02, NS054811, K08 NS054811] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; Chin J, 2004, J NEUROSCI, V24, P4692, DOI 10.1523/JNEUROSCI.0277-04.2004; Dawson HN, 2001, J CELL SCI, V114, P1179; Del Vecchio RA, 2004, NEUROSCI LETT, V367, P164, DOI 10.1016/j.neulet.2004.05.107; Dickey CA, 2006, FASEB J, V20, P753, DOI 10.1096/fj.05-5343fje; GEDDES JW, 1985, SCIENCE, V230, P1179, DOI 10.1126/science.4071042; Gong CX, 2005, J NEURAL TRANSM, V112, P813, DOI 10.1007/s00702-004-0221-0; Holsboer Florian, 2003, Curr Opin Investig Drugs, V4, P46; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; Knowles RB, 1999, P NATL ACAD SCI USA, V96, P5274, DOI 10.1073/pnas.96.9.5274; Kobayashi DT, 2005, GENES BRAIN BEHAV, V4, P173, DOI 10.1111/j.1601-183X.2005.00124.x; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Liu TB, 2004, J NEUROCHEM, V88, P554, DOI 10.1046/j.1471-4159.2003.02196.x; Lupski JR, 2006, NAT GENET, V38, P974, DOI 10.1038/ng0906-974; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Myers AJ, 2005, HUM MOL GENET, V14, P2399, DOI 10.1093/hmg/ddi241; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Olney JW, 1997, ARCH NEUROL-CHICAGO, V54, P1234, DOI 10.1001/archneur.1997.00550220042012; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Park SY, 2005, J NEUROSCI, V25, P5365, DOI 10.1523/JNEUROSCI.1125-05.2005; Planel E, 2004, J NEUROSCI, V24, P2401, DOI 10.1523/JNEUROSCI.5561-03.2004; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; STEWARD O, 1977, BRAIN RES BULL, V2, P41, DOI 10.1016/0361-9230(77)90023-5; Stoothoff WH, 2005, BBA-MOL BASIS DIS, V1739, P280, DOI 10.1016/j.bbadis.2004.06.017; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008	31	1422	1495	2	184	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2007	316	5825					750	754		10.1126/science.1141736	http://dx.doi.org/10.1126/science.1141736			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17478722				2022-12-01	WOS:000246181400048
J	Mehta, DK; Aronson, JK				Mehta, Dinesh K.; Aronson, Jeffrey K.			Give a drug a good name	LANCET			English	Editorial Material									Royal Pharmaceut Soc Great Britain, London SE1 7JN, England; Univ Oxford, Dept Clin Pharmacol, Oxford, England	University of Oxford	Mehta, DK (corresponding author), Royal Pharmaceut Soc Great Britain, London SE1 7JN, England.	dmehta@bnf.org						Aronson J, 2004, BRIT J GEN PRACT, V54, P559; Aronson Jeffrey K, 2004, Expert Opin Drug Saf, V3, P167; Aronson JK, 2000, BMJ-BRIT MED J, V320, P506, DOI 10.1136/bmj.320.7233.506; SASHKOVA G, 2004, WHO DRUG INFO, V18, P123; 2002, WHO DRUG INFO, V16, P194; 1965, WHO CHRONICLE, V19, P446	6	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2007	369	9570					1326	1328		10.1016/S0140-6736(07)60612-6	http://dx.doi.org/10.1016/S0140-6736(07)60612-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	159HL	17448803				2022-12-01	WOS:000245856100008
J	Clapham, DE				Clapham, David E.			SnapShot; Mammalian TRP channels	CELL			English	Editorial Material									Harvard Univ, Sch Med, Dept Neurobiol, Childrens Hosp, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Clapham, DE (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Childrens Hosp, HHMI, Boston, MA 02115 USA.		Clapham, David/S-1123-2019; Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428; 					0	108	121	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					220	220		10.1016/j.cell.2007.03.034	http://dx.doi.org/10.1016/j.cell.2007.03.034			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418797	Bronze			2022-12-01	WOS:000245661100023
J	Bautista, DM; Siemens, J; Glazer, JM; Tsuruda, PR; Basbaum, AI; Stucky, CL; Jordt, SE; Julius, D				Bautista, Diana M.; Siemens, Jan; Glazer, Joshua M.; Tsuruda, Pamela R.; Basbaum, Allan I.; Stucky, Cheryl L.; Jordt, Sven-Eric; Julius, David			The menthol receptor TRPM8 is the principal detector of environmental cold	NATURE			English	Article							PRIMARY SENSORY NEURONS; ION-CHANNEL TRPA1; MOLECULAR LOGIC; TRANSDUCTION; SKIN; THERMOSENSATION; TEMPERATURE; SENSATION; STIMULI; ANKTM1	Sensory nerve fibres can detect changes in temperature over a remarkably wide range, a process that has been proposed to involve direct activation of thermosensitive excitatory transient receptor potential (TRP) ion channels(1-4). One such channel TRP melastatin 8 (TRPM8) or cold and menthol receptor 1 (CMR1)-is activated by chemical cooling agents (such as menthol) or when ambient temperatures drop below similar to 26 degrees C, suggesting that it mediates the detection of cold thermal stimuli by primary afferent sensory neurons(5,6). However, some studies have questioned the contribution of TRPM8 to cold detection or proposed that other excitatory or inhibitory channels are more critical to this sensory modality in vivo(7-10). Here we show that cultured sensory neurons and intact sensory nerve fibres from TRPM8-deficient mice exhibit profoundly diminished responses to cold. These animals also show clear behavioural deficits in their ability to discriminate between cold and warm surfaces, or to respond to evaporative cooling. At the same time, TRPM8 mutant mice are not completely insensitive to cold as they avoid contact with surfaces below 10 degrees C, albeit with reduced efficiency. Thus, our findings demonstrate an essential and predominant role for TRPM8 in thermosensation over a wide range of cold temperatures, validating the hypothesis(2) that TRP channels are the principal sensors of thermal stimuli in the peripheral nervous system.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat & Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Medical College of Wisconsin; Yale University	Julius, D (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.	cstucky@mcw.edu; sven.jordt@yale.edu; julius@cmp.ucsf.edu	Jordt, Sven-Eric/ABE-6517-2020	Jordt, Sven-Eric/0000-0001-6171-5622; Siemens, Jan/0000-0001-9051-9217	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015056] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01 ES015056] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Askwith CC, 2001, P NATL ACAD SCI USA, V98, P6459, DOI 10.1073/pnas.111155398; Babes A, 2006, EUR J NEUROSCI, V24, P691, DOI 10.1111/j.1460-9568.2006.04941.x; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; DOERNER JF, 2007, J BIOL CHEM; FRUHSTORFER H, 1983, PAIN, V17, P235, DOI 10.1016/0304-3959(83)90096-9; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; HENSEL H, 1951, ACTA PHYSIOL SCAND, V24, P27, DOI 10.1111/j.1748-1716.1951.tb00824.x; IGGO A, 1969, J PHYSIOL-LONDON, V200, P403, DOI 10.1113/jphysiol.1969.sp008701; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; KREH A, 1984, EXP NEUROL, V85, P533, DOI 10.1016/0014-4886(84)90029-3; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Madrid R, 2006, J NEUROSCI, V26, P12512, DOI 10.1523/JNEUROSCI.3752-06.2006; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; McKemy DD, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-16; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; PIERAU FK, 1974, BRAIN RES, V73, P156, DOI 10.1016/0006-8993(74)91015-4; Rainville P, 1999, EXP BRAIN RES, V125, P28, DOI 10.1007/s002210050654; Reid G, 2005, PFLUG ARCH EUR J PHY, V451, P250, DOI 10.1007/s00424-005-1437-z; Reid G, 2001, NATURE, V413, P480, DOI 10.1038/35097164; Reid G, 2001, NEUROSCI LETT, V297, P171, DOI 10.1016/S0304-3940(00)01694-3; SCHAFER K, 1988, PFLUG ARCH EUR J PHY, V412, P188, DOI 10.1007/BF00583749; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Stucky CL, 1999, J NEUROSCI, V19, P8509; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	32	845	874	3	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2007	448	7150					204	208		10.1038/nature05910	http://dx.doi.org/10.1038/nature05910			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188QN	17538622				2022-12-01	WOS:000247934500045
J	Vassylyev, DG; Vassylyeva, MN; Perederina, A; Tahirov, TH; Artsimovitch, I				Vassylyev, Dmitry G.; Vassylyeva, Marina N.; Perederina, Anna; Tahirov, Tahir H.; Artsimovitch, Irina			Structural basis for transcription elongation by bacterial RNA polymerase	NATURE			English	Article							3.3 ANGSTROM RESOLUTION; ELECTRON-DENSITY MAPS; THERMUS-THERMOPHILUS; CRYSTAL-STRUCTURE; LID ELEMENT; DNA HYBRID; COMPLEX; MECHANISM; TRANSLOCATION; INITIATION	The RNA polymerase elongation complex (EC) is both highly stable and processive, rapidly extending RNA chains for thousands of nucleotides. Understanding the mechanisms of elongation and its regulation requires detailed information about the structural organization of the EC. Here we report the 2.5-angstrom resolution structure of the Thermus thermophilus EC; the structure reveals the post-translocated intermediate with the DNA template in the active site available for pairing with the substrate. DNA strand separation occurs one position downstream of the active site, implying that only one substrate at a time can specifically bind to the EC. The upstream edge of the RNA/DNA hybrid stacks on the beta'-subunit 'lid' loop, whereas the first displaced RNA base is trapped within a protein pocket, suggesting a mechanism for RNA displacement. The RNA is threaded through the RNA exit channel, where it adopts a conformation mimicking that of a single strand within a double helix, providing insight into a mechanism for hairpin-dependent pausing and termination.	Univ Alabama Birmingham, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Sch Dent, Birmingham, AL 35294 USA; Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Lied Transplant Ctr, Omaha, NE 68198 USA; Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Nebraska System; University of Nebraska Medical Center; University System of Ohio; Ohio State University	Vassylyev, DG (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Biochem & Mol Genet, 402B Kaul Genet Bldg,720 20th St S, Birmingham, AL 35294 USA.	dmitry@uab.edu	Ganesh, Dunna Sai/AGX-5170-2022; Vassylyev, Dmitry/A-9005-2008; Artsimovitch, Irina/L-3467-2019	Tahirov, Tahir/0000-0002-1238-0069				Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; ARCHAMBAULT J, 1993, MICROBIOL REV, V57, P703, DOI 10.1128/MMBR.57.3.703-724.1993; Artsimovitch I, 1998, GENE DEV, V12, P3110, DOI 10.1101/gad.12.19.3110; BAKER D, 1993, ACTA CRYSTALLOGR D, V49, P429, DOI 10.1107/S0907444993004032; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Chlenov M, 2005, J MOL BIOL, V353, P138, DOI 10.1016/j.jmb.2005.07.073; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Foster JE, 2001, CELL, V106, P243, DOI 10.1016/S0092-8674(01)00420-2; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gong XQ, 2005, MOL CELL, V18, P461, DOI 10.1016/j.molcel.2005.04.011; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Huang JB, 2000, BIOCHEMISTRY-US, V39, P11571, DOI 10.1021/bi000579d; Jiang ML, 2004, MOL CELL, V15, P777, DOI 10.1016/j.molcel.2004.07.019; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kashkina E, 2006, NUCLEIC ACIDS RES, V34, P4036, DOI 10.1093/nar/gkl559; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuznedelov K, 2002, EMBO J, V21, P1369, DOI 10.1093/emboj/21.6.1369; Landick R, 2005, TRENDS BIOCHEM SCI, V30, P651, DOI 10.1016/j.tibs.2005.10.001; MATTHEWS BW, 1975, ACTA CRYSTALLOGR A, V31, P480, DOI 10.1107/S0567739475001040; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mooney RA, 2005, MOL CELL, V20, P335, DOI 10.1016/j.molcel.2005.10.015; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; Naryshkina T, 2006, J MOL BIOL, V361, P634, DOI 10.1016/j.jmb.2006.05.034; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Santangelo TJ, 2004, MOL CELL, V14, P117, DOI 10.1016/S1097-2765(04)00154-6; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Toulokhonov I, 2006, J MOL BIOL, V361, P644, DOI 10.1016/j.jmb.2006.06.071; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; VASSYLYEV DG, 1995, CELL, V83, P773, DOI 10.1016/0092-8674(95)90190-6; Vassylyeva MN, 2002, ACTA CRYSTALLOGR D, V58, P1497, DOI 10.1107/S0907444902011770; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Wang JH, 1996, ACTA CRYSTALLOGR D, V52, P369, DOI 10.1107/S0907444995012352; Weeks CM, 1999, ACTA CRYSTALLOGR D, V55, P492, DOI 10.1107/S0907444998012633; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; Yeates TO, 1997, METHOD ENZYMOL, V276, P344, DOI 10.1016/S0076-6879(97)76068-3; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	50	318	330	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2007	448	7150					157	U3		10.1038/nature05932	http://dx.doi.org/10.1038/nature05932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188QN	17581590				2022-12-01	WOS:000247934500034
J	Ruby, JG; Jan, CH; Bartel, DP				Ruby, J. Graham; Jan, Calvin H.; Bartel, David P.			Intronic microRNA precursors that bypass Drosha processing	NATURE			English	Article							GENOME; RNAS; MATURATION; SEQUENCE; GENE	MicroRNAs ( miRNAs) are similar to 22-nucleotide endogenous RNAs that often repress the expression of complementary messenger RNAs1. In animals, miRNAs derive from characteristic hairpins in primary transcripts through two sequential RNase III-mediated cleavages; Drosha cleaves near the base of the stem to liberate a similar to 60-nucleotide pre-miRNA hairpin, then Dicer cleaves near the loop to generate a miRNA: miRNA* duplex(2,3). From that duplex, the mature miRNA is incorporated into the silencing complex. Here we identify an alternative pathway for miRNA biogenesis, in which certain debranched introns mimic the structural features of pre-miRNAs to enter the miRNA-processing pathway without Drosha-mediated cleavage. We call these pre-miRNAs/introns 'mirtrons', and have identified 14 mirtrons in Drosophila melanogaster and another four in Caenorhabditis elegans ( including the reclassification of mir-62). Some of these have been selectively maintained during evolution with patterns of sequence conservation suggesting important regulatory functions in the animal. The abundance of introns comparable in size to pre-miRNAs appears to have created a context favourable for the emergence of mirtrons in flies and nematodes. This suggests that other lineages with many similarly sized introns probably also have mirtrons, and that the mirtron pathway could have provided an early avenue for the emergence of miRNAs before the advent of Drosha.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Bartel, DP (corresponding author), MIT, Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu			NIGMS NIH HHS [R01 GM067031, R01 GM067031-04] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067031] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Dorner S, 2006, P NATL ACAD SCI USA, V103, P11880, DOI 10.1073/pnas.0605210103; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Grumbling G, 2006, NUCLEIC ACIDS RES, V34, pD484, DOI 10.1093/nar/gkj068; Han J, 2001, DRUG DELIV, V8, P125; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; LEVERETTE RD, 1992, CELL, V71, P1215, DOI 10.1016/S0092-8674(05)80069-8; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lim LP, 2001, P NATL ACAD SCI USA, V98, P11193, DOI 10.1073/pnas.201407298; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; LO PCH, 1994, GENETICS, V138, P365; PADGETT RA, 1984, SCIENCE, V225, P898, DOI 10.1126/science.6206566; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; RUBY JG, IN PRESS GENOME RES; RUSKIN B, 1985, SCIENCE, V229, P135, DOI 10.1126/science.2990042; Stein L, 2001, NUCLEIC ACIDS RES, V29, P82, DOI 10.1093/nar/29.1.82; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Yandell M, 2006, PLOS COMPUT BIOL, V2, P113, DOI 10.1371/journal.pcbi.0020015	30	1027	1123	2	86	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 5	2007	448	7149					83	86		10.1038/nature05983	http://dx.doi.org/10.1038/nature05983			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185OS	17589500	Green Accepted			2022-12-01	WOS:000247720900042
J	Wilson, JF				Wilson, Jennifer Fisher			Strategies to stop abuse of prescribed opioid drugs	ANNALS OF INTERNAL MEDICINE			English	News Item							CHRONIC PAIN; ASSOCIATION; DISORDERS					jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				Gourlay DL, 2005, PAIN MED, V6, P107, DOI 10.1111/j.1526-4637.2005.05031.x; GOURLAY DL, 2004, DRUG TESTING CLIN PR, P4349; Hariharan J, 2007, J GEN INTERN MED, V22, P485, DOI 10.1007/s11606-006-0084-1; Ives TJ, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-46; Martell BA, 2007, ANN INTERN MED, V146, P116, DOI 10.7326/0003-4819-146-2-200701160-00006; Sullivan MD, 2006, ARCH INTERN MED, V166, P2087, DOI 10.1001/archinte.166.19.2087; Sullivan MD, 2005, PAIN, V119, P95, DOI 10.1016/j.pain.2005.09.020; Turk DC, 2002, CLIN J PAIN, V18, P355, DOI 10.1097/00002508-200211000-00003; Webster LR, 2005, PAIN MED, V6, P432, DOI 10.1111/j.1526-4637.2005.00072.x	9	10	10	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 19	2007	146	12					897	900		10.7326/0003-4819-146-12-200706190-00017	http://dx.doi.org/10.7326/0003-4819-146-12-200706190-00017			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180FF	17577013				2022-12-01	WOS:000247347100013
J	Gartner, CE; Hall, WD; Vos, T; Bertram, MY; Wallace, AL; Lim, SS				Gartner, Coral E.; Hall, Wayne D.; Vos, Theo; Bertram, Melanie Y.; Wallace, Angela L.; Lim, Stephen S.			Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study	LANCET			English	Article							CIGARETTE-SMOKING; UNITED-STATES; CESSATION; PRODUCT; DEATHS; ADULTS; HEALTH; PANEL	Background Swedish snus is a smokeless tobacco product that has been suggested as a tobacco harm reduction product. Our aim was to assess the potential population health effects of snus. Methods We assessed the potential population health effects of snus in Australia with multistate life tables to estimate the difference in health-adjusted life expectancy between people who have never been smokers and various trajectories of tobacco use, including switching from smoking to snus use; and the potential for net population-level harm given different rates of snus uptake by current smokers, ex-smokers, and people who have never smoked. Findings There was little difference in health-adjusted life expectancy between smokers who quit all tobacco and smokers who switch to snus (difference of 0.1-0.3 years for men and 0.1-0.4 years for women). For net harm to occur, 14-25 ex-smokers would have to start using snus to offset the health gain from every smoker who switched to snus rather than continuing to smoke. Likewise, 14-25 people who have never smoked would need to start using snus to offset the health gain from every new tobacco user who used snus rather than smoking. Interpretation Current smokers who switch to using snus rather than continuing to smoke can realise substantial health gains. Snus could produce a net benefit to health at the population level if it is adopted in sufficient numbers by inveterate smokers. Relaxing current restrictions on the sale of snus is more likely to produce a net benefit than harm, with the size of the benefit dependent on how many inveterate smokers switch to snus.	Univ Queensland, Sch Populat Hlth, Herston, Qld 4006, Australia	University of Queensland	Hall, WD (corresponding author), Univ Queensland, Sch Populat Hlth, Publ Hlth Bldg,Herston Rd, Herston, Qld 4006, Australia.	w.hall@sph.uq.edu.au	Lim, Stephen S/B-4055-2012; Hall, Wayne D/A-3283-2008; Gartner, Coral/F-7306-2010; Vos, Theo/F-3324-2010	Hall, Wayne D/0000-0003-1984-0096; Gartner, Coral/0000-0002-6651-8035; 				Accortt NA, 2002, AM J EPIDEMIOL, V156, P730, DOI 10.1093/aje/kwf106; AIHW, 2004, AIHW DRUG STAT SER, V16; *AM CANC SOC, 1998, CANC PREV STUD, V2; BEGG S, 2004, BURDEN DIS INJURY AU; BERTRAM MY, IN PRESS TOB CONTROL; CHAPMAN S, 2007, PUBLIC HLTH ADVOCACY, pCH4; Ezzati M, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P241; FIORE MC, 1990, JAMA-J AM MED ASSOC, V263, P2760, DOI 10.1001/jama.263.20.2760; Foulds J, 2003, TOB CONTROL, V12, P349, DOI 10.1136/tc.12.4.349; Gray N, 2006, LANCET, V368, P899, DOI 10.1016/S0140-6736(06)69349-5; Hall WD, 2005, INT J DRUG POLICY, V16, P139, DOI 10.1016/j.drugpo.2005.04.002; Hill DJ, 1998, MED J AUSTRALIA, V168, P209, DOI 10.5694/j.1326-5377.1998.tb140132.x; Jamrozik K, 2005, BRIT MED J, V330, P812, DOI 10.1136/bmj.38370.496632.8F; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Kozlowski LT, 2001, TOB CONTROL, V10, P201, DOI 10.1136/tc.10.3.201; Kozlowski LT, 1998, AM J PREV MED, V15, P9, DOI 10.1016/S0749-3797(98)00004-X; Levy DT, 2006, ADDICT BEHAV, V31, P1190, DOI 10.1016/j.addbeh.2005.09.010; Levy DT, 2004, CANCER EPIDEM BIOMAR, V13, P2035; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; O'Connor RJ, 2005, ADDICT BEHAV, V30, P325, DOI 10.1016/j.addbeh.2004.05.020; PETO R, 2000, CRITICAL ISSUES GLOB; Ramstrom LM, 2006, TOB CONTROL, V15, P210, DOI 10.1136/tc.2005.014969; RODU B, 1994, AM J MED SCI, V308, P32, DOI 10.1097/00000441-199407000-00007; Rodu Brad, 2006, Harm Reduct J, V3, P37, DOI 10.1186/1477-7517-3-37; Stratton K, 2001, CLEARING SMOKE ASSES; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; SULLIVAN DF, 1971, HSMHA HEALTH REP, V86, P347, DOI 10.2307/4594169; Thun MJ, 2000, JAMA-J AM MED ASSOC, V284, P706, DOI 10.1001/jama.284.6.706; TREWIN D, 2003, 13010 ABS; WOOLACOTT NF, 2002, HLTH TECHNOL ASSESS, V6	30	114	117	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 16	2007	369	9578					2010	2014		10.1016/S0140-6736(07)60677-1	http://dx.doi.org/10.1016/S0140-6736(07)60677-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180HT	17498798				2022-12-01	WOS:000247354400024
J	Bilic, J; Huang, YL; Davidson, G; Zimmermann, T; Cruciat, CM; Bienz, M; Niehrs, C				Bilic, Josipa; Huang, Ya-Lin; Davidson, Gary; Zimmermann, Timo; Cruciat, Cristina-Maria; Bienz, Mariann; Niehrs, Christof			Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation	SCIENCE			English	Article							RECEPTOR-RELATED PROTEIN-5; SIGNALING PATHWAY; PLASMA-MEMBRANE; DIX DOMAIN; AXIN; POLARITY; ENCODES	Multiple signaling pathways, including Wnt signaling, participate in animal development, stem cell biology, and human cancer. Although many components of the Wnt pathway have been identified, unresolved questions remain as to the mechanism by which Wnt binding to its receptors Frizzled and Low-density lipoprotein receptor-related protein 6 (LRP6) triggers downstream signaling events. With live imaging of vertebrate cells, we show that Wnt treatment quickly induces plasma membrane-associated LRP6 aggregates. LRP6 aggregates are phosphorylated and can be detergent-solubilized as ribosome-sized multiprotein complexes. Phospho-LRP6 aggregates contain Wnt-pathway components but no common vesicular traffic markers except caveolin. The scaffold protein Dishevelled (Dvl) is required for LRP6 phosphorylation and aggregation. We propose that Wnts induce coclustering of receptors and Dvl in LRP6-signalosomes, which in turn triggers LRP6 phosphorylation to promote Axin recruitment and beta-catenin stabilization.	Deutsch Krebsforschungszentrum, Div Mol Embryol, D-69120 Heidelberg, Germany; European Mol Biol Lab, Adv Light Microscopy Facil, D-69117 Heidelberg, Germany; MRC, Mol Biol Lab, Cambridge C82 2QH, England	Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL); MRC Laboratory Molecular Biology	Niehrs, C (corresponding author), Deutsch Krebsforschungszentrum, Div Mol Embryol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	Niehrs@DKFZ-Heidelberg.DE	Davidson, Gary/J-6059-2013; Davidson, Gary/AAA-7321-2021; Zimmermann, Timo/G-1681-2015	Davidson, Gary/0000-0002-2264-5518; Zimmermann, Timo/0000-0001-7098-0700; Huang, Ya-Lin/0000-0002-4965-7543; Bilic Zimmermann, Josipa/0000-0001-9642-6265	MRC [MC_U105184273] Funding Source: UKRI; Medical Research Council [MC_U105184273, MC_U105192713] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056; Cliffe A, 2003, CURR BIOL, V13, P960, DOI 10.1016/S0960-9822(03)00370-1; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Itoh Keiji, 2005, J Biol, V4, P3, DOI 10.1186/jbiol20; Kishida S, 1999, MOL CELL BIOL, V19, P4414; KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118; Li L, 2002, J BIOL CHEM, V277, P5977, DOI 10.1074/jbc.M111131200; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Malbon CC, 2006, CURR TOP DEV BIOL, V72, P153, DOI 10.1016/S0070-2153(05)72002-0; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Polakis P, 2000, GENE DEV, V14, P1837; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Smalley MJ, 2005, J CELL SCI, V118, P5279, DOI 10.1242/jcs.02647; Tolwinski NS, 2004, TRENDS GENET, V20, P177, DOI 10.1016/j.tig.2004.02.003; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Weaver C, 2004, DEVELOPMENT, V131, P3491, DOI 10.1242/dev.01284; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	27	651	674	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1619	1622		10.1126/science.1137065	http://dx.doi.org/10.1126/science.1137065			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569865				2022-12-01	WOS:000247239900042
J	Hao, X				Hao, Xin			Monkey research in China: Developing a natural resource	CELL			English	Editorial Material								China's contribution to primate research is no longer limited to supplying monkeys to scientists abroad. With an abundance of wild rhesus macaques, low labor costs, and a nonhostile environment for animal research, scientists are finding that China is the place to be for research using macaques as models of human disease.											0	14	15	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2007	129	6					1033	1036		10.1016/j.cell.2007.05.051	http://dx.doi.org/10.1016/j.cell.2007.05.051			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574013	Bronze			2022-12-01	WOS:000247390400004
J	Imura, A; Tsuji, Y; Murata, M; Maeda, R; Kubota, K; Iwano, A; Obuse, C; Togashi, K; Tominaga, M; Kita, N; Tomiyama, K; Iijima, J; Nabeshima, Y; Fujioka, M; Asato, R; Tanaka, S; Kojima, K; Ito, J; Nozaki, K; Hashimoto, N; Ito, T; Nishio, T; Uchiyama, T; Fujimori, T; Nabeshima, YI				Imura, Akihiro; Tsuji, Yoshihito; Murata, Miyahiko; Maeda, Ryota; Kubota, Koji; Iwano, Akiko; Obuse, Chikashi; Togashi, Kazuya; Tominaga, Makoto; Kita, Naoko; Tomiyama, Ken-ichi; Iijima, Junko; Nabeshima, Yoko; Fujioka, Makio; Asato, Ryo; Tanaka, Shinzo; Kojima, Ken; Ito, Juichi; Nozaki, Kazuhiko; Hashimoto, Nobuo; Ito, Tetsufumi; Nishio, Takeshi; Uchiyama, Takashi; Fujimori, Toshihiko; Nabeshima, Yo-ichi			alpha-klotho as a regulator of calcium homeostasis	SCIENCE			English	Article							MICE; NA,K-ATPASE; GENE; EXPRESSION; CELLS; SUPPRESSION; ACTIVATION; NA,K-PUMP; RECEPTOR; PROTEIN	alpha-klotho was identified as a gene associated with premature aging-like phenotypes characterized by short lifespan. In mice, we found the molecular association of alpha-Klotho (alpha-Kl) and Na+, K+-adenosine triphosphatase (Na+, K+-ATPase) and provide evidence for an increase of abundance of Na+, K+-ATPase at the plasma membrane. Low concentrations of extracellular free calcium ([Ca2+](e)) rapidly induce regulated parathyroid hormone (PTH) secretion in an alpha-Kl- and Na+, K+-ATPase-dependent manner. The increased Na+ gradient created by Na+, K+-ATPase activity might drive the transepithelial transport of Ca2+ in cooperation with ion channels and transporters in the choroid plexus and the kidney. Our findings reveal fundamental roles of alpha-Kl in the regulation of calcium metabolism.	Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Horizontal Med Res Org, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Ctr Electron Microscopy, Kyoto 6068501, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Saitama 3320012, Japan; Hokkaido Univ, Grad Sch Life Sci, Lab Funct Networks Chromosome Inheritance, Sapporo, Hokkaido 0010021, Japan; Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Sect Cell Signaling, Aichi 4448787, Japan; Univ Fukui, Fac Med Sci, Dept Anat, Fukui 9101193, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); Hokkaido University; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); University of Fukui	Nabeshima, YI (corresponding author), Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto 6068501, Japan.	nabemr@lmls.med.kyoto-u.ac.jp	伊藤, 哲史/D-4275-2016; Fujimori, Toshihiko/L-7711-2016; Ito, Tetsufumi/M-2668-2019; Obuse, Chikashi/F-5273-2011	伊藤, 哲史/0000-0003-4516-9283; Fujimori, Toshihiko/0000-0001-5200-4634; Ito, Tetsufumi/0000-0003-4516-9283; Maeda, Ryota/0000-0002-1514-1071				BILEZIKIAN JP, 2005, PARATHYROIDS BASIC C; BRINGHURST FR, 2003, WILLIAMS TXB ENDOCRI; BROWN EM, 1987, METABOLISM, V36, P36, DOI 10.1016/0026-0495(87)90060-6; CAPLAN MJ, 1990, J BIOL CHEM, V265, P3528; GEERING K, 1991, FEBS LETT, V285, P189, DOI 10.1016/0014-5793(91)80801-9; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; HOOTMAN SR, 1988, METHOD ENZYMOL, V156, P213; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Ito S, 2000, MECH DEVELOP, V98, P115, DOI 10.1016/S0925-4773(00)00439-1; Ito S, 2005, J CLIN INVEST, V115, P2202, DOI 10.1172/JCI23076; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; MURPHY VA, 1989, BRAIN RES, V484, P65, DOI 10.1016/0006-8993(89)90348-X; NABESHIMA Y, 2006, SCI AGING KNOWLEDGE, DOI DOI 10.1126/SAGEKE.2006.8.PE11; Razzaque MS, 2006, FASEB J, V20, P720, DOI 10.1096/fj.05-5432fje; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; SKOU JC, 1992, J BIOENERG BIOMEMBR, V24, P249; SKOU JC, 1988, METHOD ENZYMOL, V156, P1; Somjen GG, 2002, NEUROSCIENTIST, V8, P254, DOI 10.1177/1073858402008003011; Takeshita K, 2004, CIRCULATION, V109, P1776, DOI 10.1161/01.CIR.0000124224.48962.32; Tominaga M, 2004, J NEUROBIOL, V61, P3, DOI 10.1002/neu.20079; Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Yoshida T, 2002, ENDOCRINOLOGY, V143, P683, DOI 10.1210/en.143.2.683	27	317	337	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1615	1618		10.1126/science.1135901	http://dx.doi.org/10.1126/science.1135901			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569864				2022-12-01	WOS:000247239900041
J	Mizuguchi, G; Xiao, H; Wisniewski, J; Smith, MM; Wu, C				Mizuguchi, Gaku; Xiao, Hua; Wisniewski, Jan; Smith, M. Mitchell; Wu, Carl			Nonhistone Scm3 and histones CenH3-H4 assemble the core of centromere-specific nucleosomes	CELL			English	Article							A CENP-A; BUDDING YEAST; KINETOCHORE COMPLEX; CHROMATIN; PROTEIN; DNA; CSE4P; H3; EPIGENETICS; COMPONENT	The budding yeast histone H3 variant, Cse4, replaces conventional histone H3 in centromeric chromatin and, together with centromere-specific DNA-binding factors, directs assembly of the kinetochore, a multiprotein complex mediating chromosome segregation. We have identified Scm3, a nonhistone protein that colocalizes with Cse4 and is required for its centromeric association. Bacterially expressed Scm3 binds directly to and reconstitutes a stoichiometric complex with Cse4 and histone H4 but not with conventional histone H3 and H4. A conserved acidic domain of Scm3 is responsible for directing the Cse4-specific interaction. Strikingly, binding of Scm3 can replace histones H2A-H2B from preassembled Cse4-containing histone octamers. This incompatibility between Scm3 and histones H2A-H2B is correlated with diminished in vivo occupancy of histone H2B, H2A, and H2AZ at centromeres. Our findings indicate that nonhistone Scm3 serves to assemble and maintain Cse4-H4 at centromeres and may replace histone H2A-H2B dimers in a centromere-specific nucleosome core.	NCI, Lab Biochem & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; Univ Virginia, Hlth Syst, Dept Microbiol, Charlottesville, VA 22908 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Virginia	Wu, C (corresponding author), NCI, Lab Biochem & Mol Biol, Ctr Canc Res, NIH, Bldg 37,Room 6068, Bethesda, MD 20892 USA.	carlwu@helix.nih.gov			Intramural NIH HHS Funding Source: Medline; NIGMS NIH HHS [GM28930] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC005263] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amor DJ, 2004, TRENDS CELL BIOL, V14, P359, DOI 10.1016/j.tcb.2004.05.009; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Belli G, 1998, NUCLEIC ACIDS RES, V26, P942, DOI 10.1093/nar/26.4.942; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Bloom K, 2006, CURR BIOL, V16, pR276, DOI 10.1016/j.cub.2006.03.054; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Carroll CW, 2006, TRENDS CELL BIOL, V16, P70, DOI 10.1016/j.tcb.2005.12.008; Chen YH, 2000, MOL CELL BIOL, V20, P7037, DOI 10.1128/MCB.20.18.7037-7048.2000; Choo KHA., 1997, CENTROMERE; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Collins KA, 2005, MOL BIOL CELL, V16, P5649, DOI 10.1091/mbc.E05-08-0771; Collins KA, 2004, CURR BIOL, V14, P1968, DOI 10.1016/j.cub.2004.10.024; Connelly C, 1996, CELL, V86, P275, DOI 10.1016/S0092-8674(00)80099-9; Crotti LB, 2004, EMBO J, V23, P1804, DOI 10.1038/sj.emboj.7600161; Dawe RK, 2006, TRENDS BIOCHEM SCI, V31, P662, DOI 10.1016/j.tibs.2006.10.004; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; EICKBUSH TH, 1978, BIOCHEMISTRY-US, V17, P4955, DOI 10.1021/bi00616a016; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Furuyama T, 2006, P NATL ACAD SCI USA, V103, P6172, DOI 10.1073/pnas.0601686103; Gardner RD, 2001, GENETICS, V157, P1493; Glowczewski L, 2000, MOL CELL BIOL, V20, P5700, DOI 10.1128/MCB.20.15.5700-5711.2000; GODFREY JE, 1980, BIOCHEMISTRY-US, V19, P1339, DOI 10.1021/bi00548a012; Hecht A, 1999, METHOD ENZYMOL, V304, P399; Henikoff S, 2005, CURR OPIN GENET DEV, V15, P177, DOI 10.1016/j.gde.2005.01.004; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; Izuta H, 2006, GENES CELLS, V11, P673, DOI 10.1111/j.1365-2443.2006.00969.x; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; Keith KC, 2000, GENETICS, V156, P973; Kitagawa K, 2001, NAT REV MOL CELL BIO, V2, P678, DOI 10.1038/35089568; KORNBERG RD, 1974, SCIENCE, V184, P865, DOI 10.1126/science.184.4139.865; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Lew DJ, 2003, ANNU REV GENET, V37, P251, DOI 10.1146/annurev.genet.37.042203.120656; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luk E, 2007, MOL CELL, V25, P357, DOI 10.1016/j.molcel.2006.12.015; Malik HS, 2002, CURR OPIN GENET DEV, V12, P711, DOI 10.1016/S0959-437X(02)00351-9; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; Megee PC, 1999, MOL CELL, V4, P445, DOI 10.1016/S1097-2765(00)80347-0; Meluh PB, 1997, GENE DEV, V11, P3401, DOI 10.1101/gad.11.24.3401; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Nakayama J, 2000, CELL, V101, P307, DOI 10.1016/S0092-8674(00)80840-5; NIEDENTHAL RK, 1993, NUCLEIC ACIDS RES, V21, P4726, DOI 10.1093/nar/21.20.4726; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Ortiz J, 1999, GENE DEV, V13, P1140, DOI 10.1101/gad.13.9.1140; Pietrasanta LI, 1999, P NATL ACAD SCI USA, V96, P3757, DOI 10.1073/pnas.96.7.3757; Schueler MG, 2006, ANNU REV GENOM HUM G, V7, P301, DOI 10.1146/annurev.genom.7.080505.115613; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; Sharp JA, 2003, GENE DEV, V17, P2356, DOI 10.1101/gad.1131103; Sharp JA, 2002, GENE DEV, V16, P85, DOI 10.1101/gad.925302; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; Smith MM, 1996, MOL CELL BIOL, V16, P1017; Smith MM, 2002, CURR OPIN CELL BIOL, V14, P279, DOI 10.1016/S0955-0674(02)00331-9; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; Tanaka TU, 1999, CELL, V98, P847, DOI 10.1016/S0092-8674(00)81518-4; Van Hooser AA, 2001, J CELL SCI, V114, P3529; Vos LJ, 2006, BIOCHEM CELL BIOL, V84, P619, DOI 10.1139/O06-078; Weber SA, 2004, PLOS BIOL, V2, P1340, DOI 10.1371/journal.pbio.0020260; Westermann S, 2003, J CELL BIOL, V163, P215, DOI 10.1083/jcb.200305100; Wieland G, 2004, MOL CELL BIOL, V24, P6620, DOI 10.1128/mcb.24.15.6620-6630.2004; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Yoda K, 2000, P NATL ACAD SCI USA, V97, P7266, DOI 10.1073/pnas.130189697; ZINKOWSKI RP, 1991, J CELL BIOL, V113, P1091, DOI 10.1083/jcb.113.5.1091	65	232	243	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2007	129	6					1153	1164		10.1016/j.cell.2007.04.026	http://dx.doi.org/10.1016/j.cell.2007.04.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574026	Bronze			2022-12-01	WOS:000247390400018
J	Saschenbrecker, S; Bracher, A; Rao, KV; Rao, BV; Hartl, FU; Hayer-Hartl, M				Saschenbrecker, Sandra; Bracher, Andreas; Rao, Karnam Vasudeva; Rao, Bharathi Vasudeva; Hartl, F. Ulrich; Hayer-Hartl, Manajit			Structure and function of RbcX, an assembly chaperone for hexadecameric rubisco	CELL			English	Article							RIBULOSE-BISPHOSPHATE CARBOXYLASE; MOLECULAR CHAPERONES; ESCHERICHIA-COLI; LARGE SUBUNITS; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; 1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; NASCENT CHAIN; OXYGENASE; PROTEINS; CATALYSIS	After folding, many proteins must assemble into oligomeric complexes to become biologically active. Here we describe the role of RbcX as an assembly chaperone of ribulose-bisphosphate carboxylase/oxygenase (Rubisco), the enzyme responsible for the fixation of atmospheric carbon dioxide. In cyanobacteria and plants, Rubisco is an similar to 520 kDa complex composed of eight large subunits (RbcL) and eight small subunits (RbcS). We found that cyanobacterial RbcX functions downstream of chaperonin-mediated RbcL folding in promoting the formation of RbcL(8) core complexes. Structural analysis revealed that the 15 kDa RbcX forms a homodimer with two cooperating RbcL-binding regions. A central cleft specifically binds the exposed C-terminal peptide of RbcL subunits, enabling a peripheral surface of RbcX to mediate RbcL8 assembly. Due to the dynamic nature of these interactions, RbcX is readily displaced from RbcL8 complexes by RbcS, producing the active enzyme. The strategies employed by RbcX in achieving substrate specificity and efficient product release may be generally relevant in assisted assembly reactions.	Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany	Max Planck Society	Bracher, A (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	bracher@biochem.mpg.de; uhartl@biochem.mpg.de; mhartl@biochem.mpg.de	Hayer-Hartl, Manajit/V-8078-2017; Hartl, F. Ulrich/Y-8206-2019	Hayer-Hartl, Manajit/0000-0001-8213-6742; Saschenbrecker, Sandra/0000-0002-4769-915X				Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Andersson I, 2003, ARCH BIOCHEM BIOPHYS, V414, P130, DOI 10.1016/S0003-9861(03)00164-4; Andrews T.J., 1987, BIOCH PLANTS, P131, DOI 10.1016/B978-0-12-675410-0.50009-9; Andrews TJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P159, DOI 10.1016/S0003-9861(03)00100-0; ANDREWS TJ, 1985, J BIOL CHEM, V260, P4632; ANDREWS TJ, 1988, J BIOL CHEM, V263, P12213; BARRACLOUGH R, 1980, BIOCHIM BIOPHYS ACTA, V608, P18; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; CURMI PMG, 1992, J BIOL CHEM, V267, P16980; Duff AP, 2000, J MOL BIOL, V298, P903, DOI 10.1006/jmbi.2000.3724; Ellis RJ, 2006, TRENDS BIOCHEM SCI, V31, P395, DOI 10.1016/j.tibs.2006.05.001; Emlyn-Jones D, 2006, PLANT CELL PHYSIOL, V47, P1630, DOI 10.1093/pcp/pcl028; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; GUTTERIDGE S, 1995, PLANT CELL, V7, P809, DOI 10.1105/tpc.7.7.809; Hansen WJ, 1999, J CELL BIOL, V145, P265, DOI 10.1083/jcb.145.2.265; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hill JE, 2001, CELL STRESS CHAPERON, V6, P190, DOI 10.1379/1466-1268(2001)006<0190:ATTIAI>2.0.CO;2; HUBBS AE, 1993, J BIOL CHEM, V268, P13519; LARIMER FW, 1993, GENE, V126, P85, DOI 10.1016/0378-1119(93)90593-R; Li LA, 1997, J BACTERIOL, V179, P3793, DOI 10.1128/jb.179.11.3793-3796.1997; Onizuka T, 2004, PLANT CELL PHYSIOL, V45, P1390, DOI 10.1093/pcp/pch160; ROY H, 1989, PLANT CELL, V1, P1035, DOI 10.1105/tpc.1.11.1035; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Tabita FR, 1999, PHOTOSYNTH RES, V60, P1, DOI 10.1023/A:1006211417981; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Zhu GH, 1998, PHOTOSYNTH RES, V57, P71, DOI 10.1023/A:1006020424581; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	30	102	105	2	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2007	129	6					1189	1200		10.1016/j.cell.2007.04.025	http://dx.doi.org/10.1016/j.cell.2007.04.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574029	Green Accepted, hybrid			2022-12-01	WOS:000247390400021
J	Zimmermann, K; Leffler, A; Babes, A; Cendan, CM; Carr, RW; Kobayashi, J; Nau, C; Wood, JN; Reeh, PW				Zimmermann, Katharina; Leffler, Andreas; Babes, Alexandru; Cendan, Cruz Miguel; Carr, Richard W.; Kobayashi, Jin-ichi; Nau, Carla; Wood, John N.; Reeh, Peter W.			Sensory neuron sodium channel Na(v)1.8 is essential for pain at low temperatures	NATURE			English	Article							MEMBRANE-PROPERTIES; NA+ CHANNELS; COLD; TRANSDUCTION; NERVE; POTENTIALS; DEPENDENCE; PATHWAYS; INVITRO; CELLS	Sensory acuity and motor dexterity deteriorate when human limbs cool down, but pain perception persists and cold-induced pain can become excruciating(1). Evolutionary pressure to enforce protective behaviour requires that damage-sensing neurons (nociceptors) continue to function at low temperatures. Here we show that this goal is achieved by endowing superficial endings of slowly conducting nociceptive fibres with the tetrodotoxin-resistant voltage-gated sodium channel (VGSC) Na(v)1.8 ( ref. 2). This channel is essential for sustained excitability of nociceptors when the skin is cooled. We show that cooling excitable membranes progressively enhances the voltage-dependent slow inactivation of tetrodotoxin-sensitive VGSCs. In contrast, the inactivation properties of Na(v)1.8 are entirely cold-resistant. Moreover, low temperatures decrease the activation threshold of the sodium currents and increase the membrane resistance, augmenting the voltage change caused by any membrane current. Thus, in the cold, Na(v)1.8 remains available as the sole electrical impulse generator in nociceptors that transmits nociceptive information to the central nervous system. Consistent with this concept is the observation that Na(v)1.8-null mutant mice(3) show negligible responses to noxious cold and mechanical stimulation at low temperatures. Our data present strong evidence for a specialized role of Na(v)1.8 in nociceptors as the critical molecule for the perception of cold pain and pain in the cold.	Univ Erlangen Nurnberg, Fac Med, Dept Physiol & Pathophysiol, D-91054 Erlangen, Germany; Univ Erlangen Nurnberg, Fac Med, Dept Anesthesiol, D-91054 Erlangen, Germany; Univ Bucharest, Fac Biol, Dept Anim Physiol & Biophys, Bucharest 050095, Romania; UCL, Dept Biol, London WC1E 6BT, England; Kyushu Univ, Fac Dent Sci, Dept Fixed Prosthodont, Higashi Ku, Fukuoka 8128582, Japan	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Bucharest; University of London; University College London; Kyushu University	Zimmermann, K (corresponding author), Univ Erlangen Nurnberg, Fac Med, Dept Physiol & Pathophysiol, D-91054 Erlangen, Germany.	zimmermann@physiologie1.uni-erlangen.de	Babes, Alexandru/A-6212-2010; Martínez, Cruz Miguel Cendán/ABH-1404-2020; Carr, Richard/GSD-4859-2022; Leffler, Andreas/C-6552-2009; Reeh, Peter W./J-8981-2012; Leffler, Andreas/K-1191-2012; Carr, Richard/AAE-9188-2020; Babes, Alexandru/ABB-9128-2021	Martínez, Cruz Miguel Cendán/0000-0001-5431-4513; Reeh, Peter W./0000-0002-4367-094X; Leffler, Andreas/0000-0003-1121-6387; Carr, Richard/0000-0001-8617-9133; Babes, Alexandru/0000-0002-7110-6908; Zimmermann, Katharina/0000-0003-2529-0692	Medical Research Council [G9717869] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G9717869] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Babes A, 2004, EUR J NEUROSCI, V20, P2276, DOI 10.1111/j.1460-9568.2004.03695.x; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Blair NT, 2002, J NEUROSCI, V22, P10277; BOSTOCK H, 1983, J PHYSIOL-LONDON, V341, P59, DOI 10.1113/jphysiol.1983.sp014792; Brock JA, 1998, J PHYSIOL-LONDON, V512, P211, DOI 10.1111/j.1469-7793.1998.211bf.x; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Dib-Hajj S, 2002, TRENDS NEUROSCI, V25, P253, DOI 10.1016/S0166-2236(02)02150-1; Dittert I, 2006, J NEUROSCI METH, V151, P178, DOI 10.1016/j.jneumeth.2005.07.005; Goldin AL, 2002, J EXP BIOL, V205, P575; HODKIN AL, 1949, J PHYSIOL-LONDON, V109, P240; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Leffler A, 2007, J PHARMACOL EXP THER, V320, P354, DOI 10.1124/jpet.106.109025; Matthews EA, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-5; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; PIERAU FK, 1974, BRAIN RES, V73, P156, DOI 10.1016/0006-8993(74)91015-4; REEH PW, 1986, NEUROSCI LETT, V66, P141, DOI 10.1016/0304-3940(86)90180-1; Reid G, 2001, NEUROSCI LETT, V297, P171, DOI 10.1016/S0304-3940(00)01694-3; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Rush AM, 2006, P NATL ACAD SCI USA, V103, P8245, DOI 10.1073/pnas.0602813103; Solomon S, 1999, P NATL ACAD SCI USA, V96, P13012, DOI 10.1073/pnas.96.23.13012; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Strassman AM, 1999, J NEUROPHYSIOL, V81, P413, DOI 10.1152/jn.1999.81.2.413; THOMPSON SM, 1985, J NEUROSCI, V5, P817; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; Volgushev M, 2000, J PHYSIOL-LONDON, V522, P59, DOI 10.1111/j.1469-7793.2000.0059m.x; Wood JN, 2004, J NEUROBIOL, V61, P55, DOI 10.1002/neu.20094; [No title captured]	30	297	307	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2007	447	7146					855	858		10.1038/nature05880	http://dx.doi.org/10.1038/nature05880			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17568746				2022-12-01	WOS:000247207500044
J	Johnson, DS; Mortazavi, A; Myers, RM; Wold, B				Johnson, David S.; Mortazavi, Ali; Myers, Richard M.; Wold, Barbara			Genome-wide mapping of in vivo protein-DNA interactions	SCIENCE			English	Article							NEURON-RESTRICTIVE SILENCER; TRANSCRIPTION-FACTOR	In vivo protein-DNA interactions connect each transcription factor with its direct targets to form a gene network scaffold. To map these protein-DNA interactions comprehensively across entire mammalian genomes, we developed a large-scale chromatin immunoprecipitation assay ( ChIPSeq) based on direct ultrahigh-throughput DNA sequencing. This sequence census method was then used to map in vivo binding of the neuron-restrictive silencer factor ( NRSF; also known as REST, for repressor element-1 silencing transcription factor) to 1946 locations in the human genome. The data display sharp resolution of binding position [ +/- 50 base pairs ( bp)], which facilitated our finding motifs and allowed us to identify noncanonical NRSF-binding motifs. These ChIPSeq data also have high sensitivity and specificity [ ROC ( receiver operator characteristic) area >= 0.96] and statistical confidence ( P < 10(-4)), properties that were important for inferring new candidate interactions. These include key transcription factors in the gene network that regulates pancreatic islet cell development.	Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Beckman Inst, Pasadena, CA 91125 USA	Stanford University; California Institute of Technology; California Institute of Technology	Wold, B (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	myers@shgc.stanford.edu; woldb@its.caltech.edu			NHGRI NIH HHS [U01 HG003162] Funding Source: Medline; NIGMS NIH HHS [5T32GM07616] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG003162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Atouf F, 1997, J BIOL CHEM, V272, P1929, DOI 10.1074/jbc.272.3.1929; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/S0092-8674(04)01159-6; Kim TH, 2006, ANNU REV GENOM HUM G, V7, P81, DOI 10.1146/annurev.genom.7.080505.115634; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043	7	1842	1948	5	224	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2007	316	5830					1497	1502		10.1126/science.1141319	http://dx.doi.org/10.1126/science.1141319			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17540862				2022-12-01	WOS:000247066400049
J	Quarrie, KL; Gianotti, SM; Hopkins, WG; Hume, PA				Quarrie, Kenneth L.; Gianotti, Simon M.; Hopkins, Will G.; Hume, Patria A.			Effect of nationwide injury prevention programme on serious spinal injuries in New Zealand rugby union: ecological study	BRITISH MEDICAL JOURNAL			English	Article							CORD; LESSONS	Objective To investigate the effect of RugbySmart, a nationwide educational injury prevention programme, on the frequency of spinal cord injuries. Design Ecological study. Setting New Zealand rugby union. Participants Population at risk of injury comprised all New Zealand rugby union players. Intervention From 2001, all New Zealand rugby coaches and referees have been required to complete RugbySmart, which focuses on educating rugby participants about physical conditioning, injury management, and safe techniques in the contact phases of rugby. Main outcome measures Numbers of all spinal injuries due to participation in rugby union resulting in permanent disablement in 1976-2005, grouped into five year periods; observed compared with predicted number of spinal injuries in 2001-5. Results Eight spinal injuries occurred in 2001-5, whereas the predicted number was 18.9 (relative rate=0.46, 95% confidence interval 0.19 to 1.14). Only one spinal injury resulted from scrums over the period; the predicted number was 9.0 (relative rate=0.11, 0.02 to 0.74). Corresponding observed and predicted rates for spinal injuries resulting from other phases of play (tackle, ruck, and maul) were 7 and 9.0 (relative rate=0.83, 0.29 to 2.36). Conclusions The introduction of the RugbySmart programme coincided with a reduction in the rate of disabling spinal injuries arising from scrums in rugby union. This study exemplifies the benefit of educational initiatives in injury prevention and the need for comprehensive injury surveillance systems for evaluating injury prevention initiatives in sport.	New Zealand Rugby Unit, Wellington, New Zealand; Accid Compensat Corp, Sport & Rd, Wellington, New Zealand; AUT Unit, Fac Hlth & Environm Sci, Inst Sport & Recreat Res New Zealand, Auckland, New Zealand	Auckland University of Technology	Quarrie, KL (corresponding author), New Zealand Rugby Unit, POB 2172, Wellington, New Zealand.	ken.quarrie@nzrugby.co.nz	Hume, Patria/AAN-5514-2021; Hume, Patria Anne/P-1084-2017	Hume, Patria/0000-0003-1847-8128; Hume, Patria Anne/0000-0003-1847-8128; Quarrie, Ken/0000-0003-1703-8489				Berry JG, 2006, AUST NZ J PUBL HEAL, V30, P268, DOI 10.1111/j.1467-842X.2006.tb00869.x; Bourke JB, 2006, BRIT MED J, V332, P1281, DOI 10.1136/bmj.332.7552.1281; Carmody DJ, 2005, MED J AUSTRALIA, V182, P561, DOI 10.5694/j.1326-5377.2005.tb06814.x; Chalmers DJ, 2004, J SCI MED SPORT, V7, P74, DOI 10.1016/S1440-2440(04)80046-X; GARRAWAY WM, 1991, BRIT MED J, V303, P1082, DOI 10.1136/bmj.303.6810.1082; Haylen PT, 2004, MED J AUSTRALIA, V181, P48, DOI 10.5694/j.1326-5377.2004.tb06161.x; *INT RUGB BOARD, 2004, RUGB WORLD CUP 2003; Merton RK, 1936, AM SOCIOL REV, V1, P894, DOI 10.2307/2084615; Quarrie KL, 2007, J SPORT SCI, V25, P895, DOI 10.1080/02640410600944659; Quarrie KL, 2002, SPORTS MED, V32, P633, DOI 10.2165/00007256-200232100-00003; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002	11	93	94	0	19	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 2	2007	334	7604					1150	1153		10.1136/bmj.39185.605914.AE	http://dx.doi.org/10.1136/bmj.39185.605914.AE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	177ES	17513314	Green Published, Bronze			2022-12-01	WOS:000247137000030
J	Sablina, AA; Chen, W; Arroyo, JD; Corral, L; Hector, M; Bulmer, SE; DeCaprio, JA; Hahn, WC				Sablina, Anna A.; Chen, Wen; Arroyo, Jason D.; Corral, Laura; Hector, Melissa; Bulmer, Sara E.; DeCaprio, James A.; Hahn, William C.			The tumor suppressor PP2A A beta regulates the RaIA GTPase	CELL			English	Article							PROTEIN PHOSPHATASE 2A; HUMAN CELL-TRANSFORMATION; SMALL-T-ANTIGEN; RAL-GTPASES; SUBUNIT INTERACTION; SIGNALING PATHWAY; PPP2R1B GENE; CANCER-CELLS; ACTIVATION; ALPHA	The serine-threonine protein phosphatase 2A (PP2A) is a heterotrimeric enzyme family that regulates numerous signaling pathways. Biallelic mutations of the structural PP2A A beta subunit occur in several types of human tumors; however, the functional consequences of these cancer-associated PP2A A beta mutations in cell transformation remain undefined. Here we show that suppression of PP2A A beta expression permits immortalized human cells to achieve a tumorigenic state. Cancer-associated A beta mutants fail to reverse tumorigenic phenotype induced by PP2A A beta suppression, indicating that these mutants function as null alleles. Wild-type PP2A A beta but not cancer-derived A beta mutants form a complex with the small GTPase RalA. PP2A A beta-containing complexes dephosphorylate RalA at Ser183 and Ser194, inactivating RalA and abolishing its transforming function. These observations identify PP2A A beta as a tumor suppressor gene that transforms immortalized human cells by regulating the function of RalA.	Brigham & Womens Hosp, Dept Med Oncol, Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Sun Yat Sen Univ, Sch Publ Hlth, Dept Toxicol, Guangzhou 510080, Peoples R China; Dana Farber Canc Inst, DF HCC Monoclonal Antibody Core, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Sun Yat Sen University; Harvard University; Dana-Farber Cancer Institute	Hahn, WC (corresponding author), Brigham & Womens Hosp, Dept Med Oncol, Dana Farber Canc Inst, Dept Med, 75 Francis St, Boston, MA 02115 USA.	william_hahn@dfci.harvard.edu	Sablina, Anna/P-2818-2019; Sablina, Anna/B-2217-2017	Sablina, Anna/0000-0001-9526-4014; Sablina, Anna/0000-0001-9526-4014; Arroyo, Jason/0000-0002-5674-6739; Hector-Greene, Melissa/0000-0001-7263-1440	NCI NIH HHS [P01 CA050661, P01 CA50661, P01 CA050661-190009] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA050661] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ali SH, 2001, SEMIN CANCER BIOL, V11, P15, DOI 10.1006/scbi.2000.0342; ALTSCHULER D, 1993, J BIOL CHEM, V268, P7527; Baysal BE, 2001, EUR J HUM GENET, V9, P121, DOI 10.1038/sj.ejhg.5200585; Boehm JS, 2005, MOL CELL BIOL, V25, P6464, DOI 10.1128/MCB.25.15.6464-6474.2005; Broach JR, 1997, CURR OPIN GENET DEV, V7, P1, DOI 10.1016/S0959-437X(97)80102-5; Calin GA, 2000, ONCOGENE, V19, P1191, DOI 10.1038/sj.onc.1203389; Camonis JH, 2005, TRENDS CELL BIOL, V15, P327, DOI 10.1016/j.tcb.2005.04.002; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chen W, 2005, CANCER RES, V65, P8183, DOI 10.1158/0008-5472.CAN-05-1103; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Drayton S, 2003, CANCER CELL, V4, P301, DOI 10.1016/S1535-6108(03)00242-3; EMKEY R, 1991, J BIOL CHEM, V266, P9703; Feig LA, 2003, TRENDS CELL BIOL, V13, P419, DOI 10.1016/S0962-8924(03)00152-1; Feinstein E, 2005, ONCOGENE, V24, P326, DOI 10.1038/sj.onc.1208252; Gildea JJ, 2002, CANCER RES, V62, P982; Goi T, 2000, EMBO J, V19, P623, DOI 10.1093/emboj/19.4.623; Gotz J, 2000, MECH DEVELOP, V93, P83, DOI 10.1016/S0925-4773(00)00267-7; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HEMMINGS BA, 1990, BIOCHEMISTRY-US, V29, P3166, DOI 10.1021/bi00465a002; HENDRIX P, 1993, J BIOL CHEM, V268, P15267; Hu CD, 1999, J BIOL CHEM, V274, P48, DOI 10.1074/jbc.274.1.48; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; JIANG H, 1995, NATURE, V378, P409, DOI 10.1038/378409a0; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Lundberg AS, 2002, ONCOGENE, V21, P4577, DOI 10.1038/sj.onc.1205550; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; Panner A, 2006, MOL CELL BIOL, V26, P7345, DOI 10.1128/MCB.00126-06; Quilliam LA, 2002, PROG NUCLEIC ACID RE, V71, P391, DOI 10.1016/S0079-6603(02)71047-7; QUILLIAM LA, 1991, J IMMUNOL, V147, P1628; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Ruediger R, 2001, ONCOGENE, V20, P1892, DOI 10.1038/sj.onc.1204279; Ruediger R, 2001, ONCOGENE, V20, P10, DOI 10.1038/sj.onc.1204059; Schonthal AH, 2001, CANCER LETT, V170, P1, DOI 10.1016/S0304-3835(01)00561-4; Seger YR, 2002, CANCER CELL, V2, P401, DOI 10.1016/S1535-6108(02)00183-6; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; SUGANO S, 1982, J VIROL, V41, P1073, DOI 10.1128/JVI.41.3.1073-1075.1982; SUGANUMA M, 1988, P NATL ACAD SCI USA, V85, P1768, DOI 10.1073/pnas.85.6.1768; TAKATA K, 2000, BREED RES, V2, P11; Tamaki M, 2004, ONCOL REP, V11, P655; Urano T, 1996, EMBO J, V15, P810, DOI 10.1002/j.1460-2075.1996.tb00416.x; van Dam EM, 2006, INT J BIOCHEM CELL B, V38, P1841, DOI 10.1016/j.biocel.2006.04.006; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Wu JC, 2005, J BIOL CHEM, V280, P9013, DOI 10.1074/jbc.M411068200; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yu J, 2001, VIROLOGY, V290, P192, DOI 10.1006/viro.2001.1204; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6; Zhao JJ, 2004, TRENDS MOL MED, V10, P344, DOI 10.1016/j.molmed.2004.05.005; Zhou J, 2003, BIOCHEM J, V369, P387, DOI 10.1042/BJ20021244	58	160	169	1	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2007	129	5					969	982		10.1016/j.cell.2007.03.047	http://dx.doi.org/10.1016/j.cell.2007.03.047			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540176	Bronze, Green Accepted			2022-12-01	WOS:000247084600016
J	Wang, B; Matsuoka, S; Ballif, BA; Zhang, D; Smogorzewska, A; Gygi, SP; Elledge, SJ				Wang, Bin; Matsuoka, Shuhei; Ballif, Bryan A.; Zhang, Dong; Smogorzewska, Agata; Gygi, Steven P.; Elledge, Stephen J.			Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response	SCIENCE			English	Article							LIGASE ACTIVITY; F-BOX; PHOSPHORYLATION; REPAIR; HETERODIMER; PROTEOMICS; INTERACTS; DOMAINS; BREAKS; CTIP	The BRCT repeats of the breast and ovarian cancer predisposition protein BRCA1 are essential for tumor suppression. Phosphopeptide affinity proteomic analysis identified a protein, Abraxas, that directly binds the BRCA1 BRCT repeats through a phospho- Ser-X-X-Phe motif. Abraxas binds BRCA1 to the mutual exclusion of BACH1 (BRCA1-associated C-terminal helicase) and CtIP (CtBP-interacting protein), forming a third type of BRCA1 complex. Abraxas recruits the ubiquitin-interacting motif (UIM)-containing protein RAP80 to BRCA1. Both Abraxas and RAP80 were required for DNA damage resistance, G(2)- M checkpoint control, and DNA repair. RAP80 was required for optimal accumulation of BRCA1 on damaged DNA ( foci) in response to ionizing radiation, and the UIM domains alone were capable of foci formation. The RAP80-Abraxas complex may help recruit BRCA1 to DNA damage sites in part through recognition of ubiquitinated proteins.	Harvard Univ, Brigham & Womens Hosp, Sch Med,Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med,Howard Hughes Med Inst, Ctr Genet & Genom, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02214 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Elledge, SJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med,Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu	Smogorzewska, Agata/B-8891-2011	Smogorzewska, Agata/0000-0001-6285-1562; Zhang, Dong/0000-0002-4515-2070	NATIONAL CANCER INSTITUTE [T32CA009216, K01CA116275] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [T32 CA009216, 1KO1, CA116275-01, K01 CA116275, T32CA09216] Funding Source: Medline; PHS HHS [1U19A1067751] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AMANCHY R, 2005, SCI STKE, pPL2, DOI DOI 10.1126/STKE.2672005PL2; Baer R, 2002, CURR OPIN GENET DEV, V12, P86, DOI 10.1016/S0959-437X(01)00269-6; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Everley PA, 2004, MOL CELL PROTEOMICS, V3, P729, DOI 10.1074/mcp.M400021-MCP200; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Ong SE, 2003, METHODS, V29, P124, DOI 10.1016/S1046-2023(02)00303-1; Rodriguez M, 2003, J BIOL CHEM, V278, P52914, DOI 10.1074/jbc.C300407200; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Xu B, 2002, MOL CELL BIOL, V22, P1049, DOI 10.1128/MCB.22.4.1049-1059.2002; Yan J, 2007, NUCLEIC ACIDS RES, V35, P1673, DOI 10.1093/nar/gkl1112; Yan ZJ, 2002, J BIOL CHEM, V277, P32379, DOI 10.1074/jbc.M203475200; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039	29	550	580	2	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2007	316	5828					1194	1198		10.1126/science.1139476	http://dx.doi.org/10.1126/science.1139476			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525340	Green Accepted			2022-12-01	WOS:000246724300044
J	Chretien, JP; Fukuda, M; Noedl, H				Chretien, Jean-Paul; Fukuda, Mark; Noedl, Harald			Improving surveillance for antimalarial drug resistance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MALARIA; ARTEMISININ; MUTATIONS; EFFICACY		US Dept Def, Global Emerging Infect Surveillance & Response Sy, Silver Spring, MD 20910 USA; Armed Forces Res Inst Med Sci, Dept Immunol & Med, Bangkok 10400, Thailand; Med Univ Vienna, Dept Specif Prophylaxis & Trop Med, Vienna, Austria	United States Department of Defense; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Medical University of Vienna	Chretien, JP (corresponding author), US Dept Def, Global Emerging Infect Surveillance & Response Sy, 2900 Linden Lane, Silver Spring, MD 20910 USA.	jean-paul.chretien@na.amedd.army.mil		Chretien, Jean-Paul/0000-0001-8143-6823				Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8; Afonso A, 2006, ANTIMICROB AGENTS CH, V50, P480, DOI 10.1128/AAC.50.2.480-489.2006; Attaran A, 2004, LANCET, V363, P237, DOI 10.1016/S0140-6736(03)15330-5; Francis D, 2006, J INFECT DIS, V193, P978, DOI 10.1086/500951; *GLOB FUND FIGHT A, 2004, TUB MAL REV ANT TREA; Global Fund to Fight AIDS Tuberculosis and Malaria, 2006, MON EV TOOLK HIV AID; Institute of Medicine (US) Committee on the Economics of Antimalarial Drugs, 2004, SAVING LIVES BUYING, P1125; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; Kachur SP, 2006, LANCET, V368, P10, DOI 10.1016/S0140-6736(06)68945-9; Kerr C, 2006, LANCET INFECT DIS, V6, P397, DOI 10.1016/S1473-3099(06)70508-4; Krishna S, 2006, TRENDS MOL MED, V12, P200, DOI 10.1016/j.molmed.2006.03.005; Magill A, 2005, NEW ENGL J MED, V353, P335, DOI 10.1056/NEJMp058167; Newton PN, 2006, PLOS MED, V3, P752, DOI 10.1371/journal.pmed.0030197; Noedl H, 2005, TRENDS PARASITOL, V21, P404, DOI 10.1016/j.pt.2005.06.012; Plowe CV, 1997, J INFECT DIS, V176, P1590, DOI 10.1086/514159; Price RN, 1996, LANCET, V347, P1654, DOI 10.1016/S0140-6736(96)91488-9; Sibley CH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-48; Uhlemann AC, 2005, NAT STRUCT MOL BIOL, V12, P628, DOI 10.1038/nsmb947; *WHO, 2006, FACTS ACTS; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6; World Health Organization, 2005, SUSC PLASM FALC ANT; World Health Organization, 1993, GLOB STRAT MAL CONTR; World Health Organization WHO, 2006, GUID TREATM MAL	23	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2007	297	20					2278	2281		10.1001/jama.297.20.2278	http://dx.doi.org/10.1001/jama.297.20.2278			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170JM	17522014				2022-12-01	WOS:000246659700027
J	May, J; Evans, JA; Timmann, C; Ehmen, C; Busch, W; Thye, T; Agbenyega, T; Horstmann, RD				May, Juergen; Evans, Jennifer A.; Timmann, Christian; Ehmen, Christa; Busch, Wibke; Thye, Thorsten; Agbenyega, Tsiri; Horstmann, Rolf D.			Hemoglobin variants and disease manifestations in severe falciparum malaria	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SICKLE-CELL TRAIT; AFRICAN CHILDREN; ALPHA(+)-THALASSEMIA PROTECTS; ALPHA-THALASSEMIA; GHANAIAN CHILDREN; POLYMORPHISM; CHLOROQUINE; POPULATION; RESISTANCE; PARASITES	Context The geographical distributions of hemoglobin S (HbS), hemoglobin C (HbC), and alpha(+)-thalassemia (-alpha) strongly suggest balancing selection with malaria. However, whereas several studies indicate that the HbS carrier state protects against all major forms of clinical malaria, malaria protection on clinical grounds has been more difficult to confirm for HbC and -alpha, and questions remain as to whether it applies to all forms of the disease. Objective To assess the association between major clinical forms of severe falciparum malaria and HbS, HbC, and -alpha. Design, Setting, and Participants Case-control study of 2591 children with severe falciparum malaria enrolled at a tertiary referral center in Ghana, West Africa, and 2048 age-, sex-, and ethnicity-matched control participants recruited by community surveys. Main Outcome Measures Frequencies of HbS, HbC, and -alpha in patients and controls, including stratifications of patients for signs of disease. Results Patients presented with partly overlapping signs of disease, including severe anemia (64%), cerebral malaria (22%), respiratory distress (30%), hyperparasitemia (32%), prostration (52%), acidosis (59%), and hyperlactatemia (56%). Carrier states of HbS, HbC, and -alpha were found in 1.4%, 9.4%, and 25.2% of the patients, respectively, and 14.8%, 8.7%, and 27.3% of controls. The HbS carrier state was negatively associated with all forms of the disease studied (overall odds ratio [OR], 0.08; 95% confidence interval [CI], 0.06-0.12). The HbC carrier state showed a negative association selectively with cerebral malaria (OR, 0.64; 95% CI, 0.45-0.91), and the -alpha carrier state showed a negative association selectively with severe anemia (OR, 0.82; 95% CI, 0.69-0.96). Conclusion Whereas the HbS carrier state was found to be negatively associated with all major forms of severe falciparum malaria, the negative associations of the carrier states of HbC and -alpha appeared to be limited to cerebral malaria and severe anemia, respectively.	Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; Kwame Nkrumah Univ Sci & Technol, Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; Univ Schleswig Holstein, Inst Med Biometry & Stat, Kiel, Germany; Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Kumasi, Ghana; Komfo Anokye Teaching Hosp, Dept Child Hlth, Kumasi, Ghana	Bernhard Nocht Institut fur Tropenmedizin; Kumasi Center for Collaborative Research; Kwame Nkrumah University Science & Technology; University of Kiel; Schleswig Holstein University Hospital; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology	Horstmann, RD (corresponding author), Bernhard Nocht Inst Trop Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	horstmann@bni-hamburg.de	May, Jürgen/E-7857-2011	May, Jurgen/0000-0001-7831-8420				Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; Allen S, 1996, LANCET, V348, P1168, DOI 10.1016/S0140-6736(05)65301-9; Allen SJ, 1997, P NATL ACAD SCI USA, V94, P14736, DOI 10.1073/pnas.94.26.14736; ALLISON AC, 1964, COLD SPRING HARB SYM, V29, P137, DOI 10.1101/SQB.1964.029.01.018; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; BEUTLER E, 2001, WILLIAMS HEMATOLOGY, P581; CARSON JL, 1988, LANCET, V1, P727; Chong SS, 2000, BLOOD, V95, P360; Cockburn IA, 2004, P NATL ACAD SCI USA, V101, P272, DOI 10.1073/pnas.0305306101; Evans JA, 2005, QJM-INT J MED, V98, P789, DOI 10.1093/qjmed/hci121; Evans JA, 2004, QJM-INT J MED, V97, P591, DOI 10.1093/qjmed/hch093; Fairhurst RM, 2005, NATURE, V435, P1117, DOI 10.1038/nature03631; Flint J, 1998, BAILLIERE CLIN HAEM, V11, P1, DOI 10.1016/S0950-3536(98)80069-3; GILLES HM, 1967, LANCET, V1, P138; Herrmann MG, 2000, CLIN CHEM, V46, P425; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Kyes S, 2001, ANNU REV MICROBIOL, V55, P673, DOI 10.1146/annurev.micro.55.1.673; Maitland K, 2004, ACTA TROP, V90, P131, DOI 10.1016/j.actatropica.2003.11.010; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Meerman L, 2005, J INFECT DIS, V192, P1651, DOI 10.1086/496887; Mockenhaupt FP, 2004, BLOOD, V104, P2003, DOI 10.1182/blood-2003-11-4090; Mockenhaupt FP, 2004, J INFECT DIS, V190, P1006, DOI 10.1086/422847; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; Newton CRJC, 2000, J NEUROL NEUROSUR PS, V69, P433, DOI 10.1136/jnnp.69.4.433; Pasvol G, 2006, PLOS MED, V3, P591, DOI 10.1371/journal.pmed.0030235; Rees DC, 1998, BRIT J HAEMATOL, V103, P365; Roberts DJ, 2005, CURR TOP MICROBIOL, V295, P137; Shute G. T., 1988, Malaria: principles and practice of malariology. Volume 1., P781; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; SNOW R, 2003, 11 NIH FOG INT CTR, P1; Taylor T, 2006, T ROY SOC TROP MED H, V100, P615, DOI 10.1016/j.trstmh.2005.09.021; Wambua S, 2006, PLOS MED, V3, P643, DOI 10.1371/journal.pmed.0030158; Williams TN, 2006, CURR OPIN MICROBIOL, V9, P388, DOI 10.1016/j.mib.2006.06.009; Williams TN, 2005, BLOOD, V106, P368, DOI 10.1182/blood-2005-01-0313; Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744	37	122	123	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2007	297	20					2220	2226		10.1001/jama.297.20.2220	http://dx.doi.org/10.1001/jama.297.20.2220			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170JM	17519411				2022-12-01	WOS:000246659700021
J	Watts, G				Watts, Geoff			The locked code	BRITISH MEDICAL JOURNAL			English	Article												geoff@scileg.freeserve.co.uk						CRICHTON M, 2007, NY TIMES        0213; Nuffield Council on Bioethics, 2002, ETH PAT DNA; *U SUSS SCI TECHN, 2006, PAT HUM DNA GLOB TRE; *UN, 1997, UN DECL HUM GEN HUM; *WELLC TRUST, SNP CONS INT HAPM PR	5	0	0	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 19	2007	334	7602					1032	1033		10.1136/bmj.39190.654132.94	http://dx.doi.org/10.1136/bmj.39190.654132.94			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	174AL	17510149	Green Published			2022-12-01	WOS:000246913500029
J	Chuang, CF; VanHoven, MK; Fetter, RD; Verselis, VK; Bargmann, CI				Chuang, Chiou-Fen; VanHoven, Miri K.; Fetter, Richard D.; Verselis, Vytas K.; Bargmann, Cornelia I.			An innexin-dependent cell network establishes left-right neuronal asymmetry in C. elegans	CELL			English	Article							GAP-JUNCTION PROTEINS; ODORANT RECEPTOR EXPRESSION; CAENORHABDITIS-ELEGANS; NERVOUS-SYSTEM; OLFACTORY NEURONS; XENOPUS-OOCYTES; DROSOPHILA; CHANNELS; FAMILY; MECHANISMS	Gap junctions are widespread in immature neuronal circuits, but their functional significance is poorly understood. We show here that a transient network formed by the innexin gap-junction protein NSY-5 coordinates left-right asymmetry in the developing nervous system of Caenorhabditis elegans. nsy-5 is required for the left and right AWC olfactory neurons to establish stochastic, asymmetric patterns of gene expression during embryogenesis. nsy-5-dependent gap junctions in the embryo transiently connect the AWC cell bodies with those of numerous other neurons. Both AWCs and several other classes of nsy-5-expressing neurons participate in signaling that coordinates left-right AWC asymmetry. The right AWC can respond to nsy-5 directly, but the left AWC requires nsy-5 function in multiple cells of the network. NSY-5 forms hemichannels and intercellular gap-junction channels in Xenopus oocytes, consistent with a combination of cell-intrinsic and network functions. These results provide insight into gap-junction activity in developing circuits.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA	Howard Hughes Medical Institute; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine	Bargmann, CI (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	cori@rockefeller.edu		Bargmann, Cornelia/0000-0002-8484-0618; VanHoven, Miri/0000-0001-7714-1555; Chuang, Chiou-Fen/0000-0001-7469-076X	NIDCD NIH HHS [R01 DC04089] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004089] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bauer R, 2004, MOL BIOL CELL, V15, P2992, DOI 10.1091/mbc.E04-01-0056; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; BRENNER S, 1974, GENETICS, V77, P71; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Chang Q, 1999, J NEUROSCI, V19, P10813, DOI 10.1523/JNEUROSCI.19-24-10813.1999; Chuang CF, 2005, GENE DEV, V19, P270, DOI 10.1101/gad.1276505; Curtin KD, 2002, J NEUROSCI, V22, P7088; EBIHARA L, 1993, J GEN PHYSIOL, V102, P59, DOI 10.1085/jgp.102.1.59; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Hobert O, 2002, NAT REV NEUROSCI, V3, P629, DOI 10.1038/nrn897; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kandler K, 1998, J NEUROSCI, V18, P1419; Kandler Karl, 1995, Current Opinion in Neurobiology, V5, P98, DOI 10.1016/0959-4388(95)80093-X; Landesman Y, 1999, J CELL SCI, V112, P2391; LEE SH, 1994, GLIA, V11, P315, DOI 10.1002/glia.440110404; Levin M, 1999, DEVELOPMENT, V126, P4703; Li SL, 2003, MOL BIOL CELL, V14, P2630, DOI 10.1091/mbc.E02-11-0716; Liu Q, 2006, J BIOL CHEM, V281, P7881, DOI 10.1074/jbc.M512382200; Phelan P, 1998, NATURE, V391, P181, DOI 10.1038/34426; Phelan P, 2005, BBA-BIOMEMBRANES, V1711, P225, DOI 10.1016/j.bbamem.2004.10.004; Rongo C, 1999, NATURE, V402, P195, DOI 10.1038/46065; Saez JC, 2005, BBA-BIOMEMBRANES, V1711, P215, DOI 10.1016/j.bbamem.2005.01.014; Sagasti A, 2001, CELL, V105, P221, DOI 10.1016/S0092-8674(01)00313-0; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Singer JH, 2001, J NEUROSCI, V21, P8514, DOI 10.1523/JNEUROSCI.21-21-08514.2001; Srinivas M, 2006, J GEN PHYSIOL, V127, P67, DOI 10.1085/jgp.200509397; Starich T, 2001, CELL COMMUN ADHES, V8, P311, DOI 10.3109/15419060109080744; Starich TA, 1996, J CELL BIOL, V134, P537, DOI 10.1083/jcb.134.2.537; Starich TA, 2003, DEV BIOL, V256, P403, DOI 10.1016/S0012-1606(02)00116-1; Stebbings LA, 2000, MOL BIOL CELL, V11, P2459, DOI 10.1091/mbc.11.7.2459; Stebbings LA, 2002, MECH DEVELOP, V113, P197, DOI 10.1016/S0925-4773(02)00025-4; Tanaka-Hino M, 2002, EMBO REP, V3, P56, DOI 10.1093/embo-reports/kvf001; Trexler EB, 2000, BIOPHYS J, V79, P3036, DOI 10.1016/S0006-3495(00)76539-8; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; VanHoven MK, 2006, NEURON, V51, P291, DOI 10.1016/j.neuron.2006.06.029; VERSELIS VK, 1994, NATURE, V368, P348, DOI 10.1038/368348a0; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8; ZAMPIGHI G, 1980, J CELL BIOL, V86, P190, DOI 10.1083/jcb.86.1.190	43	104	117	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2007	129	4					787	799		10.1016/j.cell.2007.02.052	http://dx.doi.org/10.1016/j.cell.2007.02.052			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512411	Bronze			2022-12-01	WOS:000246788300022
J	Charo, RA				Charo, R. Alta			Politics, parents, and prophylaxis - Mandating HPV vaccination in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Wisconsin, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Charo, RA (corresponding author), Univ Wisconsin, Madison, WI 53706 USA.			Charo, Robin Alta/0000-0003-3710-1043				Bleakley A, 2006, ARCH PEDIAT ADOL MED, V160, P1151, DOI 10.1001/archpedi.160.11.1151; Dailard C, 2006, GUTTMACHER POLICY RE, V9, P12; Hodge James G, 2001, KY Law J, V90, P831; National Foundation for Infectious Diseases, 2005, AD VACC BRIDG STRONG	4	83	85	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2007	356	19					1905	1908		10.1056/NEJMp078054	http://dx.doi.org/10.1056/NEJMp078054			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	165KX	17494922				2022-12-01	WOS:000246305500001
J	Weitzer, S; Martinez, J				Weitzer, Stefan; Martinez, Javier			The human RNA kinase hClp1 is active on 3 ' transfer RNA exons and short interfering RNAs	NATURE			English	Article							PROMOTES TRANSCRIPTION TERMINATION; POLYMERASE-II; CLEAVAGE; YEAST; COMPLEX; CELLS; REQUIREMENTS; PURIFICATION; RIBONUCLEASE; PROTEIN	RNA interference allows the analysis of gene function by introducing synthetic, short interfering RNAs (siRNAs) into cells(1). In contrast to siRNA and microRNA duplexes generated endogenously by the RNaseIII endonuclease Dicer(2), synthetic siRNAs display a 5' OH group. However, to become incorporated into the RNA-induced silencing complex (RISC) and mediate target RNA cleavage, the guide strand of an siRNA needs to display a phosphate group at the 5' end(3-5). The identity of the responsible kinase has so far remained elusive. Monitoring siRNA phosphorylation, we applied a chromatographic approach that resulted in the identification of the protein hClp1 ( human Clp1), a known component of both transfer RNA splicing(6) and messenger RNA 3'-end formation(7) machineries. Here we report that the kinase hClp1 phosphorylates and licenses synthetic siRNAs to become assembled into RISC for subsequent target RNA cleavage. More importantly, we reveal the physiological role of hClp1 as the RNA kinase that phosphorylates the 5' end of the 3' exon during human tRNA splicing(8), allowing the subsequent ligation of both exon halves by an unknown tRNA ligase. The investigation of this novel enzymatic activity of hClp1 in the context of mRNA 3'-end formation, where no RNA phosphorylation event has hitherto been predicted, remains a challenge for the future.	Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Martinez, J (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	javier.martinez@imba.oeaw.ac.at		Martinez, Javier/0000-0001-9152-7323				Abelson J, 1998, J BIOL CHEM, V273, P12685, DOI 10.1074/jbc.273.21.12685; Aranda A, 2001, MOL CELL, V7, P1003, DOI 10.1016/S1097-2765(01)00235-0; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; de Vries H, 2000, EMBO J, V19, P5895, DOI 10.1093/emboj/19.21.5895; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; FILIPOWICZ W, 1983, CELL, V32, P547, DOI 10.1016/0092-8674(83)90474-9; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; LASKI FA, 1983, J BIOL CHEM, V258, P1974; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; MinvielleSebastia L, 1997, P NATL ACAD SCI USA, V94, P7897, DOI 10.1073/pnas.94.15.7897; NISHIKURA K, 1981, J MOL BIOL, V145, P405, DOI 10.1016/0022-2836(81)90212-6; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; Pellino JL, 2005, RNA, V11, P1719, DOI 10.1261/rna.2102805; Pham JW, 2005, J BIOL CHEM, V280, P39278, DOI 10.1074/jbc.M509202200; SHUMAN S, 1979, J BIOL CHEM, V254, P396; STEVENS A, 1995, J BIOL CHEM, V270, P16063, DOI 10.1074/jbc.270.27.16063; Tanabe S, 1996, BLOOD, V88, P3535; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang LK, 2001, J BIOL CHEM, V276, P26868, DOI 10.1074/jbc.M103663200; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Wickens M, 2004, SCIENCE, V306, P1299, DOI 10.1126/science.1100137; WINICOV I, 1982, MOL CELL BIOL, V2, P241, DOI 10.1128/MCB.2.3.241; ZILLMANN M, 1991, MOL CELL BIOL, V11, P5410, DOI 10.1128/MCB.11.11.5410; ZILLMANN M, 1992, J BIOL CHEM, V267, P10289	27	158	170	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2007	447	7141					222	U8		10.1038/nature05777	http://dx.doi.org/10.1038/nature05777			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17495927				2022-12-01	WOS:000246338700047
J	Bielas, SL; Serneo, FF; Chechlacz, M; Deerinck, TJ; Perkins, GA; Allen, PB; Ellisman, MH; Gleeson, JG				Bielas, Stephanie L.; Serneo, Finley F.; Chechlacz, Magdalena; Deerinck, Thomas J.; Perkins, Guy A.; Allen, Patrick B.; Ellisman, Mark H.; Gleeson, Joseph G.			Spinophilin facilitates dephosphorylation of doublecortin by PP1 to mediate microtubule bundling at the axonal wrist	CELL			English	Article							NEURONAL MIGRATION; PROTEIN PHOSPHATASE-1; NEURABIN-II; GROWTH CONE; DENDRITIC SPINES; ACTIN-FILAMENTS; BINDING-PROTEIN; KINASE; CDK5; MICE	The axonal shafts of neurons contain bundled microtubules, whereas extending growth cones contain unbundled microtubule filaments, suggesting that localized activation of microtubule-associated proteins (MAP) at the transition zone may bundle these filaments during axonal growth. Dephosphorylation is thought to lead to MAP activation, but specific molecular pathways have remained elusive. We find that Spinophilin, a Protein-phosphatase 1 (PP1) targeting protein, is responsible for the dephosphorylation of the MAP Doublecortin (Dcx) Ser 297 selectively at the "wrist" of growing axons, leading to activation. Loss of activity at the "wrist" is evident as an impaired microtubule cytoskeleton along the shaft. These findings suggest that spatially restricted adaptor-specific MAP reactivation through dephosphorylation is important in organization of the neuronal cytoskeleton.	Univ Calif San Diego, Neurogenet Lab, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Yale University	Gleeson, JG (corresponding author), Univ Calif San Diego, Neurogenet Lab, Dept Neurosci, La Jolla, CA 92093 USA.	jogleeson@ucsd.edu	Chechlacz, Magdalena/ABB-6360-2021	Chechlacz, Magdalena/0000-0003-1811-3946; Perkins, Guy/0000-0002-1834-6646; Bielas, Stephanie/0000-0003-0567-5632	NCRR NIH HHS [P41 RR004050, P41 RR04050] Funding Source: Medline; NINDS NIH HHS [R01 NS041537, R01 NS14718, K02 NS042749-05, P30 NS047101-03S1, R01 NS041537-05, P30 NS047101-04, K02 NS042749, P30 NS047101, R01 NS014718] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041537, P30NS047101, R01NS014718, K02NS042749] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agarwal-Mawal A, 2001, J BIOL CHEM, V276, P23712, DOI 10.1074/jbc.M010002200; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; CAJAL SRY, 1988, CAJAL CEREBRAL CORTE; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Corbo JC, 2002, J NEUROSCI, V22, P7548; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; des Portes V, 1998, CELL, V92, P51; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Friocourt G, 2003, CEREB CORTEX, V13, P620, DOI 10.1093/cercor/13.6.620; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Gdalyahu A, 2004, EMBO J, V23, P823, DOI 10.1038/sj.emboj.7600079; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Kappeler C, 2006, HUM MOL GENET, V15, P1387, DOI 10.1093/hmg/ddl062; Kappeler C, 2007, J COMP NEUROL, V500, P239, DOI 10.1002/cne.21170; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704; MACKINTOSH C, 1990, FEBS LETT, V277, P137, DOI 10.1016/0014-5793(90)80828-7; MacMillan LB, 1999, J BIOL CHEM, V274, P35845, DOI 10.1074/jbc.274.50.35845; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Rothenberg ME, 2003, NEURON, V39, P779, DOI 10.1016/S0896-6273(03)00508-7; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; Szebenyi G, 1998, J NEUROSCI, V18, P7930; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; Taylor KR, 2000, J BIOL CHEM, V275, P34442, DOI 10.1074/jbc.M007078200; Tsukada M, 2006, BIOCHEM BIOPH RES CO, V343, P839, DOI 10.1016/j.bbrc.2006.03.045; Tsukada M, 2005, J BIOL CHEM, V280, P11361, DOI 10.1074/jbc.M405525200; Tsukada M, 2003, MECH DEVELOP, V120, P1033, DOI 10.1016/S0925-4773(03)00177-1; Wahlsten D, 2006, GENES BRAIN BEHAV, V5, P170, DOI 10.1111/j.1601-183X.2005.00153.x; YU WQ, 1994, J NEUROSCI, V14, P2818; Zaman K, 1999, J NEUROSCI, V19, P9821	38	110	114	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					579	591		10.1016/j.cell.2007.03.023	http://dx.doi.org/10.1016/j.cell.2007.03.023			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482550	Green Accepted, Bronze			2022-12-01	WOS:000246373600023
J	Fukao, T; Fukuda, Y; Kiga, K; Sharif, J; Hino, K; Enomoto, Y; Kawamura, A; Nakamura, K; Takeuchi, T; Tanabe, M				Fukao, Taro; Fukuda, Yoko; Kiga, Kotaro; Sharif, Jafar; Hino, Kimihiro; Enomoto, Yutaka; Kawamura, Aya; Nakamura, Kaito; Takeuchi, Tsutomu; Tanabe, Masanobu			An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling	CELL			English	Editorial Material							TRANSCRIPTIONAL REGULATION; DIFFERENTIATION; IDENTIFICATION; C/EBP; BIOGENESIS; GENOMICS	Many microRNAs (miRNAs) are evolutionarily conserved and have intriguing expression patterns. Tissue and/or time-specific expressions of some miRNAs are presumably controlled by unique cis-acting regulatory elements that coevolved with the miRNA sequences. Exploiting bioinformatics, we identified several miRNAs whose primary transcripts could be regulated by conserved genomic elements proximal to their transcription start sites. Such miRNAs include microRNA-223 (miR-223), which is reportedly controlled by a unique regulatory mechanism during granulopoiesis. Here, we define a mechanism distinct from that previously proposed to regulate miR-223 expression. We find that the mir-223 gene resembles a "myeloid gene" and might be driven by the myeloid transcription factors, PU.1 and C/EBPs. This mechanism is specified by the conserved proximal cis-regulatory element and might be common among different species. Hence, it needs to be considered that two distinct mechanisms that would play critical roles in myeloid functions and differentiation are actually concerned with the regulation of miR-223.	Univ Tokyo, Dept Chem & Biotechnol, Grad Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; Univ Tokyo, Dept Neurol, Grad Sch Med, Bunkyo Ku, Tokyo 1138656, Japan; Keio Univ, Sch Med, Dept Trop Med & Parasitol, Shinjuku Ku, Tokyo 1608582, Japan	University of Tokyo; University of Tokyo; Keio University	Fukao, T (corresponding author), Univ Tokyo, Dept Chem & Biotechnol, Grad Sch Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	tarofukao@2002.jukuin.keio.ac.jp	Nakamura, Kaito/AAY-7547-2021; Fukao, Taro/I-3246-2014; Nakamura, Kaito/AFS-6165-2022	Nakamura, Kaito/0000-0002-1009-240X; Nakamura, Kaito/0000-0002-1009-240X; Hino, Kimihiro/0000-0003-0617-8232; Enomoto, Yutaka/0000-0002-6346-9362; Fukuda-Yuzawa, Yoko/0000-0002-9887-9820				Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Carninci P, 1999, METHOD ENZYMOL, V303, P19; Carninci P, 2000, GENOME RES, V10, P1617, DOI 10.1101/gr.145100; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chen CZ, 2005, SEMIN IMMUNOL, V17, P155, DOI 10.1016/j.smim.2005.01.001; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Duprez E, 2003, EMBO J, V22, P5806, DOI 10.1093/emboj/cdg556; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Friedman AD, 2002, ONCOGENE, V21, P3377, DOI 10.1038/sj.onc.1205324; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; GROVE M, 1993, MOL CELL BIOL, V13, P5276, DOI 10.1128/MCB.13.9.5276; Himes SR, 2001, J LEUKOCYTE BIOL, V70, P812; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lipman DJ, 1997, NUCLEIC ACIDS RES, V25, P3580, DOI 10.1093/nar/25.18.3580; Mueller BU, 2006, BLOOD, V107, P3330, DOI 10.1182/blood-2005-07-3068; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Orkin SH, 2002, NAT IMMUNOL, V3, P323, DOI 10.1038/ni0402-323; Pasquinelli AE, 2005, CURR OPIN GENET DEV, V15, P200, DOI 10.1016/j.gde.2005.01.002; Qiao LP, 2005, DIABETES, V54, P1744, DOI 10.2337/diabetes.54.6.1744; Rosmarin AG, 2005, EXP HEMATOL, V33, P131, DOI 10.1016/j.exphem.2004.08.015; Sieweke MH, 1998, CURR OPIN GENET DEV, V8, P545, DOI 10.1016/S0959-437X(98)80009-9; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Venkatesh B, 2005, BIOESSAYS, V27, P100, DOI 10.1002/bies.20134; YAMANAKA I, 2001, NATURE, V409, P685; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhu J, 2002, ONCOGENE, V21, P3295, DOI 10.1038/sj.onc.1205318	38	259	278	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					617	631		10.1016/j.cell.2007.02.048	http://dx.doi.org/10.1016/j.cell.2007.02.048			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482553	Bronze			2022-12-01	WOS:000246373600026
J	Whalen, EJ; Foster, MW; Matsumoto, A; Ozawa, K; Violin, JD; Que, LG; Nelson, CD; Benhar, M; Keys, JR; Rockman, HA; Koch, WJ; Daaka, Y; Lefkowitz, RJ; Stamler, JS				Whalen, Erin J.; Foster, Matthew W.; Matsumoto, Akio; Ozawa, Kentaro; Violin, Jonathan D.; Que, Loretta G.; Nelson, Chris D.; Benhar, Moran; Keys, Janelle R.; Rockman, Howard A.; Koch, Walter J.; Daaka, Yehia; Lefkowitz, Robert J.; Stamler, Jonathan S.			Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2	CELL			English	Article							NITRIC-OXIDE SYNTHASE; HEART-FAILURE; BETA-2-ADRENERGIC RECEPTOR; SMOOTH-MUSCLE; PHOSPHORYLATION; ACTIVATION; DESENSITIZATION; TRANSLOCATION; NITROSOTHIOLS; EXPRESSION	beta-adrenergic receptors (beta-ARs), prototypic G-protein-coupled receptors (GPCRs), play a critical role in regulating numerous physiological processes. The GPCR kinases (GRKs) curtail G-protein signaling and target receptors for internalization. Nitric oxide (NO) and/or S-nitrosothiols (SNOs) can prevent the loss of beta-AR signaling in vivo, but the molecular details are unknown. Here we show in mice that SNOs increase beta-AR expression and prevent agonist-stimulated receptor downregulation; and in cells, SNOs decrease GRK2-mediated beta-AR phosphorylation and subsequent recruitment of beta-arrestin to the receptor, resulting in the attenuation of receptor desensitization and internalization. In both cells and tissues, GRK2 is S-nitrosylated by SNOs as well as by NO synthases, and GRK2 S-nitrosylation increases following stimulation of multiple GPCRs with agonists. Cys340 of GRK2 is identified as a principal locus of inhibition by S-nitrosylation. Our studies thus reveal a central molecular mechanism through which GPCR signaling is regulated.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Mol Genet, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Jefferson Med Coll, Dept Med, Philadelphia, PA 19107 USA; Med Coll Georgia, Dept Pathol, Augusta, GA 30912 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Howard Hughes Medical Institute; Jefferson University; University System of Georgia; Augusta University	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	lefko001@receptor-biol.duke.edu; staml001@mc.duke.edu	Benhar, Moran/AAV-5764-2020; Lefkowitz, Robert/AAW-2649-2021	Benhar, Moran/0000-0002-7094-3456; Stamler, Jonathan/0000-0002-6866-1572; Matsumoto, Akio/0000-0002-3402-6992	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070631, R01HL016037, R01HL061690, P01HL075443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U19ES012496] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01-HL075443, R01 HL16037, R01 HL61690, R01 HL70631] Funding Source: Medline; NIEHS NIH HHS [U19-ES012496] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Adam L, 1999, J BIOL CHEM, V274, P26337, DOI 10.1074/jbc.274.37.26337; ADAMS JA, 1995, BIOCHEMISTRY-US, V34, P2447, DOI 10.1021/bi00008a007; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Cao S, 2001, J BIOL CHEM, V276, P14249, DOI 10.1074/jbc.M006258200; Choi DJ, 1997, J BIOL CHEM, V272, P17223, DOI 10.1074/jbc.272.27.17223; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Currie GP, 2006, DRUG SAFETY, V29, P647, DOI 10.2165/00002018-200629080-00002; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Dudzinski DM, 2006, ANNU REV PHARMACOL, V46, P235, DOI 10.1146/annurev.pharmtox.44.101802.121844; Fang M, 2000, NEURON, V28, P183, DOI 10.1016/S0896-6273(00)00095-7; Felley-Bosco E, 2000, P NATL ACAD SCI USA, V97, P14334, DOI 10.1073/pnas.250406797; FERGUSON SSG, 1995, J BIOL CHEM, V270, P24782, DOI 10.1074/jbc.270.42.24782; Ferro A, 1999, BRIT J PHARMACOL, V126, P1872, DOI 10.1038/sj.bjp.0702512; Flier J, 1996, NEW ENGL J MED, V334, P580, DOI 10.1056/NEJM199602293340907; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Gaston B, 2006, AM J RESP CRIT CARE, V173, P1186, DOI 10.1164/rccm.200510-1584PP; GOSINK EC, 1993, AM J PHYSIOL, V265, pC1620, DOI 10.1152/ajpcell.1993.265.6.C1620; Gow AJ, 2002, J BIOL CHEM, V277, P9637, DOI 10.1074/jbc.C100746200; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Hansen JL, 2006, TRENDS CARDIOVAS MED, V16, P169, DOI 10.1016/j.tcm.2006.03.004; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hare JM, 2005, J CLIN INVEST, V115, P509, DOI 10.1172/JCI200524459; Hata JA, 2004, J MOL CELL CARDIOL, V37, P11, DOI 10.1016/j.yjmcc.2004.03.014; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hu LYA, 2000, J BIOL CHEM, V275, P38659, DOI 10.1074/jbc.M005938200; Huang Y, 2005, NEURON, V46, P533, DOI 10.1016/j.neuron.2005.03.028; Iaccarino G, 1998, CIRCULATION, V98, P1783, DOI 10.1161/01.CIR.98.17.1783; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Johnson M, 1998, AM J RESP CRIT CARE, V158, pS146, DOI 10.1164/ajrccm.158.supplement_2.13tac110; Ju H, 1998, J BIOL CHEM, V273, P24025, DOI 10.1074/jbc.273.37.24025; Kaiser RA, 2002, CIRC RES, V91, P292, DOI 10.1161/01.RES.0000030711.21521.AC; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; Kokkola T, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-21; Leclerc PC, 2006, BRIT J PHARMACOL, V148, P306, DOI 10.1038/sj.bjp.0706725; Lefkowitz RJ, 2000, CIRCULATION, V101, P1634; Lefkowitz RJ, 2002, MOL PHARMACOL, V62, P971, DOI 10.1124/mol.62.5.971; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lipton AJ, 2001, NATURE, V413, P171, DOI 10.1038/35093117; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Liu SL, 2005, NAT MED, V11, P952, DOI 10.1038/nm1289; Matkovich SJ, 2006, CIRC RES, V99, P996, DOI 10.1161/01.RES.0000247932.71270.2c; ONORATO JJ, 1991, BIOCHEMISTRY-US, V30, P5118, DOI 10.1021/bi00235a002; Ostrovidov S, 2004, BIOMED MICRODEVICES, V6, P279, DOI 10.1023/B:BMMD.0000048560.96140.ca; Penn RB, 1998, AM J RESP CELL MOL, V19, P338, DOI 10.1165/ajrcmb.19.2.3025; Perrino C, 2005, CIRCULATION, V111, P2579, DOI 10.1161/CIRCULATIONAHA.104.508796; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Prabhakar P, 1998, J BIOL CHEM, V273, P27383, DOI 10.1074/jbc.273.42.27383; Que LG, 2005, SCIENCE, V308, P1618, DOI 10.1126/science.1108228; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Rockman HA, 1998, P NATL ACAD SCI USA, V95, P7000, DOI 10.1073/pnas.95.12.7000; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P7674, DOI 10.1073/pnas.89.16.7674; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Sun JH, 2006, CIRC RES, V98, P403, DOI 10.1161/01.RES.0000202707.79018.0a; Tilley Douglas G, 2006, Expert Rev Cardiovasc Ther, V4, P417, DOI 10.1586/14779072.4.3.417; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Wang GF, 2006, P NATL ACAD SCI USA, V103, P1295, DOI 10.1073/pnas.0508354103; Whalen EJ, 2000, HYPERTENSION, V36, P376, DOI 10.1161/01.HYP.36.3.376; White DC, 2000, P NATL ACAD SCI USA, V97, P5428, DOI 10.1073/pnas.090091197; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; ZHAO MM, 1993, CIRC RES, V73, P943, DOI 10.1161/01.RES.73.5.943	67	236	245	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					511	522		10.1016/j.cell.2007.02.046	http://dx.doi.org/10.1016/j.cell.2007.02.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482545	Bronze			2022-12-01	WOS:000246373600018
J	McCurry, J				McCurry, Justin			Japan unveils 5-year plan to boost clinical research	LANCET			English	Editorial Material																			0	11	12	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 21	2007	369	9570					1333	1336		10.1016/S0140-6736(07)60615-1	http://dx.doi.org/10.1016/S0140-6736(07)60615-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	159HL	17455378				2022-12-01	WOS:000245856100011
J	Duarte, CM; Marba, N; Holmer, M				Duarte, Carlos M.; Marba, Nuria; Holmer, Marianne			Rapid domestication of marine species	SCIENCE			English	Editorial Material							AQUACULTURE		UIB, CSIC, IMEDEA, Inst Mediterraneo Estudios Avanzados, Esporles 07190, Mallorca, Spain; Univ So Denmark, Inst Biol, DK-5230 Odense M, Denmark	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Southern Denmark	Duarte, CM (corresponding author), UIB, CSIC, IMEDEA, Inst Mediterraneo Estudios Avanzados, Esporles 07190, Mallorca, Spain.	carlosduarte@imedea.uib.es	Holmer, Marianne/M-6989-2014; Duarte, Carlos M/A-7670-2013; Marba, Nuria/H-8136-2015; Duarte Quesada, Carlos Manuel/ABD-6208-2021; Marbà, Nuria/N-8143-2019	Holmer, Marianne/0000-0002-6095-5488; Duarte, Carlos M/0000-0002-1213-1361; Marba, Nuria/0000-0002-8048-6789; Marbà, Nuria/0000-0002-8048-6789				Diamond JM, 2001, NATURE, V411, P755, DOI 10.1038/35081231; *FAO, 2006, FAOSTAT AGR; *FAO, 2006, 500 FAO UN FAO; FAO, 2006, FAO FISH INF DAT STA; Groombridge B., 2000, GLOBAL BIODIVERSITY; Hale E. B., 1969, BEHAV DOMESTIC ANIMA, P22; Mannion AM, 1999, PROG PHYS GEOG, V23, P37, DOI 10.1191/030913399677315626; Naylor RL, 1998, SCIENCE, V282, P883, DOI 10.1126/science.282.5390.883; Neori A, 2004, AQUACULTURE, V231, P361, DOI 10.1016/j.aquaculture.2003.11.015; Normile D, 1997, SCIENCE, V275, P309, DOI 10.1126/science.275.5298.309; Olive PJW, 1999, HYDROBIOLOGIA, V402, P175, DOI 10.1023/A:1003744610012; Pullin R.S.V., 1996, P409; Sorgeloos, 1999, WORLD AQUACULTURE, V30, P11; Woods LC, 2001, AQUACULTURE, V202, P343, DOI 10.1016/S0044-8486(01)00783-9	14	170	172	2	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					382	383		10.1126/science.1138042	http://dx.doi.org/10.1126/science.1138042			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446380				2022-12-01	WOS:000245813400031
J	Hermann, JC; Marti-Arbona, R; Fedorov, AA; Fedorov, E; Almo, SC; Shoichet, BK; Raushel, FM				Hermann, Johannes C.; Marti-Arbona, Ricardo; Fedorov, Alexander A.; Fedorov, Elena; Almo, Steven C.; Shoichet, Brian K.; Raushel, Frank M.			Structure-based activity prediction for an enzyme of unknown function	NATURE			English	Article							DOCKING; INHIBITORS; CATALYSIS; ERRORS	With many genomes sequenced, a pressing challenge in biology is predicting the function of the proteins that the genes encode. When proteins are unrelated to others of known activity, bioinformatics inference for function becomes problematic. It would thus be useful to interrogate protein structures for function directly. Here, we predict the function of an enzyme of unknown activity, Tm0936 from Thermotoga maritima, by docking high- energy intermediate forms of thousands of candidate metabolites. The docking hit list was dominated by adenine analogues, which appeared to undergo C6- deamination. Four of these, including 5- methylthioadenosine and S- adenosylhomocysteine ( SAH), were tested as substrates, and three had substantial catalytic rate constants ( 10(5) M-1 s(-1)). The X- ray crystal structure of the complex between Tm0936 and the product resulting from the deamination of SAH, S- inosylhomocysteine, was determined, and it corresponded closely to the predicted structure. The deaminated products can be further metabolized by T. maritima in a previously uncharacterized SAH degradation pathway. Structure- based docking with high- energy forms of potential substrates may be a useful tool to annotate enzymes for function.	Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; Texas A&M Univ, Dept Chem, College Stn, TX 77842 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	University of California System; University of California San Francisco; Texas A&M University System; Texas A&M University College Station; Yeshiva University; Albert Einstein College of Medicine	Shoichet, BK (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, MC 2550 1700 4th St, San Francisco, CA 94158 USA.	shoichet@cgl.ucsf.edu	Raushel, Frank/B-7125-2015	Raushel, Frank/0000-0002-5918-3089	NIGMS NIH HHS [R01 GM059957, R01 GM059957-09, R01 GM071896-04, R01 GM071896] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071896, R01GM059957] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brenner SE, 1999, TRENDS GENET, V15, P132, DOI 10.1016/S0168-9525(99)01706-0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cleland W W, 1979, Methods Enzymol, V63, P103; Cleland W W, 1979, Methods Enzymol, V63, P500; Devos D, 2001, TRENDS GENET, V17, P429, DOI 10.1016/S0168-9525(01)02348-4; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; Gerlt JA, 2000, GENOME BIOL, V1; GILSON MK, 1987, NATURE, V330, P84, DOI 10.1038/330084a0; Gschwend DA, 1996, J COMPUT AID MOL DES, V10, P123, DOI 10.1007/BF00402820; Hermann JC, 2006, ORG BIOMOL CHEM, V4, P206, DOI 10.1039/b512969a; Hermann JC, 2006, J AM CHEM SOC, V128, P15882, DOI 10.1021/ja065860f; Holm L, 1997, PROTEINS, V28, P72, DOI 10.1002/(SICI)1097-0134(199705)28:1<72::AID-PROT7>3.0.CO;2-L; Irwin JJ, 2005, BIOCHEMISTRY-US, V44, P12316, DOI 10.1021/bi050801k; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; JONES TA, 1985, METHOD ENZYMOL, V115, P157; Jorgensen WL, 2004, SCIENCE, V303, P1813, DOI 10.1126/science.1096361; Kairys V, 2006, J CHEM INF MODEL, V46, P365, DOI 10.1021/ci050238c; Kalyanaraman C, 2005, BIOCHEMISTRY-US, V44, P2059, DOI 10.1021/bi0481186; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Klebe G, 2006, DRUG DISCOV TODAY, V11, P580, DOI 10.1016/j.drudis.2006.05.012; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Lorber DM, 2005, CURR TOP MED CHEM, V5, P739, DOI 10.2174/1568026054637683; Macchiarulo A, 2004, NAT BIOTECHNOL, V22, P1039, DOI 10.1038/nbt999; MENG EC, 1992, J COMPUT CHEM, V13, P505, DOI 10.1002/jcc.540130412; Mohan V, 2005, CURR PHARM DESIGN, V11, P323, DOI 10.2174/1381612053382106; MUSZBEK L, 1985, CLIN CHEM, V31, P35; Nowlan C, 2006, J AM CHEM SOC, V128, P15892, DOI 10.1021/ja0658618; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pegg SCH, 2006, BIOCHEMISTRY-US, V45, P2545, DOI 10.1021/bi052101l; RADZICKA A, 1995, SCIENCE, V267, P90, DOI 10.1126/science.7809611; Rao MS, 1999, PROTEINS, V34, P173, DOI 10.1002/(SICI)1097-0134(19990201)34:2<173::AID-PROT3>3.0.CO;2-F; Schapira M, 2003, J MED CHEM, V46, P3045, DOI 10.1021/jm0300173; Schramm VL, 2005, CURR OPIN STRUC BIOL, V15, P604, DOI 10.1016/j.sbi.2005.10.017; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; SPEEDIE MK, 1988, J BACTERIOL, V170, P4376, DOI 10.1128/jb.170.9.4376-4378.1988; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sukuru SCK, 2006, J COMPUT AID MOL DES, V20, P159, DOI 10.1007/s10822-006-9043-5; Tantillo DJ, 2002, J COMPUT CHEM, V23, P84, DOI 10.1002/jcc.10019; Tyler PC, 2007, J AM CHEM SOC, V129, P6872, DOI 10.1021/ja0708363; Warshel A, 1998, P NATL ACAD SCI USA, V95, P5950, DOI 10.1073/pnas.95.11.5950; Wei BQQ, 2002, J MOL BIOL, V322, P339, DOI 10.1016/S0022-2836(02)00777-5; Whisstock JC, 2003, Q REV BIOPHYS, V36, P307, DOI 10.1017/S0033583503003901	43	202	215	2	49	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 16	2007	448	7155					775	U2		10.1038/nature05981	http://dx.doi.org/10.1038/nature05981			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17603473	Green Accepted			2022-12-01	WOS:000248754200032
J	Nurieva, R; Yang, XXO; Martinez, G; Zhang, YL; Panopoulos, AD; Ma, L; Schluns, K; Tian, Q; Watowich, SS; Jetten, AM; Dong, C				Nurieva, Roza; Yang, Xuexian O.; Martinez, Gustavo; Zhang, Yongliang; Panopoulos, Athanasia D.; Ma, Li; Schluns, Kimberly; Tian, Qiang; Watowich, Stephanie S.; Jetten, Anton M.; Dong, Chen			Essential autocrine regulation by IL-21 in the generation of inflammatory T cells	NATURE			English	Article							MYELIN OLIGODENDROCYTE GLYCOPROTEIN; AUTOIMMUNE INFLAMMATION; ROR-GAMMA; TH1 CELLS; DIFFERENTIATION; CYTOKINE; EXPRESSION; LINEAGE; T(H)17; ENCEPHALOMYELITIS	After activation, CD4(+) helper T (T-H) cells differentiate into distinct effector subsets that are characterized by their unique cytokine expression and immunoregulatory function(1,2). During this differentiation, T(H)1 and T(H)2 cells produce interferon-gamma and interleukin (IL)-4, respectively, as autocrine factors necessary for selective lineage commitment. A distinct T-H subset, termed THIL-17, T(H)17 or inflammatory T-H (T(H)i), has been recently identified as a distinct T-H lineage mediating tissue inflammation(3,4). T(H)17 differentiation is initiated by transforming growth factor-beta and IL-6 (refs 5 - 7) and reinforced by IL-23 ( ref. 8), in which signal transduction and activators of transcription ( STAT) 3 and retinoic acid receptor-related orphan receptor (ROR)-gamma mediate the lineage specification(8-10). T(H)17 cells produce IL-17, IL-17F and IL-22, all of which regulate inflammatory responses by tissue cells but have no importance in T(H)17 differentiation(11-14). Here we show that IL-21 is another cytokine highly expressed by mouse T(H)17 cells. IL-21 is induced by IL-6 in activated T cells, a process that is dependent on STAT3 but not ROR-gamma. IL-21 potently induces T(H)17 differentiation and suppresses Foxp3 expression, which requires STAT3 and ROR-gamma, which is encoded by Rorc. IL-21 deficiency impairs the generation of T(H)17 cells and results in protection against experimental autoimmune encephalomyelitis. IL-21 is therefore an autocrine cytokine that is sufficient and necessary for T(H)17 differentiation, and serves as a target for treating inflammatory diseases.	Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; Inst Syst Engn, Seattle, WA 98103 USA; NIEHS, Cell Biol Sect, LRB, NIH, Res Triangle Pk, NC 27709 USA	University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Nurieva, R (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Immunol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	rnurieva@mdanderson.org; cdong@mdanderson.org	dong, chen/B-3181-2009; Yang, Xuexian/Y-2472-2019; Jetten, Anton/C-3736-2019	dong, chen/0000-0002-0084-9130; Yang, Xuexian/0000-0001-6816-7024; Jetten, Anton/0000-0003-0954-4445; Martinez, Gustavo/0000-0003-0178-3329; Panopoulos, Athanasia/0000-0002-9610-2604; Watowich, Stephanie/0000-0003-1969-659X	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101586, Z01ES101586] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; ANGKASEKWINAI P, IN PRESS J EXP MED; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Chung YS, 2006, CELL RES, V16, P902, DOI 10.1038/sj.cr.7310106; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Dong C, 2000, ARTHRITIS RES, V2, P179, DOI 10.1186/ar85; Glimcher LH, 2000, GENE DEV, V14, P1693; Hjelmstrom P, 1998, J IMMUNOL, V161, P4480; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kleinschek MA, 2007, J EXP MED, V204, P161, DOI 10.1084/jem.20061738; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; Laky K, 1997, J IMMUNOL, V158, P1417; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Leonard WJ, 2005, NAT REV IMMUNOL, V5, P688, DOI 10.1038/nri1688; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Okuda Y, 1999, J NEUROIMMUNOL, V101, P188, DOI 10.1016/S0165-5728(99)00139-3; Okuda Y, 2000, J NEUROIMMUNOL, V105, P120, DOI 10.1016/S0165-5728(00)00192-2; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Suto A, 2006, J IMMUNOL, V177, P3721, DOI 10.4049/jimmunol.177.6.3721; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wurster AL, 2002, J EXP MED, V196, P969, DOI 10.1084/jem.20020620; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	28	1169	1268	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2007	448	7152					480	U8		10.1038/nature05969	http://dx.doi.org/10.1038/nature05969			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17581589				2022-12-01	WOS:000248302700048
J	McHugh, TJ; Jones, MW; Quinn, JJ; Balthasar, N; Coppari, R; Elmquist, JK; Lowell, BB; Fanselow, MS; Wilson, MA; Tonegawa, S				McHugh, Thomas J.; Jones, Matthew W.; Quinn, Jennifer J.; Balthasar, Nina; Coppari, Roberto; Elmquist, Joel K.; Lowell, Bradford B.; Fanselow, Michael S.; Wilson, Matthew A.; Tonegawa, Susumu			Dentate gyrus NMDA receptors mediate rapid pattern separation in the hippocampal network	SCIENCE			English	Article							SPATIAL EXPERIENCE; NEURONAL ENSEMBLES; EPISODIC MEMORY; KNOCKOUT MICE; PLACE CELLS; CA3; REPRESENTATION; RAT; SLEEP; PLASTICITY	Forming distinct representations of multiple contexts, places, and episodes is a crucial function of the hippocampus. The dentate gyrus subregion has been suggested to fulfill this role. We have tested this hypothesis by generating and analyzing a mouse strain that lacks the gene encoding the essential subunit of the N-methyl-D-aspartate (NMDA) receptor NR1, specifically in dentate gyrus granule cells. The mutant mice performed normally in contextual fear conditioning, but were impaired in the ability to distinguish two similar contexts. A significant reduction in the context-specific modulation of firing rate was observed in the CA3 pyramidal cells when the mutant mice were transferred from one context to another. These results provide evidence that NMDA receptors in the granule cells of the dentate gyrus play a crucial role in the process of pattern separation.	MIT, Picower Inst Learning & Memory, RIKEN MIT Neurosci Res Ctr, Dept Biol, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of California System; University of California Los Angeles; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Tonegawa, S (corresponding author), MIT, Picower Inst Learning & Memory, RIKEN MIT Neurosci Res Ctr, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tonegawa@mit.edu	McHugh, Thomas J/A-6693-2010; McHugh, Thomas/M-6159-2019; Coppari, Roberto/B-4799-2014	McHugh, Thomas J/0000-0002-1243-5189; McHugh, Thomas/0000-0002-1243-5189; Jones, Matthew/0000-0001-5396-3108; COPPARI, Roberto/0000-0003-1288-6948	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058880, R01MH062122] Funding Source: NIH RePORTER; MRC [G0501146] Funding Source: UKRI; Medical Research Council [G0501146] Funding Source: Medline; NIMH NIH HHS [P50-MH58880, MH62122] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cravens CJ, 2006, EUR J NEUROSCI, V24, P1771, DOI 10.1111/j.1460-9568.2006.05044.x; FANSELOW MS, 1981, LEARN MOTIV, V12, P398, DOI 10.1016/0023-9690(81)90002-3; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Gilbert PE, 2006, BEHAV BRAIN RES, V169, P142, DOI 10.1016/j.bbr.2006.01.002; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Hollup SA, 2001, EUR J NEUROSCI, V13, P1197, DOI 10.1046/j.0953-816x.2001.01487.x; Huerta PT, 2000, NEURON, V25, P473, DOI 10.1016/S0896-6273(00)80909-5; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Leutgeb S, 2006, HIPPOCAMPUS, V16, P765, DOI 10.1002/hipo.20201; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McClelland JL, 1996, HIPPOCAMPUS, V6, P654; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; McNaughton B. L., 1990, NEUROSCIENCE CONNECT, P1; Moita MAP, 2004, J NEUROSCI, V24, P7015, DOI 10.1523/JNEUROSCI.5492-03.2004; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; Rondi-Reig L, 2001, P NATL ACAD SCI USA, V98, P3543, DOI 10.1073/pnas.041620798; SCOVILLE W, 1957, J NEUROPSYCHIATRY CL, V12, P103; Shen JM, 1998, J SLEEP RES, V7, P6, DOI 10.1046/j.1365-2869.7.s1.2.x; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520	35	660	675	0	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2007	317	5834					94	99		10.1126/science.1140263	http://dx.doi.org/10.1126/science.1140263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186KD	17556551				2022-12-01	WOS:000247776700057
J	Makary, MA; Al-Attar, A; Holzmueller, CG; Sexton, JB; Syin, D; Gilson, MM; Sulkowski, MS; Pronovost, PJ				Makary, Martin A.; Al-Attar, Ali; Holzmueller, Christine G.; Sexton, J. Bryan; Syin, Dora; Gilson, Marta M.; Sulkowski, Mark S.; Pronovost, Peter J.			Needlestick injuries among surgeons in training	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEALTH-CARE WORKERS; POSTTRAUMATIC-STRESS-DISORDER; HUMAN-IMMUNODEFICIENCY-VIRUS; OCCUPATIONAL EXPOSURES; PERCUTANEOUS INJURY; SHARPS INJURIES; HIV; BLOOD; PREVALENCE; URBAN	BACKGROUND: Surgeons in training are at high risk for needlestick injuries. The reporting of such injuries is a critical step in initiating early prophylaxis or treatment. METHODS: We surveyed surgeons in training at 17 medical centers about previous needlestick injuries. Survey items inquired about whether the most recent injury was reported to an employee health service or involved a ``high-risk'' patient (i.e., one with a history of infection with human immunodeficiency virus, hepatitis B or hepatitis C, or injection-drug use); we also asked about the perceived cause of the injury and the surrounding circumstances. RESULTS: The overall response rate was 95%. Of 699 respondents, 582 (83%) had had a needlestick injury during training; the mean number of needlestick injuries during residency increased according to the postgraduate year (PGY): PGY-1, 1.5 injuries; PGY-2, 3.7; PGY-3, 4.1; PGY-4, 5.3; and PGY-5, 7.7. By their final year of training, 99% of residents had had a needlestick injury; for 53%, the injury had involved a high-risk patient. Of the most recent injuries, 297 of 578 (51%) were not reported to an employee health service, and 15 of 91 of those involving high-risk patients (16%) were not reported. Lack of time was the most common reason given for not reporting such injuries among 126 of 297 respondents (42%). If someone other than the respondent knew about an unreported injury, that person was most frequently the attending physician (51%) and least frequently a ``significant other'' (13%). CONCLUSIONS: Needlestick injuries are common among surgeons in training and are often not reported. Improved prevention and reporting strategies are needed to increase occupational safety for surgical providers.	Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Qual & Safety Res Grp, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Surg, Ctr Outcomes Res, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; Georgetown Univ, Sch Med, Dept Plast Surg, Washington, DC USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Georgetown University	Makary, MA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Qual & Safety Res Grp, 1909 Thames St,2nd Fl, Baltimore, MD 21231 USA.	mmakary1@jhmi.edu						Babcock HM, 2003, INFECT CONT HOSP EP, V24, P731, DOI 10.1086/502121; Bakaeen Faisal, 2006, Am J Surg, V192, pe18, DOI 10.1016/j.amjsurg.2006.08.013; Berguer R, 2005, SURG CLIN N AM, V85, P1299, DOI 10.1016/j.suc.2005.09.012; Cardo DM, 1997, NEW ENGL J MED, V337, P1485, DOI 10.1056/NEJM199711203372101; *CDC, 2001, MMWR RECOMM REP, V50, P47; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P25; Do AN, 2003, INFECT CONT HOSP EP, V24, P86, DOI 10.1086/502178; Doebbeling BN, 2003, CLIN INFECT DIS, V37, P1006, DOI 10.1086/377535; GERBERDING JL, 1990, NEW ENGL J MED, V322, P1788, DOI 10.1056/NEJM199006213222506; HEALD AE, 1990, J GEN INTERN MED, V5, P389, DOI 10.1007/BF02599422; Howsepian AA, 1998, GEN HOSP PSYCHIAT, V20, P123; Jaeckel E, 2001, NEW ENGL J MED, V345, P1452, DOI 10.1056/NEJMoa011232; Jagger J, 1998, AORN J, V67, P979, DOI 10.1016/S0001-2092(06)62623-9; JAGGER J, 1995, ADV EXPOSURE PREV, V1, P1; Jagger J, 1998, ADV EXPOSURE PREVENT, V3, P1; Jagger J, 1998, AORN J, V67, P983; Jagger J, 1998, AORN J, V67, P986; Makary MA, 2006, ANN SURG, V243, P628, DOI 10.1097/01.sla.0000216410.74062.0f; Makary MA, 2006, WORLD J SURG, V30, P1224, DOI 10.1007/s00268-005-0605-9; Makary MA, 2006, JT COMM J QUAL PATIE, V32, P351, DOI 10.1016/S1553-7250(06)32045-4; Mingoli A, 1999, ANN SURG, V230, P737, DOI 10.1097/00000658-199911000-00022; *NIOSH, 1999, PUBL NIOSH; ONEILL TM, 1992, ARCH INTERN MED, V152, P1451, DOI 10.1001/archinte.152.7.1451; Osborn EHS, 1999, ANN INTERN MED, V130, P45, DOI 10.7326/0003-4819-130-1-199901050-00009; Patterson JMM, 1998, ANN SURG, V228, P266, DOI 10.1097/00000658-199808000-00017; PERRY J, 2005, ADV EXPOSURE PREV, V7, P42; Perry Jane, 2002, Bull Am Coll Surg, V87, P8; Pruss-Ustun A, 2005, AM J IND MED, V48, P482, DOI 10.1002/ajim.20230; QUEBBEMAN EJ, 1992, ARCH SURG-CHICAGO, V127, P213; Shiao JSC, 1999, AM J INFECT CONTROL, V27, P254, DOI 10.1053/ic.1999.v27.a97006; Sohn JW, 2006, J OCCUP HEALTH, V48, P474, DOI 10.1539/joh.48.474; Stringer B, 2002, OCCUP ENVIRON MED, V59, P703, DOI 10.1136/oem.59.10.703; Sulkowski MS, 2002, JAMA-J AM MED ASSOC, V287, P2406, DOI 10.1001/jama.287.18.2406; TANNER J, 2002, COCHRANE DB SYST REV, V3; Tereskerz PM, 1997, AM J PUBLIC HEALTH, V87, P1558, DOI 10.2105/AJPH.87.9.1558; TOKARS JI, 1992, JAMA-J AM MED ASSOC, V267, P2899, DOI 10.1001/jama.267.21.2899; Weiss ES, 2007, AM J SURG, V193, P55, DOI 10.1016/j.amjsurg.2006.07.008; Weiss ES, 2005, ANN SURG, V241, P803, DOI 10.1097/01.sla.0000161174.71460.1f; Worthington MG, 2006, INFECT CONT HOSP EP, V27, P215, DOI 10.1086/501155	39	193	204	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 28	2007	356	26					2693	2699		10.1056/NEJMoa070378	http://dx.doi.org/10.1056/NEJMoa070378			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183HS	17596603				2022-12-01	WOS:000247564500006
J	Vartiainen, MK; Guettler, S; Larijani, B; Treisman, R				Vartiainen, Maria K.; Guettler, Sebastian; Larijani, Banafshe; Treisman, Richard			Nuclear actin regulates dynamic subcellular localization and activity of the SRF cofactor MAL	SCIENCE			English	Article							SERUM RESPONSE FACTOR; MUTANT ACTINS; COACTIVATOR; TRANSCRIPTION; GROWTH; CELLS	Actin, which is best known as a cytoskeletal component, also participates in the control of gene expression. We report a function of nuclear actin in the regulation of MAL, a coactivator of the transcription factor serum response factor (SRF). MAL, which binds monomeric actin, is cytoplasmic in many cells but accumulates in the nucleus upon serum-induced actin polymerization. MAL rapidly shuttles between cytoplasm and nucleus in unstimulated cells. Serum stimulation effectively blocks MAL nuclear export, which requires MAL-actin interaction. Nuclear MAL binds SRF target genes but remains inactive unless actin binding is disrupted. Fluorescence resonance energy transfer analysis demonstrates that the MAL-actin interaction responds to extracellular signals. Serum-induced signaling is thus communicated to nuclear actin to control a transcriptional regulator.	Canc Res UK, London Res Inst, Transcript Lab, Lincolns Inn Fields Labs, London WC2A 3PX, England; Canc Res UK, London Res Inst, Cell Biophys Lab, Lincolns Inn Fields Labs, London WC2A 3PX, England	Cancer Research UK; Cancer Research UK	Treisman, R (corresponding author), Canc Res UK, London Res Inst, Transcript Lab, Lincolns Inn Fields Labs, 44 Lincolns Inn Fields, London WC2A 3PX, England.	Richard.Treisman@cancer.org.uk	Vartiainen, Maria/P-7043-2019; Larijani, Banafshe/H-3909-2015; Vartiainen, Maria K/F-4767-2013	Vartiainen, Maria/0000-0002-2017-0475; Larijani, Banafshe/0000-0003-4735-1169; Vartiainen, Maria K/0000-0002-2017-0475; Guettler, Sebastian/0000-0002-3135-1546; Treisman, Richard/0000-0002-9658-0067				Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Engelsma D, 2004, EMBO J, V23, P3643, DOI 10.1038/sj.emboj.7600370; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Miralles F, 2006, CURR OPIN CELL BIOL, V18, P261, DOI 10.1016/j.ceb.2006.04.009; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pederson T, 2005, MOL BIOL CELL, V16, P5055, DOI 10.1091/mbc.E05-07-0656; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Posern G, 2004, EMBO J, V23, P3973, DOI 10.1038/sj.emboj.7600404; Posern G, 2002, MOL BIOL CELL, V13, P4167, DOI 10.1091/mbc.02-05-0068; Schmierer B, 2005, MOL CELL BIOL, V25, P9845, DOI 10.1128/MCB.25.22.9845-9858.2005; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Stuven T, 2003, EMBO J, V22, P5928, DOI 10.1093/emboj/cdg565; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134	14	471	485	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2007	316	5832					1749	1752		10.1126/science.1141084	http://dx.doi.org/10.1126/science.1141084			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180XE	17588931				2022-12-01	WOS:000247400500048
J	Sugase, K; Dyson, HJ; Wright, PE				Sugase, Kenji; Dyson, H. Jane; Wright, Peter E.			Mechanism of coupled folding and binding of an intrinsically disordered protein	NATURE			English	Article							TRANSCRIPTION FACTOR-BINDING; CHEMICAL-EXCHANGE; KIX DOMAIN; UNSTRUCTURED PROTEINS; MACROMOLECULAR INTERACTIONS; TRANSACTIVATION DOMAIN; NMR-SPECTROSCOPY; CREB; CBP; COACTIVATOR	Protein folding and binding are analogous processes, in which the protein 'searches' for favourable intramolecular or intermolecular interactions on a funnelled energy landscape(1,2). Many eukaryotic proteins are disordered under physiological conditions, and fold into ordered structures only on binding to their cellular targets(3-6). The mechanism by which folding is coupled to binding is poorly understood, but it has been hypothesized on theoretical grounds that the binding kinetics may be enhanced by a 'fly-casting' effect, where the disordered protein binds weakly and non-specifically to its target and folds as it approaches the cognate binding site(7). Here we show, using NMR titrations and N-15 relaxation dispersion, that the phosphorylated kinase inducible activation domain (pKID) of the transcription factor CREB forms an ensemble of transient encounter complexes on binding to the KIX domain of the CREB binding protein. The encounter complexes are stabilized primarily by non-specific hydrophobic contacts, and evolve by way of an intermediate to the fully bound state without dissociation from KIX. The carboxy-terminal helix of pKID is only partially folded in the intermediate, and becomes stabilized by intermolecular interactions formed in the final bound state. Future applications of our method will provide new understanding of the molecular mechanisms by which intrinsically disordered proteins perform their diverse biological functions.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Suntory Inst Bioorgan Res, Shimamoto, Osaka 6188503, Japan	Scripps Research Institute; Scripps Research Institute; Suntory Holdings Ltd	Wright, PE (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wright@scripps.edu	Sugase, Kenji/AAF-4552-2021; Sugase, Kenji/S-3132-2016; Dyson, Jane/D-4160-2011	Sugase, Kenji/0000-0001-8623-7743; Sugase, Kenji/0000-0001-8623-7743; Dyson, Jane/0000-0001-6855-3398; Wright, Peter/0000-0002-1368-0223				ALLERHAN.A, 1965, J CHEM PHYS, V42, P1587, DOI 10.1063/1.1696165; BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.bb.14.060185.001023; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; De Guzman RN, 2006, J MOL BIOL, V355, P1005, DOI 10.1016/j.jmb.2005.09.059; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Gabdoulline RR, 2002, CURR OPIN STRUC BIOL, V12, P204, DOI 10.1016/S0959-440X(02)00311-1; Goto NK, 2002, J BIOL CHEM, V277, P43168, DOI 10.1074/jbc.M207660200; Grey MJ, 2003, J AM CHEM SOC, V125, P14324, DOI 10.1021/ja0367389; Huth JR, 1997, PROTEIN SCI, V6, P2359; JOHNSON CS, 1973, J CHEM EDUC, V50, P477, DOI 10.1021/ed050p477; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Levy Y, 2005, J MOL BIOL, V346, P1121, DOI 10.1016/j.jmb.2004.12.021; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; McElheny D, 2005, P NATL ACAD SCI USA, V102, P5032, DOI 10.1073/pnas.0500699102; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Parker D, 1996, MOL CELL BIOL, V16, P694; Parker D, 1998, MOL CELL, V2, P353, DOI 10.1016/S1097-2765(00)80279-8; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Selzer T, 2001, PROTEINS, V45, P190, DOI 10.1002/prot.1139; Shaywitz AJ, 2000, MOL CELL BIOL, V20, P9409, DOI 10.1128/MCB.20.24.9409-9422.2000; Shih HM, 1996, P NATL ACAD SCI USA, V93, P13896, DOI 10.1073/pnas.93.24.13896; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; SHOUP D, 1982, BIOPHYS J, V40, P33, DOI 10.1016/S0006-3495(82)84455-X; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; Tsai CJ, 1999, PROTEIN SCI, V8, P1181, DOI 10.1110/ps.8.6.1181; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Volkov AN, 2006, P NATL ACAD SCI USA, V103, P18945, DOI 10.1073/pnas.0603551103; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Zor T, 2004, J MOL BIOL, V337, P521, DOI 10.1016/j.jmb.2004.01.038	33	804	819	4	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2007	447	7147					1021	U11		10.1038/nature05858	http://dx.doi.org/10.1038/nature05858			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180NU	17522630				2022-12-01	WOS:000247373100051
J	Helgadottir, A; Thorleifsson, G; Manolescu, A; Gretarsdottir, S; Blondal, T; Jonasdottir, A; Jonasdottir, A; Sigurdsson, A; Baker, A; Palsson, A; Masson, G; Gudbjartsson, DF; Magnusson, KP; Andersen, K; Levey, AI; Backman, VM; Matthiasdottir, S; Jonsdottir, T; Palsson, S; Einarsdottir, H; Gunnarsdottir, S; Gylfason, A; Vaccarino, V; Hooper, WC; Reilly, MP; Granger, CB; Austin, H; Rader, DJ; Shah, SH; Quyyumi, AA; Gulcher, JR; Thorgeirsson, G; Thorsteinsdottir, U; Kong, A; Stefansson, K				Helgadottir, Anna; Thorleifsson, Gudmar; Manolescu, Andrei; Gretarsdottir, Solveig; Blondal, Thorarinn; Jonasdottir, Aslaug; Jonasdottir, Adalbjorg; Sigurdsson, Asgeir; Baker, Adam; Palsson, Arnar; Masson, Gisli; Gudbjartsson, Daniel F.; Magnusson, Kristinn P.; Andersen, Karl; Levey, Allan I.; Backman, Valgerdur M.; Matthiasdottir, Sigurborg; Jonsdottir, Thorbjorg; Palsson, Stefan; Einarsdottir, Helga; Gunnarsdottir, Steinunn; Gylfason, Arnaldur; Vaccarino, Viola; Hooper, W. Craig; Reilly, Muredach P.; Granger, Christopher B.; Austin, Harland; Rader, Daniel J.; Shah, Svati H.; Quyyumi, Arshed A.; Gulcher, Jeffrey R.; Thorgeirsson, Gudmundur; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari			A common variant on chromosome 9p21 affects the risk of myocardial infarction	SCIENCE			English	Article							GENOMEWIDE LINKAGE; HEART-DISEASE; ATHEROSCLEROSIS; ASSOCIATION	The global endemic of cardiovascular diseases calls for improved risk assessment and treatment. Here, we describe an association between myocardial infarction ( MI) and a common sequence variant on chromosome 9p21. This study included a total of 4587 cases and 12,767 controls. The identified variant, adjacent to the tumor suppressor genes CDKN2A and CDKN2B, was associated with the disease with high significance. Approximately 21% of individuals in the population are homozygous for this variant, and their estimated risk of suffering myocardial infarction is 1.64 times as great as that of noncarriers. The corresponding risk is 2.02 times as great for early-onset cases. The population attributable risk is 21% for MI in general and 31% for early-onset cases.	deCODE Genet, IS-101 Reykjavik, Iceland; Landspitali Univ Hosp, Reykjavik, Iceland; Emory Univ, Sch Med, Atlanta, GA 30322 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Duke Univ, Sch Med, Durham, NC 27710 USA	Landspitali National University Hospital; Emory University; University of Pennsylvania; Duke University	Kong, A (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	augustine.kong@decode.is; kstefans@decode.is	Magnusson, Kristinn P Pétur/X-4907-2019; Manolescu, Andrei/G-4565-2014; , Viola/AAW-5600-2020; Granger, Christopher B/D-3458-2014; Magnusson, Kristinn/A-6479-2011; Levey, Allan/F-2104-2011; Girelli, Domenico/B-1183-2008; Palsson, Arnar/M-2742-2015; Stefansson, Kari/AAE-7187-2019	Magnusson, Kristinn P Pétur/0000-0003-4528-6826; Manolescu, Andrei/0000-0002-0713-4664; Granger, Christopher B/0000-0002-0045-3291; Magnusson, Kristinn/0000-0003-4528-6826; Levey, Allan/0000-0002-3153-502X; Girelli, Domenico/0000-0001-9684-1899; Palsson, Arnar/0000-0002-6525-8112; Reilly, Muredach/0000-0002-3035-9386; Gudbjartsson, Daniel/0000-0002-5222-9857; Kong, Augustine/0000-0001-8193-5438				Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; MANTEL N, 1959, J NATL CANCER I, V22, P719; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Samani NJ, 2005, AM J HUM GENET, V77, P1011; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Wang Q, 2004, AM J HUM GENET, V74, P262, DOI 10.1086/381560; Zdravkovic S, 2002, J INTERN MED, V252, P247, DOI 10.1046/j.1365-2796.2002.01029.x; Zintzaras E, 2006, J HUM GENET, V51, P1015, DOI 10.1007/s10038-006-0053-x	10	1245	1312	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2007	316	5830					1491	1493		10.1126/science.1142842	http://dx.doi.org/10.1126/science.1142842			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17478679				2022-12-01	WOS:000247066400047
J	Friedman, RA; Leon, AC				Friedman, Richard A.; Leon, Andrew C.			Expanding the black box - Depression, antidepressants, and the risk of suicide	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Weil Cornell Med Coll, Psychopharmacol Clin, New York, NY 10021 USA		Friedman, RA (corresponding author), Weil Cornell Med Coll, Psychopharmacol Clin, New York, NY 10021 USA.							*AM PSYCH ASS, 2003, AM J PSYCHIAT S11, V160; Gibbons RD, 2006, AM J PSYCHIAT, V163, P1898, DOI 10.1176/appi.ajp.163.11.1898; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Harris G., 2004, NEW YORK TIMES, pC1; Leon AC, 2006, J AM ACAD CHILD PSY, V45, P1054, DOI 10.1097/01.chi.0000227875.12286.a2	5	100	104	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2007	356	23					2343	2346		10.1056/NEJMp078015	http://dx.doi.org/10.1056/NEJMp078015			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	175QY	17485726				2022-12-01	WOS:000247029300002
J	Spangler, JG				Spangler, John G.			The sounds of silence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												jspangle@wfubmc.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2007	297	21					2329	2330		10.1001/jama.297.21.2329	http://dx.doi.org/10.1001/jama.297.21.2329			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175IL	17551118				2022-12-01	WOS:000247007200001
J	Gao, HX; Zhou, ZH; Rawat, U; Huang, C; Bouakaz, L; Wang, CH; Cheng, ZH; Liu, YY; Zavialov, A; Gursky, R; Sanyal, S; Ehrenberg, M; Frank, J; Song, HW				Gao, Haixiao; Zhou, Zhihong; Rawat, Urmila; Huang, Chenhui; Bouakaz, Lamine; Wang, Chernhoe; Cheng, Zhihong; Liu, Yuying; Zavialov, Andrey; Gursky, Richard; Sanyal, Suparna; Ehrenberg, Mans; Frank, Joachim; Song, Haiwei			RF3 induces ribosomal conformational changes responsible for dissociation of class I release factors	CELL			English	Article							COLI 70S RIBOSOME; ELONGATION-FACTOR-G; FACTOR EF-TU; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; TRANSLATION TERMINATION; GTPASE ACTIVITY; TRANSFER-RNA; PROTEIN; VISUALIZATION	During translation termination, class II release factor RF3 binds to the ribosome to promote rapid dissociation of a class I release factor (RF) in a GTP-dependent manner. We present the crystal structure of E coli RF39GDP, which has a three-domain architecture strikingly similar to the structure of EF-Tu center dot GTP. Biochemical data on RF3 mutants show that a surface region involving domains II and III is important for distinct steps in the action cycle of RF3. Furthermore, we present a cryo-electron microscopy (cryo-EM) structure of the posttermination ribosome bound with RF3 in the GTP form. Our data show that RF3 center dot GTP binding induces large conformational changes in the ribosome, which break the interactions of the class I RF with both the decoding center and the GTPase-associated center of the ribosome, apparently leading to the release of the class I RF.	Hlth Res Inc, Howard Hughes Med Inst, Albany, NY 12201 USA; Watsworth Ctr, Albany, NY 12201 USA; Inst Mol & Cell Biol, Lab Macromol Struct, Singapore 138673, Singapore; Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Uppsala Univ, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden; SUNY Albany, Dept Biomed Sci, Albany, NY 12201 USA; Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Health Research Inc; Howard Hughes Medical Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Uppsala University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; National University of Singapore	Ehrenberg, M (corresponding author), Hlth Res Inc, Howard Hughes Med Inst, Empire State Plaza, Albany, NY 12201 USA.	ehrenberg@xray.bmc.uu.se; joachim@wadsworth.org; haiwei@imcb.a-star.edu.sg	song, haiwei/H-6082-2011; Cheng, Zhihong/F-8933-2011	Zavialov, Andrey/0000-0001-6420-0368	NIGMS NIH HHS [R37 GM29169, R01 GM 55440, GM70768] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029169, R01GM055440] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Agrawal RK, 2001, J MOL BIOL, V311, P777, DOI 10.1006/jmbi.2001.4907; Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bouakaz L, 2006, J BIOL CHEM, V281, P4548, DOI 10.1074/jbc.M510433200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHAPMAN MS, 1995, ACTA CRYSTALLOGR A, V51, P69, DOI 10.1107/S0108767394007130; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Freistroffer DV, 1997, EMBO J, V16, P4126, DOI 10.1093/emboj/16.13.4126; FROLOVA L, 1994, NATURE, V372, P701, DOI 10.1038/372701a0; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gao HX, 2003, CELL, V113, P789, DOI 10.1016/S0092-8674(03)00427-6; Graille M, 2005, MOL CELL, V20, P917, DOI 10.1016/j.molcel.2005.10.025; GRENTZMANN G, 1994, P NATL ACAD SCI USA, V91, P5848, DOI 10.1073/pnas.91.13.5848; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kisselev L, 2003, EMBO J, V22, P175, DOI 10.1093/emboj/cdg017; Kisselev LL, 2000, TRENDS BIOCHEM SCI, V25, P561, DOI 10.1016/S0968-0004(00)01669-8; KJELDGAARD M, 1993, STRUCTURE, V1, P35, DOI 10.1016/0969-2126(93)90007-4; Klaholz BP, 2003, NATURE, V421, P90, DOI 10.1038/nature01225; Klaholz BP, 2004, NATURE, V427, P862, DOI 10.1038/nature02332; Kong CG, 2004, MOL CELL, V14, P233, DOI 10.1016/S1097-2765(04)00206-0; La Teana A, 2001, RNA, V7, P1173, DOI 10.1017/S1355838201010366; Laurberg M, 2000, J MOL BIOL, V303, P593, DOI 10.1006/jmbi.2000.4168; MIKUNI O, 1994, P NATL ACAD SCI USA, V91, P5798, DOI 10.1073/pnas.91.13.5798; MILLER R, 1994, J APPL CRYSTALLOGR, V27, P613, DOI 10.1107/S0021889894000191; Moorhouse E. R., 1992, Biocontrol Science and Technology, V2, P49, DOI 10.1080/09583159209355217; Mora L, 2003, MOL MICROBIOL, V50, P1467, DOI 10.1046/j.1365-2958.2003.03799.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura Y, 2003, TRENDS BIOCHEM SCI, V28, P99, DOI 10.1016/S0968-0004(03)00006-9; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Rawat U, 2006, J MOL BIOL, V357, P1144, DOI 10.1016/j.jmb.2006.01.038; Rawat UBS, 2003, NATURE, V421, P87, DOI 10.1038/nature01224; REMMERS AE, 1994, J BIOL CHEM, V269, P13771; Schutze Norbert, 2005, Cell Commun Signal, V3, P5, DOI 10.1186/1478-811X-3-5; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; Shin DH, 2004, J MOL BIOL, V341, P227, DOI 10.1016/j.jmb.2004.05.055; Song HW, 1999, J MOL BIOL, V285, P1245, DOI 10.1006/jmbi.1998.2387; Spahn CMT, 2001, MOL CELL, V7, P1037, DOI 10.1016/S1097-2765(01)00238-6; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; Vestergaard B, 2005, MOL CELL, V20, P929, DOI 10.1016/j.molcel.2005.11.022; Vestergaard B, 2001, MOL CELL, V8, P1375, DOI 10.1016/S1097-2765(01)00415-4; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3; Zavialov AV, 2003, CELL, V114, P113, DOI 10.1016/S0092-8674(03)00478-1; Zavialov AV, 2001, CELL, V107, P115, DOI 10.1016/S0092-8674(01)00508-6; Zhang BL, 2005, BIOCHEMISTRY-US, V44, P2566, DOI 10.1021/bi048755w; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	57	102	107	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2007	129	5					929	941		10.1016/j.cell.2007.03.050	http://dx.doi.org/10.1016/j.cell.2007.03.050			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540173	Bronze			2022-12-01	WOS:000247084600013
J	Siepka, SM; Yoo, SH; Park, J; Song, WM; Kumar, V; Hu, YN; Lee, C; Takahashi, JS				Siepka, Sandra M.; Yoo, Seung-Hee; Park, Junghea; Song, Weimin; Kumar, Vivek; Hu, Yinin; Lee, Choogon; Takahashi, Joseph S.			Circadian mutant overtime reveals F-box protein FBXL3 regulation of cryptochrome and period gene expression	CELL			English	Article							SCF UBIQUITIN LIGASE; CLOCK; DEGRADATION; TIME; TRANSCRIPTION; BEHAVIOR; RHYTHM; OSCILLATIONS; MUTAGENESIS; COMPONENTS	Using a forward genetics ENU mutagenesis screen for recessive mutations that affect circathan rhythmicity in the mouse, we isolated a long period (similar to 26 hr) circadian mutant named Overtime (Ovtm). Positional cloning and genetic complementation reveal that Ovtm is encoded by the F-box protein FBXL3, a component of the SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligase complex. The Ovtm mutation causes an isoleucine to threonine (1364T) substitution leading to a loss of function in FBXL3, which interacts specifically with the CRYPTOCHROME (CRY) proteins. In Ovtm mice, expression of the PERIOD proteins PER1 and PER2 is reduced; however, the CRY proteins CRY1 and CRY2 are unchanged. The loss of FBXL3 function leads to a stabilization of the CRY proteins, which in turn leads to a global transcriptional repression of the Per and Cry genes. Thus, Fbxl3(ovtm) defines a molecular link between CRY turnover and CLOCK/BMAL1-dependent circadian transcription to modulate circadian period.	Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA; Northwestern Univ, Ctr Funct Genom, Evanston, IL 60208 USA; Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Florida State Univ, Coll Med, Dept Biol Sci, Tallahassee, FL 32306 USA	Howard Hughes Medical Institute; Northwestern University; Northwestern University; Northwestern University; State University System of Florida; Florida State University	Takahashi, JS (corresponding author), Northwestern Univ, Howard Hughes Med Inst, 2205 Tech Dr, Evanston, IL 60208 USA.	j-takahashi@northwestern.edu	Takahashi, Joseph S/E-8482-2012; Takahashi, Joseph S./Y-2781-2019; Kumar, Vivek/P-8749-2014	Takahashi, Joseph S/0000-0003-0384-8878; Takahashi, Joseph S./0000-0003-0384-8878; Hu, Yinin/0000-0002-4324-9530; Kumar, Vivek/0000-0001-6643-7465	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074924, R01MH078024, U01MH061915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053616] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chen WSV, 2004, NAT GENET, V36, P304, DOI 10.1038/ng1306; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Forger DB, 2003, P NATL ACAD SCI USA, V100, P14806, DOI 10.1073/pnas.2036281100; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Grima B, 2002, NATURE, V420, P178, DOI 10.1038/nature01122; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Harmon FG, 2003, CURR BIOL, V13, P2091, DOI 10.1016/j.cub.2003.11.019; He Q, 2003, EMBO J, V22, P4421, DOI 10.1093/emboj/cdg425; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Kwon I, 2006, MOL CELL BIOL, V26, P7318, DOI 10.1128/MCB.00337-06; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Leloup JC, 2004, J THEOR BIOL, V230, P541, DOI 10.1016/j.jtbi.2004.04.040; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Mas P, 2003, NATURE, V426, P567, DOI 10.1038/nature02163; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Peterson KA, 2002, GENOMICS, V80, P172, DOI 10.1006/geno.2002.6818; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Shimomura K, 2001, GENOME RES, V11, P959, DOI 10.1101/gr.171601; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Siepka SM, 2005, METHOD ENZYMOL, V393, P219, DOI 10.1016/S0076-6879(05)93007-3; Siepka SM, 2005, METHOD ENZYMOL, V393, P230, DOI 10.1016/S0076-6879(05)93008-5; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Takahashi JS, 2004, J BIOL RHYTHM, V19, P339, DOI 10.1177/0748730404269151; TAKAHASHI JS, 1994, SCIENCE, V264, P1724, DOI 10.1126/science.8209253; Vitaterna MH, 2006, TRENDS NEUROSCI, V29, P233, DOI 10.1016/j.tins.2006.02.006; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Wilsbacher LD, 2002, P NATL ACAD SCI USA, V99, P489, DOI 10.1073/pnas.012248599; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; [No title captured]	46	397	414	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2007	129	5					1011	1023		10.1016/j.cell.2007.04.030	http://dx.doi.org/10.1016/j.cell.2007.04.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17462724	Green Accepted, Bronze			2022-12-01	WOS:000247084600019
J	Zender, L; Zuber, J; Lowe, SW				Zender, Lars; Zuber, Johannes; Lowe, Scott W.			SnapShot: Genetic mouse models of cancer	CELL			English	Editorial Material									Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Zender, L (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.		Zuber, Johannes/E-7517-2011	Zuber, Johannes/0000-0001-8810-6835	NATIONAL CANCER INSTITUTE [P30CA008748, P01CA013106] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748, P01 CA013106] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))			0	8	8	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2007	129	4					838	838		10.1016/j.cell.2007.05.013	http://dx.doi.org/10.1016/j.cell.2007.05.013			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512415	Green Accepted, Bronze			2022-12-01	WOS:000246788300026
J	Martin, S; Nishimune, A; Mellor, JR; Henley, JM				Martin, Stephane; Nishimune, Atsushi; Mellor, Jack R.; Henley, Jeremy M.			SUMOylation regulates kainate-receptor-mediated synaptic transmission	NATURE			English	Article							DIFFERENTIAL REGULATION; SUMO; AMPA; PROTEINS	The small ubiquitin-like modifier protein (SUMO) regulates transcriptional activity and the translocation of proteins across the nuclear membrane(1). The identification of SUMO substrates outside the nucleus is progressing(2) but little is yet known about the wider cellular role of protein SUMOylation. Here we report that in rat hippocampal neurons multiple SUMOylation targets are present at synapses and we show that the kainate receptor subunit GluR6 is a SUMO substrate. SUMOylation of GluR6 regulates endocytosis of the kainate receptor and modifies synaptic transmission. GluR6 exhibits low levels of SUMOylation under resting conditions and is rapidly SUMOylated in response to a kainate but not an N-methyl-D-aspartate ( NMDA) treatment. Reducing GluR6 SUMOylation using the SUMO-specific isopeptidase SENP1 prevents kainate-evoked endocytosis of the kainate receptor. Furthermore, a mutated non-SUMOylatable form of GluR6 is not endocytosed in response to kainate in COS-7 cells. Consistent with this, electrophysiological recordings in hippocampal slices demonstrate that kainate-receptor-mediated excitatory postsynaptic currents are decreased by SUMOylation and enhanced by deSUMOylation. These data reveal a previously unsuspected role for SUMO in the regulation of synaptic function.	Univ Bristol, MRC, Ctr Synapt Plast, Dept Anat, Bristol BS8 1TD, Avon, England	University of Bristol	Henley, JM (corresponding author), Univ Bristol, MRC, Ctr Synapt Plast, Dept Anat, Univ Walk, Bristol BS8 1TD, Avon, England.	j.m.henley@bris.ac.uk	Martin, Stéphane/G-5954-2012; Henley, Jeremy M/A-2776-2009; MELLOR, Jack/B-4548-2019	Martin, Stéphane/0000-0001-6771-7645; MELLOR, Jack/0000-0002-7706-8105; Henley, Jeremy/0000-0003-3589-8335	MRC [G120/838] Funding Source: UKRI; Medical Research Council [G0601810, G120/838, G0601810(80974)] Funding Source: Medline; Wellcome Trust [059917] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Comerford KM, 2003, P NATL ACAD SCI USA, V100, P986, DOI 10.1073/pnas.0337412100; Coussen F, 2005, NEURON, V47, P555, DOI 10.1016/j.neuron.2005.06.033; Gong LM, 2000, J BIOL CHEM, V275, P3355, DOI 10.1074/jbc.275.5.3355; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hilgarth RS, 2004, J BIOL CHEM, V279, P53899, DOI 10.1074/jbc.R400021200; Hirbec H, 2003, NEURON, V37, P625, DOI 10.1016/S0896-6273(02)01191-1; Jaskolski F, 2005, TRENDS PHARMACOL SCI, V26, P20, DOI 10.1016/j.tips.2004.11.008; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Lerma J, 2003, NAT REV NEUROSCI, V4, P481, DOI 10.1038/nrn1118; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Martin S, 2004, EMBO J, V23, P4749, DOI 10.1038/sj.emboj.7600483; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; NISHIOKA N S, 1987, Lasers in Medical Science, V2, P21, DOI 10.1007/BF02594126; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Suzuki T, 1999, J BIOL CHEM, V274, P31131, DOI 10.1074/jbc.274.44.31131; Uchimura Y, 2004, FEBS LETT, V564, P85, DOI 10.1016/S0014-5793(04)00321-7; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; WILSON VG, 2005, SCI STKE, pPE32, DOI DOI 10.1126/STKE.2902005PE32; Zhang JH, 2002, NAT GENET, V30, P416, DOI 10.1038/ng859	22	219	235	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2007	447	7142					321	U6		10.1038/nature05736	http://dx.doi.org/10.1038/nature05736			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17486098	Green Accepted			2022-12-01	WOS:000246520300046
J	Agosti, JM; Goldie, SJ				Agosti, Jan M.; Goldie, Sue J.			Introducing HPV vaccine in developing countries - Key challenges and issues	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Bill & Melinda Gates Fdn, Global Hlth Program, Seattle, WA 98102 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Bill & Melinda Gates Foundation; Harvard University; Harvard T.H. Chan School of Public Health	Agosti, JM (corresponding author), Bill & Melinda Gates Fdn, Global Hlth Program, Seattle, WA 98102 USA.							Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026; Garnett GP, 2006, VACCINE, V24, P178, DOI 10.1016/j.vaccine.2006.05.116; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Sankaranarayanan R, 2005, INT J GYNECOL OBSTET, V89, pS4, DOI 10.1016/j.ijgo.2005.01.009	5	215	220	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2007	356	19					1908	1910		10.1056/NEJMp078053	http://dx.doi.org/10.1056/NEJMp078053			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	165KX	17494923				2022-12-01	WOS:000246305500002
J	Wang, HY; Lin, S; Allen, JP; Williams, JC; Blankert, S; Laser, C; Woodbury, NW				Wang, Haiyu; Lin, Su; Allen, James P.; Williams, JoAnn C.; Blankert, Sean; Laser, Christa; Woodbury, Neal W.			Protein dynamics control the kinetics of initial electron transfer in photosynthesis	SCIENCE			English	Article							SPHAEROIDES REACTION-CENTER; BACTERIAL REACTION CENTERS; MUTANT REACTION CENTERS; RHODOBACTER-SPHAEROIDES; CHARGE SEPARATION; WILD-TYPE; STATE; DEPENDENCE; BACTERIOCHLOROPHYLL; TEMPERATURE	The initial electron transfer dynamics during photosynthesis have been studied in Rhodobacter sphaeroides reaction centers from wild type and 14 mutants in which the driving force and the kinetics of charge separation vary over a broad range. Surprisingly, the protein relaxation kinetics, as measured by tryptophan absorbance changes, are invariant in these mutants. By applying a reaction-diffusion model, we can fit the complex electron transfer kinetics of each mutant quantitatively, varying only the driving force. These results indicate that initial photosynthetic charge separation is limited by protein dynamics rather than by a static electron transfer barrier.	Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA; Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Woodbury, NW (corresponding author), Arizona State Univ, Biodesign Inst, 1001 S McAllister Ave, Tempe, AZ 85287 USA.	Nwoodbury@asu.edu						Ando K, 1998, J PHYS CHEM B, V102, P10991, DOI 10.1021/jp982659l; BAGCHI B, 1983, J CHEM PHYS, V78, P7375, DOI 10.1063/1.444729; CHO MH, 1995, J CHEM PHYS, V103, P595, DOI 10.1063/1.470094; Deisenhofer J., 1993, PHOTOSYNTHETIC REACT, VII, P49; DU M, 1992, P NATL ACAD SCI USA, V89, P8517, DOI 10.1073/pnas.89.18.8517; GEHLEN JN, 1994, SCIENCE, V263, P499, DOI 10.1126/science.263.5146.499; Haffa ALM, 2002, J PHYS CHEM B, V106, P7376, DOI 10.1021/jp0257552; HAMM P, 1993, BIOCHIM BIOPHYS ACTA, V1142, P99, DOI 10.1016/0005-2728(93)90090-3; Huppman P, 2002, BIOPHYS J, V82, P3186, DOI 10.1016/S0006-3495(02)75661-0; JIA YW, 1993, J PHYS CHEM-US, V97, P13180, DOI 10.1021/j100152a024; Katilius E, 2004, PHOTOSYNTH RES, V81, P165, DOI 10.1023/B:PRES.0000035048.10358.90; KIRMAIER C, 1990, P NATL ACAD SCI USA, V87, P3552, DOI 10.1073/pnas.87.9.3552; Laible PD, 1997, BIOCHEMISTRY-US, V36, P8677, DOI 10.1021/bi970672a; Lin SW, 1996, BIOCHEMISTRY-US, V35, P11149, DOI 10.1021/bi960858u; LIN X, 1994, P NATL ACAD SCI USA, V91, P10265, DOI 10.1073/pnas.91.22.10265; McMahon BH, 1998, BIOPHYS J, V74, P2567, DOI 10.1016/S0006-3495(98)77964-0; Parson WW, 2004, J PHYS CHEM B, V108, P10474, DOI 10.1021/jp0495904; Potter JA, 2005, J BIOL CHEM, V280, P27155, DOI 10.1074/jbc.M501961200; Schenkl S, 2005, SCIENCE, V309, P917, DOI 10.1126/science.1111482; SUMI H, 1986, J CHEM PHYS, V84, P4272, DOI 10.1063/1.450804; TOMINAGA K, 1991, J PHYS CHEM-US, V95, P10485, DOI 10.1021/j100178a040; WARSHEL A, 1989, SCIENCE, V246, P112, DOI 10.1126/science.2675313; WILLAERT K, 1992, BIOCHEMISTRY-US, V31, P711, DOI 10.1021/bi00118a011; Williams JC, 2001, BIOCHEMISTRY-US, V40, P15403, DOI 10.1021/bi011574z; WOODBURY NW, 1995, CHEM PHYS, V197, P405, DOI 10.1016/0301-0104(95)00170-S; WOODBURY NW, 1995, ADV PHOTOSYNTH, V2, P527; ZINTH W, 1993, PHOTOSYNTHETIC REACT, P71	27	199	207	2	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2007	316	5825					747	750		10.1126/science.1140030	http://dx.doi.org/10.1126/science.1140030			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17478721				2022-12-01	WOS:000246181400047
J	Ogo, S; Kabe, R; Uehara, K; Kure, B; Nishimura, T; Menon, SC; Harada, R; Fukuzumi, S; Higuchi, Y; Ohhara, T; Tamada, T; Kuroki, R				Ogo, Seiji; Kabe, Ryota; Uehara, Keiji; Kure, Bunsho; Nishimura, Takashi; Menon, Saija C.; Harada, Ryosuke; Fukuzumi, Shunichi; Higuchi, Yoshiki; Ohhara, Takashi; Tamada, Taro; Kuroki, Ryota			A dinuclear Ni(mu-H)Ru complex derived from H-2	SCIENCE			English	Article							HYDROGENASE ACTIVE-SITE; NICKEL HYDROGENASES; NIFE HYDROGENASE; X-RAY; NEUTRON-DIFFRACTION; DESULFOVIBRIO-GIGAS; CRYSTAL-STRUCTURE; IRON; ACTIVATION; DIHYDROGEN	Models of the active site in [NiFe] hydrogenase enzymes have proven challenging to prepare. We isolated a paramagnetic dinuclear nickel-ruthenium complex with a bridging hydrido ligand from the heterolytic cleavage of H-2 by a dinuclear NiRu aqua complex in water under ambient conditions (20 degrees C and 1 atmosphere pressure). The structure of the hexacoordinate Ni(mu-H) Ru complex was unequivocally determined by neutron diffraction analysis, and it comes closest to an effective analog for the core structure of the proposed active form of the enzyme.	Kyushu Univ, Ctr Future Chem, Fukuoka 8190395, Japan; Osaka Univ, JST,Solut Oriented Res Sci & Technol, Dept Mat & Life Sci, Div Adv Sci & Biotechnol, Suita, Osaka 5650871, Japan; Univ Hyogo, Grad Sch Life sci, Dept Life Sci, Kamigori, Hyogo 6781297, Japan; Japan Atom Energy Agcy, Res Grp Mol Struct Biol, Quantum Beam Sci Directorate, Tokai, Ibaraki 3191195, Japan	Kyushu University; Japan Science & Technology Agency (JST); Osaka University; University of Hyogo; Japan Atomic Energy Agency	Ogo, S (corresponding author), Kyushu Univ, Ctr Future Chem, Fukuoka 8190395, Japan.	ogo-tcm@mbox.nc.kyushu-u.ac.jp	Fukuzumi, Shunichi/E-4728-2010; Kabe, Ryota/B-4130-2018	Kabe, Ryota/0000-0002-3647-4262; Ohhara, Takashi/0000-0002-1215-6032; Tamada, Taro/0000-0003-1419-8022				Albinati A, 1997, INORG CHIM ACTA, V259, P351, DOI 10.1016/S0020-1693(97)05521-7; ALBRACHT SPJ, 1994, BBA-BIOENERGETICS, V1188, P167, DOI 10.1016/0005-2728(94)90036-1; Alvarez HM, 2001, INORG CHEM, V40, P5736, DOI 10.1021/ic0155838; Bouwman E, 2005, COORDIN CHEM REV, V249, P1555, DOI 10.1016/j.ccr.2004.10.010; Brecht M, 2003, J AM CHEM SOC, V125, P13075, DOI 10.1021/ja036624x; Cammack R., 2001, HYDROGEN FUEL LEARNI; Cammi R, 2003, INORG CHEM, V42, P1769, DOI 10.1021/ic025870r; Carepo M, 2002, J AM CHEM SOC, V124, P281, DOI 10.1021/ja010204v; COLPAS GJ, 1990, INORG CHEM, V29, P4779, DOI 10.1021/ic00348a037; Darensbourg MY, 2000, COORDIN CHEM REV, V206, P533, DOI 10.1016/S0010-8545(00)00268-X; Drabnis MH, 1998, EUR J INORG CHEM, P851; Evans DJ, 2003, CHEM SOC REV, V32, P268, DOI 10.1039/b201317g; Foerster S, 2003, J AM CHEM SOC, V125, P83, DOI 10.1021/ja027522u; Frey M, 1998, STRUCT BOND, V90, P97; Gu ZJ, 1996, J AM CHEM SOC, V118, P11155, DOI 10.1021/ja962429p; Jahncke M, 1997, ORGANOMETALLICS, V16, P1137, DOI 10.1021/om960840f; Justice AK, 2004, J AM CHEM SOC, V126, P13214, DOI 10.1021/ja0455594; Li ZL, 2005, J AM CHEM SOC, V127, P8950, DOI 10.1021/ja051590+; Linck RC, 2001, J AM CHEM SOC, V123, P8856, DOI 10.1021/ja010603q; MARKS TJ, 1977, CHEM REV, V77, P263, DOI 10.1021/cr60306a004; Marr AC, 2001, COORDIN CHEM REV, V219, P1055, DOI 10.1016/S0010-8545(01)00396-4; Ogo S, 2002, J AM CHEM SOC, V124, P597, DOI 10.1021/ja011846l; Ontko AC, 1998, ORGANOMETALLICS, V17, P5467, DOI 10.1021/om980711u; PERUZZINI M, 2001, RECENT ADV HYDRIDE C, P139; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Pickett CJ, 2005, COORDIN CHEM REV, V249, P1517, DOI 10.1016/j.ccr.2005.04.011; Reynolds MA, 2003, ORGANOMETALLICS, V22, P1619, DOI 10.1021/om020724e; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Volbeda A, 1996, J AM CHEM SOC, V118, P12989, DOI 10.1021/ja962270g; Wang YL, 2005, POLYHEDRON, V24, P585, DOI 10.1016/j.poly.2004.12.019; Zhu WF, 2005, P NATL ACAD SCI USA, V102, P18280, DOI 10.1073/pnas.0505779102	31	220	222	0	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2007	316	5824					585	587		10.1126/science.1138751	http://dx.doi.org/10.1126/science.1138751			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463285				2022-12-01	WOS:000245983100041
J	Francis, PT				Francis, Paul T.			Surveillance of acute flaccid paralysis in India	LANCET			English	Editorial Material									Amrita Sch Med, Cochin 682026, Kerala, India	Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi	Francis, PT (corresponding author), Amrita Sch Med, Cochin 682026, Kerala, India.	paultfrancis@gmail.com						Kohler KA, 2003, B WORLD HEALTH ORGAN, V81, P2; *WHO, IMM VACC DEV VPD SUR; 2005, FIELD GUIDE SURVEILL	3	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 21	2007	369	9570					1322	1323		10.1016/S0140-6736(07)60610-2	http://dx.doi.org/10.1016/S0140-6736(07)60610-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	159HL	17448800				2022-12-01	WOS:000245856100005
J	Hankey, GJ				Hankey, Graeme J.			Clinical update: management of stroke	LANCET			English	Article							CLOPIDOGREL; PREVENTION; ASPIRIN; DIPYRIDAMOLE; TRIAL; RISK		Royal Perth Hosp, Dept Neurol, Perth, WA 6001, Australia	Royal Perth Hospital; University of Western Australia	Hankey, GJ (corresponding author), Royal Perth Hosp, Dept Neurol, Perth, WA 6001, Australia.	gjhankey@cyllene.uwa.edu.au	Hankey, Graeme J/H-4968-2014	Hankey, Graeme J/0000-0002-6044-7328				Amarenco P, 2006, NEW ENGL J MED, V355, P549; Bazzano LA, 2006, JAMA-J AM MED ASSOC, V296, P2720, DOI 10.1001/jama.296.22.2720; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Chalela JA, 2007, LANCET, V369, P293, DOI 10.1016/S0140-6736(07)60151-2; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; de Bruijn SFTM, 2006, STROKE, V37, P2531, DOI 10.1161/01.STR.0000241064.46659.69; Diener HC, 2007, CEREBROVASC DIS, V23, P368, DOI 10.1159/000100105; Halkes PHA, 2007, LANCET NEUROL, V6, P115, DOI 10.1016/S1474-4422(06)70685-8; Halkes PHA, 2006, LANCET, V367, P1665; Hand PJ, 2006, STROKE, V37, P769, DOI 10.1161/01.STR.0000204041.13466.4c; HANKEY GJ, 2005, STROKE TREATMENT PRE; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Mas J, 2006, NEW ENGL J MED, V355, P1660, DOI 10.1056/NEJMoa061752; Ringleb PA, 2006, LANCET, V368, P1239, DOI 10.1016/S0140-6736(06)69122-8; Rothwell PM, 2005, LANCET, V365, P256; Steiner T, 2006, CEREBROVASC DIS, V22, P294, DOI 10.1159/000094831; STEYER R, 2007, STREET COM      0226; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4	19	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2007	369	9570					1330	1332		10.1016/S0140-6736(07)60614-X	http://dx.doi.org/10.1016/S0140-6736(07)60614-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	159HL	17448805				2022-12-01	WOS:000245856100010
J	Nachega, JB; Hislop, M; Dowdy, DW; Chaisson, RE; Regensberg, L; Maartens, G				Nachega, Jean B.; Hislop, Michael; Dowdy, David W.; Chaisson, Richard E.; Regensberg, Leon; Maartens, Gary			Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	13th Conference on Retroviruses and Opportunistic Infections	FEB 05-09, 2006	Denver, CO				ACTIVE ANTIRETROVIRAL THERAPY; TRIPLE-COMBINATION THERAPY; DRUG-RESISTANCE MUTATIONS; SOCIETY-USA PANEL; PROTEASE INHIBITORS; VIRAL SUPPRESSION; TREATMENT FAILURE; PHARMACY RECORDS; INFECTED ADULTS; EFAVIRENZ	Background: Adherence of 95% or more to unboosted protease regimens is required for optimal virologic suppression in HIV-1 infected patients. Whether the same is true for nonnucleoside reverse transcriptase inhibitor (NNRTI)-based therapy is unclear. Objective: To assess the relationship between adherence to NNRTI-based therapy and viral load in treatment-naive patients. Design: Observational cohort study. Setting: Private-sector HIV and AIDS disease management program in South Africa. Patients: 2821 adults infected with HIV who began NNRTI-based therapy between January 1998 and March 2003 (2764 patients [98%] were enrolled after December 2000). Measurements: Adherence was assessed by monthly pharmacy claims. The primary end point was sustained viral load suppression (< 400 copies/mL) in 100% of recorded viral load measurements throughout follow-up. Secondary end points included time to initial viral load suppression and time to subsequent virologic failure (< 400 copies/mL). Results: The median follow-up period was 2.2 years (interquartile range, 1.7 to 2.7 years). The proportion of patients with sustained viral load suppression ranged from 13% (41 of 325 patients) in patients who filled less than 50% of antiretroviral drug prescriptions to 73% (725 of 997 patients) in those who filled 100% of antiretroviral drug prescriptions. Each 10% increase in pharmacy claim adherence greater than 50% was associated with a mean absolute increase of 0.10 in the proportion of patients with sustained virologic suppression (P < 0.001). Predictors for shorter time to virologic failure after initial suppression in multivariable Cox regression included CD4(+) T-cell counts of 0.50 x 10(9) cells/L or less (hazard ratio, 1.60 [95% CI, 1.22 to 2.10] vs. CD4(+) T-cell counts > 0.20 x 10(9) cells/L), baseline viral load greater than 10(5) copies/mL (hazard ratio, 1.39 [CI 1.14 to 1.70]), nevirapine-based regimen (hazard ratio, 1.43 [CI 1.16 to 1.75]), and low pharmacy claim adherence (hazard ratio, 1.58 [CI 1.48 to 1.69], per 10% decrease in adherence to 50%). Limitations: Observational study with adherence stratification at study end and lack of standardized timing for outcome measurement. Conclusion: Virologic outcomes improve in a linear dose-response manner as adherence to NNRTI-based regimens increases beyond 50%.	Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; Johns Hopkins Sch Med, Baltimore, MD USA; Univ Cape Town, Groote Schuur Hosp, ZA-7700 Rondebosch, South Africa; Aid AIDS Dis Management Programme Pty Ltd, Cape Town, South Africa	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; University of Cape Town	Nachega, JB (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, 615 N Wolfe St,Suite W5031, Baltimore, MD 21205 USA.	jnachega@jhsph.edu	Maartens, Gary/F-3836-2014; Maartens, Gary/S-2788-2019	Maartens, Gary/0000-0003-3080-6606; Maartens, Gary/0000-0003-3080-6606; Nachega, Jean/0000-0002-2862-4443	NIAID NIH HHS [R01 AI 016137, K23 AI068582-01, R01 AI 5535901] Funding Source: Medline; PHS HHS [5 T32 GMO7309] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055359, R01AI016137, K23AI068582] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201; Bacheler LT, 2000, ANTIMICROB AGENTS CH, V44, P2475, DOI 10.1128/AAC.44.9.2475-2484.2000; Bangsberg DR, 2006, CLIN INFECT DIS, V43, P939, DOI 10.1086/507526; Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Bangsberg DR, 2004, J ANTIMICROB CHEMOTH, V53, P696, DOI 10.1093/jac/dkh162; Bangsberg DR, 2003, AIDS, V17, P1925, DOI 10.1097/00002030-200309050-00011; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Bartlett JA, 2001, AIDS, V15, P1369, DOI 10.1097/00002030-200107270-00006; Benatar SR, 2004, NEW ENGL J MED, V351, P81, DOI 10.1056/NEJMhpr033471; Choo PW, 1999, MED CARE, V37, P846, DOI 10.1097/00005650-199909000-00002; Dezii C M, 2001, Manag Care, V10, P42; Dybul M, 2002, ANN INTERN MED, V137, P381, DOI 10.7326/0003-4819-137-5_Part_2-200209031-00001; Egger M, 2006, J INFECT DIS, V194, P612, DOI 10.1086/506362; Gross R, 2006, J INFECT DIS, V194, P1108, DOI 10.1086/507680; Grossberg R, 2004, J CLIN EPIDEMIOL, V57, P1107, DOI 10.1016/j.jclinepi.2004.04.002; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; Maggiolo F, 2005, CLIN INFECT DIS, V40, P158, DOI 10.1086/426595; Marzolini C, 2001, AIDS, V15, P71, DOI 10.1097/00002030-200101050-00011; Miller V, 1999, J INFECT DIS, V180, P530, DOI 10.1086/314890; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Mocroft A, 1998, AIDS, V12, P2161, DOI 10.1097/00002030-199816000-00011; Moore RD, 2005, JAIDS-J ACQ IMM DEF, V39, P195; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; RICHMAN DD, 1994, J VIROL, V68, P1660, DOI 10.1128/JVI.68.3.1660-1666.1994; Sethi AK, 2003, CLIN INFECT DIS, V37, P1112, DOI 10.1086/378301; Siddique MA, 2006, J INFECT DIS, V194, P661, DOI 10.1086/505913; Smith PF, 2005, ANTIMICROB AGENTS CH, V49, P3558, DOI 10.1128/AAC.49.8.3558-3561.2005; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7; Wong MD, 2004, J GEN INTERN MED, V19, P366, DOI 10.1111/j.1525-1497.2004.30429.x; Wood E, 2006, AIDS, V20, P1117, DOI 10.1097/01.aids.0000226951.49353.ed; Yeni PG, 2004, JAMA-J AM MED ASSOC, V292, P251, DOI 10.1001/jama.292.2.251	37	272	280	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2007	146	8					564	U16		10.7326/0003-4819-146-8-200704170-00007	http://dx.doi.org/10.7326/0003-4819-146-8-200704170-00007			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	158FV	17438315				2022-12-01	WOS:000245778000003
J	Sakamoto, N; Seto, Y; Itoh, S; Kuramoto, K; Fujino, K; Nagashima, K; Krot, AN; Yurimoto, H				Sakamoto, Naoya; Seto, Yusuke; Itoh, Shoichi; Kuramoto, Kiyoshi; Fujino, Kiyoshi; Nagashima, Kazuhide; Krot, Alexander N.; Yurimoto, Hisayoshi			Remnants of the early solar system water enriched in heavy oxygen isotopes	SCIENCE			English	Article							CARBONACEOUS CHONDRITES; NEBULA; METEORITES; MAGNETITE; RESERVOIR; EVOLUTION; ALLENDE; MATRIX; ORIGIN; GAS	Oxygen isotopic composition of our solar system is believed to have resulted from mixing of two isotopically distinct nebular reservoirs, O-16-rich and O-17,O-18-rich relative to Earth. The nature and composition of the O-17,O-18-rich reservoir are poorly constrained. We report an in situ discovery of a chemically and isotopically unique material distributed ubiquitously in fine-grained matrix of a primitive carbonaceous chondrite Acfer 094. This material formed by oxidation of Fe, Ni-metal and sulfides by water either in the solar nebula or on a planetesimal. Oxygen isotopic composition of this material indicates that the water was highly enriched in O-17 and O-18 (delta O-17,18(SMOW) = + 180 parts per thousand per mil), providing the first evidence for an extremely O-17,O-18-rich reservoir in the early solar system.	Hokkaido Univ, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan; Hokkaido Univ, Dept Cosmosci, Sapporo, Hokkaido 0600810, Japan; Univ Hawaii Manoa, Hawaii Inst Geophys & Planetol, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA; Hokkaido Univ, Isotope Imaging Lab, Creat Res Initiat Sousei, Sapporo, Hokkaido 0010021, Japan	Hokkaido University; Hokkaido University; University of Hawaii System; University of Hawaii Manoa; Hokkaido University	Yurimoto, H (corresponding author), Hokkaido Univ, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan.	yuri@ep.sci.hokudai.ac.jp	Yurimoto, Hisayoshi/S-9938-2018; Seto, Yusuke/D-5751-2015	Yurimoto, Hisayoshi/0000-0003-0702-0533; Seto, Yusuke/0000-0002-5423-2136; Nagashima, Kazuhide/0000-0002-9322-3187; Kuramoto, Kiyoshi/0000-0002-6757-8064; Itoh, Shoichi/0000-0001-9431-0525				CHASE JMW, 1998, J PHYS CHEM REFERE 1, V9; CHASE JMW, 1998, J PHYS CHEM REFERE 2, V9; Choi BG, 1998, NATURE, V392, P577, DOI 10.1038/33356; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.ea.21.050193.000555; Clayton RN, 2002, NATURE, V415, P860, DOI 10.1038/415860b; Clayton RN, 1999, GEOCHIM COSMOCHIM AC, V63, P2089, DOI 10.1016/S0016-7037(99)00090-3; Clayton RN, 2006, SCIENCE, V313, P1743, DOI 10.1126/science.1133137; Fegley B, 2000, SPACE SCI REV, V92, P177, DOI 10.1023/A:1005286910756; Fuchs L. H., 1973, SMITHSON CONTRIB EAR, V10, P1, DOI DOI 10.5479/SI.00810274.10.1; Greshake A, 1997, GEOCHIM COSMOCHIM AC, V61, P437, DOI 10.1016/S0016-7037(96)00332-8; Hong Y, 1998, METEORIT PLANET SCI, V33, P1101, DOI 10.1111/j.1945-5100.1998.tb01715.x; Ireland TR, 2006, NATURE, V440, P776, DOI 10.1038/nature04611; Itoh S, 2003, NATURE, V423, P728, DOI 10.1038/nature01699; Kobayashi S, 2003, GEOCHEM J, V37, P663, DOI 10.2343/geochemj.37.663; Krot A. N., 2000, Protostars and planets 4, P1019; Krot AN, 2002, SCIENCE, V295, P1051, DOI 10.1126/science.1068200; Krot AN, 2005, ASTROPHYS J, V622, P1333, DOI 10.1086/428382; Kunihiro T, 2005, GEOCHIM COSMOCHIM AC, V69, P763, DOI 10.1016/j.gca.2004.07.024; Lauretta DS, 1996, ICARUS, V122, P288, DOI 10.1006/icar.1996.0126; Lyons JR, 2005, NATURE, V435, P317, DOI 10.1038/nature03557; Nagashima K, 2004, NATURE, V428, P921, DOI 10.1038/nature02510; TOMEOKA K, 1985, GEOCHIM COSMOCHIM AC, V49, P2149, DOI 10.1016/0016-7037(85)90073-0; Young ED, 1998, SCIENCE, V282, P452, DOI 10.1126/science.282.5388.452; Young ED, 2001, PHILOS T ROY SOC A, V359, P2095, DOI 10.1098/rsta. 2001.0900; YOUNG ED, 2006, LUNAR PLANET SCI, V37; Yurimoto H, 2004, SCIENCE, V305, P1763, DOI 10.1126/science.1100989; Yurimoto H, 1998, SCIENCE, V282, P1874, DOI 10.1126/science.282.5395.1874; Yurimoto H, 2002, METEORIT PLANET SCI, V37, pA153; Yurimoto H., 2007, PROTOSTARS PLANETS, P849; Yurimoto L, 2003, APPL SURF SCI, V203, P793, DOI 10.1016/S0169-4332(02)00825-5	30	203	205	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2007	317	5835					231	233		10.1126/science.1142021	http://dx.doi.org/10.1126/science.1142021			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189DC	17569827	Green Submitted			2022-12-01	WOS:000247968600038
J	Mata-Haro, V; Cekic, C; Martin, M; Chilton, PM; Casella, CR; Mitchell, TC				Mata-Haro, Veronica; Cekic, Caglar; Martin, Michael; Chilton, Paula M.; Casella, Carolyn R.; Mitchell, Thomas C.			The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4	SCIENCE			English	Article							SIGNALING PATHWAY; TOLL; LIPOPOLYSACCHARIDE; EXPRESSION; ACTIVATION; ENDOTOXIN; RESPONSES; GENES; CELLS; BETA	The inflammatory toxicity of lipopolysaccharide (LPS), a component of bacterial cell walls, is driven by the adaptor proteins myeloid differentiation factor 88 (MyD88) and Toll-interleukin 1 receptor domain-containing adapter inducing interferon-beta (TRIF), which together mediate signaling by the endotoxin receptor Toll-like receptor 4 (TLR4). Monophosphoryl lipid A (MPLA) is a low-toxicity derivative of LPS with useful immunostimulatory properties, which is nearing regulatory approval for use as a human vaccine adjuvant. We report here that, in mice, the low toxicity of MPLA's adjuvant function is associated with a bias toward TRIF signaling, which we suggest is likely caused by the active suppression, rather than passive loss, of proinflammatory activity of this LPS derivative. This finding may have important implications for the development of future vaccine adjuvants.	Univ Louisville, Inst Cellular Therapeut, Louisville, KY 40202 USA; Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40202 USA; Univ Louisville, Oral Hlth & Systemat Dis Res Grp, Louisville, KY 40202 USA	University of Louisville; University of Louisville; University of Louisville	Mitchell, TC (corresponding author), Univ Louisville, Inst Cellular Therapeut, 570 S Preston St, Louisville, KY 40202 USA.	tom.mitchell@louisville.edu	Mata-Haro, Veronica/K-2559-2015; Mitchell, Thomas C/B-4193-2013	Mata-Haro, Veronica/0000-0002-7394-4569; Chilton, Paula/0000-0002-8749-0975; Cekic, Caglar/0000-0001-8081-508X	NIAID NIH HHS [R01 AI071047, AI059023, AI51377, K02 AI059023, R01 AI051377] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI059023, R01AI051377, R01AI071047] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Baldridge JR, 2004, EXPERT OPIN BIOL TH, V4, P1129, DOI 10.1517/14712598.4.7.1129; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bjorkbacka H, 2004, PHYSIOL GENOMICS, V19, P319, DOI 10.1152/physiolgenomics.00128.2004; Evans Jay T, 2003, Expert Rev Vaccines, V2, P219, DOI 10.1586/14760584.2.2.219; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; OKERNOTO K, 2006, J IMMUNOL, V176, P1203; Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; QURESHI N, 1982, J BIOL CHEM, V257, P1808; Thoelen S, 1998, VACCINE, V16, P708, DOI 10.1016/S0264-410X(97)00254-5; Thomas KE, 2006, J BIOL CHEM, V281, P31119, DOI 10.1074/jbc.M604958200; Vernacchio L, 2002, VACCINE, V20, P3658, DOI 10.1016/S0264-410X(02)00413-9; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	26	611	658	7	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2007	316	5831					1628	1632		10.1126/science.1138963	http://dx.doi.org/10.1126/science.1138963			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569868				2022-12-01	WOS:000247239900045
J	Moore, DD				Moore, David D.			Sister act	SCIENCE			English	Editorial Material							KLOTHO; HOMEOSTASIS; RECEPTORS; REGULATOR; SIGNAL; FGF23		Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine	Moore, DD (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	moore@bcm.edu						Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Ito S, 2005, J CLIN INVEST, V115, P2202, DOI 10.1172/JCI23076; Ito S, 2002, BBA-GENE STRUCT EXPR, V1576, P341, DOI 10.1016/S0167-4781(02)00281-6; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kolek OI, 2005, AM J PHYSIOL-GASTR L, V289, pG1036, DOI 10.1152/ajpgi.00243.2005; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Zhang JF, 2006, NATURE, V439, P340, DOI 10.1038/nature04368	16	37	45	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2007	316	5830					1436	1438		10.1126/science.1144837	http://dx.doi.org/10.1126/science.1144837			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556573				2022-12-01	WOS:000247066400028
J	Taylor, PD; Day, T; Wild, G				Taylor, Peter D.; Day, Troy; Wild, Geoff			Evolution of cooperation in a finite homogeneous graph	NATURE			English	Article							KIN SELECTION; VISCOUS POPULATIONS; INCLUSIVE FITNESS; STABILITY; ALTRUISM; EVOLVE; MODEL	Recent theoretical studies of selection in finite structured populations(1-7) have worked with one of two measures of selective advantage of an allele: fixation probability and inclusive fitness. Each approach has its own analytical strengths, but given certain assumptions they provide equivalent results(1). In most instances the structure of the population can be specified by a network of nodes connected by edges ( that is, a graph)(8-10), and much of the work here has focused on a continuous-time model of evolution, first described by ref. 11. Working in this context, we provide an inclusive fitness analysis to derive a surprisingly simple analytical condition for the selective advantage of a cooperative allele in any graph for which the structure satisfies a general symmetry condition ('bi-transitivity'). Our results hold for a broad class of population structures, including most of those analysed previously, as well as some for which a direct calculation of fixation probability has appeared intractable. Notably, under some forms of population regulation, the ability of a cooperative allele to invade is seen to be independent of the nature of population structure ( and in particular of how game partnerships are specified) and is identical to that for an unstructured population. For other types of population regulation our results reveal that cooperation can invade if players choose partners along relatively 'high-weight' edges.	Queens Univ, Dept Math & Stat, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Taylor, PD (corresponding author), Queens Univ, Dept Math & Stat, Kingston, ON K7L 3N6, Canada.	peter.taylor@queensu.ca		Day, Troy/0000-0002-1052-6140				FRANK SA, 1994, P ROY SOC B-BIOL SCI, V258, P153, DOI 10.1098/rspb.1994.0156; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Lessard S, 2005, THEOR POPUL BIOL, V68, P19, DOI 10.1016/j.tpb.2005.04.001; Lieberman E, 2005, NATURE, V433, P312, DOI 10.1038/nature03204; MICHOD RE, 1980, NATURE, V288, P694, DOI 10.1038/288694a0; Moran PAP., 1962, STAT PROCESSES EVOLU; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Ohtsuki H, 2006, P ROY SOC B-BIOL SCI, V273, P2249, DOI 10.1098/rspb.2006.3576; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Orzack SH, 2005, EVOLUTION, V59, P1183; Proulx S. R., 2001, SELECTION, V2, P1, DOI DOI 10.1556/SELECT.2.2001.1-2.1; Rousset F, 2000, J EVOLUTION BIOL, V13, P814, DOI 10.1046/j.1420-9101.2000.00219.x; Taylor P. A. I., 2000, SELECTION, V1, P83, DOI [10.1556/select. 1.2000.1-3.15, DOI 10.1556/SELECT.1.2000.1-3.15]; Taylor PD, 1996, J THEOR BIOL, V180, P27, DOI 10.1006/jtbi.1996.0075; TAYLOR PD, 1992, P ROY SOC B-BIOL SCI, V249, P299, DOI 10.1098/rspb.1992.0118; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; Wild G, 2004, P ROY SOC B-BIOL SCI, V271, P2345, DOI 10.1098/rspb.2004.2862; WILSON DS, 1992, EVOL ECOL, V6, P331, DOI 10.1007/BF02270969; Wright S, 1943, GENETICS, V28, P114	19	233	235	4	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2007	447	7143					469	472		10.1038/nature05784	http://dx.doi.org/10.1038/nature05784			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17522682				2022-12-01	WOS:000246693100046
J	Sayegh, MH; Remuzzi, G				Sayegh, Mohamed H.; Remuzzi, Giuseppe			Clinical update: immunosuppression minimisation	LANCET			English	Article							EARLY CYCLOSPORINE WITHDRAWAL; SIROLIMUS-BASED THERAPY; RENAL-TRANSPLANTATION; KIDNEY-TRANSPLANTATION; REJECTION; TOLERANCE; CHALLENGES; BELATACEPT; CAMPATH-1H; SURVIVAL		Mario Negri Inst Pharmacol Res, Negri Bergamo Labs, I-24125 Bergamo, Italy; Harvard Univ, Sch Med, Brigham & Womens Hosp, Transplantat Res Ctr, Boston, MA USA; Harvard Univ, Sch Med, Childrens Hosp, Boston, MA USA	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Remuzzi, G (corresponding author), Mario Negri Inst Pharmacol Res, Negri Bergamo Labs, I-24125 Bergamo, Italy.	gremuzzi@marionegri.it	; Remuzzi, Giuseppe/V-9766-2017	Sayegh, Mohamed/0000-0002-2847-588X; Remuzzi, Giuseppe/0000-0002-6194-3446				Barth RN, 2006, TRANSPL INT, V19, P885, DOI 10.1111/j.1432-2277.2006.00388.x; Curtis JJ, 2004, AM J TRANSPLANT, V4, P671, DOI 10.1111/j.1600-6143.2004.00474.x; Ekberg H, 2007, AM J TRANSPLANT, V7, P560, DOI 10.1111/j.1600-6143.2006.01645.x; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; Harmon W, 2006, J AM SOC NEPHROL, V17, P1735, DOI 10.1681/ASN.2006010049; Hricik DE, 2002, AM J TRANSPLANT, V2, P19, DOI 10.1034/j.1600-6143.2002.020105.x; Kirk AD, 2003, TRANSPLANTATION, V76, P120, DOI 10.1097/01.TP.0000071362.99021.D9; Kreis H, 2004, J AM SOC NEPHROL, V15, P809, DOI 10.1097/01.ASN.0000113248.59077.76; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P378, DOI 10.1111/j.1600-6143.2004.00332.x; Mota A, 2004, AM J TRANSPLANT, V4, P953, DOI 10.1111/j.1600-6143.2004.00446.x; Najafian N, 2006, J AM SOC NEPHROL, V17, P2652, DOI 10.1681/ASN.2005070707; Salama AD, 2001, J CLIN INVEST, V108, P943, DOI 10.1172/JCI14142; Sayegh MH, 2006, NAT CLIN PRACT NEPHR, V2, P134, DOI 10.1038/ncpneph0125; Sayegh MH, 2004, NEW ENGL J MED, V351, P2761, DOI 10.1056/NEJMon043418; Starzl TE, 2003, LANCET, V361, P1502, DOI 10.1016/S0140-6736(03)13175-3; Strom TB, 2005, NEW ENGL J MED, V353, P2394, DOI 10.1056/NEJMe058257; Terasaki PI, 2005, CURR OPIN IMMUNOL, V17, P541, DOI 10.1016/j.coi.2005.07.018; Vincenti F, 2003, J AM SOC NEPHROL, V14, P1940, DOI 10.1097/01.ASN.0000076844.59963.CF; Vincenti F, 2005, NEW ENGL J MED, V353, P770, DOI 10.1056/NEJMoa050085	20	26	28	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 20	2007	369	9574					1676	1678		10.1016/S0140-6736(07)60762-4	http://dx.doi.org/10.1016/S0140-6736(07)60762-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	169ZT	17512842				2022-12-01	WOS:000246631300010
J	Kozlowski, C; Srayko, M; Nedelec, F				Kozlowski, Cleopatra; Srayko, Martin; Nedelec, Francois			Cortical microtubule contacts position the spindle in C. elegans embryos	CELL			English	Article							ASYMMETRIC CELL-DIVISION; CAENORHABDITIS-ELEGANS; MITOTIC SPINDLE; FORCE GENERATION; PAR PROTEINS; POLARITY; IDENTIFICATION; CENTROSOMES; DYNAMICS; CORTEX	Interactions between microtubules and the cell cortex play a critical role in positioning organelles in a variety of biological contexts. Here we used Caenorhabditis elegans as a model system to study how cortex-microtubule interactions position the mitotic spindle in response to polarity cues. Imaging EBP-2::GFP and YFP::octubulin revealed that microtubules shrink soon after cortical contact, from which we propose that cortical adaptors mediate microtubule depolymerization energy into pulling forces. We also observe association of dynamic microtubules to form astral fibers that persist, despite the catastrophe events of individual microtubules. Computer simulations show that these effects, which are crucially determined by microtubule dynamics, can explain anaphase spindle oscillations and posterior displacement in 3D.	European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	European Molecular Biology Laboratory (EMBL); Max Planck Society	Nedelec, F (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany.	nedelec@embl.de	Srayko, Martin/A-3755-2014; Nedelec, Francois J/H-3317-2011; Nedelec, Francois/AAC-1673-2019	Nedelec, Francois J/0000-0002-8141-5288; Nedelec, Francois/0000-0002-8141-5288; Srayko, Martin/0000-0003-0196-0364				Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863; ALBERTSON DG, 1984, DEV BIOL, V101, P61, DOI 10.1016/0012-1606(84)90117-9; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Cowan CR, 2004, ANNU REV CELL DEV BI, V20, P427, DOI 10.1146/annurev.cellbio.19.111301.113823; Daniels BR, 2006, BIOPHYS J, V90, P4712, DOI 10.1529/biophysj.105.080606; Dogterom M, 2005, CURR OPIN CELL BIOL, V17, P67, DOI 10.1016/j.ceb.2004.12.011; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Gonczy P, 2002, TRENDS CELL BIOL, V12, P332, DOI 10.1016/S0962-8924(02)02306-1; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Grill SW, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108104; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Grill SW, 2005, DEV CELL, V8, P461, DOI 10.1016/j.devcel.2005.03.014; Grishchuk EL, 2005, NATURE, V438, P384, DOI 10.1038/nature04132; Gupta ML, 2006, NAT CELL BIOL, V8, P913, DOI 10.1038/ncb1457; HILL DP, 1988, DEV BIOL, V125, P75, DOI 10.1016/0012-1606(88)90060-7; Howard J, 2006, PHYS BIOL, V3, P54, DOI 10.1088/1478-3975/3/1/006; INOUE S, 1995, MOL BIOL CELL, V6, P1619, DOI 10.1091/mbc.6.12.1619; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Labbe JC, 2003, CURR BIOL, V13, P707, DOI 10.1016/S0960-9822(03)00251-3; Manneville JB, 2006, BIOL CELL, V98, P557, DOI 10.1042/BC20060017; McCarthy EK, 2006, CURR OPIN CELL BIOL, V18, P79, DOI 10.1016/j.ceb.2005.12.006; McCartney BM, 1999, J CELL BIOL, V146, P1303, DOI 10.1083/jcb.146.6.1303; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Nedelec F, 2002, J CELL BIOL, V158, P1005, DOI 10.1083/jcb.200202051; Pecreaux J, 2006, CURR BIOL, V16, P2111, DOI 10.1016/j.cub.2006.09.030; Praitis V, 2001, GENETICS, V157, P1217; Schlaitz AL, 2007, CELL, V128, P115, DOI 10.1016/j.cell.2006.10.050; Schmidt DJ, 2005, MOL BIOL CELL, V16, P1200, DOI 10.1091/mbc.E04-06-0523; Srayko M, 2005, DEV CELL, V9, P223, DOI 10.1016/j.devcel.2005.07.003; Strome S, 2001, MOL BIOL CELL, V12, P1751, DOI 10.1091/mbc.12.6.1751; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103	34	161	164	2	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					499	510		10.1016/j.cell.2007.03.027	http://dx.doi.org/10.1016/j.cell.2007.03.027			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482544	Bronze			2022-12-01	WOS:000246373600017
J	Schwartz, D; Collins, F				Schwartz, David; Collins, Francis			Medicine - Environmental biology and human disease	SCIENCE			English	Editorial Material							MACULAR DEGENERATION; VARIANT; GENOME; RISK								NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101946] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Craighead H, 2006, NATURE, V442, P387, DOI 10.1038/nature05061; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; GROOPMAN JD, 1992, CANCER RES, V52, P45; Kandimalla VB, 2004, ANAL BIOANAL CHEM, V380, P587, DOI 10.1007/s00216-004-2793-9; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Martinez FD, 2005, IMMUNOL ALLERGY CLIN, V25, P709, DOI 10.1016/j.iac.2005.09.001; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811	13	68	73	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2007	316	5825					695	696		10.1126/science.1141331	http://dx.doi.org/10.1126/science.1141331			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163RR	17478705				2022-12-01	WOS:000246181400027
J	van Kasteren, SI; Kramer, HB; Jensen, HH; Campbell, SJ; Kirkpatrick, J; Oldham, NJ; Anthony, DC; Davis, BG				van Kasteren, Sander I.; Kramer, Holger B.; Jensen, Henrik H.; Campbell, Sandra J.; Kirkpatrick, Joanna; Oldham, Neil J.; Anthony, Daniel C.; Davis, Benjamin G.			Expanding the diversity of chemical protein modification allows post-translational mimicry	NATURE			English	Article							BLOOD-BRAIN-BARRIER; O-GLCNAC; P-SELECTIN; TERMINAL ALKYNES; IN-VIVO; EXPRESSION; MALARIA; AZIDES; GLYCOSYLATION; GLYCOPROTEIN	One of the most important current scientific paradoxes is the economy with which nature uses genes. In all higher animals studied, we have found many fewer genes than we would have previously expected. The functional outputs of the eventual products of genes seem to be far more complex than the more restricted blueprint. In higher organisms, the functions of many proteins are modulated by post-translational modifications (PTMs)(1). These alterations of amino-acid side chains lead to higher structural and functional protein diversity and are, therefore, a leading contender for an explanation for this seeming incongruity. Natural protein production methods typically produce PTM mixtures within which function is difficult to dissect or control. Until now it has not been possible to access pure mimics of complex PTMs. Here we report a chemical tagging approach that enables the attachment of multiple modifications to bacterially expressed ( bare) protein scaffolds: this approach allows reconstitution of functionally effective mimics of higher organism PTMs. By attaching appropriate modifications at suitable distances in the widely-used LacZ reporter enzyme scaffold, we created protein probes that included sensitive systems for detection of mammalian brain inflammation and disease. Through target synthesis of the desired modification, chemistry provides a structural precision and an ability to retool with a chosen PTM in a manner not available to other approaches. In this way, combining chemical control of PTM with readily available protein scaffolds provides a systematic platform for creating probes of protein PTM interactions. We therefore anticipate that this ability to build model systems 2 will allow some of this gene product complexity to be dissected, with the aim of eventually being able to completely duplicate the patterns of a particular protein's PTMs from an in vivo assay into an in vitro system.	Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England; Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	University of Oxford; University of Oxford	Davis, BG (corresponding author), Univ Oxford, Dept Chem, Chem Res Lab, Mansfield Rd, Oxford OX1 3TA, England.	Ben.Davis@chem.ox.ac.uk	Kramer, Holger/AAL-4433-2020; Anthony, Daniel/F-7765-2010; Davis, Benjamin G/C-5281-2011	Kramer, Holger/0000-0002-6400-0945; Anthony, Daniel/0000-0003-1380-6655; Davis, Benjamin G/0000-0002-5056-407X; Oldham, Neil/0000-0001-8024-4563	Biotechnology and Biological Sciences Research Council [BB/C510824/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/D023343/1, EP/D023327/1, GR/T26542/01, EP/E000614/1, EP/D023335/1] Funding Source: researchfish; BBSRC [BB/E004350/1] Funding Source: UKRI; EPSRC [EP/E000614/1] Funding Source: UKRI; MRC [G0500853] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [EGA17763, BB/E004350/1] Funding Source: Medline; Medical Research Council [G0500853] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barkalow FJ, 1996, BLOOD, V88, P4585, DOI 10.1182/blood.V88.12.4585.bloodjournal88124585; Bernardes-Silva M, 2001, J CEREBR BLOOD F MET, V21, P1115, DOI 10.1097/00004647-200109000-00009; Campbell SJ, 1996, J CELL SCI, V109, P2619; CUBELLIS MV, 1990, GENE, V94, P89, DOI 10.1016/0378-1119(90)90472-4; Davis BG, 1998, J ORG CHEM, V63, P9614, DOI 10.1021/jo9816461; Davis BG, 2002, CHEM REV, V102, P579, DOI 10.1021/cr0004310; Davis BG, 2004, SCIENCE, V303, P480, DOI 10.1126/science.1093449; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; Easton RL, 2000, J BIOL CHEM, V275, P21928, DOI 10.1074/jbc.M001534200; ELLIOT SP, 1993, J NEUROSCI, V13, P2424, DOI 10.1523/JNEUROSCI.13-06-02424.1993; Ferrari CC, 2004, AM J PATHOL, V165, P1827, DOI 10.1016/S0002-9440(10)63438-4; Fodje MN, 2002, PROTEIN ENG, V15, P353, DOI 10.1093/protein/15.5.353; GOTSCH U, 1994, CELL ADHES COMMUN, V2, P7, DOI 10.3109/15419069409014198; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; Khidekel N, 2004, P NATL ACAD SCI USA, V101, P13132, DOI 10.1073/pnas.0403471101; Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299; Lefebvre T, 2005, EXPERT REV PROTEOMIC, V2, P265, DOI 10.1586/14789450.2.2.265; Leppanen A, 2000, J BIOL CHEM, V275, P39569, DOI 10.1074/jbc.M005005200; NELSON RM, 1993, J CLIN INVEST, V91, P1157, DOI 10.1172/JCI116275; Powlesland AS, 2006, J BIOL CHEM, V281, P20440, DOI 10.1074/jbc.M601925200; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Sibson NR, 2004, MAGN RESON MED, V51, P248, DOI 10.1002/mrm.10723; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Sun G, 2003, INFECT IMMUN, V71, P6553, DOI 10.1128/IAI.71.11.6553-6561.2003; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; van Hest JCM, 2000, J AM CHEM SOC, V122, P1282, DOI 10.1021/ja992749j; Vosseller K, 2002, CURR OPIN CHEM BIOL, V6, P851, DOI 10.1016/S1367-5931(02)00384-8; WOLD F, 1981, ANNU REV BIOCHEM, V50, P783, DOI 10.1146/annurev.bi.50.070181.004031	30	255	264	2	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2007	446	7139					1105	1109		10.1038/nature05757	http://dx.doi.org/10.1038/nature05757			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17460675				2022-12-01	WOS:000245950400055
J	Patel, SS; Belmont, BJ; Sante, JM; Rexach, MF				Patel, Samir S.; Belmont, Brian J.; Sante, Joshua M.; Rexach, Michael F.			Natively unfolded nucleoporins gate protein diffusion across the nuclear pore complex	CELL			English	Article							NUCLEOCYTOPLASMIC TRANSPORT; SACCHAROMYCES-CEREVISIAE; PROTEOMIC ANALYSIS; FG NUCLEOPORINS; PERMEABILITY; ARCHITECTURE; DETERMINANT; SYSTEM; DOMAIN	Nuclear pore complexes (NPCs) form aqueous conduits in the nuclear envelope and gate the diffusion of large proteins between the cytoplasm and nucleoplasm. NPC proteins (nucleoporins) that contain phenylalanine-glycine motifs in filamentous, natively unfolded domains (FG domains) line the diffusion conduit of the NPC, but their role in the size-selective barrier is unclear. We show that deletion of individual FG domains in yeast relaxes the NPC permeability barrier. At the molecular level, the FG domains of five nucleoporins anchored at the NPC center form a cohesive meshwork of filaments through hydrophobic interactions, which involve phenylalanines in FG motifs and are dispersed by aliphatic alcohols. In contrast, the FG domains of four peripherally anchored nucleoporins are generally noncohesive. The results support a two-gate model of NPC architecture featuring a central diffusion gate formed by a meshwork of cohesive FG nucleoporin filaments and a peripheral gate formed by repulsive FG nucleoporin filaments.	Univ Calif Santa Cruz, MCD Biol, Santa Cruz, CA 95064 USA; Stanford Univ, Stanford, CA 94305 USA	University of California System; University of California Santa Cruz; Stanford University	Rexach, MF (corresponding author), Univ Calif Santa Cruz, MCD Biol, Santa Cruz, CA 95064 USA.	rexach@biology.ucsc.edu		Patel, Samir/0000-0002-9489-5516; Belmont, Brian/0000-0002-8314-4565				Allen NPC, 2002, MOL CELL PROTEOMICS, V1, P930, DOI 10.1074/mcp.T200012-MCP200; Allen NPC, 2001, J BIOL CHEM, V276, P29268, DOI 10.1074/jbc.M102629200; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; De Souza CPC, 2004, CURR BIOL, V14, P1973, DOI 10.1016/j.cub.2004.10.050; Denning D, 2001, J CELL BIOL, V154, P937, DOI 10.1083/jcb.200101007; Denning DP, 2007, MOL CELL PROTEOMICS, V6, P272, DOI 10.1074/mcp.M600309-MCP200; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Eaglestone SS, 2000, P NATL ACAD SCI USA, V97, P240, DOI 10.1073/pnas.97.1.240; Feldherr CM, 1997, J CELL SCI, V110, P3065; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Gillen KM, 1998, J CELL SCI, V111, P3235; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kenna MA, 1996, MOL CELL BIOL, V16, P2025; Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103; Mohana-Borges R, 2000, J BIOL CHEM, V275, P4708, DOI 10.1074/jbc.275.7.4708; Rhee Y, 2000, NAT BIOTECHNOL, V18, P433, DOI 10.1038/74500; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shulga N, 2000, J CELL BIOL, V149, P1027, DOI 10.1083/jcb.149.5.1027; Shulga N, 2003, MOL CELL BIOL, V23, P534, DOI 10.1128/MCB.23.2.534-542.2003; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; YANG MJ, 1995, NUCLEIC ACIDS RES, V23, P1152, DOI 10.1093/nar/23.7.1152; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4	28	367	370	3	37	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					83	96		10.1016/j.cell.2007.01.044	http://dx.doi.org/10.1016/j.cell.2007.01.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418788	Bronze			2022-12-01	WOS:000245661100013
J	Fimia, GM; Stoykova, A; Romagnoli, A; Giunta, L; Di Bartolomeo, S; Nardacci, R; Corazzari, M; Fuoco, C; Ucar, A; Schwartz, P; Gruss, P; Piacentini, M; Chowdhury, K; Cecconi, F				Fimia, Gian Maria; Stoykova, Anastassia; Romagnoli, Alessandra; Giunta, Luigi; Di Bartolomeo, Sabrina; Nardacci, Roberta; Corazzari, Marco; Fuoco, Claudia; Ucar, Ahmet; Schwartz, Peter; Gruss, Peter; Piacentini, Mauro; Chowdhury, Kamal; Cecconi, Francesco			Ambra1 regulates autophagy and development of the nervous system	NATURE			English	Article							CELL-DEATH; EMBRYONIC-DEVELOPMENT; MOLECULAR MACHINERY; TUMOR-SUPPRESSOR; GENE; APOPTOSIS; MICE; PROTEINS; BECLIN-1; TUMORIGENESIS	Autophagy is a self-degradative process involved both in basal turnover of cellular components and in response to nutrient starvation or organelle damage in a wide range of eukaryotes(1-3). During autophagy, portions of the cytoplasm are sequestered by double-membraned vesicles called autophagosomes, and are degraded after fusion with lysosomes for subsequent recycling(4). In vertebrates, this process acts as a pro-survival or pro-death mechanism in different physiological and pathological conditions, such as neurodegeneration and cancer(2,5-7); however, the roles of autophagy during embryonic development are still largely uncharacterized(3). Beclin1 (Becn1; coiled-coil, myosin-like BCL2-interacting protein) is a principal regulator in autophagosome formation, and its deficiency results in early embryonic lethality(8,9). Here we show that Ambra1 (activating molecule in Beclin1-regulated autophagy), a large, previously unknown protein bearing a WD40 domain at its amino terminus, regulates autophagy and has a crucial role in embryogenesis. We found that Ambra1 is a positive regulator of the Becn1-dependent programme of autophagy, as revealed by its overexpression and by RNA interference experiments in vitro. Notably, Ambra1 functional deficiency in mouse embryos leads to severe neural tube defects associated with autophagy impairment, accumulation of ubiquitinated proteins, unbalanced cell proliferation and excessive apoptotic cell death. In addition to identifying a new and essential element regulating the autophagy programme, our results provide in vivo evidence supporting the existence of a complex interplay between autophagy, cell growth and cell death required for neural development in mammals.	Univ Roma Tor Vergata, Dept Biol, Dulbecco Telethon Inst, I-00133 Rome, Italy; Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany; IRCCS L Spallanzani, Natl Inst Infect Dis, I-00149 Rome, Italy; IRCCS, Fdn St Lucia, Lab Mol Neuroembryol, I-00143 Rome, Italy; Univ Gottingen, Dept Anat & Embryol, D-37085 Gottingen, Germany	Fondazione Telethon; Dulbecco Telethon Institute (DTI); University of Rome Tor Vergata; Max Planck Society; IRCCS Lazzaro Spallanzani; IRCCS Santa Lucia; University of Gottingen	Cecconi, F (corresponding author), Univ Roma Tor Vergata, Dept Biol, Dulbecco Telethon Inst, I-00133 Rome, Italy.	kchowdh@gwdg.de; francesco.cecconi@uniroma2.it	Romagnoli, Alessandra/B-5779-2017; Corazzari, Marco/J-5825-2019; Fimia, Gian Maria/K-3232-2016; Corazzari, Marco/B-4631-2019; Nardacci, Roberta/K-6555-2016; Piacentini, Mauro/I-2411-2016; Corazzari, Marco/K-6422-2016; Cecconi, Francesco/K-3969-2016; Ucar, Ahmet/E-8981-2012; Fuoco, Claudia/AAB-2268-2019; Di+Bartolomeo, Sabrina/AAB-9791-2019	Corazzari, Marco/0000-0002-6246-5968; Fimia, Gian Maria/0000-0003-4438-3325; Corazzari, Marco/0000-0002-6246-5968; Nardacci, Roberta/0000-0002-9209-1207; Piacentini, Mauro/0000-0003-2919-1296; Corazzari, Marco/0000-0002-6246-5968; Cecconi, Francesco/0000-0002-5614-4359; Fuoco, Claudia/0000-0001-8372-305X; Ucar, Ahmet/0000-0002-6551-3486; romagnoli, alessandra/0000-0003-4946-6138; DI BARTOLOMEO, Sabrina/0000-0002-5748-1541	Telethon [TCR04004] Funding Source: Medline	Telethon(Fondazione Telethon)		Baehrecke EH, 2002, NAT REV MOL CELL BIO, V3, P779, DOI 10.1038/nrm931; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Chowdhury K, 1997, NUCLEIC ACIDS RES, V25, P1531, DOI 10.1093/nar/25.8.1531; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Copp AJ, 2005, J ANAT, V207, P623, DOI 10.1111/j.1469-7580.2005.00476.x; Edinger AL, 2003, CANCER CELL, V4, P422, DOI 10.1016/S1535-6108(03)00306-4; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; HENG HHQ, 1993, CHROMOSOMA, V102, P325, DOI 10.1007/BF00661275; Huang WP, 2002, CELL STRUCT FUNCT, V27, P409, DOI 10.1247/csf.27.409; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lockshin RA, 2004, INT J BIOCHEM CELL B, V36, P2405, DOI 10.1016/j.biocel.2004.04.011; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Paglin S, 2001, CANCER RES, V61, P439; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Ranga U, 1997, J VIROL, V71, P7020, DOI 10.1128/JVI.71.9.7020-7029.1997; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; Somia NV, 1999, P NATL ACAD SCI USA, V96, P12667, DOI 10.1073/pnas.96.22.12667; Stoykova A, 1998, DEV DYNAM, V212, P198; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	34	751	787	1	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2007	447	7148					1121	U14		10.1038/nature05925	http://dx.doi.org/10.1038/nature05925			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183HT	17589504	Green Published			2022-12-01	WOS:000247564600039
J	He, L; He, XY; Lim, LP; De Stanchina, E; Xuan, ZY; Liang, Y; Xue, W; Zender, L; Magnus, J; Ridzon, D; Jackson, AL; Linsley, PS; Chen, CF; Lowe, SW; Cleary, MA; Hannon, GJ				He, Lin; He, Xingyue; Lim, Lee P.; De Stanchina, Elisa; Xuan, Zhenyu; Liang, Yu; Xue, Wen; Zender, Lars; Magnus, Jill; Ridzon, Dana; Jackson, Aimee L.; Linsley, Peter S.; Chen, Caifu; Lowe, Scott W.; Cleary, Michele A.; Hannon, Gregory J.			A microRNA component of the p53 tumour suppressor network	NATURE			English	Article							SHORT-INTERFERING RNAS; HUMAN CANCERS; EXPRESSION; TRANSCRIPTION; RESPONSES; PATHWAY; TARGETS; GENES; PCR	A global decrease in microRNA (miRNA) levels is often observed in human cancers(1,2), indicating that small RNAs may have an intrinsic function in tumour suppression. To identify miRNA components of tumour suppressor pathways, we compared miRNA expression profiles of wild-type and p53-deficient cells. Here we describe a family of miRNAs, miR-34a-c, whose expression reflected p53 status. Genes encoding miRNAs in the miR-34 family are direct transcriptional targets of p53, whose induction by DNA damage and oncogenic stress depends on p53 both in vitro and in vivo. Ectopic expression of miR-34 induces cell cycle arrest in both primary and tumour-derived cell lines, which is consistent with the observed ability of miR-34 to downregulate a programme of genes promoting cell cycle progression. The p53 network suppresses tumour formation through the coordinated activation of multiple transcriptional targets, and miR-34 may act in concert with other effectors to inhibit inappropriate cell proliferation.	Rosetta Inpharmat, Seattle, WA 98109 USA; Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Genet Program, Stony Brook, NY 11794 USA; Appl Biosyst Inc, Adv Res & Technol, Foster City, CA 94404 USA	Merck & Company; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Thermo Fisher Scientific; Applied Biosystems	Cleary, MA (corresponding author), Rosetta Inpharmat, 401 Terry Ave N, Seattle, WA 98109 USA.	michele_cleary@merck.com; hannon@cshl.org	Hannon, Gregory/AAB-3568-2019	Xue, Wen/0000-0002-9797-8042; Xuan, Zhenyu/0000-0001-9344-8493; Jackson, Aimee/0000-0002-3786-7391	NATIONAL CANCER INSTITUTE [P01CA087497, P30CA008748, P01CA013106, K99CA126186] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748, P01 CA087497, K99 CA126186-01, P01 CA013106, K99 CA126186] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; MIYASHITA T, 1995, CELL, V80, P293; Raymond CK, 2005, RNA, V11, P1737, DOI 10.1261/rna.2148705; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Spurgers KB, 2006, J BIOL CHEM, V281, P25134, DOI 10.1074/jbc.M513901200; Sutcliffe JE, 2004, FEBS LETT, V567, P86, DOI 10.1016/j.febslet.2004.03.122; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; WELCH C, 2007, ONCOGENE; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529	29	2126	2298	5	309	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2007	447	7148					1130	U16		10.1038/nature05939	http://dx.doi.org/10.1038/nature05939			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183HT	17554337	Green Accepted			2022-12-01	WOS:000247564600041
J	Nene, V; Wortman, JR; Lawson, D; Haas, B; Kodira, C; Tu, ZJ; Loftus, B; Xi, ZY; Megy, K; Grabherr, M; Ren, QH; Zdobnov, EM; Lobo, NF; Campbell, KS; Brown, SE; Bonaldo, MF; Zhu, JS; Sinkins, SP; Hogenkamp, DG; Amedeo, P; Arensburger, P; Atkinson, PW; Bidwell, S; Biedler, J; Birney, E; Bruggner, RV; Costas, J; Coy, MR; Crabtree, J; Crawford, M; deBruyn, B; DeCaprio, D; Eiglmeier, K; Eisenstadt, E; El-Dorry, H; Gelbart, WM; Gomes, SL; Hammond, M; Hannick, LI; Hogan, JR; Holmes, MH; Jaffe, D; Johnston, JS; Kennedy, RC; Koo, H; Kravitz, S; Kriventseva, EV; Kulp, D; LaButti, K; Lee, E; Li, S; Lovin, DD; Mao, CH; Mauceli, E; Menck, CFM; Miller, JR; Montgomery, P; Mori, A; Nascimento, AL; Naveira, HF; Nusbaum, C; O'Leary, S; Orvis, J; Pertea, M; Quesneville, H; Reidenbach, KR; Rogers, YH; Roth, CW; Schneider, JR; Schatz, M; Shumway, M; Stanke, M; Stinson, EO; Tubio, JMC; VanZee, JP; Verjovski-Almeida, S; Werner, D; White, O; Wyder, S; Zeng, QD; Zhao, Q; Zhao, YM; Hill, CA; Raikhel, AS; Soares, MB; Knudson, DL; Lee, NH; Galagan, J; Salzberg, SL; Paulsen, IT; Dimopoulos, G; Collins, FH; Birren, B; Fraser-Liggett, CM; Severson, DW				Nene, Vishvanath; Wortman, Jennifer R.; Lawson, Daniel; Haas, Brian; Kodira, Chinnappa; Tu, Zhijian (Jake); Loftus, Brendan; Xi, Zhiyong; Megy, Karyn; Grabherr, Manfred; Ren, Quinghu; Zdobnov, Evgeny M.; Lobo, Neil F.; Campbell, Kathryn S.; Brown, Susan E.; Bonaldo, Maria F.; Zhu, Jingsong; Sinkins, Steven P.; Hogenkamp, David G.; Amedeo, Paolo; Arensburger, Peter; Atkinson, Peter W.; Bidwell, Shelby; Biedler, Jim; Birney, Ewan; Bruggner, Robert V.; Costas, Javier; Coy, Monique R.; Crabtree, Jonathan; Crawford, Matt; deBruyn, Becky; DeCaprio, David; Eiglmeier, Karin; Eisenstadt, Eric; El-Dorry, Hamza; Gelbart, William M.; Gomes, Suely L.; Hammond, Martin; Hannick, Linda I.; Hogan, James R.; Holmes, Michael H.; Jaffe, David; Johnston, J. Spencer; Kennedy, Ryan C.; Koo, Hean; Kravitz, Saul; Kriventseva, Evgenia V.; Kulp, David; LaButti, Kurt; Lee, Eduardo; Li, Song; Lovin, Diane D.; Mao, Chunhong; Mauceli, Evan; Menck, Carlos F. M.; Miller, Jason R.; Montgomery, Philip; Mori, Akio; Nascimento, Ana L.; Naveira, Horacio F.; Nusbaum, Chad; O'Leary, Sinead; Orvis, Joshua; Pertea, Mihaela; Quesneville, Hadi; Reidenbach, Kyanne R.; Rogers, Yu-Hui; Roth, Charles W.; Schneider, Jennifer R.; Schatz, Michael; Shumway, Martin; Stanke, Mario; Stinson, Eric O.; Tubio, Jose M. C.; VanZee, Janice P.; Verjovski-Almeida, Sergio; Werner, Doreen; White, Owen; Wyder, Stefan; Zeng, Qiandong; Zhao, Qi; Zhao, Yongmei; Hill, Catherine A.; Raikhel, Alexander S.; Soares, Marcelo B.; Knudson, Dennis L.; Lee, Norman H.; Galagan, James; Salzberg, Steven L.; Paulsen, Ian T.; Dimopoulos, George; Collins, Frank H.; Birren, Bruce; Fraser-Liggett, Claire M.; Severson, David W.			Genome sequence of Aedes aegypti, a major arbovirus vector	SCIENCE			English	Article							YELLOW-FEVER MOSQUITO; ANOPHELES-GAMBIAE; DROSOPHILA-MELANOGASTER; EXPRESSION; EVOLUTION; ORGANIZATION; TRANSPOSONS; SUPERFAMILY; RECEPTORS; INSECTS	We present a draft sequence of the genome of Aedes aegypti, the primary vector for yellow fever and dengue fever, which at similar to 1376 million base pairs is about 5 times the size of the genome of the malaria vector Anopheles gambiae. Nearly 50% of the Ae. aegypti genome consists of transposable elements. These contribute to a factor of similar to 4 to 6 increase in average gene length and in sizes of intergenic regions relative to An. gambiae and Drosophila melanogaster. Nonetheless, chromosomal synteny is generally maintained among all three insects, although conservation of orthologous gene order is higher (by a factor of similar to 2) between the mosquito species than between either of them and the fruit fly. An increase in genes encoding odorant binding, cytochrome P450, and cuticle domains relative to An. gambiae suggests that members of these protein families underpin some of the biological differences between the two mosquito species.	Inst Genome Res, Rockville, MD 20850 USA; European Bioinformat Inst EMBL EBI, Hinxton CB10 1SD, Cambs, England; MIT, Broad Inst, Cambridge, MA 02141 USA; Harvard Univ, Broad Inst, Cambridge, MA 02141 USA; Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; Univ Geneva, Sch Med, CH-1211 Geneva, Switzerland; Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; Univ Notre Dame, Notre Dame, IN 46556 USA; Harvard Univ, Cambridge, MA 02138 USA; Colorado State Univ, Coll Agr Sci, Ft Collins, CO 80523 USA; Northwestern Univ, Chicago, IL 60614 USA; Univ Calif Riverside, Riverside, CA 92521 USA; Univ Oxford, Oxford OX1 3PS, England; Purdue Univ, W Lafayette, IN 47907 USA; Hosp Clin Univ Santiago, Fdn Publ Galega Med Xenom, Ctr Nacl Genotipado, E-15706 Santiago, Spain; Inst Pasteur, F-75724 Paris, France; Univ Sao Paulo, Inst Quim, BR-05508900 Sao Paulo, Brazil; Texas A&M Univ, College Stn, TX 77843 USA; Joint Technol Ctr, Rockville, MD 20850 USA; Univ Massachusetts, Amherst, MA 01003 USA; Univ Sao Paulo, Inst Biomed Sci, BR-05508900 Sao Paulo, Brazil; Inst Butantan, BR-05503900 Sao Paulo, Brazil; Univ A Coruna, La Coruna 15001, Spain; Univ Paris Diderot, CNRS, Inst Jacques Monod, F-75252 Paris, France; Univ Paris 06, F-75252 Paris, France; Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; Univ Gottingen, D-37077 Gottingen, Germany; Complexo Hosp Univ Santiago, Santiago De Compostela 15706, Spain	J. Craig Venter Institute; European Molecular Biology Laboratory (EMBL); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Virginia Polytechnic Institute & State University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Geneva; Swiss Institute of Bioinformatics; Imperial College London; University of Notre Dame; Harvard University; Colorado State University; Northwestern University; University of California System; University of California Riverside; University of Oxford; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Complexo Hospitalario Universitario de Santiago de Compostela; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universidade de Sao Paulo; Texas A&M University System; Texas A&M University College Station; University of Massachusetts System; University of Massachusetts Amherst; Universidade de Sao Paulo; Instituto Butantan; Universidade da Coruna; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; University of California System; University of California Santa Cruz; University of Gottingen; Complexo Hospitalario Universitario de Santiago de Compostela	Nene, V (corresponding author), Inst Genome Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.	nene@tigr.org; severson.1@nd.edu	Costas, Javier/B-5016-2008; Quesneville, Hadi/AAG-1048-2020; Paulsen, Ian T/K-3832-2012; Xi, Zhiyong/AAD-7936-2022; Gomes, Suely Lopes/D-8938-2012; Naveira, Horacio/H-7249-2014; Tubio, Jose M.C./H-5076-2015; Salzberg, Steven L/F-6162-2011; Naveira, Horacio/I-7802-2019; Nascimento, Ana L. T. O./E-8488-2012; Menck, Carlos FM/G-6321-2011; Zdobnov, Evgeny/AAB-2745-2022; Zeng, Qiandong/AAF-3305-2019; Pertea, Mihaela/AAT-2705-2021; Schatz, Michael/L-2690-2019; Verjovski-Almeida, Sergio/E-4082-2012; Zdobnov, Evgeny M/K-1133-2012; Stanke, Mario/P-7876-2019; Tubio, Jose/AAG-7345-2019; Salzberg, Steven/Q-6514-2019	Costas, Javier/0000-0003-0306-3990; Quesneville, Hadi/0000-0003-3001-4908; Paulsen, Ian T/0000-0001-9015-9418; Xi, Zhiyong/0000-0001-7786-012X; Gomes, Suely Lopes/0000-0002-3367-9676; Naveira, Horacio/0000-0002-3840-1569; Tubio, Jose M.C./0000-0003-3540-2459; Salzberg, Steven L/0000-0002-8859-7432; Naveira, Horacio/0000-0002-3840-1569; Nascimento, Ana L. T. O./0000-0003-4851-0870; Menck, Carlos FM/0000-0003-1941-0694; Zdobnov, Evgeny/0000-0002-5178-1498; Pertea, Mihaela/0000-0003-0762-8637; Schatz, Michael/0000-0002-4118-4446; Verjovski-Almeida, Sergio/0000-0002-6356-2401; Stanke, Mario/0000-0001-8696-0384; Tubio, Jose/0000-0003-3540-2459; Salzberg, Steven/0000-0002-8859-7432; Grabherr, Manfred/0000-0001-8792-6508; Hannick, Linda/0000-0002-8018-8466; Zhu, Jinsong/0000-0002-1587-753X; Lawson, Daniel/0000-0001-7765-983X; Nene, Vishvanath/0000-0001-7066-4169; Dimopoulos, George/0000-0001-6755-8111; Birney, Ewan/0000-0001-8314-8497; Miller, Jason/0000-0002-6912-2925; Fraser, Claire/0000-0003-1462-2428; loftus, brendan/0000-0001-8871-8356; Kulp, David/0000-0001-6540-0222; Wortman, Jennifer/0000-0002-8713-1227; Wyder, Stefan/0000-0002-3412-0292; DeCaprio, Dave/0000-0001-8931-9461; Megy, Karyn/0000-0002-2826-3879; Galagan, James/0000-0003-0542-3291	NIAID NIH HHS [R37 AI024716, UO1 AI50936, 5 R01 AI61576-2, HHSN266200400001C, HHSN266200400039C, R01 AI059492, U01 AI050936] Funding Source: Medline; NLM NIH HHS [R01 LM006845, R01 LM006845-08] Funding Source: Medline; Wellcome Trust [079059] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059492, R01AI061576, R37AI024716, U01AI050936] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Arkhipova IR, 2003, NAT GENET, V33, P123, DOI 10.1038/ng1074; Bartholomay LC, 2004, INFECT IMMUN, V72, P4114, DOI 10.1128/IAI.72.7.4114-4126.2004; Beaty B.J., 1996, BIOL DIS VECTORS; Bosio CF, 2000, GENETICS, V156, P687; Christophers SR, 1960, AEDES AEGYPTI YELLOW; Clements AN., 1992, BIOL MOSQUITOES DEV; Coy MR, 2005, INSECT MOL BIOL, V14, P537, DOI 10.1111/j.1365-2583.2005.00584.x; CRAIG NL, 2002, MOBILE DNA, V2; Feschotte C, 2004, MOL BIOL EVOL, V21, P1769, DOI 10.1093/molbev/msh188; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; HOIT RA, 2002, SCIENCE, V298, P129; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Krzywinski J, 2006, MOL PHYLOGENET EVOL, V39, P417, DOI 10.1016/j.ympev.2006.01.006; Ligon B Lee, 2006, Semin Pediatr Infect Dis, V17, P99, DOI 10.1053/j.spid.2006.04.009; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Marinotti O, 2006, INSECT MOL BIOL, V15, P1, DOI 10.1111/j.1365-2583.2006.00610.x; Mercado-Curiel RF, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-85; Pal GB, 1967, GENETICS INSECT VECT, P67; RANSON H, COMMUNICATION; Ren QH, 2004, NUCLEIC ACIDS RES, V32, pD284, DOI 10.1093/nar/gkh016; Riehle MA, 2006, PEPTIDES, V27, P2547, DOI 10.1016/j.peptides.2006.07.016; Sanders HR, 2005, INSECT BIOCHEM MOLEC, V35, P1293, DOI 10.1016/j.ibmb.2005.07.006; Schutt C, 2000, DEVELOPMENT, V127, P667; Severson DW, 2004, J HERED, V95, P103, DOI 10.1093/jhered/esh023; Severson DW, 2002, INSECT MOL BIOL, V11, P371, DOI 10.1046/j.1365-2583.2002.00347.x; Severson DW, 2001, ANNU REV ENTOMOL, V46, P183, DOI 10.1146/annurev.ento.46.1.183; Shin SW, 2006, J BIOL CHEM, V281, P39388, DOI 10.1074/jbc.M608912200; Tomori O, 2004, CRIT REV CL LAB SCI, V41, P391, DOI 10.1080/10408360490497474; Tubio JMC, 2005, MOL BIOL EVOL, V22, P29, DOI 10.1093/molbev/msh251; WARREN AM, 1991, GENET RES, V58, P225, DOI 10.1017/S0016672300029979; WHO, 2021, DENGUE DENGUE HAEMOR; Wise A, 2002, DRUG DISCOV TODAY, V7, P235, DOI 10.1016/S1359-6446(01)02131-6; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zdobnov EM, 2007, TRENDS GENET, V23, P16, DOI 10.1016/j.tig.2006.10.004; Zhang XY, 2004, GENETICS, V166, P971, DOI 10.1534/genetics.166.2.971	37	827	1131	1	354	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2007	316	5832					1718	1723		10.1126/science.1138878	http://dx.doi.org/10.1126/science.1138878			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180XE	17510324	Green Accepted			2022-12-01	WOS:000247400500039
J	Lipsky, PE				Lipsky, Peter E.			Why does rheumatoid arthritis involve the joints?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NIAMSD, Autoimmun Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Lipsky, PE (corresponding author), NIAMSD, Autoimmun Branch, NIH, Bethesda, MD 20892 USA.							Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; Huber LC, 2006, RHEUMATOLOGY, V45, P669, DOI 10.1093/rheumatology/kel065; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Lipsky PE, 2005, HARRISONS PRINCIPLES, P1968	5	24	28	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2007	356	23					2419	2420		10.1056/NEJMcibr070846	http://dx.doi.org/10.1056/NEJMcibr070846			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QY	17554126				2022-12-01	WOS:000247029300015
J	Marris, E				Marris, Emma			Counting the chemicals	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2007	447	7144					516	517						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17563934				2022-12-01	WOS:000246842000010
J	Trepat, X; Deng, LH; An, SS; Navajas, D; Tschumperlin, DJ; Gerthoffer, WT; Butler, JP; Fredberg, JJ				Trepat, Xavier; Deng, Linhong; An, Steven S.; Navajas, Daniel; Tschumperlin, Daniel J.; Gerthoffer, William T.; Butler, James P.; Fredberg, Jeffrey J.			Universal physical responses to stretch in the living cell	NATURE			English	Article							AIRWAY SMOOTH-MUSCLE; SLOW DYNAMICS; FORCE; VISCOELASTICITY; RHEOLOGY; BEHAVIOR	With every beat of the heart, inflation of the lung or peristalsis of the gut, cell types of diverse function are subjected to substantial stretch. Stretch is a potent stimulus for growth, differentiation, migration, remodelling and gene expression(1,2). Here, we report that in response to transient stretch the cytoskeleton fluidizes in such a way as to define a universal response class. This finding implicates mechanisms mediated not only by specific signalling intermediates, as is usually assumed, but also by non-specific actions of a slowly evolving network of physical forces. These results support the idea that the cell interior is at once a crowded chemical space(3) and a fragile soft material in which the effects of biochemistry, molecular crowding and physical forces are complex and inseparable, yet conspire nonetheless to yield remarkably simple phenomenological laws. These laws seem to be both universal and primitive, and thus comprise a striking intersection between the worlds of cell biology and soft matter physics.	Harvard Univ, Sch Publ Hlth, Program Mol & Integrat Physiol Sci, Boston, MA 02115 USA; Chongqing Univ, Bioengn Coll, Project Lab Biomech & Tissue Repair 111, Chongqing 400044, Peoples R China; Johns Hopkins Bloomberg Sch Publ Hlth, Div Physiol, Baltimore, MD 21205 USA; Univ Barcelona, IDIBAPS, Unitat Biofis & Bioengn, E-08036 Barcelona, Spain; Inst Bioengn Catalunya, E-08036 Barcelona, Spain; Univ Nevada, Sch Med, Dept Pharmacol, Reno, NV 89557 USA	Harvard University; Harvard T.H. Chan School of Public Health; Chongqing University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; Nevada System of Higher Education (NSHE); University of Nevada Reno	Fredberg, JJ (corresponding author), Harvard Univ, Sch Publ Hlth, Program Mol & Integrat Physiol Sci, 665 Huntington Ave, Boston, MA 02115 USA.	jeffrey_fredberg@harvard.edu	Deng, Linhong/O-3218-2019; Deng, Linhong/C-1485-2009; Navajas, Daniel/E-4233-2010; An, Steven/AAM-3848-2020; Trepat, Xavier/I-3912-2015; Fredberg, Jeffrey/M-9877-2019	Deng, Linhong/0000-0003-1970-8239; Navajas, Daniel/0000-0001-7150-9363; An, Steven/0000-0003-4723-1888; Trepat, Xavier/0000-0002-7621-5214; Gerthoffer, William/0000-0001-5154-4962	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL033009, R01HL065960, R01HL084224, R01HL102373] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL084224-03, R01 HL084224, R01 HL065960, R01 HL065960-07, P01 HL033009, P01 HL033009-06, R01 HL102373] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alcaraz J, 2003, BIOPHYS J, V84, P2071, DOI 10.1016/S0006-3495(03)75014-0; Brujic J, 2006, NAT PHYS, V2, P282, DOI 10.1038/nphys269; BULATOV VV, 1994, MODEL SIMUL MATER SC, V2, P185, DOI 10.1088/0965-0393/2/2/002; Bursac P, 2005, NAT MATER, V4, P557, DOI 10.1038/nmat1404; Cloitre M, 2000, PHYS REV LETT, V85, P4819, DOI 10.1103/PhysRevLett.85.4819; Corwin EI, 2005, NATURE, V435, P1075, DOI 10.1038/nature03698; Deng LH, 2006, NAT MATER, V5, P636, DOI 10.1038/nmat1685; Fabry B, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.041914; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Fredberg JJ, 1997, AM J RESP CRIT CARE, V156, P1752, DOI 10.1164/ajrccm.156.6.9611016; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Hoffman BD, 2006, P NATL ACAD SCI USA, V103, P10259, DOI 10.1073/pnas.0510348103; Ingber DE, 2003, J CELL SCI, V116, P1397, DOI 10.1242/jcs.00360; Johnson PA, 2005, NATURE, V437, P871, DOI 10.1038/nature04015; Kirschner M, 2005, PLAUSIBILITY LIFE RE; Kozlov MM, 2004, J CELL BIOL, V167, P1011, DOI 10.1083/jcb.200410017; Lau AWC, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.198101; MASON TG, 1995, PHYS REV LETT, V75, P2770, DOI 10.1103/PhysRevLett.75.2770; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; Miguel MC, 2006, SCIENCE, V312, P1151, DOI 10.1126/science.1127729; Minton AP, 2006, J CELL SCI, V119, P2863, DOI 10.1242/jcs.03063; Moazzam F, 1997, P NATL ACAD SCI USA, V94, P5338, DOI 10.1073/pnas.94.10.5338; Rosenblatt N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168101; Sollich P, 1997, PHYS REV LETT, V78, P2020, DOI 10.1103/PhysRevLett.78.2020; Stamenovic D, 2004, J APPL PHYSIOL, V96, P1600, DOI 10.1152/japplphysiol.00595.2003; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Trepat X, 2004, AM J PHYSIOL-LUNG C, V287, pL1025, DOI 10.1152/ajplung.00077.2004; Viasnoff V, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.065701; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Yap B, 2005, J APPL PHYSIOL, V98, P1930, DOI 10.1152/japplphysiol.01226.2004	30	515	532	8	209	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2007	447	7144					592	+		10.1038/nature05824	http://dx.doi.org/10.1038/nature05824			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17538621	Green Accepted			2022-12-01	WOS:000246842000049
J	Sawaya, MR; Sambashivan, S; Nelson, R; Ivanova, MI; Sievers, SA; Apostol, MI; Thompson, MJ; Balbirnie, M; Wiltzius, JJW; McFarlane, HT; Madsen, AO; Riekel, C; Eisenberg, D				Sawaya, Michael R.; Sambashivan, Shilpa; Nelson, Rebecca; Ivanova, Magdalena I.; Sievers, Stuart A.; Apostol, Marcin I.; Thompson, Michael J.; Balbirnie, Melinda; Wiltzius, Jed J. W.; McFarlane, Heather T.; Madsen, Anders O.; Riekel, Christian; Eisenberg, David			Atomic structures of amyloid cross-beta spines reveal varied steric zippers	NATURE			English	Article							X-RAY-DIFFRACTION; URE2P PRION FILAMENTS; FIBRIL FORMATION; SEEDING SPECIFICITY; FORMING PEPTIDE; SHEET STRUCTURE; CORE STRUCTURE; MODEL; DIVERSITY; PROTEINS	Amyloid fibrils formed from different proteins, each associated with a particular disease, contain a common cross-beta spine. The atomic architecture of a spine, from the fibril-forming segment GNNQQNY of the yeast prion protein Sup35, was recently revealed by X-ray microcrystallography. It is a pair of beta-sheets, with the facing side chains of the two sheets interdigitated in a dry 'steric zipper'. Here we report some 30 other segments from fibril-forming proteins that form amyloid-like fibrils, microcrystals, or usually both. These include segments from the Alzheimer's amyloid-beta and tau proteins, the PrP prion protein, insulin, islet amyloid polypeptide ( IAPP), lysozyme, myoglobin, alpha-synuclein and beta(2)-microglobulin, suggesting that common structural features are shared by amyloid diseases at the molecular level. Structures of 13 of these microcrystals all reveal steric zippers, but with variations that expand the range of atomic architectures for amyloid-like fibrils and offer an atomic-level hypothesis for the basis of prion strains.	Univ Calif Los Angeles, DOE Inst Genom & Proteom, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Copenhagen, Ctr Crystallog Studies, Dept Chem, DK-2100 Copenhagen, Denmark; European Synchrotron Radiat Facil, BP 220, F-38043 Grenoble, France	Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of Copenhagen; European Synchrotron Radiation Facility (ESRF)	Eisenberg, D (corresponding author), Univ Calif Los Angeles, DOE Inst Genom & Proteom, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu	Madsen, Anders Østergaard/B-4760-2015	Madsen, Anders Østergaard/0000-0001-5422-8076; Thompson, Michael/0000-0002-2914-1080; Sawaya, Michael/0000-0003-0874-9043				ASTBURY WILLIAM THOMAS, 1935, BIOCHEM JOUR, V29, P2351; Balbirnie M, 2001, P NATL ACAD SCI USA, V98, P2375, DOI 10.1073/pnas.041617698; Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; COHEN AS, 1959, NATURE, V183, P1202, DOI 10.1038/1831202a0; Diaz-Avalos R, 2005, P NATL ACAD SCI USA, V102, P10165, DOI 10.1073/pnas.0504599102; Diaz-Avalos R, 2003, J MOL BIOL, V330, P1165, DOI 10.1016/S0022-2836(03)00659-4; EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Ferguson N, 2006, P NATL ACAD SCI USA, V103, P16248, DOI 10.1073/pnas.0607815103; GEDDES AJ, 1968, J MOL BIOL, V32, P343, DOI 10.1016/0022-2836(68)90014-4; HALVERSON K, 1990, BIOCHEMISTRY-US, V29, P2639, DOI 10.1021/bi00463a003; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Ivanova MI, 2006, P NATL ACAD SCI USA, V103, P4079, DOI 10.1073/pnas.0511298103; Ivanova MI, 2004, P NATL ACAD SCI USA, V101, P10584, DOI 10.1073/pnas.0403756101; Jaroniec CP, 2004, P NATL ACAD SCI USA, V101, P711, DOI 10.1073/pnas.0304849101; JARRETT JT, 1992, BIOCHEMISTRY-US, V31, P12345, DOI 10.1021/bi00164a008; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Kajava AV, 2005, J MOL BIOL, V348, P247, DOI 10.1016/j.jmb.2005.02.029; Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101; Kheterpal I, 2000, P NATL ACAD SCI USA, V97, P13597, DOI 10.1073/pnas.250288897; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Makin OS, 2005, FEBS J, V272, P5950, DOI 10.1111/j.1742-4658.2005.05025.x; Makin OS, 2005, P NATL ACAD SCI USA, V102, P315, DOI 10.1073/pnas.0406847102; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Paravastu AK, 2006, BIOPHYS J, V90, P4618, DOI 10.1529/biophysj.105.076927; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Sambashivan S, 2005, NATURE, V437, P266, DOI 10.1038/nature03916; Serpell LC, 2000, J MOL BIOL, V299, P225, DOI 10.1006/jmbi.2000.3650; Sikorski P, 2005, BIOMACROMOLECULES, V6, P425, DOI 10.1021/bm0494388; Sikorski P, 2003, STRUCTURE, V11, P915, DOI 10.1016/S0969-2126(03)00149-7; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Westermark P, 2005, AMYLOID, V12, P1, DOI 10.1080/13506120500032196; Westermark P, 2005, FEBS J, V272, P5942, DOI 10.1111/j.1742-4658.2005.05024.x; Williams AD, 2004, J MOL BIOL, V335, P833, DOI 10.1016/j.jmb.2003.11.008	46	1712	1738	5	435	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2007	447	7143					453	457		10.1038/nature05695	http://dx.doi.org/10.1038/nature05695			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17468747				2022-12-01	WOS:000246693100042
J	Joura, EA; Leodolter, S; Hernandez-Avila, M; Wheeler, CM; Perez, G; Koutsky, LA; Garland, SM; Harper, DM; Tang, GWK; Ferris, DG; Steben, M; Jones, RW; Bryan, J; Taddeo, FJ; Bautista, OM; Esser, MT; Sings, HL; Nelson, M; Boslego, JW; Sattler, C; Barr, E; Paavonen, J				Joura, Elmar A.; Leodolter, Sepp; Hernandez-Avila, Mauricio; Wheeler, Cosette M.; Perez, Gonzalo; Koutsky, Laura A.; Garland, Suzanne M.; Harper, Diane M.; Tang, Grace W. K.; Ferris, Daron G.; Steben, Marc; Jones, Ronald W.; Bryan, Janine; Taddeo, Frank J.; Bautista, Oliver M.; Esser, Mark T.; Sings, Heather L.; Nelson, Micki; Boslego, John W.; Sattler, Carlos; Barr, Eliav; Paavonen, Jorma			Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials	LANCET			English	Article; Proceedings Paper	42nd Annual Meeting of the American-Society-of-Clinical-Oncology	JUN 02-06, 2006	Atlanta, GA	Amer Soc Clin Oncol			CERVICAL INTRAEPITHELIAL NEOPLASIA; SQUAMOUS-CELL CARCINOMA; COLD-KNIFE CONIZATION; TERM FOLLOW-UP; NATURAL-HISTORY; YOUNG-WOMEN; RISK; TRENDS; CANCER; HPV	Background Vulval and vaginal cancers among younger women are often related to infection with human papillomavirus (HPV). These cancers are preceded by high-grade vulval intraepithelial neoplasia (VIN2-3) and vaginal intraepithelial neoplasia (VaIN2-3). Our aim was to do a combined analysis of three randomised clinical trials to assess the effect of a prophylactic quadrivalent HPV vaccine on the incidence of these diseases. Methods 18 174 women (16-26 years) were enrolled and randomised to receive either quadrivalent HPV6/11/16/18 L1 virus-like-particle vaccine or placebo at day 1, and months 2 and 6. Individuals underwent detailed anogenital examination at day 1, 1 month after dose three, and at 6-12-month intervals for up to 48 months. Suspect genital lesions were biopsied and read by a panel of pathologists and vaccine HPV type-specific DNA testing was done. The primary endpoint was the combined incidence of VIN2-3 or VaIN2-3 associated with HPV16 or HPV18. Primary efficacy analyses were done in a per-protocol population. Findings The mean follow-up time was 3 years. Among women naive to HPV16 or HPV18 through 1 month after dose three (per-protocol population; vaccine n=7811; placebo n=7785), the vaccine was 100% effective (95% Cl 72-100) against VIN2-3 or VaIN2-3 associated with HPV16 or HPV18. In the intention-to-treat population (which included 18174 women who, at day 1, could have been infected with HPV16 or HPV18), vaccine efficacy against VIN2-3 or VaIN2-3 associated with HPV16 or HPV18 was 71% (37-88). The vaccine was 49% (18-69) effective against all VIN2-3 or VaIN2-3, irrespective of whether or not HPV DNA was detected in the lesion. The most common treatment-related adverse event was injection-site pain. Interpretation Prophylactic administration of quadrivalent HPV vaccine was effective in preventing high-grade vulval and vaginal lesions associated with HPV16 or HPV18 infection in women who were naive to these types before vaccination. With time, such vaccination could result in reduced rates of HPV-related vulval and vaginal cancers.	Univ Cent Hosp, Dept Obstet & Gynecol, Helsinki 00290, Finland; Med Univ Vienna, Dept Gynecol & Obstet, Vienna, Austria; Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; Univ New Mexico, Dept Obstet & Gynecol, Albuquerque, NM 87131 USA; Natl Res Ctr, Grp Saludcoop, Bogota, Colombia; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ Melbourne, Dept Microbiol & Infect Dis, Royal Hosp Women, Melbourne, Vic, Australia; Univ Melbourne, Dept Obstet & Gynecol, Melbourne, Vic, Australia; Dartmouth Coll Sch Med, Norris Cotton Canc Ctr, Dept Obstet & Gynecol, Hanover, NH USA; Dartmouth Coll Sch Med, Norris Cotton Canc Ctr, Dept Community & Family Med, Hanover, NH USA; Univ Hong Kong, Dept Obstet & Gynecol, Hong Kong, Peoples R China; Med Coll Georgia, Dept Family Med, Augusta, GA 30912 USA; Med Coll Georgia, Dept Obstet & Gynecol, Augusta, GA 30912 USA; Inst Natl Sante Publ Quebec, Direct Risques Biol Environn & Occupat, Montreal, PQ, Canada; Natl Womens Hosp, Vulvar Clin, Dept Gynecol Oncol, Auckland, New Zealand; Merck Res Labs, West Point, PA USA	University of Helsinki; Helsinki University Central Hospital; Medical University of Vienna; Instituto Nacional de Salud Publica; University of New Mexico; University of New Mexico; University of Washington; University of Washington Seattle; University of Melbourne; University of Melbourne; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Norris Cotton Cancer Center; University of Hong Kong; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Institut national de sante publique du Quebec (INSPQ); Merck & Company	Paavonen, J (corresponding author), Univ Cent Hosp, Dept Obstet & Gynecol, Haartmaninkatu 2, Helsinki 00290, Finland.	jorma.paavonen@hus.fi	Harper, Diane M./I-2180-2014; Chahchahi, Sarah/Q-6499-2016	Harper, Diane M./0000-0001-7648-883X; Bryan, Janine/0000-0002-4923-6247; Paavonen, Jorma/0000-0003-4775-606X; Steben, Marc/0000-0002-1136-3208				AHO M, 1991, CANCER, V68, P195, DOI 10.1002/1097-0142(19910701)68:1<195::AID-CNCR2820680135>3.0.CO;2-L; *AM CANC SOC, DET GUID VAG CANC WH; American College of Obstetricians and Gynecologists, HPV VACC ACOG REC; Block SL, 2006, PEDIATRICS, V118, P2135, DOI 10.1542/peds.2006-0461; Bryan JT, 2006, J MED VIROL, V78, P117, DOI 10.1002/jmv.20512; Chan ISF, 1998, COMMUN STAT-THEOR M, V27, P1305, DOI 10.1080/03610929808832160; Daling JR, 2002, GYNECOL ONCOL, V84, P263, DOI 10.1006/gyno.2001.6502; Dias D, 2005, CLIN DIAGN LAB IMMUN, V12, P959, DOI 10.1128/CDLI.12.8.959-969.2005; Dodge JA, 2001, GYNECOL ONCOL, V83, P363, DOI 10.1006/gyno.2001.6401; *FUTURE 2 STUD GRO, 2007, IN PRESS LANCET; Garland SM, 2003, CURR OPIN INFECT DIS, V16, P85, DOI 10.1097/00001432-200304000-00004; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Goffin F, 2006, J MED VIROL, V78, P814, DOI 10.1002/jmv.20628; Hampl M, 2006, OBSTET GYNECOL, V108, P1361, DOI 10.1097/01.AOG.0000245786.86267.80; Herod JJO, 1996, BRIT J OBSTET GYNAEC, V103, P446, DOI 10.1111/j.1471-0528.1996.tb09771.x; Hillemanns P, 2006, GYNECOL ONCOL, V100, P276, DOI 10.1016/j.ygyno.2005.10.003; Hillemanns P, 2006, GYNECOL ONCOL, V100, P271, DOI 10.1016/j.ygyno.2005.08.012; Jones RW, 2005, OBSTET GYNECOL, V106, P1319, DOI 10.1097/01.AOG.0000187301.76283.7f; Jones RW, 2000, OBSTET GYNECOL, V96, P470, DOI 10.1016/S0029-7844(00)00949-2; Jones RW, 1997, OBSTET GYNECOL, V90, P448, DOI 10.1016/S0029-7844(97)00298-6; Jones RW, 2001, EUR J GYNAECOL ONCOL, V22, P393; Joura EA, 2002, CURR OPIN OBSTET GYN, V14, P39, DOI 10.1097/00001703-200202000-00007; Joura EA, 2000, J REPROD MED, V45, P613; Judson PL, 2006, OBSTET GYNECOL, V107, P1018, DOI 10.1097/01.AOG.0000210268.57527.a1; Kalbfleisch JD., 2002, STAT ANAL FAILURE TI, V2, DOI [10.1002/9781118032985, DOI 10.1016/0197-2456(81)90009-X]; Kalliala I, 2005, BRIT MED J, V331, P1183, DOI 10.1136/bmj.38663.459039.7C; Le T, 2006, AM J OBSTET GYNECOL, V194, P377, DOI 10.1016/j.ajog.2005.08.022; Lehtinen M, 2006, VACCINE, V24, P233, DOI 10.1016/j.vaccine.2006.05.109; Madeleine MM, 1997, JNCI-J NATL CANCER I, V89, P1516, DOI 10.1093/jnci/89.20.1516; Mao C, 2006, OBSTET GYNECOL, V107, P18, DOI 10.1097/01.AOG.0000192397.41191.fb; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; OLSSON SE, 2007, VACCINE         0420; Parkin DM, 2002, IARC SCI PUBL, P8; Partridge JM, 2006, LANCET INFECT DIS, V6, P21, DOI 10.1016/S1473-3099(05)70323-6; Reich O, 2002, OBSTET GYNECOL, V99, P193, DOI 10.1016/S0029-7844(01)01683-0; Reich O, 2001, OBSTET GYNECOL, V97, P428, DOI 10.1016/S0029-7844(00)01174-1; Reisinger KS, 2007, PEDIATR INFECT DIS J, V26, P201, DOI 10.1097/01.inf.0000253970.29190.5a; Srodon M, 2006, AM J SURG PATHOL, V30, P1513, DOI 10.1097/01.pas.0000213291.96401.48; STURGEON SS, 1987, AM J OBSTET GYNECOL, V166, P1482; TOKI T, 1991, INT J GYNECOL PATHOL, V10, P107, DOI 10.1097/00004347-199104000-00001; van Seters M, 2005, GYNECOL ONCOL, V97, P645, DOI 10.1016/j.ygyno.2005.02.012; Villa LL, 2006, BRIT J CANCER, V95, P1459, DOI 10.1038/sj.bjc.6603469; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Von Krogh G, 2001, EUR J DERMATOL, V11, P598; Wiley DJ, 2002, CLIN INFECT DIS, V35, pS210, DOI 10.1086/342109	46	382	396	1	39	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 20	2007	369	9574					1693	1702		10.1016/S0140-6736(07)60777-6	http://dx.doi.org/10.1016/S0140-6736(07)60777-6			10	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	169ZT	17512854				2022-12-01	WOS:000246631300025
J	de Jong, N; Verhagen, H; Wolfs, MCJ; Ockfe, MC; Klungel, OH; Leufkens, HGM				de Jong, Nynke; Verhagen, Hans; Wolfs, Marion C. J.; Ockfe, Marga C.; Klungel, Olaf H.; Leufkens, Hubert G. M.			Functional foods: the case for closer evaluation	BRITISH MEDICAL JOURNAL			English	Editorial Material							SERUM-CHOLESTEROL; PLANT STANOL; MEDICINES; REDUCTION; THERAPY; STEROLS; PROGRAM; ESTERS; SAFETY; RISK					Nynke.de.jong@rivm.nl	Verhagen, Hans/ABB-9361-2020	Verhagen, Hans/0000-0001-7952-3530				Aggett PJ, 2005, EUR J NUTR, V44, P5, DOI 10.1007/s00394-005-1104-3; Allgood GS, 2001, REGUL TOXICOL PHARM, V33, P224, DOI 10.1006/rtph.2001.1460; [Anonymous], HLTH NUTR CLAIMS; [Anonymous], INT MARK FUNCT FOODS; Blair SN, 2000, AM J CARDIOL, V86, P46, DOI 10.1016/S0002-9149(00)00976-0; Butchko HH, 2001, REGUL TOXICOL PHARM, V34, P221, DOI 10.1006/rtph.2001.1500; DEJONG N, 2005, POSTLAUNCH MONITORIN, V3; DEJONG N, 2007, EUR J CLIN NUTR 0214; *EUR COMM, 2007, NOV FOODS LEG; Gilbert D, 2000, BRIT MED J, V321, P1341, DOI 10.1136/bmj.321.7272.1341; Hendriks HFJ, 1999, EUR J CLIN NUTR, V53, P319, DOI 10.1038/sj.ejcn.1600728; *HOM HLTH CAN, 2001, HLTH CAN ADV BEC PRO; Izzo AA, 2005, INT J CARDIOL, V98, P1, DOI 10.1016/j.ijcard.2003.06.039; Katan MB, 2003, MAYO CLIN PROC, V78, P965, DOI 10.4065/78.8.965; Lea LJ, 2006, FOOD CHEM TOXICOL, V44, P1213, DOI 10.1016/j.fct.2006.01.017; Mantel-Teeuwisse AK, 2005, BRIT J CLIN PHARMACO, V60, P83, DOI 10.1111/j.1365-2125.2005.02367.x; Mantel-Teeuwisse AK, 2004, HEART, V90, P1065, DOI 10.1136/hrt.2003.026187; Miettinen TA, 2004, ANN MED, V36, P126, DOI 10.1080/07853890310021625; MIETTINEN TA, 1995, NEW ENGL J MED, V333, P1308, DOI 10.1056/NEJM199511163332002; Ohnishi Noriaki, 2004, Keio Journal of Medicine, V53, P137, DOI 10.2302/kjm.53.137; PARIZA MW, 1999, NUTR TODAY, V34, P3; Patel MD, 2006, ATHEROSCLEROSIS, V186, P12, DOI 10.1016/j.atherosclerosis.2005.10.026; Pletscher W, 2004, SWISS MED WKLY, V134, P367; Ratnayake W. M. N., 2004, Phytosterols as functional food components and nutraceuticals, P365; *SCI COMM FOOD, 2002, OP SCI COMM FOOD REP; Wolfs M, 2006, FOOD CHEM TOXICOL, V44, P1682, DOI 10.1016/j.fct.2006.05.006; Zureik M, 1996, BMJ-BRIT MED J, V313, P649, DOI 10.1136/bmj.313.7058.649	27	15	16	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 19	2007	334	7602					1037	1039		10.1136/bmj.39196.666377.BE	http://dx.doi.org/10.1136/bmj.39196.666377.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	174AL	17510152	Green Published, Green Submitted			2022-12-01	WOS:000246913500032
J	Fitzpatrick, MJ; Feder, E; Rowe, L; Sokolowski, MB				Fitzpatrick, Mark J.; Feder, Elah; Rowe, Locke; Sokolowski, Marla B.			Maintaining a behaviour polymorphism by frequency-dependent selection on a single gene	NATURE			English	Article							PROTEIN-KINASE PKG; DROSOPHILA-MELANOGASTER; BALANCING SELECTION; LARVAL COMPETITION; LOCUS	Accounting for the abundance of genetic variation in the face of natural selection remains a central problem of evolutionary biology(1,2). Genetic polymorphisms are constantly arising through mutation, and although most are promptly eliminated(3), polymorphisms in functionally important traits are common. One mechanism that can maintain polymorphisms is negative frequency-dependent selection on alternative alleles, whereby the fitness of each decreases as its frequency increases(4,5). Examples of frequency-dependent selection are rare, especially when attempting to describe the genetic basis of the phenotype under selection. Here we show frequency-dependent selection in a well-known natural genetic polymorphism affecting fruitfly foraging behaviour. When raised in low nutrient conditions, both of the naturally occurring alleles of the foraging gene (for(s) and for(R)) have their highest fitness when rare - the hallmark of negative frequency-dependent selection. This effect disappears at higher resources levels, demonstrating the role of larval competition. We are able to confirm the involvement of the foraging gene by showing that a sitter-like mutant allele on a rover background has similar frequency-dependent fitness as the natural sitter allele. Our study represents a clear demonstration of frequency-dependent selection, and we are able to attribute this effect to a single, naturally polymorphic gene known to affect behaviour.	Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3G5, Canada	University of Toronto; University Toronto Mississauga; University of Toronto	Sokolowski, MB (corresponding author), Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada.	msokolow@utm.utoronto.ca	Allen, John A/B-5510-2008; Fitzpatrick, Mark J/A-3414-2008	Fitzpatrick, Mark/0000-0003-3484-4327; Sokolowski, Marla/0000-0002-7462-8007				Anholt RRH, 2004, NAT REV GENET, V5, P838, DOI 10.1038/nrg1472; ATKINSON WD, 1979, J ANIM ECOL, V48, P91, DOI 10.2307/4102; AYALA FJ, 1974, ANNU REV ECOL SYST, V5, P1115; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; DAWOOD MM, 1969, GENETICS, V63, P213; DEBELLE JS, 1987, HEREDITY, V59, P73, DOI 10.1038/hdy.1987.98; DEBELLE JS, 1993, GENOME, V36, P94, DOI 10.1139/g93-013; Fitzpatrick MJ, 2004, INTEGR COMP BIOL, V44, P28, DOI 10.1093/icb/44.1.28; Foley PA, 2001, EVOLUTION, V55, P2493, DOI 10.1111/j.0014-3820.2001.tb00764.x; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Gigord LDB, 2001, P NATL ACAD SCI USA, V98, P6253, DOI 10.1073/pnas.111162598; Houle D, 2003, AM NAT, V161, P50, DOI 10.1086/345480; HUANG SL, 1971, GENETICS, V68, P97; KALDERON D, 1989, J BIOL CHEM, V264, P10738; LANDE R, 1975, GENET RES, V26, P221, DOI 10.1017/S0016672300016037; LEWONTIN RC, 1958, GENETICS, V43, P420; MILLER RS, 1964, ECOLOGY, V45, P132, DOI 10.2307/1937114; Nasrallah ME, 2002, SCIENCE, V297, P247, DOI 10.1126/science.1072205; Olendorf R, 2006, NATURE, V441, P633, DOI 10.1038/nature04646; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; PEREIRA HS, 1993, P NATL ACAD SCI USA, V90, P5044, DOI 10.1073/pnas.90.11.5044; RODRIGUEZ L, 1990, CAN J ZOOL, V68, P2616, DOI 10.1139/z90-364; Scheiner R, 2004, LEARN MEMORY, V11, P303, DOI 10.1101/lm.71604; SNYDER TP, 1979, GENETICS, V92, P995; Sokolowski MB, 1997, P NATL ACAD SCI USA, V94, P7373, DOI 10.1073/pnas.94.14.7373; Sokolowski MB, 2001, NAT REV GENET, V2, P879, DOI 10.1038/35098592; Subramaniam B, 2000, EVOLUTION, V54, P691, DOI 10.1111/j.0014-3820.2000.tb00070.x; Turelli M, 2004, GENETICS, V166, P1053, DOI 10.1534/genetics.166.2.1053; Wingrove JA, 1999, CELL, V98, P105, DOI 10.1016/S0092-8674(00)80610-8	29	144	149	0	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2007	447	7141					210	U5		10.1038/nature05764	http://dx.doi.org/10.1038/nature05764			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17495926				2022-12-01	WOS:000246338700044
J	Shelly, M; Cancedda, L; Heilshorn, S; Sumbre, G; Poo, MM				Shelly, Maya; Cancedda, Laura; Heilshorn, Sarah; Sumbre, German; Poo, Mu-ming			LKB1/STRAD promotes axon initiation during neuronal polarization	CELL			English	Article							SAD KINASES; LKB1; CAMP; ESTABLISHMENT; POLARITY; GROWTH; PHOSPHORYLATION; ACTIVATION; SIGNALS; COMPLEX	Axon/dendrite differentiation is a critical step in neuronal development. In cultured hippocampal neurons, the accumulation of LKB1 and STRAD, two interacting proteins critical for establishing epithelial polarity, in an undifferentiated neurite correlates with its subsequent axon differentiation. Downregulation of either LKB1 or STRAD by siRNAs prevented axon differentiation, and overexpression of these proteins led to multiple axon formation. Furthermore, interaction of STRAD with LKB1 promoted LKB1 phosphorylation at a PKA site S431 and elevated the LKB1 level, and overexpressing LKB1 with a serine-to-alanine mutation at S431 (LKB1 S431 A) prevented axon differentiation. In developing cortical neurons in vivo, downregulation of LKB1 or overexpression of LKB1 S431 A also abolished axon formation. Finally, local exposure of the undifferentiated neurite to brain-derived neurotrophic factor or dibutyryl-cAMP promoted axon differentiation in a manner that depended on PKA-depenclent LKB1 phosphorylation. Thus local LKB1/STRAD accumulation and PKA-dependent LKB1 phosphorylation represents an early signal for axon initiation.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Poo, MM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	mpoo@uclink.berkeley.edu	Sumbre, German/K-7538-2017	Sumbre, German/0000-0003-4436-6840; Heilshorn, Sarah/0000-0002-9801-6304; shelly, maya/0000-0002-2211-1751; Cancedda, Laura/0000-0003-0566-057X	NINDS NIH HHS [NS-22764] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022764] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Chen YM, 2006, P NATL ACAD SCI USA, V103, P8534, DOI 10.1073/pnas.0509955103; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.neuro.17.1.267; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Gao Y, 2003, J NEUROSCI, V23, P11770; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Martone ME, 2003, NEUROINFORMATICS, V1, P379, DOI 10.1385/NI:1:4:379; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Ossipova O, 2003, NAT CELL BIOL, V5, P889, DOI 10.1038/ncb1048; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Sosa L, 2006, NAT NEUROSCI, V9, P993, DOI 10.1038/nn1742; STERNBERGER LA, 1982, P NATL ACAD SCI-BIOL, V79, P1326, DOI 10.1073/pnas.79.4.1326; Toriyama M, 2006, J CELL BIOL, V175, P147, DOI 10.1083/jcb.200604160; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012	33	275	281	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					565	577		10.1016/j.cell.2007.04.012	http://dx.doi.org/10.1016/j.cell.2007.04.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482549	Bronze			2022-12-01	WOS:000246373600022
J	Stegmeier, F; Rape, M; Draviam, VM; Nalepa, G; Sowa, ME; Ang, XLL; McDonald, ER; Li, MZ; Hannon, GJ; Sorger, PK; Kirschner, MW; Harper, JW; Elledge, SJ				Stegmeier, Frank; Rape, Michael; Draviam, Viji M.; Nalepa, Grzegorz; Sowa, Mathew E.; Ang, Xiaolu L.; McDonald, E. Robert, III; Li, Mamie Z.; Hannon, Gregory J.; Sorger, Peter K.; Kirschner, Marc W.; Harper, J. Wade; Elledge, Stephen J.			Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities	NATURE			English	Article							SPINDLE CHECKPOINT; MITOTIC CHECKPOINT; PROMOTING COMPLEX/CYCLOSOME; CYCLIN-A; MITOSIS; BISTABILITY; ANEUPLOIDY; P31(COMET); PROTEIN; CANCER	The spindle checkpoint prevents chromosome mis-segregation by delaying sister chromatid separation until all chromosomes have achieved bipolar attachment to the mitotic spindle. Its operation is essential for accurate chromosome segregation, whereas its dysregulation can contribute to birth defects and tumorigenesis. The target of the spindle checkpoint is the anaphase-promoting complex (APC), a ubiquitin ligase that promotes sister chromatid separation and progression to anaphase. Using a short hairpin RNA screen targeting components of the ubiquitin-proteasome pathway in human cells, we identified the deubiquitinating enzyme USP44 (ubiquitin-specific protease 44) as a critical regulator of the spindle checkpoint. USP44 is not required for the initial recognition of unattached kinetochores and the subsequent recruitment of checkpoint components. Instead, it prevents the premature activation of the APC by stabilizing the APC-inhibitory Mad2 - Cdc20 complex. USP44 deubiquitinates the APC coactivator Cdc20 both in vitro and in vivo, and thereby directly counteracts the APC-driven disassembly of Mad2 - Cdc20 complexes ( discussed in an accompanying paper). Our findings suggest that a dynamic balance of ubiquitination by the APC and deubiquitination by USP44 contributes to the generation of the switch-like transition controlling anaphase entry, analogous to the way that phosphorylation and dephosphorylation of Cdk1 by Wee1 and Cdc25 controls entry into mitosis.	Harvard Univ, Harvard Partners Ctr Genet & Genom, Howard Hughes Med Inst, Dept Genet,Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Cold Spring Harbor Laboratory	Elledge, SJ (corresponding author), Harvard Univ, Harvard Partners Ctr Genet & Genom, Howard Hughes Med Inst, Dept Genet,Sch Med, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	marc@hms.harvard.edu; wade_harper@hms.harvard.edu; selledge@genetics.med.harvard.edu	Hannon, Gregory/AAB-3568-2019; Cambronne, Xiaolu Ang/GRY-7149-2022	Cambronne, Xiaolu Ang/0000-0002-3547-448X; Nalepa, Grzegorz/0000-0002-5779-9103; Lab, Nalepa/0000-0002-7560-1906; Rape, Michael/0000-0003-4849-6343; Draviam, Viji/0000-0001-8295-3689; Sorger, Peter/0000-0002-3364-1838; Harper, Jeffrey/0000-0002-6944-7236	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS054507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG011085] Funding Source: Medline; NINDS NIH HHS [F31 NS054507-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Draviam VM, 2004, CURR OPIN GENET DEV, V14, P120, DOI 10.1016/j.gde.2004.02.007; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Habu T, 2002, EMBO J, V21, P6419, DOI 10.1093/emboj/cdf659; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Karess R, 2005, TRENDS CELL BIOL, V15, P386, DOI 10.1016/j.tcb.2005.05.003; Kops GJPL, 2005, J CELL BIOL, V169, P49, DOI 10.1083/jcb.200411118; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Mapelli M, 2006, EMBO J, V25, P1273, DOI 10.1038/sj.emboj.7601033; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Nasmyth K, 2005, CELL, V120, P739, DOI 10.1016/j.cell.2005.03.006; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322	25	291	301	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2007	446	7138					876	881		10.1038/nature05694	http://dx.doi.org/10.1038/nature05694			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IR	17443180				2022-12-01	WOS:000245785700034
J	Engel, GS; Calhoun, TR; Read, EL; Ahn, TK; Mancal, T; Cheng, YC; Blankenship, RE; Fleming, GR				Engel, Gregory S.; Calhoun, Tessa R.; Read, Elizabeth L.; Ahn, Tae-Kyu; Mancal, Tomas; Cheng, Yuan-Chung; Blankenship, Robert E.; Fleming, Graham R.			Evidence for wavelike energy transfer through quantum coherence in photosynthetic systems	NATURE			English	Article							2-DIMENSIONAL FEMTOSECOND SPECTROSCOPY; BACTERIOCHLOROPHYLL PROTEIN; ELECTRONIC SPECTROSCOPY; CHLOROBIUM-TEPIDUM; ANTENNA COMPLEXES; DYNAMICS; ECHOES; MODEL	Photosynthetic complexes are exquisitely tuned to capture solar light efficiently, and then transmit the excitation energy to reaction centres, where long term energy storage is initiated. The energy transfer mechanism is often described by semiclassical models that invoke 'hopping' of excited-state populations along discrete energy levels(1,2). Two-dimensional Fourier transform electronic spectroscopy(3-5) has mapped(6) these energy levels and their coupling in the Fenna - Matthews - Olson (FMO) bacteriochlorophyll complex, which is found in green sulphur bacteria and acts as an energy 'wire' connecting a large peripheral light-harvesting antenna, the chlorosome, to the reaction centre(7-9). The spectroscopic data clearly document the dependence of the dominant energy transport pathways on the spatial properties of the excited-state wavefunctions of the whole bacteriochlorophyll complex(6,10). But the intricate dynamics of quantum coherence, which has no classical analogue, was largely neglected in the analyses - even though electronic energy transfer involving oscillatory populations of donors and acceptors was first discussed more than 70 years ago(11), and electronic quantum beats arising from quantum coherence in photosynthetic complexes have been predicted(12,13) and indirectly observed(14). Here we extend previous two-dimensional electronic spectroscopy investigations of the FMO bacteriochlorophyll complex, and obtain direct evidence for remarkably long-lived electronic quantum coherence playing an important part in energy transfer processes within this system. The quantum coherence manifests itself in characteristic, directly observable quantum beating signals among the excitons within the Chlorobium tepidum FMO complex at 77 K. This wavelike characteristic of the energy transfer within the photosynthetic complex can explain its extreme efficiency, in that it allows the complexes to sample vast areas of phase space to find the most efficient path.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Washington Univ, Dept Chem, St Louis, MO 63130 USA; Washington Univ, Dept Biol, St Louis, MO 63130 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Washington University (WUSTL); Washington University (WUSTL)	Fleming, GR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	grfleming@lbl.gov	Ahn, Tae Kyu/A-5838-2013; Engel, Gregory/C-1108-2012; Cheng, Yuan-Chung/A-6566-2008; Calhoun, Tessa/AHI-1645-2022; Mančal, Tomáš/B-9688-2014	Ahn, Tae Kyu/0000-0002-7474-6513; Engel, Gregory/0000-0002-6740-5243; Cheng, Yuan-Chung/0000-0003-0125-4267; Calhoun, Tessa/0000-0002-4952-0010; Mančal, Tomáš/0000-0003-1736-3054; Read, Elizabeth/0000-0002-9186-284X				Abramavicius D, 2004, PHYS CHEM CHEM PHYS, V6, P3097, DOI 10.1039/b315252a; [Anonymous], 2002, PHOTOSYNTHETICA; Brixner T, 2005, NATURE, V434, P625, DOI 10.1038/nature03429; Brixner T, 2004, J CHEM PHYS, V121, P4221, DOI 10.1063/1.1776112; Brixner T, 2004, OPT LETT, V29, P884, DOI 10.1364/OL.29.000884; Camara-Artigas A, 2003, PHOTOSYNTH RES, V75, P49, DOI 10.1023/A:1022406703110; Cho MH, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1955444; Cho MH, 2005, J PHYS CHEM B, V109, P10542, DOI 10.1021/jp050788d; Cowan ML, 2004, CHEM PHYS LETT, V386, P184, DOI 10.1016/j.cplett.2004.01.027; DREYER J, 2003, B KOR CHEM SOC, V24, P1091; FENNA RE, 1975, NATURE, V258, P573, DOI 10.1038/258573a0; Frigo M, 2005, P IEEE, V93, P216, DOI 10.1109/JPROC.2004.840301; Grover LK, 1997, PHYS REV LETT, V79, P325, DOI 10.1103/PhysRevLett.79.325; Hochstrasser RM, 2001, CHEM PHYS, V266, P273, DOI 10.1016/S0301-0104(01)00232-4; JANG SJ, 2004, PHYS REV LETT, V92, P9312; Jonas DM, 2003, ANNU REV PHYS CHEM, V54, P425, DOI 10.1146/annurev.physchem.54.011002.103907; JOO T, 1995, OPT LETT, V20, P389, DOI 10.1364/OL.20.000389; Kempe J, 2003, CONTEMP PHYS, V44, P307, DOI 10.1080/00107151031000110776; Knox RS, 1996, PHOTOSYNTH RES, V48, P35, DOI 10.1007/BF00040993; Leegwater JA, 1996, J PHYS CHEM-US, V100, P14403, DOI 10.1021/jp961448i; Lepetit L, 1995, J OPT SOC AM B, V12, P2467, DOI 10.1364/JOSAB.12.002467; Li YF, 1997, J MOL BIOL, V271, P456, DOI 10.1006/jmbi.1997.1189; Novoderezhkin V, 2003, J PHYS CHEM B, V107, P11534, DOI 10.1021/jp035432l; Perrin F., 1932, ANN PHYS-NEW YORK, V10, P283, DOI 10.1051/anphys/193210170283; Pisliakov AV, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2200705; Renger T, 2001, PHYS REP, V343, P138, DOI 10.1016/S0370-1573(00)00078-8; Savikhin S, 1997, CHEM PHYS, V223, P303, DOI 10.1016/S0301-0104(97)00223-1; Van Amerongen H., 2000, PHOTOSYNTHETIC EXCIT; Vulto SIE, 1999, J PHYS CHEM B, V103, P8153, DOI 10.1021/jp984702a; [No title captured]	30	2320	2346	20	745	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2007	446	7137					782	786		10.1038/nature05678	http://dx.doi.org/10.1038/nature05678			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17429397	Green Submitted			2022-12-01	WOS:000245626800037
J	Zhou, Y; Atkins, JB; Rompani, SB; Bancescu, DL; Petersen, PH; Tang, HY; Zou, KY; Stewart, SB; Zhong, WM				Zhou, Yan; Atkins, Joshua B.; Rompani, Santiago B.; Bancescu, Daria L.; Petersen, Petur H.; Tang, Haiyan; Zou, Kaiyong; Stewart, Sinead B.; Zhong, Weimin			The mammalian golgi regulates numb signaling in asymmetric cell division by releasing ACBD3 during mitosis	CELL			English	Article							PROGENITOR CELLS; MOUSE NUMB; STEM-CELLS; PROTEIN; ORIENTATION; MEMBRANE; DOMAIN; FATES; IDENTIFICATION; FRAGMENTATION	Mammalian neural progenitor cells divide asymmetrically to self-renew and produce a neuron by segregating cytosolic Numb proteins primarily to one daughter cell. Numb signaling specifies progenitor over neuronal fates but, paradoxically, also promotes neuronal differentiation. Here we report that ACBD3 is a Numb partner in cell-fate specification. ACBD3 and Numb proteins interact through an essential Numb domain, and the respective loss- and gain-of-function mutant mice share phenotypic similarities. Interestingly, ACBD3 associates with the Golgi apparatus in neurons and interphase progenitor cells but becomes cytosolic after Golgi fragmentation during mitosis, when Numb activity is needed to distinguish the two daughter cells. Accordingly, cytosolic ACBD3 can act synergistically with Numb to specify cell fates, and its continuing presence during the progenitor cell cycle inhibits neuron production. We propose that Golgi fragmentation and reconstitution during cell cycle differentially regulate Numb signaling through changes in ACBD3 subcellular distribution and represent a mechanism for coupling cell-fate specification and cell-cycle progression.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Interdept Neurosci Program, New Haven, CT 06520 USA	Yale University; Yale University	Zhong, WM (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.	weimin.zhong@yale.edu	Zhou, Yan/AAM-3591-2021; , PeturHenry/H-1506-2011	Zhou, Yan/0000-0002-2713-4442; Rompani, Santiago/0000-0002-3994-3052	NINDS NIH HHS [R01 NS042048] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altan-Bonnet N, 2004, CURR OPIN CELL BIOL, V16, P364, DOI 10.1016/j.ceb.2004.06.011; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BANG AG, 1991, DEVELOPMENT, V111, P89; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Cayouette M, 2003, DEVELOPMENT, V130, P2329, DOI 10.1242/dev.00446; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Colanzi A, 2003, CURR OPIN CELL BIOL, V15, P462, DOI 10.1016/S0955-0674(03)00067-X; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Gho M, 1999, DEVELOPMENT, V126, P3573; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Huang EJ, 2005, GENE DEV, V19, P138, DOI 10.1101/gad.1246005; Knoblich JA, 1997, P NATL ACAD SCI USA, V94, P13005, DOI 10.1073/pnas.94.24.13005; Li H, 2001, MOL ENDOCRINOL, V15, P2211, DOI 10.1210/me.15.12.2211; Li SC, 1998, NAT STRUCT BIOL, V5, P1075, DOI 10.1038/4185; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Petersen PH, 2004, NAT NEUROSCI, V7, P803, DOI 10.1038/nn1289; Petersen PH, 2006, DEV NEUROSCI-BASEL, V28, P156, DOI 10.1159/000090761; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Prokopenko SN, 2005, SEMIN CELL DEV BIOL, V16, P423, DOI 10.1016/j.semcdb.2005.02.005; Qian XM, 1998, DEVELOPMENT, V125, P3143; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Shen Q, 2002, DEVELOPMENT, V129, P4843; Shorter J, 2002, ANNU REV CELL DEV BI, V18, P379, DOI 10.1146/annurev.cellbio.18.030602.133733; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; Sohda M, 2001, J BIOL CHEM, V276, P45298, DOI 10.1074/jbc.M108961200; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; Stanley H, 1997, P NATL ACAD SCI USA, V94, P14467, DOI 10.1073/pnas.94.26.14467; Sutterlin C, 2002, CELL, V109, P359, DOI 10.1016/S0092-8674(02)00720-1; Tang HY, 2005, MOL CELL BIOL, V25, P2899, DOI 10.1128/MCB.25.8.2899-2909.2005; Yaich L, 1998, J BIOL CHEM, V273, P10381, DOI 10.1074/jbc.273.17.10381; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Yang XM, 2002, CURR BIOL, V12, P667, DOI 10.1016/S0960-9822(02)00791-1; Zhong WM, 1997, DEVELOPMENT, V124, P1887; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2; Zhong WM, 2000, P NATL ACAD SCI USA, V97, P6844, DOI 10.1073/pnas.97.12.6844; Zhong WM, 2003, NEURON, V37, P11, DOI 10.1016/S0896-6273(02)01178-9	39	89	97	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 6	2007	129	1					163	178		10.1016/j.cell.2007.02.037	http://dx.doi.org/10.1016/j.cell.2007.02.037			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418793	Bronze			2022-12-01	WOS:000245661100019
J	Driscoll, CA; Menotti-Raymond, M; Roca, AL; Hupe, K; Johnson, WE; Geffen, E; Harley, EH; Delibes, M; Pontier, D; Kitchener, AC; Yamaguchi, N; O'Brien, SJ; Macdonald, DW				Driscoll, Carlos A.; Menotti-Raymond, Marilyn; Roca, Alfred L.; Hupe, Karsten; Johnson, Warren E.; Geffen, Eli; Harley, Eric H.; Delibes, Miguel; Pontier, Dominique; Kitchener, Andrew C.; Yamaguchi, Nobuyuki; O'Brien, Stephen J.; Macdonald, David W.			The Near Eastern origin of cat domestication	SCIENCE			English	Article							FELIS-SILVESTRIS; WILD; POPULATIONS; RADIATION	The world's domestic cats carry patterns of sequence variation in their genome that reflect a history of domestication and breed development. A genetic assessment of 979 domestic cats and their wild progenitors-Felis silvestris silvestris ( European wildcat), F. s. lybica ( Near Eastern wildcat), F. s. ornata ( central Asian wildcat), F. s. cafra ( southern African wildcat), and F. s. bieti ( Chinese desert cat)indicated that each wild group represents a distinctive subspecies of Felis silvestris. Further analysis revealed that cats were domesticated in the Near East, probably coincident with agricultural village development in the Fertile Crescent. Domestic cats derive from at least five founders from across this region, whose descendants were transported across the world by human assistance.	NCI, Lab Genom Divers, Frederick, MD 21702 USA; Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Oxford OX1 3PS, England; NCI, Lab Genom Divers, SAIC Frederick Inc, Frederick, MD 21702 USA; JagdEinrichtungsBuro, D-37170 Furstenhagen, Germany; Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; Univ Cape Town, Div Chem Pathol, Observ, ZA-7925 Cape Town, South Africa; CSIC, Dept Appl Biol, Estac Biol Donana, Seville 41013, Spain; Univ Lyon 1, CNRS, Biometrie & Biol Evolut UMR 5558, F-69622 Villeurbanne, France; Natl Museums Scotland, Dept Nat Sci, Edinburgh EH1 1JF, Midlothian, Scotland; Univ Edinburgh, Inst Geog, Sch Geosci, Edinburgh EH8 9XP, Midlothian, Scotland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Oxford; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Tel Aviv University; University of Cape Town; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Edinburgh	Macdonald, DW (corresponding author), NCI, Lab Genom Divers, Frederick, MD 21702 USA.	driscoll@ncifcrf.gov; obrien@ncifcrf.gov; david.macdonald@zoology.oxford.ac.uk	Johnson, Warren/D-4149-2016; OBRIEN, STEPHEN/ABD-1346-2020; Delibes, Miguel/K-2744-2014; Yamaguchi, Nobuyuki/AAN-4884-2020	Johnson, Warren/0000-0002-5954-186X; Delibes, Miguel/0000-0002-3569-567X; Yamaguchi, Nobuyuki/0000-0002-6492-6588; Pontier, Dominique/0000-0003-4700-3543; Roca, Alfred/0000-0001-9217-5593; Driscoll, Carlos/0000-0003-2392-505X; Kitchener, Andrew/0000-0003-2594-0827; OBRIEN, STEPHEN/0000-0001-7857-0757	Intramural NIH HHS [Z99 AA999999] Funding Source: Medline; NCI NIH HHS [N01CO12400, N01-CO-12400] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC005367, Z01BC005385] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 1951, CATALOGUE GENUS FELI; Beaumont M, 2001, MOL ECOL, V10, P319, DOI 10.1046/j.1365-294x.2001.01196.x; BUDIANSKY S, 1999, COVENANT WILD WHY AN; Clutton-Brock J., 1999, NATURAL HIST DOMESTI, V2nd ed.; Donalson M.D., 1999, DOMESTIC CAT ROMAN C; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Johnson WE, 2006, SCIENCE, V311, P73, DOI 10.1126/science.1122277; Kitchener A., 1991, NATURAL HIST WILD CA; KURTEN BJORN, 1965, ACTA ZOOL FENNICA, V111, P3; Lecis R, 2006, MOL ECOL, V15, P119, DOI 10.1111/j.1365-294X.2005.02812.x; LEGAY JM, 1986, CR ACAD SCI III-VIE, V303, P709; Lopez JV, 1997, MOL BIOL EVOL, V14, P277, DOI 10.1093/oxfordjournals.molbev.a025763; Macdonald D.W., 2004, SCOTTISH WILDCAT ANA; Macdonald DW, 1987, ADV ETHOL, V28, P1, DOI DOI 10.1016/0168-1591(88)90058-5; Menotti-Raymond M, 2003, CYTOGENET GENOME RES, V102, P272, DOI 10.1159/000075762; Morrell PL, 2007, P NATL ACAD SCI USA, V104, P3289, DOI 10.1073/pnas.0611377104; Nowell K., 1996, WILD CATS STATUS SUR; O'Brien SJ, 2005, ANNU REV GENOM HUM G, V6, P407, DOI 10.1146/annurev.genom.6.080604.162151; Pocock RI, 1907, P ZOOL SOC LOND, V1907, P656; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Randi E, 2001, MOL BIOL EVOL, V18, P1679, DOI 10.1093/oxfordjournals.molbev.a003956; RANDI E, 1991, J MAMMAL, V72, P79, DOI 10.2307/1381981; STEPHENS G, 2001, LEGACY CAT ULTIMATE; Sunquist M., 2002, WILD CATS WORLD; SWOFFORD D. L., 1985, PHYLOGENETIC ANAL US; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P828; Tanno K, 2006, SCIENCE, V311, P1886, DOI [10.1126/science.1124635, 10.1126/science.311.5769.1866a]; Vella CM, 2003, ROBINSONS GENETICS C; Vigne JD, 2004, SCIENCE, V304, P259, DOI 10.1126/science.1095335; WILLCOX G, 2005, 13 IWGP S, P534; Yamaguchi N, 2004, ANIM CONSERV, V7, P339, DOI 10.1017/S1367943004001520	31	316	333	16	296	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2007	317	5837					519	523		10.1126/science.1139518	http://dx.doi.org/10.1126/science.1139518			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17600185	Green Accepted, Green Submitted			2022-12-01	WOS:000248339800047
J	Outeiro, TF; Kontopoulos, E; Altmann, SM; Kufareva, I; Strathearn, KE; Amore, AM; Volk, CB; Maxwell, MM; Rochet, JC; McLean, PJ; Young, AB; Abagyan, R; Feany, MB; Hyman, BT; Kazantsev, AG				Outeiro, Tiago Fleming; Kontopoulos, Eirene; Altmann, Stephen M.; Kufareva, Irina; Strathearn, Katherine E.; Amore, Allison M.; Volk, Catherine B.; Maxwell, Michele M.; Rochet, Jean-Christophe; McLean, Pamela J.; Young, Anne B.; Abagyan, Ruben; Feany, Mel B.; Hyman, Bradley T.; Kazantsev, Aleksey G.			Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease	SCIENCE			English	Article							DROSOPHILA MODEL; LEWY BODIES; PROTEIN; AGGREGATION; DEACETYLASE; ACETYLATION; SUPPRESSION; HUNTINGTONS; SIRT2; HDAC6	The sirtuins are members of the histone deacetylase family of proteins that participate in a variety of cellular functions and play a role in aging. We identified a potent inhibitor of sirtuin 2 ( SIRT2) and found that inhibition of SIRT2 rescued alpha-synuclein toxicity and modified inclusion morphology in a cellular model of Parkinson's disease. Genetic inhibition of SIRT2 via small interfering RNA similarly rescued alpha-synuclein toxicity. Furthermore, the inhibitors protected against dopaminergic cell death both in vitro and in a Drosophila model of Parkinson's disease. The results suggest a link between neurodegeneration and aging.	Harvard Univ, Sch Med, MassGen Inst Neurodegenerat Dis, MGH, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Alzheimers Res Unit, MGH, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA	Harvard University; Harvard University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Scripps Research Institute; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Kontopoulos, E (corresponding author), Harvard Univ, Sch Med, MassGen Inst Neurodegenerat Dis, MGH, CNY 114,16th St, Charlestown, MA 02129 USA.	akazantsev@partners.org	Outeiro, Tiago/M-8106-2019; Outeiro, Tiago/L-7351-2019; Young, Anne/AAF-4283-2020; Outeiro, Tiago F/C-1067-2008	Outeiro, Tiago/0000-0003-1679-1727; Outeiro, Tiago F/0000-0003-1679-1727; Rochet, Jean-Christophe/0000-0002-6484-1541; McLean, Pamela/0000-0003-4870-5715; Feany, Mel/0000-0003-0315-7970; Kufareva, Irina/0000-0001-9083-7039	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038372, R01NS049221] Funding Source: NIH RePORTER; NINDS NIH HHS [5P50-NS38372A-06, R01-NS049221] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Alim MA, 2004, J ALZHEIMERS DIS, V6, P435; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bodner RA, 2006, P NATL ACAD SCI USA, V103, P4246, DOI 10.1073/pnas.0511256103; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jensen PH, 2000, J BIOL CHEM, V275, P21500, DOI 10.1074/jbc.M000099200; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Kontopoulos E, 2006, HUM MOL GENET, V15, P3012, DOI 10.1093/hmg/ddl243; Langley B, 2005, CNS NEUROL DISORD-DR, V4, P41, DOI 10.2174/1568007053005091; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; McLean PJ, 2001, NEUROSCIENCE, V104, P901, DOI 10.1016/S0306-4522(01)00113-0; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Outeiro TF, 2006, BIOCHEM BIOPH RES CO, V351, P631, DOI 10.1016/j.bbrc.2006.10.085; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tanaka M, 2004, J BIOL CHEM, V279, P4625, DOI 10.1074/jbc.M310994200; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Zhou WB, 2000, BRAIN RES, V866, P33, DOI 10.1016/S0006-8993(00)02215-0	25	821	855	2	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2007	317	5837					516	519		10.1126/science.1143780	http://dx.doi.org/10.1126/science.1143780			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17588900				2022-12-01	WOS:000248339800046
J	Landry, CR; Lemos, B; Rifkin, SA; Dickinson, WJ; Hartl, DL				Landry, Christian R.; Lemos, Bernardo; Rifkin, Scott A.; Dickinson, W. J.; Hartl, Daniel L.			Genetic properties influencing the evolvability of gene expression	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; EVOLUTION; GENOME; CANALIZATION; PROFILES; MUTATION; REVEALS; YEAST; NOISE; CONSEQUENCES	Identifying the properties of gene networks that influence their evolution is a fundamental research goal. However, modes of evolution cannot be inferred solely from the distribution of natural variation, because selection interacts with demography and mutation rates to shape polymorphism and divergence. We estimated the effects of naturally occurring mutations on gene expression while minimizing the effect of natural selection. We demonstrate that sensitivity of gene expression to mutations increases with both increasing trans-mutational target size and the presence of a TATA box. Genes with greater sensitivity to mutations are also more sensitive to systematic environmental perturbations and stochastic noise. These results provide a mechanistic basis for gene expression evolvability that can serve as a foundation for realistic models of regulatory evolution.	Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Harvard University; Utah System of Higher Education; University of Utah	Landry, CR (corresponding author), Univ Montreal, Dept Biochim, 2900 Blvd Edouard Montpetit, Montreal, PQ H3T 1J4, Canada.	clandry@post.harvard.edu; blemos@oeb.harvard.edu	Lemos, Bernardo/AAL-2429-2020; Landry, Christian R/F-3890-2011	Lemos, Bernardo/0000-0001-6996-9483; Rifkin, Scott/0000-0001-8476-3256; Landry, Christian/0000-0003-3028-6866				Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Denver DR, 2005, NAT GENET, V37, P544, DOI 10.1038/ng1554; Featherstone DE, 2002, BIOESSAYS, V24, P267, DOI 10.1002/bies.10054; Gibson G, 2000, BIOESSAYS, V22, P372, DOI 10.1002/(SICI)1521-1878(200004)22:4<372::AID-BIES7>3.3.CO;2-A; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Kim JW, 2004, MOL CELL BIOL, V24, P8104, DOI 10.1128/MCB.24.18.8104-8112.2004; Landry CR, 2006, GENE, V366, P343, DOI 10.1016/j.gene.2005.10.042; Lemos B, 2005, MOL BIOL EVOL, V22, P1345, DOI 10.1093/molbev/msi122; Lemos B, 2005, EVOLUTION, V59, P126; Lemos B, 2004, NAT GENET, V36, P1059, DOI 10.1038/ng1427; Lenski RE, 2006, PLOS BIOL, V4, P2190, DOI 10.1371/journal.pbio.0040428; LYNCH M, 1988, GENET RES, V51, P137, DOI 10.1017/S0016672300024150; Lynch M., 1998, AM J HUM GENET; Meiklejohn CD, 2002, TRENDS ECOL EVOL, V17, P468, DOI 10.1016/S0169-5347(02)02596-X; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Rifkin SA, 2005, NATURE, V438, P220, DOI 10.1038/nature04114; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Townsend JP, 2003, MOL BIOL EVOL, V20, P955, DOI 10.1093/molbev/msg106; Wagner GP, 1997, EVOLUTION, V51, P329, DOI 10.1111/j.1558-5646.1997.tb02420.x	24	234	236	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2007	317	5834					118	121		10.1126/science.1140247	http://dx.doi.org/10.1126/science.1140247			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186KD	17525304				2022-12-01	WOS:000247776700065
J	Chen, Z; Odstrcil, EA; Tu, BP; McKnight, SL				Chen, Zheng; Odstrcil, Elizabeth A.; Tu, Benjamin P.; McKnight, Steven L.			Restriction of DNA replication to the reductive phase of the metabolic cycle protects genome integrity	SCIENCE			English	Article							CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; CANCER-CELLS; YEAST; INSTABILITY; INHIBITOR; MUTATIONS; MECHANISM; STRESS; DAMAGE	When prototrophic yeast cells are cultured under nutrient-limited conditions that mimic growth in the wild, rather than in the high-glucose solutions used in most laboratory studies, they exhibit a robustly periodic metabolic cycle. Over a cycle of 4 to 5 hours, yeast cells rhythmically alternate between glycolysis and respiration. The cell division cycle is tightly constrained to the reductive phase of this yeast metabolic cycle, with DNA replication taking place only during the glycolytic phase. We show that cell cycle mutants impeded in metabolic cycle-directed restriction of cell division exhibit substantial increases in spontaneous mutation rate. In addition, disruption of the gene encoding a DNA checkpoint kinase that couples the cell division cycle to the circadian cycle abolishes synchrony of the metabolic and cell cycles. Thus, circadian, metabolic, and cell division cycles may be coordinated similarly as an evolutionarily conserved means of preserving genome integrity.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Baylor Univ, Med Ctr, Dallas, TX 75246 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Baylor University; Baylor University Medical Center	McKnight, SL (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Steven.McKnight@UTSouthwestern.edu		Chen, Jake/0000-0001-8829-7504				Canaple L, 2003, CANCER RES, V63, P7545; Chen JH, 2005, DNA REPAIR, V4, P1140, DOI 10.1016/j.dnarep.2005.06.003; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Futcher B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-107; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Gillette MU, 2005, SCIENCE, V309, P1196, DOI 10.1126/science.1111420; HESS B, 1971, ANNU REV BIOCHEM, V40, P237, DOI 10.1146/annurev.bi.40.070171.001321; Huang GC, 2006, EMBO J, V25, P5349, DOI 10.1038/sj.emboj.7601397; Huang ME, 2003, P NATL ACAD SCI USA, V100, P11529, DOI 10.1073/pnas.2035018100; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Klevecz RR, 2004, P NATL ACAD SCI USA, V101, P1200, DOI 10.1073/pnas.0306490101; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; Leroy C, 2001, EMBO J, V20, P2896, DOI 10.1093/emboj/20.11.2896; Lloyd D, 2005, TRENDS BIOCHEM SCI, V30, P373, DOI 10.1016/j.tibs.2005.05.005; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; NUGROHO TT, 1994, MOL CELL BIOL, V14, P3320, DOI 10.1128/MCB.14.5.3320; Pregueiro AM, 2006, SCIENCE, V313, P644, DOI 10.1126/science.1121716; Richard P, 2003, FEMS MICROBIOL REV, V27, P547, DOI 10.1016/S0168-6445(03)00065-2; Schibler U, 2005, CURR OPIN CELL BIOL, V17, P223, DOI 10.1016/j.ceb.2005.01.007; Shcherbakova PV, 1999, MOL CELL BIOL, V19, P3177; Sidorova JM, 2003, MUTAT RES-FUND MOL M, V532, P5, DOI 10.1016/j.mrfmmm.2003.08.006; Tu BP, 2006, NAT REV MOL CELL BIO, V7, P696, DOI 10.1038/nrm1980; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; WHELAN WL, 1979, GENETICS, V91, P35	26	169	172	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2007	316	5833					1916	1919		10.1126/science.1140958	http://dx.doi.org/10.1126/science.1140958			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183WI	17600220				2022-12-01	WOS:000247602700045
J	Pao, M; Ballard, ED; Rosenstein, DL				Pao, Maryland; Ballard, Elizabeth D.; Rosenstein, Donald L.			Growing up in the hospital	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHILDREN; DEPRESSION; ADOLESCENT; PREVALENCE; CARE		NIMH, NIH, Clin Res Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Pao, M (corresponding author), NIMH, NIH, Clin Res Ctr, 6-5340, Bethesda, MD 20892 USA.	paom@mail.nih.gov	Ballard, Elizabeth/O-6856-2017	Ballard, Elizabeth/0000-0001-5304-0127				Anderson GM, 2000, CHILD ADOL PSYCH CL, V9, P23; Armstrong FD, 2006, MENT RETARD DEV D R, V12, P168, DOI 10.1002/mrdd.20114; BENNETT DS, 1994, J PEDIATR PSYCHOL, V19, P149, DOI 10.1093/jpepsy/19.2.149; Bhutta AT, 2002, CLIN PERINATOL, V29, P357, DOI 10.1016/S0095-5108(02)00011-8; Dejong M, 2006, PSYCHO-ONCOLOGY, V15, P553, DOI 10.1002/pon.1002; Drotar D, 2006, CHILD HEALTH CARE, V35, P91, DOI 10.1207/s15326888chc3501_8; Erikson E.H., 1968, IDENTITY YOUTH CRISI; Jellinek M., 2002, BRIGHT FUTURES PRACT; Kanner L, 1937, J PEDIATR-US, V11, P418, DOI 10.1016/S0022-3476(37)80027-X; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Mahan, 2005, M CHILDRENS PSYCHOSO; Mayes LC, 2003, CHILD ADOL PSYCH CL, V12, P401, DOI 10.1016/S1056-4993(03)00022-1; Newacheck PW, 1998, AM J PUBLIC HEALTH, V88, P610, DOI 10.2105/AJPH.88.4.610; OWENS PL, 2003, CARE CHILDEN ADOLESC; Peebles-Kleiger MJ, 2000, B MENNINGER CLIN, V64, P257; PERRIN JM, 1993, PEDIATRICS, V92, P876; Schechter NL, 1997, PEDIATRICS, V99, P890, DOI 10.1542/peds.99.6.890; Stuber ML, 2006, CHILD ADOL PSYCH CL, V15, P597, DOI 10.1016/j.chc.2006.02.006; Stuber ML, 2006, CNS SPECTRUMS, V11, P137, DOI 10.1017/S1092852900010671; Suris JC, 2004, ARCH DIS CHILD, V89, P938, DOI 10.1136/adc.2003.045369; THOMASGARD M, 1995, J DEV BEHAV PEDIATR, V16, P47; Uman LS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005179; Yoshida K, 2005, NEUROPSYCHOBIOLOGY, V52, P55, DOI 10.1159/000086605; Zielinski Tanya A., 2000, Prim Care Companion J Clin Psychiatry, V2, P153	24	19	19	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2007	297	24					2752	2755		10.1001/jama.297.24.2752	http://dx.doi.org/10.1001/jama.297.24.2752			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	182UE	17595276				2022-12-01	WOS:000247528700025
J	Wald, NJ; Oakley, GP				Wald, Nicholas J.; Oakley, Godfrey P.			Should folic acid fortification be mandatory?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Queen Marys Sch Med & Dent, Wolfson Inst Prevent Med, London EC1M 6BQ, England; Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	University of London; Queen Mary University London; Emory University; Rollins School Public Health	Wald, NJ (corresponding author), Univ London, Queen Marys Sch Med & Dent, Wolfson Inst Prevent Med, London EC1M 6BQ, England.	n.j.wald@qmul.ac.uk	Wald, Nicholas/AAY-8924-2021; Wald, Nicholas/AAY-2814-2021						0	22	23	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 16	2007	334	7606					1252	1252		10.1136/bmj.39232.493252.47	http://dx.doi.org/10.1136/bmj.39232.493252.47			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183AM	17569931	Green Published			2022-12-01	WOS:000247545100030
J	Wadman, M				Wadman, Meredith			Meeting in the middle	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2007	447	7145					629	629		10.1038/447629a	http://dx.doi.org/10.1038/447629a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554281	Bronze			2022-12-01	WOS:000247030700014
J	Behrens, MR; Mutlu, N; Chakraborty, S; Dumitru, R; Jiang, WZ; LaVallee, BJ; Herman, PL; Clemente, TE; Weeks, DP				Behrens, Mark R.; Mutlu, Nedim; Chakraborty, Sarbani; Dumitru, Razvan; Jiang, Wen Zhi; LaVallee, Bradley J.; Herman, Patricia L.; Clemente, Thomas E.; Weeks, Donald P.			Dicamba resistance: Enlarging and preserving biotechnology-based weed management strategies	SCIENCE			English	Article							PSEUDOMONAS-MALTOPHILIA; O-DEMETHYLASE; STRAIN DI-6; HEALTH	The advent of biotechnology-derived, herbicide-resistant crops has revolutionized farming practices in many countries. Facile, highly effective, environmentally sound, and profitable weed control methods have been rapidly adopted by crop producers who value the benefits associated with biotechnology-derived weed management traits. But a rapid rise in the populations of several troublesome weeds that are tolerant or resistant to herbicides currently used in conjunction with herbicide-resistant crops may signify that the useful lifetime of these economically important weed management traits will be cut short. We describe the development of soybean and other broadleaf plant species resistant to dicamba, a widely used, inexpensive, and environmentally safe herbicide. The dicamba resistance technology will augment current herbicide resistance technologies and extend their effective lifetime. Attributes of both nuclear- and chloroplast-encoded dicamba resistance genes that affect the potency and expected durability of the herbicide resistance trait are examined.	Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; Univ Nebraska, Ctr Biotechnol, Lincoln, NE 68588 USA; Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Weeks, DP (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.	dweeks1@unl.edu	Mutlu, Nedim/B-9280-2016; MUTLU, Nedim/AAB-9844-2020	MUTLU, Nedim/0000-0001-7252-5883; Behrens, Mark/0000-0001-8230-120X				[Anonymous], [No title captured]; Cerdeira AL, 2006, J ENVIRON QUAL, V35, P1633, DOI 10.2134/jeq2005.0378; Chakraborty S, 2005, ARCH BIOCHEM BIOPHYS, V437, P20, DOI 10.1016/j.abb.2005.02.024; CORK DJ, 1991, ADV APPL MICROBIOL, V36, P1; Dufourmantel N, 2004, PLANT MOL BIOL, V55, P479, DOI 10.1007/s11103-004-0192-4; Herman PL, 2005, J BIOL CHEM, V280, P24759, DOI 10.1074/jbc.M500597200; Hossain F, 2004, INT J OCCUP ENV HEAL, V10, P296, DOI 10.1179/oeh.2004.10.3.296; Huang JK, 2005, SCIENCE, V308, P688, DOI 10.1126/science.1108972; *INT SERV ACQ AGR, 2006, GLOB STAT COMM BIOT; Maiti IB, 1998, BIOCHEM BIOPH RES CO, V244, P440, DOI 10.1006/bbrc.1998.8287; Maliga P, 2005, PHOTOCH PHOTOBIO SCI, V4, P971, DOI 10.1039/b514699m; Steven JT, 1991, HDB PESTICIDE TOXICO, P1317; *US EPA OFF DRINK, 1988, HLTH ADV SUMM DIC; Wang XZ, 1997, APPL ENVIRON MICROB, V63, P1623, DOI 10.1128/AEM.63.4.1623-1626.1997; *WEED SCI SOC AM, 1994, HERB HDB; YANG J, 1994, ANAL BIOCHEM, V219, P37, DOI 10.1006/abio.1994.1228; EXTOXNET PESTICDE IN	17	197	241	5	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1185	1188		10.1126/science.1141596	http://dx.doi.org/10.1126/science.1141596			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525337	Green Published			2022-12-01	WOS:000246724300041
J	Barsh, G; Attardi, LD				Barsh, Gregory; Attardi, Laura D.			Clinical implications of basic research: A healthy tan?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PIGMENTATION; RECEPTOR		Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Barsh, G (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.							Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; Rees JL, 2004, AM J HUM GENET, V75, P739, DOI 10.1086/425285; Slominski A, 2005, ENDOCRINOLOGY, V146, P1245, DOI 10.1210/en.2004-0733; Suzuki I, 1999, J INVEST DERM SYMP P, V4, P29, DOI 10.1038/sj.jidsp.5640177; Tsatmali M, 2000, PIGM CELL RES, V13, P125, DOI 10.1034/j.1600-0749.13.s8.22.x	5	17	17	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2007	356	21					2208	2210		10.1056/NEJMcibr071775	http://dx.doi.org/10.1056/NEJMcibr071775			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170ON	17522405				2022-12-01	WOS:000246673100016
J	Shimada, A; Niwa, H; Tsujita, K; Suetsugu, S; Nitta, K; Hanawa-Suetsugu, K; Akasaka, R; Nishino, Y; Toyama, M; Chen, LR; Liu, ZJ; Wang, BC; Yamamoto, M; Terada, T; Miyazawa, A; Tanaka, A; Sugano, S; Shirouzu, M; Nagayama, K; Takenawa, T; Yokoyama, S				Shimada, Atsushi; Niwa, Hideaki; Tsujita, Kazuya; Suetsugu, Shiro; Nitta, Koji; Hanawa-Suetsugu, Kyoko; Akasaka, Ryogo; Nishino, Yuri; Toyama, Mitsutoshi; Chen, Lirong; Liu, Zhi-Jie; Wang, Bi-Cheng; Yamamoto, Masaki; Terada, Takaho; Miyazawa, Atsuo; Tanaka, Akiko; Sugano, Sumio; Shirouzu, Mikako; Nagayama, Kuniaki; Takenawa, Tadaomi; Yokoyama, Shigeyuki			Curved EFC/F-BAR-domain dimers are joined end to end into a filament for membrane invagination in endocytosis	CELL			English	Article							ACTIN CYTOSKELETON; N-WASP; MEDIATED ENDOCYTOSIS; HOMOLOGY DOMAIN; DYNAMIN; PROTEIN; CURVATURE; TUBULATION; FAMILY; CONSTRICTION	Pombe Cdc15 homology (PCH) proteins play an important role in a variety of actin-based processes, including clathrin-mediated endocytosis (CME). The defining feature of the PCH proteins is an evolutionarily conserved EFC/F-BAR domain for membrane association and tubulation. In the present study, we solved the crystal structures of the EFC domains of human FBP17 and CIP4. The structures revealed a gently curved helical-bundle dimer of similar to 220 angstrom in length, which forms filaments through end-to-end interactions in the crystals. The curved EFC dimer fits a tubular membrane with an similar to 600 angstrom diameter. We subsequently proposed a model in which the curved EFC filament drives tubulation. In fact, striation of tubular membranes was observed by phase-contrast cryo-transmission electron microscopy, and mutations that impaired filament formation also impaired membrane tubulation and cell membrane invagination. Furthermore, FBP17 is recruited to clathrin-coated pits in the late stage of CME, indicating its physiological role.	RIKEN, SPring Ctr 8, Harima Inst, Sayo, Hyogo 6795148, Japan; Univ Tokyo, Inst Med Sci, Dept Biochem, Minato Ku, Tokyo 1088639, Japan; JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan; Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30603 USA; Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Tokyo 1130033, Japan; Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, Tokyo 1130033, Japan	RIKEN; University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); RIKEN; University System of Georgia; University of Georgia; University of Tokyo; University of Tokyo	Takenawa, T (corresponding author), RIKEN, SPring Ctr 8, Harima Inst, 1-1 Kouto, Sayo, Hyogo 6795148, Japan.	takenawa@med.kobe-u.ac.jp; yokoyama@biochem.s.u-tokyo.ac.jp	Yamamoto, Masaki/B-7844-2015; Yokoyama, Shigeyuki/N-6911-2015; Suetsugu, Shiro/ABB-6033-2020; Suetsugu, Shiro/B-3300-2010; Nagayama, Kuniaki/O-2522-2018; Suetsugu, Shiro/AAF-4427-2019; Shirouzu, Mikako/A-6521-2016; Niwa, Hideaki/C-3694-2017; Liu, Zhi-Jie/A-3946-2012	Yamamoto, Masaki/0000-0002-1311-1768; Yokoyama, Shigeyuki/0000-0003-3133-7338; Suetsugu, Shiro/0000-0002-4612-0628; Suetsugu, Shiro/0000-0002-4612-0628; Niwa, Hideaki/0000-0001-9544-9350; Liu, Zhi-Jie/0000-0001-7279-2893; Shimada, Atsushi/0000-0002-4108-770X				Aspenstrom P, 1997, CURR BIOL, V7, P479, DOI 10.1016/S0960-9822(06)00219-3; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; Danev R, 2001, ULTRAMICROSCOPY, V88, P243, DOI 10.1016/S0304-3991(01)00088-2; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kamioka Y, 2004, J BIOL CHEM, V279, P40091, DOI 10.1074/jbc.M404899200; Kessels MM, 2004, J CELL SCI, V117, P3077, DOI 10.1242/jcs.01290; Kigawa T, 1999, FEBS LETT, V442, P15, DOI 10.1016/S0014-5793(98)01620-2; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lippincott J, 2000, MICROSC RES TECHNIQ, V49, P168, DOI 10.1002/(SICI)1097-0029(20000415)49:2<168::AID-JEMT9>3.0.CO;2-T; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Miki H, 2003, J BIOCHEM, V134, P309, DOI 10.1093/jb/mvg146; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; Nagayama K, 2005, ADV IMAG ELECT PHYS, V138, P69, DOI 10.1016/S1076-5670(05)38002-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrais D, 2005, DEV CELL, V9, P581, DOI 10.1016/j.devcel.2005.10.002; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Ren G, 2006, MICROBIOL MOL BIOL R, V70, P37, DOI 10.1128/MMBR.70.1.37-120.2006; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Sitaraman K, 2004, J BIOTECHNOL, V110, P257, DOI 10.1016/j.jbiotec.2004.02.014; Suetsugu S, 2002, DEV CELL, V3, P645, DOI 10.1016/S1534-5807(02)00324-6; Suetsugu S, 2006, J BIOL CHEM, V281, P35347, DOI 10.1074/jbc.M606814200; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.E04-09-0774; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	49	303	314	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2007	129	4					761	772		10.1016/j.cell.2007.03.040	http://dx.doi.org/10.1016/j.cell.2007.03.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512409	Bronze			2022-12-01	WOS:000246788300020
J	Storici, F; Bebenek, K; Kunkel, TA; Gordenin, DA; Resnick, MA				Storici, Francesca; Bebenek, Katarzyna; Kunkel, Thomas A.; Gordenin, Dmitry A.; Resnick, Michael A.			RNA-templated DNA repair	NATURE			English	Article							DOUBLE-STRAND BREAKS; REVERSE-TRANSCRIPTASE; SACCHAROMYCES-CEREVISIAE; POLYMERASE-ETA; RECA PROTEIN; RECOMBINATION; RIBONUCLEOTIDES; REPLICATION; OLIGONUCLEOTIDES; RETROTRANSPOSONS	RNA can act as a template for DNA synthesis in the reverse transcription of retroviruses and retrotransposons(1) and in the elongation of telomeres(2). Despite its abundance in the nucleus, there has been no evidence for a direct role of RNA as a template in the repair of any chromosomal DNA lesions, including DNA double-strand breaks (DSBs), which are repaired in most organisms by homologous recombination or by non-homologous end joining(3). An indirect role for RNA in DNA repair, following reverse transcription and formation of a complementary DNA, has been observed in the non-homologous joining of DSB ends(4,5). In the yeast Saccharomyces cerevisiae, in which homologous recombination is efficient(3), RNA was shown to mediate recombination, but only indirectly through a cDNA intermediate(6,7) generated by the reverse transcriptase function of Ty retrotransposons in Ty particles in the cytoplasm(8). Although pairing between duplex DNA and single-strand (ss) RNA can occur in vitro(9,10) and in vivo(11), direct homologous exchange of genetic information between RNA and DNA molecules has not been observed. We show here that RNA can serve as a template for DNA synthesis during repair of a chromosomal DSB in yeast. The repair was accomplished with RNA oligonucleotides complementary to the broken ends. This and the observation that even yeast replicative DNA polymerases such as alpha and delta can copy short RNA template tracts in vitro demonstrate that RNA can transfer genetic information in vivo through direct homologous interaction with chromosomal DNA.	NIEHS, Mol Biol Lab, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Resnick, MA (corresponding author), NIEHS, Mol Biol Lab, NIH, US Dept HHS, POB 12233, Res Triangle Pk, NC 27709 USA.	resnick@niehs.nih.gov	resnick, Michael/F-1668-2019; Kunkel, Thomas A./D-5088-2019; Dmitry, Gordenin/C-3907-2018	resnick, Michael/0000-0002-8473-7506; Kunkel, Thomas A./0000-0002-9900-1788; Dmitry, Gordenin/0000-0002-8399-1836	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065070, Z01ES065072] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 ES065072-17] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; BALTIMORE D, 1985, CELL, V40, P481, DOI 10.1016/0092-8674(85)90190-4; BOEKE JD, 1986, MOL CELL BIOL, V6, P3575, DOI 10.1128/MCB.6.11.3575; DERR LK, 1993, NATURE, V361, P170, DOI 10.1038/361170a0; Franklin A, 2004, IMMUNOL CELL BIOL, V82, P219, DOI 10.1046/j.0818-9641.2004.01221.x; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Kasahara M, 2000, GENE DEV, V14, P360; Lesage P, 2005, CYTOGENET GENOME RES, V110, P70, DOI 10.1159/000084940; McCulloch SD, 2006, DNA REPAIR, V5, P1373, DOI 10.1016/j.dnarep.2006.06.003; McElhinny SAN, 2003, MOL CELL BIOL, V23, P2309, DOI 10.1128/MCB.23.7.2309-2315.2003; Moore JK, 1996, NATURE, V383, P644, DOI 10.1038/383644a0; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Murakami E, 2003, J BIOL CHEM, V278, P36403, DOI 10.1074/jbc.M306236200; NevoCaspi Y, 1997, CURR GENET, V32, P32, DOI 10.1007/s002940050245; Niimi A, 2004, MOL CELL BIOL, V24, P2734, DOI 10.1128/MCB.24.7.2734-2746.2004; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paques F, 1998, MOL CELL BIOL, V18, P2045, DOI 10.1128/MCB.18.4.2045; RICCHETTI M, 1993, EMBO J, V12, P387, DOI 10.1002/j.1460-2075.1993.tb05670.x; Rumbaugh JA, 1997, J BIOL CHEM, V272, P22591, DOI 10.1074/jbc.272.36.22591; Shcherbakova Polina V., 2006, V47, P391; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Storici F, 2003, P NATL ACAD SCI USA, V100, P14994, DOI 10.1073/pnas.2036296100; Storici F, 2006, MOL CELL BIOL, V26, P7645, DOI 10.1128/MCB.00672-06; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Teng SC, 1996, NATURE, V383, P641, DOI 10.1038/383641a0; Vengrova S, 2006, EMBO REP, V7, P59, DOI 10.1038/sj.embor.7400576; Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9; Zaitsev EN, 2000, GENE DEV, V14, P740	29	158	167	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2007	447	7142					338	341		10.1038/nature05720	http://dx.doi.org/10.1038/nature05720			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17429354	Green Accepted			2022-12-01	WOS:000246520300050
J	Visser, AW				Visser, Andre W.			Biomixing of the oceans?	SCIENCE			English	Editorial Material							GENERATED TURBULENCE; DIFFUSION; DISSIPATION; ENERGY		Tech Univ Denmark, Danish Inst Fisheries Res, Dept Marine Ecol & Aquaculture, DK-2920 Charlottenlund, Denmark	Technical University of Denmark	Visser, AW (corresponding author), Tech Univ Denmark, Danish Inst Fisheries Res, Dept Marine Ecol & Aquaculture, Kavalergaarden 6, DK-2920 Charlottenlund, Denmark.	awv@difres.dk	Visser, Andre/G-6317-2015	Visser, Andre/0000-0002-1604-7263				Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Britter R.E., 1985, TURBULENCE DIFFUSION, P3; Dengler M, 2002, J PHYS OCEANOGR, V32, P1165, DOI 10.1175/1520-0485(2002)032<1165:EDJAAM>2.0.CO;2; Dewar WK, 2006, J MAR RES, V64, P541, DOI 10.1357/002224006778715720; Huntley ME, 2004, MAR ECOL PROG SER, V273, P65, DOI 10.3354/meps273065; Kunze E, 2006, SCIENCE, V313, P1768, DOI 10.1126/science.1129378; Munk W, 1998, DEEP-SEA RES PT I, V45, P1977, DOI 10.1016/S0967-0637(98)00070-3; OAKEY NS, 1982, J PHYS OCEANOGR, V12, P256, DOI 10.1175/1520-0485(1982)012<0256:DOTROD>2.0.CO;2; OKUBO A, 1971, DEEP-SEA RES, V18, P789, DOI 10.1016/0011-7471(71)90046-5; OSBORN TR, 1980, J PHYS OCEANOGR, V10, P83, DOI 10.1175/1520-0485(1980)010<0083:EOTLRO>2.0.CO;2; Rehmann CR, 2004, DYNAM ATMOS OCEANS, V37, P271, DOI 10.1016/j.dynatmoce.2003.09.001; Richardson LF, 1926, P R SOC LOND A-CONTA, V110, P709, DOI 10.1098/rspa.1926.0043; Thorpe S. A, 2005, TURBULENT OCEAN; Wunsch C, 2000, NATURE, V405, P743, DOI 10.1038/35015639; YOON KH, 1990, J FLUID MECH, V215, P601, DOI 10.1017/S0022112090002786	15	65	66	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2007	316	5826					838	839		10.1126/science.1141272	http://dx.doi.org/10.1126/science.1141272			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17495157				2022-12-01	WOS:000246369800021
J	Mikkelsen, TS; Wakefield, MJ; Aken, B; Amemiya, CT; Chang, JL; Duke, S; Garber, M; Gentles, AJ; Goodstadt, L; Heger, A; Jurka, J; Kamal, M; Mauceli, E; Searle, SMJ; Sharpe, T; Baker, ML; Batzer, MA; Benos, PV; Belov, K; Clamp, M; Cook, A; Cuff, J; Das, R; Davidow, L; Deakin, JE; Fazzari, MJ; Glass, JL; Grabherr, M; Greally, JM; Gu, WJ; Hore, TA; Huttley, GA; Kleber, M; Jirtle, RL; Koina, E; Lee, JT; Mahony, S; Marra, MA; Miller, RD; Nicholls, RD; Oda, M; Papenfuss, AT; Parra, ZE; Pollock, DD; Ray, DA; Schein, JE; Speed, TP; Thompson, K; VandeBerg, JL; Wade, CM; Walker, JA; Waters, PD; Webber, C; Weidman, JR; Xie, XH; Zody, MC; Graves, JAM; Ponting, CP; Breen, M; Samollow, PB; Lander, ES; Lindblad-Toh, K				Mikkelsen, Tarjei S.; Wakefield, Matthew J.; Aken, Bronwen; Amemiya, Chris T.; Chang, Jean L.; Duke, Shannon; Garber, Manuel; Gentles, Andrew J.; Goodstadt, Leo; Heger, Andreas; Jurka, Jerzy; Kamal, Michael; Mauceli, Evan; Searle, Stephen M. J.; Sharpe, Ted; Baker, Michelle L.; Batzer, Mark A.; Benos, Panayiotis V.; Belov, Katherine; Clamp, Michele; Cook, April; Cuff, James; Das, Radhika; Davidow, Lance; Deakin, Janine E.; Fazzari, Melissa J.; Glass, Jacob L.; Grabherr, Manfred; Greally, John M.; Gu, Wanjun; Hore, Timothy A.; Huttley, Gavin A.; Kleber, Michael; Jirtle, Randy L.; Koina, Edda; Lee, Jeannie T.; Mahony, Shaun; Marra, Marco A.; Miller, Robert D.; Nicholls, Robert D.; Oda, Mayumi; Papenfuss, Anthony T.; Parra, Zuly E.; Pollock, David D.; Ray, David A.; Schein, Jacqueline E.; Speed, Terence P.; Thompson, Katherine; VandeBerg, John L.; Wade, Claire M.; Walker, Jerilyn A.; Waters, Paul D.; Webber, Caleb; Weidman, Jennifer R.; Xie, Xiaohui; Zody, Michael C.; Graves, Jennifer A. Marshall; Ponting, Chris P.; Breen, Matthew; Samollow, Paul B.; Lander, Eric S.; Lindblad-Toh, Kerstin		Broad Inst Genome Sequencing Platf; Broad Inst Whole Genome Assembly	Genome of the marsupial Monodelphis domestica reveals innovation in non-coding sequences	NATURE			English	Review							X-CHROMOSOME INACTIVATION; SHORT-TAILED OPOSSUM; TRANSPOSABLE ELEMENTS; RECOMBINATION RATES; REGULATORY NETWORKS; MOBILE ELEMENTS; EVOLUTION; GENE; VERTEBRATE; MOUSE	We report a high-quality draft of the genome sequence of the grey, short-tailed opossum ( Monodelphis domestica). As the first metatherian ('marsupial') species to be sequenced, the opossum provides a unique perspective on the organization and evolution of mammalian genomes. Distinctive features of the opossum chromosomes provide support for recent theories about genome evolution and function, including a strong influence of biased gene conversion on nucleotide sequence composition, and a relationship between chromosomal characteristics and X chromosome inactivation. Comparison of opossum and eutherian genomes also reveals a sharp difference in evolutionary innovation between protein-coding and non-coding functional elements. True innovation in protein-coding genes seems to be relatively rare, with lineage-specific differences being largely due to diversification and rapid turnover in gene families involved in environmental interactions. In contrast, about 20% of eutherian conserved non-coding elements (CNEs) are recent inventions that postdate the divergence of Eutheria and Metatheria. A substantial proportion of these eutherian-specific CNEs arose from sequence inserted by transposable elements, pointing to transposons as a major creative force in the evolution of mammalian gene regulation.	MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Cambridge, MA 02142 USA; MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3050, Australia; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Benaroya Res Inst Virginia Mason, Mol Genet Program, Seattle, WA 98101 USA; N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC 27606 USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA; Genet Informat Res Inst, Mountain View, CA 94043 USA; Univ Oxford, MRC Funct Genet Unit, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; Univ New Mexico, Ctr Evolutionary & Theoret Immunol, Dept Biol, Albuquerque, NM 87131 USA; Louisiana State Univ, Ctr Biomodular Multiscale Syst, Dept Biol Sci, Biol Computat & Visualizat Ctr, Baton Rouge, LA 70803 USA; Univ Pittsburgh, Dept Computat Biol, Pittsburgh, PA 15260 USA; Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27710 USA; Massachusetts Gen Hosp, Howard Hughes Med Inst, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Australian Natl Univ, Res Sch Biol Sci, ARC Ctr Kangaroo Genom, Canberra, ACT 2601, Australia; Yeshiva Univ Albert Einstein Coll Med, Dept Med Hematol & Mol Genet, Bronx, NY 10461 USA; Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 0200, Australia; British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z4S6, Canada; Childrens Hosp Pittsburgh, Res Ctr, Dept Pediat, Pittsburgh, PA 15213 USA; W Virginia Univ, Dept Biol, Morgantown, WV 26505 USA; SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78245 USA; SW Fdn Biomed Res, SW Natl Primate Res Ctr, San Antonio, TX 78245 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; N Carolina State Univ, Ctr Comparat Med & Translat Res, Raleigh, NC 27606 USA; Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Walter & Eliza Hall Institute; Wellcome Trust Sanger Institute; Benaroya Research Institute; Virginia Mason Medical Center; University of North Carolina; North Carolina State University; Stanford University; University of Oxford; University of New Mexico; Louisiana State University System; Louisiana State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Sydney; Duke University; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Australian National University; Yeshiva University; Albert Einstein College of Medicine; University of Colorado System; University of Colorado Anschutz Medical Campus; Australian National University; John Curtin School of Medical Research; British Columbia Cancer Agency; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; West Virginia University; Texas Biomedical Research Institute; Texas Biomedical Research Institute; Harvard University; Massachusetts General Hospital; University of North Carolina; North Carolina State University; Texas A&M University System; Texas A&M University College Station; Massachusetts Institute of Technology (MIT); Whitehead Institute	Lindblad-Toh, K (corresponding author), MIT, Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	tarjei@broad.mit.edu; lander@broad.mit.edu; kersli@broad.mit.edu	Gu, Wanjun/P-5389-2019; Waters, Paul D/B-7871-2015; Speed, Terence P/B-8085-2009; Papenfuss, Anthony T/C-6297-2008; Graves, Jennifer A.M./A-1387-2008; Marra, Marco A/B-5987-2008; Oda, Mayumi/Z-2010-2019; Mahony, Shaun/C-5699-2014; Huttley, Gavin A/G-5169-2015; Waters, Paul/D-1044-2009; Greally, John/AAF-9540-2019; Baker, Michelle L/C-9694-2013; Wakefield, Matthew/X-7593-2019; Schein, Jacquie E/G-3674-2015; Pollock, David D/M-4740-2016; Oda, Mayumi/AAU-4837-2020; Gu, Wanjun/B-3998-2010; Ponting, Chris/AAV-2621-2021; Wakefield, Matthew J/A-7795-2008; Mikkelsen, Tarjei S/A-1306-2007; Deakin, Janine/A-1941-2008; Baker, Michelle/AAX-9171-2020	Gu, Wanjun/0000-0003-4501-0539; Waters, Paul D/0000-0002-4689-8747; Speed, Terence P/0000-0002-5403-7998; Papenfuss, Anthony T/0000-0002-1102-8506; Marra, Marco A/0000-0001-7146-7175; Oda, Mayumi/0000-0001-5102-7076; Mahony, Shaun/0000-0002-2641-1807; Huttley, Gavin A/0000-0001-7224-2074; Greally, John/0000-0001-6069-7960; Baker, Michelle L/0000-0002-7993-9971; Wakefield, Matthew/0000-0001-6624-4698; Pollock, David D/0000-0002-7627-4214; Wakefield, Matthew J/0000-0001-6624-4698; Mikkelsen, Tarjei S/0000-0002-8133-3135; Deakin, Janine/0000-0002-1259-3531; Baker, Michelle/0000-0002-7993-9971; Heger, Andreas/0000-0001-7720-0447; Ray, David/0000-0002-3340-3987; Fazzari, Melissa/0000-0002-5674-3589; Hore, Timothy/0000-0002-6735-225X; Webber, Caleb/0000-0001-8063-7674; Nicol, Robert/0000-0003-1932-1392; Benos, Panayiotis/0000-0003-3172-3132; Xie, Xiaohui/0000-0002-5479-6345; Miller, Robert/0000-0002-8479-8819; Falk, Jill/0000-0003-2910-9803; Belov, Katherine/0000-0002-9762-5554; Graves, Jennifer/0000-0001-6480-7856; Breen, Matthew/0000-0002-8901-4155; Aken, Bronwen/0000-0002-3032-4095; Ponting, Chris/0000-0003-0202-7816; Grabherr, Manfred/0000-0001-8792-6508; Wade, Claire/0000-0003-3413-4771; Cuff, James/0000-0003-0570-4106	Medical Research Council [MC_U137761446] Funding Source: Medline; Wellcome Trust [062023] Funding Source: Medline; MRC [MC_U137761446] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Bailey JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r23; Bailey PJ, 2006, EXP CELL RES, V312, P3108, DOI 10.1016/j.yexcr.2006.06.017; Baker ML, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-50; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Belle EMS, 2004, J MOL EVOL, V58, P653, DOI 10.1007/s00239-004-2587-x; Belov K, 2006, PLOS BIOL, V4, P317, DOI 10.1371/journal.pbio.0040046; Belov K, 2007, GENOME RES, V17, P982, DOI 10.1101/gr.6121807; Birney E, 2006, NUCLEIC ACIDS RES, V34, pD556, DOI 10.1093/nar/gkj133; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Britten RJ, 1997, GENE, V205, P177, DOI 10.1016/S0378-1119(97)00399-5; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Brosius J, 1999, GENETICA, V107, P209, DOI 10.1023/A:1004018519722; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; CLAMP M, UNPUB NATURE; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cooper D.W., 1993, Seminars in Developmental Biology, V4, P117, DOI 10.1006/sedb.1993.1014; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Davidow LS, 2007, CHROMOSOME RES, V15, P137, DOI 10.1007/s10577-007-1121-6; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; de la Calle-Mustienes E, 2005, GENOME RES, V15, P1061, DOI 10.1101/gr.4004805; Deakin JE, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-281; Deakin JE, 2006, CYTOGENET GENOME RES, V114, p94H, DOI 10.1159/000091942; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Disteche CM, 2002, CYTOGENET GENOME RES, V99, P36, DOI 10.1159/000071572; Duke SE, 2007, CHROMOSOME RES, V15, P361, DOI 10.1007/s10577-007-1131-4; Dumas D, 2002, GENETICS, V162, P1355; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Duret L, 2006, GENE, V385, P71, DOI 10.1016/j.gene.2006.04.030; Emes RD, 2003, HUM MOL GENET, V12, P701, DOI 10.1093/hmg/ddg078; Gentles AJ, 2007, GENOME RES, V17, P992, DOI 10.1101/gr.6070707; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Goodstadt L, 2007, GENOME RES, V17, P969, DOI 10.1101/gr.6093907; Goodstadt L, 2006, PLOS COMPUT BIOL, V2, P1134, DOI 10.1371/journal.pcbi.0020133; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; Graves JAM, 2002, TRENDS GENET, V18, P517, DOI 10.1016/S0168-9525(02)02772-5; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grus WE, 2005, P NATL ACAD SCI USA, V102, P5767, DOI 10.1073/pnas.0501589102; Gu W, 2007, GENE, V396, P46, DOI 10.1016/j.gene.2007.02.028; Heard E, 2004, CURR OPIN CELL BIOL, V16, P247, DOI 10.1016/j.ceb.2004.03.005; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; HOLM P B, 1986, Tokai Journal of Experimental and Clinical Medicine, V11, P415; HOPE RM, 1993, GENETICA, V90, P165, DOI 10.1007/BF01435038; Hore TA, 2007, CHROMOSOME RES, V15, P147, DOI 10.1007/s10577-007-1119-0; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; KATO T, 1994, NUCLEIC ACIDS RES, V22, P4119, DOI 10.1093/nar/22.20.4119; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kohn M, 2004, TRENDS GENET, V20, P598, DOI 10.1016/j.tig.2004.09.008; Kondrashov FA, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-31; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lyon MF, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/59746; Ma B, 2002, BIOINFORMATICS, V18, P440, DOI 10.1093/bioinformatics/18.3.440; Ma J, 2006, GENOME RES, V16, P1557, DOI 10.1101/gr.5383506; MAHONY S, IN PRESS GENOME BIOL; Margulies EH, 2005, P NATL ACAD SCI USA, V102, P4795, DOI 10.1073/pnas.0409882102; Marino-Ramirez L, 2005, CYTOGENET GENOME RES, V110, P333, DOI 10.1159/000084965; Michael MZ, 2003, MOL CANCER RES, V1, P882; Murphy SK, 2003, BIOESSAYS, V25, P577, DOI 10.1002/bies.10277; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Nishihara H, 2006, GENOME RES, V16, P864, DOI 10.1101/gr.5255506; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Ovcharenko I, 2004, GENOMICS, V84, P890, DOI 10.1016/j.ygeno.2004.07.011; PARRA ZE, UNPUB P NATL ACAD SC; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Prabhakar S, 2006, GENOME RES, V16, P855, DOI 10.1101/gr.4717506; Rapkins RW, 2006, PLOS GENET, V2, P1666, DOI 10.1371/journal.pgen.0020182; Reik W, 2005, NAT REV GENET, V6, P403, DOI 10.1038/nrg1602; Rens W, 2001, CHROMOSOME RES, V9, P301, DOI 10.1023/A:1016646629889; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Samollow PB, 2007, CHROMOSOME RES, V15, P269, DOI 10.1007/s10577-007-1123-4; Samollow PB, 2006, AUST J ZOOL, V54, P173, DOI 10.1071/ZO05059; Samollow PB, 2004, GENETICS, V166, P307, DOI 10.1534/genetics.166.1.307; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; SHARP PJ, 1988, HEREDITY, V60, P77, DOI 10.1038/hdy.1988.12; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Silva JC, 2003, GENET RES, V82, P1, DOI 10.1017/S0016672303006268; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Stathopoulos A, 2005, DEV CELL, V9, P449, DOI 10.1016/j.devcel.2005.09.005; TYNDALEBISCOE H, 2005, LIFE MARSUPIALS, pNIL6; VANDEBERG JL, 1990, AUST J ZOOL, V37, P235, DOI 10.1071/ZO9890235; VANDEBERG JL, 1994, ARCH DERMATOL RES, V286, P12, DOI 10.1007/BF00375837; VANDEBERG JL, 1999, UFAW HDB MANAGEMENT, V1, P193; VandeBerg John L., 1997, ILAR J, V38, P4; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wakefield MJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-218; Wakefield MJ, 1997, P NATL ACAD SCI USA, V94, P9665, DOI 10.1073/pnas.94.18.9665; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Webber C, 2005, GENOME RES, V15, P1787, DOI 10.1101/gr.3896805; Weidman JR, 2004, GENOME RES, V14, P1726, DOI 10.1101/gr.2774804; Wintzer M, 2004, J ANAT, V204, P3, DOI 10.1111/j.1469-7580.2004.00258.x; Wistow G, 2005, FEBS J, V272, P2276, DOI 10.1111/j.1742-4658.2005.04655.x; Wong Emily Sw, 2006, Immunome Res, V2, P4, DOI 10.1186/1745-7580-2-4; Woodburne MO, 2003, MOL PHYLOGENET EVOL, V28, P360, DOI 10.1016/S1055-7903(03)00113-1; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xie XH, 2006, P NATL ACAD SCI USA, V103, P11659, DOI 10.1073/pnas.0604768103; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	109	539	558	2	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2007	447	7141					167	U1		10.1038/nature05805	http://dx.doi.org/10.1038/nature05805			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17495919	Green Published, Bronze			2022-12-01	WOS:000246338700035
J	Auerbach, M; Ballard, H; Glaspy, J				Auerbach, Michael; Ballard, Harold; Glaspy, John			Clinical update: intravenous iron for anaemia	LANCET			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; DEXTRAN; INFUSION; HEPCIDIN; SUCROSE; SAFETY		Georgetown Univ, Sch Med, Baltimore, MD 21237 USA; NYU, Sch Med, New York Harbor Healthcare Syst, Dept Vet Affairs, New York, NY USA; Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA	Georgetown University; New York University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Auerbach, M (corresponding author), Georgetown Univ, Sch Med, Baltimore, MD 21237 USA.	mauerbachmd@aol.com						Adamson JW, 1998, NEW ENGL J MED, V339, P625, DOI 10.1056/NEJM199808273390910; Andrews NC, 2004, J CLIN INVEST, V113, P1251, DOI 10.1172/JCI200421441; Auerbach M, 2004, J CLIN ONCOL, V22, P1301, DOI 10.1200/JCO.2004.08.119; Auerbach M, 1998, AM J KIDNEY DIS, V31, P81, DOI 10.1053/ajkd.1998.v31.pm9428456; Auerbach M, 1998, J LAB CLIN MED, V131, P257, DOI 10.1016/S0022-2143(98)90098-1; AUERBACH M, 1988, J LAB CLIN MED, V111, P566; Chandler G, 2001, AM J KIDNEY DIS, V38, P988, DOI 10.1053/ajkd.2001.28587; Chertow GM, 2006, NEPHROL DIAL TRANSPL, V21, P378, DOI 10.1093/ndt/gfi253; Chertow GM, 2004, NEPHROL DIAL TRANSPL, V19, P1571, DOI 10.1093/ndt/gfh185; FISHBANE S, 1995, AM J KIDNEY DIS, V26, P41, DOI 10.1016/0272-6386(95)90151-5; Fishbane S, 1996, AM J KIDNEY DIS, V28, P529, DOI 10.1016/S0272-6386(96)90463-1; Fishbane S, 1999, KIDNEY INT, V55, pS67, DOI 10.1046/j.1523-1755.1999.055Suppl.69067.x; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; HAMSTRA RD, 1980, JAMA-J AM MED ASSOC, V243, P1726, DOI 10.1001/jama.243.17.1726; Hedenus M, 2007, LEUKEMIA, V21, P627, DOI 10.1038/sj.leu.2404562; Henry DH, 2007, ONCOLOGIST, V12, P231, DOI 10.1634/theoncologist.12-2-231; Kanakaraddi V P, 1973, J Assoc Physicians India, V21, P849; Macdougall IC, 2005, AM J KIDNEY DIS, V46, P283, DOI 10.1053/j.ajkd.2005.04.032; MACDOUGALL IC, 1992, BRIT MED J, V304, P225, DOI 10.1136/bmj.304.6821.225; Tessitore N, 2001, NEPHROL DIAL TRANSPL, V16, P1416, DOI 10.1093/ndt/16.7.1416	20	139	149	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2007	369	9572					1502	1504		10.1016/S0140-6736(07)60689-8	http://dx.doi.org/10.1016/S0140-6736(07)60689-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164EI	17482969				2022-12-01	WOS:000246215800009
J	Lentink, D; Muller, UK; Stamhuis, EJ; de Kat, R; van Gestel, W; Veldhuis, LLM; Henningsson, P; Hedenstrom, A; Videler, JJ; van Leeuwen, JL				Lentink, D.; Muller, U. K.; Stamhuis, E. J.; de Kat, R.; van Gestel, W.; Veldhuis, L. L. M.; Henningsson, P.; Hedenstrom, A.; Videler, J. J.; van Leeuwen, J. L.			How swifts control their glide performance with morphing wings	NATURE			English	Article							BLACK VULTURE; APUS-APUS; FLIGHT; BIRDS; TUNNEL; AERODYNAMICS; ORIENTATION	Gliding birds continually change the shape and size of their wings(1-6), presumably to exploit the profound effect of wing morphology on aerodynamic performance(7-9). That birds should adjust wing sweep to suit glide speed has been predicted qualitatively by analytical glide models(2,10), which extrapolated the wing's performance envelope from aerodynamic theory. Here we describe the aerodynamic and structural performance of actual swift wings, as measured in a wind tunnel, and on this basis build a semiempirical glide model. By measuring inside and outside swifts' behavioural envelope, we show that choosing the most suitable sweep can halve sink speed or triple turning rate. Extended wings are superior for slow glides and turns; swept wings are superior for fast glides and turns. This superiority is due to better aerodynamic performance - with the exception of fast turns. Swept wings are less effective at generating lift while turning at high speeds, but can bear the extreme loads. Finally, our glide model predicts that cost-effective gliding occurs at speeds of 8 - 10 m s(-1), whereas agility-related figures of merit peak at 15 - 25 m s(-1). In fact, swifts spend the night ('roost') in flight at 8 - 10 m s(-1) ( ref. 11), thus our model can explain this choice for a resting behaviour(11,12). Morphing not only adjusts birds' wing performance to the task at hand, but could also control the flight of future aircraft(7).	Univ Wageningen & Res Ctr, Expt Zool Grp, NL-6709 PG Wageningen, Netherlands; Leiden Univ, Inst Biol, NL-2300 RA Leiden, Netherlands; Lund Univ, Dept Theoret Ecol, SE-22362 Lund, Sweden; Delft Univ Technol, Dept Aerosp Engn, NL-2629 HS Delft, Netherlands; Univ Groningen, Dept Marine Biol, NL-9750 AA Haren, Netherlands	Wageningen University & Research; Leiden University; Leiden University - Excl LUMC; Lund University; Delft University of Technology; University of Groningen	Lentink, D (corresponding author), Univ Wageningen & Res Ctr, Expt Zool Grp, NL-6709 PG Wageningen, Netherlands.	david.lentink@wur.nl	van Leeuwen, Johan/N-3437-2019; van Leeuwen, Johan L/B-7897-2011; de Kat, Roeland/A-4874-2013; Hedenström, Anders/F-5377-2010	van Leeuwen, Johan/0000-0002-4433-880X; de Kat, Roeland/0000-0002-6851-4409; Hedenström, Anders/0000-0002-1757-0945; Videler, John/0000-0003-1226-9528				[Anonymous], 1956, SWIFTS TOWER; Azuma A., 2006, BIOKINETICS FLYING S, Vsecond; Backman J, 2002, J EXP BIOL, V205, P905; Backman J, 2001, P ROY SOC B-BIOL SCI, V268, P1081, DOI 10.1098/rspb.2001.1622; Bird JD, 1969, D5045 NASA; BRUDERER B, 1972, Revue Suisse de Zoologie, V79, P1190; Glutz von Blozheim UN., 1980, HDB VOGEL MITTELEURO; Hedenstrom A, 2001, BEHAV ECOL, V12, P150, DOI 10.1093/beheco/12.2.150; Hoerner S.F, 1985, FLUID DYNAMIC LIFT; Muller UK, 2004, SCIENCE, V306, P1899, DOI 10.1126/science.1107070; NACHTIGALL W, 1979, Journal fuer Ornithologie, V120, P30, DOI 10.1007/BF01647339; NEWMAN BG, 1958, J EXP BIOL, V35, P280; PARROTT GC, 1970, J EXP BIOL, V53, P363; PENNYCUICK CJ, 1968, J EXP BIOL, V49, P509; PENNYCUICK CJ, 1987, J EXP BIOL, V128, P335; Pennycuick CJ, 1997, J EXP BIOL, V200, P1441; PENNYCUICK CJ, 1960, J EXP BIOL, V37, P330; Rayner J.M.V., 1988, Current Ornithology, V5, P1; Rosen M, 2001, J EXP BIOL, V204, P1153; Ruijgrok G. J. J., 1994, ELEMENTS AIRPLANE PE; Schlichting H, 1982, BOUNDARY LAYER THEOR; Schmitz F. W., 1942, AERODYNAMIK FLUGMODE; Thomas ALR, 1996, J THEOR BIOL, V183, P237, DOI 10.1006/jtbi.1996.0217; TUCKER VA, 1987, J EXP BIOL, V133, P33; TUCKER VA, 1970, J EXP BIOL, V52, P345; VELDHUIS LLM, 1993, 931 LSW DELFT U TECH; Videler JJ, 2004, SCIENCE, V306, P1960, DOI 10.1126/science.1104682; Vogel S., 1994, LIFE MOVING FLUIDS; Weiss P, 2003, SCI NEWS, V164, P359, DOI DOI 10.2307/4018925; WITHERS PC, 1981, J EXP BIOL, V90, P143	30	180	193	10	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2007	446	7139					1082	1085		10.1038/nature05733	http://dx.doi.org/10.1038/nature05733			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17460673				2022-12-01	WOS:000245950400050
J	Treasure, T; Utley, M; Hunt, I				Treasure, Tom; Utley, Martin; Hunt, Ian			When professional opinion is not enough	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							METASTASES		Guys Hosp, London SE1 9RT, England; UCL, Clin Operat Res Unit, London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; University College London	Treasure, T (corresponding author), Guys Hosp, London SE1 9RT, England.			Utley, Martin/0000-0001-9928-1516				DIAMOND J, 2001, SNAKE OIL; Horton R, 1996, LANCET, V347, P984, DOI 10.1016/S0140-6736(96)90137-3; Inoue M, 2004, ANN THORAC SURG, V78, P238, DOI 10.1016/j.athoracsur.2004.02.017; National Institute for Clinical Excellence (NICE), 2004, IMPR OUTC COL CANC M; Nauenheim KS, 2007, DIFFICULT DECISIONS, P151; NICE, 2005, LUNG CANC DIAGN TREA; Pastorino U, 1997, J THORAC CARDIOV SUR, V113, P37, DOI 10.1016/S0022-5223(97)70397-0; Patel A, 2007, DIFFICULT DECISIONS, P158; Porter Roy., 1997, GREATEST BENEFIT MAN; Rena O, 2002, EUR J CARDIO-THORAC, V21, P906, DOI 10.1016/S1010-7940(02)00088-X; Simmonds PC, 2006, BRIT J CANCER, V94, P982, DOI 10.1038/sj.bjc.6603033; STANGL R, 1994, LANCET, V343, P1405, DOI 10.1016/S0140-6736(94)92529-1; Young C, 2005, LANCET, V366, P107, DOI 10.1016/S0140-6736(05)66846-8	13	43	43	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2007	334	7598					831	832		10.1136/bmj.39161.403218.AD	http://dx.doi.org/10.1136/bmj.39161.403218.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	162MD	17446615	Green Published			2022-12-01	WOS:000246090800031
J	Chung, HY; Weinberger, MB; Levine, JB; Kavner, A; Yang, JM; Tolbert, SH; Kaner, RB				Chung, Hsiu-Ying; Weinberger, Michelle B.; Levine, Jonathan B.; Kavner, Abby; Yang, Jenn-Ming; Tolbert, Sarah H.; Kaner, Richard B.			Synthesis of ultra-incompressible superhard rhenium diboride at ambient pressure	SCIENCE			English	Article							LATTICE STRAINS; OSMIUM DIBORIDE; HARD; BORIDES; STATE	The quest to create superhard materials rarely strays from the use of high-pressure synthetic methods, which typically require gigapascals of applied pressure. We report that rhenium diboride (ReB2), synthesized in bulk quantities via arc-melting under ambient pressure, rivals materials produced with high-pressure methods. Microindentation measurements on ReB2 indicated an average hardness of 48 gigapascals under an applied load of 0.49 newton, and scratch marks left on a diamond surface confirmed its superhard nature. Its incompressibility along the c axis was equal in magnitude to the linear incompressibility of diamond. In situ high-pressure x-ray diffraction measurements yielded a bulk modulus of 360 gigapascals, and radial diffraction indicated that ReB2 is able to support a remarkably high differential stress. This combination of properties suggests that this material may find applications in cutting when the formation of carbides prevents the use of traditional materials such as diamond.	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Tolbert, SH (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	tolbert@chem.ucla.edu; kaner@chem.ucla.edu	Kaner, Richard B./K-1594-2019; Tolbert, Sarah H./L-2321-2016; Kavner, Abby/A-4904-2009	Kaner, Richard B./0000-0003-0345-4924; 				ALEKSANDROV IV, 1987, ZH EKSP TEOR FIZ, V66, P384; Allen PB, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.172102; Amulele GM, 2006, J APPL PHYS, V99, DOI 10.1063/1.2164533; Chiodo S, 2006, CHEM PHYS LETT, V425, P311, DOI 10.1016/j.cplett.2006.05.055; Cumberland RW, 2005, J AM CHEM SOC, V127, P7264, DOI 10.1021/ja043806y; Cynn H, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.135701; FINK CG, 1934, T ELECTROCHEM SOC, V66, P381; Gao H, 1999, NATURWISSENSCHAFTEN, V86, P507, DOI 10.1007/s001140050665; Gou HY, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2208367; HAMPEL CA, 1961, RARE METALS HDB; He DW, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.184121; He DW, 2002, APPL PHYS LETT, V81, P643, DOI 10.1063/1.1494860; Hebbache M, 2006, SOLID STATE COMMUN, V139, P227, DOI 10.1016/j.ssc.2006.05.041; Kaner RB, 2005, SCIENCE, V308, P1268, DOI 10.1126/science.1109830; Kenichi T, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.012101; Kiefer B, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.014102; LAPLACA S, 1962, ACTA CRYSTALLOGR, V15, P97, DOI 10.1107/S0365110X62000298; MANGHNAN.MH, 1974, PHYS REV B, V9, P1421, DOI 10.1103/PhysRevB.9.1421; McMillan PF, 2002, NAT MATER, V1, P19, DOI 10.1038/nmat716; MCSKIMIN HJ, 1957, PHYS REV, V105, P116, DOI 10.1103/PhysRev.105.116; Occelli F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.095502; RAO L, 1995, J MATER RES, V10, P353, DOI 10.1557/JMR.1995.0353; RUOFF AL, 1975, J APPL PHYS, V46, P1389, DOI 10.1063/1.321737; SINGH AK, 1993, J APPL PHYS, V73, P4278, DOI 10.1063/1.352809; Singh AK, 1998, J APPL PHYS, V83, P7567, DOI 10.1063/1.367872; Solozhenko VL, 2001, APPL PHYS LETT, V78, P1385, DOI 10.1063/1.1337623; VEGAS A, 1995, Z KRISTALLOGR, V210, P574, DOI 10.1524/zkri.1995.210.8.574	27	654	685	10	231	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					436	439		10.1126/science.1139322	http://dx.doi.org/10.1126/science.1139322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446399				2022-12-01	WOS:000245813400053
J	Kovaleva, EG; Lipscomb, JD				Kovaleva, Elena G.; Lipscomb, John D.			Crystal structures of Fe2+ dioxygenase superoxo, alkylperoxo, and bound product intermediates	SCIENCE			English	Article							ACTIVE-SITE FE-2+; CATECHOL 2,3-DIOXYGENASE; SUBSTRATE-BINDING; RING-CLEAVAGE; EXTRADIOL; ACTIVATION; MECHANISM; ENZYMES; COMPLEX	We report the structures of three intermediates in the O-2 activation and insertion reactions of an extradiol ring-cleaving dioxygenase. A crystal of Fe2+-containing homoprotocatechuate 2,3-dioxygenase was soaked in the slow substrate 4-nitrocatechol in a low O-2 atmosphere. The x-ray crystal structure shows that three different intermediates reside in different subunits of a single homotetrameric enzyme molecule. One of these is the key substrate-alkylperoxo-Fe2+ intermediate, which has been predicted, but not structurally characterized, in an oxygenase. The intermediates define the major chemical steps of the dioxygenase mechanism and point to a general mechanistic strategy for the diverse 2-His-1-carboxylate enzyme family.	Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Lipscomb, JD (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	lipsc001@umn.edu		Lipscomb, John/0000-0002-8158-5594	NIGMS NIH HHS [R01 GM024689, R01 GM024689-27, GM24689, R37 GM024689, R37 GM024689-26, R01 GM024689-28] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024689, R01GM024689] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARCIERO DM, 1985, J BIOL CHEM, V260, P4035; ARCIERO DM, 1986, J BIOL CHEM, V261, P2170; Bugg TDH, 2001, CHEM COMMUN, P941, DOI 10.1039/b100484k; Carredano E, 2000, J MOL BIOL, V296, P701, DOI 10.1006/jmbi.1999.3462; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Deeth RJ, 2003, J BIOL INORG CHEM, V8, P409, DOI 10.1007/s00775-002-0430-7; Groce SL, 2005, BIOCHEMISTRY-US, V44, P7175, DOI 10.1021/bi050180v; Groce SL, 2004, BIOCHEMISTRY-US, V43, P15141, DOI 10.1021/bi048690x; Hajdu J, 2000, NAT STRUCT BIOL, V7, P1006, DOI 10.1038/80911; HAN S, 1995, SCIENCE, V270, P976, DOI 10.1126/science.270.5238.976; HAYAISHI O, 1955, J AM CHEM SOC, V77, P5450, DOI 10.1021/ja01625a095; Hegg EL, 1997, EUR J BIOCHEM, V250, P625, DOI 10.1111/j.1432-1033.1997.t01-1-00625.x; Hogg M, 2004, EMBO J, V23, P1483, DOI 10.1038/sj.emboj.7600150; Karlsson A, 2003, SCIENCE, V299, P1039, DOI 10.1126/science.1078020; Komatsuzaki H, 1998, INORG CHEM, V37, P6554, DOI 10.1021/ic980509j; LIPSCOMB JD, 1992, MET IONS BIOL SYST, V28, P243; Miller MA, 1996, J BIOL CHEM, V271, P5524, DOI 10.1074/jbc.271.10.5524; Sato N, 2002, J MOL BIOL, V321, P621, DOI 10.1016/S0022-2836(02)00673-3; Senda T, 1996, J MOL BIOL, V255, P735, DOI 10.1006/jmbi.1996.0060; SHU LJ, 1995, BIOCHEMISTRY-US, V34, P6649, DOI 10.1021/bi00020a010; Siegbahn PEM, 2004, J AM CHEM SOC, V126, P8919, DOI 10.1021/ja0493805; Vetting MW, 2004, J BACTERIOL, V186, P1945, DOI 10.1128/JB.186.7.1945-1958.2004; Wallar BJ, 1996, CHEM REV, V96, P2625, DOI 10.1021/cr9500489; Wolfe MD, 2001, J BIOL CHEM, V276, P1945, DOI 10.1074/jbc.M007795200	24	286	289	2	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					453	457		10.1126/science.1134697	http://dx.doi.org/10.1126/science.1134697			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446402	Green Accepted			2022-12-01	WOS:000245813400058
J	Hernandez, RD; Hubisz, MJ; Wheeler, DA; Smith, DG; Ferguson, B; Rogers, J; Nazareth, L; Indap, A; Bourquin, T; McPherson, J; Muzny, D; Gibbs, R; Nielsen, R; Bustamante, CD				Hernandez, Ryan D.; Hubisz, Melissa J.; Wheeler, David A.; Smith, David G.; Ferguson, Betsy; Rogers, Jeffrey; Nazareth, Lynne; Indap, Amit; Bourquin, Traci; McPherson, John; Muzny, Donna; Gibbs, Richard; Nielsen, Rasmus; Bustamante, Carlos D.			Demographic histories and patterns of linkage disequilibrium in Chinese and Indian rhesus macaques	SCIENCE			English	Article							MACACA-MULATTA; MITOCHONDRIAL-DNA; HUMAN GENOME; FREQUENCIES; ORIGIN; GENES; LOCI; MAP	To understand the demographic history of rhesus macaques ( Macaca mulatta) and document the extent of linkage disequilibrium (LD) in the genome, we partially resequenced five Encyclopedia of DNA Elements regions in 9 Chinese and 38 captive-born Indian rhesus macaques. Population genetic analyses of the 1467 single-nucleotide polymorphisms discovered suggest that the two populations separated about 162,000 years ago, with the Chinese population tripling in size since then and the Indian population eventually shrinking by a factor of four. Using coalescent simulations, we confirmed that these inferred demographic events explain a much faster decay of LD in Chinese (r(2) approximate to 0.15 at 10 kilobases) versus Indian (r(2) approximate to 0.52 at 10 kilobases) macaque populations.	Cornell Univ, Ithaca, NY 14850 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Dept Anthropol, Davis, CA USA; Calif Natl Primate Res Ctr, Davis, CA USA; Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Genet Res & Informat Program, Beaverton, OR 97006 USA; Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA; SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78227 USA; Univ Copenhagen, Dept Biol, Ctr Comparat Genom, DK-2100 Copenhagen O, Denmark	Cornell University; University of Chicago; Baylor College of Medicine; Oregon Health & Science University; Oregon National Primate Research Center; University of Washington; University of Washington Seattle; Texas Biomedical Research Institute; University of Copenhagen	Bustamante, CD (corresponding author), Cornell Univ, Ithaca, NY 14850 USA.	cdb28@cornell.edu	Wheeler, David A/M-9740-2018; Nielsen, Rasmus/D-4405-2009; McPherson, John D/D-2633-2017	Wheeler, David A/0000-0002-9056-6299; Nielsen, Rasmus/0000-0003-0513-6591; McPherson, John D/0000-0001-8049-9347; Indap, Amit/0000-0002-3322-4735; Hubisz, Melissa/0000-0002-9561-6830; Bustamante, Carlos D./0000-0002-4187-7920	NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR005090, R24RR015383, P51RR000163] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abegg C, 2002, BIOL J LINN SOC, V75, P555, DOI 10.1046/j.1095-8312.2002.00045.x; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; DEISON E, 1980, MACAQUES STUDIES ECO, P10; Eberle MA, 2006, PLOS GENET, V2, P1319, DOI 10.1371/journal.pgen.0020142; Falush D, 2003, GENETICS, V164, P1567; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Ferguson B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-43; Fooden J., 1980, P1; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Hayasaka K, 1996, MOL BIOL EVOL, V13, P1044, DOI 10.1093/oxfordjournals.molbev.a025655; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Ling BH, 2002, AIDS, V16, P1489, DOI 10.1097/00002030-200207260-00005; Morales JC, 1998, J HUM EVOL, V34, P1, DOI 10.1006/jhev.1997.0171; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Raveendran M, 2006, GENOMICS, V88, P706, DOI 10.1016/j.ygeno.2006.08.009; Rogers J, 2006, GENOMICS, V87, P30, DOI 10.1016/j.ygeno.2005.10.004; Smith DG, 2005, AM J PRIMATOL, V65, P1, DOI 10.1002/ajp.20094; Viray J, 2001, COMPARATIVE MED, V51, P555; Weiss RA, 2001, NATURE, V410, P1035, DOI 10.1038/35074222	19	133	136	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					240	243		10.1126/science.1140462	http://dx.doi.org/10.1126/science.1140462			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431170				2022-12-01	WOS:000245654500040
J	Lo, JC; Wang, YG; Tumanov, AV; Bamji, M; Yao, ZM; Reardon, CA; Getz, GS; Fu, YX				Lo, James C.; Wang, Yugang; Tumanov, Alexei V.; Bamji, Michelle; Yao, Zemin; Reardon, Catherine A.; Getz, Godfrey S.; Fu, Yang-Xin			Lymphotoxin beta receptor-dependent control of lipid homeostasis	SCIENCE			English	Article							HEPATIC LIPASE; LIPOPROTEIN METABOLISM; ATHEROSCLEROSIS; INFLAMMATION; LIGHT; MICE; MECHANISMS; DISEASE; ALPHA; TNF	Hyperlipidemia, one of the most important risk factors for coronary heart disease, is often associated with inflammation. We identified lymphotoxin ( LT) and LIGHT, tumor necrosis factor cytokine family members that are primarily expressed on lymphocytes, as critical regulators of key enzymes that control lipid metabolism. Dysregulation of LIGHT expression on T cells resulted in hypertriglyceridemia and hypercholesterolemia. In low-density lipoprotein receptor-deficient mice, which lack the ability to control lipid levels in the blood, inhibition of LT and LIGHT signaling with a soluble lymphotoxin beta receptor decoy protein attenuated the dyslipidemia. These results suggest that the immune system directly influences lipid metabolism and that LT modulating agents may represent a novel therapeutic route for the treatment of dyslipidemia.	Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; Univ Ottawa, Inst Heart, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada	University of Chicago; University of Chicago; University of Ottawa; University of Ottawa Heart Institute	Fu, YX (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	getz@bsd.uchicago.edu; yfu@uchicago.edu	Tumanov, Alexei/AAR-1607-2021; Lo, James/GYR-1149-2022	Tumanov, Alexei/0000-0001-6042-0152; Lo, James/0000-0003-0244-1670; fu, yang-xin/0000-0001-8441-6617	NATIONAL CANCER INSTITUTE [P01CA097296] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anand S, 2006, J CLIN INVEST, V116, P1045, DOI 10.1172/JCI27083; Anders RA, 2005, J IMMUNOL, V175, P1295, DOI 10.4049/jimmunol.175.2.1295; Barcat D, 2006, ATHEROSCLEROSIS, V188, P347, DOI 10.1016/j.atherosclerosis.2005.11.022; Dichek HL, 2001, J LIPID RES, V42, P201; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Gommerman JL, 2003, NAT REV IMMUNOL, V3, P642, DOI 10.1038/nri1151; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Libby P, 2002, NATURE, V420, P868, DOI [10.1038/nature01323, 10.1161/ATVBAHA.108.179705]; Ozaki K, 2004, NATURE, V429, P72, DOI 10.1038/nature02502; Reardon CA, 2003, ARTERIOSCL THROM VAS, V23, P1449, DOI 10.1161/01.ATV.0000079793.58054.2E; Reardon CA, 2001, CURR OPIN LIPIDOL, V12, P167, DOI 10.1097/00041433-200104000-00010; Santamarina-Fojo S, 2004, ARTERIOSCL THROM VAS, V24, P1750, DOI 10.1161/01.ATV.0000140818.00570.2d; Schreyer SA, 2002, J BIOL CHEM, V277, P12364, DOI 10.1074/jbc.M111727200; Shaikh RB, 2001, J IMMUNOL, V167, P6330, DOI 10.4049/jimmunol.167.11.6330; Wang J, 2001, J CLIN INVEST, V108, P1771, DOI 10.1172/JCI200113827; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719	18	113	119	2	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					285	288		10.1126/science.1137221	http://dx.doi.org/10.1126/science.1137221			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431181				2022-12-01	WOS:000245654500053
J	Bennett, J				Bennett, Jean			Retinal progenitor cells - Timing is everything	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRANSPLANTATION		Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Bennett, J (corresponding author), Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA.							Humayun MS, 2000, INVEST OPHTH VIS SCI, V41, P3100; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; O'Brien KMB, 2003, MOL VIS, V9, P401; 2006, US ADULTS DIABETES F	5	12	17	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 12	2007	356	15					1577	1579		10.1056/NEJMcibr070209	http://dx.doi.org/10.1056/NEJMcibr070209			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	156CA	17429090				2022-12-01	WOS:000245624400014
J	Okita, K; Ichisaka, T; Yamanaka, S				Okita, Keisuke; Ichisaka, Tomoko; Yamanaka, Shinya			Generation of germline-competent induced pluripotent stem cells	NATURE			English	Article							SELF-RENEWAL; MOUSE DEVELOPMENT; ES CELLS; EXPRESSION; NANOG; METHYLATION; GENE; DIFFERENTIATION; IGF2R; LINES	We have previously shown that pluripotent stem cells can be induced from mouse fibroblasts by retroviral introduction of Oct3/4 (also called Pou5f1), Sox2, c-Myc and Klf4, and subsequent selection for Fbx15 (also called Fbxo15) expression. These induced pluripotent stem (iPS) cells (hereafter called Fbx15 iPS cells) are similar to embryonic stem (ES) cells in morphology, proliferation and teratoma formation; however, they are different with regards to gene expression and DNA methylation patterns, and fail to produce adult chimaeras. Here we show that selection for Nanog expression results in germline-competent iPS cells with increased ES-cell-like gene expression and DNA methylation patterns compared with Fbx15 iPS cells. The four transgenes (Oct3/4, Sox2, c-myc and Klf4) were strongly silenced in Nanog iPS cells. We obtained adult chimaeras from seven Nanog iPS cell clones, with one clone being transmitted through the germ line to the next generation. Approximately 20% of the offspring developed tumours attributable to reactivation of the c-myc transgene. Thus, iPS cells competent for germline chimaeras can be obtained from fibroblasts, but retroviral introduction of c-Myc should be avoided for clinical application.	Kyoto Univ, Inst Frontier Med Sci, Dept Stem Cell Biol, Kyoto 6068507, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi 3320012, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Yamanaka, S (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Stem Cell Biol, Kyoto 6068507, Japan.	yamanaka@frontier.kyoto-u.ac.jp	Wilson, Matthew H/K-3193-2013	Okita, Keisuke/0000-0001-5806-1090				Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; BRANDEIS M, 1993, EMBO J, V12, P3669, DOI 10.1002/j.1460-2075.1993.tb06041.x; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; DAVID B V, 1985, Pesticides (Bombay), V19, P9; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Kato Y, 1999, DEVELOPMENT, V126, P1823; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; LABOSKY PA, 1994, DEVELOPMENT, V120, P3197; Lee J, 2002, DEVELOPMENT, V129, P1807; Li Y, 2005, BLOOD, V105, P635, DOI 10.1182/blood-2004-07-2681; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Sato S, 2003, MOL REPROD DEV, V65, P41, DOI 10.1002/mrd.10264; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Testa G, 2003, NAT BIOTECHNOL, V21, P443, DOI 10.1038/nbt804; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003	28	3188	3658	54	1562	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 19	2007	448	7151					313	U1		10.1038/nature05934	http://dx.doi.org/10.1038/nature05934			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17554338				2022-12-01	WOS:000248118300049
J	Pugacheva, EN; Jablonski, SA; Hartman, TR; Henske, EP; Golemis, EA				Pugacheva, Elena N.; Jablonski, Sandra A.; Hartman, Tiffiney R.; Henske, Elizabeth P.; Golemis, Erica A.			HEF1-Dependent aurora a activation induces disassembly of the primary cilium	CELL			English	Article							HISTONE DEACETYLASE INHIBITORS; INTRAFLAGELLAR TRANSPORT; FLAGELLAR LENGTH; CELL-CYCLE; KINASE; PROTEIN; MICROTUBULES; TUBULIN; HEF1; OVEREXPRESSION	The mammalian cilium protrudes from the apical/lumenal surface of polarized cells and acts as a sensor of environmental cues. Numerous developmental disorders and pathological conditions have been shown to arise from defects in cilia-associated signaling proteins. Despite mounting evidence that cilia are essential sites for coordination of cell signaling, little is known about the cellular mechanisms controlling their formation and disassembly. Here, we show that interactions between the prometastatic scaffolding protein HEF1/Cas-L/NEDD9 and the oncogenic Aurora A (AurA) kinase at the basal body of cilia causes phosphorylation and activation of HDAC6, a tubulin deacetylase, promoting ciliary disassembly. We show that this pathway is both necessary and sufficient for ciliary resorption and that it constitutes an unexpected nonmitotic activity of AurA in vertebrates. Moreover, we demonstrate that small molecule inhibitors of AurA and HDAC6 selectively stabilize cilia from regulated resorption cues, suggesting a novel mode of action for these clinical agents.	Fox Chase Canc Ctr, Div Basic Sci, Philadelphia, PA 19111 USA; Fox Chase Canc Ctr, Div Med Sci, Philadelphia, PA 19111 USA	Fox Chase Cancer Center; Fox Chase Cancer Center	Golemis, EA (corresponding author), Fox Chase Canc Ctr, Div Basic Sci, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	ea_golemis@fccc.edu		Golemis, Erica/0000-0003-3618-3673; Pugacheva, Elena/0000-0001-9814-7446; Jablonski, Sandra/0000-0001-7220-8159	NCI NIH HHS [P30 CA006927-44, CA-06927, R01 CA063366-11, R01 CA063366, P30 CA006927, R01 CA63366] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA063366, P30CA006927] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Andrews PD, 2005, ONCOGENE, V24, P5005, DOI 10.1038/sj.onc.1208752; Benzing T, 2001, P NATL ACAD SCI USA, V98, P9784, DOI 10.1073/pnas.171269898; Benzing T, 2006, CURR OPIN NEPHROL HY, V15, P245, DOI 10.1097/01.mnh.0000222690.53970.ca; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Blagosklonny MV, 2002, MOL CANCER THER, V1, P937; Bradley BA, 2005, J CELL SCI, V118, P3317, DOI 10.1242/jcs.02455; Brush MH, 2004, J BIOL CHEM, V279, P7685, DOI 10.1074/jbc.M310997200; Cano DA, 2004, DEVELOPMENT, V131, P3457, DOI 10.1242/dev.01189; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Fukushige T, 1999, J CELL SCI, V112, P395; Goepfert TM, 2002, CANCER RES, V62, P4115; Gritsko TM, 2003, CLIN CANCER RES, V9, P1420; Hideshima T, 2005, P NATL ACAD SCI USA, V102, P8567, DOI 10.1073/pnas.0503221102; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Iomini C, 2004, J CELL BIOL, V164, P811, DOI 10.1083/jcb.200312133; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Kostic A, 2006, MOL BIOL CELL, V17, P2684, DOI 10.1091/mbc.E05-12-1161; Law SF, 1998, MOL CELL BIOL, V18, P3540, DOI 10.1128/MCB.18.6.3540; Law SF, 1996, MOL CELL BIOL, V16, P3327; Liao H, 1998, J BIOL CHEM, V273, P21901, DOI 10.1074/jbc.273.34.21901; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Marshall WF, 2005, MOL BIOL CELL, V16, P270, DOI 10.1091/mbc.E04-07-0586; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Natarajan M, 2006, ONCOGENE, V25, P1721, DOI 10.1038/sj.onc.1209199; O'Neill GM, 2000, TRENDS CELL BIOL, V10, P111, DOI 10.1016/S0962-8924(99)01714-6; Pan JM, 2005, LAB INVEST, V85, P452, DOI 10.1038/labinvest.3700253; Pan JM, 2005, DEV CELL, V9, P431, DOI 10.1016/j.devcel.2005.07.010; Pan JM, 2004, DEV CELL, V6, P445, DOI 10.1016/S1534-5807(04)00064-4; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pugacheva EN, 2006, CELL CYCLE, V5, P384, DOI 10.4161/cc.5.4.2439; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; Quarmby LM, 2005, J CELL BIOL, V169, P707, DOI 10.1083/jcb.200503053; Quarmby LM, 2004, INT REV CYTOL, V233, P47, DOI 10.1016/S0074-7696(04)33002-0; RIEDER CL, 1979, J ULTRA MOL STRUCT R, V68, P173, DOI 10.1016/S0022-5320(79)90152-7; Satinover DL, 2004, P NATL ACAD SCI USA, V101, P8625, DOI 10.1073/pnas.0402966101; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sloboda RD, 2005, J CELL BIOCHEM, V94, P266, DOI 10.1002/jcb.20323; Soncini C, 2006, CLIN CANCER RES, V12, P4080, DOI 10.1158/1078-0432.CCR-05-1964; Strickland LI, 2005, CURR BIOL, V15, P2249, DOI 10.1016/j.cub.2005.10.073; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494; TUCKER RW, 1979, CELL, V17, P527, DOI 10.1016/0092-8674(79)90261-7; Vanhaecke T, 2004, CURR MED CHEM, V11, P1629, DOI 10.2174/0929867043365099; Wilson PD, 2001, J AM SOC NEPHROL, V12, P834, DOI 10.1681/ASN.V124834; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115	52	599	623	4	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2007	129	7					1351	1363		10.1016/j.cell.2007.04.035	http://dx.doi.org/10.1016/j.cell.2007.04.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	188HQ	17604723	Bronze, Green Accepted			2022-12-01	WOS:000247911400020
J	Poole, A; Penny, D				Poole, Anthony; Penny, David			Engulfed by speculation	NATURE			English	Editorial Material							EUKARYOTES; ORIGIN		Stockholm Univ, Dept Mol Biol & Funct Genom, SE-10691 Stockholm, Sweden; Massey Univ, Inst Mol Biosci, Allan Wilson Ctr Mol Ecol & Evolut, Palmerston North, New Zealand	Stockholm University; Massey University	Poole, A (corresponding author), Stockholm Univ, Dept Mol Biol & Funct Genom, SE-10691 Stockholm, Sweden.		Penny, David/E-9410-2011	Poole, Anthony/0000-0001-9940-2824				Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; de Duve C, 2007, NAT REV GENET, V8, P395, DOI 10.1038/nrg2071; Pace NR, 2006, NATURE, V441, P289, DOI 10.1038/441289a; Poole AM, 2007, BIOESSAYS, V29, P74, DOI 10.1002/bies.20516; van der Giezen M, 2005, EMBO REP, V6, P525, DOI 10.1038/sj.embor.7400440	5	47	50	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2007	447	7147					913	913		10.1038/447913a	http://dx.doi.org/10.1038/447913a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180NU	17581566				2022-12-01	WOS:000247373100026
J	Wadman, M				Wadman, Meredith			Anaemic outlook for Amgen	NATURE			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 21	2007	447	7147					899	899		10.1038/447899a	http://dx.doi.org/10.1038/447899a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180NU	17581554	Bronze			2022-12-01	WOS:000247373100012
J	Himmelfarb, J				Himmelfarb, Jonathan			Chronic kidney disease and the public health - Gaps in evidence from interventional trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							STAGE RENAL-DISEASE; RANDOMIZED CONTROLLED-TRIALS; CARDIOVASCULAR-DISEASE; CLINICAL-TRIALS; PERITONEAL-DIALYSIS; UNITED-STATES; HEMODIALYSIS; ASSOCIATION; OUTCOMES; MORTALITY		Maine Med Ctr, Div Nephrol, Portland, ME 04102 USA	Maine Medical Center	Himmelfarb, J (corresponding author), Maine Med Ctr, Div Nephrol, 22 Bramhall St, Portland, ME 04102 USA.	himmej@mmc.org						Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Califf RM, 2007, HEALTH AFFAIR, V26, P62, DOI 10.1377/hlthaff.26.1.62; Charytan D, 2006, KIDNEY INT, V70, P2021, DOI 10.1038/sj.ki.5001934; Churchill DN, 1996, J AM SOC NEPHROL, V7, P198; Coca SG, 2006, JAMA-J AM MED ASSOC, V296, P1377, DOI 10.1001/jama.296.11.1377; Coyne DW, 2007, JAMA-J AM MED ASSOC, V297, P1713, DOI 10.1001/jama.297.15.1713; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583; Gilbertson DT, 2005, J AM SOC NEPHROL, V16, P3736, DOI 10.1681/ASN.2005010112; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Greene T, 2005, J AM SOC NEPHROL, V16, P3371, DOI 10.1681/ASN.2005030321; Himmelfarb J, 2007, ANNU REV MED, V58, P387, DOI 10.1146/annurev.med.58.061705.151442; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Johnston SC, 2006, LANCET, V367, P1319, DOI 10.1016/S0140-6736(06)68578-4; McClellan W, 2007, J AM SOC NEPHROL, V18, P1344, DOI 10.1681/ASN.2006090952; Paniagua R, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1351307; Porter ME, 2007, JAMA-J AM MED ASSOC, V297, P1103, DOI 10.1001/jama.297.10.1103; Rocco MV, 2006, ANN INTERN MED, V145, P512, DOI 10.7326/0003-4819-145-7-200610030-00009; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Schoolwerth Anton C, 2006, Prev Chronic Dis, V3, pA57; Shlipak M, 2005, J AM SOC NEPHROL, V16, P3477, DOI 10.1681/ASN.2005080806; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Strippoli GFM, 2004, J AM SOC NEPHROL, V15, P411, DOI 10.1097/01.ASN.0000100125.21491.46; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; White CA, 2007, KIDNEY INT, V71, P312, DOI 10.1038/sj.ki.5002037	25	45	47	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2007	297	23					2630	2633		10.1001/jama.297.23.2630	http://dx.doi.org/10.1001/jama.297.23.2630			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180HB	17579231				2022-12-01	WOS:000247352600026
J	Li, W; Baker, NE				Li, Wei; Baker, Nicholas E.			Engulfment is required for cell competition	CELL			English	Article							ALDRICH-SYNDROME PROTEIN; PHOSPHATIDYLSERINE RECEPTOR; APOPTOTIC CELLS; CORPSE ENGULFMENT; WING DISK; DROSOPHILA; DEATH; PHAGOCYTOSIS; CLEARANCE; GENES	Genetic mosaics that place cells in competition within tissues may model features of tissue repair and tumor development and may reveal mechanisms of growth regulation. In one example, normal cells eliminate "Minute" cells that have reduced ribosomal protein gene dose and grow at their expense, replacing the Minute cells within developing compartments. We describe genes that are required by wild-type cells to kill Minute neighbors in Drosophila. The engulfment genes draper, wasp, the phosphatidylserine receptor, mbc/dock180, and rac1 are needed in wild-type cells for the death of Minute neighbors, whose corpses are engulfed by wild-type cells. Wild-type cells can themselves be killed by cells with elevated engulfing activity. Thus engulfment genes act downstream of growth differences between cells to eliminate cells with reduced ribosomal gene dose.	Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Baker, NE (corresponding author), Albert Einstein Coll Med, Dept Mol Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	nbaker@aecom.yu.edu		Li, Wei/0000-0001-5696-4309	NIGMS NIH HHS [GM61230, R01 GM061230] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061230] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; BAKER BS, 1983, ANNU REV GENET, V17, P345, DOI 10.1146/annurev.ge.17.120183.002021; Bogdan S, 2003, DEVELOPMENT, V130, P4427, DOI 10.1242/dev.00663; BORING LF, 1989, DEV BIOL, V132, P343, DOI 10.1016/0012-1606(89)90231-5; Cikala M, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-26; Cohen Stephen M., 1993, P747; Cui P, 2004, EXP CELL RES, V293, P154, DOI 10.1016/j.yexcr.2003.09.023; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; deCelis JF, 1996, NATURE, V381, P421, DOI 10.1038/381421a0; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; FADOK VA, 1992, J IMMUNOL, V148, P2207; Firth LC, 2006, METHOD ENZYMOL, V407, P711, DOI 10.1016/S0076-6879(05)07056-4; Franc NC, 1999, CURR OPIN IMMUNOL, V11, P47, DOI 10.1016/S0952-7915(99)80009-0; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; FRISTROM D, 1969, MOL GEN GENET, V103, P363, DOI 10.1007/BF00383486; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; Gibson MC, 2005, SCIENCE, V307, P1785, DOI 10.1126/science.1104751; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hoeppner DJ, 2001, NATURE, V412, P202, DOI 10.1038/35084103; Hong JR, 2004, DEVELOPMENT, V131, P5417, DOI 10.1242/dev.01409; Huh JR, 2004, CURR BIOL, V14, P1262, DOI 10.1016/j.cub.2004.06.015; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; Lambertsson A, 1998, ADV GENET, V38, P69, DOI 10.1016/S0065-2660(08)60142-X; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Lorenzi R, 2000, BLOOD, V95, P2943, DOI 10.1182/blood.V95.9.2943.009k17_2943_2946; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Mitchell JE, 2006, J BIOL CHEM, V281, P5718, DOI 10.1074/jbc.M509775200; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; Oertel M, 2006, GASTROENTEROLOGY, V130, P507, DOI 10.1053/j.gastro.2005.10.049; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Pearson AM, 2003, MICROBES INFECT, V5, P815, DOI 10.1016/S1286-4579(03)00157-6; Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Shen J, 2005, SCIENCE, V307, P1789, DOI 10.1126/science.1104784; SIMPSON P, 1979, DEV BIOL, V69, P182, DOI 10.1016/0012-1606(79)90284-7; SIMPSON P, 1981, DEV BIOL, V85, P299, DOI 10.1016/0012-1606(81)90261-X; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; TEPASS U, 1994, DEVELOPMENT, V120, P1829; Tyler DM, 2007, GENETICS, V175, P643, DOI 10.1534/genetics.106.061929; van den Eijnde SM, 1998, APOPTOSIS, V3, P9, DOI 10.1023/A:1009650917818; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; Vidal M, 2006, DEV CELL, V10, P33, DOI 10.1016/j.devcel.2005.11.007; Wang XC, 2003, SCIENCE, V302, P1563, DOI 10.1126/science.1087641; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; XU T, 1993, DEVELOPMENT, V117, P1223; Zhang J, 1999, J EXP MED, V190, P1329, DOI 10.1084/jem.190.9.1329; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	63	173	176	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2007	129	6					1215	1225		10.1016/j.cell.2007.03.054	http://dx.doi.org/10.1016/j.cell.2007.03.054			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574031	Bronze			2022-12-01	WOS:000247390400023
J	Moreau, JW; Weber, PK; Martin, MC; Gilbert, B; Hutcheon, ID; Banfield, JF				Moreau, John W.; Weber, Peter K.; Martin, Michael C.; Gilbert, Benjamin; Hutcheon, Ian D.; Banfield, Jillian F.			Extracellular proteins limit the dispersal of biogenic nanoparticles	SCIENCE			English	Article							SULFATE-REDUCING BACTERIA; METAL; RESISTANCE; ZINC; ION; CONTAMINATION; GEOCHEMISTRY; AGGREGATION; SPHALERITE; PRODUCTS	High-spatial-resolution secondary ion microprobe spectrometry, synchrotron radiation-based Fourier-transform infrared spectroscopy, and polyacrylamide gel analysis demonstrated the intimate association of proteins with spheroidal aggregates of biogenic zinc sulfide nanocrystals, an example of extracellular biomineralization. Experiments involving synthetic zinc sulfide nanoparticles and representative amino acids indicated a driving role for cysteine in rapid nanoparticle aggregation. These findings suggest that microbially derived extracellular proteins can limit the dispersal of nanoparticulate metal-bearing phases, such as the mineral products of bioremediation, that may otherwise be transported away from their source by subsurface fluid flow.	Lawrence Livermore Natl Lab, Glenn T Seaborg Inst, Livermore, CA 94551 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Moreau, JW (corresponding author), US Geol Survey, Div Water Resources, Middleton, WI 53562 USA.	jwmoreau@usgs.gov	Weber, Peter Kilian/AAP-9517-2020; Gilbert, Benjamin/E-3182-2010; Martin, Michael C./ABH-9841-2020; 1.4, ALS Beamline/I-1886-2014; Moreau, John/A-8061-2013	Weber, Peter Kilian/0000-0001-6022-6050; Martin, Michael C./0000-0002-6611-070X; Banfield, Jill/0000-0001-8203-8771; Moreau, John W/0000-0002-5997-522X; Gilbert, Benjamin/0000-0003-0853-0826				Ahn JS, 2005, ENVIRON GEOCHEM HLTH, V27, P147, DOI 10.1007/s10653-005-0121-8; Allain C, 1996, J COLLOID INTERF SCI, V178, P411, DOI 10.1006/jcis.1996.0135; Barkay T, 2001, CURR OPIN MICROBIOL, V4, P318, DOI 10.1016/S1369-5274(00)00210-1; Bebie J., 2000, GEOCHEM T, V1, P47, DOI DOI 10.1186/1467-4866-1-47; Blindauer CA, 2001, P NATL ACAD SCI USA, V98, P9593, DOI 10.1073/pnas.171120098; Bradford SA, 2002, WATER RESOUR RES, V38, DOI 10.1029/2002WR001340; Bridge TAM, 1999, MICROBIOL-SGM, V145, P2987, DOI 10.1099/00221287-145-10-2987; Diallo MS, 2005, J NANOPART RES, V7, P325, DOI 10.1007/s11051-005-8543-x; Hauri EH, 2002, CHEM GEOL, V185, P149, DOI 10.1016/S0009-2541(01)00400-4; HERING JG, 1990, REV MINERAL, V23, P427; Hochella MF, 2002, GEOCHIM COSMOCHIM AC, V66, P735, DOI 10.1016/S0016-7037(01)00868-7; Hockin SL, 2003, APPL ENVIRON MICROB, V69, P7063, DOI 10.1128/AEM.69.12.7063-7072.2003; Honeyman BD, 1999, NATURE, V397, P23, DOI 10.1038/16150; KHAZAELI MB, 1981, APPL ENVIRON MICROB, V41, P46, DOI 10.1128/AEM.41.1.46-50.1981; Kloepfer JA, 2005, APPL ENVIRON MICROB, V71, P2548, DOI 10.1128/AEM.71.5.2548-2557.2005; KUREK E, 1991, ARCH ENVIRON CON TOX, V21, P106, DOI 10.1007/BF01055564; Labrenz M, 2000, SCIENCE, V290, P1744, DOI 10.1126/science.290.5497.1744; Lloyd JR, 2001, HYDROMETALLURGY, V59, P327, DOI 10.1016/S0304-386X(00)00175-4; Lu QY, 2002, NANOTECHNOLOGY, V13, P741, DOI 10.1088/0957-4484/13/6/309; Luther GW, 1999, GEOCHIM COSMOCHIM AC, V63, P3159, DOI 10.1016/S0016-7037(99)00243-4; Mantsch H. H., 1996, INFRARED SPECTROSCOP; Moreau JW, 2004, AM MINERAL, V89, P950; Naz N, 2005, APPL ENVIRON MICROB, V71, P4610, DOI 10.1128/AEM.71.8.4610-4618.2005; NIES DH, 1992, J BACTERIOL, V174, P8102, DOI 10.1128/JB.174.24.8102-8110.1992; RONNGREN L, 1991, J COLLOID INTERF SCI, V145, P396, DOI 10.1016/0021-9797(91)90370-N; Rosen BP, 1996, J BIOL INORG CHEM, V1, P273, DOI 10.1007/s007750050053; STUMM W, 1996, AQUATIC CHEM CHEM EQ, P400; Suzuki Y, 2002, NATURE, V419, P134, DOI 10.1038/419134a; Torres-Martinez CL, 1999, NANOTECHNOLOGY, V10, P340, DOI 10.1088/0957-4484/10/3/319; Vogel W, 2000, LANGMUIR, V16, P2032, DOI 10.1021/la9910071; WAYCHUNAS GA, 1990, REV MINERAL GEOCHEM, V44, P105; ZHANG JW, 1990, REV MINERAL, V23, P365	32	213	221	3	178	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1600	1603		10.1126/science.1141064	http://dx.doi.org/10.1126/science.1141064			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569859	Green Submitted			2022-12-01	WOS:000247239900036
J	Panne, D; Maniatis, T; Harrison, SC				Panne, Daniel; Maniatis, Tom; Harrison, Stephen C.			An atomic model of the interferon-beta enhanceosome	CELL			English	Article							PROTEIN HMG I(Y); KAPPA-B SITE; CRYSTAL-STRUCTURE; TRANSCRIPTION FACTORS; DNA-BINDING; VIRUS INDUCTION; P50/P65 HETERODIMER; COOPERATIVE BINDING; REGULATORY FACTORS; POSITIVE FEEDBACK	Transcriptional activation of the interferon-beta (IFN-beta) gene requires assembly of an enhanceo-some containing ATF-2/c-Jun, IRF-3/IRF-7, and NF kappa B. These factors bind cooperatively to the IFN-beta enhancer and recruit coactivators and chromatin-remodeling proteins to the IFN-beta promoter. We describe here a crystal structure of the DNA-binding domains of IRF-3, IRF-7, and NF kappa B, bound to one half of the enhancer, and use a previously described structure of the remaining half to assemble a complete picture of enhanceosome architecture in the vicinity of the DNA. Association of eight proteins with the enhancer creates a continuous surface for recognizing a composite DNA-binding element. Paucity of local protein-protein contacts suggests that cooperative occupancy of the enhancer comes from both binding-induced changes in DNA conformation and interactions with additional components such as CBP. Contacts with virtually every nucleotide pair account for the evolutionary invariance of the enhancer sequence.	Harvard Univ, Sch Med, Jack & Eileen Connors Struct Biol Lab, Dept Biol Chem & Mol Pharmacol,Howard Hughes Med, Boston, MA 02115 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Harrison, SC (corresponding author), Harvard Univ, Sch Med, Jack & Eileen Connors Struct Biol Lab, Dept Biol Chem & Mol Pharmacol,Howard Hughes Med, 250 Longwood Ave, Boston, MA 02115 USA.	harrison@crystal.harvard.edu	Panne, Daniel/I-8368-2017	Panne, Daniel/0000-0001-9158-5507	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020642] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI020642-23, R01 AI020642, R01AI020642] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Arnosti DN, 2005, J CELL BIOCHEM, V94, P890, DOI 10.1002/jcb.20352; Bannister AJ, 1995, ONCOGENE, V11, P2509; Berkowitz B, 2002, J BIOL CHEM, V277, P24694, DOI 10.1074/jbc.M200006200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carey M, 2000, TRANSCRIPTIONAL REGU; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Chen FE, 1999, ONCOGENE, V18, P6845, DOI 10.1038/sj.onc.1203224; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Chen-Park FE, 2002, J BIOL CHEM, V277, P24701, DOI 10.1074/jbc.M200007200; DU W, 1992, P NATL ACAD SCI USA, V89, P2150, DOI 10.1073/pnas.89.6.2150; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escalante CR, 2007, MOL CELL, V26, P703, DOI 10.1016/j.molcel.2007.04.022; Escalante CR, 2002, MOL CELL, V10, P1097, DOI 10.1016/S1097-2765(02)00703-7; Escalante CR, 2002, STRUCTURE, V10, P383, DOI 10.1016/S0969-2126(02)00723-2; Escalante CR, 1998, NATURE, V391, P103, DOI 10.1038/34224; Falvo JV, 1995, CELL, V83, P1101, DOI 10.1016/0092-8674(95)90137-X; Falvo JV, 2000, MOL CELL BIOL, V20, P4814, DOI 10.1128/MCB.20.13.4814-4825.2000; Fujii Y, 1999, EMBO J, V18, P5028, DOI 10.1093/emboj/18.18.5028; FUJITA T, 1988, EMBO J, V7, P3397, DOI 10.1002/j.1460-2075.1988.tb03213.x; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; GOODBOURN S, 1988, P NATL ACAD SCI USA, V85, P1447, DOI 10.1073/pnas.85.5.1447; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kawasaki H, 1998, GENE DEV, V12, P233, DOI 10.1101/gad.12.2.233; Klemm JD, 1996, GENE DEV, V10, P27, DOI 10.1101/gad.10.1.27; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; Lin CH, 2001, MOL CELL, V8, P581, DOI 10.1016/S1097-2765(01)00333-1; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Lomvardas S, 2001, CELL, V106, P685, DOI 10.1016/S0092-8674(01)00490-1; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Ludwig MZ, 2005, PLOS BIOL, V3, P588, DOI 10.1371/journal.pbio.0030093; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Luscombe NM, 1997, NUCLEIC ACIDS RES, V25, P4940, DOI 10.1093/nar/25.24.4940; Mamane Y, 1999, GENE, V237, P1, DOI 10.1016/S0378-1119(99)00262-0; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; Morin P, 2002, J MOL BIOL, V316, P1009, DOI 10.1006/jmbi.2001.5401; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; Munshi N, 1999, COLD SPRING HARB SYM, V64, P149, DOI 10.1101/sqb.1999.64.149; Munshi N, 2001, SCIENCE, V293, P1133, DOI 10.1126/science.293.5532.1133; Panne D, 2004, EMBO J, V23, P4384, DOI 10.1038/sj.emboj.7600453; Ptashne M., 2002, GENES SIGNALS; Qin BY, 2005, STRUCTURE, V13, P1269, DOI 10.1016/j.str.2005.06.011; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; SMALL S, 1991, GENE DEV, V5, P827, DOI 10.1101/gad.5.5.827; Struhl K, 2001, SCIENCE, V293, P1054, DOI 10.1126/science.1064050; THANOS D, 1993, COLD SPRING HARB SYM, V58, P73, DOI 10.1101/SQB.1993.058.01.011; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; Thomas JO, 2001, BIOCHEM SOC T, V29, P395, DOI 10.1042/BST0290395; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Yie JM, 1999, P NATL ACAD SCI USA, V96, P13108, DOI 10.1073/pnas.96.23.13108	59	422	433	2	31	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 15	2007	129	6					1111	1123		10.1016/j.cell.2007.05.019	http://dx.doi.org/10.1016/j.cell.2007.05.019			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574024	Bronze, Green Accepted			2022-12-01	WOS:000247390400015
J	Prusinkiewicz, P; Erasmus, Y; Lane, B; Harder, LD; Coen, E				Prusinkiewicz, Przemyslaw; Erasmus, Yvette; Lane, Brendan; Harder, Lawrence D.; Coen, Enrico			Evolution and development of inflorescence architectures	SCIENCE			English	Article							REPRODUCTIVE GROWTH; ANNUAL PLANTS; ARABIDOPSIS; ENVIRONMENTS; INITIATION; IDENTITY	To understand the constraints on biological diversity, we analyzed how selection and development interact to control the evolution of inflorescences, the branching structures that bear flowers. We show that a single developmental model accounts for the restricted range of inflorescence types observed in nature and that this model is supported by molecular genetic studies. The model predicts associations between inflorescence architecture, climate, and life history, which we validated empirically. Paths, or evolutionary wormholes, link different architectures in a multidimensional fitness space, but the rate of evolution along these paths is constrained by genetic and environmental factors, which explains why some evolutionary transitions are rare between closely related plant taxa.	John Innes Ctr, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; Univ Calgary, Dept Comp Sci, Calgary, AB T2N 1N4, Canada; Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Calgary; University of Calgary	Coen, E (corresponding author), John Innes Ctr, Dept Cell & Dev Biol, Colney Lane, Norwich NR4 7UH, Norfolk, England.	enrico.coen@bbsrc.ac.uk	Harder, Lawrence/H-9715-2012; Wilson, Yvette/C-2115-2011	Harder, Lawrence/0000-0002-2303-5076; 				BARTHELEMY D, 1991, ACTA BIOTHEOR, V39, P309, DOI 10.1007/BF00114184; BIAZQUEZ MA, 1997, DEVELOPMENT, V124, P3835; Bradley D, 1997, SCIENCE, V275, P80, DOI 10.1126/science.275.5296.80; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; ERICKSON RO, 1957, AM J BOT, V44, P297, DOI 10.2307/2438380; Etherington I.M.H., 1939, P R SOC EDINBURGH, V59, P153; GATSUK LE, 1980, J ECOL, V68, P675, DOI 10.2307/2259429; Gavrilets S., 2004, MONOGRAPHS POPULATIO; HACCOU P, 1995, THEOR POPUL BIOL, V47, P212, DOI 10.1006/tpbi.1995.1009; Hopper KR, 2003, OIKOS, V101, P219, DOI 10.1034/j.1600-0706.2003.12051.x; Keller T, 2006, PLANT CELL, V18, P598, DOI 10.1105/tpc.105.038588; Kellogg EA., 2000, MONOCOTS SYSTEMATICS, P84, DOI DOI 10.1016/J.YMPEV.2012.02.005; KING D, 1982, THEOR POPUL BIOL, V21, P194, DOI 10.1016/0040-5809(82)90013-2; KING D, 1982, THEOR POPUL BIOL, V22, P1, DOI 10.1016/0040-5809(82)90032-6; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Long J, 2000, DEV BIOL, V218, P341, DOI 10.1006/dbio.1999.9572; NIKIAS KJ, 1997, EVOLUTIONARY BIOL PL; PARRY F, 2002, DEVELOPMENT, V129, P2519; PRUSINKIEWICZ P, 1990, ALGORITHMIC BEAUTY P; RAFF RA, 1966, SHAPE LIFE; Ratcliffe OJ, 1998, DEVELOPMENT, V125, P1609; Ratcliffe OJ, 1999, DEVELOPMENT, V126, P1109; Raup D. M., 1967, Journal of Paleontology, V41, P43; RAUP DM, 1965, SCIENCE, V147, P1294, DOI 10.1126/science.147.3663.1294; Sachs T, 1999, PLANT CELL ENVIRON, V22, P757, DOI 10.1046/j.1365-3040.1999.00220.x; SCHULTZ EA, 1993, DEVELOPMENT, V119, P745; SHANNON S, 1991, PLANT CELL, V3, P877, DOI 10.1105/tpc.3.9.877; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; SMITH JM, 1985, Q REV BIOL, V60, P265, DOI 10.1086/414425; Troll W., 1969, INFLORESZENZEN, VII-1; Troll W., 1964, INFLORESZENZEN, VI; Watson L., 2006, FAMILIES FLOWERING P; Weberling F., 1992, MORPHOLOGY FLOWERS I; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; Whibley AC, 2006, SCIENCE, V313, P963, DOI 10.1126/science.1129161; [No title captured]	36	264	272	3	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2007	316	5830					1452	1456		10.1126/science.1140429	http://dx.doi.org/10.1126/science.1140429			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17525303				2022-12-01	WOS:000247066400035
J	Sridhar, VV; Kapoor, A; Zhang, KL; Zhu, JJ; Zhou, T; Hasegawa, PM; Bressan, RA; Zhu, JK				Sridhar, Vaniyambadi V.; Kapoor, Avnish; Zhang, Kangling; Zhu, Jianjun; Zhou, Tao; Hasegawa, Paul M.; Bressan, Ray A.; Zhu, Jian-Kang			Control of DNA methylation and heterochromatic silencing by histone H2B deubiquitination	NATURE			English	Article							ARABIDOPSIS-THALIANA; GLYCOSYLASE/LYASE ROS1; H3 METHYLTRANSFERASE; UBIQUITINATION; PLANTS; CHROMATIN; PATHWAYS; PATTERNS; CLONING	Epigenetic regulation involves reversible changes in DNA-methylation and/or histone modification patterns(1-7). Short interfering RNAs ( siRNAs) can direct DNA methylation and heterochromatic histone modifications, causing sequence-specific transcriptional gene silencing(1,4,8,9). In animals and yeast, histone H2B is known to be monoubiquitinated, and this regulates the methylation of histone H3 ( refs 10, 11). However, the relationship between histone ubiquitination and DNA methylation has not been investigated. Here we show that mutations in an Arabidopsis deubiquitination enzyme, SUP32/UBP26, decrease the dimethylation on lysine 9 of H3, suppress siRNA-directed methylation of DNA and release heterochromatic silencing of transgenes as well as transposons. We found that Arabidopsis histone H2B is monoubiquitinated at lysine 143 and that the levels of ubiquitinated H2B and trimethyl H3 at lysine 4 increase in sup32 mutant plants. SUP32/UBP26 can deubiquitinate H2B, and chromatin immunoprecipitation assays suggest an association between H2B ubiquitination and release of silencing. These data suggest that H2B deubiquitination by SUP32/UBP26 is required for heterochromatic histone H3 methylation and DNA methylation.	Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA; Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; Univ Calif Riverside, Mass Spectrometry Facil, Dept Chem, Riverside, CA 92521 USA; Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Zhu, JK (corresponding author), Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA.	jian-kang.zhu@ucr.edu	Zhu, Jian-Kang/F-7658-2011; Grieshaber-Bouyer, Ricardo/R-7512-2016; Hu, Ruogu/B-2203-2008	Zhu, Jian-Kang/0000-0001-5134-731X; Grieshaber-Bouyer, Ricardo/0000-0002-2873-5135; 				Agius F, 2006, P NATL ACAD SCI USA, V103, P11796, DOI 10.1073/pnas.0603563103; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chinnusamy V., 2002, SCI STKE, V140, pPL10; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Gardner RG, 2005, MOL CELL BIOL, V25, P6123, DOI 10.1128/MCB.25.14.6123-6139.2005; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; He YH, 2005, TRENDS PLANT SCI, V10, P30, DOI 10.1016/j.tplants.2004.11.003; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Ishitani M, 1997, PLANT CELL, V9, P1935, DOI 10.1105/tpc.9.11.1935; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Kapoor A, 2005, CURR BIOL, V15, P1912, DOI 10.1016/j.cub.2005.09.013; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Rao-Naik C, 2000, ARCH BIOCHEM BIOPHYS, V379, P198, DOI 10.1006/abbi.2000.1874; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tariq M, 2004, TRENDS GENET, V20, P244, DOI 10.1016/j.tig.2004.04.005; WATERBORG JH, 1987, ARCH BIOCHEM BIOPHYS, V256, P167, DOI 10.1016/0003-9861(87)90435-8; Yan N, 2000, PLANT PHYSIOL, V124, P1828, DOI 10.1104/pp.124.4.1828; Zhang Y, 2003, GENE DEV, V17, P2733, DOI 10.1101/gad.1156403; Zhu JH, 2007, CURR BIOL, V17, P54, DOI 10.1016/j.cub.2006.10.059	28	183	218	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	2007	447	7145					735	U18		10.1038/nature05864	http://dx.doi.org/10.1038/nature05864			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554311				2022-12-01	WOS:000247030700048
J	Giraud, E; Moulin, L; Vallenet, D; Barbe, V; Cytryn, E; Avarre, JC; Jaubert, M; Simon, D; Cartieaux, F; Prin, Y; Bena, G; Hannibal, L; Fardoux, J; Kojadinovic, M; Vuillet, L; Lajus, A; Cruveiller, S; Rouy, Z; Mangenot, S; Segurens, B; Dossat, C; Franck, WL; Chang, WS; Saunders, E; Bruce, D; Richardson, P; Normand, P; Dreyfus, B; Pignol, D; Stacey, G; Emerich, D; Vermeglio, A; Medigue, C; Sadowsky, M				Giraud, Eric; Moulin, Lionel; Vallenet, David; Barbe, Valerie; Cytryn, Eddie; Avarre, Jean-Christophe; Jaubert, Marianne; Simon, Damien; Cartieaux, Fabienne; Prin, Yves; Bena, Gilles; Hannibal, Laure; Fardoux, Joel; Kojadinovic, Mila; Vuillet, Laurie; Lajus, Aurelie; Cruveiller, Stephane; Rouy, Zoe; Mangenot, Sophie; Segurens, Beatrice; Dossat, Carole; Franck, William L.; Chang, Woo-Suk; Saunders, Elizabeth; Bruce, David; Richardson, Paul; Normand, Philippe; Dreyfus, Bernard; Pignol, David; Stacey, Gary; Emerich, David; Vermeglio, Andre; Medigue, Claudine; Sadowsky, Michael			Legumes symbioses: Absence of Nod genes in photosynthetic bradyrhizobia	SCIENCE			English	Article							RHIZOBIUM-LEGUMINOSARUM; SINORHIZOBIUM-MELILOTI; ROOT-NODULE; MOLECULAR-BASIS; NODULATION; JAPONICUM; GENOME; BACTERIA; AUXOTROPHS; SEQUENCE	Leguminous plants ( such as peas and soybeans) and rhizobial soil bacteria are symbiotic partners that communicate through molecular signaling pathways, resulting in the formation of nodules on legume roots and occasionally stems that house nitrogen-fixing bacteria. Nodule formation has been assumed to be exclusively initiated by the binding of bacterial, host-specific lipochito-oligosaccharidic Nod factors, encoded by the nodABC genes, to kinase-like receptors of the plant. Here we show by complete genome sequencing of two symbiotic, photosynthetic, Bradyrhizobium strains, BTAi1 and ORS278, that canonical nodABC genes and typical lipochito-oligosaccharidic Nod factors are not required for symbiosis in some legumes. Mutational analyses indicated that these unique rhizobia use an alternative pathway to initiate symbioses, where a purine derivative may play a key role in triggering nodule formation.	Univ Montpellier 2, INRA,AGRO Montpellier, Inst Rech Dev,Ctr Cooperat Int Rech Agron Dev, Lab Symbioses Trop & Mediterraneennes,UMR 113, F-34398 Montpellier 5, France; Genoscope, CNRS, UMR 8030, F-91057 Evry, France; Genoscope, Ctr Natl Sequencage, F-91057 Evry, France; Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA; Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA; Univ Minnesota, Microbial & Plant Genom Inst, St Paul, MN 55108 USA; Univ Aix Marseille, CNRS,UMR 6191,CEA Cadarache,Direct Sci Vivant, Inst Biol Environm & Biotechnol,Serv Biol Vegetal, Lab Bioenerget Cellulaire DSV IBEB SBVME LBC, F-13108 St Paul Les Durance, France; Univ Missouri, Natl Ctr Soybean Biotechnol, Div Plant Sci, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA; Univ Missouri, Natl Ctr Soybean Biotechnol, Div Biochem, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA; Los Alamos Natl Lab, US DOE, Joint Genome Inst, Los Alamos, NM 87545 USA; DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; Univ Lyon 1, CNRS, UMR 5557, F-69365 Lyon, France	CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup	Giraud, E (corresponding author), Univ Montpellier 2, INRA,AGRO Montpellier, Inst Rech Dev,Ctr Cooperat Int Rech Agron Dev, Lab Symbioses Trop & Mediterraneennes,UMR 113, TA A-82-J,Campus Baillarguet, F-34398 Montpellier 5, France.	giraud@mpl.ird.fr; sadowsky@umn.edu	Normand, Philippe/ABD-2235-2020; Moulin, Lionel/C-2921-2008; Cartieaux, Fabienne/GNH-3617-2022; Giraud, Eric/GLS-1036-2022; Normand, Philippe/A-1142-2012; Bena, Gilles/GOG-7902-2022; Sadowsky, Michael/J-2507-2016; Avarre, Jean-Christophe/E-4170-2019	Normand, Philippe/0000-0002-2139-2141; Moulin, Lionel/0000-0001-9068-6912; Sadowsky, Michael/0000-0001-8779-2781; Avarre, Jean-Christophe/0000-0001-6899-7052; Cartieaux, Fabienne/0000-0002-8992-0131; Vallenet, David/0000-0001-6648-0332; Bena, Gilles/0000-0003-3080-8441; PIGNOL, David/0000-0002-8070-0319				Barnett MJ, 2001, P NATL ACAD SCI USA, V98, P9883, DOI 10.1073/pnas.161294798; Boiero L, 2007, APPL MICROBIOL BIOT, V74, P874, DOI 10.1007/s00253-006-0731-9; Broughton WJ, 2000, J BACTERIOL, V182, P5641, DOI 10.1128/JB.182.20.5641-5652.2000; Chaintreuil C, 2001, FEMS MICROBIOL LETT, V194, P83, DOI 10.1111/j.1574-6968.2001.tb09450.x; Collavino M, 2005, MOL PLANT MICROBE IN, V18, P742, DOI 10.1094/MPMI-18-0742; COOPER JB, 1994, PLANT CELL, V6, P215, DOI 10.1105/tpc.6.2.215; COSTACURTA A, 1995, CRIT REV MICROBIOL, V21, P1, DOI 10.3109/10408419509113531; D'Haeze W, 2004, TRENDS MICROBIOL, V12, P555, DOI 10.1016/j.tim.2004.10.009; DENARIE J, COMMUNICATION; DENARIE J, 1975, SYMBIOTIC NITROGEN F, P47; Freiberg C, 1997, NATURE, V387, P394, DOI 10.1038/387394a0; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Geurts R, 2005, CURR OPIN PLANT BIOL, V8, P346, DOI 10.1016/j.pbi.2005.05.013; Giraud E, 2004, PHOTOSYNTH RES, V82, P115, DOI 10.1007/s11120-004-1768-1; Giraud E, 2000, P NATL ACAD SCI USA, V97, P14795, DOI 10.1073/pnas.250484097; Gonzalez V, 2006, P NATL ACAD SCI USA, V103, P3834, DOI 10.1073/pnas.0508502103; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Kaneko T, 2000, DNA RES, V7, P331, DOI 10.1093/dnares/7.6.331; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; LEIGH JA, 1992, ANNU REV MICROBIOL, V46, P307, DOI 10.1146/annurev.mi.46.100192.001515; Lerouge I, 2002, FEMS MICROBIOL REV, V26, P17, DOI 10.1111/j.1574-6976.2002.tb00597.x; MEADE HM, 1982, J BACTERIOL, V149, P114, DOI 10.1128/JB.149.1.114-122.1982; Moulin L, 2001, NATURE, V411, P948, DOI 10.1038/35082070; Murray JD, 2007, SCIENCE, V315, P101, DOI 10.1126/science.1132514; NEWMAN JD, 1994, J BACTERIOL, V176, P3286, DOI 10.1128/jb.176.11.3286-3294.1994; NOEL KD, 1988, ARCH MICROBIOL, V149, P499, DOI 10.1007/BF00446751; PANKHURST CE, 1974, ARCH MICROBIOL, V100, P219, DOI 10.1007/BF00446319; Parniske M, 2003, NATURE, V425, P569, DOI 10.1038/425569a; Patriarca EJ, 2002, MICROBIOL MOL BIOL R, V66, P203, DOI 10.1128/MMBR.66.2.203-222.2002; Perret X, 2000, MICROBIOL MOL BIOL R, V64, P180, DOI 10.1128/MMBR.64.1.180-201.2000; Reeve WG, 1999, MICROBIOL-SGM, V145, P1307, DOI 10.1099/13500872-145-6-1307; ROCHE P, 1991, J BIOL CHEM, V266, P10933; SADOWSKY MJ, 1986, ARCH MICROBIOL, V144, P334, DOI 10.1007/BF00409881; Schluter A, 2000, MICROBIOL-SGM, V146, P2987, DOI 10.1099/00221287-146-11-2987; SO JS, 1987, MOL GEN GENET, V207, P15, DOI 10.1007/BF00331485; Stacey G, 2006, CURR OPIN PLANT BIOL, V9, P110, DOI 10.1016/j.pbi.2006.01.005; STURTEVANT DB, 1989, PLANT PHYSIOL, V89, P1247, DOI 10.1104/pp.89.4.1247; Tirichine L, 2007, SCIENCE, V315, P104, DOI 10.1126/science.1132397; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34; YOUNG JPW, 1991, J BACTERIOL, V173, P2271	41	429	1115	5	197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2007	316	5829					1307	1312		10.1126/science.1139548	http://dx.doi.org/10.1126/science.1139548			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17540897				2022-12-01	WOS:000246885600042
J	Kuang, SH; Kuroda, K; Le Grand, F; Rudnicki, MA				Kuang, Shihuan; Kuroda, Kazuki; Le Grand, Fabien; Rudnicki, Michael A.			Asymmetric self-renewal and commitment of satellite stem cells in muscle	CELL			English	Article							SKELETAL-MUSCLE; MYOGENIC SPECIFICATION; PROGENITOR CELLS; SOMITIC ORIGIN; M-CADHERIN; EXPRESSION; MYOBLASTS; POPULATION; NUMB; DIFFERENTIATION	Satellite cells play a central role in mediating the growth and regeneration of skeletal muscle. However, whether satellite cells are stem cells, committed progenitors, or dedifferentiated myoblasts has remained unclear. Using Myf5Cre and ROSA26-YFP Cre-reporter alleles, we observed that in vivo 10% of sublaminar Pax7-expressing satellite cells have never expressed Myf5. Moreover, we found that Pax7(+)/ Myf5(-) satellite cells gave rise to Pax7(+)/Myf5(+) satellite cells through apical-basal oriented divisions that asymmetrically generated a basal Pax7(+)/Myf5(-) and an apical Pax7(+)/Myf5(+) cells. Prospective isolation and transplantation into muscle revealed that whereas Pax7(+)/Myf5(+) cells exhibited precocious differentiation, Pax7(+)/ Myf5(-) cells extensively contributed to the satellite cell reservoir throughout the injected muscle. Therefore, we conclude that satellite cells are a heterogeneous population composed of stem cells and committed progenitors. These results provide critical insights into satellite cell biology and open new avenues for therapeutic treatment of neuromuscular diseases.	Sprott Ctr Stem Cell Res, Ottawa Hlth Res Inst, Program Mol Med, Ottawa, ON K1H 8L6, Canada; Univ Ottawa, Dept Med, Ottawa, ON K1H 8L6, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Rudnicki, MA (corresponding author), Sprott Ctr Stem Cell Res, Ottawa Hlth Res Inst, Program Mol Med, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.	mrudnicki@ohri.ca	Le Grand, Fabien/D-8803-2019	Le Grand, Fabien/0000-0002-7843-3899; Rudnicki, Michael/0000-0002-3866-5249; Kuang, Shihuan/0000-0001-9180-3180	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044031] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR044031-11, R01 AR044031] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ARMAND O, 1983, ARCH ANAT MICROSC MO, V72, P163; Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; Ben-Yair R, 2005, DEVELOPMENT, V132, P689, DOI 10.1242/dev.01617; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Bischoff R., 1994, MYOLOGY, VVolume 1, P97; Blanco-Bose WE, 2001, EXP CELL RES, V265, P212, DOI 10.1006/excr.2001.5191; BORNEMANN A, 1994, ANAT REC, V239, P119, DOI 10.1002/ar.1092390202; Burkin DJ, 1999, CELL TISSUE RES, V296, P183, DOI 10.1007/s004410051279; Carmena A, 1998, GENE DEV, V12, P304, DOI 10.1101/gad.12.3.304; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; COLLO G, 1993, J BIOL CHEM, V268, P19019; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Cousins JC, 2004, J CELL SCI, V117, P3259, DOI 10.1242/jcs.01161; De Angelis L, 1999, J CELL BIOL, V147, P869, DOI 10.1083/jcb.147.4.869; Delfini MC, 2000, DEVELOPMENT, V127, P5213; El Fahime E, 2003, BIOCHEM CELL BIOL, V81, P81, DOI 10.1139/O03-054; Fan Y, 1996, MUSCLE NERVE, V19, P853, DOI 10.1002/(SICI)1097-4598(199607)19:7<853::AID-MUS7>3.0.CO;2-8; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Heslop L, 2001, GENE THER, V8, P778, DOI 10.1038/sj.gt.3301463; Heslop L, 2000, J CELL SCI, V113, P2299; Hodgetts SI, 2000, CELL TRANSPLANT, V9, P489, DOI 10.1177/096368970000900406; Holowacz T, 2006, DEV DYNAM, V235, P633, DOI 10.1002/dvdy.20672; IRINTCHEV A, 1994, DEV DYNAM, V199, P326, DOI 10.1002/aja.1001990407; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; KNOBLICH JA, 2001, S SOC EXP BIOL, V53, P75; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; McKinnell IW, 2005, CURR TOP DEV BIOL, V71, P113, DOI 10.1016/S0070-2153(05)71004-8; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Minoguchi S, 1997, MOL CELL BIOL, V17, P2679, DOI 10.1128/MCB.17.5.2679; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Qu ZQ, 1998, J CELL BIOL, V142, P1257, DOI 10.1083/jcb.142.5.1257; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Schienda J, 2006, P NATL ACAD SCI USA, V103, P945, DOI 10.1073/pnas.0510164103; Schultz E, 1996, DEV BIOL, V175, P84, DOI 10.1006/dbio.1996.0097; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tajbakhsh S, 1996, NATURE, V384, P266, DOI 10.1038/384266a0; Tallquist MD, 2000, DEVELOPMENT, V127, P5059; Venters S, 2005, ANAT EMBRYOL, V209, P449, DOI 10.1007/s00429-005-0461-2; Yablonka-Reuveni Z, 2006, DEV DYNAM, V235, P203, DOI 10.1002/dvdy.20602	54	897	930	5	101	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2007	129	5					999	1010		10.1016/j.cell.2007.03.044	http://dx.doi.org/10.1016/j.cell.2007.03.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540178	Green Accepted, Bronze			2022-12-01	WOS:000247084600018
J	Trojer, P; Li, G; Sims, RJ; Vaquero, A; Kalakonda, N; Boccuni, P; Lee, D; Erdjument-Bromage, H; Tempst, P; Nimer, SD; Wang, YH; Reinberg, D				Trojer, Patrick; Li, Guohong; Sims, Robert J., III; Vaquero, Alejandro; Kalakonda, Nagesh; Boccuni, Piernicola; Lee, Donghoon; Erdjument-Bromage, Hediye; Tempst, Paul; Nimer, Stephen D.; Wang, Yuh-Hwa; Reinberg, Danny			L3MBTL1, a histone-methylation-dependent chromatin lock	CELL			English	Article							POLYCOMB GROUP PROTEIN; RNA POLYMERASE-II; LYSINE METHYLATION; TRANSCRIPTIONAL REPRESSOR; MAMMALIAN NUCLEI; MOLECULAR-BASIS; HP1 BINDING; PHD FINGER; IN-VITRO; H3 TAIL	Distinct histone lysine methylation marks are involved in transcriptional repression linked to the formation and maintenance of facultative heterochromatin, although the underlying mechanisms remain unclear. We demonstrate that the malignant-brain-tumor (MBT) protein L3MBTL1 is in a complex with core histones, histone H1b, HP1 gamma, and Rb. The MBT domain is structurally related to protein domains that directly bind methylated histone residues. Consistent with this, we found that the L3MBTL1 MBT domains compact nucleosomal arrays dependent on mono- and dimethylation of histone H4 lysine 20 and of histone H1b lysine 26. The MBT domains bind at least two nuclecisomes simultaneously, linking repression of transcription to recognition of different histone marks by L3MBTL1. Consistently, L3MBTL1 was found to negatively regulate the expression of a subset of genes regulated by E2F, a factor that interacts with Rb.	CSIC IRB, IBMB, Barcelona 08028, Spain; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Nucl Acids Enzymol, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Nucl Acids Enzymol, Dept Biochem, Piscataway, NJ 08854 USA; NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; Sloan Kettering Inst Canc Res, Lab Mol Aspects Hemaopoiesis, New York, NY 10021 USA; Sloan Kettering Inst Canc Res, Prot Ctr, New York, NY 10021 USA; Sloan Kettering Inst Canc Res, Mol Biol Program, New York, NY 10021 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; New York University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Reinberg, D (corresponding author), ICREA, Parc Cientific Barcelona,Josep Samitier 1-5, Barcelona 08028, Spain.	reinbd01@med.nyu.edu	Vaquero, Alejandro/I-9845-2014; Vaquero, Alejandro/ABG-8634-2020	Vaquero, Alejandro/0000-0002-8735-4156; Tempst, Paul/0000-0002-6680-3987; Reinberg, Danny/0000-0003-4288-2016; Erdjument-Bromage, Hediye/0000-0003-0224-3594	NCI NIH HHS [CA085826, CA113863, CA 102202] Funding Source: Medline; NIGMS NIH HHS [GM-71166, GM-64844] Funding Source: Medline; ICREA Funding Source: Custom; NATIONAL CANCER INSTITUTE [R01CA113863, R01CA085826, R01CA102202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064844, F32GM071166] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ICREA(ICREA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 2003, EAU UPDATE; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; BEDNAR J, 1995, J CELL BIOL, V131, P1365, DOI 10.1083/jcb.131.6.1365; Boccuni P, 2003, J BIOL CHEM, V278, P15412, DOI 10.1074/jbc.M300592200; Cheung E, 2002, MOL CELL BIOL, V22, P2463, DOI 10.1128/MCB.22.8.2463-2471.2002; CROSTON GE, 1991, SCIENCE, V251, P643, DOI 10.1126/science.1899487; Daujat S, 2005, J BIOL CHEM, V280, P38090, DOI 10.1074/jbc.C500229200; Devroe E, 2004, J BIOL CHEM, V279, P24444, DOI 10.1074/jbc.M401999200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dou YL, 1999, MOL CELL, V4, P641, DOI 10.1016/S1097-2765(00)80215-4; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; LAYBOURN PJ, 1991, SCIENCE, V254, P238, DOI 10.1126/science.1718039; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; Lewis BA, 2005, MOL CELL, V18, P471, DOI 10.1016/j.molcel.2005.04.005; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Loyola A, 2001, GENE DEV, V15, P2837; MacGrogan D, 2001, ONCOGENE, V20, P4150, DOI 10.1038/sj.onc.1204540; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Meehan RR, 2003, EMBO J, V22, P3164, DOI 10.1093/emboj/cdg306; Minc E, 2000, CYTOGENET CELL GENET, V90, P279, DOI 10.1159/000056789; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Nishioka K, 2003, METHODS, V31, P49, DOI 10.1016/S1046-2023(03)00087-2; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Parseghian MH, 2001, BIOCHEM CELL BIOL, V79, P289; Patnaik D, 2004, J BIOL CHEM, V279, P53248, DOI 10.1074/jbc.M409604200; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Sato MH, 1999, FEBS LETT, V452, P267, DOI 10.1016/S0014-5793(99)00644-4; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Sims RJ, 2006, METHODS, V40, P331, DOI 10.1016/j.ymeth.2006.07.031; Springhetti EM, 2003, J BIOL CHEM, V278, P43384, DOI 10.1074/jbc.M307635200; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; van Holde K, 2006, J BIOL CHEM, V281, P12197, DOI 10.1074/jbc.R500025200; VANHOLDE KE, 1989, CHROMATIN, V1; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Wang WK, 2003, STRUCTURE, V11, P775, DOI 10.1016/S0969-2126(03)00127-8; WISMAR J, 1995, MECH DEVELOP, V53, P141, DOI 10.1016/0925-4773(95)00431-9; Wolffe AP, 1997, INT J BIOCHEM CELL B, V29, P1463, DOI 10.1016/S1357-2725(97)00026-5; WOLLFE A, 1998, CHROMATIN STRUCTURE; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yohn CB, 2003, GENETICS, V165, P1889; Zhao T, 2000, J BIOL CHEM, V275, P28332; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	62	266	272	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2007	129	5					915	928		10.1016/j.cell.2007.03.048	http://dx.doi.org/10.1016/j.cell.2007.03.048			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540172	Bronze			2022-12-01	WOS:000247084600012
J	Zeggini, E; Weedon, MN; Lindgren, CM; Frayling, TM; Elliott, KS; Lango, H; Timpson, NJ; Perry, JRB; Rayner, NW; Freathy, RM; Barrett, JC; Shields, B; Morris, AP; Ellard, S; Groves, CJ; Harries, LW; Marchini, JL; Owen, KR; Knight, B; Cardon, LR; Walker, M; Hitman, GA; Morris, AD; Doney, ASF; McCarthy, MI; Hattersley, AT				Zeggini, Eleftheria; Weedon, Michael N.; Lindgren, Cecilia M.; Frayling, Timothy M.; Elliott, Katherine S.; Lango, Hana; Timpson, Nicholas J.; Perry, John R. B.; Rayner, Nigel W.; Freathy, Rachel M.; Barrett, Jeffrey C.; Shields, Beverley; Morris, Andrew P.; Ellard, Sian; Groves, Christopher J.; Harries, Lorna W.; Marchini, Jonathan L.; Owen, Katharine R.; Knight, Beatrice; Cardon, Lon R.; Walker, Mark; Hitman, Graham A.; Morris, Andrew D.; Doney, Alex S. F.; McCarthy, Mark I.; Hattersley, Andrew T.		WTCCC	Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes	SCIENCE			English	Article							INSULIN-DEGRADING ENZYME; GENE; VARIANT; CDK4; PANCREAS; MICE; MASS; HEX; MAP	The molecular mechanisms involved in the development of type 2 diabetes are poorly understood. Starting from genome-wide genotype data for 1924 diabetic cases and 2938 population controls generated by the Wellcome Trust Case Control Consortium, we set out to detect replicated diabetes association signals through analysis of 3757 additional cases and 5346 controls and by integration of our findings with equivalent data from other international consortia. We detected diabetes susceptibility loci in and around the genes CDKAL1, CDKN2A/CDKN2B, and IGF2BP2 and confirmed the recently described associations at HHEX/IDE and SLC30A8. Our findings provide insight into the genetic architecture of type 2 diabetes, emphasizing the contribution of multiple variants of modest effect. The regions identified underscore the importance of pathways influencing pancreatic beta cell development and function in the etiology of type 2 diabetes.	Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; PEninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX1 2LU, Devon, England; Peninsula Med Sch, Inst Biomed & Clin Sci, Diabet Genet Grp, Exeter EX2 5DW, Devon, England; Univ Bristol, MRC, Ctr Casual Anal Translat Epidemiol, Bristol BS2 8PR, Avon, England; Royal Devon & Exeter NHS FDn Trust, Genet Mol Lab, Exeter EX2 5DW, Devon, England; Univ Oxford, Dept Stat, Oxford OX1 3TG, England; Univ Newcastle, Sch Clin Med Sci, Diabet Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Barts & London Royal London Hosp, Ctr Diabet & Metab Med, London E1 1BB, England; Univ Dundee, Ninewells Hosp & Med Sch, Div Med & Therapeut, Diabet Res Grp, Dundee DD1 9SY, Scotland	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Exeter; University of Exeter; University of Bristol; University of Exeter; University of Oxford; Newcastle University - UK; Barts Health NHS Trust; Royal London Hospital; University of Dundee	McCarthy, MI (corresponding author), Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, S Parks Rd, Oxford OX3 7LJ, England.	mark.mccarthy@drl.ox.ac.uk	Marchini, Jonathan/ABE-9024-2020; Harries, Lorna/D-2241-2014; Worthington, Jane/M-9770-2014; Timpson, Nicholas John/O-7548-2015; Morris, Andrew D/C-2837-2009; Hinks, Anne/E-1853-2015; Fox, Laura J/C-6249-2016; Allen, Hana Lango/G-9026-2012; Attrill, Lauren/V-1688-2018; eyre, stephen/K-3776-2017; Doney, Alexander SF/P-7437-2017; Brown, Matthew A/E-5749-2010; Study, GoDARTS/K-9448-2016; Lewis, Cathryn/A-5225-2010; Mathew, Christopher George/G-3434-2015; McCarthy, Mark/M-3763-2015; Prescott, Natalie/F-6490-2011	Marchini, Jonathan/0000-0003-0610-8322; Worthington, Jane/0000-0003-0544-042X; Timpson, Nicholas John/0000-0002-7141-9189; Hinks, Anne/0000-0001-8843-3967; Allen, Hana Lango/0000-0002-7803-8688; eyre, stephen/0000-0002-1251-6974; Doney, Alexander SF/0000-0002-6210-5620; Brown, Matthew A/0000-0003-0538-8211; Morgan, Ann/0000-0003-1109-624X; Lewis, Cathryn/0000-0002-8249-8476; Ellard, Sian/0000-0002-7620-5526; Mathew, Christopher George/0000-0003-4178-1838; McCarthy, Mark/0000-0002-4393-0510; Prescott, Natalie/0000-0002-5901-7371; Symmons, Deborah/0000-0002-8625-1200; Bruce, Ian/0000-0003-3047-500X; Barrett, Jeffrey/0000-0002-1152-370X; Zeggini, Eleftheria/0000-0003-4238-659X; Weedon, Michael/0000-0002-6174-6135; Thomson, Wendy/0000-0002-9022-5179; Lindgren, Cecilia/0000-0002-4903-9374; Frayling, Timothy/0000-0001-8362-2603; Forbes, Alastair/0000-0001-7416-9843; Hattersley, Andrew/0000-0001-5620-473X; Freathy, Rachel/0000-0003-4152-2238	Medical Research Council [G0500070, G0000934] Funding Source: Medline; Wellcome Trust [083948, 090532] Funding Source: Medline; MRC [G0500070, G0000934] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Fakhrai-Rad H, 2000, HUM MOL GENET, V9, P2149, DOI 10.1093/hmg/9.14.2149; Farris W, 2004, AM J PATHOL, V164, P1425, DOI 10.1016/S0002-9440(10)63229-4; Foley AC, 2005, GENE DEV, V19, P387, DOI 10.1101/gad.1279405; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Marzo N, 2004, DIABETOLOGIA, V47, P686, DOI 10.1007/s00125-004-1372-0; Mettus RV, 2003, ONCOGENE, V22, P8413, DOI 10.1038/sj.onc.1206888; Moritani M, 2005, MOL CELL ENDOCRINOL, V229, P175, DOI 10.1016/j.mce.2004.08.007; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Pettersson F, 2004, BIOINFORMATICS, V20, P3241, DOI 10.1093/bioinformatics/bth341; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; SELA KA, 1997, BIOCHEM BIOPH RES CO, V231, P167; SIADEK R, 2007, NATURE, V445, P881; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Ubeda M, 2006, J BIOL CHEM, V281, P28858, DOI 10.1074/jbc.M604690200; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; *WELLC TRUST CAS C, IN PRESS NATURE	25	1727	1797	0	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2007	316	5829					1336	1341		10.1126/science.1142364	http://dx.doi.org/10.1126/science.1142364			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17463249	Green Accepted			2022-12-01	WOS:000246885600050
J	Busino, L; Bassermann, F; Maiolica, A; Lee, C; Nolan, PM; Godinho, SIH; Draetta, GF; Pagano, M				Busino, Luca; Bassermann, Florian; Maiolica, Alessio; Lee, Choogon; Nolan, Patrick M.; Godinho, Sofia I. H.; Draetta, Giulio F.; Pagano, Michele			SCFFbxl3 controls the oscillation of the circadian clock by directing the degradation of cryptochrome proteins	SCIENCE			English	Article							TRCP-MEDIATED DEGRADATION; GENE-EXPRESSION; CELL-GROWTH; IN-VIVO; PLAYS; WEB	One component of the circadian clock in mammals is the Clock-Bmal1 heterodimeric transcription factor. Among its downstream targets, two genes, Cry1 and Cry2, encode inhibitors of the Clock-Bmal1 complex that establish a negative-feedback loop. We found that both Cry1 and Cry2 proteins are ubiquitinated and degraded via the SCFFbxl3 ubiquitin ligase complex. This regulation by SCFFbxl3 is a prerequisite for the efficient and timely reactivation of Clock-Bmal1 and the consequent expression of Per1 and Per2, two regulators of the circadian clock that display tumor suppressor activity. Silencing of Fbxl3 produced no effect in Cry1(-/-); Cry2(-/-) cells, which shows that Fbxl3 controls clock oscillations by mediating the degradation of CRY proteins.	NYU, Dept Pathol, Inst Canc, Sch Med, New York, NY 10016 USA; European Inst Oncol, I-20141 Milan, Italy; Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA; MRC, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England; Merck Res Labs, Boston, MA 02115 USA	New York University; IRCCS European Institute of Oncology (IEO); State University System of Florida; Florida State University; MRC Harwell; Merck & Company	Pagano, M (corresponding author), NYU, Dept Pathol, Inst Canc, Sch Med, 550 1st Ave,MSB 599, New York, NY 10016 USA.	michele.pagano@med.nyu.edu	Nolan, Patrick/W-3918-2019	Nolan, Patrick/0000-0001-5550-0334; pagano, michele/0000-0003-3210-2442	MRC [MC_UP_1502/1, MC_U142684173, MC_U142684175, MC_U142684172] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R21CA125173, R37CA076584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER; Medical Research Council [MC_UP_1502/1, MC_U142684173, MC_U142684175, MC_U142684172] Funding Source: Medline; NCI NIH HHS [R21-CA125173, R37-CA76584] Funding Source: Medline; NIGMS NIH HHS [R01-GM57587] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; GODINHO SIH, 2007, IN PRESS SCIENC 0427; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; MATSUO D, 2003, SCIENCE         0821; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Okamura H, 2004, J BIOL RHYTHM, V19, P388, DOI 10.1177/0748730404269169; PANDO MP, 2001, SCI SIKE, V2001; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Wallsser JA, 2006, DEV CELL, V10, P539, DOI 10.1016/j.devcel.2006.04.014; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301	22	374	387	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2007	316	5826					900	904		10.1126/science.1141194	http://dx.doi.org/10.1126/science.1141194			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17463251				2022-12-01	WOS:000246369800041
J	Eichler, EE; Nickerson, DA; Altshuler, D; Bowcock, AM; Brooks, LD; Carter, NP; Church, DM; Felsenfeld, A; Guyer, M; Lee, C; Lupski, JR; Mullikin, JC; Pritchard, JK; Sebat, J; Sherry, ST; Smith, D; Valle, D; Waterston, RH				Eichler, Evan E.; Nickerson, Deborah A.; Altshuler, David; Bowcock, Anne M.; Brooks, Lisa D.; Carter, Nigel P.; Church, Deanna M.; Felsenfeld, Adam; Guyer, Mark; Lee, Charles; Lupski, James R.; Mullikin, James C.; Pritchard, Jonathan K.; Sebat, Jonathan; Sherry, Stephen T.; Smith, Douglas; Valle, David; Waterston, Robert H.		Human Genome Structural Variation	Completing the map of human genetic variation	NATURE			English	Article							COPY-NUMBER POLYMORPHISMS; HUMAN GENOME; STRUCTURAL VARIATION; LINKAGE DISEQUILIBRIUM; SEGMENTAL DUPLICATIONS; DELETION POLYMORPHISMS; Y-CHROMOSOMES; IDENTIFICATION; DISEASE; REARRANGEMENTS		Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; Wellcome Trust Sanger Inst, Hinxton CB4 5RW, England; Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Agencourt Biosci Corp, Beverly, MA 01915 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD 21025 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Wellcome Trust Sanger Institute; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Chicago; Cold Spring Harbor Laboratory; Johns Hopkins University	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Altshuler, David M/A-4476-2009	Altshuler, David M/0000-0002-7250-4107; Sebat, Jonathan/0000-0002-9087-526X; Bowcock, Anne/0000-0001-8691-9090; Sherry, Stephen/0000-0002-7982-076X	Wellcome Trust [077008] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200330] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [Z01LM000160] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Bhangale TR, 2005, HUM MOL GENET, V14, P59, DOI 10.1093/hmg/ddi006; Buckland PR, 2003, ANN MED, V35, P308, DOI 10.1080/07853890310001276; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Cooley T. B., 1925, T AM PEDIATRIC SOCIE, V37, P29; Deeb SS, 2005, CLIN GENET, V67, P369, DOI 10.1111/j.1399-0004.2004.00343.x; Duncan IW, 2002, ANNU REV GENET, V36, P521, DOI 10.1146/annurev.genet.36.060402.100441; Eichler EE, 2006, NAT GENET, V38, P9, DOI 10.1038/ng0106-9; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Fucharoen S, 2002, INT J HEMATOL, V76, P83, DOI 10.1007/BF03165094; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jakobsson J, 2006, J CLIN ENDOCR METAB, V91, P687, DOI 10.1210/jc.2005-1643; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; LACKNER C, 1993, HUM MOL GENET, V2, P933, DOI 10.1093/hmg/2.7.933; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levine P, 1941, J AMER MED ASSOC, V116, P825, DOI 10.1001/jama.1941.02820090025006; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Park J, 2006, CANCER EPIDEM BIOMAR, V15, P1473, DOI 10.1158/1055-9965.EPI-06-0141; Rao YS, 2000, MOL PHARMACOL, V58, P747, DOI 10.1124/mol.58.4.747; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Schmutz J, 2004, NATURE, V431, P268, DOI 10.1038/nature02919; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2006, ANNU REV GENOM HUM G, V7, P407, DOI 10.1146/annurev.genom.7.080505.115618; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wagner F F, 2004, Immunohematology, V20, P23; Weber JL, 2002, AM J HUM GENET, V71, P854, DOI 10.1086/342727; Wilson EB, 1911, ARCH MIKROSK ANAT, V77, P249; Wirtenberger M, 2006, AM J HUM GENET, V78, P520, DOI 10.1086/500793	46	146	158	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2007	447	7141					161	165		10.1038/447161a	http://dx.doi.org/10.1038/447161a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17495918	Bronze, Green Accepted			2022-12-01	WOS:000246338700034
J	Wellen, KE; Fucho, R; Gregor, MF; Furuhashi, M; Morgan, C; Lindstad, T; Vaillancourt, E; Gorgun, CZ; Saatcioglu, F; Hotamisligil, GS				Wellen, Kathryn E.; Fucho, Raquel; Gregor, Margaret F.; Furuhashi, Masato; Morgan, Carlos; Lindstad, Torstein; Vaillancourt, Eric; Gorgun, Cem Z.; Saatcioglu, Fahri; Hotamisligil, Gokhan S.			Coordinated regulation of nutrient and inflammatory responses by STAMP2 is essential for metabolic homeostasis	CELL			English	Article							NECROSIS-FACTOR-ALPHA; INDUCED INSULIN-RESISTANCE; ADIPOSE-RELATED PROTEIN; PROSTATE-CANCER; IKK-BETA; MOLECULAR-CLONING; OBESITY; STRESS; GENE; ADIPOCYTES	Metabolic and inflammatory pathways crosstalk at many levels, and, while required for homeostasis, interaction between these pathways can also lead to metabolic dysregulation under conditions of chronic stress. Thus, we hypothesized that mechanisms might exist to prevent overt inflammatory responses during physiological fluctuations in nutrients or under nutrient-rich conditions, and we identified the six-transmembrane protein STAMP2 as a critical modulator of this integrated response system of inflammation and metabolism in adipocytes. Lack of STAMP2 in adipocytes results in aberrant inflammatory responses to both nutrients and acute inflammatory stimuli. Similarly, in whole animals, visceral adipose tissue of STAMP2(-/-) mice exhibits overt inflammation, and these mice develop spontaneous metabolic disease on a regular diet, manifesting insulin resistance, glucose intolerance, mild hyperglycemia, dyslipidemia, and fatty liver disease. We conclude that STAMP2 participates in integrating inflammatory and metabolic responses and thus plays a key role in systemic metabolic homeostasis.	Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; Univ Oslo, Dept Mol Biosci, N-0316 Oslo, Norway	Harvard University; Harvard T.H. Chan School of Public Health; University of Oslo	Hotamisligil, GS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	ghotamis@hsph.harvard.edu	Eckhardt, Erik/G-1567-2010; Furuhashi, Masato/AAT-5518-2021; Fucho, Raquel/A-6684-2016	Furuhashi, Masato/0000-0002-0145-3541; Fucho, Raquel/0000-0002-1774-9099; Vaillancourt, Eric/0000-0002-1810-126X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T90DK070078, P30DK040561, R01DK052539] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK052539-04, R01 DK052539-08, R01 DK052539-05, R01 DK052539, P30 DK040561, R01 DK052539-02, R01 DK052539-10, R01 DK052539-07, T90 DK070078, R01 DK052539-09, P30 DK040561-12, R01 DK052539-06S1, DK52539, R01 DK052539-06, R01 DK052539-03] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Einstein FH, 2005, DIABETES, V54, P672, DOI 10.2337/diabetes.54.3.672; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Fasshauer M, 2004, FEBS LETT, V560, P153, DOI 10.1016/S0014-5793(04)00096-1; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Howard JK, 2004, NAT MED, V10, P734, DOI 10.1038/nm1072; Hubert RS, 1999, P NATL ACAD SCI USA, V96, P14523, DOI 10.1073/pnas.96.25.14523; Korkmaz CG, 2005, ONCOGENE, V24, P4934, DOI 10.1038/sj.onc.1208677; Korkmaz KS, 2002, J BIOL CHEM, V277, P36689, DOI 10.1074/jbc.M202414200; Lefebvre AM, 1998, DIABETES, V47, P98, DOI 10.2337/diabetes.47.1.98; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; Moldes M, 2001, J BIOL CHEM, V276, P33938, DOI 10.1074/jbc.M105726200; Mooney RA, 2001, J BIOL CHEM, V276, P25889, DOI 10.1074/jbc.M010579200; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Passer BJ, 2003, P NATL ACAD SCI USA, V100, P2284, DOI 10.1073/pnas.0530298100; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Rosen ED, 2000, GENE DEV, V14, P1293; Slagsvold T, 2001, J BIOL CHEM, V276, P31030, DOI 10.1074/jbc.M104310200; Steiner MS, 2000, CANCER RES, V60, P4419; Steppan CM, 2004, J INTERN MED, V255, P439, DOI 10.1111/j.1365-2796.2004.01306.x; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2004, ENDOCRINOLOGY, V145, P2214, DOI 10.1210/en.2003-1580; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	38	165	179	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					537	548		10.1016/j.cell.2007.02.049	http://dx.doi.org/10.1016/j.cell.2007.02.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482547	Green Published, Green Accepted, Bronze			2022-12-01	WOS:000246373600020
J	Pettersson, A; Richiardi, L; Nordenskjold, A; Kaijser, M; Akre, O				Pettersson, Andreas; Richiardi, Lorenzo; Nordenskjold, Agneta; Kaijser, Magnus; Akre, Olof			Age at surgery for undescended testis and risk of testicular cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INGUINAL-HERNIA; CRYPTORCHIDISM; ORCHIDOPEXY; ABNORMALITIES; DESCENT; COHORT; BOYS; MEN	BACKGROUND: Undescended testis, which is a risk factor for testicular cancer, is usually treated surgically, but whether the age at treatment has any effect on the risk is unclear. We studied the relation between the age at treatment for undescended testis and the risk of testicular cancer. METHODS: We identified men who underwent orchiopexy for undescended testis in Sweden between 1964 and 1999. Cohort subjects were identified in the Swedish Hospital Discharge Register and followed for the occurrence of testicular cancer through the Swedish Cancer Registry. Vital statistics and data on migration status were taken from the Register of Population and Population Changes for the years 1965 through 2000. We estimated the relative risk of testicular cancer using Poisson regression of standardized incidence ratios, comparing the risk in the cohort with that in the general population. We also analyzed the data by means of Cox regression, using internal comparison groups. RESULTS: The cohort consisted of 16,983 men who were surgically treated for undescended testis and followed for a total of 209,984 person-years. We identified 56 cases of testicular cancer during follow-up. The relative risk of testicular cancer among those who underwent orchiopexy before reaching 13 years of age was 2.23 (95% confidence interval [CI], 1.58 to 3.06), as compared with the Swedish general population; for those treated at 13 years of age or older, the relative risk was 5.40 (95% CI, 3.20 to 8.53). The effect of age at orchiopexy on the risk of testicular cancer was similar in comparisons within the cohort. CONCLUSIONS: Treatment for undescended testis before puberty decreases the risk of testicular cancer.	Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden; Karolinska Inst, Dept Women & Child Hlth, Div Pediat Surg, Stockholm, Sweden; Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; Karolinska Inst, Danderyds Hosp, Dept Clin Sci, Stockholm, Sweden; Univ Turin, Ctr Expt Res & Med Sci, Canc Epidemiol Unit, Turin, Italy; Univ Turin, Ctr Oncol Prevent, Turin, Italy	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; University of Turin; University of Turin	Pettersson, A (corresponding author), Karolinska Univ Hosp, Clin Epidemiol Unit, M9-01, SE-17176 Stockholm, Sweden.	andreas.h.pettersson@ki.se	Kaijser, Magnus/ABB-5970-2021; richiardi, lorenzo/J-3480-2018	Kaijser, Magnus/0000-0003-4064-0822; Nordenskjold, Agneta/0000-0001-6638-4631; richiardi, lorenzo/0000-0003-0316-9402				Bergstrom R, 1996, J NATL CANCER I, V88, P727, DOI 10.1093/jnci/88.11.727; BERKOWITZ GS, 1993, PEDIATRICS, V92, P44; Dieckmann KP, 2004, WORLD J UROL, V22, P2, DOI 10.1007/s00345-004-0398-8; Ekbom A, 1998, SEMIN CANCER BIOL, V8, P237, DOI 10.1006/scbi.1998.0073; FORMAN D, 1994, BRIT MED J, V308, P1393, DOI 10.1136/bmj.308.6941.1393; Hack WWM, 2003, BJU INT, V92, P293, DOI 10.1046/j.1464-410X.2003.04317.x; Herrinton LJ, 2003, AM J EPIDEMIOL, V157, P602, DOI 10.1093/aje/kwg012; Hutson JM, 2005, CELL TISSUE RES, V322, P155, DOI 10.1007/s00441-005-1126-4; Hutson JM, 2005, J PEDIATR SURG, V40, P297, DOI 10.1016/j.jpedsurg.2004.10.033; Kass E, 1996, PEDIATRICS, V97, P590; Moller H, 1996, CANCER CAUSE CONTROL, V7, P264, DOI 10.1007/BF00051302; *NAT BOARD HLTH WE, 2005, CANC INC SWED 2004; *NAT BOARD HLTH WE, 2006, HLTH REG COV SWED IN; PIKE MC, 1986, LANCET, V1, P1246; PINCZOWSKI D, 1991, J UROLOGY, V146, P1291, DOI 10.1016/S0022-5347(17)38071-0; POTTERN LM, 1985, J NATL CANCER I, V74, P377; Prener A, 1996, EPIDEMIOLOGY, V7, P14, DOI 10.1097/00001648-199601000-00004; Rajpert-De Meyts E, 2006, HUM REPROD UPDATE, V12, P303, DOI 10.1093/humupd/dmk006; STRADER CH, 1988, AM J EPIDEMIOL, V127, P1013, DOI 10.1093/oxfordjournals.aje.a114877; Swerdlow AJ, 1997, BRIT MED J, V315, P1129; Swerdlow AJ, 1997, BRIT MED J, V314, P1507, DOI 10.1136/bmj.314.7093.1507; Toledano MB, 2003, ENVIRON HEALTH PERSP, V111, P129, DOI 10.1289/ehp.5446; Toppari J, 1999, HORM RES, V51, P261, DOI 10.1159/000023412	23	282	295	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2007	356	18					1835	1841		10.1056/NEJMoa067588	http://dx.doi.org/10.1056/NEJMoa067588			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	163CL	17476009	Green Published			2022-12-01	WOS:000246136200005
J	Singleton, RJ; Hennessy, TW; Bulkow, LR; Hammitt, LL; Zulz, T; Hurlburt, DA; Butler, JC; Rudolph, K; Parkinson, A				Singleton, Rosalyn J.; Hennessy, Thomas W.; Bulkow, Lisa R.; Hammitt, Laura L.; Zulz, Tammy; Hurlburt, Debby A.; Butler, Jay C.; Rudolph, Karen; Parkinson, Alan			Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONSUSCEPTIBLE STREPTOCOCCUS-PNEUMONIAE; FIELD GEL-ELECTROPHORESIS; ANTIMICROBIAL RESISTANCE; NASOPHARYNGEAL CARRIAGE; IMPACT; COLONIZATION; EPIDEMIOLOGY; IMMUNIZATION; POPULATION; PATTERNS	Context With routine childhood vaccination using heptavalent pneumococcal conjugate vaccine, one concern has been the potential for emergence and expansion of replacement disease caused by serotypes not contained in the heptavalent conjugate vaccine. Objective To determine whether replacement disease is associated with the overall decline in invasive pneumococcal disease among Alaska Native children. Design, Setting, and Patients Alaska statewide longitudinal population-based laboratory surveillance of invasive Streptococcus pneumoniae infections from January 1, 1995, through December 31, 2006. Main Outcome Measures Incidence and types of pneumococcal disease in children younger than 2 years. Results In the first 3 years after introduction of routine vaccination with heptavalent pneumococcal conjugate vaccine, overall invasive pneumococcal disease decreased 67% in Alaska Native children younger than 2 years (from 403.2 per 100 000 in 1995-2000 to 134.3 per 100 000 per year in 2001-2003, P < .001). However, between 2001-2003 and 2004-2006, there was an 82% increase in invasive disease in Alaska Native children younger than 2 years to 244.6/100 000 (P = .02). Since 2004, the invasive pneumococcal disease rate caused by nonvaccine serotypes has increased 140% compared with the prevaccine period (from 95.1 per 100 000 in 1995-2000 to 228.6 in 2004-2006, P = .001). During the same period, there was a 96% decrease in heptavalent vaccine serotype disease. Serotype 19A accounted for 28.3% of invasive pneumococcal disease among Alaska children younger than 2 years during 2004-2006. There was no significant increase in nonvaccine disease in non-Native Alaska children younger than 2 years. Conclusions Alaska Native children are experiencing replacement invasive pneumococcal disease with serotypes not covered by heptavalent pneumococcal conjugate vaccine. The demonstration of replacement invasive pneumococcal disease emphasizes the importance of ongoing surveillance and development of expanded valency vaccines.	Ctr Dis Control & Prevent, Arctic Invest Program, Natl Ctr Preparedness Detect & Control Infect Dis, Anchorage, AK 99508 USA; Alaska Native Tribal Hlth Consortium, Anchorage, AK USA; Alaska Div Publ Hlth, Anchorage, AK USA	Centers for Disease Control & Prevention - USA; Alaska Native Tribal Health Consortium	Singleton, RJ (corresponding author), Ctr Dis Control & Prevent, Arctic Invest Program, Natl Ctr Preparedness Detect & Control Infect Dis, 4055 Tudor Ctr Dr, Anchorage, AK 99508 USA.	ris2@cdc.gov						[Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 5 INT S PNEUM PNEUM; Black SB, 2001, PEDIATR INFECT DIS J, V20, P1105, DOI 10.1097/00006454-200112000-00002; Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820; BYLINGTON CL, 2006, PEDIATR INFECT DIS J, V25, P250; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P893; *CDCP, 2006, Q32003Q22004 CDCP NA; Dagan R, 2003, PEDIATR INFECT DIS J, V22, P532, DOI 10.1097/00006454-200306000-00009; Dagan R, 1997, PEDIATR INFECT DIS J, V16, P1060, DOI 10.1097/00006454-199711000-00011; DAVIDSON M, 1994, J INFECT DIS, V170, P368, DOI 10.1093/infdis/170.2.368; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Flannery B, 2004, JAMA-J AM MED ASSOC, V291, P2197, DOI 10.1001/jama.291.18.2197; Flannery B, 2006, ANN INTERN MED, V144, P1, DOI 10.7326/0003-4819-144-1-200601030-00004; Ghaffar F, 2004, CLIN INFECT DIS, V39, P930, DOI 10.1086/423379; Hammitt LL, 2006, J INFECT DIS, V193, P1487, DOI 10.1086/503805; HAMMITT LL, 2006, 5 INT S PNEUM PNEUM; Hennessy TW, 2005, VACCINE, V23, P5464, DOI 10.1016/j.vaccine.2005.08.100; Kaplan SL, 2004, PEDIATRICS, V113, P443, DOI 10.1542/peds.113.3.443; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; McEllistrem MC, 2005, CLIN INFECT DIS, V40, P1738, DOI 10.1086/429908; McEllistrem MC, 2000, J CLIN MICROBIOL, V38, P351; Moore MR, 2004, J INFECT DIS, V190, P2031, DOI 10.1086/425422; National Committee for Clinical Laboratory Standards, 2003, METH DIL ANT SUSC TE; O'Brien KL, 2004, AM J EPIDEMIOL, V160, P270, DOI 10.1093/aje/kwh191; O'Brien KL, 2003, LANCET, V362, P355, DOI 10.1016/S0140-6736(03)14022-6; Obaro SK, 1996, LANCET, V348, P271, DOI 10.1016/S0140-6736(05)65585-7; OBRIEN KL, 2006, 5 ANN INT S PNEUM PN; Pai R, 2005, J INFECT DIS, V192, P1988, DOI 10.1086/498043; Poehling KA, 2006, JAMA-J AM MED ASSOC, V295, P1668, DOI 10.1001/jama.295.14.1668; Porat N, 2004, J INFECT DIS, V190, P2154, DOI 10.1086/425908; Ramani RR, 2004, AM J PUBLIC HEALTH, V94, P958, DOI 10.2105/AJPH.94.6.958; Rothman KJ, 1986, MODERN EPIDEMIOLOGY; Rudolph KM, 2000, J INFECT DIS, V182, P490, DOI 10.1086/315716; Rudolph KM, 1998, J CLIN MICROBIOL, V36, P2703, DOI 10.1128/JCM.36.9.2703-2707.1998; RUDOLPH KM, 2006, 5 INT S PNEUM PNEUM; Salmon DA, 2006, EPIDEMIOL REV, V28, P27, DOI 10.1093/epirev/mxj001; Sjostrom K, 2006, CLIN INFECT DIS, V42, P451, DOI 10.1086/499242; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Tan TQ, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.1; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	43	499	520	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2007	297	16					1784	1792		10.1001/jama.297.16.1784	http://dx.doi.org/10.1001/jama.297.16.1784			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	160DW	17456820				2022-12-01	WOS:000245922100024
J	Kaufmann, T; Tai, L; Ekert, PG; Huang, DCS; Norris, F; Lindemann, RK; Johnstone, RW; Dixit, VM; Strasser, A				Kaufmann, Thomas; Tai, Lin; Ekert, Paul G.; Huang, David C. S.; Norris, Fiona; Lindemann, Ralph K.; Johnstone, Ricky W.; Dixit, Vishva M.; Strasser, Andreas			The BH3-only protein bid is dispensable for DNA darnage- and replicative stress-induced apoptosis or cell-cycle arrest	CELL			English	Article							FAMILY-MEMBER BIM; BH3 DOMAINS; BCL-2; DEATH; MITOCHONDRIA; DELETION; DAMAGE; HOMEOSTASIS; RESPONSES; PUMA	Bid, a caspase-activated proapoptotic BH3 only protein, is essential for Fas-induced hepatocyte destruction. Recent studies published in Cell produced conflicting results, indicating that loss of Bid either protects or enhances apoptosis induced by DNA damage or replicative stress. To resolve this controversy, we generated novel Bid-deficient mice on an inbred C57BL/6 background and removed the drugselection cassette from the targeted locus. Nine distinct cell types from these Bid-deficient mice underwent cell-cycle arrest and apoptosis in a manner indistinguishable from control WT cells in response to DNA damage or replicative stress. Moreover, we found that even cells from the original Bid-deficient mice responded normally to these stimuli, indicating that differences in genetic background or the presence of a strong promoter within the targeted locus are unlikely to explain the differences between our results and those reported previously. We conclude that Bid has no role in DNA damage- or replicative stress-induced apoptosis or cellcycle arrest.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Royal Childrens Hosp, Murdoch Childrens Res Inst, Childrens Canc Ctr, Parkville, Vic 3052, Australia; VCGS Pathol, Cytogenet Lab, Parkville, Vic 3052, Australia; Peter MacCallum Canc Ctr, Melbourne, Vic 3000, Australia; Genentech Inc, San Francisco, CA 94080 USA	Walter & Eliza Hall Institute; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Peter Maccallum Cancer Center; Roche Holding; Genentech	Strasser, A (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	strasser@wehi.edu.au	Strasser, Andreas/C-7581-2013; Johnstone, Ricky w/H-3748-2014; Ekert, Paul G/C-7247-2013; Ekert, Paul/Q-1842-2015; dixit, vishva m/A-4496-2012; Huang, David C. S./C-7586-2013	Strasser, Andreas/0000-0002-5020-4891; Johnstone, Ricky w/0000-0001-7053-9237; Ekert, Paul G/0000-0002-2976-8617; Ekert, Paul/0000-0002-2976-8617; dixit, vishva m/0000-0001-6983-0326; Huang, David C. S./0000-0002-3101-4873; Kaufmann, Thomas/0000-0001-9906-874X	NATIONAL CANCER INSTITUTE [R01CA080188, R01CA043540] Funding Source: NIH RePORTER; NCI NIH HHS [CA 43540, CA 80188] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Bai L, 2005, AM J PATHOL, V166, P1523, DOI 10.1016/S0002-9440(10)62368-1; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Ekert PG, 2006, BLOOD, V108, P1461, DOI 10.1182/blood-2006-03-014209; Ekert PG, 2004, J CELL BIOL, V165, P835, DOI 10.1083/jcb.200312031; Enders A, 2003, J EXP MED, V198, P1119, DOI 10.1084/jem.20030411; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Kamer I, 2005, CELL, V122, P593, DOI 10.1016/j.cell.2005.06.014; KOYASU S, 1994, EMBO J, V13, P784, DOI 10.1002/j.1460-2075.1994.tb06321.x; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Pellegrini M, 2003, P NATL ACAD SCI USA, V100, P14175, DOI 10.1073/pnas.2336198100; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Sax JK, 2002, NAT CELL BIOL, V4, P842, DOI 10.1038/ncb866; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shibue T, 2003, GENE DEV, V17, P2233, DOI 10.1101/gad.1103603; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; Tagawa H, 2005, ONCOGENE, V24, P1348, DOI 10.1038/sj.onc.1208300; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zinkel SS, 2005, CELL, V122, P579, DOI 10.1016/j.cell.2005.06.022; Zinkel SS, 2003, GENE DEV, V17, P229, DOI 10.1101/gad.1045603	34	161	165	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2007	129	2					423	433		10.1016/j.cell.2007.03.017	http://dx.doi.org/10.1016/j.cell.2007.03.017			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448999	Bronze			2022-12-01	WOS:000246474600027
J	Konstantinova, I; Nikolova, G; Ohara-Imaizumi, M; Meda, P; Kucera, T; Zarbalis, K; Wurst, W; Nagamatsu, S; Lammert, E				Konstantinova, Irena; Nikolova, Ganka; Ohara-Imaizumi, Mica; Meda, Paolo; Kucera, Tomas; Zarbalis, Konstantinos; Wurst, Wolfgang; Nagamatsu, Shinya; Lammert, Eckhard			EphA-ephrin-A-mediated beta cell communication regulates insulin secretion from pancreatic islets	CELL			English	Article							TYROSINE-PHOSPHATASE; SYNAPTIC FUNCTION; MEMBRANE DOMAINS; B-CELLS; RECEPTORS; CONTACT; GLUCOSE; ENDOCYTOSIS; EXPRESSION; REPULSION	Invertebrates, beta cells are aggregated in the form of pancreatic islets. Within these islets, communication between beta cells inhibits basal insulin secretion and enhances glucose-stimulated insulin secretion, thus contributing to glucose homeostasis during fasting and feeding. In the search for the underlying molecular mechanism, we have discovered that beta cells communicate via ephrin-As and EphAs. We provide evidence that ephrin-A5 is required for glucosestimulated insulin secretion. We further show that EphA-ephrin-A-mediated beta cell communication is bidirectional: EphA forward signaling inhibits insulin secretion, whereas ephrin-A reverse signaling stimulates insulin secretion. EphA forward signaling is downregulated in response to glucose, which indicates that, under basal conditions, beta cells use EphA forward signaling to suppress insulin secretion and that, under stimulatory conditions, they shift to ephrin-A reverse signaling to enhance insulin secretion. Thus, we explain how beta cell communication in pancreatic islets conversely affects basal and glucose-stimulated insulin secretion to improve glucose homeostasis.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Kyorin Univ, Sch Med, Tokyo 1818611, Japan; Univ Geneva, CH-1211 Geneva, Switzerland; Tech Univ Munich, GSF, Natl Res Ctr, Inst Dev Genet, D-85764 Munich, Germany	Max Planck Society; Kyorin University; University of Geneva; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Lammert, E (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	lammert@mpi-cbg.de	Kučera, Tomáš/C-7532-2017	Kučera, Tomáš/0000-0003-2134-4657; Wurst, Wolfgang/0000-0003-4422-7410				Armstrong JN, 2006, J NEUROSCI, V26, P3474, DOI 10.1523/JNEUROSCI.4338-05.2006; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; BOSCO D, 1989, EXP CELL RES, V184, P72, DOI 10.1016/0014-4827(89)90365-0; Carvalho RF, 2006, NAT NEUROSCI, V9, P322, DOI 10.1038/nn1655; Dahl U, 1996, DEVELOPMENT, V122, P2895; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Davy A, 2006, PLOS BIOL, V4, P1763, DOI 10.1371/journal.pbio.0040315; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Gao PP, 1998, P NATL ACAD SCI USA, V95, P5329, DOI 10.1073/pnas.95.9.5329; Gogg S, 2001, BIOCHEM BIOPH RES CO, V280, P1161, DOI 10.1006/bbrc.2000.4239; Grapin-Botton A, 2000, TRENDS GENET, V16, P124, DOI 10.1016/S0168-9525(99)01957-5; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; HALBAN PA, 1982, ENDOCRINOLOGY, V111, P86, DOI 10.1210/endo-111-1-86; Halban PA, 2004, NAT CELL BIOL, V6, P1021, DOI 10.1038/ncb1104-1021; Hauge-Evans AC, 1999, DIABETES, V48, P1402, DOI 10.2337/diabetes.48.7.1402; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Himanen JP, 2003, TRENDS NEUROSCI, V26, P46, DOI 10.1016/S0166-2236(02)00005-X; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; HOPCROFT DW, 1985, ENDOCRINOLOGY, V117, P2073, DOI 10.1210/endo-117-5-2073; Knoll B, 2001, DEVELOPMENT, V128, P895; Kowluru A, 2005, DIABETES, V54, P3523, DOI 10.2337/diabetes.54.12.3523; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; LI GD, 1994, MOL BIOL CELL, V5, P1199, DOI 10.1091/mbc.5.11.1199; Li JS, 2004, AM J PHYSIOL-ENDOC M, V286, pE818, DOI 10.1152/ajpendo.00307.2003; Luther MJ, 2006, BIOCHEM BIOPH RES CO, V343, P99, DOI 10.1016/j.bbrc.2006.02.003; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; MAES E, 1984, ENDOCRINOLOGY, V114, P2205, DOI 10.1210/endo-114-6-2205; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; MEDA P, 1990, J CLIN INVEST, V86, P759, DOI 10.1172/JCI114772; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Murai KK, 2004, NEUROSCIENTIST, V10, P304, DOI 10.1177/1073858403262221; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; ORCI L, 1972, SCIENCE, V175, P1128, DOI 10.1126/science.175.4026.1128; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Parri M, 2005, J BIOL CHEM, V280, P34008, DOI 10.1074/jbc.M502879200; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Ravier MA, 2005, DIABETES, V54, P1798, DOI 10.2337/diabetes.54.6.1798; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Shintani T, 2006, NAT NEUROSCI, V9, P761, DOI 10.1038/nn1697; Uhles S, 2003, J CELL BIOL, V163, P1327, DOI 10.1083/jcb.200306093; Wimmer-Kleikamp SH, 2004, J CELL BIOL, V164, P661, DOI 10.1083/jcb.200312001; Yamagata K, 2002, DIABETES, V51, P114, DOI 10.2337/diabetes.51.1.114; Zhuang GL, 2007, J BIOL CHEM, V282, P2683, DOI 10.1074/jbc.M608509200; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045	49	236	266	1	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 20	2007	129	2					359	370		10.1016/j.cell.2007.02.044	http://dx.doi.org/10.1016/j.cell.2007.02.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448994	Bronze			2022-12-01	WOS:000246474600022
J	Okamura, K; Hagen, JW; Duan, H; Tyler, DM; Lai, EC				Okamura, Katsutomo; Hagen, Joshua W.; Duan, Hong; Tyler, David M.; Lai, Eric C.			The mirtron pathway generates microRNA-class regulatory RNAs in Drosophila	CELL			English	Article							UTR SEQUENCE MOTIF; NUCLEAR EXPORT; C-ELEGANS; POSTTRANSCRIPTIONAL REGULATION; DISTINCT ROLES; K-BOX; GENES; IDENTIFICATION; INTERFERENCE; EXPRESSION	The canonical microRNA ( miRNA) pathway converts primary hairpin precursor transcripts into similar to 22 nucleotide regulatory RNAs via consecutive cleavages by two RNase III enzymes, Drosha and Dicer. In this study, we characterize Drosophila small RNAs that derive from short intronic hairpins termed `` mirtrons.'' Their nuclear biogenesis appears to bypass Drosha cleavage, which is essential for miRNA biogenesis. Instead, mirtron hairpins are defined by the action of the splicing machinery and lariat- debranching enzyme, which yield pre- miRNA- like hairpins. The mirtron pathway merges with the canonical miRNA pathway during hairpin export by Exportin- 5, and both types of hairpins are subsequently processed by Dicer- 1/ loqs. This generates small RNAs that can repress perfectly matched and seed- matched targets, and we provide evidence that they function, at least in part, via the RNA- induced silencing complex effector Ago1. These findings reveal that mirtrons are an alternate source of miRNA- type regulatory RNAs.	Mem Sloan Kettering Canc Ctr, Dept Dev Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Lai, EC (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Dev Biol, 1275 York Ave,Box 252, New York, NY 10021 USA.	laie@mskcc.org	Lai, Eric/AAO-1143-2021; Lai, Eric C/A-3412-2008	Lai, Eric/0000-0002-8432-5851; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739, R01GM083300] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM083300-01, T32 GM007739, R01 GM083300, GM07739] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Conklin JF, 2005, METHODS, V37, P368, DOI 10.1016/j.ymeth.2005.08.002; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 1998, CELL, V93, P1103, DOI 10.1016/S0092-8674(00)81454-3; Lai EC, 1997, DEVELOPMENT, V124, P4847; Lai EC, 1998, DEVELOPMENT, V125, P4077; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Ooi SL, 1998, RNA, V4, P1096, DOI 10.1017/S1355838298980785; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shibata S, 2006, NUCLEIC ACIDS RES, V34, P4711, DOI 10.1093/nar/gkl663; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu HJ, 2000, J BIOL CHEM, V275, P36957, DOI 10.1074/jbc.M005494200; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803	50	687	734	3	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2007	130	1					89	100		10.1016/j.cell.2007.06.028	http://dx.doi.org/10.1016/j.cell.2007.06.028			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WK	17599402	Bronze, Green Accepted			2022-12-01	WOS:000248587000013
J	Tauber, E; Zordan, M; Sandrelli, F; Pegoraro, M; Osterwalder, N; Breda, C; Daga, A; Selmin, A; Monger, K; Benna, C; Rosato, E; Kyriacou, CP; Costa, R				Tauber, Eran; Zordan, Mauro; Sandrelli, Federica; Pegoraro, Mirko; Osterwalder, Nicolo; Breda, Carlo; Daga, Andrea; Selmin, Alessandro; Monger, Karen; Benna, Clara; Rosato, Ezio; Kyriacou, Charalambos P.; Costa, Rodolfo			Natural selection favors a newly derived timeless allele in Drosophila melanogaster	SCIENCE			English	Article							CLOCK GENE; DIAPAUSE; MUTATIONS; REGION	Circadian and other natural clock-like endogenous rhythms may have evolved to anticipate regular temporal changes in the environment. We report that a mutation in the circadian clock gene timeless in Drosophila melanogaster has arisen and spread by natural selection relatively recently in Europe. We found that, when introduced into different genetic backgrounds, natural and artificial alleles of the timeless gene affect the incidence of diapause in response to changes in light and temperature. The natural mutant allele alters an important life history trait that may enhance the fly's adaptation to seasonal conditions.	Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Univ Padua, Dept Biol, I-35131 Padua, Italy	University of Leicester; University of Padua	Kyriacou, CP (corresponding author), Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England.	cpk@leicester.ac.uk	Tauber, Eran/AAA-1562-2022; benna, clara/K-1083-2018; Tauber, Eran/F-9826-2011; daga, andrea/J-1865-2018	Tauber, Eran/0000-0003-4018-6535; Tauber, Eran/0000-0003-4018-6535; daga, andrea/0000-0001-8935-5489; Breda, Carlo/0000-0002-6365-9828; SANDRELLI, FEDERICA/0000-0002-5631-7467; Rosato, Ezio/0000-0001-7297-4697; Pegoraro, Mirko/0000-0001-9381-5249; BENNA, CLARA/0000-0002-9077-2471	Natural Environment Research Council [NE/D012058/1] Funding Source: researchfish; NERC [NE/D012058/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bradshaw WE, 2003, AM NAT, V161, P735, DOI 10.1086/374344; COSTA R, 1992, P ROY SOC B-BIOL SCI, V250, P43, DOI 10.1098/rspb.1992.0128; Fitzpatrick MJ, 2005, TRENDS ECOL EVOL, V20, P96, DOI 10.1016/j.tree.2004.11.017; FU YX, 1993, GENETICS, V133, P693; Hall JC, 2003, ADV GENET, V48, P1, DOI 10.1016/S0065-2660(03)48000-0; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; HUDSON RR, 1994, GENETICS, V136, P1329; HUDSON RR, 1987, GENETICS, V116, P153; LACHAISE D, 1988, EVOL BIOL, V22, P159; MYERS MP, 1995, SCIENCE, V270, P805, DOI 10.1126/science.270.5237.805; Ousley A, 1998, GENETICS, V148, P815; Rosato E, 1997, GENET RES, V69, P89, DOI 10.1017/S001667239700267X; Rosato E, 1997, NUCLEIC ACIDS RES, V25, P455, DOI 10.1093/nar/25.3.455; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Sandrelli F, 2007, SCIENCE, V316, P1898, DOI 10.1126/science.1138426; SAUNDERS DS, 1989, P NATL ACAD SCI USA, V86, P3748, DOI 10.1073/pnas.86.10.3748; Sawyer LA, 1997, SCIENCE, V278, P2117, DOI 10.1126/science.278.5346.2117; Schmidt PS, 2006, EVOLUTION, V60, P1602, DOI 10.1111/j.0014-3820.2006.tb00505.x; Schmidt PS, 2005, EVOLUTION, V59, P2616, DOI 10.1111/j.0014-3820.2005.tb00974.x; Schmidt PS, 2005, EVOLUTION, V59, P1721, DOI 10.1111/j.0014-3820.2005.tb01821.x; TAJIMA F, 1989, GENETICS, V123, P585; Williams KD, 2006, P NATL ACAD SCI USA, V103, P15911, DOI 10.1073/pnas.0604592103; WILLIAMS KD, 1993, HEREDITY, V71, P312, DOI 10.1038/hdy.1993.141	23	210	213	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2007	316	5833					1895	1898		10.1126/science.1138412	http://dx.doi.org/10.1126/science.1138412			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183WI	17600215				2022-12-01	WOS:000247602700039
J	Saalmann, YB; Pigarev, IN; Vidyasagar, TR				Saalmann, Yuri B.; Pigarev, Ivan N.; Vidyasagar, Trichur R.			Neural mechanisms of visual attention: How top-down feedback highlights relevant locations	SCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; POSTERIOR PARIETAL CORTEX; EXTRASTRIATE CORTEX; FEATURE-INTEGRATION; DIRECTED ATTENTION; FUNCTIONAL MRI; MODULATION; SPOTLIGHT; MACAQUE; MONKEY	Attention helps us process potentially important objects by selectively increasing the activity of sensory neurons that represent the relevant locations and features of our environment. This selection process requires top-down feedback about what is important in our environment. We investigated how parietal cortical output influences neural activity in early sensory areas. Neural recordings were made simultaneously from the posterior parietal cortex and an earlier area in the visual pathway, the medial temporal area, of macaques performing a visual matching task. When the monkey selectively attended to a location, the timing of activities in the two regions became synchronized, with the parietal cortex leading the medial temporal area. Parietal neurons may thus selectively increase activity in earlier sensory areas to enable focused spatial attention.	Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3010, Australia; Russian Acad Sci, Inst Informat Transmiss Problems, Moscow 127994, Russia	University of Melbourne; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences	Vidyasagar, TR (corresponding author), Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3010, Australia.	trv@unimelb.edu.au	Saalmann, Yuri B/AAW-5814-2021; Vidyasagar, Trichur/D-9665-2012; ivan, pigarev/AAP-5502-2021	Vidyasagar, Trichur/0000-0002-4148-2048; Saalmann, Yuri/0000-0001-8880-6698				Balan PF, 2006, J NEUROSCI, V26, P9239, DOI 10.1523/JNEUROSCI.1898-06.2006; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; BULLIER J, 1988, EXP BRAIN RES, V70, P90; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; CORBETTA M, 1993, J NEUROSCI, V13, P1202; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Sejnowski TJ, 2006, J NEUROSCI, V26, P1673, DOI 10.1523/JNEUROSCI.3737-05d.2006; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; STEINMETZ MA, 1995, CEREB CORTEX, V5, P448, DOI 10.1093/cercor/5.5.448; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Vidyasagar TR, 1998, NEUROREPORT, V9, P1947, DOI 10.1097/00001756-199806220-00006; Vidyasagar TR, 1999, BRAIN RES REV, V30, P66, DOI 10.1016/S0165-0173(99)00005-3; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Yantis S, 2003, CURR OPIN NEUROBIOL, V13, P187, DOI 10.1016/S0959-4388(03)00033-3	29	298	301	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1612	1615		10.1126/science.1139140	http://dx.doi.org/10.1126/science.1139140			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569863				2022-12-01	WOS:000247239900040
J	Tahiliani, M; Mei, PC; Fang, R; Leonor, T; Rutenberg, M; Shimizu, F; Li, J; Rao, A; Shi, YJ				Tahiliani, Mamta; Mei, Pinchao; Fang, Rui; Leonor, Thiago; Rutenberg, Michael; Shimizu, Fumiko; Li, Jing; Rao, Anjana; Shi, Yujiang			The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation	NATURE			English	Article							RESTRICTIVE SILENCER FACTOR; DOMAIN-CONTAINING PROTEINS; TRANSCRIPTIONAL REGULATION; CO-REPRESSOR; CHANNEL; JMJC; EXPRESSION; DISORDERS; MUTATIONS; EPILEPSY	Gene transcription is critically influenced by chromatin structure and the modification status of histone tails(1). Methylation of lysine residues in histone tails is dynamically regulated by the opposing activities of histone methyltransferases and histone demethylases(2). Here we show that JARID1C/SMCX, a JmjC-domain-containing protein implicated in X-linked mental retardation and epilepsy(3,4), possesses H3K4 tri-demethylase activity and functions as a transcriptional repressor. An SMCX complex isolated from HeLa cells contains additional chromatin modifiers (the histone deacetylases HDAC1 and HDAC2, and the histone H3K9 methyltransferase G9a) and the transcriptional repressor REST(5), suggesting a direct role for SMCX in chromatin dynamics and REST-mediated repression. Chromatin immunoprecipitation reveals that SMCX and REST co-occupy the neuron-restrictive silencing elements in the promoters of a subset of REST target genes. RNA-interference-mediated depletion of SMCX derepresses several of these targets and simultaneously increases H3K4 trimethylation at the sodium channel type 2A (SCN2A) and synapsin I (SYN1) promoters. We propose that loss of SMCX activity impairs REST-mediated neuronal gene regulation, thereby contributing to SMCX-associated X-linked mental retardation.	Brigham & Womens Hosp, Dept Med, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; Brigham & Womens Hosp, BCMP, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; CBR Inst Biomed Res, Boston, MA 02115 USA; Univ Florida, Coll Med, Dept Pathol, Gainesville, FL 32610 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); State University System of Florida; University of Florida	Shi, YJ (corresponding author), Brigham & Womens Hosp, Dept Med, Div Endocrinol Diabet & Hypertens, 221 Longwood Ave, Boston, MA 02115 USA.	yujiang_shi@hms.harvard.edu	Hu, Ruogu/B-2203-2008	Mei, Pinchao/0000-0002-1564-0372; Li, Jing/0000-0001-7699-4249	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078458] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM078458] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdolmaleky HM, 2005, AM J PHARMACOGENOMIC, V5, P149, DOI 10.2165/00129785-200505030-00002; Bahn S, 2002, LANCET, V359, P310, DOI 10.1016/S0140-6736(02)07497-4; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Clissold PM, 2001, TRENDS BIOCHEM SCI, V26, P7, DOI 10.1016/S0968-0004(00)01700-X; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnson R, 2006, NUCLEIC ACIDS RES, V34, P3862, DOI 10.1093/nar/gkl525; Kearney JA, 2001, NEUROSCIENCE, V102, P307, DOI 10.1016/S0306-4522(00)00479-6; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; KUROKAWA R, 1995, NATURE, V377, P451, DOI 10.1038/377451a0; Kuwahara K, 2005, J PHARMACOL SCI, V99, P211, DOI 10.1254/jphs.FMJ05002X4; Lee MG, 2007, CELL, V128, P877, DOI 10.1016/j.cell.2007.02.004; LEE N, 2007, NATURE STRUCT MOL BI; Lohoff FW, 2006, NEUROPSYCHOPHARMACOL, V31, P2739, DOI 10.1038/sj.npp.1301196; Lossin C, 2002, NEURON, V34, P877, DOI 10.1016/S0896-6273(02)00714-6; Lubec G, 2003, J NEURAL TRANSM-SUPP, P215; MORI N, 1992, NEURON, V9, P45, DOI 10.1016/0896-6273(92)90219-4; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Nelson KB, 2001, ANN NEUROL, V49, P597, DOI 10.1002/ana.1024.abs; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Schousboe A, 2004, EUR J PHARMACOL, V500, P281, DOI 10.1016/j.ejphar.2004.07.032; Secombe J, 2007, GENE DEV, V21, P537, DOI 10.1101/gad.1523007; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Splawski I, 2006, J BIOL CHEM, V281, P22085, DOI 10.1074/jbc.M603316200; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tzschach A, 2006, HUM MUTAT, V27, P389, DOI 10.1002/humu.9420; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001	38	320	336	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2007	447	7144					601	+		10.1038/nature05823	http://dx.doi.org/10.1038/nature05823			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17468742				2022-12-01	WOS:000246842000051
J	Gornall, J				Gornall, Jonathan			Protection for the innocent	BMJ-BRITISH MEDICAL JOURNAL			English	Article												jgornall@mac.com						BATT J, 2004, STOLEN INNOCENCE STO; *BRIS CHILDR YOUNG, 2002, SUDD UN DEATHS CHILD; *DEP ED SKILLS, 2006, WORK SAF CHILDR; Dyer C, 2005, BRIT MED J, V331, P1355, DOI 10.1136/bmj.331.7529.1355-a; Dyer C, 2005, BRIT MED J, V330, P1463, DOI 10.1136/bmj.330.7506.1463-a; Dyer C, 2007, BRIT MED J, V334, P602, DOI 10.1136/bmj.39160.770637.DB; Dyer O, 2004, BRIT MED J, V329, P366, DOI 10.1136/bmj.329.7462.366-a; Fleming PJ, 2004, BMJ-BRIT MED J, V328, P331, DOI 10.1136/bmj.328.7435.331; FLEMING PJ, 1990, BRIT MED J, V301, P85, DOI 10.1136/bmj.301.6743.85; *ROYAL COLL PAED C, 2002, FUT PAED PATH SERV; *ROYAL COLL PAED C, 2007, INV NAT IMP COMPL MA; *ROYAL COLL PATH R, 2004, SUDD UN DEATH INF; Williams C, 2007, PEDIATRICS, V119, P800, DOI 10.1542/peds.2006-1980	13	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2007	334	7603					1083	1085		10.1136/bmj.39206.389711.AD	http://dx.doi.org/10.1136/bmj.39206.389711.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	174XB	17525445	Green Published			2022-12-01	WOS:000246975000025
J	Idro, R; Ndiritu, M; Ogutu, B; Mithwani, S; Maitland, K; Berkley, J; Crawley, J; Fegan, G; Bauni, E; Peshu, N; Marsh, K; Neville, B; Newton, C				Idro, Richard; Ndiritu, Moses; Ogutu, Bernhards; Mithwani, Sadik; Maitland, Kathryn; Berkley, James; Crawley, Jane; Fegan, Gregory; Bauni, Evasius; Peshu, Norbert; Marsh, Kevin; Neville, Brian; Newton, Charles			Burden, features, and outcome of neurological involvement in acute falciparum malaria in Kenyan children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLASMODIUM-FALCIPARUM; CEREBRAL MALARIA; PROGNOSTIC INDICATORS; BACTERIAL-MENINGITIS; CLINICAL-FEATURES; CHILDHOOD MALARIA; TRANSMISSION; CONVULSIONS; EPILEPSY; AFRICA	Context Plasmodium falciparum appears to have a particular propensity to involve the brain but the burden, risk factors, and full extent of neurological involvement have not been systematically described. Objectives To determine the incidence and describe the clinical phenotypes and outcomes of neurological involvement in African children with acute falciparum malaria. Design, Setting, and Patients A review of records of all children younger than 14 years admitted to a Kenyan district hospital with malaria from January 1992 through December 2004. Neurological involvement was defined as convulsive seizures, agitation, prostration, or impaired consciousness or coma. Main Outcome Measures The incidence, pattern, and outcome of neurological involvement. Results Of 58 239 children admitted, 19 560 (33.6%) had malaria as the primary clinical diagnosis. Neurological involvement was observed in 9313 children (47.6%) and manifested as seizures (6563/17517 [37.5%]), agitation (316/11193 [2.8%]), prostration (3223/15643 [20.6%]), and impaired consciousness or coma (2129/16080 [13.2%]). In children younger than 5 years, the mean annual incidence of admissions with malaria was 2694 per 100 000 persons and the incidence of malaria with neurological involvement was 1156 per 100 000 persons. However, readmissions may have led to a 10% overestimate in incidence. Children with neurological involvement were older (median, 26 [interquartile range {IQR}, 15-41] vs 21 [IQR, 10-40] months; P < .001), had a shorter duration of illness (median, 2 [IQR, 1-3] vs 3 [IQR, 2-3] days; P < .001), and a higher geometric mean parasite density (42.0 [95% confidence interval {CI}, 40.0-44.1] vs 30.4 [95% CI, 29.0-31.8] x 10(3)/mu L; P < .001). Factors independently associated with neurological involvement included past history of seizures (adjusted odds ratio [AOR], 3.50; 95% CI, 2.78-4.42), fever lasting 2 days or less (AOR, 2.02; 95% CI, 1.64-2.49), delayed capillary refill time (AOR, 3.66; 95% CI, 2.40-5.56), metabolic acidosis (AOR, 1.55; 95% CI, 1.29-1.87), and hypoglycemia (AOR, 2.11; 95% CI, 1.31-3.37). Mortality was higher in patients with neurological involvement (4.4% [95% CI, 4.2%-5.1%] vs 1.3% [95% CI, 1.1%-1.5%]; P < .001). At discharge, 159 (2.2%) of 7281 patients had neurological deficits. Conclusions Neurological involvement is common in children in Kenya with acute falciparum malaria, and is associated with metabolic derangements, impaired perfusion, parasitemia, and increased mortality and neurological sequelae. This study suggests that falciparum malaria exposes many African children to brain insults.	Kenya Govt Med Res Ctr, Wellcome Trust Res Labs, Ctr Geog Med Res, Kilifi 80108, Kenya; Makerere Univ, Mulago Hosp, Dept Pediat & Child Hlth, Kampala, Uganda; Kenya Govt Med Res Ctr, Clin Res Ctr, Walter Reed Project, Kisumu, Kenya; Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England; Univ London Imperial Coll Sci Technol & Med, Wellcome Trust Ctr Trop Med, London, England; Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England; London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Infect Dis Epidemiol Unit, London WC1, England; UCL, Inst Child Hlth, Wolfson Ctr, Neurosci Unit, London, England	Kenya Medical Research Institute; Makerere University; Mulago National Referral Hospital; Kenya Medical Research Institute; Imperial College London; Imperial College London; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Idro, R (corresponding author), Kenya Govt Med Res Ctr, Wellcome Trust Res Labs, Ctr Geog Med Res, POB 230, Kilifi 80108, Kenya.	ridro@kilifi.kemri-wellcome.org	, Ridro/ABD-3556-2020; Newton, Charles RJC/B-7578-2014; Newton, Charles/C-6222-2009; Newton, Charles/V-7872-2019; Fegan, Greg W/O-8079-2018	Newton, Charles RJC/0000-0002-6999-5507; Newton, Charles/0000-0002-6999-5507; Fegan, Greg W/0000-0002-2663-2765; Maitland, Kathryn/0000-0002-0007-0645; Berkley, James/0000-0002-1236-849X; Idro, Richard/0000-0003-4728-4605	Wellcome Trust [070114] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AKPEDE GO, 1993, J TROP PEDIATRICS, V39, P350, DOI 10.1093/tropej/39.6.350; [Anonymous], 1990, Trans R Soc Trop Med Hyg, V84 Suppl 2, P1; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Berkley JA, 2003, BRIT MED J, V326, P361, DOI 10.1136/bmj.326.7385.361; Berkley JA, 1999, QJM-INT J MED, V92, P151, DOI 10.1093/qjmed/92.3.151; Berkley JA, 2001, LANCET, V357, P1753, DOI 10.1016/S0140-6736(00)04897-2; Carter JA, 2005, J NEUROL NEUROSUR PS, V76, P476, DOI 10.1136/jnnp.2004.043893; Carter JA, 2004, EPILEPSIA, V45, P978, DOI 10.1111/j.0013-9580.2004.65103.x; *CENTR BUR STAT, 2001, KEN 1999 POP HOUS CE, V1; Central Bureau of Statistics, 1994, KEN POP CENS 1989, VI; Cowgill KD, 2006, JAMA-J AM MED ASSOC, V296, P671, DOI 10.1001/jama.296.6.671; Gravenor MB, 1998, P NATL ACAD SCI USA, V95, P7620, DOI 10.1073/pnas.95.13.7620; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; Idro R, 2006, ANN TROP MED PARASIT, V100, P95, DOI 10.1179/136485906X91459; Idro R, 2006, TROP MED INT HEALTH, V11, P115, DOI 10.1111/j.1365-3156.2005.01518.x; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Kihara M, 2006, TROP MED INT HEALTH, V11, P386, DOI 10.1111/j.1365-3156.2006.01579.x; Kirigia JM, 1998, TROP MED INT HEALTH, V3, P145, DOI 10.1046/j.1365-3156.1998.00204.x; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; MOLYNEUX ME, 1989, Q J MED, V71, P441; Murphy SC, 2001, AM J TROP MED HYG, V64, P57, DOI 10.4269/ajtmh.2001.64.57; MWENESI HA, 1995, J BIOSOC SCI, V27, P235, DOI 10.1017/S0021932000022720; Newton CRJC, 1998, PHARMACOL THERAPEUT, V79, P1, DOI 10.1016/S0163-7258(98)00008-4; Newton CRJC, 1998, ANN NEUROL, V43, P695, DOI 10.1002/ana.410430603; Newton CRJC, 1997, T ROY SOC TROP MED H, V91, P161, DOI 10.1016/S0035-9203(97)90207-8; Ngoungou EB, 2006, EPILEPSIA, V47, P2147, DOI 10.1111/j.1528-1167.2006.00890.x; Snow Robert W., 1994, Afr J Health Sci, V1, P71; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Turner G, 1997, BRAIN PATHOL, V7, P569, DOI 10.1111/j.1750-3639.1997.tb01075.x; Versteeg AC, 2003, TROP MED INT HEALTH, V8, P12, DOI 10.1046/j.1365-3156.2003.00965.x; Waruiru CM, 1996, T ROY SOC TROP MED H, V90, P152, DOI 10.1016/S0035-9203(96)90120-0; WATTANAGOON Y, 1994, T ROY SOC TROP MED H, V88, P426, DOI 10.1016/0035-9203(94)90415-4	34	96	97	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2007	297	20					2232	2240		10.1001/jama.297.20.2232	http://dx.doi.org/10.1001/jama.297.20.2232			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170JM	17519413	Green Accepted, Bronze			2022-12-01	WOS:000246659700023
J	Asara, JM; Schweitzer, MH; Freimark, LM; Phillips, M; Cantley, LC				Asara, John M.; Schweitzer, Mary H.; Freimark, Lisa M.; Phillips, Matthew; Cantley, Lewis C.			Protein sequences from mastodon and Tyrannosaurus rex revealed by mass spectrometry	SCIENCE			English	Article							OSTEOCALCIN PROTEIN; SOFT-TISSUE; PRESERVATION; COLLAGEN; BONES; DNA	Fossilized bones from extinct taxa harbor the potential for obtaining protein or DNA sequences that could reveal evolutionary links to extant species. We used mass spectrometry to obtain protein sequences from bones of a 160,000- to 600,000-year-old extinct mastodon (Mammut americanum) and a 68-million-year-old dinosaur (Tyrannosaurus rex). The presence of T. rex sequences indicates that their peptide bonds were remarkably stable. Mass spectrometry can thus be used to determine unique sequences from ancient organisms from peptide fragmentation patterns, a valuable tool to study the evolution and adaptation of ancient taxa from which genomic sequences are unlikely to be obtained.	Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; N Carolina Museum Nat Sci, Raleigh, NC 27601 USA; Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Montana State University System; Montana State University Bozeman; University of North Carolina; North Carolina State University; Harvard University; Harvard Medical School	Asara, JM (corresponding author), Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA.	jasara@bidmc.harvard.edu	schweitzer, mary h/A-6756-2010; Schweitzer, Mary/V-8143-2019; Smejda, Ladislav/B-8474-2008; Cantley, Lewis C/D-1800-2014	schweitzer, mary h/0000-0002-0427-3829; Cantley, Lewis C/0000-0002-1298-7653				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bhattacharjee A, 2005, IUBMB LIFE, V57, P161, DOI 10.1080/15216540500090710; Collins MJ, 2000, GEOLOGY, V28, P1139, DOI 10.1130/0091-7613(2000)28<1139:SRODOO>2.0.CO;2; Dayhoff M.O., 1978, ATLAS PROTEIN SEQ ST; Domon B, 2006, SCIENCE, V312, P212, DOI 10.1126/science.1124619; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Hill CL, 2006, QUATERN INT, V142, P87, DOI 10.1016/j.quaint.2005.03.007; Knott L, 1998, BONE, V22, P181, DOI 10.1016/S8756-3282(97)00279-2; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Mann M, 2003, NAT BIOTECHNOL, V21, P255, DOI 10.1038/nbt0303-255; Mariani FV, 2003, NATURE, V423, P319, DOI 10.1038/nature01655; MARIN M, 2003, NAT BIOTECHNOL, V21, P255; Nielsen-Marsh CM, 2005, P NATL ACAD SCI USA, V102, P4409, DOI 10.1073/pnas.0500450102; Nielsen-Marsh CM, 2002, GEOLOGY, V30, P1099, DOI 10.1130/0091-7613(2002)030<1099:SPOOPA>2.0.CO;2; O'Connor PM, 2005, NATURE, V436, P253, DOI 10.1038/nature03716; Ostrom PH, 2006, GEOCHIM COSMOCHIM AC, V70, P2034, DOI 10.1016/j.gca.2006.01.004; Pruvost M, 2007, P NATL ACAD SCI USA, V104, P739, DOI 10.1073/pnas.0610257104; Schweitzer MH, 2007, SCIENCE, V316, P277, DOI 10.1126/science.1138709; Schweitzer MH, 2007, P ROY SOC B-BIOL SCI, V274, P183, DOI 10.1098/rspb.2006.3705; Schweitzer MH, 2005, SCIENCE, V307, P1952, DOI 10.1126/science.1108397; Schweitzer MH, 2002, J MOL EVOL, V55, P696, DOI 10.1007/s00239-002-2365-6; Schweitzer MH, 2005, SCIENCE, V308, P1456, DOI 10.1126/science.1112158; Tauber MM, 2000, APPL ENVIRON MICROB, V66, P1634, DOI 10.1128/AEM.66.4.1634-1638.2000; TUROSS N, 1988, GEOCHIM COSMOCHIM AC, V52, P929, DOI 10.1016/0016-7037(88)90364-X; Yang H, 1996, P NATL ACAD SCI USA, V93, P1190, DOI 10.1073/pnas.93.3.1190	25	200	210	2	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					280	285		10.1126/science.1137614	http://dx.doi.org/10.1126/science.1137614			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431180				2022-12-01	WOS:000245654500052
J	Dabelea, D; Bell, RA; D'Agostino, RB; Imperatore, G; Johansen, JM; Linder, B; Liu, LL; Loots, B; Marcovina, S; Mayer-Davis, EJ; Pettitt, DJ; Waitzfelder, B				Dabelea, Dana; Bell, Ronny A.; D'Agostino, Ralph B., Jr.; Imperatore, Giuseppina; Johansen, Judith M.; Linder, Barbara; Liu, Lenna L.; Loots, Beth; Marcovina, Santica; Mayer-Davis, Elizabeth J.; Pettitt, David J.; Waitzfelder, Beth		Writing Grp SEARCH Diabet Youth St	Incidence of diabetes in youth in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACID DECARBOXYLASE GAD65; ALLEGHENY-COUNTY; AFRICAN-AMERICAN; MELLITUS; CHILDREN; ADOLESCENTS; TYPE-2; PREVALENCE; EPIDEMIC; TRENDS	Context Data on the incidence of diabetes mellitus (DM) among US youth according to racial/ethnic background and DM type are limited. Objective To estimate DM incidence in youth aged younger than 20 years according to race/ethnicity and DM type. Design, Setting, and Participants A multiethnic, population-based study (The SEARCH for Diabetes in Youth Study) of 2435 youth with newly diagnosed, nonsecondary DM in 2002 and 2003, ascertained at 10 study locations in the United States, covering a population of more than 10 million person-years. Main Outcome Measure Incidence rates by age group, sex, race/ethnicity, and DM type were calculated per 100 000 person-years at risk. Diabetes mellitus type ( type 1/type 2) was based on health care professional assignment and, in a subset, further characterized with glutamicacid decarboxylase( GAD65) autoantibody and fasting C peptide measures. Results The incidence of DM ( per 100 000 person-years) was 24.3 (95% confidence interval [CI], 23.3-25.3). Among children younger than 10 years, most had type 1 DM, regardless of race/ethnicity. The highest rates of type 1 DM were observed in non-Hispanic white youth (18.6, 28.1, and 32.9 for age groups 0-4, 5-9, and 10-14 years, respectively). Even among older youth ( >= 10 years), type 1 DM was frequent among non-Hispanic white, Hispanic, and African American adolescents. Overall, type 2 DM was still relatively infrequent, but the highest rates (17.0 to 49.4 per 100 000 person-years) were documented among 15- to 19-year-old minority groups. Conclusions Our data document the incidence rates of type 1 DM among youth of all racial/ethnic groups, with the highest rates in non-Hispanic white youth. Overall, type 2 DM is still relatively infrequent; however, the highest rates were observed among adolescent minority populations.	Univ Colorado, Hlth Sci Ctr, Dept Prevent Med & Biometr, Denver, CO 80262 USA; Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; Ctr Dis Control & Prevent, Atlanta, GA USA; Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; NIDDK, Bethesda, MD USA; Univ Washington, Inst Child Hlth, Seattle, WA 98195 USA; Childrens Hosp & Reg Med Ctr, Seattle, WA USA; Univ S Carolina, Columbia, SC 29208 USA; Sansum Diabet Res Inst, Santa Barbara, CA USA; Pacific Hlth Res Inst, Honolulu, HI USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Wake Forest University; Wake Forest Baptist Medical Center; Centers for Disease Control & Prevention - USA; Cincinnati Children's Hospital Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; William Sansum Diabetes Center; Pacific Health Research & Education Institute	Dabelea, D (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Prevent Med & Biometr, 4200 E 9th Ave,Box C245, Denver, CO 80262 USA.	dana.dabelea@uchsc.edu	Dagostino, Ralph/C-4060-2017	Dagostino, Ralph/0000-0002-3550-8395	NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U01DP000245, U01DP000246, U01DP000254, U01DP000248, U01DP000244, U01DP000247, U01DP000250] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001070, M01RR000069, M01RR008084, M01RR001271, M01RR000037] Funding Source: NIH RePORTER; NCRR NIH HHS [M01RR00037, M01 RR08084, M01 RR01070, M01 RR00069, M01RR001271] Funding Source: Medline; PHS HHS [00097] Funding Source: Medline; NCCDPHP CDC HHS [U01 DP000254, U01 DP000250, U01 DP000248, U01 DP000247, U01 DP000246, U01 DP000245, DP-05-069, U01 DP000244] Funding Source: Medline	NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NCCDPHP CDC HHS		Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; BISHOP YMM, 1975, FSHPW DISCRETE MULTI; Brooks-Worrell BM, 2004, J CLIN ENDOCR METAB, V89, P2222, DOI 10.1210/jc.2003-031360; Chen WS, 2004, ANN EPIDEMIOL, V14, P339, DOI 10.1016/j.annepidem.2003.07.002; Dabelea D, 1998, DIABETOLOGIA, V41, P904, DOI 10.1007/s001250051006; Dabelea D, 1999, ENDOCRIN METAB CLIN, V28, P709, DOI 10.1016/S0889-8529(05)70098-0; Dean HJ, 1998, LANCET, V352, P1523, DOI 10.1016/S0140-6736(05)60329-7; DOKHEEL TM, 1993, DIABETES CARE, V16, P1606, DOI 10.2337/diacare.16.12.1606; Dolan LM, 2005, J PEDIATR-US, V146, P751, DOI 10.1016/j.jpeds.2005.01.045; ESPELAND MA, 1986, COMMUN STAT SIMULAT, V15, P405, DOI 10.1080/03610918608812515; FALORNI A, 1995, J IMMUNOL METHODS, V186, P89, DOI 10.1016/0022-1759(95)00139-2; Feltbower RG, 2003, ARCH DIS CHILD, V88, P676, DOI 10.1136/adc.88.8.676; Gale EAM, 2001, DIABETOLOGIA, V44, P3, DOI 10.1007/s001250051573; Gavin JR, 1997, DIABETES CARE, V20, P1183; GREEN A, 1992, LANCET, V339, P905, DOI 10.1016/0140-6736(92)90938-Y; Green A, 2000, LANCET, V355, P873; Green A, 2001, DIABETOLOGIA, V44, pB3, DOI 10.1007/PL00002950; Harris SB, 1997, DIABETES CARE, V20, P185, DOI 10.2337/diacare.20.2.185; Hathout EH, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.6.e102; HEDING LG, 1975, DIABETOLOGIA, V11, P541, DOI 10.1007/BF01222104; Ingram DD., 2003, VITAL HLTH STAT SERI, V2; Karvonen M, 2000, DIABETES CARE, V23, P1516, DOI 10.2337/diacare.23.10.1516; KITAGAWA T, 1983, Tohoku Journal of Experimental Medicine, V141, P171; KNOWLER WC, 1978, AM J EPIDEMIOL, V108, P497, DOI 10.1093/oxfordjournals.aje.a112648; KOSTRABA JN, 1992, EPIDEMIOLOGY, V3, P232, DOI 10.1097/00001648-199205000-00008; LAPORTE RE, 1981, DIABETES, V30, P279, DOI 10.2337/diabetes.30.4.279; Libman IM, 1998, DIABETES CARE, V21, P1278, DOI 10.2337/diacare.21.8.1278; Liese AD, 2006, PEDIATRICS, V118, P1510, DOI 10.1542/peds.2006-0690; Lipman TH, 2006, DIABETES CARE, V29, P2391, DOI 10.2337/dc06-0517; Lipman TH, 2002, DIABETES CARE, V25, P1969, DOI 10.2337/diacare.25.11.1969; Lipton R, 2002, DIABETES-METAB RES, V18, P135, DOI 10.1002/dmrr.265; Macaluso CJ, 2002, PUBLIC HEALTH REP, V117, P373, DOI 10.1016/S0033-3549(04)50174-7; Marcovina SM, 2000, INT J CLIN LAB RES, V30, P21, DOI 10.1007/s005990070029; Onkamo P, 1999, DIABETOLOGIA, V42, P1395, DOI 10.1007/s001250051309; Ortega-Rodriguez E, 2001, DIABETES METAB, V27, P574; Petitti DB, 2007, ARCH PEDIAT ADOL MED, V161, P159, DOI 10.1001/archpedi.161.2.159; Pettitt DJ, 2004, CONTROL CLIN TRIALS, V25, P458, DOI 10.1016/j.cct.2004.08.002; Pihoker C, 1998, CLIN PEDIATR, V37, P97, DOI 10.1177/000992289803700206; PinhasHamiel O, 1996, J PEDIATR-US, V128, P608, DOI 10.1016/S0022-3476(96)80124-7; Rewers M, 2004, ADV EXP MED BIOL, V552, P219; REWERS M, 1987, DIABETES, V36, P106, DOI 10.2337/diabetes.36.1.106; SCHOBER E, 1988, ACTA PAEDIATR SCAND, V77, P299, DOI 10.1111/j.1651-2227.1988.tb10646.x; Scott CR, 1997, PEDIATRICS, V100, P84, DOI 10.1542/peds.100.1.84; STONE RA, 1990, DIABETES, V39, P858; TUOMILEHTO J, 1995, INT J EPIDEMIOL, V24, P984, DOI 10.1093/ije/24.5.984; Verlato G, 2000, DIABETES CARE, V23, P759, DOI 10.2337/diacare.23.6.759	46	670	682	1	31	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2007	297	24					2716	2724						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	182UE	17595272				2022-12-01	WOS:000247528700021
J	Stearns, V				Stearns, Vered			Clinical update: new treatments for hot flushes	LANCET			English	Editorial Material							VASOMOTOR SYMPTOMS; POSTMENOPAUSAL WOMEN; BREAST-CANCER; FLASHES; MENOPAUSE; TRIAL; ESTROGEN; VENLAFAXINE; MANAGEMENT; THERAPIES		Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine	Stearns, V (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA.	vstearn1@jhmi.edu						*AM COLL OBST GYN, 2004, OBSTET GYNECOL S, V104, pS106; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Butt DA, 2007, MENOPAUSE, V14, P203, DOI 10.1097/01.gme.0000235370.32103.4c; Deecher DC, 2005, EXPERT OPIN INV DRUG, V14, P435, DOI 10.1517/13543784.14.4.435; Fabre A, 2007, BRIT J CANCER, V96, P841, DOI 10.1038/sj.bjc.6603618; Freedman RR, 2005, MENOPAUSE, V12, P156, DOI 10.1097/00042192-200512020-00009; Freedman RR, 2002, FERTIL STERIL, V77, P487, DOI 10.1016/S0015-0282(01)03009-6; Gold EB, 2006, AM J PUBLIC HEALTH, V96, P1226, DOI 10.2105/AJPH.2005.066936; Loibl S, 2007, ANN ONCOL, V18, P689, DOI 10.1093/annonc/mdl478; Loprinzi CL, 2007, J CLIN ONCOL, V25, P308, DOI 10.1200/JCO.2006.07.5390; Loprinzi CL, 2006, J CLIN ONCOL, V24, P1409, DOI 10.1200/JCO.2005.04.7324; LOPRINZI CL, 1994, NEW ENGL J MED, V331, P347, DOI 10.1056/NEJM199408113310602; Nedrow A, 2006, ARCH INTERN MED, V166, P1453, DOI 10.1001/archinte.166.14.1453; Nelson HD, 2004, JAMA-J AM MED ASSOC, V291, P1610, DOI 10.1001/jama.291.13.1610; Nelson HD, 2006, JAMA-J AM MED ASSOC, V295, P2057, DOI 10.1001/jama.295.17.2057; Newton KM, 2006, ANN INTERN MED, V145, P869, DOI 10.7326/0003-4819-145-12-200612190-00003; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Santoro NF, 2004, MENOPAUSE, V11, P11; Sloan JA, 2001, J CLIN ONCOL, V19, P4280, DOI 10.1200/JCO.2001.19.23.4280; Stearns V, 2002, LANCET, V360, P1851, DOI 10.1016/S0140-6736(02)11774-0	20	25	28	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 23	2007	369	9579					2062	2064		10.1016/S0140-6736(07)60959-3	http://dx.doi.org/10.1016/S0140-6736(07)60959-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182GM	17586289				2022-12-01	WOS:000247493100009
J	Zimmet, P; Alberti, G; Kaufman, F; Tajima, N; Silink, M; Arslanian, S; Wong, G; Bennett, P; Shaw, J; Caprio, S				Zimmet, Paul; Alberti, George; Kaufman, Francine; Tajima, Naoko; Silink, Martin; Arslanian, Silva; Wong, Gary; Bennett, Peter; Shaw, Jonathan; Caprio, Sonia		Int Diabet Federation Task Force E	The metabolic syndrome in children and adolescents	LANCET			English	Editorial Material							3RD NATIONAL-HEALTH; CARDIOVASCULAR RISK-FACTORS; WAIST CIRCUMFERENCE; PREVALENCE; AMERICAN		St Marys Hosp, Dept Endocrinol & Metab Med, London W2 1NY, England; Int Diabet Inst, Melbourne, Vic, Australia; Univ London Imperial Coll Sci Technol & Med, London, England; Childrens Hosp, Los Angeles, CA USA; Jikei Univ, Sch Med, Tokyo, Japan; Westmead Hosp, Sydney, NSW, Australia; Childrens Hosp, Pittsburgh, PA 15213 USA; Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China; NIDDK, Phoenix Epidemiol & Clin Res Branch, Phoenix, AZ USA; Yale Univ, Sch Med, New Haven, CT USA	Imperial College London; Imperial College London; Children's Hospital Los Angeles; Jikei University; University of Sydney; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chinese University of Hong Kong; Prince of Wales Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Yale University	Alberti, G (corresponding author), St Marys Hosp, Dept Endocrinol & Metab Med, Praed St, London W2 1NY, England.	George.alberti@ncl.ac.uk	Shaw, Jonathan/E-7388-2010; Bennett, Peter/AAH-9605-2021; Wong, Gary WK/AAY-9207-2020; Zimmet, Paul/O-8486-2019	Shaw, Jonathan/0000-0002-6187-2203; Wong, Gary WK/0000-0001-5939-812X; Zimmet, Paul/0000-0003-0627-0776				Alberti G, 2004, DIABETES CARE, V27, P1798, DOI 10.2337/diacare.27.7.1798; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Bacha F, 2006, DIABETES CARE, V29, P1599, DOI 10.2337/dc06-0581; Burke V, 2005, INT J OBESITY, V29, P15, DOI 10.1038/sj.ijo.0802750; Cook S, 2003, ARCH PEDIAT ADOL MED, V157, P821, DOI 10.1001/archpedi.157.8.821; de Ferranti SD, 2004, CIRCULATION, V110, P2494, DOI 10.1161/01.CIR.0000145117.40114.C7; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fernandez JR, 2004, J PEDIATR-US, V145, P439, DOI 10.1016/j.jpeds.2004.06.044; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Gungor N, 2004, PEDIATR RES, V55, p145A; Jolliffe CJ, 2007, J AM COLL CARDIOL, V49, P891, DOI 10.1016/j.jacc.2006.08.065; Lee SJ, 2006, J PEDIATR-US, V149, P809, DOI 10.1016/j.jpeds.2006.08.075; Maffeis C, 2001, OBES RES, V9, P179, DOI 10.1038/oby.2001.19; Singh R, 2004, PEDIATR DIABETES, V5, P154, DOI 10.1111/j.1399-543X.2004.00060.x	14	648	727	0	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 23	2007	369	9579					2059	2061		10.1016/S0140-6736(07)60958-1	http://dx.doi.org/10.1016/S0140-6736(07)60958-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182GM	17586288				2022-12-01	WOS:000247493100008
J	Bakal, C; Aach, J; Church, G; Perrimon, N				Bakal, Chris; Aach, John; Church, George; Perrimon, Norbert			Quantitative morphological signatures define local signaling networks regulating cell morphology	SCIENCE			English	Article							MEMBRANE PROTRUSION; LEADING-EDGE; DROSOPHILA; ADHESION; COMPLEX; LOCALIZATION; ACTIVATION; RESTRICTS; PAXILLIN; BEHAVIOR	Although classical genetic and biochemical approaches have identified hundreds of proteins that function in the dynamic remodeling of cell shape in response to upstream signals, there is currently little systems-level understanding of the organization and composition of signaling networks that regulate cell morphology. We have developed quantitative morphological profiling methods to systematically investigate the role of individual genes in the regulation of cell morphology in a fast, robust, and cost-efficient manner. We analyzed a compendium of quantitative morphological signatures and described the existence of local signaling networks that act to regulate cell protrusion, adhesion, and tension.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02215 USA; MIT, Comp Sci & Technol Lab, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Bakal, C (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.			Bakal, Chris/0000-0002-0413-6744; church, george/0000-0001-6232-9969; Perrimon, Norbert/0000-0001-7542-472X				Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Biyasheva A, 2004, J CELL SCI, V117, P837, DOI 10.1242/jcs.00921; Brown MC, 2005, MOL BIOL CELL, V16, P4316, DOI 10.1091/mbc.E05-02-0131; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Huelsmann S, 2006, DEVELOPMENT, V133, P2915, DOI 10.1242/dev.02449; Knox AL, 2002, SCIENCE, V295, P1285, DOI 10.1126/science.1067549; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Mayhew MW, 2006, J PROTEOME RES, V5, P2417, DOI 10.1021/pr060140t; MURAYAMA K, 2006, J BIOL CHEM     1226; Nishita M, 2004, J BIOL CHEM, V279, P7193, DOI 10.1074/jbc.M312591200; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Singh SR, 2006, DEV GROWTH DIFFER, V48, P169, DOI 10.1111/j.1440-169x.2006.00854.x; Sone M, 1997, SCIENCE, V275, P543, DOI 10.1126/science.275.5299.543; Takagi Y, 1998, NEUROSCI LETT, V244, P149, DOI 10.1016/S0304-3940(98)00145-1; Wang H, 2006, DEV CELL, V10, P117, DOI 10.1016/j.devcel.2005.11.004; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Zallen JA, 2002, J CELL BIOL, V156, P689, DOI 10.1083/jcb.200109057; Zebda N, 2000, J CELL BIOL, V151, P1119, DOI 10.1083/jcb.151.5.1119	25	224	232	4	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 22	2007	316	5832					1753	1756		10.1126/science.1140324	http://dx.doi.org/10.1126/science.1140324			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	180XE	17588932				2022-12-01	WOS:000247400500049
J	Barry, M				Barry, Michele			The tail end of guinea worm - Global eradication without a drug or a vaccine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Yale Univ, Sch Med, New Haven, CT 06520 USA	Yale University	Barry, M (corresponding author), Yale Univ, Sch Med, New Haven, CT 06520 USA.							[Anonymous], 2004, Wkly Epidemiol Rec, V79, P234; Hopkins DR, 2005, AM J TROP MED HYG, V73, P669, DOI 10.4269/ajtmh.2005.73.669; Rwakimari JB, 2006, AM J TROP MED HYG, V75, P3, DOI 10.4269/ajtmh.2006.75.3; 2007, WKLY EPIDEMIOL REC, V82, P133	4	36	37	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 21	2007	356	25					2561	2564		10.1056/NEJMp078089	http://dx.doi.org/10.1056/NEJMp078089			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	180GN	17582064				2022-12-01	WOS:000247351200001
J	Roman-Leshkov, Y; Barrett, CJ; Liu, ZY; Dumesic, JA				Roman-Leshkov, Yuriy; Barrett, Christopher J.; Liu, Zhen Y.; Dumesic, James A.			Production of dimethylfuran for liquid fuels from biomass-derived carbohydrates	NATURE			English	Article							SUPPORTED COPPER; HYDROGENATION; CATALYSTS; FRUCTOSE; 2-METHYLFURAN; EQUILIBRIA; MEDIA	Diminishing fossil fuel reserves and growing concerns about global warming indicate that sustainable sources of energy are needed in the near future. For fuels to be useful in the transportation sector, they must have specific physical properties that allow for efficient distribution, storage and combustion; these properties are currently fulfilled by non-renewable petroleum-derived liquid fuels. Ethanol, the only renewable liquid fuel currently produced in large quantities, suffers from several limitations, including low energy density, high volatility, and contamination by the absorption of water from the atmosphere. Here we present a catalytic strategy for the production of 2,5-dimethylfuran from fructose ( a carbohydrate obtained directly from biomass or by the isomerization of glucose) for use as a liquid transportation fuel. Compared to ethanol, 2,5-dimethylfuran has a higher energy density ( by 40 per cent), a higher boiling point ( by 20 K), and is not soluble in water. This catalytic strategy creates a route for transforming abundant renewable biomass resources(1,2) into a liquid fuel suitable for the transportation sector, and may diminish our reliance on petroleum.	Univ Wisconsin, Dept Biol & Chem Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Dumesic, JA (corresponding author), Univ Wisconsin, Dept Biol & Chem Engn, Madison, WI 53706 USA.	dumesic@engr.wisc.edu	Barrett, Christopher J/B-7474-2008; Knafo-Noam, Ariel/E-8067-2011; Roman-Leshkov, Yuriy/E-1387-2014	Barrett, Christopher J/0000-0001-6194-9066; Knafo-Noam, Ariel/0000-0003-0613-1960; Roman-Leshkov, Yuriy/0000-0002-0025-4233				Barlow M. T., 1983, Fuel composition. Eur. Pat., Patent No. [EP0082689, 0082689]; Broughton D.B., 1961, Patent No. [US2985589A, 2985589, 2,985,589]; BROWN DW, 1982, J CHEM TECHNOL BIOT, V32, P920, DOI 10.1002/jctb.5030320730; EISEN EO, 1966, J CHEM ENG DATA, V11, P480, DOI 10.1021/je60031a007; GRABOSKI M, 2003, ANAL ALTERNATIVES UN; Hashimoto K., 1993, PREPARATIVE PRODUCTI, P395; HELMS CR, 1978, SURF SCI, V72, P229, DOI 10.1016/0039-6028(78)90292-3; JONES DT, 1986, MICROBIOL REV, V50, P484, DOI 10.1128/MMBR.50.4.484-524.1986; JONES JH, 2001, IND ENG CHEM PROD RD, V10, P57; KUSTER BFM, 1990, STARCH-STARKE, V42, P314, DOI 10.1002/star.19900420808; MANLY DG, 1958, J ORG CHEM, V23, P1093, DOI 10.1021/jo01102a002; Moreau C, 2004, TOP CATAL, V27, P11, DOI 10.1023/B:TOCA.0000013537.13540.0e; NEIER W, 1982, Patent No. 3040997; Parikka M, 2004, BIOMASS BIOENERG, V27, P613, DOI 10.1016/j.biombioe.2003.07.005; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Ramey D. E., 1998, US Patent, Patent No. [5753474, 5,753,474]; Rao RS, 1999, CATAL LETT, V60, P51, DOI 10.1023/A:1019090520407; Roman-Leshkov Y, 2006, SCIENCE, V312, P1933, DOI 10.1126/science.1126337; SINFELT JH, 1976, J CATAL, V42, P227, DOI 10.1016/0021-9517(76)90257-8; SINFELT JH, 1973, J CATAL, V29, P308, DOI 10.1016/0021-9517(73)90234-0; SZMANT HH, 1981, J CHEM TECHNOL BIOT, V31, P135, DOI 10.1002/jctb.280310119; Tan TC, 1999, FLUID PHASE EQUILIBR, V163, P243, DOI 10.1016/S0378-3812(99)00231-9; Twigg MV, 2001, APPL CATAL A-GEN, V212, P161, DOI 10.1016/S0926-860X(00)00854-1; VANDAM HE, 1986, STARCH-STARKE, V38, P95, DOI 10.1002/star.19860380308; Zheng HY, 2006, J MOL CATAL A-CHEM, V246, P18, DOI 10.1016/j.molcata.2005.10.003	25	1749	1879	27	1048	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2007	447	7147					982	U5		10.1038/nature05923	http://dx.doi.org/10.1038/nature05923			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	180NU	17581580				2022-12-01	WOS:000247373100042
J	Jacob, M; Chappell, D; Rehm, M				Jacob, Matthias; Chappell, Daniel; Rehm, Markus			Clinical update: perioperative fluid management	LANCET			English	Article							RADICAL HYSTERECTOMY; INDUCED HYPOTENSION; SURGERY; TRIAL; RESTRICTION; VOLUME; RESPONSIVENESS; RESECTION; RECOVERY; THERAPY		Univ Munich, Clin Anaesthesiol, D-80336 Munich, Germany	University of Munich	Jacob, M (corresponding author), Univ Munich, Clin Anaesthesiol, D-80336 Munich, Germany.	matthias.jacob@med.uni-muenchen.de						Bendjelid K, 2003, INTENS CARE MED, V29, P352, DOI 10.1007/s00134-002-1615-9; Brandstrup B, 2003, ANN SURG, V238, P641, DOI 10.1097/01.sla.0000094387.50865.23; Desborough JP, 2000, BRIT J ANAESTH, V85, P109, DOI 10.1093/bja/85.1.109; Holte K, 2006, J AM COLL SURGEONS, V202, P971, DOI 10.1016/j.jamcollsurg.2006.01.003; JACKSON R, 1995, BRIT J ANAESTH, V75, P262, DOI 10.1093/bja/75.3.262; LAMKE LO, 1977, ACTA CHIR SCAND, V143, P279; Lobo DN, 2002, LANCET, V359, P1812, DOI 10.1016/S0140-6736(02)08711-1; MacKay G, 2006, BRIT J SURG, V93, P1469, DOI 10.1002/bjs.5593; Moller AM, 2002, EUR J ANAESTH, V19, P57, DOI 10.1017/S0265021502000091; Nisanevich V, 2005, ANESTHESIOLOGY, V103, P25, DOI 10.1097/00000542-200507000-00008; Noblett SE, 2006, BRIT J SURG, V93, P1069, DOI 10.1002/bjs.5454; Rehm M, 2001, ANESTHESIOLOGY, V95, P849, DOI 10.1097/00000542-200110000-00011; Rehm M, 2000, ANESTHESIOLOGY, V92, P657, DOI 10.1097/00000542-200003000-00008; Sear JW, 2005, BRIT J ANAESTH, V95, P20, DOI 10.1093/bja/aei018; SHIRES T, 1961, ANN SURG, V154, P803, DOI 10.1097/00000658-196111000-00005; SHOEMAKER WC, 1973, ARCH SURG-CHICAGO, V106, P630; Solus-Biguenet H, 2006, BRIT J ANAESTH, V97, P808, DOI 10.1093/bja/ael250; Spahn DR, 2006, ANESTH ANALG, V102, P344, DOI 10.1213/01.ane.0000196511.48033.0b; Tavernier B, 1998, ANESTHESIOLOGY, V89, P1313, DOI 10.1097/00000542-199812000-00007; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564	20	90	95	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 16	2007	369	9578					1984	1986		10.1016/S0140-6736(07)60926-X	http://dx.doi.org/10.1016/S0140-6736(07)60926-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180HT	17574081				2022-12-01	WOS:000247354400009
J	Walkley, CR; Olsen, GH; Dworkin, S; Fabb, SA; Swann, J; McArthur, GA; Westmoreland, SV; Chambon, P; Scadden, DT; Purton, LE				Walkley, Carl R.; Olsen, Gemma Haines; Dworkin, Sebastian; Fabb, Stewart A.; Swann, Jeremy; McArthur, Grant A.; Westmoreland, Susan V.; Chambon, Pierre; Scadden, David T.; Purton, Louise E.			A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency	CELL			English	Article							TUMOR-NECROSIS-FACTOR; HEMATOPOIETIC STEM-CELLS; BONE-MARROW; SELF-RENEWAL; DIFFERENTIATION; MICE; INFLAMMATION; PROGENITORS; EXPRESSION; DISEASE	Myeloproliferative syndromes (IMPS) are a heterogeneous subclass of nonlymphoid hematopoietic neoplasms which are considered to be intrinsic to hematopoietic cells. The causes of MPS are largely unknown. Here, we demonstrate that mice deficient for retinoic acid receptor gamma (RAR gamma), develop MPS induced solely by the RAR gamma-deficient microenvironment. RAR gamma(-/-) mice had significantly increased granulocyte/macrophage progenitors and granulocytes in bone marrow (BM), peripheral blood, and spleen. The MPS phenotype continued for the lifespan of the mice and was more pronounced in older mice. Unexpectedly, transplant studies revealed this disease was not intrinsic to the hematopoietic cells. BM from wild-type mice transplanted into mice with an RAR gamma(-/-) microenvironment rapidly developed the MPS, which was partially caused by significantly elevated TNF alpha in RAR gamma(-/-) mice. These data show that loss of RAR gamma results in a nonhematopoietic cell-intrinsic MPS, revealing the capability of the microenvironment to be the sole cause of hematopoietic disorders.	Peter MacCallum Canc Ctr, Trescowthick Res Labs, Melbourne, Vic 3002, Australia; Univ Melbourne, Dept Med, Fitzroy, Vic 3065, Australia; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Hematol Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA; Peter MacCallum Canc Ctr, Dept Haematol & Oncol, Melbourne, Vic 3002, Australia; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; ULP, INSERM, CNRS, Coll France,Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, CU Strasbourg, France; Harvard Univ, Stem Cell Inst, Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA	Peter Maccallum Cancer Center; University of Melbourne; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Peter Maccallum Cancer Center; Harvard University; Massachusetts General Hospital; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Harvard University; Massachusetts General Hospital	Purton, LE (corresponding author), Peter MacCallum Canc Ctr, Trescowthick Res Labs, Melbourne, Vic 3002, Australia.	lpurton@partners.org	Purton, Louise/AAI-8956-2021; Walkley, Carl/AAO-6021-2020	Purton, Louise/0000-0001-6593-3168; Walkley, Carl/0000-0002-4784-9031; Fabb, Stewart/0000-0002-8887-7661; Dworkin, Sebastian/0000-0001-5828-9992	NHLBI NIH HHS [R01 HL044851, R01 HL044851-14] Funding Source: Medline; NIDDK NIH HHS [R21 DK071773, R21 DK071773-02, DK84551, DK71773, R21 DK071773-01A1] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK071773] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Altucci L, 2001, NAT REV CANCER, V1, P181, DOI 10.1038/35106036; Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Balmer JE, 2005, J STEROID BIOCHEM, V96, P347, DOI 10.1016/j.jsbmb.2005.05.005; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Bennett BD, 1996, CURR BIOL, V6, P1170, DOI 10.1016/S0960-9822(02)70684-2; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Corre J, 2004, BRIT J HAEMATOL, V127, P344, DOI 10.1111/j.1365-2141.2004.05198.x; Cousin B, 2003, BIOCHEM BIOPH RES CO, V301, P1016, DOI 10.1016/S0006-291X(03)00061-5; Flores-Figueroa E, 2002, LEUKEMIA RES, V26, P677, DOI 10.1016/S0145-2126(01)00193-X; Gainsford T, 1996, P NATL ACAD SCI USA, V93, P14564, DOI 10.1073/pnas.93.25.14564; GIROIR BP, 1992, P NATL ACAD SCI USA, V89, P4864, DOI 10.1073/pnas.89.11.4864; HANGOC G, 1993, EXP HEMATOL, V21, P502; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Kastner P, 2001, BLOOD, V97, P1314, DOI 10.1182/blood.V97.5.1314; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; Kuwata T, 2000, BLOOD, V95, P3349, DOI 10.1182/blood.V95.11.3349; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Le DT, 2004, BLOOD, V103, P4243, DOI 10.1182/blood-2003-08-2650; LOHNES D, 1993, CELL, V73, P643, DOI 10.1016/0092-8674(93)90246-M; Minucci S, 1999, SEMIN CELL DEV BIOL, V10, P215, DOI 10.1006/scdb.1999.0303; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Purton LE, 2000, BLOOD, V95, P470, DOI 10.1182/blood.V95.2.470; Purton LE, 1999, BLOOD, V94, P483, DOI 10.1182/blood.V94.2.483.414k12_483_495; Purton LE, 2006, J EXP MED, V203, P1283, DOI 10.1084/jem.20052105; Rupec RA, 2005, IMMUNITY, V22, P479, DOI 10.1016/j.immuni.2005.02.009; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; Szlosarek P, 2006, EUR J CANCER, V42, P745, DOI 10.1016/j.ejca.2006.01.012; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; TRENTIN JJ, 1971, AM J PATHOL, V65, P621; Ueda Y, 2005, J EXP MED, V201, P1771, DOI 10.1084/jem.20041419; Ueda Y, 2004, J EXP MED, V199, P47, DOI 10.1084/jem.20031104; Van Etten RA, 2004, CANCER CELL, V6, P547, DOI 10.1016/j.ccr.2004.12.004; Vettor R, 2005, ALIMENT PHARM THER, V22, P3, DOI 10.1111/j.1365-2036.2005.02587.x; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Walkley CR, 2005, NAT CELL BIOL, V7, P172, DOI 10.1038/ncb1214; Walkley CR, 2002, LEUKEMIA, V16, P1763, DOI 10.1038/sj.leu.2402625; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; YAN XQ, 1994, ONCOGENE, V9, P163; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	44	395	409	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2007	129	6					1097	1110		10.1016/j.cell.2007.05.014	http://dx.doi.org/10.1016/j.cell.2007.05.014			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574023	Bronze, Green Accepted			2022-12-01	WOS:000247390400014
J	Higashi, T; Wenger, NS; Adams, JL; Fung, C; Roland, M; McGlynn, EA; Reeves, D; Asch, SM; Kerr, EA; Shekelle, PG				Higashi, Takahiro; Wenger, Neil S.; Adams, John L.; Fung, Constance; Roland, Martin; McGlynn, Elizabeth A.; Reeves, David; Asch, Steven M.; Kerr, Eve A.; Shekelle, Paul G.			Relationship between number of medical conditions and quality of care	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VULNERABLE OLDER-PEOPLE; UNITED-STATES; HEALTH-CARE; PRACTICE GUIDELINES; PERFORMANCE DATA; DIABETES CARE; DISEASES; ELDERS; PAY; GENERALIST	BACKGROUND: There is emerging concern that the methods used to measure the quality of care unfairly penalize providers caring for patients with multiple chronic conditions. We therefore sought to study the relationship between the quality of care and the number of medical conditions a patient has. METHODS: We assessed measurements of the quality of medical care received in three cohorts of community-dwelling adult patients in the Community Quality Index study, the Assessing Care of Vulnerable Elders study, and the Veterans Health Administration project (7680 patients in total). We analyzed the relationship between the quality of care that patients received, defined as the percentage of quality indicators satisfied among those for which patients were eligible, and the number of chronic medical conditions each patient had. We further explored the roles of characteristics of patients, use of health care (number of office visits and hospitalizations), and care provided by specialists as explanations for the observed relationship. RESULTS: The quality of care increased as the number of medical conditions increased. Each additional condition was associated with an increase in the quality score of 2.2% (95% confidence interval [CI], 1.7 to 2.7) in the Community Quality Index cohort, of 1.7% (95% CI, 1.1 to 2.4) in the Assessing Care of Vulnerable Elders cohort, and of 1.7% (95% CI, 0.7 to 2.8) in the Veterans Health Administration cohort. The relationship between the quality of care and the number of conditions was little affected by adjustment for the difficulty of delivering the care recommended in a quality indicator and for the fact that, because of multiple conditions requiring the same care, a patient could be eligible to receive the same care process more than once. Adjustment for characteristics of patients, use of health care, and care provided by specialists diminished the relationship, but it remained positive. CONCLUSIONS: The quality of care, measured according to whether patients were offered recommended services, increases as a patient's number of chronic conditions increases.	RAND Corp, Santa Monica, CA 90407 USA; Univ Calif Los Angeles, Los Angeles, CA USA; Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; Kyoto Univ, Kyoto, Japan; Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester, Lancs, England; Vet Affairs Ann Arbor Hlth Care Syst, Ann Arbor, MI USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	RAND Corporation; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Kyoto University; University of Manchester; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Shekelle, PG (corresponding author), RAND Corp, 1776 Main St,POB 2138, Santa Monica, CA 90407 USA.	shekelle@rand.org	Adams, John/ABE-6170-2021; Kerr, Eve/I-3330-2013; Reeves, David/H-6203-2014	Reeves, David/0000-0001-6377-6859; Roland, Martin/0000-0002-8533-3060				Asch SM, 2004, ANN INTERN MED, V141, P938, DOI 10.7326/0003-4819-141-12-200412210-00010; BERENSON RA, 2003, HLTH AFF MILLWOOD S; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Christianson JB, 2006, J GEN INTERN MED, V21, pS9, DOI 10.1111/j.1525-1497.2006.00356.x; Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278; Davies HTO, 1999, LANCET, V353, P1639, DOI 10.1016/S0140-6736(99)90047-8; Davies HTO, 2002, J HEALTH POLIT POLIC, V27, P379, DOI 10.1215/03616878-27-3-379; Desai MM, 2002, AM J PSYCHIAT, V159, P1584, DOI 10.1176/appi.ajp.159.9.1584; Diette GB, 2001, PEDIATRICS, V108, P432, DOI 10.1542/peds.108.2.432; Donohoe MT, 1998, ARCH INTERN MED, V158, P1596, DOI 10.1001/archinte.158.15.1596; Epstein AM, 2006, NEW ENGL J MED, V355, P406, DOI 10.1056/NEJMe068131; Forrest CB, 2006, AM J MANAG CARE, V12, P83; Harrold LR, 1999, J GEN INTERN MED, V14, P499, DOI 10.1046/j.1525-1497.1999.08168.x; Heflin MT, 2002, J AM GERIATR SOC, V50, P1651, DOI 10.1046/j.1532-5415.2002.50456.x; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; Kizer KW, 2000, MED CARE, V38, pS7; Mannion Russell, 2005, J Health Serv Res Policy, V10, P18; Marshall MN, 2000, JAMA-J AM MED ASSOC, V283, P1866, DOI 10.1001/jama.283.14.1866; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Min LC, 2005, J AM GERIATR SOC, V53, P1705, DOI 10.1111/j.1532-5415.2005.53520.x; Ostbye T, 2005, ANN FAM MED, V3, P209, DOI 10.1370/afm.310; Piette JD, 2006, DIABETES CARE, V29, P725, DOI 10.2337/diacare.29.03.06.dc05-2078; *RAND, 2006, QUAL HLTH CAR DEL AD; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; Saliba D, 2001, J AM GERIATR SOC, V49, P1691, DOI 10.1046/j.1532-5415.2001.49281.x; Schuster MA, 1998, MILBANK Q, V76, P517, DOI 10.1111/1468-0009.00105; Shekelle PG, 2001, ANN INTERN MED, V135, P647, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00003; Shen YJ, 2003, HEALTH SERV RES, V38, P535, DOI 10.1111/1475-6773.00132; Walter LC, 2004, JAMA-J AM MED ASSOC, V291, P2466, DOI 10.1001/jama.291.20.2466; Wenger NS, 2003, ANN INTERN MED, V139, P740, DOI 10.7326/0003-4819-139-9-200311040-00008; Wenger NS, 2001, ANN INTERN MED, V135, P642, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00002; Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635	34	209	210	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2007	356	24					2496	2504		10.1056/NEJMsa066253	http://dx.doi.org/10.1056/NEJMsa066253			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	178DR	17568030				2022-12-01	WOS:000247201900009
J	Schwab, JM; Chiang, N; Arita, M; Serhan, CN				Schwab, Jan M.; Chiang, Nan; Arita, Makoto; Serhan, Charles N.			Resolvin E1 and protectin D1 activate inflammation-resolution programmes	NATURE			English	Article							ANTIINFLAMMATORY PROPERTIES; DOCOSAHEXAENOIC ACID; APOPTOTIC LEUKOCYTES; PHAGOCYTOSIS; MACROPHAGES; CELLS; CYCLOOXYGENASE; DOCOSATRIENES	Resolution of acute inflammation is an active process essential for appropriate host responses, tissue protection and the return to homeostasis(1-3). During resolution, specific omega-3 polyunsaturated fatty-acid-derived mediators are generated within resolving exudates, including resolvin E1 (RvE1)(4) and protectin D1 (PD1)(5). It is thus important to pinpoint specific actions of RvE1 and PD1 in regulating tissue resolution. Here we report that RvE1 and PD1 in nanogram quantities promote phagocyte removal during acute inflammation by regulating leukocyte infiltration, increasing macrophage ingestion of apoptotic polymorphonuclear neutrophils in vivo and in vitro, and enhancing the appearance of phagocytes carrying engulfed zymosan in lymph nodes and spleen. In this tissue terrain, inhibition of either cyclooxygenase or lipoxygenases - pivotal enzymes in the temporal generation of both pro-inflammatory and pro-resolving mediators - caused a 'resolution deficit' that was rescued by RvE1, PD1 or aspirin-triggered lipoxin A(4) analogue. Also, new resolution routes were identified that involve phagocytes traversing perinodal adipose tissues and non-apoptotic polymorphonuclear neutrophils carrying engulfed zymosan to lymph nodes. Together, these results identify new active components for postexudate resolution traffic, and demonstrate that RvE1 and PD1 are potent agonists for resolution of inflamed tissues.	Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Serhan, CN (corresponding author), Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA.	cnserhan@zeus.bwh.harvard.edu	Chiang, Nan/ABA-4924-2021	Schwab, Jan/0000-0001-6784-4919; Arita, Makoto/0000-0001-9902-0463	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE016191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038765, R01GM038765] Funding Source: NIH RePORTER; NIDCR NIH HHS [P50 DE016191, P50 DE016191-03] Funding Source: Medline; NIDDK NIH HHS [R01 DK074448-02, R01 DK074448] Funding Source: Medline; NIGMS NIH HHS [R01 GM038765, R37 GM038765, R37 GM038765-20] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Bazan NG, 2006, TRENDS NEUROSCI, V29, P263, DOI 10.1016/j.tins.2006.03.005; Bellingan GJ, 2002, J EXP MED, V196, P1515, DOI 10.1084/jem.20011794; Cao CZ, 2005, BLOOD, V106, P3234, DOI 10.1182/blood-2005-03-1288; Cotran R. S., 1999, ROBBINS PATHOLOGIC B; Freire-de-Lima CG, 2006, J BIOL CHEM, V281, P38376, DOI 10.1074/jbc.M605146200; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Gronert K, 2005, J BIOL CHEM, V280, P15267, DOI 10.1074/jbc.M410638200; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Liu YQ, 1999, J IMMUNOL, V162, P3639; Maddox JE, 1996, J EXP MED, V183, P137, DOI 10.1084/jem.183.1.137; Maderna P, 2005, J IMMUNOL, V174, P3727, DOI 10.4049/jimmunol.174.6.3727; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Pond CM, 2005, PROSTAG LEUKOTR ESS, V73, P17, DOI 10.1016/j.plefa.2005.04.005; Reville K, 2006, J IMMUNOL, V176, P1878, DOI 10.4049/jimmunol.176.3.1878; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; Sadik CD, 2003, BIOCHEM PHARMACOL, V65, P773, DOI 10.1016/S0006-2952(02)01621-0; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Sawatzky DA, 2006, AM J PATHOL, V168, P33, DOI 10.2353/ajpath.2006.050058; Serhan CN, 2006, J IMMUNOL, V176, P1848, DOI 10.4049/jimmunol.176.3.1848; Serhan CN, 2005, PROSTAG LEUKOTR ESS, V73, P139, DOI 10.1016/j.plefa.2005.07.001; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Underhill DM, 2003, J ENDOTOXIN RES, V9, P176, DOI 10.1179/096805103125001586; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102	29	885	930	3	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2007	447	7146					869	874		10.1038/nature05877	http://dx.doi.org/10.1038/nature05877			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17568749	Green Accepted			2022-12-01	WOS:000247207500047
J	Thermann, R; Hentze, MW				Thermann, Rolf; Hentze, Matthias W.			Drosophila miR2 induces pseudo-polysomes and inhibits translation initiation	NATURE			English	Article							MESSENGER-RNA DEGRADATION; HUMAN-CELLS; CAENORHABDITIS-ELEGANS; PROTEIN-SYNTHESIS; MICRORNA TARGETS; IDENTIFICATION; MECHANISM; REPRESS; BODIES; GENES	MicroRNAs (miRs) inhibit protein synthesis by mechanisms that are as yet unresolved(1-11). We developed a cell-free system from Drosophila melanogaster embryos that faithfully recapitulates miR2-mediated translational control by means of the 39 untranslated region of the D. melanogaster reaper messenger RNA. Here we show that miR2 inhibits translation initiation without affecting mRNA stability. Surprisingly, miR2 induces the formation of dense ( heavier than 80S) miRNPs ('pseudo-polysomes') even when polyribosome formation and 60S ribosomal subunit joining are blocked. An mRNA bearing an ApppG instead of anm(7) GpppG cap structure escapes the miR2-mediated translational block. These results directly show the inhibition of m(7) GpppG cap-mediated translation initiation as the mechanism of miR2 function, and uncover pseudo-polysomal messenger ribonucleoprotein assemblies that may help to explain earlier findings.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Hentze, MW (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	hentze@embl.de	Hentze, Matthias W/V-3980-2017	Hentze, Matthias W/0000-0002-4023-7876				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; ANTHONY DD, 1992, J BIOL CHEM, V267, P1554; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Beckmann K, 2005, CELL, V122, P529, DOI 10.1016/j.cell.2005.06.011; Chekulaeva M, 2006, CELL, V124, P521, DOI 10.1016/j.cell.2006.01.031; Gebauer F, 2003, MOL CELL, V11, P1397, DOI 10.1016/S1097-2765(03)00176-X; GRAY NK, 1994, EMBO J, V13, P3882, DOI 10.1002/j.1460-2075.1994.tb06699.x; HERSHEY JWB, 1966, J MOL BIOL, V18, P68, DOI 10.1016/S0022-2836(66)80077-3; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	29	239	248	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2007	447	7146					875	878		10.1038/nature05878	http://dx.doi.org/10.1038/nature05878			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17507927				2022-12-01	WOS:000247207500048
J	Chanock, SJ; Manolio, T; Boehnke, M; Boerwinkle, E; Hunter, DJ; Thomas, G; Hirschhorn, JN; Abecasis, G; Altshuler, D; Bailey-Wilson, JE; Brooks, LD; Cardon, LR; Daly, M; Donnelly, P; Fraumeni, JF; Freimer, NB; Gerhard, DS; Gunter, C; Guttmacher, AE; Guyer, MS; Harris, EL; Hoh, J; Hoover, R; Kong, CA; Merikangas, KR; Morton, CC; Palmer, LJ; Phimister, EG; Rice, JP; Roberts, J; Rotimi, C; Tucker, MA; Vogan, KJ; Wacholder, S; Wijsman, EM; Winn, DM; Collins, FS				Chanock, Stephen J.; Manolio, Teri; Boehnke, Michael; Boerwinkle, Eric; Hunter, David J.; Thomas, Gilles; Hirschhorn, Joel N.; Abecasis, Goncalo; Altshuler, David; Bailey-Wilson, Joan E.; Brooks, Lisa D.; Cardon, Lon R.; Daly, Mark; Donnelly, Peter; Fraumeni, Joseph F., Jr.; Freimer, Nelson B.; Gerhard, Daniela S.; Gunter, Chris; Guttmacher, Alan E.; Guyer, Mark S.; Harris, Emily L.; Hoh, Josephine; Hoover, Robert; Kong, C. Augustine; Merikangas, Kathleen R.; Morton, Cynthia C.; Palmer, Lyle J.; Phimister, Elizabeth G.; Rice, John P.; Roberts, Jerry; Rotimi, Charles; Tucker, Margaret A.; Vogan, Kyle J.; Wacholder, Sholom; Wijsman, Ellen M.; Winn, Deborah M.; Collins, Francis S.		NCI-NHGRI Working Grp Rep	Replicating genotype-phenotype associations	NATURE			English	Article							GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISMS; COMMON GENETIC-VARIANTS; FACTOR-H POLYMORPHISM; PARKINSON-DISEASE; PROSTATE-CANCER; DYSBINDIN GENE; RISK LOCUS; DTNBP1; SUSCEPTIBILITY		NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; NCI, Canc Res Ctr, Bethesda, MD 20892 USA; NHGRI, NIH, Bethesda, MD 20892 USA; Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77030 USA; Harvard Univ, Sch Med, Childrens Hosp, Broad Inst MIT & Harvard,Cambridge Ctr 7, Boston, MA 02114 USA; Massachusetts Gen Hosp, Broad Inst MIT & Harvard, Boston, MA 02114 USA; Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA; Univ Oxford, Oxford OX1 3TG, England; Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA; NCI, Off Canc Genom, NIH, Bethesda, MD 20892 USA; Nature, New York, NY 10013 USA; Yale Univ, Sch Med, New Haven, CT 06510 USA; DeCode Genet, IS-101 Reykjavik, Iceland; NIMH, NIH, Bethesda, MD 20892 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA; Western Australian Inst Med Res, Nedlands, WA 6009, Australia; Univ Western Australia, Queen Elizabeth II Med Ctr, Nedlands, WA 6009, Australia; New England Journal Med, Boston, MA 02115 USA; Washington Univ, Sch Med, St Louis, MO 63110 USA; Howard Univ, Genet Epidemiol Unit, Natl Human Genome Ctr, Washington, DC 20060 USA; Nature Genet, Cambridge, MA 02141 USA; Univ Washington, Div Med Genet, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; NCI, Epidemiol & Genet Res Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Michigan System; University of Michigan; University of Texas System; University of Texas Health Science Center Houston; Harvard University; Boston Children's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Broad Institute; Fred Hutchinson Cancer Center; University of Oxford; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); Yale University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Western Australia; University of Western Australia; Washington University (WUSTL); Howard University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chanock, SJ (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	chanocks@mail.nih.gov; manoliot@nhgri.nih.gov	Daly, Mark J/B-2453-2017; Tucker, Margaret A/B-4297-2015; Gunter, Chris/AHA-7271-2022; Altshuler, David M/A-4476-2009; Abecasis, Goncalo R/B-7840-2010; Palmer, Lyle John/K-3196-2014; Palmer, Lyle John/N-1948-2019	Daly, Mark J/0000-0002-0949-8752; Altshuler, David M/0000-0002-7250-4107; Palmer, Lyle John/0000-0002-1628-3055; Palmer, Lyle John/0000-0002-1628-3055; Gunter, Chris/0000-0001-9369-7537; Donnelly, Peter/0000-0001-9495-3408; Wijsman, Ellen/0000-0002-2725-6669; Merikangas, Kathkeen/0000-0002-4667-2414; Bailey-Wilson, Joan/0000-0002-9153-2920; Abecasis, Goncalo/0000-0003-1509-1825; Kong, Augustine/0000-0001-8193-5438; Vogan, Kyle/0000-0001-9565-9665	NATIONAL CANCER INSTITUTE [Z01SC010083] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200331, Z01HG000153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002804] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; ANGELL M, 1990, NEW ENGL J MED, V323, P823, DOI 10.1056/NEJM199009203231209; [Anonymous], 1999, NAT GENET, V22, P1; Bray NJ, 2005, HUM MOL GENET, V14, P1947, DOI 10.1093/hmg/ddi199; Chandak GR, 2007, DIABETOLOGIA, V50, P63, DOI 10.1007/s00125-006-0502-2; Clarimon J, 2006, AM J HUM GENET, V78, P1082, DOI 10.1086/504727; Clark AG, 2005, GENOME RES, V15, P1463, DOI 10.1101/gr.4244005; Clarke R, 2006, PLOS GENET, V2, P990, DOI 10.1371/journal.pgen.0020107; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; EASTON DF, 2007, NATURE          0527, DOI DOI 10.1038/NATURE05887; Economou M, 2004, AM J GASTROENTEROL, V99, P2393, DOI 10.1111/j.1572-0241.2004.40304.x; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Farrer MJ, 2006, AM J HUM GENET, V78, P1084, DOI 10.1086/504728; Field SF, 2007, DIABETOLOGIA, V50, P212, DOI 10.1007/s00125-006-0506-y; Flint J, 2007, PSYCHOL MED, V37, P163, DOI 10.1017/S0033291706008750; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Freimer N, 2003, NAT GENET, V34, P15, DOI 10.1038/ng0503-15; Freimer NB, 2007, NATURE, V445, P828, DOI 10.1038/nature05568; Funke B, 2004, AM J HUM GENET, V75, P891, DOI 10.1086/425279; Gavin JR, 1997, DIABETES CARE, V20, P1183; Goris A, 2006, AM J HUM GENET, V78, P1088, DOI 10.1086/504726; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gretarsdottir S, 2005, STROKE, V36, P1824, DOI 10.1161/01.STR.0000176497.94458.27; Groves CJ, 2006, DIABETES, V55, P2640, DOI 10.2337/db06-0355; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hall DH, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-83; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Horikoshi M, 2007, DIABETOLOGIA, V50, P747, DOI 10.1007/s00125-006-0588-6; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Ioannidis JPA, 2006, JNCI-J NATL CANCER I, V98, P1350, DOI 10.1093/jnci/djj392; Ioannidis JPA, 2006, AM J EPIDEMIOL, V164, P609, DOI 10.1093/aje/kwj259; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1439, DOI 10.1001/archopht.119.10.1439; Kirov G, 2004, BIOL PSYCHIAT, V55, P971, DOI 10.1016/j.biopsych.2004.01.025; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Li YH, 2006, AM J HUM GENET, V78, P1090, DOI 10.1086/504725; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Loos RJF, 2007, SCIENCE, V315, DOI [10.1126/science.1130012, 10.1126/science.1129402, 10.1126/science.1130571]; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; MCPHERSON R, 2007, SCIENCE         0503, DOI DOI 10.1126/SCIENCE.11142447; Mutsuddi M, 2006, AM J HUM GENET, V79, P903, DOI 10.1086/508942; Myers RH, 2006, AM J HUM GENET, V78, P1081; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Patterson M, 2005, PLOS BIOL, V3, P1511, DOI 10.1371/journal.pbio.0030327; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Roeder K, 2006, AM J HUM GENET, V78, P243, DOI 10.1086/500026; Rosand J, 2006, NAT GENET, V38, P1091, DOI 10.1038/ng1006-1091; Rothman N, 2006, LANCET ONCOL, V7, P27, DOI 10.1016/S1470-2045(05)70434-4; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2006, DIABETES, V55, P2890, DOI 10.2337/db06-0381; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Spielman RS, 1996, AM J HUM GENET, V59, P983; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Todd JA, 2006, NAT GENET, V38, P731, DOI 10.1038/ng0706-731; Van Den Bogaert A, 2003, AM J HUM GENET, V73, P1438, DOI 10.1086/379928; Wacholder S, 2000, J NATL CANCER I, V92, P1151, DOI 10.1093/jnci/92.14.1151; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821	79	1091	1116	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2007	447	7145					655	660		10.1038/447655a	http://dx.doi.org/10.1038/447655a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554299	Green Submitted, Bronze			2022-12-01	WOS:000247030700034
J	Rothman, DH; Forney, DC				Rothman, Daniel H.; Forney, David C.			Physical model for the decay and preservation of marine organic carbon	SCIENCE			English	Article							MATTER DECOMPOSITION; SEDIMENTS; FLUXES; SOILS	Degradation of marine organic carbon provides a major source of atmospheric carbon dioxide, whereas preservation in sediments results in accumulation of oxygen. These processes involve the slow decay of chemically recalcitrant compounds and physical protection. To assess the importance of physical protection, we constructed a reaction-diffusion model in which organic matter differs only in its accessibility to microbial degradation but not its intrinsic reactivity. The model predicts that organic matter decays logarithmically with time t and that decay rates decrease approximately as 0.2 x t(-1) until burial. Analyses of sediment-core data are consistent with these predictions.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Rothman, DH (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	dhr@mit.edu						ABELSON PH, 1978, ANNU REV EARTH PL SC, V6, P325, DOI 10.1146/annurev.ea.06.050178.001545; Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; Bender C.M., 1978, ADV MATH METHODS SCI; Berner R., 2004, PHANEROZOIC CARBON C; Berner RA., 1980, PRINCETON SERIES GEO, P241, DOI 10.1515/9780691209401; BETTS JN, 1991, GLOBAL PLANET CHANGE, V97, P5, DOI 10.1016/0031-0182(91)90178-T; BOUDREAU BP, 1991, AM J SCI, V291, P507, DOI 10.2475/ajs.291.5.507; Burdige DJ, 1999, GEOCHIM COSMOCHIM AC, V63, P1507, DOI 10.1016/S0016-7037(99)00066-6; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; HEDGES JI, 1995, MAR CHEM, V49, P81, DOI 10.1016/0304-4203(95)00008-F; Hedges JI, 1997, ORG GEOCHEM, V27, P319, DOI 10.1016/S0146-6380(97)00056-9; Hedges JI, 2001, NATURE, V409, P801, DOI 10.1038/35057247; Holland H.D., 1978, CHEM ATMOSPHERE OCEA; JORGENSEN BB, 1978, GEOMICROBIOL J, V1, P29; KEIL RG, 1994, GEOCHIM COSMOCHIM AC, V58, P879, DOI 10.1016/0016-7037(94)90512-6; KEIL RG, 1994, NATURE, V370, P549, DOI 10.1038/370549a0; KIRKPATRICK S, 1973, REV MOD PHYS, V45, P574, DOI 10.1103/RevModPhys.45.574; Knoll AH., 2003, LIFE YOUNG PLANET; Largeau C, 1993, ORGANIC GEOCHEMISTRY, P23, DOI [10.1007/978-1-4615-2890-6_2, DOI 10.1007/978-1-4615-2890-6]; MAYER LM, 1994, GEOCHIM COSMOCHIM AC, V58, P1271, DOI 10.1016/0016-7037(94)90381-6; MAYER LM, 1994, CHEM GEOL, V114, P347, DOI 10.1016/0009-2541(94)90063-9; MIDDELBURG JJ, 1993, GLOBAL PLANET CHANGE, V8, P47, DOI 10.1016/0921-8181(93)90062-S; MIDDELBURG JJ, 1989, GEOCHIM COSMOCHIM AC, V53, P1577, DOI 10.1016/0016-7037(89)90239-1; Premuzic E.T., 1982, ORG GEOCHEM, V4, P63, DOI [10.1016/0146-6380(82)90009-2., DOI 10.1016/0146-6380(82)90009-2]; Ransom B, 1997, MAR GEOL, V138, P1, DOI 10.1016/S0025-3227(97)00012-1; REIMERS CE, 1983, MAR CHEM, V13, P141, DOI 10.1016/0304-4203(83)90022-1; Schmidt JL, 1998, LIMNOL OCEANOGR, V43, P976, DOI 10.4319/lo.1998.43.5.0976; Schrag DP, 2007, SCIENCE, V315, P812, DOI 10.1126/science.1137632; SMITH DC, 1992, NATURE, V359, P139, DOI 10.1038/359139a0; Steen AD, 2006, MAR CHEM, V101, P266, DOI 10.1016/j.marchem.2006.04.001; TEGELAAR EW, 1989, GEOCHIM COSMOCHIM AC, V53, P3103, DOI 10.1016/0016-7037(89)90191-9; Vetter YA, 1998, MICROBIAL ECOL, V36, P75, DOI 10.1007/s002489900095	32	89	91	3	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2007	316	5829					1325	1328		10.1126/science.1138211	http://dx.doi.org/10.1126/science.1138211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17540901				2022-12-01	WOS:000246885600047
J	Samet, JM; Geyh, AS; Utell, MJ				Samet, Jonathan M.; Geyh, Alison S.; Utell, Mark J.			The legacy of World Trade Center dust	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CENTER DISASTER; EXPOSURE; COLLAPSE; FIRE		Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA; Univ Rochester, Sch Med & Dent, Rochester, NY USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Rochester	Samet, JM (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA.							Banauch GI, 2006, AM J RESP CRIT CARE, V174, P312, DOI 10.1164/rccm.200511-1736OC; Edelman P, 2003, ENVIRON HEALTH PERSP, V111, P1906, DOI 10.1289/ehp.6315; Fireman EM, 2004, ENVIRON HEALTH PERSP, V112, P1564, DOI 10.1289/ehp.7233; Geyh AS, 2005, J OCCUP ENVIRON HYG, V2, P179, DOI 10.1080/15459620590923154; Landrigan PJ, 2004, ENVIRON HEALTH PERSP, V112, P731, DOI 10.1289/ehp.6702	5	16	16	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2007	356	22					2233	2236		10.1056/NEJMp068287	http://dx.doi.org/10.1056/NEJMp068287			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	172PO	17538082				2022-12-01	WOS:000246816500001
J	Martens, S; Kozlov, MM; McMahon, HT				Martens, Sascha; Kozlov, Michael M.; McMahon, Harvey T.			How synaptotagmin promotes membrane fusion	SCIENCE			English	Article							TANDEM C2 DOMAINS; NEUROTRANSMITTER RELEASE; PHOSPHOLIPID-BINDING; TRANSMITTER RELEASE; C(2)A DOMAIN; CA2+; PENETRATION; EXOCYTOSIS; AFFINITY; MODEL	Synaptic vesicles loaded with neurotransmitters are exocytosed in a soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE)-dependent manner after presynaptic depolarization induces calcium ion (Ca2+) influx. The Ca2+ sensor required for fast fusion is synaptotagmin-1. The activation energy of bilayer-bilayer fusion is very high (approximate to 40 k(B)T). We found that, in response to Ca2+ binding, synaptotagmin-1 could promote SNARE-mediated fusion by lowering this activation barrier by inducing high positive curvature in target membranes on C2-domain membrane insertion. Thus, synaptotagmin-1 triggers the fusion of docked vesicles by local Ca2+-dependent buckling of the plasma membrane together with the zippering of SNAREs. This mechanism may be widely used in membrane fusion.	MRC, Mol Biol Lab, Cambridge CB2 0QH, England; Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel	MRC Laboratory Molecular Biology; Tel Aviv University; Sackler Faculty of Medicine	McMahon, HT (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	hmm@mrc-lmb.cam.ac.uk	Martens, Sascha/C-3693-2011	Martens, Sascha/0000-0003-3786-8199	Medical Research Council [MC_U105178795] Funding Source: Medline; MRC [MC_U105178795] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Cheng Y, 2004, PROTEIN SCI, V13, P2665, DOI 10.1110/ps.04832604; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Dai H, 2007, J MOL BIOL, V367, P848, DOI 10.1016/j.jmb.2007.01.040; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Herrick DZ, 2006, BIOCHEMISTRY-US, V45, P9668, DOI 10.1021/bi060874j; Hui EF, 2006, BIOPHYS J, V91, P1767, DOI 10.1529/biophysj.105.080325; Kozlovsky Y, 2002, BIOPHYS J, V82, P882, DOI 10.1016/S0006-3495(02)75450-7; Kuzmin PI, 2001, P NATL ACAD SCI USA, V98, P7235, DOI 10.1073/pnas.121191898; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Rhee JS, 2005, P NATL ACAD SCI USA, V102, P18664, DOI 10.1073/pnas.0509153102; Rickman C, 2004, BIOCHEM J, V378, P681, DOI 10.1042/BJ20031407; Rickman C, 2006, MOL BIOL CELL, V17, P283, DOI 10.1091/mbc.E05-07-0620; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; Shao XG, 1998, BIOCHEMISTRY-US, V37, P16106, DOI 10.1021/bi981789h; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X	26	393	400	2	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1205	1208		10.1126/science.1142614	http://dx.doi.org/10.1126/science.1142614			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17478680	Green Submitted			2022-12-01	WOS:000246724300047
J	Hamer, DH; Ndhlovu, M; Zurovac, D; Fox, M; Yeboah-Antwi, K; Chanda, P; Sipilinyambe, N; Simon, JL; Snow, RW				Hamer, Davidson H.; Ndhlovu, Micky; Zurovac, Dejan; Fox, Matthew; Yeboah-Antwi, Kojo; Chanda, Pascalina; Sipilinyambe, Naawa; Simon, Jonathon L.; Snow, Robert W.			Improved diagnostic testing and malaria treatment practices in Zambia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FEBRILE ILLNESS; CASE-MANAGEMENT; MICROSCOPY; TANZANIA	Context Improving the accuracy of malaria diagnosis with rapid antigen-detection diagnostic tests (RDTs) has been proposed as an approach for reducing overtreatment of malaria in the current era of widespread implementation of artemisinin-based combination therapy in sub-Saharan Africa. Objective To assess the association between use of microscopy and RDT and the prescription of antimalarials. Design, Setting, and Participants Cross-sectional, cluster sample survey, carried out between March and May 2006, of all outpatients treated during 1 working day at government and mission health facilities in 4 sentinel districts in Zambia. Main Outcome Measure Proportions of patients undergoing malaria diagnostic procedures and receiving antimalarial treatment. Results Seventeen percent of the 104 health facilities surveyed had functional microscopy, 63% had RDTs available, and 73% had 1 or more diagnostics available. Of patients with fever (suspected malaria), 27.8% (95% confidence interval [CI], 13.1%-42.5%) treated in health facilities with malaria diagnostics were tested and 44.6% had positive test results. Of patients with negative blood smear results, 58.4% (95% CI, 36.7%-80.2%) were prescribed an antimalaria drug, as were 35.5% (95% CI, 16.0%-55.0%) of those with a negative RDT result. Of patients with fever who did not have diagnostic tests done, 65.9% were also prescribed antimalarials. In facilities with artemether-lumefantrine in stock, this antimalarial was prescribed to a large proportion of febrile patients with a positive diagnostic test result (blood smear, 75.0% [95% CI, 51.7%-98.3%]; RDT, 70.4% [95% CI, 39.3%-100.0%]), but also to some of those with a negative diagnostic test result (blood smear, 30.4% [95% CI, 8.0%-52.9%]; RDT, 26.7% [95% CI, 5.7%-47.7%]). Conclusions Despite efforts to expand the provision of malaria diagnostics in Zambia, they continue to be underused and patients with negative test results frequently receive antimalarials. Provision of new tools to reduce inappropriate use of new expensive antimalarial treatments must be accompanied by a major change in clinical treatment of patients presenting with fever but lacking evidence of malaria infection.	Boston Univ, Sch Publ Hlth, Ctr Int Hlth & Dev, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Infect Dis Sect, Boston, MA 02118 USA; Chainama Hills Coll Hosp Hlth Sci, Lusaka, Zambia; KEMRI Wellcome Trust Collaborat Programme, Ctr Geog Med, Malaria Publ Hlth & Epidemiol Grp, Nairobi, Kenya; Univ Oxford, John Radcliffe Hosp, Ctr Trop Med, Oxford OX3 9DU, England; Minist Hlth, Natl Malaria Control Ctr, Lusaka, Zambia	Boston University; Boston University; University of Oxford	Hamer, DH (corresponding author), Boston Univ, Sch Publ Hlth, Ctr Int Hlth & Dev, 85 Concord St,5th Floor, Boston, MA 02118 USA.	dhamer@bu.edu	Snow, Robert William/AFR-1436-2022; Hamer, Davidson Howes/J-2020-2019; Yeboah-Antwi, Kojo/AAI-8519-2020	Snow, Robert William/0000-0003-3725-6088; Hamer, Davidson Howes/0000-0002-4700-1495; Yeboah-Antwi, Kojo/0000-0002-3516-9266; Chanda-Kapata, Pascalina/0000-0003-3271-5265; Simon, Jonathon/0000-0001-6740-549X; Fox, Matthew/0000-0001-9887-0634	Wellcome Trust [058992, 079080] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; Barat L, 1999, AM J TROP MED HYG, V60, P1024, DOI 10.4269/ajtmh.1999.60.1024; Barnish G, 2004, BRIT MED J, V328, P1151; Bell D, 2006, NAT REV MICROBIOL, pS7, DOI [10.1038/nrmico1525, 10.1038/nrmicro1525]; Central Board of Health (Zambia), 2003, GUID DIAGN TREATM MA; *MIN HLTH, 2006, ROAD MAP IMP MAL ZAM; *MIN HLTH CENTR ST, 2006, ZAMB NAT MAL IND SUR; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; MUDONDO C, 2005, ARTEMISININ BASED CO; Murray CK, 2003, TROP MED INT HEALTH, V8, P876, DOI 10.1046/j.1365-3156.2003.01115.x; *NAT MAL CONTR CTR, 2004, TRAIN DIAGN MAN MAL; *NAT MAL CONTR CTR, 2005, 2004 FOLL UP ROLL BA; Proux S, 2001, TROP MED INT HEALTH, V6, P99, DOI 10.1046/j.1365-3156.2001.00694.x; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; *WHO, 2006, WHOHTMMAL20061108; Zurovac D, 2006, TROP MED INT HEALTH, V11, P1185, DOI 10.1111/j.1365-3156.2006.01674.x; Zurovac D, 2006, TROP MED INT HEALTH, V11, P432, DOI 10.1111/j.1365-3156.2006.01587.x; Zurovac D, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-31	19	193	193	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2007	297	20					2227	2231		10.1001/jama.297.20.2227	http://dx.doi.org/10.1001/jama.297.20.2227			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	170JM	17519412	Green Accepted			2022-12-01	WOS:000246659700022
J	Lee, SH; Lim, CS; Park, H; Lee, JA; Han, JH; Kim, H; Cheang, YH; Lee, SH; Lee, YS; Ko, HG; Jang, DH; Kim, H; Miniaci, MC; Bartsch, D; Kim, E; Bailey, CH; Kandel, ER; Kaang, BK				Lee, Seung-Hee; Lim, Chae-Seok; Park, Hyungju; Lee, Jin-A; Han, Jin-Hee; Kim, Hyoung; Cheang, Ye-Hwang; Lee, Sue-Hyun; Lee, Yong-Seok; Ko, Hyoung-Gon; Jang, Dong-Hyuk; Kim, Hyongkyu; Miniaci, Maria C.; Bartsch, Dusan; Kim, Eunjoon; Bailey, Craig H.; Kandel, Eric R.; Kaang, Bong-Kiun			Nuclear translocation of CAM-associated protein activates transcription for long-term facilitation in Aplysia	CELL			English	Article							CELL-ADHESION MOLECULES; SYNAPTIC PLASTICITY; SENSORY NEURONS; MOTOR SYNAPSES; MEMORY STORAGE; PHOSPHORYLATION; EXPRESSION; OVEREXPRESSION; CONSOLIDATION; MODULATION	Repeated pulses of serotonin (5-HT) induce long-term facilitation (LTF) of the synapses between sensory and motor neurons of the gill-withdrawal reflex in Aplysia. To explore how apCAM downregulation at the plasma membrane and CREB-mediated transcription in the nucleus, both of which are required for the formation of LTF, might relate to each other, we cloned an apCAM-associated protein (CAMAP) by yeast two-hybrid screening. We found that 5-HT signaling at the synapse activates PKA which in turn phosphorylates CAMAP to induce the dissociation of CAMAP from apCAM and the subsequent translocation of CAMAP into the nucleus of sensory neurons. In the nucleus, CAMAP acts as a transcriptional coactivator for CREB1 and is essential for the activation of ApC/EBP required for the initiation of LTF. Combined, our data suggest that CAMAP is a retrograde signaling component that translocates from activated synapses to the nucleus during synapse-specific LTF.	[Lee, Seung-Hee; Lim, Chae-Seok; Park, Hyungju; Lee, Jin-A; Han, Jin-Hee; Kim, Hyoung; Cheang, Ye-Hwang; Lee, Sue-Hyun; Lee, Yong-Seok; Ko, Hyoung-Gon; Jang, Dong-Hyuk; Kaang, Bong-Kiun] Seoul Natl Univ, Coll Nat Sci, Inst Mol Biol & Genet, Dept Biol Sci,RIO, Seoul 151747, South Korea; [Kim, Hyongkyu] Chungbuk Natl Univ, Coll Med, Cheongju 361763, South Korea; [Bartsch, Dusan] Cent Inst Mental Hlth, Dept Mol Biol, D-68159 Mannheim, Germany; [Kim, Eunjoon] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Kandel, Eric R.] Howard Hughes Med Inst, New York, NY 10032 USA; [Miniaci, Maria C.; Bailey, Craig H.; Kandel, Eric R.] Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Kavli Inst Brain Sci, New York State Psychiat Inst, New York, NY 10032 USA	Seoul National University (SNU); Chungbuk National University; Central Institute of Mental Health; Korea Advanced Institute of Science & Technology (KAIST); Howard Hughes Medical Institute; Columbia University; New York State Psychiatry Institute	Kaang, BK (corresponding author), Seoul Natl Univ, Coll Nat Sci, Inst Mol Biol & Genet, Dept Biol Sci,RIO, San 56-1 Silim Dong, Seoul 151747, South Korea.	kaang@snu.ac.kr	Lee, Sue-Hyun/F-5490-2015; Lee, Seung-Hee/J-5971-2013; Han, Jin-Hee/C-2069-2011; Park, Hyungju/C-4608-2016; Kim, Eunjoon/C-1566-2011	Lee, Sue-Hyun/0000-0002-5318-5657; Park, Hyungju/0000-0002-9010-9434; Ko, Hyoung-Gon/0000-0002-7730-6986; Han, Jin-Hee/0000-0002-2139-5596; Miniaci, Maria/0000-0003-3844-0581				ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; Bailey CH, 1997, NEURON, V18, P913, DOI 10.1016/S0896-6273(00)80331-1; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Betschinger J, 2005, CURR BIOL, V15, P276, DOI 10.1016/j.cub.2005.01.012; Byrne JH, 1996, J NEUROSCI, V16, P425; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Fields RD, 1996, TRENDS NEUROSCI, V19, P473, DOI 10.1016/S0166-2236(96)30013-1; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Han JH, 2004, LEARN MEMORY, V11, P421, DOI 10.1101/lm.61104; Juliano RL, 2002, ANNU REV PHARMACOL, V42, P283, DOI 10.1146/annurev.pharmtox.42.090401.151133; KAANG BK, 1993, NEURON, V10, P427, DOI 10.1016/0896-6273(93)90331-K; KAANG BK, 1992, P NATL ACAD SCI USA, V89, P1133, DOI 10.1073/pnas.89.3.1133; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; KELLER F, 1990, J CELL BIOL, V111, P2637, DOI 10.1083/jcb.111.6.2637; Kim H, 2006, NEURON, V49, P707, DOI 10.1016/j.neuron.2006.01.035; Kim JH, 2003, NEURON, V40, P151, DOI 10.1016/S0896-6273(03)00595-6; Lee JA, 2001, LEARN MEMORY, V8, P220, DOI 10.1101/lm.40201; Lee JA, 2006, J CELL BIOL, V174, P827, DOI 10.1083/jcb.200512066; Li Z, 2003, NAT REV MOL CELL BIO, V4, P833, DOI 10.1038/nrm1242; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; Murase S, 1999, CURR OPIN CELL BIOL, V11, P549, DOI 10.1016/S0955-0674(99)00019-8; SCHACHER S, 1983, J NEUROSCI, V3, P2403; Shen X, 1998, MOL BIOL CELL, V9, P3309, DOI 10.1091/mbc.9.12.3309; Thompson KR, 2004, NEURON, V44, P997, DOI 10.1016/j.neuron.2004.11.025; Tran NH, 2005, J BIOL CHEM, V280, P16244, DOI 10.1074/jbc.M501185200	29	42	43	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2007	129	4					801	812		10.1016/j.cell.2007.03.041	http://dx.doi.org/10.1016/j.cell.2007.03.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512412	Bronze			2022-12-01	WOS:000246788300023
J	Zhang, LF; Huynh, KD; Lee, JT				Zhang, Li-Feng; Huynh, Khanh D.; Lee, Jeannie T.			Perinucleolar targeting of the inactive X during S phase: Evidence for a role in the maintenance of silencing	CELL			English	Article							EARLY MOUSE EMBRYOS; TRANSFER-RNA GENES; CHROMOSOME INACTIVATION; DNA-REPLICATION; HUMAN-FIBROBLASTS; XIST GENE; INTERPHASE; TSIX; LOCALIZATION; CELL	In mammalian females, two X chromosomes are epigenetically distinguished as active and inactive chromosomes to balance X-linked gene dosages between males and females. How the Xs are maintained differently in the same nucleus remains unknown. Here, we demonstrate that the inactive X (Xi) is targeted to a distinct nuclear compartment following pairing with its homologous partner. During mid-to-late S phase, 80%-90% of Xi contact the nucleolus and reside within a Snf2h-enriched ring. Autosomes carrying ectopic X-inactivation center sequences are also targeted to the perinucleolar compartment. Deleting Xist results in a loss of nucleolar association and an inability to maintain Xi heterochromatin, leading to Xi reactivation at the single gene level. We propose that the Xi must continuously visit the perinucleolar compartment to maintain its epigenetic state. These data raise a mechanism by which chromatin states can be replicated by spatial and temporal separation in the nucleus.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02114 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Biol Mol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lee, JT (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02114 USA.	lee@molbio.mgh.harvard.edu	Zhang, Li-Feng/A-2209-2011	Zhang, Li-Feng/0000-0003-0917-0017	NATIONAL CANCER INSTITUTE [K01CA115593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058839] Funding Source: NIH RePORTER; NCI NIH HHS [K01-CA115593] Funding Source: Medline; NIGMS NIH HHS [R01-GM58839] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; Bailis JM, 2003, CELL CYCLE, V2, P303, DOI 10.4161/cc.2.4.434; BARR ML, 1949, NATURE, V163, P676, DOI 10.1038/163676a0; BARTON DE, 1964, ANN HUM GENET, V28, P123, DOI 10.1111/j.1469-1809.1964.tb00467.x; BELMONT AS, 1986, EXP CELL RES, V165, P165, DOI 10.1016/0014-4827(86)90541-0; BORDEN J, 1988, SCIENCE, V242, P1687, DOI 10.1126/science.3201257; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BOURGEOIS CA, 1985, HUM GENET, V69, P122, DOI 10.1007/BF00293281; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1994, NATURE, V368, P154, DOI 10.1038/368154a0; BROWN M, 1986, J VIROL, V60, P290, DOI 10.1128/JVI.60.1.290-293.1986; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Collins N, 2002, NAT GENET, V32, P627, DOI 10.1038/ng1046; COMINGS DE, 1968, AM J HUM GENET, V20, P440; Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; Csankovszki G, 2001, J CELL BIOL, V153, P773, DOI 10.1083/jcb.153.4.773; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Diaz-Perez SV, 2006, GENETICS, V174, P1115, DOI 10.1534/genetics.105.051375; DYER KA, 1989, CYTOGENET CELL GENET, V50, P116, DOI 10.1159/000132736; Eils R, 1996, J CELL BIOL, V135, P1427, DOI 10.1083/jcb.135.6.1427; Furuyama T, 2006, P NATL ACAD SCI USA, V103, P6172, DOI 10.1073/pnas.0601686103; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hall LL, 2002, P NATL ACAD SCI USA, V99, P8677, DOI 10.1073/pnas.132468999; Huang S, 2000, J STRUCT BIOL, V129, P233, DOI 10.1006/jsbi.2000.4247; HULL MW, 1994, MOL CELL BIOL, V14, P1266, DOI 10.1128/MCB.14.2.1266; Huynh KD, 2005, NAT REV GENET, V6, P410, DOI 10.1038/nrg1604; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; Lee JT, 2005, SCIENCE, V309, P768, DOI 10.1126/science.1113673; Lee JT, 1999, P NATL ACAD SCI USA, V96, P3836, DOI 10.1073/pnas.96.7.3836; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lee JT, 1997, NATURE, V386, P275, DOI 10.1038/386275a0; Lee JT, 1996, CELL, V86, P83, DOI 10.1016/S0092-8674(00)80079-3; Lucchesi JC, 2005, ANNU REV GENET, V39, P615, DOI 10.1146/annurev.genet.39.073003.094210; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; McNairn AJ, 2003, BIOESSAYS, V25, P647, DOI 10.1002/bies.10305; NAKAYASU H, 1989, J CELL BIOL, V108, P1, DOI 10.1083/jcb.108.1.1; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Stavropoulos N, 2005, MOL CELL BIOL, V25, P2757, DOI 10.1128/MCB.25.7.2757-2769.2005; Thorvaldsen JL, 2006, DEV BIOL, V298, P344, DOI 10.1016/j.ydbio.2006.07.011; Wang L, 2005, J BIOL CHEM, V280, P8637, DOI 10.1074/jbc.C500017200; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984	47	250	262	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2007	129	4					693	706		10.1016/j.cell.2007.03.036	http://dx.doi.org/10.1016/j.cell.2007.03.036			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512404	Bronze			2022-12-01	WOS:000246788300015
J	Serrano, M				Serrano, Manuel			Cancer regression by senescence	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							P53 RESTORATION		Spanish Natl Canc Res Ctr, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Serrano, M (corresponding author), Spanish Natl Canc Res Ctr, Madrid, Spain.		Serrano, Manuel/H-2634-2015	Serrano, Manuel/0000-0001-7177-9312				Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529	4	35	35	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2007	356	19					1996	1997		10.1056/NEJMcibr071461	http://dx.doi.org/10.1056/NEJMcibr071461			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165KX	17494935				2022-12-01	WOS:000246305500015
J	Mant, D; Mayon-White, R				Mant, David; Mayon-White, Richard			Tuberculosis: think globally and act locally	LANCET			English	Editorial Material									Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England; Directorate Publ Hlth & Hlth Policy, Oxford, England	University of Oxford; University of Oxford	Mant, D (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England.	David.mant@dphpc.ox.ac.uk	Mant, David CA/C-7763-2009					Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Griffiths C, 2007, LANCET, V369, P1528, DOI 10.1016/S0140-6736(07)60707-7; *HLTH PROT AG, 2005, ANN REP TUB CAS REP; *HLTH PROT AG, 2006, FOC TUB ANN SURV REP; Musher DM, 2003, NEW ENGL J MED, V348, P1256, DOI 10.1056/NEJMra021771; *NAT STAT, FOC PEOPL MIGR; *NIH CLIN EXC, 2006, TUB CLIN DIAGN MAN T; Ormerod P, 2000, THORAX, V55, P887; WHO, 2006, WHO REP 2006 GLOB TU; WOODBRIDGE J, SIZING UNAUTHORISED	10	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2007	369	9572					1493	1494		10.1016/S0140-6736(07)60684-9	http://dx.doi.org/10.1016/S0140-6736(07)60684-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	164EI	17482964				2022-12-01	WOS:000246215800004
J	Liu, AC; Welsh, DK; Ko, CH; Tran, HG; Zhang, EE; Priest, AA; Buhr, ED; Singer, O; Meeker, K; Verma, IM; Doyle, FJ; Takahashi, JS; Kay, SA				Liu, Andrew C.; Welsh, David K.; Ko, Caroline H.; Tran, Hien G.; Zhang, Eric E.; Priest, Aaron A.; Buhr, Ethan D.; Singer, Oded; Meeker, Kirsten; Verma, Inder M.; Doyle, Francis J., III; Takahashi, Joseph S.; Kay, Steve A.			Intercellular coupling confers robustness against mutations in the SCN circadian clock network	CELL			English	Article							GENE-EXPRESSION; INDIVIDUAL FIBROBLASTS; REVEALS PERSISTENT; PERIOD; MOUSE; RHYTHMS; TIME; SYNCHRONIZATION; OSCILLATORS; MICE	Molecular mechanisms of the mammalian circadian clock have been studied primarily by genetic perturbation and behavioral analysis. Here, we used bioluminescence imaging to monitor Per2 gene expression in tissues and cells from clock mutant mice. We discovered that Per1 and Cry1 are required for sustained rhythms in peripheral tissues and cells, and in neurons dissociated from the suprachiasmatic nuclei (SCN). Per2 is also required for sustained rhythms, whereas Cry2 and Per3 deficiencies cause only period length defects. However, oscillator network interactions in the SCN can compensate for Per1 or Cry1 deficiency, preserving sustained rhythmicity in mutant SCN slices and behavior. Thus, behavior does not necessarily reflect cell-autonomous clock phenotypes. Our studies reveal previously unappreciated requirements for Per1, Per2, and Cry1 in sustaining cellular circadian rhythmicity and demonstrate that SCN intercellular coupling is essential not only to synchronize component cellular oscillators but also for robustness against genetic perturbations.	Scripps Res Inst, Dept Biochem, La Jolla, CA 92037 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; Vet Affairs San Diego Healthcare Syst, La Jolla, CA 92161 USA; Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA; Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada; Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; Univ Calif Santa Barbara, Dept Comp Sci, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA	Scripps Research Institute; Novartis; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Howard Hughes Medical Institute; Northwestern University; Northwestern University; University of Toronto; Salk Institute; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Kay, SA (corresponding author), Scripps Res Inst, Dept Biochem, La Jolla, CA 92037 USA.	stevek@scripps.edu	Ko, Caroline/E-6877-2010; Takahashi, Joseph S./Y-2781-2019; Liu, Andrew C/B-3548-2009; Welsh, David K/G-2277-2011; Kay, Steve A/F-6025-2011; Meeker, Kirsten/AAL-1555-2020; Jansen, Heiko T./A-5770-2008; Takahashi, Joseph S/E-8482-2012	Takahashi, Joseph S./0000-0003-0384-8878; Liu, Andrew C/0000-0003-1927-0900; Kay, Steve A/0000-0002-0402-2878; Jansen, Heiko T./0000-0003-0178-396X; Takahashi, Joseph S/0000-0003-0384-8878; Buhr, Ethan/0000-0002-9250-6644; Zhang, Eric/0000-0002-4472-7493; Meeker, Kirsten/0000-0002-2080-8459	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074924, R01MH051573, K08MH067657, U01MH061915] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM074868] Funding Source: Medline; NIMH NIH HHS [K08 MH067657, U01 MH061915, U01 MH061915-05, P50 MH074924, R01 MH051573, P50 MH074924-02] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aton SJ, 2005, NEURON, V48, P531, DOI 10.1016/j.neuron.2005.11.001; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Brown SA, 2005, PLOS BIOL, V3, P1813, DOI 10.1371/journal.pbio.0030338; Bucan M, 2002, NAT REV GENET, V3, P114, DOI 10.1038/nrg728; Buijs RM, 2001, NAT REV NEUROSCI, V2, P521, DOI 10.1038/35081582; Cermakian N, 2001, EMBO J, V20, P3967, DOI 10.1093/emboj/20.15.3967; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Forger DB, 2005, P NATL ACAD SCI USA, V102, P321, DOI 10.1073/pnas.0408465102; Garcia-Ojalvo J, 2004, P NATL ACAD SCI USA, V101, P10955, DOI 10.1073/pnas.0307095101; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Hastings MH, 2004, J BIOL RHYTHM, V19, P400, DOI 10.1177/0748730404268786; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Horikawa K, 2006, NATURE, V441, P719, DOI 10.1038/nature04861; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Krishnan B, 2001, NATURE, V411, P313, DOI 10.1038/35077094; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Leloup JC, 2003, P NATL ACAD SCI USA, V100, P7051, DOI 10.1073/pnas.1132112100; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; Low-Zeddies SS, 2001, CELL, V105, P25, DOI 10.1016/S0092-8674(01)00294-X; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Masamizu Y, 2006, P NATL ACAD SCI USA, V103, P1313, DOI 10.1073/pnas.0508658103; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; MURAKAMI N, 1991, BRAIN RES, V545, P347, DOI 10.1016/0006-8993(91)91312-O; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Nakamura W, 2002, NAT NEUROSCI, V5, P399, DOI 10.1038/nn843; Ohta H, 2005, NAT NEUROSCI, V8, P267, DOI 10.1038/nn1395; Oster H, 2002, GENE DEV, V16, P2633, DOI 10.1101/gad.233702; Pando MP, 2002, CELL, V110, P107, DOI 10.1016/S0092-8674(02)00803-6; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Shen HM, 1997, J NEUROSCI, V17, P5221; SMOLEN P, 1993, BIOPHYS J, V64, P1668, DOI 10.1016/S0006-3495(93)81539-X; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Takahashi JS, 2004, J BIOL RHYTHM, V19, P339, DOI 10.1177/0748730404269151; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Welsh DK, 2005, METHOD ENZYMOL, V393, P269, DOI 10.1016/S0076-6879(05)93011-5; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	49	511	520	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					605	616		10.1016/j.cell.2007.02.047	http://dx.doi.org/10.1016/j.cell.2007.02.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482552	Green Accepted, Bronze			2022-12-01	WOS:000246373600025
J	Funk, JL; Vitousek, PM				Funk, Jennifer L.; Vitousek, Peter M.			Resource-use efficiency and plant invasion in low-resource systems	NATURE			English	Article							COMMUNITY STRUCTURE; CONSTRUCTION COST; INVASIBILITY; GRASSLAND; LEAF; INVASIVENESS; AVAILABILITY; ASSIMILATION; RESTORATION; RESPONSES	No species can maximize growth, reproduction and competitive ability across all environments, so the success of invasive species is habitat-dependent. Nutrient-rich habitats often experience more invasion than resource-poor habitats(1-4), a pattern consistent with traits generally associated with successful invaders ( high growth rates, early reproduction and many offspring(5-8)). However, invaders do colonize resource-poor environments, and the mechanisms that allow their success in these systems are poorly understood. Traits associated with resource conservation are widespread among species adapted to resource-poor environments(9-11), and invasive species may succeed in low-resource environments by employing resource conservation traits such as high resource-use efficiency ( RUE; carbon assimilation per unit of resource). We investigated RUE in invasive and native species from three habitats in Hawaii where light, water or nutrient availability was limiting to plant growth. Here we show that across multiple growth forms and broad taxonomic diversity invasive species were generally more efficient than native species at using limiting resources on short timescales and were similarly efficient when RUE measures were integrated over leaf lifespans. Our data challenge the idea that native species generally outperform invasive species under conditions of low resource availability(3), and suggest that managing resource levels is not always an effective strategy for invasive species control.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Funk, JL (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	funk@stanford.edu	Funk, Jennifer/AAX-9325-2021; Funk, Jennifer/B-6328-2009; Funk, Jennifer/AAL-6185-2021	Funk, Jennifer/0000-0002-1916-5513				Agrawal AA, 2003, ECOL LETT, V6, P712, DOI 10.1046/j.1461-0248.2003.00498.x; [Anonymous], 2005, EC HUM WELL BEING BI; Baruch Z, 1999, OECOLOGIA, V121, P183, DOI 10.1007/s004420050920; Blumenthal D, 2005, SCIENCE, V310, P243, DOI 10.1126/science.1114851; Blumenthal DM, 2003, ECOL APPL, V13, P605, DOI 10.1890/1051-0761(2003)013[0605:SCACWA]2.0.CO;2; Burke MJW, 1996, ECOLOGY, V77, P776, DOI 10.2307/2265501; Burns JH, 2006, ECOL APPL, V16, P1367, DOI 10.1890/1051-0761(2006)016[1367:RAEATA]2.0.CO;2; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; D'Antonio CM., 1999, ECOSYSTEMS DISTURBED, P413; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Gross KL, 2005, ECOLOGY, V86, P476, DOI 10.1890/04-0122; Grotkopp E, 2002, AM NAT, V159, P396, DOI 10.1086/338995; Hamilton MA, 2005, ECOL LETT, V8, P1066, DOI 10.1111/j.1461-0248.2005.00809.x; HUENNEKE LF, 1990, ECOLOGY, V71, P478, DOI 10.2307/1940302; Mitchell CE, 2006, ECOL LETT, V9, P726, DOI 10.1111/j.1461-0248.2006.00908.x; Nagel JM, 2005, NEW PHYTOL, V166, P513, DOI 10.1111/j.1469-8137.2005.01341.x; PYSEK P, 1995, PLANT INVASIONS, P39; Reed HE, 2005, ECOL APPL, V15, P1560, DOI 10.1890/04-0407; Reich PB, 2004, ECOL MONOGR, V74, P3, DOI 10.1890/02-4047; REICH PB, 1992, ECOL MONOGR, V62, P365, DOI 10.2307/2937116; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Suding KN, 2004, OECOLOGIA, V141, P526, DOI 10.1007/s00442-004-1678-0; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; VITOUSEK P, 1982, AM NAT, V119, P553, DOI 10.1086/283931; VITOUSEK PM, 1993, BIOGEOCHEMISTRY, V23, P197, DOI 10.1007/BF00023752; VITOUSEK PM, 1990, OIKOS, V57, P7, DOI 10.2307/3565731; WILLIAMS K, 1987, PLANT CELL ENVIRON, V10, P725	30	583	653	23	476	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2007	446	7139					1079	1081		10.1038/nature05719	http://dx.doi.org/10.1038/nature05719			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17460672				2022-12-01	WOS:000245950400049
J	Purohit, P; Mitra, A; Auerbach, A				Purohit, Prasad; Mitra, Ananya; Auerbach, Anthony			A stepwise mechanism for acetylcholine receptor channel gating	NATURE			English	Article							CYS-LOOP RECEPTOR; GATED ION-CHANNEL; TRANSITION-STATE; ALPHA-SUBUNIT; M2 SEGMENT; TRANSMEMBRANE SEGMENT; NICOTINIC RECEPTORS; PORE; DYNAMICS; RESIDUES	Muscle contraction is triggered by the opening of acetylcholine receptors at the vertebrate nerve - muscle synapse(1-4). The M2 helix of this allosteric membrane protein lines the channel, and contains a 'gate' that regulates the flow of ions through the pore. We used single-molecule kinetic analysis to probe the transition state of the gating conformational change and estimate the relative timing of M2 motions in the alpha-subunit of the murine acetylcholine receptor(5). This analysis produces a 'Phi-value' for a given residue that reflects its open-like versus closed-like character at the transition state. Here we show that most of the residues throughout the length of M2 have a Phi-value of similar to 0.64 but that some near the middle have lower Phi-values of 0.52 or 0.31, suggesting that alpha M2 moves in three discrete steps. The core of the channel serves both as a gate that regulates ion flow and as a hub that directs the propagation of the gating isomerization through the membrane domain of the acetylcholine receptor.	SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Auerbach, A (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA.	auerbach@buffalo.edu						AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; Auerbach A, 2005, P NATL ACAD SCI USA, V102, P1408, DOI 10.1073/pnas.0406787102; BALI M, IN PRESS J GEN PHYSL; Beckstein O, 2006, PHYS BIOL, V3, P147, DOI 10.1088/1478-3975/3/2/007; CADUGAN DJ, IN PRESS BIOPHYS J; Chakrapani S, 2005, P NATL ACAD SCI USA, V102, P87, DOI 10.1073/pnas.0406777102; Chakrapani S, 2003, J GEN PHYSIOL, V122, P521, DOI 10.1085/jgp.200308885; Chakrapani S, 2004, J GEN PHYSIOL, V123, P341, DOI 10.1085/jgp.200309004; Cymes GD, 2002, BIOCHEMISTRY-US, V41, P5548, DOI 10.1021/bi011864f; Edelstein SJ, 1998, ADV PROTEIN CHEM, V51, P121; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Grunwald E., 1989, RATES EQUILIBRIA ORG; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Mitra A, 2004, STRUCTURE, V12, P1909, DOI 10.1016/j.str.2004.08.004; Mitra A, 2005, P NATL ACAD SCI USA, V102, P15069, DOI 10.1073/pnas.0505090102; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Paas Y, 2005, P NATL ACAD SCI USA, V102, P15877, DOI 10.1073/pnas.0507599102; Panicker S, 2002, J NEUROSCI, V22, P1629, DOI 10.1523/JNEUROSCI.22-05-01629.2002; Pascual JM, 1998, J GEN PHYSIOL, V111, P717, DOI 10.1085/jgp.111.6.717; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; VILLARROEL A, 1991, P ROY SOC B-BIOL SCI, V243, P69, DOI 10.1098/rspb.1991.0012; Wilson GG, 1998, NEURON, V20, P1269, DOI 10.1016/S0896-6273(00)80506-1; Zhang H, 1998, BIOCHEMISTRY-US, V37, P7952, DOI 10.1021/bi980143m; Zhou Y, 2005, BIOPHYS J, V89, P3680, DOI 10.1529/biophysj.105.067215	29	118	120	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2007	446	7138					930	933		10.1038/nature05721	http://dx.doi.org/10.1038/nature05721			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IR	17443187				2022-12-01	WOS:000245785700046
J	Lerdau, M				Lerdau, Manuel			A positive feedback with negative consequences	SCIENCE			English	Editorial Material							ORGANIC-COMPOUND EMISSIONS; ISOPRENE EMISSION; BIOGENIC ISOPRENE; FOREST; LEAVES; PLANTS; PATHWAY		Univ Virginia, Dept Environm Sci, Blandy Expt Farm, Charlottesville, VA 22904 USA	University of Virginia	Lerdau, M (corresponding author), Univ Virginia, Dept Environm Sci, Blandy Expt Farm, Charlottesville, VA 22904 USA.	mlerdau@virginia.edu	Lerdau, Manuel/E-7320-2011	Lerdau, Manuel/0000-0003-1864-0834				Fiore AM, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005485; Friedlingstein P, 1999, GLOBAL CHANGE BIOL, V5, P755, DOI 10.1046/j.1365-2486.1999.00269.x; Geron C, 2002, ATMOS ENVIRON, V36, P3793, DOI 10.1016/S1352-2310(02)00301-1; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Horowitz LW, 1999, J GEOPHYS RES-ATMOS, V104, P23823, DOI 10.1029/1999JD900205; Keller M, 1999, GLOBAL BIOGEOCHEM CY, V13, P19, DOI 10.1029/1998GB900007; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; Loreto F, 2007, PLANT PHYSIOL, V143, P1096, DOI 10.1104/pp.106.091892; MONSON RK, 1995, ATMOS ENVIRON, V29, P2989, DOI 10.1016/1352-2310(94)00360-W; RASMUSSEN RA, 1970, ENVIRON SCI TECHNOL, V4, P667, DOI 10.1021/es60043a008; Sanadze GA, 2004, RUSS J PLANT PHYSL+, V51, P729, DOI 10.1023/B:RUPP.0000047821.63354.a4; Sharkey TD, 2001, ANNU REV PLANT PHYS, V52, P407, DOI 10.1146/annurev.arplant.52.1.407; Sharkey TD, 2005, PLANT PHYSIOL, V137, P700, DOI 10.1104/pp.104.054445; SHARKEY TD, 1995, NATURE, V374, P769, DOI 10.1038/374769a0; Velikova V, 2005, PLANT CELL ENVIRON, V28, P318, DOI 10.1111/j.1365-3040.2004.01314.x; Wiedinmyer C, 2006, EARTH INTERACT, V10, DOI 10.1175/EI174.1	17	48	52	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					212	213		10.1126/science.1141486	http://dx.doi.org/10.1126/science.1141486			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	156MV	17431162				2022-12-01	WOS:000245654500032
J	Schweitzer, MH; Suo, Z; Avci, R; Asara, JM; Allen, MA; Arce, FT; Horner, JR				Schweitzer, Mary Higby; Suo, Zhiyong; Avci, Recep; Asara, John M.; Allen, Mark A.; Arce, Fernando Teran; Horner, John R.			Analyses of soft tissue from Tyrannosaurus rex suggest the presence of protein	SCIENCE			English	Article							FOSSIL BONES; CELLULAR PRESERVATION; ANCIENT DNA; COLLAGEN; STABILIZATION; EXTRACTION; MATRIX; IRON	We performed multiple analyses of Tyrannosaurus rex ( specimen MOR 1125) fibrous cortical and medullary tissues remaining after demineralization. The results indicate that collagen I, the main organic component of bone, has been preserved in low concentrations in these tissues. The findings were independently confirmed by mass spectrometry. We propose a possible chemical pathway that may contribute to this preservation. The presence of endogenous protein in dinosaur bone may validate hypotheses about evolutionary relationships, rates, and patterns of molecular change and degradation, as well as the chemical stability of molecules over time.	N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA; N Carolina Museum Nat Sci, Raleigh, NC 27601 USA; Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; Montana State Univ, Image & Chem Anal Lab Facil, Dept Phys, Bozeman, MT 59717 USA; Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; Univ Chicago, Ctr Nanomed Pulm & Crit Care Med, Dept Med, Chicago, IL 60637 USA	University of North Carolina; North Carolina State University; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Montana State University System; Montana State University Bozeman; University of Chicago	Schweitzer, MH (corresponding author), N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Box 8208, Raleigh, NC 27695 USA.	schweitzer@ncsu.edu	Schweitzer, Mary/V-8143-2019; schweitzer, mary h/A-6756-2010; Teran Arce, Fernando/I-7835-2018; Allen, Mark/K-8070-2018	schweitzer, mary h/0000-0002-0427-3829; Teran Arce, Fernando/0000-0002-6518-8695; Allen, Mark/0000-0002-1825-0118				Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614; Avci R, 2005, LANGMUIR, V21, P3584, DOI 10.1021/la047682e; Bada JL, 1999, PHILOS T ROY SOC B, V354, P77, DOI 10.1098/rstb.1999.0361; Bann JG, 2000, J BIOL CHEM, V275, P24466, DOI 10.1074/jbc.M003336200; Berna F, 2004, J ARCHAEOL SCI, V31, P867, DOI 10.1016/j.jas.2003.12.003; Briggs DEG, 2003, ANNU REV EARTH PL SC, V31, P275, DOI 10.1146/annurev.earth.31.100901.144746; Briggs DEG, 2000, PALEOBIOLOGY, V26, P169, DOI 10.1666/0094-8373(2000)26[169:TBPOCF]2.0.CO;2; DENIRO MJ, 1988, GEOCHIM COSMOCHIM AC, V52, P2415, DOI 10.1016/0016-7037(88)90298-0; EGLINTON G, 1991, PHILOS T ROY SOC B, V333, P315, DOI 10.1098/rstb.1991.0081; GLIMCHER MJ, 1990, PALEOBIOLOGY, V16, P219, DOI 10.1017/S0094837300009891; Gotliv BA, 2006, J STRUCT BIOL, V156, P320, DOI 10.1016/j.jsb.2006.02.005; GUTTERIDGE JMC, 1981, BIOCHEM J, V199, P263, DOI 10.1042/bj1990263; Holtz Thomas R. Jr, 2000, Gaia (Lisboa), V15, P5; Hoss M, 2000, NATURE, V404, P453, DOI 10.1038/35006551; HUGHES JM, 1989, AM MINERAL, V74, P870; KEENE DR, 1991, J HISTOCHEM CYTOCHEM, V39, P59, DOI 10.1177/39.1.1983874; LINDAHL T, 1993, NATURE, V365, P700, DOI 10.1038/365700a0; MINDENKA P, 2006, FREE RADICAL RES, V40, P263; MOSBACH K, 1994, TRENDS BIOCHEM SCI, V19, P9, DOI 10.1016/0968-0004(94)90166-X; NEMETHY G, 1986, BIOCHEMISTRY-US, V25, P3184, DOI 10.1021/bi00359a016; Ottani V, 2001, MICRON, V32, P251, DOI 10.1016/S0968-4328(00)00042-1; Pruvost M, 2007, P NATL ACAD SCI USA, V104, P739, DOI 10.1073/pnas.0610257104; Rimblot-Baly Frederique, 1995, Annales de Paleontologie, V81, P49; Salamon M, 2005, P NATL ACAD SCI USA, V102, P13783, DOI 10.1073/pnas.0503718102; Schafer FQ, 2000, CELL MOL BIOL, V46, P657; Schmidt-Schultz TH, 2004, AM J PHYS ANTHROPOL, V123, P30, DOI 10.1002/ajpa.10308; Schweitzer MH, 2007, P ROY SOC B-BIOL SCI, V274, P183, DOI 10.1098/rspb.2006.3705; Schweitzer MH, 2005, SCIENCE, V307, P1952, DOI 10.1126/science.1108397; Schweitzer MH, 2005, SCIENCE, V308, P1456, DOI 10.1126/science.1112158; SEMAL P, 1995, J ARCHAEOL SCI, V22, P463, DOI 10.1006/jasc.1995.0045; Stankiewicz BA, 2000, GEOLOGY, V28, P559, DOI 10.1130/0091-7613(2000)028<0559:AOOAPI>2.3.CO;2; Sykes GA, 1995, ORG GEOCHEM, V23, P1059, DOI 10.1016/0146-6380(95)00086-0; TUROSS N, 1993, METHOD ENZYMOL, V224, P121, DOI 10.1016/0076-6879(93)24010-R; VANDERREST M, 1991, BONE BONE MATRIX BON, V3, P187; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Zylberberg L, 2004, CR PALEVOL, V3, P591, DOI 10.1016/j.crpv.2004.07.012	36	126	132	4	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					277	280		10.1126/science.1138709	http://dx.doi.org/10.1126/science.1138709			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431179				2022-12-01	WOS:000245654500051
J	Cassenaer, S; Laurent, G				Cassenaer, Stijn; Laurent, Gilles			Hebbian STDP in mushroom bodies facilitates the synchronous flow of olfactory information in locusts	NATURE			English	Article							ODOR REPRESENTATIONS; TEMPORAL INFORMATION; ANTENNAL LOBE; SYNCHRONIZATION; OSCILLATIONS; PROPAGATION; PLASTICITY; RECEPTORS; NEURONS; MEMORY	Odour representations in insects undergo progressive transformations and decorrelation(1-3) from the receptor array to the presumed site of odour learning, the mushroom body(4-7). There, odours are represented by sparse assemblies of Kenyon cells in a large population(2). Using intracellular recordings in vivo, we examined transmission and plasticity at the synapse made by Kenyon cells onto downstream targets in locusts. We find that these individual synapses are excitatory and undergo hebbian spike-timing dependent plasticity (STDP)(8-10) on a+/-25 ms timescale. When placed in the context of odour-evoked Kenyon cell activity (a 20-Hz oscillatory population discharge), this form of STDP enhances the synchronization of the Kenyon cells' targets and thus helps preserve the propagation of the odour-specific codes through the olfactory system.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Laurent, G (corresponding author), CALTECH, Div Biol, 139-74, Pasadena, CA 91125 USA.	laurentg@caltech.edu	Laurent, Gilles/A-4583-2012	Laurent, Gilles/0000-0002-2296-114X				ARTHUR J., 2006, ADV NEURAL INFORM PR, V18, P75; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Blum KI, 1996, NEURAL COMPUT, V8, P85, DOI 10.1162/neco.1996.8.1.85; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; Drew PJ, 2006, P NATL ACAD SCI USA, V103, P8876, DOI 10.1073/pnas.0600676103; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; Jortner RA, 2007, J NEUROSCI, V27, P1659, DOI 10.1523/JNEUROSCI.4171-06.2007; Leitch B, 1996, J COMP NEUROL, V372, P487; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; MacLeod K, 1998, NATURE, V395, P693, DOI 10.1038/27201; MAKRAM H, 1997, SCIENCE, V275, P213; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Nowotny T, 2003, J COMPUT NEUROSCI, V15, P271, DOI 10.1023/A:1025825111088; Perez-Orive J, 2004, J NEUROSCI, V24, P6037, DOI 10.1523/JNEUROSCI.1084-04.2004; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Roberts PD, 2002, BIOL CYBERN, V87, P392, DOI 10.1007/s00422-002-0361-y; Suri RE, 2002, BIOL CYBERN, V87, P440, DOI 10.1007/s00422-002-0355-9; Tanimoto H, 2004, NATURE, V430, P983, DOI 10.1038/430983a; ULTSCH A, 1993, FEBS LETT, V324, P171, DOI 10.1016/0014-5793(93)81387-F; Vogels TP, 2005, ANNU REV NEUROSCI, V28, P357, DOI 10.1146/annurev.neuro.28.061604.135637; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Yu DH, 2005, CELL, V123, P945, DOI 10.1016/j.cell.2005.09.037; Zars T., 2000, Science (Washington D C), V288, P672, DOI 10.1126/science.288.5466.672; Zhigulin VP, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.021901	31	201	202	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2007	448	7154					709	U12		10.1038/nature05973	http://dx.doi.org/10.1038/nature05973			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197ZY	17581587				2022-12-01	WOS:000248598000048
J	Ferguson, AD; McKeever, BM; Xu, SH; Wisniewski, D; Miller, DK; Yamin, TT; Spencer, RH; Chu, L; Ujjainwalla, F; Cunningham, BR; Evans, JF; Becker, JW				Ferguson, Andrew D.; McKeever, Brian M.; Xu, Shihua; Wisniewski, Douglas; Miller, Douglas K.; Yamin, Ting-Ting; Spencer, Robert H.; Chu, Lin; Ujjainwalla, Feroze; Cunningham, Barry R.; Evans, Jilly F.; Becker, Joseph W.			Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein	SCIENCE			English	Article							LEUKOTRIENE BIOSYNTHESIS INHIBITORS; MICROSOMAL GLUTATHIONE TRANSFERASE; AMINO-ACID-RESIDUES; ACTIVATING PROTEIN; C-4 SYNTHASE; IN-VIVO; BINDING; IDENTIFICATION; LEUKOCYTES; PROJECTION	Leukotrienes are proinflammatory products of arachidonic acid oxidation by 5-lipoxygenase that have been shown to be involved in respiratory and cardiovascular diseases. The integral membrane protein FLAP is essential for leukotriene biosynthesis. We describe the x-ray crystal structures of human FLAP in complex with two leukotriene biosynthesis inhibitors at 4.0 and 4.2 angstrom resolution, respectively. The structures show that inhibitors bind in membrane-embedded pockets of FLAP, which suggests how these inhibitors prevent arachidonic acid from binding to FLAP and subsequently being transferred to 5-lipoxygenase, thereby preventing leukotriene biosynthesis. This structural information provides a platform for the development of therapeutics for respiratory and cardiovascular diseases.	Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA; Merck Res Labs, Dept Infect Dis, Rahway, NJ 07065 USA; Merck Res Labs, Dept Cardiovasc Dis, Rahway, NJ 07065 USA; Merck Res Labs, Dept Pain Res, West Point, PA 19486 USA; Vitae Pharmaceut, Ft Washington, PA 19034 USA; Wyeth Ayerst Res, Collegeville, PA 19426 USA; Cara Therapeut, Tarrytown, NY 10591 USA; Amira Pharmaceut, San Diego, CA 92121 USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Pfizer	Becker, JW (corresponding author), Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA.	joseph_becker@merck.com	Wisniewski, Douglas/AAT-9198-2021					ANDERSSON C, 1994, BBA-PROTEIN STRUCT M, V1204, P298, DOI 10.1016/0167-4838(94)90021-3; Binkowski TA, 2003, J MOL BIOL, V332, P505, DOI 10.1016/S0022-2836(03)00882-9; Bresell A, 2005, FEBS J, V272, P1688, DOI 10.1111/j.1742-4658.2005.04596.x; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; DIAMANT Z, 1995, J ALLERGY CLIN IMMUN, V95, P42, DOI 10.1016/S0091-6749(95)70151-6; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; Folco G, 2006, PHARMACOL REV, V58, P375, DOI 10.1124/pr.58.3.8; Funk CD, 2005, NAT REV DRUG DISCOV, V4, P664, DOI 10.1038/nrd1796; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Holm PJ, 2006, J MOL BIOL, V360, P934, DOI 10.1016/j.jmb.2006.05.056; Lam BK, 1997, J BIOL CHEM, V272, P13923, DOI 10.1074/jbc.272.21.13923; MANCINI JA, 1993, FEBS LETT, V318, P277, DOI 10.1016/0014-5793(93)80528-3; MANCINI JA, 1994, LIFE SCI, V54, P137; Mandal AK, 2004, P NATL ACAD SCI USA, V101, P6587, DOI 10.1073/pnas.0308523101; MILLER DK, 1990, NATURE, V343, P278, DOI 10.1038/343278a0; Plante H, 2006, BIOCHEM J, V393, P211, DOI 10.1042/BJ20060669; Radmark O, 2005, BIOCHEM BIOPH RES CO, V338, P102, DOI 10.1016/j.bbrc.2005.08.013; ROUZER CA, 1990, J BIOL CHEM, V265, P1436; Schmidt- Krey I, 2004, STRUCTURE, V12, P2009, DOI 10.1016/j.str.2004.08.008; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Thoren S, 2003, J BIOL CHEM, V278, P22199, DOI 10.1074/jbc.M303227200; VICKERS PJ, 1993, J LIPID MEDIATOR, V6, P31; VICKERS PJ, 1992, MOL PHARMACOL, V42, P94; Weinander R, 1997, J BIOL CHEM, V272, P8871; WOODS JW, 1993, J EXP MED, V178, P1935, DOI 10.1084/jem.178.6.1935; YOUNG RN, 1993, J LIPID MEDIATOR, V6, P233; Young RN, 1999, EUR J MED CHEM, V34, P671, DOI 10.1016/S0223-5234(99)00225-1	28	181	189	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2007	317	5837					510	512		10.1126/science.1144346	http://dx.doi.org/10.1126/science.1144346			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17600184				2022-12-01	WOS:000248339800044
J	Liu, B; Yang, YH; Chernishof, V; Loo, RRO; Jang, H; Tahk, S; Yang, R; Mink, S; Shultz, D; Bellone, CJ; Loo, JA; Shuai, K				Liu, Bin; Yang, Yonghui; Chernishof, Vasili; Loo, Rachel R. Ogorzalek; Jang, Hyunduk; Tahk, Samuel; Yang, Randy; Mink, Sheldon; Shultz, David; Bellone, Clifford J.; Loo, Joseph A.; Shuai, Ke			Proinflammatory stimuli induce IKK alpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity	CELL			English	Article							NF-KAPPA-B; NEGATIVE REGULATION; GENE-ACTIVATION; KINASE-ALPHA; PROTEINS; TRANSCRIPTION; INHIBITION; CYTOKINE	How inflammatory stimuli signal to the nucleus to restrict inflammation is poorly understood. Protein inhibitor of activated STAT1 (PIAS1), a transcriptional regulator that possesses small ubiquitin-related modifier (SUMO) E3 ligase activity, inhibits immune responses by selectively blocking the binding of NF-kappa B and STAT1 to gene promoters. We report here that PIAS1 becomes rapidly phosphorylated on Ser90 residue in response to various inflammatory stimuli. Mutational studies indicate that Ser90 phosphorylation is required for PIAS1 to repress transcription. Upon TNF treatment, wild-type PIAS1, but not the Ser90A mutant, becomes rapidly associated with the promoters of NF-kappa B target genes. Furthermore, IKK alpha, but not IKK beta, interacts with PIAS1 in vivo and mediates PIAS1 Ser90 phosphorylation, a process that requires the SUMO ligase activity of PIAS1. Our results identify a signaling pathway in which proinflammatory stimuli activate the IKK alpha-mediated sumoylation-dependent phosphorylation of PIAS1 for the immediate repression of inflammatory gene activation.	Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, UCLA, DOE Inst Genom & Proteom, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44195 USA; St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Cleveland Clinic Foundation; Saint Louis University	Shuai, K (corresponding author), Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA.	kshuai@mednet.ucla.edu		Shultz, David/0000-0001-8242-6555	NIAMS NIH HHS [K01 AR52717-01] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR052717] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Bottero V, 2006, CELL DEATH DIFFER, V13, P785, DOI 10.1038/sj.cdd.4401888; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Godambe Sandip A., 1995, Am J Ther, V2, P677, DOI 10.1097/00045391-199509000-00017; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Li NX, 1998, P NATL ACAD SCI USA, V95, P13012, DOI 10.1073/pnas.95.22.13012; Li QT, 2005, P NATL ACAD SCI USA, V102, P12425, DOI 10.1073/pnas.0505997102; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu B, 2004, NAT IMMUNOL, V5, P891, DOI 10.1038/ni1104; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Liu B, 2005, MOL CELL BIOL, V25, P1113, DOI 10.1128/MCB.25.3.1113-1123.2005; Liu B, 2001, P NATL ACAD SCI USA, V98, P3203, DOI 10.1073/pnas.051489598; Naka T, 2005, ADV IMMUNOL, V87, P61, DOI 10.1016/S0065-2776(05)87003-8; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Sharrocks AD, 2006, GENE DEV, V20, P754, DOI 10.1101/gad.1421006; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576	26	123	129	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2007	129	5					903	914		10.1016/j.cell.2007.03.056	http://dx.doi.org/10.1016/j.cell.2007.03.056			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540171	Bronze			2022-12-01	WOS:000247084600011
J	Raval, A; Tanner, SM; Byrd, JC; Angerman, EB; Perko, JD; Chen, SS; Hackanson, B; Grever, MR; Lucas, DM; MatkoviC, JJ; Lin, TS; Kipps, TJ; Murray, F; Weisenburger, D; Sanger, W; Lynch, J; Watson, P; Jansen, M; Yoshinaga, Y; Rosenquist, R; de Jong, PJ; Coggill, P; Beck, S; Lynch, H; de la Chapelle, A; Plass, C				Raval, Aparna; Tanner, Stephan M.; Byrd, John C.; Angerman, Elizabeth B.; Perko, James D.; Chen, Shih-Shih; Hackanson, Bjoern; Grever, Michael R.; Lucas, David M.; MatkoviC, Jennifer J.; Lin, Thomas S.; Kipps, Thomas J.; Murray, Fiona; Weisenburger, Dennis; Sanger, Warren; Lynch, Jane; Watson, Patrice; Jansen, Mary; Yoshinaga, Yuko; Rosenquist, Richard; de Jong, Pieter J.; Coggill, Penny; Beck, Stephan; Lynch, Henry; de la Chapelle, Albert; Plass, Christoph			Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia	CELL			English	Article							TUMOR-SUPPRESSOR GENES; P2X7 RECEPTOR GENE; DNA HYPERMETHYLATION; APOPTOTIC CHECKPOINT; CPG ISLAND; KINASE; CANCER; METHYLATION; TRANSCRIPTION; POLYMORPHISM	The heritability of B cell chronic lymphocytic leukemia (CLL) is relatively high; however, no predisposing mutation has been convincingly identified. We show that loss or reduced expression of death-associated protein kinase 1 (DAPK1) underlies cases of heritable predisposition to CLL and the majority of sporadic CLL. Epigenetic silencing of DAPK1 by promoter methylation occurs in almost all sporadic CLL cases. Furthermore, we defined a disease haplotype, which segregates with the CLL phenotype in a large family. DAM expression of the CLL allele is downregulated by 75% in germline cells due to increased HOXB7 binding. In the blood cells from affected family members, promoter methylation results in additional loss of DAM expression. Thus, reduced expression of DAM can result from germline predisposition, as well as epigenetic or somatic events causing or contributing to the CILL phenotype.	Ohio State Univ, Ctr Comprehens Canc, Human Canc Gent Program, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43214 USA; Ohio State Univ, Div Hematol & Oncol, Dept Internal Med, Columbus, OH 43214 USA; Childrens Hosp Oakland Res Inst, Oakland, CA 94609 USA; Creighton Univ, Dept Prevent Med & Publ Hlth, Omaha, NE 68178 USA; Wellcome Trust Sanger Inst, Cambridge, England; Univ Calif San Diego, Dept Internal Med, San Diego, CA 92093 USA; Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden; Univ Freiburg, Ctr Med, Dept Hematol Oncol, Freiburg, Germany	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Creighton University; Wellcome Trust Sanger Institute; University of California System; University of California San Diego; Uppsala University; University of Freiburg	de la Chapelle, A (corresponding author), Ohio State Univ, Human Canc Genet Program, Tzagournis Med Res Facil 464A, 420 W 12th Ave, Columbus, OH 43210 USA.	albert.delachapelle@osumc.edu; christoph.plass@osumc.edu	Plass, Christoph/H-7192-2014; Lucas, David M/E-3555-2011	Edsall, Lee Elizabeth/0000-0002-0326-2829; Rosenquist, Richard/0000-0002-0211-8788	NCI NIH HHS [P30 CA016058, CA81534, P01 CA101956, T32 CA106196, U01 CA086389, 5U01 CA86389, P01 CA081534, CA110496, P30 CA16058, CA101956, R21 CA110496] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA081534, U01CA086389, P01CA101956, P20CA081534, T32CA106196, R21CA110496, P30CA016058] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Bullrich F, 2001, CANCER RES, V61, P6640; Calin GA, 2006, SEMIN ONCOL, V33, P167, DOI 10.1053/j.seminoncol.2006.01.010; Calin GA, 2005, NEW ENGL J MED, V352, P1667, DOI 10.1056/NEJMoa042280; Caporaso N, 2006, BLOOD, V108, P415, DOI 10.1182/blood-2006-05-019489; Chen CH, 2005, EMBO J, V24, P294, DOI 10.1038/sj.emboj.7600510; Cheson BD, 1996, BLOOD, V87, P4990, DOI 10.1182/blood.V87.12.4990.bloodjournal87124990; Chim CS, 2006, J HUM GENET, V51, P832, DOI 10.1007/s10038-006-0029-x; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cohen O, 1997, EMBO J, V16, P998, DOI 10.1093/emboj/16.5.998; Cohen O, 1999, J CELL BIOL, V146, P141; Corcoran M, 2005, HAEMATOLOGICA, V90, P1078; Dao-Ung LP, 2004, BRIT J HAEMATOL, V125, P815, DOI 10.1111/j.1365-2141.2004.04976.x; DEISS LP, 1995, GENE DEV, V9, P15, DOI 10.1101/gad.9.1.15; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Frissora F, 2003, EUR J IMMUNOL, V33, P907, DOI 10.1002/eji.200323657; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Goldin LR, 2004, BLOOD, V104, P1850, DOI 10.1182/blood-2004-01-0341; Goldin LR, 2003, BRIT J HAEMATOL, V121, P866, DOI 10.1046/j.1365-2141.2003.04372.x; Inbal B, 1997, NATURE, V390, P180, DOI 10.1038/36599; Jang CW, 2002, NAT CELL BIOL, V4, P51, DOI 10.1038/ncb731; Kasper D, 2005, HARRISONS PRINCIPLES; Katzenellenbogen RA, 1999, BLOOD, V93, P4347, DOI 10.1182/blood.V93.12.4347.412k31_4347_4353; Leu YW, 2004, CANCER RES, V64, P8184, DOI 10.1158/0008-5472.CAN-04-2045; Liechti-Gallati S, 1999, EUR J HUM GENET, V7, P590, DOI 10.1038/sj.ejhg.5200338; LILL MC, 1995, BLOOD, V85, P692, DOI 10.1182/blood.V85.3.692.bloodjournal853692; Lynch HT, 2002, AM J MED GENET, V115, P113, DOI 10.1002/ajmg.10686; Martoriati A, 2005, ONCOGENE, V24, P1461, DOI 10.1038/sj.onc.1208256; Mertens D, 2002, BLOOD, V99, P4116, DOI 10.1182/blood.V99.11.4116; PAPADOPOULOS N, 1995, NAT GENET, V11, P99, DOI 10.1038/ng0995-99; Raval A, 2005, J CLIN ONCOL, V23, P3877, DOI 10.1200/JCO.2005.02.196; Raveh T, 2001, NAT CELL BIOL, V3, P1, DOI 10.1038/35050500; Risch N, 2001, CANCER EPIDEM BIOMAR, V10, P733; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Rudd MF, 2006, BLOOD, V108, P638, DOI 10.1182/blood-2005-12-5022; Rush LJ, 2004, CANCER RES, V64, P2424, DOI 10.1158/0008-5472.CAN-03-2870; Sellick GS, 2006, SEMIN ONCOL, V33, P195, DOI 10.1053/j.seminoncol.2006.01.013; Sellick GS, 2005, AM J HUM GENET, V77, P420, DOI 10.1086/444472; SHEN WF, 1989, ADV EXP MED BIOL, V271, P211; Stilgenbauer S, 2005, CURR TOP MICROBIOL, V294, P147, DOI 10.1007/3-540-29933-5_9; Stirzaker C, 2004, CANCER RES, V64, P3871, DOI 10.1158/0008-5472.CAN-03-3690; Thunberg U, 2002, LANCET, V360, P1935, DOI 10.1016/S0140-6736(02)11917-9; Wiley JS, 2002, LANCET, V359, P1114, DOI 10.1016/S0140-6736(02)08156-4; Yu L, 2004, GENOMICS, V84, P647, DOI 10.1016/j.ygeno.2004.06.010; Yu L, 2005, NAT GENET, V37, P265, DOI 10.1038/ng1521; Yuille MR, 2000, BRIT J HAEMATOL, V109, P794, DOI 10.1046/j.1365-2141.2000.02111.x	52	284	303	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2007	129	5					879	890		10.1016/j.cell.2007.03.043	http://dx.doi.org/10.1016/j.cell.2007.03.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540169	Green Published, Bronze			2022-12-01	WOS:000247084600009
J	Wahlman, J; DeMartino, GN; Skach, WR; Bulleid, NJ; Brodsky, JL; Johnson, AE				Wahlman, Judit; DeMartino, George N.; Skach, William R.; Bulleid, Neil J.; Brodsky, Jeffrey L.; Johnson, Arthur E.			Real-time fluorescence detection of ERAD substrate retrotranslocation in a mammalian in vitro system	CELL			English	Article							PROTEIN DISULFIDE-ISOMERASE; RETICULUM-ASSOCIATED DEGRADATION; MISFOLDED SECRETORY PROTEIN; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; MEMBRANE-PROTEIN; RETRO-TRANSLOCATION; MOLECULAR CHAPERONES; CHOLERA-TOXIN; PROTEASOME	Secretory proteins unable to assemble into their native states in the endoplasmic reticulum (ER) are transported back or "retrotranslocated" into the cytosol for ER-associated degradation (ERAD). To examine the roles of different components in ERAD, one fluorescencelabeled ERAD substrate was encapsulated with selected lumenal factors inside mammalian microsomes. After mixing microsomes with fluorescence-quenching agents and selected cytosolic proteins, the rate of substrate efflux was monitored continuously in real time by the decrease in fluorescence intensity as cytosolic quenchers contacted dye-labeled substrates. The retrotranslocation kinetics of nonglycosylated pro-alpha factor were not significantly altered by replacing all lumenal proteins with only protein disuifide isomerase or all cytosolic proteins with only PA700, the 19S regulatory particle of the 26S proteasome. Retrotranslocation was blocked by antibodies against a putative retrotranslocation channel protein, derlin-1, but not Sec61 alpha. In addition, pro-alpha factor photocrosslinked derlin-1, but not Sec61 alpha. Thus, derlin-1 appears to be involved in pro-alpha factor retrotranslocation.	Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA; Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; Texas A&M Univ Syst, Ctr Hlth Sci, Dept Mol & Cellular Med, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Oregon Health & Science University; University of Manchester; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Texas A&M University System; Texas A&M University College Station	Johnson, AE (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	ajohnson@medicine.tamhsc.edu	Johnson, Arthur E/G-3457-2012	Bulleid, Neil/0000-0002-9839-5279	Biotechnology and Biological Sciences Research Council [BB/D00764X/1] Funding Source: Medline; NIDDK NIH HHS [DK51818, R01 DK051818, R56 DK046181, DK46181, R01 DK046181] Funding Source: Medline; NIGMS NIH HHS [GM53457, R01 GM026494, GM26494, GM75061, R01 GM053457, R01 GM075061] Funding Source: Medline; Wellcome Trust [074081] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051818, R01DK046181, R56DK046181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026494, R01GM075061, R01GM053457] Funding Source: NIH RePORTER; BBSRC [BB/D00764X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alder NN, 2005, J CELL BIOL, V168, P389, DOI 10.1083/jcb.200409174; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; BULLEID NJ, 1988, NATURE, V335, P649, DOI 10.1038/335649a0; CAI H, 1994, J BIOL CHEM, V269, P24550; CAPLAN S, 1991, J BACTERIOL, V173, P627, DOI 10.1128/jb.173.2.627-635.1991; Carlson EJ, 2006, EMBO J, V25, P4557, DOI 10.1038/sj.emboj.7601307; Chillaron J, 2000, MOL BIOL CELL, V11, P217, DOI 10.1091/mbc.11.1.217; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; DEMARTINO GN, 1994, J BIOL CHEM, V269, P20878; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fewell SW, 2001, J BIOL CHEM, V276, P910, DOI 10.1074/jbc.M008535200; Flanagan JJ, 2003, J BIOL CHEM, V278, P18628, DOI 10.1074/jbc.M300173200; Gaczynska Maria, 2005, V301, P3; Gillece P, 2000, P NATL ACAD SCI USA, V97, P4609, DOI 10.1073/pnas.090083497; Gillece P, 1999, J CELL BIOL, V147, P1443, DOI 10.1083/jcb.147.7.1443; Haigh NG, 2002, J CELL BIOL, V156, P261, DOI 10.1083/jcb.200110074; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Johnson AE, 2000, CELL, V102, P709, DOI 10.1016/S0092-8674(00)00059-3; Johnson AE, 2005, TRAFFIC, V6, P1078, DOI 10.1111/j.1600-0854.2005.00340.x; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; JOHNSON AE, 1982, J MOL BIOL, V156, P113, DOI 10.1016/0022-2836(82)90462-4; Kabani M, 2003, MOL BIOL CELL, V14, P3437, DOI 10.1091/mbc.E02-12-0847; Kalies KU, 2005, EMBO J, V24, P2284, DOI 10.1038/sj.emboj.7600731; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Kothe M, 2005, J BIOL CHEM, V280, P28127, DOI 10.1074/jbc.M503138200; KRIEG UC, 1986, P NATL ACAD SCI USA, V83, P8604, DOI 10.1073/pnas.83.22.8604; Lee RJ, 2004, EMBO J, V23, P2206, DOI 10.1038/sj.emboj.7600232; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lilley BN, 2006, J VIROL, V80, P8739, DOI 10.1128/JVI.00791-06; Liu CW, 2002, J BIOL CHEM, V277, P26815, DOI 10.1074/jbc.M201782200; Mayer TU, 1998, EMBO J, V17, P3251, DOI 10.1093/emboj/17.12.3251; McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; McCracken AA, 2003, BIOESSAYS, V25, P868, DOI 10.1002/bies.10320; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Ng WY, 2007, J CELL SCI, V120, P682, DOI 10.1242/jcs.03351; NICCHITTA CV, 1993, CELL, V73, P989, DOI 10.1016/0092-8674(93)90276-V; Nishikawa S, 2005, J BIOCHEM, V137, P551, DOI 10.1093/jb/mvi068; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; PUIG A, 1994, J BIOL CHEM, V269, P7764; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Schekman R, 2004, NATURE, V429, P817, DOI 10.1038/429817a; Schmitz A, 2000, J CELL BIOL, V148, P1203, DOI 10.1083/jcb.148.6.1203; SOMMER T, 1993, NATURE, V365, P176, DOI 10.1038/365176a0; Strickland E, 2000, J BIOL CHEM, V275, P5565, DOI 10.1074/jbc.275.8.5565; SU K, 1993, J BIOL CHEM, V268, P14301; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Walter J, 2001, EMBO J, V20, P3124, DOI 10.1093/emboj/20.12.3124; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; YE J, 1991, J BIOL CHEM, V266, P23016; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Zhou MY, 1999, MOL CELL, V4, P925, DOI 10.1016/S1097-2765(00)80222-1	67	106	107	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2007	129	5					943	955		10.1016/j.cell.2007.03.046	http://dx.doi.org/10.1016/j.cell.2007.03.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540174	hybrid, Green Published			2022-12-01	WOS:000247084600014
J	Dettman, JR; Sirjusingh, C; Kohn, LM; Anderson, JB				Dettman, Jeremy R.; Sirjusingh, Caroline; Kohn, Linda M.; Anderson, James B.			Incipient speciation by divergent adaptation and antagonistic epistasis in yeast	NATURE			English	Article							ANTIFUNGAL DRUG-RESISTANCE; MISMATCH REPAIR SYSTEM; EXPERIMENTAL EVOLUTION; BUDDING YEAST; SACCHAROMYCES; HYBRID; BOTTLENECKS; MECHANISMS; DROSOPHILA; STERILITY	Establishing the conditions that promote the evolution of reproductive isolation and speciation has long been a goal in evolutionary biology(1-3). In ecological speciation, reproductive isolation between populations evolves as a by-product of divergent selection and the resulting environment-specific adaptations(4-6). The leading genetic model of reproductive isolation predicts that hybrid inferiority is caused by antagonistic epistasis between incompatible alleles at interacting loci(1,7). The fundamental link between divergent adaptation and reproductive isolation through genetic incompatibilities has been predicted(1,4,5), but has not been directly demonstrated experimentally. Here we empirically tested key predictions of speciation theory by evolving the initial stages of speciation in experimental populations of the yeast Saccharomyces cerevisiae. After replicate populations adapted to two divergent environments, we consistently observed the evolution of two forms of postzygotic isolation in hybrids: reduced rate of mitotic reproduction and reduced efficiency of meiotic reproduction. This divergent selection resulted in greater reproductive isolation than parallel selection, as predicted by the ecological speciation theory. Our experimental system allowed controlled comparison of the relative importance of ecological and genetic isolation, and we demonstrated that hybrid inferiority can be ecological and/or genetic in basis. Overall, our results show that adaptation to divergent environments promotes the evolution of reproductive isolation through antagonistic epistasis, providing evidence of a plausible common avenue to speciation and adaptive radiation in nature.	Univ Toronto, Dept Ecol & Evolutionary Biol, Mississauga, ON L5L 1C6, Canada	University of Toronto; University Toronto Mississauga	Dettman, JR (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Mississauga, ON L5L 1C6, Canada.	jdettman@utm.utoronto.ca						Anderson JB, 2006, EUKARYOT CELL, V5, P1243, DOI 10.1128/EC.00048-06; Anderson JB, 2003, GENETICS, V163, P1287; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Coyne J.A., 2004, SPECIATION; COYNE JA, 1992, NATURE, V355, P511, DOI 10.1038/355511a0; de Oliveira A. K., 1980, HEREDITY, V44, P123; Delneri D, 2003, NATURE, V422, P68, DOI 10.1038/nature01418; Demuth JP, 2005, AM NAT, V165, P524, DOI 10.1086/429276; Dobzhansky T, 1937, GENETICS ORIGIN SPEC; Fischer G, 2000, NATURE, V405, P451, DOI 10.1038/35013058; Funk DJ, 2006, P NATL ACAD SCI USA, V103, P3209, DOI 10.1073/pnas.0508653103; Greig D, 2003, J EVOLUTION BIOL, V16, P429, DOI 10.1046/j.1420-9101.2003.00546.x; Greig D, 2002, P ROY SOC B-BIOL SCI, V269, P1167, DOI 10.1098/rspb.2002.1989; Greig D, 2007, PLOS GENET, V3, P281, DOI 10.1371/journal.pgen.0030021; Hunter N, 1996, EMBO J, V15, P1726, DOI 10.1002/j.1460-2075.1996.tb00518.x; Kohn LM, 2005, ANNU REV PHYTOPATHOL, V43, P279, DOI 10.1146/annurev.phyto.43.040204.135958; Leu JY, 2006, CURR BIOL, V16, P280, DOI 10.1016/j.cub.2005.12.028; McKinnon JS, 2004, NATURE, V429, P294, DOI 10.1038/nature02556; Mooers AO, 1999, AM NAT, V153, P437, DOI 10.1086/303186; Muller H., 1942, BIOL S, V6, P71; Orr HA, 2001, EVOLUTION, V55, P1085; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Rundle HD, 2005, PLOS BIOL, V3, P1988, DOI 10.1371/journal.pbio.0030368; Rundle HD, 2003, EVOLUTION, V57, P2557; Rundle HD, 2001, EVOLUTION, V55, P198; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schluter D., 2000, ECOLOGY ADAPTIVE RAD	30	143	145	2	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2007	447	7144					585	+		10.1038/nature05856	http://dx.doi.org/10.1038/nature05856			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17538619				2022-12-01	WOS:000246842000047
J	Panowski, SH; Wolff, S; Aguilaniu, H; Durieux, J; Dillin, A				Panowski, Siler H.; Wolff, Suzanne; Aguilaniu, Hugo; Durieux, Jenni; Dillin, Andrew			PHA-4/Foxa mediates diet-restriction-induced longevity of C-elegans	NATURE			English	Article							SUPEROXIDE-DISMUTASE GENE; NUCLEAR FACTOR 3-GAMMA; LIFE-SPAN; CAENORHABDITIS-ELEGANS; INSULIN-RECEPTOR; GLUCOSE-HOMEOSTASIS; OXIDATIVE STRESS; DAF-16; EXPRESSION; HEPATOCYTE	Reduced food intake as a result of dietary restriction increases the lifespan of a wide variety of metazoans and delays the onset of multiple age-related pathologies. Dietary restriction elicits a genetically programmed response to nutrient availability that cannot be explained by a simple reduction in metabolism or slower growth of the organism. In the nematode worm Caenorhabditis elegans, the transcription factor PHA-4 has an essential role in the embryonic development of the foregut and is orthologous to genes encoding the mammalian family of Foxa transcription factors, Foxa1, Foxa2 and Foxa3. Foxa family members have important roles during development, but also act later in life to regulate glucagon production and glucose homeostasis, particularly in response to fasting. Here we describe a newly discovered, adult-specific function for PHA-4 in the regulation of diet-restriction-mediated longevity in C. elegans. The role of PHA-4 in lifespan determination is specific for dietary restriction, because it is not required for the increased longevity caused by other genetic pathways that regulate ageing.	Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Dillin, A (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dillin@salk.edu						Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; AVERY L, 1993, GENETICS, V133, P897; Azzaria M, 1996, DEV BIOL, V178, P289, DOI 10.1006/dbio.1996.0219; BRENNER S, 1974, GENETICS, V77, P71; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Clancy DJ, 2002, SCIENCE, V296, P319, DOI 10.1126/science.1069366; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Fujii M, 1998, DNA Res, V5, P25, DOI 10.1093/dnares/5.1.25; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; GIGLIO AM, 1994, BIOCHEM MOL BIOL INT, V33, P41; GIGLIO MP, 1994, BIOCHEM MOL BIOL INT, V33, P37; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; HOPE IA, 1999, C ELEGANS PRACTICAL, P88; Horner MA, 1998, GENE DEV, V12, P1947, DOI 10.1101/gad.12.13.1947; Houthoofd K, 2003, EXP GERONTOL, V38, P947, DOI 10.1016/S0531-5565(03)00161-X; Hunter T, 1997, J BIOL CHEM, V272, P28652, DOI 10.1074/jbc.272.45.28652; Kaestner KH, 1999, GENE DEV, V13, P495, DOI 10.1101/gad.13.4.495; Kaestner KH, 1998, MOL CELL BIOL, V18, P4245, DOI 10.1128/MCB.18.7.4245; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; MANGO SE, 1994, DEVELOPMENT, V120, P3019; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shen W, 2001, J BIOL CHEM, V276, P42812, DOI 10.1074/jbc.M106344200; Shih DQ, 1999, P NATL ACAD SCI USA, V96, P10152, DOI 10.1073/pnas.96.18.10152; Suzuki N, 1996, DNA Res, V3, P171, DOI 10.1093/dnares/3.3.171; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tsuchiya T, 2004, PHYSIOL GENOMICS, V17, P307, DOI 10.1152/physiolgenomics.00039.2004; Tu MP, 2002, AGING CELL, V1, P75, DOI 10.1046/j.1474-9728.2002.00010.x; Wolff S, 2006, CELL, V124, P1039, DOI 10.1016/j.cell.2005.12.042; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002	50	406	446	7	76	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 31	2007	447	7144					550	+		10.1038/nature05837	http://dx.doi.org/10.1038/nature05837			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17476212				2022-12-01	WOS:000246842000039
J	Jiang, W; Yun, D; Saleh, L; Barr, EW; Xing, G; Hoffart, LM; Maslak, MA; Krebs, C; Bollinger, JM				Jiang, Wei; Yun, Danny; Saleh, Lana; Barr, Eric W.; Xing, Gang; Hoffart, Lee M.; Maslak, Monique-Anne; Krebs, Carsten; Bollinger, J. Martin, Jr.			A manganese(IV)/iron(III) cofactor in Chlamydia trachomatis ribonucleotide reductase	SCIENCE			English	Article							ESCHERICHIA-COLI; NITRIC-OXIDE; INACTIVATION; RADICALS; ENZYME; DIPHOSPHATES; CATALYSIS; MECHANISM; IRON; SITE	In a conventional class I ribonucleotide reductase (RNR), a diiron(II/II) cofactor in the R2 subunit reacts with oxygen to produce a diiron(III/IV) intermediate, which generates a stable tyrosyl radical (Y.). The Y. reversibly oxidizes a cysteine residue in the R1 subunit to a cysteinyl radical (C.), which abstracts the 3'-hydrogen of the substrate to initiate its reduction. The RNR from Chlamydia trachomatis lacks the Y., and it had been proposed that the diiron(III/IV) complex in R2 directly generates the C. in R1. By enzyme activity measurements and spectroscopic methods, we show that this RNR actually uses a previously unknown stable manganese(IV)/iron( III) cofactor for radical initiation.	Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Krebs, C (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	ckrebs@psu.edu	Bollinger, Joseph/C-1425-2016; Krebs, Carsten/D-4773-2009	Krebs, Carsten/0000-0002-3302-7053	NIGMS NIH HHS [GM55365] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Behravan G, 1995, BBA-GENE STRUCT EXPR, V1264, P323, DOI 10.1016/0167-4781(95)00168-9; ELIASSON R, 1994, J BIOL CHEM, V269, P26116; Fontecave M, 1998, CELL MOL LIFE SCI, V54, P684, DOI 10.1007/s000180050195; Fontecave M, 2002, PROG NUCLEIC ACID RE, V72, P95, DOI 10.1016/S0079-6603(02)72068-0; Fritscher J, 2005, J AM CHEM SOC, V127, P7729, DOI 10.1021/ja043111x; Guittet O, 1999, CELL MOL LIFE SCI, V55, P1054, DOI 10.1007/s000180050356; HASSAN HM, 1994, FEMS MICROBIOL REV, V14, P315, DOI 10.1111/j.1574-6976.1994.tb00105.x; Hogbom M, 2004, SCIENCE, V305, P245, DOI 10.1126/science.1098419; Lawrence CC, 1998, CURR OPIN CHEM BIOL, V2, P650, DOI 10.1016/S1367-5931(98)80097-5; LEPOIVRE M, 1991, BIOCHEM BIOPH RES CO, V179, P442, DOI 10.1016/0006-291X(91)91390-X; Licht S, 1996, SCIENCE, V271, P477, DOI 10.1126/science.271.5248.477; Munck E., 2000, PHYS METHODS BIOINOR, P287; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Roshick C, 2000, J BIOL CHEM, V275, P38111, DOI 10.1074/jbc.M006367200; SALOWE S, 1993, BIOCHEMISTRY-US, V32, P12749, DOI 10.1021/bi00210a026; Sinnecker S, 2005, J BIOL INORG CHEM, V10, P231, DOI 10.1007/s00775-005-0633-9; SJOBERG BM, 1983, J BIOL CHEM, V258, P8060; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; Stubbe J, 2000, CURR OPIN STRUC BIOL, V10, P731, DOI 10.1016/S0959-440X(00)00153-6; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; Stubble J, 2003, CURR OPIN CHEM BIOL, V7, P183, DOI 10.1016/S1367-5931(03)00025-5; THELANDER L, 1976, J BIOL CHEM, V251, P1398; Voevodskaya N, 2006, P NATL ACAD SCI USA, V103, P9850, DOI 10.1073/pnas.0600603103; Voevodskaya N, 2005, BIOCHEM BIOPH RES CO, V330, P1213, DOI 10.1016/j.bbrc.2005.03.104; ZHENG M, 1994, INORG CHEM, V33, P382, DOI 10.1021/ic00080a030	25	154	156	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1188	1191		10.1126/science.1141179	http://dx.doi.org/10.1126/science.1141179			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525338				2022-12-01	WOS:000246724300042
J	Barton, ES; White, DW; Cathelyn, JS; Brett-McClellan, KA; Engle, M; Diamond, MS; Miller, VL; Virgin, HW				Barton, Erik S.; White, Douglas W.; Cathelyn, Jason S.; Brett-McClellan, Kelly A.; Engle, Michael; Diamond, Michael S.; Miller, Virginia L.; Virgin, Herbert W.			Herpesvirus latency confers symbiotic protection from bacterial infection	NATURE			English	Article							MURINE GAMMAHERPESVIRUS 68; EPSTEIN-BARR-VIRUS; CD8(+) T-CELLS; GAMMA-INTERFERON; CYTOMEGALOVIRUS; IMMUNITY; ANTIGEN; MEMORY; CD4; EBV	All humans become infected with multiple herpesviruses during childhood. After clearance of acute infection, herpesviruses enter a dormant state known as latency. Latency persists for the life of the host and is presumed to be parasitic, as it leaves the individual at risk for subsequent viral reactivation and disease(1). Here we show that herpesvirus latency also confers a surprising benefit to the host. Mice latently infected with either murine gammaherpesvirus 68 or murine cytomegalovirus, which are genetically highly similar to the human pathogens Epstein - Barr virus and human cytomegalovirus(2), respectively, are resistant to infection with the bacterial pathogens Listeria monocytogenes and Yersinia pestis. Latency-induced protection is not antigen specific but involves prolonged production of the antiviral cytokine interferon-gamma and systemic activation of macrophages. Latency thereby upregulates the basal activation state of innate immunity against subsequent infections. We speculate that herpesvirus latency may also sculpt the immune response to self and environmental antigens through establishment of a polarized cytokine environment. Thus, whereas the immune evasion capabilities and lifelong persistence of herpesviruses are commonly viewed as solely pathogenic, our data suggest that latency is a symbiotic relationship with immune benefits for the host.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Div Rheumatol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Virgin, HW (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave, St Louis, MO 63110 USA.	virgin@wustl.edu	White, D/GRR-2943-2022; Diamond, Michael/AAH-1733-2019	Diamond, Michael/0000-0002-8791-3165; White, Douglas/0000-0002-0366-9047; Miller, Virginia/0000-0002-9522-1767; Virgin, Herbert/0000-0001-8580-7628; Barton, Erik/0000-0001-6942-6315				Amyes E, 2003, J EXP MED, V198, P903, DOI 10.1084/jem.20022058; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Braaten Douglas C, 2006, PLoS Pathog, V2, pe37, DOI 10.1371/journal.ppat.0020037; Cathelyn JS, 2006, P NATL ACAD SCI USA, V103, P13514, DOI 10.1073/pnas.0603456103; Christensen JP, 1999, J VIROL, V73, P4279, DOI 10.1128/JVI.73.5.4279-4283.1999; Dunn HS, 2002, J INFECT DIS, V186, P15, DOI 10.1086/341079; Edelson BT, 2000, CURR OPIN IMMUNOL, V12, P425, DOI 10.1016/S0952-7915(00)00112-6; Edelson BT, 2001, IMMUNITY, V14, P503, DOI 10.1016/S1074-7613(01)00139-X; Flano E, 2001, J VIROL, V75, P7744, DOI 10.1128/JVI.75.16.7744-7748.2001; Hislop AD, 2005, J CLIN INVEST, V115, P2546, DOI 10.1172/JCI24810; MACKANESS GB, 1969, J EXP MED, V129, P973, DOI 10.1084/jem.129.5.973; MACKANESS GB, 1964, J EXP MED, V120, P105, DOI 10.1084/jem.120.1.105; McClellan JS, 2004, J VIROL, V78, P6836, DOI 10.1128/JVI.78.13.6836-6845.2004; McClellan KB, 2006, PLOS PATHOG, V2, P578, DOI 10.1371/journal.ppat.0020058; Moorman NJ, 2003, J VIROL, V77, P10295, DOI 10.1128/JVI.77.19.10295-10303.2003; Nilsson C, 2005, J ALLERGY CLIN IMMUN, V116, P438, DOI 10.1016/j.jaci.2005.04.027; Polic B, 1998, J EXP MED, V188, P1047, DOI 10.1084/jem.188.6.1047; Rickinson AB., 2007, FIELDS VIROLOGY, VFifth, P2655; ROIZMAN B, 2007, FIELDS VIROLOGY, P2475; Sarawar SR, 1997, J VIROL, V71, P3916, DOI 10.1128/JVI.71.5.3916-3921.1997; Schaub B, 2006, J ALLERGY CLIN IMMUN, V117, P969, DOI 10.1016/j.jaci.2006.03.003; Selin LK, 2006, IMMUNOL REV, V211, P164, DOI 10.1111/j.0105-2896.2006.00394.x; Shrestha B, 2006, J VIROL, V80, P5338, DOI 10.1128/JVI.00274-06; Takeuchi K, 2006, PATHOL INT, V56, P112, DOI 10.1111/j.1440-1827.2006.01936.x; Tan LC, 1999, J IMMUNOL, V162, P1827; Theil D, 2003, AM J PATHOL, V163, P2179, DOI 10.1016/S0002-9440(10)63575-4; Tibbetts SA, 2002, J VIROL, V76, P7125, DOI 10.1128/JVI.76.14.7125-7132.2002; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Weck KE, 1999, J VIROL, V73, P3273, DOI 10.1128/JVI.73.4.3273-3283.1999	30	510	532	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2007	447	7142					326	U7		10.1038/nature05762	http://dx.doi.org/10.1038/nature05762			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17507983				2022-12-01	WOS:000246520300047
J	Engelbrecht, BMJ; Comita, LS; Condit, R; Kursar, TA; Tyree, MT; Turner, BL; Hubbell, SP				Engelbrecht, Bettina M. J.; Comita, Liza S.; Condit, Richard; Kursar, Thomas A.; Tyree, Melvin T.; Turner, Benjamin L.; Hubbell, Stephen P.			Drought sensitivity shapes species distribution patterns in tropical forests	NATURE			English	Article							RAIN-FOREST; FLORISTIC COMPOSITION; HABITAT ASSOCIATIONS; NEOTROPICAL FOREST; CLIMATIC GRADIENT; MOIST FOREST; DIVERSITY; SEEDLINGS; TREES; TOLERANCE	Although patterns of tree species distributions along environmental gradients have been amply documented in tropical forests(1-7), mechanisms causing these patterns are seldom known. Efforts to evaluate proposed mechanisms have been hampered by a lack of comparative data on species' reactions to relevant axes of environmental variation(1). Here we show that differential drought sensitivity shapes plant distributions in tropical forests at both regional and local scales. Our analyses are based on experimental field assessments of drought sensitivity of 48 species of trees and shrubs, and on their local and regional distributions within a network of 122 inventory sites spanning a rainfall gradient across the Isthmus of Panama. Our results suggest that niche differentiation with respect to soil water availability is a direct determinant of both local- and regional-scale distributions of tropical trees. Changes in soil moisture availability caused by global climate change and forest fragmentation are therefore likely to alter tropical species distributions, community composition and diversity.	Smithsonian Trop Res Inst, Balboa 03092, Panama; Univ Kaiserslautern, Dept Plant Ecol & Systemat, D-67663 Kaiserslautern, Germany; Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; US Forest Serv, USDA, Burlington, VT 05402 USA; Univ Alberta, Dept Renewable Resources, Edmonton, AB T6G 2E3, Canada	Smithsonian Institution; Smithsonian Tropical Research Institute; University of Kaiserslautern; University System of Georgia; University of Georgia; Utah System of Higher Education; University of Utah; United States Department of Agriculture (USDA); United States Forest Service; University of Alberta	Engelbrecht, BMJ (corresponding author), Smithsonian Trop Res Inst, Apartado 0843, Balboa 03092, Panama.	engelbrb@si.edu	Turner, Benjamin L/E-5940-2011; Engelbrecht, Bettina/E-9914-2012	Turner, Benjamin L/0000-0002-6585-0722; Comita, Liza/0000-0002-9169-1331				Bongers F, 1999, J VEG SCI, V10, P371, DOI 10.2307/3237066; Comita LS, 2007, J VEG SCI, V18, P163, DOI 10.1658/1100-9233(2007)18[163:POWPSA]2.0.CO;2; Comita LS, 2007, J ECOL, V95, P482, DOI 10.1111/j.1365-2745.2007.01229.x; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Condit R, 2004, J TROP ECOL, V20, P51, DOI 10.1017/S0266467403001081; CONDIT R, 2005, BARRO COLORADO FORES; Daws MI, 2002, PLANT SOIL, V238, P79, DOI 10.1023/A:1014289930621; Engelbrecht BMJ, 2005, TREES-STRUCT FUNCT, V19, P312, DOI 10.1007/s00468-004-0393-0; Engelbrecht BMJ, 2003, OECOLOGIA, V136, P383, DOI 10.1007/s00442-003-1290-8; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Givnish TJ, 1999, J ECOL, V87, P193, DOI 10.1046/j.1365-2745.1999.00333.x; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Hubbell Stephen P., 2001, V32, pi; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Magurran A.E, 1995, BIOL DIVERSITY, V32, P668, DOI 10.2307/2404662; Malhi Y, 2004, PHILOS T R SOC B, V359, P549, DOI 10.1098/rstb.2003.1449; Niinemets U, 2006, ECOL MONOGR, V76, P521, DOI 10.1890/0012-9615(2006)076[0521:TTSDAW]2.0.CO;2; Palmiotto PA, 2004, J ECOL, V92, P609, DOI 10.1111/j.0022-0477.2004.00894.x; PEREZ R, 2005, RIO CHAGRES PANAMA M; Potts MD, 2003, J ECOL, V91, P467, DOI 10.1046/j.1365-2745.2003.00779.x; Pyke CR, 2001, J VEG SCI, V12, P553, DOI 10.2307/3237007; Schimper, 1903, PLANT GEOGRAPHY PHYS; *SMITHS TROP RES I, 2006, ACP PHYS MON DOWNL; Ter Steege H, 2003, BIODIVERS CONSERV, V12, P2255, DOI 10.1023/A:1024593414624; Tyree MT, 2003, PLANT PHYSIOL, V132, P1439, DOI 10.1104/pp.102.018937; Veenendaal E. M., 1998, Dynamics of tropical communities : the 37th symposium of the British Ecological Society, Cambridge University, 1996., P163; Veenendaal EM, 1996, FUNCT ECOL, V10, P501, DOI 10.2307/2389943; Walsh R.P.D., 1996, PW RICHARDS 1996 TRO, P159; Webb CO, 2000, J ECOL, V88, P464, DOI 10.1046/j.1365-2745.2000.00462.x; WELDEN CW, 1991, ECOLOGY, V72, P35, DOI 10.2307/1938900	30	731	776	19	509	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2007	447	7140					80	U2		10.1038/nature05747	http://dx.doi.org/10.1038/nature05747			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17476266				2022-12-01	WOS:000246149300047
J	Reese, TA; Liang, HE; Tager, AM; Luster, AD; Van Rooijen, N; Voehringer, D; Locksley, RM				Reese, Tiffany A.; Liang, Hong-Erh; Tager, Andrew M.; Luster, Andrew D.; Van Rooijen, Nico; Voehringer, David; Locksley, Richard M.			Chitin induces accumulation in tissue of innate immune cells associated with allergy	NATURE			English	Article							ACIDIC MAMMALIAN CHITINASE; TYPE-2 IMMUNITY; LEUKOTRIENE B-4; IN-VIVO; RECEPTOR; MACROPHAGES; GENE; CHITOTRIOSIDASE; IDENTIFICATION; INFLAMMATION	Allergic and parasitic worm immunity is characterized by infiltration of tissues with interleukin (IL)-4- and IL-13-expressing cells, including T-helper-2 cells, eosinophils and basophils(1). Tissue macrophages assume a distinct phenotype, designated alternatively activated macrophages(2). Relatively little is known about the factors that trigger these host responses. Chitin, a widespread environmental biopolymer of N-acetyl-beta-D-glucosamine, provides structural rigidity to fungi, crustaceans, helminths and insects(3). Here, we show that chitin induces the accumulation in tissue of IL-4- expressing innate immune cells, including eosinophils and basophils, when given to mice. Tissue infiltration was unaffected by the absence of Toll-like-receptor-mediated lipopolysaccharide recognition but did not occur if the injected chitin was pre-treated with the IL-4- and IL-13-inducible mammalian chitinase, AMCase(4), or if the chitin was injected into mice that overexpressed AMCase. Chitin mediated alternative macrophage activation in vivo and the production of leukotriene B-4, which was required for optimal immune cell recruitment. Chitin is a recognition element for tissue infiltration by innate cells implicated in allergic and helminth immunity and this process can be negatively regulated by a vertebrate chitinase.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Immunol Microbiol, San Francisco, CA 94143 USA; Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Vrije Univ Amsterdam, Dept Mol Cell Biol, NL-1091 BT Amsterdam, Netherlands	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Harvard University; Vrije Universiteit Amsterdam	Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, San Francisco, CA 94143 USA.	locksley@medicine.ucsf.edu	Luster, Andrew/ABE-6504-2020; Voehringer, David/K-2776-2019; Van Rooijen, Nico/Z-1578-2019	Luster, Andrew/0000-0001-9679-7912; Reese, Tiffany/0000-0003-2325-6546	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026918, R37AI040618, R01AI030663, R37AI026918] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI030663, R37 AI026918-20, R01 AI026918, R37 AI026918, R37 AI040618] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; BOOT RG, 1995, J BIOL CHEM, V270, P26252, DOI 10.1074/jbc.270.44.26252; Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Cartier Andre, 2004, Int J Circumpolar Health, V63 Suppl 2, P333; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; GLASSER SW, 1991, AM J PHYSIOL, V261, P349; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Huang WW, 1998, J EXP MED, V188, P1063, DOI 10.1084/jem.188.6.1063; Jin HM, 1998, GENOMICS, V54, P316, DOI 10.1006/geno.1998.5593; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Keyhani NO, 1999, BBA-GEN SUBJECTS, V1473, P108, DOI 10.1016/S0304-4165(99)00172-5; Machado ER, 2005, J IMMUNOL, V175, P3892, DOI 10.4049/jimmunol.175.6.3892; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Nair MG, 2006, J IMMUNOL, V177, P1393, DOI 10.4049/jimmunol.177.3.1393; Phillips C, 2003, J LEUKOCYTE BIOL, V73, P165, DOI 10.1189/jlb.0702356; Prada JAH, 2006, NAT IMMUNOL, V7, P875, DOI 10.1038/ni1359; Ramalingam TR, 2005, CURR OPIN ALLERGY CL, V5, P392, DOI 10.1097/01.all.0000182542.30100.6f; Reinhardt RL, 2006, J IMMUNOL, V177, P1618, DOI 10.4049/jimmunol.177.3.1618; Shibata Y, 2000, J IMMUNOL, V164, P1314, DOI 10.4049/jimmunol.164.3.1314; Tager AM, 2000, J EXP MED, V192, P439, DOI 10.1084/jem.192.3.439; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; Usami Y, 1998, J BIOMED MATER RES, V42, P517; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Wolters PJ, 2005, CLIN EXP ALLERGY, V35, P82, DOI 10.1111/j.1365-2222.2005.02136.x; Zhang JQQ, 2004, EUR J IMMUNOL, V34, P1175, DOI 10.1002/eji.200324723; Zhang YH, 2005, DEV BIOL, V285, P330, DOI 10.1016/j.ydbio.2005.06.037; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	31	577	601	7	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2007	447	7140					92	U7		10.1038/nature05746	http://dx.doi.org/10.1038/nature05746			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17450126	Green Accepted			2022-12-01	WOS:000246149300050
J	Leibundgut, M; Jenni, S; Frick, C; Ban, N				Leibundgut, Marc; Jenni, Simon; Frick, Christian; Ban, Nenad			Structural basis for substrate delivery by acyl carrier protein in the yeast fatty acid synthase	SCIENCE			English	Article							BINDING-SITES; BIOSYNTHESIS; SYNTHETASE; IDENTIFICATION; ARCHITECTURE; RESOLUTION; REDUCTASE; PEPTIDE; ENZYMES; BIOLOGY	In the multifunctional fungal fatty acid synthase (FAS), the acyl carrier protein (ACP) domain shuttles reaction intermediates covalently attached to its prosthetic phosphopantetheine group between the different enzymatic centers of the reaction cycle. Here, we report the structure of the Saccharomyces cerevisiae FAS determined at 3.1 angstrom resolution with its ACP stalled at the active site of ketoacyl synthase. The ACP contacts the base of the reaction chamber through conserved, charge-complementary surfaces, which optimally position the ACP toward the catalytic cleft of ketoacyl synthase. The conformation of the prosthetic group suggests a switchblade mechanism for acyl chain delivery to the active site of the enzyme.	ETH, Inst Mol Biol & Biophys, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Ban, N (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8092 Zurich, Switzerland.	ban@mol.biol.ethz.ch						Bhaumik P, 2005, CURR OPIN STRUC BIOL, V15, P621, DOI 10.1016/j.sbi.2005.10.010; Crump MP, 1997, BIOCHEMISTRY-US, V36, P6000, DOI 10.1021/bi970006+; Fichtlscherer F, 2000, EUR J BIOCHEM, V267, P2666, DOI 10.1046/j.1432-1327.2000.01282.x; Findlow SC, 2003, BIOCHEMISTRY-US, V42, P8423, DOI 10.1021/bi0342259; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; HOLAK TA, 1988, EUR J BIOCHEM, V175, P9, DOI 10.1111/j.1432-1033.1988.tb14159.x; Jenni S, 2006, SCIENCE, V311, P1263, DOI 10.1126/science.1123251; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; Koglin A, 2006, SCIENCE, V312, P273, DOI 10.1126/science.1122928; KRESZE GB, 1977, EUR J BIOCHEM, V79, P181, DOI 10.1111/j.1432-1033.1977.tb11796.x; LYNEN F, 1980, EUR J BIOCHEM, V112, P431; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; MOHAMED AH, 1988, J BIOL CHEM, V263, P12315; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Rafi S, 2006, J BIOL CHEM, V281, P39285, DOI 10.1074/jbc.M608758200; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; SCHRECKENBACH T, 1977, EUR J BIOCHEM, V80, P13, DOI 10.1111/j.1432-1033.1977.tb11850.x; SCHUSTER H, 1995, EUR J BIOCHEM, V228, P417; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; von Wettstein-Knowles P, 2006, FEBS J, V273, P695, DOI 10.1111/j.1742-4658.2005.05101.x; Weissman KJ, 2004, PHILOS T R SOC A, V362, P2671, DOI 10.1098/rsta.2004.1470; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Wong HC, 2002, J BIOL CHEM, V277, P15874, DOI 10.1074/jbc.M112300200; Xu GY, 2001, STRUCTURE, V9, P277, DOI 10.1016/S0969-2126(01)00586-X; Zhang YM, 2003, J BIOL CHEM, V278, P52935, DOI 10.1074/jbc.M309874200; Zhang YM, 2001, J BIOL CHEM, V276, P8231, DOI 10.1074/jbc.M008042200; Zornetzer GA, 2006, BIOCHEMISTRY-US, V45, P5217, DOI 10.1021/bi052062d	29	147	157	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					288	290		10.1126/science.1138249	http://dx.doi.org/10.1126/science.1138249			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431182				2022-12-01	WOS:000245654500054
J	Fukuda, R; Zhang, HF; Kim, JW; Shimoda, L; Dang, CV; Semenza, GL				Fukuda, Ryo; Zhang, Huafeng; Kim, Jung-whan; Shimoda, Larissa; Dang, Chi V.; Semenza, Gregg L.			HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells	CELL			English	Article							INDUCIBLE FACTOR 1-ALPHA; PAS DOMAIN PROTEIN-1; C-OXIDASE; SACCHAROMYCES-CEREVISIAE; GROWTH-FACTOR; FACTOR-I; EXPRESSION; FACTOR-1; YEAST; GENE	O-2 is the ultimate electron acceptor for mitochondrial respiration, a process catalyzed by cytochrome c oxidase (COX). In yeast, COX subunit composition is regulated by COX5a and COX5b gene transcription in response to high and low O-2, respectively. Here we demonstrate that in mammalian cells, expression of the COX4-1 and COX4-2 isoforms is O-2 regulated. Under conditions of reduced O-2 availability, hypoxia-inducible factor 1 (HIF-1) reciprocally regulates COX4 subunit expression by activating transcription of the genes encoding COX4-2 and LON, a mitochondrial protease that is required for COX4-1 degradation. The effects of manipulating COX4 subunit expression on COX activity, ATP production, O-2 consumption, and reactive oxygen species generation indicate that the COX4 subunit switch is a homeostatic response that optimizes the efficiency of respiration at different O-2 concentrations. Thus, mammalian cells respond to hypoxia by altering COX subunit composition, as previously observed in yeast, but by a completely different molecular mechanism.	Johns Hopkins Univ, Sch Med, Vasc Biol Program, Inst Cell Engn, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Semenza, GL (corresponding author), Johns Hopkins Univ, Sch Med, Vasc Biol Program, Inst Cell Engn, Baltimore, MD 21205 USA.	gsemenza@jhmi.edu	Zhang, Huafeng/A-7188-2012; Dang, Chi/Y-3375-2019	Kim, Jung-whan/0000-0002-7829-1480; Dang, Chi/0000-0002-4031-2522				ALLEN LA, 1995, J BIOL CHEM, V270, P110, DOI 10.1074/jbc.270.1.110; Bonnet S, 2006, CIRCULATION, V113, P2630, DOI 10.1161/CIRCULATIONAHA.105.609008; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Burke PV, 1998, J EXP BIOL, V201, P1163; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; FORSBURG SL, 1989, ANNU REV CELL BIOL, V5, P153, DOI 10.1146/annurev.cb.05.110189.001101; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hervouet E, 2006, BIOCHEM BIOPH RES CO, V344, P1086, DOI 10.1016/j.bbrc.2006.04.014; Hori O, 2002, J CELL BIOL, V157, P1151, DOI 10.1083/jcb.200108103; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huttemann M, 2001, GENE, V267, P111, DOI 10.1016/S0378-1119(01)00385-7; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Kelly BD, 2003, CIRC RES, V93, P1074, DOI 10.1161/01.RES.0000102937.50486.1B; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim JY, 2004, J EXP MED, V199, P113, DOI 10.1084/jem.20030613; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Kwast KE, 1998, J EXP BIOL, V201, P1177; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lofstedt T, 2004, J BIOL CHEM, V279, P39223, DOI 10.1074/jbc.M402904200; LOWRY CV, 1984, P NATL ACAD SCI-BIOL, V81, P6129, DOI 10.1073/pnas.81.19.6129; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MCEWEN JE, 1986, J BIOL CHEM, V261, P1872; Mukhopadhyay CK, 2000, J BIOL CHEM, V275, P21048, DOI 10.1074/jbc.M000636200; Napiwotzki J, 1998, BIOL CHEM, V379, P335, DOI 10.1515/bchm.1998.379.3.335; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; Okuyama H, 2006, J BIOL CHEM, V281, P15554, DOI 10.1074/jbc.M602003200; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Shima DT, 1996, J BIOL CHEM, V271, P3877, DOI 10.1074/jbc.271.7.3877; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang J, 2006, CIRC RES, V98, P1528, DOI 10.1161/01.RES.0000227551.68124.98; WATERLAND RA, 1991, J BIOL CHEM, V266, P4180; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	43	878	913	8	81	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					111	122		10.1016/j.cell.2007.01.047	http://dx.doi.org/10.1016/j.cell.2007.01.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418790	Bronze			2022-12-01	WOS:000245661100015
J	Somesh, BP; Sigurdsson, S; Saeki, H; Erdjument-Bromage, H; Tempst, P; Svejstrup, JQ				Somesh, Baggavalli P.; Sigurdsson, Stefan; Saeki, Hideaki; Erdjument-Bromage, Hediye; Tempst, Paul; Svejstrup, Jesper Q.			Communication between distant sites in RNA polymerase II through ubiquitylation factors and the polymerase CTD	CELL			English	Article							UBIQUITIN-PROTEIN LIGASE; COUPLED DNA-REPAIR; STRUCTURAL BASIS; LARGE SUBUNIT; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION ELONGATION; IN-VIVO; COMPLEX; DEGRADATION; RESOLUTION	Transcriptional arrest triggers ubiquitylation of RNA polymerase II (RNAPII). We mapped the yeast RNAPII ubiquitylation sites and found that they play an important role in elongation and the DNA-damage response. One site lies in a protein domain that is unordered in free RNAPII, but ordered in the elongating form, helping explain the preferential ubiguitylation of this form. The other site is > 125 Angstroms away, yet mutation of either site affects ubiquitylation of the other, in vitro and in vivo. The basis for this remarkable coupling was uncovered: an Rsp5 (E3) dimer assembled on the RNAPII C-terminal domain (CTD). The ubiquitylation sites bind Ubc5 (E2), which in turn binds Rsp5 to allow modification. Evidence for folding of the CTD compatible with this mechanism of communication between distant sites is provided. These data reveal the specificity and mechanism of RNAPII ubiquitylation and demonstrate that Us can play a crucial role in substrate recognition.	Canc Res UK London Res Inst, Mech & Transcript Lab, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Cancer Research UK; Memorial Sloan Kettering Cancer Center	Svejstrup, JQ (corresponding author), Canc Res UK London Res Inst, Mech & Transcript Lab, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	j.svejstrup@cancer.org.uk	Sigurdsson, Stefan/L-9820-2015	Sigurdsson, Stefan/0000-0002-5284-0058; Svejstrup, Jesper/0000-0003-4964-6147; Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594				Archambault J, 1998, J BACTERIOL, V180, P2590, DOI 10.1128/JB.180.10.2590-2598.1998; Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Beaudenon SL, 1999, MOL CELL BIOL, V19, P6972; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Boeger H, 2005, FEBS LETT, V579, P899, DOI 10.1016/j.febslet.2004.11.027; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Hemming SA, 2000, J BIOL CHEM, V275, P35506, DOI 10.1074/jbc.M004721200; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Huibregtse JM, 1997, P NATL ACAD SCI USA, V94, P3656, DOI 10.1073/pnas.94.8.3656; Kobor MS, 2002, BBA-GENE STRUCT EXPR, V1577, P261, DOI 10.1016/S0167-4781(02)00457-8; Li SS, 2002, EMBO J, V21, P5921, DOI 10.1093/emboj/cdf589; LI Y, 1994, P NATL ACAD SCI USA, V91, P2362, DOI 10.1073/pnas.91.6.2362; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; NONET M, 1987, CELL, V50, P909, DOI 10.1016/0092-8674(87)90517-4; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Ratner JN, 1998, J BIOL CHEM, V273, P5184, DOI 10.1074/jbc.273.9.5184; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Svejstrup JQ, 2003, J CELL SCI, V116, P447, DOI 10.1242/jcs.00271; VANGOOL AJ, 1994, EMBO J, V13, P5361, DOI 10.1002/j.1460-2075.1994.tb06871.x; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a	27	59	60	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					57	68		10.1016/j.cell.2007.01.046	http://dx.doi.org/10.1016/j.cell.2007.01.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418786	Bronze			2022-12-01	WOS:000245661100011
J	Wernig, M; Meissner, A; Foreman, R; Brambrink, T; Ku, MC; Hochedlinger, K; Bernstein, BE; Jaenisch, R				Wernig, Marius; Meissner, Alexander; Foreman, Ruth; Brambrink, Tobias; Ku, Manching; Hochedlinger, Konrad; Bernstein, Bradley E.; Jaenisch, Rudolf			In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state	NATURE			English	Article							DE-NOVO METHYLATION; DEVELOPMENTAL REGULATORS; RETROVIRAL GENOMES; SOMATIC-CELLS; EXPRESSION; DIFFERENTIATION; TRANSCRIPTION; POLYCOMB; CLONING; GENES	Nuclear transplantation can reprogramme a somatic genome back into an embryonic epigenetic state, and the reprogrammed nucleus can create a cloned animal or produce pluripotent embryonic stem cells. One potential use of the nuclear cloning approach is the derivation of 'customized' embryonic stem (ES) cells for patient-specific cell treatment, but technical and ethical considerations impede the therapeutic application of this technology. Reprogramming of fibroblasts to a pluripotent state can be induced in vitro through ectopic expression of the four transcription factors Oct4 (also called Oct3/4 or Pou5f1), Sox2, c-Myc and Klf4. Here we show that DNA methylation, gene expression and chromatin state of such induced reprogrammed stem cells are similar to those of ES cells. Notably, the cells - derived from mouse fibroblasts - can form viable chimaeras, can contribute to the germ line and can generate live late-term embryos when injected into tetraploid blastocysts. Our results show that the biological potency and epigenetic state of in-vitro-reprogrammed induced pluripotent stem cells are indistinguishable from those of ES cells.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	Jaenisch, R (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; CHAPMAN V, 1984, NATURE, V307, P284, DOI 10.1038/307284a0; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Eads Cindy A, 2002, Methods Mol Biol, V200, P71; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hochedlinger K, 2003, NEW ENGL J MED, V349, P275, DOI 10.1056/NEJMra035397; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Holm TM, 2005, CANCER CELL, V8, P275, DOI 10.1016/j.ccr.2005.09.007; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jaenisch R, 2004, NEW ENGL J MED, V351, P2787, DOI 10.1056/NEJMp048304; JAHNER D, 1982, NATURE, V298, P623, DOI 10.1038/298623a0; LABOSKY PA, 1994, DEVELOPMENT, V120, P3197; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lucifero D, 2002, GENOMICS, V79, P530, DOI 10.1006/geno.2002.6732; MAHERALI N, IN PRESS CELL STEM C; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; STEWART CL, 1982, P NATL ACAD SCI-BIOL, V79, P4098, DOI 10.1073/pnas.79.13.4098; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Wernig M, 2004, J NEUROSCI, V24, P5258, DOI 10.1523/JNEUROSCI.0428-04.200; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973	34	2024	2297	7	354	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 19	2007	448	7151					318	U2		10.1038/nature05944	http://dx.doi.org/10.1038/nature05944			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191GC	17554336				2022-12-01	WOS:000248118300050
J	Johnson, DS; Bai, L; Smith, BY; Patel, SS; Wang, MD				Johnson, Daniel S.; Bai, Lu; Smith, Benjamin Y.; Patel, Smita S.; Wang, Michelle D.			Single-molecule studies reveal dynamics of DNA unwinding by the ring-shaped T7 helicase	CELL			English	Article							STRANDED-DNA; CRYSTAL-STRUCTURE; HEXAMERIC HELICASE; BACTERIOPHAGE T7; RECBCD ENZYME; MACROMOLECULAR MACHINES; ACTIVE MECHANISM; GENE-4 PROTEIN; COLI UVRD; TRANSLOCATION	Helicases are molecular motors that separate DNA strands for efficient replication of genomes. We probed the kinetics of individual ring-shaped T7 helicase molecules as they unwound double-stranded DNA (dsDNA) or translocated on single-stranded DNA (ssDNA). A distinctive DNA sequence dependence was observed in the unwinding rate that correlated with the local DNA unzipping energy landscape. The unwinding rate increased similar to 10- fold (approaching the ssDNA translocation rate) when a destabilizing force on the DNA fork junction was increased from 5 to 11 pN. These observations reveal a fundamental difference between the mechanisms of ring-shaped and nonring-shaped helicases. The observed force-velocity and sequence dependence are not consistent with a simple passive unwinding model. However, an active unwinding model fully supports the data even though the helicase on its own does not unwind at its optimal rate. This work offers insights into possible ways helicase activity is enhanced by associated proteins.	Cornell Univ, Dept Phys, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Cornell University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Wang, MD (corresponding author), Cornell Univ, Dept Phys, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA.	mdw17@cornell.edu		Johnson, Daniel/0000-0001-8906-0509	NIGMS NIH HHS [R01 GM059849-08, R01 GM059849-09, R01 GM059849-06A1, GM55310, R01 GM059849-05, R01 GM059849, R01 GM059849-04, R01 GM055310, R01 GM059849-07] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059849, R01GM055310] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adelman K, 2002, P NATL ACAD SCI USA, V99, P13538, DOI 10.1073/pnas.212358999; Ahnert P, 1997, J BIOL CHEM, V272, P32267, DOI 10.1074/jbc.272.51.32267; AMARATUNGA M, 1993, BIOCHEMISTRY-US, V32, P6815, DOI 10.1021/bi00078a003; Bertram RD, 2002, BIOCHEMISTRY-US, V41, P7725, DOI 10.1021/bi025755s; BETTERDON MD, 2005, SOFT MATTER PHYS, V71; Betterton MD, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.258103; Bockelmann U, 1997, PHYS REV LETT, V79, P4489, DOI 10.1103/PhysRevLett.79.4489; Brendza KM, 2005, P NATL ACAD SCI USA, V102, P10076, DOI 10.1073/pnas.0502886102; CHEN YZ, 1992, J BIOMOL STRUCT DYN, V10, P415, DOI 10.1080/07391102.1992.10508656; Cheng W, 2002, P NATL ACAD SCI USA, V99, P16006, DOI 10.1073/pnas.242479399; Delagoutte E, 2002, Q REV BIOPHYS, V35, P431, DOI 10.1017/S0033583502003852; Delagoutte E, 2001, BIOCHEMISTRY-US, V40, P4459, DOI 10.1021/bi001306l; Dessinges MN, 2004, P NATL ACAD SCI USA, V101, P6439, DOI 10.1073/pnas.0306713101; Dillingham MS, 2003, NATURE, V423, P893, DOI 10.1038/nature01673; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Dohoney KM, 2001, NATURE, V409, P370, DOI 10.1038/35053124; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; GEISELMANN J, 1993, P NATL ACAD SCI USA, V90, P7754, DOI 10.1073/pnas.90.16.7754; Hacker KJ, 1997, BIOCHEMISTRY-US, V36, P14080, DOI 10.1021/bi971644v; Israelachvili J., 1992, INTERMOLECULAR SURFA; Jeong YJ, 2004, P NATL ACAD SCI USA, V101, P7264, DOI 10.1073/pnas.0400372101; Johnson DS, 2004, BIOPHYS J, V86, p328A; Kaplan DL, 2004, MOL CELL, V15, P453, DOI 10.1016/j.molcel.2004.06.039; Kim DE, 2002, J MOL BIOL, V321, P807, DOI 10.1016/S0022-2836(02)00733-7; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Koch SJ, 2002, BIOPHYS J, V83, P1098, DOI 10.1016/S0006-3495(02)75233-8; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; MATSON SW, 1983, J BIOL CHEM, V258, P4017; MATSON SW, 1983, J BIOL CHEM, V258, P4009; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; PATEL SS, 1992, J BIOL CHEM, V267, P15013; PATEL SS, 1993, J BIOL CHEM, V268, P10668; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Perkins TT, 2004, BIOPHYS J, V86, P1640, DOI 10.1016/S0006-3495(04)74232-0; Peterman EJG, 2003, BIOPHYS J, V84, P1308, DOI 10.1016/S0006-3495(03)74946-7; RICHARDSON CC, 1983, CELL, V33, P315, DOI 10.1016/0092-8674(83)90411-7; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Shundrovsky A, 2006, NAT STRUCT MOL BIOL, V13, P549, DOI 10.1038/nsmb1102; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Singleton MR, 2002, J BACTERIOL, V184, P1819, DOI 10.1128/JB.184.7.1819-1826.2002; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Soultanas P, 2001, TRENDS BIOCHEM SCI, V26, P47, DOI 10.1016/S0968-0004(00)01734-5; Soultanas P, 2000, EMBO J, V19, P3799, DOI 10.1093/emboj/19.14.3799; Spies M, 2003, CELL, V114, P647, DOI 10.1016/S0092-8674(03)00681-0; Stano NM, 2005, NATURE, V435, P370, DOI 10.1038/nature03615; TABOR S, 1981, P NATL ACAD SCI-BIOL, V78, P205, DOI 10.1073/pnas.78.1.205; Taylor AF, 2003, NATURE, V423, P889, DOI 10.1038/nature01674; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; von Hippel PH, 2001, CELL, V104, P177, DOI 10.1016/S0092-8674(01)00203-3; WONG I, 1992, SCIENCE, V256, P350, DOI 10.1126/science.256.5055.350	58	184	188	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2007	129	7					1299	1309		10.1016/j.cell.2007.04.038	http://dx.doi.org/10.1016/j.cell.2007.04.038			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	188HQ	17604719	Green Accepted, Bronze			2022-12-01	WOS:000247911400016
J	Chan, CS; Guzman, JN; Ilijic, E; Mercer, JN; Rick, C; Tkatch, T; Meredith, GE; Surmeier, DJ				Chan, C. Savio; Guzman, Jaime N.; Ilijic, Ema; Mercer, Jeff N.; Rick, Caroline; Tkatch, Tatiana; Meredith, Gloria E.; Surmeier, D. James			'Rejuvenation' protects neurons in mouse models of Parkinson's disease	NATURE			English	Article							MIDBRAIN DOPAMINERGIC-NEURONS; MITOCHONDRIAL-DNA DELETIONS; SUBSTANTIA-NIGRA NEURONS; MEDIUM SPINY NEURONS; CA2+ CHANNELS; CHOLINERGIC INTERNEURONS; CALCIUM-ANTAGONISTS; STRIATAL LEVEL; PATHOGENESIS; MECHANISMS	Why dopamine-containing neurons of the brain's substantia nigra pars compacta die in Parkinson's disease has been an enduring mystery. Our studies suggest that the unusual reliance of these neurons on L-type Ca(v)1.3 Ca2+ channels to drive their maintained, rhythmic pacemaking renders them vulnerable to stressors thought to contribute to disease progression. The reliance on these channels increases with age, as juvenile dopamine-containing neurons in the substantia nigra pars compacta use pacemaking mechanisms common to neurons not affected in Parkinson's disease. These mechanisms remain latent in adulthood, and blocking Ca(v)1.3 Ca2+ channels in adult neurons induces a reversion to the juvenile form of pacemaking. Such blocking ('rejuvenation') protects these neurons in both in vitro and in vivo models of Parkinson's disease, pointing to a new strategy that could slow or stop the progression of the disease.	Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA; Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Mol & Cellular Pharmacol, Chicago, IL 60064 USA	Northwestern University; Feinberg School of Medicine; Chicago Medical School; Rosalind Franklin University Medical & Science	Surmeier, DJ (corresponding author), Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu	Tuluc, Petronel/C-2527-2011	Chan, C. Savio/0000-0002-3474-1718; Tkatch, Tatiana/0000-0001-6626-7435	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008152] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Ai Y, 2003, J COMP NEUROL, V461, P250, DOI 10.1002/cne.10689; Beal MF, 1998, ANN NEUROL, V44, pS110; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Bywood PT, 2003, EXP NEUROL, V179, P47, DOI 10.1006/exnr.2002.8044; Chan CS, 2004, J NEUROSCI, V24, P9921, DOI 10.1523/JNEUROSCI.2162-04.2004; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Fahn S, 2005, J NEUROL, V252, P37, DOI 10.1007/s00415-005-4008-5; GRACE AA, 1984, J NEUROSCI, V4, P2866; GRACE AA, 1989, J NEUROSCI, V9, P3463; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; GROSSMAN E, 1991, AM J CARDIOL, V68, P65, DOI 10.1016/0002-9149(91)90712-T; Hasbani DM, 2005, J NEUROSCI, V25, P9428, DOI 10.1523/JNEUROSCI.0130-05.2005; Hines ML, 2001, NEUROSCIENTIST, V7, P123, DOI 10.1177/107385840100700207; HORNYKIEWICZ O, 1966, PHARMACOL REV, V18, P925; Hows MEP, 2004, J NEUROSCI METH, V137, P221, DOI 10.1016/j.jneumeth.2004.02.011; Jiang Q, 2006, J NEUROSCI, V26, P4318, DOI 10.1523/JNEUROSCI.0118-06.2006; Johnson BA, 2001, AM J PSYCHIAT, V158, P1191, DOI 10.1176/appi.ajp.158.8.1191; Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Krieger C, 2002, EUR J PHARMACOL, V447, P177, DOI 10.1016/S0014-2999(02)01842-3; Kupsch A, 1996, BRAIN RES, V741, P185, DOI 10.1016/S0006-8993(96)00917-1; KUPSCH A, 1995, NEUROREPORT, V6, P621, DOI 10.1097/00001756-199503000-00009; Kwong JQ, 2006, J NEUROCHEM, V97, P1659, DOI 10.1111/j.1471-4159.2006.03990.x; Mandir AS, 1999, P NATL ACAD SCI USA, V96, P5774, DOI 10.1073/pnas.96.10.5774; Maurice N, 2004, J NEUROSCI, V24, P10289, DOI 10.1523/JNEUROSCI.2155-04.2004; MERCURI NB, 1994, BRIT J PHARMACOL, V113, P831, DOI 10.1111/j.1476-5381.1994.tb17068.x; Meredith GE, 2006, MOVEMENT DISORD, V21, P1595, DOI 10.1002/mds.21010; MICHEL D, 1990, CERAM TRANS, V6, P435; MIGLIORE M, 1995, J NEUROPHYSIOL, V73, P1157, DOI 10.1152/jn.1995.73.3.1157; NEDERGAARD S, 1993, J PHYSIOL-LONDON, V466, P727; Nelson EL, 1996, J COMP NEUROL, V369, P361, DOI 10.1002/(SICI)1096-9861(19960603)369:3<361::AID-CNE3>3.0.CO;2-3; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Paxinos G., 2004, MOUSE BRAIN STEREOTA, V2; Petroske E, 2001, NEUROSCIENCE, V106, P589, DOI 10.1016/S0306-4522(01)00295-0; Phinney AL, 2006, PARKINSONISM RELAT D, V12, P228, DOI 10.1016/j.parkreldis.2005.12.002; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Przedborski S, 2003, ANN NY ACAD SCI, V991, P189; RIEDERER P, 1976, J NEURAL TRANSM, V38, P277, DOI 10.1007/BF01249445; Rodnitzky RL, 1999, DRUGS, V57, P845, DOI 10.2165/00003495-199957060-00001; Scholze A, 2001, MOL ENDOCRINOL, V15, P1211, DOI 10.1210/me.15.7.1211; Shen WX, 2005, J NEUROSCI, V25, P7449, DOI 10.1523/JNEUROSCI.1381-05.2005; Shepard PD, 1999, BRAIN RES, V817, P104, DOI 10.1016/S0006-8993(98)01231-1; Song WJ, 1998, J NEUROSCI, V18, P3124; Surmeier DJ, 2005, CURR OPIN NEUROBIOL, V15, P312, DOI 10.1016/j.conb.2005.05.007; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417; Tkatch T, 1998, NEUROREPORT, V9, P1935, DOI 10.1097/00001756-199806220-00004; Verkhratsky A, 2005, PHYSIOL REV, V85, P201, DOI 10.1152/physrev.00004.2004; Wang J, 2002, NEURON, V36, P451, DOI 10.1016/S0896-6273(02)00968-6; Wilson CJ, 2000, J NEUROPHYSIOL, V83, P3084, DOI 10.1152/jn.2000.83.5.3084; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; YAMADA T, 1990, BRAIN RES, V526, P303, DOI 10.1016/0006-8993(90)91236-A; YUNG WH, 1991, J PHYSIOL-LONDON, V436, P643, DOI 10.1113/jphysiol.1991.sp018571; Zecca L, 2003, TRENDS NEUROSCI, V26, P578, DOI 10.1016/j.tins.2003.08.009; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211; Zolles G, 2006, NEURON, V52, P1027, DOI 10.1016/j.neuron.2006.12.005	66	612	629	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2007	447	7148					1081	U5		10.1038/nature05865	http://dx.doi.org/10.1038/nature05865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183HT	17558391				2022-12-01	WOS:000247564600031
J	Feudtner, C; Feinstein, JA; Satchell, M; Zhao, HQ; Kang, TI				Feudtner, Chris; Feinstein, James A.; Satchell, Marlon; Zhao, Huaqing; Kang, Tammy I.			Shifting place of death among children with complex chronic conditions in the United States, 1989-2003	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; MULTIPLE IMPUTATION; ETHNIC-DIFFERENCES; WASHINGTON-STATE; PALLIATIVE CARE; CANCER-PATIENTS; HOME; HOSPICE; TRENDS; SITE	Context The place where children with complex chronic conditions are dying may be shifting toward residential homes due to the evolving epidemiology of life-threatening childhood conditions, advances in home-based medical technology, and changes in attitudes about pediatric palliative care and hospice services. Objectives To determine whether pediatric deaths attributed to complex chronic conditions are increasingly occurring in the home and to assess race and ethnicity disparities in the location of death. Design, Setting, and Participants Retrospective national-level case series drawn from the National Center for Health Statistics' Multiple Cause of Death Files spanning 1989-2003. Participants included all deceased individuals aged 19 years or younger with a complex chronic condition excluding injury and noncomplex chronic conditions ( as classified by International Classification of Diseases, Ninth Revision or International Classification of Diseases, Tenth Revision). Main Outcome Measure Place where death occurred. Results Among the 22.1% of deaths ( 198 160 of 896 509 total deaths) attributed to a complex chronic condition between 1989 and 2003, the percentage of individuals dying at home increased significantly ( P <. 001) over time for infants ( aged < 1 year) (4.9% in 1989 and 7.3% in 2003); 1- to 9-year-olds (17.9% and 30.7%); and for 10- to 19-year-olds (18.4% and 32.2%). Adjusting for decedent characteristics, the odds of dying at home increased significantly each year ( odds ratio, 1.04; 95% confidence interval, 1.03-1.04) and were reduced among both black and Hispanic decedents ( odds ratio, 0.50; 95% confidence interval, 0.48-0.52 and odds ratio, 0.52; 95% confidence interval, 0.50-0.54, respectively) compared with white decedents. Conclusions Children who die with underlying complex chronic conditions increasingly are dying at home. Racial and ethnic disparities regarding place of death may represent important limitations and opportunities for improvement in the current systems of pediatric chronic and palliative care.	Childrens Hosp Philadelphia, Pediat Adv Care Team, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Pediat Generalist Res Grp, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Biostat & Data Management Core, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Div Gen Pediat, Philadelphia, PA 19104 USA; Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Feudtner, C (corresponding author), Childrens Hosp Philadelphia, Pediat Adv Care Team, 3535 Market St,Room 1523,34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	feudtner@email.chop.edu	Feinstein, James Aaron/I-6373-2013; Feudtner, Chris/AAI-1126-2019	Feinstein, James Aaron/0000-0003-3074-8805; Feudtner, Chris/0000-0002-5879-0434	AHRQ HHS [K08 HS00002] Funding Source: Medline; NINR NIH HHS [R21-NR008614] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS000002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R21NR008614] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Burge F, 2003, CAN MED ASSOC J, V168, P265; Burge FI, 2005, J RURAL HEALTH, V21, P233, DOI 10.1111/j.1748-0361.2005.tb00088.x; Caveney AF, 2006, PUBLIC HEALTH REP, V121, P275, DOI 10.1177/003335490612100309; *CDCP, 1996, DOC PUBL US MULT CAU; *COMM PALL END OF, 2003, CHILDR DIE IMPR PALL; Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care; Board on Health Sciences Policy; Institute on Medicine, 2003, UN TREATM CONFR RAC; Davies E, 2006, BRIT J CANCER, V95, P593, DOI 10.1038/sj.bjc.6603305; Enguidanos S, 2005, J AM GERIATR SOC, V53, P1411, DOI 10.1111/j.1532-5415.2005.53410.x; Feudtner C, 2000, PEDIATRICS, V106, P205; Feudtner C, 2002, PEDIATRICS, V109, P656, DOI 10.1542/peds.109.4.656; Feudtner Chris, 2005, BMC Pediatr, V5, P8, DOI 10.1186/1471-2431-5-8; Flory J, 2004, HEALTH AFFAIR, V23, P194, DOI 10.1377/hlthaff.23.3.194; Fox CS, 2005, AM J CARDIOL, V95, P856, DOI 10.1016/j.amjcard.2004.12.011; GOLDMAN A, 1990, ARCH DIS CHILD, V65, P641, DOI 10.1136/adc.65.6.641; Gomes B, 2006, BMJ-BRIT MED J, V332, P515, DOI 10.1136/bmj.38740.614954.55; Guyer B, 2000, PEDIATRICS, V106, P1307, DOI 10.1542/peds.106.6.1307; Himelstein BP, 2004, NEW ENGL J MED, V350, P1752, DOI 10.1056/NEJMra030334; Iwashyna TJ, 2002, J AM GERIATR SOC, V50, P1113, DOI 10.1046/j.1532-5415.2002.50269.x; Johnson KS, 2005, J AM GERIATR SOC, V53, P2209, DOI 10.1111/j.1532-5415.2005.00502.x; KATZ BP, 1979, PUBLIC HEALTH REP, V94, P522; Kreicbergs U, 2005, J CLIN ONCOL, V23, P9162, DOI 10.1200/JCO.2005.08.557; LAUER ME, 1989, CANCER, V63, P988, DOI 10.1002/1097-0142(19890301)63:5<988::AID-CNCR2820630534>3.0.CO;2-Y; Leuthner Steven R, 2004, J Palliat Med, V7, P269, DOI 10.1089/109662104773709396; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; MCCUSKER J, 1983, PUBLIC HEALTH REP, V98, P170; Meier DE, 2007, J PALLIAT MED, V10, P284, DOI 10.1089/jpm.2006.9985; MOINPOUR CM, 1989, AM J PUBLIC HEALTH, V79, P1549, DOI 10.2105/AJPH.79.11.1549; MOR V, 1983, J HEALTH SOC BEHAV, V24, P375, DOI 10.2307/2136403; Mor Vincent, 2005, J Palliat Med, V8, P58, DOI 10.1089/jpm.2005.8.58; MULHERN RK, 1983, PEDIATRICS, V71, P743; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; PALFREY JS, 1994, PUBLIC HEALTH REP, V109, P226; Polissar L, 1987, J Community Health, V12, P40, DOI 10.1007/BF01321396; Royston P, 2005, STATA J, V5, P188, DOI 10.1177/1536867X0500500204; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Stuart G, 2002, HEART, V88, pI1; Surkan PJ, 2006, PALLIATIVE MED, V20, P161, DOI 10.1191/0269216306pm1139oa; Vincer MJ, 2006, PEDIATRICS, V118, pE1621, DOI 10.1542/peds.2006-1522; Weitzen S, 2003, MED CARE, V41, P323, DOI 10.1097/00005650-200302000-00013; Wolfe J, 2000, JAMA-J AM MED ASSOC, V284, P2469, DOI 10.1001/jama.284.19.2469	40	158	162	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2007	297	24					2725	2732		10.1001/jama.297.24.2725	http://dx.doi.org/10.1001/jama.297.24.2725			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	182UE	17595273	Bronze			2022-12-01	WOS:000247528700022
J	Day, M				Day, Michael			Don't blame it all on the bogey	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia	University of Sydney	Day, M (corresponding author), Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia.	miday@f2s.com							0	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 16	2007	334	7606					1250	1251		10.1136/bmj.39244.680880.59	http://dx.doi.org/10.1136/bmj.39244.680880.59			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	183AM	17569929	Green Published			2022-12-01	WOS:000247545100029
J	Jordan, N; Boody, G; Broussard, W; Glover, JD; Keeney, D; McCown, BH; McIsaac, G; Muller, M; Murray, H; Neal, J; Pansing, C; Turner, RE; Warner, K; Wyse, D				Jordan, N.; Boody, G.; Broussard, W.; Glover, J. D.; Keeney, D.; McCown, B. H.; McIsaac, G.; Muller, M.; Murray, H.; Neal, J.; Pansing, C.; Turner, R. E.; Warner, K.; Wyse, D.			Environment - Sustainable development of the agricultural bio-economy	SCIENCE			English	Editorial Material							UNITED-STATES; BIOMASS; BIOFUELS		Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN 55018 USA; Land Stewardship Project, White Bear Lake, MN 55110 USA; Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA; Land Inst, Salina, KS 67401 USA; Inst Agr & Trade Policy, Minneapolis, MN 55404 USA; Univ Wisconsin, Ctr Integrated Agr Syst, Madison, WI 53706 USA; Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA; Univ Minnesota, Minnesota Inst Sustainable Agr, St Paul, MN 55108 USA; Iowa State Univ, Leopold Ctr Sustainable Agr, Ames, IA 50011 USA; Mississippi River Basin Alliance, Minneapolis, MN USA; Louisiana State Univ, Coastal Ecol Inst, Baton Rouge, LA 70803 USA; Santa Clara Univ, Inst Environm Studies, Santa Clara, CA 94053 USA	University of Minnesota System; University of Minnesota Twin Cities; Louisiana State University System; Louisiana State University; University of Wisconsin System; University of Wisconsin Madison; University of Illinois System; University of Illinois Urbana-Champaign; University of Minnesota System; University of Minnesota Twin Cities; Iowa State University; Louisiana State University System; Louisiana State University; Santa Clara University	Jordan, N (corresponding author), Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN 55018 USA.	jorda020@umn.edu		Broussard, Whitney/0000-0001-6000-2751				Boody G, 2005, BIOSCIENCE, V55, P27, DOI 10.1641/0006-3568(2005)055[0027:MAITUS]2.0.CO;2; Brown RA, 2000, AGR ECOSYST ENVIRON, V78, P31, DOI 10.1016/S0167-8809(99)00115-2; DUFFY M, 2004, AGDM NEWSL       OCT; Eaglesham A., 2006, SUMM P 3 ANN WORLD C; ERS, 2007, FARM INC DAT FIL; GANTZER CJ, 1990, J SOIL WATER CONSERV, V45, P641; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Hey DL, 2005, ECOL ENG, V24, P279, DOI 10.1016/j.ecoleng.2004.11.014; *IATP, 2006, ASS BIOEC SURV; Jorgensen U, 2005, BIOMASS BIOENERG, V28, P237, DOI 10.1016/j.biombioe.2004.08.006; Keeney D, 2004, NATO ASI S 4 SCI TEC, V41, P29; Kennedy D, 2007, SCIENCE, V316, P515, DOI 10.1126/science.1142978; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; LUBOWSKI RN, 2006, 25 ERS; Reijnders L, 2006, ENERG POLICY, V34, P863, DOI 10.1016/j.enpol.2004.09.001; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; STOFFERHAN CW, 2006, IND FORMING ITS RELA; SULLIVAN P, 2004, 834 ERS; Thornley P, 2006, ENERG POLICY, V34, P2087, DOI 10.1016/j.enpol.2005.02.006; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; *USDA ERS, 2000, HIST AM AGR 1607 200	21	188	195	5	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2007	316	5831					1570	1571		10.1126/science.1141700	http://dx.doi.org/10.1126/science.1141700			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569847				2022-12-01	WOS:000247239900023
J	Rucci, M; Iovin, R; Poletti, M; Santini, F				Rucci, Michele; Iovin, Ramon; Poletti, Martina; Santini, Fabrizio			Miniature eye movements enhance fine spatial detail	NATURE			English	Article							VISUAL-CORTEX; MOTION; MICROSACCADES; VISION; IMAGES; STATISTICS; FIXATION; STRIATE; CELLS	Our eyes are constantly in motion. Even during visual fixation, small eye movements continually jitter the location of gaze(1-4). It is known that visual percepts tend to fade when retinal image motion is eliminated in the laboratory(5-9). However, it has long been debated whether, during natural viewing, fixational eye movements have functions in addition to preventing the visual scene from fading(10-17). In this study, we analysed the influence in humans of fixational eye movements on the discrimination of gratings masked by noise that has a power spectrum similar to that of natural images. Using a new method of retinal image stabilization(18), we selectively eliminated the motion of the retinal image that normally occurs during the intersaccadic intervals of visual fixation. Here we show that fixational eye movements improve discrimination of high spatial frequency stimuli, but not of low spatial frequency stimuli. This improvement originates from the temporal modulations introduced by fixational eye movements in the visual input to the retina, which emphasize the high spatial frequency harmonics of the stimulus. In a natural visual world dominated by low spatial frequencies, fixational eye movements appear to constitute an effective sampling strategy by which the visual system enhances the processing of spatial detail.	Boston Univ, Dept Cognit & Neural Syst, Boston, MA 02215 USA	Boston University	Rucci, M (corresponding author), Boston Univ, Dept Cognit & Neural Syst, Boston, MA 02215 USA.	rucci@cns.bu.edu		Poletti, Martina/0000-0002-4773-8745; Rucci, Michele/0000-0002-3066-1964				Ahissar E, 2001, NEURON, V32, P185, DOI 10.1016/S0896-6273(01)00466-4; AREND LE, 1973, PSYCHOL REV, V80, P374, DOI 10.1037/h0020072; Averill HL, 1925, J COMP PSYCHOL, V5, P147, DOI 10.1037/h0072373; Ditchburn R. W., 1955, OPT ACTA, V1, P171; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Greschner M, 2002, NAT NEUROSCI, V5, P341, DOI 10.1038/nn821; HERING E, 1899, MATH PHYS KLASSE, V20, P16; KAPOULA ZA, 1986, EXP BRAIN RES, V61, P386; KELLY DH, 1979, J OPT SOC AM, V69, P1266, DOI 10.1364/JOSA.69.001266; KOENDERINK JJ, 1972, J OPT SOC AM, V62, P685, DOI 10.1364/JOSA.62.000685; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; Macmillan NA., 2005, DETECTION THEORY USE, V2; Marshall W. H., 1942, BIOL S VISUAL MECHAN, V7, P117; Martinez-Conde S, 2006, NEURON, V49, P297, DOI 10.1016/j.neuron.2005.11.033; Martinez-Conde S, 2000, NAT NEUROSCI, V3, P251, DOI 10.1038/72961; Murakami I, 1998, NATURE, V395, P798, DOI 10.1038/27435; Olveczky BP, 2003, NATURE, V423, P401, DOI 10.1038/nature01652; RATLIFF F, 1950, J EXP PSYCHOL, V40, P687, DOI 10.1037/h0057754; RIGGS LA, 1953, J OPT SOC AM, V43, P495, DOI 10.1364/JOSA.43.000495; RIGGS LA, 1952, J OPT SOC AM, V42, P872; Rucci M, 2005, NETWORK-COMP NEURAL, V16, P121, DOI 10.1080/09548980500300507; SANTINI F, IN PRESS BEHAV RES M; Snodderly DM, 2001, VISUAL NEUROSCI, V18, P259, DOI 10.1017/S0952523801182118; STEINMAN RM, 1967, SCIENCE, V155, P1577, DOI 10.1126/science.155.3769.1577; STEINMAN RM, 1973, SCIENCE, V181, P810, DOI 10.1126/science.181.4102.810; STEINMAN RM, 1980, VISION RES, V20, P415, DOI 10.1016/0042-6989(80)90032-2; TULUNAY-KEESEY U, 1976, Vision Research, V16, P481, DOI 10.1016/0042-6989(76)90026-2; TULUNAYKEESEY U, 1982, J OPT SOC AM, V72, P440, DOI 10.1364/JOSA.72.000440; Yarbus A. L., 1967, EYE MOVEMENTS VISION	30	229	230	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 14	2007	447	7146					851	854		10.1038/nature05866	http://dx.doi.org/10.1038/nature05866			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17568745				2022-12-01	WOS:000247207500043
J	Kim, H; Chen, JJ; Yu, XH				Kim, Hongtae; Chen, Junjie; Yu, Xiaochun			Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response	SCIENCE			English	Article							BRCA1; CHECKPOINT; BRCA1-BARD1; INTERACTS; REPAIR; KINASE; FANCD2; CHK1	Mutations in the breast cancer susceptibility gene 1 (BRCA1) are associated with an increased risk of breast and ovarian cancers. BRCA1 participates in the cellular DNA damage response. We report the identification of receptor-associated protein 80 (RAP80) as a BRCA1-interacting protein in humans. RAP80 contains a tandem ubiquitin-interacting motif domain, which is required for its binding with ubiquitin in vitro and its damage-induced foci formation in vivo. Moreover, RAP80 specifically recruits BRCA1 to DNA damage sites and functions with BRCA1 in G(2)/M checkpoint control. Together, these results suggest the existence of a ubiquitination-dependent signaling pathway involved in the DNA damage response.	Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; Univ Michigan, Sch Med, Dept Internal Med, Div Med & Mol Genet, Ann Arbor, MI 48109 USA	Yale University; University of Michigan System; University of Michigan	Chen, JJ (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, POB 208040, New Haven, CT 06520 USA.	Junjie.chen@yale.edu; xiayu@med.umich.edu			NATIONAL CANCER INSTITUTE [R01CA089239] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA089239] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Chen A, 2002, J BIOL CHEM, V277, P22085, DOI 10.1074/jbc.M201252200; Couch FJ, 1997, NEW ENGL J MED, V336, P1409, DOI 10.1056/NEJM199705153362002; de Oca RM, 2005, BLOOD, V105, P1003, DOI 10.1182/blood-2003-11-3997; Deming PB, 2001, P NATL ACAD SCI USA, V98, P12044, DOI 10.1073/pnas.221430898; Deng CX, 2000, BIOESSAYS, V22, P728; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P272, DOI 10.1038/nsmb1051; Liu QH, 2000, GENE DEV, V14, P1448; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Su TT, 2006, ANNU REV GENET, V40, P187, DOI 10.1146/annurev.genet.40.110405.090428; Takai H, 2000, GENE DEV, V14, P1439; Wang XZ, 2004, MOL CELL BIOL, V24, P5850, DOI 10.1128/MCB.24.13.5850-5862.2004; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Yan ZJ, 2002, J BIOL CHEM, V277, P32379, DOI 10.1074/jbc.M203475200; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	21	437	446	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1202	1205		10.1126/science.1139621	http://dx.doi.org/10.1126/science.1139621			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525342				2022-12-01	WOS:000246724300046
J	Matsuoka, S; Ballif, BA; Smogorzewska, A; McDonald, ER; Hurov, KE; Luo, J; Bakalarski, CE; Zhao, ZM; Solimini, N; Lerenthal, Y; Shiloh, Y; Gygi, SP; Elledge, SJ				Matsuoka, Shuhei; Ballif, Bryan A.; Smogorzewska, Agata; McDonald, E. Robert, III; Hurov, Kristen E.; Luo, Ji; Bakalarski, Corey E.; Zhao, Zhenming; Solimini, Nicole; Lerenthal, Yaniv; Shiloh, Yosef; Gygi, Steven P.; Elledge, Stephen J.			ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage	SCIENCE			English	Article							TYROSINE PHOSPHORYLATION; IDENTIFICATION; CHECKPOINTS; INVOLVEMENT; PROTEOMICS; PATHWAYS; FANCD2; SITES; SMC1	Cellular responses to DNA damage are mediated by a number of protein kinases, including ATM ( ataxia telangiectasia mutated) and ATR ( ATM and Rad3-related). The outlines of the signal transduction portion of this pathway are known, but little is known about the physiological scope of the DNA damage response (DDR). We performed a large-scale proteomic analysis of proteins phosphorylated in response to DNA damage on consensus sites recognized by ATM and ATR and identified more than 900 regulated phosphorylation sites encompassing over 700 proteins. Functional analysis of a subset of this data set indicated that this list is highly enriched for proteins involved in the DDR. This set of proteins is highly interconnected, and we identified a large number of protein modules and networks not previously linked to the DDR. This database paints a much broader landscape for the DDR than was previously appreciated and opens new avenues of investigation into the responses to DNA damage in mammals.	Harvard Univ, Brigham & Womens Hosp, Sch Med,Howard HUghes Med Inst, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med,Howard HUghes Med Inst, Ctr Genet & Genom, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Taplin Biol Mass Spectrometry Facil, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02214 USA; Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Tel Aviv University; Sackler Faculty of Medicine	Elledge, SJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med,Howard HUghes Med Inst, Dept Genet, Boston, MA 02115 USA.	steven_gygi@hms.harvard.edu; selledge@genetics.med.harvard.edu	Smogorzewska, Agata/B-8891-2011	Smogorzewska, Agata/0000-0001-6285-1562; Bakalarski, Corey/0000-0003-1085-7828	PHS HHS [1U19A1067751] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Azzalin CM, 2006, CURR BIOL, V16, P433, DOI 10.1016/j.cub.2006.01.018; Ballif BA, 2006, J PROTEOME RES, V5, P2372, DOI 10.1021/pr060206k; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Dephoure N, 2005, P NATL ACAD SCI USA, V102, P17940, DOI 10.1073/pnas.0509080102; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Ho GPH, 2006, MOL CELL BIOL, V26, P7005, DOI 10.1128/MCB.02018-05; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Kozlov SV, 2006, EMBO J, V25, P3504, DOI 10.1038/sj.emboj.7601231; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; O'Neill T, 2000, J BIOL CHEM, V275, P22719, DOI 10.1074/jbc.M001002200; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Salomon AR, 2003, P NATL ACAD SCI USA, V100, P443, DOI 10.1073/pnas.2436191100; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; THORNE KC, 2000, J BIOL CHEM, V275, P35233; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Yang DQ, 2000, NAT CELL BIOL, V2, P893, DOI 10.1038/35046542; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702; Yoo HY, 2004, J BIOL CHEM, V279, P53353, DOI 10.1074/jbc.M408026200; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	31	2249	2774	11	289	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1160	1166		10.1126/science.1140321	http://dx.doi.org/10.1126/science.1140321			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525332				2022-12-01	WOS:000246724300034
J	Davis, MC; Dahn, RD; Shubin, NH				Davis, Marcus C.; Dahn, Randall D.; Shubin, Neil H.			An autopodial-like pattern of Hox expression in the fins of a basal actinopterygian fish	NATURE			English	Article							SONIC-HEDGEHOG EXPRESSION; PECTORAL FIN; POLARIZING ACTIVITY; POLYODON-SPATHULA; LIMB; EVOLUTION; GENES; ORIGIN; DHAND; BUD	Comparative analyses of Hox gene expression and regulation in teleost fish and tetrapods support the long-entrenched notion that the distal region of tetrapod limbs, containing the wrist, ankle and digits, is an evolutionary novelty(1-4). Data from fossils support the notion that the unique features of tetrapod limbs were assembled over evolutionary time in the paired fins of fish(5). The challenge in linking developmental and palaeontological approaches has been that developmental data for fins and limbs compare only highly derived teleosts and tetrapods; what is lacking are data from extant taxa that retain greater portions of the fin skeletal morphology considered primitive to all bony fish(6,7). Here, we report on the expression and function of genes implicated in the origin of the autopod in a basal actinopterygian, Polyodon spathula. Polyodon exhibits a late-phase, inverted collinear expression of 5' HoxD genes, a pattern of expression long considered a developmental hallmark of the autopod and shown in tetrapods to be controlled by a 'digit enhancer' region. These data show that aspects of the development of the autopod are primitive to tetrapods and that the origin of digits entailed the redeployment of ancient patterns of gene activity.	Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; Field Museum Nat Hist, Chicago, IL 60605 USA	University of Chicago; Field Museum of Natural History (Chicago)	Shubin, NH (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	nshubin@uchicago.edu		Davis, Marcus/0000-0002-2462-0138				Altaba ARI, 1999, DEVELOPMENT, V126, P3205; BEMIS WE, 1992, J MORPHOL, V213, P47, DOI 10.1002/jmor.1052130106; Charite J, 2000, DEVELOPMENT, V127, P2461; Dahn RD, 2007, NATURE, V445, P311, DOI 10.1038/nature05436; Davis MC, 2004, J MORPHOL, V262, P608, DOI 10.1002/jmor.10264; Fernandez-Teran M, 2000, DEVELOPMENT, V127, P2133; Freitas R, 2006, NATURE, V442, P1033, DOI 10.1038/nature04984; Hoffman L, 2002, INT J DEV BIOL, V46, P949; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Mabee PM, 2000, AM ZOOL, V40, P789, DOI 10.1668/0003-1569(2000)040[0789:DDAPSE]2.0.CO;2; Metscher BD, 2005, EVOL DEV, V7, P186, DOI 10.1111/j.1525-142X.2005.05021.x; Prince VE, 1998, DEVELOPMENT, V125, P407; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Ros MA, 2003, DEVELOPMENT, V130, P527, DOI 10.1242/dev.00245; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; Shubin N.H., 2006, NATURE, V440, P747; Sordino P, 1996, TRENDS ECOL EVOL, V11, P114, DOI 10.1016/0169-5347(96)81089-5; SORDINO P, 1995, NATURE, V375, P678, DOI 10.1038/375678a0; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Tarchini B, 2006, DEV CELL, V10, P93, DOI 10.1016/j.devcel.2005.11.014; Wagner GR, 2001, J EXP ZOOL, V291, P226, DOI 10.1002/jez.1100; Yelon D, 2000, DEVELOPMENT, V127, P2573	22	106	113	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2007	447	7143					473	U3		10.1038/nature05838	http://dx.doi.org/10.1038/nature05838			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17522683				2022-12-01	WOS:000246693100047
J	Kaiser, BK; Yim, D; Chow, IT; Gonzalez, S; Dai, Z; Mann, HH; Strong, RK; Groh, V; Spies, T				Kaiser, Brett K.; Yim, Daesong; Chow, I-Ting; Gonzalez, Segundo; Dai, Zhenpeng; Mann, Henning H.; Strong, Roland K.; Groh, Veronika; Spies, Thomas			Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands	NATURE			English	Article							T-CELLS; IN-VIVO; RECEPTOR; MHC; EXPRESSION; MICA; CYTOTOXICITY; IMMUNITY; ACTIVATION; EXCHANGE	Tumour-associated ligands of the activating NKG2D ( natural killer group 2, member D; also called KLRK1) receptor - which are induced by genotoxic or cellular stress - trigger activation of natural killer cells and co-stimulation of effector T cells, and may thus promote resistance to cancer(1-6). However, many progressing tumours in humans counter this anti-tumour activity by shedding the soluble major histocompatibility complex class-I-related ligand MICA, which induces internalization and degradation of NKG2D and stimulates population expansions of normally rare NKG2D(+) CD4(+) T cells with negative regulatory functions(7-9). Here we show that on the surface of tumour cells, MICA associates with endoplasmic reticulum protein 5 (ERp5; also called PDIA6 or P5), which, similar to protein disulphide isomerase, usually assists in the folding of nascent proteins inside cells(10). Pharmacological inhibition of thioreductase activity and ERp5 gene silencing revealed that cell-surface ERp5 function is required for MICA shedding. ERp5 and membrane-anchored MICA form transitory mixed disulphide complexes from which soluble MICA is released after proteolytic cleavage near the cell membrane. Reduction of the seemingly inaccessible disulphide bond in the membrane-proximal alpha 3 domain of MICA must involve a large conformational change that enables proteolytic cleavage. These results uncover a molecular mechanism whereby domain-specific deconstruction regulates MICA protein shedding, thereby promoting tumour immune evasion, and identify surface ERp5 as a strategic target for therapeutic intervention.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Chow, IT (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N, Seattle, WA 98109 USA.		Gonzalez, Segundo/AAK-8719-2021	Gonzalez, Segundo/0000-0003-4631-9255				Ahamed J, 2006, P NATL ACAD SCI USA, V103, P13932, DOI 10.1073/pnas.0606411103; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(09)00098-3; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Doubrovina ES, 2003, J IMMUNOL, V171, P6891, DOI 10.4049/jimmunol.171.12.6891; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; ESSEX DW, 1995, BLOOD, V86, P2168, DOI 10.1182/blood.V86.6.2168.bloodjournal8662168; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Gallina A, 2002, J BIOL CHEM, V277, P50579, DOI 10.1074/jbc.M204547200; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Gonzalez S, 2006, CURR TOP MICROBIOL, V298, P121; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 2006, NAT IMMUNOL, V7, P755, DOI 10.1038/ni1350; Jinushi M, 2006, P NATL ACAD SCI USA, V103, P9190, DOI 10.1073/pnas.0603503103; Jordan PA, 2006, ANTIOXID REDOX SIGN, V8, P312, DOI 10.1089/ars.2006.8.312; Kikuchi M, 2002, J BIOCHEM, V132, P451, DOI 10.1093/oxfordjournals.jbchem.a003242; Li PW, 1999, IMMUNITY, V10, P577, DOI 10.1016/S1074-7613(00)80057-6; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; Maekawa A, 2006, J IMMUNOL, V176, P6873, DOI 10.4049/jimmunol.176.11.6873; Matthias LJ, 2002, NAT IMMUNOL, V3, P727, DOI 10.1038/ni815; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Smyth MJ, 2005, J EXP MED, V202, P583, DOI 10.1084/jem.20050994; Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172	28	282	303	3	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2007	447	7143					482	U5		10.1038/nature05768	http://dx.doi.org/10.1038/nature05768			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17495932				2022-12-01	WOS:000246693100049
J	Fu, ZQ; Guo, M; Jeong, BR; Tian, F; Elthon, TE; Cerny, RL; Staiger, D; Alfano, JR				Fu, Zheng Qing; Guo, Ming; Jeong, Byeong-ryool; Tian, Fang; Elthon, Thomas E.; Cerny, Ronald L.; Staiger, Dorothee; Alfano, James R.			A type III effector ADP-ribosylates RNA-binding proteins and quells plant immunity	NATURE			English	Article							PROGRAMMED CELL-DEATH; SECRETION SYSTEM EFFECTORS; PV. TOMATO DC3000; PSEUDOMONAS-SYRINGAE; ARABIDOPSIS-THALIANA; INNATE IMMUNITY; TYROSINE-PHOSPHATASE; BACTERIAL TOXINS; IDENTIFICATION; GENE	The bacterial plant pathogen Pseudomonas syringae injects effector proteins into host cells through a type III protein secretion system to cause disease. The enzymatic activities of most of P. syringae effectors and their targets remain obscure. Here we show that the type III effector HopU1 is a mono-ADP-ribosyltransferase (ADP-RT). HopU1 suppresses plant innate immunity in a manner dependent on its ADP-RT active site. The HopU1 substrates in Arabidopsis thaliana extracts were RNA-binding proteins that possess RNA-recognition motifs (RRMs). A. thaliana knockout lines defective in the glycine-rich RNA-binding protein GRP7 ( also known as AtGRP7), a HopU1 substrate, were more susceptible than wild-type plants to P. syringae. The ADP-ribosylation of GRP7 by HopU1 required two arginines within the RRM, indicating that this modification may interfere with GRP7' s ability to bind RNA. Our results suggest a pathogenic strategy where the ADP-ribosylation of RNA-binding proteins quells host immunity by affecting RNA metabolism and the plant defence transcriptome.	Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68588 USA; Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68588 USA; Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA; Univ Bielefeld, D-33501 Bielefeld, Germany	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Bielefeld	Alfano, JR (corresponding author), Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68588 USA.	jalfano2@unl.edu	Jeong, Byeong-ryool/N-1661-2019	Jeong, Byeong-ryool/0000-0003-0642-1650; Staiger, Dorothee/0000-0002-1341-1381				Abramovitch RB, 2006, NAT REV MOL CELL BIO, V7, P601, DOI 10.1038/nrm1984; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Barbieri JT, 2005, REV PHYSIOL BIOCH P, V152, P79, DOI 10.1007/s10254-004-0031-7; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Bretz JR, 2003, MOL MICROBIOL, V49, P389, DOI 10.1046/j.1365-2958.2003.03616.x; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Corda D, 2003, EMBO J, V22, P1953, DOI 10.1093/emboj/cdg209; Coye LH, 2004, MOL MICROBIOL, V54, P89, DOI 10.1111/j.1365-2958.2004.04262.x; Espinosa A, 2004, CELL MICROBIOL, V6, P1027, DOI 10.1111/j.1462-5822.2004.00452.x; Espinosa A, 2003, MOL MICROBIOL, V49, P377, DOI 10.1046/j.1365-2958.2003.03588.x; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; GOMEZ J, 1988, NATURE, V334, P262, DOI 10.1038/334262a0; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Guo M, 2005, J BACTERIOL, V187, P4257, DOI 10.1128/JB.187.12.4257-4269.2005; Guttman DS, 2002, SCIENCE, V295, P1722, DOI 10.1126/science.295.5560.1722; Han S, 2002, INT J MED MICROBIOL, V291, P523; He SY, 2004, BBA-MOL CELL RES, V1694, P181, DOI 10.1016/j.bbamcr.2004.03.011; Heintzen C, 1997, P NATL ACAD SCI USA, V94, P8515, DOI 10.1073/pnas.94.16.8515; Jamir Y, 2004, PLANT J, V37, P554, DOI 10.1046/j.1365-313X.2003.01982.x; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; JESSEN TH, 1991, EMBO J, V10, P3447, DOI 10.1002/j.1460-2075.1991.tb04909.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Lindeberg M, 2006, MOL PLANT MICROBE IN, V19, P1151, DOI 10.1094/MPMI-19-1151; Lopez-Solanilla E, 2004, MOL MICROBIOL, V54, P353, DOI 10.1111/j.1365-2958.2004.04285.x; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Mota LJ, 2005, ANN MED, V37, P234, DOI 10.1080/07853890510037329; Mudgett MB, 2005, ANNU REV PLANT BIOL, V56, P509, DOI 10.1146/annurev.arplant.56.032604.144218; Naqvi SMS, 1998, PLANT MOL BIOL, V37, P571, DOI 10.1023/A:1006031316476; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; OHTA M, 1995, PLANT MOL BIOL, V27, P529, DOI 10.1007/BF00019319; Okuda J, 2005, BIOCHEM BIOPH RES CO, V333, P531, DOI 10.1016/j.bbrc.2005.05.145; Petnicki-Ocwieja T, 2002, P NATL ACAD SCI USA, V99, P7652, DOI 10.1073/pnas.112183899; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Staiger D, 2003, PLANT J, V33, P361, DOI 10.1046/j.1365-313X.2003.01629.x; Sun JJ, 2003, J BIOL CHEM, V278, P32794, DOI 10.1074/jbc.M304290200; VANNOCKER S, 1993, PLANT MOL BIOL, V21, P695, DOI 10.1007/BF00014552; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; Yates SP, 2006, TRENDS BIOCHEM SCI, V31, P123, DOI 10.1016/j.tibs.2005.12.007	42	272	290	3	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2007	447	7142					284	U1		10.1038/nature05737	http://dx.doi.org/10.1038/nature05737			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17450127				2022-12-01	WOS:000246520300037
J	Godinho, SIH; Maywood, ES; Shaw, L; Tucci, V; Barnard, AR; Busino, L; Pagano, M; Kendall, R; Quwailid, MM; Romero, MR; O'Neill, J; Chesham, JE; Brooker, D; Lalanne, Z; Hastings, MH; Nolan, PM				Godinho, Sofia I. H.; Maywood, Elizabeth S.; Shaw, Linda; Tucci, Valter; Barnard, Alun R.; Busino, Luca; Pagano, Michele; Kendall, Rachel; Quwailid, Mohamed M.; Romero, M. Rosario; O'Neill, John; Chesham, Johanna E.; Brooker, Debra; Lalanne, Zuzanna; Hastings, Michael H.; Nolan, Patrick M.			The after-hours mutant reveals a role for Fbxl3 in determining mammalian circadian period	SCIENCE			English	Article							DEGRADATION; RHYTHM; CLOCK; FAMILY; GENE	By screening N-ethyl-N-nitrosourea-mutagenized animals for alterations in rhythms of wheel-running activity, we identified a mouse mutation, after hours (Afh). The mutation, a Cys(358)Ser substitution in Fbxl3, an F-box protein with leucine-rich repeats, results in long free-running rhythms of about 27 hours in homozygotes. Circadian transcriptional and translational oscillations are attenuated in Afh mice. The Afh allele significantly affected Per2 expression and delayed the rate of Cry protein degradation in Per2:: Luciferase tissue slices. Our in vivo and in vitro studies reveal a central role for Fbxl3 in mammalian circadian timekeeping.	MRC, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England; MRC, Mol Biol Lab, Div Neurobiol, Cambridge CB2 2QH, England; NYU, Dept Pathol, Inst Canc, Sch Med, New York, NY 10016 USA	MRC Harwell; MRC Laboratory Molecular Biology; New York University	Nolan, PM (corresponding author), MRC, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England.	p.nolan@har.mrc.ac.uk	Nolan, Patrick/W-3918-2019	Nolan, Patrick/0000-0001-5550-0334; pagano, michele/0000-0003-3210-2442; O'Neill, John Stuart/0000-0003-2204-6096; Tucci, Valter/0000-0002-3796-3826; Hastings, Michael Harvey/0000-0001-8576-6651	MRC [MC_UP_1502/1, MC_U142684175, MC_U105170643, MC_U142684173, MC_U142684172] Funding Source: UKRI; Medical Research Council [MC_U142684173, MC_UP_1502/1, MC_U142684172, MC_U105170643, MC_U142684175] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bacon Y, 2004, GENES BRAIN BEHAV, V3, P196, DOI 10.1111/j.1601-183X.2004.00070.x; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; LopezMolina L, 1997, EMBO J, V16, P6762, DOI 10.1093/emboj/16.22.6762; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Mas P, 2003, NATURE, V426, P567, DOI 10.1038/nature02163; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	20	353	365	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2007	316	5826					897	900		10.1126/science.1141138	http://dx.doi.org/10.1126/science.1141138			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17463252				2022-12-01	WOS:000246369800040
J	Waite, JH; Young, DT; Cravens, TE; Coates, AJ; Crary, FJ; Magee, B; Westlake, J				Waite, J. H., Jr.; Young, D. T.; Cravens, T. E.; Coates, A. J.; Crary, F. J.; Magee, B.; Westlake, J.			The process of tholin formation in Titan's upper atmosphere	SCIENCE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; SOOT FORMATION; CHEMISTRY; BENZENE; PHOTOCHEMISTRY; MOLECULES; METHANE; IONS	Titan's lower atmosphere has long been known to harbor organic aerosols (tholins) presumed to have been formed from simple molecules, such as methane and nitrogen (CH4 and N-2). Up to now, it has been assumed that tholins were formed at altitudes of several hundred kilometers by processes as yet unobserved. Using measurements from a combination of mass/charge and energy/ charge spectrometers on the Cassini spacecraft, we have obtained evidence for tholin formation at high altitudes (similar to 1000 kilometers) in Titan's atmosphere. The observed chemical mix strongly implies a series of chemical reactions and physical processes that lead from simple molecules (CH4 and N-2) to larger, more complex molecules ( 80 to 350 daltons) to negatively charged massive molecules (similar to 8000 daltons), which we identify as tholins. That the process involves massive negatively charged molecules and aerosols is completely unexpected.	SW Res Inst, Space Sci & Engn Div, San Antonio, TX 78238 USA; Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA; UCL, Mullard Space Sci Lab, Dept Space & Climate Phys, Dorking RH5 6NT, Surrey, England; Univ Texas, Dept Phys & Astron, San Antonio, TX 78249 USA	Southwest Research Institute; University of Kansas; University of London; University College London; University of Texas System	Waite, JH (corresponding author), SW Res Inst, Space Sci & Engn Div, 6220 Culebra Rd, San Antonio, TX 78238 USA.	hwaite@swri.edu; bmagee@swri.edu	Coates, Andrew/C-2396-2008; Westlake, Joseph/G-2732-2015; Westlake, Joseph/AAZ-9404-2020	Coates, Andrew/0000-0002-6185-3125; Westlake, Joseph/0000-0003-0472-8640; Westlake, Joseph/0000-0003-0472-8640	Science and Technology Facilities Council [PP/E001173/1] Funding Source: researchfish; UK Space Agency [PP/D00084X/1] Funding Source: researchfish; STFC [PP/E001173/1] Funding Source: UKRI	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Anicich V.G., 2003, JPL PUBLICATION; Anicich VG, 2006, J AM SOC MASS SPECTR, V17, P544, DOI 10.1016/j.jasms.2005.11.022; Anicich VG, 1997, PLANET SPACE SCI, V45, P897, DOI 10.1016/S0032-0633(97)00053-6; BOHME DK, 1992, CHEM REV, V92, P1487, DOI 10.1021/cr00015a002; CALCOTE HF, 1990, PURE APPL CHEM, V62, P815, DOI 10.1351/pac199062050815; Clarke MC, 2006, SCHIZOPHRENIA BULL, V32, P3, DOI 10.1093/schbul/sbj028; COATES AJ, 2006, EOS T AM GEOPHYS U S, V87, P52; COUSTENIS A, IN PRESS ICARUS; Cravens TE, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023249; CROVISIER J, 1994, J GEOPHYS RES-PLANET, V99, P3777, DOI 10.1029/93JE02088; CRUICKSHANK DP, IN PRESS ICARUS; DELAHAYE V, 2005, THESIS U MICHIGAN AN; Frenklach M, 2002, PHYS CHEM CHEM PHYS, V4, P2028, DOI 10.1039/b110045a; Friedson AJ, 2002, ICARUS, V158, P389, DOI 10.1006/icar.2002.6885; GOETZ CK, 1989, REV GEOPHYS, V27, P271; Kivelson M.G., 1995, INTRO SPACE PHYS; LIANG MC, 2006, 38 ANN M DIV PLAN SC; Linstrom P. J., 2020, NIST STANDARD REFERE; McKay CP, 2001, PLANET SPACE SCI, V49, P79, DOI 10.1016/S0032-0633(00)00051-9; McLain JL, 2004, J PHYS CHEM A, V108, P6704, DOI [10.1021/jp040215l, 10.1021/jp0402151]; Moses JI, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002411; Moustefaoui T, 1998, FARADAY DISCUSS, V109, P71, DOI 10.1039/a800490k; NAKASHIMA N, 1983, J CHEM PHYS, V79, P2727, DOI 10.1063/1.446176; Niemann HB, 2005, NATURE, V438, P779, DOI 10.1038/nature04122; Pavlov AA, 2003, GEOLOGY, V31, P87, DOI 10.1130/0091-7613(2003)031<0087:MRPA>2.0.CO;2; Richter H, 2000, PROG ENERG COMBUST, V26, P565, DOI 10.1016/S0360-1285(00)00009-5; SAGAN C, 1979, NATURE, V277, P102, DOI 10.1038/277102a0; SHINDO K, 1966, J CHEM PHYS, V45, P2292, DOI 10.1063/1.1727923; Tokmakov IV, 1999, J PHYS CHEM A, V103, P3636, DOI 10.1021/jp983140s; Vuitton V, 2006, ASTROPHYS J, V647, pL175, DOI 10.1086/507467; Waite JH, 2005, SCIENCE, V308, P982, DOI 10.1126/science.1110652; Wilson EH, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001896; YELLE RV, 2006, ICARUS, V72, P468; YOKOYAMA A, 1990, J CHEM PHYS, V92, P4222, DOI 10.1063/1.457780; Young DT, 2004, SPACE SCI REV, V114, P1, DOI 10.1007/s11214-004-1406-4; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963; Zhang XH, 2006, CHEM COMMUN, P758, DOI 10.1039/b515843e	37	484	487	1	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2007	316	5826					870	875		10.1126/science.1139727	http://dx.doi.org/10.1126/science.1139727			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17495166				2022-12-01	WOS:000246369800032
J	Fischer, A; Sananbenesi, F; Wang, XY; Dobbin, M; Tsai, LH				Fischer, Andre; Sananbenesi, Farahnaz; Wang, Xinyu; Dobbin, Matthew; Tsai, Li-Huei			Recovery of learning and memory is associated with chromatin remodelling	NATURE			English	Article							ENVIRONMENTAL ENRICHMENT; MOUSE MODEL; PLASTICITY; ACETYLATION; EXPRESSION; DISEASE; ROLES; CDK5; MICE; P25	Neurodegenerative diseases of the central nervous system are often associated with impaired learning and memory, eventually leading to dementia. An important aspect in pre-clinical research is the exploration of strategies to re-establish learning ability and access to long-term memories. By using a mouse model that allows temporally and spatially restricted induction of neuronal loss, we show here that environmental enrichment reinstated learning behaviour and re-established access to long-term memories after significant brain atrophy and neuronal loss had already occurred. Environmental enrichment correlated with chromatin modifications ( increased histone-tail acetylation). Moreover, increased histone acetylation by inhibitors of histone deacetylases induced sprouting of dendrites, an increased number of synapses, and reinstated learning behaviour and access to long-term memories. These data suggest that inhibition of histone deacetylases might be a suitable therapeutic avenue for neurodegenerative diseases associated with learning and memory impairment, and raises the possibility of recovery of long-term memories in patients with dementia.	MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Howard Hughes Med Inst, Cambridge, MA 02139 USA; Riken MIT Neurosci Res Ctr, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Howard Hughes Medical Institute; RIKEN	Tsai, LH (corresponding author), MIT, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Vassar St,Bldg 46, Cambridge, MA 02139 USA.	andre.fischer@mpi-mail.mpg.de; lhtsai@mit.edu	Fischer, Andre/AAU-7487-2021	Fischer, Andre/0000-0001-8546-1161				Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Bradshaw J, 2004, J NEUROL NEUROSUR PS, V75, P382, DOI 10.1136/jnnp.2002.002576; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Cruz JC, 2004, CURR OPIN NEUROBIOL, V14, P390, DOI 10.1016/j.conb.2004.05.002; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Fischer A, 2002, J NEUROSCI, V22, P3700; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; HORN D, 1993, NEURAL COMPUT, V5, P736, DOI 10.1162/neco.1993.5.5.736; Horn D, 1996, NEURAL COMPUT, V8, P1227, DOI 10.1162/neco.1996.8.6.1227; Iacomino G, 2001, BIOCHEM BIOPH RES CO, V285, P1280, DOI 10.1006/bbrc.2001.5323; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; LI RW, 2006, BMC GENOMICS, V14, P1; Need AC, 2003, GENES BRAIN BEHAV, V2, P132, DOI 10.1034/j.1601-183X.2003.00020.x; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; Ruppin E, 1996, SCHIZOPHRENIA BULL, V22, P105, DOI 10.1093/schbul/22.1.105; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; SCOVILLE WB, 1957, NEUROPSYCHIATRY CLIN, V1, P103; Tabuchi Y, 2006, FEBS LETT, V580, P3035, DOI 10.1016/j.febslet.2006.04.048; Tang YP, 2001, NEUROPHARMACOLOGY, V41, P779, DOI 10.1016/S0028-3908(01)00122-8; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166	29	871	955	2	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2007	447	7141					178	U2		10.1038/nature05772	http://dx.doi.org/10.1038/nature05772			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17468743				2022-12-01	WOS:000246338700036
J	Giordano, TP; Henderson, L; Landgren, O; Chiao, EY; Kramer, JR; El-Serag, H; Engels, EA				Giordano, Thomas P.; Henderson, Louise; Landgren, Ola; Chiao, Elizabeth Y.; Kramer, Jennifer R.; El-Serag, Hashem; Engels, Eric A.			Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADMINISTRATION MEDICAL SYSTEM; THYROID-CANCER; UNITED-STATES; WALDENSTROM MACROGLOBULINEMIA; MONOCLONAL GAMMOPATHY; INFECTION; PREVALENCE; CRYOGLOBULINEMIA; ASCERTAINMENT; REGRESSION	Context Hepatitis C virus (HCV) infection causes liver cancer and cirrhosis and may also increase the risk of other tumors, particularly hematopoietic malignancies and thyroid cancer. Previous studies have been too small to adequately assess these risks. Objective To test the hypothesis that HCV infection is associated with increased risk for hematological malignancies, related lymphoproliferative disorders, and thyroid cancer. Design, Setting, and Patients A retrospective cohort study of users of US Veterans Affairs health care facilities from 1997-2004, which included 146 394 patients infected with HCV who had at least 2 visits with a diagnostic code for HCV infection, and 572 293 patients uninfected with HCV. To assemble the HCV-uninfected cohort, we randomly selected up to 4 patients per patient infected with HCV from all veterans who matched on age, sex, and baseline visit date and type (inpatient or outpatient). Individuals with human immunodeficiency virus were excluded. Main Outcome Measures Risks of hematopoietic malignancies, related lymphoproliferative precursor diseases, and thyroid cancer, adjusting for selection factors, race, era of military service, and use of medical services. Results The mean (SD) age of the patients was 52 (8) years, and 97% were men. Risks for non-Hodgkin lymphoma (n = 1359), Waldenstrom macroglobulinemia (n = 165), and cryoglobulinemia (n = 551) were increased with HCV infection (adjusted hazard ratio [ HR], 1.28; 95% confidence interval [ CI], 1.12-1.45; adjusted HR, 2.76; 95% CI, 2.01-3.79; and adjusted HR, 3.98; 95% CI, 3.36-4.72; respectively). We found no significantly increased risk for other hematological malignancies. Although thyroiditis risk was slightly increased, risk for thyroid cancer (n = 320) was not (adjusted HR, 0.72; 95% CI, 0.52-0.99). Adjusted P values for non-Hodgkin lymphoma, Waldenstrom macroglobulinemia, cryoglobulinemia, and thyroiditis were all < .0038, the Bonferroni threshold for statistical significance considering multiple comparisons. Conclusions Hepatitis C virus infection confers a 20% to 30% increased risk of non-Hodgkin lymphoma overall, and a 3-fold higher risk of Waldenstrom macroglobulinemia, a low-grade lymphoma. Risks were also increased for cryoglobulinemia. These results support an etiological role for HCV in causing lymphoproliferation and causing non-Hodgkin lymphoma.	Michael E DeBakey Vet Affairs Med Ctr, Houston Ctr Qual Care & Utilizat Studies, Hlth Serv Res & Dev Serv, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; NCI, NIH, Rockville, MD USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Giordano, TP (corresponding author), Michael E DeBakey Vet Affairs Med Ctr, Houston Ctr Qual Care & Utilizat Studies, Hlth Serv Res & Dev Serv, VA152,2002 Holcombe Blvd, Houston, TX 77030 USA.	tpg@bcm.tmc.edu		Giordano, Thomas/0000-0002-9346-5530; Chiao, Elizabeth/0000-0001-5752-2916	NATIONAL CANCER INSTITUTE [K23CA124318, Z01CP010176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH067505] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [K23CA124318] Funding Source: Medline; NIMH NIH HHS [K23MH67505] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AGNELLO V, 1992, NEW ENGL J MED, V327, P1490, DOI 10.1056/NEJM199211193272104; Amin J, 2006, J HEPATOL, V45, P197, DOI 10.1016/j.jhep.2006.02.014; Antonelli A, 1999, JAMA-J AM MED ASSOC, V281, P1588, DOI 10.1001/jama.281.17.1588; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Bini EJ, 2004, ARCH INTERN MED, V164, P2371, DOI 10.1001/archinte.164.21.2371; Dal Maso L, 2006, CANCER EPIDEM BIOMAR, V15, P2078, DOI 10.1158/1055-9965.EPI-06-0308; Dominitz JA, 2005, HEPATOLOGY, V41, P88, DOI 10.1002/hep.20502; Duberg AS, 2005, HEPATOLOGY, V41, P652, DOI 10.1002/hep.20608; El-Serag HB, 2002, HEPATOLOGY, V36, P1439, DOI 10.1053/jhep.2002.37191; Engels EA, 2004, INT J CANCER, V111, P76, DOI 10.1002/ijc.20021; FISHER SG, 1995, AM J EPIDEMIOL, V141, P242, DOI 10.1093/oxfordjournals.aje.a117426; Fujino Y, 2004, INT J CANCER, V112, P722, DOI 10.1002/ijc.20440; HARRIS RE, 1989, CANCER-AM CANCER SOC, V64, P1160, DOI 10.1002/1097-0142(19890901)64:5<1160::AID-CNCR2820640533>3.0.CO;2-B; Hermine O, 2002, NEW ENGL J MED, V347, P89, DOI 10.1056/NEJMoa013376; HOLM LE, 1985, NEW ENGL J MED, V312, P601, DOI 10.1056/NEJM198503073121001; Huang MJ, 1999, CLIN ENDOCRINOL, V50, P503, DOI 10.1046/j.1365-2265.1999.00686.x; Izumi T, 1996, AM J HEMATOL, V52, P238, DOI 10.1002/(SICI)1096-8652(199607)52:3<238::AID-AJH25>3.0.CO;2-A; Kyle RA, 2006, NEW ENGL J MED, V354, P1362, DOI 10.1056/NEJMoa054494; Machida K, 2005, J VIROL, V79, P8079, DOI 10.1128/JVI.79.13.8079-8089.2005; Mazzaro C, 1996, CANCER, V77, P2604, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2604::AID-CNCR26>3.0.CO;2-V; Montella M, 2000, INT J CANCER, V87, P611, DOI 10.1002/1097-0215(20000815)87:4&lt;611::AID-IJC24&gt;3.0.CO;2-N; NAMBOODIRI KK, 1991, CANCER-AM CANCER SOC, V68, P1123, DOI 10.1002/1097-0142(19910901)68:5<1123::AID-CNCR2820680540>3.0.CO;2-L; Negri E, 2004, INT J CANCER, V111, P1, DOI 10.1002/ijc.20205; Page WF, 1996, ANN EPIDEMIOL, V6, P102, DOI 10.1016/1047-2797(95)00126-3; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; SANTINI GF, 1993, BLOOD, V82, P2932; Veneri D, 2004, AM J HEMATOL, V77, P421, DOI 10.1002/ajh.20219	27	243	254	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2007	297	18					2010	2017		10.1001/jama.297.18.2010	http://dx.doi.org/10.1001/jama.297.18.2010			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165JM	17488966	Bronze			2022-12-01	WOS:000246301800023
J	Hemelaar, J				Hemelaar, Joris			Minimising risk in first-in-man trials	LANCET			English	Editorial Material							TGN1412		Univ Oxford Magdalen Coll, Oxford OX1 4AU, England	University of Oxford	Hemelaar, J (corresponding author), Univ Oxford Magdalen Coll, Oxford OX1 4AU, England.	joris.hemelaar@trinity.oxon.org		Hemelaar, Joris/0000-0003-3523-7457				Beyersdorf N, 2006, AUTOIMMUN REV, V5, P40, DOI 10.1016/j.autrev.2005.06.001; Department of Health, 2006, EXP SCI GROUP PHAS O; European Medicines Agency, 2007, GUID REQ 1 MAN CLIN; Kenter MJH, 2006, LANCET, V368, P1387, DOI 10.1016/S0140-6736(06)69562-7; Medicines and Healthcare Products Regulatory Agency, 2006, INV ADV INC CLIN TRI; Royal Statistical Society, 2007, REP WORK PART STAT I; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842	7	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2007	369	9572					1496	1497		10.1016/S0140-6736(07)60686-2	http://dx.doi.org/10.1016/S0140-6736(07)60686-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164EI	17482966				2022-12-01	WOS:000246215800006
J	Belenky, P; Racette, FG; Bogan, KL; McClure, JM; Smith, JS; Brenner, C				Belenky, Peter; Racette, Frances G.; Bogan, Katrina L.; McClure, Julie M.; Smith, Jeffrey S.; Brenner, Charles			Nicotinamide riboside promotes Sir2 silencing and extends lifespan via Nrk and Urh1/Pnp1/Meu1 pathways to NAD(+)	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; NUCLEOSIDE HYDROLASE; AXONAL DEGENERATION; N-RIBOHYDROLASE; PROTEIN SIR2; GENE; PHOSPHORYLASE; LONGEVITY; EXPRESSION	Although NAD(+) biosynthesis is required for Sir2 functions and replicative lifespan in yeast, alterations in NAD(+) precursors have been reported to accelerate aging but not to extend lifespan. In eukaryotes, nicotinamide riboside is a newly discovered NAD(+) precursor that is converted to nicotinamide mononucleotide by specific nicotinamide riboside kinases, Nrk1 and Nrk2. In this study, we discovered that exogenous nicotinamide riboside promotes Sir2-dependent repression of recombination, improves gene silencing, and extends lifespan without calorie restriction. The mechanism of action of nicotinamide riboside is totally dependent on increased net NAD+ synthesis through two pathways, the Nrk1 pathway and the Urh1/ Pnp1/Meu1 pathway, which is Nrk1 independent. Additionally, the two nicotinamide riboside salvage pathways contribute to NAD(+) metabolism in the absence of nicotinamide-riboside supplementation. Thus, like calorie restriction in the mouse, nicotinamide riboside elevates NAD(+) and increases Sir2 function.	Dartmouth Med Sch, Dept Biochem & Genet, Lebanon, NH 03756 USA; Dartmouth Med Sch, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA; Univ Virginia, Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; University of Virginia	Smith, JS (corresponding author), Dartmouth Med Sch, Dept Biochem & Genet, Rubin 733-HB7937, Lebanon, NH 03756 USA.	jss5y@virginia.edu; charles.brenner@dartmouth.edu	Brenner, Charles/D-6339-2014	Brenner, Charles/0000-0002-4955-3226; Belenky, Peter/0000-0002-1682-945X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075240, T32GM008136] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM75240, T32 GM008136] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKSOY S, 1994, J BIOL CHEM, V269, P14835; Anderson RM, 2003, SCIENCE, V302, P2124, DOI 10.1126/science.1088697; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Benyo Z, 2005, J CLIN INVEST, V115, P3634, DOI 10.1172/JCI23626; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bieganowski P, 2003, J BIOL CHEM, V278, P33049, DOI 10.1074/jbc.M302257200; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Brachmann CB, 1998, YEAST, V14, P115; Buck SW, 2002, CELL, V111, P1003, DOI 10.1016/S0092-8674(02)01193-5; Burke D., 2000, METHODS YEAST GENETI; Catz P, 2005, J CHROMATOGR B, V829, P123, DOI 10.1016/j.jchromb.2005.10.003; Degano M, 1996, BIOCHEMISTRY-US, V35, P5971, DOI 10.1021/bi952999m; Domergue R, 2005, SCIENCE, V308, P866, DOI 10.1126/science.1108640; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Ghislain M, 2002, YEAST, V19, P215, DOI 10.1002/yea.810; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; GROSSMAN L, 1958, J BIOL CHEM, V231, P717; Guarente L, 2000, GENE DEV, V14, P1021; Harden A, 1906, P R SOC LOND B-CONTA, V77, P405, DOI 10.1098/rspb.1906.0029; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; IMAI T, 1987, ARCH BIOCHEM BIOPHYS, V254, P253, DOI 10.1016/0003-9861(87)90101-9; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kaneko S, 2006, J NEUROSCI, V26, P9794, DOI 10.1523/JNEUROSCI.2116-06.2006; KENNEDY BK, 1994, J CELL BIOL, V127, P1985, DOI 10.1083/jcb.127.6.1985; KREHL WA, 1945, SCIENCE, V101, P489, DOI 10.1126/science.101.2628.489; Kurtz JE, 2002, CURR GENET, V41, P132, DOI 10.1007/s00294-002-0296-9; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lecoq K, 2001, J BACTERIOL, V183, P4910, DOI 10.1128/JB.183.16.4910-4913.2001; Lewandowicz A, 2003, J BIOL CHEM, V278, P31465, DOI 10.1074/jbc.C300259200; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SS, 2001, J BIOL CHEM, V276, P36000, DOI 10.1074/jbc.M103509200; MARKERT M L, 1991, Immunodeficiency Reviews, V3, P45; Mitterbauer R, 2002, APPL ENVIRON MICROB, V68, P1336, DOI 10.1128/AEM.68.3.1336-1343.2002; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; ROWEN JW, 1951, J BIOL CHEM, V193, P497; Sandmeier JJ, 2002, GENETICS, V160, P877; Sasaki Y, 2006, J NEUROSCI, V26, P8484, DOI 10.1523/JNEUROSCI.2320-06.2006; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schramm VL, 2002, BBA-MOL BASIS DIS, V1587, P107, DOI 10.1016/S0925-4439(02)00073-X; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shi WX, 1999, J BIOL CHEM, V274, P21114, DOI 10.1074/jbc.274.30.21114; Sinclair DA, 2006, SCI AM, V294, P48, DOI 10.1038/scientificamerican0306-48; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Smith JS, 1999, MOL CELL BIOL, V19, P3184; Subhi AL, 2003, J BIOL CHEM, V278, P49868, DOI 10.1074/jbc.M308451200; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; WICKERHAM LJ, 1946, J BACTERIOL, V52, P293, DOI 10.1128/JB.52.3.293-301.1946; WielgusKutrowska B, 1997, EUR J BIOCHEM, V243, P408, DOI 10.1111/j.1432-1033.1997.0408a.x; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	66	277	292	6	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					473	484		10.1016/j.cell.2007.03.024	http://dx.doi.org/10.1016/j.cell.2007.03.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17482543	Bronze			2022-12-01	WOS:000246373600015
J	Burg, TP; Godin, M; Knudsen, SM; Shen, W; Carlson, G; Foster, JS; Babcock, K; Manalis, SR				Burg, Thomas P.; Godin, Michel; Knudsen, Scott M.; Shen, Wenjiang; Carlson, Greg; Foster, John S.; Babcock, Ken; Manalis, Scott R.			Weighing of biomolecules, single cells and single nanoparticles in fluid	NATURE			English	Article							RESONANT MASS SENSOR; DENSITY SENSOR	Nanomechanical resonators enable the measurement of mass with extraordinary sensitivity(1-7). Previously, samples as light as 7 zeptograms ( 1 zg = 10(-21) g) have been weighed in vacuum, and proton-level resolution seems to be within reach(8). Resolving small mass changes requires the resonator to be light and to ring at a very pure tone - that is, with a high quality factor(9). In solution, viscosity severely degrades both of these characteristics, thus preventing many applications in nanotechnology and the life sciences where fluid is required(10). Although the resonant structure can be designed to minimize viscous loss, resolution is still substantially degraded when compared to measurements made in air or vacuum(11-14). An entirely different approach eliminates viscous damping by placing the solution inside a hollow resonator that is surrounded by vacuum(15,16). Here we demonstrate that suspended microchannel resonators can weigh single nanoparticles, single bacterial cells and sub-monolayers of adsorbed proteins in water with sub-femtogram resolution ( 1 Hz bandwidth). Central to these results is our observation that viscous loss due to the fluid is negligible compared to the intrinsic damping of our silicon crystal resonator. The combination of the low resonator mass ( 100 ng) and high quality factor ( 15,000) enables an improvement in mass resolution of six orders of magnitude over a high-end commercial quartz crystal microbalance(17). This gives access to intriguing applications, such as mass-based flow cytometry, the direct detection of pathogens, or the non-optical sizing and mass density measurement of colloidal particles.	MIT, Dept Biol Engn, Cambridge, MA 02139 USA; MIT, Dept Mech Engn, Cambridge, MA 02139 USA; Innovat Micro Technol, Santa Barbara, CA 93117 USA; Affin Biosensors, Santa Barbara, CA 93117 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Manalis, SR (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	scottm@media.mit.edu		Godin, Michel/0000-0002-9360-0675	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762] Funding Source: NIH RePORTER; NIGMS NIH HHS [P50 GM068762] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal A, 2006, ANAL CHEM, V78, P1061, DOI 10.1021/ac051801t; AKERLUND T, 1995, J BACTERIOL, V177, P6791, DOI 10.1128/jb.177.23.6791-6797.1995; Angenendt P, 2003, J CHROMATOGR A, V1009, P97, DOI 10.1016/S0021-9673(03)00769-6; Backmann N, 2005, P NATL ACAD SCI USA, V102, P14587, DOI 10.1073/pnas.0504917102; Braun T, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031907; Burg TP, 2006, J MICROELECTROMECH S, V15, P1466, DOI 10.1109/JMEMS.2006.883568; Burg TP, 2003, APPL PHYS LETT, V83, P2698, DOI 10.1063/1.1611625; Ekinci KL, 2004, J APPL PHYS, V95, P2682, DOI 10.1063/1.1642738; Enoksson P, 1996, SENSOR ACTUAT A-PHYS, V54, P558, DOI 10.1016/S0924-4247(97)80014-3; Forsen E, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1999838; Gupta A, 2004, APPL PHYS LETT, V84, P1976, DOI 10.1063/1.1667011; Ilic B, 2004, J APPL PHYS, V95, P3694, DOI 10.1063/1.1650542; Lange D, 2002, ANAL CHEM, V74, P3084, DOI 10.1021/ac011269j; Lavrik NV, 2003, APPL PHYS LETT, V82, P2697, DOI 10.1063/1.1569050; Lucklum R, 2006, ANAL BIOANAL CHEM, V384, P667, DOI 10.1007/s00216-005-0236-x; Myszka DG, 2004, ANAL BIOCHEM, V329, P316, DOI 10.1016/j.ab.2004.03.028; Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755; Ono T, 2003, REV SCI INSTRUM, V74, P1240, DOI 10.1063/1.1536262; Pang W, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2213975; *Q SENS, MOD D3000 SPEC; Sarid D., 1994, SCANNING FORCE MICRO; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; THUNDAT T, 1995, APPL PHYS LETT, V66, P1695, DOI 10.1063/1.113896; Weinberg MS, 2003, J MICROELECTROMECH S, V12, P567, DOI 10.1109/JMEMS.2003.818452; Westberg D, 1997, J MICROMECH MICROENG, V7, P253, DOI 10.1088/0960-1317/7/3/047; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Wu GH, 2001, NAT BIOTECHNOL, V19, P856, DOI 10.1038/nbt0901-856; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064; Yang YT, 2006, NANO LETT, V6, P583, DOI 10.1021/nl052134m; Zhang H, 2005, J MICROELECTROMECH S, V14, P699, DOI 10.1109/JMEMS.2005.845405	30	897	941	13	378	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2007	446	7139					1066	1069		10.1038/nature05741	http://dx.doi.org/10.1038/nature05741			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17460669	Green Published			2022-12-01	WOS:000245950400046
J	Gedik, N; Yang, DS; Logvenov, G; Bozovic, I; Zewail, AH				Gedik, Nuh; Yang, Ding-Shyue; Logvenov, Gennady; Bozovic, Ivan; Zewail, Ahmed H.			Nonequilibrium phase transitions in cuprates observed by ultrafast electron crystallography	SCIENCE			English	Article							SINGLE-CRYSTAL; DIFFRACTION; MICROSCOPY; CHEMISTRY; ENERGY; OXIDES; STATE	Nonequilibrium phase transitions, which are defined by the formation of macroscopic transient domains, are optically dark and cannot be observed through conventional temperature- or pressure-change studies. We have directly determined the structural dynamics of such a nonequilibrium phase transition in a cuprate superconductor. Ultrafast electron crystallography with the use of a tilted optical geometry technique afforded the necessary atomic-scale spatial and temporal resolutions. The observed transient behavior displays a notable "structural isosbestic" point and a threshold effect for the dependence of c-axis expansion (Delta c) on fluence ( F), with Delta c/F = 0.02 angstrom/(millijoule per square centimeter). This threshold for photon doping occurs at similar to 0.12 photons per copper site, which is unexpectedly close to the density ( per site) of chemically doped carriers needed to induce superconductivity.	CALTECH, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA; Brookhaven Natl Lab, Upton, NY 11973 USA	California Institute of Technology; United States Department of Energy (DOE); Brookhaven National Laboratory	Zewail, AH (corresponding author), CALTECH, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA.	zewail@caltech.edu	Yang, Ding-Shyue/A-8648-2010	Yang, Ding-Shyue/0000-0003-2713-9128; gaber, sarah/0000-0002-5995-7291				Bargheer M, 2006, CHEMPHYSCHEM, V7, P783, DOI 10.1002/cphc.200500591; Basov DN, 2005, REV MOD PHYS, V77, P721, DOI 10.1103/RevModPhys.77.721; Baum P, 2006, P NATL ACAD SCI USA, V103, P16105, DOI 10.1073/pnas.0607451103; BLOEMBERGEN N, 1994, AIP CONF P, V288, P3; Bozovic I, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.132503; Bozovic I, 2001, IEEE T APPL SUPERCON, V11, P2686, DOI 10.1109/77.919617; Bressler C, 2004, CHEM REV, V104, P1781, DOI 10.1021/cr0206667; Cavalleri A, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.011004; Collet E, 2003, SCIENCE, V300, P612, DOI 10.1126/science.1082001; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Grinolds MS, 2006, P NATL ACAD SCI USA, V103, P18427, DOI 10.1073/pnas.0609233103; KUMAGAI K, 1988, PHYS REV LETT, V60, P724, DOI 10.1103/PhysRevLett.60.724; MARCUS RA, 1993, ANGEW CHEM INT EDIT, V32, P1111, DOI 10.1002/anie.199311113; McMillan PF, 2005, PHILOS T R SOC A, V363, P311, DOI 10.1098/rsta.2004.1512; MOKHTARI A, 1990, NATURE, V348, P225, DOI 10.1038/348225a0; Moller KB, 1998, CHEM PHYS LETT, V295, P1, DOI 10.1016/S0009-2614(98)00927-0; Pergament A, 2006, J PHYS A-MATH GEN, V39, P4619, DOI 10.1088/0305-4470/39/17/S48; Perkins JD, 1998, PHYS REV B, V58, P9390, DOI 10.1103/PhysRevB.58.9390; PIVETEAU B, 1991, PHYS REV B, V43, P493, DOI 10.1103/PhysRevB.43.493; RAMDAS S, 1980, NATURE, V284, P153, DOI 10.1038/284153a0; Rousse A, 2001, REV MOD PHYS, V73, P17, DOI 10.1103/RevModPhys.73.17; Ruan CY, 2004, SCIENCE, V304, P80, DOI 10.1126/science.1094818; Siwick BJ, 2003, SCIENCE, V302, P1382, DOI 10.1126/science.1090052; SUZUKI M, 1989, PHYS REV B, V39, P2312, DOI 10.1103/PhysRevB.39.2312; Thomas JM, 2005, ANGEW CHEM INT EDIT, V44, P5563, DOI 10.1002/anie.200501466; THOMAS JM, 1974, PHILOS T R SOC A, V277, P251, DOI 10.1098/rsta.1974.0051; vonderLinde D, 1997, APPL SURF SCI, V109, P1, DOI 10.1016/S0169-4332(96)00611-3; WANG ZL, 1996, REFLECTION ELECT MIC; WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447; Yang DS, 2007, J PHYS CHEM C, V111, P4889, DOI 10.1021/jp067466+; Yonemitsu K, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.011008; Yu JD, 1996, PHYS REV B, V54, P7455, DOI 10.1103/PhysRevB.54.7455; Zewail AH, 2006, ANNU REV PHYS CHEM, V57, P65, DOI 10.1146/annurev.physchem.57.032905.104748; ZOU X, 2006, ELECT CRYSTALLOGRAPH; [No title captured]	35	187	188	0	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2007	316	5823					425	429		10.1126/science.1138834	http://dx.doi.org/10.1126/science.1138834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446397				2022-12-01	WOS:000245813400050
J	Fuyuno, I				Fuyuno, Ichiko			Plastic promises	NATURE			English	News Item																			0	3	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2007	446	7137					715	715		10.1038/446715a	http://dx.doi.org/10.1038/446715a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17429369	Bronze			2022-12-01	WOS:000245626800010
J	Smith, KL; Robison, BH; Helly, JJ; Kaufmann, RS; Ruhl, HA; Shaw, TJ; Twining, BS; Vernet, M				Smith, Kenneth L., Jr.; Robison, Bruce H.; Helly, John J.; Kaufmann, Ronald S.; Ruhl, Henry A.; Shaw, Timothy J.; Twining, Benjamin S.; Vernet, Maria			Free-drifting icebergs: Hot spots of chemical and biological enrichment in the Weddell Sea	SCIENCE			English	Article							SOUTHERN-OCEAN; ANTARCTIC PENINSULA; MARINE MAMMALS; CLIMATE-CHANGE; IRON; ICE; PHYTOPLANKTON; DISSOLUTION; OXIDE	The proliferation of icebergs from Antarctica over the past decade has raised questions about their potential impact on the surrounding pelagic ecosystem. Two free-drifting icebergs, 0.1 and 30.8 square kilometers in aerial surface area, and the surrounding waters were sampled in the northwest Weddell Sea during austral spring 2005. There was substantial enrichment of terrigenous material, and there were high concentrations of chlorophyll, krill, and seabirds surrounding each iceberg, extending out to a radial distance of similar to 3.7 kilometers. Extrapolating these results to all icebergs in the same size range, with the use of iceberg population estimates from satellite surveys, indicates that they similarly affect 39% of the surface ocean in this region. These results suggest that free-drifting icebergs can substantially affect the pelagic ecosystem of the Southern Ocean and can serve as areas of enhanced production and sequestration of organic carbon to the deep sea.	Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; Univ San Diego, Marine Sci & Environm Studies Dept, San Diego, CA 92110 USA; Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; Univ Calif San Diego, Integrat Oceanog Div, Scripps Inst Oceanog, La Jolla, CA 92093 USA	Monterey Bay Aquarium Research Institute; University of California System; University of California San Diego; University of San Diego; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of California System; University of California San Diego; Scripps Institution of Oceanography	Smith, KL (corresponding author), Monterey Bay Aquarium Res Inst, 7700 Sandholdt Rd, Moss Landing, CA 95039 USA.	ksmith@mbari.org		Twining, Benjamin/0000-0002-1365-9192; Shaw, Timothy/0000-0002-0032-457X				Arrigo K.R., 2002, GEOPHYS RES LETT, V29; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; de Baar H.J.W., 2001, BIOGEO CHEM IRON SEA, P123; DEBAAR HJW, 1995, NATURE, V373, P412, DOI 10.1038/373412a0; FINDEN DAS, 1984, NATURE, V309, P783, DOI 10.1038/309783a0; JOIRIS CR, 1991, POLAR BIOL, V11, P415; Kaufmann RS, 1995, MAR BIOL, V124, P387, DOI 10.1007/BF00363912; Kraemer SM, 2005, REV MINERAL GEOCHEM, V59, P53, DOI 10.2138/rmg.2005.59.4; KRISTENSEN M, 1983, PROG PHYS GEOG, V7, P313, DOI 10.1177/030913338300700301; Loscher BM, 1997, DEEP-SEA RES PT II, V44, P143, DOI 10.1016/S0967-0645(96)00101-4; Marinov I, 2006, NATURE, V441, P964, DOI 10.1038/nature04883; Orheim O, 1988, ANN GLACIOL, V11, P205; Pakhomov EA, 2002, DEEP-SEA RES PT II, V49, P1881, DOI 10.1016/S0967-0645(02)00017-6; RIBIC CA, 1991, ANTARCT SCI, V3, P181, DOI 10.1017/S0954102091000214; RICH HW, 1990, LIMNOL OCEANOGR, V35, P652, DOI 10.4319/lo.1990.35.3.0652; Rignot E, 2002, SCIENCE, V296, P2020, DOI 10.1126/science.1070942; Scambos TA, 2000, J GLACIOL, V46, P516, DOI 10.3189/172756500781833043; SMITH WO, 1985, SCIENCE, V227, P163, DOI 10.1126/science.227.4683.163; STONE G, 2001, NAT GEOG MAG     DEC, P36; Sugihara G, 2003, P NATL ACAD SCI USA, V100, P5246, DOI 10.1073/pnas.0831096100; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; Thomas R, 2004, SCIENCE, V306, P255, DOI 10.1126/science.1099650; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; Vaughan DG, 2001, SCIENCE, V293, P1777, DOI 10.1126/science.1065116; Velicogna I, 2006, SCIENCE, V311, P1754, DOI 10.1126/science.1123785; WAITE TD, 1984, J COLLOID INTERF SCI, V102, P121, DOI 10.1016/0021-9797(84)90206-6; WELLS ML, 1983, J MAR RES, V41, P731, DOI 10.1357/002224083788520478; Williams RN, 1999, INT J REMOTE SENS, V20, P3183, DOI 10.1080/014311699211697; [No title captured]	31	185	191	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2007	317	5837					478	482		10.1126/science.1142834	http://dx.doi.org/10.1126/science.1142834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17588896				2022-12-01	WOS:000248339800035
J	Lewis, MH; Gohagan, JK; Merenstein, DJ				Huckaby Lewis, Michelle; Gohagan, John K.; Merenstein, Daniel J.			The locality rule and the physician's dilemma - Local medical practices vs the national standard of care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Johns Hopkins Berman Inst Bioeth, Greenwall Fellowship Program Bioeth & Hlth Policy, Baltimore, MD 21201 USA; Johns Hopkins Sch Med, Robert Wood Johnson Clin Scholars Program, Baltimore, MD USA; Georgetown Univ, Dept Family Med, Washington, DC USA; NCI, Div Canc Prevent, US Natl Inst Hlth, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Georgetown University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lewis, MH (corresponding author), Johns Hopkins Berman Inst Bioeth, Greenwall Fellowship Program Bioeth & Hlth Policy, 100 N Charles St,Suite 740, Baltimore, MD 21201 USA.	michellelewismd@yahoo.com						CRAMM T, 2002, WAKE FOREST LAW REV, V37, P699; Eddy DM, 2001, J HEALTH POLIT POLIC, V26, P387, DOI 10.1215/03616878-26-2-387; Garner Bryan A, 2021, BLACKS LAW DICT; GROSS SR, 1991, WISC LAW REV, P1113; Merenstein D, 2004, JAMA-J AM MED ASSOC, V291, P15, DOI 10.1001/jama.291.1.15; Peters Jr. Philip G., 2000, WASHINGTON LEE LAW R, V57, P163; Peters PG, 2002, IOWA LAW REV, V87, P909; SWARTZ LC, 2005, 3698 PBI; WALTZ JR, 1969, DEPAUL L REV, V18, P408; WENNBERG JE, 1987, LANCET, V1, P1185, DOI 10.1016/s0140-6736(87)92152-0	10	33	33	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2007	297	23					2633	2637		10.1001/jama.297.23.2633	http://dx.doi.org/10.1001/jama.297.23.2633			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180HB	17579232				2022-12-01	WOS:000247352600027
J	Weitzel, JN; Lagos, VI; Cullinane, CA; Gambol, PJ; Culver, JO; Blazer, KR; Palomares, MR; Lowstuter, KJ; MacDonald, DJ				Weitzel, Jeffrey N.; Lagos, Veronica I.; Cullinane, Carey A.; Gambol, Patricia J.; Culver, Julie O.; Blazer, Kathleen R.; Palomares, Melanie R.; Lowstuter, Katrina J.; MacDonald, Deborah J.			Limited family structure and BRCA gene mutation status in single cases of breast cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONTRALATERAL PROPHYLACTIC MASTECTOMY; ASHKENAZI JEWISH CARRIERS; OF-CLINICAL-ONCOLOGY; OVARIAN-CANCER; RISK-ASSESSMENT; SCORING SYSTEM; SUSCEPTIBILITY; WOMEN; STATEMENT; HISTORY	Context An autosomal dominant pattern of hereditary breast cancer may be masked by small family size or transmission through males given sex-limited expression. Objective To determine if BRCA gene mutations are more prevalent among single cases of early onset breast cancer in families with limited vs adequate family structure than would be predicted by currently available probability models. Design, Setting, and Participants A total of 1543 women seen at US high-risk clinics for genetic cancer risk assessment and BRCA gene testing were enrolled in a prospective registry study between April 1997 and February 2007. Three hundred six of these women had breast cancer before age 50 years and no first- or second-degree relatives with breast or ovarian cancers. Main Outcome Measure The main outcome measure was whether family structure, assessed from multigenerational pedigrees, predicts BRCA gene mutation status. Limited family structure was defined as fewer than 2 first- or second-degree female relatives surviving beyond age 45 years in either lineage. Family structure effect and mutation probability by the Couch, Myriad, and BRCAPRO models were assessed with stepwise multiple logistic regression. Model sensitivity and specificity were determined and receiver operating characteristic curves were generated. Results Family structure was limited in 153 cases (50%). BRCA gene mutations were detected in 13.7% of participants with limited vs 5.2% with adequate family structure. Family structure was a significant predictor of mutation status ( odds ratio, 2.8; 95% confidence interval, 1.19-6.73; P=.02). Although none of the models performed well, receiver operating characteristic analysis indicated that modification of BRCAPRO output by a corrective probability index accounting for family structure was the most accurate BRCA gene mutation status predictor ( area under the curve, 0.72; 95% confidence interval, 0.63- 0.81; P <. 001) for single cases of breast cancer. Conclusions Family structure can affect the accuracy of mutation probability models. Genetic testing guidelines may need to be more inclusive for single cases of breast cancer when the family structure is limited and probability models need to be recreated using limited family history as an actual variable.	City Hope Natl Med Ctr, Dept Clin Canc Genet, Duarte, CA 91010 USA; City Hope Natl Med Ctr, Dept Gen Oncol Surg, Duarte, CA 91010 USA	City of Hope; City of Hope	Weitzel, JN (corresponding author), City Hope Natl Med Ctr, Dept Clin Canc Genet, 1500 E Duarte Rd, Duarte, CA 91010 USA.	jweitzel@coh.org	Blazer, Kathleen/ABC-8530-2021		NATIONAL CANCER INSTITUTE [R25CA085771] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000043] Funding Source: NIH RePORTER; NCI NIH HHS [R25 CA85771, R25 CA085771] Funding Source: Medline; NCRR NIH HHS [M01 RR00043, M01 RR000043] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		*AM COLL MED GEN, 1999, GEN SUSC BREAST OV C, P1; *AM SOC HUM GEN, 1994, AM J HUM GENET, V55, P22; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2002, BRIT J CANCER, V86, P76, DOI 10.1038/sj.bjc.6600008; Antoniou AC, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1365; Antoniou AC, 2004, BRIT J CANCER, V91, P1580, DOI 10.1038/sj.bjc.6602175; Barcenas CH, 2006, J CLIN ONCOL, V24, P354, DOI 10.1200/JCO.2005.02.2368; Berg AO, 2005, ANN INTERN MED, V143, P355, DOI 10.7326/0003-4819-143-5-200509060-00011; Bruinooge SS, 2003, J CLIN ONCOL, V21, P2397, DOI 10.1200/JCO.2003.03.189; Couch FJ, 1997, NEW ENGL J MED, V336, P1409, DOI 10.1056/NEJM199705153362002; Culver JO, 2005, ANN INTERN MED; Domchek SM, 2003, J CLIN ONCOL, V21, P593, DOI 10.1200/JCO.2003.07.007; Evans DGR, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.031989; Evans DGR, 2004, J MED GENET, V41, P474, DOI 10.1136/jmg.2003.017996; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Frank TS, 2002, J CLIN ONCOL, V20, P1480, DOI 10.1200/JCO.20.6.1480; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Herrinton LJ, 2005, J CLIN ONCOL, V23, P4275, DOI 10.1200/JCO.2005.10.080; James PA, 2006, J CLIN ONCOL, V24, P707, DOI 10.1200/JCO.2005.01.9737; KANDEL MJ, 2006, 42 ANN M AM SOC CLIN; KRIEGE M, 2003, AM SOC CLIN ONC 39 A; McDonnell SK, 2001, J CLIN ONCOL, V19, P3938, DOI 10.1200/JCO.2001.19.19.3938; Metcalfe K, 2004, J CLIN ONCOL, V22, P2328, DOI 10.1200/JCO.2004.04.033; Metcalfe KA, 2005, GYNECOL ONCOL, V96, P222, DOI 10.1016/j.ygyno.2004.09.039; National Comprehensive Cancer Network, 2007, NCCN CLIN PRACT GUID; Offit K, 1996, J CLIN ONCOL, V14, P1730, DOI 10.1200/JCO.1996.14.5.1730; Parmigiani G, 1998, AM J HUM GENET, V62, P145, DOI 10.1086/301670; Peralta EA, 2000, AM J SURG, V180, P439, DOI 10.1016/S0002-9610(00)00505-5; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; Rebbeck TR, 2004, J CLIN ONCOL, V22, P1055, DOI 10.1200/JCO.2004.04.188; Satagopan JM, 2002, CLIN CANCER RES, V8, P3776; Satagopan JM, 2001, CANCER EPIDEM BIOMAR, V10, P467; Schwartz MD, 2004, J CLIN ONCOL, V22, P1823, DOI 10.1200/JCO.2004.04.086; Shih HA, 2002, J CLIN ONCOL, V20, P994, DOI 10.1200/JCO.20.4.994; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; WAMER E, 2004, JAMA-J AM MED ASSOC, V292, P1317; Weitzel JN, 2003, ARCH SURG-CHICAGO, V138, P1323, DOI 10.1001/archsurg.138.12.1323; Weitzel JN, 1999, CANCER, V86, P2483, DOI 10.1002/(SICI)1097-0142(19991201)86:11+<2483::AID-CNCR5>3.0.CO;2-4; Weitzel JN, 2004, BREAST DIS YB Q, V14, P354; Yong MC, 2003, ONCOLOGY-BASEL, V64, P220, DOI 10.1159/000069309	40	139	141	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2007	297	23					2587	2595		10.1001/jama.297.23.2587	http://dx.doi.org/10.1001/jama.297.23.2587			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	180HB	17579227	Bronze			2022-12-01	WOS:000247352600021
J	Chendrimada, TP; Finn, KJ; Ji, XJ; Baillat, D; Gregory, RI; Liebhaber, SA; Pasquinelli, AE; Shiekhattar, R				Chendrimada, Thimmaiah P.; Finn, Kenneth J.; Ji, Xinjun; Baillat, David; Gregory, Richard I.; Liebhaber, Stephen A.; Pasquinelli, Amy E.; Shiekhattar, Ramin			MicroRNA silencing through RISC recruitment of eIF6	NATURE			English	Article							EUKARYOTIC INITIATION FACTOR-6; MESSENGER-RNA DEGRADATION; TRANSLATION INITIATION; CAENORHABDITIS-ELEGANS; C-ELEGANS; LIN-4 RNA; GENE; PROTEIN; BIOGENESIS; ASSOCIATION	MicroRNAs ( miRNAs) are a class of small RNAs that act post-transcriptionally to regulate messenger RNA stability and translation. To elucidate how miRNAs mediate their repressive effects, we performed biochemical and functional assays to identify new factors in the miRNA pathway. Here we show that human RISC ( RNA-induced silencing complex) associates with a multiprotein complex containing MOV10 - which is the homologue of Drosophila translational repressor Armitage and proteins of the 60S ribosome subunit. Notably, this complex contains the anti-association factor eIF6 ( also called ITGB4BP or p27BBP), a ribosome inhibitory protein known to prevent productive assembly of the 80S ribosome. Depletion of eIF6 in human cells specifically abrogates miRNA-mediated regulation of target protein and mRNA levels. Similarly, depletion of eIF6 in Caenorhabditis elegans diminishes lin-4 miRNA-mediated repression of the endogenous LIN-14 and LIN-28 target protein and mRNA levels. These results uncover an evolutionarily conserved function of the ribosome anti-association factor eIF6 in miRNA-mediated post-transcriptional silencing.	Univ Penn, Sch Med, Dept Genet & Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Wistar Inst, Philadelphia, PA 19104 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	University of Pennsylvania; The Wistar Institute; University of Pennsylvania; University of California System; University of California San Diego	Pasquinelli, AE (corresponding author), Ctr Regulacio Genom, Dr Aiguader 88, Barcelona 08003, Spain.	apasquin@ucsd.edu; ramin.shiekhattar@crg.es			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071654] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARASU P, 1991, GENE DEV, V5, P1825, DOI 10.1101/gad.5.10.1825; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Basu U, 2001, MOL CELL BIOL, V21, P1453, DOI 10.1128/MCB.21.5.1453-1462.2001; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Feinbaum R, 1999, DEV BIOL, V210, P87, DOI 10.1006/dbio.1999.9272; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Jackson R.J., 2007, SCI STKE, pre1, DOI DOI 10.1126/STKE.3672007RE1; Ji XJ, 2003, MOL CELL BIOL, V23, P899, DOI 10.1128/MCB.23.3.899-907.2003; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Nelson PT, 2004, RNA, V10, P387, DOI 10.1261/rna.5181104; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; RAYCHAUDHURI P, 1984, J BIOL CHEM, V259, P1930; Reinhard J, 2001, J INSECT BEHAV, V14, P157, DOI 10.1023/A:1007881510237; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; RUSSELL DW, 1979, J BIOL CHEM, V254, P8796; Sanvito F, 1999, J CELL BIOL, V144, P823, DOI 10.1083/jcb.144.5.823; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Si K, 1997, P NATL ACAD SCI USA, V94, P14285, DOI 10.1073/pnas.94.26.14285; Si K, 1999, MOL CELL BIOL, V19, P1416; Strezoska Z, 2000, MOL CELL BIOL, V20, P5516, DOI 10.1128/MCB.20.15.5516-5528.2000; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; VALENZUELA DM, 1982, J BIOL CHEM, V257, P7712; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu LG, 2005, MOL CELL BIOL, V25, P9198, DOI 10.1128/MCB.25.21.9198-9208.2005	36	363	408	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2007	447	7146					823	U1		10.1038/nature05841	http://dx.doi.org/10.1038/nature05841			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17507929				2022-12-01	WOS:000247207500036
J	Spence, D				Spence, Des			Wanted: stress monkeys	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 9	2007	334	7605					1224	1224		10.1136/bmj.39237.429178.59	http://dx.doi.org/10.1136/bmj.39237.429178.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179GF	17556483	Green Published			2022-12-01	WOS:000247277000042
J	Villa, L; Perez, G; Kjaer, S; Lehtinen, M; Paavonen, J; Munoz, N; Sigurdsson, K; Hernandez-Avila, M; Iversen, OE; Thoresen, S; Garcia, P; Majewski, S; Tay, EH; Bosch, FX; Dillner, J; Olsson, SE; Ault, K; Brown, D; Ferris, D; Giuliano, A; Koutsky, L; Kurman, R; Myers, E; Barr, E; Boslego, J; Bryan, J; Esser, M; Hesley, T; Lupinacci, L; Railkar, R; Sings, H; Taddeo, F; Thornton, A				Villa, L.; Perez, G.; Kjaer, S.; Lehtinen, M.; Paavonen, J.; Munoz, N.; Sigurdsson, K.; Hernandez-Avila, M.; Iversen, O. E.; Thoresen, S.; Garcia, P.; Majewski, S.; Tay, E. H.; Bosch, F. X.; Dillner, J.; Olsson, S. E.; Ault, K.; Brown, D.; Ferris, D.; Giuliano, A.; Koutsky, L.; Kurman, R.; Myers, E.; Barr, E.; Boslego, J.; Bryan, J.; Esser, M.; Hesley, T.; Lupinacci, L.; Railkar, R.; Sings, H.; Taddeo, F.; Thornton, A.		Future II Study Grp	Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials	LANCET			English	Article							QUADRIVALENT VACCINE; SUSTAINED EFFICACY; FOLLOW-UP; TYPE-18; ADOLESCENTS; LESIONS; WOMEN	Background Cervical cancer and its obligate precursors, cervical intraepithelial neoplasia grades 2 and 3 (CIN2/3), and adenocarcinona in situ (AIS), are caused by oncogenic human papillomavirus (HPV). In this combined analysis of four clinical trials we assessed the effect of prophylactic HPV vaccination on these diseases. Methods 20 583 women aged 16-26 years were randomised to receive quadrivalent HPV6/11/16/18 vaccine (n=9087), its HPV16 vaccine component (n=1204), or placebo (n=10292). They underwent periodic Papanicolaou testing, with colposcopy or biopsy for detected abnormalities. The primary composite endpoint was the combined incidence of HPV16/18-related CIN2/3, AIS, or cervical cancer. These trials are registered at ClinicalTrials.gov, numbers NCT00365378, NCT00365716, NCT00092521, and NCT00092534. Findings Mean follow-up was 3.0 years (SD 0.66) after first dose. In women negative for HPV16 or HPV18 infection during the vaccination regimen (n=17129, per protocol), vaccine efficacy was 99% for the primary endpoint (95% Cl 93-100), meeting the statistical criterion for success. In an intention-to-treat analysis of all randomised women (including those who were HPV16/18 naive or HPV16/18-infected at day 1), efficacy was 44% (95% Cl 31-55); all but one case in vaccine recipients occurred in women infected with HPV16 or HPV18 before vaccination. In a second intention-to-treat analysis we noted an 18% reduction (95% CI 7-29) in the overall rate of CIN2/3 or AIS due to any HPV type. Interpretation Administration of HPV vaccine to HPV-naive women, and women who are already sexually active, could substantially reduce the incidence of HPV16/18-related cervical precancers and cervical cancer.	Emory Univ, Sch Med, Dept Obstet & Gynecol, Atlanta, GA 30303 USA; Ludwig Inst Canc Res, Dept Virol, Sao Paulo, Brazil; Natl Res Ctr, Grp Saludcoop, Bogota, Colombia; Danish Canc Soc Rigshosp, Inst Canc Epidemiol, Dept Virus Hormones & Canc, Copenhagen, Denmark; Natl Publ Hlth Inst, Dept Oulu, Oulu, Finland; Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; Int Agcy Res Canc, F-69372 Lyon, France; Natl Canc Detent Clin, Reykjavik, Iceland; Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico; Haukeland Hosp, Dept Obstet & Gynecol, N-5021 Bergen, Norway; Univ Bergen, Inst Clin Med, Bergen, Norway; Canc Registry Norway, Montebello, Norway; Univ Peruana Cayetano Heredia, Epidemiol HIV & STD Unit, Lima, Peru; Warsaw Med Univ, Ctr Diagnost & Treatment Sexually Transmitted Dis, Dept Dermatol & Venereol, Warsaw, Poland; KK Womens & Childrens Hosp, Singapore, Singapore; IDIBELL, Inst Catala Oncol, Barcelona, Spain; Lund Univ, Dept Med Microbiol, S-22100 Lund, Sweden; Danderyd Hosp, Karolinska Inst, Stockholm, Sweden; Indiana Univ, Sch Med, Dept Med, Indianapolis, IN USA; Med Coll Georgia, Dept Family Med & Obstet & Gynecol, Augusta, GA 30912 USA; Univ Arizona, Ctr Canc, Tucson, AZ USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Duke Univ, Med Ctr, Dept Obstet & Gynecol, Durham, NC 27710 USA; Merck Res Labs, West Point, PA USA	Emory University; Ludwig Institute for Cancer Research; Danish Cancer Society; Finland National Institute for Health & Welfare; University of Helsinki; World Health Organization; International Agency for Research on Cancer (IARC); Instituto Nacional de Salud Publica; University of Bergen; Haukeland University Hospital; University of Bergen; University of Oslo; Universidad Peruana Cayetano Heredia; Medical University of Warsaw; KK Women's & Children's Hospital; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Lund University; Danderyds Hospital; Karolinska Institutet; Indiana University System; Indiana University-Purdue University Indianapolis; University System of Georgia; Augusta University; University of Arizona; University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Duke University; Merck & Company	Ault, K (corresponding author), Emory Univ, Sch Med, Dept Obstet & Gynecol, 69 Jesse Hill Jr Dr SE, Atlanta, GA 30303 USA.	kevin.ault@emory.edu	JOSÉ, FRANCESC XAVIER BOSCH/J-6339-2012; VILLA, LUISA/AAH-4761-2019	JOSÉ, FRANCESC XAVIER BOSCH/0000-0002-7172-3412; VILLA, LUISA/0000-0003-4074-2335; lehtinen, matti/0000-0002-9481-0535				Block SL, 2006, PEDIATRICS, V118, P2135, DOI 10.1542/peds.2006-0461; Bryan JT, 2006, J MED VIROL, V78, P117, DOI 10.1002/jmv.20512; Castellsague X, 2006, JNCI-J NATL CANCER I, V98, P303, DOI 10.1093/jnci/djj067; Chan ISF, 1998, COMMUN STAT-THEOR M, V27, P1305, DOI 10.1080/03610929808832160; Collins S, 2002, BJOG-INT J OBSTET GY, V109, P96, DOI 10.1111/j.1471-0528.2002.01053.x; Dias D, 2005, CLIN DIAGN LAB IMMUN, V12, P959, DOI 10.1128/CDLI.12.8.959-969.2005; Elbasha EH, 2007, EMERG INFECT DIS, V13, P28, DOI 10.3201/eid1301.060438; FERLAY J, 2002, GLOBOCAN 2002 CANC I; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Joura EA, 2007, LANCET, V369, P1693, DOI 10.1016/S0140-6736(07)60777-6; Kalbfleisch JD., 2002, STAT ANAL FAILURE TI, V2, DOI [10.1002/9781118032985, DOI 10.1016/0197-2456(81)90009-X]; Mao C, 2006, OBSTET GYNECOL, V107, P18, DOI 10.1097/01.AOG.0000192397.41191.fb; Martin DO, 1996, EPIDEMIOLOGY, V7, P29, DOI 10.1097/00001648-199601000-00006; Moscicki AB, 1996, OBSTET GYN CLIN N AM, V23, P675; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Pagliusi SR, 2004, VACCINE, V23, P569, DOI 10.1016/j.vaccine.2004.07.046; PRATT D, 1 FDA; Sheets EE, 2002, CURR OPIN OBSTET GYN, V14, P53, DOI 10.1097/00001703-200202000-00009; STOELR MH, 2004, CERVICAL CANC ETIOLO, P3; Villa LL, 2006, BRIT J CANCER, V95, P1459, DOI 10.1038/sj.bjc.6603469; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; Zaino RJ, 2002, INT J GYNECOL PATHOL, V21, P314, DOI 10.1097/00004347-200210000-00002	25	432	449	1	38	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 2	2007	369	9576					1861	1868		10.1016/S0140-6736(07)60852-6	http://dx.doi.org/10.1016/S0140-6736(07)60852-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173ZS	17544766				2022-12-01	WOS:000246911600029
J	Scott, LJ; Mohlke, KL; Bonnycastle, LL; Willer, CJ; Li, Y; Duren, WL; Erdos, MR; Stringham, HM; Chines, PS; Jackson, AU; Prokunina-Olsson, L; Ding, CJ; Swift, AJ; Narisu, N; Hu, T; Pruim, R; Xiao, R; Li, XY; Conneely, KN; Riebow, NL; Sprau, AG; Tong, M; White, PP; Hetrick, KN; Barnhart, MW; Bark, CW; Goldstein, JL; Watkins, L; Xiang, F; Saramies, J; Buchanan, TA; Watanabe, RM; Valle, TT; Kinnunen, L; Abecasis, GR; Pugh, EW; Doheny, KF; Bergman, RN; Tuomilehto, J; Collins, FS; Boehnke, M				Scott, Laura J.; Mohlke, Karen L.; Bonnycastle, Lori L.; Willer, Cristen J.; Li, Yun; Duren, William L.; Erdos, Michael R.; Stringham, Heather M.; Chines, Peter S.; Jackson, Anne U.; Prokunina-Olsson, Ludmila; Ding, Chia-Jen; Swift, Amy J.; Narisu, Narisu; Hu, Tianle; Pruim, Randall; Xiao, Rui; Li, Xiao-Yi; Conneely, Karen N.; Riebow, Nancy L.; Sprau, Andrew G.; Tong, Maurine; White, Peggy P.; Hetrick, Kurt N.; Barnhart, Michael W.; Bark, Craig W.; Goldstein, Janet L.; Watkins, Lee; Xiang, Fang; Saramies, Jouko; Buchanan, Thomas A.; Watanabe, Richard M.; Valle, Timo T.; Kinnunen, Leena; Abecasis, Gonalo R.; Pugh, Elizabeth W.; Doheny, Kimberly F.; Bergman, Richard N.; Tuomilehto, Jaakko; Collins, Francis S.; Boehnke, Michael			A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants	SCIENCE			English	Article							BODY-MASS INDEX; ZINC TRANSPORTER; RISK LOCI; INSULIN; GENE; EXPRESSION; IDENTIFICATION	Identifying the genetic variants that increase the risk of type 2 diabetes (T2D) in humans has been a formidable challenge. Adopting a genome-wide association strategy, we genotyped 1161 Finnish T2D cases and 1174 Finnish normal glucose tolerant (NGT) controls with >315,000 single-nucleotide polymorphisms (SNPs) and imputed genotypes for an additional >2 million autosomal SNPs. We carried out association analysis with these SNPs to identify genetic variants that predispose to T2D, compared our T2D association results with the results of two similar studies, and genotyped 80 SNPs in an additional 1215 Finnish T2D cases and 1258 Finnish NGT controls. We identify T2D-associated variants in an intergenic region of chromosome 11p12, contribute to the identification of T2D-associated variants near the genes IGF2BP2 and CDKAL1 and the region of CDKN2A and CDKN2B, and confirm that variants near TCF7L2, SLC30A8, HHEX, FTO, PPARG, and KCNJ11 are associated with T2D risk. This brings the number of T2D loci now confidently identified to at least 10.	Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr State Genet, Ann Arbor, MI 48109 USA; Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; Calvin Coll, Dept Math & Stat, Grand Rapids, MI 49546 USA; Johns Hopkins Univ, Sch Med, Inst Med Genet, Ctr Inherited Dis Res, Baltimore, MD 21224 USA; Savitaipale Hlth Ctr, Savitaipate 54800, Finland; Univ So Calif, Keck Sch Med, Div Endocrinol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Diabet Unit, SF-00300 Helsinki, Finland; Univ Helsinki, Dept Publ Hlth, Helsinki 00014, Finland; S Ostrobothnia Cent Hosp, Seinajoki 60220, Finland	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Calvin University; Johns Hopkins University; University of Southern California; University of Southern California; University of Southern California; Finland National Institute for Health & Welfare; University of Helsinki	Boehnke, M (corresponding author), Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA.	francisc@mail.nih.gov; boehnke@umich.edu	Abecasis, Goncalo R/B-7840-2010; Hu, Tianle/H-9105-2012; Kinnunen, Leena/B-7059-2012; Prokunina-Olsson, Ludmila/V-7960-2019; Prokunina-Olsson, Ludmila/A-8240-2019; Narisu, Narisu/T-6908-2019	Kinnunen, Leena/0000-0001-8739-4812; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Bergman, Richard/0000-0003-1539-4471; Abecasis, Goncalo/0000-0003-1509-1825; Willer, Cristen/0000-0001-5645-4966	Intramural NIH HHS [Z01 HG000024-13, Z01 HG000024] Funding Source: Medline; NHGRI NIH HHS [N01HG65403, T32 HG000040, HG002651, R01 HG002651-01, N01 HG065403, R01 HG002651] Funding Source: Medline; NHLBI NIH HHS [HL084729, U01 HL084729, U01 HL084729-01] Funding Source: Medline; NIDA NIH HHS [U54 DA021519, U54 DA021519-02] Funding Source: Medline; NIDDK NIH HHS [R56 DK062370, U01 DK062370, R01 DK029867, R01 DK062370-04, R01 DK062370, DK072193, DK062370, R01 DK072193-04, R01 DK072193] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000024] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Ching YP, 2002, J BIOL CHEM, V277, P15237, DOI 10.1074/jbc.C200032200; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dunn MF, 2005, BIOMETALS, V18, P295, DOI 10.1007/s10534-005-3685-y; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; LI Y, UNPUB; Neel J. V, 1976, GENETICS DIABETES ME, P1; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; RICH SS, 1990, DIABETES, V39, P1315, DOI 10.2337/diabetes.39.11.1315; Saaristo Timo, 2005, Diab Vasc Dis Res, V2, P67, DOI 10.3132/dvdr.2005.011; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Silander K, 2004, DIABETES, V53, P821, DOI 10.2337/diabetes.53.3.821; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Tsutsui T, 1999, MOL CELL BIOL, V19, P7011; Ubeda M, 2004, ENDOCRINOLOGY, V145, P3023, DOI 10.1210/en.2003-1522; Ubeda M, 2006, J BIOL CHEM, V281, P28858, DOI 10.1074/jbc.M604690200; Valle T, 1998, DIABETES CARE, V21, P949, DOI 10.2337/diacare.21.6.949; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; *WELLC TRUST CAS C, IN PRESS NATURE; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	31	2119	2220	1	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2007	316	5829					1341	1345		10.1126/science.1142382	http://dx.doi.org/10.1126/science.1142382			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17463248	Green Submitted, Green Accepted			2022-12-01	WOS:000246885600051
J	Major, MB; Camp, ND; Berndt, JD; Yi, XH; Goldenberg, SJ; Hubbert, C; Biechele, TL; Gingras, AC; Zheng, N; MacCoss, MJ; Angers, S; Moon, RT				Major, Michael B.; Camp, Nathan D.; Berndt, Jason D.; Yi, XianHua; Goldenberg, Seth J.; Hubbert, Charlotte; Biechele, Travis L.; Gingras, Anne-Claude; Zheng, Ning; MacCoss, Michael J.; Angers, Stephane; Moon, Randall T.			Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling	SCIENCE			English	Article							PATHWAY	Aberrant WNT signal transduction is involved in many diseases. In colorectal cancer and melanoma, mutational disruption of proteins involved in the degradation of beta-catenin, the key effector of the WNT signaling pathway, results in stabilization of beta-catenin and, in turn, activation of transcription. We have used tandem-affinity protein purification and mass spectrometry to define the protein interaction network of the beta-catenin destruction complex. This assay revealed that WTX, a protein encoded by a gene mutated in Wilms tumors, forms a complex with beta-catenin, AXIN1, beta-TrCP2 (beta-transducin repeat-containing protein 2), and APC ( adenomatous polyposis coli). Functional analyses in cultured cells, Xenopus, and zebrafish demonstrate that WTX promotes beta-catenin ubiquitination and degradation, which antagonize WNT/beta-catenin signaling. These data provide a possible mechanistic explanation for the tumor suppressor activity of WTX.	Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON M5S 3M2, Canada	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Moon, RT (corresponding author), Univ Washington, Sch Med, Howard Hughes Med Inst, Box 357370, Seattle, WA 98195 USA.	rtmoon@u.washington.edu	Gingras, Anne-Claude/E-9982-2010; Moon, Randall T/B-1743-2014; Moon, Randall/M-5605-2019; Gingras, Anne-Claude/ABA-8341-2020; Angers, Stephane/E-1432-2014	Gingras, Anne-Claude/0000-0002-6090-4437; Moon, Randall T/0000-0002-9352-1408; Moon, Randall/0000-0002-9352-1408; Gingras, Anne-Claude/0000-0002-6090-4437; Angers, Stephane/0000-0001-7241-9044; Major, Michael/0000-0002-6753-8513				Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Koesters R, 1999, CANCER RES, V59, P3880; Koesters R, 2003, J PATHOL, V199, P68, DOI 10.1002/path.1248; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006	10	316	342	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					1043	1046		10.1126/science/1141515	http://dx.doi.org/10.1126/science/1141515			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17510365				2022-12-01	WOS:000246554000051
J	Hudson, KL				Hudson, Kathy L.			Prohibiting genetic discrimination	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COLORECTAL-CANCER		Johns Hopkins Genet & Publ Policy Ctr, Washington, DC USA; Johns Hopkins Univ, Berman Bioeth Inst, Baltimore, MD USA; Johns Hopkins Univ, Inst Med Genet, Baltimore, MD USA; Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Hudson, KL (corresponding author), Johns Hopkins Genet & Publ Policy Ctr, Washington, DC USA.							Apse KA, 2004, GENET MED, V6, P510, DOI 10.1097/01.GIM.0000144013.96456.6C; Hadley DW, 2003, ARCH INTERN MED, V163, P573, DOI 10.1001/archinte.163.5.573; LANMAN RB, 2005, ANAL ADEQUACY CURREN; Matloff ET, 2000, J CLIN ONCOL, V18, P2484, DOI 10.1200/JCO.2000.18.12.2484	4	40	40	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2007	356	20					2021	2023		10.1056/NEJMp078033	http://dx.doi.org/10.1056/NEJMp078033			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167ZD	17507700				2022-12-01	WOS:000246490500002
J	Medeiros, RB; Burbach, BJ; Mueller, KL; Srivastava, R; Moon, JJ; Highfill, S; Peterson, EJ; Shimizu, Y				Medeiros, Ricardo B.; Burbach, Brandon J.; Mueller, Kristen L.; Srivastava, Rupa; Moon, James J.; Highfill, Sarah; Peterson, Erik J.; Shimizu, Yoji			Regulation of NF-kappa B activation in T cells via association of the adapter proteins ADAP and CARMA1	SCIENCE			English	Article							EXTENDED SH3 DOMAIN; KINASE-C-THETA; ANTIGEN-RECEPTOR; MAGUK FAMILY; SCAFFOLDING PROTEINS; INTEGRIN ACTIVATION; PLASMA-MEMBRANE; MALT LYMPHOMA; ADHESION; BCL10	The adapter protein ADAP regulates T lymphocyte adhesion and activation. We present evidence for a previously unrecognized function for ADAP in regulating T cell receptor (TCR)-mediated activation of the transcription factor NF-kappa B. Stimulation of ADAP-deficient mouse T cells with antibodies to CD3 and CD28 resulted in impaired nuclear translocation of NF-kappa B, a reduced DNA binding, and delayed degradation and decreased phosphorylation of I kappa B ( inhibitor of NF-kappa B). TCR-stimulated assembly of the CARMA1-BCL-10-MALT1 complex was substantially impaired in the absence of ADAP. We further identified a region of ADAP that is required for association with the CARMA1 adapter and NF-kappa B activation but is not required for ADAP-dependent regulation of adhesion. These findings provide new insights into ADAP function and the mechanism by which CARMA1 regulates NF-kappa B activation in T cells.	Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Ctr Canc, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Dept Med, Ctr Immunol,Canc Ctr, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Medeiros, RB (corresponding author), Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Ctr Canc, Minneapolis, MN 55455 USA.	shimi002@umn.edu	Peterson, Erik/M-9365-2013; moon, james/F-1031-2014	moon, james/0000-0001-8071-1491; Burbach, Brandon/0000-0003-0922-7722; Shimizu, Yoji/0000-0001-9760-0288	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056016, F32AI063793, R01AI038474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007288] Funding Source: NIH RePORTER; NIAID NIH HHS [R01AI038474, F32 AI063793, F32AI063793, F32 AI063793-01A1, R01AI056016] Funding Source: Medline; NIDCR NIH HHS [T32DE007288] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; CHEN CC, 1995, AGENT ACTION SUPPL, V47, P135; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; George TC, 2006, J IMMUNOL METHODS, V311, P117, DOI 10.1016/j.jim.2006.01.018; George TC, 2004, CYTOM PART A, V59A, P237, DOI 10.1002/cyto.a.20048; Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397; Hara H, 2004, J EXP MED, V200, P1167, DOI 10.1084/jem.20032246; Heuer K, 2005, J MOL BIOL, V348, P1025, DOI 10.1016/j.jmb.2005.02.069; Heuer K, 2004, STRUCTURE, V12, P603, DOI 10.1016/j.str.2004.02.021; Heuer K, 2006, J MOL BIOL, V361, P94, DOI 10.1016/j.jmb.2006.06.004; Hurez Vincent, 2002, BMC Immunol, V3, P4, DOI 10.1186/1471-2172-3-4; Kliche S, 2006, MOL CELL BIOL, V26, P7130, DOI 10.1128/MCB.00331-06; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Wang HY, 2004, J EXP MED, V200, P1063, DOI 10.1084/jem.20040780; Wang HY, 2003, NAT IMMUNOL, V4, P366, DOI 10.1038/ni913; Wu JN, 2006, J IMMUNOL, V176, P6681, DOI 10.4049/jimmunol.176.11.6681	30	80	85	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2007	316	5825					754	758		10.1126/science.1137895	http://dx.doi.org/10.1126/science.1137895			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17478723				2022-12-01	WOS:000246181400049
J	Vincent, JL; Patel, GH; Fox, MD; Snyder, AZ; Baker, JT; Van Essen, DC; Zempel, JM; Snyder, LH; Corbetta, M; Raichle, ME				Vincent, J. L.; Patel, G. H.; Fox, M. D.; Snyder, A. Z.; Baker, J. T.; Van Essen, D. C.; Zempel, J. M.; Snyder, L. H.; Corbetta, M.; Raichle, M. E.			Intrinsic functional architecture in the anaesthetized monkey brain	NATURE			English	Article							MACAQUE MONKEY; PARIETAL LOBE; DEFAULT MODE; CONNECTIONS; NETWORKS; CORTEX; ORGANIZATION; DYNAMICS; IMAGES; AREAS	The traditional approach to studying brain function is to measure physiological responses to controlled sensory, motor and cognitive paradigms. However, most of the brain's energy consumption is devoted to ongoing metabolic activity not clearly associated with any particular stimulus or behaviour(1). Functional magnetic resonance imaging studies in humans aimed at understanding this ongoing activity have shown that spontaneous fluctuations of the blood-oxygen-level-dependent signal occur continuously in the resting state. In humans, these fluctuations are temporally coherent within widely distributed cortical systems that recapitulate the functional architecture of responses evoked by experimentally administered tasks(2-6\). Here, we show that the same phenomenon is present in anaesthetized monkeys even at anaesthetic levels known to induce profound loss of consciousness. We specifically demonstrate coherent spontaneous fluctuations within three well known systems ( oculomotor, somatomotor and visual) and the 'default' system, a set of brain regions thought by some to support uniquely human capabilities. Our results indicate that coherent system fluctuations probably reflect an evolutionarily conserved aspect of brain functional organization that transcends levels of consciousness.	Washington Univ, Dept Radiol, St Louis, MO 63110 USA; Washington Univ, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA; Harvard Univ, Dept Psychol, Ctr Brain Sci, Cambridge, MA 02138 USA; Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Harvard University; Harvard University; Massachusetts General Hospital	Raichle, ME (corresponding author), Washington Univ, Dept Radiol, St Louis, MO 63110 USA.	marc@npg.wustl.edu	Vincent, Justin L/B-5033-2012; Snyder, Lawrence H/A-4593-2017; Kennedy, Kristen M/B-4699-2008; Patel, Gaurav/AAW-3195-2021; anand, amit/A-7222-2009; Corbetta, Maurizio/AAZ-5219-2020; Fox, Michael D./AAZ-3928-2020	Kennedy, Kristen M/0000-0001-5373-9026; Patel, Gaurav/0000-0003-0028-2098; Fox, Michael D./0000-0001-8848-6399; Baker, Justin/0000-0002-6629-2195; CORBETTA, MAURIZIO/0000-0001-8295-3304	NINDS NIH HHS [F31 NS051972] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Baker JT, 2006, CEREB CORTEX, V16, P447, DOI 10.1093/cercor/bhi124; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Black KJ, 2004, METHOD ENZYMOL, V385, P91; Brodmann K., 1994, LOCALISATION CEREBRA; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; GATTASS R, 1988, J NEUROSCI, V8, P1831; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Karnath HO, 2001, NAT REV NEUROSCI, V2, P568, DOI 10.1038/35086057; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Lancaster JL, 1995, HUM BRAIN MAPP, V3, P209, DOI 10.1002/hbm.460030305; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Llinas R.R., 2001, I VORTEX NEURONS SEL; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; MAUNSELL JHR, 1987, J COMP NEUROL, V266, P535, DOI 10.1002/cne.902660407; MORCOM AM, IN PRESS NEUROIMAGE; Raichle ME, 2006, SCIENCE, V314, P1249, DOI 10.1126/science.1134405; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; Tulving E, 2005, COGN SELF REFLECTIVE, P3, DOI DOI 10.1093/ACPROF:OSO/9780195161564.003.0001; VANESSEN DC, 1984, VISION RES, V24, P429, DOI 10.1016/0042-6989(84)90041-5; VANESSEN DC, 1982, J NEUROSCI, V2, P265; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001	33	1314	1339	3	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2007	447	7140					83	U4		10.1038/nature05758	http://dx.doi.org/10.1038/nature05758			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17476267	Green Published			2022-12-01	WOS:000246149300048
J	Friis-Moller, N; Reiss, P; Sabin, CA; Weber, R; Monforte, AD; El-Sadr, W; De Wit, S; Kirk, O; Fontas, E; Law, MG; Phillips, A; Lundgren, JD				Friis-Moller, Nina; Reiss, Peter; Sabin, Caroline A.; Weber, Rainer; Monforte, Antonella d'Arminio; El-Sadr, Wafaa; De Wit, Stephane; Kirk, Ole; Fontas, Eric; Law, Matthew G.; Phillips, Andrew; Lundgren, Jens D.		DAD Study Grp	Class of antiretroviral drugs and the risk of myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; HIV PROTEASE INHIBITORS; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; THERAPY; COHORT; LIPIDS; HAART; ATHEROSCLEROSIS; MORTALITY	BACKGROUND: We have previously demonstrated an association between combination antiretroviral therapy and the risk of myocardial infarction. It is not clear whether this association differs according to the class of antiretroviral drugs. We conducted a study to investigate the association of cumulative exposure to protease inhibitors and nonnucleoside reverse-transcriptase inhibitors with the risk of myocardial infarction. METHODS: We analyzed data collected through February 2005 from our prospective observational study of 23,437 patients infected with the human immunodeficiency virus. The incidence rates of myocardial infarction during the follow-up period were calculated, and the associations between myocardial infarction and exposure to protease inhibitors or nonnucleoside reverse-transcriptase inhibitors were determined. RESULTS: Three hundred forty-five patients had a myocardial infarction during 94,469 person-years of observation. The incidence of myocardial infarction increased from 1.53 per 1000 person-years in those not exposed to protease inhibitors to 6.01 per 1000 person-years in those exposed to protease inhibitors for more than 6 years. After adjustment for exposure to the other drug class and established cardiovascular risk factors (excluding lipid levels), the relative rate of myocardial infarction per year of protease-inhibitor exposure was 1.16 (95% confidence interval [CI], 1.10 to 1.23), whereas the relative rate per year of exposure to nonnucleoside reverse-transcriptase inhibitors was 1.05 (95% CI, 0.98 to 1.13). Adjustment for serum lipid levels further reduced the effect of exposure to each drug class to 1.10 (95% CI, 1.04 to 1.18) and 1.00 (95% CI, 0.93 to 1.09), respectively. CONCLUSIONS: Increased exposure to protease inhibitors is associated with an increased risk of myocardial infarction, which is partly explained by dyslipidemia. We found no evidence of such an association for nonnucleoside reverse-transcriptase inhibitors; however, the number of person-years of observation for exposure to this class of drug was less than that for exposure to protease inhibitors.	Univ Copenhagen, Panum Inst, Copenhagen HIV Program, DK-2200 Copenhagen N, Denmark; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; UCL Royal Free & Univ Coll London, London, England; Univ Zurich Hosp, CH-8091 Zurich, Switzerland; Univ Milan, Milan, Italy; Columbia Univ, Harlem Hosp, New York, NY USA; Univ Bordeaux 2, INSERM, E0338, F-33076 Bordeaux, France; Univ Bordeaux 2, INSERM, U593, F-33076 Bordeaux, France; Ctr Hosp Univ St Pierre, Brussels, Belgium; Univ Copenhagen, Copenhagen, Denmark; Ctr Hosp Univ Nice, Nice, France; Hop Archet, Nice, France; Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia	University of Copenhagen; University of Amsterdam; Academic Medical Center Amsterdam; University of London; University College London; University of Zurich; University Zurich Hospital; University of Milan; Columbia University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Copenhagen; CHU Nice; CHU Nice; University of New South Wales Sydney; Kirby Institute	Lundgren, JD (corresponding author), Univ Copenhagen, Panum Inst, Copenhagen HIV Program, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	jdl@cphiv.dk	Weber, Rainer/D-5175-2012; Torres, Ferran/D-1296-2011; VALLET, Yannick/F-9979-2011; Lundgren, Jens/AAE-6876-2019; Streinu-Cercel, Adrian/M-5835-2017; Sabin, Caroline/C-2464-2008; kirk, ole/ABB-4746-2021; Phillips, Andrew N/B-4427-2008	Torres, Ferran/0000-0002-7355-7913; Streinu-Cercel, Adrian/0000-0001-6382-5067; Sabin, Caroline/0000-0001-5173-2760; Phillips, Andrew N/0000-0003-2384-4807; Collins, Simon/0000-0002-3537-2432; Friis-Moller, Nina/0000-0002-7449-7393; Lundgren, Jens/0000-0001-8901-7850; Law, Matthew/0000-0002-3540-8837	NIAID NIH HHS [5U01AI042170-10, 5U01AI046362-03] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI046362, U01AI042170] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allred KF, 2006, J BIOL CHEM, V281, P1419, DOI 10.1074/jbc.M506046200; CONSTANS J, 1994, EUR J CLIN INVEST, V24, P416, DOI 10.1111/j.1365-2362.1994.tb02185.x; Currier JS, 2003, JAIDS-J ACQ IMM DEF, V33, P506, DOI 10.1097/00126334-200308010-00012; Dieleman JP, 2002, AIDS, V16, P737, DOI 10.1097/00002030-200203290-00009; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Fontas E, 2004, J INFECT DIS, V189, P1056, DOI 10.1086/381783; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; FriisMoller N, 2004, NEW ENGL J MED, V350, P955; GRUNFELD C, 1992, J CLIN ENDOCR METAB, V74, P1045, DOI 10.1210/jc.74.5.1045; Holmberg SD, 2002, LANCET, V360, P1747, DOI 10.1016/S0140-6736(02)11672-2; Iloeje UH, 2005, HIV MED, V6, P37, DOI 10.1111/j.1468-1293.2005.00265.x; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Mary-Krause M, 2003, AIDS, V17, P2479, DOI 10.1097/00002030-200311210-00010; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Mocroft A, 2002, ANTIVIR THER, V7, P21; Monforte AD, 2000, AIDS, V14, P499, DOI 10.1097/00002030-200003310-00005; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pernerstorfer-Schoen H, 2001, AIDS, V15, P725, DOI 10.1097/00002030-200104130-00008; PHILLIPS A, 2007, 14 C RETR OPP INF LO; Riddler SA, 2003, JAMA-J AM MED ASSOC, V289, P2978, DOI 10.1001/jama.289.22.2978; SABIN C, 2005, 12 C RETR OPP INF BO; Saves M, 2003, CLIN INFECT DIS, V37, P292, DOI 10.1086/375844; Sax PE, 2004, JAIDS-J ACQ IMM DEF, V37, P1434; Sax PE, 2004, JAIDS-J ACQ IMM DEF, V37, P1111, DOI 10.1097/01.qai.0000138420.38995.86; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; van der Valk M, 2001, AIDS, V15, P2407, DOI 10.1097/00002030-200112070-00008; van Leth F, 2004, PLOS MED, V1, P237, DOI 10.1371/journal.pmed.0010073; van Leth F, 2004, PLOS MED, V1, P64, DOI 10.1371/journal.pmed.0010019; WHO MONICA Project, 1999, MONICA MAN 4; Zhou HP, 2005, MOL PHARMACOL, V68, P690, DOI 10.1124/mol.105.012898	32	1104	1128	1	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 26	2007	356	17					1723	1735		10.1056/NEJMoa062744	http://dx.doi.org/10.1056/NEJMoa062744			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	160LQ	17460226	Green Published, Bronze			2022-12-01	WOS:000245942600007
J	Quinn, AE; Georges, A; Sarre, SD; Guarino, F; Ezaz, T; Graves, JAM				Quinn, Alexander E.; Georges, Arthur; Sarre, Stephen D.; Guarino, Fiorenzo; Ezaz, Tariq; Graves, Jennifer A. Marshall			Temperature sex reversal implies sex gene dosage in a reptile	SCIENCE			English	Article									Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia; Australian Natl Univ, Res Sch Biol Sci, Comparat Genom Grp, Canberra, ACT 2601, Australia	University of Canberra; Australian National University	Quinn, AE (corresponding author), Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia.	quinn@aerg.canberra.edu.au	Ezaz, Tariq/D-9875-2011; Graves, Jennifer A.M./A-1387-2008; Sarre, Stephen D/C-6795-2011; Quinn, Alexander/C-2778-2013; Georges, Arthur/D-2153-2009	Ezaz, Tariq/0000-0003-4763-1347; Georges, Arthur/0000-0003-2428-0361; Sarre, Stephen D./0000-0002-7158-2517; Graves, Jennifer/0000-0001-6480-7856; Guarino, Fiorenzo/0000-0002-1458-7389				[Anonymous], 2004, TEMPERATURE DEPENDEN; Bull J.J., 1983, EVOLUTION SEX DETERM; Ezaz T, 2005, CHROMOSOME RES, V13, P763, DOI 10.1007/s10577-005-1010-9; Sarre SD, 2004, BIOESSAYS, V26, P639, DOI 10.1002/bies.20050; Shine R, 2002, ECOL LETT, V5, P486, DOI 10.1046/j.1461-0248.2002.00351.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407	6	203	210	1	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2007	316	5823					411	411		10.1126/science.1135925	http://dx.doi.org/10.1126/science.1135925			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446395	Green Submitted			2022-12-01	WOS:000245813400046
J	Wang, M; Ramos, BP; Paspalas, CD; Shu, YS; Simen, A; Duque, A; Vijayraghavan, S; Brennan, A; Dudley, A; Nou, E; Mazer, JA; McCormick, DA; Arnsten, AFT				Wang, Min; Ramos, Brian P.; Paspalas, Constantinos D.; Shu, Yousheng; Simen, Arthur; Duque, Alvaro; Vijayraghavan, Susheel; Brennan, Avis; Dudley, Anne; Nou, Eric; Mazer, James A.; McCormick, David A.; Arnsten, Amy F. T.			alpha 2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex	CELL			English	Article							PROTEIN-KINASE-A; COGNITIVE DECLINE; PYRAMIDAL NEURONS; DOPAMINE D1; PERFORMANCE; MECHANISMS; GUANFACINE; MONKEYS; EXCITABILITY; DENDRITES	Spatial working memory (WM; i.e., '' scratchpad '' memory) is constantly updated to guide behavior based on representational knowledge of spatial position. It is maintained by spatially tuned, recurrent excitation within networks of prefrontal cortical (PFC) neurons, evident during delay periods in WM tasks. Stimulation of postsynaptic alpha 2A adrenoceptors (alpha 2A-ARs) is critical for WM. We report that alpha 2A-AR stimulation strengthens WM through inhibition of cAMP, closing Hyperpolarization-activated Cyclic Nucleotide-gated (HCN) channels and strengthening the functional connectivity of PFC networks. Ultrastructurally, HCN channels and alpha 2A-ARs were colocalized in dendritic spines in PFC. In electrophysiological studies, either alpha 2A-AR stimulation, cAMP inhibition or HCN channel blockade enhanced spatially tuned delay-related firing of PFC neurons. Conversely, delay-related network firing collapsed under conditions of excessive cAMP. In behavioral studies, either blockade or knockdown of HCN1 channels in PFC improved WM performance. These data reveal a powerful mechanism for rapidly altering the strength of WM networks in PFC.	Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA; Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; Univ Crete, Sch Med, Div Neuroanat, Iraklion, Greece	Yale University; Yale University; Yale University; University of Crete	Arnsten, AFT (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA.	amy.arnsten@yale.edu	Kobelt, Liza/F-5926-2011; Paspalas, Constantinos/G-2327-2014; Shu, Yousheng/AAC-3881-2020	Shu, Yousheng/0000-0002-2834-2876	NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR017594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH068789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS026143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG006036] Funding Source: NIH RePORTER; NCRR NIH HHS [K12RR17594] Funding Source: Medline; NIA NIH HHS [R37 AG06036, R37 AG006036] Funding Source: Medline; NIMH NIH HHS [P50MH068789] Funding Source: Medline; NINDS NIH HHS [R37 NS026143] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMSTEN AF, 1988, J NEUROSCI, V8, P4287; Aoki C, 1998, CEREB CORTEX, V8, P269, DOI 10.1093/cercor/8.3.269; Arnsten AFT, 2000, PROG BRAIN RES, V126, P183; ARNSTEN AFT, 1985, SCIENCE, V230, P1273, DOI 10.1126/science.2999977; Aston-Jones G, 1999, BIOL PSYCHIAT, V46, P1309, DOI 10.1016/S0006-3223(99)00140-7; Auricchio A, 2001, HUM GENE THER, V12, P71, DOI 10.1089/104303401450988; Chen C, 2004, EUR J NEUROSCI, V19, P643, DOI 10.1111/j.0953-816X.2003.03174.x; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; Day M, 2005, J NEUROSCI, V25, P8776, DOI 10.1523/JNEUROSCI.2650-05.2005; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Franowicz JS, 2002, J NEUROSCI, V22, P8771; FUSTER JM, 1985, HUM NEUROBIOL, V4, P169; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; GOLDMANRAKIC PS, 1990, J NEUROSCI, V10, P2125; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Jakala P, 1999, NEUROPSYCHOPHARMACOL, V20, P460, DOI 10.1016/S0893-133X(98)00127-4; Kirkpatrick B, 2006, J COMP NEUROL, V497, P436, DOI 10.1002/cne.21007; KRITZER MF, 1995, J COMP NEUROL, V359, P131, DOI 10.1002/cne.903590109; LARSEN JK, 1978, PHYSIOL PSYCHOL, V6, P15; LI BM, 1994, BEHAV NEURAL BIOL, V62, P134, DOI 10.1016/S0163-1047(05)80034-2; Li BM, 1999, NEUROPSYCHOPHARMACOL, V21, P601, DOI 10.1016/S0893-133X(99)00070-6; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Mao ZM, 1999, BIOL PSYCHIAT, V46, P1259, DOI 10.1016/S0006-3223(99)00139-0; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; MCCLURE MM, 2006, IN PRESS BIOL PSYCHI; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Miller EK, 1996, J NEUROSCI, V16, P5154; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/j.cell.2004.11.020; Nolan MF, 2003, CELL, V115, P551, DOI 10.1016/S0092-8674(03)00884-5; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Paspalas CD, 2004, J NEUROSCI, V24, P5292, DOI 10.1523/JNEUROSCI.0195-04.2004; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Ramos BP, 2003, NEURON, V40, P835, DOI 10.1016/S0896-6273(03)00694-9; Ramos BP, 2006, LEARN MEMORY, V13, P770, DOI 10.1101/lm.298006; Runyan JD, 2005, LEARN MEMORY, V12, P232, DOI 10.1101/lm.92405; Scahill L, 2001, AM J PSYCHIAT, V158, P1067, DOI 10.1176/appi.ajp.158.7.1067; Shu YS, 2003, J NEUROSCI, V23, P10388; SMILEY JF, 1994, P NATL ACAD SCI USA, V91, P5720, DOI 10.1073/pnas.91.12.5720; Taylor FB, 2001, J CLIN PSYCHOPHARM, V21, P223, DOI 10.1097/00004714-200104000-00015; Taylor JR, 1999, J NEUROSCI, V19; Ulens C, 2001, J BIOL CHEM, V276, P6069, DOI 10.1074/jbc.C000738200; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846	45	448	462	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2007	129	2					397	410		10.1016/j.cell.2007.03.015	http://dx.doi.org/10.1016/j.cell.2007.03.015			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448997	Bronze			2022-12-01	WOS:000246474600025
J	Bankovich, AJ; Raunser, S; Juo, ZS; Walz, T; Davis, MM; Garcia, KC				Bankovich, Alexander J.; Raunser, Stefan; Juo, Z. Sean; Walz, Thomas; Davis, Mark M.; Garcia, K. Christopher			Structural insight into pre-B cell receptor function	SCIENCE			English	Article							SURROGATE LIGHT-CHAIN; HEAVY-CHAIN; V-H; LAMBDA-5; LYMPHOCYTES; REPERTOIRE; DIVERSITY; VPREB; GENE; MECHANISMS	The pre-B cell receptor (pre-BCR) serves as a checkpoint in B cell development. In the 2.7 angstrom structure of a human pre-BCR Fab-like fragment, consisting of an antibody heavy chain (HC) paired with the surrogate light chain, the "unique regions" of VpreB and lambda 5 replace the complementarity-determining region 3 (CDR3) loop of an antibody light chain and appear to "probe" the HC CDR3, potentially influencing the selection of the antibody repertoire. Biochemical analysis indicates that the pre-BCR is impaired in its ability to recognize antigen, which, together with electron microscopic visualization of a pre-BCR dimer, suggests ligand-independent oligomerization as the likely signaling mechanism.	Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Harvard University; Harvard Medical School	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA.	kcgarcia@stanford.edu	Raunser, Stefan/AHE-1573-2022	Raunser, Stefan/0000-0001-9373-3016; Walz, Thomas/0000-0003-2606-2835; Davis, Mark/0000-0001-6868-657X; Bankovich, Alexander/0000-0003-2368-4479	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Bradl H, 2003, J IMMUNOL, V171, P2338, DOI 10.4049/jimmunol.171.5.2338; Davis MM, 2004, SEMIN IMMUNOL, V16, P239, DOI 10.1016/j.smim.2004.08.003; DECKER DJ, 1991, J IMMUNOL, V146, P350; Gauthier L, 2002, P NATL ACAD SCI USA, V99, P13014, DOI 10.1073/pnas.202323999; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; HENDERSHOT LM, 1990, J CELL BIOL, V111, P829, DOI 10.1083/jcb.111.3.829; Hess J, 2001, P NATL ACAD SCI USA, V98, P1745, DOI 10.1073/pnas.041492098; KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0; KEYNA U, 1995, J IMMUNOL, V155, P5536; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KUDO A, 1987, EMBO J, V6, P2267, DOI 10.1002/j.1460-2075.1987.tb02500.x; KUDO A, 1989, PROGR IMMUNOLOGY, V7, P339; Lanig H, 2004, MOL IMMUNOL, V40, P1263, DOI 10.1016/j.molimm.2003.11.030; MELCHERS F, 1993, IMMUNOL TODAY, V14, P60, DOI 10.1016/0167-5699(93)90060-X; Milili M, 1996, EUR J IMMUNOL, V26, P63, DOI 10.1002/eji.1830260110; Minegishi Y, 1999, P NATL ACAD SCI USA, V96, P3041, DOI 10.1073/pnas.96.6.3041; Minegishi Y, 1998, J EXP MED, V187, P71, DOI 10.1084/jem.187.1.71; Ohnishi K, 2003, NAT IMMUNOL, V4, P849, DOI 10.1038/ni959; PILLAI S, 1987, NATURE, V329, P172, DOI 10.1038/329172a0; SAKAGUCHI N, 1986, NATURE, V324, P579, DOI 10.1038/324579a0; tenBoekel E, 1997, IMMUNITY, V7, P357; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; TSUBATA T, 1990, J EXP MED, V172, P973, DOI 10.1084/jem.172.3.973; Wang LD, 2003, IMMUNOLOGY, V110, P411, DOI 10.1111/j.1365-2567.2003.01756.x; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; Zemlin M, 2003, J MOL BIOL, V334, P733, DOI 10.1016/j.jmb.2003.10.007	28	74	90	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					291	294		10.1126/science.1139412	http://dx.doi.org/10.1126/science.1139412			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431183				2022-12-01	WOS:000245654500055
J	Sarkar, AK; Luijten, M; Miyashima, S; Lenhard, M; Hashimoto, T; Nakajima, K; Scheres, B; Heidstra, R; Laux, T				Sarkar, Ananda K.; Luijten, Marijn; Miyashima, Shunsuke; Lenhard, Michael; Hashimoto, Takashi; Nakajima, Keiji; Scheres, Ben; Heidstra, Renze; Laux, Thomas			Conserved factors regulate signalling in Arabidopsis thaliana shoot and root stem cell organizers	NATURE			English	Article							TRANSCRIPTION FACTOR; MERISTEM; WUSCHEL; GENE; FATE; MAINTENANCE; EMBRYO; PLANTS; NICHE; CLV3	Throughout the lifespan of a plant, which in some cases can last more than one thousand years, the stem cell niches in the root and shoot apical meristems provide cells for the formation of complete root and shoot systems, respectively. Both niches are superficially different and it has remained unclear whether common regulatory mechanisms exist. Here we address whether root and shoot meristems use related factors for stem cell maintenance. In the root niche the quiescent centre cells, surrounded by the stem cells, express the homeobox gene WOX5 (WUSCHEL-RELATED HOMEOBOX 5)(1), a homologue of the WUSCHEL (WUS) gene that non-cell-autonomously maintains stem cells in the shoot meristem(2). Loss of WOX5 function in the root meristem stem cell niche causes terminal differentiation in distal stem cells and, redundantly with other regulators, also provokes differentiation of the proximal meristem. Conversely, gain of WOX5 function blocks differentiation of distal stem cell descendents that normally differentiate. Importantly, both WOX5 and WUS maintain stem cells in either a root or shoot context. Together, our data indicate that stem cell maintenance signalling in both meristems employs related regulators.	Univ Freiburg, Inst Biol 3, D-79104 Freiburg, Germany; Univ Utrecht, Dept Mol Cell Biol, NL-3584 CH Utrecht, Netherlands; Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan	University of Freiburg; Utrecht University; Nara Institute of Science & Technology	Laux, T (corresponding author), Univ Freiburg, Inst Biol 3, Schanzlestr 1, D-79104 Freiburg, Germany.	laux@biologie.uni-freiburg.de	Lenhard, Michael/J-1554-2015; Miyashima, Shunsuke/AAV-1196-2021	Scheres, Ben/0000-0001-5400-9578; Nakajima, Keiji/0000-0002-1580-3354; Miyashima, Shunsuke/0000-0001-8267-3978				Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; BERLETH T, 1993, DEVELOPMENT, V118, P575; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Casamitjana-Martinez E, 2003, CURR BIOL, V13, P1435, DOI 10.1016/S0960-9822(03)00533-5; Gallois JL, 2004, GENE DEV, V18, P375, DOI 10.1101/gad.291204; Haecker A, 2004, DEVELOPMENT, V131, P657, DOI 10.1242/dev.00963; Hamada S, 2000, PLANT J, V24, P91, DOI 10.1046/j.1365-313x.2000.00858.x; Hobe M, 2003, DEV GENES EVOL, V213, P371, DOI 10.1007/s00427-003-0329-5; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Kenrick P., 1997, ORIGIN EARLY DIVERSI; Laux T, 2003, CELL, V113, P281, DOI 10.1016/S0092-8674(03)00312-X; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Ulmasov T, 1997, SCIENCE, V276, P1865, DOI 10.1126/science.276.5320.1865; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; Vernoux T, 2005, CURR OPIN GENET DEV, V15, P388, DOI 10.1016/j.gde.2005.06.008; Weijers D, 2006, DEV CELL, V10, P265, DOI 10.1016/j.devcel.2005.12.001; Wildwater M, 2005, CELL, V123, P1337, DOI 10.1016/j.cell.2005.09.042; Willemsen V, 1998, DEVELOPMENT, V125, P521	24	698	754	12	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2007	446	7137					811	814		10.1038/nature05703	http://dx.doi.org/10.1038/nature05703			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17429400				2022-12-01	WOS:000245626800044
J	McNally, LM; Jeena, PM; Gajee, K; Thula, SA; Sturm, AW; Cassol, S; Tomkins, AM; Coovadia, HM; Goldblatt, D				McNally, Lisa M.; Jeena, Prakash M.; Gajee, Kovitha; Thula, Stanley A.; Sturm, A. Willem; Cassol, Sharon; Tomkins, Andrew M.; Coovadia, Hoosen M.; Goldblatt, David			Effect of age, polymicrobial disease,, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RESPIRATORY-TRACT INFECTIONS; PNEUMOCYSTIS-CARINII-PNEUMONIA; BRONCHOALVEOLAR LAVAGE; GAMBIAN CHILDREN; ETIOLOGY; MORTALITY; COMMUNITY; CYTOMEGALOVIRUS; INFANTS	Background HIV-related pneumonia is the main cause of paediatric hospital admissions in southern Africa. We aimed to measure predictors of treatment failure and the cause of non-responsive pneumonia in children admitted to hospital with severe pneumonia in Durban, South Africa. Methods We investigated 358 children aged 1-59 months who presented with WHO-defined severe or very severe pneumonia. Children were recruited irrespective of HIV status and started on a standard antimicrobial regimen of benzylpenicillin and gentamicin. All infants also received high-dose trimethoprim-sulfamethoxazole. The primary outcome measure was treatment failure at 48 h. Findings 242 (68%) children were HIV infected, 41 (12%) HIV exposed, unindected, and 75 (21%) HIV uninfected. Failure to respond by 48 h was predicted by age under 1 year (adjusted odds ratio 6.38, 95% CI 2.72-14.91, p < 0.0001), very severe disease (2.47, 1.17-5.24, p=0.0181), HIV status (HIV infected 10.3, 3.26-32.51; HIV exposed, uninfected 6.02, 1.55-23.38; p=0.0003), and polymicrobial disease (one organism 2.06, 1.05-4.05; two organisms 10.75, 4.38-26.36; p < 0.0001) on logistic regression analysis. All children with three organisms failed treatment. 72/110 treatment failures had at least two organisms isolated. Three of nine HIV-exposed, uninfected infants, 29/74 HIV-infected, but no HIV-uninfected infants who failed study therapy had Pneumocystis jirovecii pneumonia. Interpretation For children younger than 1 year, the WHO guidelines are inadequate and need to be revised since both HIV-infected and HIV-exposed, uninfected infants had more treatment failures than did HIV-uninfected infants. Polymicrobial disease is an important reason for treatment failure, and we need to identify rapid low-cost diagnostic methods to assist clinicians.	UCL, Inst Child Hlth, Ctr Int Child Hlth & Dev, London WC1N 1EH, England; UCL, Inst Child Hlth, Immunobiol Unit, London WC1N 1EH, England; Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Paediat & Child Hlth, Durban, South Africa; Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Med Microbiol, Durban, South Africa; Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, Durban, South Africa; Univ Pretoria, Fac Hlth Sci, Dept Immunol, MRC,Unit Inflammat & Immun, ZA-0002 Pretoria, South Africa	University of London; University College London; University of London; University College London; University of Kwazulu Natal; University of Kwazulu Natal; University of Kwazulu Natal; University of Pretoria	McNally, LM (corresponding author), GlaxoSmithKline Biol, B43,Rue Inst 89, B-1330 Rixensart, Belgium.	lisa.m.mc-nally@gskbio.com	Goldblatt, David/C-5972-2008	Goldblatt, David/0000-0002-0769-5242	Wellcome Trust [GR056609MA] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Addo-Yobo E, 2004, LANCET, V364, P1141, DOI 10.1016/S0140-6736(04)17100-6; ADEGBOLA RA, 1994, PEDIATR INFECT DIS J, V13, P975, DOI 10.1097/00006454-199411000-00008; AMAROGALVEZ R, 1991, PEDIATR INFECT DIS J, V10, P473, DOI 10.1097/00006454-199106000-00015; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Burmester M, 2001, INTENS CARE MED, V27, P716, DOI 10.1007/s001340100904; Chintu C, 2002, LANCET, V360, P985, DOI 10.1016/S0140-6736(02)11082-8; Clerici M, 2000, BLOOD, V96, P3866, DOI 10.1182/blood.V96.12.3866.h8003866_3866_3871; Delport SD, 2002, SAMJ S AFR MED J, V92, P907; deMoraesPinto MI, 1996, J INFECT DIS, V173, P1077, DOI 10.1093/infdis/173.5.1077; Duke T, 2002, LANCET, V359, P474, DOI 10.1016/S0140-6736(02)07677-8; Falade AG, 1997, ANN TROP PAEDIATR, V17, P315, DOI 10.1080/02724936.1997.11747904; FORGIE IM, 1991, PEDIATR INFECT DIS J, V10, P42, DOI 10.1097/00006454-199101000-00009; FORGIE IM, 1992, PEDIATR INFECT DIS J, V11, P466, DOI 10.1097/00006454-199206000-00009; FORGIE IM, 1991, PEDIATR INFECT DIS J, V10, P33, DOI 10.1097/00006454-199101000-00008; Gilks CF, 1997, T ROY SOC TROP MED H, V91, P627, DOI 10.1016/S0035-9203(97)90498-3; Graham SM, 2000, LANCET, V355, P369, DOI 10.1016/S0140-6736(98)11074-7; Heresi GP, 1997, CLIN INFECT DIS, V25, P739, DOI 10.1086/516938; Jeena PM, 1996, ANN TROP PAEDIATR, V16, P361, DOI 10.1080/02724936.1996.11747852; Kuhn L, 2005, CLIN INFECT DIS, V41, P1654, DOI 10.1086/498029; Lucas SB, 1996, E AFR MED J, V73, pS7; Madhi SA, 2000, CLIN INFECT DIS, V31, P170, DOI 10.1086/313925; Mann M, 1997, AM J RESP CRIT CARE, V155, P1723, DOI 10.1164/ajrccm.155.5.9154883; Martin M, 2004, PEDIATR INFECT DIS J, V23, P842, DOI 10.1097/01.inf.0000137575.82874.0c; McNally LM, 2005, AIDS, V19, P1548, DOI 10.1097/01.aids.0000183941.67730.3a; Mermin J, 2005, AIDS, V19, P1035, DOI 10.1097/01.aids.0000174449.32756.c7; NATHOO KJ, 1993, ANN TROP PAEDIATR, V13, P253, DOI 10.1080/02724936.1993.11747655; Nesheim S, 2003, JAIDS-J ACQ IMM DEF, V32, P192, DOI 10.1097/00126334-200302010-00011; Nielsen SD, 2001, BLOOD, V98, P398, DOI 10.1182/blood.V98.2.398; Pillay T, 2004, LANCET INFECT DIS, V4, P155, DOI 10.1016/S1473-3099(04)00939-9; PRINSLOO JG, 1974, S AFR MED J, V48, P597; *S AFR NAT DEP HLT, 2002, ANT SYPH HIV SER DAT; SCHINDLER MB, 1994, ANAESTH INTENS CARE, V22, P66, DOI 10.1177/0310057X9402200111; Shann F, 2001, LANCET, V357, P2070, DOI 10.1016/S0140-6736(00)05226-0; Sherman GG, 2005, PEDIATR INFECT DIS J, V24, P993, DOI 10.1097/01.inf.0000187036.73539.8d; Smyth A, 1997, ARCH DIS CHILD, V77, P227, DOI 10.1136/adc.77.3.227; Statistics South Africa, 2001, NAT CENS; *WHO, 1990, 5 WHO PROGR CONTR AC; *WHO BOST U, 2004, MAN CHILDR PNEUM HIV; Williams AJ, 2001, AIDS, V15, P335, DOI 10.1097/00002030-200102160-00006; Woolfson A, 1997, B WORLD HEALTH ORGAN, V75, P453; Zar Heather J., 2001, Pediatr Crit Care Med, V2, P108, DOI 10.1097/00130478-200104000-00003; Zar HJ, 2001, ACTA PAEDIATR, V90, P119, DOI 10.1080/080352501300049163; Zwi K, 2000, ARCH DIS CHILD, V83, P227, DOI 10.1136/adc.83.3.227	43	205	207	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2007	369	9571					1440	1451		10.1016/S0140-6736(07)60670-9	http://dx.doi.org/10.1016/S0140-6736(07)60670-9			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161LW	17467514				2022-12-01	WOS:000246017700030
J	Mucida, D; Park, Y; Kim, G; Turovskaya, O; Scott, I; Kronenberg, M; Cheroutre, H				Mucida, Daniel; Park, Yunji; Kim, Gisen; Turovskaya, Olga; Scott, Iain; Kronenberg, Mitchell; Cheroutre, Hilde			Reciprocal T(H)17 and regulatory T cell differentiation mediated by retinoic acid	SCIENCE			English	Article							TGF-BETA; INFLAMMATION; GENERATION; FOXP3	The cytokine transforming growth factor-beta (TGF-beta) converts naive T cells into regulatory T (Treg) cells that prevent autoimmunity. However, in the presence of interleukin-6 (IL-6), TGF-beta has also been found to promote the differentiation of naive T lymphocytes into proinflammatory IL-17 cytokine-producing T helper 17 (TH17) cells, which promote autoimmunity and inflammation. This raises the question of how TGF-beta can generate such distinct outcomes. We identified the vitamin A metabolite retinoic acid as a key regulator of TGF-beta-dependent immune responses, capable of inhibiting the IL-6-driven induction of proinflammatory TH17 cells and promoting anti-inflammatory Treg cell differentiation. These findings indicate that a common metabolite can regulate the balance between pro- and anti-inflammatory immunity.	La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA	La Jolla Institute for Immunology	Cheroutre, H (corresponding author), La Jolla Inst Allergy & Immunol, 9420 Athena Circle, La Jolla, CA 92037 USA.	hilde@liai.org	Eckhardt, Erik/G-1567-2010; Kronenberg, Mitchell/AAT-6078-2021	Mucida, Daniel/0000-0002-0000-0452; Park, Yunji/0000-0003-0042-202X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050265] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI050265-06] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Furuzawa-Carballeda J, 2007, AUTOIMMUN REV, V6, P169, DOI 10.1016/j.autrev.2006.10.002; Hadley GA, 1997, J IMMUNOL, V159, P3748; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Li Y, 1999, J BIOL CHEM, V274, P15360, DOI 10.1074/jbc.274.22.15360; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; SOMMER A, 1993, J INFECT DIS, V167, P1003, DOI 10.1093/infdis/167.5.1003; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001	17	1486	1592	2	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2007	317	5835					256	260		10.1126/science.1145697	http://dx.doi.org/10.1126/science.1145697			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189DC	17569825				2022-12-01	WOS:000247968600046
J	Borg, NA; Wun, KS; Kjer-Nielsen, L; Wilce, MCJ; Pellicci, DG; Koh, R; Besra, GS; Bharadwaj, M; Godfrey, DI; McCluskey, J; Rossjohn, J				Borg, Natalie A.; Wun, Kwok S.; Kjer-Nielsen, Lars; Wilce, Matthew C. J.; Pellicci, Daniel G.; Koh, Ruide; Besra, Gurdyal S.; Bharadwaj, Mandvi; Godfrey, Dale I.; McCluskey, James; Rossjohn, Jamie			CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor	NATURE			English	Article							ALPHA-GALACTOSYLCERAMIDE; ANTIGEN PRESENTATION; STRUCTURAL BASIS; HIGH-AFFINITY; HUMAN CD1D; TCR; SELECTION; COMPLEX; BINDING; GLYCOSPHINGOLIPIDS	The CD1 family is a large cluster of non-polymorphic, major histocompatibility complex (MHC) class-I-like molecules that bind distinct lipid-based antigens that are recognized by T cells. The most studied group of T cells that interact with lipid antigens are natural killer T (NKT) cells, which characteristically express a semi-invariant T-cell receptor ( NKT TCR) that specifically recognizes the CD1 family member, CD1d. NKT-cell-mediated recognition of the CD1d - antigen complex has been implicated in microbial immunity, tumour immunity, autoimmunity and allergy. Here we describe the structure of a human NKT TCR in complex with CD1d bound to the potent NKT-cell agonist alpha-galactosylceramide, the archetypal CD1d-restricted glycolipid. In contrast to T-cell receptor - peptide- antigen - MHC complexes, the NKT TCR docked parallel to, and at the extreme end of the CD1d-binding cleft, which enables a lock-and-key type interaction with the lipid antigen. The structure provides a basis for the interaction between the highly conserved NKT TCR alpha-chain and the CD1d - antigen complex that is typified in innate immunity, and also indicates how variability of the NKT TCR beta-chain can impact on recognition of other CD1d - antigen complexes. These findings provide direct insight into how a T-cell receptor recognizes a lipid-antigen-presenting molecule of the immune system.	Monash Univ, Prot Crystallog Unit, ARC Ctr Excellence Struct & Funct Microbial Genom, Dept Biochem & Mol Biol,Sch Biomed Sci, Clayton, Vic 3800, Australia; Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	Monash University; University of Melbourne; University of Birmingham	Rossjohn, J (corresponding author), Monash Univ, Prot Crystallog Unit, ARC Ctr Excellence Struct & Funct Microbial Genom, Dept Biochem & Mol Biol,Sch Biomed Sci, Clayton, Vic 3800, Australia.	jamesm1@unimelb.edu.au; jamie.rossjohn@med.monash.edu.au	Pellicci, Daniel/AAX-8539-2020; Bharadwaj, Mandvi/C-4446-2014; Rossjohn, Jamie/F-9032-2013; McCluskey, James/A-1291-2007	Rossjohn, Jamie/0000-0002-2020-7522; McCluskey, James/0000-0002-8597-815X; Pellicci, Daniel/0000-0001-5305-2398; Godfrey, Dale/0000-0002-3009-5472; Wun, Kwok/0000-0002-1908-4596; Besra, Gurdyal/0000-0002-5605-0395; Borg, Natalie/0000-0002-8677-9056	Medical Research Council [G0400421] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0400421] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Burdin N, 2000, P NATL ACAD SCI USA, V97, P10156, DOI 10.1073/pnas.97.18.10156; Cantu C, 2003, J IMMUNOL, V170, P4673, DOI 10.4049/jimmunol.170.9.4673; Clements CS, 2006, CURR OPIN STRUC BIOL, V16, P787, DOI 10.1016/j.sbi.2006.09.004; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; DELLABONA P, 1994, J EXP MED, V180, P1171, DOI 10.1084/jem.180.3.1171; FISCHER B, 1985, FERTILITAT, V1, P101; Gadola SD, 2006, J EXP MED, V203, P699, DOI 10.1084/jem.20052369; Gadola SD, 2002, J IMMUNOL, V168, P5514, DOI 10.4049/jimmunol.168.11.5514; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Godfrey DI, 2005, NAT IMMUNOL, V6, P754, DOI 10.1038/ni0805-754; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Kamada N, 2001, INT IMMUNOL, V13, P853, DOI 10.1093/intimm/13.7.853; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Kjer-Nielsen L, 2006, J EXP MED, V203, P661, DOI 10.1084/jem.20051777; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; PORCELLI S, 1993, J EXP MED, V178, P1, DOI 10.1084/jem.178.1.1; Pyz E, 2006, J IMMUNOL, V176, P7447, DOI 10.4049/jimmunol.176.12.7447; Rauch J, 2003, J BIOL CHEM, V278, P47508, DOI 10.1074/jbc.M308089200; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Schumann J, 2005, J IMMUNOL, V175, P7303, DOI 10.4049/jimmunol.175.11.7303; Schumann J, 2003, J IMMUNOL, V170, P5815, DOI 10.4049/jimmunol.170.12.5815; Sidobre S, 2002, J IMMUNOL, V169, P1340, DOI 10.4049/jimmunol.169.3.1340; Sidobre S, 2004, P NATL ACAD SCI USA, V101, P12254, DOI 10.1073/pnas.0404632101; Sriram V, 2005, EUR J IMMUNOL, V35, P1692, DOI 10.1002/eji.200526157; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Wu DY, 2003, J EXP MED, V198, P173, DOI 10.1084/jem.20030446; Zajonc DM, 2005, NAT IMMUNOL, V6, P810, DOI 10.1038/ni1224; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	36	464	506	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2007	448	7149					44	49		10.1038/nature05907	http://dx.doi.org/10.1038/nature05907			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185OS	17581592				2022-12-01	WOS:000247720900033
J	Sarkar, I; Hauber, I; Hauber, J; Buchholz, F				Sarkar, Indrani; Hauber, Ilona; Hauber, Joachim; Buchholz, Frank			HIV-1 proviral DNA excision using an evolved recombinase	SCIENCE			English	Article							SITE-SPECIFIC RECOMBINATION; LONG TERMINAL REPEAT; CRE RECOMBINASE; ANTIRETROVIRAL THERAPY; INFECTION; EVOLUTION; REPLICATION; SPECIFICITY; RESISTANCE; INHIBITOR	HIV-1 integrates into the host chromosome and persists as a provirus flanked by long terminal repeats (LTRs). To date, treatment regimens primarily target the virus enzymes or virus-cell fusion, but not the integrated provirus. We report here the substrate-linked protein evolution of a tailored recombinase that recognizes an asymmetric sequence within an HIV-1 LTR. This evolved recombinase efficiently excised integrated HIV proviral DNA from the genome of infected cells. Although a long way from use in the clinic, we speculate that this type of technology might be adapted in future antiretroviral therapies, among other possible uses.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Heinrich Pette Inst Expt Virol & Immunol, D-20251 Hamburg, Germany	Max Planck Society; Heinrich Pette Institute	Hauber, J (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	joachim.hauber@hpi.uni-hamburg.de; buchholz@mpi-cbg.de	Buchholz, Frank/B-4700-2017	Buchholz, Frank/0000-0002-4577-3344				Akoplan A, 2005, ADV GENET, V55, P1, DOI 10.1016/S0065-2660(05)55001-6; Blackard JT, 1999, VIROLOGY, V254, P220, DOI 10.1006/viro.1998.9504; Bloom JD, 2005, CURR OPIN STRUC BIOL, V15, P447, DOI 10.1016/j.sbi.2005.06.004; Buchholz F, 2001, NAT BIOTECHNOL, V19, P1047, DOI 10.1038/nbt1101-1047; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Donzella GA, 1998, NAT MED, V4, P72, DOI 10.1038/nm0198-072; Emerman M, 1998, SCIENCE, V280, P1880, DOI 10.1126/science.280.5371.1880; Flowers CC, 1997, J VIROL, V71, P2685, DOI 10.1128/JVI.71.4.2685-2692.1997; Glaser S, 2005, NAT GENET, V37, P1187, DOI 10.1038/ng1668; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hauber I, 2005, J CLIN INVEST, V115, P76, DOI 10.1172/JCI200521949; Hazuda DJ, 2004, SCIENCE, V305, P528, DOI 10.1126/science.1098632; Huthoff H, 2005, VIROLOGY, V334, P147, DOI 10.1016/j.virol.2005.01.038; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lee YS, 1998, BIOCHEM BIOPH RES CO, V253, P588, DOI 10.1006/bbrc.1998.9814; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Matsumura I, 2001, J MOL BIOL, V305, P331, DOI 10.1006/jmbi.2000.4259; Rufer AW, 2002, NUCLEIC ACIDS RES, V30, P2764, DOI 10.1093/nar/gkf399; Santoro SW, 2002, P NATL ACAD SCI USA, V99, P4185, DOI 10.1073/pnas.022039799; Saraf-Levy T, 2006, BIOORGAN MED CHEM, V14, P3081, DOI 10.1016/j.bmc.2005.12.016; Van Duyne GD, 2001, ANNU REV BIOPH BIOM, V30, P87, DOI 10.1146/annurev.biophys.30.1.87	23	147	161	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2007	316	5833					1912	1915		10.1126/science.1141453	http://dx.doi.org/10.1126/science.1141453			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183WI	17600219				2022-12-01	WOS:000247602700044
J	Yang, T; Shadlen, MN				Yang, Tianming; Shadlen, Michael N.			Probabilistic reasoning by neurons	NATURE			English	Article							LATERAL INTRAPARIETAL AREA; POSTERIOR PARIETAL CORTEX; DEVELOPING OCULOMOTOR COMMANDS; PERCEPTUAL DECISION; VISUAL-CORTEX; SENSORY STIMULI; PREMOTOR CORTEX; MACAQUE MONKEY; REPRESENTATION; TASK	Our brains allow us to reason about alternatives and to make choices that are likely to pay off. Often there is no one correct answer, but instead one that is favoured simply because it is more likely to lead to reward. A variety of probabilistic classification tasks probe the covert strategies that humans use to decide among alternatives based on evidence that bears only probabilistically on outcome. Here we show that rhesus monkeys can also achieve such reasoning. We have trained two monkeys to choose between a pair of coloured targets after viewing four shapes, shown sequentially, that governed the probability that one of the targets would furnish reward. Monkeys learned to combine probabilistic information from the shape combinations. Moreover, neurons in the parietal cortex reveal the addition and subtraction of probabilistic quantities that underlie decision-making on this task.	Univ Washington, Howard Hughes Med Inst, Dept Physiol & Biophys, Natl Primate Res Ctr, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Yang, T (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Physiol & Biophys, Natl Primate Res Ctr, Box 357290, Seattle, WA 98195 USA.	tianming@u.washington.edu; shadlen@u.washington.edu	Yang, Tianming/D-3582-2014; Shadlen, Michael Neil/AAL-1870-2020	Yang, Tianming/0000-0001-6976-9246; Shadlen, Michael/0000-0002-2002-2210	NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011378] Funding Source: NIH RePORTER; NCRR NIH HHS [P51 RR000166] Funding Source: Medline; NEI NIH HHS [R01 EY011378] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BARLOW H, 1990, VISION RES, V30, P1561, DOI 10.1016/0042-6989(90)90144-A; Bisley JW, 2004, J NEUROSCI, V24, P1833, DOI 10.1523/JNEUROSCI.5007-03.2004; Bracewell RM, 1996, J NEUROPHYSIOL, V76, P1457, DOI 10.1152/jn.1996.76.3.1457; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Ditterich J, 2003, NAT NEUROSCI, V6, P891, DOI 10.1038/nn1094; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; GEISLER WS, 1997, VISUAL CORTEX NEURON, P897; Glimcher PW, 2003, ANNU REV NEUROSCI, V26, P133, DOI 10.1146/annurev.neuro.26.010302.081134; Gluck MA, 2002, LEARN MEMORY, V9, P408, DOI 10.1101/lm.45202; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Gold JI, 2003, J NEUROSCI, V23, P632, DOI 10.1523/JNEUROSCI.23-02-00632.2003; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gold JI, 2002, NEURON, V36, P299, DOI 10.1016/S0896-6273(02)00971-6; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; GOOD IJ, 1979, BIOMETRIKA, V66, P393, DOI 10.1093/biomet/66.2.393; GREEN DM, 1966, SIGNAL DETECTION THE; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Hanks TD, 2006, BAYESIAN BRAIN PROBA, P209, DOI [10.7551/mitpress/9780262042383.003.0010, DOI 10.7551/MITPRESS/9780262042383.003.0010]; Hayes A, 1982, WESCON C P, V2, P1; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1268; Holmes P, 2005, IEICE T FUND ELECTR, VE88A, P2496, DOI 10.1093/ietfec/e88.a.10.2496; Horwitz GD, 2004, J NEUROPHYSIOL, V91, P2281, DOI 10.1152/jn.00872.2003; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Ipata AE, 2006, J NEUROSCI, V26, P3656, DOI 10.1523/JNEUROSCI.5074-05.2006; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Knowlton B J, 1994, Learn Mem, V1, P106; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; LINK SW, 1975, PSYCHOMETRIKA, V40, P77, DOI 10.1007/BF02291481; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Roitman JD, 2002, J NEUROSCI, V22, P9475; Romo R, 2004, NEURON, V41, P165, DOI 10.1016/S0896-6273(03)00817-1; Schall JD, 2003, CURR OPIN NEUROBIOL, V13, P182, DOI 10.1016/S0959-4388(03)00039-4; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Sereno AB, 2006, J NEUROPHYSIOL, V95, P1078, DOI 10.1152/jn.00431.2005; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; Wald A, 1947, SEQUENTIAL ANAL; Wise SP, 1999, HIPPOCAMPUS, V9, P101, DOI 10.1002/(SICI)1098-1063(1999)9:2<101::AID-HIPO3>3.0.CO;2-L; ZOHARY E, 1994, NATURE, V370, P1405; ZOHARY E, 1994, NATURE, V371, P6495	57	337	344	3	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2007	447	7148					1075	U2		10.1038/nature05852	http://dx.doi.org/10.1038/nature05852			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183HT	17546027				2022-12-01	WOS:000247564600030
J	Khuri, FR				Khuri, Fadlo R.			Weighing the hazards of erythropoirsis stimulation in patients with cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DOUBLE-BLIND		Emory Winship Canc Inst, Atlanta, GA USA		Khuri, FR (corresponding author), Emory Winship Canc Inst, Atlanta, GA USA.		Khuri, Fadlo R./AAU-4942-2020	Khuri, Fadlo R./0000-0002-8638-7618				Goldberg P, 2007, CANC LETT, V33, P1; Henke, 2007, J CLIN ONCOL, V25, P1457, DOI 10.1200/JCO.2007.11.6244; Henke M, 2003, LANCET, V362, P1255, DOI 10.1016/S0140-6736(03)14567-9; Henke M, 2006, J CLIN ONCOL, V24, P4708, DOI 10.1200/JCO.2006.06.2737; Leyland-Jones B, 2005, J CLIN ONCOL, V23, P5960, DOI 10.1200/JCO.2005.06.150; Wright JR, 2007, J CLIN ONCOL, V25, P1027, DOI 10.1200/JCO.2006.07.1514	6	83	93	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 14	2007	356	24					2445	2448		10.1056/NEJMp078101	http://dx.doi.org/10.1056/NEJMp078101			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	178DR	17568023				2022-12-01	WOS:000247201900001
J	Nijnik, A; Woodbine, L; Marchetti, C; Dawson, S; Lambe, T; Liu, C; Rodrigues, NP; Crockford, TL; Cabuy, E; Vindigni, A; Enver, T; Bell, JI; Slijepcevic, P; Goodnow, CC; Jeggo, PA; Cornall, RJ				Nijnik, Anastasia; Woodbine, Lisa; Marchetti, Caterina; Dawson, Sara; Lambe, Teresa; Liu, Cong; Rodrigues, Neil P.; Crockford, Tanya L.; Cabuy, Erik; Vindigni, Alessandro; Enver, Tariq; Bell, John I.; Slijepcevic, Predrag; Goodnow, Christopher C.; Jeggo, Penelope A.; Cornall, Richard J.			DNA repair is limiting for haematopoietic stem cells during ageing	NATURE			English	Article							STRAND BREAK REPAIR; LIGASE-IV; COMBINED IMMUNODEFICIENCY; MUTATIONS; TELOMERE; IDENTIFICATION; LETHALITY; MECHANISM; APOPTOSIS; COMPLEX	Accumulation of DNA damage leading to adult stem cell exhaustion has been proposed to be a principal mechanism of ageing. Here we address this question by taking advantage of the highly specific role of DNA ligase IV in the repair of DNA double-strand breaks by non-homologous end-joining, and by the discovery of a unique mouse strain with a hypomorphic Lig4(Y288C) mutation. The Lig4(Y288C) mouse, identified by means of a mutagenesis screening programme, is a mouse model for human LIG4 syndrome, showing immunodeficiency and growth retardation. Diminished DNA double-strand break repair in the Lig4(Y288C) strain causes a progressive loss of haematopoietic stem cells and bone marrow cellularity during ageing, and severely impairs stem cell function in tissue culture and transplantation. The sensitivity of haematopoietic stem cells to non-homologous end-joining deficiency is therefore a key determinant of their ability to maintain themselves against physiological stress over time and to withstand culture and transplantation.	Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; Univ Oxford, Oxford OX3 9DU, England; Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; Australian Natl Univ, Australia & Australian Phenom Facil, Australian Canc Res Fdn Genet Lab, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DS, England; Brunel Univ, Brunel Inst Canc Genet & Pharmacogenom, Uxbridge UB8 3PH, Middx, England	University of Sussex; University of Oxford; International Center for Genetic Engineering & Biotechnology (ICGEB); Australian National University; John Curtin School of Medical Research; University of Oxford; Brunel University	Jeggo, PA (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England.	p.a.jeggo@sussex.ac.uk; richard.cornall@ndm.ox.ac.uk	Goodnow, Christopher C/V-8108-2018; Liu, Cong/GOE-5572-2022; Nijnik, Anastasia/W-2697-2019; Lambe, Teresa/E-5733-2016	Goodnow, Christopher C/0000-0001-5296-6155; Liu, Cong/0000-0001-5192-6784; Lambe, Teresa/0000-0001-7711-897X; Rodrigues, Neil/0000-0002-1925-7733	MRC [G0500897, MC_U137973817, MC_U137884178] Funding Source: UKRI; Medical Research Council [MC_U137973817, G0500897, MC_U137884178] Funding Source: Medline; Wellcome Trust Funding Source: Medline; Medical Research Council [G0300662B] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Barnes DE, 1998, CURR BIOL, V8, P1395, DOI 10.1016/S0960-9822(98)00021-9; Becker KA, 2007, J CELL PHYSIOL, V210, P517, DOI 10.1002/jcp.20903; Ben-Omran TI, 2005, AM J MED GENET A, V137A, P283, DOI 10.1002/ajmg.a.30869; Bender CF, 2002, GENE DEV, V16, P2237, DOI 10.1101/gad.1007902; Bhattacharya D, 2006, J EXP MED, V203, P73, DOI 10.1084/jem.20051714; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Cabuy E, 2004, CYTOM PART A, V62A, P150, DOI 10.1002/cyto.a.20096; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; di Fagagna FD, 2001, CURR BIOL, V11, P1192, DOI 10.1016/S0960-9822(01)00328-1; Dumble M, 2007, BLOOD, V109, P1736, DOI 10.1182/blood-2006-03-010413; Enders A, 2006, J IMMUNOL, V176, P5060, DOI 10.4049/jimmunol.176.8.5060; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Girard PM, 2004, HUM MOL GENET, V13, P2369, DOI 10.1093/hmg/ddh274; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; Gruhn B, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-5; Hasty P, 2004, AGING CELL, V3, P55, DOI 10.1111/j.1474-9728.2004.00082.x; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P12454, DOI 10.1073/pnas.96.22.12454; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Karanjawala ZE, 2002, CURR BIOL, V12, P397, DOI 10.1016/S0960-9822(02)00684-X; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Marchetti C, 2006, DNA REPAIR, V5, P788, DOI 10.1016/j.dnarep.2006.03.011; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Nelms KA, 2001, IMMUNITY, V15, P409, DOI 10.1016/S1074-7613(01)00199-6; O'Driscoll M, 2001, MOL CELL, V8, P1175, DOI 10.1016/S1097-2765(01)00408-7; OKADA S, 1992, BLOOD, V80, P3044; Orelio C, 2007, LEUKEMIA LYMPHOMA, V48, P16, DOI 10.1080/10428190601032529; Park Y, 2005, ANNU REV MED, V56, P495, DOI 10.1146/annurev.med.56.082103.104546; Quwailid MM, 2004, MAMM GENOME, V15, P585, DOI 10.1007/s00335-004-2379-z; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Rodriguez-Lopez J, 2005, LECT SER COMPUTER CO, V2, P106; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Sekiguchi JM, 2006, CELL, V124, P260, DOI 10.1016/j.cell.2006.01.010; Toita N, 2007, AM J MED GENET A, V143A, P742, DOI 10.1002/ajmg.a.31644; van der Burg M, 2006, J CLIN INVEST, V116, P137, DOI 10.1172/JCI26121; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Weterings E, 2004, DNA REPAIR, V3, P1425, DOI 10.1016/j.dnarep.2004.06.003	42	411	432	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 7	2007	447	7145					686	U9		10.1038/nature05875	http://dx.doi.org/10.1038/nature05875			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175RI	17554302				2022-12-01	WOS:000247030700037
J	Radelet, S; Siddiqi, B				Radelet, Steven; Siddiqi, Bilal			Global Fund grant programmes: an analysis of evaluation scores	LANCET			English	Article								Background The Global Fund to Fight AIDS, Tuberculosis and Malaria evaluates programme performance after 2 years to help decide whether to continue funding. We aimed to identify the correlation between programme evaluation scores and characteristics of the programme, the health sector, and the recipient country. Methods We obtained data on the first 140 Global Fund grants evaluated in 2006, and analysed 134 of these. We used an ordered probit multivariate analysis to link evaluation scores to different characteristics, allowing us to record the association between changes in those characteristics and the probability of a programme receiving a particular evaluation score. Findings Programmes that had government agencies as principal recipients, had a large amount of funding, were focused on malaria, had weak initial proposals, or were evaluated by the accounting firm KPMG, scored lowest. Countries with a high number of doctors per head, high measles immunisation rates, few health-sector donors, and high disease-prevalence rates had higher evaluation scores. Poor countries, those with small government budget deficits, and those that have or have had socialist governments also received higher scores. Interpretation Our results show associations, not causality, and they focus on evaluation scores rather than actual performance of the programmes. Yet they provide some early indications of characteristics that can help the Global Fund identify and monitor programmes that might be at risk. The results should not be used to influence the distribution of funding, but rather to allocate resources for oversight and risk management.	Ctr Global Dev, Washington, DC 20036 USA		Radelet, S (corresponding author), Ctr Global Dev, 1776 Massachusetts Ave NW, Washington, DC 20036 USA.	sradelet@cgdev.org						*AIDSPAN, 2005, AN GLOB FUND GRANTS; Gauri V, 2002, WORLD DEV, V30, P2109, DOI 10.1016/S0305-750X(02)00151-1; *GLOB FUND FIGHT A, 2006, INV IMP MID RES REP; *GLOB FUND FIGHT A, 2005, 3 GFATM; *GLOB FUND FIGHT A, TUB MAL PHAS 2 GRANT; *GLOB FUND FIGHT A, CURR GRNT COMM DISB; Lu C, 2006, LANCET, V368, P483, DOI 10.1016/S0140-6736(06)69156-3; Radelet S., 2004, GLOBAL FUND FIGHT AI; *TECHN EV REF GROU, 2005, REP ASS COUNTR COORD; *US GOV ACC OFF, 2005, GLOB FUND FIGHT AIDS; *WORLD BANK, 2006, WORLDW GOV IND	11	20	20	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 26	2007	369	9575					1807	1813		10.1016/S0140-6736(07)60818-6	http://dx.doi.org/10.1016/S0140-6736(07)60818-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	172QP	17531888				2022-12-01	WOS:000246819300031
J	Gullison, RE; Frumhoff, PC; Canadell, JG; Field, CB; Nepstad, DC; Hayhoe, K; Avissar, R; Curran, LM; Friedlingstein, P; Jones, CD; Nobre, C				Gullison, Raymond E.; Frumhoff, Peter C.; Canadell, Josep G.; Field, Christopher B.; Nepstad, Daniel C.; Hayhoe, Katharine; Avissar, Roni; Curran, Lisa M.; Friedlingstein, Pierre; Jones, Chris D.; Nobre, Carlos			Tropical forests and climate policy	SCIENCE			English	Editorial Material									Union Concerned Sci, Cambridge, MA 02238 USA; Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada; CSIRO Marine & Atmospher Res, Global Carbon Project, Canberra, ACT 2601, Australia; Carnegie Inst, Dept Global Ecol, Stanford, CA 94305 USA; Woods Hole Res Ctr, Woods Hole, MA 02543 USA; Texas Tech Univ, Dept Geosci, Lubbock, TX 79409 USA; Duke Univ, Dept Civil & Environm Engn, Durham, NC 27708 USA; YAle Sch Forestry & Environm Studies, Trop Resources Inst, New Haven, CT 06511 USA; CEA, CNRS, Unite Mixte Rech 1572, Lab Sci Climate & Environm IPSL LSCE, F-91191 Gif Sur Yvette, France; Hadley Ctr Climate Predict & Res, Met Off, Exeter EX1 3PB, Devon, England; CPTEC, Cachoeira Paulista, SP, Brazil	University of British Columbia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Carnegie Institution for Science; Woods Hole Research Center; Texas Tech University System; Texas Tech University; Duke University; Yale University; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Met Office - UK; Hadley Centre; Instituto Nacional de Pesquisas Espaciais (INPE)	Gullison, RE (corresponding author), Union Concerned Sci, Cambridge, MA 02238 USA.		Jones, Chris/I-2983-2014; Friedlingstein, Pierre/H-2700-2014; Canadell, Pep/E-9419-2010	Jones, Chris/0000-0002-7141-9285; Friedlingstein, Pierre/0000-0003-3309-4739; Canadell, Pep/0000-0002-8788-3218				CHOMITZ K, 2006, LOGGERHEADS AGR EXPA; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Gitz V, 2004, CLIMATIC CHANGE, V67, P161, DOI 10.1007/s10584-004-0065-5; Houghton R.A., 2005, TROPICAL DEFORESTATI, P13; Kauppi PE, 2006, P NATL ACAD SCI USA, V103, P17574, DOI 10.1073/pnas.0608343103; Laurance WF, 2007, BIOTROPICA, V39, P20, DOI 10.1111/j.1744-7429.2006.00229.x; Moutinho P., 2005, TROPICAL DEFORESTATI; NABUURS GJ, IN PRESS CLIMATE CHA, pCH9; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; Sabine CL, 2004, SCOPE SER, V62, P17; Scholze M, 2006, P NATL ACAD SCI USA, V103, P13116, DOI 10.1073/pnas.0601816103; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; Stern N, 2006, EC CLIMATE CHANGE ST; UNFCCC, 2007, 2 WORKSH RED EM DEF; *UNFCCC, 2005, C PART MONTR 28 NOV; UNFCCC, 2006, 1A UNFCCC; UNFCCC, 2007, SUBS BOD SCI TECHN A; van der Werf GR, 2004, SCIENCE, V303, P73, DOI 10.1126/science.1090753	18	318	326	4	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					985	986		10.1126/science.1136163	http://dx.doi.org/10.1126/science.1136163			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	168WF	17495140				2022-12-01	WOS:000246554000029
J	Saadat, I; Higashi, H; Obuse, C; Umeda, M; Murata-Kamiya, N; Saito, Y; Lu, HS; Ohnishi, N; Azuma, T; Suzuki, A; Ohno, S; Hatakeyama, M				Saadat, Iraj; Higashi, Hideaki; Obuse, Chikashi; Umeda, Mayumi; Murata-Kamiya, Naoko; Saito, Yasuhiro; Lu, Huaisheng; Ohnishi, Naomi; Azuma, Takeshi; Suzuki, Atsushi; Ohno, Shigeo; Hatakeyama, Masanori			Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity	NATURE			English	Article							VIRULENCE FACTOR CAGA; ELEGANS EMBRYOS; PROTEIN; LOCALIZATION; MARK/PAR-1; MUTATIONS; PAR-1; ESTABLISHMENT; LEUKEMIA; GENE	Helicobacter pylori cagA-positive strains are associated with gastritis, ulcerations and gastric adenocarcinoma(1). CagA is delivered into gastric epithelial cells(2) and, on tyrosine phosphorylation, specifically binds and activates the SHP2 oncoprotein(3-7), thereby inducing the formation of an elongated cell shape known as the 'hummingbird' phenotype(2,3). In polarized epithelial cells, CagA also disrupts the tight junction and causes loss of apical basolateral polarity(8,9). We show here that H. pylori CagA specifically interacts with PAR1/MARK kinase, which has an essential role in epithelial cell polarity(10,11). Association of CagA inhibits PAR1 kinase activity and prevents atypical protein kinase C ( aPKC)-mediated PAR1 phosphorylation, which dissociates PAR1 from the membrane(12,13), collectively causing junctional and polarity defects. Because of the multimeric nature of PAR1 (ref. 14), PAR1 also promotes CagA multimerization, which stabilizes the CagA - SHP2 interaction(15). Furthermore, induction of the hummingbird phenotype by CagA-activated SHP2 requires simultaneous inhibition of PAR1 kinase activity by CagA. Thus, the CagA - PAR1 interaction not only elicits the junctional and polarity defects but also promotes the morphogenetic activity of CagA. Our findings revealed that PAR1 is a key target of H. pylori CagA in the disorganization of gastric epithelial architecture underlying mucosal damage, inflammation and carcinogenesis.	Hokkaido Univ, Grad Sch Sci, Inst Med Genet, Div Mol Oncol, Sapporo, Hokkaido 0600815, Japan; Hokkaido Univ, Grad Sch Sci, Div Chem, Sapporo, Hokkaido 0600815, Japan; Hokkaido Univ, Grad Sch Life Sci, Div Mol Life Sci, Sapporo, Hokkaido 0010021, Japan; Kobe Univ, Grad Sch Med, Internal Ctr Med Res & Treatment, Kobe, Hyogo 6500017, Japan; Yokohama City Univ, Grad Sch Med Sci, Dept Mol Biol, Yokohama, Kanagawa 2360004, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Kobe University; Yokohama City University	Hatakeyama, M (corresponding author), Hokkaido Univ, Grad Sch Sci, Inst Med Genet, Div Mol Oncol, Sapporo, Hokkaido 0600815, Japan.	mhata@igm.hokudai.ac.jp	Obuse, Chikashi/F-5273-2011; Ohno, Shigeo/B-1768-2010; OHNISHI, Naomi/F-6914-2012; Higashi, Hideaki/F-6872-2012	Ohno, Shigeo/0000-0002-1294-5269; OHNISHI, Naomi/0000-0002-2382-3152; Saadat, Iraj/0000-0002-8169-4707				Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Bagnoli F, 2005, P NATL ACAD SCI USA, V102, P16339, DOI 10.1073/pnas.0502598102; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Bohm H, 1997, CURR BIOL, V7, P603, DOI 10.1016/S0960-9822(06)00260-0; Churin Y, 2003, J CELL BIOL, V161, P249, DOI 10.1083/jcb.200208039; Cohen D, 2004, J CELL BIOL, V164, P717, DOI 10.1083/jcb.200308104; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Higashi H, 2005, J BIOL CHEM, V280, P23130, DOI 10.1074/jbc.M503583200; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0; NOACH LA, 1994, J CLIN PATHOL, V47, P699, DOI 10.1136/jcp.47.8.699; Panneerselvam S, 2006, STRUCTURE, V14, P173, DOI 10.1016/j.str.2005.09.022; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Ren SM, 2006, J BIOL CHEM, V281, P32344, DOI 10.1074/jbc.M606172200; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Suzuki M, 2005, J EXP MED, V202, P1235, DOI 10.1084/jem.20051027; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Watts JL, 1996, DEVELOPMENT, V122, P3133	30	353	366	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2007	447	7142					330	U8		10.1038/nature05765	http://dx.doi.org/10.1038/nature05765			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17507984				2022-12-01	WOS:000246520300048
J	Day, M				Day, Michael			Mapping the alternative	BRITISH MEDICAL JOURNAL			English	Article												miday@f2s.com						*DEP HLTH, 2007, TRUST ASS SAF REG HL; *HOUS LORDS SEL CO, 2000, 6 HOUS LORDS SEL COM; VANHERWEGHEM JL, 1993, LANCET, V341, P387, DOI 10.1016/0140-6736(93)92984-2; Vincent C, 2001, BRIT MED J, V323, P467, DOI 10.1136/bmj.323.7311.467	4	4	4	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 5	2007	334	7600					929	931		10.1136/bmj.39192.475382.AD	http://dx.doi.org/10.1136/bmj.39192.475382.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165YN	17478842	Green Published			2022-12-01	WOS:000246343800033
J	Coombes, R				Coombes, Rebecca			Bad blood	BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmjgroup.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 28	2007	334	7599					879	880		10.1136/bmj.39195.621528.59	http://dx.doi.org/10.1136/bmj.39195.621528.59			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164FB	17463458	Green Published			2022-12-01	WOS:000246217800026
J	Ferguson, SM; Brasnjo, G; Hayashi, M; Wolfel, M; Collesi, C; Giovedi, S; Raimondi, A; Gong, LW; Ariel, P; Paradise, S; O'Toole, E; Flavell, R; Cremona, O; Miesenbock, G; Ryan, TA; De Camilli, P				Ferguson, Shawn M.; Brasnjo, Gabor; Hayashi, Mitsuko; Woelfel, Markus; Collesi, Chiara; Giovedi, Silvia; Raimondi, Andrea; Gong, Liang-Wei; Ariel, Pablo; Paradise, Summer; O'Toole, Eileen; Flavell, Richard; Cremona, Ottavio; Miesenboeck, Gero; Ryan, Timothy A.; De Camilli, Pietro			A selective activity-dependent requirement for dynamin 1 in synaptic vesicle endocytosis	SCIENCE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; KISS-AND-RUN; TRANSMITTER RELEASE; MEMBRANE; MUTATIONS; PROTEINS; KINETICS; FUSION; MODES; BLOCK	Dynamin 1 is a neuron-specific guanosine triphosphatase thought to be critically required for the fission reaction of synaptic vesicle endocytosis. Unexpectedly, mice lacking dynamin 1 were able to form functional synapses, even though their postnatal viability was limited. However, during spontaneous network activity, branched, tubular plasma membrane invaginations accumulated, capped by clathrin-coated pits, in synapses of dynamin 1-knockout mice. Synaptic vesicle endocytosis was severely impaired during strong exogenous stimulation but resumed efficiently when the stimulus was terminated. Thus, dynamin 1-independent mechanisms can support limited synaptic vesicle endocytosis, but dynamin 1 is needed during high levels of neuronal activity.	Yale Univ, Sch Med, Howard Hughes Med Inst, Kavli Inst Neurosci, New Haven, CT 06510 USA; Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA; Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Rockefeller Univ, David Rockefeller Grad Program, New York, NY 10021 USA; FIRC Inst Mol Oncol Fdn, IFOM, Milan, Italy; Univ Vita Salute San Raffaele, Milan, Italy; Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder Lab Electron Microscopy Cells 3D, Boulder, CO 80309 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University; Cornell University; Rockefeller University; IFOM - FIRC Institute of Molecular Oncology; Vita-Salute San Raffaele University; University of Colorado System; University of Colorado Boulder	De Camilli, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Kavli Inst Neurosci, New Haven, CT 06510 USA.	pietro.decamilli@yale.edu	Raimondi, Andrea/AAN-2475-2020; Ryan, Timothy/AAO-8286-2020; Giovedì, Silvia/AAB-7614-2019; Collesi, Chiara/AAB-8979-2019; Cremona, Ottavio/AAB-8793-2019	Cremona, Ottavio/0000-0001-9462-1040; Raimondi, Andrea/0000-0002-4563-386X; GIOVEDI', SILVIA/0000-0001-7949-4274; COLLESI, CHIARA/0000-0003-3909-422X; Miesenboeck, Gero/0000-0003-2940-3228; Ariel, Pablo/0000-0002-8494-0379; Ryan, Timothy/0000-0003-2533-9548	NATIONAL CANCER INSTITUTE [P01CA046128] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036942, R01NS036251, R37NS036942, R37NS036251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017297, P30DA018343] Funding Source: NIH RePORTER; NCI NIH HHS [CA46128] Funding Source: Medline; NCRR NIH HHS [RR-000592] Funding Source: Medline; NIDA NIH HHS [DA018343, P30 DA018343, DA17297] Funding Source: Medline; NIDDK NIH HHS [DK45735] Funding Source: Medline; NINDS NIH HHS [NS036942, R01 NS036942, NS36251] Funding Source: Medline; Telethon [D.061] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon)		Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Cook T, 1996, J NEUROCHEM, V67, P927; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; Dickman DK, 2006, CURR BIOL, V16, P591, DOI 10.1016/j.cub.2006.02.058; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; Harata NC, 2006, J NEUROCHEM, V97, P1546, DOI 10.1111/j.1471-4159.2006.03987.x; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; ITOH T, 2000, BIOCHIM BIOPHYS ACTA, V1761, P897; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Larsen MR, 2004, MOL CELL PROTEOMICS, V3, P456, DOI 10.1074/mcp.M300105-MCP200; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Poskanzer KE, 2006, NEURON, V50, P49, DOI 10.1016/j.neuron.2006.02.021; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sever S, 2000, TRAFFIC, V1, P385, DOI 10.1034/j.1600-0854.2000.010503.x; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Wienisch M, 2006, NAT NEUROSCI, V9, P1019, DOI 10.1038/nn1739; Yamashita T, 2005, SCIENCE, V307, P124, DOI 10.1126/science.1103631; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9	36	374	388	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2007	316	5824					570	574		10.1126/science.1140621	http://dx.doi.org/10.1126/science.1140621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463283				2022-12-01	WOS:000245983100037
J	Obot, IS				Obot, Isidore S.			Limits of substance-use interventions in developing countries	LANCET			English	Editorial Material									Morgan State Univ, Sch Publ Hlth & Policy, Dept Behav Hlth Sci, Baltimore, MD 21251 USA	Morgan State University	Obot, IS (corresponding author), Morgan State Univ, Sch Publ Hlth & Policy, Dept Behav Hlth Sci, Baltimore, MD 21251 USA.	isobot@moac.morgan.edu	Obot, Isidore/AAZ-8477-2020	Obot, Isidore/0000-0002-7207-0652				[Anonymous], 2002, WORLD HLTH REP 2002; Babor T., 2003, ALCOHOL NO ORDINARY; Obot I. S., 2005, Substance use among young people in urban environments, P203; Obot IS, 2005, ADDICTION, V100, P1210, DOI 10.1111/j.1360-0443.2005.01156.x; Obot IS, 2004, SUBST USE MISUSE, V39, P1287, DOI 10.1081/JA-120038687; PARRY C.D.H., 2006, AFR J DRUG ALCOHOL S, V5, P41; TOURNBOUROU JW, 2007, LANCET	7	10	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2007	369	9570					1323	1325		10.1016/S0140-6736(07)60373-0	http://dx.doi.org/10.1016/S0140-6736(07)60373-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	159HL	17448801				2022-12-01	WOS:000245856100006
J	Sykes, NP				Sykes, Nigel P.			Morphine kills the pain, not the patient	LANCET			English	Editorial Material							OPIOID USE; LIFE; END; CANCER		St Christophers Hospice, London SE26 6DZ, England		Sykes, NP (corresponding author), St Christophers Hospice, London SE26 6DZ, England.	n.sykes@stchristophers.org.uk						BILLINGS A, 2007, BBC THOUGHT DAY; *INT NARC CONTR BO, 2006, NARC DRUGS EST WORLD, P109; MORGAN J P, 1985, Advances in Alcohol and Substance Abuse, V5, P163; Morita Tatsuya, 2003, J Palliat Med, V6, P557, DOI 10.1089/109662103768253669; Pargeon KL, 1999, J PAIN SYMPTOM MANAG, V18, P358, DOI 10.1016/S0885-3924(99)00097-4; Portenoy RK, 2006, J PAIN SYMPTOM MANAG, V32, P532, DOI 10.1016/j.jpainsymman.2006.08.003; PORTER J, 1980, NEW ENGL J MED, V302, P123; Regnard C, 2003, PALLIATIVE MED, V17, P714, DOI 10.1191/0269216303pm838cr; Seale C, 2006, PALLIATIVE MED, V20, P3, DOI 10.1191/0269216306pm1094oa; Stjernsward J, 2004, OXFORD TXB PALLIATIV, P1199; Sykes N, 2003, LANCET ONCOL, V4, P312, DOI 10.1016/S1470-2045(03)01079-9; Thorns A, 2000, LANCET, V356, P398, DOI 10.1016/S0140-6736(00)02534-4; WALSH TD, 1984, RECENT RESULTS CANC, V89, P115; *WHO, 1987, CANC PAIN REL	14	15	15	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 21	2007	369	9570					1325	1326		10.1016/S0140-6736(07)60611-4	http://dx.doi.org/10.1016/S0140-6736(07)60611-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	159HL	17448802				2022-12-01	WOS:000245856100007
J	Reddy, SK; Rape, M; Margansky, WA; Kirschner, MW				Reddy, S. K.; Rape, M.; Margansky, W. A.; Kirschner, M. W.			Ubiquitination by the anaphase-promoting complex drives spindle checkpoint inactivation	NATURE			English	Article							ASSEMBLY CHECKPOINT; MITOTIC CHECKPOINT; PROTEIN BUBR1; MAD2; ACTIVATION; BINDING; UBCH10; OVEREXPRESSION; INHIBITION; CARCINOMAS	Eukaryotic cells rely on a surveillance mechanism known as the spindle checkpoint to ensure accurate chromosome segregation. The spindle checkpoint prevents sister chromatids from separating until all kinetochores achieve bipolar attachments to the mitotic spindle(1-3). Checkpoint proteins tightly inhibit the anaphase-promoting complex (APC), a ubiquitin ligase required for chromosome segregation and progression to anaphase. Unattached kinetochores promote the binding of checkpoint proteins Mad2 and BubR1 to the APC-activator Cdc20, rendering it unable to activate APC. Once all kinetochores are properly attached, however, cells inactivate the checkpoint within minutes, allowing for the rapid and synchronous segregation of chromosomes(4). How cells switch from strong APC inhibition before kinetochore attachment to rapid APC activation once attachment is complete remains a mystery. Here we show that checkpoint inactivation is an energy-consuming process involving APC-dependent multi-ubiquitination. Multi-ubiquitination by APC leads to the dissociation of Mad2 and BubR1 from Cdc20, a process that is reversed by a Cdc20-directed de-ubiquitinating enzyme(5). The mutual regulation between checkpoint proteins and APC leaves the cell poised for rapid checkpoint inactivation and ensures that chromosome segregation promptly follows the completion of kinetochore attachment. In addition, our results suggest a mechanistic basis for how cancer cells can have a compromised spindle checkpoint without corresponding mutations in checkpoint genes(6).	Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Harvard Mit Div Hlth Sci & Technol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	marc@hms.harvard.edu		Rape, Michael/0000-0003-4849-6343				Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Luo XL, 2004, NAT STRUCT MOL BIOL, V11, P338, DOI 10.1038/nsmb748; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Mapelli M, 2006, EMBO J, V25, P1273, DOI 10.1038/sj.emboj.7601033; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Okamoto Y, 2003, CANCER RES, V63, P4167; Pallante P, 2005, BRIT J CANCER, V93, P464, DOI 10.1038/sj.bjc.6602721; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; STEGMEIER F, IN PRESS NATURE; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Tao WK, 2005, CANCER CELL, V8, P49, DOI 10.1016/j.ccr.2005.06.003; Wagner KW, 2004, ONCOGENE, V23, P6621, DOI 10.1038/sj.onc.1207861; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Yu HT, 2006, J CELL BIOL, V173, P153, DOI 10.1083/jcb.200601172; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4	22	272	282	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2007	446	7138					921	925		10.1038/nature05734	http://dx.doi.org/10.1038/nature05734			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IR	17443186				2022-12-01	WOS:000245785700044
J	Gupta, GP; Nguyen, DX; Chiang, AC; Bos, PD; Kim, JY; Nadal, C; Gomis, RR; Manova-Todorova, K; Massague, J				Gupta, Gaorav P.; Nguyen, Don X.; Chiang, Anne C.; Bos, Paula D.; Kim, Juliet Y.; Nadal, Cristina; Gomis, Roger R.; Manova-Todorova, Katia; Massague, Joan			Mediators of vascular remodelling co-opted for sequential steps in lung metastasis	NATURE			English	Article							GROWTH-FACTOR RECEPTOR; BREAST-CANCER METASTASIS; TUMOR; ANGIOGENESIS; CYCLOOXYGENASE-2; GENES; INHIBITOR; CELECOXIB; SURVIVAL; EFFICACY	Metastasis entails numerous biological functions that collectively enable cancerous cells from a primary site to disseminate and overtake distant organs. Using genetic and pharmacological approaches, we show that the epidermal growth factor receptor ligand epiregulin, the cyclooxygenase COX2, and the matrix metalloproteinases 1 and 2, when expressed in human breast cancer cells, collectively facilitate the assembly of new tumour blood vessels, the release of tumour cells into the circulation, and the breaching of lung capillaries by circulating tumour cells to seed pulmonary metastasis. These findings reveal how aggressive primary tumorigenic functions can be mechanistically coupled to greater lung metastatic potential, and how such biological activities may be therapeutically targeted with specific drug combinations.	Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Mol Cytol Core Facil, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	j-massague@ski.mskcc.org	Gupta, Gaorav/AAL-4472-2021; Gomis, Roger R/E-9788-2016	Gomis, Roger R/0000-0001-6473-2858; Massague, Joan/0000-0001-9324-8408				Baselga J, 2002, CANCER CELL, V1, P319, DOI 10.1016/S1535-6108(02)00066-1; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Dannenberg AJ, 2005, J CLIN ONCOL, V23, P254, DOI 10.1200/JCO.2005.09.112; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gately S, 2004, SEMIN ONCOL, V31, P2, DOI 10.1053/j.seminoncol.2004.03.040; GIJBELS K, 1994, J CLIN INVEST, V94, P2177, DOI 10.1172/JCI117578; Giordano SH, 2004, CANCER, V100, P44, DOI 10.1002/cncr.11859; Goldstein NI, 1995, CLIN CANCER RES, V1, P1311; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Gupta GP, 2005, COLD SH Q B, V70, P149, DOI 10.1101/sqb.2005.70.018; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Howe LR, 2005, CANCER RES, V65, P10113, DOI 10.1158/0008-5472.CAN-05-1524; Hynes RO, 2003, CELL, V113, P821, DOI 10.1016/S0092-8674(03)00468-9; Jacoby RF, 2000, CANCER RES, V60, P5040; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Karashima T, 2002, CLIN CANCER RES, V8, P1253; Krysan K, 2005, CANCER RES, V65, P6275, DOI 10.1158/0008-5472.CAN-05-0216; Luo FR, 2005, CANCER CHEMOTH PHARM, V56, P455, DOI 10.1007/s00280-005-1022-3; Massague J, 2007, NEW ENGL J MED, V356, P294, DOI 10.1056/NEJMe068292; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Niederberger E, 2001, FASEB J, V15, P1622, DOI 10.1096/fj.00-0716fje; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Solomayer EF, 2000, BREAST CANCER RES TR, V59, P271, DOI 10.1023/A:1006308619659; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wary Kishore K, 2003, Mol Cancer, V2, P25, DOI 10.1186/1476-4598-2-25; Wild R, 2000, MICROVASC RES, V59, P368, DOI 10.1006/mvre.1999.2233	37	540	564	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2007	446	7137					765	U2		10.1038/nature05760	http://dx.doi.org/10.1038/nature05760			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17429393				2022-12-01	WOS:000245626800033
J	Koh, HK; Joossens, LX; Connolly, GN				Koh, Howard K.; Joossens, Luk X.; Connolly, Gregory N.			Making smoking history worldwide	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Assoc European Canc Leagues, Brussels, Belgium	Harvard University; Harvard T.H. Chan School of Public Health	Koh, HK (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.							Fichtenberg CM, 2002, BMJ-BRIT MED J, V325, P188, DOI 10.1136/bmj.325.7357.188; Fong GT, 2006, TOB CONTROL, V15, P51, DOI 10.1136/tc.2005.013649; HHS (Department of Health and Human Services), 2006, HLTH CONS INV EXP TO; Mackay J, 2006, TOBACCO ATLAS; Scollo M, 2003, TOB CONTROL, V12, P13, DOI 10.1136/tc.12.1.13	5	68	72	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 12	2007	356	15					1496	1498		10.1056/NEJMp068279	http://dx.doi.org/10.1056/NEJMp068279			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	156CA	17429081	Bronze			2022-12-01	WOS:000245624400002
J	Lau, KS; Partridge, EA; Grigorian, A; Silvescu, CI; Reinhold, VN; Demetriou, M; Dennis, JW				Lau, Ken S.; Partridge, Emily A.; Grigorian, Ani; Silvescu, Cristina I.; Reinhold, Vernon N.; Demetriou, Michael; Dennis, James W.			Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation	CELL			English	Article							ACETYLGLUCOSAMINYLTRANSFERASE-V; CAENORHABDITIS-ELEGANS; LINKED GLYCOSYLATION; MATHEMATICAL-MODEL; TGF-BETA; RECEPTOR; GROWTH; MICE; BIOSYNTHESIS; ENDOCYTOSIS	The number of N-glycans (n) is a distinct feature of each glycoprotein sequence and cooperates with the physical properties of the Golgi N-glycan-branching pathway to regulate surface glycoprotein levels. The Golgi pathway is ultrasensitive to hexosamine flux for the production of tri- and tetra-antennary N-glycans, which bind to galectins and form a molecular lattice that opposes glycoprotein endocytosis. Glycoproteins with few N-glycans (e.g., T beta R, CTLA-4, and GLUT4) exhibit enhanced cell-surface expression with switch-like responses to increasing hexosamine concentration, whereas glycoproteins with high numbers of N-glycans (e.g., EGFR, IGFR, FGFR, and PDGFR) exhibit hyperbolic responses. Computational and experimental data reveal that these features allow nutrient flux stimulated by growth-promoting high-n receptors to drive arrest/differentiation programs by increasing surface levels of low-n glycoproteins. We have identified a mechanism for metabolic regulation of cellular transition between growth and arrest in mammals arising from apparent coevolution of N-glycan number and branching.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1L5, Canada; Univ Toronto, Dept Lab Med & Pathol, Toronto, ON M5G 1L5, Canada; Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Neurol, Irvine, CA 92862 USA; Univ New Hampshire, Durham, NH 03824 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University of California System; University of California Irvine; University of California System; University of California Irvine; University System Of New Hampshire; University of New Hampshire	Dennis, JW (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave R988, Toronto, ON M5G 1X5, Canada.	dennis@mshri.on.ca	Lau, Ken/I-7958-2019; Dennis, James/E-7268-2013	Lau, Ken/0000-0001-8438-0319; Demetriou, Michael/0000-0002-2224-7798				Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Al-Hasani H, 2002, J CELL SCI, V115, P131; Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Boehmelt G, 2000, EMBO J, V19, P5092, DOI 10.1093/emboj/19.19.5092; Bradshaw JD, 1997, BIOCHEMISTRY-US, V36, P15975, DOI 10.1021/bi971762i; Broschat KO, 2002, J BIOL CHEM, V277, P14764, DOI 10.1074/jbc.M201056200; Buckhaults P, 1997, J BIOL CHEM, V272, P19575, DOI 10.1074/jbc.272.31.19575; Chikuma Shunsuke, 2002, Mol Interv, V2, P205, DOI 10.1124/mi.2.4.205; Cipollo JF, 2005, J BIOL CHEM, V280, P26063, DOI 10.1074/jbc.M503828200; Collins BE, 2006, NAT IMMUNOL, V7, P199, DOI 10.1038/ni1283; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; DO KY, 1994, J BIOL CHEM, V269, P23456; Ehrlich M, 2001, J CELL SCI, V114, P1777; Elleman TC, 2000, BIOCHEM J, V347, P771, DOI 10.1042/0264-6021:3470771; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Granovsky M, 2000, NAT MED, V6, P306; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Ishida H, 2005, FEBS LETT, V579, P71, DOI 10.1016/j.febslet.2004.11.037; KATZ EB, 1995, NATURE, V377, P151, DOI 10.1038/377151a0; Klein P, 2003, CURR BIOL, V13, P1669, DOI 10.1016/j.cub.2003.09.027; Koli KM, 1997, J BIOL CHEM, V272, P6423, DOI 10.1074/jbc.272.10.6423; Kolm-Litty V, 1998, J CLIN INVEST, V101, P160, DOI 10.1172/JCI119875; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; Krambeck FJ, 2005, BIOTECHNOL BIOENG, V92, P711, DOI 10.1002/bit.20645; KUMAR R, 1989, MOL CELL BIOL, V9, P5713, DOI 10.1128/MCB.9.12.5713; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Morgan R, 2004, J IMMUNOL, V173, P7200, DOI 10.4049/jimmunol.173.12.7200; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Sasai K, 2002, GLYCOBIOLOGY, V12, P119, DOI 10.1093/glycob/12.2.119; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Slawson C, 2006, J CELL BIOCHEM, V97, P71, DOI 10.1002/jcb.20676; SOBKO A, 2006, SCI STKE, pRE9; Takamatsu S, 1999, CANCER RES, V59, P3949; Tsao TS, 1996, DIABETES, V45, P28, DOI 10.2337/diabetes.45.1.28; Umana P, 1997, BIOTECHNOL BIOENG, V55, P890, DOI 10.1002/(SICI)1097-0290(19970920)55:6<890::AID-BIT7>3.0.CO;2-B; vanDelft S, 1997, J CELL BIOL, V136, P811, DOI 10.1083/jcb.136.4.811; VILAR J, 2006, PLOS COMPUT BIOL, V2; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Wang Y, 2001, GLYCOBIOLOGY, V11, P1051, DOI 10.1093/glycob/11.12.1051; Warren CE, 2002, J BIOL CHEM, V277, P22829, DOI 10.1074/jbc.M201390200; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43; Zhen YJ, 2003, BIOCHEMISTRY-US, V42, P5478, DOI 10.1021/bi027101p; Zhu SX, 2004, BIOCHEM J, V382, P995, DOI 10.1042/BJ20040793	51	629	659	3	97	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					123	134		10.1016/j.cell.2007.01.049	http://dx.doi.org/10.1016/j.cell.2007.01.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418791	Bronze			2022-12-01	WOS:000245661100016
J	Cognet, L; Tsyboulski, DA; Rocha, JDR; Doyle, CD; Tour, JM; Weisman, RB				Cognet, Laurent; Tsyboulski, Dmitri A.; Rocha, John-David R.; Doyle, Condell D.; Tour, James M.; Weisman, R. Bruce			Stepwise quenching of exciton fluorescence in carbon nanotubes by single-molecule reactions	SCIENCE			English	Article							FUNCTIONALIZATION	Single-molecule chemical reactions with individual single-walled carbon nanotubes were observed through near-infrared photoluminescence microscopy. The emission intensity within distinct submicrometer segments of single nanotubes changed in discrete steps after exposure to acid, base, or diazonium reactants. The steps were uncorrelated in space and time and reflected the quenching of mobile excitons at localized sites of reversible or irreversible chemical attack. Analysis of step amplitudes revealed an exciton diffusional range of about 90 nanometers, independent of nanotube structure. Each exciton visited about 10,000 atomic sites during its lifetime, providing highly efficient sensing of local chemical and physical perturbations.	Univ Bordeaux 1, Ctr Phys Mol Opt & Hertzienne, F-33405 Talence, France; CNRS, F-33405 Talence, France; Rice Univ, Dept Chem, Ctr Biol & Environm Nanotechnol, Houston, TX 77005 USA; Rice Univ, RE Smalley Inst Nanoscale Sci & Technol, Houston, TX 77005 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); Rice University; Rice University	Cognet, L (corresponding author), Univ Bordeaux 1, Ctr Phys Mol Opt & Hertzienne, F-33405 Talence, France.	lcognet@u-bordeaux1.fr; weisman@rice.edu	Cognet, Laurent/M-4505-2019; Cognet, Laurent/F-4163-2011; Rocha, John-David Ray/AAV-1170-2020	Cognet, Laurent/0000-0002-3573-5387; Rocha, John-David Ray/0000-0001-6394-4349; Tour, James/0000-0002-8479-9328; Weisman, R. Bruce/0000-0001-8546-9980				Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; Bahr JL, 2001, J AM CHEM SOC, V123, P6536, DOI 10.1021/ja010462s; Bonifazi D, 2006, NANO LETT, V6, P1408, DOI 10.1021/nl060394d; Chen J, 2005, SCIENCE, V310, P1171, DOI 10.1126/science.1119177; Cognet L., 2006, SCI STKE, V2006, ppe13, DOI DOI 10.1126/STKE.3272006PE13; Dickson RM, 1996, SCIENCE, V274, P966, DOI 10.1126/science.274.5289.966; Dresselhaus M.S., 2001, CARBON NANOTUBES SYN; Dukovic G, 2004, J AM CHEM SOC, V126, P15269, DOI 10.1021/ja046526r; Dyke CA, 2004, SYNLETT, P155, DOI 10.1055/s-2003-44983; Hagen A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.197401; Hartschuh A, 2003, SCIENCE, V301, P1354, DOI 10.1126/science.1087118; Heller DA, 2004, J AM CHEM SOC, V126, P14567, DOI 10.1021/ja046450z; Htoon H, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.027401; Jones M, 2007, NANO LETT, V7, P300, DOI 10.1021/nl0622808; Korovyanko OJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.017403; Lefebvre J, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.075403; Ma YZ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.157402; Moerner WE, 1999, SCIENCE, V283, P1670, DOI 10.1126/science.283.5408.1670; O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631; Pedersen TG, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.073401; Perebeinos V, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.257402; Russo RM, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.041405; Spataru CD, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.247402; Spataru CD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.077402; Strano MS, 2003, J PHYS CHEM B, V107, P6979, DOI 10.1021/jp027664a; Strano MS, 2003, SCIENCE, V301, P1519, DOI 10.1126/science.1087691; Tsyboulski DA, 2005, NANO LETT, V5, P975, DOI 10.1021/nl050366f; Usrey ML, 2005, J AM CHEM SOC, V127, P16129, DOI 10.1021/ja0537530; Wang F, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.241403	29	387	393	7	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2007	316	5830					1465	1468		10.1126/science.1141316	http://dx.doi.org/10.1126/science.1141316			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556581	Green Submitted			2022-12-01	WOS:000247066400039
J	MacDonald, R				MacDonald, Rhona			The continuing battle over baby-milk formula	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		MacDonald, R (corresponding author), Lancet, London NW1 7BY, England.							Cawthorne P, 2007, LANCET, V369, P974, DOI 10.1016/S0140-6736(07)60473-5; Ferriman A, 1999, BRIT MED J, V318, P417, DOI 10.1136/bmj.318.7181.417a; Moorhead Joanna, 2007, GUARDIAN        0515; PARSONS H, 2007, GUARDIAN        0522, P35; *SAV CHILDR UK, 2007, GEN BAB MILK MARK ST	5	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2007	369	9575					1773	1773		10.1016/S0140-6736(07)60795-8	http://dx.doi.org/10.1016/S0140-6736(07)60795-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	172QP	17531871				2022-12-01	WOS:000246819300009
J	Berghuis, P; Rajnicek, AM; Morozov, YM; Ross, RA; Mulder, J; Urban, GM; Monory, K; Marsicano, G; Matteoli, M; Canty, A; Irving, AJ; Katona, I; Yanagawa, Y; Rakic, P; Lutz, B; Mackie, K; Harkany, T				Berghuis, Paul; Rajnicek, Ann M.; Morozov, Yury M.; Ross, Ruth A.; Mulder, Jan; Urban, Gabriella M.; Monory, Krisztina; Marsicano, Giovanni; Matteoli, Michela; Canty, Alison; Irving, Andrew J.; Katona, Istvan; Yanagawa, Yuchio; Rakic, Pasko; Lutz, Beat; Mackie, Ken; Harkany, Tibor			Hardwiring the brain: Endocannabinoids shape neuronal connectivity	SCIENCE			English	Article							GROWTH CONE GUIDANCE; RHO GTPASES; CANNABINOIDS; INTERNEURONS; EXPRESSION; SYNAPSES; KINASE	The roles of endocannabinoid signaling during central nervous system development are unknown. We report that CB1 cannabinoid receptors (CB(1)Rs) are enriched in the axonal growth cones of gamma-aminobutyric acid-containing ( GABAergic) interneurons in the rodent cortex during late gestation. Endocannabinoids trigger CB1R internalization and elimination from filopodia and induce chemorepulsion and collapse of axonal growth cones of these GABAergic interneurons by activating RhoA. Similarly, endocannabinoids diminish the galvanotropism of Xenopus laevis spinal neurons. These findings, together with the impaired target selection of cortical GABAergic interneurons lacking CB(1)Rs, identify endocannabinoids as axon guidance cues and demonstrate that endocannabinoid signaling regulates synaptogenesis and target selection in vivo.	Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Neurobiol, S-17177 Stockholm, Sweden; Univ Aberdeen, Inst Med Sci, Sch Med Sci, Aberdeen AB25 2ZD, Scotland; Yale Univ, Sch Med, Kavli Inst Neurosci, Dept Neurobiol, New Haven, CT 06510 USA; Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; Hungarian Acad Sci, Inst Expt Med, Lab Cerebral Cortex Res, H-1083 Budapest, Hungary; Johannes Gutenberg Univ Mainz, Dept Physiol Chem, D-55099 Mainz, Germany; Univ Milan, Dept Med Pharmacol, I-20129 Milan, Italy; Univ Milan, CNR, Inst Neurosci, I-20129 Milan, Italy; Univ Dundee, Ninewells Hosp & Med Sch, Inst Neurosci, Div Pathol & Neurosci, Dundee DD1 9SY, Scotland; Gunma Univ, Grad Sch Med, Maebashi, Gunma 3718511, Japan; Japan Sci & Technol Corp, Solut Oriented Res Sci & Technol, Maebashi, Gunma 3718511, Japan; Univ Washington, Dept Anesthesiol Physiol, Seattle, WA 98195 USA; Univ Washington, Dept Biophys, Seattle, WA 98195 USA	Karolinska Institutet; University of Aberdeen; Yale University; Karolinska Institutet; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Johannes Gutenberg University of Mainz; University of Milan; Consiglio Nazionale delle Ricerche (CNR); University of Milan; University of Dundee; Gunma University; Japan Science & Technology Agency (JST); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Harkany, T (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Neurobiol, S-17177 Stockholm, Sweden.	Tibor.Harkany@ki.se	Lutz, Beat/AAG-4538-2022; Mulder, Jan/G-3909-2011; Matteoli, Michela/K-4526-2018; Mulder, Jan/B-2972-2010; Marsicano, Giovanni/I-9603-2016; Lutz, Beat/AFK-6229-2022; Rajnicek, Ann/K-7991-2014; Mackie, Kenneth P/B-7358-2011; Mulder, Jan/AAG-9761-2021; Canty, Alison/J-7649-2014; Katona, Istvan/D-9729-2011; Mackie, Ken/E-3715-2013	Mulder, Jan/0000-0003-3717-5018; Matteoli, Michela/0000-0002-3569-7843; Rajnicek, Ann/0000-0003-2706-0014; Canty, Alison/0000-0001-5165-2365; Katona, Istvan/0000-0003-2808-3330; Mackie, Ken/0000-0001-8501-6199; Marsicano, Giovanni/0000-0003-3804-1951; Morozov, Yury/0000-0002-3679-6819	NIDA NIH HHS [DA11322, DA015916, DA00286] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011322, K02DA000286, P01DA015916] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Aguado T, 2005, FASEB J, V19, P1704, DOI 10.1096/fj.05-3995fje; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Berghuis P, 2005, P NATL ACAD SCI USA, V102, P19115, DOI 10.1073/pnas.0509494102; BICKNESE AR, 1994, J NEUROSCI, V14, P3500; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Derkinderen P, 2003, J NEUROSCI, V23, P2371; Domenici MR, 2006, J NEUROSCI, V26, P5794, DOI 10.1523/JNEUROSCI.0372-06.2006; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Harkany T, 2004, J NEUROSCI, V24, P4978, DOI 10.1523/JNEUROSCI.4884-03.2004; Hioki H, 2004, CEREB CORTEX, V14, P1266, DOI 10.1093/cercor/bhh088; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kim D, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-10-j0004.2001; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Mato S, 2003, EUR J NEUROSCI, V17, P1747, DOI 10.1046/j.1460-9568.2003.02599.x; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Morii H, 2006, J NEUROBIOL, V66, P1101, DOI 10.1002/neu.20295; Morozov YM, 2003, EUR J NEUROSCI, V18, P1213, DOI 10.1046/j.1460-9568.2003.02852.x; Morozov YM, 2006, J NEUROSCI, V26, P5017, DOI 10.1523/JNEUROSCI.0272-06.2006; OCONNOR TP, 1990, J NEUROSCI, V10, P3935, DOI 10.1523/JNEUROSCI.10-12-03935.1990; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Rajnicek AM, 2006, J CELL SCI, V119, P1723, DOI 10.1242/jcs.02896; Rakic P, 2006, CEREB CORTEX, V16, pI3, DOI 10.1093/cercor/bhk036; Spano MS, 2007, BIOL PSYCHIAT, V61, P554, DOI 10.1016/j.biopsych.2006.03.073; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Wang X, 2003, NEUROSCIENCE, V118, P681, DOI 10.1016/S0306-4522(03)00020-4; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895	28	365	377	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1212	1216		10.1126/science.1137406	http://dx.doi.org/10.1126/science.1137406			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525344				2022-12-01	WOS:000246724300049
J	Thery, M; Jimenez-Dalmaroni, A; Racine, V; Bornens, M; Julicher, F				Thery, Manuel; Jimenez-Dalmaroni, Andrea; Racine, Victor; Bornens, Michel; Juelicher, Frank			Experimental and theoretical study of mitotic spindle orientation	NATURE			English	Article							CELL-DIVISION AXIS; FORCE GENERATORS; CENTROSOME; CUES; PINS	The architecture and adhesiveness of a cell microenvironment is a critical factor for the regulation of spindle orientation in vivo(1,2). Using a combination of theory and experiments, we have investigated spindle orientation in HeLa ( human) cells. Here we show that spindle orientation can be understood as the result of the action of cortical force generators, which interact with spindle microtubules and are activated by cortical cues. We develop a simple physical description of this spindle mechanics, which allows us to calculate angular profiles of the torque acting on the spindle, as well as the angular distribution of spindle orientations. Our model accounts for the preferred spindle orientation and the shape of the full angular distribution of spindle orientations observed in a large variety of different cellular microenvironment geometries. It also correctly describes asymmetric spindle orientations, which are observed for certain distributions of cortical cues. We conclude that, on the basis of a few simple assumptions, we can provide a quantitative description of the spindle orientation of adherent cells.	Inst Curie, CNRS, UMR 144, F-75248 Paris, France; Comm Energie Atom, DSV, iRTSV, Lab Biopuces, F-38054 Grenoble, France; Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Universite Paris Cite; CEA; Max Planck Society	Bornens, M (corresponding author), Inst Curie, CNRS, UMR 144, 26 Rue Ulm, F-75248 Paris, France.	michel.bornens@curie.fr; julicher@pks.mpg.de	Julicher, Frank/B-1828-2009; Racine, Victor/I-4576-2014	Julicher, Frank/0000-0003-4731-9185; Racine, Victor/0000-0002-1486-8973				Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Cuvelier D, 2003, EUR BIOPHYS J BIOPHY, V32, P342, DOI 10.1007/s00249-003-0282-2; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Grill SW, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108104; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lu BW, 2001, NATURE, V409, P522, DOI 10.1038/35054077; MITCHISON TJ, 1992, CELL MOTIL CYTOSKEL, V22, P135, DOI 10.1002/cm.970220207; Pecreaux J, 2006, CURR BIOL, V16, P2111, DOI 10.1016/j.cub.2006.09.030; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Siegrist SE, 2006, DEVELOPMENT, V133, P529, DOI 10.1242/dev.02211; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795	18	307	312	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2007	447	7143					493	U6		10.1038/nature05786	http://dx.doi.org/10.1038/nature05786			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17495931				2022-12-01	WOS:000246693100051
J	Frayling, TM; Timpson, NJ; Weedon, MN; Zeggini, E; Freathy, RM; Lindgren, CM; Perry, JRB; Elliott, KS; Lango, H; Rayner, NW; Shields, B; Harries, LW; Barrett, JC; Ellard, S; Groves, CJ; Knight, B; Patch, AM; Ness, AR; Ebrahim, S; Lawlor, DA; Ring, SM; Ben-Shlomo, Y; Jarvelin, MR; Sovio, U; Bennett, AJ; Melzer, D; Ferrucci, L; Loos, RJF; Barroso, I; Wareham, NJ; Karpe, F; Owen, KR; Cardon, LR; Walker, M; Hitman, GA; Palmer, CNA; Doney, ASF; Morris, AD; Smith, GD; Hattersley, AT; McCarthy, MI				Frayling, Timothy M.; Timpson, Nicholas J.; Weedon, Michael N.; Zeggini, Eleftheria; Freathy, Rachel M.; Lindgren, Cecilia M.; Perry, John R. B.; Elliott, Katherine S.; Lango, Hana; Rayner, Nigel W.; Shields, Beverley; Harries, Lorna W.; Barrett, Jeffrey C.; Ellard, Sian; Groves, Christopher J.; Knight, Bridget; Patch, Ann-Marie; Ness, Andrew R.; Ebrahim, Shah; Lawlor, Debbie A.; Ring, Susan M.; Ben-Shlomo, Yoav; Jarvelin, Marjo-Riitta; Sovio, Ulla; Bennett, Amanda J.; Melzer, David; Ferrucci, Luigi; Loos, Ruth J. F.; Barroso, Ines; Wareham, Nicholas J.; Karpe, Fredrik; Owen, Katharine R.; Cardon, Lon R.; Walker, Mark; Hitman, Graham A.; Palmer, Colin N. A.; Doney, Alex S. F.; Morris, Andrew D.; Smith, George Davey; Hattersley, Andrew T.; McCarthy, Mark I.		Wellcome Trust Case Control	A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity	SCIENCE			English	Article							ENPP1; GAD2	Obesity is a serious international health problem that increases the risk of several common diseases. The genetic factors predisposing to obesity are poorly understood. A genome-wide search for type 2 diabetes-susceptibility genes identified a common variant in the FTO ( fat mass and obesity associated) gene that predisposes to diabetes through an effect on body mass index (BMI). An additive association of the variant with BMI was replicated in 13 cohorts with 38,759 participants. The 16% of adults who are homozygous for the risk allele weighed about 3 kilograms more and had 1.67-fold increased odds of obesity when compared with those not inheriting a risk allele. This association was observed from age 7 years upward and reflects a specific increase in fat mass.	Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter, Devon, England; Univ Oxford, Wellcome Trust, Ctr Human Genet, Oxford, England; Univ Bristol, MRC, Ctr Casual Anal Translat Epidemiol, Bristol, Avon, England; Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; Royal Devon & Exeter Natl Hlth Serv Fdn Trust, Mol Genet Lab, Exeter, Devon, England; Univ Bristol, Dept Oral & Dent Sci, Sch Dent, Bristol, Avon, England; London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; Univ Bristol, Dept Social Med, Bristol, Avon, England; Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; Univ Oulu, Dept Publ Hlth Sci & Gen Practice, FIN-90014 Oulu, Finland; Peninsula Med Sch, Epidemiol & Publ Hlth Grp, Exeter, Devon, England; NIA, Lonitudinal Studies Sect, Clin Res Branch, NIH, Baltimore, MD 21224 USA; Strangeways Res Labs, MRC, Epidemiol Unit, Cambridge, England; Sanger Inst, Metab Dis Grp, Wellcome Trust, Cambridge, England; Univ Newcastle, Diabet Res Grp, Sch Clin Med Sci, Newcastle Upon Tyne, Tyne & Wear, England; Barts & London Royal London Hosp, Dept Diabet & Metab Med, London, England; Univ Dundee, Populat Pharmacogenet Grp, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland; Univ Dundee, Ninewells Hosp & Med Sch, Diabet Res Grp, Div Med & Therapeut,Sch Med, Dundee DD1 9SY, Scotland	University of Exeter; University of Oxford; Wellcome Centre for Human Genetics; University of Bristol; University of Oxford; University of Bristol; University of London; London School of Hygiene & Tropical Medicine; University of Bristol; Imperial College London; University of Oulu; University of Exeter; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Wellcome Trust Sanger Institute; Newcastle University - UK; Barts Health NHS Trust; Royal London Hospital; University of Dundee; University of Dundee	Hattersley, AT (corresponding author), Peninsula Med Sch, Inst Biomed & Clin Sci, Magdalen Rd, Exeter, Devon, England.	Andrew.Hattersley@pms.ac.uk	Harries, Lorna/D-2241-2014; Patch, Ann-Marie/C-4201-2018; Ben-Shlomo, Yoav/ABD-2004-2021; Study, GoDARTS/K-9448-2016; Ness, Andy R/M-7612-2013; Loos, Ruth J F/Q-2862-2016; Palmer, Colin NA/C-7053-2008; Doney, Alexander SF/P-7437-2017; Fox, Laura J/C-6249-2016; Morris, Andrew D/C-2837-2009; Patch, Ann-Marie/F-8060-2011; Loos, Ruth/GON-5877-2022; Allen, Hana Lango/G-9026-2012; Davey Smith, George/A-7407-2013; Attrill, Lauren/V-1688-2018; Timpson, Nicholas John/O-7548-2015; Berryman, Katie/J-4236-2014; Sovio, Ulla/H-8532-2019; Lunnon, Katie/C-4638-2012; McCarthy, Mark/M-3763-2015	Patch, Ann-Marie/0000-0001-6121-4019; Ben-Shlomo, Yoav/0000-0001-6648-3007; Ness, Andy R/0000-0003-3548-9523; Loos, Ruth J F/0000-0002-8532-5087; Palmer, Colin NA/0000-0002-6415-6560; Doney, Alexander SF/0000-0002-6210-5620; Allen, Hana Lango/0000-0002-7803-8688; Davey Smith, George/0000-0002-1407-8314; Timpson, Nicholas John/0000-0002-7141-9189; Sovio, Ulla/0000-0002-0799-1105; bennett, amanda/0000-0003-2140-8710; Melzer, David/0000-0002-0170-3838; Zeggini, Eleftheria/0000-0003-4238-659X; Lawlor, Debbie A/0000-0002-6793-2262; Lunnon, Katie/0000-0001-7570-6065; Weedon, Michael/0000-0002-6174-6135; Barroso, Ines/0000-0001-5800-4520; Lindgren, Cecilia/0000-0002-4903-9374; Frayling, Timothy/0000-0001-8362-2603; Karpe, Fredrik/0000-0002-2751-1770; Ellard, Sian/0000-0002-7620-5526; Barrett, Jeffrey/0000-0002-1152-370X; Harries, Lorna/0000-0001-7791-8061; s, hema/0000-0002-3440-9475; McCarthy, Mark/0000-0002-4393-0510; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Freathy, Rachel/0000-0003-4152-2238; Hattersley, Andrew/0000-0001-5620-473X	Medical Research Council [G0500070, MC_U106179471, G0000934, MC_U106188470, G0600705, G9815508] Funding Source: researchfish; MRC [MC_U106188470, G0000934, G0600705, G0500070] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [Z01AG000965, Z01AG000631] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Boutin P, 2003, PLOS BIOL, V1, P361, DOI 10.1371/journal.pbio.0000068; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; Groves CJ, 2006, DIABETES, V55, P1884, DOI 10.2337/db05-1674; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Lobstein T., 2004, OBES REV, V5, P4, DOI [DOI 10.1111/J.1467-789X.2004.00133.X, 10.1111/j.1467-789X.2004.00133.x]; Loos RJF, 2007, SCIENCE, V315, DOI [10.1126/science.1130012, 10.1126/science.1129402, 10.1126/science.1130571]; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Meyre D, 2005, NAT GENET, V37, P863, DOI 10.1038/ng1604; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Peters T, 2002, MAMM GENOME, V13, P186, DOI 10.1007/s00335-001-2142-7; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Swarbrick MM, 2005, PLOS BIOL, V3, P1662, DOI 10.1371/journal.pbio.0030315; VANDERHOEVEN F, 1994, DEVELOPMENT, V120, P2601; Weedon MN, 2006, DIABETES, V55, P3175, DOI 10.2337/db06-0410; Zhang SL, 2003, GENET EPIDEMIOL, V24, P44, DOI 10.1002/gepi.10196	16	3126	3321	7	559	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2007	316	5826					889	894		10.1126/science.1141634	http://dx.doi.org/10.1126/science.1141634			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17434869	Green Accepted, Green Published			2022-12-01	WOS:000246369800038
J	Lehmann, J				Lehmann, Johannes			A handful of carbon	NATURE			English	Editorial Material									Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14853 USA	Cornell University	Lehmann, J (corresponding author), Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14853 USA.		Lehmann, Johannes/H-2682-2014	Lehmann, Johannes/0000-0002-4701-2936				Baldock JA, 2002, ORG GEOCHEM, V33, P1093, DOI 10.1016/S0146-6380(02)00062-1; *EIA, 2006, DOEEIA0573; Gaunt J., 2007, POW GEN REN EN FUELS; IPCC, 2007, IPCC CLIM CHANG 2007; Jackson RB, 2004, P NATL ACAD SCI USA, V101, P15827, DOI 10.1073/pnas.0403631101; Lackner KS, 2003, SCIENCE, V300, P1677, DOI 10.1126/science.1079033; Lehmann J., 2006, Mitigation and Adaptation Strategies for Global Change, V11, P403, DOI 10.1007/s11027-005-9006-5; LEHMANN J, IN PRESS FRONTIERS E; Liang B, 2006, SOIL SCI SOC AM J, V70, P1719, DOI 10.2136/sssaj2005.0383; McCarl BA, 2001, SCIENCE, V294, P2481, DOI 10.1126/science.1064193; Stern N., 2007, EC CLIMATE CHANGE, DOI 10.1017/CBO9780511817434	11	1574	1852	93	1181	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2007	447	7141					143	144		10.1038/447143a	http://dx.doi.org/10.1038/447143a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17495905				2022-12-01	WOS:000246338700019
J	Almany, GR; Berumen, ML; Thorrold, SR; Planes, S; Jones, GP				Almany, Glenn R.; Berumen, Michael L.; Thorrold, Simon R.; Planes, Serge; Jones, Geoffrey P.			Local replenishment of coral reef fish populations in a marine reserve	SCIENCE			English	Article							DISPERSAL DISTANCE; SELF-RECRUITMENT; LARVAE; CONNECTIVITY; RETENTION; DESIGN; CONSEQUENCES; MECHANISMS; HOME	The scale of larval dispersal of marine organisms is important for the design of networks of marine protected areas. We examined the fate of coral reef fish larvae produced at a small island reserve, using a mass-marking method based on maternal transmission of stable isotopes to offspring. Approximately 60% of settled juveniles were spawned at the island, for species with both short (< 2 weeks) and long (> 1 month) pelagic larval durations. If natal homing of larvae is a common life-history strategy, the appropriate spatial scales for the management and conservation of coral reefs are likely to be much smaller than previously assumed.	James Cook Univ N Queensland, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; James Cook Univ N Queensland, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; Ecole Prat Hautes Etud, CNRS, Joint Res Unit 5244, Ctr Biol & Ecol Trop & Mediterraneene, F-66850 Perpignan, France	James Cook University; James Cook University; University of Arkansas System; University of Arkansas Fayetteville; Woods Hole Oceanographic Institution; Centre National de la Recherche Scientifique (CNRS); Universite Perpignan Via Domitia	Almany, GR (corresponding author), James Cook Univ N Queensland, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia.	glenn.almany@jcu.edu.au	Jones, Geoffrey P./E-9306-2010; Berumen, Michael L/F-7745-2011; PLANES, Serge/ABF-1360-2021; Thorrold, Simon R/B-7565-2012	Jones, Geoffrey P./0000-0002-6244-1245; Berumen, Michael L/0000-0003-2463-2742; Thorrold, Simon R/0000-0002-1533-7517				Botsford LW, 2001, ECOL LETT, V4, P144; Botsford LW, 2005, B MAR SCI, V76, P245; Botsford LW, 2003, ECOL APPL, V13, pS25; Conover DO, 2006, J FISH BIOL, V69, P21, DOI 10.1111/j.1095-8649.2006.01274.x; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Gerlach G, 2007, P NATL ACAD SCI USA, V104, P858, DOI 10.1073/pnas.0606777104; Halpern BS, 2003, P ROY SOC B-BIOL SCI, V270, P1871, DOI 10.1098/rspb.2003.2405; Hilborn R, 2006, CAN J FISH AQUAT SCI, V63, P642, DOI 10.1139/f05-243; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Lecchini D, 2005, OECOLOGIA, V143, P326, DOI 10.1007/s00442-004-1805-y; Leis JM, 2006, ADV MAR BIOL, V51, P57, DOI 10.1016/S0065-2881(06)51002-8; Palumbi SR, 2003, ECOL APPL, V13, pS146; Paris CB, 2004, LIMNOL OCEANOGR, V49, P1964, DOI 10.4319/lo.2004.49.6.1964; Sala E, 2002, SCIENCE, V298, P1991, DOI 10.1126/science.1075284; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Shanks AL, 2003, ECOL APPL, V13, pS159; Simpson SD, 2005, SCIENCE, V308, P221, DOI 10.1126/science.1107406; Strathmann RR, 2002, B MAR SCI, V70, P377; Swearer SE, 2002, B MAR SCI, V70, P251; Thorrold SR, 2006, CAN J FISH AQUAT SCI, V63, P1193, DOI 10.1139/F06-048; Thorrold SR, 2002, B MAR SCI, V70, P291; Warner RR, 2002, B MAR SCI, V70, P245	24	437	443	0	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2007	316	5825					742	744		10.1126/science.1140597	http://dx.doi.org/10.1126/science.1140597			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17478720				2022-12-01	WOS:000246181400045
J	Check, E				Check, Erika			Patenting the obvious?	NATURE			English	News Item																		Wadman M, 2005, NATURE, V435, P272, DOI 10.1038/435272a	1	4	4	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2007	447	7140					16	17		10.1038/447016a	http://dx.doi.org/10.1038/447016a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17476235				2022-12-01	WOS:000246149300013
J	Barabe, F; Kennedy, JA; Hope, KJ; Dick, JE				Barabe, Frederic; Kennedy, James A.; Hope, Kristin J.; Dick, John E.			Modeling the initiation and progression of human acute leukemia in mice	SCIENCE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; GENE REARRANGEMENT; STEM-CELLS; MLL; LINEAGE; TRANSLOCATIONS; TRANSFORMATION; TUMORIGENESIS; PROGENITORS	Our understanding of leukemia development and progression has been hampered by the lack of in vivo models in which disease is initiated from primary human hematopoietic cells. We showed that upon transplantation into immunodeficient mice, primitive human hematopoietic cells expressing a mixed-lineage leukemia (MLL) fusion gene generated myeloid or lymphoid acute leukemias, with features that recapitulated human diseases. Analysis of serially transplanted mice revealed that the disease is sustained by leukemia-initiating cells (L-ICs) that have evolved over time from a primitive cell type with a germline immunoglobulin heavy chain (IgH) gene configuration to a cell type containing rearranged IgH genes. The L-ICs retained both myeloid and lymphoid lineage potential and remained responsive to microenvironmental cues. The properties of these cells provide a biological basis for several clinical hallmarks of MLL leukemias.	Univ Hlth Network, Div Cell & Mol Biol, Toronto, ON M5G 1L7, Canada; Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; Hop Enfants Jesus, Dept Hematol, Quebec City, PQ G1J 1Z4, Canada; CHU Laval, Ctr Hosp Univ Quebec, Res Ctr Infect Dis, Quebec City, PQ G1V 4G2, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Laval University; Laval University; Laval University; University of Toronto	Dick, JE (corresponding author), Univ Hlth Network, Div Cell & Mol Biol, Toronto, ON M5G 1L7, Canada.	jdick@uhnres.utoronto.ca		Dick, John/0000-0002-9527-8317; Hope, Kristin/0000-0003-1449-4948				Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chen WL, 2006, BLOOD, V108, P669, DOI 10.1182/blood-2005-08-3498; Chudnovsky Y, 2005, NAT GENET, V37, P745, DOI 10.1038/ng1586; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Daser A, 2004, GENE DEV, V18, P965, DOI 10.1101/gad.1195504; Drynan LF, 2005, EMBO J, V24, P3136, DOI 10.1038/sj.emboj.7600760; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Forestier E, 2006, J PEDIAT HEMATOL ONC, V28, P486, DOI 10.1097/01.mph.0000212972.90877.28; Germano Giuseppe, 2006, Haematologica, V91, pECR09; Guenechea G, 2001, NAT IMMUNOL, V2, P75, DOI 10.1038/83199; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Jiang JG, 2005, LEUKEMIA LYMPHOMA, V46, P1223, DOI 10.1080/10428190500086055; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; LeBien TW, 2000, BLOOD, V96, P9, DOI 10.1182/blood.V96.1.9; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Metzler M, 2006, ONCOGENE, V25, P3093, DOI 10.1038/sj.onc.1209636; PUI CH, 1994, J CLIN ONCOL, V12, P909, DOI 10.1200/JCO.1994.12.5.909; Rego EM, 1998, CYTOMETRY, V34, P22, DOI 10.1002/(SICI)1097-0320(19980215)34:1<22::AID-CYTO4>3.0.CO;2-G; Rich JN, 2001, CANCER RES, V61, P3556; Ridge SA, 1995, LEUKEMIA, V9, P2023; Rubnitz JE, 1999, J CLIN ONCOL, V17, P191, DOI 10.1200/JCO.1999.17.1.191; So CW, 2003, CANCER CELL, V3, P161, DOI 10.1016/S1535-6108(03)00019-9; Zeisig BB, 2003, ONCOGENE, V22, P1629, DOI 10.1038/sj.onc.1206104	25	256	271	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2007	316	5824					600	604		10.1126/science.1139851	http://dx.doi.org/10.1126/science.1139851			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463288				2022-12-01	WOS:000245983100046
J	Buesseler, KO; Lamborg, CH; Boyd, PW; Lam, PJ; Trull, TW; Bidigare, RR; Bishop, JKB; Casciotti, KL; Dehairs, F; Elskens, M; Honda, M; Karl, DM; Siegel, DA; Silver, MW; Steinberg, DK; Valdes, J; Van Mooy, B; Wilson, S				Buesseler, Ken O.; Lamborg, Carl H.; Boyd, Philip W.; Lam, Phoebe J.; Trull, Thomas W.; Bidigare, Robert R.; Bishop, James K. B.; Casciotti, Karen L.; Dehairs, Frank; Elskens, Marc; Honda, Makio; Karl, David M.; Siegel, David A.; Silver, Mary W.; Steinberg, Deborah K.; Valdes, Jim; Van Mooy, Benjamin; Wilson, Stephanie			Revisiting carbon flux through the ocean's twilight zone	SCIENCE			English	Article							ORGANIC-MATTER; TRANSPORT; PUMP	The oceanic biological pump drives sequestration of carbon dioxide in the deep sea via sinking particles. Rapid biological consumption and remineralization of carbon in the "twilight zone" ( depths between the euphotic zone and 1000 meters) reduce the efficiency of sequestration. By using neutrally buoyant sediment traps to sample this chronically understudied realm, we measured a transfer efficiency of sinking particulate organic carbon between 150 and 500 meters of 20 and 50% at two contrasting sites. This large variability in transfer efficiency is poorly represented in biogeochemical models. If applied globally, this is equivalent to a difference in carbon sequestration of more than 3 petagrams of carbon per year.	Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; Univ Otago, Natl Inst Water, Dunedin, New Zealand; Univ Otago, Atmospher Res Ctr Phys & Chem Oceanog, Dept Chem, Dunedin, New Zealand; Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas 7001, Australia; CSIRO, Marine & Atmospher Res, Hobart, Tas 7001, Australia; Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; Free Univ Brussels, B-1050 Brussels, Belgium; Mutsu Inst Oceanog, JAMSTEC, Kanagawa 2370061, Japan; Univ Calif Santa Barbara, Inst Computat Earth Syst Sci, Santa Barbara, CA 93106 USA; Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; Coll William & Mary, Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA; Woods Hole Oceanog Inst, Dept Phys Oceanog, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution; University of Otago; University of Otago; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Hawaii System; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of California System; University of California Santa Barbara; University of California System; University of California Santa Cruz; William & Mary; Virginia Institute of Marine Science; Woods Hole Oceanographic Institution	Buesseler, KO (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.	kbuesseler@whoi.edu	Karl, David/AFP-3837-2022; Trull, Tom W/B-7028-2014; Siegel, David A/C-5587-2008; Lam, Phoebe/GQQ-7325-2022; Boyd, Philip W/J-7624-2014	Boyd, Philip W/0000-0001-7850-1911; Wilson, Stephanie/0000-0002-1280-5506; Casciotti, Karen/0000-0002-5286-7795; Karl, David/0000-0002-6660-6721; Lam, Phoebe J./0000-0001-6609-698X; Bishop, James/0000-0002-8036-3017				Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; BISHOP JKB, 1989, LIFE SCI R, V44, P117; Bopp L, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023653; Boyd PW, 2007, PROG OCEANOGR, V72, P276, DOI 10.1016/j.pocean.2006.10.007; Buesseler KO, 2000, DEEP-SEA RES PT I, V47, P277, DOI 10.1016/S0967-0637(99)00056-4; BUESSELER KO, 1991, NATURE, V353, P420, DOI 10.1038/353420a0; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; FOWLER SW, 1986, PROG OCEANOGR, V16, P147, DOI 10.1016/0079-6611(86)90032-7; Francois R, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001722; Honda MC, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026466; Honda MC, 2003, J OCEANOGR, V59, P671, DOI 10.1023/B:JOCE.0000009596.57705.0c; HONJO S, 1982, DEEP-SEA RES, V29, P609, DOI 10.1016/0198-0149(82)90079-6; Howard MT, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002499; Ito T, 2005, J MAR RES, V63, P813, DOI 10.1357/0022240054663231; Karl DM, 1996, DEEP-SEA RES PT II, V43, P539, DOI 10.1016/0967-0645(96)00002-1; Klaas C, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001765; Laws EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1231, DOI 10.1029/1999GB001229; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; MICHAELS AF, 1988, DEEP-SEA RES, V35, P473, DOI 10.1016/0198-0149(88)90126-4; MORTLOCK RA, 1989, DEEP-SEA RES, V36, P1415, DOI 10.1016/0198-0149(89)90092-7; Najjar RG, 1992, GLOBAL BIOGEOCHEM CY, V6, P45, DOI 10.1029/91GB02718; PEINERT R, 1989, LIFE SCI R, V44, P35; Schlitzer R, 2002, DEEP-SEA RES PT II, V49, P1623, DOI 10.1016/S0967-0645(02)00004-8; TRULL T, 2006, ASLO TOS AGU OC SCI; VOLK T, 1985, GEOPHYS MONOGR AM GE, V32; Yamanaka Y, 1996, GLOBAL BIOGEOCHEM CY, V10, P361, DOI 10.1029/96GB00634	26	432	440	5	205	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2007	316	5824					567	570		10.1126/science.1137959	http://dx.doi.org/10.1126/science.1137959			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17463282				2022-12-01	WOS:000245983100036
J	Pulendran, B				Pulendran, Bali			Tolls and beyond - Many roads to vaccine immunity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA	Emory University	Pulendran, B (corresponding author), Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA.		Pulendran, Bali/AAW-9550-2021					Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720	3	15	18	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 26	2007	356	17					1776	1778		10.1056/NEJMcibr070454	http://dx.doi.org/10.1056/NEJMcibr070454			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	160LQ	17460233				2022-12-01	WOS:000245942600017
J	Doyle, J; Csete, M				Doyle, John; Csete, Marie			Rules of engagement - Complex engineered and biological systems share protocol-based architectures that make them robust and evolvable, but with hidden fragilities to rare perturbations.	NATURE			English	Editorial Material									CALTECH, Pasadena, CA 91125 USA; Emory Univ, Atlanta, GA 30322 USA	California Institute of Technology; Emory University	Doyle, J (corresponding author), CALTECH, Pasadena, CA 91125 USA.							Doyle JC, 2005, P NATL ACAD SCI USA, V102, P14497, DOI 10.1073/pnas.0501426102; Moritz MA, 2005, P NATL ACAD SCI USA, V102, P17912, DOI 10.1073/pnas.0508985102	2	37	37	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2007	446	7138					860	860		10.1038/446860a	http://dx.doi.org/10.1038/446860a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IR	17443168	Bronze			2022-12-01	WOS:000245785700023
J	Reay, D; Sabine, C; Smith, P; Hymus, G				Reay, Dave; Sabine, Christopher; Smith, Pete; Hymus, Graham			Spring-time for sinks	NATURE			English	Editorial Material									Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JN, Midlothian, Scotland; NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; Univ Aberdeen, Aberdeen AB9 1FX, Scotland; No Arizona Univ, Flagstaff, AZ 86011 USA	University of Edinburgh; National Oceanic Atmospheric Admin (NOAA) - USA; University of Aberdeen; Northern Arizona University	Reay, D (corresponding author), Univ Edinburgh, Sch Geosci, W Mains Rd, Edinburgh EH9 3JN, Midlothian, Scotland.	David.Reay@ed.ac.uk	Reay, David/F-4054-2010; Blenkinsopp, Chris/AFF-8523-2022; Smith, Pete/G-1041-2010; Turner, Ian L/H-7122-2014; Masselink, Gerd/B-6743-2015; Alecha, Maria/B-4717-2016	Blenkinsopp, Chris/0000-0001-5784-2805; Smith, Pete/0000-0002-3784-1124; Turner, Ian L/0000-0001-9884-6917; Masselink, Gerd/0000-0001-6079-7611; Alecha, Maria/0000-0003-1540-1870; Reay, Dave/0000-0001-5829-9007	Natural Environment Research Council [NE/C51755X/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; RAUPACH MR, 2004, GLOBAL CARBON CYCLE, P526; ROSE S, 2007, ENERGY MODELING FORU; Tans P.P., 2007, TRENDS ATMOSPHERIC C; Watson AJ, 2003, GLO CH IGBP, P123; Watson RT, 2000, IPCC SPECIAL REPORT	7	34	36	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2007	446	7137					727	728		10.1038/446727a	http://dx.doi.org/10.1038/446727a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17429376				2022-12-01	WOS:000245626800017
J	Jackson, DJ; Macis, L; Reitner, J; Degnan, BM; Worheide, G				Jackson, Daniel J.; Macis, Luciana; Reitner, Joachim; Degnan, Bernard M.; Woerheide, Gert			Sponge paleogenomics reveals an ancient role for carbonic anhydrase in skeletogenesis	SCIENCE			English	Article							MATRIX PROTEIN; EVOLUTION; SHELL	Sponges (phylum Porifera) were prolific reef-building organisms during the Paleozoic and Mesozoic similar to 542 to 65 million years ago. These ancient animals inherited components of the first multicellular skeletogenic toolkit from the last common ancestor of the Metazoa. Using a paleogenomics approach, including gene- and protein-expression techniques and phylogenetic reconstruction, we show that a molecular component of this toolkit was the precursor to the alpha-carbonic anhydrases (alpha-CAs), a gene family used by extant animals in a variety of fundamental physiological processes. We used the coralline demosponge Astrosclera willeyana, a "living fossil" that has survived from the Mesozoic, to provide insight into the evolution of the ability to biocalcify, and show that the alpha-CA family expanded from a single ancestral gene through several independent gene- duplication events in sponges and eumetazoans.	Geosci Ctr Gottingen, Dept Geobiol, D-37077 Gottingen, Germany; Univ Queensland, Sch Integrat Biol, Brisbane, Qld 4072, Australia	University of Gottingen; University of Queensland	Worheide, G (corresponding author), Geosci Ctr Gottingen, Dept Geobiol, Goldschmidtstr 3, D-37077 Gottingen, Germany.	gert.woerheide@geo.uni-goettingen.de	Wörheide, Gert/C-1080-2008; Jackson, Daniel J./J-5158-2012	Wörheide, Gert/0000-0002-6380-7421; Jackson, Daniel J./0000-0001-9045-381X; Degnan, Bernard/0000-0001-7573-8518				BENGTSON S, 1992, SCIENCE, V257, P367, DOI 10.1126/science.257.5068.367; Bottjer DJ, 2006, SCIENCE, V314, P956, DOI 10.1126/science.1132310; Chombard C, 1997, BIOL BULL, V193, P359, DOI 10.2307/1542938; deBoer ML, 2006, BIOL BULL-US, V211, P18, DOI 10.2307/4134574; Henry RP, 1996, ANNU REV PHYSIOL, V58, P523, DOI 10.1146/annurev.ph.58.030196.002515; HewettEmmett D, 1996, MOL PHYLOGENET EVOL, V5, P50, DOI 10.1006/mpev.1996.0006; JACKSON DJ, 2006, BMC BIOL, V4; Kawasaki K, 2006, J EXP ZOOL PART B, V306B, P295, DOI 10.1002/jez.b.21088; KEMPE S, 1985, CHEM GEOL, V53, P95, DOI 10.1016/0009-2541(85)90023-3; Knoll AH, 2003, REV MINERAL GEOCHEM, V54, P329, DOI 10.2113/0540329; Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2; Livingston BT, 2006, DEV BIOL, V300, P335, DOI 10.1016/j.ydbio.2006.07.047; Love AC, 2007, EVOL DEV, V9, P51, DOI 10.1111/j.1525-142X.2006.00137.x; Miyamoto H, 2003, J MOLLUS STUD, V69, P87, DOI 10.1093/mollus/69.1.87; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Morris SC, 2000, P NATL ACAD SCI USA, V97, P4426, DOI 10.1073/pnas.97.9.4426; Rahman MA, 2006, MAR BIOTECHNOL, V8, P415, DOI 10.1007/s10126-005-6150-6; Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472; WILBUR KM, 1948, J BIOL CHEM, V176, P147; WOOD R, 1990, AM SCI, V78, P224; Worheide G, 1998, FACIES, V38, P1, DOI 10.1007/BF02537358	21	98	102	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2007	316	5833					1893	1895		10.1126/science.1141560	http://dx.doi.org/10.1126/science.1141560			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183WI	17540861				2022-12-01	WOS:000247602700038
J	Karsak, M; Gaffal, E; Date, R; Wang-Eckhardt, L; Rehnelt, J; Petrosino, S; Starowicz, K; Steuder, R; Schlicker, E; Cravatt, B; Mechoulam, R; Buettner, R; Werner, S; Di Marzo, V; Tuting, T; Zimmer, A				Karsak, Meliha; Gaffal, Evelyn; Date, Rahul; Wang-Eckhardt, Lihua; Rehnelt, Jennifer; Petrosino, Stefania; Starowicz, Katarzyna; Steuder, Regina; Schlicker, Eberhard; Cravatt, Benjamin; Mechoulam, Raphael; Buettner, Reinhard; Werner, Sabine; Di Marzo, Vincenzo; Tueting, Thomas; Zimmer, Andreas			Attenuation of allergic contact dermatitis through the endocannabinoid system	SCIENCE			English	Article							CANNABINOID CB2 RECEPTOR; INVERSE AGONIST; GENE ONTOLOGY; KNOCKOUT MICE; ANANDAMIDE; HYPERSENSITIVITY; INVOLVEMENT; NEUTROPHILS; PROTEIN-1; DEFICIENT	Allergic contact dermatitis affects about 5% of men and 11% of women in industrialized countries and is one of the leading causes for occupational diseases. In an animal model for cutaneous contact hypersensitivity, we show that mice lacking both known cannabinoid receptors display exacerbated allergic inflammation. In contrast, fatty acid amide hydrolase-deficient mice, which have increased levels of the endocannabinoid anandamide, displayed reduced allergic responses in the skin. Cannabinoid receptor antagonists exacerbated allergic inflammation, whereas receptor agonists attenuated inflammation. These results demonstrate a protective role of the endocannabinoid system in contact allergy in the skin and suggest a target for therapeutic intervention.	Univ Bonn, Dept Mol Psychiat, D-5300 Bonn, Germany; Univ Bonn, Dept Dermatol, Lab Expt Dermatol, D-5300 Bonn, Germany; Life & Brain GmbH, Bonn, Germany; CNR, Inst Biomol Chem, Endocannabinoid Res Grp, Naples, Italy; Univ Bonn, Inst Pharmacol & Toxicol, D-5300 Bonn, Germany; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA USA; Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Hebrew Univ Jerusalem, Dept Med Chem & Nat Prod, IL-91905 Jerusalem, Israel; Univ Bonn, Dept Pathol, D-5300 Bonn, Germany; ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland	University of Bonn; University of Bonn; Consiglio Nazionale delle Ricerche (CNR); University of Bonn; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Hebrew University of Jerusalem; University of Bonn; Swiss Federal Institutes of Technology Domain; ETH Zurich	Zimmer, A (corresponding author), Univ Bonn, Dept Mol Psychiat, D-5300 Bonn, Germany.	thomas.tueting@ukb.uni-bonn.de; a.zimmer@uni-bonn.de	Zimmer, Andreas/B-8357-2009; Di Marzo, Vincenzo/AAD-7742-2019; Starowicz, Katarzyna/AAB-8595-2022; Schlicker, Eberhard/GVT-2661-2022; Tüting, Thomas/AAJ-3610-2021	Di Marzo, Vincenzo/0000-0002-1490-3070; Tüting, Thomas/0000-0001-7146-0934; Date, Rahul/0000-0002-6322-1201; Werner, Sabine/0000-0001-7397-8710; Starowicz, Katarzyna/0000-0003-0091-0066				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bachmann MF, 2006, NAT REV IMMUNOL, V6, P159, DOI 10.1038/nri1776; Bisogno T, 2005, PHARMACOL BIOCHEM BE, V81, P224, DOI 10.1016/j.pbb.2005.01.027; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Cravatt BF, 2004, P NATL ACAD SCI USA, V101, P10821, DOI 10.1073/pnas.0401292101; de Paulis A, 2001, INT ARCH ALLERGY IMM, V124, P146, DOI 10.1159/000053694; Di Marzo V, 2000, J NEUROCHEM, V75, P2434, DOI 10.1046/j.1471-4159.2000.0752434.x; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; Ibrahim MM, 2005, P NATL ACAD SCI USA, V102, P3093, DOI 10.1073/pnas.0409888102; Klein TW, 2005, NAT REV IMMUNOL, V5, P400, DOI 10.1038/nri1602; KNOP J, 1982, NATURE, V296, P757, DOI 10.1038/296757a0; Lee JSM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-189; LEHRER RI, 1969, NATURE, V223, P78, DOI 10.1038/223078a0; Lunn CA, 2006, J PHARMACOL EXP THER, V316, P780, DOI 10.1124/JPET.105.093500; Maccarrone M, 2003, J BIOL CHEM, V278, P33896, DOI 10.1074/jbc.M303994200; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Oka S, 2006, J IMMUNOL, V177, P8796, DOI 10.4049/jimmunol.177.12.8796; Stander S, 2005, J DERMATOL SCI, V38, P177, DOI 10.1016/j.jdermsci.2005.01.007; TAUB DD, 1995, J CLIN INVEST, V95, P1370, DOI 10.1172/JCI117788; Ueda Y, 2005, EUR J PHARMACOL, V520, P164, DOI 10.1016/j.ejphar.2005.08.013; WERNER S, 1994, SCIENCE, V266, P819, DOI 10.1126/science.7973639; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	23	252	278	4	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2007	316	5830					1494	1497		10.1126/science.1142265	http://dx.doi.org/10.1126/science.1142265			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556587				2022-12-01	WOS:000247066400048
J	Ford, ES; Ajani, UA; Croft, JB; Critchley, JA; Labarthe, DR; Kottke, TE; Giles, WH; Capewell, S				Ford, Earl S.; Ajani, Umed A.; Croft, Janet B.; Critchley, Julia A.; Labarthe, Darwin R.; Kottke, Thomas E.; Giles, Wayne H.; Capewell, Simon			Explaining the decrease in US deaths from coronary disease, 1980-2000	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NUTRITION EXAMINATION SURVEY; IMPAIRED GLUCOSE-TOLERANCE; RISK-FACTOR CHANGES; HEART-DISEASE; UNITED-STATES; NATIONAL-HEALTH; MYOCARDIAL-INFARCTION; MORTALITY-RATES; DECLINE; PREVALENCE	BACKGROUND: Mortality from coronary heart disease in the United States has decreased substantially in recent decades. We conducted a study to determine how much of this decrease could be explained by the use of medical and surgical treatments as opposed to changes in cardiovascular risk factors. METHODS: We applied a previously validated statistical model, IMPACT, to data on the use and effectiveness of specific cardiac treatments and on changes in risk factors between 1980 and 2000 among U.S. adults 25 to 84 years old. The difference between the observed and expected number of deaths from coronary heart disease in 2000 was distributed among the treatments and risk factors included in the analyses. RESULTS: From 1980 through 2000, the age-adjusted death rate for coronary heart disease fell from 542.9 to 266.8 deaths per 100,000 population among men and from 263.3 to 134.4 deaths per 100,000 population among women, resulting in 341,745 fewer deaths from coronary heart disease in 2000. Approximately 47% of this decrease was attributed to treatments, including secondary preventive therapies after myocardial infarction or revascularization (11%), initial treatments for acute myocardial infarction or unstable angina (10%), treatments for heart failure (9%), revascularization for chronic angina (5%), and other therapies (12%). Approximately 44% was attributed to changes in risk factors, including reductions in total cholesterol (24%), systolic blood pressure (20%), smoking prevalence (12%), and physical inactivity (5%), although these reductions were partially offset by increases in the body-mass index and the prevalence of diabetes, which accounted for an increased number of deaths (8% and 10%, respectively). CONCLUSIONS: Approximately half the decline in U.S. deaths from coronary heart disease from 1980 through 2000 may be attributable to reductions in major risk factors and approximately half to evidence-based medical therapies.	Univ Liverpool, Div Publ Hlth, Liverpool L69 3GB, Merseyside, England; Ctr Dis Control & Prevent, Div Adult & Community Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Healthpartners Res Fdn, Minneapolis, MN USA	University of Liverpool; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Newcastle University - UK; HealthPartners Institute for Education & Research	Capewell, S (corresponding author), Univ Liverpool, Div Publ Hlth, Whelan Bldg, Liverpool L69 3GB, Merseyside, England.	capewell@liverpool.ac.uk	Shao, Ruitai/AAU-7642-2021	Critchley, Julia/0000-0002-5248-4188	MRC [G0500920] Funding Source: UKRI; Medical Research Council [G0500920] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], MED EXP PAN SURV; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; BEAGLEHOLE R, 1986, BMJ-BRIT MED J, V292, P33, DOI 10.1136/bmj.292.6512.33; Bots M L, 1996, J Cardiovasc Risk, V3, P271, DOI 10.1097/00043798-199606000-00002; BRIGGS A, 1994, HEALTH ECON, V3, P95, DOI 10.1002/hec.4730030206; Burt VL, 1996, HYPERTENSION, V27, P1192; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Butler J, 2002, J AM COLL CARDIOL, V40, P1589, DOI 10.1016/S0735-1097(02)02379-3; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; Capewell S, 2000, EUR HEART J, V21, P1833, DOI 10.1053/euhj.2000.2318; Capewell S, 2000, CIRCULATION, V102, P1511, DOI 10.1161/01.CIR.102.13.1511; *CDCP, PERC AD WHO CURR FOR; Cooper Keith, 2002, Health Care Manag Sci, V5, P259, DOI 10.1023/A:1020378022303; Critchley J, 2004, CIRCULATION, V110, P1236, DOI 10.1161/01.CIR.0000140668.91896.AE; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; DOLISZNY KM, 1994, J AM COLL CARDIOL, V24, P95, DOI 10.1016/0735-1097(94)90547-9; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Ford ES, 2003, CIRCULATION, V107, P2185, DOI 10.1161/01.CIR.0000066320.27195.B4; GOLDMAN L, 1984, ANN INTERN MED, V101, P825, DOI 10.7326/0003-4819-101-6-825; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; HARRIS MI, 1987, DIABETES, V36, P523, DOI 10.2337/diabetes.36.4.523; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Hippisley-Cox J, 2006, BRIT MED J, V332, P912; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; JOHNSON CL, 1993, JAMA-J AM MED ASSOC, V269, P3002, DOI 10.1001/jama.269.23.3002; Laatikainen T, 2005, AM J EPIDEMIOL, V162, P764, DOI 10.1093/aje/kwi274; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2003, LANCET, V361, P1060; MANT J, 1995, BMJ-BRIT MED J, V311, P793, DOI 10.1136/bmj.311.7008.793; McAlister FA, 2002, INT J EPIDEMIOL, V31, P76, DOI 10.1093/ije/31.1.76; Mokdad Ali H, 2003, MMWR Recomm Rep, V52, P1; *MORB MORT, 2004, 2004 CHART BOOK CARD; *NAT CTR HLTH STAT, 2000, DHHS PUBL; *NAT CTR HLTH STAT, NHANES 1999 2000; National Centre for Classification in Health, 2010, INT STAT CLASS DIS R; Nichol MB, 1999, ANN PHARMACOTHER, V33, P531, DOI 10.1345/aph.18233; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Rogers WJ, 2000, J AM COLL CARDIOL, V36, P2056, DOI 10.1016/S0735-1097(00)00996-7; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; RYAN R, 2001, HLTH STAT Q, V12, P34; Thom T, 2006, CIRCULATION, V113, pE696, DOI 10.1161/CIRCULATIONAHA.106.174501; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Thom T, 2006, CIRCULATION, V114, pE630, DOI 10.1161/CIRCULATIONAHA.106.180110; Unal B, 2005, BMJ-BRIT MED J, V331, P614, DOI 10.1136/bmj.38561.633345.8F; Unal B, 2005, AM J PUBLIC HEALTH, V95, P103, DOI 10.2105/AJPH.2003.029579; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; URAL B, 2006, IMPACT VALIDATED COM; VARTIAINEN E, 1994, BMJ-BRIT MED J, V309, P23, DOI 10.1136/bmj.309.6946.23; World Health Organization, 1980, INT CLASSIFICATION D; 2004, MMWR MORB MORTAL WKL, V53, P82; [No title captured]	53	1930	2018	1	69	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 7	2007	356	23					2388	2398		10.1056/NEJMsa053935	http://dx.doi.org/10.1056/NEJMsa053935			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	175QY	17554120				2022-12-01	WOS:000247029300008
J	Richards, T				Richards, Tessa			Europe on the rocks - Doctors should do more to tackle alcohol abuse - could a European initiative help galvanise them?	BRITISH MEDICAL JOURNAL			English	Editorial Material												trichards@bmj.com							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 2	2007	334	7604					1142	1142		10.1136/bmj.39227.654838.59	http://dx.doi.org/10.1136/bmj.39227.654838.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	177ES	17540942	Green Published			2022-12-01	WOS:000247137000027
J	Mangan, KP; Levenson, JM				Mangan, Kile P.; Levenson, Jonathan M.			Turning back the clock on neurodegeneration	CELL			English	Editorial Material							MEMORY; P25		Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53719 USA; Univ Wisconsin, Dept Physiol, Madison, WI 53719 USA; Univ Wisconsin, Dept Pharmacol, Madison, WI 53719 USA; Univ Wisconsin, Waisman Ctr, Madison, WI 53719 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Levenson, JM (corresponding author), Galenea Corp, 300 Technol Sq, Cambridge, MA 02139 USA.	jlevenson@wisc.edu						Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; VECSEY CG, 2007, J NEUROSCI; Williams BM, 2001, PHYSIOL BEHAV, V73, P649, DOI 10.1016/S0031-9384(01)00543-1	8	0	0	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2007	129	5					851	853		10.1016/j.cell.2007.05.033	http://dx.doi.org/10.1016/j.cell.2007.05.033			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	176KT	17540162	Bronze			2022-12-01	WOS:000247084600002
J	Murata, S; Sasaki, K; Kishimoto, T; Niwa, S; Hayashi, H; Takahama, Y; Tanaka, K				Murata, Shigeo; Sasaki, Katsuhiro; Kishimoto, Toshihiko; Niwa, Shin-ichiro; Hayashi, Hidemi; Takahama, Yousuke; Tanaka, Keiji			Regulation of CD8+ T cell development by thymus-specific proteasomes	SCIENCE			English	Article							20S PROTEASOME; ANTIGEN PRESENTATION; MICE LACKING; GENERATION; SELECTION; PROTEINS; IMMUNOPROTEASOMES; TOLERANCE	Proteasomes are responsible for generating peptides presented by the class I major histocompatibility complex (MHC) molecules of the immune system. Here, we report the identification of a previously unrecognized catalytic subunit called beta 5t. beta 5t is expressed exclusively in cortical thymic epithelial cells, which are responsible for the positive selection of developing thymocytes. Although the chymotrypsin-like activity of proteasomes is considered to be important for the production of peptides with high affinities for MHC class I clefts, incorporation of beta 5t into proteasomes in place of beta 5 or beta 5i selectively reduces this activity. We also found that beta 5t-deficient mice displayed defective development of CD8(+) T cells in the thymus. Our results suggest a key role for beta 5t in generating the MHC class I-restricted CD8(+) T cell repertoire during thymic selection.	Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci Core Technol & Res Ctr, Bunkyo Ku, Tokyo 1138613, Japan; Japan Sci & TEchnol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan; Toho Univ, Fac Sci, Proteome Anal Ctr, Chiba 2748510, Japan; Toho Univ, Fac Sci, Dept Biomol Sci, Chiba 2748510, Japan; Link Genom, Chuo Ku, Tokyo 1030024, Japan; Univ Tokushima, Grad Sch Med Sci, Inst Genome Res, Div Expt Immunol, Tokushima 7708503, Japan	Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST); Toho University; Toho University; Tokushima University	Murata, S (corresponding author), Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci Core Technol & Res Ctr, Bunkyo Ku, Tokyo 1138613, Japan.	smurata@rinshoken.or.jp	Takahama, Yousuke/A-5863-2010; Murata, Shigeo/A-1426-2010	Takahama, Yousuke/0000-0002-4992-9174; Murata, Shigeo/0000-0002-3177-3503				Akiyama T, 2005, SCIENCE, V308, P248, DOI 10.1126/science.1105677; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Chen P, 1996, CELL, V86, P961, DOI 10.1016/S0092-8674(00)80171-3; COUK O, 1996, ANNU REV BIOCHEM, V65, P801; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; GACZYNSKA M, 1994, P NATL ACAD SCI USA, V91, P9213, DOI 10.1073/pnas.91.20.9213; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Gray DHD, 2002, J IMMUNOL METHODS, V260, P15, DOI 10.1016/S0022-1759(01)00493-8; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; MACDONALD HR, 1988, EUR J IMMUNOL, V18, P519, DOI 10.1002/eji.1830180405; Murata S, 2001, EMBO J, V20, P5898, DOI 10.1093/emboj/20.21.5898; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Schmidtke G, 1996, EMBO J, V15, P6887, DOI 10.1002/j.1460-2075.1996.tb01081.x; SEEMULLER E, 1995, SCIENCE, V268, P579, DOI 10.1126/science.7725107; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Tanaka K, 1998, IMMUNOL REV, V163, P161; URINO M, 2002, STRUCTURE, V10, P609; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1; YOUNG ACM, 1995, FASEB J, V9, P26, DOI 10.1096/fasebj.9.1.7821756	26	423	431	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2007	316	5829					1349	1353		10.1126/science.1141915	http://dx.doi.org/10.1126/science.1141915			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17540904				2022-12-01	WOS:000246885600053
J	Porter, SM				Porter, Susannah M.			Seawater chemistry and early carbonate biomineralization	SCIENCE			English	Article							FLUID INCLUSIONS; OSCILLATIONS; HALITE; RATIO		Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Porter, SM (corresponding author), Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA.	porter@geol.ucsb.edu						Bengtson S., 1992, ORIGIN EARLY EVOLUTI, P447; Brennan ST, 2004, GEOLOGY, V32, P473, DOI 10.1130/g20251.1; Knoll AH, 2003, REV MINERAL GEOCHEM, V54, P329, DOI 10.2113/0540329; Kovalevych VM, 2006, TERRA NOVA, V18, P95, DOI 10.1111/j.1365-3121.2006.00668.x; Lowenstein TK, 2001, SCIENCE, V294, P1086, DOI 10.1126/science.1064280; Maloof AC, 2005, CAN J EARTH SCI, V42, P2195, DOI 10.1139/E05-062; Morse JW, 1997, GEOLOGY, V25, P85, DOI 10.1130/0091-7613(1997)025<0085:IOTAMC>2.3.CO;2; Petrychenko OY, 2005, CHEM GEOL, V219, P149, DOI 10.1016/j.chemgeo.2005.02.003; Ries JB, 2005, PALEOBIOLOGY, V31, P445, DOI 10.1666/0094-8373(2005)031[0445:APICSE]2.0.CO;2; Stanley SM, 1998, PALAEOGEOGR PALAEOCL, V144, P3, DOI 10.1016/S0031-0182(98)00109-6; Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001	11	138	145	2	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2007	316	5829					1302	1302		10.1126/science.1137284	http://dx.doi.org/10.1126/science.1137284			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17540895				2022-12-01	WOS:000246885600040
J	Fox, GC; Shafiq, M; Briggs, DC; Knowles, PP; Collister, M; Didmon, MJ; Makrantoni, V; Dickinson, RJ; Hanrahan, S; Totty, N; Stark, MJR; Keyse, SM; McDonald, NQ				Fox, G. C.; Shafiq, M.; Briggs, D. C.; Knowles, P. P.; Collister, M.; Didmon, M. J.; Makrantoni, V.; Dickinson, R. J.; Hanrahan, S.; Totty, N.; Stark, M. J. R.; Keyse, S. M.; McDonald, N. Q.			Redox-mediated substrate recognition by Sdp1 defines a new group of tyrosine phosphatases	NATURE			English	Article							SPECIFICITY PROTEIN PHOSPHATASE; MAP KINASE; SACCHAROMYCES-CEREVISIAE; DIFFERENTIAL REGULATION; YEAST; ACTIVATION; PATHWAY; PYST1; ERK2	Reactive oxygen species trigger cellular responses by activation of stress-responsive mitogen-activated protein kinase ( MAPK) signalling pathways(1,2). Reversal of MAPK activation requires the transcriptional induction of specialized cysteine-based phosphatases that mediate MAPK dephosphorylation(3). Paradoxically, oxidative stresses generally inactivate cysteine-based phosphatases by thiol modification and thus could lead to sustained or uncontrolled MAPK activation(4,5). Here we describe how the stress-inducible MAPK phosphatase, Sdp1, presents an unusual solution to this apparent paradox by acquiring enhanced catalytic activity under oxidative conditions. Structural and biochemical evidence reveals that Sdp1 employs an intramolecular disulphide bridge and an invariant histidine side chain to selectively recognize a tyrosine-phosphorylated MAPK substrate. Optimal activity critically requires the disulphide bridge, and thus, to the best of our knowledge, Sdp1 is the first example of a cysteine-dependent phosphatase that couples oxidative stress with substrate recognition. We show that Sdp1, and its paralogue Msg5, have similar properties and belong to a new group of phosphatases unique to yeast and fungal taxa.	Canc Res UK, Struct Biol Lab, London Res Inst, London WC2A 3PX, England; Canc Res UK, Prot Anal Lab, London Res Inst, London WC2A 3PX, England; Univ London Birkbeck Coll, Sch Crystallog, London WC1E 7HX, England; Ninewells Hosp, Canc Res UK, Stress Response Lab, Ctr Biomed Res, Dundee DD1 9SY, Scotland; Univ Dundee, Div Gene Regulat & Express, Coll Life Sci, Dundee DD1 5EH, Scotland	Cancer Research UK; Cancer Research UK; University of London; Birkbeck University London; Cancer Research UK; University of Dundee; University of Dundee	McDonald, NQ (corresponding author), Canc Res UK, Struct Biol Lab, London Res Inst, 44 Lincolns Inn Fields, London WC2A 3PX, England.	neil.mcdonald@cancer.org.uk	Briggs, David/F-1199-2010; Keyse, Stephen M./B-9575-2009; Stark, Michael J. R./B-2815-2014	Keyse, Stephen M./0000-0002-5150-8221; Stark, Michael J. R./0000-0001-9086-191X; Makrantoni, Vasso/0000-0003-0668-6157; Briggs, David/0000-0002-9793-7339	Biotechnology and Biological Sciences Research Council [BB/C007077/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alic N, 2003, J BIOL CHEM, V278, P41849, DOI 10.1074/jbc.M307760200; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Barford D, 2004, CURR OPIN STRUC BIOL, V14, P679, DOI 10.1016/j.sbi.2004.09.012; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Collister M, 2002, FEBS LETT, V527, P186, DOI 10.1016/S0014-5793(02)03220-9; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Flandez M, 2004, J BIOL CHEM, V279, P11027, DOI 10.1074/jbc.M306412200; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; Hahn JS, 2002, J BIOL CHEM, V277, P21278, DOI 10.1074/jbc.M202557200; Ikner A, 2005, MUTAT RES-FUND MOL M, V569, P13, DOI 10.1016/j.mrfmmm.2004.09.006; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Krasley E, 2006, GENETICS, V172, P1477, DOI 10.1534/genetics.105.052266; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Martin H, 2005, MOL MICROBIOL, V58, P6, DOI 10.1111/j.1365-2958.2005.04822.x; Mattison CP, 1999, MOL CELL BIOL, V19, P7651; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; Rhee S G, 2000, Sci STKE, V2000, ppe1; Salmeen A, 2005, ANTIOXID REDOX SIGN, V7, P560, DOI 10.1089/ars.2005.7.560; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Seth D, 2006, BIOCHEMISTRY-US, V45, P8476, DOI 10.1021/bi060157p; Staleva L, 2004, MOL BIOL CELL, V15, P5574, DOI 10.1091/mbc.E04-02-0142; Stewart AE, 1999, NAT STRUCT BIOL, V6, P174; Todd JL, 1999, J BIOL CHEM, V274, P13271, DOI 10.1074/jbc.274.19.13271; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; Vilella F, 2005, J BIOL CHEM, V280, P9149, DOI 10.1074/jbc.M411062200	30	35	38	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2007	447	7143					487	492		10.1038/nature05804	http://dx.doi.org/10.1038/nature05804			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17495930				2022-12-01	WOS:000246693100050
J	Taubenberger, JK; Morens, DM; Fauci, AS				Taubenberger, Jeffery K.; Morens, David M.; Fauci, Anthony S.			The next influenza pandemic - Can it be predicted?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							H5N1 INFLUENZA; A VIRUSES; TRANSMISSION; ASIA; VIRULENCE; EVOLUTION; IMMUNE; HUMANS; GENE		NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Morens, DM (corresponding author), Bldg 31,Room 7A-10,31 Ctr Dr,MSC 2520, Bethesda, MD 20892 USA.	dmorens@niaid.nih.gov	Taubenberger, Jeffery/AAQ-1407-2021		Intramural NIH HHS [Z01 AI000995-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000995, Z01AI000986] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALEXANDER DJ, 2006, VACCINE; Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Reid AH, 2004, NAT REV MICROBIOL, V2, P909, DOI 10.1038/nrmicro1027; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; SUBBARAO EK, 1993, J VIROL, V67, P7223, DOI 10.1128/JVI.67.12.7223-7228.1993; Taubenberger JK, 2006, FUTURE VIROL, V1, P415, DOI 10.2217/17460794.1.4.415; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tweed SA, 2004, EMERG INFECT DIS, V10, P2196, DOI 10.3201/eid1012.040961; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; World Health Organization, WHO GLOB INFL PROGR	24	83	86	1	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2007	297	18					2025	2027		10.1001/jama.297.18.2025	http://dx.doi.org/10.1001/jama.297.18.2025			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165JM	17488968	Green Accepted			2022-12-01	WOS:000246301800025
J	Kurotaki, Y; Hatta, K; Nakao, K; Nabeshima, Y; Fujimori, T				Kurotaki, Yoko; Hatta, Kohei; Nakao, Kazuki; Nabeshima, Yo-ichi; Fujimori, Toshihiko			Blastocyst axis is specified independently of early cell lineage but aligns with the ZP shape	SCIENCE			English	Article							1ST 2 BLASTOMERES; MOUSE BLASTOCYST; BILATERAL SYMMETRY; CLEAVAGE; TROPHECTODERM; EMBRYO; PROTEIN; ZYGOTE; STAGE; DIFFERENTIATION	The mechanisms controlling the establishment of the embryonic-abembryonic (E-Ab) axis of the mammalian blastocyst are controversial. We used in vitro time-lapse imaging and in vivo lineage labeling to provide evidence that the E-Ab axis of the mouse blastocyst is generated independently of early cell lineage. Rather, both the boundary between two-cell blastomeres and the E-Ab axis of the blastocyst align relative to the ellipsoidal shape of the zona pellucida (ZP), an extraembryonic structure. Lack of correlation between cell lineage and the E-Ab axis can be explained by the rotation of the embryo within the ZP.	Kyoto Univ, Grad Sch Sci, Dept Pathol & Tumor Biol, Sakyo Ku, Kyoto 6068501, Japan; JST, CREST, Kawaguchi, Saitama 3320012, Japan; RIKEN, Ctr Dev Biol, Vertebrate Body Plan Grp, Chuo Ku, Kobe, Hyogo 6500047, Japan; Riken Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan	Kyoto University; Japan Science & Technology Agency (JST); RIKEN; RIKEN	Fujimori, T (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Pathol & Tumor Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	fujimori@lmls.med.kyoto-u.ac.jp	Fujimori, Toshihiko/L-7711-2016	Fujimori, Toshihiko/0000-0001-5200-4634; zhong wei, he gui/0000-0002-3066-3564				Alarcon VB, 2005, MOL REPROD DEV, V72, P354, DOI 10.1002/mrd.20353; Alarcon VB, 2003, BIOL REPROD, V69, P1208, DOI 10.1095/biolreprod.103.018283; Chroscicka A, 2004, MOL REPROD DEV, V68, P308, DOI 10.1002/mrd.20081; FLEMING TP, 1987, DEV BIOL, V119, P520, DOI 10.1016/0012-1606(87)90055-8; Fujimori T, 2003, DEVELOPMENT, V130, P5113, DOI 10.1242/dev.00725; Gardner RL, 2007, HUM REPROD, V22, P798, DOI 10.1093/humrep/del424; Gardner RL, 1997, DEVELOPMENT, V124, P289; Gardner RL, 2006, HUM REPROD, V21, P492, DOI 10.1093/humrep/dei318; Gardner RL, 2001, DEVELOPMENT, V128, P839; Gardner RL, 2002, HUM REPROD, V17, P1839, DOI 10.1093/humrep/17.7.1839; Gray D, 2004, CURR BIOL, V14, P397, DOI 10.1016/j.cub.2004.02.031; HANDYSIDE AH, 1978, J EMBRYOL EXP MORPH, V45, P37; Hatta K, 2006, NAT PROTOC, V1, P960, DOI 10.1038/nprot.2006.96; JOHNSON MH, 1981, CELL, V24, P71, DOI 10.1016/0092-8674(81)90502-X; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; KESSLER DS, 1995, DEVELOPMENT, V121, P2155; Motosugi N, 2005, GENE DEV, V19, P1081, DOI 10.1101/gad.1304805; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Piotrowska K, 2001, DEVELOPMENT, V128, P3739; Piotrowska-Nitsche K, 2005, DEVELOPMENT, V132, P479, DOI 10.1242/dev.01602; Piotrowska-Nitsche K, 2005, MECH DEVELOP, V122, P487, DOI 10.1016/j.mod.2004.11.014; Plusa B, 2005, NATURE, V434, P391, DOI 10.1038/nature03388; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; TARKOWSKI AK, 1967, J EMBRYOL EXP MORPH, V18, P155; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Waksmundzka M, 2006, BIOL REPROD, V75, P582, DOI 10.1095/biolreprod.106.053165	27	149	155	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2007	316	5825					719	723		10.1126/science.1138591	http://dx.doi.org/10.1126/science.1138591			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17446354				2022-12-01	WOS:000246181400038
J	Alonso-Alonso, M; Pascual-Leone, A				Alonso-Alonso, Miguel; Pascual-Leone, Alvaro			The right brain hypothesis for obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DECISION-MAKING; SELF; EXERCISE; DEFICITS		Beth Israel Deaconess Med Ctr, Dept Neurol, Behav Neurol Unit, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Pascual-Leone, A (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Behav Neurol Unit, Berenson Allen Ctr Noninvas Brain Stimulat, 330 Brookline Ave,KS 452, Boston, MA 02215 USA.	apleone@bidmc.harvard.edu	Pascual-Leone, Alvaro/AAC-5101-2019; Pascual-Leone, Alvaro/G-6566-2011	Pascual-Leone, Alvaro/0000-0001-8975-0382; Alonso-Alonso, Miguel/0000-0003-3372-9933	NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR018875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200] Funding Source: NIH RePORTER; NCRR NIH HHS [K24 RR018875] Funding Source: Medline; NIDDK NIH HHS [P30 DK46200] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anthony K, 2006, DIABETES, V55, P2986, DOI 10.2337/db06-0376; Arias M, 2002, REV NEUROLOGIA, V35, P531, DOI 10.33588/rn.3506.2002264; Berridge CW, 2003, ASYMMETRICAL BRAIN, P69; Bjorntorp P, 2000, NUTRITION, V16, P924, DOI 10.1016/S0899-9007(00)00422-6; Cameron O.G., 2002, VISCERAL SENSORY NEU; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Davis C, 2004, OBES RES, V12, P929, DOI 10.1038/oby.2004.113; de Garine I, 1995, SOCIAL ASPECTS OBESI; DelParigi A, 2007, INT J OBESITY, V31, P440, DOI 10.1038/sj.ijo.0803431; Freeman W., 1950, PSYCHOSURGERY TREATM; JALKANEN L, 1987, SCAND J SOC MED, V15, P191, DOI 10.1177/140349488701500311; Keenan JP, 2000, TRENDS COGN SCI, V4, P338, DOI 10.1016/S1364-6613(00)01521-7; Knoch D, 2006, J NEUROSCI, V26, P6469, DOI 10.1523/JNEUROSCI.0804-06.2006; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; LICHTMAN SW, 1992, NEW ENGL J MED, V327, P1893, DOI 10.1056/NEJM199212313272701; Martins JM, 2001, INT J OBESITY, V25, P24, DOI 10.1038/sj.ijo.0801500; Matochik JA, 2005, J CLIN ENDOCR METAB, V90, P2851, DOI 10.1210/jc.2004-1979; Mikheev M, 2002, NEUROPSYCHOLOGIA, V40, P1209, DOI 10.1016/S0028-3932(01)00227-5; Miller BL, 2001, NEUROLOGY, V57, P817, DOI 10.1212/WNL.57.5.817; Regard M, 1997, NEUROLOGY, V48, P1185, DOI 10.1212/WNL.48.5.1185; Short RA, 2005, ARCH NEUROL-CHICAGO, V62, P1106, DOI 10.1001/archneur.62.7.1106; Sturm VE, 2006, BRAIN, V129, P2508, DOI 10.1093/brain/awl145; Tranel D, 2002, CORTEX, V38, P589, DOI 10.1016/S0010-9452(08)70024-8; Uher R, 2005, J NEUROL NEUROSUR PS, V76, P852, DOI 10.1136/jnnp.2004.048819; Zhu KM, 2006, PREV MED, V42, P381, DOI 10.1016/j.ypmed.2006.01.020	25	133	133	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2007	297	16					1819	1822		10.1001/jama.297.16.1819	http://dx.doi.org/10.1001/jama.297.16.1819			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	160DW	17456824				2022-12-01	WOS:000245922100028
J	Soulard, A; Hall, MN				Soulard, Alexandre; Hall, Michael N.			SnapShot: mTOR signaling	CELL			English	Editorial Material							TRANSDUCTION PATHWAYS; KINASE-ACTIVITY; GROWTH; INSULIN; RICTOR; PHOSPHORYLATION; PROLIFERATION; REVEALS; GTPASE; PRAS40		Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Basel	Soulard, A (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.			Soulard, Alexandre/0000-0003-3556-1994; Hall, Michael N/0000-0002-2998-0757				Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206	15	43	48	3	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 20	2007	129	2					434	U14	E1	10.1016/j.cell.2007.04.010	http://dx.doi.org/10.1016/j.cell.2007.04.010			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17449000	Bronze			2022-12-01	WOS:000246474600028
J	Jenni, S; Leibundgut, M; Boehringer, D; Frick, C; Mikolasek, B; Ban, N				Jenni, Simon; Leibundgut, Marc; Boehringer, Daniel; Frick, Christian; Mikolasek, Bohdan; Ban, Nenad			Structure of fungal fatty acid synthase and implications for iterative substrate shuttling	SCIENCE			English	Article							MULTIFUNCTIONAL ENZYME TYPE-2; CARRIER PROTEIN TRANSACYLASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ACTIVE-SITE; PALMITOYL TRANSFERASE; MULTIENZYME COMPLEX; YEAST; SYNTHETASE; MALONYL	We report crystal structures of the 2.6-megadalton alpha(6)beta(6) heterododecameric fatty acid synthase from Thermomyces lanuginosus at 3.1 angstrom resolution. The alpha and beta polypeptide chains form the six catalytic domains required for fatty acid synthesis and numerous expansion segments responsible for extensive intersubunit connections. Detailed views of all active sites provide insights into substrate specificities and catalytic mechanisms and reveal their unique characteristics, which are due to the integration into the multienzyme. The mode of acyl carrier protein attachment in the reaction chamber, together with the spatial distribution of active sites, suggests that iterative substrate shuttling is achieved by a relatively restricted circular motion of the carrier domain in the multifunctional enzyme.	ETH, Inst Mol Biol & Biophys, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Ban, N (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8092 Zurich, Switzerland.	ban@mol.biol.ethz.ch						Asturias FJ, 2005, NAT STRUCT MOL BIOL, V12, P225, DOI 10.1038/nsmb899; Campbell JW, 2001, ANNU REV MICROBIOL, V55, P305, DOI 10.1146/annurev.micro.55.1.305; ENGESER H, 1979, EUR J BIOCHEM, V101, P407, DOI 10.1111/j.1432-1033.1979.tb19733.x; ENGESER H, 1979, EUR J BIOCHEM, V101, P413, DOI 10.1111/j.1432-1033.1979.tb19734.x; FOX JL, 1980, EUR J BIOCHEM, V109, P417, DOI 10.1111/j.1432-1033.1980.tb04810.x; Ha JY, 2006, J BIOL CHEM, V281, P18660, DOI 10.1074/jbc.M601658200; Haapalainen AM, 2006, TRENDS BIOCHEM SCI, V31, P64, DOI 10.1016/j.tibs.2005.11.011; Heath RJ, 2000, NATURE, V406, P145, DOI 10.1038/35018162; Hubbard PA, 2003, J BIOL CHEM, V278, P37553, DOI 10.1074/jbc.M304642200; Ishikawa M, 2004, EMBO J, V23, P2745, DOI 10.1038/sj.emboj.7600298; Jenni S, 2006, SCIENCE, V311, P1263, DOI 10.1126/science.1123251; Keatinge-Clay AT, 2003, STRUCTURE, V11, P147, DOI 10.1016/S0969-2126(03)00004-2; Kolodziej SJ, 1997, J STRUCT BIOL, V120, P158, DOI 10.1006/jsbi.1997.3911; Koski MK, 2005, J MOL BIOL, V345, P1157, DOI 10.1016/j.jmb.2004.11.009; Koski MK, 2004, J BIOL CHEM, V279, P24666, DOI 10.1074/jbc.M400293200; LEIBUNDGUT M, 2006, SCIENCE, V316, pR30; LYNEN F, 1980, EUR J BIOCHEM, V112, P431; LYNEN F, 1967, BIOCHEM J, V102, P381, DOI 10.1042/bj1020381; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; Marrakchi H, 2003, BIOCHEM J, V370, P1055, DOI 10.1042/BJ20021699; Oefner C, 2006, ACTA CRYSTALLOGR D, V62, P613, DOI 10.1107/S0907444906009474; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001; Price AC, 2001, BIOCHEMISTRY-US, V40, P12772, DOI 10.1021/bi010737g; Price AC, 2004, STRUCTURE, V12, P417, DOI 10.1016/j.str.2004.02.008; Qin YM, 2000, J BIOL CHEM, V275, P4965, DOI 10.1074/jbc.275.7.4965; RADFORD SE, 1989, J BIOL CHEM, V264, P767; Rangan VS, 1997, J BIOL CHEM, V272, P11975, DOI 10.1074/jbc.272.18.11975; SCHUSTER H, 1995, EUR J BIOCHEM, V228, P417; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; SERRE L, 1995, J BIOL CHEM, V270, P12961, DOI 10.1074/jbc.270.22.12961; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; STOOPS JK, 1980, P NATL ACAD SCI-BIOL, V77, P4544, DOI 10.1073/pnas.77.8.4544; STOOPS JK, 1992, P NATL ACAD SCI USA, V89, P6585, DOI 10.1073/pnas.89.14.6585; STOOPS JK, 1978, J BIOL CHEM, V253, P4464; Tang YY, 2006, P NATL ACAD SCI USA, V103, P11124, DOI 10.1073/pnas.0601924103; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; WERKMEISTER K, 1981, EUR J BIOCHEM, V116, P303, DOI 10.1111/j.1432-1033.1981.tb05334.x; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; WIELAND F, 1978, P NATL ACAD SCI USA, V75, P5792, DOI 10.1073/pnas.75.12.5792	40	170	181	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					254	261		10.1126/science.1138248	http://dx.doi.org/10.1126/science.1138248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431175				2022-12-01	WOS:000245654500045
J	Korn, T; Bettelli, E; Gao, W; Awasthi, A; Jager, A; Strom, TB; Oukka, M; Kuchroo, VK				Korn, Thomas; Bettelli, Estelle; Gao, Wenda; Awasthi, Amit; Jaeger, Anneli; Strom, Terry B.; Oukka, Mohamed; Kuchroo, Vijay K.			IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells	NATURE			English	Article							MYELIN OLIGODENDROCYTE GLYCOPROTEIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; REGULATORY T-CELLS; IL-6-DEFICIENT MICE; CHRONIC INFLAMMATION; HELPER-CELLS; DIFFERENTIATION; ACTIVATION; CYTOKINE; BETA	On activation, naive T cells differentiate into effector T-cell subsets with specific cytokine phenotypes and specialized effector functions(1). Recently a subset of T cells, distinct from T helper (T-H) 1 and T(H)2 cells, producing interleukin (IL)-17 (T(H)17) was defined and seems to have a crucial role in mediating autoimmunity and inducing tissue inflammation(2-5). We and others have shown that transforming growth factor (TGF)-beta and IL-6 together induce the differentiation of T(H)17 cells, in which IL-6 has a pivotal function in dictating whether T cells differentiate into Foxp3(+) regulatory T cells (T-reg cells) or T(H)17 cells(6-9). Whereas TGF-beta induces Foxp3 and generates T-reg cells, IL-6 inhibits the generation of T-reg cells and induces the production of IL-17, suggesting a reciprocal developmental pathway for T(H)17 and T-reg cells. Here we show that IL-6-deficient (Il6(-/-)) mice do not develop a T(H)17 response and their peripheral repertoire is dominated by Foxp3(+) T-reg cells. However, deletion of T-reg cells leads to the reappearance of T(H)17 cells in Il6(-/-) mice, suggesting an additional pathway by which T(H)17 cells might be generated in vivo. We show that an IL-2 cytokine family member, IL-21, cooperates with TGF-beta to induce T(H)17 cells in naive Il6(-/-) T cells and that IL-21-receptor-deficient T cells are defective in generating a T(H)17 response.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Cambridge, MA 02139 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Transplant Res Ctr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Oukka, M (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, 65 Landsdowne St, Cambridge, MA 02139 USA.	moukka@rics.bwh.harvard.edu; vkuchroo@rics.bwh.harvard.edu	Korn, Thomas/AAE-6960-2019; Strom, Terry B./E-9268-2010	Korn, Thomas/0000-0002-3633-0955; Strom, Terry B./0000-0002-7570-0736	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073542] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI073542, R01 AI073542-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Eugster HP, 1998, EUR J IMMUNOL, V28, P2178, DOI 10.1002/(SICI)1521-4141(199807)28:07<2178::AID-IMMU2178>3.0.CO;2-D; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kasaian MT, 2002, IMMUNITY, V16, P559, DOI 10.1016/S1074-7613(02)00295-9; Kleinschek MA, 2007, J EXP MED, V204, P161, DOI 10.1084/jem.20061738; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Leonard WJ, 2005, NAT REV IMMUNOL, V5, P688, DOI 10.1038/nri1688; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mendel I, 1998, EUR J IMMUNOL, V28, P1727, DOI 10.1002/(SICI)1521-4141(199805)28:05<1727::AID-IMMU1727>3.0.CO;2-#; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; Nakamura T, 1997, J IMMUNOL, V158, P1085; Okuda Y, 1999, J NEUROIMMUNOL, V101, P188, DOI 10.1016/S0165-5728(99)00139-3; Okuda Y, 1998, INT IMMUNOL, V10, P703, DOI 10.1093/intimm/10.5.703; Reddy J, 2003, J IMMUNOL, V170, P870, DOI 10.4049/jimmunol.170.2.870; Samoilova EB, 1998, J IMMUNOL, V161, P6480; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Vollmer TL, 2005, J IMMUNOL, V174, P2696, DOI 10.4049/jimmunol.174.5.2696; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zeng R, 2007, BLOOD, V109, P4135, DOI 10.1182/blood-2006-10-054973	30	1430	1552	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2007	448	7152					484	U9		10.1038/nature05970	http://dx.doi.org/10.1038/nature05970			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17581588	Green Accepted			2022-12-01	WOS:000248302700049
J	Vassylyev, DG; Vassylyeva, MN; Zhang, JW; Palangat, M; Artsimovitch, I; Landick, R				Vassylyev, Dmitry G.; Vassylyeva, Marina N.; Zhang, Jinwei; Palangat, Murali; Artsimovitch, Irina; Landick, Robert			Structural basis for substrate loading in bacterial RNA polymerase	NATURE			English	Article							3.3 ANGSTROM RESOLUTION; ELECTRON-DENSITY MAPS; II ELONGATION COMPLEX; ACTIVE-CENTER; CRYSTAL-STRUCTURE; TRANSCRIPTION ELONGATION; CATALYTIC RESIDUES; MECHANISM; NTP; DISCRIMINATION	The mechanism of substrate loading in multisubunit RNA polymerase is crucial for understanding the general principles of transcription yet remains hotly debated. Here we report the 3.0-angstrom resolution structures of the Thermus thermophilus elongation complex (EC) with a non-hydrolysable substrate analogue, adenosine-5'-[(alpha,beta)-methyleno]-triphosphate (AMPcPP), and with AMPcPP plus the inhibitor streptolydigin. In the EC/AMPcPP structure, the substrate binds to the active ('insertion') site closed through refolding of the trigger loop (TL) into two alpha-helices. In contrast, the EC/AMPcPP/streptolydigin structure reveals an inactive ('preinsertion') substrate configuration stabilized by streptolydigin-induced displacement of the TL. Our structural and biochemical data suggest that refolding of the TL is vital for catalysis and have three main implications. First, despite differences in the details, the two-step preinsertion/insertion mechanism of substrate loading may be universal for all RNA polymerases. Second, freezing of the preinsertion state is an attractive target for the design of novel antibiotics. Last, the TL emerges as a prominent target whose refolding can be modulated by regulatory factors.	Univ Alabama, Dept Biochem & Mol Genet, Sch Med, Birmingham, AL 35294 USA; Univ Alabama, Sch Dent, Birmingham, AL 35294 USA; Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University System of Ohio; Ohio State University	Vassylyev, DG (corresponding author), Univ Alabama, Dept Biochem & Mol Genet, Sch Med, 402B Kaul Genet Bldg,720 20th St S, Birmingham, AL 35294 USA.	dmitry@uab.edu	Zhang, Jinwei/AAU-9195-2020; Vassylyev, Dmitry/A-9005-2008; Artsimovitch, Irina/L-3467-2019; Zhang, Jinwei/D-8953-2012; Palangat, Murali/AAK-5445-2021	Zhang, Jinwei/0000-0002-2114-173X; Palangat, Murali/0000-0002-3327-3844				Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Artsimovitch I, 2003, J BIOL CHEM, V278, P12344, DOI 10.1074/jbc.M211214200; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DIECI G, 1995, EMBO J, V14, P3766, DOI 10.1002/j.1460-2075.1995.tb00046.x; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Epshtein V, 2002, MOL CELL, V10, P623, DOI 10.1016/S1097-2765(02)00640-8; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Foster JE, 2001, CELL, V106, P243, DOI 10.1016/S0092-8674(01)00420-2; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gong XQ, 2005, MOL CELL, V18, P461, DOI 10.1016/j.molcel.2005.04.011; Holmes SF, 2006, J BIOL CHEM, V281, P18677, DOI 10.1074/jbc.M600543200; Huang JB, 2000, BIOCHEMISTRY-US, V39, P11571, DOI 10.1021/bi000579d; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kashkina E, 2006, NUCLEIC ACIDS RES, V34, P4036, DOI 10.1093/nar/gkl559; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Landick R, 2005, TRENDS BIOCHEM SCI, V30, P651, DOI 10.1016/j.tibs.2005.10.001; Langelier MF, 2005, NUCLEIC ACIDS RES, V33, P2629, DOI 10.1093/nar/gki570; Laptenko O, 2003, EMBO J, V22, P6322, DOI 10.1093/emboj/cdg610; LEE JY, 1991, P NATL ACAD SCI USA, V88, P6018, DOI 10.1073/pnas.88.14.6018; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Nickels BE, 2004, CELL, V118, P281, DOI 10.1016/j.cell.2004.07.021; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; Sosunov V, 2005, NUCLEIC ACIDS RES, V33, P4202, DOI 10.1093/nar/gki688; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; Sosunova E, 2003, P NATL ACAD SCI USA, V100, P15469, DOI 10.1073/pnas.2536698100; Svetlov V, 2004, J BIOL CHEM, V279, P38087, DOI 10.1074/jbc.C400316200; Temiakov D, 2005, MOL CELL, V19, P655, DOI 10.1016/j.molcel.2005.07.020; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; TOULOKHONOV I, IN PRESS MOL CELL; Tuske S, 2005, CELL, V122, P541, DOI 10.1016/j.cell.2005.07.017; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Werner F, 2002, MOL CELL, V10, P635, DOI 10.1016/S1097-2765(02)00629-9; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Zaychikov E, 1996, SCIENCE, V273, P107, DOI 10.1126/science.273.5271.107; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	41	275	285	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2007	448	7150					163	U4		10.1038/nature05931	http://dx.doi.org/10.1038/nature05931			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188QN	17581591				2022-12-01	WOS:000247934500035
J	Moskowitz, IPG; Kim, JB; Moore, ML; Wolf, CM; Peterson, MA; Shendure, J; Nobrega, MA; Yokota, Y; Berul, C; Izumo, S; Seidman, JG; Seidman, CE				Moskowitz, Ivan P. G.; Kim, Jae B.; Moore, Meredith L.; Wolf, Cordula M.; Peterson, Michael A.; Shendure, Jay; Nobrega, Marcelo A.; Yokota, Yoshifumi; Berul, Charles; Izumo, Seigo; Seidman, J. G.; Seidman, Christine E.			A molecular pathway including Id2, Tbx5, and Nkx2-5 required for cardiac conduction system development	CELL			English	Article							HOLT-ORAM-SYNDROME; TRANSCRIPTION FACTOR TBX5; P204 PROTEIN OVERCOMES; PURKINJE-FIBERS; HEART-DISEASE; DIFFERENTIATION; EXPRESSION; GENE; INHIBITION; MUTATIONS	The cardiac conduction system is an anatomically discrete segment of specialized myocardium that initiates and propagates electrical impulses to coordinate myocardial contraction. To define the molecular composition of the mouse ventricular conduction system we used microdissection and transcriptional profiling by serial analysis of gene expression (SAGE). Conduction-system-specific expression for Id2, a member of the Id gene family of transcriptional repressors, was identified. Analyses of Id2-deficient mice demonstrated structural and functional conduction system abnormalities, including left bundle branch block. A 1.2 kb fragment of the Id2 promoter proved sufficient for cooperative regulation by Nkx2-5 and Tbx5 in vitro and for conduction-system-specific gene expression in vivo. Furthermore, compound haploinsufficiency of Tbx5 and Nkx2-5 or Tbx5 and Id2 prevented embryonic specification of the ventricular conduction system. We conclude that a molecular pathway including Tbx5, Nkx2-5, and Id2 coordinates specification of ventricular myocytes into the ventricular conduction system lineage.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Childrens Hosp, Dept Pathol, Cardiac Registry, Boston, MA 02115 USA; Brigham & Womens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Fukui, Sch Med, Dept Mol Genet, Matsuoka, Fukui 9111193, Japan; Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; Novartis Inst BioMed Res, Cambridge, MA 02139 USA; Univ Chicago, Inst Mol Pediat Sci, Dept Pediat & Pathol, Chicago, IL 60637 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; University of Chicago; University of Fukui; Harvard University; Boston Children's Hospital; Novartis; University of Chicago	Seidman, CE (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	cseidman@genetics.med.harvard.edu	Shendure, Jay/AAU-3684-2021	Shendure, Jay/0000-0002-1516-1865				BASSON CT, 1994, NEW ENGL J MED, V330, P885, DOI 10.1056/NEJM199403313301302; Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154; Berul CI, 1996, CIRCULATION, V94, P2641, DOI 10.1161/01.CIR.94.10.2641; Bonaldo MF, 2004, GENOME RES, V14, P2053, DOI 10.1101/gr.2601304; Bruneau BG, 1999, DEV BIOL, V211, P100, DOI 10.1006/dbio.1999.9298; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Cheng G, 1999, DEVELOPMENT, V126, P5041; DELORME B, 1995, DEV DYNAM, V204, P358, DOI 10.1002/aja.1002040403; Ding B, 2006, J BIOL CHEM, V281, P14893, DOI 10.1074/jbc.M511748200; Fraidenraich D, 2004, SCIENCE, V306, P247, DOI 10.1126/science.1102612; GOURDIE RG, 1995, DEVELOPMENT, V121, P1423; Harris BS, 2006, DEV DYNAM, V235, P38, DOI 10.1002/dvdy.20580; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Jay PY, 2004, J CLIN INVEST, V113, P1130, DOI 10.1172/JCI200419846; Kondo RP, 2003, J CARDIOVASC ELECTR, V14, P383, DOI 10.1046/j.1540-8167.2003.02467.x; Kupershmidt S, 1999, CIRC RES, V84, P146, DOI 10.1161/01.RES.84.2.146; LEV M, 1973, ACTA ANAT, V85, P342; Li QY, 1997, NAT GENET, V15, P21; Liu CJ, 2002, MOL CELL BIOL, V22, P2893, DOI 10.1128/MCB.22.9.2893-2905.2002; Martinsen BJ, 1998, SCIENCE, V281, P988, DOI 10.1126/science.281.5379.988; Moorman AFM, 1998, CIRC RES, V82, P629, DOI 10.1161/01.RES.82.6.629; Morley GE, 2001, MICROSC RES TECHNIQ, V52, P241, DOI 10.1002/1097-0029(20010201)52:3<241::AID-JEMT1010>3.0.CO;2-3; Moskowitz IPG, 2004, DEVELOPMENT, V131, P4107, DOI 10.1242/dev.01265; Palaniswamy SK, 2005, BIOINFORMATICS, V21, P835, DOI 10.1093/bioinformatics/bti119; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Prall OWJ, 2002, ANN MED, V34, P148; Rentschler S, 2001, DEVELOPMENT, V128, P1785; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Sedmera D, 2003, AM J PHYSIOL-HEART C, V284, pH1152, DOI 10.1152/ajpheart.00870.2002; Sedmera D, 2003, ANAT REC PART A, V274A, P773, DOI 10.1002/ar.a.10085; St Croix B, 2000, SCIENCE, V289, P1197; TAWARA S, 1906, REIZLETIUNGSSYSTEM S; Thomas PS, 2001, ANAT RECORD, V263, P307, DOI 10.1002/ar.1106; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; ZAHLER R, 1992, P NATL ACAD SCI USA, V89, P99, DOI 10.1073/pnas.89.1.99; ZELLER R, 1987, GENE DEV, V1, P693, DOI 10.1101/gad.1.7.693	37	192	196	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2007	129	7					1365	1376		10.1016/j.cell.2007.04.036	http://dx.doi.org/10.1016/j.cell.2007.04.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	188HQ	17604724	Bronze			2022-12-01	WOS:000247911400021
J	Matsumoto, M; Hikosaka, O				Matsumoto, Masayuki; Hikosaka, Okihide			Lateral habenula as a source of negative reward signals in dopamine neurons	NATURE			English	Article							VENTRAL TEGMENTAL AREA; SUBSTANTIA-NIGRA; CAUDATE-NUCLEUS; COMPLEX; RATS; PREDICTION; MOTIVATION; SEROTONIN; RESPONSES; SACCADES	Midbrain dopamine neurons are key components of the brain's reward system(1), which is thought to guide reward-seeking behaviours(2-4). Although recent studies have shown how dopamine neurons respond to rewards and sensory stimuli predicting reward(1,5,6), it is unclear which parts of the brain provide dopamine neurons with signals necessary for these actions. Here we show that the primate lateral habenula, part of the structure called the epithalamus, is a major candidate for a source of negative reward-related signals in dopamine neurons. We recorded the activity of habenula neurons and dopamine neurons while rhesus monkeys were performing a visually guided saccade task with positionally biased reward outcomes(7). Many habenula neurons were excited by a no-reward-predicting target and inhibited by a reward-predicting target. In contrast, dopamine neurons were excited and inhibited by reward-predicting and no-reward-predicting targets, respectively. Each time the rewarded and unrewarded positions were reversed, both habenula and dopamine neurons reversed their responses as the bias in saccade latency reversed. In unrewarded trials, the excitation of habenula neurons started earlier than the inhibition of dopamine neurons. Furthermore, weak electrical stimulation of the lateral habenula elicited strong inhibitions in dopamine neurons. These results suggest that the inhibitory input from the lateral habenula plays an important role in determining the reward-related activity of dopamine neurons.	NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Hikosaka, O (corresponding author), NEI, Sensorimotor Res Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	oh@lsr.nei.nih.gov	Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X	NATIONAL EYE INSTITUTE [Z01EY000415, ZIAEY000415] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amat J, 2001, BRAIN RES, V917, P118, DOI 10.1016/S0006-8993(01)02934-1; CALDECOTTHAZARD S, 1988, J NEUROSCI, V8, P1951; CHRISTOPH GR, 1986, J NEUROSCI, V6, P613; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; ELLISON G, 1994, BRAIN RES REV, V19, P223, DOI 10.1016/0165-0173(94)90012-4; Gao DM, 1996, EUR J NEUROSCI, V8, P1474, DOI 10.1111/j.1460-9568.1996.tb01609.x; HERKENHAM M, 1979, J COMP NEUROL, V187, P19, DOI 10.1002/cne.901870103; Hikosaka O, 2006, J NEUROPHYSIOL, V95, P567, DOI 10.1152/jn.00458.2005; Kawagoe R, 2004, J NEUROPHYSIOL, V91, P1013, DOI 10.1152/jn.00721.2003; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Lecourtier L, 2005, NEUROPSYCHOPHARMACOL, V30, P484, DOI 10.1038/sj.npp.1300595; Mikhael, 2019, UNIFIED FRAMEWORK DO; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Murphy CA, 1996, BEHAV BRAIN RES, V81, P43, DOI 10.1016/S0166-4328(96)00041-1; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Nakamura K, 2006, J NEUROSCI, V26, P5360, DOI 10.1523/JNEUROSCI.4853-05.2006; PARENT A, 1981, BRAIN RES BULL, V6, P23, DOI 10.1016/S0361-9230(81)80066-4; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; SANDYK R, 1991, INT J NEUROSCI, V61, P189, DOI 10.3109/00207459108990738; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Seymour B, 2005, NAT NEUROSCI, V8, P1234, DOI 10.1038/nn1527; Shepard PD, 2006, SCHIZOPHRENIA BULL, V32, P417, DOI 10.1093/schbul/sbj083; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; SUTHERLAND RJ, 1982, NEUROSCI BIOBEHAV R, V6, P1, DOI 10.1016/0149-7634(82)90003-3; Takikawa Y, 2004, J NEUROPHYSIOL, V92, P2520, DOI 10.1152/jn.00238.2004; THORNTON EW, 1989, PHYSIOL BEHAV, V45, P929, DOI 10.1016/0031-9384(89)90217-5; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360	31	828	852	3	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2007	447	7148					1111	U11		10.1038/nature05860	http://dx.doi.org/10.1038/nature05860			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183HT	17522629	Green Published			2022-12-01	WOS:000247564600037
J	Smith, CD; Shu, SQ; Mungall, CJ; Karpen, GH				Smith, Christopher D.; Shu, ShengQiang; Mungall, Christopher J.; Karpen, Gary H.			The Release 5.1 annotation of Drosophila melanogaster heterochromatin	SCIENCE			English	Article							HONEY-BEE; IDENTIFICATION; CHROMOSOME; SEQUENCES; INTRONS; ODORANT	The repetitive DNA that constitutes most of the heterochromatic regions of metazoan genomes has hindered the comprehensive analysis of gene content and other functions. We have generated a detailed computational and manual annotation of 24 megabases of heterochromatic sequence in the Release 5 Drosophila melanogaster genome sequence. The heterochromatin contains a minimum of 230 to 254 protein-coding genes, which are conserved in other Drosophilids and more diverged species, as well as 32 pseudogenes and 13 noncoding RNAs. Improved methods revealed that more than 77% of this heterochromatin sequence, including introns and intergenic regions, is composed of fragmented and nested transposable elements and other repeated DNAs. Drosophila heterochromatin contains "islands" of highly conserved genes embedded in these "oceans" of complex repeats, which may require special expression and splicing mechanisms.	Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome & Computat Biol, Drosophila Heterochromatin Genome Project, Berkeley, CA 94720 USA; San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Natl Ctr Biomed Ontol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; California State University System; San Francisco State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Karpen, GH (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome & Computat Biol, Drosophila Heterochromatin Genome Project, Berkeley, CA 94720 USA.	karpen@fruitfly.org	Mungall, Chris/I-6006-2019	Mungall, Chris/0000-0002-6601-2165; Shu, Shengqiang/0000-0002-4336-8994	NHGRI NIH HHS [U54 HG004028-01, P41 HG000739-15, R01-HG000747, U54 HG004028, R01 HG000747-16, R01 HG000747] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004028, R01HG000747, P41HG000739] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Bayraktaroglu L., 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-12-RESEARCH0082; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bergman CM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r112; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Burnette JM, 2005, GENETICS, V170, P661, DOI 10.1534/genetics.104.039701; Drysdale RA, 2005, NUCLEIC ACIDS RES, V33, pD390, DOI 10.1093/nar/gki046; Elgin SCR, 2003, CURR BIOL, V13, pR895, DOI 10.1016/j.cub.2003.11.006; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Harrison PM, 2003, NUCLEIC ACIDS RES, V31, P1033, DOI 10.1093/nar/gkg169; Hild M, 2004, GENOME BIOL, V5; HOSKINS RA, 2002, GENOME BIOL, V0003; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; KAMINKER JS, 2002, GENOME BIOL, V0003; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Manak JR, 2006, NAT GENET, V38, P1151, DOI 10.1038/ng1875; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101; Quesneville H, 2005, PLOS COMPUT BIOL, V1, P166, DOI 10.1371/journal.pcbi.0010022; Reugels AM, 2000, GENETICS, V154, P759; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Slawson EE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r15; Smith CD, 2007, GENE, V389, P1, DOI 10.1016/j.gene.2006.09.011; Sullivan BA, 2001, NAT REV GENET, V2, P584, DOI 10.1038/35084512; Torrents D, 2003, GENOME RES, V13, P2559, DOI 10.1101/gr.1455503; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	26	152	159	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2007	316	5831					1586	1591		10.1126/science.1139815	http://dx.doi.org/10.1126/science.1139815			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178SH	17569856	Green Accepted			2022-12-01	WOS:000247239900032
J	Walkley, CR; Shea, JM; Sims, NA; Purton, LE; Orkin, SH				Walkley, Carl R.; Shea, Jeremy M.; Sims, Natalie A.; Purton, Louise E.; Orkin, Stuart H.			Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment	CELL			English	Article							SELF-RENEWAL; IN-VIVO; NONAUTONOMOUS FUNCTION; TUMOR-SUPPRESSOR; DIFFERENTIATION; PROGENITOR; MICE; QUIESCENCE; EXPRESSION; OSTEOBLAST	Hematopoiesis is maintained by stem cells (HSCs) that undergo fate decisions by integrating intrinsic and extrinsic signals, with the latter derived from the bone marrow (BM) microenvironment. Cell-cycle regulation can modulate stem cell fate, but it is unknown whether this represents an intrinsic or extrinsic effector of fate decisions. We have investigated the role of the retinoblastoma protein (RB), a central regulator of the cell cycle, in hematopoiesis. Widespread inactivation of RB in the murine hematopoietic system resulted in profound myeloproliferation. HSCs were lost from the BM due to mobilization to extramedullary sites and differentiation. This phenotype was not intrinsic to HSCs, but, rather, was the consequence of an RB-dependent interaction between myeloid-derived cells and the microenvironment. These findings demonstrate that myeloproliferation may result from perturbed interactions between hematopoietic cells and the niche. Therefore, RB extrinsically regulates HSCs by maintaining the capacity of the BM to support normal hematopoiesis and HSCs.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Div HematolOncol,Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Harvard Stem Cell Inst, Childrens Hosp Boston,Stem Cell Program, Boston, MA 02115 USA; Univ Melbourne, St Vincents Hosp, St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia; Harvard Univ, Stem Cell Inst, Ctr Regenerat Med, Boston, MA 02114 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; St Vincent's Hospital Melbourne; St. Vincent's Institute of Medical Research; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; Harvard University; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Div HematolOncol,Dept Pediat Oncol, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu	Sims, Natalie Ann/A-7192-2012; Walkley, Carl/AAO-6021-2020; Purton, Louise/AAI-8956-2021	Sims, Natalie Ann/0000-0003-1421-8468; Walkley, Carl/0000-0002-4784-9031; Purton, Louise/0000-0001-6593-3168	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032259] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL032259-27, R01 HL032259] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Anderson ARA, 2006, CELL, V127, P905, DOI 10.1016/j.cell.2006.09.042; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bradford GB, 1997, EXP HEMATOL, V25, P445; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chan IT, 2004, J CLIN INVEST, V113, P528, DOI 10.1172/JCI200420476; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Chien WM, 2006, P NATL ACAD SCI USA, V103, P4122, DOI 10.1073/pnas.0509514103; Clark AJ, 2004, BLOOD, V104, P1324, DOI 10.1182/blood-2004-02-0618; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Ghiaur G, 2006, BLOOD, V108, P2087, DOI 10.1182/blood-2006-02-001560; Gothot A, 1998, BLOOD, V92, P2641, DOI 10.1182/blood.V92.8.2641.420k36_2641_2649; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hideshima T, 2002, NAT REV CANCER, V2, P927, DOI 10.1038/nrc952; Hill R, 2005, CELL, V123, P1001, DOI 10.1016/j.cell.2005.09.030; HODGSON GS, 1979, NATURE, V281, P381, DOI 10.1038/281381a0; Hu NP, 1997, CANCER RES, V57, P4123; Iavarone A, 2004, NATURE, V432, P1040, DOI 10.1038/nature03068; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Kramer AK, 2002, LEUKEMIA, V16, P1844, DOI 10.1038/sj.leu.2402609; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Krosl J, 2003, IMMUNITY, V18, P561, DOI 10.1016/S1074-7613(03)00090-6; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Le DT, 2004, BLOOD, V103, P4243, DOI 10.1182/blood-2003-08-2650; LERNER C, 1990, EXP HEMATOL, V18, P114; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; LI CL, 1994, BLOOD, V84, P408, DOI 10.1182/blood.V84.2.408.bloodjournal842408; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Mitsiades CS, 2006, EUR J CANCER, V42, P1564, DOI 10.1016/j.ejca.2005.12.025; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; Oh P, 2004, NATURE, V429, P629, DOI 10.1038/nature02580; OKADA S, 1992, BLOOD, V80, P3044; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Purton LE, 2000, BLOOD, V95, P470, DOI 10.1182/blood.V95.2.470; Purton LE, 1999, BLOOD, V94, P483, DOI 10.1182/blood.V94.2.483.414k12_483_495; Purton LE, 2006, J EXP MED, V203, P1283, DOI 10.1084/jem.20052105; Rasheed N, 2006, HUM MOL GENET, V15, P1938, DOI 10.1093/hmg/ddl116; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; SPANGRUDE GJ, 1995, BLOOD, V85, P1006, DOI 10.1182/blood.V85.4.1006.bloodjournal8541006; Spike BT, 2004, EMBO J, V23, P4319, DOI 10.1038/sj.emboj.7600432; St Croix B, 2000, SCIENCE, V289, P1197; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Stepanova L, 2005, BLOOD, V106, P827, DOI 10.1182/blood-2004-06-2242; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; Tajima F, 2000, BLOOD, V96, P1989, DOI 10.1182/blood.V96.5.1989.h8001989_1989_1993; TASWELL C, 1981, J IMMUNOL, V126, P1614; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Varnum-Finney B, 1998, BLOOD, V91, P4084, DOI 10.1182/blood.V91.11.4084.411k05_4084_4091; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Walkley CR, 2006, P NATL ACAD SCI USA, V103, P9057, DOI 10.1073/pnas.0603389103; Walkley CR, 2005, NAT CELL BIOL, V7, P172, DOI 10.1038/ncb1214; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Whyatt D, 2002, EMBO REP, V3, P130, DOI 10.1093/embo-reports/kvf033; Wildwater M, 2005, CELL, V123, P1337, DOI 10.1016/j.cell.2005.09.042; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	78	318	331	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	2007	129	6					1081	1095		10.1016/j.cell.2007.03.055	http://dx.doi.org/10.1016/j.cell.2007.03.055			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	180UA	17574022	Bronze, Green Accepted			2022-12-01	WOS:000247390400013
J	Yagoda, N; von Rechenberg, M; Zaganjor, E; Bauer, AJ; Yang, WS; Fridman, DJ; Wolpaw, AJ; Smukste, I; Peltier, JM; Boniface, JJ; Smith, R; Lessnick, SL; Sahasrabudhe, S; Stockwell, BR				Yagoda, Nicholas; von Rechenberg, Moritz; Zaganjor, Elma; Bauer, Andras J.; Yang, Wan Seok; Fridman, Daniel J.; Wolpaw, Adam J.; Smukste, Inese; Peltier, John M.; Boniface, J. Jay; Smith, Richard; Lessnick, Stephen L.; Sahasrabudhe, Sudhir; Stockwell, Brent R.			RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels	NATURE			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; HUMAN TUMOR-CELLS; APOPTOSIS; MECHANISM; GENE; PERMEABILITY; ACTIVATION; THERAPY; LIBRARY; CANCER	Therapeutics that discriminate between the genetic makeup of normal cells and tumour cells are valuable for treating and understanding cancer. Small molecules with oncogene-selective lethality may reveal novel functions of oncoproteins and enable the creation of more selective drugs(1). Here we describe the mechanism of action of the selective anti-tumour agent erastin, involving the RAS - RAF - MEK signalling pathway functioning in cell proliferation, differentiation and survival. Erastin exhibits greater lethality in human tumour cells harbouring mutations in the oncogenes HRAS, KRAS or BRAF. Using affinity purification and mass spectrometry, we discovered that erastin acts through mitochondrial voltage-dependent anion channels (VDACs) - a novel target for anti-cancer drugs. We show that erastin treatment of cells harbouring oncogenic RAS causes the appearance of oxidative species and subsequent death through an oxidative, non-apoptotic mechanism. RNA-interference-mediated knockdown of VDAC2 or VDAC3 caused resistance to erastin, implicating these two VDAC isoforms in the mechanism of action of erastin. Moreover, using purified mitochondria expressing a single VDAC isoform, we found that erastin alters the permeability of the outer mitochondrial membrane. Finally, using a radiolabelled analogue and a filter-binding assay, we show that erastin binds directly to VDAC2. These results demonstrate that ligands to VDAC proteins can induce non-apoptotic cell death selectively in some tumour cells harbouring activating mutations in the RAS - RAF - MEK pathway.	Columbia Univ, Fairchild Ctr, Dept Biol Sci, New York, NY 10027 USA; Columbia Univ, Dept Chem, New York, NY 10027 USA; Prolexys Pharmaceut, Salt Lake City, UT 84116 USA; Huntsman Canc Inst, Ctr Children, Salt Lake City, UT 84112 USA	Columbia University; Columbia University; Huntsman Cancer Institute	Stockwell, BR (corresponding author), Columbia Univ, Fairchild Ctr, Dept Biol Sci, 1212 Amsterdam Ave,MC 2406, New York, NY 10027 USA.	stockwell@biology.columbia.edu	Stockwell, Brent R/AAE-7200-2019	Stockwell, Brent R/0000-0002-3532-3868; Wolpaw, Adam/0000-0002-1373-7648	NCI NIH HHS [R01 CA097061-09, R01 CA097061-08S1, R01 CA097061-06, R01 CA097061-02, R01 CA097061-01, R01 CA097061-05A1, R01 CA097061-03, R01 CA097061-08, R01 CA097061, R01 CA097061-04, R01 CA097061-07, R01 CA097061-09S1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA097061] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baker MA, 2004, J BIOL CHEM, V279, P4811, DOI 10.1074/jbc.M311020200; Beck W T, 1991, Semin Cancer Biol, V2, P235; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Graham BH, 2004, CURR TOP DEV BIOL, V59, P87, DOI 10.1016/S0070-2153(04)59004-X; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Koppel DA, 1998, J BIOL CHEM, V273, P13794, DOI 10.1074/jbc.273.22.13794; MAJNO G, 1995, AM J PATHOL, V146, P3; Mannella CA, 1997, J BIOENERG BIOMEMBR, V29, P525, DOI 10.1023/A:1022489832594; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Poyurovsky MV, 2003, MOL CELL, V12, P875, DOI 10.1016/S1097-2765(03)00400-3; Root DE, 2003, CHEM BIOL, V10, P881, DOI 10.1016/j.chembiol.2003.08.009; Rostovtseva T, 1996, J BIOL CHEM, V271, P28006, DOI 10.1074/jbc.271.45.28006; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Song ZW, 1999, TRENDS CELL BIOL, V9, pM49, DOI 10.1016/S0968-0004(99)01485-1; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Xu X, 1999, J MEMBRANE BIOL, V170, P89, DOI 10.1007/s002329900540; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zhen YJ, 2004, J AM SOC MASS SPECTR, V15, P803, DOI 10.1016/S1044-0305(04)00131-X	24	763	798	20	172	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2007	447	7146					864	868		10.1038/nature05859	http://dx.doi.org/10.1038/nature05859			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17568748	Green Accepted			2022-12-01	WOS:000247207500046
J	Kim, JB; Porreca, GJ; Song, L; Greenway, SC; Gorham, JM; Church, GM; Seidman, CE; Seidman, JG				Kim, Jae Bum; Porreca, Gregory J.; Song, Lei; Greenway, Steven C.; Gorham, Joshua M.; Church, George M.; Seidman, Christine E.; Seidman, J. G.			Polony multiplex analysis of gene expression (PMAGE) in mouse hypertrophic cardiomyopathy	SCIENCE			English	Article							GROWTH; REPRODUCIBILITY; TRANSCRIPTOME; MORPHOGENESIS; ABUNDANCE; MUTATION; RATS; HOP	We describe a sensitive mRNA profiling technology, PMAGE ( for "polony multiplex analysis of gene expression"), which detects messenger RNAs ( mRNAs) as rare as one transcript per three cells. PMAGE incorporates an improved ligation-based method to sequence 14-nucleotide tags derived from individual mRNA molecules. One sequence tag from each mRNA molecule is amplified onto a separate 1-micrometer bead, denoted as a polymerase colony or polony, and about 5 million polonies are arrayed in a flow cell for parallel sequencing. Using PMAGE, we identified early transcriptional changes that preceded pathological manifestations of hypertrophic cardiomyopathy in mice carrying a disease-causing mutation. PMAGE provided a comprehensive profile of cardiac mRNAs, including low-abundance mRNAs encoding signaling molecules and transcription factors that are likely to participate in disease pathogenesis.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Seidman, JG (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	cseidman@genetics.med.harvard.edu; seidman@genetics.med.harvard.edu	Greenway, Steven C/S-7777-2019	church, george/0000-0001-6232-9969				Ahmed MS, 2004, J MOL CELL CARDIOL, V36, P393, DOI 10.1016/j.yjmcc.2003.12.004; Albert Y, 2005, J CELL BIOL, V169, P257, DOI 10.1083/jcb.200501156; Asahi M, 2004, P NATL ACAD SCI USA, V101, P9199, DOI 10.1073/pnas.0402596101; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bienengraeber M, 2004, NAT GENET, V36, P382, DOI 10.1038/ng1329; BLACKSHAW S, 2002, CURRENT PROTOCOLS MO; Chen F, 2002, CELL, V110, P713, DOI 10.1016/S0092-8674(02)00932-7; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Dinel S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni025; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Dressman D, 2003, P NATL ACAD SCI USA, V100, P8817, DOI 10.1073/pnas.1133470100; GeisterferLowrance AAT, 1996, SCIENCE, V272, P731, DOI 10.1126/science.272.5262.731; Georgakopoulos D, 1999, NAT MED, V5, P327, DOI 10.1038/6549; Harris KM, 2006, CIRCULATION, V114, P216, DOI 10.1161/CIRCULATIONAHA.105.583500; HASTIE ND, 1976, CELL, V9, P761, DOI 10.1016/0092-8674(76)90139-2; Holland MJ, 2002, J BIOL CHEM, V277, P14363, DOI 10.1074/jbc.C200101200; LEE RT, 1988, J CLIN INVEST, V81, P431, DOI 10.1172/JCI113337; Lijnen PJ, 2000, MOL GENET METAB, V71, P418, DOI 10.1006/mgme.2000.3032; Maeda T, 2002, J BIOL CHEM, V277, P48889, DOI 10.1074/jbc.M206858200; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Shin CH, 2002, CELL, V110, P725, DOI 10.1016/S0092-8674(02)00933-9; SRIVASTAVA D, 1995, SCIENCE, V270, P1995, DOI 10.1126/science.270.5244.1995; Varnava AM, 2001, AM J CARDIOL, V88, P275, DOI 10.1016/S0002-9149(01)01640-X; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; Zingman LV, 2002, P NATL ACAD SCI USA, V99, P13278, DOI 10.1073/pnas.212315199	29	146	229	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2007	316	5830					1481	1484		10.1126/science.1137325	http://dx.doi.org/10.1126/science.1137325			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176EE	17556586				2022-12-01	WOS:000247066400044
J	Saxena, R; Voight, BF; Lyssenko, V; Burtt, NP; de Bakker, PIW; Chen, H; Roix, JJ; Kathiresan, S; Hirschhorn, JN; Daly, MJ; Hughes, TE; Groop, L; Altshuler, D; Almgren, P; Florez, JC; Meyer, J; Ardlie, K; Bostrom, KB; Isomaa, B; Lettre, G; Lindblad, U; Lyon, HN; Melander, O; Newton-Cheh, C; Nilsson, P; Orho-Melander, M; Rastam, L; Speliotes, EK; Taskinen, MR; Tuomi, T; Guiducci, C; Berglund, A; Carlson, J; Gianniny, L; Hackett, R; Hall, L; Holmkvist, J; Laurila, E; Sjogren, M; Sterner, M; Surti, A; Svensson, M; Svensson, M; Tewhey, R; Blumenstiel, B; Parkin, M; DeFelice, M; Barry, R; Brodeur, W; Camarata, J; Chia, N; Fava, M; Gibbons, J; Handsaker, B; Healy, C; Nguyen, K; Gates, C; Sougnez, C; Gage, D; Nizzari, M; Gabriel, SB; Chirn, GW; Ma, QC; Parikh, H; Richardson, D; Ricke, D; Purcell, S				Saxena, Richa; Voight, Benjamin F.; Lyssenko, Valeriya; Burtt, Noel P.; de Bakker, Paul I. W.; Chen, Hong; Roix, Jeffrey J.; Kathiresan, Sekar; Hirschhorn, Joel N.; Daly, Mark J.; Hughes, Thomas E.; Groop, Leif; Altshuler, David; Almgren, Peter; Florez, Jose C.; Meyer, Joanne; Ardlie, Kristin; Bostroem, Kristina Bengtsson; Isomaa, Bo; Lettre, Guillaume; Lindblad, Ulf; Lyon, Helen N.; Melander, Olle; Newton-Cheh, Christopher; Nilsson, Peter; Orho-Melander, Marju; Rastam, Lennart; Speliotes, Elizabeth K.; Taskinen, Marja-Riitta; Tuomi, Tiinamaija; Guiducci, Candace; Berglund, Anna; Carlson, Joyce; Gianniny, Lauren; Hackett, Rachel; Hall, Liselotte; Holmkvist, Johan; Laurila, Esa; Sjoegren, Marketa; Sterner, Maria; Surti, Aarti; Svensson, Margareta; Svensson, Malin; Tewhey, Ryan; Blumenstiel, Brendan; Parkin, Melissa; DeFelice, Matthew; Barry, Rachel; Brodeur, Wendy; Camarata, Jody; Chia, Nancy; Fava, Mary; Gibbons, John; Handsaker, Bob; Healy, Claire; Nguyen, Kieu; Gates, Casey; Sougnez, Carrie; Gage, Diane; Nizzari, Marcia; Gabriel, Stacey B.; Chirn, Gung-Wei; Ma, Qicheng; Parikh, Hemang; Richardson, Delwood; Ricke, Darrell; Purcell, Shaun		Diabet Genetics Initiative Broad In; Novartis Inst BioMedical Res	Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels	SCIENCE			English	Article							RNA-BINDING PROTEIN; MACULAR DEGENERATION; RISK LOCI; OVEREXPRESSION; SUSCEPTIBILITY; GLUCOKINASE; POPULATION; VARIANTS; GENE; AGE	New strategies for prevention and treatment of type 2 diabetes (T2D) require improved insight into disease etiology. We analyzed 386,731 common single-nucleotide polymorphisms (SNPs) in 1464 patients with T2D and 1467 matched controls, each characterized for measures of glucose metabolism, lipids, obesity, and blood pressure. With collaborators (FUSION and WTCCC/UKT2D), we identified and confirmed three loci associated with T2D - in a noncoding region near CDKN2A and CDKN2B, in an intron of IGF2BP2, and an intron of CDKAL1 - and replicated associations near HHEX and in SLC30A8 found by a recent whole-genome association study. We identified and confirmed association of a SNP in an intron of glucokinase regulatory protein (GCKR) with serum triglycerides. The discovery of associated variants in unsuspected genes and outside coding regions illustrates the ability of genome-wide association studies to provide potentially important clues to the pathogenesis of common diseases.	Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Diabet & Endocrinol Res Unit, Malmo, Sweden; Novartis Inst Biomed Res, Diabet & Metab Dis Area, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; Childrens Hosp, Div Genet, Boston, MA 02115 USA; Univ Helsinki, Univ Helsinki Hosp, Dept Med, Helsinki, Finland; Skaraborg Inst, Skovde, Sweden; Malmska Municipal Hlth Ctr & Hosp, Pietarsaari, Finland; Folkhalsan Res Ctr, Helsinki, Finland; Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Community Med Res Unit, Malmo, Sweden; Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Med Res Unit, Malmo, Sweden; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Lund University; Skane University Hospital; Novartis; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Hughes, TE (corresponding author), Harvard Univ, Broad Inst, Cambridge, MA 02142 USA.	thomase.hughes@novartis.com; leif.groop@med.lu.se; altshuler@molbio.mgh.harvard.edu	Taskinen, Marja-Riitta/AAN-5432-2020; Voight, Benjamin/F-1775-2011; de Bakker, Paul IW/B-8730-2009; Ricke, Darrell O./GNP-5137-2022; Parikh, Hemang/AAY-7174-2021; Handsaker, Bob/AAX-9095-2021; Altshuler, David M/A-4476-2009; Daly, Mark J/B-2453-2017; Saxena, Richa/AAG-7279-2020	Taskinen, Marja-Riitta/0000-0002-6229-3588; de Bakker, Paul IW/0000-0001-7735-7858; Handsaker, Bob/0000-0002-3128-3547; Altshuler, David M/0000-0002-7250-4107; Daly, Mark J/0000-0002-0949-8752; Ricke, Darrell/0000-0002-2842-2809; Melander, Olle/0000-0002-2581-484X; Saxena, Richa/0000-0003-2233-1065; Tuomi, Tiinamaija/0000-0002-8306-6202	NHGRI NIH HHS [U01 HG004171] Funding Source: Medline; NHLBI NIH HHS [K23-HL083102] Funding Source: Medline; NIDDK NIH HHS [K23 DK65978-04, F32 DK079466-01, K23 DK067288, F32 DK079466, K23 DK080145, K23 DK080145-01] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL083102] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK079466, K23DK065978, K23DK067288, K23DK080145] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Ferre T, 1996, FASEB J, V10, P1213, DOI 10.1096/fasebj.10.10.8751724; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Hani EH, 1998, DIABETOLOGIA, V41, P1511, DOI 10.1007/s001250051098; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; KIMURA M, 1973, GENETICS, V75, P199; KOLOWSKI IK, 2006, AM J HUM GENET, V78, P410; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Nielsen FC, 2001, SCAND J CLIN LAB INV, V61, P93; O'Doherty RM, 1999, DIABETES, V48, P2022, DOI 10.2337/diabetes.48.10.2022; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Slosberg ED, 2001, DIABETES, V50, P1813, DOI 10.2337/diabetes.50.8.1813; Spagnoli FM, 2006, DEV BIOL, V292, P442, DOI 10.1016/j.ydbio.2006.01.022; Ubeda M, 2006, J BIOL CHEM, V281, P28858, DOI 10.1074/jbc.M604690200; Wagner M, 2003, GASTROENTEROLOGY, V124, P1901, DOI 10.1016/S0016-5085(03)00402-5; *WELLC TRUST CAS C, IN PRESS NATURE; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	30	2240	2330	2	249	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2007	316	5829					1331	1336		10.1126/science.1142358	http://dx.doi.org/10.1126/science.1142358			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17463246				2022-12-01	WOS:000246885600049
J	Tanne, JH				Tanne, Janice Hopkins			Study links diabetes-drug to heart deaths	BRITISH MEDICAL JOURNAL			English	News Item																			0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 26	2007	334	7603					1073	1073		10.1136/bmj.39224.364630.DB	http://dx.doi.org/10.1136/bmj.39224.364630.DB			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	174XB	17525413	Green Published			2022-12-01	WOS:000246975000012
J	Hovi, P; Andersson, S; Eriksson, JG; Jarvenpaa, A; Strang-Karlsson, S; Makitie, O; Kajantie, E				Hovi, Petteri; Andersson, Sture; Eriksson, Johan G.; Jarvenpaa, Anna-Liisa; Strang-Karlsson, Sonja; Makitie, Outi; Kajantie, Eero			Glucose regulation in young adults with very low birth weight	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOVASCULAR RISK-FACTORS; INSULIN-RESISTANCE; GESTATIONAL-AGE; BLOOD-PRESSURE; PRETERM INFANTS; PLASMA-GLUCOSE; GROWTH; CHILDREN; SENSITIVITY; BORN	Background: The association between small size at birth and impaired glucose regulation later in life is well established in persons born at term. Preterm birth with very low birth weight (< 1500 g) is also associated with insulin resistance in childhood. If insulin resistance persists into adulthood, preterm birth with very low birth weight also may be associated with an increased risk of disease in adulthood. We assessed glucose tolerance and insulin sensitivity and measured serum lipid levels and blood pressure in young adults with very low birth weight. Methods: We performed a standard 75-g oral glucose-tolerance test, measuring insulin and glucose concentrations at baseline and at 120 minutes in 163 young adults (age range, 18 to 27 years) with very low birth weight and in 169 subjects who had been born at term and were not small for gestational age. The two groups were similar with regard to age, sex, and birth hospital. We measured blood pressure and serum lipid levels, and in 150 very-low-birth-weight subjects and 136 subjects born at term, we also measured body composition by means of dual-energy x-ray absorptiometry. Results: As compared with the subjects born at term, the very-low-birth-weight subjects had a 6.7% increase in the 2-hour glucose concentration (95% confidence interval [CI], 0.8 to 12.9), a 16.7% increase in the fasting insulin concentration (95% CI, 4.6 to 30.2), a 40.0% increase in the 2-hour insulin concentration (95% CI, 17.5 to 66.8), an 18.9% increase in the insulin-resistance index determined by homeostatic model assessment (95% CI, 5.7 to 33.7), and an increase of 4.8 mm Hg in systolic blood pressure (95% CI, 2.1 to 7.4). Adjustment for the lower lean body mass in the very-low-birth-weight subjects did not attenuate these relationships. Conclusions: Young adults with a very low birth weight have higher indexes of insulin resistance and glucose intolerance and higher blood pressure than those born at term.	Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, FI-00300 Helsinki, Finland; Univ Helsinki, Hosp Children & Adolescents, Inst Clin Med, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki	Hovi, P (corresponding author), Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, Mannerheimintie 166, FI-00300 Helsinki, Finland.	petteri.hovi@helsinki.fi		Makitie, Outi/0000-0002-4547-001X; Eriksson, Johan/0000-0002-2516-2060				Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; Arends NJT, 2005, CLIN ENDOCRINOL, V62, P44, DOI 10.1111/j.1365-2265.2004.02171.x; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Bazaes RA, 2004, J CLIN ENDOCR METAB, V89, P1267, DOI 10.1210/jc.2003-031239; Bloomfield FH, 2003, SCIENCE, V300, P606, DOI 10.1126/science.1080803; Chen H, 2005, DIABETES, V54, P1914, DOI 10.2337/diabetes.54.7.1914; Doyle LW, 2003, PEDIATRICS, V111, P252, DOI 10.1542/peds.111.2.252; Eriksson JG, 2006, DIABETOLOGIA, V49, P2853, DOI 10.1007/s00125-006-0459-1; Fewtrell MS, 2000, DIABETOLOGIA, V43, P714, DOI 10.1007/s001250051368; Finken MJJ, 2006, DIABETOLOGIA, V49, P478, DOI 10.1007/s00125-005-0118-y; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Gillman MW, 2005, NEW ENGL J MED, V353, P1848, DOI 10.1056/NEJMe058187; Gluckman PD, 2006, DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, P33, DOI 10.1017/CBO9780511544699.004; Hack M, 1999, EARLY HUM DEV, V53, P193, DOI 10.1016/S0378-3782(98)00052-8; Hack M, 2005, PEDIATR RES, V58, P677, DOI 10.1203/01.PDR.0000180551.93470.56; HACK M, 1989, NEW ENGL J MED, V321, P1642, DOI 10.1056/NEJM198912143212405; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hofman PL, 2004, NEW ENGL J MED, V351, P2888; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Hofman PL, 1997, J CLIN ENDOCR METAB, V82, P402, DOI 10.1210/jc.82.2.402; Hu G., 2004, DIABETOLOGIA, V47, P1245; Irving RJ, 2000, LANCET, V356, P514; Irving RJ, 2000, LANCET, V355, P2135, DOI 10.1016/S0140-6736(00)02384-9; Jaquet D, 2000, J CLIN ENDOCR METAB, V85, P1401, DOI 10.1210/jc.85.4.1401; JARVENPAA AL, 1991, ANN MED, V23, P699, DOI 10.3109/07853899109148106; Keijzer-Veen MG, 2005, PEDIATRICS, V116, P725, DOI 10.1542/peds.2005-0309; Keller H, 2000, MED SCI SPORT EXER, V32, P278, DOI 10.1097/00005768-200002000-00005; Kunst A., 1984, METHOD ENZYMAT AN, VVI, P163; Leger J, 1997, BRIT MED J, V315, P341; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Newsome CA, 2003, DIABETIC MED, V20, P339, DOI 10.1046/j.1464-5491.2003.00871.x; Nijpels G, 1998, EUR J CLIN INVEST, V28, P8; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; Philip AGS, 2005, PEDIATR RES, V58, P799, DOI 10.1203/01.PDR.0000151693.46655.66; PHILLIPS DIW, 1994, DIABETIC MED, V11, P286, DOI 10.1111/j.1464-5491.1994.tb00273.x; Pihkala J, 1989, Duodecim, V105, P1540; Pyorala M, 2000, DIABETES CARE, V23, P1097, DOI 10.2337/diacare.23.8.1097; Rasmussen EL, 2005, DIABETES CARE, V28, P151, DOI 10.2337/diacare.28.1.151; Regan FM, 2006, PEDIATRICS, V118, P1943, DOI 10.1542/peds.2006-0733; ROBINSON S, 1992, DIABETOLOGIA, V35, P444, DOI 10.1007/BF02342441; Roseboom T, 2006, EARLY HUM DEV, V82, P485, DOI 10.1016/j.earlhumdev.2006.07.001; Stevenson CJ, 2001, ARCH DIS CHILD-FETAL, V84, pF18, DOI 10.1136/fn.84.1.F18; Stoelhorst GMSJ, 2005, PEDIATRICS, V115, P396, DOI 10.1542/peds.2004-1497; TOIVONEN E, 1986, CLIN CHEM, V32, P637	44	376	387	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2007	356	20					2053	2063		10.1056/NEJMoa067187	http://dx.doi.org/10.1056/NEJMoa067187			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	167ZD	17507704				2022-12-01	WOS:000246490500006
J	Ito, M; Yang, ZX; Andl, T; Cui, C; Kim, N; Millar, SE; Cotsarelis, G				Ito, Mayumi; Yang, Zaixin; Andl, Thomas; Cui, Chunhua; Kim, Noori; Millar, Sarah E.; Cotsarelis, George			Wnt-dependent de novo hair follicle regeneration in adult mouse skin after wounding	NATURE			English	Article							EPITHELIAL STEM-CELLS; BETA-CATENIN; TRANSIENT ACTIVATION; DIFFERENTIATION; MORPHOGENESIS; GROWTH; NICHE; CYCLE	The mammalian hair follicle is a complex 'mini-organ' thought to form only during development 1; loss of an adult follicle is considered permanent. However, the possibility that hair follicles develop de novo following wounding was raised in studies on rabbits (2,3), mice(4) and even humans fifty years ago(5). Subsequently, these observations were generally discounted because definitive evidence for follicular neogenesis was not presented(6). Here we show that, after wounding, hair follicles form de novo in genetically normal adult mice. The regenerated hair follicles establish a stem cell population, express known molecular markers of follicle differentiation, produce a hair shaft and progress through all stages of the hair follicle cycle. Lineage analysis demonstrated that the nascent follicles arise from epithelial cells outside of the hair follicle stem cell niche, suggesting that epidermal cells in the wound assume a hair follicle stem cell phenotype. Inhibition of Wnt signalling after re-epithelialization completely abrogates this wounding-induced folliculogenesis, whereas overexpression of Wnt ligand in the epidermis increases the number of regenerated hair follicles. These remarkable regenerative capabilities of the adult support the notion that wounding induces an embryonic phenotype in skin, and that this provides a window for manipulation of hair follicle neogenesis by Wnt proteins. These findings suggest treatments for wounds, hair loss and other degenerative skin disorders.	Univ Penn, Sch Med, Dept Dermatol, Kligman Labs, Philadelphia, PA 19104 USA	University of Pennsylvania	Cotsarelis, G (corresponding author), Univ Penn, Sch Med, Dept Dermatol, Kligman Labs, Philadelphia, PA 19104 USA.	cotsarel@mail.med.upenn.edu		Millar, Sarah/0000-0001-8792-6890; Andl, Thomas/0000-0002-5555-468X				Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Atala A, 2005, EXPERT OPIN BIOL TH, V5, P879, DOI 10.1517/14712598.5.7.879; BILLINGHAM RE, 1956, NATURE, V177, P791, DOI 10.1038/177791b0; BREEDIS C, 1954, CANCER RES, V14, P575; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Fathke C, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-4; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; HANDJISKI BK, 1994, BRIT J DERMATOL, V131, P303, DOI 10.1111/j.1365-2133.1994.tb08515.x; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Kishimoto J, 2000, GENE DEV, V14, P1181; KLIGMAN AM, 1956, J INVEST DERMATOL, V27, P19, DOI 10.1038/jid.1956.71; LACASSAGNE A, 1946, CANCER RES, V6, P183; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; Millar SE, 2005, PLOS BIOL, V3, P1873, DOI 10.1371/journal.pbio.0030372; Millar SE, 1999, DEV BIOL, V207, P133, DOI 10.1006/dbio.1998.9140; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; STRAILE WE, 1967, ADV BIOL SKIN, V9, P369; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Van Mater D, 2003, GENE DEV, V17, P1219, DOI 10.1101/gad.1076103; Wunderlich FT, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.10.e47	31	683	730	7	307	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 17	2007	447	7142					316	U4		10.1038/nature05766	http://dx.doi.org/10.1038/nature05766			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17507982				2022-12-01	WOS:000246520300045
J	Bruey, JM; Bruey-Sedano, N; Luciano, F; Zhai, DY; Balpai, R; Xu, CY; Kress, CL; Bailly-Maitre, B; Li, XQ; Osterman, A; Matsuzawa, SI; Terskikh, AV; Faustin, B; Reed, JC				Bruey, Jean-Marie; Bruey-Sedano, Nathalie; Luciano, Frederic; Zhai, Dayong; Balpai, Ruchi; Xu, Chunyan; Kress, Christina L.; Bailly-Maitre, Beatrice; Li, Xiaoqing; Osterman, Andrei; Matsuzawa, Shu-ichi; Terskikh, Alexey V.; Faustin, Benjamin; Reed, John C.			Bcl-2 and Bcl-X-L regulate proinf lammatory caspase-1 activation by interaction with NALP1	CELL			English	Article							BACTERIAL MURAMYL DIPEPTIDE; PROGRAMMED CELL-DEATH; INFLAMMATORY CASPASES; IMMUNE-SYSTEM; CYTOCHROME-C; APOPTOSIS; INNATE; IDENTIFICATION; IPAF; BAX	Caspases are intracellular proteases that cleave substrates involved in apoptosis or inflammation. In C. elegans, a paradigm for caspase regulation exists in which caspase CED-3 is activated by In ucleotide-binding protein CED-4, which is suppressed by Bcl-2-family protein CED-9. We have identified a mammalian analog of this caspase-regulatory system in the NLR-family protein NALP1, a nucleotide-dependent activator of cytokine-processing protease caspase-1, which responds to bacterial ligand muramyl-dipeptide (MDP). Antiapoptotic proteins Bcl-2 and Bcl-X-L bind and suppress NALP1, reducing caspase-1 activation and interleukin-1 beta (IL-1 beta) production. When exposed to MDP, Bcl-2-deficient macrophages exhibit more caspase-1 processing and IL-1 beta production, whereas Bcl-2-overexpressing macrophages demonstrate less caspase-1 processing and IL-1 beta production. The findings reveal an interaction of host defense and apoptosis machinery.	Burnham Inst Med Res, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Reed, JC (corresponding author), Burnham Inst Med Res, La Jolla, CA 92037 USA.	reedoffice@burnham.org	Terskikh, Alexey/U-8407-2019; luciano, frederic/P-6264-2016	luciano, frederic/0000-0001-9253-4998; Bailly-Maitre, Beatrice/0000-0002-8389-8498				Adams JM, 2002, CURR OPIN CELL BIOL, V14, P715, DOI 10.1016/S0955-0674(02)00381-2; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Chang BS, 1997, EMBO J, V16, P968, DOI 10.1093/emboj/16.5.968; Chu ZL, 2001, J BIOL CHEM, V276, P9239, DOI 10.1074/jbc.M006309200; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Kufer TA, 2005, TRENDS MICROBIOL, V13, P381, DOI 10.1016/j.tim.2005.06.004; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Navarre WW, 2000, CELL MICROBIOL, V2, P265, DOI 10.1046/j.1462-5822.2000.00056.x; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Saito H, 2003, MECH AGEING DEV, V124, P1047, DOI 10.1016/j.mad.2003.08.002; Stehlik C, 2004, J EXP MED, V200, P551, DOI 10.1084/jem.20032234; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Wang SJ, 2005, DEV BIOL, V279, P205, DOI 10.1016/j.ydbio.2004.12.017; Yan N, 2005, NATURE, V437, P831, DOI 10.1038/nature04002; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; ZHAI D, 2006, IN PRESS CELL DEATH; Zhang WH, 2003, P NATL ACAD SCI USA, V100, P16012, DOI 10.1073/pnas.2534856100; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	32	248	267	1	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					45	56		10.1016/j.cell.2007.01.045	http://dx.doi.org/10.1016/j.cell.2007.01.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418785	Bronze			2022-12-01	WOS:000245661100010
J	Stoleru, D; Nawathean, P; Fernandez, MDLP; Menet, JS; Ceriani, MF; Rosbash, M				Stoleru, Dan; Nawathean, Pipat; Fernandez, Maria de la Paz; Menet, Jerome S.; Ceriani, M. Fernanda; Rosbash, Michael			The Drosophila circadian network is a seasonal timer	CELL			English	Article							NEGATIVE FEEDBACK LOOP; CLOCK-GENE; TRANSCRIPTIONAL REPRESSOR; FUNCTIONAL-ANALYSIS; BEHAVIORAL RHYTHMS; PACEMAKER NEURONS; LIGHT RESPONSE; PERIOD PROTEIN; CRYPTOCHROME; MELANOGASTER	Previous work in Drosophila has defined two populations of circadian brain neurons, morning cells (M-cells) and evening cells (E-cells), both of which keep circadian time and regulate morning and evening activity, respectively. It has long been speculated that a multiple oscillator circadian network in animals underlies the behavioral and physiological pattern variability caused by seasonal fluctuations of photoperiod. We have manipulated separately the circadian photoentrainment pathway within E- and M-cells and show that E-cells process light information and function as master clocks in the presence of light. M-cells in contrast need darkness to cycle autonomously and dominate the network. The results indicate that the network switches control between these two centers as a function of photoperiod. Together with the different entraining properties of the two clock centers, the results suggest that the functional organization of the network underlies the behavioral adjustment to variations in daylength and season.	Brandeis Univ, Howard Hughes Med Inst, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Natl Ctr Behav Genom, Dept Biol, Waltham, MA 02454 USA; Fdn Inst Leloir, Lab Genet Comportamiento, RA-1405 Buenos Aires, DF, Argentina	Brandeis University; Howard Hughes Medical Institute; Brandeis University; Leloir Institute	Rosbash, M (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Dept Biol, Waltham, MA 02454 USA.	rosbash@brandeis.edu	de la Paz Fernandez, Maria/ABC-5366-2020; Menet, Jerome/B-7054-2015	de la Paz Fernandez, Maria/0000-0002-9261-6114; Menet, Jerome/0000-0002-7682-0967; Ceriani, Maria/0000-0001-8945-3070	NIGMS NIH HHS [GM66778] Funding Source: Medline; NINDS NIH HHS [T32 NS007292, NS44232] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007292, P01NS044232] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akten B, 2003, NAT NEUROSCI, V6, P251, DOI 10.1038/nn1007; ASCHOFF J, 1979, Z TIERPSYCHOL, V49, P225; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Collins B, 2006, CURR BIOL, V16, P441, DOI 10.1016/j.cub.2006.01.034; Dissel S, 2004, NAT NEUROSCI, V7, P834, DOI 10.1038/nn1285; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Hall JC, 2003, ADV GENET, V48, P1, DOI 10.1016/S0065-2660(03)48000-0; HAMBLEN M, 1986, J NEUROGENET, V3, P249, DOI 10.3109/01677068609106855; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Kaneko M, 2000, J NEUROBIOL, V43, P207, DOI 10.1002/(SICI)1097-4695(20000605)43:3<207::AID-NEU1>3.0.CO;2-0; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-5; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; Lin FJ, 2001, MOL CELL BIOL, V21, P7287, DOI 10.1128/MCB.21.21.7287-7294.2001; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Magnusson A, 2003, CHRONOBIOL INT, V20, P189, DOI 10.1081/CBI-120019310; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Murad A, 2007, NEURON, V53, P689, DOI 10.1016/j.neuron.2007.01.034; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Nawathean P, 2004, MOL CELL, V13, P213, DOI 10.1016/S1097-2765(03)00503-3; Nawathean P, 2005, METHOD ENZYMOL, V393, P610, DOI 10.1016/S0076-6879(05)93032-2; Papadopoulou D, 2004, MOL CELL BIOL, V24, P4909, DOI 10.1128/MCB.24.11.4909-4919.2004; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Qiu J, 1996, MOL CELL BIOL, V16, P4182; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rieger D, 2006, J NEUROSCI, V26, P2531, DOI 10.1523/JNEUROSCI.1234-05.2006; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Rosato E, 2001, CURR BIOL, V11, P909, DOI 10.1016/S0960-9822(01)00259-7; Ruel L, 1999, J BIOL CHEM, V274, P21790, DOI 10.1074/jbc.274.31.21790; Rush BL, 2006, J BIOL RHYTHM, V21, P272, DOI 10.1177/0748730406290416; Rutila JE, 1998, J BIOL RHYTHM, V13, P380, DOI 10.1177/074873098129000200; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Shafer OT, 2004, CURR BIOL, V14, P424, DOI 10.1016/j.cub.2004.02.038; Shafer OT, 2002, J NEUROSCI, V22, P5946; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Sugano S, 1999, P NATL ACAD SCI USA, V96, P12362, DOI 10.1073/pnas.96.22.12362; Suri VP, 1998, NEURON, V21, P225, DOI 10.1016/S0896-6273(00)80529-2; Worby C A, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.95.pl1; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Yuan Q, 2005, NEURON, V47, P115, DOI 10.1016/j.neuron.2005.05.027; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0	55	183	188	0	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					207	219		10.1016/j.cell.2007.02.038	http://dx.doi.org/10.1016/j.cell.2007.02.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418796	Bronze			2022-12-01	WOS:000245661100022
J	Gray, RH; Makumbi, F; Serwadda, D; Lutalo, T; Nalugoda, F; Opendi, P; Kigozi, G; Reynolds, SJ; Sewankambo, NK; Wawer, MJ				Gray, Ronald H.; Makumbi, Fredrick; Serwadda, David; Lutalo, Tom; Nalugoda, Fred; Opendi, Pius; Kigozi, Godfrey; Reynolds, Steven J.; Sewankambo, Nelson K.; Wawer, Maria J.			Limitations of rapid HIV-1 tests during screening for trials in Uganda: diagnostic test accuracy study	BRITISH MEDICAL JOURNAL			English	Article								Objective To evaluate the limitations of rapid tests for HIV-1. Design Diagnostic test accuracy study. Setting Rural Rakai, Uganda. Participants 1517 mates aged 15-49 screened for trials of circumcision for HIV prevention. Main outcome measures Sensitivity, specificity, negative predictive values, and positive predictive values of an algorithm using three rapid tests for HIV, compared with the results of enzyme immunoassay and western blotting as the optimal methods. Results Rapid test results were evaluated by enzyme immunoassay and western blotting. Sensitivity was 97.7%. Among 639 samples where the strength of positive bands was coded if the sample showed positivity for HIV, the algorithm had low specificity (94.1%) and a low positive predictive value (74.0%). Exclusion of 37 samples (5.8%) with a weak positive band improved the specificity (99.6%) and positive predictive value (97.7%.). Conclusion Weak positive bands on rapid tests for HIV should be confirmed by enzyme immunoassay and western blotting before disclosing the diagnosis. Programmes using rapid tests routinely should use standard serological assays for quality control.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; Uganda Virus Res Inst, Rakai Hlth Sci Program, Entebbe, Uganda; Makerere Univ, Inst Publ Hlth, Kampala, Uganda; NIH, NIAID, Entebbe, Uganda; Makerere Univ, Sch Med, Kampala, Uganda	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Columbia University; Rakai Health Sciences Program; Uganda Virus Research Institute; Makerere University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Makerere University	Gray, RH (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	rgray@jhsph.edu		Reynolds, Steven/0000-0002-5403-2759; Sewankambo, Nelson/0000-0001-9362-053X	FIC NIH HHS [2D43TW00001019-AITRP] Funding Source: Medline; NIAID NIH HHS [UO1 AI11171-01-02] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000361, Z01AI001040] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		De Cock KM, 2006, NEW ENGL J MED, V354, P440, DOI 10.1056/NEJMp058327; Downing RG, 1998, J ACQ IMMUN DEF SYND, V18, P384, DOI 10.1097/00042560-199808010-00011; Kassler WJ, 1998, INT J STD AIDS, V9, P134, DOI 10.1258/0956462981921882; McKenna SL, 1997, AIDS, V11, pS103; Wright AA, 2006, NEW ENGL J MED, V354, P437, DOI 10.1056/NEJMp058302	5	88	91	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 28	2007	335	7612					188	190		10.1136/bmj.39210.582801.BE	http://dx.doi.org/10.1136/bmj.39210.582801.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	198YA	17545184	Green Submitted, Bronze, Green Published			2022-12-01	WOS:000248662200029
J	Easton, DF; Pooley, KA; Dunning, AM; Pharoah, PDP; Thompson, D; Ballinger, DG; Struewing, JP; Morrison, J; Field, H; Luben, R; Wareham, N; Ahmed, S; Healey, CS; Bowman, R; Meyer, KB; Haiman, CA; Kolonel, LK; Henderson, BE; Le Marchand, L; Brennan, P; Sangrajrang, S; Gaborieau, V; Odefrey, F; Shen, CY; Wu, PE; Wang, HC; Eccles, D; Evans, DG; Peto, J; Fletcher, O; Johnson, N; Seal, S; Stratton, MR; Rahman, N; Chenevix-Trench, G; Bojesen, SE; Nordestgaard, BG; Axelsson, CK; Garcia-Closas, M; Brinton, L; Chanock, S; Lissowska, J; Peplonska, B; Nevanlinna, H; Fagerholm, R; Eerola, H; Kang, D; Yoo, KY; Noh, DY; Ahn, SH; Hunter, DJ; Hankinson, SE; Cox, DG; Hall, P; Wedren, S; Liu, JJ; Low, YL; Bogdanova, N; Schurmann, P; Dork, T; Tollenaar, RAEM; Jacobi, CE; Devilee, P; Klijn, JGM; Sigurdson, AJ; Doody, MM; Alexander, BH; Zhang, JH; Cox, A; Brock, IW; MacPherson, G; Reed, MWR; Couch, FJ; Goode, EL; Olson, JE; Meijers-Heijboer, H; van den Ouweland, A; Uitterlinden, A; Rivadeneira, F; Milne, RL; Ribas, G; Gonzalez-Neira, A; Benitez, J; Hopper, JL; McCredie, M; Southey, M; Giles, GG; Schroen, C; Justenhoven, C; Brauch, H; Hamann, U; Ko, YD; Spurdle, AB; Beesley, J; Chen, XQ; Mannermaa, A; Kosma, VM; Kataja, V; Hartikainen, J; Day, NE; Cox, DR; Ponder, BAJ				Easton, Douglas F.; Pooley, Karen A.; Dunning, Alison M.; Pharoah, Paul D. P.; Thompson, Deborah; Ballinger, Dennis G.; Struewing, Jeffery P.; Morrison, Jonathan; Field, Helen; Luben, Robert; Wareham, Nicholas; Ahmed, Shahana; Healey, Catherine S.; Bowman, Richard; Meyer, Kerstin B.; Haiman, Christopher A.; Kolonel, Laurence K.; Henderson, Brian E.; Le Marchand, Loic; Brennan, Paul; Sangrajrang, Suleeporn; Gaborieau, Valerie; Odefrey, Fabrice; Shen, Chen-Yang; Wu, Pei-Ei; Wang, Hui-Chun; Eccles, Diana; Evans, D. Gareth; Peto, Julian; Fletcher, Olivia; Johnson, Nichola; Seal, Sheila; Stratton, Michael R.; Rahman, Nazneen; Chenevix-Trench, Georgia; Bojesen, Stig E.; Nordestgaard, Borge G.; Axelsson, Christen K.; Garcia-Closas, Montserrat; Brinton, Louise; Chanock, Stephen; Lissowska, Jolanta; Peplonska, Beata; Nevanlinna, Heli; Fagerholm, Rainer; Eerola, Hannaleena; Kang, Daehee; Yoo, Keun-Young; Noh, Dong-Young; Ahn, Sei-Hyun; Hunter, David J.; Hankinson, Susan E.; Cox, David G.; Hall, Per; Wedren, Sara; Liu, Jianjun; Low, Yen-Ling; Bogdanova, Natalia; Schuermann, Peter; Doerk, Thilo; Tollenaar, Rob A. E. M.; Jacobi, Catharina E.; Devilee, Peter; Klijn, Jan G. M.; Sigurdson, Alice J.; Doody, Michele M.; Alexander, Bruce H.; Zhang, Jinghui; Cox, Angela; Brock, Ian W.; MacPherson, Gordon; Reed, Malcolm W. R.; Couch, Fergus J.; Goode, Ellen L.; Olson, Janet E.; Meijers-Heijboer, Hanne; van den Ouweland, Ans; Uitterlinden, Andre; Rivadeneira, Fernando; Milne, Roger L.; Ribas, Gloria; Gonzalez-Neira, Anna; Benitez, Javier; Hopper, John L.; McCredie, Margaret; Southey, Melissa; Giles, Graham G.; Schroen, Chris; Justenhoven, Christina; Brauch, Hiltrud; Hamann, Ute; Ko, Yon-Dschun; Spurdle, Amanda B.; Beesley, Jonathan; Chen, Xiaoqing; Mannermaa, Arto; Kosma, Veli-Matti; Kataja, Vesa; Hartikainen, Jaana; Day, Nicholas E.; Cox, David R.; Ponder, Bruce A. J.		SEARCH Collaborators; kConFab; AOCS Management Grp	Genome-wide association study identifies novel breast cancer susceptibility loci	NATURE			English	Article							GROWTH-FACTOR RECEPTOR-2; OVARIAN-CANCER; BRCA2 MUTATIONS; PROSTATE-CANCER; GENE; DISEASE; CHEK2-ASTERISK-1100DELC; POPULATIONS; PATTERNS; DATABASE	Breast cancer exhibits familial aggregation, consistent with variation in genetic susceptibility to the disease. Known susceptibility genes account for less than 25% of the familial risk of breast cancer, and the residual genetic variance is likely to be due to variants conferring more moderate risks. To identify further susceptibility alleles, we conducted a two-stage genome-wide association study in 4,398 breast cancer cases and 4,316 controls, followed by a third stage in which 30 single nucleotide polymorphisms (SNPs) were tested for confirmation in 21,860 cases and 22,578 controls from 22 studies. We used 227,876 SNPs that were estimated to correlate with 77% of known common SNPs in Europeans at r(2) > 0.5. SNPs in five novel independent loci exhibited strong and consistent evidence of association with breast cancer (P < 10(-7)). Four of these contain plausible causative genes (FGFR2, TNRC9, MAP3K1 and LSP1). At the second stage, 1,792 SNPs were significant at the P < 0.05 level compared with an estimated 1,343 that would be expected by chance, indicating that many additional common susceptibility alleles may be identifiable by this approach.	Univ Cambridge, Dept Publ Hlth & Primary Care, CR UK Genet Epidemiol Unit, Cambridge CB1 8RN, England; Univ Cambridge, Dept Oncol, Cambridge CB1 8RN, England; Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic 3053, Australia; Univ Otago, Dept Prevent & Social Med, Dunedin 9001, New Zealand; Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Carlton, Vic 3053, Australia; Spanish Natl Canc Ctr CNIO, E-28029 Madrid, Spain; Erasmus Univ, Dept Clin Genet, NL-3015 GE Rotterdam, Netherlands; Mayo Clin, Coll Med, Rochester, MN 55905 USA; Univ Sheffield, Sch Med, Acad Unit Surg Oncol, Sheffield S10 2RX, S Yorkshire, England; Univ Sheffield, Sch Med, Inst Canc Studies, Sheffield S10 2RX, S Yorkshire, England; Univ Minnesota, Minneapolis, MN 55455 USA; NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,DHHS, Bethesda, MD 20892 USA; Dr Daniel Den Hoed Canc Ctr, Erasmus MC, Dept Med Oncol, Family Canc Clin, NL-3075 EA Rotterdam, Netherlands; Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZA Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Pathol, NL-2333 ZA Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Med Decis Making, NL-2333 ZA Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Surg, NL-2333 ZA Leiden, Netherlands; Hannover Med Sch, Dept Obstet & Gynecol, D-30625 Hannover, Germany; Hannover Med Sch, Dept Radiat Oncol, D-30625 Hannover, Germany; Genome Inst Singapore, Singapore 138672, Singapore; Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; Harvard Univ, Sch Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; Univ Ulsan, Coll Med, Ulsan 680749, South Korea; Natl Canc Ctr, Goyang 411769, South Korea; Seoul Natl Univ, Coll Med, Seoul 151742, South Korea; Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki 00029, Finland; Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, Helsinki 00029, Finland; Nofer Inst Occupat Med, PL-90950 Lodz, Poland; M Sklodowska Curie Inst Oncol, PL-02781 Warsaw, Poland; Ctr Canc, PL-02781 Warsaw, Poland; NCI, Ctr Adv Technol, Gaithersburg, MD 20877 USA; NCI, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA; Univ Copenhagen, Herlev Univ Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; Univ Copenhagen, Bispebjerg Univ Hosp, Dept Breast Surg, DK-2730 Herlev, Denmark; Queensland Inst Med Res, Brisbane, Qld 4006, Australia; Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge CB10 1SA, England; Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Breakthrought Breast Canc Res Ctr, London SW3 6JB, England; Inst Canc Res, Sutton SM2 5NG, Surrey, England; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; St Marys Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England; Princess Anne Hosp, Wessex Clin Genet Serv, Southampton SO16 5YA, Hants, England; Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; NCI, Bangkok 10400, Thailand; Int Agcy Res Canc, F-69008 Lyon, France; Univ Hawaii, Canc Res Ctr Hawaii, Program Epidemiol, Honolulu, HI 96813 USA; Univ Calif Los Angeles, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; MRC, Dunn Clin Nutr Ctr, Cambridge CB2 0XY, England; Univ Cambridge, Dept Publ Hlth & Primary Care, EPIC, Cambridge CB1 8RN, England; NCI, Lab Populat Genet, Bethesda, MD 20892 USA; Perlegen Sci Inc, Mountain View, CA 94043 USA; Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Parkville, Vic 3052, Australia; Vaasa Cent Hosp, Dept Oncol, Vaasa 65130, Finland; Kuopio Univ Hosp, Dept Oncol, FIN-70211 Kuopio, Finland; Kuopio Univ Hosp, Dept Pathol, FIN-70211 Kuopio, Finland; Univ Kuopio, Inst Clin Med Pathol & Forens Med, FIN-70210 Kuopio, Finland; Peter MacCallum Canc Ctr, Melbourne, Vic 3002, Australia; Evangel Kliniken Bonn GGmbh, Johanniter Krankenhaus, D-53113 Bonn, Germany; Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany; Univ Tubingen, D-72074 Tubingen, Germany; Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany	University of Cambridge; University of Cambridge; Cancer Council Victoria; University of Otago; University of Melbourne; Centro Nacional de Investigaciones Oncologicas (CNIO); Erasmus University Rotterdam; Mayo Clinic; University of Sheffield; University of Sheffield; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Hannover Medical School; Hannover Medical School; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Karolinska Institutet; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of Ulsan; National Cancer Center - Korea (NCC); Seoul National University (SNU); University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Nofer Institute of Occupational Medicine; Maria Sklodowska-Curie National Research Institute of Oncology; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Bispebjerg Hospital; QIMR Berghofer Medical Research Institute; University of Cambridge; Wellcome Trust Sanger Institute; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; University of London; London School of Hygiene & Tropical Medicine; University of Manchester; Academia Sinica - Taiwan; World Health Organization; International Agency for Research on Cancer (IARC); Cancer Research Center of Hawaii; University of Hawaii System; University of California System; University of California Los Angeles; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Melbourne; Vaasa Central Hospital; Kuopio University Hospital; Kuopio University Hospital; University of Eastern Finland; Peter Maccallum Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ); Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Easton, DF (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, CR UK Genet Epidemiol Unit, Cambridge CB1 8RN, England.	d.easton@srl.cam.ac.uk	Garcia-Closas, Montserrat/F-3871-2015; Ribas-Despuig, Gloria/M-6190-2017; Amor, David J/A-6478-2018; Dörk, Thilo/J-8620-2012; Struewing, Jeffery P/I-7502-2013; Taylor, Donna B/I-5714-2015; Luben, Robert N/H-5519-2015; Shen, CY/F-6271-2010; Lissowska, Jolanta/AAH-3252-2020; Yoo, Keun-Young/J-5548-2012; Hartikainen, Jaana M/E-6256-2015; Evans, D Gareth/AAB-4308-2022; Bowtell, David/H-1007-2016; Spurdle, Amanda B/A-4978-2011; Noh, Dong-Young/G-5531-2011; Pharoah, Paul/V-6658-2019; Rahman, Nazneen/B-8890-2012; Chenevix-Trench, Georgia/AAV-2014-2020; DEVILEE, PETER/ABR-2140-2022; Liu, Jianjun/AAK-4989-2020; Eccles, Diana/K-6327-2019; Wang, Hui-Chun/C-5680-2009; Devilee, Peter/GXV-8005-2022; Rivadeneira, Fernando/O-5385-2015; Osborne, Richard H/A-9447-2010; Peplonska, Beata/AAO-1265-2020; Peplonska, Beata/F-6004-2010; Brennan, Meagan E/P-8274-2019; Bogdanova, Natalia V./Y-2205-2019; Gonzalez-Neira, Anna/C-5791-2015; Ward, Robyn L/I-2313-2013; Cox, David G/A-2023-2009; Reed, Malcolm Walter/AAG-9219-2020; Nordestgaard, Borge Gronne/ABF-1310-2020; xin, xp/C-7350-2009; Garcia-Closas, Montserrat/AAZ-6930-2021; Zhang, Jing/GWZ-7332-2022; Cox, David/ABA-7454-2020; Kang, Dae Hee/E-8631-2012; Brinton, Louise A/G-7486-2015; DeFazio, Anna/O-2385-2019; Rahman, Nazneen/D-2802-2013; Mann, Graham/G-4758-2014; Ribas, Gloria/K-3379-2013; Scott, Rodney/B-2827-2013; Webb, Penelope/D-5736-2013; Jenkins, Mark/P-7803-2015; Saunders, Christobel/H-5779-2014	Garcia-Closas, Montserrat/0000-0003-1033-2650; Amor, David J/0000-0001-7191-8511; Dörk, Thilo/0000-0002-9458-0282; Struewing, Jeffery P/0000-0002-4848-3334; Taylor, Donna B/0000-0002-1481-1141; Luben, Robert N/0000-0002-5088-6343; Lissowska, Jolanta/0000-0003-2695-5799; Hartikainen, Jaana M/0000-0001-8267-1905; Evans, D Gareth/0000-0002-8482-5784; Bowtell, David/0000-0001-9089-7525; Spurdle, Amanda B/0000-0003-1337-7897; Pharoah, Paul/0000-0001-8494-732X; Chenevix-Trench, Georgia/0000-0002-1878-2587; Liu, Jianjun/0000-0002-3255-3019; Eccles, Diana/0000-0002-9935-3169; Rivadeneira, Fernando/0000-0001-9435-9441; Osborne, Richard H/0000-0002-9081-2699; Peplonska, Beata/0000-0003-3915-2872; Brennan, Meagan E/0000-0002-3281-7643; Gonzalez-Neira, Anna/0000-0002-5421-2020; Ward, Robyn L/0000-0002-6877-8906; Cox, David G/0000-0002-2152-9259; Reed, Malcolm Walter/0000-0001-7442-2132; Garcia-Closas, Montserrat/0000-0003-1033-2650; Brinton, Louise A/0000-0003-3853-8562; DeFazio, Anna/0000-0003-0057-4744; Edsall, Lee Elizabeth/0000-0002-0326-2829; Kataja, Vesa/0000-0003-4846-4843; Rahman, Nazneen/0000-0003-4376-0440; Wang, Hui-Chun/0000-0003-1414-1595; Mann, Graham/0000-0003-1301-405X; Shelling, Andrew/0000-0002-5300-1934; Cox, Angela/0000-0002-5138-1099; Kang, Daehee/0000-0003-4031-5878; Phillips, Kelly-Anne/0000-0002-0475-1771; Ribas, Gloria/0000-0001-6883-4130; Kefford, Richard/0000-0001-9251-9229; Southey, Melissa/0000-0002-6313-9005; Scott, Rodney/0000-0001-7724-3404; Nevanlinna, Heli/0000-0002-0916-2976; Bennett, Ian/0000-0002-3634-9680; Callen, David/0000-0002-6189-9991; Clarke, Christine/0000-0001-7568-111X; Webb, Penelope/0000-0003-0733-5930; Cox, David/0000-0003-2047-4687; Robinson, Bridget/0000-0001-9483-9146; Brauch, Hiltrud/0000-0001-7531-2736; Winship, Ingrid/0000-0001-8535-6003; Lindeman, Geoffrey/0000-0001-9386-2416; Richards, Robert Ian/0000-0002-5978-6453; Jenkins, Mark/0000-0002-8964-6160; Saunders, Christobel/0000-0003-2281-9829; Thorne, Heather/0000-0003-3610-2511; Bowman, Richard/0000-0002-6348-2241; Giles, Graham/0000-0003-4946-9099; Dunning, Alison Margaret/0000-0001-6651-7166; Brown, Melissa/0000-0002-2830-9259; Fletcher, Olivia/0000-0001-9387-7116; Gaff, Clara/0000-0003-0160-4159; Bowcock, Anne/0000-0001-8691-9090; Beesley, Jonathan/0000-0003-1942-325X	Cancer Research UK [A3353] Funding Source: Medline; Breast Cancer Now [2004NOV49, BREAST CANCER NOW RESEARCH CENTRE] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01SC010083] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); Breast Cancer Now; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADNANE J, 1991, ONCOGENE, V6, P659; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2004, BRIT J CANCER, V91, P1580, DOI 10.1038/sj.bjc.6602175; Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Cox A, 2007, NAT GENET, V39, P688, DOI 10.1038/ng0507-688b; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Day N, 1999, BRIT J CANCER, V80, P95; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; EASTON DF, 1999, BREAST CANCER RES, V1, P1; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Ferretti V, 2007, NUCLEIC ACIDS RES, V35, pD122, DOI 10.1093/nar/gkl879; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Jang JH, 2001, CANCER RES, V61, P3541; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Lesueur F, 2005, HUM MOL GENET, V14, P2349, DOI 10.1093/hmg/ddi237; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Moffa AB, 2004, MOL CANCER RES, V2, P643; Pharoah P, 2006, JNCI-J NATL CANCER I, V98, P1382, DOI 10.1093/jnci/djj374; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Satagopan JM, 2002, BIOMETRICS, V58, P163, DOI 10.1111/j.0006-341X.2002.00163.x; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Smith P, 2006, GENE CHROMOSOME CANC, V45, P646, DOI 10.1002/gcc.20330; Thomas DC, 2005, AM J HUM GENET, V77, P337, DOI 10.1086/432962; Thompson D, 2005, JNCI-J NATL CANCER I, V97, P813, DOI 10.1093/jnci/dji141; Tyrer J, 2006, GENET EPIDEMIOL, V30, P636, DOI 10.1002/gepi.20175; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	40	1767	1839	2	231	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 28	2007	447	7148					1087	U7		10.1038/nature05887	http://dx.doi.org/10.1038/nature05887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	183HT	17529967	Green Accepted, Green Published			2022-12-01	WOS:000247564600032
J	Pandey, UB; Nie, ZP; Batlevi, Y; McCray, BA; Ritson, GP; Nedelsky, NB; Schwartz, SL; DiProspero, NA; Knight, MA; Schuldiner, O; Padmanabhan, R; Hild, M; Berry, DL; Garza, D; Hubbert, CC; Yao, TP; Baehrecke, EH; Taylor, JP				Pandey, Udai Bhan; Nie, Zhiping; Batlevi, Yakup; McCray, Brett A.; Ritson, Gillian P.; Nedelsky, Natalia B.; Schwartz, Stephanie L.; DiProspero, Nicholas A.; Knight, Melanie A.; Schuldiner, Oren; Padmanabhan, Ranjani; Hild, Marc; Berry, Deborah L.; Garza, Dan; Hubbert, Charlotte C.; Yao, Tso-Pang; Baehrecke, Eric H.; Taylor, J. Paul			HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS	NATURE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; ANDROGEN RECEPTOR; PROTEIN; DISEASE; DEGRADATION; DROSOPHILA; ACETYLATION; INCLUSIONS; TOXICITY; PATHWAYS	A prominent feature of late-onset neurodegenerative diseases is accumulation of misfolded protein in vulnerable neurons(1). When levels of misfolded protein overwhelm degradative pathways, the result is cellular toxicity and neurodegeneration(2). Cellular mechanisms for degrading misfolded protein include the ubiquitin-proteasome system ( UPS), the main non-lysosomal degradative pathway for ubiquitinated proteins, and autophagy, a lysosome-mediated degradative pathway(3). The UPS and autophagy have long been viewed as complementary degradation systems with no point of intersection(4,5). This view has been challenged by two observations suggesting an apparent interaction: impairment of the UPS induces autophagy in vitro, and conditional knockout of autophagy in the mouse brain leads to neurodegeneration with ubiquitin-positive pathology(6-9). It is not known whether autophagy is strictly a parallel degradation system, or whether it is a compensatory degradation system when the UPS is impaired; furthermore, if there is a compensatory interaction between these systems, the molecular link is not known. Here we show that autophagy acts as a compensatory degradation system when the UPS is impaired in Drosophila melanogaster, and that histone deacetylase 6 (HDAC6), a microtubule-associated deacetylase that interacts with polyubiquitinated proteins(10), is an essential mechanistic link in this compensatory interaction. We found that compensatory autophagy was induced in response to mutations affecting the proteasome and in response to UPS impairment in a fly model of the neurodegenerative disease spinobulbar muscular atrophy. Autophagy compensated for impaired UPS function in an HDAC6-dependent manner. Furthermore, expression of HDAC6 was sufficient to rescue degeneration associated with UPS dysfunction in vivo in an autophagy-dependent manner. This study suggests that impairment of autophagy ( for example, associated with ageing or genetic variation) might predispose to neurodegeneration. Morover, these findings suggest that it may be possible to intervene in neurodegeneration by augmenting HDAC6 to enhance autophagy.	Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; Univ Maryland, Inst Biotechnol, Ctr Biosyst Res, College Pk, MD 20742 USA; NINDS, Neurogenet Branch, NIH, Bethesda, MD 20817 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Novartis Inst Biomed Res, Cambridge, MA 02139 USA; Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	University of Pennsylvania; University System of Maryland; University of Maryland Baltimore; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Stanford University; Novartis; Duke University	Taylor, JP (corresponding author), Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA.	jpt@mail.med.upenn.edu	Schuldiner, Oren/K-1353-2012; Taylor, J. Paul/N-2482-2018	Schuldiner, Oren/0000-0002-7350-9380; Taylor, J. Paul/0000-0002-5794-0349	NINDS NIH HHS [R01 NS054022-02, R01 NS054022] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054022, Z01NS003038] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chan HYE, 2002, HUM MOL GENET, V11, P2895, DOI 10.1093/hmg/11.23.2895; CIECHANOVER A, 1984, CELL, V37, P57, DOI 10.1016/0092-8674(84)90300-3; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harris Thurl E, 2003, Sci STKE, V2003, pre15; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Li M, 1998, ANN NEUROL, V44, P249, DOI 10.1002/ana.410440216; McGuire S. E., 2004, SCI STKE, V2004, pp16, DOI DOI 10.1125/STKE.2202004P16; Neefjes J, 2004, NAT REV DRUG DISCOV, V3, P58, DOI 10.1038/nrd1282; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rideout HJ, 2004, INT J BIOCHEM CELL B, V36, P2551, DOI 10.1016/j.biocel.2004.05.008; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Smyth KA, 1999, GENETICS, V151, P211; Takeyama K, 2002, NEURON, V35, P855, DOI 10.1016/S0896-6273(02)00875-9; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Taylor JP, 2003, GENE DEV, V17, P1463, DOI 10.1101/gad.1087503; Trojanowski JQ, 2000, ANN NY ACAD SCI, V924, P62	25	945	980	0	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 14	2007	447	7146					859	863		10.1038/nature05853	http://dx.doi.org/10.1038/nature05853			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178FV	17568747				2022-12-01	WOS:000247207500045
J	Iheanacho, I				Iheanacho, Ike			All together now	BRITISH MEDICAL JOURNAL			English	Editorial Material												iiheanacho@bmjgroup.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 9	2007	334	7605					1224	1224		10.1136/bmj.39234.611505.59	http://dx.doi.org/10.1136/bmj.39234.611505.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	179GF	17556482	Green Published			2022-12-01	WOS:000247277000043
J	Maga, G; Villani, G; Crespan, E; Wimmer, U; Ferrari, E; Bertocci, B; Hubscher, U				Maga, Giovanni; Villani, Giuseppe; Crespan, Emmanuele; Wimmer, Ursula; Ferrari, Elena; Bertocci, Barbara; Huebscher, Ulrich			8-oxo-guanine bypass by human DNA polymerases in the presence of auxiliary proteins	NATURE			English	Article							CELL NUCLEAR ANTIGEN; IN-VITRO; REPLICATION; LAMBDA; BETA; ETA; ALPHA; IOTA; PCNA; MU	Specialized DNA polymerases (DNA pols) are required for lesion bypass in human cells(1). Auxiliary factors have an important, but so far poorly understood, role. Here we analyse the effects of human proliferating cell nuclear antigen (PCNA) and replication protein A (RP-A) on six different human DNA pols - belonging to the B, Y and X classes - during in vitro bypass of different lesions. The mutagenic lesion 8-oxo-guanine (8-oxo-G) has high miscoding potential(2-4). A major and specific effect was found for 8-oxo-G bypass with DNA pols lambda and eta. PCNA and RP-A allowed correct incorporation of dCTP opposite a 8-oxo-G template 1,200-fold more efficiently than the incorrect dATP by DNA pol lambda, and 68-fold by DNA pol eta, respectively. Experiments with DNA-pol-lambda-null cell extracts suggested an important role for DNA pol lambda. On the other hand, DNA pol iota, together with DNA pols a, delta and beta, showed a much lower correct bypass efficiency. Our findings show the existence of an accurate mechanism to reduce the deleterious consequences of oxidative damage and, in addition, point to an important role for PCNA and RP-A in determining a functional hierarchy among different DNA pols in lesion bypass.	CNR, Inst Mol Genet IGM, I-27100 Pavia, Italy; CNRS, IPBS, F-31077 Toulouse, France; Univ Paris 05, Fac Med Rene Descartes, Inst Natl Francais Rech Med, F-75730 Paris, France; Univ Zurich Irchel, Inst Vet Biochem & Mol Biol, CH-8057 Zurich, Switzerland	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of Zurich	Maga, G (corresponding author), CNR, Inst Mol Genet IGM, Via Abbiategrasso 207, I-27100 Pavia, Italy.	maga@igm.cnr.it	Crespan, Emmanuele/F-3899-2018; Bertocci, Barbara/L-9115-2018; Maga, Giovanni/C-5409-2009	Crespan, Emmanuele/0000-0003-0597-6929; Maga, Giovanni/0000-0001-8092-1552				Bassett E, 2002, DNA REPAIR, V1, P1003, DOI 10.1016/S1568-7864(02)00150-7; Bertocci B, 2006, IMMUNITY, V25, P31, DOI 10.1016/j.immuni.2006.04.013; Blanca G, 2004, BIOCHEMISTRY-US, V43, P11605, DOI 10.1021/bi049050x; Collins AR, 1999, BIOESSAYS, V21, P238, DOI 10.1002/(SICI)1521-1878(199903)21:3<238::AID-BIES8>3.0.CO;2-3; Haracska L, 2000, NAT GENET, V25, P458, DOI 10.1038/78169; Haracska L, 2001, P NATL ACAD SCI USA, V98, P14256, DOI 10.1073/pnas.261560798; Haracska L, 2001, MOL CELL, V8, P407, DOI 10.1016/S1097-2765(01)00319-7; HOFFMANN JS, 1995, P NATL ACAD SCI USA, V92, P5356, DOI 10.1073/pnas.92.12.5356; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Krahn JM, 2003, STRUCTURE, V11, P121, DOI 10.1016/S0969-2126(02)00930-9; Maga G, 2006, NUCLEIC ACIDS RES, V34, P1405, DOI 10.1093/nar/gkl032; Maga G, 2005, J BIOL CHEM, V280, P1971, DOI 10.1074/jbc.M411650200; Maga G, 2002, J BIOL CHEM, V277, P48434, DOI 10.1074/jbc.M206889200; Maga G, 2001, J BIOL CHEM, V276, P18235, DOI 10.1074/jbc.M009599200; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Vaisman A, 2001, EMBO J, V20, P6520, DOI 10.1093/emboj/20.22.6520; WEISER T, 1991, J BIOL CHEM, V266, P10420; Zhang YB, 2002, J BIOL CHEM, V277, P44582, DOI 10.1074/jbc.M207297200	19	186	195	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2007	447	7144					606	+		10.1038/nature05843	http://dx.doi.org/10.1038/nature05843			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17507928				2022-12-01	WOS:000246842000052
J	Yeh, BJ; Rutigliano, RJ; Deb, A; Bar-Sagi, D; Lim, WA				Yeh, Brian J.; Rutigliano, Robert J.; Deb, Anrica; Bar-Sagi, Dafna; Lim, Wendell A.			Rewiring cellular morphology pathways with synthetic guanine nucleotide exchange factors	NATURE			English	Article							RHO GTPASES; PROTEIN-KINASE; N-WASP; DOMAINS; ACTIVATION; MECHANISMS; CIRCUITS; SIGNALS; COMPLEX; CASCADE	Eukaryotic cells mobilize the actin cytoskeleton to generate a remarkable diversity of morphological behaviours, including motility, phagocytosis and cytokinesis. Much of this diversity is mediated by guanine nucleotide exchange factors ( GEFs) that activate Rho family GTPases - the master regulators of the actin cytoskeleton(1-3). There are over 80 Rho GEFs in the human genome ( compared to only 22 genes for the Rho GTPases themselves), and the evolution of new and diverse GEFs is thought to provide a mechanism for linking the core cytoskeletal machinery to a wide range of new control inputs. Here we test this hypothesis and ask if we can systematically reprogramme cellular morphology by engineering synthetic GEF proteins. We focused on Dbl family Rho GEFs, which have a highly modular structure common to many signalling proteins(4,5): they contain a catalytic Dbl homology (DH) domain linked to diverse regulatory domains, many of which autoinhibit GEF activity(2,3). Here we show that by recombining catalytic GEF domains with new regulatory modules, we can generate synthetic GEFs that are activated by non-native inputs. We have used these synthetic GEFs to reprogramme cellular behaviour in diverse ways. The GEFs can be used to link specific cytoskeletal responses to normally unrelated upstream signalling pathways. In addition, multiple synthetic GEFs can be linked as components in series to form an artificial cascade with improved signal processing behaviour. These results show the high degree of evolutionary plasticity of this important family of modular signalling proteins, and indicate that it may be possible to use synthetic biology approaches to manipulate the complex spatio-temporal control of cell morphology.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA USA; Univ Calif San Francisco, Cell Propuls Lab, UCSF UCB NIH Nanomed Dev Ctr, San Francisco, CA USA; Univ Calif San Francisco, Chem & Chem Biol Grad Program, San Francisco, CA USA; SUNY Stony Brook, Sch Med, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; New York University	Bar-Sagi, D (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA USA.	dafna.bar-sagi@med.nyu.edu; lim@cmp.ucsf.edu		Bar-Sagi, Dafna/0000-0003-2597-8948				Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Dueber JE, 2003, SCIENCE, V301, P1904, DOI 10.1126/science.1085945; DUEBER JE, 2007, IN PRESS NATURE BIOT; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Hoffman GR, 2002, FEBS LETT, V513, P85, DOI 10.1016/S0014-5793(01)03310-5; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Howard PL, 2003, P NATL ACAD SCI USA, V100, P11267, DOI 10.1073/pnas.1934711100; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Patel JC, 2005, CURR OPIN MICROBIOL, V8, P10, DOI 10.1016/j.mib.2004.09.001; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; SEAMON KB, 1981, J CYCLIC NUCL PROT, V7, P201; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Voigt CA, 2006, CURR OPIN BIOTECH, V17, P548, DOI 10.1016/j.copbio.2006.09.001; WALSH DA, 1994, FASEB J, V8, P1227, DOI 10.1096/fasebj.8.15.8001734; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064; Yamauchi J, 2005, P NATL ACAD SCI USA, V102, P14889, DOI 10.1073/pnas.0507125102; Zamanian JL, 2003, MOL BIOL CELL, V14, P1624, DOI 10.1091/mbc.E02-08-0494; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	30	98	102	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2007	447	7144					596	600		10.1038/nature05851	http://dx.doi.org/10.1038/nature05851			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172YZ	17515921				2022-12-01	WOS:000246842000050
J	Shiroguchi, K; Kinosita, K				Shiroguchi, Katsuyuki; Kinosita, Kazuhiko, Jr.			Myosin V walks by lever action and Brownian motion	SCIENCE			English	Article							HAND-OVER-HAND; UNCONVENTIONAL MYOSIN; PROCESSIVE MYOSIN; MECHANISM; MOTOR; KINESIN; STEPS; FILAMENTS; DYNAMICS; HEAD	Myosin V is a molecular motor that moves cargo along actin filaments. Its two heads, each attached to a long and relatively stiff neck, move alternately forward in a "hand-over-hand" fashion. To observe under a microscope how the necks move, we attached a micrometer-sized rod to one of the necks. The leading neck swings unidirectionally forward, whereas the trailing neck, once lifted, undergoes extensive Brownian rotation in all directions before landing on a site ahead of the leading head. The neck-neck joint is essentially free, and the neck motion supports a mechanism where the active swing of the leading neck biases the random motion of the lifted head to let it eventually land on a forward site.	Waseda Univ, Fac Sci & Engn, Dept Phys, Shinjuku Ku, Tokyo 1698555, Japan	Waseda University	Kinosita, K (corresponding author), Waseda Univ, Fac Sci & Engn, Dept Phys, Shinjuku Ku, Okubo 3-4-1, Tokyo 1698555, Japan.	kazuhiko@waseda.jp						Ali MY, 2004, BIOPHYS J, V86, P3804, DOI 10.1529/biophysj.103.037416; Ali MY, 2002, NAT STRUCT BIOL, V9, P464, DOI 10.1038/nsb803; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Crevel IMTC, 2004, EMBO J, V23, P23, DOI 10.1038/sj.emboj.7600042; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Dunn AR, 2007, NAT STRUCT MOL BIOL, V14, P246, DOI 10.1038/nsmb1206; ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541; Forkey JN, 2003, NATURE, V422, P399, DOI 10.1038/nature01529; HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356; KINOSITA K, 1984, BIOCHEMISTRY-US, V23, P5963, DOI 10.1021/bi00320a012; Kinosita K, 2005, ADV EXP MED BIOL, V565, P205; Kinosita K, 2007, ADV EXP MED BIOL, V592, P369; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Moore JR, 2001, J CELL BIOL, V155, P625, DOI 10.1083/jcb.200103128; Nishikawa S, 2002, BIOCHEM BIOPH RES CO, V290, P311, DOI 10.1006/bbrc.2001.6142; Okada T, 2007, BIOCHEM BIOPH RES CO, V354, P379, DOI 10.1016/j.bbrc.2006.12.200; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Sellers JR, 2006, CURR OPIN CELL BIOL, V18, P68, DOI 10.1016/j.ceb.2005.12.014; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Toprak E, 2006, P NATL ACAD SCI USA, V103, P6495, DOI 10.1073/pnas.0507134103; Vale RD, 2003, J CELL BIOL, V163, P445, DOI 10.1083/jcb.200308093; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Walker ML, 2000, NATURE, V405, P804, DOI 10.1038/35015592; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yildiz A, 2004, J BIOL CHEM, V279, P37223, DOI 10.1074/jbc.C400252200; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	31	99	103	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1208	1212		10.1126/science.1140468	http://dx.doi.org/10.1126/science.1140468			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17525343				2022-12-01	WOS:000246724300048
J	Reynwar, BJ; Illya, G; Harmandaris, VA; Muller, MM; Kremer, K; Deserno, M				Reynwar, Benedict J.; Illya, Gregoria; Harmandaris, Vagelis A.; Mueller, Martin M.; Kremer, Kurt; Deserno, Markus			Aggregation and vesiculation of membrane proteins by curvature-mediated interactions	NATURE			English	Article							ENDOPLASMIC-RETICULUM; DYNAMICS; BAR; ATTRACTION; INCLUSIONS; GEOMETRY; BILAYERS; SURFACE; COATS	Membrane remodelling(1-5) plays an important role in cellular tasks such as endocytosis, vesiculation and protein sorting, and in the biogenesis of organelles such as the endoplasmic reticulum or the Golgi apparatus. It is well established that the remodelling process is aided by specialized proteins that can sense(4) as well as create(6) membrane curvature, and trigger tubulation(7-9) when added to synthetic liposomes. Because the energy needed for such large-scale changes in membrane geometry significantly exceeds the binding energy between individual proteins and between protein and membrane, cooperative action is essential. It has recently been suggested(10,11) that curvature-mediated attractive interactions could aid cooperation and complement the effects of specific binding events on membrane remodelling. But it is difficult to experimentally isolate curvature-mediated interactions from direct attractions between proteins. Moreover, approximate theories predict repulsion between isotropically curving proteins(12-15). Here we use coarse-grained membrane simulations to show that curvature-inducing model proteins adsorbed on lipid bilayer membranes can experience attractive interactions that arise purely as a result of membrane curvature. We find that once a minimal local bending is realized, the effect robustly drives protein cluster formation and subsequent transformation into vesicles with radii that correlate with the local curvature imprint. Owing to its universal nature, curvature-mediated attraction can operate even between proteins lacking any specific interactions, such as newly synthesized and still immature membrane proteins in the endoplasmic reticulum.	Max Planck Inst Polymer Res, D-55128 Mainz, Germany	Max Planck Society	Deserno, M (corresponding author), Max Planck Inst Polymer Res, Ackermannweg 10, D-55128 Mainz, Germany.	kremer@mpip-mainz.mpg.de; deserno@mpip-mainz.mpg.de	Müller, Martin Michael/B-3677-2009; Kremer, Kurt/G-5652-2011; Harmandaris, Vagelis/B-2958-2009; Deserno, Markus/P-1699-2014	Müller, Martin Michael/0000-0002-6062-8073; Kremer, Kurt/0000-0003-1842-9369; Harmandaris, Vagelis/0000-0002-9613-7639; Deserno, Markus/0000-0001-5692-1595				Antonny B, 2006, CURR OPIN CELL BIOL, V18, P386, DOI 10.1016/j.ceb.2006.06.003; Bannykh SI, 1997, J CELL BIOL, V138, P1, DOI 10.1083/jcb.138.1.1; Bartolo D, 2003, EUR PHYS J E, V11, P141, DOI 10.1140/epje/i2002-10154-5; Blood PD, 2006, P NATL ACAD SCI USA, V103, P15068, DOI 10.1073/pnas.0603917103; Brannigan G, 2006, EUR BIOPHYS J BIOPHY, V35, P104, DOI 10.1007/s00249-005-0013-y; Chou T, 2001, BIOPHYS J, V80, P1075, DOI 10.1016/S0006-3495(01)76086-9; Cooke IR, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.011506; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Fournier JB, 2003, CR BIOL, V326, P467, DOI 10.1016/S1631-0691(03)00096-9; Gottwein E, 2003, J VIROL, V77, P9474, DOI 10.1128/JVI.77.17.9474-9485.2003; Goulding D, 1999, EUROPHYS LETT, V46, P407, DOI 10.1209/epl/i1999-00276-4; GOULIAN M, 1993, EUROPHYS LETT, V22, P145, DOI 10.1209/0295-5075/22/2/012; Harmandaris VA, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2372761; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kim KS, 1998, BIOPHYS J, V75, P2274, DOI 10.1016/S0006-3495(98)77672-6; Koltover I, 1999, PHYS REV LETT, V82, P1991, DOI 10.1103/PhysRevLett.82.1991; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Muller M, 2006, PHYS REP, V434, P113, DOI 10.1016/j.physrep.2006.08.003; Muller MM, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.061407; Muller MM, 2005, EUROPHYS LETT, V69, P482, DOI 10.1209/epl/i2004-10368-1; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Venturoli M, 2006, PHYS REP, V437, P1, DOI 10.1016/j.physrep.2006.07.006; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Weikl TR, 1998, PHYS REV E, V57, P6988, DOI 10.1103/PhysRevE.57.6988; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784; Zimmerberg J, 2004, CURR BIOL, V14, pR250, DOI 10.1016/j.cub.2004.02.060	29	580	586	1	230	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2007	447	7143					461	464		10.1038/nature05840	http://dx.doi.org/10.1038/nature05840			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	170VA	17522680				2022-12-01	WOS:000246693100044
J	Barski, A; Cuddapah, S; Cui, KR; Roh, TY; Schones, DE; Wang, ZB; Wei, G; Chepelev, I; Zhao, KJ				Barski, Artern; Cuddapah, Suresh; Cui, Kairong; Roh, Tae-Young; Schones, Dustin E.; Wang, Zhibin; Wei, Gang; Chepelev, Iouri; Zhao, Keji			High-resolution profiling of histone methylations in the human genome	CELL			English	Article							EMBRYONIC STEM-CELLS; ACTIVE GENES; T-CELLS; DEVELOPMENTAL REGULATORS; SACCHAROMYCES-CEREVISIAE; MAMMALIAN CHROMATIN; CODING REGIONS; WIDE; H2A.Z; H3	Histone modifications are implicated in influencing gene expression. We have generated high-resolution maps for the genome-wide distribution of 20 histone lysine and arginine methylations as well as histone variant H2A.Z, RNA polymerase II, and the insulator binding protein CTCF across the human genome using the Solexa 1G sequencing technology. Typical patterns of histone methylations exhibited at promoters, insulators, enhancers, and transcribed regions are identified. The monomethylations of H3K27, H3K9, H4K20, H3K79, and H2BK5 are all linked to gene activation, whereas trimethylations of H3K27, H3K9, and H3K79 are linked to repression. H2A.Z associates with functional regulatory elements, and CTCF marks boundaries of histone methylation domains. Chromosome banding patterns are correlated with unique patterns of histone modifications. Chromosome breakpoints detected in T cell cancers frequently reside in chromatin regions associated with H3K4 methylations. Our data provide new insights into the function of histone methylation and chromatin organization in genome function.	NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; Univ Calif Los Angeles, Gonda Neurosci & Genet Res Ctr, Dept Human Genet, Los Angeles, CA 90095 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of California System; University of California Los Angeles	Zhao, KJ (corresponding author), NHLBI, Lab Mol Immunol, NIH, Bldg 10, Bethesda, MD 20892 USA.	zhaok@nhlbi.nih.gov	Wei, Gang/A-3291-2011; Cuddapah, Suresh/AAU-4288-2021	Roh, Tae-Young/0000-0001-5833-0844; Chepelev, Iouri/0000-0002-2121-8805; Barski, Artem/0000-0002-1861-5316; Cuddapah, Suresh/0000-0002-4556-2029	Intramural NIH HHS Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005801, ZIAHL005801] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abeysinghe SS, 2004, HUM MUTAT, V23, P219, DOI 10.1002/humu.20006; ALLIS CD, 1980, CELL, V20, P609, DOI 10.1016/0092-8674(80)90307-4; An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bruce K, 2005, NUCLEIC ACIDS RES, V33, P5633, DOI 10.1093/nar/gki874; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; CRAIG JM, 1993, BIOESSAYS, V15, P349, DOI 10.1002/bies.950150510; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Guillemette B, 2006, BIOCHEM CELL BIOL, V84, P528, DOI 10.1139/O06-077; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; KENT TH, 2007, CELL, V128, P1231; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lee YH, 2002, MOL CELL BIOL, V22, P3621, DOI 10.1128/MCB.22.11.3621-3632.2002; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Miller W, 2004, ANNU REV GENOM HUM G, V5, P15, DOI 10.1146/annurev.genom.5.061903.180057; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rangasamy D, 2003, EMBO J, V22, P1599, DOI 10.1093/emboj/cdg160; Roh TY, 2007, GENOME RES, V17, P74, DOI 10.1101/gr.5767907; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Roh TY, 2004, NAT BIOTECHNOL, V22, P1013, DOI 10.1038/nbt990; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Shnyreva M, 2004, P NATL ACAD SCI USA, V101, P12622, DOI 10.1073/pnas.0400849101; Sims JK, 2006, J BIOL CHEM, V281, P12760, DOI 10.1074/jbc.M513462200; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Talasz H, 2005, J BIOL CHEM, V280, P38814, DOI 10.1074/jbc.M505563200; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang JX, 2006, BIOINFORMATICS, V22, P385, DOI 10.1093/bioinformatics/bti796; Zhang YM, 2006, DNA REPAIR, V5, P1282, DOI 10.1016/j.dnarep.2006.05.020	54	4767	4943	14	586	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2007	129	4					823	837		10.1016/j.cell.2007.05.009	http://dx.doi.org/10.1016/j.cell.2007.05.009			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	172FA	17512414	Bronze			2022-12-01	WOS:000246788300025
J	Benitez-Nelson, CR; Bidigare, RR; Dickey, TD; Landry, MR; Leonard, CL; Brown, SL; Nencioli, F; Rii, YM; Maiti, K; Becker, JW; Bibby, TS; Black, W; Cai, WJ; Carlson, CA; Chen, FZ; Kuwahara, VS; Mahaffey, C; McAndrew, PM; Quay, PD; Rappe, MS; Selph, KE; Simmons, MP; Yang, EJ				Benitez-Nelson, Claudia R.; Bidigare, Robert R.; Dickey, Tommy D.; Landry, Michael R.; Leonard, Carrie L.; Brown, Susan L.; Nencioli, Francesco; Rii, Yoshimi M.; Maiti, Kanchan; Becker, Jamie W.; Bibby, Thomas S.; Black, Wil; Cai, Wei-Jun; Carlson, Craig A.; Chen, Feizhou; Kuwahara, Victor S.; Mahaffey, Claire; McAndrew, Patricia M.; Quay, Paul D.; Rappe, Michael S.; Selph, Karen E.; Simmons, Melinda P.; Yang, Eun Jin			Mesoscale eddies drive increased silica export in the subtropical Pacific Ocean	SCIENCE			English	Article							ORGANIC-CARBON FLUX; COMMUNITY STRUCTURE; IRON FERTILIZATION; CYCLONIC EDDY; SARGASSO SEA; WATERS; GYRE; GROWTH	Mesoscale eddies may play a critical role in ocean biogeochemistry by increasing nutrient supply, primary production, and efficiency of the biological pump, that is, the ratio of carbon export to primary production in otherwise nutrient-deficient waters. We examined a diatom bloom within a cold-core cyclonic eddy off Hawaii. Eddy primary production, community biomass, and size composition were markedly enhanced but had little effect on the carbon export ratio. Instead, the system functioned as a selective silica pump. Strong trophic coupling and inefficient organic export may be general characteristics of community perturbation responses in the warm waters of the Pacific Ocean.	Univ S Carolina, Dept Geol Sci & Marine Sci, Columbia, SC 29208 USA; Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA; Univ Calif Santa Barbara, Ocean Phys Lab, Goleta, CA 93117 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; BAE Syst, Honolulu, HI 96813 USA; Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; Univ Southampton, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Soka Univ, Fac Educ, Tokyo 1928577, Japan; Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; Gordon & Betty Moore Fdn, San Francisco, CA 94129 USA; Korea Ocean Res & Dev Inst, MArine Environm Res Dept, Seoul 425600, South Korea	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Hawaii System; University of Hawaii Manoa; University of California System; University of California Santa Barbara; University of California System; University of California San Diego; Scripps Institution of Oceanography; Bae Systems; University of Hawaii System; NERC National Oceanography Centre; University of Southampton; Rutgers State University New Brunswick; University System of Georgia; University of Georgia; University of California System; University of California Santa Barbara; Soka University; University of Washington; University of Washington Seattle; Korea Institute of Ocean Science & Technology (KIOST)	Benitez-Nelson, CR (corresponding author), Univ S Carolina, Dept Geol Sci & Marine Sci, Columbia, SC 29208 USA.	cbnelson@geol.sc.edu	Cai, Wei-Jun/C-1361-2013; Bibby, Thomas/C-9159-2014; Maiti, Kanchan/E-1936-2013	Cai, Wei-Jun/0000-0003-3606-8325; Becker, Jamie/0000-0003-4564-3192; Becker, Jamie/0000-0001-5308-1818; Selph, Karen/0000-0001-7281-4706; Bibby, Thomas/0000-0003-1743-473X; Yang, Eun Jin/0000-0002-8639-5968; Nencioli, Francesco/0000-0001-6107-2479; Kuwahara, Victor S./0000-0003-4171-3894; Benitez-Nelson, Claudia/0000-0002-1004-5048				Benitez-Nelson C, 2001, DEEP-SEA RES PT I, V48, P2595, DOI 10.1016/S0967-0637(01)00032-2; Bidigare RR, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016393; Boyd PW, 1999, DEEP-SEA RES PT I, V46, P63, DOI 10.1016/S0967-0637(98)00066-1; Buesseler KO, 1998, GLOBAL BIOGEOCHEM CY, V12, P297, DOI 10.1029/97GB03366; Chavanne C, 2002, CAN J REMOTE SENS, V28, P466, DOI 10.5589/m02-047; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; DELONG EF, 1993, LIMNOL OCEANOGR, V38, P924, DOI 10.4319/lo.1993.38.5.0924; DUGDALE RC, 1995, DEEP-SEA RES PT I, V42, P697, DOI 10.1016/0967-0637(95)00015-X; Emerson S, 1997, NATURE, V389, P951, DOI 10.1038/40111; FALKOWSKI PG, 1991, NATURE, V352, P55, DOI 10.1038/352055a0; Giovannoni S., 2000, P47; JURANEK IW, 2005, GLOBAL BIOGEOCHEM CY, V19; Landry MR, 2000, MAR ECOL PROG SER, V201, P57, DOI 10.3354/meps201057; Laws EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1231, DOI 10.1029/1999GB001229; McGillicuddy DJ, 1998, NATURE, V394, P263, DOI 10.1038/28367; MICHAELS AF, 1988, DEEP-SEA RES, V35, P473, DOI 10.1016/0198-0149(88)90126-4; MOREL A, 1988, J GEOPHYS RES-OCEANS, V93, P10749, DOI 10.1029/JC093iC09p10749; Nelson DM, 1997, LIMNOL OCEANOGR, V42, P473, DOI 10.4319/lo.1997.42.3.0473; Oschlies A, 2001, DEEP-SEA RES PT II, V48, P2173, DOI 10.1016/S0967-0645(00)00184-3; Patzert W. C, 1969, HIG698 U HAW; Ragueneau O, 2002, DEEP-SEA RES PT II, V49, P3127, DOI 10.1016/S0967-0645(02)00075-9; Reichenbach H., 1992, PROKARYOTES, P3631; SAKAMOTO C, 2004, J GEOPHYS RES, V109; Scharek R, 1999, DEEP-SEA RES PT I, V46, P1051, DOI 10.1016/S0967-0637(98)00102-2; Seki MP, 2001, GEOPHYS RES LETT, V28, P1583, DOI 10.1029/2000GL012439; Vaillancourt RD, 2003, DEEP-SEA RES PT I, V50, P829, DOI 10.1016/S0967-0637(03)00059-1	27	201	210	3	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					1017	1021		10.1126/science.1136221	http://dx.doi.org/10.1126/science.1136221			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17510362				2022-12-01	WOS:000246554000044
J	Elbaum, R; Zaltzman, L; Burgert, I; Fratzl, P				Elbaum, Rivka; Zaltzman, Liron; Burgert, Ingo; Fratzl, Peter			The role of wheat awns in the seed dispersal unit	SCIENCE			English	Article							BIOLOGICAL SIGNIFICANCE; DIASPORE MORPHOLOGY; GRASSES; CELLULOSE; STRAW; WOOD	The dispersal unit of wild wheat bears two pronounced awns that balance the unit as it falls. We discovered that the awns are also able to propel the seeds on and into the ground. The arrangement of cellulose fibrils causes bending of the awns with changes in humidity. Silicified hairs that cover the awns allow propulsion of the unit only in the direction of the seeds. This suggests that the dead tissue is analogous to a motor. Fueled by the daily humidity cycle, the awns induce the motility required for seed dispersal.	Max Planck Inst Colloids & Interfaces, Biomat Dept, Golm, Germany; Tel Hai Acad Coll, Dept Biotechnol, Upper Galilee, Israel	Max Planck Society; Tel Hai Academy College	Elbaum, R (corresponding author), Max Planck Inst Colloids & Interfaces, Biomat Dept, Golm, Germany.	elbaum@mpikg.mpg.de; fratzl@mpikg.mpg.de	Elbaum, Rivka/AAR-3482-2020; Fratzl, Peter/H-9095-2012	Fratzl, Peter/0000-0003-4437-7830				CAVE ID, 1969, WOOD SCI TECHNOL, V3, P40, DOI 10.1007/BF00349983; CHAMBERS JC, 1991, ECOLOGY, V72, P1668, DOI 10.2307/1940966; CHAMBERS JC, 1994, ANNU REV ECOL SYST, V25, P263, DOI 10.1146/annurev.es.25.110194.001403; Dawson J, 1997, NATURE, V390, P668, DOI 10.1038/37745; GRUNDBACHER FJ, 1963, BOT REV, V29, P366, DOI 10.1007/BF02860824; HARPER J. L., 1970, Annual review of ecology and systematics., V1, P327, DOI 10.1146/annurev.es.01.110170.001551; Keckes J, 2003, NAT MATER, V2, P810, DOI 10.1038/nmat1019; Liu RG, 2005, CELLULOSE, V12, P25, DOI 10.1023/B:CELL.0000049346.28276.95; ODOGHERTY MJ, 1995, J AGR ENG RES, V62, P133, DOI 10.1006/jaer.1995.1072; PEART MH, 1987, J ECOL, V75, P569, DOI 10.2307/2260435; PEART MH, 1979, J ECOL, V67, P843, DOI 10.2307/2259218; PEART MH, 1981, J ECOL, V69, P425, DOI 10.2307/2259677; PEART MH, 1984, J ECOL, V72, P437, DOI 10.2307/2260057; Reiterer A, 1999, PHILOS MAG A, V79, P2173, DOI 10.1080/01418619908210415; Sidorenko A, 2007, SCIENCE, V315, P487, DOI 10.1126/science.1135516; STAMP NE, 1989, AM J BOT, V76, P555, DOI 10.2307/2444350; van der Pijl L, 1982, PRINCIPLES DISPERSAL, DOI DOI 10.1007/978-3-642-87925-8_5; WITZTUM A, 1995, J THEOR BIOL, V176, P531, DOI 10.1006/jtbi.1995.0219; ZOHARY MICHAEL, 1937, BEIH BOT CENTRALBL ABT A, V56, P1	19	412	424	11	251	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2007	316	5826					884	886		10.1126/science.1140097	http://dx.doi.org/10.1126/science.1140097			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17495170				2022-12-01	WOS:000246369800036
J	Aelony, Y				Aelony, Yossef			Talc pleurodesis and acute respiratory distress syndrome	LANCET			English	Editorial Material							MALIGNANT PLEURAL EFFUSION; POUDRAGE; SLURRY		Harbor UCLA Med Ctr, Torrance, CA 90502 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Aelony, Y (corresponding author), Harbor UCLA Med Ctr, Torrance, CA 90502 USA.	y.aelony@cox.net						Aelony Y, 2004, AM J RESP CRIT CARE, V169, P1075; Aelony Y, 1998, CHEST, V113, P1007, DOI 10.1378/chest.113.4.1007; AELONY Y, 2002, CHEST, V165, pA35; BOUTIN C, 1991, PRACTICAL THORACOSCO, P68; Dresler CM, 2005, CHEST, V127, P909, DOI 10.1378/chest.127.3.909; Ferrer J, 2001, CHEST, V119, P1901, DOI 10.1378/chest.119.6.1901; Janssen JP, 2007, LANCET, V369, P1535, DOI 10.1016/S0140-6736(07)60708-9; Manes Nuria, 2000, Chest, V118, p131S; Montes JF, 2003, AM J RESP CRIT CARE, V168, P348, DOI 10.1164/rccm.200207-767OC; Rehse DH, 1999, AM J SURG, V177, P437, DOI 10.1016/S0002-9610(99)00075-6; RINALDO JE, 1983, J THORAC CARDIOV SUR, V85, P523; SANCHEZARMENGOL A, 1993, CHEST, V104, P1482, DOI 10.1378/chest.104.5.1482; Tremblay A, 2006, CHEST, V129, P362, DOI 10.1378/chest.129.2.362; Viallat JR, 1996, CHEST, V110, P1387, DOI 10.1378/chest.110.6.1387; Yim APC, 1996, ANN THORAC SURG, V62, P1655, DOI 10.1016/S0003-4975(96)00808-9	15	11	11	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2007	369	9572					1494	1496		10.1016/S0140-6736(07)60685-0	http://dx.doi.org/10.1016/S0140-6736(07)60685-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164EI	17482965				2022-12-01	WOS:000246215800005
J	Nugent, FS; Penick, EC; Kauer, JA				Nugent, Fereshteh S.; Penick, Esther C.; Kauer, Julie A.			Opioids block long-term potentiation of inhibitory synapses	NATURE			English	Article							VENTRAL TEGMENTAL AREA; GAMMA-VINYL-GABA; DOPAMINE NEURONS; NITRIC-OXIDE; SYNAPTIC-TRANSMISSION; SINGLE EXPOSURE; COCAINE; MORPHINE; RELEASE; LTP	Excitatory brain synapses are strengthened or weakened in response to specific patterns of synaptic activation, and these changes in synaptic strength are thought to underlie persistent pathologies such as drug addiction, as well as learning(1). In contrast, there are few examples of synaptic plasticity of inhibitory GABA (gamma-aminobutyric acid)-releasing synapses. Here we report long-term potentiation of GABA(A)-mediated synaptic transmission (LTPGABA) onto dopamine neurons of the rat brain ventral tegmental area, a region required for the development of drug addiction. This novel form of LTP is heterosynaptic, requiring postsynaptic NMDA (N-methyl-D-aspartate) receptor activation at glutamate synapses, but resulting from increased GABA release at neighbouring inhibitory nerve terminals. NMDA receptor activation produces nitric oxide, a retrograde signal released from the postsynaptic dopamine neuron. Nitric oxide initiates LTPGABA by activating guanylate cyclase in GABA-releasing nerve terminals. Exposure to morphine both in vitro and in vivo prevents LTPGABA. Whereas brief treatment with morphine in vitro blocks LTPGABA by inhibiting presynaptic glutamate release, in vivo exposure to morphine persistently interrupts signalling from nitric oxide to guanylate cyclase. These neuroadaptations to opioid drugs might contribute to early stages of addiction, and may potentially be exploited therapeutically using drugs targeting GABA(A) receptors.	Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA	Brown University	Kauer, JA (corresponding author), Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.	Julie_Kauer@brown.edu		Nugent, Fereshteh/0000-0002-8840-6923; Kauer, Julie/0000-0002-3362-1642	NATIONAL INSTITUTE ON DRUG ABUSE [F32DA021973] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; Barrett AC, 2005, J PHARMACOL EXP THER, V315, P858, DOI 10.1124/jpet.105.086033; Bonci A, 1996, NEURON, V16, P631, DOI 10.1016/S0896-6273(00)80082-3; Brenman JE, 1997, CURR OPIN NEUROBIOL, V7, P374, DOI 10.1016/S0959-4388(97)80065-7; Brodie JD, 2003, SYNAPSE, V50, P261, DOI 10.1002/syn.10278; Carlezon WA, 1997, SCIENCE, V277, P812, DOI 10.1126/science.277.5327.812; Faleiro LJ, 2004, NEUROPSYCHOPHARMACOL, V29, P2115, DOI 10.1038/sj.npp.1300495; JOHNSON SW, 1992, J NEUROSCI, V12, P483; Klejbor I, 2004, FOLIA HISTOCHEM CYTO, V42, P83; Komatsu Y, 1996, J NEUROSCI, V16, P6342; Li DP, 2002, J NEUROPHYSIOL, V88, P2664, DOI 10.1152/jn.00540.2002; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Margolis EB, 2006, P NATL ACAD SCI USA, V103, P2938, DOI 10.1073/pnas.0511159103; Melis M, 2002, J NEUROSCI, V22, P2074, DOI 10.1523/JNEUROSCI.22-06-02074.2002; Ouardouz M, 2000, J NEUROPHYSIOL, V84, P1414, DOI 10.1152/jn.2000.84.3.1414; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Safo PK, 2006, CEREBELLUM, V5, P134, DOI 10.1080/14734220600791477; Schulteis G, 1997, PSYCHOPHARMACOLOGY, V129, P56, DOI 10.1007/s002130050162; Shew T, 2000, J NEUROPHYSIOL, V83, P3388, DOI 10.1152/jn.2000.83.6.3388; Shoji Y, 1999, J NEUROSCI, V19, P2347; Stern JE, 2001, AM J PHYSIOL-REG I, V280, pR1815, DOI 10.1152/ajpregu.2001.280.6.R1815; Stromberg MF, 2001, PHARMACOL BIOCHEM BE, V68, P291, DOI 10.1016/S0091-3057(00)00456-1; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Vanderschuren LJMJ, 2001, EUR J NEUROSCI, V14, P1533, DOI 10.1046/j.0953-816x.2001.01775.x; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; YIM CY, 1980, BRAIN RES, V181, P301; Yu D, 2005, J COMP NEUROL, V483, P278, DOI 10.1002/cne.20416; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	30	232	238	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2007	446	7139					1086	1090		10.1038/nature05726	http://dx.doi.org/10.1038/nature05726			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17460674				2022-12-01	WOS:000245950400051
J	Fine, PEM; Griffiths, UK				Fine, Paul E. M.; Griffiths, Ulla Kou			Global poliomyelitis eradication: status and implications	LANCET			English	Editorial Material									Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Fine, PEM (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	Paul.fine@lshtm.ac.uk						Arita I, 2006, SCIENCE, V312, P852, DOI 10.1126/science.1124959; Dowdle W, 2006, RISK ANAL, V26, P1449, DOI 10.1111/j.1539-6924.2006.00844.x; Fine P E, 2001, Dev Biol (Basel), V105, P129; Fine PEM, 1999, AM J EPIDEMIOL, V150, P1001, DOI 10.1093/oxfordjournals.aje.a009924; *GAVI, 2006, GAVI ROADM; GRASSLY NC, 2007, LANCET; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; MacLennan C, 2004, LANCET, V363, P1509, DOI 10.1016/S0140-6736(04)16150-3; Thomsen C, 2001, ANN PHYS-BERLIN, V10, P7; WHO, 2006, WKLY EPIDEMIOL REC, V81, P453; WHO, 2006, WKLY EPIDEMIOL REC, V81, P465	12	15	15	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2007	369	9570					1321	1322		10.1016/S0140-6736(07)60533-9	http://dx.doi.org/10.1016/S0140-6736(07)60533-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	159HL	17448799				2022-12-01	WOS:000245856100004
J	Strandberg, TE; Pitkala, KH				Strandberg, Timo E.; Pitkala, Kaisu H.			Frailty in elderly people	LANCET			English	Editorial Material							OLDER-ADULTS; CATABOLISM; HEALTH		Univ Oulu, FIN-90014 Oulu, Finland; Univ Helsinki, Helsinki, Finland	University of Oulu; University of Helsinki	Strandberg, TE (corresponding author), Univ Oulu, FIN-90014 Oulu, Finland.	timo.strandberg@oulu.fi		young, john/0000-0003-4085-9306; Clegg, Andrew/0000-0001-5972-1097; Iliffe, Stephen/0000-0003-2806-3997; Pitkala, Kaisu/0000-0001-9659-6985	The Dunhill Medical Trust [RCP/DMT 2ND ROUND (2)] Funding Source: Medline	The Dunhill Medical Trust(Dunhill Medical Trust)		Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262; Boockvar KS, 2006, JAMA-J AM MED ASSOC, V296, P2245, DOI 10.1001/jama.296.18.2245; Drachman DA, 2006, NEUROLOGY, V67, P1340, DOI 10.1212/01.wnl.0000240127.89601.83; Ferrucci L, 2002, J Endocrinol Invest, V25, P10; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Morley JE, 2006, MED CLIN N AM, V90, P837, DOI 10.1016/j.mcna.2006.05.019; Newman AB, 2001, J GERONTOL A-BIOL, V56, pM158, DOI 10.1093/gerona/56.3.M158; Omwancha J, 2006, CURR OPIN INVEST DR, V7, P873; Ozaki A, 2007, J AM GERIATR SOC, V55, P95, DOI 10.1111/j.1532-5415.2006.01019.x; Purser JL, 2006, J AM GERIATR SOC, V54, P1674, DOI 10.1111/j.1532-5415.2006.00914.x; Roubenoff R, 2003, CURR OPIN CLIN NUTR, V6, P295, DOI 10.1097/01.mco.0000068965.34812.62; Sanders PM, 2005, BRIT J CANCER, V93, P425, DOI 10.1038/sj.bjc.6602725; Sullivan DH, 2007, J AM GERIATR SOC, V55, P20, DOI 10.1111/j.1532-5415.2006.01010.x	14	1174	1254	5	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2007	369	9570					1328	1329		10.1016/S0140-6736(07)60613-8	http://dx.doi.org/10.1016/S0140-6736(07)60613-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	159HL	17448804				2022-12-01	WOS:000245856100009
